PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Thompson, R; Adams, H; Odoi, A; Kennedy, M				Thompson, Riley; Adams, Hayley; Odoi, Agricola; Kennedy, Melissa			Seroprevalence of viral and vector-borne bacterial pathogens in domestic dogs (Canis familiaris) in northern Botswana	PLOS ONE			English	Article							LYCAON-PICTUS; DIROFILARIA-IMMITIS; DISTEMPER VIRUS; EHRLICHIA-CANIS; WILD; DISEASE; INFECTIONS; AGENT; TICKS	Background Domestic dogs (Canis familiaris) have the potential to act as disease reservoirs for wildlife and are important sentinels for common circulating pathogens. Therefore, the infectious disease seroprevalence among domestic dogs in northern Botswana may be indicative of pathogen exposure of various wildlife species. The objective of this study was to assess the seroprevalence of Ehrlichia spp., Borrelia burgdorferi, Anaplasma spp., Dirofilaria immitis, canine adenovirus, canine parvovirus, and canine distemper virus in domestic dogs as proxies of disease prevalence in the local wildlife in the Okavango Delta region of Botswana. Statistical analysis assessed crude and factor-specific seroprevalence proportions in relation to age, sex, and geographical location as predictors of seropositivity. Logistic regression was used to identify adjusted predictors of seropositivity for each of the pathogens of interest. Results Samples from 233 dogs in a total of seven locations in Maun, Botswana, and surrounding villages were collected and serologically analyzed. No dogs were seropositive for B. burgdorferi, while low seroprevalence proportions were observed for Anaplasma spp. (2.2%) and D. immitis (0.9%). Higher seroprevalence proportions were observed for the tick-borne pathogen Ehrlichia spp. (21.0%), and 19.7% were seropositive for canine adenovirus (hepatitis). The highest seroprevalence proportions were for canine parvovirus (70.0%) and canine distemper virus (44.8%). The predictors of seropositivity revealed that adults were more likely to be seropositive for canine adenovirus, canine distemper virus, and canine parvovirus than juveniles, and location was a risk factor for canine adenovirus, canine distemper virus, canine parvovirus, and Ehrlichia spp. Conclusions Results indicate that increasing tick control and vaccination campaigns for domestic dogs may improve the health of domestic animals, and potentially wildlife and humans in the Okavango Delta since viral and vector-borne bacterial pathogens can be transmitted between them.	[Thompson, Riley] Univ Tennessee, Coll Vet Med, Dept Large Anim Clin Sci, Knoxville, TN USA; [Adams, Hayley] Silent Heroes Fdn, St Simon Isl, GA USA; [Odoi, Agricola; Kennedy, Melissa] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, POB 1071, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kennedy, M (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, POB 1071, Knoxville, TN 37996 USA.	mkenned2@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737; Thompson, Riley/0000-0003-1592-1307	Morris Animal Foundation Veterinary Student Scholars [D16CA-605]	Morris Animal Foundation Veterinary Student Scholars	Funded by MAK. Grant #D16CA-605. Morris Animal Foundation Veterinary Student Scholars. https://www.morrisanimalfoundation.org/sites/default/files/filesync/VSS-Guidelines.pdf.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426; Bacon R., 2008, SURVEILLANCE LYME DI; Buller RS, 1999, NEW ENGL J MED, V341, P148, DOI 10.1056/NEJM199907153410303; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Cleaveland S, 2006, VET MICROBIOL, V117, P43, DOI 10.1016/j.vetmic.2006.04.009; CONRAD ME, 1989, AM J MED SCI, V297, P35, DOI 10.1097/00000441-198901000-00008; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Day MJ, 2011, PARASITE VECTOR, V4, DOI [10.1186/1756-3305-4-49, 10.1186/1756-3305-4-48]; De Ybanez MRR, 2006, VET REC, V158, P240, DOI 10.1136/vr.158.7.240; Decaro N, 2008, VET CLIN N AM-SMALL, V38, P799, DOI 10.1016/j.cvsm.2008.02.006; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P199; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Eygelaar D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0627-y; Goddard A, 2010, VET CLIN N AM-SMALL, V40, P1041, DOI 10.1016/j.cvsm.2010.07.007; GRIEVE RB, 1983, EPIDEMIOL REV, V5, P220, DOI 10.1093/oxfordjournals.epirev.a036260; GROVES MG, 1975, AM J VET RES, V36, P937; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; IUCN, 2019, IUCN RED LIST THREAT; JOHNSON RC, 1984, INT J SYST BACTERIOL, V34, P496, DOI 10.1099/00207713-34-4-496; Laurenson K, 1997, ONDERSTEPOORT J VET, V64, P313; McRee A, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1110; Mmopelwa G, 2006, S AFR J ECON MANAG S, V9, P113; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; van de Bildt MWG, 2002, EMERG INFECT DIS, V8, P211; Williams BM, 2014, PARASITOL RES, V113, P911, DOI 10.1007/s00436-013-3722-7; Woodroffe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030099	30	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0220593	10.1371/journal.pone.0220593	http://dx.doi.org/10.1371/journal.pone.0220593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914123	Green Submitted, Green Published, gold			2022-12-26	WOS:000534337700001
J	Helm, ET; Curry, SM; De Mille, CM; Schweer, WP; Burrough, ER; Gabler, NK				Helm, Emma T.; Curry, Shelby M.; De Mille, Carson M.; Schweer, Wesley P.; Burrough, Eric R.; Gabler, Nicholas K.			Impact of viral disease hypophagia on pig jejunal function and integrity	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; EPIDEMIC DIARRHEA VIRUS; INTESTINAL INTEGRITY; GROWTH-PERFORMANCE; BARRIER FUNCTION; WEANED PIGS; HEAT-STRESS; GUT HEALTH; CELL; CHALLENGE	Pathogen challenges are often accompanied by reductions in feed intake, making it difficult to differentiate impacts of reduced feed intake from impacts of pathogen on various response parameters. Therefore, the objective of this study was to determine the impact of Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and feed intake on parameters of jejunal function and integrity in growing pigs. Twenty-four pigs (11.34 +/- 1.54 kg BW) were randomly selected and allotted to 1 of 3 treatments (n = 8 pigs/treatment): 1) PRRSV naive, ad libitum fed (Ad), 2) PRRSV-inoculated, ad libitum fed (PRRS+), and 3) PRRSV naive, pair-fed to the PRRS+ pigs' daily feed intake (PF). At 17 days post inoculation, all pigs were euthanized and the jejunum was collected for analysis. At days post inoculation 17, PRRS+ and PF pigs had decreased (P < 0.05) transepithelial resistance compared with Ad pigs; whereas fluorescein isothiocyanate-dextran 4 kDa permeability was not different among treatments. Active glucose transport was increased (P < 0.05) in PRRS+ and PF pigs compared with Ad pigs. Brush border carbohydrase activity was reduced in PRRS+ pigs compared with PF pigs for lactase (55%; P = 0.015), sucrase (37%; P = 0.002), and maltase (30%; P = 0.015). For all three carbohydrases, Ad pigs had activities intermediate that of PRRS+ and PF pigs. The mRNA abundance of the tight junction proteins claudin 2, claudin 3, claudin 4, occludin, and zonula occludens-1 were reduced in PRRS+ pigs compared with Ad pigs; however, neither the total protein abundance nor the cellular compartmentalization of these tight junction proteins differed among treatments. Taken together, this study demonstrates that the changes that occur to intestinal epithelium structure, function, and integrity during a systemic PRRSV challenge can be partially explained by reductions in feed intake. Further, long term adaptation to PRRSV challenge and caloric restriction does reduce intestinal transepithelial resistance but does not appear to reduce the integrity of tight junction protein complexes.	[Helm, Emma T.; Curry, Shelby M.; De Mille, Carson M.; Schweer, Wesley P.; Gabler, Nicholas K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Burrough, Eric R.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA	Iowa State University; Iowa State University	Gabler, NK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	ngabler@iastate.edu		Helm, Emma/0000-0002-8025-9690; Gabler, Nicholas/0000-0001-7283-4782	Agriculture and Food Research Initiative Competitive Grant [2016-67015-24574]; USDA National Institute of Food and Agriculture National Needs Fellowship program	Agriculture and Food Research Initiative Competitive Grant; USDA National Institute of Food and Agriculture National Needs Fellowship program	Funding for this research was provided by the Agriculture and Food Research Initiative Competitive Grant #2016-67015-24574 (awarded to NKG) and the USDA National Institute of Food and Agriculture National Needs Fellowship program (support of E. T. Helm's graduate studies).	Adamo SA, 2005, ARCH INSECT BIOCHEM, V60, P185, DOI 10.1002/arch.20068; Adewole DI, 2016, ASIAN AUSTRAL J ANIM, V29, P909, DOI 10.5713/ajas.15.0795; Barreau F, 2014, CURR OPIN MICROBIOL, V17, P91, DOI 10.1016/j.mib.2013.12.003; Binder HJ, 2012, MED PHYSL, P949; Boudry G, 2002, J PEDIATR GASTR NUTR, V34, P180, DOI 10.1097/00005176-200202000-00014; Brown DR, 2016, ADV EXP MED BIOL, V874, P79, DOI 10.1007/978-3-319-20215-0_3; BROWN HO, 1963, AM J PHYSIOL, V205, P868, DOI 10.1152/ajplegacy.1963.205.5.868; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Council N.R., 2012, NUTR REQ SWIN; Curry SM, 2017, VET MICROBIOL, V211, P58, DOI 10.1016/j.vetmic.2017.09.021; Curry SM, 2017, J ANIM SCI, V95, P173, DOI 10.2527/jas.2016.1000; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Escobar J, 2006, J ANIM SCI, V84, P2101, DOI 10.2527/jas.2005-616; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Garas LC, 2018, BRIT J NUTR, V120, P1131, DOI 10.1017/S0007114518002507; Garas LC, 2016, FOOD FUNCT, V7, P665, DOI [10.1039/c5fo01217a, 10.1039/C5FO01217A]; Habold C, 2004, SCAND J GASTROENTERO, V39, P531, DOI 10.1080/00365520410004514; Harvald EB, 2017, CELL SYST, V5, P38, DOI 10.1016/j.cels.2017.06.004; Helm ET, 2019, J ANIM SCI, V97, P3213, DOI 10.1093/jas/skz168; Helm ET, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216070; Helm ET, 2019, J ANIM SCI, V97, P2376, DOI 10.1093/jas/skz112; Helm ET, 2018, J ANIM SCI, V96, P3196, DOI 10.1093/jas/sky220; Hou YQ, 2011, BRIT J NUTR, V106, P357, DOI 10.1017/S0007114511000249; Jacobi SK, 2013, WORLD J GASTROENTERO, V19, P5094, DOI 10.3748/wjg.v19.i31.5094; Johnson RW, 2002, VET IMMUNOL IMMUNOP, V87, P443, DOI 10.1016/S0165-2427(02)00069-7; Jung K, 2006, RES VET SCI, V81, P310, DOI 10.1016/j.rvsc.2006.03.005; Jung K, 2017, RES VET SCI, V110, P12, DOI 10.1016/j.rvsc.2016.10.009; Klinge KL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-177; Li QY, 2019, J ANIM SCI, V97, P2139, DOI 10.1093/jas/skz093; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Moeser AJ, 2017, ANIM NUTR, V3, P313, DOI 10.1016/j.aninu.2017.06.003; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nathues H, 2017, PREV VET MED, V142, P16, DOI 10.1016/j.prevetmed.2017.04.006; Nunez MC, 1996, J NUTR, V126, P933, DOI 10.1093/jn/126.4.933; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pearce SC, 2014, J ANIM SCI, V92, P5444, DOI 10.2527/jas.2014-8407; Pearce SC, 2013, J ANIM SCI, V91, P5183, DOI 10.2527/jas.2013-6759; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; PlataSalaman CR, 1996, NUTRITION, V12, P69, DOI 10.1016/S0899-9007(96)90702-9; Rakhshandeh A, 2012, J ANIM SCI, V90, P233, DOI 10.2527/jas.53976; Rochell SJ, 2015, J ANIM SCI, V93, P2987, DOI 10.2527/jas.2014-8462; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; RONCARI G, 1969, INT J PROT RES, V1, P45; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schweer W, 2017, TRANSL ANIM SCI, DOI [10.2527/tas2016.0008, DOI 10.2527/TAS2016.0008]; Schweer WP, 2016, J ANIM SCI, V94, P514, DOI 10.2527/jas.2015-9834; Schweer WP, 2016, J ANIM SCI, V94, P523, DOI 10.2527/jas.2015-9836; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Toepfer-Berg TL, 2004, J ANIM SCI, V82, P1942; UEDA I, 1970, ANAL BIOCHEM, V37, P169, DOI 10.1016/0003-2697(70)90273-3; Ueno PM, 2011, AM J PHYSIOL-GASTR L, V301, pG612, DOI 10.1152/ajpgi.00531.2010; van der Wolf PJ, 2017, J ANIM SCI, V95, P2879, DOI 10.2527/jas.2016.1136; van Goudoever JB, 2000, P NATL ACAD SCI USA, V97, P11620, DOI 10.1073/pnas.200371497; VanItallie CM, 1997, J CELL SCI, V110, P1113; Wiren M, 1999, SCAND J GASTROENTERO, V34, P156, DOI 10.1080/00365529950173014	60	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227265	10.1371/journal.pone.0227265	http://dx.doi.org/10.1371/journal.pone.0227265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910236	Green Published, gold			2022-12-26	WOS:000534333800036
J	Koren, O; Rozner, E; Yosefia, S; Turgeman, Y				Koren, Ofir; Rozner, Ehud; Yosefia, Sawsan; Turgeman, Yoav			Therapeutic hypothermia after out of hospital cardiac arrest improve 1-year survival rate for selective patients	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; TASK-FORCE; REPERFUSION; COMMITTEE; EFFICACY; INJURY	Background Therapeutic Hypothermia (TH) is a standard of care after out-of-hospital cardiac arrest (OHCA). Previous reports failed to prove a significant benefit for survival or neurological outcomes. We examined whether the proper selection of patients would enhance treatment efficacy. Method We conducted a retrospective cohort study. Data was collected from January 2000 and August 2018. Patients were enrolled after OHCA and classified into two groups, patients treated with TH and patients who were not treated with TH. Results A total of 92 patients were included in the study. 57 (63%) patients were in the TH Group and 34 (37%) in the Non-TH group. There was no statistical difference in favorable neurological outcomes between the groups. Patients presenting with ventricular fibrillation had a higher 1-year survival rate from TH, while patients with asystole were found to benefit only if they were younger than 65 years (p < .007, p < .02, respectively). Conclusion Therapeutic Hypothermia patients failed to demonstrate a significant benefit in terms of improved neurological outcomes. Patients treated with TH following ventricular fibrillation experienced the most benefit in terms of 1-year survival, while patients who had suffered from asystole experienced a modest benefit only if they were younger than 65 years of age. Guidelines should address age and primary arrhythmia for proper treatment selection.	[Koren, Ofir; Rozner, Ehud; Turgeman, Yoav] Emek Med Ctr, Heart Inst, Afula, Israel; [Koren, Ofir; Turgeman, Yoav] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel; [Yosefia, Sawsan] Emek Med Ctr, Internal Med C, Afula, Israel	Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Emek Medical Center	Koren, O (corresponding author), Emek Med Ctr, Heart Inst, Afula, Israel.; Koren, O (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel.	Ofirko1@clalit.org.il	Koren, Ofir/GYU-7333-2022; Koren, Ofir/AAZ-8573-2021	Koren, Ofir/0000-0002-8666-8276				Ajam K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-38; BENSON D W, 1959, Anesth Analg, V38, P423; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard S, 2009, CRIT CARE MED, V37, pS227, DOI 10.1097/CCM.0b013e3181aa5d0c; Bhattacharjee S, 2016, J CLIN ANESTH, V33, P225, DOI 10.1016/j.jclinane.2016.03.001; Buxton AE, 2006, CIRCULATION, V114, P2534, DOI 10.1161/CIRCULATIONAHA.106.180199; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; Dunkley S, 2017, NURS CRIT CARE, V22, P150, DOI 10.1111/nicc.12242; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; FELDMAN E, 1960, JAMA-J AM MED ASSOC, V173, P499, DOI 10.1001/jama.1960.03020230025006; Frohlich GM, 2013, CURR CARDIOL REV, V9, P316, DOI 10.2174/1573403X10666140214121152; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hovdenes J, 2007, ACTA ANAESTH SCAND, V51, P137, DOI 10.1111/j.1399-6576.2006.01209.x; Jolly SS, 2011, HEART, V97, P197, DOI 10.1136/hrt.2010.195511; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Merchant RM, 2009, CIRC-CARDIOVASC QUAL, V2, P421, DOI 10.1161/CIRCOUTCOMES.108.839605; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Sanders AB, 2006, CURRENT OPINION CRIT, V12; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Yang HJ, 2015, J KOREAN MED SCI, V30, P95, DOI 10.3346/jkms.2015.30.1.95	35	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226956	10.1371/journal.pone.0226956	http://dx.doi.org/10.1371/journal.pone.0226956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910226	gold, Green Published			2022-12-26	WOS:000534333800021
J	Rossetto, F; Iglesias-Caballero, M; Liedtke, HC; Gomez-Mestre, I; Berciano, JM; Perez-Suarez, G; de Paz, O; Ibanez, C; Echevarria, JE; Casas, I; Juste, J				Rossetto, Federica; Iglesias-Caballero, Maria; Liedtke, H. Christoph; Gomez-Mestre, Ivan; Berciano, Jose M.; Perez-Suarez, Gonzalo; de Paz, Oscar; Ibanez, Carlos; Echevarria, Juan E.; Casas, Inmaculada; Juste, Javier			Mating strategy is determinant of adenovirus prevalence in European bats	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; HOST; DISEASE; RESERVOIRS; EVOLUTION; VIRUS; TRANSMISSION; INFECTION; PACKAGE; ILLNESS	Adenoviruses are double-strained DNA viruses found in a great number of vertebrates, including humans. In order to understand their transmission dynamics, it is crucial, even from a human health perspective, to investigate how host traits influence their prevalence. Bats are important reservoirs for adenoviruses, and here we use the results of recent screenings in Western Europe to evaluate the association between characteristic traits of bat species and their probability of hosting adenoviruses, taking into account their phylogenetic relationships. Across species, we found an important phylogenetic component in the presence of adenoviruses and mating strategy as the most determinant factor conditioning the prevalence of adenoviruses across bat species. Contrary to other more stable mating strategies (e.g. harems), swarming could hinder transmission of adenoviruses since this strategy implies that contacts between individuals are too short. Alternatively, bat species with more promiscuous behavior may develop a stronger immune system. Outstandingly high prevalence of adenoviruses was reported for the Iberian species Pipistrellus pygmaeus, P. kuhlii and Nyctalus lasiopterus and we found that in the latter, males were more likely to be infected by adenoviruses than females, due to the immunosuppressing consequence of testosterone during the mating season. As a general trend across species, we found that the number of adenoviruses positive individuals was different across localities and that the difference in prevalence between populations was correlated with their geographic distances for two of the three studied bat species (P. pygmaeus and P.kuhlii). These results increase our knowledge about the transmission mechanisms of adenoviruses.	[Rossetto, Federica; Liedtke, H. Christoph; Gomez-Mestre, Ivan; Ibanez, Carlos; Juste, Javier] CSIC, Estn Biol Donana, Evolutionary Biol Unit, Seville, Spain; [Iglesias-Caballero, Maria; Berciano, Jose M.; Echevarria, Juan E.; Casas, Inmaculada] ISCIII, Natl Ctr Microbiol, Madrid, Spain; [Perez-Suarez, Gonzalo; de Paz, Oscar] Univ Alcala, Dept Life Sci, Madrid, Spain; [Echevarria, Juan E.; Juste, Javier] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Rossetto, F (corresponding author), CSIC, Estn Biol Donana, Evolutionary Biol Unit, Seville, Spain.	federica.rossetto1991@gmail.com	Ibanez, Carlos/H-7577-2015; Casas, Inmaculada/H-9442-2015; Echevarria, Juan E./F-7913-2016; Liedtke, H. Christoph/K-2253-2015; Juste, Javier/B-9253-2013; Gomez-Mestre, Ivan/F-8226-2014	Ibanez, Carlos/0000-0003-1181-7641; Casas, Inmaculada/0000-0003-1840-1198; Echevarria, Juan E./0000-0001-7522-850X; Liedtke, H. Christoph/0000-0002-6221-8043; Juste, Javier/0000-0003-1383-8462; Paz Garcia-Guerrero, Oscar de/0000-0003-0005-6760; Rossetto, Federica/0000-0001-7479-063X; Gomez-Mestre, Ivan/0000-0003-0094-8195	 [SAF2006-12784-C02/01-02];  [SAF2009-09172];  [SAF2013-47194-P];  [SAF2017-89355-P];  [PI15CIII/00028]	; ; ; ; 	This work received support from: grant number: SAF2006-12784-C02/01-02 to JE, JJ, IC; URLs to sponsors' websites: http://www.ciencia.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid= beebec05f2a7d210VgnVCM1000001d04140aR CRD; grant numbers: SAF2009-09172 to JE, JJ; URLs to sponsors' websites: http://www.ciencia.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/vgnextoid= fe5aec1eb658c310VgnVCM1000001d04140aR CRD; grant numbers: SAF2013-47194-P to JE, JJ, GP, OP; URLs to sponsors' websites: http://www.ciencia.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid= 0b7f11a1c35d0610VgnVCM1000001d04140aR CRD; grant numbers: SAF2017-89355-P to JE, JJ, GP, OP, JB; URLs to sponsors' websites: http://www.ciencia.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid= abf192b9036c2210VgnVCM1000001d04140aR CRD; grant numbers: PI15CIII/00028 to IC, MMIC; URLs to sponsors' websites: http://www.ciencia.gob.es/portal/site/MICINN.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Baker KS, 2014, J ANIM ECOL, V83, P415, DOI 10.1111/1365-2656.12153; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D., 2007, R PACKAGE VERSION, P74, DOI DOI 10.18637/JSS.V067.I01; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BRANDT CD, 1969, AM J EPIDEMIOL, V90, P484, DOI 10.1093/oxfordjournals.aje.a121094; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Calvo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132162; Casas I, 2005, J CLIN MICROBIOL, V43, P6176, DOI 10.1128/JCM.43.12.6176-6182.2005; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Dietrich M, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180041; Dietz C., 2009, BATS BRITAIN EUROPE; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gervasi SS, 2015, TRENDS PARASITOL, V31, P419, DOI 10.1016/j.pt.2015.05.002; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guillen-Servent A, 2003, PHYLOGENY BIOGEOGRAP; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Ibanez C, 2006, IBERIAN CONTRIBUTION; Iglesias-Caballero M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080443; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Kanuch P, 2007, RAPID PCR BASED TEST; Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kunz T.H., 1982, P1; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lipson C, 1973, STAT DESIGN ANAL ENG; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Maeda K, 2008, EMERG INFECT DIS, V14, P347, DOI 10.3201/eid1402.070932; MANTEL N, 1967, CANCER RES, V27, P209; MARCHAIS G, 2018, ACTION PLAN CONSERVA; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Orme D., 2013, CAPER PACKAGE COMP A, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Pica N, 2012, CURR OPIN VIROL, V2, P90, DOI 10.1016/j.coviro.2011.12.003; Podgorski II, 2018, ACTA VET HUNG, V66, P474, DOI 10.1556/004.2018.042; Pozo F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169153; R Core Team, 2021, R LANGUAGE ENV STAT; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Sandrock C, 2008, CHEST, V133, P1221, DOI 10.1378/chest.07-0778; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Stadelmann B, 2004, PHYLOGENY AFRICAN MY; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Symonds M. R. E., 2014, MODERN PHYLOGENETIC, P105, DOI DOI 10.1007/978-3-662-43550-2_5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Tsagkogeorga G, 2013, CURR BIOL, V23, P2262, DOI 10.1016/j.cub.2013.09.014; VanderWaal KL, 2016, FUNCT ECOL, V30, P1606, DOI 10.1111/1365-2435.12645; Vidovszky MZ, 2015, ACTA VET HUNG, V63, P508, DOI 10.1556/004.2015.047; Webber QMR, 2017, ECOHEALTH, V14, P652, DOI 10.1007/s10393-017-1276-3	77	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226203	10.1371/journal.pone.0226203	http://dx.doi.org/10.1371/journal.pone.0226203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910439	Green Published, Green Submitted, gold			2022-12-26	WOS:000534333800010
J	Fujii, Y; Matsumura, H; Yamazaki, S; Shirasu, A; Nakakura, H; Ogihara, T; Ashida, A				Fujii, Yuko; Matsumura, Hideki; Yamazaki, Satoshi; Shirasu, Akihiko; Nakakura, Hyogo; Ogihara, Tohru; Ashida, Akira			Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome	PLOS ONE			English	Article							PERMEABILITY TRANSITION; RADICAL SCAVENGER; OXIDATIVE STRESS; PODOCYTE INJURY; CYCLOSPORINE-A; MITO-TEMPO; DYSFUNCTION; SUPEROXIDE; INHIBITION; EDARAVONE	Background Oxidative stress is a major factor responsible for minimal-change nephrotic syndrome (MCNS), which occurs most commonly in children. However, the influence of oxidative stress localized to mitochondria remains unclear. We examined the effect of a mitochondrion-targeting antioxidant, MitoTEMPO, in rats with puromycin aminonucleoside (PAN)induced MCNS to clarify the degree to which mitochondrial oxidative stress affects MCNS. Materials and methods Thirty Wistar rats were divided into three groups: normal saline group (n = 7), PAN group (n = 12), and PAN + MitoTEMPO group (n = 11). Rats in the PAN and PAN + MitoTEMPO groups received PAN on day 1, and those in the PAN + MitoTEMPO group received MitoTEMPO on days 0 to 9. Whole-day urine samples were collected on days 3 and 9, and samples of glomeruli and blood were taken for measurement of lipid peroxidation products. We also estimated the mitochondrial damage score in podocytes in all 3 groups using electron microscopy. Results Urinary protein excretion on day 9 and the levels of lipid peroxidation products in urine, glomeruli, and blood were significantly lower in the PAN+MitoTEMPO group than in the PAN group (p = 0.0019, p = 0.011, p = 0.039, p = 0.030). The mitochondrial damage score in podocytes was significantly lower in the PAN+MitoTEMPO group than in the PAN group (p < 0.0001). Conclusions This mitochondrion-targeting agent was shown to reduce oxidative stress and mitochondrial damage in a MCNS model. A radical scavenger targeting mitochondria could be a promising drug for treatment of MCNS.	[Fujii, Yuko; Matsumura, Hideki; Yamazaki, Satoshi; Ogihara, Tohru; Ashida, Akira] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka, Japan; [Shirasu, Akihiko] Hirakata City Hosp, Dept Pediat, Hirakata, Osaka, Japan; [Nakakura, Hyogo] Arisawa Gen Hosp, Dept Hemodialysis & Apheresis, Hirakata, Osaka, Japan	Osaka Medical College	Ashida, A (corresponding author), Osaka Med Coll, Dept Pediat, Takatsuki, Osaka, Japan.	ped006@osaka-med.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17K10161]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP17K10161. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z; Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Che RC, 2015, PPAR RES, V2015, DOI 10.1155/2015/720383; Cui J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11256; Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dong LF, 2014, PROG MOL BIOL TRANSL, V127, P211, DOI 10.1016/B978-0-12-394625-6.00008-8; Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214; Granata S, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0044-z; Guan N, 2015, NEPHROL DIAL TRANSPL, V30, P957, DOI 10.1093/ndt/gfv015; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Gwinner W, 1997, J AM SOC NEPHROL, V8, P1722; Hasegawa M, 2009, BRAIN RES, V1283, P1, DOI 10.1016/j.brainres.2009.06.016; Holthofer H, 1999, FASEB J, V13, P523, DOI 10.1096/fasebj.13.3.523; Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x; Rocha VCJ, 2016, CANCER CHEMOTH PHARM, V77, P659, DOI 10.1007/s00280-015-2949-7; Kezic A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2950503; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Li XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092003; Lin CH, 2012, KAOHSIUNG J MED SCI, V28, pS53, DOI 10.1016/j.kjms.2012.05.011; Matsumura H, 2006, CLIN NEPHROL, V66, P405; Nakakura H, 2004, PEDIATR NEPHROL, V19, P266, DOI 10.1007/s00467-003-1332-9; Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Papazova DA, 2015, AM J PHYSIOL-RENAL, V308, pF22, DOI 10.1152/ajprenal.00278.2014; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Picone P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/780179; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Sesso A, 2012, ANAT REC, V295, P1647, DOI 10.1002/ar.22553; Shen XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32087; Siemen D, 2013, IUBMB LIFE, V65, P255, DOI 10.1002/iub.1130; Sweetwyne MT, 2017, KIDNEY INT, V91, P1126, DOI 10.1016/j.kint.2016.10.036; SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181; Takayasu Y, 2007, J PHARMACOL SCI, V103, P434, DOI 10.1254/jphs.SC0070014; Vega-Warner V, 2004, KIDNEY INT, V66, P1881, DOI 10.1111/j.1523-1755.2004.00962.x; Zhang ZW, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6859523; Zhu CH, 2011, AM J PATHOL, V178, P2020, DOI 10.1016/j.ajpath.2011.01.029; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	41	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227414	10.1371/journal.pone.0227414	http://dx.doi.org/10.1371/journal.pone.0227414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905213	gold, Green Published			2022-12-26	WOS:000534327700021
J	Konishi, HA; Yoshimura, SH				Konishi, Hide A.; Yoshimura, Shige H.			Interactions between non-structured domains of FG- and non-FG-nucleoporins coordinate the ordered assembly of the nuclear pore complex in mitosis	FASEB JOURNAL			English	Article						intrinsically disordered region; molecular crowding; nuclear pore complex; self-assembly	PHASE-TRANSITIONS; PHOSPHORYLATION; ORGANIZATION; HYDROGEL; PROLINE	In this study, we examined how channel-forming subunits of the nuclear pore complex (NPC) are assembled into a selective channel within a highly structured scaffold ring during postmitotic assembly. We focused on non-structured domains of the scaffold Nups and performed in vitro self-assembled particle assays with those derived from channel-forming FG-Nups. We found that non-structured domains of ELYS and Nup35N interacted with channel-forming FG-Nups to form a self-assembled particle. Sequential addition of FG-Nups into the scaffold particle revealed that ELYS, which initiates postmitotic NPC reassembly, interacts with early assembling FG-Nups (Nups98 and 153) but not middle stage-assembling FG-Nups (Nups58 and 62). Nup35, which assembles between the early and middle stages, facilitated the assembly of Nup62 into the early assembling Nups both in vitro and in vivo. These results demonstrate that ELYS and Nup35 have a role of facilitator in the ordered assembly of channel-forming FG-Nups during mitosis.	[Konishi, Hide A.; Yoshimura, Shige H.] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto, Japan; [Konishi, Hide A.] Rockefeller Univ, Lab Chromosome & Cell Biol, 1230 York Ave, New York, NY 10021 USA	Kyoto University; Rockefeller University	Yoshimura, SH (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Sakyo Ku, Kyoto 6068501, Japan.	yoshimura@lif.kyoto-u.ac.jp	Yoshimura, Shige H./AAF-5463-2019	Yoshimura, Shige H./0000-0001-6033-1301; Konishi, Hide/0000-0001-9529-9321	MEXT | Japan Society for the Promotion of Science (JSPS) [LS076]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: LS076	Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Iwashita K, 2018, INT J BIOL MACROMOL, V120, P10, DOI 10.1016/j.ijbiomac.2018.08.063; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Konishi HA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05959-w; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Linder MI, 2017, DEV CELL, V43, P141, DOI 10.1016/j.devcel.2017.08.020; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Otsuka S, 2018, FEBS LETT, V592, P475, DOI 10.1002/1873-3468.12905; Otsuka S, 2014, METHOD CELL BIOL, V122, P219, DOI 10.1016/B978-0-12-417160-2.00010-2; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Ullman KS, 2015, SCIENCE, V350, P33, DOI 10.1126/science.aad3797; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923	31	3	3	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1532	1545		10.1096/fj.201901669R	http://dx.doi.org/10.1096/fj.201901669R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914646	Green Submitted			2022-12-26	WOS:000507308900101
J	Yang, C; Leitkam, S; Cote, JN				Yang, Chen; Leitkam, Samuel; Cote, Julie N.			Effects of different fatigue locations on upper body kinematics and inter-joint coordination in a repetitive pointing task	PLOS ONE			English	Article							MULTIJOINT MOVEMENT; MUSCULAR FATIGUE; SHOULDER; POSTURE; VARIABILITY; PERFORMANCE; ADAPTATIONS; DISORDERS; SYSTEMS; MOTION	Studies have shown that muscle fatigue can lead to posture, joint angle, inter-joint coordination and variability alterations. However, the three-dimensional kinematic effects of localized muscular fatigue on a multijoint movement remain unclear. Healthy young adults (N = 17, 10 females) performed a standing repetitive pointing task when they were non-fatigued, and after localized muscle fatigue was induced at the elbow, the shoulder, and the trunk using isometric protocols performed until exhaustion. Joint angles and angular standard deviation (SD) of trunk, shoulder and elbow, and continuous relative phase (CRP) and CRP SD between trunk and shoulder, and shoulder and elbow were computed and compared between fatigue conditions. Results showed that trunk lateral flexion SD increased after fatigue of the elbow (0.1 degrees, p = 0.04), shoulder (0.1 degrees, p = 0.04) and trunk (0.1 degrees, p<0.01). However,fatigue at different muscles brought different kinematic changes. Shoulder fatigue induced the greatest overall changes, with angular changes at all three joints. Trunk fatigue increased the shoulder horizontal abduction SD, elbow flexion SD and trunk-shoulder CRP. Elbow fatigue induced angular changes at trunk, shoulder and elbow, but did not affect CRP or CRP SD. This study highlights the crucial role of trunk variability in compensating for localized muscle fatigue during a repetitive upper limb task performed while standing.	[Yang, Chen; Leitkam, Samuel; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Yang, Chen; Leitkam, Samuel; Cote, Julie N.] Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada	McGill University; McGill University	Yang, C (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.; Yang, C (corresponding author), Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada.	chen.yang4@mail.mcgill.ca		Yang, Chen/0000-0002-9945-7435	Bloomberg Manulife Fellowship; Centre for Interdisciplinary Research in Rehabilitation of Great Montreal (CRIR) Doctoral Bursary Program; Canadian MSK Rehab Research Network Trainee Award; Fond de Recherche du Quebec - Sante (FRQS); Natural Sciences and Engineering Council of Canada	Bloomberg Manulife Fellowship; Centre for Interdisciplinary Research in Rehabilitation of Great Montreal (CRIR) Doctoral Bursary Program; Canadian MSK Rehab Research Network Trainee Award; Fond de Recherche du Quebec - Sante (FRQS); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by PhD fellowships from the Bloomberg Manulife Fellowship, Centre for Interdisciplinary Research in Rehabilitation of Great Montreal (CRIR) Doctoral Bursary Program, Canadian MSK Rehab Research Network Trainee Award, Fond de Recherche du Quebec - Sante (FRQS) and operating grants from Natural Sciences and Engineering Council of Canada.	BEELEN A, 1991, J APPL PHYSIOL, V71, P2332, DOI 10.1152/jappl.1991.71.6.2332; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein N, 1967, COORDINATION REGULAT; Bernstein's N., 1967, COORDINATION REGULAT; BIGLANDRITCHIE B, 1983, J NEUROPHYSIOL, V50, P313, DOI 10.1152/jn.1983.50.1.313; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouffard J, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0175-9; Cote JN, 2005, CLIN BIOMECH, V20, P581, DOI 10.1016/j.clinbiomech.2005.02.012; Cote JN, 2002, EXP BRAIN RES, V146, P394, DOI 10.1007/s00221-002-1186-6; Cote JN, 2008, MOTOR CONTROL, V12, P79, DOI 10.1123/mcj.12.2.79; Cowley JC, 2017, HUM MOVEMENT SCI, V56, P109, DOI 10.1016/j.humov.2017.10.015; Cowley JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172835; Davidson BS, 2004, EUR J APPL PHYSIOL, V93, P183, DOI 10.1007/s00421-004-1195-1; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Dounskaia NV, 1998, EXP BRAIN RES, V121, P239, DOI 10.1007/s002210050457; Emery K, 2010, CLIN BIOMECH, V25, P124, DOI 10.1016/j.clinbiomech.2009.10.003; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Fuller JR, 2013, HUM MOVEMENT SCI, V32, P618, DOI 10.1016/j.humov.2013.03.002; Fuller JR, 2011, EXP BRAIN RES, V211, P133, DOI 10.1007/s00221-011-2661-8; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gates DH, 2008, EXP BRAIN RES, V187, P573, DOI 10.1007/s00221-008-1326-8; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hamill J, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-45; Heiderscheit BC, 2002, J APPL BIOMECH, V18, P110, DOI 10.1123/jab.18.2.110; Huffenus AF, 2006, EXP BRAIN RES, V170, P438, DOI 10.1007/s00221-005-0227-3; Lomond KV, 2011, CLIN BIOMECH, V26, P123, DOI 10.1016/j.clinbiomech.2010.09.012; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Naseri P., 2016, J PARAMED SCI, V7, P32; Selen LPJ, 2007, EXP BRAIN RES, V181, P99, DOI 10.1007/s00221-007-0909-0; SOMMERICH CM, 1993, ERGONOMICS, V36, P697, DOI 10.1080/00140139308967931; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Statistics Canada CoC, 2016, CAN COMM HLTH SURV 2; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yang C, 2018, J BIOMECH, V76, P212, DOI 10.1016/j.jbiomech.2018.05.025	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227247	10.1371/journal.pone.0227247	http://dx.doi.org/10.1371/journal.pone.0227247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891644	gold, Green Published			2022-12-26	WOS:000515096600071
J	Kubo, K; Wadasaki, K; Komichi, D; Sasaki, T; Yamada, H; Matsugu, Y; Itamoto, T; Doi, M; Shinozaki, K				Kubo, Katsumaro; Wadasaki, Koichi; Komichi, Daisuke; Sasaki, Tamito; Yamada, Hiroyasu; Matsugu, Yasuhiro; Itamoto, Toshiyuki; Doi, Mihoko; Shinozaki, Katsunori			A single institution experience of the treatment of pancreatic ductal carcinoma: The demand and the role of radiation therapy	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; LONG-TERM OUTCOMES; INDUCTION CHEMOTHERAPY; GEMCITABINE; CANCER; CHEMORADIATION; CHEMORADIOTHERAPY; OXALIPLATIN; FOLFIRINOX; SURVIVAL	We aimed to demonstrate a single institution experience of treatment of pancreatic ductal carcinoma and to identify the role of radiation therapy. We assessed all patients who were diagnosed with pancreatic ductal carcinoma from January 2011 to December 2017. A total of 342 patients were enrolled. Thirteen, 131, 36, and 162 patients had stage I, II, III, and IV disease, respectively (UICC TNM, 7th edition). Among the patients with stages I-III disease, 94 underwent surgery, and the median overall survival (OS) was 33 months. Of patients with stages I-III disease who were not suitable for surgery, 58 patients received chemotherapy, and the median OS was 12 months. Among them, 17 patients received chemoradiotherapy added on chemotherapy and their OS was significantly better than that of patients who received chemotherapy alone. Of patients with stage IV disease, 111 received chemotherapy, and the median OS was 6 months. This study evaluated the demand, role, and outcome of each treatment modality and demonstrated a single institution experience of treatment of pancreatic ductal carcinoma. The demand and role of radiation therapy remained small; however, radiation therapy might have some importance as a local treatment.	[Kubo, Katsumaro] Hiroshima High Precis Radiotherapy Canc Ctr, Dept Radiat Oncol, Hiroshima, Hiroshima, Japan; [Wadasaki, Koichi] Hiroshima Prefectural Hosp, Dept Radiat Oncol, Hiroshima, Hiroshima, Japan; [Komichi, Daisuke; Sasaki, Tamito; Yamada, Hiroyasu] Hiroshima Prefectural Hosp, Dept Gastroenterol, Hiroshima, Hiroshima, Japan; [Matsugu, Yasuhiro; Itamoto, Toshiyuki] Hiroshima Prefectural Hosp, Dept Surg, Hiroshima, Hiroshima, Japan; [Doi, Mihoko; Shinozaki, Katsunori] Hiroshima Prefectural Hosp, Dept Clin Oncol, Hiroshima, Hiroshima, Japan		Kubo, K (corresponding author), Hiroshima High Precis Radiotherapy Canc Ctr, Dept Radiat Oncol, Hiroshima, Hiroshima, Japan.	maro1987@hotmail.co.jp		/0000-0001-9021-3955; Kubo, Katsumaro/0000-0001-5601-8961				Abelson JA, 2012, INT J RADIAT ONCOL, V82, pE595, DOI 10.1016/j.ijrobp.2011.09.035; Arvold ND, 2012, CANCER-AM CANCER SOC, V118, P3026, DOI 10.1002/cncr.26633; Butturini G, 2008, ARCH SURG-CHICAGO, V143, P75, DOI 10.1001/archsurg.2007.17; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; de Geus SWL, 2017, CANCER-AM CANCER SOC, V123, P4158, DOI 10.1002/cncr.30856; Esnaola NF, 2014, INT J RADIAT ONCOL, V88, P837, DOI 10.1016/j.ijrobp.2013.12.030; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Jethwa K R, 2018, RADIAT ONCOL, V3, P314, DOI DOI 10.1016/j.adro.2018.04.003; Katz MHG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3441-z; Katz MHG, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.1137; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Krishnan S, 2016, INT J RADIAT ONCOL, V94, P755, DOI 10.1016/j.ijrobp.2015.12.003; Leone F, 2013, CANCER-AM CANCER SOC, V119, P277, DOI 10.1002/cncr.27736; Mellon EA, 2015, ACTA ONCOL, V54, P979, DOI 10.3109/0284186X.2015.1004367; National Cancer Center Center for Cancer Control and Information Services, LAT CANC STAT 2017; National Comprehensive Cancer Network Inc, 2018, PANCR AD VERS 2; Palta M, PRINCIPLES PRACTICE, P1189; Sen N, 2014, CLIN ONCOL-UK, V26, P551, DOI 10.1016/j.clon.2014.06.003; Tabernero J, 2015, ONCOLOGIST, V20, P143, DOI 10.1634/theoncologist.2014-0394; Yamaguchi K, 2017, PANCREAS, V46, P595, DOI 10.1097/MPA.0000000000000816; Yovino S, 2011, INT J RADIAT ONCOL, V79, P158, DOI 10.1016/j.ijrobp.2009.10.043; Zhu XF, 2019, INT J RADIAT ONCOL, V104, P101, DOI 10.1016/j.ijrobp.2019.01.075	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227305	10.1371/journal.pone.0227305	http://dx.doi.org/10.1371/journal.pone.0227305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887205	Green Published, gold			2022-12-26	WOS:000515092200090
J	Plandowska, M; Lichota, M; Gorniak, K				Plandowska, Magdalena; Lichota, Malgorzata; Gorniak, Krystyna			Postural stability of 5-year-old girls and boys with different body heights	PLOS ONE			English	Article							DEVELOPMENTAL PERSPECTIVE; PHYSICAL-ACTIVITY; BALANCE CONTROL; CHILDREN; SEX; RELIABILITY; SYSTEMS; GENDER; STANCE; AGE	Background Postural stability is one of the determinants of proper body posture and a condition for developing motor abilities in every human being. The measurement of the centre of pressure (COP) location and displacement is the most common technique of postural stability assessment. Objective The aim of this study was to assess differences in postural stability depending on sex of 5-year-old children with different body heights. Methods A study included 435 healthy children (200 girls and 235 boys) born in 2010 whose parents gave a written consent to their participation in the project. Postural stability was assessed with the use of the dynamographic platform (Zebris FDM 1.8). The assessment of postural stability was based on COP shift parameters (sway path length of COP and average velocity of COP) and COP surface area parameters (area of the ellipse, length of ellipse in the anterior-posterior direction and length of the ellipse in the medial-lateral direction). Body height was measured with Holtein anthropometer and the obtained values were compared with percentile ranks determined by the WHO. Results The analysis of the parameters describing postural stability in the examined children revealed dimorphism. For the COP shift parameters and COP surface area parameters, the level of statistical significance was recorded for girls and boys. Girls achieved lower results of these parameters than boys regardless of their body height. In the groups of normal- and tall-statured children, differences between the genders were statistically significant. Conclusions The present study characterised sex differences in postural stability of 5-year-old children. Sex-related differences were found during a natural stance for all COP parameters. Girls maintained a two-legged standing position with lower sway velocity and a smaller range of sway than their male counterparts. Normal- and tall-statured girls demonstrated better postural stability significantly more often than boys.	[Plandowska, Magdalena; Lichota, Malgorzata; Gorniak, Krystyna] Jozef Pilsudski Univ Phys Educ, Fac Phys Educ & Hlth, Warsaw, Poland	Jozef Pilsudski University Physical Education in Warsaw	Plandowska, M (corresponding author), Jozef Pilsudski Univ Phys Educ, Fac Phys Educ & Hlth, Warsaw, Poland.	magdalena.plandowska@awf-bp.edu.pl	Plandowska, Magdalena/GQQ-6887-2022; Plandowska, Magdalena/AAJ-8947-2020; Plandowska, Magdalena/AAX-3776-2021; Lichota, Malgorzata/AAH-1202-2020; gorniak, krystyna/AAB-5128-2021	Plandowska, Magdalena/0000-0002-5011-794X; Plandowska, Magdalena/0000-0002-5011-794X; Plandowska, Magdalena/0000-0002-5011-794X; Lichota, Malgorzata/0000-0003-4848-2179; gorniak, krystyna/0000-0002-3103-9448				Alexander GM, 2012, CHILD DEV PERSPECT, V6, P400, DOI 10.1111/j.1750-8606.2012.00247.x; Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Berger W., 1995, GAIT POSTURE, V3, P149; de Sa CDC, 2018, BRAZ J PHYS THER, V22, P70, DOI 10.1016/j.bjpt.2017.10.006; Clark J.E., 2002, MOTOR DEV RES REV, P163, DOI DOI 10.4081/IJAS.2015.3862; Demura S., 2006, SPORT SCI HLTH, V1, P158, DOI [10.1007/s11332-006-0028-5, DOI 10.1007/S11332-006-0028-5]; Forssberg H, 1999, CURR OPIN NEUROBIOL, V9, P676, DOI 10.1016/S0959-4388(99)00037-9; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; Hay L, 1999, EXP BRAIN RES, V125, P153, DOI 10.1007/s002210050670; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Huxham FE, 2001, AUST J PHYSIOTHER, V47, P89, DOI 10.1016/S0004-9514(14)60300-7; Ivanenko Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00171; Kokstejn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176556; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Livesey D, 2007, CHILD CARE HLTH DEV, V33, P713, DOI 10.1111/j.1365-2214.2007.00733.x; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Massion J, 1998, NEUROSCI BIOBEHAV R, V22, P465, DOI 10.1016/S0149-7634(97)00031-6; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Moein E., 2016, TURKISH J SPORT EXER, V18, P45, DOI 10.15314/tjse.65406; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Plandowska M., 2016, FULFILLING PRESCHOOL; Schedler S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214434; Smith AW, 2012, J HUM KINET, V33, P25, DOI 10.2478/v10078-012-0041-5; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Venetsanou F., 2011, PHYS ED SPORT, P81; Webster EK, 2019, J SPORT HEALTH SCI, V8, P114, DOI 10.1016/j.jshs.2018.11.006; *WHO MULT GROWTH R, 2006, LENGTH HEIGHT FOR AG; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Wojtowicz-Chomicz K, 2017, PSYCHOPHYSICAL STATE; Wolariski N., 2012, BIOL DEV HUMAN FUNDA; World Health Organization, HEIGHT FOR AG 5 19	38	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227119	10.1371/journal.pone.0227119	http://dx.doi.org/10.1371/journal.pone.0227119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887198	gold, Green Published			2022-12-26	WOS:000515092200077
J	Sulser, P; Pickel, C; Gunter, J; Leissing, TM; Crean, D; Schofield, CJ; Wenger, RH; Scholz, CC				Sulser, Pascale; Pickel, Christina; Gunter, Julia; Leissing, Thomas M.; Crean, Daniel; Schofield, Christopher J.; Wenger, Roland H.; Scholz, Carsten C.			HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity	FASEB JOURNAL			English	Article						anemia; hypoxia; 2-oxoglutarate oxygenase inhibitor; prolyl hydroxylase inhibitor; Roxadustat	NF-KAPPA-B; PHARMACOLOGICAL INHIBITION; ASPARAGINYL HYDROXYLASE; HYPOXIA; PROLYL; EXPRESSION; PROTEIN; HIF-1-ALPHA; ACTIVATION; ADAPTATION	Pharmacologic HIF hydroxylase inhibitors (HIs) are effective for the treatment of anemia in chronic kidney disease patients and may also be beneficial for the treatment of diseases such as chronic inflammation and ischemia-reperfusion injury. The selectivities of many HIs for HIF hydroxylases and possible off-target effects in cellulo are unclear, delaying the translation from preclinical studies to clinical trials. We developed a novel assay that discriminates between the inhibition of HIF-alpha prolyl-4-hydroxylase domain (PHD) enzymes and HIF-alpha asparagine hydroxylase factor inhibiting HIF (FIH). We characterized 15 clinical and preclinical HIs, categorizing them into pan-HIF-alpha hydroxylase (broad spectrum), PHD-selective, and FIH-selective inhibitors, and investigated their effects on HIF-dependent transcriptional regulation, erythropoietin production, and cellular energy metabolism. While energy homeostasis was generally maintained following HI treatment, the pan-HIs led to a stronger increase in pericellular pO(2) than the PHD/FIH-selective HIs. Combined knockdown of FIH and PHD-selective inhibition did not further increase pericellular pO(2). Hence, the additional increase in pericellular pO(2) by pan- over PHD-selective HIs likely reflects HIF hydroxylase independent off-target effects. Overall, these analyses demonstrate that HIs can lead to oxygen redistribution within the cellular microenvironment, which should be considered as a possible contributor to HI effects in the treatment of hypoxia-associated diseases.	[Sulser, Pascale; Pickel, Christina; Gunter, Julia; Wenger, Roland H.; Scholz, Carsten C.] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Gunter, Julia; Wenger, Roland H.; Scholz, Carsten C.] Natl Ctr Competence Res Kidney, Zurich, Switzerland; [Leissing, Thomas M.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Crean, Daniel] Univ Coll Dublin, Conway Inst, Sch Vet Med, Dublin, Ireland; [Crean, Daniel] Univ Coll Dublin, Conway Inst, UCI Diabet Complicat Res Ctr, Dublin, Ireland	University of Zurich; University of Oxford; University College Dublin; University College Dublin	Wenger, RH; Scholz, CC (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	roland.wenger@access.uzh.ch; carsten.scholz@uzh.ch	Scholz, Carsten C./P-3185-2019; Wenger, Roland/B-7953-2009	Scholz, Carsten C./0000-0001-6579-8015; Pickel, Christina/0000-0001-7476-2954; Wenger, Roland/0000-0001-7592-4839	SNSF [002031003A_165679]; Forschungskredit of the University of Zurich [FK-15-046]; Junior Grant of the NCCR Kidney.CH; BBSRC [BB/R000344/1] Funding Source: UKRI	SNSF(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; Junior Grant of the NCCR Kidney.CH; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SNSF, Grant/Award Number: 002031003A_165679; Forschungskredit of the University of Zurich, Grant/Award Number: FK-15-046; Junior Grant of the NCCR Kidney.CH, Grant/Award Number: Junior Grant	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Ariazi JL, 2017, J PHARMACOL EXP THER, V363, P336, DOI 10.1124/jpet.117.242503; Barrett TD, 2011, MOL PHARMACOL, V79, P910, DOI 10.1124/mol.110.070508; Beck H, 2018, CHEMMEDCHEM, V13, P988, DOI 10.1002/cmdc.201700783; Bonnici J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0071; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUSTOVETSKY NN, 1993, FEBS LETT, V315, P233, DOI 10.1016/0014-5793(93)81170-5; Chan MC, 2016, J BIOL CHEM, V291, P20661, DOI 10.1074/jbc.M116.749291; Chan MC, 2016, MOL ASPECTS MED, V47-48, P54, DOI 10.1016/j.mam.2016.01.001; Cho EA, 2013, J CELL BIOCHEM, V114, P864, DOI 10.1002/jcb.24423; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cosin-Roger J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00213-3; Crean D, 2015, TOXICOL IN VITRO, V30, P128, DOI 10.1016/j.tiv.2014.11.015; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Debenham JS, 2016, J MED CHEM, V59, P11039, DOI 10.1021/acs.jmedchem.6b01242; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Gutsche K, 2016, FREE RADICAL BIO MED, V101, P129, DOI 10.1016/j.freeradbiomed.2016.10.002; Haase VH, 2017, EXP CELL RES, V356, P160, DOI 10.1016/j.yexcr.2017.05.004; Hampton-Smith RJ, 2009, ANN NY ACAD SCI, V1177, P19, DOI 10.1111/j.1749-6632.2009.05035.x; Imeri F, 2019, KIDNEY INT, V95, P375, DOI 10.1016/j.kint.2018.08.043; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Madsen CD, 2015, EMBO REP, V16, P1394, DOI 10.15252/embr.201540107; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McMurray F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121829; Nolan KA, 2018, CURR OPIN NEPHROL HY, V27, P277, DOI 10.1097/MNH.0000000000000420; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pickel C, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101265; Pickel C, 2018, METHODS MOL BIOL, V1742, P1, DOI 10.1007/978-1-4939-7665-2_1; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Roatsch M, 2019, ACS CHEM BIOL, V14, P1737, DOI 10.1021/acschembio.9b00289; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Schley G, 2012, AM J PATHOL, V181, P1595, DOI 10.1016/j.ajpath.2012.07.010; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Scholz CC, 2013, BIOL CHEM, V394, P479, DOI 10.1515/hsz-2012-0338; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Vogler M, 2015, PFLUG ARCH EUR J PHY, V467, P2141, DOI 10.1007/s00424-014-1667-z; Wang J, 2002, FEBS LETT, V529, P309, DOI 10.1016/S0014-5793(02)03389-6; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger RH, 2015, HYPOXIA, V3, P35, DOI 10.2147/HP.S92198; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhdanov AV, 2015, BBA-BIOENERGETICS, V1847, P1254, DOI 10.1016/j.bbabio.2015.06.016	71	18	18	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2344	2358		10.1096/fj.201902240R	http://dx.doi.org/10.1096/fj.201902240R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908020				2022-12-26	WOS:000503399600001
J	Capell-Hattam, IM; Sharpe, LJ; Qian, L; Hart-Smith, G; Prabhu, AV; Brown, AJ				Capell-Hattam, Isabelle M.; Sharpe, Laura J.; Qian, Lydia; Hart-Smith, Gene; Prabhu, Anika V.; Brown, Andrew J.			Twin enzymes, divergent control: The cholesterogenic enzymes DHCR14 and LBR are differentially regulated transcriptionally and post-translationally	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; endoplasmic reticulum-associated protein degradation (ERAD); protein degradation; enzyme degradation; DHCR14; LBR; TM7SF2	LAMIN-B RECEPTOR; MEIOSIS-ACTIVATING STEROLS; 3-BETA-HYDROXYSTEROL DELTA(14)-REDUCTASE; SQUALENE MONOOXYGENASE; UBIQUITIN LIGASES; REDUCTASE; TM7SF2; DEGRADATION; MUTATIONS; DYSPLASIA	Cholesterol synthesis is a tightly regulated process, both transcriptionally and post-translationally. Transcriptional control of cholesterol synthesis is relatively well-understood. However, of the ?20 enzymes in cholesterol biosynthesis, post-translational regulation has only been examined for a small number. Three of the four sterol reductases in cholesterol production, 7-dehydrocholesterol reductase (DHCR7), 14-dehydrocholesterol reductase (DHCR14), and lamin-B receptor (LBR), share evolutionary ties with a high level of sequence homology and predicted structural homology. DHCR14 and LBR uniquely share the same ?-14 reductase activity in cholesterol biosynthesis, yet little is known about their post-translational regulation. We have previously identified specific modes of post-translational control of DHCR7, but it is unknown whether these regulatory mechanisms are shared by DHCR14 and LBR. Using CHO-7 cells stably expressing epitope-tagged DHCR14 or LBR, we investigated the post-translational regulation of these enzymes. We found that DHCR14 and LBR undergo differential post-translational regulation, with DHCR14 being rapidly turned over, triggered by cholesterol and other sterol intermediates, whereas LBR remained stable. DHCR14 is degraded via the ubiquitin-proteasome system, and we identified several DHCR14 and DHCR7 putative interaction partners, including a number of E3 ligases that modulate DHCR14 levels. Interestingly, we found that gene expression across an array of human tissues showed a negative relationship between the C14-sterol reductases; one enzyme or the other tends to be predominantly expressed in each tissue. Overall, our findings indicate that whereas LBR tends to be the constitutively active C14-sterol reductase, DHCR14 levels are tunable, responding to the local cellular demands for cholesterol.	[Capell-Hattam, Isabelle M.; Sharpe, Laura J.; Qian, Lydia; Hart-Smith, Gene; Prabhu, Anika V.; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Hart-Smith, Gene] Macquarie Univ, Dept Mol Sci, Macquarie Pk, NSW 2109, Australia	University of New South Wales Sydney; Macquarie University	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Hart-Smith, Gene/0000-0003-3907-0367; Prabhu, Anika/0000-0002-3809-1716; Capell-Hattam, Isabelle M/0000-0002-0902-0062; Sharpe, Laura/0000-0002-9896-294X	Australian Research Council [DP170101178]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP170101178 to (A. J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Byskov AG, 1999, J EXP ZOOL, V285, P237, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;237::AID-JEZ6&gt;3.0.CO;2-S; Byskov AG, 1998, J MOL MED-JMM, V76, P818, DOI 10.1007/s001090050286; Chen L, 2019, J LIPID RES, V60, P1765, DOI 10.1194/jlr.RA119000201; Chua NK, 2019, BIOCHEM J, V476, P2545, DOI 10.1042/BCJ20190418; Chua NK, 2019, J BIOL CHEM, V294, P8134, DOI 10.1074/jbc.RA119.007798; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Clayton P, 2010, NUCLEUS-PHILA, V1, P354, DOI 10.4161/nucl.1.4.12435; Cohen TV, 2008, HUM MOL GENET, V17, P2921, DOI 10.1093/hmg/ddn191; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hart-Smith G, 2012, J AM SOC MASS SPECTR, V23, P124, DOI 10.1007/s13361-011-0273-y; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; KIM CK, 1995, BBA-LIPID LIPID MET, V1259, P39, DOI 10.1016/0005-2760(95)00128-Y; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liokatis S, 2012, J BIOL CHEM, V287, P1032, DOI 10.1074/jbc.M111.281303; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Platt FM, 2014, ANNU REV GENOM HUM G, V15, P173, DOI 10.1146/annurev-genom-091212-153412; Prabhu AV, 2017, J STEROID BIOCHEM, V165, P363, DOI 10.1016/j.jsbmb.2016.08.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prakash A, 2002, J BIOSCIENCES, V27, P105, DOI 10.1007/BF02703766; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Scott NA, 2020, BIOCHEM J, V477, P541, DOI 10.1042/BCJ20190647; Sharpe LJ, 2019, J BIOL CHEM, V294, P2436, DOI 10.1074/jbc.RA118.005069; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Smith DL, 2018, ANAL CHEM, V90, P9101, DOI 10.1021/acs.analchem.8b01525; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Tsai PL, 2016, ELIFE, V5, DOI 10.7554/eLife.16011; Wassif CA, 2007, HUM MOL GENET, V16, P1176, DOI 10.1093/hmg/ddm065; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	60	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2850	2865		10.1074/jbc.RA119.011323	http://dx.doi.org/10.1074/jbc.RA119.011323			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31911440	Green Published, hybrid			2022-12-26	WOS:000519969100026
J	Kang, JH; Jung, MY; Choudhury, M; Leof, EB				Kang, Jeong-Han; Jung, Mi-Yeon; Choudhury, Malay; Leof, Edward B.			Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles	FASEB JOURNAL			English	Article						fibroblast; checkpoint inhibitor; extracellular vesicles; signaling	IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; MESENCHYMAL TRANSITION; LUNG FIBROSIS; B7 FAMILY; CELLS; INHIBITION; RECEPTOR; KINASE; ACTIVATION	Transforming growth factor-beta (TGF beta) is an enigmatic protein with various roles in healthy tissue homeostasis/development as well as the development or progression of cancer, wound healing, fibrotic disorders, and immune modulation, to name a few. As TGF beta is causal to various fibroproliferative disorders featuring localized or systemic tissue/organ fibrosis as well as the activated stroma observed in various malignancies, characterizing the pathways and players mediating its action is fundamental. In the current study, we found that TGF beta induces the expression of the immunoinhibitory molecule Programed death-ligand 1 (PD-L1) in human and murine fibroblasts in a Smad2/3- and YAP/TAZ-dependent manner. Furthermore, PD-L1 knockdown decreased the TGF beta-dependent induction of extracellular matrix proteins, including collagen I alpha 1 (colI alpha 1) and alpha-smooth muscle actin (alpha-SMA), and cell migration/wound healing. In addition to an endogenous role for PD-L1 in profibrotic TGF beta signaling, TGF beta stimulated-human lung fibroblast-derived PD-L1 into extracellular vesicles (EVs) capable of inhibiting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cell migration. These findings provide new insights and potential targets for a variety of fibrotic and malignant diseases.	[Kang, Jeong-Han; Jung, Mi-Yeon; Choudhury, Malay; Leof, Edward B.] Mayo Clin Coll Med, Dept Biochem,Div Pulm,Thorac Dis Res Unit, Crit Care Med,Mol Biol, Rochester, MN USA; Mayo Clin Coll Med, 200 Second St, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kang, JH (corresponding author), Mayo Clin Coll Med, Dept Biochem,Div Pulm,Thorac Dis Res Unit, Crit Care Med,Mol Biol, Rochester, MN USA.	kang.jeonghan@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R37-GM055816, R01-GM054200] Funding Source: Medline	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Antoniou KM, 2015, CURR OPIN PULM MED, V21, P626, DOI 10.1097/MCP.0000000000000217; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Celada LJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar8356; Chanda D, 2019, AM J RESP CELL MOL, V60, P279, DOI 10.1165/rcmb.2018-0062OC; Chen M, 2019, ACM T INTERNET TECHN, V19, DOI 10.1145/3239565; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Dezutter-Dambuyant C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1091146; Dong HD, 1999, NAT MED, V5, P1365; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; Feng JS, 2017, NANO ENERGY, V36, P1, DOI 10.1016/j.nanoen.2017.04.010; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Futakuchi A, 2018, INVEST OPHTH VIS SCI, V59, P3069, DOI 10.1167/iovs.18-24258; Geng Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125326; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MH, 2018, CANCER IMMUNOL RES, V6, P255, DOI 10.1158/2326-6066.CIR-17-0320; Kim S, 2016, HUM PATHOL, V58, P7, DOI 10.1016/j.humpath.2016.07.007; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Kouidhi S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00353; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Li YY, 2018, J CELL PHYSIOL, V233, P2590, DOI 10.1002/jcp.26134; Lim S, 2017, CANCER RES, V77, P1245, DOI 10.1158/0008-5472.CAN-16-1647; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Martin-Medina A, 2018, AM J RESP CRIT CARE, V198, P1527, DOI 10.1164/rccm.201708-1580OC; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miao J, 2017, ONCOTARGET, V8, P89802, DOI 10.18632/oncotarget.21155; Miranda MZ, 2017, J BIOL CHEM, V292, P14902, DOI 10.1074/jbc.M117.780502; Nana-Sinkam SP, 2017, AM J RESP CRIT CARE, V196, P1510, DOI 10.1164/rccm.201612-2457PP; Neuzillet C, 2014, ONCOTARGET, V5, P78, DOI 10.18632/oncotarget.1569; Ni K, 2018, AM J RESP CELL MOL, V58, P684, DOI 10.1165/rcmb.2017-0326OC; Ou JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00295; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Santarpia M, 2015, TRANSL LUNG CANCER R, V4, P728, DOI 10.3978/j.issn.2218-6751.2015.12.04; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soukupova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12837-y; Starke A, 2007, NEPHRON EXP NEPHROL, V107, pE22, DOI 10.1159/000106506; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Szul T, 2016, AM J RESP CELL MOL, V54, P359, DOI 10.1165/rcmb.2015-0108OC; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; Vancheri C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0478-1; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang LT, 2017, CANCER RES, V77, P4065, DOI 10.1158/0008-5472.CAN-17-0090; Wangpaichitr M, 2017, CELL DEV BIOL, V6, P1; Watanabe R, 2017, J CLIN INVEST, V127, P2725, DOI 10.1172/JCI92167; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zank DC, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00010	80	37	37	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2213	2226		10.1096/fj.201902354R	http://dx.doi.org/10.1096/fj.201902354R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907984				2022-12-26	WOS:000514663600020
J	Omeragic, A; Saikali, MF; Currier, S; Volsky, DJ; Cummins, CL; Bendayan, R				Omeragic, Amila; Saikali, Michael F.; Currier, Sydney; Volsky, David J.; Cummins, Carolyn L.; Bendayan, Reina			Selective peroxisome proliferator-activated receptor-gamma modulator, INT131 exhibits anti-inflammatory effects in an EcoHIV mouse model	FASEB JOURNAL			English	Article						HAND; HIV-1; glial cells; neuroinflammation; PPARgamma	IMMUNODEFICIENCY-VIRUS TYPE-1; NEUROCOGNITIVE DISORDER; ANTIRETROVIRAL THERAPY; P-GLYCOPROTEIN; FUNCTIONAL EXPRESSION; HIV-1 DNA; BRAIN; ASTROCYTES; PATHOGENESIS; INFECTION	Despite the use of antiretroviral therapy for the treatment of HIV-1 infection, cognitive impairments, that is, HIV-1-associated neurocognitive disorders remain prevalent potentially due to persistent viral replication, production of viral proteins, associated brain inflammation or in certain instances, antiretroviral neurotoxicity. Cellular targets in the brain include microglia which in response to infection release inflammatory markers and viral proteins. Evidence suggests that PPAR gamma agonists exert anti-inflammatory properties in neurological disorders. However, these agonists namely, thiazolidinediones have limited use in the clinic due to reported adverse side effects. INT131 is a novel non-thiazolidinedione compound that belongs to a new class of drugs known as selective PPAR gamma modulators. INT131 is considered to have a safer profile; however, its neuroprotective role in vivo is not known.The goal of this study was to examine the effect of INT131 in the context of EcoHIV-induced inflammation in vitro, in primary cultures of mouse glial cells and in vivo, in a mouse model of EcoHIV-associated brain inflammation, as well as characterize its pharmacokinetic properties and brain penetration. In primary cultures of glial cells and in the in vivo mouse model, EcoHIV exposure resulted in a significant elevation of inflammatory markers such as TNF alpha, IL-1 beta, CCL3, and C3 which were attenuated with INT131 treatment. Pharmacokinetic analyses revealed that INT131 penetrates into the brain with a brain to blood partition ratio Kp value of 8.5%. Overall, this is the first report to demonstrate that INT131 could be a potential candidate for the treatment of HIV-1-associated brain inflammation.	[Omeragic, Amila; Saikali, Michael F.; Currier, Sydney; Cummins, Carolyn L.; Bendayan, Reina] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sciences, Toronto, ON, Canada; [Volsky, David J.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY USA; Univ Toronto, Toronto, ON M5S 3M2, Canada	University of Toronto; Icahn School of Medicine at Mount Sinai; University of Toronto	Bendayan, R (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sciences, Toronto, ON, Canada.	r.bendayan@utoronto.ca		Cummins, Carolyn/0000-0001-7603-6577				An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Anderson CE, 2003, NEUROPATH APPL NEURO, V29, P378, DOI 10.1046/j.1365-2990.2003.00475.x; Asahchop EL, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0370-5; Ashraf T, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-91; Ashraf T, 2011, J NEUROSCI RES, V89, P1773, DOI 10.1002/jnr.22720; Bernardo A, 2008, PPAR RES, V2008, DOI 10.1155/2008/864140; Bertoldi A, 2017, NEW MICROBIOL, V40, P1; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Carvallo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179882; Cavalcante GIT, 2010, INT J NEUROSCI, V120, P739, DOI 10.3109/00207454.2010.520541; Chang KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09000; Churchill MJ, 2015, J NEUROVIROL, V21, P290, DOI 10.1007/s13365-014-0271-5; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cotto B, 2019, J NEUROVIROL, V25, P722, DOI 10.1007/s13365-019-00721-6; DePaoli AM, 2014, DIABETES CARE, V37, P1918, DOI 10.2337/dc13-2480; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Eggers C, 2017, J NEUROL, V264, P1715, DOI 10.1007/s00415-017-8503-2; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Godoy JA, 2017, BIOCHEM BIOPH RES CO, V490, P955, DOI 10.1016/j.bbrc.2017.06.146; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gu CJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007061; Guha D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-138; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Higgins LS, 2008, PPAR RES, V2008, DOI 10.1155/2008/936906; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang W, 2014, J CEREBR BLOOD F MET, V34, P646, DOI 10.1038/jcbfm.2013.240; Huang W, 2011, FASEB J, V25, P3979, DOI 10.1096/fj.11-188607; Jones LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151702; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kaplan J, 2007, SHOCK, V28, P722, DOI 10.1097/shk.0b013e318055683a; Kelschenbach J, 2019, MBIO, V10, DOI 10.1128/mBio.00591-19; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Langford D, 2004, J NEUROPATH EXP NEUR, V63, P1038, DOI 10.1093/jnen/63.10.1038; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lee DH, 2012, AM J PHYSIOL-ENDOC M, V302, pE552, DOI 10.1152/ajpendo.00569.2011; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li GH, 2016, CURR HIV RES, V14, P373, DOI 10.2174/1570162X14666161006121455; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Maschke M, 2000, J NEUROL NEUROSUR PS, V69, P376, DOI 10.1136/jnnp.69.3.376; McRae M, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1143543; Moidunny S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0613-8; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nakatsumi H, 2017, CELL REP, V21, P2471, DOI 10.1016/j.celrep.2017.11.014; Nedelcovych MT, 2017, J MED CHEM, V60, P7186, DOI 10.1021/acs.jmedchem.7b00966; Nwogu JN, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/2587094; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Omeragic A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45878-6; Omeragic A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0957-8; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Piacenti FJ, 2006, PHARMACOTHERAPY, V26, P1111, DOI 10.1592/phco.26.8.1111; Potula R, 2008, AIDS, V22, P1539, DOI 10.1097/QAD.0b013e3283081e08; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Robillard KR, 2014, ANTIMICROB AGENTS CH, V58, P1713, DOI 10.1128/AAC.02031-13; Ronaldson PT, 2008, GLIA, V56, P1711, DOI 10.1002/glia.20725; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Russell RA, 2017, CELL REP, V18, P1473, DOI 10.1016/j.celrep.2017.01.027; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Saylor D, 2018, INFECT NEUROINFECTIO, V24, P1397, DOI DOI 10.1212/C0N.0000000000000647; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Schildge S., 2013, JOVE-J VIS EXP, P1; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Sillman Brady, 2018, Handb Clin Neurol, V152, P21, DOI 10.1016/B978-0-444-63849-6.00003-7; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Weber SM, 2004, AM J ENDOCRINOL META, V63104, P329; Xie X, 2017, MBIO, V8, P1	74	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1996	2010		10.1096/fj.201901874R	http://dx.doi.org/10.1096/fj.201901874R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907999				2022-12-26	WOS:000514663600007
J	Volkening, L; Vatselia, A; Asgedom, G; Bastians, H; Lavin, M; Schindler, D; Schambach, A; Bousset, K; Dork, T				Voelkening, Lea; Vatselia, Anna; Asgedom, Girmay; Bastians, Holger; Lavin, Martin; Schindler, Detlev; Schambach, Axel; Bousset, Kristine; Doerk, Thilo			RAD50 regulates mitotic progression independent of DNA repair functions	FASEB JOURNAL			English	Article						ATR; cell division; mitotic delay; MRN complex; RAD50 phosphorylation	DAMAGE RESPONSE; ATM; PHOSPHORYLATION; REPLICATION; PROMOTES; PATHWAY; MITOSIS	The Mre11A/RAD50/NBN complex (MRN) is an essential regulator of the cellular damage response after DNA double-strand breaks (DSBs). More recent work has indicated that MRN may also impact on the duration of mitosis. We show here that RAD50-deficient fibroblasts exhibit a marked delay in mitotic progression that can be rescued by lentiviral transduction of RAD50. The delay was observed throughout all mitotic phases in live cell imaging using GFP-labeled H2B as a fluorescent marker. In complementation assays with RAD50 phosphorylation mutants, modifications at Ser635 had little effect on mitotic progression. By contrast with RAD50, fibroblast strains deficient in ATM or NBN did not show a significant slowing of mitotic progression. Ataxia-telangiectasia-like disorder (ATLD) fibroblasts with nuclease-deficient MRE11A (p.W210C) tended to show slower mitosis, though by far not as significant as RAD50-deficient cells. Inhibitor studies indicated that ATM kinase activity might not grossly impact on mitotic progression, while treatment with MRE11A inhibitor PFM39 modestly prolonged mitosis. Inhibition of ATR kinase significantly prolonged mitosis but this effect was mostly independent of RAD50 status. Taken together, our data unravel a mitotic role of RAD50 that can be separated from its known functions in DNA repair.	[Voelkening, Lea; Vatselia, Anna; Bousset, Kristine; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Asgedom, Girmay; Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Bastians, Holger] Univ Med Gottingen, Inst Mol Oncol, Gottingen, Germany; [Lavin, Martin] Queensland Inst Med Res, Brisbane, Qld, Australia; [Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Bioctr, Wurzburg, Germany; [Schambach, Axel] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Hannover Medical School; Hannover Medical School; University of Gottingen; QIMR Berghofer Medical Research Institute; University of Wurzburg; Harvard University; Boston Children's Hospital; Harvard Medical School	Dork, T (corresponding author), Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany.	doerk.thilo@mh-hannover.de	Schambach, Axel/C-5491-2011; Dörk, Thilo/J-8620-2012; Lavin, Martin/F-5961-2014	Dörk, Thilo/0000-0002-9458-0282; Lavin, Martin/0000-0002-5940-4769				Aze A, 2016, NAT CELL BIOL, V18, P684, DOI 10.1038/ncb3344; Bakhoum SF, 2017, TRENDS CANCER, V3, P225, DOI 10.1016/j.trecan.2017.02.001; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Gatei M, 2014, HUM MOL GENET, V23, P4232, DOI 10.1093/hmg/ddu141; Gatei M, 2011, J BIOL CHEM, V286, P31542, DOI 10.1074/jbc.M111.258152; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jones GN, 2018, BRIT J CANCER, V119, P1233, DOI 10.1038/s41416-018-0286-4; Jullien D, 2002, J CELL SCI, V115, P71; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Laulier C, 2011, NUCLEIC ACIDS RES, V39, P5935, DOI 10.1093/nar/gkr187; Lemmens B, 2018, MOL CELL, V71, P117, DOI 10.1016/j.molcel.2018.05.026; Li J, 2018, BIOCHEM J, V475, P981, DOI 10.1042/BCJ20170520; Li ZG, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00595-16; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Palazzo L, 2014, CELL CYCLE, V13, P1091, DOI 10.4161/cc.27945; Reynolds JJ, 2013, DNA REPAIR, V12, P588, DOI 10.1016/j.dnarep.2013.04.011; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rozier L, 2013, MOL CELL, V49, P1097, DOI 10.1016/j.molcel.2013.01.023; Schroder-Heurich B, 2014, FASEB J, V28, P1331, DOI 10.1096/fj.13-236984; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Xu R, 2018, P NATL ACAD SCI USA, V115, pE10079, DOI 10.1073/pnas.1806665115; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016	31	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2812	2820		10.1096/fj.201902318R	http://dx.doi.org/10.1096/fj.201902318R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908056				2022-12-26	WOS:000514663600060
J	Duan, YP; Shang, BR; Liang, W; Yang, M; Brehm, W				Duan, Yanping; Shang, Borui; Liang, Wei; Yang, Min; Brehm, Walter			Psychosocial profiles of physical activity fluctuation in office employees: A latent profile analysis	PLOS ONE			English	Article							HEALTH BEHAVIOR-CHANGE; QUALITY-OF-LIFE; COMMITMENT; OVERWEIGHT; ADULTHOOD; PATTERNS; BENEFITS; STUDENTS; STAGE	Objectives Fluctuation is a common but neglected phenomenon of physical activity (PA) behavior. This study aimed to explore the psychosocial profiles of PA fluctuation in office employees, and to examine the association of latent profiles with demographics and PA level. Method 434 Chinese office employees who were identified as PA fluctuators (M = 32.4 years, SD = 6.9, 55.5% female) completed a cross-sectional online survey covering demographics, PA behavior, and six psychosocial indicators (self-efficacy, planning, action control, affective attitude, social support, and perceived barriers). Latent profile analysis was used to determine PA fluctuators' psychosocial profiles. Associated factors of profile membership were identified with multinomial logistic regression. Results The two-profile model (uncommitted vs. moderately committed) was selected as the best solution. The moderately committed group (n = 346, 79.7%) possessed a more active mindset by reporting significantly higher scores of self-efficacy (t = 9.42 p <.001), planning (t = 16.33 p <.001), action control (t = 14.55 p <.001), affective attitude (t = 13.33 p <.001), and social support (t = 11.50 p <.001) compared with the uncommitted group (n = 88, 20.3%). Results from a multinomial logistic regression showed that the moderately committed profile was associated with normal weight status (OR = 2.00, p<.05), having a medium managerial position (OR = 2.54, p<.01), and high level of moderate to vigorous PA behavior (OR = 4.85, p<.001). Conclusions These findings demonstrate the variability of PA fluctuators' mindsets. Future tailored interventions are recommended to promote PA behavior for this population based on the categorization from the present study.	[Duan, Yanping; Liang, Wei] Hong Kong Baptist Univ, Dept Sport & Phys Educ, Hong Kong, Peoples R China; [Shang, Borui] Hebei Sport Univ, Dept Kinesiol, Shijiazhuang, Hebei, Peoples R China; [Yang, Min] Wuhan Sports Univ, Grad Sch, Wuhan, Peoples R China; [Brehm, Walter] Univ Bayreuth, Inst Sports Sci, Bayreuth, Germany	Hong Kong Baptist University; Hebei Sport University; Wuhan Sports University; University of Bayreuth	Shang, BR (corresponding author), Hebei Sport Univ, Dept Kinesiol, Shijiazhuang, Hebei, Peoples R China.	borui_shang_pe@qq.com		Shang, Borui/0000-0003-3009-950X; Liang, Wei/0000-0002-8120-7905; Duan, Yanping/0000-0002-6432-7542	Research Committee of Hong Kong Baptist University [[FRG1/17-18/007]]	Research Committee of Hong Kong Baptist University	The study was funded by Research Committee of Hong Kong Baptist University (Grant number: [FRG1/17-18/007]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault S, 2015, J CANCER SURVIV, V9, P532, DOI 10.1007/s11764-015-0430-6; [Anonymous], HEATH, DOI DOI 10.4236/health.2016.84037; Asparouhov, 2014, AUXILIARY VARIABLES, DOI DOI 10.1080/10705511.2014.915181; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; Biddle SJH, 2009, PSYCHOL SPORT EXERC, V10, P410, DOI 10.1016/j.psychsport.2009.02.011; Biernat E, 2010, BIOL SPORT, V27, P289, DOI 10.5604/20831862.927495; Chen DD, 2016, J CLEAN PROD, V112, P3750, DOI 10.1016/j.jclepro.2015.08.109; Cheng OY, 2019, AM J HEALTH BEHAV, V43, P569, DOI 10.5993/AJHB.43.3.11; Clemes SA, 2014, J OCCUP ENVIRON MED, V56, P298, DOI 10.1097/JOM.0000000000000101; Collins JD, 2015, INT J IND ERGONOM, V46, P85, DOI 10.1016/j.ergon.2014.12.013; Duan Y., 2006, STAGE MODELS PHYS AC; Duan YP, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7152; Duan YP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2931-2; Duan YP, 2015, J PHYS ACT HEALTH, V12, P1461, DOI 10.1123/jpah.2014-0389; Duan YP, 2013, J EXERC SCI FIT, V11, P63, DOI 10.1016/j.jesf.2013.07.001; Duan YP, 2010, BAYREUTH CONTRIBUTIO, V13, P1436; Ekkekakis P, 2013, PSYCHOL SPORT EXERC, V14, P751, DOI 10.1016/j.psychsport.2013.04.007; Fuchs R., 1999, PSYCHOL SPORT EXERC; Gabriele JM, 2011, J PHYS ACT HEALTH, V8, P420, DOI 10.1123/jpah.8.3.420; Gerber M, 2014, PSYCHOL SPORT EXERC, V15, P649, DOI 10.1016/j.psychsport.2014.07.012; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Godin G., 2011, HLTH FITNESS J CANAD, V4, P18, DOI [10.2466/03.27.PMS.120v19x7, DOI 10.14288/HFJC.V4I1.82]; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hipp JR, 2006, PSYCHOL METHODS, V11, P36, DOI 10.1037/1082-989X.11.1.36; Kahlert Daniela, 2015, Prev Med Rep, V2, P178, DOI 10.1016/j.pmedr.2015.02.013; Kurka JM, 2015, HEALTH PLACE, V34, P164, DOI 10.1016/j.healthplace.2015.05.006; Lam TH, 2004, PREV MED, V38, P302, DOI 10.1016/j.ypmed.2003.10.005; Larimer ME, 1999, ALCOHOL RES HEALTH, V23, P151; [李里特 Li Lite], 2002, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V17, P1; Lin CY, 2012, HONG KONG J OCCUP TH, V22, P31, DOI 10.1016/j.hkjot.2012.06.001; Lin YC, 2019, J CHILD FAM STUD, V28, P286, DOI 10.1007/s10826-018-1247-5; Lindberg CM, 2018, OCCUP ENVIRON MED, V75, P689, DOI 10.1136/oemed-2018-105077; Lippke S, 2006, J HEALTH PSYCHOL, V11, P37, DOI 10.1177/1359105306058845; Lovell GP, 2010, INT J ENV RES PUB HE, V7, P784, DOI 10.3390/ijerph7030784; Marsh HW, 2009, STRUCT EQU MODELING, V16, P191, DOI 10.1080/10705510902751010; Meyer JP, 2016, J ORGAN BEHAV, V37, P584, DOI 10.1002/job.2085; Morin AJS, 2015, STRUCT EQU MODELING, V22, P39, DOI 10.1080/10705511.2014.919825; Muthen L.K., 2012, MPLUS STAT ANAL LATE; Ou HT, 2017, APPL RES QUAL LIFE, V12, P799, DOI 10.1007/s11482-016-9488-1; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Pastor DA, 2007, CONTEMP EDUC PSYCHOL, V32, P8, DOI 10.1016/j.cedpsych.2006.10.003; Peugh JL, 2013, STRUCT EQU MODELING, V20, P314, DOI [10.1080/10705511.2013.769395, 10.1080/10705511.2013.824780]; Richert J, 2013, HEALTH PSYCHOL, V32, P273, DOI 10.1037/a0028915; Sampasa-Kanyinga H, 2017, PUBLIC HEALTH, V146, P75, DOI 10.1016/j.puhe.2017.01.002; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Shang BR, 2018, EUR J SPORT SCI, V18, P266, DOI 10.1080/17461391.2017.1417486; Smith L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061214; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Vartanian L.R., 2018, STIGMA HEALTH, V3, P85, DOI [10.1037/sah0000077, DOI 10.1037/SAH0000077]; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilson PM, 2004, PSYCHOL SPORT EXERC, V5, P405, DOI 10.1016/S1469-0292(03)00035-9; World Health Organization, 2007, STEPS HLTH EUR FRAM; World Health Organization, PHYS ACT AD REC LEV	54	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227182	10.1371/journal.pone.0227182	http://dx.doi.org/10.1371/journal.pone.0227182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914138	Green Published, gold			2022-12-26	WOS:000534337700031
J	Zhou, SX; Ni, SH; Dai, JH; Zhou, QJ; Zhou, RC; Liu, Y				Zhou, Shuaixi; Ni, Shuheng; Dai, Jinhong; Zhou, Qiujie; Zhou, Renchao; Liu, Ying			Natural hybridization between Phyllagathis and Sporoxeia species produces a hybrid without reproductive organs	PLOS ONE			English	Article								Natural hybridization plays important roles in plant evolution and speciation. In this study, we sequenced ribosomal internal transcribed spacer (nrITS), four low-copy nuclear genes (Dbr1, SOS4a, SOS4b and PCRF1) and the chloroplast intergenic spacer trnV-trnM to test the hypothesis of hybridization between two species of Phyllagathis and Sporoxeia (Sonerileae/Dissochaeteae, Melastomataceae). Our results provided compelling evidence for the hybridization hypothesis. All hybrid individuals sampled were first-generation hybrids. The failure of flower production in the F1 hybrid individuals may work as the barrier preventing later-generation hybridization or backcross. Analysis of the chloroplast trnV-trnM sequences showed that the hybridization is bidirectional with S. petelotii as the major maternal parent. Several factors, such as sympatry, similar habitat preference, overlapping flowering season and shared pollinators, might have contributed to this hybridization event. The "intergeneric" hybridization reported in this study suggests close relationship between P. longicalcarata and S. petelotii.	[Zhou, Shuaixi; Ni, Shuheng; Dai, Jinhong; Zhou, Qiujie; Zhou, Renchao; Liu, Ying] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Zhou, Shuaixi; Ni, Shuheng; Dai, Jinhong; Zhou, Qiujie; Zhou, Renchao; Liu, Ying] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, RC; Liu, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	zhrench@mail.sysu.edu.cn; liliumrosa@163.com	Dai, Jin/GVT-2414-2022	Dai, Jin/0000-0003-3063-746X; Liu, Ying/0000-0003-0613-837X	National Natural Science Foundation of China [31770214, 31670210, 31811530297]; Chang Hungta Science Foundation of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chang Hungta Science Foundation of Sun Yat-sen University	This work was supported by the National Natural Science Foundation of China (31770214, 31670210 and 31811530297) and Chang Hungta Science Foundation of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; ALMEDA F JR, 1978, University of California Publications in Botany, V75, P1; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Campbell LG, 2007, NEW PHYTOL, V173, P648, DOI 10.1111/j.1469-8137.2006.01941.x; DOBZHANSKY T., 1951, Genetics and the origin of species.; Goulet BE, 2017, PLANT PHYSIOL, V173, P65, DOI 10.1104/pp.16.01340; Grant V., 1981, PLANT SPECIATION; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; Ionta GM, 2007, INT J PLANT SCI, V168, P1055, DOI 10.1086/518837; Kearns AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03294-w; Kleindorfer S, 2014, AM NAT, V183, P325, DOI 10.1086/674899; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; RENNER S S, 1986, Acta Amazonica, V16-17, P197; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Zhou QJ, 2019, J SYST EVOL, V57, P256, DOI 10.1111/jse.12451; Zhou QJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01477; Zhou Qiujie, 2017, Biodiversity Science, V25, P638, DOI 10.17520/biods.2017060	28	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227625	10.1371/journal.pone.0227625	http://dx.doi.org/10.1371/journal.pone.0227625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914145	Green Published, gold			2022-12-26	WOS:000534337700052
J	Mengsteab, PY; Conroy, P; Badon, M; Otsuka, T; Kan, HM; Vella, AT; Nair, LS; Laurencin, CT				Mengsteab, Paulos Y.; Conroy, Patrick; Badon, Mary; Otsuka, Takayoshi; Kan, Ho-Man; Vella, Anthony T.; Nair, Lakshmi S.; Laurencin, Cato T.			Evaluation of a bioengineered ACL matrix's osteointegration with BMP-2 supplementation	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; INITIAL GRAFT TENSION; RABBIT MODEL; TENDON GRAFT; ANTERIOR; FIBRIN; FIXATION; RHBMP-2	A poly (l-lactic) acid bioengineered anterior cruciate ligament (ACL) matrix has previously demonstrated the ability to support tissue regeneration in a rabbit ACL reconstruction model. The matrix was designed for optimal bone and ligament regeneration by developing a matrix with differential pore sizes in its bone and ligament compartments. Building upon past success, we designed a new bioengineered ACL matrix that is easier to install and can be used with endobutton fixation during ACL reconstruction. To achieve this, a new braiding procedure was developed to allow the matrix to be folded in half, making two-limbs, while maintaining its bone and ligament compartments. The osteointegration of the matrix with and without bone morphogenetic protein 2 (BMP-2) supplementation was evaluated in a rabbit ACL reconstruction model. Two doses of BMP-2 were evaluated, 1 and 10 mu g, and delivered by saline injection into the bone tunnel at the end of surgery. A fibrous matrix-to-bone interface with occasional Sharpey's fibers was the primary mode of osteointegration observed. The matrix was also found to support a fibrocartilage matrix-to-bone interface. In some cases, the presence of chondrocyte-like cells was observed at the aperture of the bone tunnel and the center of the matrix within the bone tunnel. Treatment with BMP-2 was associated with a trend towards smaller bone tunnel cross-sectional areas, and 1 mu g of BMP-2 was found to significantly enhance osteoid seam width in comparison with no BMP-2 or 10 mu g of BMP-2 treatment. Regenerated tissue was well organized within the bioengineered ACL matrix and aligned with the poly (l-lactic) acid fibers. Disorganized tissue was found between the two-limbs of the bioengineered ACL matrix and hypothesized to be due to a lack of structural scaffolding. This study suggests that the bioengineered ACL matrix can undergo similar modes of osteointegration as current autografts and allografts, and that BMP-2 treatment may enhance osteoblastic activity within the bone tunnels.	[Mengsteab, Paulos Y.; Conroy, Patrick; Badon, Mary; Otsuka, Takayoshi; Kan, Ho-Man; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut Hlth, Connecticut Convergence Inst Translat Regenerat E, Farmington, CT 06030 USA; [Mengsteab, Paulos Y.; Conroy, Patrick; Otsuka, Takayoshi; Kan, Ho-Man; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT 06030 USA; [Mengsteab, Paulos Y.; Otsuka, Takayoshi; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut Hlth, Dept Orthoped Surg, Farmington, CT 06030 USA; [Mengsteab, Paulos Y.; Conroy, Patrick; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06030 USA; [Vella, Anthony T.] Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT USA; [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA; [Laurencin, Cato T.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA; [Laurencin, Cato T.] Univ Connecticut, Hlth Ctr, Dept Reconstruct Sci, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut	Laurencin, CT (corresponding author), Univ Connecticut Hlth, Connecticut Convergence Inst Translat Regenerat E, Farmington, CT 06030 USA.; Laurencin, CT (corresponding author), Univ Connecticut Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT 06030 USA.; Laurencin, CT (corresponding author), Univ Connecticut Hlth, Dept Orthoped Surg, Farmington, CT 06030 USA.; Laurencin, CT (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06030 USA.; Laurencin, CT (corresponding author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.; Laurencin, CT (corresponding author), Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.; Laurencin, CT (corresponding author), Univ Connecticut, Hlth Ctr, Dept Reconstruct Sci, Farmington, CT 06030 USA.	laurencin@uchc.edu	Otsuka, Takayoshi/AAZ-4773-2021; Mengsteab, Paulos/AAA-2077-2021	Otsuka, Takayoshi/0000-0002-7954-0637; Mengsteab, Paulos/0000-0001-7160-9356; Laurencin, Cato/0000-0001-6765-3047	Raymond; Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, NIH [R01AR063698, DP1 AR068147]	Raymond; Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, NIH	This research was supported by funding from the Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, NIH R01AR063698, and NIH DP1 AR068147.	Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Carson E, 2010, J KNEE SURG, V17, P127; Cheng PF, 2016, BIOMATERIALS, V81, P14, DOI 10.1016/j.biomaterials.2015.12.005; Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104; Dong Y, 2012, INT J MOL SCI, V13, P13605, DOI 10.3390/ijms131013605; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Fealy S, 2006, ARTHROSCOPY, V22, P595, DOI 10.1016/j.arthro.2006.03.008; FLEMING B, 1993, AM J SPORT MED, V21, P82, DOI 10.1177/036354659302100115; Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9; Gulotta LV, 2007, CLIN SPORT MED, V26, P509, DOI 10.1016/j.csm.2007.06.007; Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447; Hearle J.W. S., 2006, ATLAS FIBRE FRACTURE; Kaipel M, 2012, J ORTHOP RES, V30, P1563, DOI 10.1002/jor.22132; Kim HJ, 2007, CONNECT TISSUE RES, V48, P309, DOI 10.1080/03008200701692610; Kim SG, 2006, ARCH ORTHOP TRAUM SU, V126, P260, DOI 10.1007/s00402-005-0045-x; Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2; Li YF, 2016, ARCH MED SCI, V12, P494, DOI 10.5114/aoms.2016.59922; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Madhavarapu S, 2017, TECHNOLOGY, V5, P98, DOI 10.1142/S2339547817500066; Mansour JM, 1998, ANN BIOMED ENG, V26, P353, DOI 10.1114/1.133; Mengsteab PY, 2016, REGEN MED, V11, P871, DOI 10.2217/rme-2016-0125; Milano G, 2006, ARTHROSCOPY, V22, P660, DOI 10.1016/j.arthro.2006.04.082; Miura K, 2006, AM J SPORT MED, V34, P577, DOI 10.1177/0363546505281814; Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236; Nicholas SJ, 2004, AM J SPORT MED, V32, P1881, DOI 10.1177/0363546504265924; Numazaki H, 2002, AM J SPORT MED, V30, P800, DOI 10.1177/03635465020300060801; Pan WM, 2013, BIOMATERIALS, V34, P9926, DOI 10.1016/j.biomaterials.2013.09.018; Pan WM, 2011, J ORTHOP RES, V29, P1015, DOI 10.1002/jor.21351; Paterno MV, 2014, AM J SPORT MED, V42, P1567, DOI 10.1177/0363546514530088; Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201; Sajovic M, 2018, AM J SPORT MED, V46, P1800, DOI 10.1177/0363546518768768; Schutzenberger S, 2012, ARCH ORTHOP TRAUM SU, V132, P1363, DOI 10.1007/s00402-012-1551-2; Song EK, 2004, ARTHROSCOPY, V20, P424, DOI 10.1016/j.arthro.2004.01.005; Soon MYH, 2007, AM J SPORT MED, V35, P962, DOI 10.1177/0363546507300057; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; van der Stok J, 2015, EUR CELLS MATER, V29, P141, DOI 10.22203/eCM.v029a11; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Walsh WR, 2015, ORTHOP J SPORT ME S2, V3, DOI [10.1177/2325967115S00033., DOI 10.1177/2325967115S00033, 10.1177/2325967115S00033]; Weiler A, 2002, ARTHROSCOPY, V18, P124, DOI 10.1053/jars.2002.30657; Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039; YOSHIYA S, 1987, AM J SPORT MED, V15, P464, DOI 10.1177/036354658701500506	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227181	10.1371/journal.pone.0227181	http://dx.doi.org/10.1371/journal.pone.0227181			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910231	Green Published, gold			2022-12-26	WOS:000534333800030
J	de Winter, W; Donker, J; Sterk, G; van Beem, J; Ruessink, G				de Winter, Winnie; Donker, Jasper; Sterk, Geert; van Beem, Job; Ruessink, Gerben			Regional versus local wind speed and direction at a narrow beach with a high and steep foredune	PLOS ONE			English	Article							AEOLIAN SEDIMENT TRANSPORT; SAND TRANSPORT; FLOW DYNAMICS; GEOMORPHOLOGY; PREDICTION; FETCH	Dune growth and post-storm recovery of foredune systems is predominantly determined by the aeolian sand transport through the beach-dune interface. Potential sand transport rates, estimated with empirical transport equations using regionally representative wind conditions, are generally too high. This positive bias might be, at least partly, due to the effect of the beach and foredune topography on the regional airflow. Here, we investigate the relation between local (on the beach) and regional wind velocities and direction in front of the high (similar to 22 m) and steep (similar to 1:2.5) foredune partially vegetated with Marram grass at Egmond aan Zee, The Netherlands based on a dataset with a large variety in wind speeds spanning over all onshore wind directions. We observed that local 10-minute averaged wind speed and direction can differ from the regional wind conditions (here measured 15 km away from the study site) depending on the regional approach angle of the wind. The ratio of local over regional wind speed is smallest (similar to 0.39) when the wind direction is dune-normal. This ratio increases with increasing obliquity towards almost 1 for alongshore winds. Wind steering only happens at the dune foot and is the largest (similar to 13 degrees) with oblique approaching winds of 40 degrees from the dune normal. Perpendicular and nearly alongshore winds do not show any steering near the dune foot. The use of local rather than regional wind conditions in a potential transport equation reduces the predicted annual supply from 86 to 32 m(3)/m/y, substantially closer to the measured deposition of 15 m(3)/m/y. The drop in velocity was more important to the reduction in predicted supply than the alongshore steering.	[de Winter, Winnie; Donker, Jasper; Sterk, Geert; van Beem, Job; Ruessink, Gerben] Univ Utrecht, Dept Phys Geog, Fac Geosci, Utrecht, Netherlands	Utrecht University	de Winter, W (corresponding author), Univ Utrecht, Dept Phys Geog, Fac Geosci, Utrecht, Netherlands.	w.dewinter@uu.nl		Ruessink, Gerben/0000-0001-9526-6087	Dutch Technology Foundation STW - Ministry of Economic Affairs [13709]	Dutch Technology Foundation STW - Ministry of Economic Affairs	This research is funded under contract 13709 to GR by the Dutch Technology Foundation STW, which is partly funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony EJ, 2009, GEOMORPHOLOGY, V105, P95, DOI 10.1016/j.geomorph.2007.12.013; Arens SM, 1996, GEOMORPHOLOGY, V17, P339, DOI 10.1016/0169-555X(96)00016-5; ARENS SM, 1995, EARTH SURF PROCESSES, V20, P315, DOI 10.1002/esp.3290200403; Bagnold R., 1941, PHYS BLOWN SAND DESE; Barchyn TE, 2014, AEOLIAN RES, V15, P245, DOI 10.1016/j.aeolia.2014.07.002; Bauer BO, 2009, GEOMORPHOLOGY, V105, P106, DOI 10.1016/j.geomorph.2008.02.016; Bauer BO, 2012, EARTH SURF PROC LAND, V37, P1661, DOI 10.1002/esp.3306; Bowen A. J., 1977, Boundary-Layer Meteorology, V12, P259, DOI 10.1007/BF00121466; BOWEN AJ, 1983, J WIND ENG IND AEROD, V15, P259, DOI 10.1016/0167-6105(83)90196-4; Chapman C, 2013, EARTH SURF PROC LAND, V38, P1735, DOI 10.1002/esp.3428; Chapman CA, 2012, GEOMORPHOLOGY, V151, P1, DOI 10.1016/j.geomorph.2011.11.015; Davidson-Arnott R.G.D., 2001, CAN COAST C CCSEA QU, P309; DavidsonArnott RGD, 1996, J COASTAL RES, V12, P654; de Vries S, 2014, AEOLIAN RES, V15, P235, DOI 10.1016/j.aeolia.2014.08.001; de Vries S, 2014, AEOLIAN RES, V12, P75, DOI 10.1016/j.aeolia.2013.11.005; de Vries S, 2012, COAST ENG, V67, P41, DOI 10.1016/j.coastaleng.2012.04.002; de Winter RC, 2015, COAST ENG, V99, P167, DOI 10.1016/j.coastaleng.2015.02.005; Delgado-Fernandez I, 2011, GEOMORPHOLOGY, V126, P217, DOI 10.1016/j.geomorph.2010.11.005; Delgado-Fernandez I, 2010, AEOLIAN RES, V2, P61, DOI 10.1016/j.aeolia.2010.04.001; Donker J, 2018, J MAR SCI ENG, V6, DOI 10.3390/jmse6040126; Donker JJA, 2018, 20 EGU GEN ASS EGU20, P8748; Duarte-Campos L, 2018, J MAR SCI ENG, V6, DOI 10.3390/jmse6040127; Grilliot MJ, 2018, GEOSCIENCES, V8, DOI 10.3390/geosciences8050147; Hage PM, 2018, GEOMORPHOLOGY, V129, P258; Hesp P, 2002, GEOMORPHOLOGY, V48, P245, DOI 10.1016/S0169-555X(02)00184-8; Hesp PA, 2005, GEOMORPHOLOGY, V65, P71, DOI 10.1016/j.geomorph.2004.08.001; Hesp PA, 1996, SEDIMENTOLOGY, V43, P505, DOI 10.1046/j.1365-3091.1996.d01-22.x; Hesp PA, 2015, GEOMORPHOLOGY, V230, P64, DOI 10.1016/j.geomorph.2014.11.005; Hoonhout BM, 2016, J GEOPHYS RES-EARTH, V121, P1555, DOI 10.1002/2015JF003692; HSU SA, 1971, J GEOPHYS RES, V76, P8684, DOI 10.1029/JC076i036p08684; Kadib A., 1965, FUNCTION SAND MOVEME; Kawamura R., 1951, REPT I SCI TECHNOL, V5, P95, DOI DOI 10.2115/FIBER.7.95; Keijsers JGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091115; Lettau K., 1978, EXPLORING WORLDS DRI, P110; Miot da Silva G, 2018, AEOLIAN RES, V33, P1; OWEN PR, 1964, J FLUID MECH, V20, P225, DOI 10.1017/S0022112064001173; Qian G, 2011, J GEOPHYS RES, V116, P1; Sherman DJ, 2012, AEOLIAN RES, V3, P371, DOI 10.1016/j.aeolia.2011.06.002; Smyth TAG, 2015, COAST ENG, V99, P38, DOI 10.1016/j.coastaleng.2015.02.011; Sorensen M, 2004, GEOMORPHOLOGY, V59, P53, DOI 10.1016/j.geomorph.2003.09.005; Tsoar H, 1996, LANDSCAPE URBAN PLAN, V34, P171, DOI 10.1016/0169-2046(95)00235-9; van Boxel JH, 2004, GEOMORPHOLOGY, V59, P131, DOI 10.1016/j.geomorph.2003.09.011; van der Wal D, 1998, J ARID ENVIRON, V39, P533, DOI 10.1006/jare.1997.0364; Walker IJ, 2017, EARTH-SCI REV, V171, P220, DOI 10.1016/j.earscirev.2017.04.011; WIERINGA J, 1980, B AM METEOROL SOC, V61, P962, DOI 10.1175/1520-0477(1980)061<0962:ROWOAA>2.0.CO;2; Wiggs GFS, 1996, GEOMORPHOLOGY, V17, P29, DOI 10.1016/0169-555X(95)00093-K; Zingg A.W., 1953, P 5 HYDRAULICS C B, V34, P111	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226983	10.1371/journal.pone.0226983	http://dx.doi.org/10.1371/journal.pone.0226983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KB6PA	31895928	Green Published, gold			2022-12-26	WOS:000506613500001
J	Li, J; Deng, ZY; Zhang, X; Liu, F; Yang, CZ; Shi, GP				Li, Jie; Deng, Zhiyong; Zhang, Xian; Liu, Feng; Yang, Chongzhe; Shi, Guo-Ping			Deficiency of immunoglobulin E protects mice from experimental abdominal aortic aneurysms	FASEB JOURNAL			English	Article						abdominal aortic aneurysm; Fc epsilon R1; IgE; IL6; MAPK; neutrophil	HIGH-AFFINITY RECEPTOR; NEUTROPHIL RECRUITMENT; CELL SURVIVAL; MAST-CELLS; IGE; ACTIVATION; EXPRESSION; JNK; PATHOGENESIS; P38	Allergic asthma with high plasma IgE levels is a significant risk factor of human abdominal aortic aneurysm (AAA). This study tests a direct role of IgE in angiotensin-II (Ang-II) perfusion- and peri-aortic CaCl2 injury-induced AAA in mice. In both models, IgE-deficiency in Apoe(-/-)Ige(-/-) mice blunts AAA growth and reduces lesion accumulation of macrophages, CD4(+) and CD8(+) T cells, and lesion MHC class-II expression, CD31(+) microvessel growth, and media smooth muscle cell loss, compared with those from Apoe(-/-) control mice. Real time-PCR reveals significant reductions in expression of neutrophil chemoattractants MIP-2 alpha and CXCL5 in AAA lesions or macrophages from Apoe(-/-)Ige(-/-) mice, along with reduced lesion Ly6G(+) neutrophil accumulation. Consistent with reduced lesion inflammatory cell accumulation, we find significant reductions of plasma and AAA lesion IL6 expression in Apoe(-/-)Ige(-/-) mice. Immunofluorescent staining and FACS analysis show that AAA lesion neutrophils express Fc epsilon R1. Mechanistic study demonstrates that IgE induces neutrophil Fc epsilon R1 expression, activates MAPK signaling, and promotes IL6 production. This study supports a direct role of IgE in AAA by promoting lesion chemokine expression, inflammatory cell accumulation, MAPK signaling, and cytokine expression. IgE inhibition may represent a novel therapeutic approach in AAA management.	[Li, Jie; Liu, Feng; Yang, Chongzhe] South China Univ Technol, Sch Med, Guangzhou First Peoples Hosp, Natl Key Clin Specialty,Dept Geriatr, Guangzhou, Guangdong, Peoples R China; [Li, Jie; Deng, Zhiyong; Zhang, Xian; Yang, Chongzhe; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Li, Jie; Deng, Zhiyong; Zhang, Xian; Yang, Chongzhe; Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Deng, Zhiyong; Yang, Chongzhe] Guangzhou Med Univ, Guangzhou First Peoples Hosp, Dept Geriatr, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Guangzhou Medical University; South China University of Technology	Shi, GP (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 77 Ave Louis Pasteur,NRB 7, Boston, MA 02115 USA.; Yang, CZ (corresponding author), Guangzhou First Peoples Hosp, Dept Geriatr, 1 Panfu Rd,Pansong Bldg 7, Guangzhou 510180, Guangdong, Peoples R China.	eyyangchongzhe@scut.edu.cn; gshi@bwh.harvard.edu		Zhang, Xian/0000-0002-6055-0130; Yang, Chongzhe/0000-0002-0338-8245	National Natural Science Foundation of China [81300176]; Fundamental Research Funds for the Central Universities, SCUT [D2180650]; Science Foundation of Guangzhou First People's Hospital [2019]; National Institutes of Health [HL123568, HL60942, AG058670]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Science Foundation of Guangzhou First People's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Natural Science Foundation of China, Grant/Award Number: 81300176; Fundamental Research Funds for the Central Universities, SCUT, Grant/Award Number: D2180650; Science Foundation of Guangzhou First People's Hospital, Grant/Award Number: 2019; National Institutes of Health, Grant/Award Number: HL123568, HL60942 and AG058670	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Anzai A, 2015, CIRC RES, V116, P612, DOI 10.1161/CIRCRESAHA.116.304918; APPELBERG R, 1992, J LEUKOCYTE BIOL, V52, P303, DOI 10.1002/jlb.52.3.303; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; Disteldorf EM, 2015, J AM SOC NEPHROL, V26, P55, DOI 10.1681/ASN.2013101061; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Golledge J, 2019, NAT REV CARDIOL, V16, P225, DOI 10.1038/s41569-018-0114-9; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Gray RD, 2018, THORAX, V73, P134, DOI 10.1136/thoraxjnl-2017-210134; Rosa SIG, 2016, PHYTOMEDICINE, V23, P9, DOI 10.1016/j.phymed.2015.11.003; Guo WJ, 2019, AGING DIS, V10, P699, DOI 10.14336/AD.2018.1128; Hannawa KK, 2005, CIRCULATION, V112, P241, DOI 10.1161/CIRCULATIONAHA.105.535625; He L, 2018, ARTERIOSCL THROM VAS, V38, P1616, DOI 10.1161/ATVBAHA.118.311289; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kasper B, 2006, BLOOD, V107, P1768, DOI 10.1182/blood-2005-06-2501; Keeling W Brent, 2005, Vasc Endovascular Surg, V39, P457, DOI 10.1177/153857440503900601; Kelly BT, 2016, ANN ALLERG ASTHMA IM, V116, P183, DOI 10.1016/j.anai.2015.10.026; Kim HW, 2017, AM J PHYSIOL-HEART C, V313, pH1168, DOI 10.1152/ajpheart.00296.2017; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146565; Liu CL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11983-3; Liu CL, 2018, NAT REV CARDIOL, V15, P351, DOI 10.1038/s41569-018-0002-3; Liu CL, 2016, ARTERIOSCL THROM VAS, V36, P69, DOI 10.1161/ATVBAHA.115.305911; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Monteseirin J, 2001, CLIN EXP ALLERGY, V31, P889, DOI 10.1046/j.1365-2222.2001.01083.x; Monteseirin J, 2007, J IMMUNOL, V179, P2634, DOI 10.4049/jimmunol.179.4.2634; Moxon JV, 2010, CURR PROB CARDIOLOGY, V35, P512, DOI 10.1016/j.cpcardiol.2010.08.004; Nishi H, 2017, J CLIN INVEST, V127, P3810, DOI 10.1172/JCI94039; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Qin ZX, 2015, J MOL CELL CARDIOL, V87, P160, DOI 10.1016/j.yjmcc.2015.08.014; Ramos-Mozo P, 2012, ATHEROSCLEROSIS, V220, P552, DOI 10.1016/j.atherosclerosis.2011.11.023; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sampson UKA, 2014, GLOB HEART, V9, P171, DOI 10.1016/j.gheart.2013.12.010; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P21; Tsai SH, 2013, CARDIOVASC RES, V100, P501, DOI 10.1093/cvr/cvt230; Wang J, 2015, J VASC SURG, V62, P1615, DOI 10.1016/j.jvs.2014.06.004; Wang J, 2014, EMBO MOL MED, V6, P952, DOI 10.15252/emmm.201303811; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yamaguchi T, 2008, J CELL PHYSIOL, V217, P423, DOI 10.1002/jcp.21517; Yan HM, 2016, ARTERIOSCL THROM VAS, V36, P1660, DOI 10.1161/ATVBAHA.116.307786; Yang LL, 2017, CELL PHYSIOL BIOCHEM, V43, P2074, DOI 10.1159/000484192; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200; Zhang XJ, 2015, VASC PHARMACOL, V73, P86, DOI 10.1016/j.vph.2015.04.003	59	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3091	3104		10.1096/fj.201902095RR	http://dx.doi.org/10.1096/fj.201902095RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909541	Green Accepted			2022-12-26	WOS:000505525200001
J	Tran, PHT; Malmgaard-Clausen, NM; Puggaard, RS; Svensson, RB; Nybing, JD; Hansen, P; Schjerling, P; Zinglersen, AH; Couppe, C; Boesen, M; Magnusson, SP; Kjaer, M				Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Nybing, Janus D.; Hansen, Philip; Schjerling, Peter; Zinglersen, Amanda H.; Couppe, Christian; Boesen, Mikael; Magnusson, S. Peter; Kjaer, Michael			Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signaling	FASEB JOURNAL			English	Article						clinical; inflammation; mRNA; tendinopathy; ultrasound	HUMAN PATELLAR TENDON; VISA-A QUESTIONNAIRE; MECHANICAL-PROPERTIES; ACHILLES TENDINOSIS; COLLAGEN FIBRILS; GENE-EXPRESSION; SUBSTANCE-P; NEOVASCULARIZATION; IMMOBILIZATION; INFLAMMATION	Overloading of tendon tissue with resulting chronic pain (tendinopathy) is a common disorder in occupational-, leisure- and sports-activity, but its pathogenesis remains poorly understood. To investigate the very early phase of tendinopathy, Achilles and patellar tendons were investigated in 200 physically active patients and 50 healthy control persons. Patients were divided into three groups: symptoms for 0-1 months (T1), 1-2 months (T2) or 2-3 months (T3). Tendinopathic Achilles tendon cross-sectional area determined by ultrasonography (US) was similar to 25% larger than in healthy control persons. Both Achilles and patellar anterior-posterior diameter were elevated in tendinopathy, and only later in Achilles was the width increased. Increased tendon size was accompanied by an increase in hypervascularization (US Doppler flow) without any change in mRNA for angiogenic factors. From patellar biopsies taken bilaterally, mRNA for most growth factors and tendon components remained unchanged (except for TGF-beta1 and substance-P) in early tendinopathy. Tendon stiffness remained unaltered over the first three months of tendinopathy and was similar to the asymptomatic contra-lateral tendon. In conclusion, this suggests that tendinopathy pathogenesis represents a disturbed tissue homeostasis with fluid accumulation. The disturbance is likely induced by repeated mechanical overloading rather than a partial rupture of the tendon.	[Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Schjerling, Peter; Zinglersen, Amanda H.; Couppe, Christian; Magnusson, S. Peter; Kjaer, Michael] Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Bldg 8,Nielsine Nielsens Vej 11, DK-2400 Copenhagen NV, Denmark; [Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Schjerling, Peter; Zinglersen, Amanda H.; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Couppe, Christian; Magnusson, S. Peter] Bispebjerg Hosp, Dept Phys & Occupat Therapy, Copenhagen, Denmark; [Nybing, Janus D.; Hansen, Philip; Boesen, Mikael] Bispebjerg Frederiksberg Hosp, Dept Radiol, Frederiksberg, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Tran, PHT (corresponding author), Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Bldg 8,Nielsine Nielsens Vej 11, DK-2400 Copenhagen NV, Denmark.	tranenpeter@gmail.com	Magnusson, Peter/AAN-1631-2020; Kjaer, Michael/W-6842-2019; Magnusson, S. Peter/AAD-5903-2022; Zinglersen, Amanda Hempel/ABH-2482-2020; Svensson, Rene B./AGZ-3181-2022; Schjerling, Peter/F-6194-2011	Kjaer, Michael/0000-0002-4582-8755; Magnusson, S. Peter/0000-0002-4308-5484; Svensson, Rene B./0000-0002-1607-5379; Schjerling, Peter/0000-0001-7138-3211; Zinglersen, Amanda Hempel/0000-0003-2880-1638; Hansen, Philip/0000-0002-6972-7852	Lundbeck Foundation [R198-2015-207]; Nordea Foundation; Augustinus Foundation [17-3727]; Novo Nordisk Foundation [NNF16-0C0022846]; Ministry of Culture [FPK-2016-0069]; Danish Rheumatism Association [R150-A4500]	Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; Augustinus Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ministry of Culture; Danish Rheumatism Association	Lundbeck Foundation, Grant/Award Number: R198-2015-207; Nordea Foundation; Augustinus Foundation, Grant/Award Number: 17-3727; Novo Nordisk Foundation, Grant/Award Number: NNF16-0C0022846; Ministry of Culture, Grant/Award Number: FPK-2016-0069; The Danish Rheumatism Association, Grant/Award Number: R150-A4500	Ackermann PW, 2003, J ORTHOP RES, V21, P432, DOI 10.1016/S0736-0266(02)00207-3; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Beyer R, 2018, TRANSL SPORTS MED, V1, P79, DOI 10.1002/tsm2.19; Boesen AP, 2014, J APPL PHYSIOL, V116, P192, DOI 10.1152/japplphysiol.01077.2013; Child S, 2010, AM J SPORT MED, V38, P1885, DOI 10.1177/0363546510366234; Couppe C, 2013, SCAND J MED SCI SPOR, V23, pe89, DOI 10.1111/sms.12023; Couppe C, 2012, CLIN BIOMECH, V27, P949, DOI 10.1016/j.clinbiomech.2012.06.003; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; de Boer MD, 2007, J PHYSIOL-LONDON, V583, P1079, DOI 10.1113/jphysiol.2007.135392; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Gardin A, 2016, J MAGN RESON IMAGING, V43, P1417, DOI 10.1002/jmri.25104; Gotoh M, 1998, J ORTHOP RES, V16, P618, DOI 10.1002/jor.1100160515; Hansen P, 2006, CLIN BIOMECH, V21, P54, DOI 10.1016/j.clinbiomech.2005.07.008; Heinemeier KM, 2016, J APPL PHYSIOL, V120, P1000, DOI 10.1152/japplphysiol.00870.2015; Heinemeier KM, 2017, J APPL PHYSIOL, V123, P1397, DOI 10.1152/japplphysiol.00281.2017; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hullfish TJ, 2018, J APPL PHYSIOL, V125, P453, DOI 10.1152/japplphysiol.00012.2018; Iversen JV, 2016, SCAND J MED SCI SPOR, V26, P1423, DOI 10.1111/sms.12576; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Kjaer M, 2013, J APPL PHYSIOL, V115, P879, DOI 10.1152/japplphysiol.00120.2013; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277, DOI 10.3109/17453679608994688; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Maganaris CN, 2003, P ROY SOC B-BIOL SCI, V270, pS39, DOI 10.1098/rsbl.2003.0004; Magnusson SP, 2010, NAT REV RHEUMATOL, V6, P262, DOI 10.1038/nrrheum.2010.43; Magnusson SP, 2018, J PHYSL, V597, P1283; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Nadeau MJ, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0164-3; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Pingel J, 2014, J ANAT, V224, P548, DOI 10.1111/joa.12164; Pingel J, 2013, EUR J APPL PHYSIOL, V113, P2101, DOI 10.1007/s00421-013-2638-3; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Rigozzi S, 2011, J STRUCT BIOL, V176, P9, DOI 10.1016/j.jsb.2011.07.002; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; Zanetti M, 2003, RADIOLOGY, V227, P556, DOI 10.1148/radiol.2272012069; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	43	33	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					776	788		10.1096/fj.201901309R	http://dx.doi.org/10.1096/fj.201901309R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914656				2022-12-26	WOS:000507308900053
J	Zhou, C; Zhang, JC; Zhang, M; Wang, DB; Ma, Y; Wang, Y; Wang, YZ; Huang, YM; Zhang, Y				Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Ma, Yi; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong			Transcriptional memory inherited from donor cells is a developmental defect of bovine cloned embryos	FASEB JOURNAL			English	Article						Transcriptional memory gene; somatic cell nuclear transfer reprogramming; bovine	PLURIPOTENT STEM-CELLS; EPIGENETIC MEMORY; GENE-EXPRESSION; NUCLEAR; METHYLATION; IDENTIFICATION; FIBROBLASTS; PROTEIN-1; OOCYTES; FETAL	Studies on the effects of transcriptional memory on clone reprogramming in mammals are limited. In the present study, we observed higher levels of active histone H3 lysine 4 trimethylation (H3K4me3 and 5-hydroxymethylcytosine) and repressive (5-methylcytosine) epigenetic modifications in bovine early cloned embryos than in in vitro fertilized embryos. We hypothesized that aberrant epigenetic modification may result in transcriptional disorders in bovine somatic cell nuclear transfer (SCNT) embryos. RNA sequencing results confirmed that both abnormal transcriptional silencing and transcriptional activation are involved in bovine SCNT reprogramming. The cloned embryos exhibited excessive transcription in RNA processing- and translation-related genes as well as transcriptional defects in reproduction-related genes whose transcriptional profiles were similar to those in donor cells. These results demonstrated the existence of active and silent memory genes inherited from donor cells in early bovine SCNT embryos. Further, H3K4me3-specific demethylase 5B (KDM5B) mRNA was injected into the reconstructed embryos to reduce the increased H3K4me3 modification. KDM5B overexpression not only reduced the transcriptional level of active memory genes, but also promoted the expression of silent memory genes; in particular, it rescued the expression of multiple development-related genes. These results showed that transcriptional memory acts as a reprogramming barrier and KDM5B improves SCNT reprogramming via bidirectional regulation effects on transcriptional memory genes in bovines.	[Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Engn Ctr Anim Embryo Technol, Yangling, Shaanxi, Peoples R China; [Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Northwest A&F Univ, Lab Embryo Technol Livestock, Yangling, Shaanxi, Peoples R China; [Ma, Yi] Tianjin Inst Anim Sci & Vet, Tianjin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn			National Natural Science Foundation of China [31772603]; National Major Project for Production of Transgenic Breeding [2016ZX08007-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding	National Natural Science Foundation of China, Grant/Award Number: 31772603; National Major Project for Production of Transgenic Breeding, Grant/Award Number: 2016ZX08007-003	Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Cao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144897; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Gao R, 2018, CELL STEM CELL, V23, P426, DOI 10.1016/j.stem.2018.07.017; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Han J, 2018, THERIOGENOLOGY, V108, P46, DOI 10.1016/j.theriogenology.2017.11.029; Hormanseder E, 2017, CELL STEM CELL, V21, P135, DOI 10.1016/j.stem.2017.03.003; Hu JJ, 2010, DEV DYNAM, V239, P407, DOI 10.1002/dvdy.22170; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Liu Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5091-1; Lonergan P, 2007, THERIOGENOLOGY, V68, P1128, DOI 10.1016/j.theriogenology.2007.08.012; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rissi VB, 2019, REPRODUCTION, V157, P123, DOI 10.1530/REP-18-0366; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Singh SK, 2018, CELL STEM CELL, V23, P252, DOI 10.1016/j.stem.2018.06.001; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024; Yang L, 2018, EMBO REP, V19, DOI 10.15252/embr.201846240; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zhang JC, 2017, J BIOL CHEM, V292, P15916, DOI 10.1074/jbc.M117.796771; Zhang ZR, 2018, CELL PHYSIOL BIOCHEM, V45, P1529, DOI 10.1159/000487579; Zhou C, 2019, FASEB J, V33, P4638, DOI 10.1096/fj.201801887R	52	25	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1637	1651		10.1096/fj.201900578RR	http://dx.doi.org/10.1096/fj.201900578RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914649				2022-12-26	WOS:000507308900108
J	Goldstick, JE; Walton, MA; Bohnert, ASB; Heinze, JE; Cunningham, RM				Goldstick, Jason E.; Walton, Maureen A.; Bohnert, Amy S. B.; Heinze, Justin E.; Cunningham, Rebecca M.			Predictors of alcohol use transitions among drug-using youth presenting to an urban emergency department	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE-ABUSE TREATMENT; UNITED-STATES; PROTECTIVE FACTORS; FIREARM VIOLENCE; SELF-REPORT; RISK; ADOLESCENTS; DRINKING; INVOLVEMENT	Background Precipitants of alcohol use transitions can differ from generalized risk factors. We extend prior research by predicting transitions in alcohol use disorder (AUD) during adolescence and emerging adulthood. Methods From 12/2009-9/2011, research assistants recruited 599 drug-using youth age 1424 from Level-1 Emergency Department in Flint, Michigan. Youth were assessed at baseline and four biannual follow-ups, including a MINI Neuropsychiatric interview to diagnose AUD (abuse/dependence). We modeled AUD transitions using continuous time Markov Chains with transition probabilities modulated by validated measures of demographics, anxiety/depression symptoms, cannabis use, peer drinking, parental drinking, and violence exposure. Separate models were fit for underage (<21) and those of legal drinking age. Results We observed 2,024 pairs of consecutive AUD states, including 264 transitions (119 No-AUD?AUD; 145 AUD?No-AUD); 194 (32.4%) individuals were diagnosed with AUD at =1 assessment. Among age 1420, peer drinking increased AUD onset (No-AUD?AUD transition) rates (Hazard ratioHR = 1.70; 95%CI: [1.13,2.54]), parental drinking lowered AUD remission (AUD?No-AUD transition) rates (HR = 0.53; 95%CI: [0.29,0.97]), and cannabis use severity both hastened AUD onset (HR = 1.18; 95%CI: [1.06,1.32]) and slowed AUD remission (HR = 0.85; 95%CI: [0.76,0.95]). Among age 2124, anxiety/depression symptoms both increased AUD onset rates (HR = 1.35; 95%CI: [1.13,1.60]) and decreased AUD remission rates (HR = 0.74; 95%CI: [0.63,0.88]). Friend drinking hastened AUD onset (HR = 1.18, 95%CI: [1.05,1.33]), and slowed AUD remission (HR = 0.84; 95%CI: [0.75,0.95]). Community violence exposure slowed AUD remission (HR = 0.69, 95%CI: [0.48,0.99]). In both age groups, males had >2x the AUD onset rate of females, but there were no sex differences in AUD remission rates. Limitations, most notably that this study occurred at a single site, are discussed. Conclusions Social influences broadly predicted AUD transitions in both age groups. Transitions among younger youth were predicted by cannabis use, while those among older youth were predicted more by internalizing symptoms and stress exposure (e.g., community violence). Our results suggest age-specific AUD etiology, and contrasts between prevention and treatment strategies.	[Goldstick, Jason E.; Cunningham, Rebecca M.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Goldstick, Jason E.; Walton, Maureen A.; Bohnert, Amy S. B.; Heinze, Justin E.; Cunningham, Rebecca M.] Univ Michigan, Injury Prevent Ctr, Ann Arbor, MI 48109 USA; [Walton, Maureen A.; Bohnert, Amy S. B.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI USA; [Heinze, Justin E.; Cunningham, Rebecca M.] Univ Michigan, Sch Publ Hlth, Youth Violence Prevent Ctr, Ann Arbor, MI 48109 USA; [Heinze, Justin E.; Cunningham, Rebecca M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Cunningham, Rebecca M.] Hurley Med Ctr, Dept Emergency Med, Flint, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldstick, JE (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Goldstick, JE (corresponding author), Univ Michigan, Injury Prevent Ctr, Ann Arbor, MI 48109 USA.	jasoneg@umich.edu			National Institutes on Alcohol Abuse and Alcoholism [R03AA025449]; National Institute on Drug Abuse [R01DA024646]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA025449] Funding Source: NIH RePORTER	National Institutes on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grants from the National Institutes on Alcohol Abuse and Alcoholism, R03AA025449 (https://www.niaaa.nih.gov/)-JG was PI and authors MW, AB, and JH were co-Investigators. The parent study was funded by a grant to the National Institute on Drug Abuse, R01DA024646 (https://www.drugabuse.gov/) RC was PI and MWwas a Co-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Hernandez R, 2002, STAT MED, V21, P1899, DOI 10.1002/sim.1152; [Anonymous], [No title captured]; Bohnert KM, 2015, ADDICT BEHAV, V41, P97, DOI 10.1016/j.addbeh.2014.09.019; Bonar EE, 2019, ALCOHOL ALCOHOLISM; Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003; Bucholz KK, 2017, ALCOHOL CLIN EXP RES, V41, P359, DOI 10.1111/acer.13293; Cadigan JM, 2015, J CONSULT CLIN PSYCH, V83, P430, DOI 10.1037/a0038394; Caldwell TM, 2002, ADDICTION, V97, P583, DOI 10.1046/j.1360-0443.2002.00092.x; Carter PM, 2015, PEDIATRICS, V135, P805, DOI 10.1542/peds.2014-3572; Chen MJ, 2010, ADDICTION, V105, P270, DOI 10.1111/j.1360-0443.2009.02772.x; Chermack ST, 2002, DRUG ALCOHOL DEPEN, V66, P29, DOI 10.1016/S0376-8716(01)00180-6; Chou SP, 2006, DRUG ALCOHOL DEPEN, V83, P137, DOI 10.1016/j.drugalcdep.2005.11.001; Cunningham R, 2009, ANN EMERG MED, V53, P310, DOI 10.1016/j.annemergmed.2008.07.018; Cunningham R, 2009, ANN EMERG MED, V53, P490, DOI 10.1016/j.annemergmed.2008.11.014; Cunningham RM, 2015, JAMA PEDIATR, V169, P63, DOI 10.1001/jamapediatrics.2014.1900; Cunningham RM, 2014, PEDIATRICS, V133, pE96, DOI 10.1542/peds.2013-1864; D'Amico EJ, 2018, J CONSULT CLIN PSYCH, V86, P775, DOI 10.1037/ccp0000332; Dawson DA, 2009, ALCOHOL ALCOHOLISM, V44, P84, DOI 10.1093/alcalc/agn094; Ellis DA, 1997, ALCOHOL HEALTH RES W, V21, P218; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Goldstick JE, 2017, ANN INTERN MED, V166, P707, DOI 10.7326/M16-1927; Goldstick JE, 2015, SUBST USE MISUSE, V50, P674, DOI 10.3109/10826084.2014.998235; Goldstick JE, 2018, ALCOHOL ALCOHOLISM; Goldstick JE, 2018, J RES ADOLESCENCE; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Hakkarainen P, 2009, EUR ADDICT RES, V15, P113, DOI 10.1159/000209244; Handelsman L, 2005, DRUG ALCOHOL DEPEN, V80, P63, DOI 10.1016/j.drugalcdep.2005.03.022; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Jackson CH, 2011, J STAT SOFTW, V38, P1; Johnston LD, 2013, MONITORING FUTURE NA, P85; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V93, P21, DOI 10.1016/j.drugalcdep.2007.08.017; Kuntsche E, 2005, CLIN PSYCHOL REV, V25, P841, DOI 10.1016/j.cpr.2005.06.002; Maio RF, 2005, ANN EMERG MED, V45, P420, DOI 10.1016/j.annemergmed.2004.10.013; Marschall-Levesque S, 2014, ADDICT BEHAV, V39, P48, DOI 10.1016/j.addbeh.2013.09.025; McCarty CA, 2012, J STUD ALCOHOL DRUGS, V73, P444, DOI 10.15288/jsad.2012.73.444; Patrick ME, 2011, DEV PSYCHOL, V47, P311, DOI 10.1037/a0021939; Perkins HW, 2005, J STUD ALCOHOL, V66, P470, DOI 10.15288/jsa.2005.66.470; PIERSMA HL, 1994, J CLIN PSYCHOL, V50, P555, DOI 10.1002/1097-4679(199407)50:4<555::AID-JCLP2270500410>3.0.CO;2-G; Prince MA, 2010, ADDICT BEHAV, V35, P940, DOI 10.1016/j.addbeh.2010.06.006; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; Rehm J, 2011, ALCOHOL RES HEALTH, V34, P135; Roche JS, 2018, ACAD EMERG MED, V25, P1204, DOI 10.1111/acem.13495; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Savasan A, 2017, ARCH PSYCHIAT NURS, V31, P274, DOI 10.1016/j.apnu.2017.01.002; Scheier LM, 1997, J STUD ALCOHOL, V58, P652, DOI 10.15288/jsa.1997.58.652; Sheehan D.V., 1998, J CLIN PSYCHIAT; Sieving RE, 2001, J ADOLESCENT HEALTH, V28, P73, DOI 10.1016/S1054-139X(00)00155-5; STEINBERG L, 1994, PEDIATRICS, V93, P1060; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Steinka-Fry KT, 2017, J SUBST ABUSE TREAT, V75, P22, DOI 10.1016/j.jsat.2017.01.006; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Walden B, 2004, J ABNORM PSYCHOL, V113, P440, DOI 10.1037/0021-843x.113.3.440; Walton MA, 2011, J ADOLESCENT HEALTH, V48, P303, DOI 10.1016/j.jadohealth.2010.07.005; Walton MA, 2010, JAMA-J AM MED ASSOC, V304, P527, DOI 10.1001/jama.2010.1066; Walton MA, 2009, J ADOLESCENT HEALTH, V45, P77, DOI 10.1016/j.jadohealth.2008.12.005; Zimmerman MA, 2002, J APPL SOC PSYCHOL, V32, P86, DOI 10.1111/j.1559-1816.2002.tb01421.x	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227140	10.1371/journal.pone.0227140	http://dx.doi.org/10.1371/journal.pone.0227140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891632	Green Published, gold			2022-12-26	WOS:000515096600064
J	Goss, JA; Huang, AY; Smith, E; Konczyk, DJ; Smits, PJ; Sudduth, CL; Stapleton, C; Patel, A; Alexandrescu, S; Warman, ML; Greene, AK				Goss, Jeremy A.; Huang, August Y.; Smith, Edward; Konczyk, Dennis J.; Smits, Patrick J.; Sudduth, Christopher L.; Stapleton, Christopher; Patel, Aman; Alexandrescu, Sanda; Warman, Matthew L.; Greene, Arin K.			Somatic mutations in intracranial arteriovenous malformations	PLOS ONE			English	Article							KRAS MUTATIONS; BRAF; CARCINOMAS	Background Intracranial arteriovenous malformation (AVM) is a common cause of primary intracerebral hemorrhage in young adults. Lesions typically are sporadic and contain somatic mutations in KRAS or BRAF. The purpose of this study was to identify somatic mutations in a cohort of participants with brain AVM and to determine if any genotype-phenotype associations exist. Methods Human brain AVM specimens (n = 16) were collected during a clinically-indicated procedure and subjected to multiplex targeted sequencing using molecular inversion probe (MIP-seq) for mutations in KRAS, BRAF, HRAS, NRAS, and MAP2K1. Endothelial cells (ECs) were separated from non-ECs by immune-affinity purification. Droplet digital PCR (ddPCR) was used to confirm mutations and to screen for mutations that may have been missed by MIP-seq. Patient and AVM characteristics were recorded. Results We detected somatic mutations in 10 of 16 specimens (63%). Eight had KRAS mutations [G12D (n = 5), G12V (n = 3)] and two had BRAF mutations [V600E (n = 1), Q636X (n = 1)]. We found no difference in age, sex, presenting symptom, AVM location, or AVM size between patients with a confirmed mutation and those without. Nor did we observe differences in these features between patients with KRAS or BRAF mutations. However, two patients with BRAF mutations presented at an older age than other study participants. Conclusions Somatic mutations in KRAS and, less commonly in BRAF, are found in many but not all intracranial AVM samples. Currently, there are no obvious genotype-phenotype correlations that can be used to predict whether a somatic mutation will be detected and, if so, which gene will be mutated.	[Goss, Jeremy A.; Konczyk, Dennis J.; Smits, Patrick J.; Sudduth, Christopher L.; Greene, Arin K.] Harvard Med Sch, Dept Plast & Oral Surg, Boston Childrens Hosp, Boston, MA 02115 USA; [Huang, August Y.; Alexandrescu, Sanda] Harvard Med Sch, Dept Pathol, Boston Childrens Hosp, Boston, MA 02115 USA; [Smith, Edward] Harvard Med Sch, Dept Neurosurg, Boston Childrens Hosp, Boston, MA 02115 USA; [Stapleton, Christopher; Patel, Aman] Harvard Med Sch, Dept Neurosurg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Med Sch, Dept Orthoped Surg, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Greene, AK (corresponding author), Harvard Med Sch, Dept Plast & Oral Surg, Boston Childrens Hosp, Boston, MA 02115 USA.	arin.greene@childrens.harvard.edu	Huang, August Yue/E-9983-2016	Huang, August Yue/0000-0002-0416-2854; Smith, Edward/0000-0002-6317-8450	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R01HD093735]; Translational Research Program Boston Children's Hospital; National Institutes of Health [NIH R01AR064231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD093735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064231] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Translational Research Program Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (https://www.nichd.nih.gov/) under Award Number R01HD093735 (AKG), the Translational Research Program Boston Children's Hospital (AKG), and the National Institutes of Health (https://www.nih.gov/) under Award Number NIH R01AR064231 (MLW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahi R, 2001, BRAIN, V124, P1900, DOI 10.1093/brain/124.10.1900; Amyere M, 2017, CIRCULATION, V136, P1037, DOI 10.1161/CIRCULATIONAHA.116.026886; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Cooke SL, 2017, CLIN CANCER RES, V23, P7633, DOI 10.1158/1078-0432.CCR-17-1789; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; Hong T, 2019, BRAIN, V142, P23, DOI 10.1093/brain/awy307; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Nikolaev SI, 2018, NEW ENGL J MED, V378, P250, DOI 10.1056/NEJMoa1709449; Pender A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139074; Priemer DS, 2019, HUM PATHOL, V89, P33, DOI 10.1016/j.humpath.2019.04.004; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Thiex R, 2010, AM J NEURORADIOL, V31, P775, DOI 10.3174/ajnr.A1907; Yuen ST, 2002, CANCER RES, V62, P6451	20	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226852	10.1371/journal.pone.0226852	http://dx.doi.org/10.1371/journal.pone.0226852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891627	gold, Green Published			2022-12-26	WOS:000515096600035
J	Zabala, V; Boylan, JM; Thevenot, P; Frank, A; Senthoor, D; Iyengar, V; Kim, H; Cohen, A; Gruppuso, PA; Sanders, JA				Zabala, Valerie; Boylan, Joan M.; Thevenot, Paul; Frank, Anderson; Senthoor, Dewahar; Iyengar, Varun; Kim, Hannah; Cohen, Ari; Gruppuso, Philip A.; Sanders, Jennifer A.			Transcriptional changes during hepatic ischemia-reperfusion in the rat	PLOS ONE			English	Article							LIVER RESECTION; GENE-EXPRESSION; INJURY; TRANSPLANTATION; METAANALYSIS; OUTCOMES; IMPACT; TARGET; FETAL	There are few effective targeted strategies to reduce hepatic ischemia-reperfusion (IR) injury, a contributor to poor outcomes in liver transplantation recipients. It has been proposed that IR injury is driven by the generation of reactive oxygen species (ROS). However, recent studies implicate other mediators of the injury response, including mitochondrial metabolic dysfunction. We examined changes in global gene expression after transient hepatic ischemia and at several early reperfusion times to identify potential targets that could be used to protect against IR injury. Male Wistar rats were subjected to 30 minutes of 70% partial warm ischemia followed by 0, 0.5, 2, or 6 hours of reperfusion. RNA was extracted from the reperfused and non-ischemic lobes at each time point for microarray analysis. Identification of differentially expressed genes and pathway analysis were used to characterize IRinduced changes in the hepatic transcriptome. Changes in the reperfused lobes were specific to the various reperfusion times. We made the unexpected observation that many of these changes were also present in tissue from the paired non-ischemic lobes. However, the earliest reperfusion time, 30 minutes, showed a marked increase in the expression of a set of immediate-early genes (c-Fos, c-Jun, Atf3, Egr1) that was exclusive to the reperfused lobe. We interpreted these results as indicating that this early response represented a tissue autonomous response to reperfusion. In contrast, the changes that occurred in both the reperfused and non-ischemic lobes were interpreted as indicating a non-autonomous response resulting from hemodynamic changes and/or circulating factors. These tissue autonomous and non-autonomous responses may serve as targets to ameliorate IR injury.	[Zabala, Valerie; Boylan, Joan M.; Gruppuso, Philip A.; Sanders, Jennifer A.] Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Zabala, Valerie; Boylan, Joan M.; Gruppuso, Philip A.; Sanders, Jennifer A.] Brown Univ, Providence, RI 02912 USA; [Zabala, Valerie; Boylan, Joan M.; Kim, Hannah] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Thevenot, Paul; Frank, Anderson; Cohen, Ari] Ochsner Hlth Syst, Inst Translat Res, New Orleans, LA USA; [Senthoor, Dewahar; Iyengar, Varun] Warren Alpert Med Sch, Providence, RI USA; [Gruppuso, Philip A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Sanders, Jennifer A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Ochsner Health System; Brown University; Brown University; Brown University	Sanders, JA (corresponding author), Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.; Sanders, JA (corresponding author), Brown Univ, Providence, RI 02912 USA.; Sanders, JA (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Jennifer_Sanders@brown.edu		Frank, Anderson/0000-0003-2239-9975; Sanders, Jennifer/0000-0002-4714-5114; Thevenot, Paul/0000-0002-6483-6259	NSF Graduate Fellowship Program; Rhode Island Department of Pediatrics; Ochsner Translational Medicine Research Initiative Grant	NSF Graduate Fellowship Program(National Science Foundation (NSF)); Rhode Island Department of Pediatrics; Ochsner Translational Medicine Research Initiative Grant	VZ was a Howard Hughes Medical Institute Gilliam Fellow and was supported by the NSF Graduate Fellowship Program. These studies were supported by the Rhode Island Department of Pediatrics and Ochsner Translational Medicine Research Initiative Grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2012, LANGENBECK ARCH SURG, V397, P579, DOI 10.1007/s00423-012-0913-0; Barrier A, 2005, FASEB J, V19, P1617, DOI 10.1096/fj.04-3445com; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Boylan JM, 2017, TRANSPLANTATION, V101, P2349, DOI 10.1097/TP.0000000000001882; Boylan JM, 2015, AM J PHYSIOL-REG I, V309, pR22, DOI 10.1152/ajpregu.00114.2015; Braet Filip, 2004, Comp Hepatol, V3, P7, DOI 10.1186/1476-5926-3-7; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Dergunova LV, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5039-5; Desai BN, 2017, MOL METAB, V6, P1395, DOI 10.1016/j.molmet.2017.08.004; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu JF, 2016, J HEPATOL, V64, P146, DOI 10.1016/j.jhep.2015.08.021; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Karatzas T, 2014, J SURG RES, V191, P399, DOI 10.1016/j.jss.2014.06.024; Kim WR, 2018, AM J TRANSPLANT, V18, P172, DOI 10.1111/ajt.14559; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Michael AOA, 2017, ONCOTARGET, V8, P26041, DOI 10.18632/oncotarget.15219; Motino O, 2019, HEPATOLOGY, V70, P650, DOI 10.1002/hep.30241; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nakatsuka H, 2006, AM J PHYSIOL-GASTR L, V291, pG26, DOI 10.1152/ajpgi.00467.2005; O'Neill S, 2013, BRIT J SURG, V100, P1689, DOI 10.1002/bjs.9277; Olthof PB, 2017, BBA-MOL BASIS DIS, V1863, P375, DOI 10.1016/j.bbadis.2016.10.022; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Ozhathil DK, 2011, LIVER TRANSPLANT, V17, P1191, DOI 10.1002/lt.22343; Planavila A, 2015, CARDIOVASC RES, V106, P19, DOI 10.1093/cvr/cvu263; Prieto I, 2017, REDOX BIOL, V12, P1020, DOI 10.1016/j.redox.2017.04.036; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robertson FP, 2016, TRANSPL INT, V29, P1147, DOI 10.1111/tri.12849; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Simillis C, 2016, SURGERY, V159, P1157, DOI 10.1016/j.surg.2015.10.011; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Sun K, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-26; Tan EK, 2017, OCHSNER J, V17, P31; Wang XD, 2019, HEPATOLOGY, V69, P314, DOI 10.1002/hep.30169; Yamanaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122214; Ye DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19776; Ye LX, 2019, EXP NEUROL, V317, P34, DOI 10.1016/j.expneurol.2019.02.013; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451; Zhu JJ, 2015, TRANSPLANTATION, V99, P48, DOI 10.1097/TP.0000000000000476	49	5	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227038	10.1371/journal.pone.0227038	http://dx.doi.org/10.1371/journal.pone.0227038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891620	Green Published, gold			2022-12-26	WOS:000515096600053
J	Braun, MM; Damjanac, T; Zhang, YX; Chen, C; Hu, JH; Maher, LJ				Braun, Megan M.; Damjanac, Tamara; Zhang, Yuxia; Chen, Chuan; Hu, Jinghua; Maher, L. James, III			Modeling succinate dehydrogenase loss disorders in C. elegans through effects on hypoxia-inducible factor	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX II; GENE; PARAGANGLIOMA; MUTATIONS; PHEOCHROMOCYTOMA; DISEASES; NEMATODE; TARGETS; CYCLE	Mitochondrial disorders arise from defects in nuclear genes encoding enzymes of oxidative metabolism. Mutations of metabolic enzymes in somatic tissues can cause cancers due to oncometabolite accumulation. Paraganglioma and pheochromocytoma are examples, whose etiology and therapy are complicated by the absence of representative cell lines or animal models. These tumors can be driven by loss of the tricarboxylic acid cycle enzyme succinate dehydrogenase. We exploit the relationship between succinate accumulation, hypoxic signaling, egg-laying behavior, and morphology in C. elegans to create genetic and pharmacological models of succinate dehydrogenase loss disorders. With optimization, these models may enable future high-throughput screening efforts.	[Braun, Megan M.; Damjanac, Tamara; Zhang, Yuxia; Chen, Chuan; Hu, Jinghua; Maher, L. James, III] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Braun, Megan M.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Damjanac, Tamara] Univ Minnesota, Med Sch Twin Cities, Minneapolis, MN USA; [Zhang, Yuxia] Univ Texas Dallas, MD Anderson Canc Ctr, Dallas, TX USA	Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Dallas; UTMD Anderson Cancer Center	Maher, LJ (corresponding author), Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	maher@mayo.edu	wang, meng/GWZ-9558-2022	Braun, Megan/0000-0002-8756-417X; Chen, Chuan/0000-0002-0694-0867; Maher, Louis/0000-0002-5043-6422	Mayo Foundation; Paradifference Foundation; NIH [CA166025]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090728, R01DK099160, R01DK090038] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Mayo Foundation; Paradifference Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Mayo Foundation, the Paradifference Foundation, and by NIH grant CA166025 (LJM). Some C. elegans strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bancos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056827; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Berends AMA, 2018, EUR J INTERN MED, V51, P68, DOI 10.1016/j.ejim.2018.01.015; Bezawork-Geleta A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04603-z; Bezawork-Geleta A, 2017, TRENDS BIOCHEM SCI, V42, P312, DOI 10.1016/j.tibs.2017.01.003; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Favier J, 2015, NAT REV ENDOCRINOL, V11, P101, DOI 10.1038/nrendo.2014.188; Fets L, 2018, NAT CHEM BIOL, V14, P1032, DOI 10.1038/s41589-018-0136-y; Gardner M, 2013, JOVE-J VIS EXP, DOI 10.3791/51203; Her YF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296167; Her YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127471; Her YF, 2015, INT J ENDOCRINOL, V2015, P1, DOI DOI 10.1016/J.CCR.2005.06.017; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Lepoutre-Lussey C, 2016, MOL CELL ENDOCRINOL, V421, P40, DOI 10.1016/j.mce.2015.06.027; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; TRENT C, 1983, GENETICS, V104, P619; Woods S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003330; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112	41	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227033	10.1371/journal.pone.0227033	http://dx.doi.org/10.1371/journal.pone.0227033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887185	Green Published, gold			2022-12-26	WOS:000515092200065
J	Liao, LN; Li, CI; Wu, FY; Yang, CW; Lin, CH; Liu, CS; Lin, WY; Li, TC; Lin, CC				Liao, Li-Na; Li, Chia-Ing; Wu, Fang-Yang; Yang, Chuan-Wei; Lin, Chih-Hsueh; Liu, Chiu-Shong; Lin, Wen-Yuan; Li, Tsai-Chung; Lin, Cheng-Chieh			Important gene-gene interaction of TNF-alpha and VDR on osteoporosis in community-dwelling elders	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; NECROSIS-FACTOR-ALPHA; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; NUCLEOTIDE VARIANT; PROMOTER REGION; POLYMORPHISM; CYTOKINES; INTERLEUKIN-6; MECHANISMS	Gene effects on osteoporosis have been studied separately and may have been masked by gene-gene and gene-environment interactions. We evaluated gene-gene and gene-physical activity interactions of the variants of tumor necrosis factor-alpha (TNF-alpha) and vitamin D receptor (VDR) genes on osteoporosis. A total of 472 elders were included. Seven variants (TNF-alpha: rs1799964, rs1800629, rs3093662; VDR: rs7975232, rs1544410, rs2239185, rs3782905) were genotyped. Bone mineral densities of the lumbar spine, femoral neck, and total hip were measured by dual-energy X-ray absorptiometry. Predictive models' ability to discriminate osteoporosis status was evaluated by areas under the receiver operating characteristics (AUROC) curve. After multivariable adjustment, significant interactions of TNF-alpha rs1800629 and VDR rs3782905 were observed on overall and lumbar spine osteoporosis. In elderly women, we found that those carrying the CG/CC genotype of VDR rs3782905 were significantly associated with increased odds of overall osteoporosis compared with those carrying the GG genotype of VDR rs3782905 among those carrying TNF-alpha rs1800629 GG genotype. The adjusted odds ratios (ORs) for VDR rs3782905 CG/CC genotype in elderly women carrying TNF-alpha rs1800629 AG/AA and GG genotypes were 0.1 (0.01, 0.98) and 3.54 (1.51, 8.30), respectively. We observed significant differences in AUROCs between the model with traditional covariates plus variants and their interaction term and the model with traditional covariates only (AUROCs: 0.77 and 0.81; p = 0.028). Although the sample size of this study may have been relatively small, our results suggest that the interaction of the CG/CC genotype of VDR rs3782905 with TNF-alpha rs1800629 GG genotype was associated with increased odds of overall and lumbar spine osteoporosis in elderly women.	[Liao, Li-Na; Wu, Fang-Yang; Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Li, Chia-Ing; Yang, Chuan-Wei; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Li, Chia-Ing; Lin, Chih-Hsueh; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Chih-Hsueh; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Li, TC (corresponding author), China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.; Li, TC (corresponding author), Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan.	tcli@mail.cmu.edu.tw; cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	National Health Research Institutes of Taiwan; Ministry of Science and Technology, Taiwan [104-2314-B039-016, MOST 105-2314-B-039 -025-MY3, MOST 105-2314-B-039-021-MY3, MOST 1082314-B-039-031-MY2, MOST 108-2314-B-039035-MY3]; China Medical University Hospital [DMR107-088]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	Funded by National Health Research Institutes of Taiwan. NHRI-EX98-9838PI Ministry of Science and Technology, Taiwan. http://dx.doi.org/10.13039/501100004663.MOST 104-2314-B039-016 & MOST 105-2314-B-039 -025-MY3 & MOST 105-2314-B-039-021-MY3 & MOST 1082314-B-039-031-MY2 & MOST 108-2314-B-039035-MY3 China Medical University Hospital. DMR107-088. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bikle DD, 2010, NUTR HEALTH SER, P277, DOI 10.1007/978-1-60327-303-9_12; Boron D, 2015, OSTEOPOROSIS INT, V26, P1045, DOI 10.1007/s00198-014-2947-3; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Choi M, 2013, CYTOKINE, V63, P27, DOI 10.1016/j.cyto.2013.03.018; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Fairbrother UL, 2007, J BONE MINER RES, V22, P544, DOI 10.1359/jbmr.070114; Ferrari Serge L., 2005, Molecular Aspects of Medicine, V26, P145, DOI 10.1016/j.mam.2005.01.002; Furuta I, 2004, CALCIFIED TISSUE INT, V74, P509, DOI 10.1007/s00223-003-0105-6; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Garnero P, 2002, BONE, V31, P43, DOI 10.1016/S8756-3282(02)00810-4; Jia F, 2013, GENET TEST MOL BIOMA, V17, P30, DOI 10.1089/gtmb.2012.0267; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kotrych D, 2016, EUR J OBSTET GYN R B, V199, P92, DOI 10.1016/j.ejogrb.2016.01.037; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Li CI, 2016, AGE, V38, DOI 10.1007/s11357-016-9909-y; Lin CC, 2016, MOL BIOL REP, V43, P1179, DOI 10.1007/s11033-016-4037-4; Lin CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021841; Lio D, 2003, J MED GENET, V40, P296, DOI 10.1136/jmg.40.4.296; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Manolagas SC, 1998, ANN NY ACAD SCI, V840, P194, DOI 10.1111/j.1749-6632.1998.tb09563.x; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; McCormick RK, 2007, ALTERN MED REV, V12, P113; MELHUS H, 1994, LANCET, V344, P949, DOI 10.1016/S0140-6736(94)92297-7; Mencej-Bedrac S, 2009, J MOL ENDOCRINOL, V42, P239, DOI 10.1677/JME-08-0108; Menezes RJ, 2008, CANCER EPIDEM BIOMAR, V17, P1104, DOI 10.1158/1055-9965.EPI-07-2713; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Ota N, 2000, GENES IMMUN, V1, P260, DOI 10.1038/sj.gene.6363668; Ota N, 2002, ANN HUM BIOL, V29, P550, DOI 10.1080/03014460210135730; Ota N, 2001, J HUM GENET, V46, P267, DOI 10.1007/s100380170077; Pacifici R, 1996, J BONE MINER RES, V11, P1043; PEDEUTOUR F, 1994, GENOMICS, V22, P512, DOI 10.1006/geno.1994.1424; Qin G, 2013, MOL BIOL REP, V40, P497, DOI 10.1007/s11033-012-2086-x; Ren HW, 2018, EXP THER MED, V15, P5183, DOI 10.3892/etm.2018.5857; Richards C, 1995, ROLE CYTOKINES ACUTE, P253; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sassi R, 2015, CLIMACTERIC, V18, P624, DOI 10.3109/13697137.2015.1007123; SPECTOR TD, 1995, BRIT MED J, V310, P1357, DOI 10.1136/bmj.310.6991.1357; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu FY, 2014, OSTEOPOROSIS INT, V25, P1917, DOI 10.1007/s00198-014-2691-8; Zhang L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18670-7; Zhao BZ, 2016, ARCH MED SCI, V12, P25, DOI 10.5114/aoms.2016.57475	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226973	10.1371/journal.pone.0226973	http://dx.doi.org/10.1371/journal.pone.0226973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887189	Green Published, gold			2022-12-26	WOS:000515092200059
J	Nunez, FJ; Johnstone, TB; Corpuz, ML; Kazarian, AG; Mohajer, NN; Tliba, O; Panettieri, RA; Koziol-White, C; Roosan, MR; Ostrom, RS				Nunez, Francisco J.; Johnstone, Timothy B.; Corpuz, Maia L.; Kazarian, Austin G.; Mohajer, Nicole N.; Tliba, Omar; Panettieri, Reynold A.; Koziol-White, Cynthia; Roosan, Moom R.; Ostrom, Rennolds S.			Glucocorticoids rapidly activate cAMP production via G(alpha s) to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects	FASEB JOURNAL			English	Article						airway smooth muscle; corticosteroids; G protein-coupled receptors; membrane glucocorticoid receptor; RNA sequencing	RNA-SEQ DATA; INHALED CORTICOSTEROIDS; SINGLE INHALER; RECEPTOR; BUDESONIDE/FORMOTEROL; EXPRESSION; BIOCONDUCTOR; PROGESTERONE; MAINTENANCE; EFFICACY	Glucocorticoids are widely used for the suppression of inflammation, but evidence is growing that they can have rapid, non-genomic actions that have been unappreciated. Diverse cell signaling effects have been reported for glucocorticoids, leading us to hypothesize that glucocorticoids alone can swiftly increase the 3 ',5 '-cyclic adenosine monophosphate (cAMP) production. We found that prednisone, fluticasone, budesonide, and progesterone each increased cAMP levels within 3 minutes without phosphodiesterase inhibitors by measuring real-time cAMP dynamics using the cAMP difference detector in situ assay in a variety of immortalized cell lines and primary human airway smooth muscle (HASM) cells. A membrane- impermeable glucocorticoid showed similarly rapid stimulation of cAMP, implying that responses are initiated at the cell surface. siRNA knockdown of G(alpha s) virtually eliminated glucocorticoid-stimulated cAMP responses, suggesting that these drugs activate the cAMP production via a G protein-coupled receptor. Estradiol had small effects on cAMP levels but G protein estrogen receptor antagonists had little effect on responses to any of the glucocorticoids tested. The genomic and non-genomic actions of budesonide were analyzed by RNA-Seq analysis of 24 hours treated HASM, with and without knockdown of G(alpha s). A 140-gene budesonide signature was identified, of which 48 genes represent a non-genomic signature that requires G(alpha s) signaling. Collectively, this non-genomic cAMP signaling modality contributes to one-third of the gene expression changes induced by glucocorticoid treatment and shifts the view of how this important class of drugs exerts its effects.	[Nunez, Francisco J.; Johnstone, Timothy B.; Corpuz, Maia L.; Kazarian, Austin G.; Mohajer, Nicole N.; Ostrom, Rennolds S.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, 9401 Jeronimo Rd, Irvine, CA 92618 USA; [Tliba, Omar] Long Isl Univ, Coll Vet Med, Dept Biomed Sci, Brookville, NY USA; [Panettieri, Reynold A.; Koziol-White, Cynthia] Rutgers State Univ, Inst Child Hlth, Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [Roosan, Moom R.] Chapman Univ, Sch Pharm, Dept Pharm Practice, Irvine, CA USA	Chapman University System; Chapman University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chapman University System; Chapman University	Ostrom, RS (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, 9401 Jeronimo Rd, Irvine, CA 92618 USA.	rostrom@chapman.edu		Roosan, Moom/0000-0002-5318-5120	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM107094]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [P01HL11447, HL111541]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM107094; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P01HL11447 and HL111541	Buttgereit F, 1997, BIOCHEM J, V326, P329, DOI 10.1042/bj3260329; COLLINS S, 1988, J BIOL CHEM, V263, P9067; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Flaherty RL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0823-8; Gai MN, 2005, J CHROMATOGR SCI, V43, P201, DOI 10.1093/chromsci/43.4.201; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han JZ, 2005, ACTA PHARMACOL SIN, V26, P199, DOI 10.1111/j.1745-7254.2005.00539.x; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Horvath G, 2011, PULM PHARMACOL THER, V24, P654, DOI 10.1016/j.pupt.2011.08.002; Ishimoto H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003843; Johnstone TB, 2018, AM J RESP CELL MOL, V58, P530, DOI 10.1165/rcmb.2017-0294OC; Kan MY, 2019, AM J RESP CELL MOL, V61, P110, DOI 10.1165/rcmb.2018-0385OC; Koziol-White C, 2019, AM J PHYSL LUN UNPUB; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Liu XQ, 2010, AM J PHYSIOL-LUNG C, V298, pL819, DOI 10.1152/ajplung.00429.2009; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MOORE FL, 1994, HORM BEHAV, V28, P512, DOI 10.1006/hbeh.1994.1049; Newton R, 2016, BRIT J PHARMACOL, V173, P3405, DOI 10.1111/bph.13628; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2019, TRENDS PHARMACOL SCI, V40, P38, DOI 10.1016/j.tips.2018.11.002; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scicchitano R, 2004, CURR MED RES OPIN, V20, P1403, DOI 10.1185/030079904X2051; Shen Y, 2015, BIOINFORMATICS, V31, P1745, DOI 10.1093/bioinformatics/btv031; Smit P, 2012, J EUR ACAD DERMATOL, V26, P1197, DOI 10.1111/j.1468-3083.2012.04449.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Timmermans S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01545; Urbach V, 2006, STEROIDS, V71, P323, DOI 10.1016/j.steroids.2005.09.014; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; Vernocchi S, 2013, MOL CELL PROTEOMICS, V12, P1764, DOI 10.1074/mcp.M112.022947; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Yu T, 2017, ONCOGENE, V36, P2131, DOI 10.1038/onc.2016.370; Yu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191418; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012; Zhang YM, 2012, AM J PHYSIOL-ENDOC M, V302, pE747, DOI 10.1152/ajpendo.00302.2011	47	15	16	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2882	2895		10.1096/fj.201902521R	http://dx.doi.org/10.1096/fj.201902521R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908022	hybrid, Green Published			2022-12-26	WOS:000504677500001
J	Shen, WY; Luo, C; Hurtado, PR; Hurtado-Perez, E; Luo, RY; Hu, ZL; Li, H; Xu, JM; Zhou, XF; Dai, RP				Shen, Wei-Yun; Luo, Cong; Reinaldo Hurtado, Plinio; Hurtado-Perez, Ernesto; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Zhou, Xin-Fu; Dai, Ru-Ping			The regulatory role of ProBDNF in monocyte function: Implications in Stanford type-A aortic dissection disease	FASEB JOURNAL			English	Article						inflammatory disease; monocytes; proBDNF; Stanford type-A acute aortic dissection	NERVOUS-SYSTEM; BDNF; P75(NTR); INFLAMMATION; BLOOD; POLARIZATION; INJURY; CELLS	Brain-derived neurotrophic factor precursor (proBDNF) has been reported to strengthen the dysfunction of monocytes/macrophages in animal studies. However, it is still unknown the roles of proBDNF in the dysfunction of monocytes in the inflammatory diseases in humans. In the present study, we showed that proBDNF and pan neurotrophic receptor p75 were significantly upregulated in monocytes from healthy donors (HD) after lipopolysaccharide treatment. Exogenous proBDNF treatment upregulated CD40 and proinflammatory cytokines expression in monocytes including interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha. In Stanford type-A acute aortic dissection (AAD) patients, proBDNF was upregulated in CD14(+)CD163(+)CX3CR1(+) M2- but not CD14(+)CD68(+)CCR2(+)M1-like monocytes. In addition, sera from AAD patients activated gene expression of proinflammatory cytokines in cultured PBMCs from HD, which was attenuated by proBDNF monoclonal antibody (Ab-proB) treatment. These findings suggested that upregulation of proBDNF in M2-like monocytes may contribute to the proinflammatory response in the AAD.	[Shen, Wei-Yun; Luo, Cong; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Dai, Ru-Ping] Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, 139 Ren Min Cent Rd, Changsha 410011, Hunan, Peoples R China; [Shen, Wei-Yun; Luo, Cong; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Dai, Ru-Ping] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China; [Reinaldo Hurtado, Plinio; Hurtado-Perez, Ernesto] Royal Adelaide Hosp, Dept Renal Med, Adelaide, SA, Australia; [Zhou, Xin-Fu] Univ South Australia, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA, Australia	Central South University; Central South University; Royal Adelaide Hospital; University of South Australia	Luo, C; Dai, RP (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, 139 Ren Min Cent Rd, Changsha 410011, Hunan, Peoples R China.	Luocong1988@csu.edu.cn; xyeyyrupingdai@csu.edu.cn	Hu, Zhaolan/GYU-4213-2022		National Natural Science Foundation of China [81773154, 81471106, 81873770]; National Key R&D Program of China [2018YFC2001902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	National Natural Science Foundation of China, Grant/Award Number: 81773154, 81471106 and 81873770; National Key R&D Program of China, Grant/Award Number: 2018YFC2001902	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azoulay D, 2008, J NEUROIMMUNOL, V195, P186, DOI 10.1016/j.jneuroim.2008.01.010; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Bonizzi G, 2004, TRENDS IMMUNOL, V35, P270; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Cifani N, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/9782594; Cordova ZM, 2016, ONCOTARGET, V7, P54392, DOI 10.18632/oncotarget.11106; Del Porto F, 2010, ANN MED, V42, P622, DOI 10.3109/07853890.2010.518156; Dusedau HP, 2019, GLIA, V67, P193, DOI 10.1002/glia.23553; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Fadini GP, 2013, DIABETOLOGIA, V56, P1856, DOI 10.1007/s00125-013-2918-9; Fadini GP, 2014, ATHEROSCLEROSIS, V237, P805, DOI 10.1016/j.atherosclerosis.2014.10.106; Fleitas C, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0411-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Fukui S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01958; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jiang YM, 2008, MOL IMMUNOL, V45, P1557, DOI 10.1016/j.molimm.2007.10.008; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kaess BM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001544; Lansac G, 2006, J NEUROIMMUNOL, V171, P57, DOI 10.1016/j.jneuroim.2005.09.019; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lim Y, 2015, J NEUROCHEM, V134, P75, DOI 10.1111/jnc.13108; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27171; Luo F, 2009, AGEING RES REV, V8, P31, DOI 10.1016/j.arr.2008.08.001; Morimura S, 2016, J DERMATOL SCI, V82, P175, DOI 10.1016/j.jdermsci.2016.03.004; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.53, 10.1038/nrdp.2016.71]; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Rost B, 2005, REGUL PEPTIDES, V124, P19, DOI 10.1016/j.regpep.2004.06.024; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Tasci I, 2012, ANADOLU KARDIYOL DER, V12, P684, DOI 10.5152/akd.2012.221; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; van Diepen JA, 2016, CELL MOL LIFE SCI, V73, P4675, DOI 10.1007/s00018-016-2316-9; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Zhao GQ, 2017, MOL NEUROBIOL, V54, P5573, DOI 10.1007/s12035-016-0098-6; Zhou L, 2018, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0015-4; Zhou L, 2013, J AFFECT DISORDERS, V150, P776, DOI 10.1016/j.jad.2013.03.002; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x	43	10	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2541	2553		10.1096/fj.201901905RR	http://dx.doi.org/10.1096/fj.201901905RR		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908023	Bronze			2022-12-26	WOS:000504090300001
J	Zhang, L; Liu, LM; Bai, M; Liu, MN; Wei, L; Yang, Z; Qian, Q; Ning, XX; Sun, SR				Zhang, Lei; Liu, Limin; Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Qian, Qi; Ning, Xiaoxuan; Sun, Shiren			Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-kappa B	FASEB JOURNAL			English	Article						chronic hypoxia; extracellular matrix; human epididymis secretory protein 4; NF-kappa B; renal fibrosis	EPIDIDYMIS PROTEIN 4; KIDNEY-DISEASE; ACTIVATION; EXPRESSION; FIBROGENESIS; PROGRESSION; ADENOSINE; BIOMARKER; INVASION; MCP-1	Hypoxia-induced extracellular matrix (ECM) deposition is an important cause of renal fibrosis that is triggered by unknown mechanisms. Human epididymis secretory protein 4 (HE4) is a newly discovered key molecule that causes ECM deposition. We used the unilateral ureteral obstruction (UUO) mouse model to investigate the expression and mechanisms of HE4 in the pathogenesis of renal fibrosis. Results were confirmed in the HK2 cell line and in human donors of kidney tissue with chronic kidney disease. Hypoxia significantly increased HE4 in renal tubular epithelial cells. HE4 overexpression activated the NF-kappa B pathway through the NF-kappa B transcription-activating group P65 by phosphorylation and nuclear translocation. NF-kappa B upregulated tissue inhibitor metalloproteinases 1, which may inhibit ECM degradation through inhibition of matrix metallopeptidase 2 activity. Silencing HE4 inhibited hypoxia-induced ECM deposition and alleviated fibrosis in UUO mice in vivo and blocked NF-kappa B activation in vitro. Expression of HE4 in the tubulointerstitium was positively correlated with tubulointerstitial fibrosis in tissue samples from patients with chronic kidney disease. Our results suggest that hypoxia induces renal fibrosis by upregulating HE4 and activating the HIF-1 alpha/HE4/NF-kappa B signaling pathway. Uncovering the molecular mechanisms and function of HE4 overexpression in hypoxia-induced renal fibrosis will provide important insights into understanding renal fibrosis and antifibrotic strategies.	[Zhang, Lei; Liu, Limin; Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Zhang, Lei] PLA Joint Logist Support Force, Hosp 987, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Liu, Limin] Xian PeiHua Univ, Sch Med, Xian, Shaanxi, Peoples R China; [Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Ning, Xiaoxuan; Sun, Shiren] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Qian, Qi] Mayo Clin, Dept Med, Coll Med, Rochester, MN USA; [Qian, Qi] Mayo Grad Sch, Rochester, MN USA; [Ning, Xiaoxuan] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Mayo Clinic; Mayo Clinic; Air Force Military Medical University	Ning, XX; Sun, SR (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Nephrol, 15 Chang West Rd, Xian 710032, Shaanxi, Peoples R China.	ningxx01@fmmu.edu.cn; sunshiren@medmail.com.cn	Liu, Minna/AAV-1609-2020; liu, li/HGC-0900-2022		National Natural Science Foundation of China [81670655, 81700584]; National Natural Science Foundation of Shaanxi Province [2019JQ-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shaanxi Province	National Natural Science Foundation of China, Grant/Award Number: 81670655 and 81700584; National Natural Science Foundation of Shaanxi Province, Grant/Award Number: 2019JQ-036	Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Chuang PY, 2013, J MOL MED, V91, P549, DOI 10.1007/s00109-012-0983-z; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Escudero JM, 2011, CLIN CHEM, V57, P1534, DOI 10.1373/clinchem.2010.157073; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jia QQ, 2013, MOLECULES, V18, P13061, DOI 10.3390/molecules181013061; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Krishnamachary B, 2003, CANCER RES, V63, P1138; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Ma YG, 2012, J CARDIOVASC TRANSL, V5, P848, DOI 10.1007/s12265-012-9398-z; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nagy B, 2016, CHEST, V150, P661, DOI 10.1016/j.chest.2016.04.006; Nakamura A, 2004, J AM SOC NEPHROL, V15, P316, DOI 10.1097/01.ASN.0000111247.76908.59; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Sato Y, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0048-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tanaka T, 2017, MED MOL MORPHOL, V50, P1, DOI 10.1007/s00795-016-0146-3; Wan JX, 2016, ONCOTARGET, V7, P67748, DOI 10.18632/oncotarget.11682; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang XQ, 2016, J RECEPT SIG TRANSD, V36, P152, DOI 10.3109/10799893.2015.1061002; Yang ZX, 2016, J CLIN LAB ANAL, V30, P897, DOI 10.1002/jcla.21954	28	28	28	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2554	2567		10.1096/fj.201901950R	http://dx.doi.org/10.1096/fj.201901950R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909536	Bronze			2022-12-26	WOS:000503399900001
J	Gao, DT; Ashraf, MZ; Zhang, LF; Kar, N; Byzova, TV; Podrez, EA				Gao, Detao; Ashraf, Mohammad Z.; Zhang, Lifang; Kar, Niladri; Byzova, Tatiana V.; Podrez, Eugene A.			Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization, in vivo detection, and functional implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high-density lipoprotein (HDL); apolipoprotein; oxidative stress; atherosclerosis; cardiovascular disease; phospholipid metabolism; lipid metabolism; cholesterol efflux; cross-linking; oxidized phospholipid-apoprotein adduct; oxidized phospholipids	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; COVALENT MODIFICATIONS; PROTEIN ADDUCTS; ARTERY WALL; FOAM CELLS; OXIDATION; MYELOPEROXIDASE; EFFLUX	Apolipoprotein A-I (apoA-I) is cross-linked and dysfunctional in human atheroma. Although multiple mechanisms of apoA-I cross-linking have been demonstrated in vitro, the in vivo mechanisms of cross-linking are not well-established. We have recently demonstrated the highly selective and efficient modification of high-density lipoprotein (HDL) apoproteins by endogenous oxidized phospholipids (oxPLs), including ?-ketoalkenal phospholipids. In the current study, we report that ?-ketoalkenal phospholipids effectively cross-link apoproteins in HDL. We further demonstrate that cross-linking impairs the cholesterol efflux mediated by apoA-I or HDL3 in vitro and in vivo. Using LC-MS/MS analysis, we analyzed the pattern of apoprotein cross-linking in isolated human HDL either by synthetic ?-ketoalkenal phospholipids or by oxPLs generated during HDL oxidation in plasma by the physiologically relevant MPO-H2O2-NO2? system. We found that five histidine residues in helices 5?8 of apoA-I are preferably cross-linked by oxPLs, forming stable pyrrole adducts with lysine residues in the helices 3?4 of another apoA-I or in the central domain of apoA-II. We also identified cross-links of apoA-I and apoA-II with two minor HDL apoproteins, apoA-IV and apoE. We detected a similar pattern of apoprotein cross-linking in oxidized murine HDL. We further detected oxPL cross-link adducts of HDL apoproteins in plasma and aorta of hyperlipidemic LDLR?/? mice, including cross-link adducts of apoA-I His-165?apoA-I Lys-93, apoA-I His-154?apoA-I Lys-105, apoA-I His-154?apoA-IV Lys-149, and apoA-II Lys-30?apoE His-227. These findings suggest an important mechanism that contributes to the loss of HDL's atheroprotective function in vivo.	[Gao, Detao; Ashraf, Mohammad Z.; Zhang, Lifang; Kar, Niladri; Podrez, Eugene A.] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA; [Byzova, Tatiana V.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Ashraf, Mohammad Z.] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India; [Kar, Niladri] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Jamia Millia Islamia; Cleveland Clinic Foundation	Podrez, EA (corresponding author), 9500 Euclid Ave,NB5-87, Cleveland, OH 44195 USA.	podreze@ccf.org			National Institutes of Health [HL145536, HL077213, HL073311, HL126738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL145536 (to T. V. B.) and HL077213, HL073311, and HL126738 (to E. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisvert WA, 1999, ARTERIOSCL THROM VAS, V19, P525, DOI 10.1161/01.ATV.19.3.525; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; CHACKO GK, 1988, J LIPID RES, V29, P319; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Choi J, 2011, BIOORGAN MED CHEM, V19, P580, DOI 10.1016/j.bmc.2010.10.058; Codreanu SG, 2012, METHODS MOL BIOL, V803, P77, DOI 10.1007/978-1-61779-364-6_7; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Feingold KR, 2016, CURR OPIN LIPIDOL, V27, P521, DOI 10.1097/MOL.0000000000000333; Gao DT, 2018, FREE RADICAL BIO MED, V115, P57, DOI 10.1016/j.freeradbiomed.2017.11.012; Gao DT, 2014, ANAL CHEM, V86, P1254, DOI 10.1021/ac4035949; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Gao X, 2008, J MOL BIOL, V376, P997, DOI 10.1016/j.jmb.2007.12.030; Gillard BK, 2005, BIOCHEMISTRY-US, V44, P471, DOI 10.1021/bi048591j; He Y, 2019, MOL CELL PROTEOMICS, V18, P854, DOI 10.1074/mcp.RA118.000878; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jayaraman S, 2008, BIOCHEMISTRY-US, V47, P3875, DOI 10.1021/bi7023783; Kim HYH, 2009, MOL CELL PROTEOMICS, V8, P2080, DOI 10.1074/mcp.M900121-MCP200; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; Miller YI, 1996, ARCH BIOCHEM BIOPHYS, V326, P252, DOI 10.1006/abbi.1996.0073; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; MOREL DW, 1994, BIOCHEM BIOPH RES CO, V200, P408, DOI 10.1006/bbrc.1994.1464; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Namiri-Kalantari R, 2015, BIOFACTORS, V41, P153, DOI 10.1002/biof.1205; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2010, CLIN EXP PHARMACOL P, V37, P719, DOI 10.1111/j.1440-1681.2010.05380.x; Pollard RD, 2016, BIOCHEMISTRY-US, V55, P4971, DOI 10.1021/acs.biochem.6b00347; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; SAKAI M, 1992, FEBS LETT, V314, P199, DOI 10.1016/0014-5793(92)80974-L; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; SHOUKRY MI, 1994, BBA-LIPID LIPID MET, V1210, P355, DOI 10.1016/0005-2760(94)90240-2; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	50	7	8	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1973	1984		10.1074/jbc.RA119.008445	http://dx.doi.org/10.1074/jbc.RA119.008445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31907281	Green Published, hybrid			2022-12-26	WOS:000517128200016
J	Lecronier, M; Tashk, P; Tamzali, Y; Tenaillon, O; Denamur, E; Barrou, B; Aron-Wisnewsky, J; Tourret, J				Lecronier, Marie; Tashk, Parvine; Tamzali, Yanis; Tenaillon, Olivier; Denamur, Erick; Barrou, Benoit; Aron-Wisnewsky, Judith; Tourret, Jerome			Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FAECALIBACTERIUM-PRAUSNITZII; INSULIN SENSITIVITY; METABOLIC SYNDROME; OBESE; INDIVIDUALS; ALTERS; INFLAMMATION; IMPROVEMENT; PREVENTION	Background The gut dysbiosis associated with diabetes acquired before or after kidney transplantation (KT) has not been explored. Methods Patients transplanted at our institution provided fecal samples before, and 3-9 months after KT. Fecal bacterial DNA was extracted and 9 bacteria or bacterial groups were quantified by qPCR. Results 50 patients (19 controls without diabetes, 15 who developed New Onset Diabetes After Transplantation, NODAT, and 16 with type 2 diabetes before KT) were included. Before KT, Lactobacillus sp. tended to be less frequently detected in controls than in those who would become diabetic following KT (NODAT) and in initially diabetic patients (60%, 87.5%, and 100%, respectively, p = 0.08). The relative abundance of Faecalibacterium prausnitzii was 30 times lower in initially diabetic patients than in controls (p = 0.002). The relative abundance of F. prausnitzii of NODAT patients was statistically indistinguishable from controls and from diabetic patients. The relative abundance of Lactobacillus sp. increased following KT in NODAT and in initially diabetic patients (20-fold, p = 0.06, and 25-fold, p = 0.02, respectively). In contrast, the proportion of Akkermansia muciniphila decreased following KT in NODAT and in initially diabetic patients (2,500-fold, p = 0.04, and 50,000-fold, p<0.0001, respectively). The proportion of Lactobacillus and A. muciniphila did not change in controls between before and after the transplantation. Consequently, after KT the relative abundance of Lactobacillus sp. was 25 times higher (p = 0.07) and the relative abundance of A. muciniphila was 2,000 times lower (p = 0.002) in diabetics than in controls. Conclusion An alteration of the gut microbiota composition involving Lactobacillus sp., A. muciniphila and F. prausnitzii is associated with the glycemic status in KT recipients, raising the question of their role in the genesis of NODAT.	[Lecronier, Marie; Tashk, Parvine; Tenaillon, Olivier; Denamur, Erick; Tourret, Jerome] Univ Paris Diderot, INSERM, Sorbonne Paris Cite, IAME,UMR 1137, Paris, France; [Tamzali, Yanis; Barrou, Benoit; Tourret, Jerome] GH Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France; [Denamur, Erick] Hop Bichat Claude Bernard, AP HP, Lab Genet Mol, Paris, France; [Barrou, Benoit; Aron-Wisnewsky, Judith; Tourret, Jerome] Sorbonne Univ, Paris, France; [Aron-Wisnewsky, Judith] GH Pitie Salpetriere Charles Foix, AP HP, Inst Cardiometab & Nutr, ICAN,Serv Nutr, Paris, France; [Aron-Wisnewsky, Judith] INSERM, UMR S U1166, Equipe NutriOm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tourret, J (corresponding author), Univ Paris Diderot, INSERM, Sorbonne Paris Cite, IAME,UMR 1137, Paris, France.; Tourret, J (corresponding author), GH Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France.; Tourret, J (corresponding author), Sorbonne Univ, Paris, France.	jerome.tourret@aphp.fr		TAMZALI, Yanis/0000-0003-0710-8869; Tenaillon, Olivier/0000-0002-3796-1601; Tourret, Jerome/0000-0003-2998-6531	la Fondation du Rein	la Fondation du Rein	JT was supported by an award from "la Fondation du Rein" named "Don de soi, don de vie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boots JMM, 2002, J AM SOC NEPHROL, V13, P221, DOI 10.1681/ASN.V131221; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Hecking M, 2013, NEPHROL DIAL TRANSPL, V28, P550, DOI 10.1093/ndt/gfs583; Hippe B, 2016, BENEF MICROBES, V7, P511, DOI 10.3920/BM2015.0075; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li HK, 2016, EXPERT OPIN DRUG MET, V12, P31, DOI 10.1517/17425255.2016.1121234; Luan FL, 2010, SEMIN DIALYSIS, V23, P198, DOI 10.1111/j.1525-139X.2010.00708.x; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Remely M, 2016, ENDOCR METAB IMMUNE, V16, P99, DOI 10.2174/1871530316666160831093813; Thomas V, 2015, FUTURE MICROBIOL, V10, P1485, DOI 10.2217/fmb.15.87; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tourret J, 2017, TRANSPLANTATION, V101, P74, DOI 10.1097/TP.0000000000001492; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yassour M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0271-6; Yoshifuji A, 2016, NEPHROL DIAL TRANSPL, V31, P401, DOI 10.1093/ndt/gfv353; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	40	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227373	10.1371/journal.pone.0227373	http://dx.doi.org/10.1371/journal.pone.0227373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910227	Green Published, gold			2022-12-26	WOS:000534333800045
J	West, CL; Stanisz, AM; Mao, YK; Champagne-Jorgensen, K; Bienenstock, J; Kunze, WA				West, Christine L.; Stanisz, Andrew M.; Mao, Yu-Kang; Champagne-Jorgensen, Kevin; Bienenstock, John; Kunze, Wolfgang A.			Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; GRAM-POSITIVE BACTERIA; DSM 17938; RHAMNOSUS GG; DOUBLE-BLIND; PROBIOTICS; RELEASE; IMMUNE	Microvesicles are small lipid, bilayer structures (20-400 nm in diameter) secreted by bacteria, fungi, archaea and parasites involved in inter-bacterial communication and host-pathogen interactions. Lactobacillus reuteri DSM-17938 (DSM) has been shown to have clinical efficacy in the treatment of infantile colic, diarrhea and constipation. We have shown previously that luminal administration to the mouse gut promotes reduction of jejunal motility but increases that in the colon. The production of microvesicles by DSM has been characterized, but the effect of these microvesicles on gastrointestinal motility has yet to be evaluated. To investigate a potential mechanism for the effects of DSM on the intestine, the bacteria and its products have here been tested for changes in velocity, frequency, and amplitude of contractions in intact segments of jejunum and colon excised from mice. The effect of the parent bacteria (DSM) was compared to the conditioned media in which it was grown, and the microvesicles it produced. The media used to culture the bacteria (broth) was tested as a negative control and the conditioned medium was tested after the microvesicles had been removed. DSM, conditioned medium, and the microvesicles all produced comparable effects in both the jejunum and the colon. The treatments individually decreased the velocity and frequency of propagating contractile cluster contractions in the jejunum and increased them in the colon to a similar degree. The broth control had little effect in both tissues. Removal of the microvesicles from the conditioned medium almost completely eradicated their effect on motility in both tissues. These results show that the microvesicles from DSM alone can completely reproduce the effects of the whole bacteria on gut motility. Furthermore, they suggest a new approach to the formulation of orally active bacterial therapeutics and offer a novel way to begin to identify the active bacterial components.	[West, Christine L.; Stanisz, Andrew M.; Mao, Yu-Kang; Champagne-Jorgensen, Kevin; Bienenstock, John; Kunze, Wolfgang A.] McMaster Brain Body Inst, St Josephs Healthcare, Hamilton, ON, Canada; [West, Christine L.; Kunze, Wolfgang A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	West, CL (corresponding author), McMaster Brain Body Inst, St Josephs Healthcare, Hamilton, ON, Canada.; West, CL (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	westcl2@mcmaster.ca	Champagne-Jorgensen, Kevin/AFK-0579-2022	Champagne-Jorgensen, Kevin/0000-0002-1445-1449; West, Christine/0000-0001-6518-8137	BioGaia (Stockholm, Sweden); Natural Sciences and Engineering Research Council Canada (NSERC) [2014-05517]	BioGaia (Stockholm, Sweden); Natural Sciences and Engineering Research Council Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded in part by an unrestricted grant in support of research from BioGaia (Stockholm, Sweden). BioGaia was not involved in any way in the study design, conduct or execution of the study, data collection and analysis, or preparation of the manuscript. The study was also funded by the Natural Sciences and Engineering Research Council Canada (NSERC) #2014-05517 by a grant awarded to WAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2015, FASEB J, V29, P684, DOI 10.1096/fj.14-259721; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Bitto NJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061287; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Cao YN, 2018, WORLD J GASTROENTERO, V24, P338, DOI 10.3748/wjg.v24.i3.338; Chau K, 2015, J PEDIATR-US, V166, P74, DOI 10.1016/j.jpeds.2014.09.020; Coccorullo P, 2010, J PEDIATR-US, V157, P598, DOI 10.1016/j.jpeds.2010.04.066; Dean S.N., 2019, SCI REP-UK, V9, P1; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Delungahawatta T, 2017, FRONT NEUROSCI, V11, P1, DOI [10.3389/fnins.2017.00001, DOI 10.3389/FNINS.2017.00001]; Dinleyici EC, 2014, ACTA PAEDIATR, V103, pe300, DOI 10.1111/apa.12617; Rubio APD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01783; Grande R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01040; He XH, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43003; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Indrio F, 2011, EUR J CLIN INVEST, V41, P417, DOI 10.1111/j.1365-2362.2010.02425.x; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0977-7; Lyte M, 2011, BIOESSAYS, V33, P574, DOI 10.1002/bies.201100024; Maghsood F, 2018, CELL J, V19, P559, DOI 10.22074/cellj.2018.4447; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Urbanska M, 2014, EUR J PEDIATR, V173, P1327, DOI 10.1007/s00431-014-2328-0; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; West C, 2016, WORLD J GASTROENTERO, V22, P10532, DOI 10.3748/wjg.v22.i48.10532; Wu RY, 2013, NEUROGASTROENT MOTIL, V25, pE205, DOI 10.1111/nmo.12072	33	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0225481	10.1371/journal.pone.0225481	http://dx.doi.org/10.1371/journal.pone.0225481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910436	Green Published, gold			2022-12-26	WOS:000534333800009
J	Aldrete, S; Jang, JH; Easley, KA; Okulicz, J; Dai, T; Chen, YN; Pino, M; Agan, BK; Maves, RC; Paiardini, M; Marconi, VC				Aldrete, Sol; Jang, Jeong Hoon; Easley, Kirk A.; Okulicz, Jason; Dai, Tian; Chen, Yi No; Pino, Maria; Agan, Brian K.; Maves, Ryan C.; Paiardini, Mirko; Marconi, Vincent C.			CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy	PLOS ONE			English	Article							LONG-TERM COMPLICATIONS; AIDS-RELATED EVENTS; CELL COUNT; FOLLOW-UP; INDIVIDUALS; MORTALITY; RECOVERY; RESPONSES; CART; RISK	Objectives Immune non-responders (INR) have poor CD4 recovery and are associated with increased risk of serious events despite antiretroviral therapy (ART). A clinically relevant definition for INR is lacking. Methods We conducted a retrospective analysis of three large cohorts: Infectious Disease Clinic at the Atlanta Veterans Affairs Medical Center, the US Military HIV Natural History Study and Infectious Disease Program of the Grady Health System in Atlanta, Georgia. Two-stage modeling and joint model (JM) approaches were used to evaluate the association between CD4 (or CD4/CD8 ratio) slope within two years since ART initiation and a composite end-point (AIDS, serious non-AIDS events and death) after two years of ART. We compared the predictive capacity of four CD4 count metrics (estimated CD4 slope, estimated CD4/CD8 ratio slope during two years following ART initiation and CD4 at 1 and 2 years following ART initiation) using Cox regression models. Results We included 2,422 patients. Mean CD4 slope (+/- standard error) during two years of ART was 102 +/- 2 cells/mu l/year (95% confidence interval: 98-106 cells/mu l/year), this increase was uniform among the three cohorts (p = 0.80). There were 267 composite events after two years on ART. Using the JM approach, a CD4 slope >= 100 cells/mu L/year or CD4/CD8 ratio slope > 0.1 higher rate per year were associated with lower composite endpoint rates (adjusted hazard ratio [HR] = 0.80, p = 0.04 and HR = 0.75 p < 0.01, respectively). All four CD4 metrics showed modest predictive capacity. Conclusions Using a complex JM approach, CD4 slope and CD4/CD8 ratio slope the first two years after ART initiation were associated with lower rates of the composite outcome. Moreover, the uniformity observed in the mean CD4 slope regardless of the cohort suggests a common CD4 response pattern independent of age or CD4 nadir. Given the consistency observed with CD4 slope, availability and ease of interpretation, this study provides strong rationale for using CD4 gains < 100 cells/mu l/year to identify patients at risk for adverse events.	[Aldrete, Sol] Med Coll Wisconsin, Div Infect Dis, Milwaukee, WI 53226 USA; [Jang, Jeong Hoon; Easley, Kirk A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Okulicz, Jason] San Antonio Mil Med Ctr, Div Internal Med, San Antonio, TX USA; [Okulicz, Jason] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Dai, Tian] Amgen Inc, Thousand Oaks, CA USA; [Chen, Yi No] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Pino, Maria; Paiardini, Mirko; Marconi, Vincent C.] Yerkes Nonhuman Primates Res Ctr, Div Microbiol & Immunol, Atlanta, GA USA; [Pino, Maria; Paiardini, Mirko; Marconi, Vincent C.] Emory Vaccine Ctr, Atlanta, GA USA; [Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Rockville, MD USA; [Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Maves, Ryan C.] Naval Med Ctr San Diego, Div Infect Dis, San Diego, CA USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Marconi, Vincent C.] Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Marconi, Vincent C.] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	Medical College of Wisconsin; Emory University; Rollins School Public Health; San Antonio Military Medical Center; San Antonio Military Medical Center; Amgen; Emory University; Emory University; Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Navy; Naval Medical Center San Diego; Emory University; Emory University; Rollins School Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Aldrete, S (corresponding author), Med Coll Wisconsin, Div Infect Dis, Milwaukee, WI 53226 USA.	saldrete@mcw.edu	Easley, Kirk A/K-6910-2015; Marconi, Vincent/N-3210-2014; Marconi, Vincent/AFK-5812-2022; Maves, Ryan C/AGG-3988-2022; Marconi, Vincent/GRJ-4553-2022; Jang, Jeong Hoon/AAO-8249-2020	Easley, Kirk A/0000-0003-4419-2617; Marconi, Vincent/0000-0001-8409-4689; Maves, Ryan C/0000-0001-6234-6160; Marconi, Vincent/0000-0001-8409-4689; Jang, Jeong Hoon/0000-0003-0811-2296; Agan, Brian/0000-0002-5114-1669; Aldrete, Sol del Mar/0000-0002-4524-1583; Pino Claveria, Maria/0000-0003-4954-5215	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [1R01AI110334]; Emory Center for AIDS Research [P30AI050409]; Infectious Diseases Clinical Research Program (IDCRP); NIH/NIAID under Inter-Agency [Y1-AI-5072]	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory Center for AIDS Research; Infectious Diseases Clinical Research Program (IDCRP); NIH/NIAID under Inter-Agency	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [1R01AI110334] (VCM, MP); Emory Center for AIDS Research [P30AI050409] (VCM); and the Infectious Diseases Clinical Research Program (IDCRP) (BA), a DoD/USU program including federal funds from NIH/NIAID under Inter-Agency Agreement Y1-AI-5072. TD is a paid employee of Amgen. The specific role of this author is articulated in the 'author contributions' section. Amgen Inc did not play a role in the study design, data collection and analysis, decision to publish or provided other financial support to TD.	Achhra AC, 2014, CURR OPIN HIV AIDS, V9, P63, DOI 10.1097/COH.0000000000000017; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Brombin C, 2016, STAT METHODS MED RES, V25, P2472, DOI 10.1177/0962280214526192; Castilho JL, 2016, AIDS, V30, P899, DOI 10.1097/QAD.0000000000001005; Cenderello G, 2016, EXPERT REV ANTI-INFE, V14, P29, DOI 10.1586/14787210.2016.1106937; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Department for Health and Human Services, GUIDELINES USE ANTIR; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Guest JL, 2017, INT J EPIDEMIOL, V46, P1727, DOI 10.1093/ije/dyx153; Guest JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062273; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kelly C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156099, 10.1371/journal.pone]; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lim H, 2013, J MED STAT INFORM, V1; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Pacheco YM, 2015, ANTIVIR RES, V117, P69, DOI 10.1016/j.antiviral.2015.03.002; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rizopoulos D, 2011, BIOMETRICS, V67, P819, DOI 10.1111/j.1541-0420.2010.01546.x; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Song X, 2002, BIOMETRICS, V58, P742, DOI 10.1111/j.0006-341X.2002.00742.x; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Wulfsohn MS, 1997, BIOMETRICS, V53, P330, DOI 10.2307/2533118; Zhang DJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i03	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227124	10.1371/journal.pone.0227124	http://dx.doi.org/10.1371/journal.pone.0227124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905222	Green Published, gold			2022-12-26	WOS:000534327700017
J	Wallis, LJ; Iotchev, IB; Kubinyi, E				Wallis, Lisa J.; Iotchev, Ivaylo B.; Kubinyi, Eniko			Assertive, trainable and older dogs are perceived as more dominant in multi-dog households	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; PERSONALITY DIMENSIONS; SOCIAL-DOMINANCE; DECISION-MAKING; SHEPHERD DOGS; TEMPERAMENT; BEHAVIOR; TRAITS; SEX; AGE	Social dominance is an important and widely used concept, however, different interpretations have led to ambiguity in the scientific literature and in popular science. Even though in ethology dominance is an attribute of dyadic encounters, and not a characteristic of the individual, 'dominance' has often been referred to as a personality trait in animals. Since few studies have specifically examined the link between personality traits and dominance status, we investigated this in dogs living in multi-dog households using a questionnaire, which required owners to specify whether the dog had a dominant or submissive status, and comprised items of both the features of the individual (i.e. personality traits) and previous social experience (interactions with group members and strangers). Four distinct personality factors emerged from 23 behavioural items by principal component analysis, labelled as assertiveness, trainability, intraspecific aggression and independence. Binomial logistic regression was used to examine how the demographic information of the dogs and the personality factors predicted the owner's estimate of the dog' status as dominant or submissive. The personality factor assertiveness accounted for 34% of the variance in dominance status, trainability 5% and dog age contributed 4%. Dogs perceived as dominant scored more highly on the factors assertiveness and trainability, which can help explain why 'dominance' has often been suggested to be a personality trait, rather than a dyad-specific social status according to different traditions in behavioural research. Similar to the 'social dominance' trait in humans, owner ascribed dominance showed a quadratic trajectory in cross-sectional mean change across the lifespan, increasing during adulthood and then maintaining high levels until old age. Overall, our study proposes a multifactorial background of dominance relationships in pet dogs, suggesting that not only previous experience of social interactions between individuals but also age and personality traits influence owner perceived dominance status in multi-dog households.	[Wallis, Lisa J.; Iotchev, Ivaylo B.; Kubinyi, Eniko] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary	Eotvos Lorand University	Wallis, LJ (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	lisa.wallis@live.co.uk	Wallis, Lisa/GVS-6425-2022; Kubinyi, Eniko/B-5824-2013	Wallis, Lisa/0000-0003-3931-3250; Kubinyi, Eniko/0000-0002-4468-9845	European Research Council (ERC) under the European Union [680040]; Ja'nos Bolyai Research Scholarship of the Hungarian Academy of Sciences; UNKP-Bolyai+ Scholarship	European Research Council (ERC) under the European Union(European Research Council (ERC)); Ja'nos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); UNKP-Bolyai+ Scholarship	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant Agreement No. 680040; https://erc.europa.eu/), from the Ja ' nos Bolyai Research Scholarship of the Hungarian Academy of Sciences, and from theU ' NKP-Bolyai+ Scholarship (https://ttk.elte.hu/content/uj-nemeztikivalosag-program-unkp-2018-2019-es-tanev.t.1158?m=178), all to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Akos Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003446; Anestis SF, 2005, BEHAVIOUR, V142, P1245, DOI 10.1163/156853905774539418; [Anonymous], 2014, THE SOCIAL DOG; BEAUDET R, 1994, APPL ANIM BEHAV SCI, V40, P273, DOI 10.1016/0168-1591(94)90068-X; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Bonanni R, 2017, BEHAV ECOL, V28, P1004, DOI 10.1093/beheco/arx059; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Bradshaw JWS, 2016, J VET BEHAV, V11, P102, DOI 10.1016/j.jveb.2015.11.008; Briffa M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1007; BUIRSKI P, 1978, ANIM BEHAV, V26, P123, DOI 10.1016/0003-3472(78)90011-8; Cafazzo S, 2016, PEERJ, V4, DOI 10.7717/peerj.2707; Cafazzo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098594; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Campbell WE, 1972, MOD VET PRACT, V12, P29; Carrier LO, 2013, APPL ANIM BEHAV SCI, V146, P96, DOI 10.1016/j.applanim.2013.04.002; CATTELL RB, 1973, BEHAV BIOL, V9, P15, DOI 10.1016/S0091-6773(73)80165-8; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Dan D, 2018, DOMINANT VS SUBMISSI; David M, 2011, ANIM BEHAV, V81, P219, DOI 10.1016/j.anbehav.2010.10.008; de Waal F.B.M., 1989, Special Publication of the British Ecological Society, P243; deWaal FBM, 1996, J COMP PSYCHOL, V110, P147, DOI 10.1037/0735-7036.110.2.147; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Eckardt W, 2015, J COMP PSYCHOL, V129, P26, DOI 10.1037/a0038370; Familypet, WHAT IS DEF DOM DOG; Fox RA, 2009, ANIM BEHAV, V77, P1441, DOI 10.1016/j.anbehav.2009.02.022; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Frick E.E., 2016, ESTABLISHING LINK PE; GODDARD ME, 1985, ANIM BEHAV, V33, P1338, DOI 10.1016/S0003-3472(85)80195-0; Gold KC, 1994, PERS ASSESS, P522; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 1998, ANTHROZOOS, V11, P148, DOI 10.2752/089279398787000661; Gosling SD, 1998, J COMP PSYCHOL, V112, P107, DOI 10.1037/0735-7036.112.2.107; GUDJONSSON GH, 1994, PERS INDIV DIFFER, V17, P302, DOI 10.1016/0191-8869(94)90040-X; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; Humphrey ES, 1934, J HERED, V25, P129, DOI 10.1093/oxfordjournals.jhered.a103899; JAMES WT, 1951, J COMP PHYSIOL PSYCH, V44, P71, DOI 10.1037/h0061218; John OP, 2008, HDB PERSONAL THEORY, V3, P881; Jones, 2008, DEV VALIDATION DOG P; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; King JE, 2008, J COMP PSYCHOL, V122, P418, DOI 10.1037/a0013125; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Kubinyi E, 2019, PEERJ, V7, DOI 10.7717/peerj.6838; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kuhar CW, 2006, APPL ANIM BEHAV SCI, V96, P315, DOI 10.1016/j.applanim.2005.06.004; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Langley EJG, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171475; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2007, ANTHROZOOS, V20, P113, DOI 10.2752/175303707X207909; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lindsay S, 2001, HDB APPL DOG BEHAV T, V2; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Miklosi A., 2008, DOG BEHAV EVOLUTION; Muner Kroll Dantas de Castro M, 2017, ASSESSING SOCIAL ORG; Overall KL, 2016, J VET BEHAV, V11, P1, DOI 10.1016/j.jveb.2015.12.004; Pederson AK, 2005, J RES PERS, V39, P534, DOI 10.1016/j.jrp.2004.07.002; Pongracz P, 2008, ANIM COGN, V11, P75, DOI 10.1007/s10071-007-0090-7; Pongracz P, 2012, BEHAVIOUR, V149, P111, DOI 10.1163/156853912X629148; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SCHENKEL R, 1967, AM ZOOL, V7, P319; Silk MJ, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0536; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Trisko RK, 2016, BEHAVIOUR, V153, P693, DOI 10.1163/1568539X-00003352; Trisko RK, 2015, BEHAVIOUR, V152, P677, DOI 10.1163/1568539X-00003249; Wahlgren K, 2003, PSYCHOL REP, V92, P828; Wallis LJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00071; Yasui S, 2013, ZOO BIOL, V32, P70, DOI 10.1002/zoo.21045	83	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227253	10.1371/journal.pone.0227253	http://dx.doi.org/10.1371/journal.pone.0227253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899765	Green Published, gold			2022-12-26	WOS:000534322000018
J	Williams, SH; Levy, A; Yates, RA; Somaweera, N; Neville, PJ; Nicholson, J; Lindsay, MDA; Mackenzie, JS; Jain, K; Imrie, A; Smith, DW; Lipkin, WI				Williams, Simon H.; Levy, Avram; Yates, Rachel A.; Somaweera, Nilusha; Neville, Peter J.; Nicholson, Jay; Lindsay, Michael D. A.; Mackenzie, John S.; Jain, Komal; Imrie, Allison; Smith, David W.; Lipkin, W. Ian			Discovery of Jogalong virus, a novel hepacivirus identified in a Culex annulirostris (Skuse) mosquito from the Kimberley region of Western Australia	PLOS ONE			English	Article							WORLD	The discovery of hepaciviruses in non-human hosts has accelerated following the advancement of high-throughput sequencing technology. Hepaciviruses have now been described in reptiles, fish, birds, and an extensive array of mammals. Using metagenomic sequencing on pooled samples of field-collected Culex annulirostris mosquitoes, we discovered a divergent hepacivirus-like sequence, named Jogalong virus, from the Kimberley region in northern Western Australia. Using PCR, we screened the same 300 individual mosquitoes and found just a single positive sample (1/300, 0.33%). Phylogenetic analysis of the hepacivirus NS5B protein places Jogalong virus within the genus Hepacivirus but on a distinct and deeply rooted monophyletic branch shared with duck hepacivirus, suggesting a notably different evolutionary history. Vertebrate barcoding PCR targeting two mitochondrial genes, cytochrome c oxidase subunit I and cytochrome b, indicated that the Jogalong virus-positive mosquito had recently fed on the tawny frogmouth (Podargus strigoides), although it is currently unknown whether this bird species contributes to the natural ecology of this virus.	[Williams, Simon H.; Yates, Rachel A.; Jain, Komal; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10032 USA; [Williams, Simon H.; Imrie, Allison; Smith, David W.] Univ Western Australia, Fac Hlth & Med Sci, Nedlands, WA, Australia; [Levy, Avram; Mackenzie, John S.; Smith, David W.] PathWest Lab Med WA, Nedlands, WA, Australia; [Somaweera, Nilusha; Neville, Peter J.; Nicholson, Jay; Lindsay, Michael D. A.] Dept Hlth, Publ & Aboriginal Hlth Div, Environm Hlth Directorate, Perth, WA, Australia; [Mackenzie, John S.] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia	Columbia University; University of Western Australia; Curtin University	Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10032 USA.	wil2001@cumc.columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Levy, Avram/0000-0002-0934-2387; Williams, Simon/0000-0002-6276-4685; Smith, David/0000-0002-3107-5182; Yates, Rachel/0000-0002-0606-1395	National Institutes of Health (Center for Research in Diagnostics and Discovery) [U19AI109761]; NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID); Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE)	National Institutes of Health (Center for Research in Diagnostics and Discovery)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID)(National Health and Medical Research Council (NHMRC) of Australia); Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE)	This work was supported by a grant from the National Institutes of Health (U19AI109761 Center for Research in Diagnostics and Discovery). The sequencing work was supported by funding from the NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID) and the Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baechlein C, 2015, J VIROL, V89, P7007, DOI 10.1128/JVI.00534-15; BROOM AK, 1995, AM J TROP MED HYG, V53, P95, DOI 10.4269/ajtmh.1995.53.95; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Canuti M, 2019, ARCH VIROL, V164, P509, DOI 10.1007/s00705-018-4099-9; Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09; Chu LL, 2019, J GEN VIROL, V100, P1234, DOI 10.1099/jgv.0.001298; Corman VM, 2015, J VIROL, V89, P5876, DOI 10.1128/JVI.00393-15; DESOUZA WM, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11030297; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Government of Western Australia, 2018, MED ENT 2017 2018 SU; Hartlage AS, 2016, ANNU REV VIROL, V3, P53, DOI 10.1146/annurev-virology-100114-055104; Harvey E, 2019, J VIROL, V93, DOI 10.1128/JVI.01358-18; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauck M, 2013, J VIROL, V87, P8971, DOI 10.1128/JVI.00888-13; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020; LIEHNE PFS, 1991, ATLAS MOSQUITOES W A; Madeley CF, 1988, LAB DIAGNOSIS INFECT, V2, P7; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Reeves Lawrence E, 2018, PLoS Negl Trop Dis, V12, pe0006767, DOI 10.1371/journal.pntd.0006767; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Serventy D. L., 1936, Emu, V36, P74; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15; Stephenson E, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3405-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; Wu ZQ, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0554-9	36	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227114	10.1371/journal.pone.0227114	http://dx.doi.org/10.1371/journal.pone.0227114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899786	Green Published, gold			2022-12-26	WOS:000534322000014
J	Fierro-Fernandez, M; Miguel, V; Marquez-Exposito, L; Nuevo-Tapioles, C; Herrero, JI; Blanco-Ruiz, E; Tituana, J; Castillo, C; Cannata, P; Monsalve, M; Ruiz-Ortega, M; Ramos, R; Lamas, S				Fierro-Fernandez, Marta; Miguel, Veronica; Marquez-Exposito, Laura; Nuevo-Tapioles, Cristina; Herrero, J. Ignacio; Blanco-Ruiz, Eva; Tituana, Jessica; Castillo, Carolina; Cannata, Pablo; Monsalve, Maria; Ruiz-Ortega, Marta; Ramos, Ricardo; Lamas, Santiago			MiR-9-5p protects from kidney fibrosis by metabolic reprogramming	FASEB JOURNAL			English	Article						chronic kidney disease; fatty acid oxidation; fibrosis; metabolism; microRNAs; mitochondria	PROMOTES RENAL FIBROSIS; FIBROGENIC TRANSFORMATION; TUBULE INJURY; UP-REGULATION; EXPRESSION; MICRORNAS; TARGET; NEPHROPATHY; PGC-1-ALPHA; MECHANISMS	MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and control biological processes (BPs), including fibrogenesis. Kidney fibrosis remains a clinical challenge and miRNAs may represent a valid therapeutic avenue. We show that miR-9-5p protected from renal fibrosis in the mouse model of unilateral ureteral obstruction (UUO). This was reflected in reduced expression of pro-fibrotic markers, decreased number of infiltrating monocytes/macrophages, and diminished tubular epithelial cell injury and transforming growth factor-beta 1 (TGF-beta 1)-dependent de-differentiation in human kidney proximal tubular (HKC-8) cells. RNA-sequencing (RNA-Seq) studies in the UUO model revealed that treatment with miR-9-5p prevented the downregulation of genes related to key metabolic pathways, including mitochondrial function, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and glycolysis. Studies in human tubular epithelial cells demonstrated that miR-9-5p impeded TGF-beta 1-induced bioenergetics derangement. The expression of the FAO-related axis peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha)-peroxisome proliferator-activated receptor alpha (PPAR alpha) was reduced by UUO, although preserved by the administration of miR-9-5p. We found that in mice null for the mitochondrial master regulator PGC-1 alpha, miR-9-5p was unable to promote a protective effect in the UUO model. We propose that miR-9-5p elicits a protective response to chronic kidney injury and renal fibrosis by inducing reprogramming of the metabolic derangement and mitochondrial dysfunction affecting tubular epithelial cells.	[Fierro-Fernandez, Marta; Miguel, Veronica; Nuevo-Tapioles, Cristina; Herrero, J. Ignacio; Blanco-Ruiz, Eva; Tituana, Jessica; Lamas, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain; [Marquez-Exposito, Laura; Cannata, Pablo; Ruiz-Ortega, Marta] Fdn Jimenez Diaz (UAM), Inst Invest Sanitaria, Madrid, Spain; [Castillo, Carolina] Hosp Univ Principe Asturias, Madrid, Spain; [Monsalve, Maria] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Ramos, Ricardo] Fdn Parque Cient Madrid, Serv Genom, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Prince of Asturias University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Lamas, S (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain.	slamas@cbm.csic.es	Nuevo-Tapioles, Cristina/AAT-5772-2021; Miguel, Veronica/AAA-3645-2021; Monsalve, Maria/K-4416-2014; Ruiz-Ortega, Marta/D-3584-2012; Nuevo-Tapioles, Cristina/F-5970-2016; Lamas, Santiago/G-7308-2015; ramos-ruiz, ricardo/Q-2237-2016	Monsalve, Maria/0000-0003-2796-1453; Ruiz-Ortega, Marta/0000-0002-1495-6535; Nuevo-Tapioles, Cristina/0000-0001-5809-2030; Lamas, Santiago/0000-0001-5166-4155; Miguel, Veronica/0000-0001-9863-0710; Blanco-Ruiz, Eva/0000-0001-5940-1827; TITUANA FAJARDO, JESSICA/0000-0002-3337-8363; ramos-ruiz, ricardo/0000-0002-6331-9786	Ministerio de Economia y Competitividad (MINECO) [SAF2015-66107-R, SAF 2012-31388, SAF2015-63904-R, BES-2013-065986, BES-2014-068929]; MINECO Instituto de Salud Carlos III (ISCIII) [RD12/0021/0009, RD16/0009/0016, PI17/00119]; Comunidad de Madrid [B2017/BMD-3751]; FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	Ministerio de Economia y Competitividad (MINECO); MINECO Instituto de Salud Carlos III (ISCIII); Comunidad de Madrid(Comunidad de Madrid); FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2015-66107-R, SAF 2012-31388, SAF2015-63904-R, BES-2013-065986 and BES-2014-068929; MINECO Instituto de Salud Carlos III (ISCIII), Grant/Award Number: RD12/0021/0009, RD16/0009/0016 and PI17/00119; Comunidad de Madrid, Grant/Award Number: B2017/BMD-3751; FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Breyer MD, 2016, NAT REV DRUG DISCOV, V15, P568, DOI 10.1038/nrd.2016.67; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chang-Panesso M, 2017, NAT REV NEPHROL, V13, P39, DOI 10.1038/nrneph.2016.169; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ACK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00050; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; Dennis G, 2003, GENOME BIOL, V4; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Espinosa-Diez C, 2015, ANTIOXID REDOX SIGN, V23, P1092, DOI 10.1089/ars.2014.6025; Fierro-Fernandez M, 2016, REDOX BIOL, V7, P58, DOI 10.1016/j.redox.2015.11.006; Fierro-Fernandez M, 2015, EMBO REP, V16, P1358, DOI 10.15252/embr.201540750; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gomez IG, 2016, AM J PHYSIOL-RENAL, V310, pP931, DOI 10.1152/ajprenal.00523.2015; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Han SH, 2017, J AM SOC NEPHROL, V28, P3312, DOI 10.1681/ASN.2017020130; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Lavoz C, 2015, J PATHOL, V236, P407, DOI 10.1002/path.4537; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li R, 2013, KIDNEY INT, V84, P1129, DOI 10.1038/ki.2013.272; Li SY, 2018, SEMIN NEPHROL, V38, P121, DOI 10.1016/j.semnephrol.2018.01.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lynch MR, 2018, AM J PHYSIOL-RENAL, V314, pF1, DOI 10.1152/ajprenal.00263.2017; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; Maheshwari R, 2017, NANOMEDICINE-UK, V12, P2653, DOI 10.2217/nnm-2017-0210; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Miguel V, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0044-2; O'Reilly S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0929-x; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ralto KM, 2016, SEMIN NEPHROL, V36, P8, DOI 10.1016/j.semnephrol.2016.01.005; Remuzzi A, 2016, J AM SOC NEPHROL, V27, P699, DOI 10.1681/ASN.2014100971; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shihab FS, 2007, CLIN J AM SOC NEPHRO, V2, P876, DOI 10.2215/CJN.02660707; Simon N, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00052; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Stadler K, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0611-8; Szeto HH, 2017, J AM SOC NEPHROL, V28, P2856, DOI 10.1681/ASN.2017030247; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang JY, 2016, J DIABETES COMPLICAT, V30, P406, DOI 10.1016/j.jdiacomp.2015.12.011; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang F, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0771-9; Zhao H, 2019, CLIN CHIM ACTA, V491, P59, DOI 10.1016/j.cca.2019.01.008; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	76	32	35	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					410	431		10.1096/fj.201901599RR	http://dx.doi.org/10.1096/fj.201901599RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914684	Green Published, Green Submitted			2022-12-26	WOS:000507308900029
J	Khan, YA; Maurya, SK; Kulkarni, C; Tiwari, MC; Nagar, GK; Chattopadhyay, N				Khan, Yasir Akhtar; Maurya, Shailendra Kumar; Kulkarni, Chirag; Tiwari, Mahesh Chandra; Nagar, Geet Kumar; Chattopadhyay, Naibedya			Fasciola helminth defense molecule-1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response	FASEB JOURNAL			English	Article						bone; cartilage; collagen-induced arthritis; helminth defense molecule; lysosome; osteoclast	RHEUMATOID-ARTHRITIS; BONE LOSS; T-CELLS; H+-ATPASE; PATHOGENESIS; DESTRUCTION; CYTOKINES; ACIDIFICATION; DEGENERATION; MACROPHAGES	An inverse correlation between helminth infection and the autoimmune disease appears to be contributed by the anti-inflammatory factors produced by these organisms. Suppressing osteoclast function without affecting the systemic immunological response is an emerging therapeutic strategy for rheumatoid arthritis (RA). We observed that a synthetic peptide corresponding to 34 amino acids of C-terminal sequence of Fasciola helminth defense molecule-1 (C-FhHDM-1) inhibited RANKL-induced osteoclast formation and lysosomal acidification with an attendant upregulation of sequestome1/p62, a negative regulator of NF-kappa B expression. C-FhHDM-1 also suppressed RANKL production from osteoblasts. Macrophages are the major inflammatory cells in the joints of RA and C-FhHDM-1 suppressed ICAM-1 (an inflammatory surrogate) expression in these cells. In a murine model of collagen II-induced arthritis (CIA), C-FhHDM-1 improved clinical score, protected against cartilage destruction, and maintained bone mass and bone architecture of joints compared with the CIA group. C-FhHDM-1 suppressed the CIA-induced expression of TNF, IL-17, and IFN-gamma in joints but not their serum levels. The peptide also had no effect on the CIA-induced suppression of T regulatory response. We conclude that C-FhHDM-1 has a joint-specific protective effect in experimental arthritis without mitigating systemic inflammation, and thus could become an adjuvant anti-arthritis therapy to prevent RA-induced osteopenia.	[Khan, Yasir Akhtar; Maurya, Shailendra Kumar; Kulkarni, Chirag; Tiwari, Mahesh Chandra; Nagar, Geet Kumar; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India; [Khan, Yasir Akhtar] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh 202002, Uttar Pradesh, India; [Kulkarni, Chirag; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Acad Sci & Innovat Res, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Aligarh Muslim University; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Chattopadhyay, N (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.; Khan, YA (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh 202002, Uttar Pradesh, India.	yasirkhanakhtar@gmail.com; n_chattopadhyay@cdri.res.in	Chattopadhyay, Naibedya/AAQ-3213-2021	Chattopadhyay, Naibedya/0000-0003-2473-0246	Department of Science and Technology-Science and Engineering Research Board, Government of India [PDF/2015/000790]; Department of Science and Technology, Government of India [SB/SO/HS/048/2014]	Department of Science and Technology-Science and Engineering Research Board, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	Department of Science and Technology-Science and Engineering Research Board, Government of India, Grant/Award Number: PDF/2015/000790; Department of Science and Technology, Government of India, Grant/Award Number: SB/SO/HS/048/2014	Alvarado R, 2017, FASEB J, V31, P85, DOI 10.1096/fj.201500093R; Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Bonnet CS, 2015, ANN RHEUM DIS, V74, P242, DOI 10.1136/annrheumdis-2013-203670; Boraschi-Diaz I, 2016, CYTOTECHNOLOGY, V68, P105, DOI 10.1007/s10616-014-9759-3; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chen YM, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1763-0; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Garimella MG, 2015, J IMMUNOL, V195, P5136, DOI 10.4049/jimmunol.1500332; Garrood T, 2006, RHEUMATOLOGY, V45, P250, DOI 10.1093/rheumatology/kei207; Gelman A, 2011, DEV CELL, V21, P808, DOI 10.1016/j.devcel.2011.10.021; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gu W., 2017, ONCOTARGET, V8; Heidari B, 2011, CASP J INTERN MED, V2, P161; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Henriksen K, 2006, J BONE MINER RES, V21, P58, DOI 10.1359/JBMR.050905; Hubbard AK, 2000, INFLAMMATION, V24, P115, DOI 10.1023/A:1007029409521; Jung SM, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/263625; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kato G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0753-8; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kelly C, 2002, Eur J Intern Med, V13, P423, DOI 10.1016/S0953-6205(02)00129-2; Khan YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126429; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kour S, 2016, J IMMUNOL, V196, P5024, DOI 10.4049/jimmunol.1500907; Kumar RA, 2018, INT IMMUNOPHARMACOL, V65, P348, DOI 10.1016/j.intimp.2018.10.016; Lacombe J, 2013, CELL CYCLE, V12, P2744, DOI 10.4161/cc.25825; Langdon K, 2019, INT IMMUNOPHARMACOL, V66, P366, DOI 10.1016/j.intimp.2018.11.034; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Lund ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep37789; Matsumoto N, 2019, BIOCHEM BIOPH RES CO, V510, P421, DOI 10.1016/j.bbrc.2019.01.118; Matsumoto N, 2014, BBA-BIOENERGETICS, V1837, P744, DOI 10.1016/j.bbabio.2014.02.011; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Meyer PWA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/158514; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109; Niikura K, 2007, BONE, V40, P888, DOI 10.1016/j.bone.2006.10.015; Pal S, 2019, J ETHNOPHARMACOL, V235, P8, DOI 10.1016/j.jep.2019.01.029; Pal S, 2016, TOXICOL APPL PHARM, V295, P12, DOI 10.1016/j.taap.2016.02.002; Pereira M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216267; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sato W, 2012, J IMMUNOL, V189, P5057, DOI 10.4049/jimmunol.1202026; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Srivastava RK, 2011, J IMMUNOL, V186, P2262, DOI 10.4049/jimmunol.1002691; Swarnkar G, 2012, BRIT J PHARMACOL, V165, P1526, DOI 10.1111/j.1476-5381.2011.01637.x; SZEKANECZ Z, 1994, ARTHRITIS RHEUM, V37, P221, DOI 10.1002/art.1780370211; Takeuchi T, 2016, ANN RHEUM DIS, V75, P983, DOI 10.1136/annrheumdis-2015-208052; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Tripathi JK, 2015, BIOMATERIALS, V56, P92, DOI 10.1016/j.biomaterials.2015.03.046; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Vomero M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01577; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; Zhu SP, 2016, J CELL BIOCHEM, V117, P1464, DOI 10.1002/jcb.25442	58	6	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1091	1106		10.1096/fj.201901480RR	http://dx.doi.org/10.1096/fj.201901480RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914677				2022-12-26	WOS:000507308900074
J	Sun, XY; Gao, XQ; Deng, ZH; Zhang, LL; McGilvray, K; Gadomski, BC; Amra, S; Bao, G; Huard, J				Sun, Xuying; Gao, Xueqin; Deng, Zhenhan; Zhang, Linlin; McGilvray, Kirk; Gadomski, Benjamin C.; Amra, Sarah; Bao, Gang; Huard, Johnny			High bone microarchitecture, strength, and resistance to bone loss in MRL/MpJ mice correlates with activation of different signaling pathways and systemic factors	FASEB JOURNAL			English	Article						MRL; MpJ mice; osteoblasts; osteoclasts; ovariectomy; tibia fracture	MESENCHYMAL STEM-CELLS; MINERAL DENSITY; ARTICULAR-CARTILAGE; DIGIT TIP; MRL MICE; IGF-I; REGENERATION; FRACTURE; EXPRESSION; DENOSUMAB	The MRL/MpJ mice have demonstrated an enhanced tissue regeneration capacity for various tissues. In the present study, we systematically characterized bone microarchitecture and found that MRL/MpJ mice exhibit higher bone microarchitecture and strength compared to both C57BL/10J and C57BL/6J WT mice at 2, 4, and 10 months of age. The higher bone mass in MRL/MpJ mice was correlated to increased osteoblasts, decreased osteoclasts, higher cell proliferation, and bone formation, and enhanced pSMAD5 signaling earlier during postnatal development (2-month old) in the spine trabecular bone, and lower bone resorption rate at later age. Furthermore, these mice exhibit accelerated fracture healing via enhanced pSMAD5, pAKT and p-P38MAPK pathways compared to control groups. Moreover, MRL/MpJ mice demonstrated resistance to ovariectomy-induced bone loss as evidenced by maintaining higher bone volume/tissue volume (BV/TV) and lower percentage of bone loss later after ovariectomy. The consistently higher serum IGF1 level and lower RANKL level in MRL/MpJ mice may contribute to the maintenance of high bone mass in uninjured and injured bone. In conclusion, our results indicate that enhanced pSMAD5, pAKT, and p-P38MAPK signaling, higher serum IGF-1, and lower RANKL level contribute to the higher bone microarchitecture and strength, accelerated healing, and resistance to osteoporosis in MRL/MpJ mice.	[Sun, Xuying; Gao, Xueqin; Deng, Zhenhan; Amra, Sarah; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Dept Orthopaed Surg, 1881 East Rd,Room 3SCR6-3607, Houston, TX 77054 USA; [Gao, Xueqin; Huard, Johnny] Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA; [Zhang, Linlin; Bao, Gang] Rice Univ, Dept Biomed Engn, Houston, TX USA; [McGilvray, Kirk; Gadomski, Benjamin C.] Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA; [McGilvray, Kirk; Gadomski, Benjamin C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	University of Texas System; University of Texas Health Science Center Houston; Steadman Philippon Research Institute; Rice University; Colorado State University; Colorado State University	Gao, XQ; Huard, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Dept Orthopaed Surg, 1881 East Rd,Room 3SCR6-3607, Houston, TX 77054 USA.; Gao, XQ; Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA.	Xueqin.Gao@uth.tmc.edu; jhuard@sprivail.org	Deng, Zhenhan/AAB-4968-2021; Deng, Zhenhan/AAR-2420-2021	Deng, Zhenhan/0000-0003-0522-8269; Zhang, Linlin/0000-0003-3240-1215; McGilvray, Kirk/0000-0003-1302-9307; Gao, Xueqin/0000-0001-5833-1548	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	Anagnostis P, 2018, HAEMOPHILIA, V24, P316, DOI 10.1111/hae.13384; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Buckley G, 2011, J ANAT, V218, P163, DOI 10.1111/j.1469-7580.2010.01313.x; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Christians JK, 2019, GROWTH HORM IGF RES, V44, P6, DOI 10.1016/j.ghir.2018.10.006; de Souza KSC, 2016, DIABETES-METAB RES, V32, P589, DOI 10.1002/dmrr.2772; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dempster DW, 2012, CLIN THER, V34, P521, DOI 10.1016/j.clinthera.2012.02.002; Deng ZH, 2019, FASEB J, V33, P8809, DOI 10.1096/fj.201802132RR; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Esapa Christopher T, 2012, Curr Protoc Mouse Biol, V2, P365, DOI 10.1002/9780470942390.mo120124; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Fornari R, 2018, EAT WEIGHT DISORD-ST, V23, P375, DOI 10.1007/s40519-017-0362-4; Gao XQ, 2016, HUM MOL GENET, V25, P3216, DOI 10.1093/hmg/ddw172; Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965; Gao XQ, 2014, BIOMATERIALS, V35, P6859, DOI 10.1016/j.biomaterials.2014.04.113; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Hinton RJ, 2017, J DENT RES, V96, P23, DOI 10.1177/0022034516668321; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Ibrahim MM, 2014, WOUND REPAIR REGEN, V22, P755, DOI 10.1111/wrr.12238; Idris AI, 2012, METHODS MOL BIOL, V816, P545, DOI 10.1007/978-1-61779-415-5_34; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kwiatkowski A, 2016, BIOCHEM BIOPH RES CO, V473, P907, DOI 10.1016/j.bbrc.2016.03.149; Langdahl B, 2016, THER ADV MUSCULOSKEL, V8, P225, DOI 10.1177/1759720X16670154; Lau KHW, 2016, BONE, V92, P18, DOI 10.1016/j.bone.2016.08.005; Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x; Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; LEVAME M, 1987, PATHOL BIOL, V35, P1183; Li GY, 2017, BBA-MOL BASIS DIS, V1863, P2848, DOI 10.1016/j.bbadis.2017.07.036; Mak J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23076; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Naseem RH, 2007, PHYSIOL GENOMICS, V30, P44, DOI 10.1152/physiolgenomics.00070.2006; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Paccou J, 2012, JOINT BONE SPINE, V79, P78, DOI 10.1016/j.jbspin.2011.06.002; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Rai MF, 2014, MATRIX BIOL, V39, P50, DOI 10.1016/j.matbio.2014.08.011; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; Ramcharan MA, 2017, OSTEOPOROSIS INT, V28, P1133, DOI 10.1007/s00198-016-3801-6; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Sankaran JS, 2017, MAMM GENOME, V28, P476, DOI 10.1007/s00335-017-9717-4; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Selvamurugan N, 2004, J BIOL CHEM, V279, P19327, DOI 10.1074/jbc.M314048200; Simintiriadis D, 2013, SCAND J CLIN LAB INV, V73, P34, DOI 10.3109/00365513.2012.733409; Sims NA, 2014, CURR OSTEOPOROS REP, V12, P98, DOI 10.1007/s11914-014-0196-1; Sinha KM, 2019, FASEB J, V33, P8321, DOI 10.1096/fj.201801794R; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thuret S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030904; Tsai JN, 2017, BONE, V95, P20, DOI 10.1016/j.bone.2016.11.009; Tseng C, 2019, STEM CELLS, V37, P357, DOI 10.1002/stem.2957; Turner NJ, 2013, J TISSUE ENG REGEN M, V7, P139, DOI 10.1002/term.508; Tuzcu S, 2017, Z RHEUMATOL, V76, P716, DOI 10.1007/s00393-016-0171-6; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yuan YY, 2008, OSTEOPOROSIS INT, V19, P625, DOI 10.1007/s00198-007-0509-7	68	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					789	806		10.1096/fj.201901229RR	http://dx.doi.org/10.1096/fj.201901229RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914651				2022-12-26	WOS:000507308900054
J	Wu, DC; Dasgupta, A; Chen, KH; Neuber-Hess, M; Patel, J; Hurst, TE; Mewburn, JD; Lima, PDA; Alizadeh, E; Martin, A; Wells, M; Snieckus, V; Archer, SL				Wu, Danchen; Dasgupta, Asish; Chen, Kuang-Hueih; Neuber-Hess, Monica; Patel, Jignesh; Hurst, Timothy E.; Mewburn, Jeffrey D.; Lima, Patricia D. A.; Alizadeh, Elahe; Martin, Ashley; Wells, Michael; Snieckus, Victor; Archer, Stephen L.			Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury	FASEB JOURNAL			English	Article						breast cancer; ellipticine; lung cancer; mitochondrial dynamics; mitochondrial division inhibitor 1 (mdivi-1); mitochondrial fission; right ventricle	MITOCHONDRIAL DYNAMICS; FISSION; DIVISION; DYSFUNCTION; MDIVI-1; INJURY	Mitochondrial fission is important in physiological processes, including coordination of mitochondrial and nuclear division during mitosis, and pathologic processes, such as the production of reactive oxygen species (ROS) during cardiac ischemia-reperfusion injury (IR). Mitochondrial fission is mainly mediated by dynamin-related protein 1 (Drp1), a large GTPase. The GTPase activity of Drp1 is essential for its fissogenic activity. Therefore, we aimed to identify Drp1 inhibitors and evaluate their anti-neoplastic and cardioprotective properties in five cancer cell lines (A549, SK-MES-1, SK-LU-1, SW 900, and MCF7) and an experimental cardiac IR injury model. Virtual screening of a chemical library revealed 17 compounds with high predicted affinity to the GTPase domain of Drp1. In silico screening identified an ellipticine compound, Drpitor1, as a putative, potent Drp1 inhibitor. We also synthesized a congener of Drpitor1 to remove the methoxymethyl group and reduce hydrolytic lability (Drpitor1a). Drpitor1 and Drpitor1a inhibited the GTPase activity of Drp1 without inhibiting the GTPase of dynamin 1. Drpitor1 and Drpitor1a have greater potency than the current standard Drp1 GTPase inhibitor, mdivi-1, (IC50 for mitochondrial fragmentation are 0.09, 0.06, and 10 mu M, respectively). Both Drpitors reduced proliferation and induced apoptosis in cancer cells. Drpitor1a suppressed lung cancer tumor growth in a mouse xenograft model. Drpitor1a also inhibited mitochondrial ROS production, prevented mitochondrial fission, and improved right ventricular diastolic dysfunction during IR injury. In conclusion, Drpitors are useful tools for understanding mitochondrial dynamics and have therapeutic potential in treating cancer and cardiac IR injury.	[Wu, Danchen; Dasgupta, Asish; Chen, Kuang-Hueih; Neuber-Hess, Monica; Mewburn, Jeffrey D.; Martin, Ashley; Archer, Stephen L.] Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada; [Patel, Jignesh; Hurst, Timothy E.; Snieckus, Victor] Queens Univ, Dept Chem, Kingston, ON, Canada; [Lima, Patricia D. A.; Alizadeh, Elahe] Queens Univ, Dept Med, Translat Inst Med TIME, Queens Cardiopulm Unit QCPU, Kingston, ON, Canada; [Wells, Michael] Queens Univ, Off Partnerships & Innovat, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca	Wu, Danchen/W-4727-2019; wu, danchen/Y-8493-2019	Wu, Danchen/0000-0003-3901-5907; Alizadeh, Elahe/0000-0003-4046-1226	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR); HHS | National Institutes of Health (NIH) [NIH-R01-HL071115, 1RC1HL099462]; Canada Research Chairs (Chaires de recherche du Canada) [950-229252]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR); HHS | National Institutes of Health (NIH), Grant/Award Number: NIH-R01-HL071115; HHS | National Institutes of Health (NIH), Grant/Award Number: 1RC1HL099462; Canada Research Chairs (Chaires de recherche du Canada), Grant/Award Number: 950-229252; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bernardo PH, 2004, J MED CHEM, V47, P4958, DOI 10.1021/jm049625o; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Maneechote C, 2017, J CELL MOL MED, V21, P2643, DOI 10.1111/jcmm.13330; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nishiyama T, 2017, EUR J MED CHEM, V136, P1, DOI 10.1016/j.ejmech.2017.04.071; Peiris-Pages Maria, 2018, Oncotarget, V9, P13254, DOI 10.18632/oncotarget.24285; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Ruiz A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00003; Sharp Willard W, 2015, Crit Care Med, V43, pe38, DOI 10.1097/CCM.0000000000000817; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sumida M, 2015, J AM SOC NEPHROL, V26, P2378, DOI 10.1681/ASN.2014080750; Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492; Tian L, 2017, J MOL MED, V95, P381, DOI 10.1007/s00109-017-1522-8; WATANABE M, 1980, J AM CHEM SOC, V102, P1457, DOI 10.1021/ja00524a059; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894	26	41	42	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1447	1464		10.1096/fj.201901467R	http://dx.doi.org/10.1096/fj.201901467R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914641	Bronze			2022-12-26	WOS:000507308900096
J	Foronda, M; Tarumoto, Y; Schatoff, EM; Leach, BI; Diaz, BJ; Zimmerman, J; Goswami, S; Shusterman, M; Vakoc, CR; Dow, LE				Foronda, Miguel; Tarumoto, Yusuke; Schatoff, Emma M.; Leach, Benjamin, I; Diaz, Bianca J.; Zimmerman, Jill; Goswami, Sukanya; Shusterman, Michael; Vakoc, Christopher R.; Dow, Lukas E.			Tankyrase inhibition sensitizes cells to CDK4 blockade	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; LUNG-CANCER; EGFR INHIBITION; BETA-CATENIN; WNT; SENESCENCE; DIFFERENTIATION; COLON; RESTORATION; PORCUPINE	Tankyrase (INKS) 1/2 are positive regulators of WNT signaling by controlling the activity of the B-catenin destruction complex. INKS inhibitors provide an opportunity to suppress hyperactive WNT signaling in tumors, however, they have shown limited anti-proliferative activity as a monotherapy in human cancer cell lines. Here we perform a kinome-focused CRISPR screen to identify potential effective drug combinations with INKS inhibition. We show that the loss of CDK4, but not CDK6, synergizes with TNKS1/2 blockade to drive G1 cell cycle arrest and senescence. Through precise modelling of cancer-associated mutations using cytidine base editors, we show that this therapeutic approach is absolutely dependent on suppression of canonical WNT signaling by INKS inhibitors and is effective in cells from multiple epithelial cancer types. Together, our results suggest that combined WNT and CDK4 inhibition might provide a potential therapeutic strategy for difficult-to-treat epithelial tumors.	[Foronda, Miguel; Schatoff, Emma M.; Leach, Benjamin, I; Diaz, Bianca J.; Zimmerman, Jill; Goswami, Sukanya; Shusterman, Michael; Dow, Lukas E.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Tarumoto, Yusuke; Vakoc, Christopher R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Schatoff, Emma M.] Weill Cornell Med, Triinst MD PhD Program, New York, NY USA; [Dow, Lukas E.] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Dow, Lukas E.] Weill Cornell Med, Dept Biochem, New York, NY 10065 USA; [Leach, Benjamin, I] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA	Cornell University; Cold Spring Harbor Laboratory; Cornell University; Cornell University; Cornell University; City of Hope	Dow, LE (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Dow, LE (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.; Dow, LE (corresponding author), Weill Cornell Med, Dept Biochem, New York, NY 10065 USA.	lud2005@med.cornell.edu	Tarumoto, Yusuke/AAV-5246-2020	Tarumoto, Yusuke/0000-0001-6652-9618; Dow, Lukas/0000-0001-7048-1418	NIH/NCI [CA195787-01]; Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant [SU2C-AACR-DT22-17]; Stand Up to Cancer is a program of the Entertainment Industry Foundation; NCI/NIH [CA 181280-01]; NATIONAL CANCER INSTITUTE [K22CA181280] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant; Stand Up to Cancer is a program of the Entertainment Industry Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a project grant from the NIH/NCI (CA195787-01) and a Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant (SU2C-AACR-DT22-17). Stand Up to Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, a scientific partner of SU2C. LED was supported by a K22 Career Development Award from the NCI/NIH (CA 181280-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques O, 2016, CLIN CANCER RES, V22, P644, DOI 10.1158/1078-0432.CCR-14-3081; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Elzi DJ, 2012, MOL CELL BIOL, V32, P4388, DOI 10.1128/MCB.06023-11; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fry DW, 2004, MOL CANCER THER, V3, P1427; Galluzzi L, 2019, TRENDS CELL BIOL, V29, P44, DOI 10.1016/j.tcb.2018.08.005; Ha GH, 2012, CELL DEATH DIFFER, V19, P321, DOI 10.1038/cdd.2011.101; Han T, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15945; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harburg G, 2014, STEM CELL REP, V3, P385, DOI 10.1016/j.stemcr.2014.07.007; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; McCabe N, 2009, ONCOGENE, V28, P1465, DOI 10.1038/onc.2008.483; Menon M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36447-4; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Norum JH, 2018, BIOL RES, V51, DOI 10.1186/s40659-017-0151-6; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090; Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schatoff EM, 2017, CURR COLORECT CANC R, V13, P101, DOI 10.1007/s11888-017-0354-9; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schoumacher M, 2014, CANCER RES, V74, P3294, DOI 10.1158/0008-5472.CAN-14-0138-T; Solberg NT, 2018, MOL CANCER RES, V16, P543, DOI 10.1158/1541-7786.MCR-17-0362; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Stokes KL, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0133-3; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Tarumoto Y, 2018, MOL CELL, V69, P1017, DOI 10.1016/j.molcel.2018.02.011; Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217; Wang H, 2016, J BIOL CHEM, V291, P15256, DOI 10.1074/jbc.M116.722967; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Xia HW, 2011, DYNAMICS FOR SUSTAINABLE ENGINEERING, VOL 1, P183; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang XY, 2015, DRUG DES DEV THER, V9, P2399, DOI 10.2147/DDDT.S76602	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226645	10.1371/journal.pone.0226645	http://dx.doi.org/10.1371/journal.pone.0226645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891587	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000515096600022
J	Pajkossy, P; Racsmany, M				Pajkossy, Peter; Racsmany, Mihaly			How the size of the to-be-learned material influences the encoding and later retrieval of associative memories: A pupillometric assessment	PLOS ONE			English	Article							LONG-TERM-MEMORY; PUPILLARY RESPONSES; LOCUS-COERULEUS; RECOGNITION; DIAMETER; RECALL; LOAD; RECOLLECTION; STRENGTH	Pupillometry have recently added valuable insights about the cognitive and possible neurobiological processes underlying episodic memory. Most of the studies, however, investigated recognition memory, which only partially relies on cue-driven recollection, the hallmark feature of episodic memory. Here we measured pupil size during a paired associate learning task, where participants encoded word-pairs, and after a short delay they took part in a cued recall. Importantly, we manipulated the size of the learning set: participants either learnt two, four or eight word-pairs in a row. As expected, increasing set size resulted in larger forgetting, assumingly as a consequence of weaker memory strength for the word pairs. Our results show an important difference between pupil size changes observed during encoding and retrieval. During retrieval, the pupil instantly begun to dilate, as a sign of increased processing load accompanying the retrieval of the target memory. Importantly, large set size was also associated with larger pupil dilation during retrieval. This supports the notion that pupil dilation can be regarded as a marker of memory strength. In contrast, during encoding, pupil dilation decreased with increasing amount of encoded information, which might be due to the overuse of attentional resources. Furthermore, we also found that serial position during encoding modulated subsequent memory effects: for the first three serial positions, successful recall was predicted by larger pupil dilation during encoding, whereas such subsequent memory effect was absent for later serial positions. These results suggest that the amount of information independently modulates pupil dilation during encoding and retrieval, and support the assumption that pupillometric investigation of paired associate learning could be an informative way to investigate the cognitive and neurobiological processes of episodic memory.	[Pajkossy, Peter; Racsmany, Mihaly] Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Pajkossy, Peter; Racsmany, Mihaly] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics	Pajkossy, P (corresponding author), Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.; Pajkossy, P (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.	ppajkossy@cogsci.bme.hu		Pajkossy, Peter/0000-0002-6879-6784	National Brain Research Program, Hungary [2017-1.2.1-NKP-2017-00002]; NKFI [K124098]; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences	National Brain Research Program, Hungary; NKFI(National Research, Development & Innovation Office (NRDIO) - Hungary); Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the 2017-1.2.1-NKP-2017-00002 Research Grant (National Brain Research Program, Hungary) and the NKFI K124098 Research Grant (both awarded to MR). PP was supported by the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K, 1997, NEUROPSYCHOLOGIA, V35, P387, DOI 10.1016/S0028-3932(96)00094-2; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; [Anonymous], 1983, CANADIAN PSYCHOL; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; Barbur JL, 2004, THE VISUAL NEUROSCIE, P641; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Bergt A, 2018, EUR J NEUROSCI, V47, P1525, DOI 10.1111/ejn.13984; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bradley MM, 2015, PSYCHOPHYSIOLOGY, V52, P1186, DOI 10.1111/psyp.12442; Chen ZJ, 2005, J EXP PSYCHOL LEARN, V31, P1235, DOI 10.1037/0278-7393.31.6.1235; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; CONWAY MA, 1992, NATO ADV SCI INST SE, V65, P167; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Easton A, 2012, NEUROPSYCHOLOGIA, V50, P3156, DOI 10.1016/j.neuropsychologia.2012.07.022; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; HESS EH, 1965, SCI AM, V212, P46, DOI 10.1038/scientificamerican0465-46; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kafkas A, 2018, NEUROSCI LETT, V680, P60, DOI 10.1016/j.neulet.2018.01.053; Kafkas A, 2011, Q J EXP PSYCHOL, V64, P1971, DOI 10.1080/17470218.2011.588335; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Konya A., 1985, HUNGARIAN PSYCHOL RE, V2, P93; Kucewicz MT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23197-6; Larsen RS, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00021; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; Lynn R., 1966, ATTENTION AROUSAL OR; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meeter M, 2004, PSYCHOL BULL, V130, P843, DOI 10.1037/0033-2909.130.6.843; Miller AL, 2019, J MEM LANG, V104, P25, DOI 10.1016/j.jml.2018.09.005; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Moscovitch Morris, 1994, P269; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Naber M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13188; Naber M, 2013, J VISION, V13, DOI 10.1167/13.2.11; Nobel PA, 2001, J EXP PSYCHOL LEARN, V27, P384, DOI 10.1037/0278-7393.27.2.384; Otero SC, 2011, PSYCHOPHYSIOLOGY, V48, P1346, DOI 10.1111/j.1469-8986.2011.01217.x; Pajkossy P, 2017, PSYCHOPHYSIOLOGY, V54, P1839, DOI 10.1111/psyp.12964; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Papesh MH, 2012, INT J PSYCHOPHYSIOL, V83, P56, DOI 10.1016/j.ijpsycho.2011.10.002; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Reimer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13289; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Semon R.W., 1921, THE MNEME; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; TULVING E, 1983, PHILOS T ROY SOC B, V302, P361, DOI 10.1098/rstb.1983.0060; Unsworth N, 2018, COGN AFFECT BEHAV NE, V18, P638, DOI 10.3758/s13415-018-0594-4; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018; Wang CA, 2014, J NEUROSCI, V34, P408, DOI 10.1523/JNEUROSCI.3550-13.2014; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Wilding E. L., 2012, OXFORD HDB EVENT REL, P373; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Wolffsohn JS, 2001, OPHTHAL PHYSL OPT, V21, P108, DOI 10.1016/S0275-5408(00)00050-8; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226684	10.1371/journal.pone.0226684	http://dx.doi.org/10.1371/journal.pone.0226684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891588	Green Published, gold, Green Accepted			2022-12-26	WOS:000515096600023
J	Dizin, E; Olivier, V; Maire, C; Komarynets, O; Sassi, A; Roth, I; Loffing, J; de Seigneux, S; Maillard, M; Rutkowski, JM; Edwards, A; Feraille, E				Dizin, Eva; Olivier, Valerie; Maire, Charline; Komarynets, Olga; Sassi, Ali; Roth, Isabelle; Loffing, Johannes; de Seigneux, Sophie; Maillard, Marc; Rutkowski, Joseph M.; Edwards, Aurelie; Feraille, Eric			Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium	FASEB JOURNAL			English	Article						aldosterone paradox; edema; ENaC; hyperkalemia; proteinuria; SRAA	EPITHELIAL NA+ CHANNEL; INCREASED EXPRESSION; SURFACE EXPRESSION; ANGIOTENSIN-II; ALDOSTERONE; KIDNEY; COTRANSPORTER; ENAC; ACTIVATION; MECHANISMS	The mechanism of sodium retention and its location in kidney tubules may vary with time in nephrotic syndrome (NS). We studied the mechanisms of sodium retention in transgenic POD-ATTAC mice, which display an inducible podocyte-specific apoptosis. At day 2 after the induction of NS, the increased abundance of NHE3 and phosphorylated NCC in nephrotic mice compared with controls suggest that early sodium retention occurs mainly in the proximal and distal tubules. At day 3, the abundance of NHE3 normalized, phosphorylated NCC levels decreased, and cleavage and apical localization of gamma-ENaC increased in nephrotic mice. These findings indicate that sodium retention shifted from the proximal and distal tubules to the collecting system. Increased cleavage and apical localization of gamma-ENaC persisted at day 5 in nephrotic mice when hypovolemia resolved and steady-state was reached. Sodium retention and gamma-ENaC cleavage were independent of the increased plasma levels of aldosterone. Nephrotic mice displayed decreased glomerular filtration rate and urinary potassium excretion associated with hyperkaliemia at day 3. Feeding nephrotic mice with a low potassium diet prevented hyperkaliemia, gamma-ENaC cleavage, and led to persistent increased phosphorylation of NCC. These results suggest that potassium homeostasis is a major determinant of the tubular site of sodium retention in nephrotic mice.	[Dizin, Eva; Olivier, Valerie; Maire, Charline; Komarynets, Olga; Sassi, Ali; Roth, Isabelle; de Seigneux, Sophie; Feraille, Eric] Univ Geneva, Dept Cellular Physiol & Metab, CMU, Geneva, Switzerland; [Dizin, Eva; Olivier, Valerie; Maire, Charline; Roth, Isabelle; Loffing, Johannes; de Seigneux, Sophie; Feraille, Eric] Natl Ctr Competence Res Kidney Ch, Zurich, Switzerland; [Loffing, Johannes] Univ Zurich, Inst Anat, Zurich, Switzerland; [Maillard, Marc] CHU Vaudois, Serv Nephrol, Lausanne, Switzerland; [Rutkowski, Joseph M.] Texas A&M Univ, Dept Med Physiol, Hlth Sci Ctr, Bryan, TX USA; [Edwards, Aurelie] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Geneva; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Boston University	Feraille, E (corresponding author), Univ Geneva, Dept Cellular Physiol & Metab, Fac Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@unige.ch	Maillard, Marc/AAY-8604-2020; Loffing, Johannes/ABG-9973-2020	Feraille, Eric/0000-0003-1656-8365; SASSI, ALI/0000-0002-3194-777X; Loffing, Johannes/0000-0002-9415-6588	Swiss National Science Foundation [310030_143929/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: 31003A_156736/1; Swiss National Science Foundation, Grant/Award Number: 310030_143929/1	Amlal H, 2001, AM J PHYSIOL-RENAL, V280, pF513, DOI 10.1152/ajprenal.2001.280.3.F513; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Bohnert BN, 2018, KIDNEY INT, V93, P159, DOI 10.1016/j.kint.2017.07.023; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; de Seigneux S, 2006, AM J PHYSIOL-RENAL, V291, pF208, DOI 10.1152/ajprenal.00399.2005; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Frindt G, 2015, AM J PHYSIOL-RENAL, V308, pF572, DOI 10.1152/ajprenal.00585.2014; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Houillier P, 1996, KIDNEY INT, V50, P1496, DOI 10.1038/ki.1996.464; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; HUMPHREYS MH, 1994, KIDNEY INT, V45, P266, DOI 10.1038/ki.1994.33; ICHIKAWA I, 1983, J CLIN INVEST, V71, P91, DOI 10.1172/JCI110756; Jarvie BC, 2017, NAT NEUROSCI, V20, P167, DOI 10.1038/nn.4451; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; KIM JK, 1990, KIDNEY INT, V38, P818, DOI 10.1038/ki.1990.276; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Koizumi M, 2019, HYPERTENSION, V74, P509, DOI 10.1161/HYPERTENSIONAHA.118.12352; Layton AT, 2016, AM J PHYSIOL-RENAL, V310, pF1269, DOI 10.1152/ajprenal.00543.2015; Lourdel S, 2005, J AM SOC NEPHROL, V16, P3642, DOI 10.1681/ASN.2005040363; Mollet G, 2009, J AM SOC NEPHROL, V20, P2181, DOI 10.1681/ASN.2009040379; Motoyoshi Y, 2008, KIDNEY INT, V74, P1262, DOI 10.1038/ki.2008.405; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Siddall EC, 2012, KIDNEY INT, V82, P635, DOI 10.1038/ki.2012.180; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Terker AS, 2016, J AM SOC NEPHROL, V27, P2436, DOI 10.1681/ASN.2015070815; Terker AS, 2016, KIDNEY INT, V89, P127, DOI 10.1038/ki.2015.289; Udwan K, 2017, J PHYSIOL-LONDON, V595, P6905, DOI 10.1113/JP274927; Volk KA, 2005, J BIOL CHEM, V280, P18348, DOI 10.1074/jbc.M413689200; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Youn JH, 2013, SEMIN NEPHROL, V33, P248, DOI 10.1016/j.semnephrol.2013.04.005	43	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2408	2424		10.1096/fj.201901345R	http://dx.doi.org/10.1096/fj.201901345R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908015	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000504855000001
J	Yoo, SM; Yamashita, S; Kim, H; Na, D; Lee, H; Kim, SJ; Cho, DH; Kanki, T; Jung, YK				Yoo, Seung-Min; Yamashita, Shun-ichi; Kim, Hyunjoo; Na, DoHyeong; Lee, Haneul; Kim, Seo Jin; Cho, Dong-Hyung; Kanki, Tomotake; Jung, Yong-Keun			FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions	FASEB JOURNAL			English	Article						FKBP8; mitochondria fission; mitophagy; OPA1; stress	AUTOPHAGOSOME FORMATION; CELL-DEATH; FISSION; DEGRADATION; PROTEIN; REQUIRES; PARKIN; DRP1; OPA1; RECRUITMENT	Mitochondrial quality control maintains mitochondrial function by regulating mitochondrial dynamics and mitophagy. Despite the identification of mitochondrial quality control factors, little is known about the crucial regulators coordinating both mitochondrial fission and mitophagy. Through a cell-based functional screening assay, FK506 binding protein 8 (FKBP8) was identified to target microtubule-associated protein 1 light chain 3 (LC3) to the mitochondria and to change mitochondrial morphology. Microscopy analysis revealed that the formation of tubular and enlarged mitochondria was observed in FKBP8 knockdown HeLa cells and the cortex of Fkbp8 heterozygote-knockout mouse embryos. Under iron depletion-induced stress, FKBP8 was recruited to the site of mitochondrial division through budding and colocalized with LC3. FKBP8 was also found to be required for mitochondrial fragmentation and mitophagy under hypoxic stress. Conversely, FKBP8 overexpression induced mitochondrial fragmentation in HeLa cells, human fibroblasts and mouse embryo fibroblasts (MEFs), and this fragmentation occurred in Drp1 knockout MEF cells, FIP200 knockout HeLa cells and BNIP3/NIX double knockout HeLa cells, but not in Opa1 knockout MEFs. Interestingly, we found an LIR motif-like sequence (LIRL), as well as an LIR motif, at the N-terminus of FKBP8 and LIRL was essential for both inducing mitochondrial fragmentation and binding of FKBP8 to OPA1. Together, we suggest that FKBP8 plays an essential role in mitochondrial fragmentation through LIRL during mitophagy and this activity of FKBP8 together with LIR is required for mitophagy under stress conditions.	[Yoo, Seung-Min; Kim, Hyunjoo; Na, DoHyeong; Lee, Haneul; Kim, Seo Jin; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea; [Yamashita, Shun-ichi; Kanki, Tomotake] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cellular Physiol, Niigata, Japan; [Cho, Dong-Hyung] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea	Seoul National University (SNU); Niigata University; Kyungpook National University	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	ykjung@snu.ac.kr	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379; Jung, Yong-Keun/0000-0002-9686-3120	CRI grant [NRF-2019R1A2B5B03070352]; Bio & Medical Technology Development Program of the National Research Foundation [NRF-2017M3A9G7073521]; Japan's Society for the Promotion of Science [KAKENHI 19H05712]	CRI grant; Bio & Medical Technology Development Program of the National Research Foundation; Japan's Society for the Promotion of Science	CRI grant, Grant/Award Number: NRF-2019R1A2B5B03070352; Bio & Medical Technology Development Program of the National Research Foundation, Grant/Award Number: NRF-2017M3A9G7073521; Japan's Society for the Promotion of Science, Grant/Award Number: KAKENHI 19H05712	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Frezza Christian, 2007, Methods Mol Biol, V372, P405, DOI 10.1007/978-1-59745-365-3_29; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32933; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Nah J, 2017, COMPR PHYSIOL, V7, P1407, DOI 10.1002/cphy.c170005; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Oettinghaus B, 2016, BBA-BIOENERGETICS, V1857, P1267, DOI 10.1016/j.bbabio.2016.03.016; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Padgett ME, 2016, JOVE-J VIS EXP, DOI 10.3791/54166; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wong RLY, 2008, HUM MOL GENET, V17, P587, DOI 10.1093/hmg/ddm333; Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102; Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277	47	19	19	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2944	2957		10.1096/fj.201901735R	http://dx.doi.org/10.1096/fj.201901735R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908024				2022-12-26	WOS:000504668100001
J	Hu, J; Shrestha, S; Zhou, YX; Mudge, J; Liu, XL; Lamour, K				Hu, Jian; Shrestha, Sandesh; Zhou, Yuxin; Mudge, Joann; Liu, Xili; Lamour, Kurt			Dynamic Extreme Aneuploidy (DEA) in the vegetable pathogen Phytophthora capsici and the potential for rapid asexual evolution	PLOS ONE			English	Article							MEFENOXAM INSENSITIVITY; CLONAL LINEAGES; MICHIGAN; MEIOSIS	Oomycete plant pathogens are difficult to control and routine genetic research is challenging. A major problem is instability of isolates. Here we characterize > 600 field and single zoospore isolates of Phytophthora capsici for inheritance of mating type, sensitivity to mefenoxam, chromosome copy number and heterozygous allele frequencies. The A2 mating type was highly unstable with 26% of 241 A2 isolates remaining A2. The A1 mating type was stable. Isolates intermediately resistant to mefenoxam produced fully resistant single-spore progeny. Sensitive isolates remained fully sensitive. Genome re-sequencing of single zoospore isolates revealed extreme aneuploidy; a phenomenon dubbed Dynamic Extreme Aneuploidy (DEA). DEA is characterized by the asexual inheritance of diverse intra-genomic combinations of chromosomal ploidy ranging from 2N to 3N and heterozygous allele frequencies that do not strictly correspond to ploidy. Isolates sectoring on agar media showed dramatically altered heterozygous allele frequencies. DEA can explain the rapid increase of advantageous alleles (e.g. drug resistance), mating type switches and copy neutral loss of heterozygosity (LOH). Although the mechanisms driving DEA are unknown, it can play an important role in adaptation and evolution and seriously hinders all aspects of P. capsici research.	[Hu, Jian] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Peoples R China; [Shrestha, Sandesh] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Zhou, Yuxin] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China; [Mudge, Joann] Natl Ctr Genome Resources, Santa Fe, NM USA; [Liu, Xili] China Agr Univ, Coll Plant Pathol, Beijing, Peoples R China; [Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	Nanjing Agricultural University; Kansas State University; Nanjing Agricultural University; National Center for Genome Resources (NCGR); China Agricultural University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Lamour, K (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	klamour@utk.edu		Mudge, Joann/0000-0002-2972-1640; Lamour, Kurt/0000-0001-6407-8825				Barchenger DW, 2017, MYCOL PROG, V16, P955, DOI 10.1007/s11557-017-1330-0; Castro-Rocha A, 2017, MYCOL PROG, V16, P999, DOI 10.1007/s11557-017-1334-9; Castro-Rocha A, 2016, MYCOL PROG, V15, DOI 10.1007/s11557-016-1157-0; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Erwin DC, 1996, PHYTOPHTHORA DIS WOR, Vxii; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Gevens AJ, 2007, PHYTOPATHOLOGY, V97, P421, DOI 10.1094/PHYTO-97-4-0421; Gobena D, 2012, MYCOL PROG, V11, P761, DOI 10.1007/s11557-011-0787-5; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082691; Hu J, 2013, PHYTOPATHOLOGY, V103, P920, DOI 10.1094/PHYTO-01-13-0016-R; Hulvey J, 2010, MYCOLOGIA, V102, P1127, DOI 10.3852/09-221; Hurtado-Gonzales O, 2008, PHYTOPATHOLOGY, V98, P688, DOI 10.1094/PHYTO-98-6-0688; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kumar Y, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0104-2; Lamour K, 2009, OOMYCETE GENETICS GE, Vxvii; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Lamour KH, 2002, PHYTOPATHOLOGY, V92, P681, DOI 10.1094/PHYTO.2002.92.6.681; Lamour KH, 2001, PHYTOPATHOLOGY, V91, P553, DOI 10.1094/PHYTO.2001.91.6.553; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Lamour KH, 2007, FEMS MICROBIOL LETT, V274, P1, DOI 10.1111/j.1574-6968.2007.00786.x; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Lyon R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148385; Phytophthora Lamour K, 2013, GLOBAL PERSPECTIVE, Vxi; Rosenberg SM, 2011, MBIO, V2, DOI 10.1128/mBio.00200-11; SANSOME E, 1965, CYTOLOGIA, V30, P103, DOI 10.1508/cytologia.30.103; SANSOME E, 1961, NATURE, V191, P827, DOI 10.1038/191827a0; Shrestha S, 2014, MYCOLOGIA, V106, P676, DOI 10.3852/13-165	28	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227250	10.1371/journal.pone.0227250	http://dx.doi.org/10.1371/journal.pone.0227250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910244	Green Published, Green Submitted, gold			2022-12-26	WOS:000534333800034
J	Oh, SW; Lee, JE; Shin, E; Kwon, H; Choe, EK; Choi, SY; Rhee, H; Choi, SH				Oh, Seung-Won; Lee, Jong-Eun; Shin, Eunsoon; Kwon, Hyuktae; Choe, Eun Kyung; Choi, Su-Yeon; Rhee, Hwanseok; Choi, Seung Ho			Genome-wide association study of metabolic syndrome in Korean populations	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIPID-LEVELS; TRIGLYCERIDE LEVELS; GENETIC-VARIANTS; FASTING GLUCOSE; RISK; LOCI; POLYMORPHISM; SUSCEPTIBILITY	Metabolic syndrome (MetS) which is caused by obesity and insulin resistance, is well known for its predictive capability for the risk of type 2 diabetes mellitus and cardiovascular disease. The development of MetS is associated with multiple genetic factors, environmental factors and lifestyle. We performed a genome-wide association study to identify single-nucleotide polymorphism (SNP) related to MetS in large Korean population based samples of 1,362 subjects with MetS and 6,061 controls using the Axiom (R) Korean Biobank Array 1.0. We replicated the data in another sample including 502 subjects with MetS and 1,751 controls. After adjusting for age and sex, rs662799 located in the APOA5 gene were significantly associated with MetS. 15 SNPs in GCKR, C2orf16, APOA5, ZPR1, and BUD13 were associated with high triglyceride (TG). 14 SNPs in APOA5, ALDH1A2, LIPC, HERPUD1, and CETP, and 2 SNPs in MTNR1B were associated with low high density lipoprotein cholesterol (HDL-C) and high fasting blood glucose respectively. Among these SNPs, 6 TG SNPs: rs1260326, rs1260333, rs1919127, rs964184, rs2075295 and rs1558861 and 11 HDL-C SNPs: rs4775041, rs10468017, rs1800588, rs72786786, rs173539, rs247616, rs247617, rs3764261, rs4783961, rs708272, and rs7499892 were first discovered in Koreans. Additional research is needed to confirm these 17 novel SNPs in Korean population.	[Oh, Seung-Won] Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Lee, Jong-Eun; Shin, Eunsoon; Rhee, Hwanseok] DNA Link Inc, Seoul, South Korea; [Kwon, Hyuktae] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Choe, Eun Kyung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Surg, Seoul, South Korea; [Choi, Su-Yeon; Choi, Seung Ho] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; DNA Link, Inc.; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Oh, SW (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	sw.oh@snu.ac.kr; cshmed@snuh.org	Choi, Su-Yeon/C-4312-2013; Oh, Seung-Won/GLS-0494-2022	Choi, Su-Yeon/0000-0001-9977-4740; Oh, Seung-Won/0000-0003-3800-0754	Ministry of Trade, Industry & Energy (MOTIE, Korea) [10050154]	Ministry of Trade, Industry & Energy (MOTIE, Korea)	This work was supported by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). Jong-Eun Lee, Eunsoon Shin and Hwanseok Rhee are employed by DNA Link, Inc. DNA Link, Inc. provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Brooks MA, 2009, NUCLEIC ACIDS RES, V37, P129, DOI 10.1093/nar/gkn894; Caussy C, 2014, AM J HUM GENET, V94, P129, DOI 10.1016/j.ajhg.2013.12.001; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; El Kares R, 2010, KIDNEY INT, V78, P96, DOI 10.1038/ki.2010.101; Galcheva-Gargova Z, 1998, MOL BIOL CELL, V9, P2963, DOI 10.1091/mbc.9.10.2963; Go MJ, 2013, J HUM GENET, V58, P362, DOI 10.1038/jhg.2013.14; Jeong Seok Won, 2014, Genomics & Informatics, V12, P187, DOI 10.5808/GI.2014.12.4.187; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim JY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-82; Kim M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26106-z; Kim SJ, 2012, CIRC J, V76, P907, DOI 10.1253/circj.CJ-11-0713; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kurano M, 2016, J HUM GENET, V61, P427, DOI 10.1038/jhg.2015.170; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lee HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23074-2; Lee HJ, 2015, CLIN CHIM ACTA, V450, P155, DOI 10.1016/j.cca.2015.08.012; Lim JE, 2019, GENET EPIDEMIOL; Lim S, 2006, J ENDOCRINOL INVEST, V29, P313, DOI 10.1007/BF03344102; Liu SJ, 2012, CHINESE MED J-PEKING, V125, P801, DOI 10.3760/cma.j.issn.0366-6999.2012.05.014; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; Maasz A, 2007, PATHOL ONCOL RES, V13, P243, DOI 10.1007/BF02893505; Melegh BI, 2012, CURR MED CHEM, V19, P6163; Moon S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37832-9; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Nakayama K, 2011, J HUM GENET, V56, P828, DOI 10.1038/jhg.2011.109; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Park YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030235; Perez-Martinez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020555; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Shen Y-Y, 2013, PLOS ONE, V8; Shou WH, 2014, BBA-MOL BASIS DIS, V1842, P2147, DOI 10.1016/j.bbadis.2014.08.006; Son KY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0111-5; Song KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585134; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Takeuchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046385; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-176; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Ye HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135683	52	24	24	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227357	10.1371/journal.pone.0227357	http://dx.doi.org/10.1371/journal.pone.0227357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910446	Green Published, gold			2022-12-26	WOS:000534333800044
J	Boyle, CJ; Carpanen, D; Pandelani, T; Higgins, CA; Masen, MA; Masouros, SD				Boyle, Colin J.; Carpanen, Diagarajen; Pandelani, Thanyani; Higgins, Claire A.; Masen, Marc A.; Masouros, Spyros D.			Lateral pressure equalisation as a principle for designing support surfaces to prevent deep tissue pressure ulcers	PLOS ONE			English	Article							INTERFACE PRESSURES; WHEELCHAIR CUSHIONS; SKIN; DEFORMATION; MUSCLE; INJURY; MODEL; COMPRESSION; DAMAGE; MRI	When immobile or neuropathic patients are supported by beds or chairs, their soft tissues undergo deformations that can cause pressure ulcers. Current support surfaces that redistribute under-body pressures at vulnerable body sites have not succeeded in reducing pressure ulcer prevalence. Here we show that adding a supporting lateral pressure can counteract the deformations induced by under-body pressure, and that this 'pressure equalisation' approach is a more effective way to reduce ulcer-inducing deformations than current approaches based on redistributing under-body pressure. A finite element model of the seated pelvis predicts that applying a lateral pressure to the soft tissue reduces peak von Mises stress in the deep tissue by a factor of 2.4 relative to a standard cushion (from 113 kPa to 47 kPa)-a greater effect than that achieved by using a more conformable cushion, which reduced von Mises stress to 75 kPa. Combining both a conformable cushion and lateral pressure reduced peak von Mises stresses to 25 kPa. The ratio of peak lateral pressure to peak under-body pressure was shown to regulate deep tissue stress better than under-body pressure alone. By optimising the magnitude and position of lateral pressure, tissue deformations can be reduced to that induced when suspended in a fluid. Our results explain the lack of efficacy in current support surfaces and suggest a new approach to designing and evaluating support surfaces: ensuring sufficient lateral pressure is applied to counteract under-body pressure.	[Boyle, Colin J.; Carpanen, Diagarajen; Pandelani, Thanyani; Higgins, Claire A.; Masouros, Spyros D.] Imperial Coll London, Dept Bioengn, London, England; [Boyle, Colin J.; Masen, Marc A.] Imperial Coll London, Dept Mech Engn, London, England	Imperial College London; Imperial College London	Boyle, CJ (corresponding author), Imperial Coll London, Dept Bioengn, London, England.; Boyle, CJ (corresponding author), Imperial Coll London, Dept Mech Engn, London, England.	c.boyle@imperial.ac.uk	Boyle, Colin/S-6168-2018; Masen, Marc/AAD-5948-2019; Masouros, Spyros/ABI-3500-2020	Boyle, Colin/0000-0002-7508-8508; Masen, Marc/0000-0002-9423-7193; Masouros, Spyros/0000-0003-1700-5548; Carpanen, Diagarajen/0000-0002-6558-134X; Higgins, Claire/0000-0002-9742-5149; Pandelani, Thanyani/0000-0003-2107-5194	Imperial Innovations Ltd.; EPSRC [EP/N026845/1]; Imperial College London	Imperial Innovations Ltd.; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College London(General Electric)	This project was partly funded by an Imperial College London and Imperial Innovations Ltd. Proof of Concept funding to CB and SM and EPSRC funding to CH, MM and SM (EP/N026845/1). The EPSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imperial College London provided support in the form of salaries for authors [CJB, SDM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. To clarify further, Imperial Innovations Ltd. is a technology-transfer company that acted as the tech-transfer office of Imperial College London from 1986 to 2019. The awarding of Proof of Concept funding or any other associate with Imperial Innovations Ltd does not alter our adherence to PLOS ONE policies on sharing data and materials.; We would like to thank Surbhi Gupta and all those involved at Imperial Innovations Ltd. for their support in delivering this project.	Al-Dirini RMA, 2015, CLIN BIOMECH, V30, P662, DOI 10.1016/j.clinbiomech.2015.05.008; [Anonymous], 2016, AB 2016 DOC; Bader DL, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0470-z; Bouten CV, 2003, ARCH PHYS MED REHAB, V84, P616, DOI 10.1053/apmr.2003.50038; Bridel J, 1993, J Wound Care, V2, P230; Brienza DM, 1996, IEEE T REHABIL ENG, V4, P320, DOI 10.1109/86.547933; Ceelen KK, 2008, J BIOMECH, V41, P3399, DOI 10.1016/j.jbiomech.2008.09.016; CHOW WW, 1978, J BIOMECH ENG-T ASME, V100, P79, DOI 10.1115/1.3426196; Dabnichki P. A., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P9, DOI 10.1177/095441199420800102; Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281; Gawlitta D, 2007, ANN BIOMED ENG, V35, P273, DOI 10.1007/s10439-006-9222-5; Gefen A., 2007, Journal of Medical Engineering & Technology, V31, P375, DOI 10.1080/03091900601165256; Gil-Agudo A, 2009, CLIN BIOMECH, V24, P558, DOI 10.1016/j.clinbiomech.2009.04.006; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Holzapfel G., 2001, HDB MAT BEHAV MODELS, V3, P1049, DOI DOI 10.1016/13978-012443341-0/50107-1; Holzapfel G., 2000, NONLINEAR SOLID MECH; James R, 1970, Patent No. [US3678520A, 3678520]; JOHNSON T. R., Patent No. [US211741A, 211741]; Keller BPJA, 2005, INJURY, V36, P946, DOI 10.1016/j.injury.2004.09.017; KOSIAK M, 1961, Arch Phys Med Rehabil, V42, P19; KROUSKOP TA, 1983, MED HYPOTHESES, V11, P255, DOI 10.1016/0306-9877(83)90067-1; Linder-Ganz E, 2007, J BIOMECH, V40, P1443, DOI 10.1016/j.jbiomech.2006.06.020; Linder-Ganz E, 2006, J BIOMECH, V39, P2725, DOI 10.1016/j.jbiomech.2005.08.010; Luboz V, 2014, J BIOMECH, V47, P2231, DOI 10.1016/j.jbiomech.2014.05.004; Marin J, 2013, SPINAL CORD, V51, P522, DOI 10.1038/sc.2013.29; McInnes E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001735.pub5; MELAMED Y, 1992, NEW ENGL J MED, V326, P30; Morrow DA, 2010, J MECH BEHAV BIOMED, V3, P124, DOI 10.1016/j.jmbbm.2009.03.004; Mueller MJ, 2005, DIABETES CARE, V28, P2908, DOI 10.2337/diacare.28.12.2908; Nixon J, 2019, ECLINICALMEDICINE, V14, P42, DOI 10.1016/j.eclinm.2019.07.018; NPUAP, 2007, SUPP SURF IN TERMS D; Olesen CG, 2010, J APPL PHYSIOL, V108, P1458, DOI 10.1152/japplphysiol.01006.2009; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Oomens CWJ, 2015, ANN BIOMED ENG, V43, P297, DOI 10.1007/s10439-014-1202-6; Peirce SM, 2000, WOUND REPAIR REGEN, V8, P68, DOI 10.1046/j.1524-475x.2000.00068.x; Ragan R, 2002, ARCH PHYS MED REHAB, V83, P872, DOI 10.1053/apmr.2002.32677; REDDY NP, 1981, J BIOMECH, V14, P879, DOI 10.1016/0021-9290(81)90015-4; Reenalda J, 2009, ASSIST TECHNOL, V21, P76, DOI 10.1080/10400430903050437; Regan MA, 2009, ARCH PHYS MED REHAB, V90, P213, DOI 10.1016/j.apmr.2008.08.212; Shabshin N, 2010, J REHABIL RES DEV, V47, P31, DOI 10.1682/JRRD.2009.07.0105; Shelton F, 1998, APPL ERGON, V29, P491, DOI 10.1016/S0003-6870(97)00069-0; Soetens JFJ, 2018, J MECH BEHAV BIOMED, V86, P423, DOI 10.1016/j.jmbbm.2018.07.008; Sommer G, 2013, ACTA BIOMATER, V9, P9036, DOI 10.1016/j.actbio.2013.06.011; Van Loocke M, 2006, J BIOMECH, V39, P2999, DOI 10.1016/j.jbiomech.2005.10.016; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Verver M. M., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P193, DOI 10.1080/10255840410001727832; Walia GS, 2016, ADV SKIN WOUND CARE, V29, P566	47	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227064	10.1371/journal.pone.0227064	http://dx.doi.org/10.1371/journal.pone.0227064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899778	Green Published, Green Submitted, gold			2022-12-26	WOS:000534322000012
J	Wibble, T; Sodergard, U; Traisk, F; Pansell, T				Wibble, Tobias; Sodergard, Ulrika; Traisk, Frank; Pansell, Tony			Intensified visual clutter induces increased sympathetic signalling, poorer postural control, and faster torsional eye movements during visual rotation	PLOS ONE			English	Article							MOTION SICKNESS; OCULAR TORSION; VERTIGO; DIZZINESS; PUPIL; BURDEN	Many dizzy patients express a hypersensitivity to visual motion and clutter. This study aims to investigate how exposure to rotating visual clutter affects ocular torsion, vertical skewing, body-sway, the autonomic pupillary response, and the subjective feeling of discomfort to the stimulation. Sixteen healthy subjects were exposed to 20 seconds rotational visual stimulation (72 deg/s; 50 deg visual field). Visual stimuli were comprised of black lines on a white background, presented at low and high intensity levels of visual clutter, holding 19 lines and 38 lines respectively. Ocular torsion and vertical skewing were recorded using the Chronos Eye Tracker, which also measured pupil size as a reflection of the autonomic response. Postural control was evaluated by measuring body-sway area on the Wii Balance Board. Values were compared to data retrieved 20 seconds before and after the optokinetic stimulation, as subjects viewed the stationary visual scene. The high intensity stimulus resulted in significantly higher torsional velocities. Subjects who were exposed to low intensity first exhibited higher velocities for both intensities. Both pupil size and body sway increased for the higher intensity to both the moving and stationary visual scene, and were positively correlated to torsional velocity. In conclusion, exposure to visual clutter was reflected in the eye movement response, changes in postural control, and the autonomic response. This response may hold clinical utility when assessing patients suffering from visual motion hypersensitivity, while also providing some context as to why some healthy people feel discomfort in visually cluttered surroundings.	[Wibble, Tobias; Sodergard, Ulrika; Traisk, Frank; Pansell, Tony] Karolinska Inst, Div Ophthalmol & Vis, Dept Clin Neurosci, Marianne Bernadotte Ctr, Stockholm, Sweden; [Wibble, Tobias; Traisk, Frank; Pansell, Tony] St Erik Eye Hosp, Stockholm, Sweden	Karolinska Institutet	Wibble, T (corresponding author), Karolinska Inst, Div Ophthalmol & Vis, Dept Clin Neurosci, Marianne Bernadotte Ctr, Stockholm, Sweden.; Wibble, T (corresponding author), St Erik Eye Hosp, Stockholm, Sweden.	tobias.wibble@ki.se	Pansell, Tony/L-9487-2017; Wibble, Tobias/AAF-9625-2020	Wibble, Tobias/0000-0002-4224-6274; Pansell, Tony/0000-0001-7642-8263				Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; BRANDT T, 1974, EXP BRAIN RES, V21, P337; BRANDT T, 1993, ANN NEUROL, V33, P528, DOI 10.1002/ana.410330518; Bronstein Adolfo M, 2013, Handb Clin Neurol, V110, P189, DOI 10.1016/B978-0-444-52901-5.00016-2; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Bronstein AM, 2004, J NEUROL, V251, P381, DOI 10.1007/s00415-004-0410-7; BRONSTEIN AM, 1995, ACTA OTO-LARYNGOL, P45; BROWN B, 1972, VISION RES, V12, P305, DOI 10.1016/0042-6989(72)90120-4; CHEUNG BSK, 1991, VISION RES, V31, P1327, DOI 10.1016/0042-6989(91)90054-9; COLLEWIJN H, 1985, EXP BRAIN RES, V59, P185, DOI 10.1007/BF00237678; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Heerwagen J H, 1995, AAOHN J, V43, P458; Kennedy RS, 1996, J VESTIBUL RES-EQUIL, V6, P331, DOI 10.1016/0957-4271(96)00002-X; Lubeck AJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144034; MacNeilage PR, 2010, J NEUROPHYSIOL, V104, P765, DOI 10.1152/jn.01067.2009; Mueller M, 2014, EUR J PUBLIC HEALTH, V24, P802, DOI 10.1093/eurpub/ckt171; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Newton RA, 2003, GENERATIONS, V27, P27; Pansell T, 2006, EXP BRAIN RES, V175, P567, DOI 10.1007/s00221-006-0574-8; Park DS, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-99; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pedrotti M, 2014, INT J HUM-COMPUT INT, V30, P220, DOI 10.1080/10447318.2013.848320; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Skoien AK, 2008, BRIT J GEN PRACT, V58, P619, DOI 10.3399/bjgp08X330744; Tehrani ASS, 2013, ACAD EMERG MED, V20, P689, DOI 10.1111/acem.12168; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; Van Ombergen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154528; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Wibble T, 2019, INVEST OPHTH VIS SCI, V60, P1021, DOI 10.1167/iovs.19-26706; Wollseifen T., 2011, PHARM PROGRAMMING, V4, P91, DOI [10.1179/175709311X13166801334271, DOI 10.1179/175709311X13166801334271]; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227370	10.1371/journal.pone.0227370	http://dx.doi.org/10.1371/journal.pone.0227370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31900468	gold, Green Published, Green Submitted			2022-12-26	WOS:000534322000024
J	Atack, JM; Guo, CY; Yang, L; Zhou, YQ; Jennings, MP				Atack, John M.; Guo, Chengying; Yang, Long; Zhou, Yaoqi; Jennings, Michael P.			DNA sequence repeats identify numerous Type I restriction-modification systems that are potential epigenetic regulators controlling phase-variable regulons; phasevarions	FASEB JOURNAL			English	Article						bacterial pathogenesis; epigenetics; phase variation; phasevarion; R-M systems	FUSOBACTERIUM-NUCLEATUM; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; MODIFICATION ENZYMES; RECOGNITION DOMAINS; DAM METHYLATION; GENES; EXPRESSION; RECOMBINATION; SPECIFICITY	Over recent years several examples of randomly switching methyltransferases, associated with Type III restriction-modification (R-M) systems, have been described in pathogenic bacteria. In every case examined, changes in simple DNA sequence repeats result in variable methyltransferase expression and result in global changes in gene expression, and differentiation of the bacterial cell into distinct phenotypes. These epigenetic regulatory systems are called phasevarions, phase-variable regulons, and are widespread in bacteria, with 17.4% of Type III R-M system containing simple DNA sequence repeats. A distinct, recombination-driven random switching system has also been described in Streptococci in Type I R-M systems that also regulate gene expression. Here, we interrogate the most extensive and well-curated database of R-M systems, REBASE, by searching for all possible simple DNA sequence repeats in the hsdRMS genes that encode Type I R-M systems. We report that 7.9% of hsdS, 2% of hsdM, and of 4.3% of hsdR genes contain simple sequence repeats that are capable of mediating phase variation. Phase variation of both hsdM and hsdS genes will lead to differential methyltransferase expression or specificity, and thereby the potential to control phasevarions. These data suggest that in addition to well characterized phasevarions controlled by Type III mod genes, and the previously described Streptococcal Type I R-M systems that switch via recombination, approximately 10% of all Type I R-M systems surveyed herein have independently evolved the ability to randomly switch expression via simple DNA sequence repeats.	[Atack, John M.; Zhou, Yaoqi; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld 4215, Australia; [Guo, Chengying; Yang, Long] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China	Griffith University; Shandong Agricultural University	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld 4215, Australia.	m.jennings@griffith.edu.au	Zhou, Yaoqi/B-3284-2009; Jennings, Michael P/G-4822-2013; Zhou, Yaoqi/ABD-1125-2020	Zhou, Yaoqi/0000-0002-9958-5699; Jennings, Michael P/0000-0002-1027-4684; Yang, Long/0000-0002-9990-8398	Department of Health \ National Health and Medical Research Council (NHMRC) [1071659, 1138466, 1099279, 1121629]; Department of Education and Training \ Australian Research Council (ARC) [170104691, 180100976, 180102060]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Department of Education and Training \ Australian Research Council (ARC)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1071659, 1138466, 1099279 and 1121629; Department of Education and Training vertical bar Australian Research Council (ARC), Grant/Award Number: 170104691, 180100976 and 180102060	Adamczyk-Poplawska M, 2011, J BACTERIOL, V193, P6750, DOI 10.1128/JB.05672-11; An RS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-19; Atack JM, 2018, TRENDS MICROBIOL, V26, P715, DOI 10.1016/j.tim.2018.01.008; Atack JM, 2018, NUCLEIC ACIDS RES, V46, P3532, DOI 10.1093/nar/gky192; Atack JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8828; Atack JM, 2015, J INFECT DIS, V212, P645, DOI 10.1093/infdis/jiv103; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; Blakeway LV, 2014, FASEB J, V28, P5197, DOI 10.1096/fj.14-256578; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; Boyle B, 2012, J BACTERIOL, V194, P529, DOI 10.1128/JB.06246-11; Brocchi M, 2007, GENET MOL BIOL, V30, P236, DOI 10.1590/S1415-47572007000200011; BULLAS LR, 1976, J GEN MICROBIOL, V95, P166, DOI 10.1099/00221287-95-1-166; COWAN GM, 1989, CELL, V56, P103, DOI 10.1016/0092-8674(89)90988-4; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; Dawid S, 1999, P NATL ACAD SCI USA, V96, P1077, DOI 10.1073/pnas.96.3.1077; De Ste Croix M, 2017, FEMS MICROBIOL REV, V41, pS3, DOI 10.1093/femsre/fux025; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; Fox KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090505; Frey J, 2011, VET MICROBIOL, V153, P51, DOI 10.1016/j.vetmic.2011.05.018; FULLERPACE FV, 1984, P NATL ACAD SCI-BIOL, V81, P6095, DOI 10.1073/pnas.81.19.6095; Furi L, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00370-19; GANN AAF, 1987, MOL MICROBIOL, V1, P13, DOI 10.1111/j.1365-2958.1987.tb00521.x; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; GUBLER M, 1992, EMBO J, V11, P233, DOI 10.1002/j.1460-2075.1992.tb05046.x; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Highlander SK, 1996, GENE, V178, P89, DOI 10.1016/0378-1119(96)00340-X; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hu YM, 2016, INFECT IMMUN, V84, P2243, DOI 10.1128/IAI.00324-16; Huo WW, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02174-18; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Jeraldo P, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01154-15; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lai QL, 2011, INT J SYST EVOL MICR, V61, P295, DOI 10.1099/ijs.0.022962-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; MacWilliams MP, 1996, EMBO J, V15, P4775, DOI 10.1002/j.1460-2075.1996.tb00855.x; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Mei-Dan O, 2008, KNEE SURG SPORT TR A, V16, P15, DOI 10.1007/s00167-007-0379-8; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; NAGARAJA V, 1985, NATURE, V316, P371, DOI 10.1038/316371a0; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Oliver MB, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00386-17; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; PRICE C, 1989, J MOL BIOL, V205, P115, DOI 10.1016/0022-2836(89)90369-0; PRICE C, 1987, EMBO J, V6, P1493, DOI 10.1002/j.1460-2075.1987.tb02391.x; Rao DN, 2014, NUCLEIC ACIDS RES, V42, P45, DOI 10.1093/nar/gkt616; Reinert K, 2015, ANNU REV GENOM HUM G, V16, P133, DOI 10.1146/annurev-genom-090413-025358; Ren Z, 1999, J BACTERIOL, V181, P5865, DOI 10.1128/JB.181.18.5865-5870.1999; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Seib KL, 2011, FASEB J, V25, P3622, DOI 10.1096/fj.11-183590; Seib KL, 2002, FEMS IMMUNOL MED MIC, V32, P159; Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71; Sitaraman R, 1997, MOL MICROBIOL, V26, P109, DOI 10.1046/j.1365-2958.1997.5571938.x; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00319-17; Srikhanta YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027569; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Zaleski P, 2005, MICROBIOL-SGM, V151, P3361, DOI 10.1099/mic.0.28184-0; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	76	12	12	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1038	1051		10.1096/fj.201901536RR	http://dx.doi.org/10.1096/fj.201901536RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914596	Green Published, hybrid			2022-12-26	WOS:000507308900070
J	Gwon, MG; An, HJ; Kim, JY; Kim, WH; Gu, H; Kim, HJ; Leem, J; Jung, HJ; Park, KK				Gwon, Mi-Gyeong; An, Hyun-Jin; Kim, Jung-Yeon; Kim, Woon-Hae; Gu, Hyemin; Kim, Hyun-Ju; Leem, Jaechan; Jung, Hyun Jin; Park, Kwan-Kyu			Anti-fibrotic effects of synthetic TGF-beta 1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions	FASEB JOURNAL			English	Article						EndoMT; epithelial dedifferentiation; kidney fibrosis; TGF-beta 1; Smad oligodeoxynucleotide; UUO	GROWTH-FACTOR-BETA; RENAL INTERSTITIAL FIBROSIS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; URETERAL OBSTRUCTION; MECHANISMS; INJURY; MYOFIBROBLAST; FIBROBLASTS; EXPRESSION	Kidney fibrosis is a common process of various kidney diseases leading to end-stage renal failure irrespective of etiology. Myofibroblasts are crucial mediators in kidney fibrosis through production of extracellular matrix (ECM), but their origin has not been clearly identified. Many study proposed that epithelial and endothelial cells become myofibroblasts by epithelial dedifferentiation and endothelial-mesenchymal transition (EndoMT). TGF-beta 1/Smad signaling plays a crucial role in partly epithelial-mensencymal transition (EMT) and EndoMT. Thus, we designed the TGF-beta 1/Smad oligodeoxynucleotide (ODN), a synthetic short DNA containing complementary sequence for Smad transcription factor and TGF-beta 1 mRNA. Therefore, this study investigated the anti-fibrotic effect of synthetic TGF-beta 1/Smad ODN on UUO-induced kidney fibrosis in vivo model and TGF-beta 1-induced in vitro model. To examine the effect of TGF-beta 1/Smad ODN, we performed various experiments to evaluate kidney fibrosis. The results showed that UUO induced inflammation, ECM accumulation, epithelial dedifferentiation and EndoMT processes, and tubular atrophy. However, synthetic TGF-beta 1/Smad ODN significantly suppressed UUO-induced fibrosis. Furthermore, synthetic ODN attenuated TGF-beta 1-induced epithelial dedifferentiation and EndoMT program via blocking TGF-beta 1/Smad signaling. In conclusion, this study demonstrated that administration of synthetic TGF-beta 1/Smad ODN attenuates kidney fibrosis, epithelial dedifferentiation, and EndoMT processes. The findings propose the possibility of synthetic ODN as a new effective therapeutic tool for kidney fibrosis.	[Gwon, Mi-Gyeong; An, Hyun-Jin; Gu, Hyemin; Kim, Hyun-Ju; Park, Kwan-Kyu] Catholic Univ Daegu, Sch Med, Dept Pathol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea; [Kim, Jung-Yeon; Leem, Jaechan] Catholic Univ Daegu, Sch Med, Dept Immunol, Daegu, South Korea; [Kim, Woon-Hae] DGIST, Dept New Biol, Daegu, South Korea; [Jung, Hyun Jin] Catholic Univ Daegu, Sch Med, Dept Urol, Daegu, South Korea	Catholic University of Daegu; Catholic University of Daegu; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Catholic University of Daegu	Park, KK (corresponding author), Catholic Univ Daegu, Sch Med, Dept Pathol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.	kkpark@cu.ac.kr	Leem, Jaechan/AAQ-6648-2020; Kim, Woon-Hae/AAS-9817-2021	Kim, Woon-Hae/0000-0002-1536-5374; Leem, Jaechan/0000-0003-2329-4374	National Research Foundation of Korea (NRF) [NRF-2019R1F1A1061019]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2019R1F1A1061019	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cai GY, 2008, NEPHROL DIAL TRANSPL, V23, P1861, DOI 10.1093/ndt/gfm666; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng X, 2019, NEPHROL DIAL TRANSPL, V34, P242, DOI 10.1093/ndt/gfy107; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi BM, 1996, IMMUNOL CELL BIOL, V74, P144, DOI 10.1038/icb.1996.19; Collins AJ, 2009, AM J KIDNEY DIS, V55, pS1; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gerarduzzi C, 2017, INFLAMM RES, V66, P451, DOI 10.1007/s00011-016-1019-x; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Haller H, 1998, KIDNEY INT, V53, P1550, DOI 10.1046/j.1523-1755.1998.00927.x; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Higashi AY, 2019, J AM SOC NEPHROL, V30, P80, DOI 10.1681/ASN.2018060644; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; Hung TW, 2016, CELL PHYSIOL BIOCHEM, V40, P1029, DOI 10.1159/000453159; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kim KH, 2013, J MOL MED, V91, P573, DOI 10.1007/s00109-012-0972-2; Kim WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17873-2; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Li YJ, 2012, KIDNEY INT, V81, P880, DOI 10.1038/ki.2011.469; Liang M, 2015, AM J PATHOL, V185, P1234, DOI 10.1016/j.ajpath.2015.01.027; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lyman J L, 1986, Emerg Med Clin North Am, V4, P223; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Overstreet JM, 2017, FASEB J, V31, P4407, DOI 10.1096/fj.201601359RR; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Ramseyer VD, 2013, AM J PHYSIOL-RENAL, V304, pF1231, DOI 10.1152/ajprenal.00557.2012; Riedel K, 2008, IN VIVO, V22, P1; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sung WJ, 2013, EXP MOL PATHOL, V95, P136, DOI 10.1016/j.yexmp.2013.06.008; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wang ZJ, 2017, J CELL MOL MED, V21, P2359, DOI 10.1111/jcmm.13157; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu CG, 2016, MOL MED REP, V13, P901, DOI 10.3892/mmr.2015.4631; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yasar A, 2013, KAOHSIUNG J MED SCI, V29, P19, DOI 10.1016/j.kjms.2012.08.003; Yhee JY, 2008, J VET DIAGN INVEST, V20, P585, DOI 10.1177/104063870802000508; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang LJ, 2015, DRUG DES DEV THER, V9, P4669, DOI [10.2147/DDDT.S66770, 10.2147/DDDT.S86770]	70	17	19	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					333	349		10.1096/fj.201901307RR	http://dx.doi.org/10.1096/fj.201901307RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914629				2022-12-26	WOS:000507308900024
J	Penrad-Mobayed, M; Perrin, C; Herman, L; Todeschini, AL; Nigon, F; Cosson, B; Caburet, S; Veitia, RA				Penrad-Mobayed, May; Perrin, Caroline; Herman, Laetitia; Todeschini, Anne-Laure; Nigon, Fabienne; Cosson, Bertrand; Caburet, Sandrine; Veitia, Reiner A.			Conventional and unconventional interactions of the transcription factor FOXL2 uncovered by a proteome-wide analysis	FASEB JOURNAL			English	Article						DNA recombination and repair; protein-protein interaction; proteomics; mRNA splicing; RNA processing	GONADOTROPIN-RELEASING-HORMONE; GRANULOSA-CELL TUMORS; FORKHEAD TRANSCRIPTION; U2 SNRNP; GENE; EXPRESSION; BINDING; MOUSE; DEMETHYLATION; MITOCHONDRIA	Beyond the study of its transcriptional target genes, the identification of the various interactors of a transcription factor (TF) is crucial to understand its diverse cellular roles. We focused on FOXL2, a winged-helix forkhead TF important for ovarian development and maintenance. FOXL2 has been implicated in diverse cellular processes, including apoptosis, the control of cell cycle or the regulation of steroid hormone synthesis. To reliably identify partners of endogenous FOXL2, we performed a proteome-wide analysis using co-immunoprecipitation in the murine granulosa cell-derived AT29c and the pituitary-derived alpha-T3 cell lines, using three antibodies targeting different parts of the protein. Following a stringent selection of mass spectrometry data on the basis of identification reliability and protein enrichment, we identified a core set of 255 partners common to both cell lines. Their analysis showed that we could co-precipitate several complexes involved in mRNA processing, chromatin remodeling and DNA replication and repair. We further validated (direct and/or indirect) interactions with selected partners, suggesting an unexpected role for FOXL2 in those processes. Overall, this comprehensive analysis of the endogenous FOXL2 interactome sheds light on its numerous and diverse interactors and unconventional cellular roles.	[Penrad-Mobayed, May; Perrin, Caroline; Herman, Laetitia; Todeschini, Anne-Laure; Caburet, Sandrine; Veitia, Reiner A.] Univ Paris, CNRS, Inst Jacques Monod, UMR7592, 15 Rue Helene Brion, F-75013 Paris, France; [Nigon, Fabienne; Cosson, Bertrand] Univ Paris, CNRS, Epigenet & Cell Fate, UMR7216, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Caburet, S; Veitia, RA (corresponding author), Univ Paris, CNRS, Inst Jacques Monod, UMR7592, 15 Rue Helene Brion, F-75013 Paris, France.	sandrine.caburet@ijm.fr; reiner.veitia@ijm.fr	Caburet, Sandrine/AAH-3435-2019		Universite de Paris; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM)	Universite de Paris; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Universite de Paris; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM)	Alemasova EE, 2017, ACTA NATURAE, V9, P4, DOI 10.32607/20758251-2017-9-2-4-16; Alves-Fernandes DK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133153; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; Burg JM, 2016, BIOCHEMISTRY-US, V55, P1652, DOI 10.1021/acs.biochem.5b01135; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Curmi F, 2018, BIOCHEM SOC T, V46, P329, DOI 10.1042/BST20180016; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Elzaiat M, 2019, MOL CELL PROTEOMICS, V18, P1307, DOI 10.1074/mcp.RA119.001461; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Fujiyama-Nakamura S, 2009, MOL CELL PROTEOMICS, V8, P1552, DOI 10.1074/mcp.M900147-MCP200; Galganski L, 2017, NUCLEIC ACIDS RES, V45, P10350, DOI 10.1093/nar/gkx759; Gandoura S, 2013, J HEPATOL, V58, P936, DOI 10.1016/j.jhep.2012.12.025; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kim KH, 2014, CANCER GENET-NY, V207, P365, DOI 10.1016/j.cancergen.2014.04.004; Kim SY, 2009, ENDOCRINOLOGY, V150, P5085, DOI 10.1210/en.2009-0313; Kim S, 2017, J BIOENERG BIOMEMBR, V49, P335, DOI 10.1007/s10863-017-9705-0; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Lesnik C, 2015, RNA BIOL, V12, P801, DOI 10.1080/15476286.2015.1058686; Lettieri-Barbato D, 2019, METABOLISM, V95, P84, DOI 10.1016/j.metabol.2019.04.006; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Li YL, 2018, AM J CANCER RES, V8, P1343; Liu XR, 2019, BBA-REV CANCER, V1871, P179, DOI 10.1016/j.bbcan.2018.12.007; MacDonald CC, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1526; Madabhushi R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071917; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Marongiu M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0072-y; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Noli L, 2015, STEM CELL REP, V5, P946, DOI 10.1016/j.stemcr.2015.10.006; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rambout X, 2018, CHEM REV, V118, P4339, DOI 10.1021/acs.chemrev.7b00470; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shiomi Y, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020052; Sperling J, 2017, METHODS, V125, P70, DOI 10.1016/j.ymeth.2017.04.005; Thore S, 2019, BIOCHIMIE, V164, P105, DOI 10.1016/j.biochi.2019.03.016; Ting NSY, 2005, NUCLEIC ACIDS RES, V33, P2090, DOI 10.1093/nar/gki342; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Wang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051266	78	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					571	587		10.1096/fj.201901573R	http://dx.doi.org/10.1096/fj.201901573R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914586				2022-12-26	WOS:000507308900039
J	Tibaldi, E; Brocca, A; Sticca, A; Gola, E; Pizzi, M; Bordin, L; Pagano, MA; Mazzorana, M; Dona, G; Violi, P; Marin, O; Romano, A; Angeli, P; Carraro, A; Brunati, AM				Tibaldi, Elena; Brocca, Alessandra; Sticca, Antonietta; Gola, Elisabetta; Pizzi, Marco; Bordin, Luciana; Pagano, Mario Angelo; Mazzorana, Marco; Dona, Gabriella; Violi, Paola; Marin, Oriano; Romano, Antonella; Angeli, Paolo; Carraro, Amedeo; Brunati, Anna Maria			Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis	FASEB JOURNAL			English	Article						bile duct ligation; Golgi apparatus; hepatic stellate cells; osteopontin; phosphorylation	POSTTRANSLATIONAL MODIFICATIONS; CASEIN KINASE; FIBROSIS; INFLAMMATION; INHIBITION; BINDING; INJURY	Osteopontin (OPN) is a phosphoglycoprotein secreted into the extracellular matrix upon liver injury, acting as a cytokine stimulates the deposition of fibrillary collagen in liver fibrogenesis. In livers of mice subjected to bile duct ligation (BDL) and in cultured activated hepatic stellate cells (HSCs), we show that OPN, besides being overexpressed, is substantially phosphorylated by family with sequence similarity 20, member C (Fam20C), formerly known as Golgi casein kinase (G-CK), which is exclusively resident in the Golgi apparatus. In both experimental models, Fam20C becomes overactive when associated with a 500-kDa multiprotein complex, as compared with the negligible activity in livers of sham-operated rats and in quiescent HSCs. Fam20C knockdown not only confirmed the role of Fam20C itself in OPN phosphorylation, but also revealed that phosphorylation was essential for OPN secretion. However, OPN acts as a fibrogenic factor independently of its phosphorylation state, as demonstrated by the increased expression of Collagen-I by HSCs incubated with either a phosphorylated or nonphosphorylated form of recombinant OPN. Collectively, our results confirm that OPN promotes liver fibrosis and highlight Fam20C as a novel factor driving this process by favoring OPN secretion from HSCs, opening new avenues for deciphering yet unidentified mechanisms underlying liver fibrogenesis.	[Tibaldi, Elena; Bordin, Luciana; Pagano, Mario Angelo; Dona, Gabriella; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Viale G Colombo 3, I-35131 Padua, Italy; [Brocca, Alessandra; Sticca, Antonietta; Gola, Elisabetta; Romano, Antonella; Angeli, Paolo] Univ Padua, Dept Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy; [Pizzi, Marco] Univ Padua, Dept Med DIMED, Gen Pathol & Cytopathol Unit, Padua, Italy; [Mazzorana, Marco] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Violi, Paola; Carraro, Amedeo] Univ Hosp Verona, Dept Gen Surg & Odontoiatr, Liver Transplant Unit, Verona, Italy; [Marin, Oriano] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Padua; University of Padua; Diamond Light Source; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua	Pagano, MA (corresponding author), Univ Padua, Dept Mol Med, Viale G Colombo 3, I-35131 Padua, Italy.; Angeli, P (corresponding author), Univ Padua, Dept Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy.	mario.pagano@unipd.it; pangeli@unipd.it	Bordin, Luciana/I-6972-2019; Pizzi, Marco/H-6273-2016	Bordin, Luciana/0000-0003-4238-3153; Carraro, Amedeo/0000-0001-6449-4597; Pagano, Mario Angelo/0000-0003-4186-7658; Pizzi, Marco/0000-0003-4006-7317	DOR; University of Padova	DOR; University of Padova	DOR; University of Padova	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567; Chen YH, 2018, EXP CELL RES, V362, P343, DOI 10.1016/j.yexcr.2017.11.035; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Cordero-Espinoza L, 2018, J CLIN INVEST, V128, P85, DOI 10.1172/JCI93562; Cui JX, 2017, ELIFE, V6, DOI 10.7554/eLife.23990; Cui JX, 2015, ELIFE, V4, DOI 10.7554/eLife.06120; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4; Gringeri E, 2010, BIOCHEM J, V425, P401, DOI 10.1042/BJ20090902; Haghgoo SM, 2019, CLIN CHEM LAB MED, V57, P577, DOI 10.1515/cclm-2018-0357; Hui T, 2015, MATRIX BIOL, V41, P19, DOI 10.1016/j.matbio.2014.11.005; Icer MA, 2018, CLIN BIOCHEM, V59, P17, DOI 10.1016/j.clinbiochem.2018.07.003; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Klaning E, 2015, BBA-PROTEINS PROTEOM, V1854, P930, DOI 10.1016/j.bbapap.2015.03.008; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Leung TM, 2013, LAB INVEST, V93, P1082, DOI 10.1038/labinvest.2013.104; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Ohyama Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27784; Oyama M, 2018, BIOCHEM J, V475, P1583, DOI 10.1042/BCJ20170205; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; RUZZENE M, 1999, PROTEIN PHOSPHORYLAT, P221; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tibaldi E, 2006, CELL MOL LIFE SCI, V63, P378, DOI 10.1007/s00018-005-5506-4; Tibaldi E, 2014, BBA-MOL CELL RES, V1843, P288, DOI 10.1016/j.bbamcr.2013.10.010; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Wen YK, 2016, INT J BIOL SCI, V12, P1121, DOI 10.7150/ijbs.16445; Whyte MP, 2017, J BONE MINER RES, V32, P757, DOI 10.1002/jbmr.3034; Yang M, 2014, TOXICOL LETT, V224, P186, DOI 10.1016/j.toxlet.2013.10.030; Yanguas SC, 2016, ARCH TOXICOL, V90, P1025, DOI 10.1007/s00204-015-1543-4; Zhang JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798699; Zhao HL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0391-6	49	4	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1122	1135		10.1096/fj.201900880R	http://dx.doi.org/10.1096/fj.201900880R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914633				2022-12-26	WOS:000507308900076
J	Min-DeBartolo, J; Schlerman, F; Akare, S; Wang, J; McMahon, J; Zhan, YT; Syed, J; He, W; Zhang, BH; Martinez, RV				Min-DeBartolo, Jessica; Schlerman, Franklin; Akare, Sandeep; Wang, Ju; McMahon, James; Zhan, Yutian; Syed, Jameel; He, Wen; Zhang, Baohong; Martinez, Robert, V			Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)	PLOS ONE			English	Article							FACTOR-BETA ACTIVATION; FATTY LIVER-DISEASE; GLUTAMATE-DEHYDROGENASE; HEPATIC-FIBROSIS; CONTROLLED-TRIAL; MOUSE MODEL; PEPTIDE; PIOGLITAZONE; INFLAMMATION; BIOMARKER	Non-alcoholic fatty liver disease (NAFLD) is a progressive liver disease characterized by dysregulated lipid metabolism and chronic inflammation ultimately resulting in fibrosis. Untreated, NAFLD may progress to non-alcoholic steatohepatitis (NASH), cirrhosis and death. However, currently there are no FDA approved therapies that treat NAFLD/NASH. Thrombospondin-I (TSP-1) is a large glycoprotein in the extracellular matrix that regulates numerous cellular pathways including transforming growth factor beta 1 (TGF-(31) activation, angiogenesis, inflammation and cellular adhesion. Increased expression of TSP-1 has been reported in various liver diseases; however, its role in NAFLD/NASH is not well understood. We first examined TSP-1 modulation in hepatic stellate cell activation, a critical initiating step in hepatic fibrosis. Knockdown or inhibition of TSP-1 attenuated HSC activation measured by alpha smooth muscle actin (alpha-SMA) and Collagen I expression. To investigate the impact of TSP-1 modulation in context of NAFLD/NASH, we examined the effect of TSP-1 deficiency in the choline deficient L-amino acid defined high fat diet (CDAHFD) model of NASH in mice by assessing total body and liver weight, serum liver enzyme levels, serum lipid levels, liver steatosis, liver fibrosis and liver gene expression in wild type (WT) and TSP-1 null mice. CDAHFD fed mice, regardless of genotype, developed phenotypes of NASH, including significant increase in liver weight and liver enzymes, steatosis and fibrosis. However, in comparison to WT, CDAHFD-fed TSP-1 deficient mice were protected against numerous NASH phenotypes. TSP-1 null mice exhibited a decrease in serum lipid levels, inflammation markers and hepatic fibrosis. RNA-seq based transcriptomic profiles from the liver of CDAHFD fed mice determined that both WT and TSP-1 null mice exhibited similar gene expression signatures following CDAHFD, similar to biophysical and histological assessment comparison. Comparison of transcriptomic profiles based on genotype suggested that peroxisome proliferator activated receptor alpha (PPAR alpha) pathway and amino acid metabolism pathways are differentially expressed in TSP-1 null mice. Activation of PPAR alpha pathway was supported by observed decrease in serum lipid levels. Our findings provide important insights into the role of TSP-1 in context of NAFLD/NASH and TSP-1 may be a target of interest to develop anti-fibrotic therapeutics for NAFLD/NASH.	[Min-DeBartolo, Jessica] Pfizer Worldwide Res & Dev, BioMed Design, Cambridge, MA 02139 USA; [Min-DeBartolo, Jessica] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Schlerman, Franklin; Wang, Ju; McMahon, James; Martinez, Robert, V] Pfizer Worldwide Res & Dev, Inflammat & Immunol Res Unit, Cambridge, MA 02139 USA; [Akare, Sandeep; Zhan, Yutian; Syed, Jameel] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT USA; [He, Wen; Zhang, Baohong] Pfizer Worldwide Res & Dev, Early Clin Dev, Cambridge, MA USA; [Akare, Sandeep] Wave Life Sci, Cambridge, MA USA; [Zhang, Baohong] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA	Pfizer; Boston University; Pfizer; Pfizer; Pfizer; Biogen	Min-DeBartolo, J (corresponding author), Pfizer Worldwide Res & Dev, BioMed Design, Cambridge, MA 02139 USA.; Min-DeBartolo, J (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.; Martinez, RV (corresponding author), Pfizer Worldwide Res & Dev, Inflammat & Immunol Res Unit, Cambridge, MA 02139 USA.	Jessica.Min-DeBartolo@pfizer.com; Robert.martinez@pfizer.com		Min-DeBartolo, Jessica/0000-0002-1554-8365; Zhang, Baonhong/0000-0003-4735-4212				Basaranoglu M, 1999, J HEPATOL, V31, P384, DOI 10.1016/S0168-8278(99)80243-8; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Belmadani S, 2007, AM J PATHOL, V171, P777, DOI 10.2353/ajpath.2007.070056; Bril F, 2018, CLIN GASTROENTEROL H, V16, P558, DOI 10.1016/j.cgh.2017.12.001; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Cheng SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138889; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cui WP, 2013, AM J PHYSIOL-RENAL, V305, pF871, DOI 10.1152/ajprenal.00209.2013; El-Youssef M, 1999, J PEDIATR GASTR NUTR, V28, P386, DOI 10.1097/00005176-199904000-00008; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Fernandez-Miranda C, 2008, DIGEST LIVER DIS, V40, P200, DOI 10.1016/j.dld.2007.10.002; Hannah WN, 2016, HEPATOLOGY, V63, P1762, DOI 10.1002/hep.28504; Idowu MO, 2015, LIVER TRANSPLANT, V21, P1395, DOI 10.1002/lt.24223; Inoue M, 2013, ENDOCRINOLOGY, V154, P4548, DOI 10.1210/en.2013-1587; Jaeschke H, 2013, TOXICOL SCI, V134, P221, DOI 10.1093/toxsci/kft087; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Kondou H, 2003, J HEPATOL, V39, P742, DOI 10.1016/S0168-8278(03)00377-5; Kong P, 2013, AM J PHYSIOL-ENDOC M, V305, pE439, DOI 10.1152/ajpendo.00006.2013; Kuroki H, 2015, BRIT J SURG, V102, P813, DOI 10.1002/bjs.9765; Laurin J, 1996, HEPATOLOGY, V23, P1464; Liao F, 2016, EXP THER MED, V12, P2537, DOI 10.3892/etm.2016.3640; Lu AL, 2011, AM J PATHOL, V178, P2573, DOI 10.1016/j.ajpath.2011.02.039; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Brien PJ, 2002, LAB ANIM-UK, V36, P313, DOI 10.1258/002367702320162414; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosini S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar2566; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Smalling RV, 2013, AM J PHYSIOL-GASTR L, V305, pG364, DOI 10.1152/ajpgi.00077.2013; Soto-Pantoja DR, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.37; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461; Sunny NE, 2015, AM J PHYSIOL-ENDOC M, V309, pE311, DOI 10.1152/ajpendo.00161.2015; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yamakado M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14974-w; Zhao SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2356-9	48	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226854	10.1371/journal.pone.0226854	http://dx.doi.org/10.1371/journal.pone.0226854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891606	Green Published, Green Submitted, gold			2022-12-26	WOS:000515096600036
J	Liu, XY; Li, W; Cai, J; Yan, ZD; Shao, X; Xie, KN; Guo, XE; Luo, EP; Jing, D				Liu, Xiyu; Li, Wei; Cai, Jing; Yan, Zedong; Shao, Xi; Xie, Kangning; Guo, X. Edward; Luo, Erping; Jing, Da			Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone	FASEB JOURNAL			English	Article						bone remodeling; diffuse microdamage; fatigue loading; linear microcracks; type 1 diabetes mellitus (T1DM)	STRUCTURAL-PROPERTIES; MATRIX MICRODAMAGE; TYPE-1; STREPTOZOTOCIN; DAMAGE; MODEL; MICROCRACKS; DEGRADATION; OSTEOCYTES; INSULITIS	The skeleton of type 1 diabetes mellitus (T1DM) has deteriorated mechanical integrity and increased fragility, whereas the mechanisms are not fully understood. Load-induced microdamage naturally occurs in bone matrix and can be removed by initiating endogenous targeted bone remodeling. However, the microdamage accumulation in diabetic skeleton and the corresponding bone remodeling mechanisms remain poorly understood. Herein, streptozotocin-induced T1DM rats and age-matched non-diabetic rats were subjected to daily uniaxial ulnar loading for 1, 4, 7, and 10 days, respectively. The SPECT/CT and basic fuchsin staining revealed significant higher-density spatial accumulation of linear and diffuse microdamage in diabetic ulnae than non-diabetic ulnae. Linear microcracks increased within 10-day loading in diabetic bone, whereas peaked at Day 7 in non-diabetic bone. Moreover, diabetic fatigued ulnae had more severe disruptions of osteocyte canaliculi around linear microcracks. Immunostaining results revealed that diabetes impaired targeted remodeling in fatigued bone at every key stage, including increased apoptosis of bystander osteocytes, decreased RANKL secretion, reduced osteoclast recruitment and bone resorption, and impaired osteoblast-mediated bone formation. This study characterizes microdamage accumulation and abnormal remodeling mechanisms in the diabetic skeleton, which advances our etiologic understanding of diabetic bone deterioration and increased fragility from the aspect of microdamage accumulation and bone remodeling.	[Liu, Xiyu; Li, Wei; Yan, Zedong; Shao, Xi; Xie, Kangning; Luo, Erping; Jing, Da] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Cai, Jing] Shaanxi Univ Chinese Med, Coll Basic Med, Xianyang, Peoples R China; [Guo, X. Edward] Columbia Univ, Dept Biomed Engn, Bone Bioengn Lab, New York, NY USA	Air Force Military Medical University; Shaanxi University of Chinese Medicine; Columbia University	Luo, EP; Jing, D (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	luoerping@fmmu.edu.cn; jingdaasq@126.com	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China (NSFC) [31500760, 51777211, 31670953]; Young Talent Supporting Project in Military Technology of China [17-JCJQ-QT-038]; Shaanxi Provincial Natural Science Foundation of China [2018JQ8056]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Young Talent Supporting Project in Military Technology of China; Shaanxi Provincial Natural Science Foundation of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31500760, 51777211 and 31670953; Young Talent Supporting Project in Military Technology of China, Grant/Award Number: No. 17-JCJQ-QT-038; Shaanxi Provincial Natural Science Foundation of China, Grant/Award Number: No. 2018JQ8056	Alexopoulou O, 2006, DIABETES METAB, V32, P453, DOI 10.1016/S1262-3636(07)70303-8; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Brondum E, 2005, HORM METAB RES, V37, pS56, DOI 10.1055/s-2005-861370; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; CHAUDHURI TK, 1983, SEMIN NUCL MED, V13, P75; Chen J, 2015, MOL IMAGING BIOL, V17, P337, DOI 10.1007/s11307-014-0787-3; Cheung WY, 2016, J BONE MINER RES, V31, P890, DOI 10.1002/jbmr.2740; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Danielson KK, 2009, OSTEOPOROSIS INT, V20, P923, DOI 10.1007/s00198-008-0763-3; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Farlay D, 2016, J BONE MINER RES, V31, P190, DOI 10.1002/jbmr.2607; Farr JN, 2016, BONE, V82, P28, DOI 10.1016/j.bone.2015.07.027; Forsen L, 1999, DIABETOLOGIA, V42, P920, DOI 10.1007/s001250051248; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Horcajada-Molteni MN, 2001, J BONE MINER RES, V16, P958, DOI 10.1359/jbmr.2001.16.5.958; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2018, BONE, V106, P11, DOI 10.1016/j.bone.2017.10.001; Kalaitzoglou E, 2016, CURR OSTEOPOROS REP, V14, P310, DOI 10.1007/s11914-016-0329-9; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Kim AR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1681-6; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Lynch JA, 2008, BONE, V42, P942, DOI 10.1016/j.bone.2008.01.004; Macione J, 2011, J MECH BEHAV BIOMED, V4, P841, DOI 10.1016/j.jmbbm.2011.03.010; Mastrandrea LD, 2008, DIABETES CARE, V31, P1729, DOI 10.2337/dc07-2426; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Muir P, 2007, BONE, V40, P948, DOI 10.1016/j.bone.2006.11.012; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; O'Brien FJ, 2000, J ANAT, V197, P413, DOI 10.1046/j.1469-7580.2000.19730413.x; Ogasawara A, 2008, BONE, V43, P832, DOI 10.1016/j.bone.2008.07.246; Ohbayashi Y, 2017, ODONTOLOGY, V105, P382, DOI 10.1007/s10266-016-0279-9; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papaccio G, 2000, J CELL BIOCHEM, V77, P82, DOI 10.1002/(SICI)1097-4644(20000401)77:1<82::AID-JCB9>3.3.CO;2-M; Parajuli A, 2015, BONE, V81, P152, DOI 10.1016/j.bone.2015.07.012; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Rubin MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154700; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; Seref-Ferlengez Z, 2014, J BONE MINER RES, V29, P2537, DOI 10.1002/jbmr.2309; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; WANG ZY, 1993, DIABETES, V42, P420, DOI 10.2337/diabetes.42.3.420; Weber DR, 2016, CURR OSTEOPOROSIS RE, V14, P1; Wong KK, 2013, J NUCL MED, V54, P590, DOI 10.2967/jnumed.112.114298; Yan YH, 2014, TOXICOL APPL PHARM, V281, P211, DOI 10.1016/j.taap.2014.10.005; Zhang XH, 2018, BONE, V108, P156, DOI 10.1016/j.bone.2018.01.011; ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420; Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024; ZWAS ST, 1987, J NUCL MED, V28, P452	62	6	6	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2579	2594		10.1096/fj.201902011RR	http://dx.doi.org/10.1096/fj.201902011RR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908007	Bronze			2022-12-26	WOS:000504089200001
J	Nigam, AK; Li, JLG; Lall, K; Shi, D; Bush, KT; Bhatnagar, V; Abagyan, R; Nigam, SK				Nigam, Anisha K.; Li, Julia G.; Lall, Kaustubh; Shi, Da; Bush, Kevin T.; Bhatnagar, Vibha; Abagyan, Ruben; Nigam, Sanjay K.			Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; transporter; multidrug transporter; mouse; metabolomics; cheminformatics; machine-learning; organic anion transporter	ORGANIC ANION TRANSPORTERS; RENAL TRANSPORTERS; CHOROID-PLEXUS; UREMIC TOXINS; KNOCKOUT MICE; SLC22 FAMILY; KIDNEY; PATHWAYS; SYSTEMS; IDENTIFICATION	The multispecific organic anion transporters, OAT1 (SLC22A6) and OAT3 (SLC22A8), the main kidney elimination pathways for many common drugs, are often considered to have largely-redundant roles. However, whereas examination of metabolomics data from Oat-knockout mice (Oat1 and Oat3KO) revealed considerable overlap, over a hundred metabolites were increased in the plasma of one or the other of these knockout mice. Many of these relatively unique metabolites are components of distinct biochemical and signaling pathways, including those involving amino acids, lipids, bile acids, and uremic toxins. Cheminformatics, together with a ?logical? statistical and machine learning-based approach, identified a number of molecular features distinguishing these unique endogenous substrates. Compared with OAT1, OAT3 tends to interact with more complex substrates possessing more rings and chiral centers. An independent ?brute force? approach, analyzing all possible combinations of molecular features, supported the logical approach. Together, the results suggest the potential molecular basis by which OAT1 and OAT3 modulate distinct metabolic and signaling pathways in vivo. As suggested by the Remote Sensing and Signaling Theory, the analysis provides a potential mechanism by which ?multispecific? kidney proximal tubule transporters exert distinct physiological effects. Furthermore, a strong metabolite-based machine-learning classifier was able to successfully predict unique OAT1 versus OAT3 drugs; this suggests the feasibility of drug design based on knockout metabolomics of drug transporters. The approach can be applied to other SLC and ATP-binding cassette drug transporters to define their nonredundant physiological roles and for analyzing the potential impact of drug?metabolite interactions.	[Nigam, Anisha K.; Shi, Da; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Li, Julia G.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Lall, Kaustubh] Univ Calif San Diego, Dept Comp Engn, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Abagyan, R; Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ruben@ucsd.edu; snigam@ucsd.edu	Shi, Da/ABD-4722-2020	Shi, Da/0000-0002-1953-2299	NIDDK Grant [DK109392]; Eunice Kennedy Shriver NICHD Grant [HD090259]	NIDDK Grant; Eunice Kennedy Shriver NICHD Grant	This work was supported by NIDDK Grant DK109392 and Eunice Kennedy Shriver NICHD Grant HD090259 (to S. K. N.). R. A. is a founder of Molsoft LLC. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Almazroo OA, 2017, CLIN LIVER DIS, V21, P1, DOI 10.1016/j.cld.2016.08.001; An GH, 2014, DRUG METAB DISPOS, V42, P1357, DOI 10.1124/dmd.114.059337; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Demsar J, 2007, J BIOMED INFORM, V40, P661, DOI 10.1016/j.jbi.2007.03.010; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ivanyuk A, 2017, CLIN PHARMACOKINET, V56, P825, DOI 10.1007/s40262-017-0506-8; Jansen J, 2019, P NATL ACAD SCI USA, V116, P16105, DOI 10.1073/pnas.1821809116; Jelena D, 2019, COMP BIOCHEM PHYS B, V236, DOI 10.1016/j.cbpb.2019.110309; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kouznetsova VL, 2011, BIOORGAN MED CHEM, V19, P3320, DOI 10.1016/j.bmc.2011.04.045; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Liu HC, 2016, J PHARMACOL EXP THER, V359, P215, DOI 10.1124/jpet.116.232660; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lozano E, 2018, J PERS MED, V8, DOI 10.3390/jpm8020014; Martinez D, 2018, CLIN PHARMACOL THER, V104, P687, DOI 10.1002/cpt.1008; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Masereeuw R, 2010, PHARMACOL THERAPEUT, V126, P200, DOI 10.1016/j.pharmthera.2010.02.007; Matsson Par, 2015, In Silico Pharmacology, V3, P8, DOI 10.1186/s40203-015-0012-3; Morrissey KM, 2013, ANNU REV PHARMACOL, V53, P503, DOI 10.1146/annurev-pharmtox-011112-140317; Murray M, 2017, BRIT J PHARMACOL, V174, P1908, DOI 10.1111/bph.13785; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; O'Hagan S, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0198-y; O'Hagan S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00105; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Ritthoff O., 2001, LLWA 01; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Robertson EE, 2006, PHARMACOL THERAPEUT, V109, P399, DOI 10.1016/j.pharmthera.2005.07.005; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Stanley LA, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P527, DOI 10.1016/B978-0-12-802104-0.00027-5; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Ullrich KJ, 1997, J MEMBRANE BIOL, V158, P95, DOI 10.1007/s002329900247; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Vriend J, 2019, BIOL CHEM, V400, P1347, DOI 10.1515/hsz-2018-0446; Wang X, 2018, TOXICOL SCI, V161, P321, DOI 10.1093/toxsci/kfx216; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	71	22	22	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1829	1842		10.1074/jbc.RA119.010729	http://dx.doi.org/10.1074/jbc.RA119.010729			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31896576	Green Published, hybrid			2022-12-26	WOS:000517128200005
J	Young, KZ; Lee, SJ; Zhang, XJ; Cartee, NMP; Torres, M; Keep, SG; Gabbireddy, SR; Fontana, JL; Qi, L; Wang, MM				Young, Kelly Z.; Lee, Soo Jung; Zhang, Xiaojie; Cartee, Naw May Pearl; Torres, Mauricio; Keep, Simon G.; Gabbireddy, Sairisheel R.; Fontana, Julia L.; Qi, Ling; Wang, Michael M.			NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch protein; vascular smooth muscle cells; proteolysis; protein processing; stroke; arteries; cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); cysteine residues; NOTCH3; small-vessel disease	AUTOSOMAL-DOMINANT ARTERIOPATHY; ASP-PRO BOND; SUBCORTICAL INFARCTS; NEUROPATHOLOGIC ASSESSMENT; AUTOCATALYTIC CLEAVAGE; ALZHEIMERS-DISEASE; RISK-FACTORS; LOW PH; CADASIL; MUTATIONS	The small-vessel disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) arises from mutations in the human gene encoding NOTCH3 and results in vascular smooth muscle cell degeneration, stroke, and dementia. However, the structural changes in NOTCH3 involved in CADASIL etiology are unclear. Here, we discovered site-specific fragmentation of NOTCH3 protein in pathologically affected vessels of human CADASIL-affected brains. EM-based experiments to pinpoint NOTCH3 localization in these brains indicated accumulation of NOTCH3 fragmentation products in the basement membrane, collagen fibers, and granular osmiophilic material within the cerebrovasculature. Using antibodies generated against a disease-linked neo-epitope found in degenerating vascular medium of CADASIL brains, we mapped the site of fragmentation to the NOTCH3 N terminus at the peptide bond joining Asp(80) and Pro(81). Cleavage at this site was predicted to separate the first epidermal growth factor (EGF)-like domain from the remainder of the protein. We found that the cleavage product from this fragmentation event is released into the conditioned medium of cells expressing recombinant NOTCH3 fragments. Mutagenesis of Pro(81) abolished the fragmentation, and low pH and reducing conditions enhanced NOTCH3 proteolysis. Furthermore, substitution of multiple cysteine residues of the NOTCH3 N terminus activated proteolytic release of the first EGF-like repeat, suggesting that the elimination of multiple disulfide bonds in NOTCH3 accelerates its fragmentation. These characteristics link the signature molecular genetic alterations present in individuals with CADASIL to a post-translational protein alteration in degenerating brain arteries. The cellular consequences of these pathological NOTCH3 fragments are an important area for future investigation.	[Young, Kelly Z.; Lee, Soo Jung; Zhang, Xiaojie; Cartee, Naw May Pearl; Keep, Simon G.; Gabbireddy, Sairisheel R.; Fontana, Julia L.; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Young, Kelly Z.; Torres, Mauricio; Qi, Ling; Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), 7725 Med Sci Bldg 2 Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu		Keep, Simon/0000-0002-4139-1672; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044; Young, Kelly/0000-0002-6714-7563; Qi, Ling/0000-0001-8229-0184	National Institutes of Health [NS099783, NS099160, R35GM130292, HL108842, T32-HL125242, T32 GM007863]; United States Department of Veterans Affairs [BX003855, BX003824]; Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; CADASIL Together We Have Hope	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; CADASIL Together We Have Hope	This study was supported by National Institutes of Health Grants NS099783 and NS099160 (to M. M. W.), R35GM130292 (to L. Q.), HL108842 (to S. G. K.; awarded to Dr. Jimo Borjigin), and T32-HL125242 and T32 GM007863 (to K. Z. Y.) and United States Department of Veterans Affairs Grants BX003855 and BX003824 (to M. M. W.). This work was also supported by the Frankel Cardiovascular Center Summer Undergraduate Fellowship Program (to J. L. F. and S. R. G.), CADASIL Together We Have Hope, and members of the international CADASIL communitywhomadedonations used in this study. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Arboleda-Velasquez JF, 2011, P NATL ACAD SCI USA, V108, pE128, DOI 10.1073/pnas.1101964108; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Caplan LR, 2015, J STROKE, V17, P2, DOI 10.5853/jos.2015.17.1.2; de Groot JC, 2000, ANN NEUROL, V47, P145; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dong HR, 2013, STROKE, V44, P1456, DOI 10.1161/STROKEAHA.111.000721; Dong HR, 2012, BRAIN RES, V1456, P64, DOI 10.1016/j.brainres.2012.03.037; Duering M, 2011, HUM MOL GENET, V20, P3256, DOI 10.1093/hmg/ddr237; Fairchild TA, 2001, J BIOL CHEM, V276, P26674, DOI 10.1074/jbc.M103647200; Ghezali L, 2018, ANN NEUROL, V84, P246, DOI 10.1002/ana.25284; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Ishiko A, 2006, ACTA NEUROPATHOL, V112, P333, DOI 10.1007/s00401-006-0116-2; Jackson C, 2005, BRAIN, V128, P2507, DOI 10.1093/brain/awh636; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kast J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0096-8; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lovendahl KN, 2018, ADV EXP MED BIOL, V1066, P47, DOI 10.1007/978-3-319-89512-3_3; Meng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044964; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Monet-Lepretre M, 2013, BRAIN, V136, P1830, DOI 10.1093/brain/awt092; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morris GP, 2018, ACTA NEUROPATHOL, V136, P663, DOI 10.1007/s00401-018-1918-8; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; Rutten JW, 2016, ANN CLIN TRANSL NEUR, V3, P844, DOI 10.1002/acn3.344; SEGALAS I, 1995, FEBS LETT, V371, P171, DOI 10.1016/0014-5793(95)00844-Y; Skribanek Z, 2002, J PEPT SCI, V8, P398, DOI 10.1002/psc.395; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; TUSZYNSKI MH, 1989, STROKE, V20, P990, DOI 10.1161/01.STR.20.8.990; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Zhang XJ, 2015, TRANSL STROKE RES, V6, P148, DOI 10.1007/s12975-014-0379-1; Zhang XJ, 2014, BRAIN RES, V1583, P230, DOI 10.1016/j.brainres.2014.08.018	45	8	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1960	1972		10.1074/jbc.RA119.007724	http://dx.doi.org/10.1074/jbc.RA119.007724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31901894	hybrid, Green Published			2022-12-26	WOS:000517128200015
J	Strainic, MG; Pohlmann, E; Valley, CC; Sammeta, A; Hussain, W; Lidke, DS; Medof, ME				Strainic, Michael G.; Pohlmann, Elliot; Valley, Christopher C.; Sammeta, Ajay; Hussain, Wasim; Lidke, Diane S.; Medof, M. Edward			RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint	FASEB JOURNAL			English	Article						IL-6 receptor; local complement; VEGFR2 signaling	GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; EGF RECEPTOR; ERK1/2 ACTIVATION; C5A RECEPTOR; BETA; PHOSPHORYLATION; TRANSACTIVATION; SUPPRESSOR; SPHINGOSINE-1-PHOSPHATE	How receptor tyrosine kinase (RTK) growth signaling is controlled physiologically is incompletely understood. We have previously provided evidence that the survival and mitotic activities of vascular endothelial cell growth factor receptor-2 (VEGFR2) signaling are dependent on C3a/C5a receptor (C3ar1/C5ar1) and IL-6 receptor (IL-6R)-gp130 joint signaling in a physically interactive platform. Herein, we document that the platelet derived and epidermal growth factor receptors (PDGFR and EGFR) are regulated by the same interconnection and clarify the mechanism underlying the dependence. We show that the joint signaling is required to overcome dominant restraint on RTK function by the combined repression of tonically activated PHLPP, SOCS1/SOCS3, and CK2/Fyn dependent PTEN. Signaling studies showed that augmented PI-3K gamma activation is the process that overcomes the multilevel growth restraint. Live-cell flow cytometry and single-particle tracking indicated that blockade of C3ar1/C5ar1 or IL-6R signaling suppresses RTK growth factor binding and RTK complex formation. C3ar1/C5ar1 blockade abrogated growth signaling of four additional RTKs. Active relief of dominant growth repression via joint C3ar1/C5ar1 and IL-6R joint signaling thus enables RTK mitotic/survival signaling.	[Strainic, Michael G.; Pohlmann, Elliot; Sammeta, Ajay; Hussain, Wasim; Medof, M. Edward] Case w Reserve Univ, Dept Pathol, Cleveland Hts, OH USA; [Strainic, Michael G.; Pohlmann, Elliot; Sammeta, Ajay; Hussain, Wasim; Medof, M. Edward] Case w Reserve Univ Sch Med, Cleveland Hts, OH USA; [Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico Hlth Sciences Ctr, Comprehens Canc Ctr, Dept Pathol, Albuquerque, NM USA; Inst Pathol Room 301, Edward Medof, 2085 Adelbert Rd, Cleveland Hts, OH 44106 USA		Medof, ME (corresponding author), Case w Reserve Univ, Dept Pathol, Cleveland Hts, OH USA.	mxm16@case.edu		Strainic, Michael/0000-0003-2438-8540; Hussain, Wasim/0000-0001-7659-6654	NCI NIH HHS [P30 CA118100] Funding Source: Medline; NEI NIH HHS [P30 EY011373] Funding Source: Medline; NHLBI NIH HHS [R01 HL109561] Funding Source: Medline; NIAMS NIH HHS [R01 AR067182] Funding Source: Medline; NIGMS NIH HHS [P50 GM085273, R35 GM126934] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; BUHL AM, 1993, FEBS LETT, V323, P132, DOI 10.1016/0014-5793(93)81464-B; Burg M, 1995, FEBS LETT, V377, P426, DOI 10.1016/0014-5793(95)01379-2; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Fragoso R, 2015, METHODS, V77-78, P75, DOI 10.1016/j.ymeth.2014.10.015; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gupta MK, 2018, INT REV CEL MOL BIO, V339, P63, DOI 10.1016/bs.ircmb.2018.03.002; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Hwang MS, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219352; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Kato K, 2012, LIFE SCI, V90, P71, DOI 10.1016/j.lfs.2011.10.023; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; LEE CH, 1995, MOL PHARMACOL, V47, P218; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lima-Fernandes E, 2011, EMBO J, V30, P2557, DOI 10.1038/emboj.2011.178; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Liu ZJ, 2000, LIVER, V20, P114, DOI 10.1034/j.1600-0676.2000.020002114.x; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mahabeleshwar Ganapati H., 2006, V129, P197; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Rodriguez-Berriguete G, 2010, EUR CYTOKINE NETW, V21, P241, DOI 10.1684/ecn.2010.0211; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Schlessinger J, 2014, COLD SPRING HARB PER, V6, P3, DOI DOI 10.1101/CSHPERSPECT.A008912; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Spets H, 2002, EUR J HAEMATOL, V69, P76, DOI 10.1034/j.1600-0609.2002.01549.x; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang WJ, 2018, TRENDS PHARMACOL SCI, V39, P367, DOI 10.1016/j.tips.2018.01.001; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Williams JJL, 2014, CELLS-BASEL, V3, P546, DOI 10.3390/cells3020546; Yamada E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089604; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	60	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2105	2125		10.1096/fj.201900677R	http://dx.doi.org/10.1096/fj.201900677R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908021	Green Accepted, Bronze			2022-12-26	WOS:000514663600014
J	Wu, SP; Anderson, ML; Wang, TY; Zhou, LC; Emery, OM; Li, XL; DeMayo, FJ				Wu, San-Pin; Anderson, Matthew L.; Wang, Tianyuan; Zhou, Lecong; Emery, Olivia M.; Li, Xilong; DeMayo, Francesco J.			Dynamic transcriptome, accessible genome, and PGR cistrome profiles in the human myometrium	FASEB JOURNAL			English	Article						genome accessibility; human myometrial tissue; PGR cistrome; transcriptome	FUNCTIONAL PROGESTERONE WITHDRAWAL; SPONTANEOUS HUMAN LABOR; CELL-PROLIFERATION; GENE-EXPRESSION; PRETERM LABOR; RECEPTOR; ACTIVATION; PREGNANCY; TERM; CHROMATIN	The myometrium undergoes structural and functional remodeling during pregnancy. We hypothesize that myometrial genomic elements alter correspondingly in preparation for parturition. Human myometrial tissues from nonpregnant (NP) and term pregnant (TP) human subjects were examined by RNAseq, ATACseq, and PGR ChIPseq assays to profile transcriptome, assessible genome, and PGR occupancy. NP and TP specimens exhibit 2890 differentially expressed genes, reflecting an increase of metabolic, inflammatory, and PDGF signaling, among others, in adaptation to pregnancy. At the epigenome level, patterns of accessible genome change between NP and TP myometrium, leading to the altered enrichment of binding motifs for hormone and muscle regulators such as the progesterone receptor (PGR), Kruppel-like factors, and MEF2A transcription factors. PGR genome occupancy exhibits a significant difference between the two stages of the myometrium, concomitant with distinct transcriptomic profiles including genes such as ENO1, LHDA, and PLCL1 in the glycolytic and calcium signaling pathways. Over-representation of SRF, MYOD, and STAT binding motifs in PGR occupying sites further suggests interactions between PGR and major muscle regulators for myometrial gene expression. In conclusion, changes in accessible genome and PGR occupancy are part of the myometrial remodeling process and may serve as mechanisms to formulate the state-specific transcriptome profiles.	[Wu, San-Pin; Emery, Olivia M.; DeMayo, Francesco J.] NIEHS, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Anderson, Matthew L.] Univ S Florida, Morsani Coll Med, Dept Obstet & Gynecol, Tampa, FL 33620 USA; [Anderson, Matthew L.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Wang, Tianyuan; Zhou, Lecong] NIEHS, Integrat Bioinformat Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Xilong] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	DeMayo, FJ (corresponding author), NIEHS, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	francesco.demayo@nih.gov	, San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [Z1AES103311-01] Funding Source: Medline	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)		Ackerman WE, 2018, BIOL REPROD, V98, P834, DOI 10.1093/biolre/ioy040; Akerman AW, 2018, ANN VASC SURG, V46, P193, DOI 10.1016/j.avsg.2017.10.001; Amini P, 2019, MOL CELL ENDOCRINOL, V479, P1, DOI 10.1016/j.mce.2018.08.005; Anamthathmakula P, 2019, EBIOMEDICINE, V39, P520, DOI 10.1016/j.ebiom.2018.11.038; Baek S, 2017, CELL REP, V19, P1710, DOI 10.1016/j.celrep.2017.05.003; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhurke AS, 2016, AM J REPROD IMMUNOL, V75, P237, DOI 10.1111/aji.12473; Birth P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181219; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; CHOW L, 1994, AM J OBSTET GYNECOL, V170, P788, DOI 10.1016/S0002-9378(94)70284-5; Ciarmela P, 2009, ENDOCRINOLOGY, V150, P906, DOI 10.1210/en.2008-0880; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Gao Y, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125146; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Hanley JA, 2015, J PHYSIOL-LONDON, V593, P4603, DOI 10.1113/JP270631; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; Joshi S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006600; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Kimura T, 1996, ENDOCRINOLOGY, V137, P780, DOI 10.1210/en.137.2.780; Kyathanahalli C, 2013, ENDOCRINOLOGY, V154, P4873, DOI 10.1210/en.2013-1325; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WS, 1997, NAT MED, V3, P1005, DOI 10.1038/nm0997-1005; Lee Y, 2012, J CELL MOL MED, V16, P2487, DOI 10.1111/j.1582-4934.2012.01567.x; Lei KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050167; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Li QX, 2016, ENDOCRINOLOGY, V157, P1764, DOI 10.1210/en.2015-2031; Li YP, 2007, J CELL BIOCHEM, V100, P129, DOI 10.1002/jcb.21033; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Madaan A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.072; Mazur EC, 2015, ENDOCRINOLOGY, V156, P2239, DOI 10.1210/en.2014-1566; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Medina-Rivera A, 2018, TRENDS BIOCHEM SCI, V43, P452, DOI 10.1016/j.tibs.2018.03.004; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mittal P, 2010, J PERINAT MED, V38, P617, DOI [10.1515/JPM.2010.097, 10.1515/jpm.2010.097]; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; Nadeem L, 2018, J CELL MOL MED, V22, P452, DOI 10.1111/jcmm.13335; Nadeem L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13488-9; Nadeem L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11565; Navathe R, 2016, CURR OPIN OBSTET GYN, V28, P464, DOI 10.1097/GCO.0000000000000327; Noakes, 2019, VET REPROD OBSTET, P148; Oldenhof AD, 2002, AM J PHYSIOL-CELL PH, V283, pC1530, DOI 10.1152/ajpcell.00607.2001; Ono M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127126; Ono M, 2013, P NATL ACAD SCI USA, V110, P17053, DOI 10.1073/pnas.1313650110; Pabona JMP, 2015, J CLIN ENDOCR METAB, V100, P166, DOI 10.1210/jc.2014-2846; PARRATT J, 1994, LANCET, V344, P717, DOI 10.1016/S0140-6736(94)92209-8; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Payson M, 2009, FERTIL STERIL, V92, P748, DOI 10.1016/j.fertnstert.2008.06.030; Pont JNA, 2012, MOL ENDOCRINOL, V26, P1743, DOI 10.1210/me.2012-1057; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Renthal NE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023069; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2010, REPRODUCTION, V139, P247, DOI 10.1530/REP-09-0260; Stanfield Z, 2019, MOL HUM REPROD, V25, P408, DOI 10.1093/molehr/gaz028; Stanfield Z, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00185; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Welsh T, 2012, J ENDOCRINOL, V212, P227, DOI 10.1530/JOE-11-0358; Whirledge S, 2012, HORM CANCER-US, V3, P79, DOI 10.1007/s12672-012-0103-0; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Wu SP, 2017, CURR TOP DEV BIOL, V125, P171, DOI 10.1016/bs.ctdb.2017.03.001; Zeng ZY, 2008, BIOL REPROD, V78, P1029, DOI 10.1095/biolreprod.107.065821; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao QY, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0635-9	85	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2252	2268		10.1096/fj.201902654R	http://dx.doi.org/10.1096/fj.201902654R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908010	Green Submitted, Bronze			2022-12-26	WOS:000514663600023
J	Pathan, SI; Arfaioli, P; Ceccherini, MT; Ascher-Jenull, J; Pietramellara, G				Pathan, Shamina Imran; Arfaioli, Paola; Ceccherini, Maria Teresa; Ascher-Jenull, Judith; Pietramellara, Giacomo			Preliminary evidences of the presence of extracellular DNA single stranded forms in soil	PLOS ONE			English	Article							SELF-ORGANIZATION; ADSORPTION; MONTMORILLONITE; BINDING; DECOMPOSITION; DYNAMICS; ROLES; PH	The relevance of extracellular DNA (eDNA) in the soil ecosystem is becoming more and more evident to the scientific community by the progressive discovery of functions accompanying to natural gene transformation. However, despite the increased number of published articles dedicated to eDNA in soil, so far only few are focused on its single stranded form (eDNAss). The present paper is the first to investigate the quantitative relevance of eDNAss in the total soil eDNA pool, discriminating between its linear (eDNAssl) and circular (eDNAssc) forms and the respective weakly (wa) and tightly (ta) adsorbed fractions. The results showed the prevalence of eDNAss and its linear form in both the total soil eDNA pool and its wa and ta fractions. Both of the eDNAss fractions (linear and circular) were characterized by small fragments.	[Pathan, Shamina Imran; Arfaioli, Paola; Ceccherini, Maria Teresa; Pietramellara, Giacomo] Univ Florence, Dept Agri Food Environm Forestry Sci & Technol DA, Piazzale Cascine, Florence, Italy; [Ascher-Jenull, Judith] Univ Innsbruck, Inst Microbiol, Innsbruck, Austria	University of Florence; University of Innsbruck	Pietramellara, G (corresponding author), Univ Florence, Dept Agri Food Environm Forestry Sci & Technol DA, Piazzale Cascine, Florence, Italy.	giacomo.pietramellara@unifi.it	; Pietramellara, Giacomo/L-6698-2015	PATHAN, SHAMINA IMRAN/0000-0002-5177-2866; Pietramellara, Giacomo/0000-0003-1562-8784	RICATEN 19, University of Florence	RICATEN 19, University of Florence	This research was supported by the RICATEN 19, University of Florence which was assigned to GP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Agnelli A, 2007, BIOL FERT SOILS, V44, P353, DOI 10.1007/s00374-007-0213-y; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Ascher J, 2009, APPL SOIL ECOL, V42, P176, DOI 10.1016/j.apsoil.2009.03.005; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Beall GW, 2009, BIOMACROMOLECULES, V10, P105, DOI 10.1021/bm800970v; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242; Ceccherini MT, 2009, ANTON LEEUW INT J G, V96, P653, DOI 10.1007/s10482-009-9354-3; Ceecherini MT, 2007, SOIL BIOL BIOCHEM, V39, P158, DOI 10.1016/j.soilbio.2006.07.006; Cleaves HJ, 2011, CHEMOSPHERE, V83, P1560, DOI 10.1016/j.chemosphere.2011.01.023; Crawford JW, 2012, J R SOC INTERFACE, V9, P1302, DOI 10.1098/rsif.2011.0679; Demaneche S, 2001, APPL ENVIRON MICROB, V67, P293, DOI 10.1128/AEM.67.1.293-299.2001; DSOUZA DJ, 1994, BIOORG MED CHEM LETT, V4, P965, DOI 10.1016/S0960-894X(01)80664-8; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; Gagic D, 2015, MOL ECOL RESOUR, V15, P464, DOI 10.1111/1755-0998.12321; Gardner CM, 2017, CHEMOSPHERE, V175, P45, DOI 10.1016/j.chemosphere.2017.02.030; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hawes MC, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6010005; Hawes MC, 2012, PLANT SOIL, V355, P1, DOI 10.1007/s11104-012-1218-3; KHANNA M, 1992, APPL ENVIRON MICROB, V58, P1930, DOI 10.1128/AEM.58.6.1930-1939.1992; Matsuura Y, 2014, APPL CLAY SCI, V101, P591, DOI 10.1016/j.clay.2014.09.023; Mazzoleni S, 2015, NEW PHYTOL, V206, P127, DOI 10.1111/nph.13306; Morrissey EM, 2015, SOIL BIOL BIOCHEM, V86, P42, DOI 10.1016/j.soilbio.2015.03.020; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Nagler M, 2018, APPL MICROBIOL BIOT, V102, P6343, DOI 10.1007/s00253-018-9120-4; Paungfoo-Lonhienne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011915; Pedreira-Segade U, 2018, LIFE-BASEL, V8, DOI 10.3390/life8040059; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pietramellara G, 2001, BIOL FERT SOILS, V33, P402, DOI 10.1007/s003740100341; Poly F, 2000, LANGMUIR, V16, P1233, DOI 10.1021/la990506z; Saeki K, 2010, CURRENT RES TECHNOLO, V1, P188; Saeki K, 2011, ENVIRON CHEM LETT, V9, P505, DOI 10.1007/s10311-011-0310-x; Sanesi G, 2005, J PLANT NUTR SOIL SC, V168, P392, DOI 10.1002/jpln.200421651; Stotzky G, 2000, J ENVIRON QUAL, V29, P691, DOI 10.2134/jeq2000.00472425002900030003x; Swenson TL, 2018, PLANT SOIL, V429, P53, DOI 10.1007/s11104-017-3537-x; Vorkapic D, 2016, CURR GENET, V62, P71, DOI 10.1007/s00294-015-0514-x; Wang F, 2019, J SOIL SEDIMENT, V19, P91, DOI 10.1007/s11368-018-2176-z; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394	41	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227296	10.1371/journal.pone.0227296	http://dx.doi.org/10.1371/journal.pone.0227296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910237	Green Published, gold			2022-12-26	WOS:000534333800039
J	Franzolin, E; Coletta, S; Ferraro, P; Pontarin, G; D'Aronco, G; Stevanoni, M; Palumbo, E; Cagnin, S; Bertoldi, L; Feltrin, E; Valle, G; Russo, A; Bianchi, V; Rampazzo, C				Franzolin, Elisa; Coletta, Sara; Ferraro, Paola; Pontarin, Giovanna; D'Aronco, Giulia; Stevanoni, Martina; Palumbo, Elisa; Cagnin, Stefano; Bertoldi, Loris; Feltrin, Erika; Valle, Giorgio; Russo, Antonella; Bianchi, Vera; Rampazzo, Chiara			SAMHD1-deficient fibroblasts from Aicardi-Goutieres Syndrome patients can escape senescence and accumulate mutations	FASEB JOURNAL			English	Article						deoxynucleotide catabolism; deoxynucleotide pool imbalance; sterile alpha motif and HD domain containing protein 1 (SAMHD1); UV-induced DNA repair	RESTRICTION FACTOR SAMHD1; DNA-REPLICATION; TRIPHOSPHOHYDROLASE ACTIVITY; READ ALIGNMENT; ORIGIN CHOICE; GENOME-WIDE; DNTP POOLS; S-PHASE; CANCER; GENE	In mammalian cells, the catabolic activity of the dNTP triphosphohydrolase SAMHD1 sets the balance and concentration of the four dNTPs. Deficiency of SAMHD1 leads to unequally increased pools and marked dNTP imbalance. Imbalanced dNTP pools increase mutation frequency in cancer cells, but it is not known if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-transformed cells. Here, we have investigated how fibroblasts from Aicardi-Goutieres Syndrome (AGS) patients with mutated SAMHD1 react to the constitutive pool imbalance characterized by a huge dGTP pool. We focused on the effects on dNTP pools, cell cycle progression, dynamics and fidelity of DNA replication, and efficiency of UV-induced DNA repair. AGS fibroblasts entered senescence prematurely or upregulated genes involved in G1/S transition and DNA replication. The normally growing AGS cells exhibited unchanged DNA replication dynamics and, when quiescent, faster rate of excision repair of UV-induced DNA damages. To investigate whether the lack of SAMHD1 affects DNA replication fidelity, we compared de novo mutations in AGS and WT cells by exome next-generation sequencing. Somatic variant analysis indicated a mutator phenotype suggesting that SAMHD1 is a caretaker gene whose deficiency is per se mutagenic, promoting genome instability in non-transformed cells.	[Franzolin, Elisa; Coletta, Sara; Ferraro, Paola; Pontarin, Giovanna; D'Aronco, Giulia; Stevanoni, Martina; Cagnin, Stefano; Bertoldi, Loris; Feltrin, Erika; Valle, Giorgio; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Palumbo, Elisa; Russo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Cagnin, Stefano] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Cagnin, Stefano] Univ Padua, CIR Myo Myol Ctr, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Rampazzo, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	chiara.rampazzo.1@unipd.it	Russo, Antonella/K-8970-2016; Cagnin, Stefano/B-4800-2014; Palumbo, Elisa/J-9121-2016	Russo, Antonella/0000-0001-6691-257X; Cagnin, Stefano/0000-0001-7271-4625; Palumbo, Elisa/0000-0002-5812-6760; Bertoldi, Loris/0000-0002-8516-7680	Fondazione Telethon [GGP14005]; Associazione Italiana per la ricerca sul cancro (AIRC project) Dipartimento di Biologia-BIRD2018 (Universita di Padova) [IG15818]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Associazione Italiana per la ricerca sul cancro (AIRC project) Dipartimento di Biologia-BIRD2018 (Universita di Padova)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Telethon (project GGP14005 to V.B), Associazione Italiana per la ricerca sul cancro (AIRC project IG15818 to VB) Dipartimento di Biologia-BIRD2018 (Universita di Padova) to CR	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Daddacha W, 2017, CELL REP, V20, P1921, DOI 10.1016/j.celrep.2017.08.008; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Franzolin E, 2015, J BIOL CHEM, V290, P25986, DOI 10.1074/jbc.M115.675082; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; GODAY A, 1984, CLIN EXP IMMUNOL, V56, P39; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Johansson P, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-017-0036-5; Kasher PR, 2015, J IMMUNOL, V194, P2819, DOI 10.4049/jimmunol.1403157; Kolinjivadi AM, 2017, FEBS LETT, V591, P1083, DOI 10.1002/1873-3468.12556; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lee EJ, 2017, ONCOTARGET, V8, P68517, DOI 10.18632/oncotarget.19704; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Nguyen LA, 2014, J BIOL CHEM, V289, P2489, DOI 10.1074/jbc.C113.522326; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Palumbo E, 2013, EXP CELL RES, V319, P3081, DOI 10.1016/j.yexcr.2013.10.001; Palumbo E, 2013, GENE CHROMOSOME CANC, V52, P832, DOI 10.1002/gcc.22079; Palumbo E, 2010, CHROMOSOMA, V119, P575, DOI 10.1007/s00412-010-0279-4; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ramesh V, 2010, DEV MED CHILD NEUROL, V52, P725, DOI 10.1111/j.1469-8749.2010.03727.x; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmidt TT, 2019, NUCLEIC ACIDS RES, V47, P237, DOI 10.1093/nar/gky1154; Stevanoni M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006201; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Thyagarajan B, 2007, MUTAGENESIS, V22, P147, DOI 10.1093/mutage/gel071; Tramentozzi E, 2018, CELL CYCLE, V17, P1102, DOI 10.1080/15384101.2018.1480216; Wang JL, 2014, BIOCHEM BIOPH RES CO, V455, P229, DOI 10.1016/j.bbrc.2014.10.153; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6	63	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					631	647		10.1096/fj.201902508R	http://dx.doi.org/10.1096/fj.201902508R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914608	Green Published			2022-12-26	WOS:000507308900044
J	Lee, Y; Park, J; Kim, SM; Nam, K; Lee, W; Cho, H; Han, IO				Lee, Yunkyoung; Park, Jiwon; Kim, Sang-Min; Nam, Kyunghyun; Lee, Woojoo; Cho, Hyeongjin; Han, Inn-Oc			Sleep deprivation impairs learning and memory by decreasing protein O-GlcNAcylation in the brain of adult zebrafish	FASEB JOURNAL			English	Article						Danio rerio; glucosamine; HBP; learning and memory; OGA; sleep deprivation	SYNAPTIC PLASTICITY; HIPPOCAMPUS; GLUCOSE; TAU	Sleep is an evolutionarily conserved physiological process implicated in the consolidation of learning and memory (L/M). Here, we report that sleep deprivation (SD)-induced cognitive deficits in zebrafish are mediated through reduction in O-GlcNAcylation of brain. Microarray-based gene expression profiling of zebrafish brain demonstrated significant changes in genes involved in metabolism by SD or fear conditioning (FC), compared to the control group. In particular, it was observed that a marked decrease in the number of genes involved in carboxylic acid and organic acid metabolic processes in the brains of SD group compared to control group. SD downregulated O-GlcNAc transferase (OGT) and O-GlcNAcylation, while the expression of O-GlcNAcase was upregulated. FC activated protein kinase A (PKA) and phosphorylated cAMP response element binding protein (p-CREB), an effect that was greatly inhibited by SD. Moreover, FC upregulated expressions of OGT and increased O-GlcNAcylation in the brains of normal but not SD zebrafish. Intriguingly, upregulation of O-GlcNAcylation by glucosamine restored defects in L/M functions and PKA/p-CREB activity in SD group. Our findings highlight the O-GlcNAcylation changes in the brain during the L/M process and further provide a foundation for future studies seeking the molecular and biochemical mechanisms by which HBP of glucose metabolism affects cognitive function.	[Lee, Yunkyoung; Park, Jiwon; Kim, Sang-Min; Han, Inn-Oc] Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea; [Nam, Kyunghyun; Lee, Woojoo] Inha Univ, Dept Stat, Incheon, South Korea; [Cho, Hyeongjin] Inha Univ, Dept Chem, Incheon, South Korea	Inha University; Inha University; Inha University	Han, IO (corresponding author), Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea.	iohan@inha.ac.kr			National Research Foundation [NRF-2017R1A2B2007199, NRF-2017R1D1A1B03031431]; Inha University	National Research Foundation; Inha University	National Research Foundation, Grant/Award Number: NRF-2017R1A2B2007199 and NRF-2017R1D1A1B03031431; Inha University	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Gerlai R, 2011, REV NEUROSCIENCE, V22, P3, DOI 10.1515/RNS.2011.002; Havekes R, 2015, CURR TOP BEHAV NEURO, V25, P183, DOI 10.1007/7854_2015_369; Hwang SY, 2013, AM J PHYSIOL-CELL PH, V305, pC601, DOI 10.1152/ajpcell.00042.2013; Jacobsen KT, 2011, BIOCHEM BIOPH RES CO, V404, P882, DOI 10.1016/j.bbrc.2010.12.080; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lee Y, 2018, MOL NEUROBIOL, V55, P8738, DOI 10.1007/s12035-018-1017-9; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Monti B, 2005, HIPPOCAMPUS, V15, P1041, DOI 10.1002/hipo.20099; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Pinheiro-da-Silva J, 2017, PHARMACOL BIOCHEM BE, V159, P36, DOI 10.1016/j.pbb.2017.06.011; Sigurgeirsson B, 2013, BEHAV BRAIN RES, V256, P377, DOI 10.1016/j.bbr.2013.08.032; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b	27	3	3	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					853	864		10.1096/fj.201901399RR	http://dx.doi.org/10.1096/fj.201901399RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914627				2022-12-26	WOS:000507308900058
J	Levin-Schwartz, Y; Curtin, P; Svensson, K; Fernandez, NF; Kim-Schulze, S; Hair, GM; Flores, D; Pantic, I; Tamayo-Ortiz, M; Pizano-Zarate, ML; Gennings, C; Satlin, LM; Baccarelli, AA; Tellez-Rojo, MM; Wright, RO; Sanders, AP				Levin-Schwartz, Yuri; Curtin, Paul; Svensson, Katherine; Fernandez, Nicolas F.; Kim-Schulze, Seunghee; Hair, Gleicy M.; Flores, Daniel; Pantic, Ivan; Tamayo-Ortiz, Marcela; Luisa Pizano-Zarate, Maria; Gennings, Chris; Satlin, Lisa M.; Baccarelli, Andrea A.; Tellez-Rojo, Martha M.; Wright, Robert O.; Sanders, Alison P.			Length of gestation and birth weight are associated with indices of combined kidney biomarkers in early childhood	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; GELATINASE-ASSOCIATED LIPOCALIN; INJURY BIOMARKERS; URINE BIOMARKERS; PLASMA CREATININE; US POPULATION; CHILDREN; INFANTS; AGE; EXPRESSION	Infants born prematurely or with low birth weights are more susceptible to kidney dysfunction throughout their lives. Multiple proteins measured in urine are noninvasive biomarkers of subclinical kidney damage, but few studies have examined the joint effects of multiple biomarkers. We conducted an exploratory study of 103 children in the Programing Research in Obesity, Growth, Environment, and Social Stressors (PROGRESS) longitudinal birth cohort, and measured nine proteins selected a priori in banked spot urine samples collected at ages 4-6. The goal of our study was to explore the combined effects of kidney damage biomarkers previously associated with birth outcomes. To do this, we generated kidney biomarker indices using weighted quantile sum regression and assessed associations with length of gestation or birth weight. A decile increase in each kidney biomarker index was associated with 2-day shorter gestations (beta =-2.0, 95% CI:-3.2,-0.9) and 59-gram lower birth weights (beta =-58.5, 95% CI:-98.3,-18.7), respectively. Weights highlighting the contributions showed neutrophil gelatinase-associated lipocalin (NGAL) (60%) and osteopontin (19%) contributed most to the index derived for gestational age. NGAL (66%) and beta-2-microglobulin (10%) contributed most to the index derived for birth weight. Joint analyses of multiple kidney biomarkers can provide integrated measures of kidney dysfunction and improved statistical assessments compared to biomarkers assessed individually. Additionally, shorter gestations and lower birth weights may contribute to subclinical kidney damage measurable in childhood.	[Levin-Schwartz, Yuri; Curtin, Paul; Svensson, Katherine; Hair, Gleicy M.; Gennings, Chris; Wright, Robert O.; Sanders, Alison P.] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Fernandez, Nicolas F.; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Flores, Daniel; Satlin, Lisa M.; Wright, Robert O.; Sanders, Alison P.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Pantic, Ivan; Tamayo-Ortiz, Marcela; Tellez-Rojo, Martha M.] Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Pantic, Ivan] Natl Inst Perinatol, Dept Dev Neurobiol, Mexico City, DF, Mexico; [Tamayo-Ortiz, Marcela] Natl Council Sci & Technol, Mexico City, DF, Mexico; [Luisa Pizano-Zarate, Maria] Natl Inst Perinatol, Div Community Intervent Res, Mexico City, DF, Mexico; [Baccarelli, Andrea A.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Instituto Nacional de Salud Publica; Columbia University	Sanders, AP (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.; Sanders, AP (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.	alison.sanders@mssm.edu	Tamayo-Ortiz, Marcela/AAP-2122-2020; Tamayo-Ortiz, Marcela/AAQ-3189-2020	Tamayo-Ortiz, Marcela/0000-0002-7018-3602; Tamayo-Ortiz, Marcela/0000-0002-7018-3602; Wright, Robert/0000-0003-1180-6459; PIZANO-ZARATE, MARIA LUISA/0000-0002-2190-6421; Tellez Rojo, Martha/0000-0003-3322-3334; Sanders, Alison/0000-0001-8252-4016	Mount Sinai Children's Center Foundation; National Institutes of Health; National Institute of Environmental Health Sciences [T32HD049311, K99ES027508, R00ES027508, P30ES023515, R01ES013744, R01ES020268, R24ES02852, R01ES021357]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES027508, R01ES021357, R01ES013744, P30ES023515] Funding Source: NIH RePORTER	Mount Sinai Children's Center Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by funding from the Mount Sinai Children's Center Foundation (https://www.mountsinai.org/locations/kravis-childrens/services/child-family-support/childrens-center-foundation), National Institutes of Health (https://www.nih.gov), and National Institute of Environmental Health Sciences (https://www.niehs.nih.gov): T32HD049311 (ROW), K99ES027508 (APS), R00ES027508 (APS), P30ES023515 (ROW), R01ES013744 (ROW), R01ES020268 (ROW), R24ES02852 (ROW) and R01ES021357 (AAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa MC, 2016, PEDIATR NEPHROL, V31, P2277, DOI 10.1007/s00467-016-3484-4; Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213; Askenazi DJ, 2016, CLIN J AM SOC NEPHRO, V11, P1527, DOI 10.2215/CJN.13381215; Askenazi DJ, 2011, PEDIATR RES, V70, P302, DOI 10.1203/PDR.0b013e3182275164; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Barton KT, 2018, CLIN KIDNEY J, V11, P797, DOI 10.1093/ckj/sfy056; Beitland S, 2019, CRIT CARE RES PRACT, V2019, DOI 10.1155/2019/4384796; Brunst KJ, 2017, AM J EPIDEMIOL, V186, P1227, DOI 10.1093/aje/kwx183; Burris HH, 2013, EPIGENOMICS-UK, V5, P271, DOI [10.2217/EPI.13.24, 10.2217/epi.13.24]; Carrico C, 2015, J AGR BIOL ENVIR ST, V20, P100, DOI 10.1007/s13253-014-0180-3; Ciccia E, 2017, INT J NEPHROL RENOV, V10, P77, DOI 10.2147/IJNRD.S103785; Crump C, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1346; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; DeFreitas MJ, 2016, PEDIATR NEPHROL, V31, P1179, DOI 10.1007/s00467-016-3327-3; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265; DVERGSTEN J, 1994, KIDNEY INT, V45, P828, DOI 10.1038/ki.1994.109; Edelstein CL, 2017, BIOMARKERS OF KIDNEY DISEASE, 2ND EDITION, P241, DOI 10.1016/B978-0-12-803014-1.00006-6; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Greenberg JH, 2017, CLIN J AM SOC NEPHRO, V12, P1551, DOI 10.2215/CJN.12851216; Greenberg JH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-184; Groesbeck D, 2008, CLIN J AM SOC NEPHRO, V3, P1777, DOI 10.2215/CJN.00840208; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Henn BC, 2018, ENVIRON RES, V161, P588, DOI 10.1016/j.envres.2017.12.003; Hibi Y, 2015, PEDIATR INT, V57, P79, DOI 10.1111/ped.12470; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Izzedine H, 2017, KIDNEY INT REP, V2, P504, DOI 10.1016/j.ekir.2017.02.008; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; Ladeiras R, 2018, MINERVA PEDIAT; Lavery AP, 2008, PEDIATR RES, V64, P423, DOI 10.1203/PDR.0b013e318181b3b2; Liborio AB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/601568; Ling CX, 2018, TOXICS, V6, DOI 10.3390/toxics6030041; Matsumura K, 2018, CLIN EXP NEPHROL; McWilliam SJ, 2014, BIOMARK MED, V8, P1189, DOI [10.2217/BMM.14.36, 10.2217/bmm.14.36]; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; O'Brien Katie M, 2017, Curr Environ Health Rep, V4, P44, DOI 10.1007/s40572-017-0122-7; O'Brien KM, 2016, ENVIRON HEALTH PERSP, V124, P220, DOI 10.1289/ehp.1509693; Pottel H, 2015, PEDIATR NEPHROL, V30, P821, DOI 10.1007/s00467-014-3002-5; Ryan D, 2018, EBIOMEDICINE, V27, P275, DOI 10.1016/j.ebiom.2017.12.016; Saeidi B, 2015, PEDIATR NEPHROL, V30, P2037, DOI 10.1007/s00467-015-3129-z; Sanders AP, 2015, EPIGENETICS-US, V10, P221, DOI 10.1080/15592294.2015.1006498; SAVORY DJ, 1990, ANN CLIN BIOCHEM, V27, P99, DOI 10.1177/000456329002700201; Schmidt IM, 2005, KIDNEY INT, V68, P731, DOI 10.1111/j.1523-1755.2005.00451.x; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; SHIHABI ZK, 1991, CLIN CHEM, V37, P621; Stritzke Amelie, 2017, Mol Cell Pediatr, V4, P2, DOI 10.1186/s40348-016-0068-0; Tsuboi N, 2014, CLIN KIDNEY J, V7, P107, DOI 10.1093/ckj/sfu018; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yamanari T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3024698; Zaffanello M, 2010, ACTA PAEDIATR, V99, P1192, DOI 10.1111/j.1651-2227.2010.01799.x; Zeng Xu, 2014, J Biomark, V2014, P492838, DOI 10.1155/2014/492838; Zhang AH, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/314251; Zheng JY, 2013, PEDIATR CARDIOL, V34, P880, DOI 10.1007/s00246-012-0563-6	60	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227219	10.1371/journal.pone.0227219	http://dx.doi.org/10.1371/journal.pone.0227219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891650	Green Published, gold			2022-12-26	WOS:000515096600069
J	Schekler, I; Kiat, Y; Dor, R				Schekler, Inbal; Kiat, Yosef; Dor, Roi			Age-dependent survival rate of the colonial Little Tern (Sternula albifrons)	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; POPULATION-DYNAMICS; ADULT SURVIVAL; DENSITY; HABITAT; EXPERIENCE; FECUNDITY	Many ground-nesting bird species are suffering from habitat loss and population decline. Data on population ecology and demography in colonies of threatened species are thus essential for designing effective conservation protocols. Here, we used extensive ringing and observation data to estimate directly, for the first time, the survival rate of juvenile and adult Little Tern (Sternula albifrons), as well as testing for a possible effect of age on probability of survival. We estimated adult annual survival rate to be 0.77, and juvenile (first year) survival to be 0.49 with a possible linear decrease in the survival rate of the juveniles that ranged from 0.681 to 0.327. We found no evidence that survival was age-dependent among the early age classes after the first year. We discuss these findings in light of survival estimates for other species, and their implications for the Little Tern conservation.	[Schekler, Inbal; Dor, Roi] Tel Aviv Univ, Fac Life Sci, Sch Zool, Tel Aviv, Israel; [Schekler, Inbal; Kiat, Yosef] Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel; [Schekler, Inbal; Kiat, Yosef] Soc Protect Nat Israel, Israel Ornithol Ctr, Tel Aviv, Israel	Tel Aviv University; University of Haifa	Dor, R (corresponding author), Tel Aviv Univ, Fac Life Sci, Sch Zool, Tel Aviv, Israel.	roidor@tauex.tau.ac.il		Dor, Roi/0000-0002-8743-9387; Kiat, Yosef/0000-0002-3485-3517	Salt of the Earth Ltd.; Society for the Protection of Nature in Israel (SPNI); Hoopoe Foundation	Salt of the Earth Ltd.; Society for the Protection of Nature in Israel (SPNI); Hoopoe Foundation	This research was supported by 'Salt of the Earth Ltd.', the Society for the Protection of Nature in Israel (SPNI), and the Hoopoe Foundation.	AEBISCHER NJ, 1990, J ANIM ECOL, V59, P1063, DOI 10.2307/5031; Akcakaya HR, 2003, J WILDLIFE MANAGE, V67, P829, DOI 10.2307/3802690; Alon D, 2008, ENDANGERED BIRDS REP; Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; BirdLife International, 2020, IUCN RED LIST BIRDS; BRADLEY JS, 1989, J ANIM ECOL, V58, P175, DOI 10.2307/4993; Breton AR, 2014, IBIS, V156, P534, DOI 10.1111/ibi.12161; Bridge ES, 2005, MOL PHYLOGENET EVOL, V35, P459, DOI 10.1016/j.ympev.2004.12.010; Burnham K.P., 1998, MODEL SELECTION INFE, P75; Cabot D, 2013, COLLINS NEW NATURALI, V123; Cam E, 2011, J ORNITHOL, V152, P187, DOI 10.1007/s10336-011-0707-0; Catry T, 2004, IBIS, V146, P247, DOI 10.1046/j.1474-919X.2004.00254.x; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Fay R, 2015, J ANIM ECOL, V84, P1423, DOI 10.1111/1365-2656.12390; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Forslund Piir, 1995, AGE REPROD BIRDS HYP, VI; Frederiksen M, 2000, J ANIM ECOL, V69, P737, DOI 10.1046/j.1365-2656.2000.00435.x; Fujita G, 2009, BIOL CONSERV, V142, P1891, DOI 10.1016/j.biocon.2009.02.024; Hartmann SA, 2017, OECOLOGIA, V183, P597, DOI 10.1007/s00442-016-3763-6; Hatzofe O, 2009, TERNS BREEDING ISARA; Kendall WL, 1997, ECOLOGY, V78, P563; Le Galliard JF, 2010, J ANIM ECOL, V79, P1296, DOI 10.1111/j.1365-2656.2010.01732.x; Lebreton JD, 2010, MODELING SURVIVAL TE, V62, P67, DOI [10.2307/2937171, DOI 10.2307/2937171]; MASSEY BW, 1992, CONDOR, V94, P976, DOI 10.2307/1369293; Meroz A, 2017, RED BOOK BIRDS ISRAE; Nisbet ICT, 2002, J APPL STAT, V29, P65, DOI 10.1080/02664760120108467; Palestis BG, 2014, CURR ZOOL, V60, P500, DOI 10.1093/czoolo/60.4.500; Peter J, 2000, PETRELS INSIGHTS DIE; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; PUGESEK BH, 1995, ANIM BEHAV, V49, P641; PYLE P, 1991, AUK, V108, P25; RENKEN RB, 1995, J FIELD ORNITHOL, V66, P112; Roodbergen M, 2012, J ORNITHOL, V153, P53, DOI 10.1007/s10336-011-0733-y; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; Senner SE, 1984, CONSERVATION NEARCTI, P379; Seward A, 2019, J ANIM ECOL, V88, P138, DOI 10.1111/1365-2656.12904; Shirihai H., 1996, BIRDS ISRAEL; Tavecchia G, 2005, J AVIAN BIOL, V36, P501, DOI 10.1111/j.0908-8857.2005.03440.x; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; [No title captured]	48	0	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226819	10.1371/journal.pone.0226819	http://dx.doi.org/10.1371/journal.pone.0226819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891943	gold, Green Published			2022-12-26	WOS:000515096600032
J	Kolesnikov, AV; Chrispell, JD; Osawa, S; Kefalov, VJ; Weiss, ER				Kolesnikov, Alexander V.; Chrispell, Jared D.; Osawa, Shoji; Kefalov, Vladimir J.; Weiss, Ellen R.			Phosphorylation at Serine 21 in G protein-coupled receptor kinase 1 (GRK1) is required for normal kinetics of dark adaption in rod but not cone photoreceptors	FASEB JOURNAL			English	Article						cAMP; photoreceptor; phototransduction; protein phosphorylation; vision	VISUAL-PIGMENT REGENERATION; RHODOPSIN KINASE; LIGHT ADAPTATION; DOMINANT RETINAS; CYCLIC-AMP; WILD-TYPE; PHOTOTRANSDUCTION; MICE; EXPRESSION; RECOVERIN	Timely recovery of the light response in photoreceptors requires efficient inactivation of photoactivated rhodopsin. This process is initiated by phosphorylation of its carboxyl terminus by G protein-coupled receptor kinase 1 (GRK1). Previously, we showed that GRK1 is phosphorylated in the dark at Ser21 in a cAMP-dependent manner and dephosphorylated in the light. Results in vitro indicate that dephosphorylation of Ser21 increases GRK1 activity, leading to increased phosphorylation of rhodopsin. This creates the possibility of light-dependent regulation of GRK1 activity and its efficiency in inactivating the visual pigment. To address the functional role of GRK1 phosphorylation in rods and cones in vivo, we generated mutant mice in which Ser21 is substituted with alanine (GRK1-S21A), preventing dark-dependent phosphorylation of GRK1. GRK1-S21A mice had normal retinal morphology, without evidence of degeneration. The function of dark-adapted GRK1-S21A rods and cones was also unaffected, as demonstrated by the normal amplitude and kinetics of their responses obtained by ex vivo and in vivo ERG recordings. In contrast, rod dark adaptation following exposure to bright bleaching light was significantly delayed in GRK1-S21A mice, suggesting that the higher activity of this kinase results in enhanced rhodopsin phosphorylation and therefore delays its regeneration. In contrast, dark adaptation of cones was unaffected by the S21A mutation. Taken together, these data suggest that rhodopsin phosphorylation/dephosphorylation modulates the recovery of rhodopsin to the ground state and rod dark adaptation. They also reveal a novel role for cAMP-dependent phosphorylation of GRK1 in regulating the dark adaptation of rod but not cone photoreceptors.	[Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA; [Chrispell, Jared D.; Osawa, Shoji; Weiss, Ellen R.] Univ N Carolina, Dept Cell Biol & Physiol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.; Weiss, ER (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, CB 7545,5340B MBRB,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	kefalov@wustl.edu; erweiss@med.unc.edu	Weiss, Ellen/AAK-9868-2020; Kolesnikov, Alexander V/O-1840-2016		HHS \ NIH \ National Eye Institute (NEI) [EY01224, EY005722, EY026675, EY019312, EY02687]; Research to Prevent Blindness (RPB)	HHS \ NIH \ National Eye Institute (NEI); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY01224, EY005722 (Duke Univ. Core), EY026675, EY019312 and EY02687 (Washington Univ. Core); Research to Prevent Blindness (RPB)	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Berry J, 2016, J NEUROSCI, V36, P6973, DOI 10.1523/JNEUROSCI.3544-15.2016; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen CK, 2015, J GEN PHYSIOL, V145, P213, DOI 10.1085/jgp.201411273; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; COHEN AI, 1990, VISUAL NEUROSCI, V4, P43, DOI 10.1017/S0952523800002753; FARBER DB, 1981, INVEST OPHTH VIS SCI, V20, P24; Frederiksen R, 2016, J GEN PHYSIOL, V148, P1, DOI 10.1085/jgp.201511538; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kolesnikov AV, 2017, P NATL ACAD SCI USA, V114, pE9675, DOI 10.1073/pnas.1712405114; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Latek D, 2012, ACTA BIOCHIM POL, V59, P515; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Orban T, 2012, BIOCHEMISTRY-US, V51, P3404, DOI 10.1021/bi300295y; Osawa S, 2012, ADV EXP MED BIOL, V723, P821, DOI 10.1007/978-1-4614-0631-0_105; Osawa S, 2011, J BIOL CHEM, V286, P20923, DOI 10.1074/jbc.M111.230904; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; Sakurai K, 2015, J BIOL CHEM, V290, P9239, DOI 10.1074/jbc.M115.639591; Sakurai K, 2011, INVEST OPHTH VIS SCI, V52, P6793, DOI 10.1167/iovs.11-7158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schott RK, 2018, MOL BIOL EVOL, V35, P1376, DOI 10.1093/molbev/msy025; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wada Y, 2006, J NEUROCHEM, V98, P824, DOI 10.1111/j.1471-4159.2006.03920.x; Weiss E R, 1998, Mol Vis, V4, P27; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Yamaoka H, 2015, J BIOL CHEM, V290, P24381, DOI 10.1074/jbc.M115.674101; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124	50	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2677	2690		10.1096/fj.201902535R	http://dx.doi.org/10.1096/fj.201902535R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908030	Green Accepted			2022-12-26	WOS:000504872400001
J	Newman, JA; Aitkenhead, H; Gavard, AE; Rota, IA; Handel, AE; Hollander, GA; Gileadi, O				Newman, Joseph A.; Aitkenhead, Hazel; Gavard, Angeline E.; Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.; Gileadi, Opher			The crystal structure of human forkhead box N1 in complex with DNA reveals the structural basis for forkhead box family specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA?protein interaction; immunodeficiency; transcription factor; crystal structure; gene regulation; forkhead box N1; thymus	BINDING-SPECIFICITY; DOMAIN; RECOGNITION; METHYLATION; PROTEIN; MOUSE	Forkhead box N1 (FOXN1) is a member of the forkhead box family of transcription factors and plays an important role in thymic epithelial cell differentiation and development. FOXN1 mutations in humans and mice give rise to the ?nude? phenotype, which is marked by athymia. FOXN1 belongs to a subset of the FOX family that recognizes an alternative forkhead-like (FHL) consensus sequence (GACGC) that is different from the more widely recognized forkhead (FKH) sequence RYAAAYA (where R is purine, and Y is pyrimidine). Here, we present the FOXN1 structure in complex with DNA containing an FHL motif at 1.6 ? resolution, in which the DNA sequence is recognized by a mixture of direct and water-mediated contacts provided by residues in an ?-helix inserted in the DNA major groove (the recognition helix). Comparisons with the structure of other FOX family members revealed that the FKH and FHL DNA sequences are bound in two distinct modes, with partially different registers for the protein DNA contacts. We identified a single alternative rotamer within the recognition helix itself as an important determinant of DNA specificity and found protein sequence features in the recognition helix that could be used to predict the specificity of other FOX family members. Finally, we demonstrate that the C-terminal region of FOXN1 is required for high-affinity DNA binding and that FOXN1 has a significantly reduced affinity for DNA that contains 5?-methylcytosine, which may have implications for the role of FOXN1 in thymic involution.	[Newman, Joseph A.; Aitkenhead, Hazel; Gavard, Angeline E.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.] Univ Oxford, Dept Paediat, Oxford OX3 9DS, England; [Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Handel, Adam E.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Hollander, Georg A.] Univ Basel, Dept Biomed, Paediat Immunol, CH-4056 Basel, Switzerland; [Hollander, Georg A.] Univ Childrens Hosp Basel, CH-4056 Basel, Switzerland; [Aitkenhead, Hazel] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Basel; University of Basel; University of Oxford; Wellcome Centre for Human Genetics	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; Handel, Adam/0000-0001-8385-6346; Hollander, Georg/0000-0002-8790-0874	Structural Genomics Consortium [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen; Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Grants [106169/ZZ14/Z, 211944/Z/18/Z]	Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Grants	This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766, Janssen, Merck KGaA, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Grants 106169/ZZ14/Z (to I. A. R., A. E. H., and G. A. H.) and 211944/Z/18/Z (to J. A. N., H. A., A. E. G., and O. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams EJ, 2019, NATURE, V571, P408, DOI 10.1038/s41586-019-1318-9; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boura E, 2010, ACTA CRYSTALLOGR D, V66, P1351, DOI 10.1107/S0907444910042228; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Ignat'eva E. L., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P76; Jackson Brian C., 2010, Human Genomics, V4, P345; Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaestner KH, 2000, GENE DEV, V14, P142; Li J, 2017, BIOCHEMISTRY-US, V56, P3745, DOI 10.1021/acs.biochem.7b00211; Littler DR, 2010, NUCLEIC ACIDS RES, V38, P4527, DOI 10.1093/nar/gkq194; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Parolia A, 2019, NATURE, V571, P413, DOI 10.1038/s41586-019-1347-4; Rogers JM, 2019, MOL CELL, V74, P245, DOI 10.1016/j.molcel.2019.01.019; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsai KL, 2006, J BIOL CHEM, V281, P17400, DOI 10.1074/jbc.M600478200; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zampieri M, 2015, MECH AGEING DEV, V151, P60, DOI 10.1016/j.mad.2015.02.002; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	32	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2948	2958		10.1074/jbc.RA119.010365	http://dx.doi.org/10.1074/jbc.RA119.010365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31914405	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000519597300007
J	Abdi, AI; Nichols, PGH; Kaur, P; Wintle, BJ; Erskine, W				Abdi, Abdi I.; Nichols, Phillip G. H.; Kaur, Parwinder; Wintle, Bradley J.; Erskine, William			Morphological diversity within a core collection of subterranean clover (Trifolium subterraneum L.): Lessons in pasture adaptation from the wild	PLOS ONE			English	Article							GENETIC-IMPROVEMENT; LEAF-AREA; POPULATIONS; RESISTANCE; DISEASE; TRAITS; IDENTIFICATION; CALYCOMORPHUM; CULTIVARS; EVOLUTION	Subterranean clover (Trifolium subterraneum L.) is a diploid self-pollinated annual pasture legume native to the Mediterranean region and widely sown in southern Australia and other countries with Mediterranean-type climates. This study utilised a core collection of 97 lines, representing around 80% of the genetic diversity of the species, to examine morphological diversity within subterranean clover. A total of 23 quantitative agro-morphological and 13 semi-quantitative morphological marker traits were assayed on the core collection and 28 diverse Australian cultivars as spaced plants in a replicated common garden experiment. Relationships between these traits and 24 climatic and edaphic parameters at their sites of origin were also examined within the core collection. Significant diversity was present for all traits. The Australian cultivars had similar levels of diversity to the core collection for several traits. Among the agro-morphological traits, time to flowering, leaf size and petiole diameter in mid-winter, plant area in late winter, maximum stem length, content of the oestogenic isoflavone biochanin A and total isoflavone content, were correlated with seven or more environmental variables. These can be considered highly adaptive, being the result of strong environmental selection pressure over time. For the first time in a clover species, morphological markers, including leaf mark, anthocyanin pigmentation and pubescence traits, have been associated with rainfall and soil parameters. This suggests they either have an adaptive role or the genes controlling them may be linked to other genes controlling adaptive traits. This study demonstrated the value of core collections to examine diversity within much larger global collections. It also identified adaptive traits from wild plants that can be utilised to develop more productive and persistent subterranean clover cultivars. The high heritability of these traits indicates that selection gains can be readily made.	[Abdi, Abdi I.; Nichols, Phillip G. H.; Kaur, Parwinder; Wintle, Bradley J.; Erskine, William] Univ Western Australia, Sch Agr & Environm, Ctr Plant Genet & Breeding, Crawley, WA, Australia; [Nichols, Phillip G. H.; Kaur, Parwinder; Wintle, Bradley J.; Erskine, William] Univ Western Australia, Inst Agr, Crawley, WA, Australia; [Abdi, Abdi I.] Univ Duhok, Dept Plant Protect, Coll Agr Engn Sci, Duhok, Kurdistan Regio, Iraq	University of Western Australia; University of Western Australia; University of Duhok	Nichols, PGH (corresponding author), Univ Western Australia, Sch Agr & Environm, Ctr Plant Genet & Breeding, Crawley, WA, Australia.; Nichols, PGH (corresponding author), Univ Western Australia, Inst Agr, Crawley, WA, Australia.	phillip.nichols@uwa.edu.au		Abdi, Abdi/0000-0003-2514-2198; Erskine, William/0000-0002-2074-4299; Kaur, Parwinder/0000-0003-0201-0766; Nichols, Phillip/0000-0001-6778-5525	Kurdistan Regional Government; Meat & Livestock Australia [P.PBE.0037]	Kurdistan Regional Government; Meat & Livestock Australia(Meat and Livestock Australia)	AA conducted this research as part of his MSc studies at the University of Western Australia, funded by the Kurdistan Regional Government under the KRG-Scholarship program, Human Capacity Development (HCDP). Funding was also provided by Meat & Livestock Australia (MLA; www.mla.com.au), as part of the project `Prebreeding in annual legumes' (P.PBE.0037). PN and BW were employed by the Western Australian government in the Department of Primary Industries and Regional Development (DPIRD) at the time this research was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbetti MJ, 1996, BULLETIN, V4327; Baresel JP, 2018, GENET RESOUR CROP EV, V65, P2057, DOI 10.1007/s10722-018-0672-z; Bennett SJ, 1997, AUST J AGR RES, V48, P969, DOI 10.1071/A96158; BLACK J. N., 1960, AUSTRALIAN JOUR AGRIC RES, V11, P277, DOI 10.1071/AR9600277; BLACK JN, 1963, AUST J AGR RES, V14, P20, DOI 10.1071/AR9630020; Brown AG, 1999, BRIT GEOMOR, P1; COCKS PS, 1992, AUST J AGR RES, V43, P1583, DOI 10.1071/AR9921583; COLLINS WJ, 1984, AUST J AGR RES, V35, P399, DOI 10.1071/AR9840399; Collins WJ, 1984, FORAGE LEGUMES ENERG, P268; Cox R. I., 1974, Proceedings of the Australian Society of Animal Production, V10, P122; Ehrman T, 1996, VEGETATIO, V122, P47, DOI 10.1007/BF00052815; El Bouhssini M, 2011, PLANT BREEDING, V130, P96, DOI 10.1111/j.1439-0523.2010.01814.x; ERSKINE W, 1989, EUPHYTICA, V43, P97, DOI 10.1007/BF00037901; Falconer D. S., 1996, INTRO QUANTITATIVE G; FALISTOCCO E, 1987, CARYOLOGIA, V40, P123, DOI 10.1080/00087114.1987.10797816; FRANCIS CM, 1965, AUST J AGR RES, V16, P557, DOI 10.1071/AR9650557; Ghamkhar K, 2015, J AGR SCI-CAMBRIDGE, V153, P1069, DOI 10.1017/S0021859614000793; Ghamkhar K, 2012, MOL BREEDING, V30, P213, DOI 10.1007/s11032-011-9612-8; GLADSTON.JS, 1967, AUST J AGR RES, V18, P713, DOI 10.1071/AR9670713; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; KATZNELSON J, 1965, ISRAEL J BOT, V14, P112; KATZNELSON J, 1974, ISRAEL J BOT, V23, P69; Kaur N, 2008, EUR J PLANT PATHOL, V121, P387, DOI 10.1007/s10658-007-9252-3; Kaur P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01463; Khazaei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063107; Mackay M. C., 1995, P199; McGuire W.S, 1985, CLOVER SCI TECHNOLOG, P515; Morley F. H. W., 1965, The genetics of colonizing species., P269; Nichols PGH, 2007, AUST J EXP AGR, V47, P223, DOI 10.1071/EA05282; Nichols PGH, 2014, CROP PASTURE SCI, V65, P1207, DOI 10.1071/CP14031; Nichols PGH, 2013, CROP PASTURE SCI, V64, P312, DOI 10.1071/CP13118; Nichols PGH, 2010, CROP PASTURE SCI, V61, P44, DOI 10.1071/CP09161; Nichols PGH, 2009, EUPHYTICA, V169, P31, DOI 10.1007/s10681-009-9906-7; Nichols PGH, 2006, AUST J EXP AGR, V46, P1105, DOI 10.1071/EA05083; Nichols PGH, 2019, P 19 AUSTR AGR C 25; PBR database, 2019, PLANT BREEDERS RIGHT; Pecetti L, 1998, GENET RESOUR CROP EV, V45, P161, DOI 10.1023/A:1008616706588; Pecetti L, 2002, GENET RESOUR CROP EV, V49, P189, DOI 10.1023/A:1014795116603; PIANO E, 1993, EUPHYTICA, V68, P43, DOI 10.1007/BF00024153; Piano E., 1982, Revista di Agronomia, V16, P273; PIANO E, 1984, Genetica Agraria, V38, P75; Piano E, 1996, EUPHYTICA, V92, P39, DOI 10.1007/BF00022826; Piluzza G, 2005, GENET RESOUR CROP EV, V52, P193, DOI 10.1007/s10722-003-4449-6; Quadrana L, 2016, ANNU REV GENET, V50, P467, DOI 10.1146/annurev-genet-120215-035254; ROSSITER RC, 1974, AUST J AGR RES, V25, P757, DOI 10.1071/AR9740757; Ryan MH, 2016, APPL SOIL ECOL, V98, P221, DOI 10.1016/j.apsoil.2015.10.019; Smetham ML, 2003, ADV AGRON, V79, P303, DOI 10.1016/S0065-2113(02)79006-8; TAN BH, 1987, AUST J AGR RES, V38, P547, DOI 10.1071/AR9870547; WILLIAMS RF, 1964, AUST J AGR RES, V15, P231, DOI 10.1071/AR9640231; WorldClim, 2006, WORLDCLIM GLOB CLIM; Zohary M., 1984, THE GENUS TRIFOLIUM	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0223699	10.1371/journal.pone.0223699	http://dx.doi.org/10.1371/journal.pone.0223699			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914457	Green Published, gold			2022-12-26	WOS:000534337700006
J	Diaz-Caro, I; Gomez-Heras, SG				Diaz-Caro, Isabel; Garcia Gomez-Heras, Soledad			Incidence of hospital-acquired pressure ulcers in patients with "minimal risk" according to the "Norton-MI" scale	PLOS ONE			English	Article							PREVALENCE	Introduction Pressure ulcers (PUs) nowadays are a major health problem in society, associated with increased morbidity and increased health care costs. The incidence of HAPU is an indicator of health care quality. Objective To describe the profile of patients with minimal risk on the Norton-MI scale who developed PUs during hospitalization, and to identify the incidence of hospital-acquired pressure ulcers (HAPU). Methods Retrospective cohort study conducted between 2014 and 2017. Study population Patients over 18 years of age classified as "minimum risk" according to Norton-MI, admitted to acute hospital units of the Severo Ochoa University Hospital-Madrid-Spain. Patients were classified as patients with hospital-acquired pressure ulcers (PWHAPU) if they developed one or more new PU during their hospitalization. Variables Sociodemographic variables, hospitalization units, Morton-MI score and characteristics of the risk factors of HAPU were studied. Results The risk of PU was evaluated in 5530 patients, being 1260 patients classified as "minimum risk", with a median of 16 points in the Norton-MI scale. The average age was 76 years old and 52.5% were women. Principal causes of admission: traumatological pathologies (20.8%) and cardiovascular pathologies (20%). 129 HAPU were diagnosed in 112 patients, implying an incidence of HAPU of 8.89% (CI95%: 7.44-10.59). 106 PWHAPU (94.6%) presented up to 6 risk factors. The excess pressure and altered skin sensibility were identified as statistically significant risk factors as predictive factors of HAPU. In terms of severity, 55% of the HAPU were category I and 42.6% were category II, mainly with anatomical sacro-coxygeal location. In 65.2% of the patients the HAPU appeared in the first week of hospitalization. Conclusion In our study the incidence of HAPU in patients classified as minimum risk with Norton-MI scale was 8.89%. This elevated risk suggests for future investigations to develop new validity studies of the Norton-MI scale and to maintain a continuo training of professionals in the knowledge of PU risk assessment scales for their safe application in the patients, since it directs the practice of care in the prevention of PUs. It would be advisable to specially control the risk of PUs in care units, mainly in the first week of their hospital stay to minimize the HAPU incidence.	[Diaz-Caro, Isabel] Rey Juan Carlos Univ, Int Doctoral Sch, Madrid, Spain; [Diaz-Caro, Isabel] Hosp Univ Severo Ochoa, Madrid, Spain; [Garcia Gomez-Heras, Soledad] Rey Juan Carlos Univ, Fac Hlth Sci, Basic Hlth Sci Dept, Madrid, Spain	Universidad Rey Juan Carlos; Severo Ochoa University Hospital; Universidad Rey Juan Carlos	Gomez-Heras, SG (corresponding author), Rey Juan Carlos Univ, Fac Hlth Sci, Basic Hlth Sci Dept, Madrid, Spain.	soledad.garcia@urjc.es						[Anonymous], 2017, 5 NATL STUDY PREVALE; Aydin C, 2015, HEALTH SERV RES, V50, P351, DOI 10.1111/1475-6773.12244; Baron Burgos MM, 2015, GUIDE PREVENTION MAN; Bauer K, PRESSURE ULCERS UNIT; Berlowitz D., 2014, PRESSURE ULCERS AGIN, P19, DOI [DOI 10.1007/978-1-62703-700-6_2, 10.1007/978-1-62703-700-6_2]; CALZADA ML, 2007, GEROKOMOS, V18, DOI DOI 10.1088/0957-4484/18/37/375603; Camargo-Figuera F.A., 2017, GEROKOMOS, V28, P200; Coleman S, 2013, INT J NURS STUD, V50, P974, DOI 10.1016/j.ijnurstu.2012.11.019; Crawford B, 2014, J NURS CARE QUAL, V29, P303, DOI 10.1097/NCQ.0000000000000060; Diez-Manglano J, 2016, REV CLIN ESP, V216, P461, DOI 10.1016/j.rce.2016.07.003; Downie F., 2013, WOUNDS UK, V9, P16; European Pressure Ulcer Advisory Panel National Pressure Ulcer Advisory Panel (U.S.), 2014, PAN PAC PRESS INJ AL; García Fernández Francisco Pedro, 2008, Gerokomos, V19, P136, DOI 10.4321/s1134-928x2008000300005; GRANADOS JAT, 1994, MED CLIN-BARCELONA, V103, P140; Hibbs P, 1988, Decubitus, V1, P32; Hidalgo PLP, 2008, ASSESSMENT RISK DEVE, V19, P84; Institute Nacional de la Salud (Espanya) Subdireccion General de Coordinacion Administrativa, 1996, NURS CAR GUID PRESS; Kayser SA, 2019, INT J NURS STUD, V89, P46, DOI 10.1016/j.ijnurstu.2018.09.003; Meddings J, 2015, J AM GERIATR SOC, V63, P1407, DOI 10.1111/jgs.13475; National Pressure Ulcer Advisory Panel European Pressure Ulcer Advisory Panel Pan Pacific Pressure Injury Alliance, 2014, PAN PACIFIC PRESSURE; Pancorbo-Hidalgo Pedro L., 2014, Gerokomos, V25, P162, DOI 10.4321/S1134-928X2014000400006; Pancorbo-Hidalgo Pedro L., 2008, Gerokomos, V19, P40, DOI 10.4321/s1134-928x2008000200005; Papanikolaou P, 2007, INT J NURS STUD, V44, P285, DOI 10.1016/j.ijnurstu.2006.01.015; Peralta Vargas CE, 2012, REV MED HEREDIANA, V20, P16; Peralta Vargas CE, 2009, REV MED HEREDIANA, V20, P16; Pieper B, PRESSURE ULCERS IMPA, P16; Prieto JMR, 2010, ENFERMERIA DERMATOLO, V4, P21; Qaseem A, 2015, ANN INTERN MED, V162, P359, DOI 10.7326/M14-1567; Romanos Calvo B, 2017, GEROKOMOS, V28, P194; Satekova L, 2015, CENT EUR J NURS MIDW, V6, P283, DOI DOI 10.15452/CEJNM.2015.06.0017; Schmitt S, 2017, J WOUND OSTOMY CONT, V44, P458, DOI 10.1097/WON.0000000000000361; Stegensek Mejla EM, 2015, ENFERMERIA U, V12, P173; Tizon Bouza E, 2014, GEROKOMOS, V25, P53; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Zuniga-Castro C, 2015, REV ENFERMERIA HERED, V7, P155	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227052	10.1371/journal.pone.0227052	http://dx.doi.org/10.1371/journal.pone.0227052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914154	Green Published, gold			2022-12-26	WOS:000534337700027
J	Liu, YT; Mao, C; Wang, M; Liu, N; Ouyang, LL; Liu, SP; Tang, HS; Cao, Y; Liu, S; Wang, X; Xiao, DS; Chen, CS; Shi, Y; Yan, Q; Tao, YG				Liu, Yating; Mao, Chao; Wang, Min; Liu, Na; Ouyang, Lianlian; Liu, Shouping; Tang, Haosheng; Cao, Ya; Liu, Shuang; Wang, Xiang; Xiao, Desheng; Chen, Ceshi; Shi, Ying; Yan, Qin; Tao, Yongguang			Cancer progression is mediated by proline catabolism in non-small cell lung cancer	ONCOGENE			English	Article							NF-KAPPA-B; MITOCHONDRIAL TUMOR-SUPPRESSOR; SUCCINATE-DEHYDROGENASE; METHYLATION PATTERNS; OXIDASE; P53; GENE; EXPRESSION; ALPHA; LSH	Dysregulated metabolism contributes to cancer initiation and progression, but the key drivers of these pathways are just being discovered. Here, we report a critical role for proline catabolism in non-small cell lung cancer (NSCLC). Proline dehydrogenase (PRODH) is activated to reduce proline levels by the chromatin remodeling factor lymphoid-specific helicase (LSH), an epigenetic driver of NSCLC. PRODH promotes NSCLC tumorigenesis by inducing epithelial to mesenchymal transition (EMT) and IKK alpha-dependent inflammatory genes, including CXCL1, LCN2, and IL17C. Consistently, proline addition promotes the expression of these inflammatory genes, as well as EMT, tumor cell proliferation, and migration in vitro and tumor growth in vivo, while the depletion or inhibition of PRODH blocks these phenotypes. In summary, we reveal an essential metabolic pathway amenable to targeting in NSCLC.	[Liu, Yating; Mao, Chao; Wang, Min; Liu, Na; Ouyang, Lianlian; Liu, Shouping; Tang, Haosheng; Cao, Ya; Shi, Ying; Tao, Yongguang] Cent South Univ, Xiangya Hosp, Dept Pathol, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Changsha 410078, Hunan, Peoples R China; [Liu, Yating; Mao, Chao; Wang, Min; Liu, Na; Ouyang, Lianlian; Liu, Shouping; Tang, Haosheng; Shi, Ying; Tao, Yongguang] Cent South Univ, NHC Key Lab Carcinogenesis, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Liu, Yating; Mao, Chao; Wang, Min; Liu, Na; Ouyang, Lianlian; Liu, Shouping; Tang, Haosheng; Shi, Ying; Tao, Yongguang] Cent South Univ, Sch Basic Med, Changsha 410078, Hunan, Peoples R China; [Liu, Shuang] Cent South Univ, Xiangya Hosp, Inst Med Sci, Dept Oncol, Changsha 410008, Hunan, Peoples R China; [Wang, Xiang; Tao, Yongguang] Cent South Univ, Xiangya Hosp 2, Dept Thorac Surg, Changsha 410011, Hunan, Peoples R China; [Xiao, Desheng] Cent South Univ, Sch Basic Med, Dept Pathol, Changsha 410008, Hunan, Peoples R China; [Xiao, Desheng] Cent South Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Collaborat Innovat Ctr Canc Med, Key Lab Anim Models & Human Dis Mech,Chinese Acad, Kunming 650223, Yunnan, Peoples R China; [Yan, Qin] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Kunming Institute of Zoology; Yale University	Shi, Y; Tao, YG (corresponding author), Cent South Univ, Xiangya Hosp, Dept Pathol, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Changsha 410078, Hunan, Peoples R China.; Shi, Y; Tao, YG (corresponding author), Cent South Univ, NHC Key Lab Carcinogenesis, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.; Shi, Y; Tao, YG (corresponding author), Cent South Univ, Sch Basic Med, Changsha 410078, Hunan, Peoples R China.; Tao, YG (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Thorac Surg, Changsha 410011, Hunan, Peoples R China.; Yan, Q (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA.	yingshi@csu.edu.cn; qin.yan@yale.edu; taoyong@csu.edu.cn	Mao, Chao/AAM-6358-2020	, chao/0000-0002-8685-8539	National Natural Science Foundation of China [81872285, 81728014, 81672787, 81672991, 81874139, 81672308, 81772496]; National Basic Research Program of China [2015CB553903]; Overseas Expertize Introduction Project for Discipline Innovation (111 Project) [111-2-12]; Hunan Provincial Key Area RD Programs [2019SK2253]; Fundamental Research Funds for the Central Universities [1502211723]; Open projects of Key Laboratory of Carcinogenesis and Invasion, Ministry of Education (Central South University) [201805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Overseas Expertize Introduction Project for Discipline Innovation (111 Project); Hunan Provincial Key Area RD Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open projects of Key Laboratory of Carcinogenesis and Invasion, Ministry of Education (Central South University)	This work was supported by the National Natural Science Foundation of China [81872285 (YS), 81728014 (YT), 81672787 (YT), 81672991, and 81874139 (SL), 81672308 (XW), 81772496 (DX)]; the National Basic Research Program of China [2015CB553903 (YT)], the Overseas Expertize Introduction Project for Discipline Innovation (111 Project, No. 111-2-12), Hunan Provincial Key Area R&D Programs [2019SK2253 (XW)], the Fundamental Research Funds for the Central Universities [1502211723 (YL)], and Open projects of Key Laboratory of Carcinogenesis and Invasion, Ministry of Education (Central South University) [201805, (CC and YT)].	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Balgkouranidou I, 2013, BIOMARK MED, V7, P49, DOI [10.2217/BMM.12.111, 10.2217/bmm.12.111]; Bononi A, 2017, CELL DEATH DIFFER, V24, P1694, DOI 10.1038/cdd.2017.95; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen L, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0302-9; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Donald SP, 2001, CANCER RES, V61, P1810; Elia I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15267; Fan T, 2003, CANCER RES, V63, P4677; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gomez-Chou SB, 2017, CANCER RES, V77, P2647, DOI 10.1158/0008-5472.CAN-16-1986; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Han F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13630; He XZ, 2016, CANCER RES, V76, P5743, DOI 10.1158/0008-5472.CAN-16-0268; He YC, 2019, INT J BIOL SCI, V15, P1187, DOI 10.7150/ijbs.33496; He YC, 2017, BBA-REV CANCER, V1868, P359, DOI 10.1016/j.bbcan.2017.07.002; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Jia JT, 2016, ONCOTARGET, V7, P27280, DOI 10.18632/oncotarget.8465; Jiang YQ, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0248-x; Jiang YQ, 2017, THERANOSTICS, V7, P3293, DOI 10.7150/thno.19988; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Jung M, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3241; Jungnickel C, 2017, ONCOGENE, V36, P4182, DOI 10.1038/onc.2017.28; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liu S, 2014, BBA-GENE REGUL MECH, V1839, P592, DOI 10.1016/j.bbagrm.2014.05.017; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17206; Liu W, 2012, BIOFACTORS, V38, P398, DOI 10.1002/biof.1036; Liu W, 2012, AUTOPHAGY, V8, P1407, DOI 10.4161/auto.21152; Liu W, 2012, CANCER RES, V72, P3677, DOI 10.1158/0008-5472.CAN-12-0080; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Mao C, 2018, AM J CANCER RES, V8, P1214; Mao C, 2018, CANCER RES, V78, P3484, DOI 10.1158/0008-5472.CAN-17-3454; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; McDoniels-Silvers AL, 2002, NEOPLASIA, V4, P141, DOI 10.1038/sj.neo.7900217; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Olivares O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16031; Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Phang JM, 2019, ANTIOXID REDOX SIGN, V30, P635, DOI 10.1089/ars.2017.7350; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shi Y, 2012, CARCINOGENESIS, V33, P1468, DOI 10.1093/carcin/bgs171; Shi Y, 2018, CANCER LETT, V422, P81, DOI 10.1016/j.canlet.2018.02.028; Tang HQ, 2016, CELL REP, V17, P2837, DOI 10.1016/j.celrep.2016.11.038; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang DZ, 2017, CANCER RES, V77, P3655, DOI 10.1158/0008-5472.CAN-16-3199; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Xiao DS, 2017, THERANOSTICS, V7, P132, DOI 10.7150/thno.17032; Xiao DS, 2016, ONCOTARGET, V7, P59049, DOI 10.18632/oncotarget.10011; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0542-9; Yan YT, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0466-z; Yang R, 2019, ONCOGENE, V38, P7133, DOI 10.1038/s41388-019-0909-0; Yang R, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1276-y; Yu WS, 2014, GENOME RES, V24, P1613, DOI 10.1101/gr.172015.114; Yu WS, 2014, P NATL ACAD SCI USA, V111, P5890, DOI 10.1073/pnas.1320945111; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang Y, 2011, CELL RES, V21, P373, DOI 10.1038/cr.2011.33; Zhang ZY, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0074-5; Zhu JJ, 2016, P NATL ACAD SCI USA, V113, P9822, DOI 10.1073/pnas.1610387113	78	34	35	8	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2358	2376		10.1038/s41388-019-1151-5	http://dx.doi.org/10.1038/s41388-019-1151-5		JAN 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31911619				2022-12-26	WOS:000508154600001
J	Naik, P; Dave, VP; Joseph, J				Naik, Poonam; Dave, Vivek Pravin; Joseph, Joveeta			Detection of Torque Teno Virus (TTV) and TTV-Like Minivirus in patients with presumed infectious endophthalmitis in India	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN VIROME; DNA VIRUS; ANELLOVIRUSES; CHILDREN; PCR	Human anelloviruses (Torque Teno Virus (TTV) and TTV Like Mini Virus (TLMV)) are now being reported at a high prevalence across the world, with a controversial disease-inducing potential. The aim of this study was to investigate the role of these anellovirus in vitreous of patients with presumed infectious endophthalmitis. After informed consent, vitreous fluid from patients with endophthalmitis (n = 103) and non-infectious pathologies (n = 102) were analyzed for the presence of TTV and TLMV DNA by qPCR with the limit of quantification defined as 100 copies per reaction. Among the patients clinically diagnosed with endophthalmitis, 29 of the 40 culture proven samples (72.5%) and 42 out of 63 (66.6%) of culture-negative samples were positive for presence of TTV/TLMV. Interestingly, 51 of the 102 (50%) samples in the control group were also positive for TTV/TLMV. Comparing the clinical outcome among patients diagnosed with endophthalmitis, we observed no significant association in the final visual acuity of patients who were positive for presence of TTV/TLMV, however, these patients had significantly higher repeat antibiotic injections (p = 0.03). Further evidence is however needed to correlate TTV / TLMV with a particular pathology or group of pathologies in the eye.	[Naik, Poonam; Joseph, Joveeta] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Hyderabad, India; [Naik, Poonam] Manipal Acad Higher Educ, Manipal, India; [Dave, Vivek Pravin] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Hyderabad, India	L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE); L. V. Prasad Eye Institute	Joseph, J (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Hyderabad, India.	joveeta@lvpei.org		NAIK, POONAM/0000-0003-1240-1621	DST-SERB [EMR/2016/002259]	DST-SERB	This work was supported by a grant from the DST-SERB to Dr Joveeta Joseph (File Number: EMR/2016/002259) India.	Ai JW, 2018, EMERG INFECT DIS, V24, P1087, DOI 10.3201/eid2406.171612; Anand AR, 2000, J INFECTION, V41, P221, DOI 10.1053/jinf.2000.0731; Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Bendinelli M, 2001, CLIN MICROBIOL REV, V14, P98, DOI 10.1128/CMR.14.1.98-113.2001; Coburn PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154560; Coburn PS, 2015, INVEST OPHTH VIS SCI, V56, P7303, DOI 10.1167/iovs.15-17488; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Emre S, 2007, CLIN EXP OPHTHALMOL, V35, P759, DOI 10.1111/j.1442-9071.2007.01575.x; Focosi D, 2016, CLIN MICROBIOL INFEC, V22, P589, DOI 10.1016/j.cmi.2016.04.007; Jung J, 2016, ANTIMICROB AGENTS CH, V60, P2012, DOI 10.1128/AAC.02651-15; Kunimoto DY, 1999, AM J OPHTHALMOL, V128, P240, DOI 10.1016/S0002-9394(99)00112-9; Lee AY, 2015, OPHTHALMOLOGY, V122, P524, DOI 10.1016/j.ophtha.2014.09.001; Li LL, 2015, J CLIN VIROL, V72, P106, DOI 10.1016/j.jcv.2015.09.004; Maggi F, 2009, CURR TOP MICROBIOL, V331, P65; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Moen EM, 2002, J VIROL METHODS, V104, P59, DOI 10.1016/S0166-0934(02)00039-3; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Sharma S, 1996, RETINA-J RET VIT DIS, V16, P525, DOI 10.1097/00006982-199616060-00010; Smits SL, 2012, J INFECT DIS, V205, P1877, DOI 10.1093/infdis/jis284; Takahashi K, 2000, ARCH VIROL, V145, P979, DOI 10.1007/s007050050689; TeKippe EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050937; Therese KL, 1998, BRIT J OPHTHALMOL, V82, P1078, DOI 10.1136/bjo.82.9.1078	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227121	10.1371/journal.pone.0227121	http://dx.doi.org/10.1371/journal.pone.0227121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910220	Green Published, gold, Green Submitted			2022-12-26	WOS:000534333800027
J	Shin, E; Park, KA; Oh, SY				Shin, Eunhae; Park, Kyung-Ah; Oh, Sei Yeul			Dome-shaped macula in children and adolescents	PLOS ONE			English	Article							HIGHLY MYOPIC EYES; FEATURES	Purpose We sought to evaluate the incidence and characteristics of dome-shaped macula (DSM) in children and adolescents with myopia. Methods A retrospective review of medical records was performed to identify subjects who were younger than 19 years with myopia of - 3.0 diopters or greater. The results of optical coherence tomography images were analyzed to identify DSM. The height and diameter of the dome were measured. Age, best-corrected visual acuity (BCVA), and refractive error of study participants who exhibited DSM were compared with those of patients who did not. Results Among the 1,042 eyes of 615 patients, eight eyes (0.77%) of seven patients had DSM. Six of these eight eyes were not highly myopic (i.e., less than -6.0 diopters of spherical equivalents). Additionally, the mean height and diameter of the identified domes were 146.50 +/- 42.33 mu m and 4779.75 +/- 699.38 mu m, respectively. Patients with DSM were significantly older (mean age: 15.88 +/- 2.36 years) than patients without it (11.51 +/- 4.60 years; p = 0.007). The youngest affected patient was 11 years old. There was no significant difference in refractive errors (p = 0.629) or BCVA (p = 0.314) between the two groups. Conclusions Although the incidence in this study was very low, DSM was found even in children and adolescents. In addition, 75% of affected individuals were not highly myopic. These results suggest that inherent traits may be involved in development of DSM.	[Shin, Eunhae; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, KA (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	kparkoph@skku.edu		Shin, Eunhae/0000-0002-2889-6860; Park, Kyung-Ah/0000-0001-7907-5635	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT [2019R1F1A1048920]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science and ICT (2019R1F1A1048920). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byeon SH, 2011, AM J OPHTHALMOL, V151, P1101, DOI 10.1016/j.ajo.2011.01.054; Caillaux V, 2013, AM J OPHTHALMOL, V156, P958, DOI 10.1016/j.ajo.2013.06.032; Cebeci Z, 2015, CASE REP OPHTHALMOL, V2015, DOI 10.1155/2015/213968; Coco RM, 2012, OPHTHALMOLOGICA, V228, P7, DOI 10.1159/000336910; Ellabban AA, 2014, AM J OPHTHALMOL, V158, P1062, DOI 10.1016/j.ajo.2014.08.006; Ellabban AA, 2013, AM J OPHTHALMOL, V155, P320, DOI 10.1016/j.ajo.2012.08.007; Errera MH, 2014, GRAEF ARCH CLIN EXP, V252, P499, DOI 10.1007/s00417-013-2561-7; Fang YX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178998; Garcia-Ben A, 2017, GRAEF ARCH CLIN EXP, V255, P903, DOI 10.1007/s00417-017-3587-z; Gaucher D, 2008, AM J OPHTHALMOL, V145, P909, DOI 10.1016/j.ajo.2008.01.012; Imamura Y, 2011, AM J OPHTHALMOL, V151, P297, DOI 10.1016/j.ajo.2010.08.014; Liang IC, 2015, OPHTHALMOLOGY, V122, P1591, DOI 10.1016/j.ophtha.2015.04.012; Lorenzo D, 2017, RETINA-J RET VIT DIS, V37, P680, DOI 10.1097/IAE.0000000000001222; Mehdizadeh M, 2008, AM J OPHTHALMOL, V146, P478, DOI 10.1016/j.ajo.2008.05.045; Ohsugi H, 2014, AM J OPHTHALMOL, V158, P162, DOI 10.1016/j.ajo.2014.02.054; Pilotto E, 2018, RETINA-J RET VIT DIS, V38, P922, DOI 10.1097/IAE.0000000000001621; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Soudier G, 2016, OPHTHALMOLOGICA, V236, P148, DOI 10.1159/000450556; Soudier G, 2016, RETINA-J RET VIT DIS, V36, P944, DOI 10.1097/IAE.0000000000000806; Viola F, 2015, AM J OPHTHALMOL, V159, P44, DOI 10.1016/j.ajo.2014.09.026; Xu X, 2020, RETINA-J RET VIT DIS, V40, P225, DOI 10.1097/IAE.0000000000002395	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227292	10.1371/journal.pone.0227292	http://dx.doi.org/10.1371/journal.pone.0227292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910232	Green Published, gold			2022-12-26	WOS:000534333800038
J	Witulla, B; Goerig, N; Putz, F; Frey, B; Engelhorn, T; Dorfler, A; Uder, M; Fietkau, R; Bert, C; Laun, FB				Witulla, Barbara; Goerig, Nicole; Putz, Florian; Frey, Benjamin; Engelhorn, Tobias; Doerfler, Arnd; Uder, Michael; Fietkau, Rainer; Bert, Christoph; Laun, Frederik Bernd			On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data	PLOS ONE			English	Article							PRIMARY BRAIN-TUMORS; TARGET VOLUME; WALLERIAN DEGENERATION; RADIATION-THERAPY; TRACTOGRAPHY; GROWTH; RECURRENCE; PRINCIPLES; NOISE; MODEL	Radiotherapy (RT) is commonly applied for the treatment of glioblastoma multiforme (GBM). Following the planning target volume (PTV) definition procedure standardized in guidelines, a 20% risk of missing non-local recurrences is present. Purpose of this study was to evaluate whether diffusion tensor imaging (DTI)-based fiber tracking may be beneficial for PTV definition taking into account the prediction of distant recurrences. 56 GBM patients were examined with magnetic resonance imaging (MRI) including DTI performed before RT after resection of the primary tumor. Follow-up MRIs were acquired in three month intervals. For the seven patients with a distant recurrence, fiber tracking was performed with three algorithms and it was evaluated whether connections existed from the primary tumor region to the distant recurrence. It depended strongly on the used tracking algorithm and the used tracking parameters whether a connection was observed. Most of the connections were weak and thus not usable for PTV definition. Only in one of the seven patients with a recurring tumor, a clear connection was present. It seems unlikely that DTI-based fiber tracking can be beneficial for predicting distant recurrences in the planning of PTVs for glioblastoma multiforme.	[Witulla, Barbara; Goerig, Nicole; Putz, Florian; Frey, Benjamin; Fietkau, Rainer; Bert, Christoph] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, Erlangen, Germany; [Engelhorn, Tobias; Doerfler, Arnd] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Neuroradiol, Erlangen, Germany; [Uder, Michael; Laun, Frederik Bernd] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Radiol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Bert, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, Erlangen, Germany.	christoph.bert@uk-erlangen.de	Witulla, Barbara/AAB-5101-2021; Putz, Florian/GLT-8227-2022; Frey, Benjamin/D-9565-2017; Laun, Frederik Bernd/O-4810-2016; Bert, Christoph/C-2585-2013	Putz, Florian/0000-0003-3966-2872; Frey, Benjamin/0000-0001-6743-3351; Laun, Frederik Bernd/0000-0002-9269-5609; Bert, Christoph/0000-0002-8539-6600				Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Adeberg S, 2014, INT J RADIAT ONCOL, V90, P886, DOI 10.1016/j.ijrobp.2014.07.027; Alghamdi M, 2018, J RADIOSURGERY SBRT, V5, P191; Angeli S, 2018, NEUROIMAGE-CLIN, V20, P664, DOI 10.1016/j.nicl.2018.08.032; Azizi AA, 2018, STRAHLENTHER ONKOL, V194, P552, DOI 10.1007/s00066-018-1260-z; Bach M, 2014, MAGN RESON MED, V71, P1108, DOI 10.1002/mrm.24774; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Berberat J, 2014, STRAHLENTHER ONKOL, V190, P939, DOI 10.1007/s00066-014-0676-3; Bondiau PY, 2011, PHYS MEDICA, V27, P103, DOI 10.1016/j.ejmp.2010.05.002; Brainlab, IPLAN FIB TRACK CLIN; Cazzaniga LF, 1998, RADIOTHER ONCOL, V47, P293, DOI 10.1016/S0167-8140(98)00028-0; Chamberland M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00059; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Freitag MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164679; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Hart MG, 2016, BRIT J NEUROSURG, V30, P506, DOI 10.1080/02688697.2016.1208809; Hathout L, 2016, INT J ONCOL, V49, P1081, DOI 10.3892/ijo.2016.3595; Jayachandra MR, 2008, MAGN RESON MED, V60, P1207, DOI 10.1002/mrm.21775; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; Jensen MB, 2017, ACTA ONCOL, V56, P1639, DOI 10.1080/0284186X.2017.1374559; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; Krishnan AP, 2008, INT J RADIAT ONCOL, V71, P1553, DOI 10.1016/j.ijrobp.2008.04.017; Laun FB, 2011, RADIOLOGE, V51, P170, DOI 10.1007/s00117-010-2057-y; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Liu M, 2013, NEUROIMAGE, V74, P128, DOI 10.1016/j.neuroimage.2013.01.069; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2000, ANN NEUROL, V47, P412, DOI 10.1002/1531-8249(200003)47:3<412::AID-ANA28>3.0.CO;2-H; Neher PF, 2017, NEUROIMAGE, V158, P417, DOI 10.1016/j.neuroimage.2017.07.028; Neher PF, 2014, MAGN RESON MED, V72, P1460, DOI 10.1002/mrm.25045; Notohamiprodjo M, 2015, MAGN RESON MED, V73, P1526, DOI 10.1002/mrm.25245; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Reddy CP, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00166; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Robert Koch Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland, 2017, KREBS DEUTSCHL 2013; Smoll NR, 2013, J CLIN NEUROSCI, V20, P670, DOI 10.1016/j.jocn.2012.05.040; Stieltjes B, 2006, NEUROIMAGE, V31, P531, DOI 10.1016/j.neuroimage.2005.12.052; Straube C, 2017, STRAHLENTHER ONKOL, V193, P897, DOI 10.1007/s00066-017-1161-6; Sulman EP, 2017, J CLIN ONCOL, V35, P361, DOI 10.1200/JCO.2016.70.7562; Takemura H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004692; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Unkelbach J, 2014, PHYS MED BIOL, V59, P747, DOI 10.1088/0031-9155/59/3/747; Wang S, 2014, AM J NEURORADIOL, V35, P928, DOI 10.3174/ajnr.A3871; Weinstein D, 1999, VIS 99 P	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227146	10.1371/journal.pone.0227146	http://dx.doi.org/10.1371/journal.pone.0227146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905221	Green Published, gold			2022-12-26	WOS:000534327700018
J	Ni, TT; Fu, Y; Zhou, W; Chen, M; Shao, JW; Zhou, WJ; Mao, EQ; Chen, EZ				Ni, Tongtian; Fu, Yi; Zhou, Wei; Chen, Min; Shao, Jianwei; Zhou, Weijun; Mao, Enqiang; Chen, Erzhen			Carotid plaques and neurological impairment in patients with acute cerebral infarction	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; PROGRESSION; ATHEROSCLEROSIS; ULTRASOUND; GUIDELINES; ARTERY	Objective To determine whether the coexistence of carotid atherosclerosis plaque affects the neurological function of cerebral infarction. Methods A total of 1078 patients with acute cerebral infarction were enrolled, all patients were divided into carotid plaque group (n = 702) and non-carotid plaque group (n = 376). Meanwhile, all patients were divided into mild group (n = 624) and moderate to severe group (n = 454). The difference of the incidence of carotid plaque between the mild and moderate to severe group was analyzed. Results In the 1078 patients with cerebral infarction, the NIHSS score in the carotid plaque group was significantly higher than that in the non-carotid plaque group (P<0.05). The number of mild cases without carotid artery plaque group was larger than that of plaque group (P<0.05), and the number of moderate to severe cases in carotid plaque group was larger than that in non-plaque group (P<0.05). In patients with carotid atherosclerotic plaque, the risk of moderate to severe cerebral infarction was 2.11 times higher than that without carotid artery plaque. Lastly, patients with single plaques were 1.82 times more likely to develop moderate to severe cerebral infarction than those without carotid plaque, while patients with multiple carotid plaques were 2.41 times higher to get moderate or severe cerebral infarction than those without carotid plaque. Conclusions The incidence of carotid atherosclerotic plaques may be related to neurological deficits in patients with acute cerebral infarction.	[Ni, Tongtian; Chen, Min; Shao, Jianwei; Zhou, Weijun; Mao, Enqiang; Chen, Erzhen] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Emergency Med, Shanghai, Peoples R China; [Fu, Yi] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurol, Shanghai, Peoples R China; [Fu, Yi] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Inst Neurol, Shanghai, Peoples R China; [Zhou, Wei] Shanghai Jiao Tong Univ, Dept Ultrasound, Rui Jin Hosp, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, WJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Emergency Med, Shanghai, Peoples R China.	zhouweijun-1972@163.com	Ni, Tongtian/GXA-3621-2022		Shanghai Key Project for Basic Research [S30202]; Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201917]	Shanghai Key Project for Basic Research; Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the Shanghai Key Project for Basic Research (S30202), the Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201917). These two funds provided the testing fees.	Alawneh JA, 2009, STROKE, V40, pE443, DOI 10.1161/STROKEAHA.108.532465; Arnold JAC, 1999, STROKE, V30, P61, DOI 10.1161/01.STR.30.1.61; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott TG, 2011, STROKE, V42, pE420, DOI 10.1161/STR.0b013e3182112d08; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Fisher M, 2005, STROKE, V36, P253, DOI 10.1161/01.STR.0000152336.71224.21; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Gupta A, 2013, STROKE, V44, P3071, DOI 10.1161/STROKEAHA.113.002551; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Ho SSY, 2016, QUANT IMAG MED SURG, V6, P285, DOI 10.21037/qims.2016.05.03; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Huibers A, 2016, EUR J VASC ENDOVASC, V51, P616, DOI 10.1016/j.ejvs.2015.11.013; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Jung KW, 2012, J CLIN NEUROL, V8, P104, DOI 10.3988/jcn.2012.8.2.104; Kakkos SK, 2013, J VASC SURG, V57, P609, DOI 10.1016/j.jvs.2012.09.045; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Li Guang-wen, 2010, Chinese Medical Sciences Journal, V25, P32; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lorenz MW, 2015, DIABETES CARE, V38, P1921, DOI 10.2337/dc14-2732; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mughal MM, 2011, EXPERT REV CARDIOVAS, V9, P1315, DOI [10.1586/erc.11.120, 10.1586/ERC.11.120]; Nagai Y, 2002, ULTRASOUND MED BIOL, V28, P1231, DOI 10.1016/S0301-5629(02)00578-1; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Ouhlous M, 2005, AM J NEURORADIOL, V26, P1044; Parodi JC, 2005, J VASC SURG, V41, P416, DOI 10.1016/j.jvs.2005.01.003; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Plichart M, 2011, ATHEROSCLEROSIS, V219, P917, DOI 10.1016/j.atherosclerosis.2011.09.024; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Sabetai MM, 2000, STROKE, V31, P2189, DOI 10.1161/01.STR.31.9.2189; Spence JD, 2002, STROKE, V33, P2916, DOI 10.1161/01.STR.0000042207.16156.B9; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tong JJ, 2012, AM J EMERG MED, V30, P1313, DOI 10.1016/j.ajem.2012.05.012; Touze E, 2009, STROKE, V40, pE683, DOI 10.1161/STROKEAHA.109.562041; Usman A, 2015, J ATHEROSCLER THROMB, V22, P739, DOI 10.5551/jat.30460; Wang BJ, 2013, EXP THER MED, V6, P407, DOI 10.3892/etm.2013.1129; Wannarong T, 2013, STROKE, V44, P1859, DOI 10.1161/STROKEAHA.113.001461; Winship IR, 2015, MICROCIRCULATION, V22, P228, DOI 10.1111/micc.12177	48	7	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226961	10.1371/journal.pone.0226961	http://dx.doi.org/10.1371/journal.pone.0226961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899784	Green Published, gold			2022-12-26	WOS:000534322000007
J	da Cunha, JA; Rolim, PM; da Silva, KSF; Damasceno, C; Sousa, FC; Nabas, RC; Seabra, LMJ				da Cunha, Josiane Araujo; Rolim, Priscilla Moura; Florentino da Silva, Karla Suzanne; Damasceno, Chaves; de Sousa Junior, Francisco Caninde; Nabas, Roseane Claro; Juca Seabra, Larissa Mont'Alverne			From seed to flour: Sowing sustainability in the use of cantaloupe melon residue (Cucumis melo L. var. reticulatus)	PLOS ONE			English	Article							NUTRITIONAL COMPOSITION; CHEMICAL-COMPOSITION; BIOACTIVE COMPOUNDS; CUCURBITA-MAXIMA; FOOD; VEGETABLES; PULP	Reduction of waste from food industry and food services is a current concern due to the large amount of waste generated, including peels and fruit seeds. The objective of this study was to obtain a flour produced from Cantaloupe melon seeds (Cucumis melo L. var. reticulatus) and to evaluate the viability of using the product as an ingredient in cake manufacturing. In this study, different formulations were developed: standard cake-0% (F1) and cakes containing melon seed flour as substitute of wheat flour in 10% (F2), 30% (F3), and 50% (F4) concentrations. Centesimal composition, dietary fibre, structural and morphological characterization, determination of mineral composition, and evaluation of fatty acids profile in melon seed flour were carried out. To determine the overall acceptance of cake formulations, sensory analysis was performed with 135 non-trained panelists, which also included the identification of sensorial attributes using the Just About Right ideal scale test. The results showed that the melon seed flour has considerable nutritional value, with 18% proteins, 3% moisture, 4% ash, 30% lipids, and 35% dietary fibre. Melon flour also has a significantly high content of minerals, mainly phosphorus (1507.62 mg/100 g), potassium (957.35 mg/100 g), and magnesium (504.03 mg/100 g). The polyunsaturated fatty acid fraction was the most abundant in melon seed flour, with predominance of omega-6 fatty acids (17.95 g/mg of sample). Sensorial analysis disclosed good acceptance for formulations containing 10% and 30% of melon seed flour, with the 10% formulation being the most accepted. The research showed the feasibility of using the melon seed flour in cake production, as well as the possibility of using food waste in restaurants and food industries in order to adhere to sustainable production actions.	[da Cunha, Josiane Araujo; Florentino da Silva, Karla Suzanne; Damasceno, Chaves; de Sousa Junior, Francisco Caninde; Juca Seabra, Larissa Mont'Alverne] Univ Fed Rio Grande do Norte, Postgrad Program Nutr, Natal, RN, Brazil; [Rolim, Priscilla Moura; Nabas, Roseane Claro] Univ Fed Rio Grande do Norte, Nutr Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Seabra, LMJ (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Nutr, Natal, RN, Brazil.	larissaseabra@yahoo.com.br	Seabra, Larissa/AAS-9907-2020; ROLIM, PRISCILLA/AAP-2817-2021	Seabra, Larissa/0000-0002-1878-4283; Florentino da Silva Chaves Damasceno, Karla Suzanne/0000-0001-6884-1023; MOURA ROLIM, PRISCILLA/0000-0002-3847-5744	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil - CAPES [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil - CAPES	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil - CAPES -Financial Code 001. The research had a collaboration of Fundacao de Apoio a Pesquisa do Rio Grande do Norte FAPERN.	Abelama V. D., 2017, Contextos da Alimentacao, V5, P71; Abiad MG, 2018, FOOD SECUR, V10, P311, DOI 10.1007/s12571-018-0782-7; [Anonymous], 2014, OFFICIAL METHODS REC; [Anonymous], 2016, MED J CHEM, DOI DOI 10.13171/mjc.5.1/0160130/kajima; AOAC Research Institute International, 2005, RAP TEST KITS PERF T; Araujo KTA, 2017, REV BRASILEIRA AGROT, V7, P110; Association of Official Analytical Chemistry (AOAC) Official Methods of Analysis of Association of Official Analytical Chemistry Internacional, 2002, OFF METH AN ASS OFF, P173; Azhari S, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.074913; Bender Ana Betine Beutinger, 2016, Braz. J. Food Technol., V19, pe2016010, DOI 10.1590/1981-6723.1016; Brasil. Ministerio da Saude. Agencia Nacional de Vigilancia Sanitaria-ANVISA, 2005, MET FIS QUIM AN AL; Cardoso F.T, 2015, SUSTENTABILIDADE DEB, V6, P131; Conrad Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195405; Gorgonio CMD, 2011, CIENCIA TECNOL ALIME, V31, P109, DOI 10.1590/S0101-20612011000100015; de Oliveira JG, 2010, REV BRAS FRUTIC, V32, P961, DOI 10.1590/S0100-29452011005000003; Dietary Reference Intakes for Energy Carbohydrate, 2002, J ACAD NUTR DIET, V102, P1621; Dutcosky S.D., 2013, ANALISE SENSORIAL AL; Ebert AW, 2014, SUSTAINABILITY-BASEL, V6, P319, DOI 10.3390/su6010319; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA), 2008, CULT MEL; Food and Drug Administration (FDA), 1992, BACTERIOLOGICAL ANAL, V7; Franklin T.A., 2016, REV SAUDE, V12, P482; Fundo JF, 2018, J FOOD MEAS CHARACT, V12, P292, DOI 10.1007/s11694-017-9640-0; Guimaraes RR, 2010, CIENCIA TECNOL ALIME, V30, P354, DOI 10.1590/S0101-20612010000200011; Gupta, 2015, J PHARM PHYTOCHEM, V3, P98; Hampson CR, 2014, POSTHARVEST BIOL TEC, V91, P104, DOI 10.1016/j.postharvbio.2013.12.022; Hartman L., 1973, Laboratory Practice, V22 [7] 475-476, P494; Jaeger SR, 2015, FOOD QUAL PREFER, V44, P70, DOI 10.1016/j.foodqual.2015.04.001; Lago AMT, 2017, J FOOD SCI, V82, P492, DOI 10.1111/1750-3841.13586; Mallek-Ayadi S, 2019, J SCI FOOD AGR, V99, P1294, DOI 10.1002/jsfa.9304; Mallek-Ayadi S, 2018, PROCESS SAF ENVIRON, V113, P68, DOI 10.1016/j.psep.2017.09.016; Miguel ACA, 2008, FOOD SCI TECHNOL, V3; Morais DR, 2017, J BRAZIL CHEM SOC, V28, P308, DOI 10.5935/0103-5053.20160178; Nucleo de Estudos e Pesquisas em Alimentacao Universidade Estadual de Campinas, 2011, TAB BRAS COMP AL; Oliveira DM, 2013, ACTA SCI-TECHNOL, V35, P427, DOI 10.4025/actascitechnol.v35i3.13176; Olubunmi I. P., 2019, INT J BIOCH REREV, P1; Oluwabamiwo F, 2015, LIFE SCI ARCH LSA, V1, P59; Oomah BD, 2000, FOOD CHEM, V69, P187, DOI 10.1016/S0308-8146(99)00260-5; Padilha VM, 2010, CIENCIA TECNOL ALIME, V30, P735, DOI 10.1590/S0101-20612010000300026; Petkova Zhana, 2015, Cogent Food & Agriculture, V1, DOI 10.1080/23311932.2015.1018779; Pumar M, 2008, CIENCIA TECNOL ALIME, V28, P7, DOI 10.1590/S0101-20612008000500002; Ramírez Pimentel Juan Gabriel, 2016, Rev. Mex. Cienc. Agríc, V7, P1667; Malacrida CR, 2007, REV CIENC AGRON, V38, P372; Rolim PM, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176069, 10.1590/1414-431x20176069]; Rolim PM, 2020, FOOD REV INT, V36, P15, DOI 10.1080/87559129.2019.1613662; Rolim PM, 2018, J FOOD NUTR RES-SLOV, V57, P315; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Schanes K, 2018, J CLEAN PROD, V182, P978, DOI 10.1016/j.jclepro.2018.02.030; Silva J. B., 2010, REV BRASILEIRA TECNO, V4, P58; Silva M.A, 2018, TRENDS FOOD SCI TECH, V81, P61; Silva N., 2010, MANUAL METODOS ANALI; Singh J, 2017, FOOD CHEM, V221, P1778, DOI 10.1016/j.foodchem.2016.10.104; Sociedade Brasileira de Cardiologia, 2017, REV SOC BRAS CARD S1, V109; Spada FP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197654; Storck CR, 2013, CIENC RURAL, V43, P537, DOI 10.1590/S0103-84782013000300027; Strasburg VJ, 2017, ENG SANIT AMBIENT, V22, P3, DOI [10.1590/s1413-41522017155538, 10.1590/S1413-41522017155538]; Umar K J, 2013, Pak J Biol Sci, V16, P536, DOI 10.3923/pjbs.2013.536.540; USEPA, 2000, IND COUPL PLASM AT E; Valcarcel-Yamani B., 2012, Food and Public Health, V2, P265; Vieira R. F. F. A., 2017, CONEXAO CIENCIA, V12, P22, DOI [10.24862/cco.v12i2.611, DOI 10.24862/CCO.V12I2.611]; Ye JP, 2018, FOOD RES INT, V106, P404, DOI 10.1016/j.foodres.2018.01.008	59	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0219229	10.1371/journal.pone.0219229	http://dx.doi.org/10.1371/journal.pone.0219229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895921	gold, Green Submitted, Green Published			2022-12-26	WOS:000534267300001
J	Ponzi, E; Vineis, P; Chung, KF; Blangiardo, M				Ponzi, Erica; Vineis, Paolo; Chung, Kian Fan; Blangiardo, Marta			Accounting for measurement error to assess the effect of air pollution on omic signals	PLOS ONE			English	Article							ENVIRONMENTAL EPIDEMIOLOGY; MODELS; MORTALITY; DISEASE	Studies on the effects of air pollution and more generally environmental exposures on health require measurements of pollutants, which are affected by measurement error. This is a cause of bias in the estimation of parameters relevant to the study and can lead to inaccurate conclusions when evaluating associations among pollutants, disease risk and biomarkers. Although the presence of measurement error in such studies has been recognized as a potential problem, it is rarely considered in applications and practical solutions are still lacking. In this work, we formulate Bayesian measurement error models and apply them to study the link between air pollution and omic signals. The data we use stem from the "Oxford Street II Study", a randomized crossover trial in which 60 volunteers walked for two hours in a traffic-free area (Hyde Park) and in a busy shopping street (Oxford Street) of London. Metabolomic measurements were made in each individual as well as air pollution measurements, in order to investigate the association between short-term exposure to traffic related air pollution and perturbation of metabolic pathways. We implemented error-corrected models in a classical framework and used the flexibility of Bayesian hierarchical models to account for dependencies among omic signals, as well as among different pollutants. Models were implemented using traditional Markov Chain Monte Carlo (MCMC) simulative methods as well as integrated Laplace approximation. The inclusion of a classical measurement error term resulted in variable estimates of the association between omic signals and traffic related air pollution measurements, where the direction of the bias was not predictable a priori. The models were successful in including and accounting for different correlation structures, both among omic signals and among different pollutant exposures. In general, more associations were identified when the correlation among omics and among pollutants were modeled, and their number increased when a measurement error term was additionally included in the multivariate models (particularly for the associations between metabolomics and NO2).	[Ponzi, Erica] Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Hirschengraben 84, CH-8001 Zurich, Switzerland; [Ponzi, Erica] Univ Oslo, Oslo Ctr Epidemiol & Biostat, Dept Biostat, Oslo, Norway; [Ponzi, Erica; Vineis, Paolo; Blangiardo, Marta] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Vineis, Paolo] IIGM, Turin, Italy; [Chung, Kian Fan] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, London, England	University of Zurich; University of Oslo; Imperial College London; Italian Institute for Genomic Medicine (IIGM); Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Ponzi, E (corresponding author), Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Hirschengraben 84, CH-8001 Zurich, Switzerland.; Ponzi, E (corresponding author), Univ Oslo, Oslo Ctr Epidemiol & Biostat, Dept Biostat, Oslo, Norway.; Ponzi, E (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	erica.ponzi@uzh.ch		Ponzi, Erica/0000-0002-6089-3512	European Commission [308610]; Swiss National Science Foundation (SNSF grant) [P1ZHP2_178207]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation (SNSF grant)(Swiss National Science Foundation (SNSF))	This work was supported by the grant FP7 of the European Commission 'Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe' (EXPOsOMICS grant 308610 to PV). Erica Ponzi was funded by a Doc.Mobility grant from the Swiss National Science Foundation (SNSF grant P1ZHP2_178207).	Alexeeff SE, 2016, BIOSTATISTICS, V17, P377, DOI 10.1093/biostatistics/kxv048; Baker D., 2008, ENV EPIDEMIOLOGY STU; Baxter LK, 2010, J EXPO SCI ENV EPID, V20, P101, DOI 10.1038/jes.2009.5; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Brakenhoff TB, 2018, J CLIN EPIDEMIOL, V98, P89, DOI 10.1016/j.jclinepi.2018.02.023; Carroll RJ, 2006, MEASUREMENT ERROR NO; Clayton D., 1992, GEOGRAPHICAL ENV EPI; Coker E, 2016, ENVIRON INT, V91, P1, DOI 10.1016/j.envint.2016.02.011; Edwards Jessie K, 2017, Curr Environ Health Rep, V4, P79, DOI 10.1007/s40572-017-0125-4; Goldman GT, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-61; Gryparis A, 2007, J EXPO SCI ENV EPID, V17, pS20, DOI 10.1038/sj.jes.7500624; Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033; Gustafson P, 2005, STAT SCI, V20, P111, DOI 10.1214/088342305000000098; Huang GW, 2018, STAT MED, V37, P1134, DOI 10.1002/sim.7570; Mallick B, 2002, BIOMETRICS, V58, P13, DOI 10.1111/j.0006-341X.2002.00013.x; Muff S, 2017, COMPUT STAT DATA AN, V113, P177, DOI 10.1016/j.csda.2017.03.001; Muff S, 2015, J R STAT SOC C-APPL, V64, P231, DOI 10.1111/rssc.12069; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Pekkanen J, 2001, ENVIRON HEALTH PERSP, V109, P1, DOI 10.2307/3434913; Rhomberg LR, 2011, CRIT REV TOXICOL, V41, P651, DOI 10.3109/10408444.2011.563420; RICHARDSON S, 1993, STAT MED, V12, P1703, DOI 10.1002/sim.4780121806; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Shaw PA, 2018, ANN EPIDEMIOL, V28, P821, DOI 10.1016/j.annepidem.2018.09.001; Sinharay R, 2018, LANCET, V391, P339, DOI 10.1016/S0140-6736(17)32643-0; Stephens DA, 1992, BAYESIAN STAT 4; Van Roosbroeck S, 2006, EPIDEMIOLOGY, V368, P174; van Veldhoven K, 2019, ENVIRON INT, V123, P124, DOI 10.1016/j.envint.2018.11.034; Ventrucci M, 2011, BIOSTATISTICS, V12, P51, DOI 10.1093/biostatistics/kxq040; Vineis P, 2017, INT J HYG ENVIR HEAL, V220, P142, DOI 10.1016/j.ijheh.2016.08.001; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226102	10.1371/journal.pone.0226102	http://dx.doi.org/10.1371/journal.pone.0226102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31896134	Green Published, Green Submitted, gold			2022-12-26	WOS:000534267300003
J	Hollenhorst, MI; Jurastow, I; Nandigama, R; Appenzeller, S; Li, L; Vogel, J; Wiederhold, S; Althaus, M; Empting, M; Altmuller, J; Hirsch, AKH; Flockerzi, V; Canning, BJ; Saliba, AE; Krasteva-Christ, G				Hollenhorst, Monika I.; Jurastow, Innokentij; Nandigama, Rajender; Appenzeller, Silke; Li, Lei; Vogel, Joerg; Wiederhold, Stephanie; Althaus, Mike; Empting, Martin; Altmueller, Janine; Hirsch, Anna K. H.; Flockerzi, Veit; Canning, Brendan J.; Saliba, Antoine-Emmanuel; Krasteva-Christ, Gabriela			Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signaling	FASEB JOURNAL			English	Article						acetylcholine; brush cells; mucociliary clearance; single-cell RNA-seq; taste	CHOLINERGIC CHEMOSENSORY CELLS; TUFT CELLS; TASTE; RECEPTORS; MECHANISM; TRIGGERS; IMMUNITY; CILIA; MICE	For protection from inhaled pathogens many strategies have evolved in the airways such as mucociliary clearance and cough. We have previously shown that protective respiratory reflexes to locally released bacterial bitter "taste" substances are most probably initiated by tracheal brush cells (BC). Our single-cell RNA-seq analysis of murine BC revealed high expression levels of cholinergic and bitter taste signaling transcripts (Tas2r108, Gnat3, Trpm5). We directly demonstrate the secretion of acetylcholine (ACh) from BC upon stimulation with the Tas2R agonist denatonium. Inhibition of the taste transduction cascade abolished the increase in [Ca2+](i) in BC and subsequent ACh-release. ACh-release is regulated in an autocrine manner. While the muscarinic ACh-receptors M3R and M1R are activating, M2R is inhibitory. Paracrine effects of ACh released in response to denatonium included increased [Ca2+](i) in ciliated cells. Stimulation by denatonium or with Pseudomonas quinolone signaling molecules led to an increase in mucociliary clearance in explanted tracheae that was Trpm5- and M3R-mediated. We show that ACh-release from BC via the bitter taste cascade leads to immediate paracrine protective responses that can be boosted in an autocrine manner. This mechanism represents the initial step for the activation of innate immune responses against pathogens in the airways.	[Hollenhorst, Monika I.; Krasteva-Christ, Gabriela] Saarland Univ, Inst Anat & Cell Biol, Homburg, Germany; [Jurastow, Innokentij; Wiederhold, Stephanie] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Jurastow, Innokentij] Humboldt Univ, Univ Hosp Charite, Dept Anesthesiol & Intens Care Med CS, Berlin, Germany; [Nandigama, Rajender] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany; [Appenzeller, Silke] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Li, Lei] Univ Wurzburg, Core Unit SysMed, Wurzburg, Germany; [Vogel, Joerg; Saliba, Antoine-Emmanuel] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany; [Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Empting, Martin; Hirsch, Anna K. H.] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat DDOP, Saarbrucken, Germany; [Empting, Martin; Hirsch, Anna K. H.] Saarland Univ, Dept Pharm, Saarbrucken, Germany; [Empting, Martin; Hirsch, Anna K. H.] German Ctr Infect Res DZIF, Saarbrucken, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Flockerzi, Veit] Saarland Univ, Inst Expt & Clin Pharmacol & Toxicol PZMS, Homburg, Germany; [Canning, Brendan J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA	Universitatsklinikum des Saarlandes; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Newcastle University - UK; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; German Center for Infection Research; University of Cologne; Universitatsklinikum des Saarlandes; Johns Hopkins University	Krasteva-Christ, G (corresponding author), Saarland Univ, Inst Anat & Cell Biol, UKS, Gebaude 61, D-66421 Homburg, Germany.	Gabriela.Krasteva-Christ@uks.eu	Canning, Brendan/ABE-5261-2020; Vogel, Jörg/D-5574-2011; Canning, Brendan/AAM-9404-2021; Krasteva-Christ, Gabriela/CAI-9036-2022; Saliba, Antoine-Emmanuel/AAC-1252-2022	Vogel, Jörg/0000-0003-2220-1404; Canning, Brendan/0000-0003-4197-5560; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Jurastow, Innokentij/0000-0002-5946-3363; Althaus, Mike/0000-0002-3554-7538; Empting, Martin/0000-0002-0503-5830; Altmuller, Janine/0000-0003-4372-1521; Nandigama, Rajender/0000-0002-7344-4732; Appenzeller, Silke/0000-0002-5472-8692	German Research Society [DFG SFB TRR 152]; Helmholtz Association's Initiative and Networking Fund	German Research Society(German Research Foundation (DFG)); Helmholtz Association's Initiative and Networking Fund	German Research Society, Grant/Award Number: DFG SFB TRR 152; Helmholtz Association's Initiative and Networking Fund	Allegretta G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00924; Bakshani CR, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-018-0057-2; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Carey RM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092017; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Dando R, 2012, J PHYSIOL-LONDON, V590, P3009, DOI 10.1113/jphysiol.2012.232009; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Droguett K, 2017, J PHYSIOL-LONDON, V595, P4755, DOI 10.1113/JP273996; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger TE, 2011, F1000 BIOL REP, V3, P1; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; FRYER AD, 1993, LIFE SCI, V52, P529, DOI 10.1016/0024-3205(93)90311-P; Fu ZY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00071; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Hecker A, 2015, J IMMUNOL, V195, P2325, DOI 10.4049/jimmunol.1400974; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Konig P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004938; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liu SY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00739; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; LUCIANO L, 1968, Z ZELLFORSCH MIK ANA, V85, P350, DOI 10.1007/BF00328847; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Ogura T, 2011, J NEUROPHYSIOL, V106, P1274, DOI 10.1152/jn.00186.2011; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Richter K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28660; Richter K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01604; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Runer T, 1998, OTOLARYNG HEAD NECK, V119, P278, DOI 10.1016/S0194-5998(98)70063-4; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schmid A, 2011, BIOL CELL, V103, P159, DOI 10.1042/BC20100120; Schutz B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00087; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yamashita J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189340; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003	52	24	24	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					316	332		10.1096/fj.201901314RR	http://dx.doi.org/10.1096/fj.201901314RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914675	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000507308900023
J	Li, SP; Wen, HS; Du, SJ				Li, Siping; Wen, Haishen; Du, Shaojun			Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants	FASEB JOURNAL			English	Article						knockout; sarcomere; slow fibers; smyhc1; zebrafish	MESSENGER-RNA DECAY; SHELDON-SYNDROME; MYOSIN ISOFORMS; FIBER TYPES; IN-VIVO; SKELETAL; ZEBRAFISH; EXPRESSION; MUTATION; HEDGEHOG	Zebrafish skeletal muscles are broadly divided into slow-twitch and fast-twitch muscle fibers. The slow fibers, which express a slow fiber-specific myosin heavy chain 1 (Smyhc1), are the first group of muscle fibers formed during myogenesis. To uncover Smyhc1 function in muscle growth, we generated three mutant alleles with reading frame shift mutations in the zebrafish smyhc1 gene using CRISPR. The mutants showed shortened sarcomeres with no thick filaments and M-lines in slow fibers of the mutant embryos. However, the formation of slow muscle precursors and expression of other slow muscle genes were not affected and fast muscles appeared normal. The smyhc1 mutant embryos and larvae showed reduced locomotion and food intake. The mutant larvae exhibited increased lethality of incomplete penetrance. Approximately 2/5 of the homozygous mutants were viable and grew into reproductive adults. These adult mutants displayed a typical pattern of slow and fast muscle fiber distribution, and regained normal slow muscle formation. Together, our studies indicate that Smyhc1 is essential for myogenesis in embryonic slow muscles, and loss of Smyhc1 results in defective sarcomere assembly, reduces larval motility and fish survival, but has no visible impact on muscle growth in juvenile and adult zebrafish that escape the larval lethality.	[Li, Siping; Du, Shaojun] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, 701 East Pratt St, Baltimore, MD 21202 USA; [Li, Siping; Wen, Haishen] Ocean Univ China, Fishery Coll, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Ocean University of China	Du, SJ (corresponding author), Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, 701 East Pratt St, Baltimore, MD 21202 USA.	sdu@som.umaryland.edu			National Institutes of Health [R01AR072703]; China Scholarship Council; National Institutes of Health SIG [1S10RR26870-1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institutes of Health SIG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01AR072703; China Scholarship Council; National Institutes of Health SIG, Grant/Award Number: 1S10RR26870-1	AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Ali AM, 2017, CASE REPORTS GENETIC, V2017, P1; Allen DL, 2000, MICROSC RES TECHNIQ, V50, P492, DOI 10.1002/1097-0029(20000915)50:6<492::AID-JEMT6>3.3.CO;2-A; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Berger J, 2017, HUM MOL GENET, V26, P1146, DOI 10.1093/hmg/ddx025; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Cai MX, 2018, MAR BIOTECHNOL, V20, P168, DOI 10.1007/s10126-018-9794-8; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Ehler E, 1999, J CELL SCI, V112, P1529; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fenix AM, 2018, ELIFE, V7, DOI 10.7554/eLife.42144; Gautel M, 2016, J EXP BIOL, V219, P135, DOI 10.1242/jeb.124941; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Gurung R, 2017, GENETICS, V205, P725, DOI 10.1534/genetics.116.192864; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Holtzer H, 1997, CELL STRUCT FUNCT, V22, P83, DOI 10.1247/csf.22.83; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Lamont PJ, 2014, HUM MUTAT, V35, P868, DOI 10.1002/humu.22553; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McGuigan K, 2004, MOL BIOL EVOL, V21, P1042, DOI 10.1093/molbev/msh103; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nord H, 2014, MOL BIOL CELL, V25, P1384, DOI 10.1091/mbc.E13-08-0486; Ortolano S, 2011, NEUROMUSCULAR DISORD, V21, P254, DOI 10.1016/j.nmd.2010.12.011; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Racca AW, 2015, HUM MOL GENET, V24, P3348, DOI 10.1093/hmg/ddv084; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; RHEE D, 1994, CELL MOTIL CYTOSKEL, V28, P1, DOI 10.1002/cm.970280102; Ruggiero L, 2015, BIOCHEM BIOPH RES CO, V457, P262, DOI 10.1016/j.bbrc.2014.12.098; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Rutland CS, 2011, DEVELOPMENT, V138, P3955, DOI 10.1242/dev.059063; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Schiaffino S, 2015, SKELET MUSCLE, V15, P5; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sharma A, 2019, BIORXIV261685; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T; Tajsharghi H, 2014, EUR J HUM GENET, V22, P801, DOI 10.1038/ejhg.2013.250; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Toydemir RM, 2006, AM J MED GENET A, V140A, P2387, DOI 10.1002/ajmg.a.31495; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Velten BP, 2014, AM J PHYSIOL-REG I, V306, pR845, DOI 10.1152/ajpregu.00041.2014; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; Walsh R, 2010, CARDIOLOGY, V115, P49, DOI 10.1159/000252808; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Xu J, 2012, J GENET GENOMICS, V39, P69, DOI 10.1016/j.jgg.2012.01.005	62	5	5	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1378	1397		10.1096/fj.201900935RR	http://dx.doi.org/10.1096/fj.201900935RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914689	Green Accepted			2022-12-26	WOS:000507308900092
J	Matsuhisa, K; Saito, A; Cai, LJ; Kaneko, M; Okamoto, T; Sakaue, F; Asada, R; Urano, F; Yanagida, K; Okochi, M; Kudo, Y; Matsumoto, M; Nakayama, KI; Imaizumi, K				Matsuhisa, Koji; Saito, Atsushi; Cai, Longjie; Kaneko, Masayuki; Okamoto, Takumi; Sakaue, Fumika; Asada, Rie; Urano, Fumihiko; Yanagida, Kanta; Okochi, Masayasu; Kudo, Yukitsuka; Matsumoto, Masaki; Nakayama, Keiichi I.; Imaizumi, Kazunori			Production of BBF2H7-derived small peptide fragments via endoplasmic reticulum stress-dependent regulated intramembrane proteolysis	FASEB JOURNAL			English	Article						endoplasmic reticulum stress; regulated intramembrane proteolysis; site-2 protease; transmembrane transcription factor	ALZHEIMERS GAMMA-SECRETASE; BZIP TRANSCRIPTION FACTOR; ER STRESS; SITE-1 PROTEASE; LUMINAL DOMAIN; CLEAVAGE; PROTEINS; SUBSTRATE; MECHANISM; PATHWAY	Intramembrane cleavage of transmembrane proteins is a fundamental cellular process to produce important signals that elicit biological responses. These proteolytic events are known as regulated intramembrane proteolysis (RIP). ATF6 and BBF2H7 are transmembrane basic leucine zipper transcription factors and are subjected to RIP by site-1 protease (S1P) and site-2 protease (S2P) sequentially in response to endoplasmic reticulum (ER) stress. However, the detailed mechanisms responsible for RIP of the transcription factors, including the precise cutting sites, are still unknown. In this study, we demonstrated that S1P cleaves BBF2H7 just before the RXXL S1P recognition motif. Conversely, S2P cut at least three different sites in the membrane (next to Leu380, Met381, and Leu385), indicating that S2P cleaves the substrates at variable sites or via a multistep process. Interestingly, we found BBF2H7-derived small peptide (BSP) fragments located between the S1P and S2P cleavage sites in cells exposed to ER stress. Major type of BSP fragments was composed of 45 amino acid including partial transmembrane and luminal regions and easily aggregates like amyloid beta (A beta) protein. These results advance the understanding of poorly characterized ER stress-dependent RIP. Furthermore, the aggregable peptides produced by ER stress could link to the pathophysiology of neurodegenerative disorders.	[Matsuhisa, Koji; Saito, Atsushi; Cai, Longjie; Kaneko, Masayuki; Okamoto, Takumi; Sakaue, Fumika; Asada, Rie; Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Matsuhisa, Koji; Saito, Atsushi; Sakaue, Fumika] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Stress Prot Proc, Hiroshima, Japan; [Asada, Rie; Urano, Fumihiko] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Yanagida, Kanta; Okochi, Masayasu] Osaka Univ, Grad Sch Med, Dept Integrated Med, Neuropsychiat,Div Internal Med, Osaka, Japan; [Kudo, Yukitsuka] Tohoku Univ, Inst Dev Aging & Canc, Dept Gerontol & Geriatr, Sendai, Miyagi, Japan; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka, Fukuoka, Japan	Hiroshima University; Hiroshima University; Washington University (WUSTL); Osaka University; Tohoku University; Kyushu University	Imaizumi, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	imaizumi@hiroshima-u.ac.jp	Kaneko, Masayuki/F-9302-2011; Urano, Fumihiko/AAF-4492-2020	Kaneko, Masayuki/0000-0002-0477-0171; Kitamura, Rie/0000-0001-8347-6909; Matsuhisa, Koji/0000-0003-0707-9025; Matsumoto, Masaki/0000-0002-6987-0288; Sakaue, Fumika/0000-0003-1364-8730	Japan Society for the Promotion of Science KAKENHI [JP16K18395, JP17H01424, JP17H06416]; Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP16K18395, JP17H01424 and JP17H06416; Japan Intractable Diseases Research Foundation; The Uehara Memorial Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cathcart JM, 2015, FRONT BIOSCI-LANDMRK, V20, P1164, DOI 10.2741/4365; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Close W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03164-5; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Gerakis Y, 2018, FEBS J, V285, P995, DOI 10.1111/febs.14332; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hale JE, 1996, AMINO ACIDS, V10, P243, DOI 10.1007/BF00807326; Hanna A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0509-3; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Iwamoto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125982; Kanemoto S, 2015, J CELL SCI, V128, P4353, DOI 10.1242/jcs.176057; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Koide K, 2008, J BIOL CHEM, V283, P9562, DOI 10.1074/jbc.M709984200; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Makioka K, 2010, J NEUROL SCI, V297, P60, DOI 10.1016/j.jns.2010.06.019; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Mercado G, 2016, BRAIN RES, V1648, P626, DOI 10.1016/j.brainres.2016.04.042; Morishima-Kawashima M, 2014, FRONT PHYSIOL, P5; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Peer E, 2019, CANCERS, V11, DOI 10.3390/cancers11040538; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2013, BBA-BIOMEMBRANES, V1828, P2801, DOI 10.1016/j.bbamem.2013.03.031; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	53	2	2	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					865	880		10.1096/fj.201901748R	http://dx.doi.org/10.1096/fj.201901748R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914686	hybrid			2022-12-26	WOS:000507308900059
J	Okuyama, Y; Nagashima, H; Ushio-Fukai, M; Croft, M; Ishii, N; So, T				Okuyama, Yuko; Nagashima, Hiroyuki; Ushio-Fukai, Masuko; Croft, Michael; Ishii, Naoto; So, Takanori			IQGAP1 restrains T-cell cosignaling mediated by OX40	FASEB JOURNAL			English	Article						autoimmunity; CD4(+) T cells; cosignaling; T-cell inflammation; TNFRSF	LIGAND INTERACTION; COSTIMULATORY MOLECULE; PROTEINS; CDC42; AMELIORATION; GENERATION; BLOCKADE; IMMUNITY; BIOLOGY; MEMBERS	A costimulatory signal from the tumor necrosis factor receptor (TNFR) family molecule OX40 (CD134), which is induced on activated T cells, is important for T-cell immunity. Aberrant OX40 cosignaling has been implicated in autoimmune and inflammatory disorders. However, the molecular mechanism by which the OX40 cosignaling regulates the T-cell response remains obscure. We found that OX40 associated with a scaffold protein, IQ motif-containing GTPase-activating protein 1 (IQGAP1) after ligation by its ligand OX40L. Naive CD4(+) T cells from Iqgap1(-/-) mice displayed enhanced proliferation and cytokine secretion upon receiving OX40 cosignaling. A C-terminal IQGAP1 region was responsible for its association with OX40, and TNFR-associated factor 2 (TRAF2) bridged these two proteins. The enhanced cytokine response in Iqgap1(-/-) T cells was restored by the expression of the C-terminal IQGAP1. Thus, the IQGAP1 binding limits the OX40 cosignaling. Disease severity of experimental autoimmune encephalomyelitis (EAE) was significantly exacerbated in Iqgap1(-/-) mice as compared to wild-type mice. Additionally, recipient mice with Iqgap1(-/-) donor CD4(+) T cells exhibited significantly higher EAE scores than those with their wild-type counterparts, and OX40 blockade led to a significant reduction in the EAE severity. Thus, our study defines an important component of the OX40 cosignaling that restricts inflammation driven by antigen-activated T cells.	[Okuyama, Yuko; Nagashima, Hiroyuki; Ishii, Naoto; So, Takanori] Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi, Japan; [Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA; [So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Mol Cell Biol Lab, 2630 Sugitani, Toyama, Toyama 9300194, Japan	Tohoku University; University System of Georgia; Augusta University; La Jolla Institute for Immunology; University of Toyama	So, T (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Mol Cell Biol Lab, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	tso@pha.u-toyama.ac.jp	So, Takanori/R-6175-2019; Nagashima, Hiroyuki/AAL-3128-2021	So, Takanori/0000-0003-3004-8526; Ishii, Naoto/0000-0002-0549-8245; Nagashima, Hiroyuki/0000-0001-8405-6746	Takeda Scientific Foundation; Suzuken Memorial Foundation; SENSHIN Medical Research Foundation; Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science [JP15K19123, JP14J06157, JP24590571, JP15H04640, JP18H02572, JP24390118, JP15H04742]	Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Takeda Scientific Foundation; The Suzuken Memorial Foundation; The SENSHIN Medical Research Foundation; The Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science, Grant/Award Number: JP15K19123, JP14J06157, JP24590571, JP15H04640, JP18H02572, JP24390118 and JP15H04742	Bahou WF, 2004, J BIOL CHEM, V279, P22571, DOI 10.1074/jbc.M402561200; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Carboni S, 2003, J NEUROIMMUNOL, V145, P1, DOI 10.1016/j.jneuroim.2003.07.001; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Linch SN, 2016, P NATL ACAD SCI USA, V113, pE319, DOI 10.1073/pnas.1510518113; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagashima H, 2016, J IMMUNOL, V196, P4082, DOI 10.4049/jimmunol.1501610; Ndhlovu LC, 2001, J IMMUNOL, V167, P2991, DOI 10.4049/jimmunol.167.5.2991; Nohara C, 2001, J IMMUNOL, V166, P2108, DOI 10.4049/jimmunol.166.3.2108; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pelikan-Conchaudron A, 2011, J BIOL CHEM, V286, P35119, DOI 10.1074/jbc.M111.258772; Prell RA, 2003, J IMMUNOL, V171, P5997, DOI 10.4049/jimmunol.171.11.5997; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sagiv-Barfi I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4488; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; So T, 2011, P NATL ACAD SCI USA, V108, P2903, DOI 10.1073/pnas.1008765108; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Webb GJ, 2016, CLIN REV ALLERG IMMU, V50, P312, DOI 10.1007/s12016-015-8498-3; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	45	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					540	554		10.1096/fj.201900879RR	http://dx.doi.org/10.1096/fj.201900879RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914585	hybrid			2022-12-26	WOS:000507308900037
J	Qin, Y; Li, AQ; Liu, BL; Jiang, WT; Gao, M; Tian, XG; Gong, GH				Qin, Yuan; Li, Anqi; Liu, Bilin; Jiang, Wenting; Gao, Meng; Tian, Xiangang; Gong, Guohua			Mitochondrial fusion mediated by fusion promotion and fission inhibition directs adult mouse heart function toward a different direction	FASEB JOURNAL			English	Article						adult heart; cardiac function; mitochondrial dynamics; mitochondrial fitness; therapeutic target	ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; MITOFUSIN 2; MITOPHAGY; DYNAMICS; CA2+; DYSFUNCTION; AUTOPHAGY; ISCHEMIA; PROTECTS	Mitochondrial fusion and fission are essential for heart function. Abrogating mitochondrial dynamism leads to cardiomyopathy. Excessive mitochondrial fragmentation is involved in most heart diseases, thus enhancing mitochondrial fusion will be a potential therapeutic strategy. To understand the effects of promoting mitochondrial fusion in adult cardiac, we investigated mice hearts, and cultured murine embryonic fibroblasts (MEFs), in which mitofusin 2 (Mfn2) overexpressed or dynamin-related protein 1 (Drp1) was abrogated concomitantly forcing mitochondrial fusion. Parallel studies revealed that fission-defective Drp1 knockout hearts and MEFs evoked stronger mitochondrial enlargement, enhanced mitophagy with mitochondrial volume decrease and increased mitochondrial calcium uptake, superoxide production, and permeability transition pore opening, contributed to cardiomyocyte apoptosis and dilated cardiomyopathy. Mfn2 overexpression in the adult heart is comparable with the control except for slight mitochondrial enlargement and mitochondrial volume increase, but without mitophagy induction. Moreover, Mfn2 overexpression increases mitochondrial biogenesis and fusion could protect against mitochondrial fragmentation and Drp1 deletion evoking mitophagy in MEFs. Our findings indicate that mitochondrial fusion provoked by fusion promotion and fission inhibition direct the different fate of heart, Mfn2 upregulation other than Drp1 downregulation well maintains heart mitochondrial function is a more safe strategy for correcting excessive mitochondrial fragmentation in hearts.	[Qin, Yuan; Li, Anqi; Liu, Bilin; Jiang, Wenting; Gao, Meng; Gong, Guohua] Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China; [Qin, Yuan] Tongji Univ, Shanghai East Hosp, Dept Pharm, Shanghai, Peoples R China; [Tian, Xiangang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Tongji University; Tongji University; Army Medical University	Gong, GH (corresponding author), Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	guohgong@tongji.edu.cn			Ministry of Science and Technology of the People's Republic of China (MOST) [2017YFA0105601]; National Natural Science Foundation of China (NSFC) [31771524]; Shanghai Municipal Education Commission [TP2017036]; Science and Technology Commission of Shanghai Municipality (STCSM) [17PJ1409600]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM))	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018YFA0107102; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2017YFA0105601; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771524; Shanghai Municipal Education Commission, Grant/Award Number: TP2017036; Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 17PJ1409600	Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Bi JB, 2019, REDOX BIOL, V20, P296, DOI 10.1016/j.redox.2018.10.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2015, J CELL BIOL, V211, P795, DOI 10.1083/jcb.201507035; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen L, 2017, METHOD ENZYMOL, V588, P187, DOI 10.1016/bs.mie.2016.10.038; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Diaz-Trelles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12088; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Gong GH, 2014, J MOL CELL CARDIOL, V76, P235, DOI 10.1016/j.yjmcc.2014.09.012; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hansford RG, 1999, BIOCHEM SOC SYMP, V66, P141, DOI 10.1042/bss0660141; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Kim YY, 2018, ACTA BIOCH BIOPH SIN, V50, P209, DOI 10.1093/abbs/gmx137; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Oliveira JMA, 2010, EMBO MOL MED, V2, P487, DOI 10.1002/emmm.201000104; Ong SB, 2015, THROMB HAEMOSTASIS, V113, P513, DOI 10.1160/TH14-07-0592; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Park SJ, 2012, FEBS LETT, V586, P4303, DOI 10.1016/j.febslet.2012.10.035; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Qin Y, 2018, BIOCHEM BIOPH RES CO, V503, P729, DOI 10.1016/j.bbrc.2018.06.068; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song MS, 2014, CIRC RES, V115, P348, DOI 10.1161/CIRCRESAHA.115.304384; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739; Yan QW, 2019, NEUROSCI LETT, V701, P84, DOI 10.1016/j.neulet.2019.02.030; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2017, CHIN AUTOM CONGR, P1; Zhang J, 2017, DYN GAMES APPL, V7, P112, DOI 10.1007/s13235-015-0165-z; Zhou YQ, 2019, J CLIN INVEST, V129, P1756, DOI 10.1172/JCI124194; Zhu TT, 2017, EUR J PHARMACOL, V809, P42, DOI 10.1016/j.ejphar.2017.05.003	47	18	20	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					663	675		10.1096/fj.201901671R	http://dx.doi.org/10.1096/fj.201901671R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914595				2022-12-26	WOS:000507308900046
J	Zhang, SS; Xu, XX; Xiang, WW; Zhang, HH; Lin, HL; Shen, LE; Lin, Q; Lin, F; Zhou, ZY				Zhang, Si-Si; Xu, Xin-Xin; Xiang, Wei-Wei; Zhang, Hui-Heng; Lin, Hui-Long; Shen, Lai-En; Lin, Qi; Lin, Feng; Zhou, Zhi-Yang			Using 17 beta-estradiol heparin-poloxamer thermosensitive hydrogel to enhance the endometrial regeneration and functional recovery of intrauterine adhesions in a rat model	FASEB JOURNAL			English	Article						17 beta-estradiol; apoptosis; heparin-poloxamer hydrogel; intrauterine adhesions; kisspeptin; regeneration	IN-VITRO; STEM/PROGENITOR CELLS; ASHERMANS-SYNDROME; STEM-CELLS; KISSPEPTIN; TRANSPLANTATION; IMPLANTATION; RECEPTIVITY; EXPRESSION; RECEPTORS	Mechanical damage or infection to the endometrium can lead to the formation of adhesions in the uterine cavity, which may result in reduced reproductive outcome and/or pregnancy complications. The prognosis of this disease is poor due to few effective treatments and the complex environment of endometrium. Heparin-Poloxamer Hydrogel (HP hydrogel) is a nontoxic and biodegradable biomaterial, which has been commonly used as a sustained-release delivery system. In this study, we applied a mini-endometrial curette to scrape the endometrium of rats to mimic the process of curettage in patients. After the establishment of IUA model in rats, we injected the thermo-sensitive hydrogel(E-2-HP hydrogel) into the injured uterine cavity and evaluated the therapeutic effect of E-2-HP hydrogel on the recovery of IUA. Our results showed that E-2-HP hydrogel can significantly facilitate the regeneration of injured endometrium along with inhibiting the cell apoptosis in IUA model. Furthermore, we revealed that E-2-HP hydrogel on the recovery of IUA was closely associated with the upregulation of kisspeptin through activating the ERK1/2 and MAPKs p38 pathways. In conclusion, E-2-HP hydrogel can effectively transfer E-2 into the injured endometrium and it can be considered as a promising therapeutic method for the women with intrauterine adhesions.	[Zhang, Si-Si; Lin, Hui-Long; Shen, Lai-En; Lin, Qi; Lin, Feng; Zhou, Zhi-Yang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynaecol, Wenzhou 325035, Zhejiang, Peoples R China; [Xu, Xin-Xin] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynaecol, Hangzhou, Zhejiang, Peoples R China; [Xiang, Wei-Wei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China; [Zhang, Hui-Heng] Wenzhou Med Univ, Sch Clin Med Sci 2, Wenzhou, Peoples R China; [Zhou, Zhi-Yang] Shanghai Jiao Tong Univ, Int Peace Maternal & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Zhou, Zhi-Yang] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China	Wenzhou Medical University; Zhejiang University; Shanghai Jiao Tong University; Wenzhou Medical University; Shanghai Jiao Tong University	Lin, F; Zhou, ZY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynaecol, Wenzhou 325035, Zhejiang, Peoples R China.	23489067@qq.com; zhouzhiyang.19@hotmail.com			Zhejiang Provincal Administration of traditional Chinese Medicine [2016ZB079]; Medicine Grant from Wenzhou Bureau of Science and Technology [Y20180018]; National Natural Science Foundation of China [81803781]; Natural Science Foundation of Zhejiang Province, China [LQ18H280007]	Zhejiang Provincal Administration of traditional Chinese Medicine; Medicine Grant from Wenzhou Bureau of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	Zhejiang Provincal Administration of traditional Chinese Medicine, Grant/Award Number: 2016ZB079; Medicine Grant from Wenzhou Bureau of Science and Technology, Grant/Award Number: Y20180018; National Natural Science Foundation of China, Grant/Award Number: 81803781; Natural Science Foundation of Zhejiang Province, China, Grant/Award Number: LQ18H280007	Abomaray FM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5184601; Aghajanova L, 2018, J ASSIST REPROD GEN, V35, P757, DOI 10.1007/s10815-018-1130-8; Cai HH, 2016, REPROD SCI, V23, P1208, DOI 10.1177/1933719116632923; Calder M, 2014, ENDOCRINOLOGY, V155, P3065, DOI 10.1210/en.2013-1916; Roman AC, 2012, FERTIL STERIL, V97, P1213, DOI 10.1016/j.fertnstert.2012.02.021; Clarkson J, 2013, FRONT NEUROENDOCRIN, V34, P120, DOI 10.1016/j.yfrne.2013.02.002; Ding LJ, 2014, BIOMATERIALS, V35, P4888, DOI 10.1016/j.biomaterials.2014.02.046; Evans-Hoeker EA, 2014, SEMIN REPROD MED, V32, P392, DOI 10.1055/s-0034-1376358; Fayazi M, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0105-1; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gilman AR, 2016, J OBSTET GYNAECOL CA, V38, P453, DOI 10.1016/j.jogc.2016.03.003; Jamil Z, 2017, REPROD BIOMED ONLINE, V34, P147, DOI 10.1016/j.rbmo.2016.11.004; Johary J, 2014, J MINIM INVAS GYN, V21, P44, DOI 10.1016/j.jmig.2013.07.018; Liu AZ, 2016, GYNECOL ENDOCRINOL, V32, P737, DOI 10.3109/09513590.2016.1160375; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Mittelman-Smith MA, 2015, ENDOCRINOLOGY, V156, P2162, DOI 10.1210/en.2014-1803; Quinn CE, 2009, HUM REPROD UPDATE, V15, P229, DOI 10.1093/humupd/dmn052; Salazar CA, 2017, CURR OPIN OBSTET GYN, V29, P249, DOI 10.1097/GCO.0000000000000378; Salma U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/589296; Santamaria X, 2016, HUM REPROD, V31, P1087, DOI 10.1093/humrep/dew042; Sardo AD, 2016, EUR J OBSTET GYN R B, V203, P182, DOI 10.1016/j.ejogrb.2016.05.050; Tan JC, 2016, HUM REPROD, V31, P2723, DOI 10.1093/humrep/dew235; Taylor J, 2014, MOL REPROD DEV, V81, P42, DOI 10.1002/mrd.22279; Wahab F, 2016, NAT REV UROL, V13, P21, DOI 10.1038/nrurol.2015.277; Wei P, 2004, MOL REPROD DEV, V68, P456, DOI 10.1002/mrd.20104; Wiater J, 2018, REPROD DOMEST ANIM, V53, P333, DOI 10.1111/rda.13109; Xiao B, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801455; Xu HL, 2017, DRUG DELIV, V24, P867, DOI 10.1080/10717544.2017.1333173; Yoo MK, 2005, DRUG DEV IND PHARM, V31, P455, DOI 10.1080/03639040500214688; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097647; Zhang S, 2018, REPROD DOMEST ANIM, V53, P143, DOI 10.1111/rda.13083; Zhang SS, 2017, INT J NANOMED, V12, P5643, DOI 10.2147/IJN.S137237; Zhang SW, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1155-7; Zhu XX, 2019, CURR STEM CELL RES T, V14, P293, DOI 10.2174/1574888X14666181205120110; Zhu Y, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.896028	35	21	24	5	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					446	457		10.1096/fj.201901603RR	http://dx.doi.org/10.1096/fj.201901603RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914682				2022-12-26	WOS:000507308900031
J	Ajisegiri, WS; Abubakar, AA; Gobir, AA; Balogun, MS; Sabitu, K				Ajisegiri, Whenayon Simeon; Abubakar, Aisha A.; Gobir, Abdulrazaq A.; Balogun, Muhammad Shakir; Sabitu, Kabiru			Palliative care for people living with HIV/AIDS: Factors influencing healthcare workers' knowledge, attitude and practice in public health facilities, Abuja, Nigeria	PLOS ONE			English	Article							NURSES	Background Physicians and nurses play vital roles in addressing palliative care (PC) needs of people living with HIV/AIDS (PLWHA). The healthcare workers' (HCWs) experiences determine the success of palliative care delivery. There is paucity of data on PC for PLWHA. For this reason, we assessed the knowledge, attitude and practice of PC for PLWHA and associated factors among health care professionals. Methods We conducted a cross-sectional descriptive study among HCWs in public health facilities in the Federal Capital Territory, Nigeria between February and May, 2017. Multistage sampling technique with proportionate-to-size allocation was used to determine facility sample size and HCWs per professional discipline. Data were collected with questionnaires adapted from Palliative Care Quiz for Nursing, Frommelt Attitude toward Care of the Dying and practical questions adapted from PC standard guidelines. Participants' knowledge, attitude and practice were assessed by awarding one (1) point for each correct answer; incorrect or "not sure" answers took a zero (0) score. Correct responses were summed up to get a total score for each participant. Descriptive statistics was done to describe frequencies and proportions displayed on tables. Linear regression was done to determine factors associated with HCW's knowledge, attitude and practice of PC for PLWHA Result With a 100% response rate, the mean age of the 348 participants was 37.5 years (SD: 8.9), 201 (57.8%) were female, 222 (63.8) were nurses and 230 (66.0%) had a work experience of 10 years or less. Majority of the participants, 310 (89.1%) agreed that palliative care focuses on the relief and prevention of suffering and 319 (91.7%) believe that PLWHA required palliative care. Misconceptions about palliative care include "palliative care is disease-oriented and not person oriented", 252 (72.6%) believed; "palliative care is concerned with prolongation of life", 279 (80.6%); and "use of placebos is appropriate in the treatment of some types of pain", 252 (72.6%). Among the participants, 52% disagreed that "palliative care should be given only for dying PLWHA" while only 18 (5.2%) were right on "family should be involved in the physical care of the dying PLWHA". Majority of the participants, 292 (84.1%) initiated palliative care discussion during patients' diagnosis while 290 (83.6%) informed terminally ill patients about their diagnosis. Regarding psychological issues, 22 (6.3%) participants hid the truth from the patients while 196 (56.3%) provided emotional support to the patients. Morphine 240 (69.0%) and Pentazocine 194 (55.7%) were the most commonly used drugs for treatment of severe pain by participants across all centres. Conclusion In-service training and undergraduate training on palliative care were associated with knowledge and practice of palliative care for people living with HIV/AIDS. We recommended continuous quality in-service training and education on palliative care for HCWs. While we ensure voluntariness of participation and other ethical principles, the high response rate could be as a result of more motivated health worker than the norm. The results are unlikely to be representative of doctors and nurses in primary health care centres.	[Ajisegiri, Whenayon Simeon; Balogun, Muhammad Shakir] NFELTP, Abuja, Federal Capital, Nigeria; [Ajisegiri, Whenayon Simeon; Abubakar, Aisha A.; Gobir, Abdulrazaq A.; Sabitu, Kabiru] Ahmadu Bello Univ, Dept Community Med, Zaria, Kaduna State, Nigeria; [Ajisegiri, Whenayon Simeon] Nigerian Field Epidemiol & Lab Training Programme, Abuja, Nigeria	Ahmadu Bello University	Ajisegiri, WS (corresponding author), NFELTP, Abuja, Federal Capital, Nigeria.; Ajisegiri, WS (corresponding author), Ahmadu Bello Univ, Dept Community Med, Zaria, Kaduna State, Nigeria.; Ajisegiri, WS (corresponding author), Nigerian Field Epidemiol & Lab Training Programme, Abuja, Nigeria.	doctorajisegiri@yahoo.com	Ajisegiri, Whenayon S/V-6028-2018; BALOGUN, MUHAMMAD/ABH-4227-2020	BALOGUN, MUHAMMAD/0000-0002-4846-9698; Ahmed Abubakar, Aisha/0000-0002-0112-9717; /0000-0002-8081-7058				Abu-Saad Huijer Huda, 2007, J Med Liban, V55, P121; Ali W.G.M., 2010, J MED BIOMEDICAL SCI, V1, P16; [Anonymous], 2000, UNAIDS TECHNICAL UPD; [Anonymous], 2006, NATL GUIDELINES HIVA, P1; Anstey S, 2016, BMJ SUPPORT PALLIAT, V6, P353, DOI 10.1136/bmjspcare-2015-000956; Anteneh S, 2016, ADV BIOL RES, V10, P110, DOI DOI 10.5829/IDOSI.ABR.2016.10.2.10397; Ayed A., 2015, NURSES KNOWLEDGE ATT; Bello OO, 2018, OPEN J OBSTET GYNECO, V8, P559; Commission N.P, 2017, NIG POP NOW 182 MILL; Das AG, 2015, INT J SCI RES, V4, P1790, DOI DOI 10.21275/V4I11.NOV151510; Fadare JO, 2014, INDIAN J PALLIAT CAR, V20, P1, DOI 10.4103/0973-1075.125547; Family Health International, 2009, PALL CAR STRAT HIV O; Gedamu, 2016, KNOWLEDGE ATTITUDE N; Green K, 2006, PALLIATIVE CARE VIET; Harding R, 2005, SEX TRANSM INFECT, V81, P5, DOI 10.1136/sti.2004.010132; Harding R, 2013, AIDS CARE, V25, P795, DOI 10.1080/09540121.2012.736608; Heath KV, 2003, CURR DRUG TARGETS, V4, P13, DOI 10.2174/1389450033347109; Jacquie P, 2005, PERSPECTIVE HOSPICE, P45; Kassa H, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-6; Khosla D, 2012, INDIAN J PALLIAT CAR, V18, P149, DOI 10.4103/0973-1075.105683; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Lorensen M, 2003, NURS ETHICS, V10, P175, DOI 10.1191/0969733003ne592oa; Meaza D, 2012, KNOWLEDGE ATTITUDE P, P1; Merlin J, 2018, PALLIATIVE CARE ISSU; Metropole C, 2011, FACTORS INFLUENCING; National Agency for the Control of AIDS, 2019, NIG HIV PREV RAT; National Agency for the Control of AIDS, 2015, HIV EP NIG NACA NIG; National Patient Safety Foundation, 2015, FREE HARM ACC PAT SA, P1; Onyeka TC, 2013, EUR J CANCER CARE, V22, P597, DOI 10.1111/ecc.12064; Onyeka TC, 2011, INDIAN J PALLIAT CAR, V17, P131, DOI 10.4103/0973-1075.84534; Oyebola F.O, 2017, J EMERGENCY INTERNAL, V1; Population Reference BBureau, 2015, WORLD POP DAT SHEET, P20; The Henry J. Kaiser Family Foundation, 2016, GLOB HLTH POL; World Health Organization, PALL CAR; Yang FM, 2017, PATIENT PREFER ADHER, V11, P853, DOI 10.2147/PPA.S132093; Youssef W, 2014, ADV LIFE SCI TECHNOL, V24, P100	36	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0207499	10.1371/journal.pone.0207499	http://dx.doi.org/10.1371/journal.pone.0207499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891577	Green Submitted, Green Published, gold			2022-12-26	WOS:000515096600001
J	Nogueira, YAC; da Costa, LNG; Levy, CE; Orsi, FA; de Lima, F; Annichinno-Bizzacchi, JM; De Paula, EV				Campos Nogueira, Yzabella Alves; Gomes da Costa, Loredana Nilkenes; Levy, Carlos Emilio; Orsi, Fernanda Andrade; de Lima, Franciele; Annichinno-Bizzacchi, Joyce M.; De Paula, Erich Vinicius			Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; HOST-DEFENSE; FIBRINOLYSIS; COAGULATION; INHIBITOR; PERITONITIS; INFECTION; RESPONSES; TYPE-1	The biological relevance of fibrinolysis to the host response to sepsis is illustrated by pathogens such as S. pyogenes and Y. pestis, whose virulence factors are proteins that challenge the balance between pro- and anti-fibrinolytic factors of the host, and by the consistent finding of hypofibrinolysis in the early stages of sepsis. Whether this hypofibrinolytic response is beneficial or detrimental to the host, by containing the spread of pathogens while at the same time limiting the access of immune cell to infectious foci, is still a matter of debate. Tranexamic acid (TnxAc) is an antifibrinolytic agent that is being increasingly used to prevent and control bleeding in conditions such as elective orthopedic surgery, trauma, and postpartum-hemorrhage, which are frequently followed by infection and sepsis. Here we used a model of polymicrobial sepsis to evaluate whether hypofibrinolysis induced by TnxAc influenced survival, tissue injury and pathogen spread. Mice were treated with two doses of TnxAc bid for 48h, and then sepsis was induced by cecal ligation and puncture. Despite the induction of hypofibrinolysis by TnxAc, no difference could be observed in survival, tissue injury (measured by biochemical and histological parameters), cytokine levels or pathogen spread. Our results contribute with a new piece of data to the understanding of the complex interplay between fibrinolysis and innate immunity. While our results do not support the use of TnxAc in sepsis, they also address the thrombotic safety of TnxAc, a low cost and widely used agent to prevent bleeding.	[Campos Nogueira, Yzabella Alves; Gomes da Costa, Loredana Nilkenes; Levy, Carlos Emilio; Orsi, Fernanda Andrade; de Lima, Franciele; Annichinno-Bizzacchi, Joyce M.; De Paula, Erich Vinicius] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil; [Gomes da Costa, Loredana Nilkenes] Univ Fed Piaui, Parnaiba, PI, Brazil; [Annichinno-Bizzacchi, Joyce M.; De Paula, Erich Vinicius] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal do Piaui; Universidade Estadual de Campinas	De Paula, EV (corresponding author), Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.; De Paula, EV (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	erich@unicamp.br	Orsi, Fernanda L.A./H-1203-2014; Levy, Carlos/AAN-7226-2020; Levy, Carlos/L-2116-2013; De Paula, Erich V/C-5943-2012	Orsi, Fernanda L.A./0000-0002-7908-9073; Levy, Carlos/0000-0002-4862-8900; De Paula, Erich V/0000-0003-1539-7912	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; Sao Paulo Research Foundation [2016/14172-6, 2014/0984-3]; CNPq Brazil [309317/2016]; FAEPEXUNICAMP	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPEXUNICAMP	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) (www.capes.gov.br) -Finance Code 001 to YACN and was also funded by Sao Paulo Research Foundation (www.fapesp.br) grants #2016/14172-6 and 2014/0984-3; and CNPq Brazil (www.cnpq.br) grant #309317/2016; and FAEPEXUNICAMP to EVDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENHOLZ DH, 1980, SURGERY, V88, P41; Alves GSA, 2016, BLOOD COAGUL FIBRIN, V27, P500, DOI 10.1097/MBC.0000000000000444; Asakura H, 2004, INTENS CARE MED, V30, P1950, DOI 10.1007/s00134-004-2349-7; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Dallaku Kastriot, 2019, Wellcome Open Res, V4, P21, DOI 10.12688/wellcomeopenres.14977.1; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fox MA, 2010, ANESTH ANALG, V111, P580, DOI 10.1213/ANE.0b013e3181e2914d; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gando S, 2013, SEMIN THROMB HEMOST, V39, P392, DOI 10.1055/s-0033-1334140; Guo YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024774; HAVERKATE F, 1995, THROMB HAEMOSTASIS, V73, P561; Huet O, 2013, SHOCK, V39, P488, DOI 10.1097/SHK.0b013e3182939831; Joshi N, 2014, J PHARMACOL EXP THER, V349, P383, DOI 10.1124/jpet.113.210880; Kager LM, 2011, J THROMB HAEMOST, V9, P2020, DOI 10.1111/j.1538-7836.2011.04473.x; Kager LM, 2012, CRIT CARE MED, V40, P2168, DOI 10.1097/CCM.0b013e31824ea05e; Klak M, 2010, SCAND J INFECT DIS, V42, P351, DOI 10.3109/00365540903510690; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Lim JH, 2011, BIOCHEM BIOPH RES CO, V414, P67, DOI 10.1016/j.bbrc.2011.09.023; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; Fiusa MML, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0327-2; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; POLK HC, 1980, ANN SURG, V192, P350, DOI 10.1097/00000658-198009000-00010; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Renckens R, 2006, J IMMUNOL, V177, P1189, DOI 10.4049/jimmunol.177.2.1189; Risch A, 2000, ANAESTHESIST, V49, P279, DOI 10.1007/s001010050829; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schultz G, 2010, ARTERIOSCL THROM VAS, V30, P1363, DOI 10.1161/ATVBAHA.109.202259; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shao Z, 2015, J THROMB HAEMOST, V13, P1090, DOI 10.1111/jth.12956; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Tengborn L, 2015, THROMB RES, V135, P231, DOI 10.1016/j.thromres.2014.11.012; Tipoe TL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01218; van Veen SQ, 2007, SHOCK, V27, P534, DOI 10.1097/01.shk.0000246897.27574.1b; VANDEVENTER SJH, 1990, BLOOD, V76, P2520; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226871	10.1371/journal.pone.0226871	http://dx.doi.org/10.1371/journal.pone.0226871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891611	Green Submitted, Green Published, gold			2022-12-26	WOS:000515096600038
J	Stenfeldt, C; Pacheco, JM; Singanallur, NB; Vosloo, W; Rodriguez, LL; Arzt, J				Stenfeldt, Carolina; Pacheco, Juan M.; Singanallur, Nagendrakumar B.; Vosloo, Wilna; Rodriguez, Luis L.; Arzt, Jonathan			Virulence beneath the fleece; a tale of foot-and-mouth disease virus pathogenesis in sheep	PLOS ONE			English	Article							SIMULATED-NATURAL INOCULATION; DOSE-DEPENDENT RESPONSES; DIRECT-CONTACT CHALLENGE; KIDNEY-CELL LINE; CARRIER STATE; HIGH-POTENCY; HETEROLOGOUS CHALLENGE; SUBCLINICAL INFECTION; MONOVALENT VACCINE; AFRICAN BUFFALO	Foot-and-mouth disease virus (FMDV) is capable of infecting all cloven-hoofed domestic livestock species, including cattle, pigs, goats, and sheep. However, in contrast to cattle and pigs, the pathogenesis of FMDV in small ruminants has been incompletely elucidated. The objective of the current investigation was to characterize tissue- and cellular tropism of early and late stages of FMDV infection in sheep following three different routes of simulated natural virus exposure. Extensive post-mortem harvest of tissue samples at pre-determined time points during early infection (24 and 48 hours post infection) demonstrated that tissues specifically susceptible to primary FMDV infection included the paraepiglottic- and palatine tonsils, as well as the nasopharyngeal mucosa. Additionally, experimental aerosol inoculation of sheep led to substantial virus replication in the lungs at 24-48 hours post-inoculation. During persistent infection (35 days post infection), the paraepiglottic- and palatine tonsils were the only tissues from which infectious FMDV was recovered. This is strikingly different from cattle, in which persistent FMDV infection has consistently been located to the nasopharyngeal mucosa. Analysis of tissue sections by immunomicroscopy revealed a strict epithelial tropism during both early and late phases of infection as FMDV was consistently localized to cytokeratin-expressing epithelial cells. This study expands upon previous knowledge of FMDV pathogenesis in sheep by providing detailed information on the temporo-anatomic distribution of FMDV in ovine tissues. Findings are discussed in relation to similar investigations previously performed in cattle and pigs, highlighting similarities and differences in FMDV pathogenesis across natural host species.	[Stenfeldt, Carolina; Pacheco, Juan M.; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Dept Agr, Foreign Anim Dis Res Unit, US Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Stenfeldt, Carolina] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Singanallur, Nagendrakumar B.; Vosloo, Wilna] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia	Kansas State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Arzt, J (corresponding author), ARS, Dept Agr, Foreign Anim Dis Res Unit, US Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	Jonathan.Arzt@usda.gov	Singanallur, Nagendrakumar Balasubramanian/G-9349-2013; Stenfeldt, Carolina/AAG-7940-2021	Singanallur, Nagendrakumar Balasubramanian/0000-0002-0523-3853; Stenfeldt, Carolina/0000-0002-2074-3886; Arzt, Jonathan/0000-0002-7517-7893; Pacheco, Juan/0000-0001-5477-0201	Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Australian Animal Health Laboratory (AAHL); Agricultural Research Service (ARS) of the US Department of Agriculture (USDA); CSIRO; Australia through Animal Health Australia (AHA); Cattle Council of Australia; Australian Dairy Farmers; Australian Lot Feeders Association; Wool Producers Australia, Sheepmeat Council of Australia; Australian Pork Limited; AHA funds were matched through the Meat and Livestock Australia (MLA) Donor Company by the Australian Government [P.PSH 0652]; USDA ARS; (JA) current research information system Project [1940-32000-057-00D]	Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Australian Animal Health Laboratory (AAHL); Agricultural Research Service (ARS) of the US Department of Agriculture (USDA); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australia through Animal Health Australia (AHA); Cattle Council of Australia; Australian Dairy Farmers; Australian Lot Feeders Association; Wool Producers Australia, Sheepmeat Council of Australia; Australian Pork Limited(Australian Pork Limited); AHA funds were matched through the Meat and Livestock Australia (MLA) Donor Company by the Australian Government; USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); (JA) current research information system Project	This study was a collaboration between The Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Australian Animal Health Laboratory (AAHL) and the Agricultural Research Service (ARS) of the US Department of Agriculture (USDA), who co-funded the work. Funding through CSIRO (NS, WV) was provided in part by the livestock industries in Australia through Animal Health Australia (AHA). The relevant industry bodies are the Cattle Council of Australia, Australian Dairy Farmers, Australian Lot Feeders Association, Wool Producers Australia, Sheepmeat Council of Australia, Australian Pork Limited and the Goat Industry Council of Australia. The AHA funds were matched through the Meat and Livestock Australia (MLA) Donor Company by the Australian Government under MLA Project P.PSH 0652. Additional funding came from USDA ARS (LR, JA) current research information system Project 1940-32000-057-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal N, 2002, VACCINE, V20, P2508, DOI 10.1016/S0264-410X(02)00178-0; Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Alexandersen S, 2001, J GEN VIROL, V82, P747, DOI 10.1099/0022-1317-82-4-747; ANDERSON EC, 1976, J HYG-CAMBRIDGE, V76, P395, DOI 10.1017/S0022172400055315; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0758-9; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Barnett PV, 2004, VACCINE, V22, P1221, DOI 10.1016/j.vaccine.2003.09.024; Bertram MR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00174; BROWN F, 1960, J IMMUNOL, V85, P309; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; BURROWS R, 1968, J HYG-CAMB, V66, P633, DOI 10.1017/S0022172400028369; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Casteleyn C, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/472460; Cocquyt G, 2005, VET IMMUNOL IMMUNOP, V107, P79, DOI 10.1016/j.vetimm.2005.03.012; CONDY JB, 1985, COMP IMMUNOL MICROB, V8, P259, DOI 10.1016/0147-9571(85)90004-9; Cox SJ, 2006, VACCINE, V24, P3184, DOI 10.1016/j.vaccine.2006.01.037; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; De Rueda CB, 2015, EPIDEMIOL INFECT, V143, P2279, DOI 10.1017/S0950268814003033; Fukai K, 2015, ARCH VIROL, V160, P129, DOI 10.1007/s00705-014-2239-4; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; GIBSON CF, 1986, RES VET SCI, V41, P45, DOI 10.1016/S0034-5288(18)30570-8; Gulbahar MY, 2007, VET PATHOL, V44, P589, DOI 10.1354/vp.44-5-589; Hayer SS, 2018, TRANSBOUND EMERG DIS, V65, P253, DOI 10.1111/tbed.12627; Horsington J, 2007, J VIROL METHODS, V144, P149, DOI 10.1016/j.jviromet.2007.05.002; Horsington J, 2018, VACCINE, V36, P6095, DOI 10.1016/j.vaccine.2018.08.073; Horsington J, 2015, VACCINE, V33, P422, DOI 10.1016/j.vaccine.2014.11.043; Hughes GJ, 2002, VET REC, V150, P724, DOI 10.1136/vr.150.23.724; Hughes GJ, 2002, J COMP PATHOL, V127, P22, DOI 10.1053/jcpa.2002.0560; Kitching RP, 2002, REV SCI TECH OIE, V21, P505, DOI 10.20506/rst.21.3.1342; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; LITTLEJOHN AI, 1970, STATE VET J, V25, P97; Madhanmohan M, 2012, RES VET SCI, V93, P1050, DOI 10.1016/j.rvsc.2011.10.006; Mansley LM, 2003, VET REC, V153, P43, DOI 10.1136/vr.153.2.43; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Pacheco JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146445; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; Ryan E, 2008, J COMP PATHOL, V138, P108, DOI 10.1016/j.jcpa.2007.12.001; Ryan E, 2007, J COMP PATHOL, V136, P256, DOI 10.1016/j.jcpa.2007.03.001; Ryan E, 2008, VET MICROBIOL, V127, P258, DOI 10.1016/j.vetmic.2007.08.029; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sellers R, 2008, VET J, V177, P159, DOI 10.1016/j.tvjl.2007.03.009; Singanallur NB, 2017, ANTIVIR RES, V145, P114, DOI 10.1016/j.antiviral.2017.07.020; Stenfeldt C, 2016, TRANSBOUND EMERG DIS, V63, P152, DOI 10.1111/tbed.12235; Stenfeldt C, 2014, RES VET SCI, V96, P396, DOI 10.1016/j.rvsc.2014.01.009; Stenfeldt C, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00493-18; Stenfeldt C, 2018, VIROLOGY, V516, P115, DOI 10.1016/j.virol.2018.01.008; Stenfeldt C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18112-4; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Stenfeldt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143666; Stenfeldt C, 2015, VET MICROBIOL, V178, P50, DOI 10.1016/j.vetmic.2015.04.004; Stenfeldt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106859; SWANEY LM, 1988, VET MICROBIOL, V18, P1, DOI 10.1016/0378-1135(88)90111-3; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016; Yang M, 2007, VET IMMUNOL IMMUNOP, V115, P126, DOI 10.1016/j.vetimm.2006.10.002; Yoon H, 2015, TRANSBOUND EMERG DIS, V62, P252, DOI 10.1111/tbed.12109; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227061	10.1371/journal.pone.0227061	http://dx.doi.org/10.1371/journal.pone.0227061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891626	Green Published, gold			2022-12-26	WOS:000515096600054
J	Patino-Medina, JA; Reyes-Mares, NY; Valle-Maldonado, MI; Jacome-Galarza, IE; Perez-Arques, C; Nunez-Anita, RE; Campos-Garcia, J; Anaya-Martinez, V; Ortiz-Alvarado, R; Ramirez-Diaz, MI; Lee, SC; Garre, V; Meza-Carmen, V				Alberto Patino-Medina, J.; Reyes-Mares, Nancy Y.; Valle-Maldonado, Marco, I; Jacome-Galarza, Irvin E.; Perez-Arques, Carlos; Nunez-Anita, Rosa E.; Campos-Garcia, Jesus; Anaya-Martinez, Veronica; Ortiz-Alvarado, Rafael; Ramirez-Diaz, Martha, I; Lee, Soo Chan; Garre, Victoriano; Meza-Carmen, Victor			Heterotrimeric G-alpha subunits Gpa11 and Gpa12 define a transduction pathway that control spore size and virulence in Mucor circinelloides	PLOS ONE			English	Article							PROTEIN-KINASE-A; ENCODING GENES; SYN. RACEMOSUS; DIMORPHISM; FUNGI; DEHYDROGENASE; EPIDEMIOLOGY; CALCINEURIN; EXPRESSION; PHYSIOLOGY	Mucor circinelloides is one of the causal agents of mucormycosis, an emerging and high mortality rate fungal infection produced by asexual spores (sporangiospores) of fungi that belong to the order Mucorales. M. circinelloides has served as a model genetic system to understand the virulence mechanism of this infection. Although the G-protein signaling cascade plays crucial roles in virulence in many pathogenic fungi, its roles in Mucorales are yet to be elucidated. Previous study found that sporangiospore size and calcineurin are related to the virulence in Mucor, in which larger spores are more virulent in an animal mucormycosis model and loss of a calcineurin A catalytic subunit CnaA results in larger spore production and virulent phenotype. The M. circinelloides genome is known to harbor twelve gpa (gpa1 to gpa12) encoding G-protein alpha subunits and the transcripts of the gpa11 and gpa12 comprise nearly 72% of all twelve gpa genes transcript in spores. In this study we demonstrated that loss of function of Gpa11 and Gpa12 led to larger spore size associated with reduced activation of the calcineurin pathway. Interestingly, we found lower levels of the cnaA mRNAs in sporangiospores from the Delta gpa12 and double Delta gpa11/Delta gpa12 mutant strains compared to wild-type and the cnaA mutant had significantly lower gpa11 and gpa12 mRNA levels compared to wild-type. However, in contrast to the high virulence showed by the large spores of Delta cnaA, the spores from Delta gpa11/Delta gpa12 were avirulent and produced lower tissue invasion and cellular damage, suggesting that the gpa11 and gpa12 define a signal pathway with two branches. One of the branches controls spore size through regulation of calcineurin pathway, whereas virulences is controlled by an independent pathway. This virulence-related regulatory pathway could control the expression of genes involved in cellular responses important for virulence, since sporangiospores of Delta gpa11/Delta gpa12 were less resistant to oxidative stress and phagocytosis by macrophages than the Delta cnaA and wild-type strains. The characterization of this pathway could contribute to decipher the signals and mechanism used by Mucorales to produce mucormycosis.	[Alberto Patino-Medina, J.; Reyes-Mares, Nancy Y.; Valle-Maldonado, Marco, I; Campos-Garcia, Jesus; Ramirez-Diaz, Martha, I; Meza-Carmen, Victor] UMSNH, Inst Invest Quim Biol, Morelia, Michoacan, Mexico; [Jacome-Galarza, Irvin E.] Lab Estatal Salud Publ Estado Michoacan, Dept Biol Mol, Morelia, Michoacan, Mexico; [Perez-Arques, Carlos; Garre, Victoriano] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia, Spain; [Nunez-Anita, Rosa E.] Univ Michoacana, Fac Med Vet & Zootecnia, Morelia, Michoacan, Mexico; [Anaya-Martinez, Veronica] Univ Anahuac, Fac Ciencias Salud, Naucalpan De Juarez, Estado De Mexic, Mexico; [Ortiz-Alvarado, Rafael] Univ Michoacana, Fac Quim Farmacobiol, Morelia, Michoacan, Mexico; [Lee, Soo Chan] Univ Texas San Antonio, STCEID, Dept Biol, San Antonio, TX USA	Universidad Michoacana de San Nicolas de Hidalgo; University of Murcia; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Anahuac; Universidad Michoacana de San Nicolas de Hidalgo; University of Texas System; University of Texas at San Antonio (UTSA)	Meza-Carmen, V (corresponding author), UMSNH, Inst Invest Quim Biol, Morelia, Michoacan, Mexico.	victor_meza2004@yahoo.com.mx	Campos-Garcia, Jesus/A-9368-2013; Pérez-Arques, Carlos/ABI-7891-2020; Garre, Victoriano/H-2533-2015	Campos-Garcia, Jesus/0000-0002-8337-5830; Pérez-Arques, Carlos/0000-0003-1384-3608; Valle-Maldonado, Marco Ivan/0000-0002-9808-741X; Garre, Victoriano/0000-0001-7605-1726	Coordinacion de la Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo, Mexico [2.6, 2.35]; Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT) [181747, 167071, 256119]; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia, Spain [19339/PI/14]	Coordinacion de la Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo, Mexico; Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia, Spain(Fundacion Seneca)	V M-C, MI R-D Coordinacion de la Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo, Mexico (2.6, 2.35). https://www.cic.umich.mx V M-C, MI R-D, J C-G Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT; 181747, 167071, and 256119). https://www.conacyt.gob.mx V G Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia, Spain (19339/PI/14). https://www.fseneca.es The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Patino-Medina JA, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103737; Patino-Medina JA, 2018, CURR GENET, V64, P853, DOI 10.1007/s00294-017-0798-0; ARNAU J, 1993, CURR GENET, V23, P542, DOI 10.1007/BF00312649; Baldin C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006408; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; Chamilos G, 2008, ANTIMICROB AGENTS CH, V52, P722, DOI 10.1128/AAC.01136-07; Chander J, 2015, MYCOPATHOLOGIA, V180, P181, DOI 10.1007/s11046-015-9908-z; Corrochano LM, 2016, CURR BIOL, V26, P1577, DOI 10.1016/j.cub.2016.04.038; Desnos-Ollivier M, 2015, MBIO, V6, DOI 10.1128/mBio.00311-15; Diaz-Perez SP, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00434-19; Fuller KK, 2012, VIRULENCE, V3, P109, DOI 10.4161/viru.19396; Gutierrez A, 2011, J MICROBIOL METH, V84, P442, DOI 10.1016/j.mimet.2011.01.002; Hassan MIA, 2019, MED MYCOL, V57, pS245, DOI 10.1093/mmy/myz011; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Ibrahim AS, 2012, CLIN INFECT DIS, V54, pS16, DOI 10.1093/cid/cir865; Navarro-Mendoza MI, 2019, CURR BIOL, V29, P3791, DOI 10.1016/j.cub.2019.09.024; Valle-Maldonado MI, 2015, FUNGAL BIOL-UK, V119, P1179, DOI 10.1016/j.funbio.2015.08.009; Jenks JD, 2018, INT J ANTIMICROB AG, V52, P706, DOI 10.1016/j.ijantimicag.2018.08.005; Jeong W, 2019, CLIN MICROBIOL INFEC, V25, P26, DOI 10.1016/j.cmi.2018.07.011; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; Lewis RE, 2013, FUTURE MICROBIOL, V8, P1163, DOI 10.2217/fmb.13.78; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; Lopez-Munoz A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30754-6; Lubbehusen TL, 2003, J APPL MICROBIOL, V95, P1152, DOI 10.1046/j.1365-2672.2003.02098.x; Lubbehusen TL, 2003, MYCOL RES, V107, P223, DOI 10.1017/S0953756203007299; McIntyre M, 2002, APPL MICROBIOL BIOT, V58, P495, DOI 10.1007/s00253-001-0916-1; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Morin-Sardin S, 2017, FUNGAL BIOL REV, V31, P12, DOI 10.1016/j.fbr.2016.11.002; Navarro E, 2001, MOL GENET GENOMICS, V266, P463, DOI 10.1007/s004380100558; Nicolas FE, 2007, FUNGAL GENET BIOL, V44, P504, DOI 10.1016/j.fgb.2006.09.003; Ocampo J, 2009, EUKARYOT CELL, V8, P933, DOI 10.1128/EC.00026-09; ORLOWSKI M, 1991, MICROBIOL REV, V55, P234, DOI 10.1128/MMBR.55.2.234-258.1991; Oshel P., 1997, MICROSCOPY TODAY, V5, P16, DOI 10.1017/S155192950006140X; Peng XD, 2015, INT J OPHTHALMOL-CHI, V8, P441, DOI 10.3980/j.issn.2222-3959.2015.03.02; PHILLIPS DJ, 1987, PHYTOPATHOLOGY, V77, P1606, DOI 10.1094/Phyto-77-1606; Rangel-Porras RA, 2005, MOL GENET GENOMICS, V274, P354, DOI 10.1007/s00438-005-0025-4; Rodriguez C, 2013, FUNGAL GENET BIOL, V53, P34, DOI 10.1016/j.fgb.2013.01.007; Rodriguez-Andrade E, 2016, ANTON LEEUW INT J G, V109, P389, DOI 10.1007/s10482-015-0642-9; Roze LV, 2004, MYCOPATHOLOGIA, V158, P219, DOI 10.1023/B:MYCO.0000041841.71648.6e; SALCEDOHERNANDEZ R, 1993, EXP MYCOL, V17, P142, DOI 10.1006/emyc.1993.1013; Sambrook J., 2001, MOL CLONING LAB MANU; Sephton-Clark PCS, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00403-18, 10.1128/msphere.00403-18]; Skiada A, 2018, MED MYCOL, V56, pS93, DOI 10.1093/mmy/myx101; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Trieu TA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006150; Valle-Maldonado MI, 2015, MOL BIOL REP, V42, P705, DOI 10.1007/s11033-014-3818-x; VANHEESWIJCK R, 1984, CARLSBERG RES COMMUN, V49, P691, DOI 10.1007/BF02907500; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wijayawardene NN, 2018, FUNGAL DIVERS, V92, P43, DOI 10.1007/s13225-018-0409-5; Wolff AM, 2002, FUNGAL GENET BIOL, V35, P21, DOI 10.1006/fgbi.2001.1313; Wuthrich M, 2012, ANNU REV IMMUNOL, V30, P115, DOI 10.1146/annurev-immunol-020711-074958; YORDY MR, 1993, KIDNEY INT, V43, P940, DOI 10.1038/ki.1993.132; Zhu J, 2017, FUNGAL GENET BIOL, V98, P52, DOI 10.1016/j.fgb.2016.12.004	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226682	10.1371/journal.pone.0226682	http://dx.doi.org/10.1371/journal.pone.0226682			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887194	Green Published, gold			2022-12-26	WOS:000515092200026
J	Di, WD; Gasser, RB; He, L; Li, FF; Liu, XF; Zhou, CX; Zhou, YQ; Fang, R; Zhao, JL; Hu, M				Di, Wenda; Gasser, Robin B.; He, Li; Li, Fangfang; Liu, Xiaofang; Zhou, Caixian; Zhou, Yanqin; Fang, Rui; Zhao, Junlong; Hu, Min			A serine/threonine-specific protein kinase of Haemonchus contortus with a role in the development	FASEB JOURNAL			English	Article						akt-1; expression; functional genomics; kinase; signaling	STRONGYLOIDES-STERCORALIS; RNA INTERFERENCE; IN-VITRO; GENE; EXPRESSION; LONGEVITY; ELEGANS; AKT; REPRODUCTION; INHIBITORS	In the free-living nematode Caenorhabditis elegans, the serine/threonine-specific protein kinase, AKT, is known to play a key role in dauer formation, life-span, and stress-resistance through the insulin-like signaling pathway. Although the structure and function of AKT-coding genes of C. elegans are understood, this is not the case for homologous genes in parasitic nematodes. In the present study, we explored a C. elegans akt-1 gene homolog in the parasitic nematode Haemonchus contortus, investigated its transcript isoforms (Hc-akt-1a and Hc-akt-1b), and studied expression and function using both homologous and heterologous functional genomic tools. In C. elegans, we showed that the predicted promoter of Hc-akt-1 drives substantial expression in ASJ neurons of the N2 (wild-type) strain. In H. contortus (Haecon-5 stain), RNAi (soaking) led to a significantly decreased transcript abundance for both Hc-akt-1a and Hc-akt-1b, and reduced larval development in larval stages in vitro. Chemical inhibition was also shown to block larval development. Taken together, the evidence from this study points to a key functional role for Hc-akt-1 in H. contortus.	[Di, Wenda; Gasser, Robin B.; He, Li; Li, Fangfang; Liu, Xiaofang; Zhou, Caixian; Zhou, Yanqin; Fang, Rui; Zhao, Junlong; Hu, Min] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Key Lab Dev Vet Prod,Minist Agr, Wuhan 430070, Hubei, Peoples R China; [Gasser, Robin B.] Univ Melbourne, Dept Vet Biosci, Fac Vet & Agr Sci, Parkville, Vic, Australia	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; University of Melbourne	Gasser, RB; Hu, M (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Key Lab Dev Vet Prod,Minist Agr, Wuhan 430070, Hubei, Peoples R China.	robinbg@unimelb.edu.au; mhu@mail.hzau.edu.cn	Gasser, Robin/ABH-6185-2020	Gasser, Robin/0000-0002-4423-1690; , Wenda Di/0000-0003-1037-0286	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31172310]; National Key Basic Research Program (973 program) of China [2015CB150300]; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) [2017CFA020]; Huazhong Agricultural University Scientific & Technological Self Innovation Foundation [2015RC005]	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Key Basic Research Program (973 program) of China(National Basic Research Program of China); Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation); Huazhong Agricultural University Scientific & Technological Self Innovation Foundation	NSFC vertical bar National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31172310; National Key Basic Research Program (973 program) of China, Grant/Award Number: 2015CB150300; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation), Grant/Award Number: 2017CFA020; Huazhong Agricultural University Scientific & Technological Self Innovation Foundation, Grant/Award Number: 2015RC005	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Ailion M, 2003, GENETICS, V165, P127; Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Ashton FT, 2007, EXP PARASITOL, V115, P92, DOI 10.1016/j.exppara.2006.08.010; Ashton FT, 1999, VET PARASITOL, V84, P297, DOI 10.1016/S0304-4017(99)00037-0; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Ding HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1991-1; FRANKE TF, 1994, ONCOGENE, V9, P141; Gems D, 1998, GENETICS, V150, P129; He L, 2018, INT J PARASITOL, V48, P1023, DOI 10.1016/j.ijpara.2018.06.005; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kotze AC, 2006, MOL BIOCHEM PARASIT, V145, P101, DOI 10.1016/j.molbiopara.2005.09.012; Lei WQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07991-2; Li FC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1351-6; Li FC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0498-2; Li FC, 2014, INT J PARASITOL, V44, P485, DOI 10.1016/j.ijpara.2014.03.005; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MAPES CJ, 1969, PARASITOLOGY, V59, P215, DOI 10.1017/S0031182000069961; Massey HC, 2013, INT J PARASITOL, V43, P515, DOI 10.1016/j.ijpara.2013.01.008; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohandas N, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1341-8; Morel M, 2014, INT J PARASITOL-DRUG, V4, P256, DOI 10.1016/j.ijpddr.2014.09.004; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Riehle MA, 2003, INSECT MOL BIOL, V12, P225, DOI 10.1046/j.1365-2583.2003.00405.x; SOMMERVILLE RI, 1966, J PARASITOL, V52, P127, DOI 10.2307/3276403; Stecher G, 2014, BIOINFORMATICS, V30, P1305, DOI 10.1093/bioinformatics/btu018; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Stoltzfus JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038587; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissenbaum HA, 1998, GENETICS, V148, P703; Zawadzki JL, 2012, PARASITOLOGY, V139, P613, DOI 10.1017/S0031182012000121	38	6	7	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2075	2086		10.1096/fj.201900888RR	http://dx.doi.org/10.1096/fj.201900888RR		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907982				2022-12-26	WOS:000504677400001
J	Dwivedi, SKD; Shameer, K; Dey, A; Mustafi, SB; Xiong, XH; Bhattacharya, U; Neizer-Ashun, F; Rao, G; Wang, Y; Ivan, C; Yang, D; Dudley, JT; Xu, C; Wren, JD; Mukherjee, P; Bhattacharya, R				Dwivedi, Shailendra Kumar Dhar; Shameer, Khader; Dey, Anindya; Mustafi, Soumyajit Banerjee; Xiong, Xunhao; Bhattacharya, Udayan; Neizer-Ashun, Fiifi; Rao, Geeta; Wang, Yue; Ivan, Cristina; Yang, Da; Dudley, Joel T.; Xu, Chao; Wren, Jonathan D.; Mukherjee, Priyabrata; Bhattacharya, Resham			KRCC1: A potential therapeutic target in ovarian cancer	FASEB JOURNAL			English	Article						KRCC1; ovarian cancer; systems biology	PROTEIN PHOSPHATASE-1; COMPLEXES; CHROMATIN; NETWORK; INHIBITOR; CELLS	Using a systems biology approach to prioritize potential points of intervention in ovarian cancer, we identified the lysine rich coiled-coil 1 (KRCC1), as a potential target. High-grade serous ovarian cancer patient tumors and cells express significantly higher levels of KRCC1 which correlates with poor overall survival and chemoresistance. We demonstrate that KRCC1 is predominantly present in the chromatin-bound nuclear fraction, interacts with HDAC1, HDAC2, and with the serine-threonine phosphatase PP1CC. Silencing KRCC1 inhibits cellular plasticity, invasive properties, and potentiates apoptosis resulting in reduced tumor growth. These phenotypes are associated with increased acetylation of histones and with increased phosphorylation of H2AX and CHK1, suggesting the modulation of transcription and DNA damage that may be mediated by the action of HDAC and PP1CC, respectively. Hence, we address an urgent need to develop new targets in cancer.	[Dwivedi, Shailendra Kumar Dhar; Dey, Anindya; Bhattacharya, Udayan; Neizer-Ashun, Fiifi; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Shameer, Khader; Dudley, Joel T.] Mt Sinai Hlth Syst, Dept Genet & Genom Sci, Icahn Inst Data Sci & Genom Technol, Inst Next Generat Healthcare INGH, New York, NY USA; [Mustafi, Soumyajit Banerjee] Burst Biol Smart Surg Inc, Res & Dev, 3501 W Elder St, Boise, ID USA; [Xiong, Xunhao; Rao, Geeta; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Wang, Yue; Yang, Da] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA USA; [Ivan, Cristina] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ivan, Cristina] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Xu, Chao] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Mukherjee, Priyabrata; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Icahn School of Medicine at Mount Sinai; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Dept Obstet & Gynecol, 975 NE 10th St,BRC 1409B, Oklahoma City, OK 73104 USA.	Resham-Bhattacharya@ouhsc.edu	Xu, Chao/AAN-6427-2020; Bhattacharya, Udayan/ABG-5402-2021	Xu, Chao/0000-0002-3821-6187; Bhattacharya, Udayan/0000-0001-5380-7498	HHS \ National Institutes of Health (NIH) [CA157481, UL1TR000067, 5U54GM104938]; University of Oklahoma; National Institute of General Medical Sciences; Core; National Center for Advancing Translational Sciences	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Core(Luxembourg National Research Fund); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: CA157481, UL1TR000067 and 5U54GM104938; University of Oklahoma; National Institute of General Medical Sciences; Core; National Center for Advancing Translational Sciences	Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cohen PTW, 2002, J CELL SCI, V115, P241; Cortez AJ, 2018, CANCER CHEMOTH PHARM, V81, P17, DOI 10.1007/s00280-017-3501-8; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Castro IJ, 2017, CELL CYCLE, V16, P2011, DOI 10.1080/15384101.2017.1371883; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dwivedi SKD, 2016, ONCOTARGET, V7, P15093, DOI 10.18632/oncotarget.7618; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; Freeman AK, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-27; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang X, 2019, CANCER MANAG RES, V11, P4371, DOI 10.2147/CMAR.S200524; Ju JH, 2009, ORG LETT, V11, P1639, DOI 10.1021/ol900293j; Klymenko Y, 2017, CANCERS, V9, DOI 10.3390/cancers9080104; Krzyzosiak A, 2018, CELL, V174, P1216, DOI 10.1016/j.cell.2018.06.030; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mistry D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187091; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mustafi SB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0617-8; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Peters LA, 2017, NAT GENET, V49, P1437, DOI 10.1038/ng.3947; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Saha S, 2016, ACS NANO, V10, P10636, DOI 10.1021/acsnano.6b02231; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Seidel C, 2012, BIOCHIMIE, V94, P2264, DOI 10.1016/j.biochi.2012.05.012; Shan WW, 2012, CELL CYCLE, V11, P2107, DOI 10.4161/cc.20544; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang HM, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.41; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Vagnarelli P, 2018, CELL, V174, P1049, DOI 10.1016/j.cell.2018.08.007; Verheyen T, 2015, NUCLEIC ACIDS RES, V43, P5771, DOI 10.1093/nar/gkv500; Wang FF, 2019, CANCER RES, V79, P2526, DOI 10.1158/0008-5472.CAN-18-1673; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Winkler C, 2015, J CELL SCI, V128, P4526, DOI 10.1242/jcs.175588; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yadav BS, 2018, CURR TOP MED CHEM, V18, P1737, DOI 10.2174/1568026618666181025112344; Yao YL, 2005, CURR CANCER DRUG TAR, V5, P595, DOI 10.2174/156800905774932815; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	56	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2287	2300		10.1096/fj.201902259R	http://dx.doi.org/10.1096/fj.201902259R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908025	Green Accepted, Bronze			2022-12-26	WOS:000504091300001
J	Inoue, K; Hu, XY; Zhao, BH				Inoue, Kazuki; Hu, Xiaoyu; Zhao, Baohong			Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption	FASEB JOURNAL			English	Article						inflammatory bone resorption; osteoclast; osteoimmunology; rheumatoid arthritis	NF-KAPPA-B; CALCIUM-SENSING RECEPTOR; RBP-J; RHEUMATOID-ARTHRITIS; INDUCED OSTEOCLASTOGENESIS; NOTCH; TNF; TRANSCRIPTION; EXPRESSION; MIR-182	Bone resorption is a severe consequence of inflammatory diseases associated with osteolysis, such as rheumatoid arthritis (RA), often leading to disability in patients. In physiological conditions, the differentiation of bone-resorbing osteoclasts is delicately regulated by the balance between osteoclastogenic and anti-osteoclastogenic mechanisms. Inflammation has complex impact on osteoclastogenesis and bone destruction, and the underlying mechanisms of which, especially feedback inhibition, are underexplored. Here, we identify a novel regulatory network mediated by RBP-J/NFATc1-miR182 in TNF-induced osteoclastogenesis and inflammatory bone resorption. This network includes negative regulator RBP-J and positive regulators, NFATc1 and miR182, of osteoclast differentiation. In this network, miR182 is a direct target of both RBP-J and NFATc1. RBP-J represses, while NFATc1 activates miR182 expression through binding to specific open chromatin regions in the miR182 promoter. Inhibition of miR182 by RBP-J servers as a critical mechanism that limits TNF-induced osteoclast differentiation and inflammatory bone resorption. Inflammation, such as that which occurs in RA, shifts the expression levels of the components in this network mediated by RBP-J/NFATc1-miR182-FoxO3/PKR (previously identified miR182 targets) towards more osteoclastogenic, rather than healthy conditions. Treatment with TNF inhibitors in RA patients reverses the expression changes of the network components and osteoclastogenic potential. Thus, this network controls the balance between activating and repressive signals that determine the extent of osteoclastogenesis. These findings collectively highlight the biological significance and translational implication of this newly identified intrinsic regulatory network in inflammatory osteoclastogenesis and osteolysis.	[Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Hu, Xiaoyu] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Hu, Xiaoyu] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Zhao, Baohong] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Cell & Dev Biol, New York, NY 10021 USA	Cornell University; Tsinghua University; Tsinghua University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Zhao, BH (corresponding author), Hosp Special Surg, Res Inst R804,535 East 70th St, New York, NY 10021 USA.	zhaob@hss.edu	Inoue, Kazuki/GRY-3245-2022; Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR062047, AR068970, AR071463]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR062047; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR068970; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR071463	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bao QW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02705-0; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Binder N, 2017, J IMMUNOL, V198, P3436, DOI 10.4049/jimmunol.1601716; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Foldi J, 2016, PROTEIN CELL, V7, P201, DOI 10.1007/s13238-016-0248-7; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Gregersen PK, 2013, CELL, V155, P11, DOI 10.1016/j.cell.2013.08.050; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; Hendy GN, 2016, SEMIN CELL DEV BIOL, V49, P37, DOI 10.1016/j.semcdb.2015.11.006; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Inoue K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06446-0; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Kitaura H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/181849; Klein GL, 2016, SEMIN CELL DEV BIOL, V49, P52, DOI 10.1016/j.semcdb.2015.08.006; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Miller CH, 2016, J IMMUNOL, V196, P4977, DOI 10.4049/jimmunol.1502044; Nakashima T, 2011, ANN NY ACAD SCI, V1240, pE13, DOI 10.1111/j.1749-6632.2011.06373.x; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Olive V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005813; Orozco G, 2014, ARTHRITIS RHEUMATOL, V66, P24, DOI 10.1002/art.38196; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Royce BF, 2007, ANN NY ACAD SCI, V1116, P245, DOI 10.1196/annals.1402.084; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shang YL, 2016, PROTEIN CELL, V7, P159, DOI 10.1007/s13238-016-0250-0; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Sokhi UK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03081-7; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Swarnkar G, 2015, P NATL ACAD SCI USA, V112, P154, DOI 10.1073/pnas.1415213112; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Wang Y, 2015, J IMMUNOL, V194, P2878, DOI 10.4049/jimmunol.1402211; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yarilina A, 2011, P NATL ACAD SCI USA, V108, P1573, DOI 10.1073/pnas.1010030108; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zhao BH, 2017, CURR OSTEOPOROS REP, V15, P126, DOI 10.1007/s11914-017-0358-z; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	60	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2392	2407		10.1096/fj.201902227R	http://dx.doi.org/10.1096/fj.201902227R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908034	Bronze, Green Accepted			2022-12-26	WOS:000504093800001
J	Chrissian, C; Camacho, E; Fu, MS; Prados-Rosales, R; Chatterjee, S; Cordero, RJB; Lodge, JK; Casadevall, A; Stark, RE				Chrissian, Christine; Camacho, Emma; Fu, Man Shun; Prados-Rosales, Rafael; Chatterjee, Subhasish; Cordero, Radames J. B.; Lodge, Jennifer K.; Casadevall, Arturo; Stark, Ruth E.			Melanin deposition in two Cryptococcus species depends on cell-wall composition and flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell wall; polysaccharide; nuclear magnetic resonance (NMR); solid state NMR; Cryptococcus; melanin; molecular structure; opportunistic pathogen; virulence factor	SOLID-STATE NMR; DEACETYLATED CHITINS CHITOSANS; VANCOUVER-ISLAND; NEOFORMANS; VIRULENCE; GATTII; MELANIZATION; OUTBREAK; POLYSACCHARIDE; BIOSYNTHESIS	Cryptococcus neoformans and Cryptococcus gattii are two species complexes in the large fungal genus Cryptococcus and are responsible for potentially lethal disseminated infections. These two complexes share several phenotypic traits, such as production of the protective compound melanin. In C. neoformans, the pigment associates with key cellular constituents that are essential for melanin deposition within the cell wall. Consequently, melanization is modulated by changes in cell-wall composition or ultrastructure. However, whether similar factors influence melanization in C. gattii is unknown. Herein, we used transmission EM, biochemical assays, and solid-state NMR spectroscopy of representative isolates and ?leaky melanin? mutant strains from each species complex to examine the compositional and structural factors governing cell-wall pigment deposition in C. neoformans and C. gattii. The principal findings were the following. 1) C. gattii R265 had an exceptionally high chitosan content compared with C. neoformans H99; a rich chitosan composition promoted homogeneous melanin distribution throughout the cell wall but did not increase the propensity of pigment deposition. 2) Strains from both species manifesting the leaky melanin phenotype had reduced chitosan content, which was compensated for by the production of lipids and other nonpolysaccharide constituents that depended on the species or mutation. 3) Changes in the relative rigidity of cell-wall chitin were associated with aberrant pigment retention, implicating cell-wall flexibility as an independent variable in cryptococcal melanin assembly. Overall, our results indicate that cell-wall composition and molecular architecture are critical factors for the anchoring and arrangement of melanin pigments in both C. neoformans and C. gattii species complexes.	[Chrissian, Christine; Chatterjee, Subhasish; Stark, Ruth E.] CUNY City Coll, Dept Chem & Biochem, MR 1024, New York, NY 10031 USA; [Chrissian, Christine; Chatterjee, Subhasish; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Chrissian, Christine; Stark, Ruth E.] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Stark, Ruth E.] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA; [Camacho, Emma; Fu, Man Shun; Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Prados-Rosales, Rafael] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10033 USA; [Prados-Rosales, Rafael] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth & Microbiol, E-28049 Madrid, Spain; [Lodge, Jennifer K.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Chatterjee, Subhasish] Columbia Univ, Dept Chem, Barnard Coll, New York, NY 10027 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Autonomous University of Madrid; Washington University (WUSTL); Columbia University	Stark, RE (corresponding author), CUNY City Coll, Dept Chem & Biochem, MR 1024, New York, NY 10031 USA.	rstark@ccny.cuny.edu	Prados-Rosales, Rafael/D-5840-2019; Chatterjee, Subhasish/AAT-6069-2020; Cordero, Radames JB/F-6912-2011	Prados-Rosales, Rafael/0000-0001-5964-0166; Chatterjee, Subhasish/0000-0003-1351-3537; Chrissian, Christine/0000-0003-2858-4864; Cordero, Radames JB/0000-0002-3026-7094; Stark, Ruth E/0000-0002-3132-4580	National Institutes of Health [R01-AI052733]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01-AI052733 (to A. C. and R. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the respon-sibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agustinho DP, 2019, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180040; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Baker LG, 2009, EUKARYOT CELL, V8, P1692, DOI 10.1128/EC.00227-09; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BULL A T, 1970, Journal of General Microbiology, V63, P75; Camacho E, 2017, MICROBIOL-SGM, V163, P1540, DOI 10.1099/mic.0.000552; Casadevall A, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00103-17, 10.1128/msphere.00103-17]; Chatterjee S, 2018, J BIOL CHEM, V293, P20157, DOI 10.1074/jbc.RA118.005791; Chatterjee S, 2015, J BIOL CHEM, V290, P13779, DOI 10.1074/jbc.M114.618389; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; Cui JH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010061; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; EMMONS CW, 1955, AM J HYG, V62, P227, DOI 10.1093/oxfordjournals.aje.a119775; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Freij JB, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00946-17, 10.1128/iai.00946-17]; Gerstein AC, 2017, YEAST, V34, P143, DOI 10.1002/yea.3222; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Grifoll-Romero L, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10040352; Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y; HING AW, 1993, J MAGN RESON SER A, V103, P151, DOI 10.1006/jmra.1993.1146; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; Kwon-Chung KJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00357-16; Lam WC, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00644-19; Latge JP, 2014, CURR OPIN MICROBIOL, V20, P111, DOI 10.1016/j.mib.2014.05.009; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Liu L, 1999, INFECT IMMUN, V67, P108, DOI 10.1128/IAI.67.1.108-112.1999; May RC, 2016, NAT REV MICROBIOL, V14, P106, DOI 10.1038/nrmicro.2015.6; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Oh DX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23245; P?rez P., 2013, LAB PROTOCOLS FUNGAL, P175, DOI 10.1007/978-1-4614-2356-0_12; Perez Pilar, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.top079897; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; Quemeneur F, 2008, BIOMACROMOLECULES, V9, P396, DOI 10.1021/bm700943j; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1261, DOI 10.1128/JCM.34.5.1261-1263.1996; Stavenga DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049743; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tsirilakis K, 2012, MYCOPATHOLOGIA, V173, P83, DOI 10.1007/s11046-011-9483-x; VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S; VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2; Walker CA, 2010, EUKARYOT CELL, V9, P1329, DOI 10.1128/EC.00051-10; Walker L, 2018, MBIO, V9, DOI 10.1128/mBio.02383-17; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang Z, 1999, INFECT IMMUN, V67, P6619; Watson HR, 2009, BIOMACROMOLECULES, V10, P793, DOI 10.1021/bm8012814; Weinhold MX, 2009, CARBOHYD POLYM, V78, P678, DOI 10.1016/j.carbpol.2009.06.001; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang YC, 2012, J PHYS CHEM B, V116, P1579, DOI 10.1021/jp210043w; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	65	21	21	4	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1815	1828		10.1074/jbc.RA119.011949	http://dx.doi.org/10.1074/jbc.RA119.011949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31896575	Green Published, hybrid			2022-12-26	WOS:000517128200004
J	Chang, CY; Lin, F; Zhou, X; Zhao, GX				Chang, Chunyan; Lin, Fen; Zhou, Xue; Zhao, Gengxing			Hyper-spectral response and estimation model of soil degradation in Kenli County, the Yellow River Delta	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; LAND DEGRADATION; QUALITY; STATE; RISK	The ecological environment of the Yellow River Delta is fragile, and the soil degradation in the region is serious. Therefore it is important to discern the status of the soil degradation in a timely manner for soil conservation and utilization. The study area of this study was Kenli County in the Yellow River Delta of China. First, physical and chemical data of the soil were obtained by field investigations and soil sample analyses, and the hyper-spectra of air-dried soil samples were obtained via spectrometer. Then, the soil degradation index (SDI) was constructed by the key indicators of soil degradation, including pH, SSC, OM, AN, AP, AK, and soil texture. Next, according to a cluster analysis, soil degradation was divided into the following three grades: light degradation, moderate degradation, and heavy degradation. Moreover, the spectral characteristics of soil degradation were analyzed, and an estimation model of SDI was established by multiple stepwise regression. The results showed that the overall level of reflectance spectra increased with increased degree of soil degradation, that both derivative transformation and waveband reorganization could enhance the spectral information of soil degradation, and that the correlation between SDI and the spectral parameter of (R-lambda 2+R-lambda 1)/(R-lambda 2-R-lambda 1) was the highest among all the spectral parameters studied. On this basis, the optimum estimation model of SDI was established with the correlation coefficient of 0.811. This study fully embodies the potential of hyper-spectral technology in the study of soil degradation and provides a technical reference for the rapid extraction of information from soil degradation. Additionally, the study area is typical and representative, and thus can indirectly reflect the soil degradation situation of the whole Yellow River Delta.	[Chang, Chunyan; Lin, Fen; Zhou, Xue; Zhao, Gengxing] Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Lin, Fen] Qingdao Hengyuande Real Estate Appraisal Ltd Co, Qingdao, Shandong, Peoples R China; [Zhou, Xue] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Shandong Agricultural University; State University System of Florida; University of Florida	Zhao, GX (corresponding author), Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Coll Resources & Environm, Tai An, Shandong, Peoples R China.	zhaogx@sdau.edu.cn			National Natural Science Foundation of China [41877003]; National Science and Technology Projects [2015BAD23B0202]; Funds of Shandong "Double Tops" Program [SYL2017XTTD02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Projects; Funds of Shandong "Double Tops" Program	This work was financially supported by the National Natural Science Foundation of China (grant number 41877003), National Science and Technology Projects (grant numbers 2015BAD23B0202) and Funds of Shandong "Double Tops" Program (SYL2017XTTD02).	An DY, 2016, INT J REMOTE SENS, V37, P455, DOI 10.1080/01431161.2015.1129562; [Anonymous], 1954, 34 USDA; Bednar M, 2018, ENVIRON RES, V164, P660, DOI 10.1016/j.envres.2018.03.042; Ben-Dor E, 2009, REMOTE SENS ENVIRON, V113, pS38, DOI 10.1016/j.rse.2008.09.019; Cannane NOA, 2013, SPECTROCHIM ACTA A, V110, P46, DOI 10.1016/j.saa.2013.03.040; Cavalli A. C., 2000, Acta Scientiarum, V22, P1037; Chang CW, 2002, SOIL SCI, V167, P110, DOI 10.1097/00010694-200202000-00003; Chen HY, 2016, APPL SPECTROSC, V70, P1589, DOI 10.1177/0003702816662605; Cloutis EA, 1996, INT J REMOTE SENS, V17, P2215, DOI 10.1080/01431169608948770; Confalonieri M, 2001, J NEAR INFRARED SPEC, V9, P123, DOI 10.1255/jnirs.299; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; DeTar WR, 2008, T ASABE, V51, P463, DOI 10.13031/2013.24388; Fan X, 2012, LAND DEGRAD DEV, V23, P175, DOI 10.1002/ldr.1071; Filep T, 2016, VIB SPECTROSC, V84, P16, DOI 10.1016/j.vibspec.2016.02.005; Gholizadeh A, 2013, APPL SPECTROSC, V67, P1349, DOI 10.1366/13-07288; Guo B, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8319-8; Jiang R, 2000, SOIL AGR CHEM ANAL, P178; Kassahun D, 2006, INT J REMOTE SENS, V27, P4213, DOI 10.1080/01431160600702418; Leone AP, 2000, REMOTE SENS ENVIRON, V72, P346, DOI 10.1016/S0034-4257(99)00110-8; Li J, 2014, STANDARD SCI, P34; Li J, 2014, SPECTROSC SPECT ANAL, V34, P520, DOI 10.3964/j.issn.1000-0593(2014)02-0520-06; [李西灿 Li Xican], 2014, [测绘科学技术学报, Journal of Geomatics Science and Technology], V31, P593; Li YanLing, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P173; Lu D, 2007, LAND DEGRAD DEV, V18, P41, DOI 10.1002/ldr.762; Mathieu R, 2007, EARTH SURF PROC LAND, V32, P13, DOI 10.1002/esp.1343; Mirzaee S, 2016, CATENA, V145, P118, DOI 10.1016/j.catena.2016.05.023; Ni JiuPai, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P202; Omuto CT, 2007, INT J REMOTE SENS, V28, P4785, DOI 10.1080/01431160701260357; Qi SZ, 2017, NAT HAZARDS, V85, P1907, DOI 10.1007/s11069-016-2638-9; [乔蕻强 Qiao Hongqiang], 2016, [土壤通报, Chinese Journal of Soil Science], V47, P302; RAINA P, 1993, ARID SOIL RES REHAB, V7, P145, DOI 10.1080/15324989309381344; SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004; Su B, 2016, IDENTIFICATION ASSES, P84; [孙战秀 Sun Zhanxiu], 2018, [自然资源学报, Journal of Natural Resources], V33, P262; Sur K, 2019, GEOMAT NAT HAZ RISK, V10, P898, DOI 10.1080/19475705.2018.1552629; Symeonakis E, 2004, INT J REMOTE SENS, V25, P573, DOI 10.1080/0143116031000095998; Tao M, 2015, 2015 INTERNATIONAL CONFERENCE ON MATERIALS AND ENGINEERING AND INDUSTRIAL APPLICATIONS (MEIA 2015), P9; Terhoeven-Urselmans T, 2008, SOIL BIOL BIOCHEM, V40, P1178, DOI 10.1016/j.soilbio.2007.12.011; Thiam AK, 2003, LAND DEGRAD DEV, V14, P133, DOI 10.1002/ldr.533; Tian Y, 1997, NATL SOIL SURVEY DAT, P132; Wang Q, 2012, GEODERMA, V170, P103, DOI 10.1016/j.geoderma.2011.10.015; [王晓慧 Wang Xiaohui], 2011, [山地学报, Journal of Mountain Science], V29, P442; Wang XP, 2018, SCI TOTAL ENVIRON, V615, P918, DOI 10.1016/j.scitotenv.2017.10.025; Wang ZR, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5777-x; [王卓然 Wang Zhuoran], 2016, [生态学报, Acta Ecologica Sinica], V36, P1040; Wessels KJ, 2004, REMOTE SENS ENVIRON, V91, P47, DOI 10.1016/j.rse.2004.02.005; Wu CS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050855; [Zhang Xuefei 张雪飞], 2018, [Journal of Resources and Ecology, 资源与生态学报], V9, P135; Zhao HG, 2018, J GEOGR SCI, V28, P175, DOI 10.1007/s11442-018-1466-0	49	2	2	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227594	10.1371/journal.pone.0227594	http://dx.doi.org/10.1371/journal.pone.0227594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914170	gold, Green Published			2022-12-26	WOS:000534337700050
J	Thompson, KM; Huber, DPW; Murray, BW				Thompson, Kirsten M.; Huber, Dezene P. W.; Murray, Brent W.			Autumn shifts in cold tolerance metabolites in overwintering adult mountain pine beetles	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE; CLIMATE; HARDINESS; PROLINE	The mountain pine beetle, Dendroctonus ponderosae (Coleoptera: Curculionidae) is a major forest pest of pines in western North America. Beetles typically undergo a one-year life cycle with larval cold hardening in preparation for overwintering. Two-year life cycle beetles have been observed but not closely studied. This study tracks cold-hardening and preparation for overwintering by adult mountain pine beetles in their natal galleries. Adults were collected in situ between September and December 2016 for a total of nine time points during 91 days. Concentrations of 41 metabolites in these pooled samples were assessed using quantitative nuclear magnetic resonance (NMR). Levels of glycerol and proline increased significantly with lowering temperature during the autumn. Newly eclosed mountain pine beetles appear to prepare for winter by generating the same cold-tolerance compounds found in other insect larvae including mountain pine beetle, but high on-site mortality suggested that two-year life cycle adults have a less efficacious acclimation process. This is the first documentation of cold acclimation metabolite production in overwintering new adult beetles and is evidence of physiological plasticity that would allow evolution by natural selection of alternate life cycles (shortened or lengthened) under a changing climate or during expansion into new geoclimatic areas. This research was supported by a grant from the Natural Science and Engineering Research Council of Canada (grant no. NET GP 434810-12) < http://www.nserc-crsng.gc.ca/index_ eng.asp) to the TRIA Network and its research partners (KMT, DPWH, BWM); a Research Project Award < https://www.unbc.ca/graduate-programs/awards/awards-and-scholarships-introduction > grant from the University of Northern British Columbia (KMT); a Natural Science and Engineering Research Council of Canada < http://www.nserc-crsng.gc.ca/index_eng.asp > Discovery Grant (DPWH), the Canada Research Chair program < http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx > (DPWH); The Canada Foundation for Innovation < https://www.innovation.ca/> (DPWH) and the BC Knowledge Development Fund < https://www2.gov.bc.ca/gov/content/governments/about-the-bc-government/technology-innovation/bckdf > (DPWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Thompson, Kirsten M.; Huber, Dezene P. W.; Murray, Brent W.] Univ Northern British Columbia, Nat Resources & Environm Studies, Prince George, BC, Canada	University of Northern British Columbia	Thompson, KM (corresponding author), Univ Northern British Columbia, Nat Resources & Environm Studies, Prince George, BC, Canada.	kthompso@unbc.ca		Huber, Dezene/0000-0002-6495-1759	Natural Science and Engineering Research Council of Canada [NET GP 434810-12]; University of Northern British Columbia; Natural Science and Engineering Research Council of Canada; Canada Research Chair program; Canada Foundation for Innovation; BC Knowledge Development Fund	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Northern British Columbia; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); BC Knowledge Development Fund(General Electric)	This research was supported by a grant from the Natural Science and Engineering Research Council of Canada (grant no. NET GP 434810-12) < http://www.nserc-crsng.gc.ca/index_ eng.asp) to the TRIA Network and its research partners (KMT, DPWH, BWM); a Research Project Award < https://www.unbc.ca/graduate-programs/awards/awards-and-scholarships-introduction > grant from the University of Northern British Columbia (KMT); a Natural Science and Engineering Research Council of Canada < http://www.nserc-crsng.gc.ca/index_eng.asp > Discovery Grant (DPWH), the Canada Research Chair program < http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx > (DPWH); The Canada Foundation for Innovation < https://www.innovation.ca/> (DPWH) and the BC Knowledge Development Fund < https://www2.gov.bc.ca/gov/content/governments/about-the-bc-government/technology-innovation/bckdf > (DPWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMAN G D, 1973, Environmental Entomology, V2, P541, DOI 10.1093/ee/2.4.541; Bentz BJ, 2016, FORESTRY, V89, P271, DOI 10.1093/forestry/cpv054; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bentz BJ, 2014, AM NAT, V184, P787, DOI 10.1086/678405; Bentz BJ, 1991, PHYSL CHEM ECOL, V28, P577, DOI [10.1093/ee/28.4.577, DOI 10.1093/EE/28.4.577]; Bleiker KP, 2017, ENVIRON ENTOMOL, V46, P1165, DOI 10.1093/ee/nvx127; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; Bracewell RR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01761-4; Carrasco MA, 2012, J PROTEOMICS, V75, P1220, DOI 10.1016/j.jprot.2011.10.034; Carroll A. L., 2003, MOUNT PIN BEETL S CH, P223; Chong J, 2018, BIOINFORMATICS, V34, P4313, DOI 10.1093/bioinformatics/bty528; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; DE LEON D., 1934, Journal of Forestry, V32, P430; Elnitsky MA, 2008, J EXP BIOL, V211, P524, DOI 10.1242/jeb.011874; Feng YQ, 2016, AGR FOREST ENTOMOL, V18, P302, DOI 10.1111/afe.12162; Fraser JD, 2017, PEERJ, V5, DOI 10.7717/peerj.3284; Gade G, 2002, COMP BIOCHEM PHYS B, V132, P117, DOI 10.1016/S1096-4959(01)00541-3; Goodsman DW, 2018, GLOBAL CHANGE BIOL, V24, P3620, DOI 10.1111/gcb.14284; Hrinkevich K, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00150.1; Janes JK, 2014, MOL BIOL EVOL, V31, P1803, DOI 10.1093/molbev/msu135; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kostal V, 2011, J INSECT PHYSIOL, V57, P1136, DOI 10.1016/j.jinsphys.2011.03.011; Leather S.R., 1995, ECOLOGY INSECT OVERW; LOGAN JA, 1995, USDA ROCKY, V262, P92; MILLER LK, 1987, CAN J ZOOL, V65, P2927, DOI 10.1139/z87-444; Pemberton TA, 2012, ACTA CRYSTALLOGR D, V68, P1010, DOI 10.1107/S0907444912019580; Pitt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110673; Regniere J, 2007, J INSECT PHYSIOL, V53, P559, DOI 10.1016/j.jinsphys.2007.02.007; Robert JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2109; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Safranyik L., 1998, Journal of the Entomological Society of British Columbia, V95, P81; Six D., 2015, BARK BEETLES BIOL EC, P305, DOI [10.1016/B978-0-12-417156-5.00008-3, DOI 10.1016/B978-0-12-417156-5.00008-3]; Storey KB, 2012, CAN J ZOOL, V90, P456, DOI 10.1139/Z2012-011; STORY JM, 1983, J COMP PHYSIOL, V149, P495, DOI 10.1007/BF00690008; Teulier L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0333; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34698; Wertman DL, 2018, CAN ENTOMOL, V150, P622, DOI 10.4039/tce.2018.38	38	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227203	10.1371/journal.pone.0227203	http://dx.doi.org/10.1371/journal.pone.0227203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914144	Green Published, Green Submitted, gold			2022-12-26	WOS:000534337700032
J	Bagheri-Fam, S; Chen, HJ; Wilson, S; Ayers, K; Hughes, J; Sloan-Bena, F; Calvel, P; Robevska, G; Puisac, B; Kusz-Zamelczyk, K; Gimelli, S; Spik, A; Jaruzelska, J; Warenik-Szymankiewicz, A; Faradz, S; Nef, S; Pie, J; Thomas, P; Sinclair, A; Wilhelm, D				Bagheri-Fam, Stefan; Chen, Huijun; Wilson, Sean; Ayers, Katie; Hughes, James; Sloan-Bena, Frederique; Calvel, Pierre; Robevska, Gorjana; Puisac, Beatriz; Kusz-Zamelczyk, Kamila; Gimelli, Stefania; Spik, Anna; Jaruzelska, Jadwiga; Warenik-Szymankiewicz, Alina; Faradz, Sultana; Nef, Serge; Pie, Juan; Thomas, Paul; Sinclair, Andrew; Wilhelm, Dagmar			The gene encoding the ketogenic enzyme HMGCS2 displays a unique expression during gonad development in mice	PLOS ONE			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY; AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; FUNCTIONAL-ANALYSIS; DYNAMIC EXPRESSION; BETA-CATENIN; SRY; TESTIS; SOX9; MUTATIONS	Disorders/differences of sex development (DSD) cause profound psychological and reproductive consequences for the affected individuals, however, most are still unexplained at the molecular level. Here, we present a novel gene, 3-hydroxy-3-methylglutaryl coenzyme A synthase 2 (HMGCS2), encoding a metabolic enzyme in the liver important for energy production from fatty acids, that shows an unusual expression pattern in developing fetal mouse gonads. Shortly after gonadal sex determination it is up-regulated in the developing testes following a very similar spatial and temporal pattern as the male-determining gene Sry in Sertoli cells before switching to ovarian enriched expression. To test if Hmgcs2 is important for gonad development in mammals, we pursued two lines of investigations. Firstly, we generated Hmgcs2-null mice using CRISPR/Cas9 and found that these mice had gonads that developed normally even on a sensitized background. Secondly, we screened 46,XY DSD patients with gonadal dysgenesis and identified two unrelated patients with a deletion and a deleterious missense variant in HMGCS2 respectively. However, both variants were heterozygous, suggesting that HMGCS2 might not be the causative gene. Analysis of a larger number of patients in the future might shed more light into the possible association of HMGCS2 with human gonadal development.	[Bagheri-Fam, Stefan; Wilhelm, Dagmar] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Chen, Huijun] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wilson, Sean; Ayers, Katie; Robevska, Gorjana; Sinclair, Andrew] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ayers, Katie; Robevska, Gorjana; Sinclair, Andrew] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Hughes, James; Thomas, Paul] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Sloan-Bena, Frederique; Gimelli, Stefania; Nef, Serge] Univ Geneva Hosp, Serv Genet Med, Geneva, Switzerland; [Calvel, Pierre] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Puisac, Beatriz; Pie, Juan] Univ Zaragoza, Sch Med, Dept Pharmacol Physiol, Unit Clin Genet & Funct Genom,CIBERER GCV02, Zaragoza, Spain; [Puisac, Beatriz; Pie, Juan] ISS Aragon, Zaragoza, Spain; [Kusz-Zamelczyk, Kamila; Spik, Anna; Jaruzelska, Jadwiga] Polish Acad Sci, Inst Human Genet, Poznan, Poland; [Warenik-Szymankiewicz, Alina] Poznan Univ Med Sci, Dept Gynecol Endocrinol, Poznan, Poland; [Faradz, Sultana] Diponegoro Univ FM DU, Fac Med, Ctr Biomed Res, Semarang, Indonesia; [Calvel, Pierre] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France	University of Melbourne; University of Queensland; Murdoch Children's Research Institute; University of Melbourne; University of Adelaide; University of Geneva; University of Geneva; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Poznan University of Medical Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wilhelm, D (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.	dagmar.wilhelm@unimelb.edu.au	Sinclair, Andrew H/A-3598-2010; Nef, Serge/AAV-6445-2020; Wilhelm, Dagmar/B-6915-2009	Sinclair, Andrew H/0000-0003-2741-7992; Nef, Serge/0000-0001-5462-0676; Wilhelm, Dagmar/0000-0002-7757-4075; Puisac Uriol, Beatriz/0000-0003-0170-7326; Jaruzelska, Jadwiga/0000-0003-2355-0729; ayers, katie/0000-0002-6840-3186; Kusz-Zamelczyk, Kamila/0000-0002-6567-1193	Australian Research Council Future Fellowship [FT110100327]; Australian Research Council [DP170100045]; National Health & Medical Research Council program grant [APP1074258]; Riset Unggulan Univeritas Diponegoro [PNBP] [316-01/UN7.5.1/PG/2015]; Swiss National Science Foundation [IZ73Z0_152347/1]; Diputacion General de Aragon [B32_17R]; European Social Fund [FEDER]	Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council(Australian Research Council); National Health & Medical Research Council program grant; Riset Unggulan Univeritas Diponegoro [PNBP]; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Diputacion General de Aragon(Gobierno de Aragon); European Social Fund [FEDER](European Social Fund (ESF)European Commission)	This work was supported by an Australian Research Council Future Fellowship [FT110100327] and an Australian Research Council discovery grant [DP170100045] to DW, a National Health & Medical Research Council program grant [APP1074258] to AS, as well as partly funded by Riset Unggulan Univeritas Diponegoro [PNBP no 316-01/UN7.5.1/PG/2015] to SF, the Swiss National Science Foundation [joint research project SCOPES IZ73Z0_152347/1] to SN and JJ and the Diputacion General de Aragon [Grupo B32_17R] and European Social Fund [FEDER] to BP and JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aledo R, 2006, J INHERIT METAB DIS, V29, P207, DOI 10.1007/s10545-006-0214-2; Aledo R, 2001, HUM GENET, V109, P19, DOI 10.1007/s004390100554; Auguste A, 2011, SEX DEV, V5, P304, DOI 10.1159/000334517; Bagheri-Fam S, 2017, ENDOCRINOLOGY, V158, P3832, DOI 10.1210/en.2017-00674; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Baxter RM, 2015, J CLIN ENDOCR METAB, V100, pE333, DOI 10.1210/jc.2014-2605; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bouchard L, 2001, PEDIATR RES, V49, P326, DOI 10.1203/00006450-200103000-00005; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Callier P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004340; Camats N, 2018, EUR J HUM GENET, V26, P1329, DOI 10.1038/s41431-018-0202-7; Carre GA, 2018, HUM MOL GENET, V27, P190, DOI 10.1093/hmg/ddx398; CASALS N, 1992, BIOCHEM J, V283, P261, DOI 10.1042/bj2830261; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chen HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041683; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Conboy E, 2018, JIMD REP, V40, P63, DOI 10.1007/8904_2017_59; Eggers S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1105-y; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hughes IA., 2006, J PEDIATR UROL, V2, P148, DOI [DOI 10.1016/J.JPUROL.2006.03.004, 10.1101/gr.247007.118]; Hughes J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12574-2; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Matoba S, 2005, J CELL SCI, V118, P1449, DOI 10.1242/jcs.01738; Matoba S, 2008, DEV BIOL, V324, P76, DOI 10.1016/j.ydbio.2008.09.004; Mazen I, 2016, SEX DEV, V10, P147, DOI 10.1159/000445983; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Ostrer H, 2014, J CLIN ENDOCR METAB, V99, P1503, DOI 10.1210/jc.2013-3690; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Pitt JJ, 2015, J INHERIT METAB DIS, V38, P459, DOI 10.1007/s10545-014-9801-9; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; Puisac B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041010; Ramos M, 2013, EUR J MED GENET, V56, P411, DOI 10.1016/j.ejmg.2013.05.008; Robevska G, 2018, HUM MUTAT, V39, P124, DOI 10.1002/humu.23354; ROYO T, 1993, J LIPID RES, V34, P867; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shafqat N, 2010, J MOL BIOL, V398, P497, DOI 10.1016/j.jmb.2010.03.034; Shapouri F, 2016, CELL TISSUE RES, V364, P443, DOI 10.1007/s00441-015-2328-z; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Svingen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052620; Thompson GN, 1997, NEW ENGL J MED, V337, P1203, DOI 10.1056/NEJM199710233371704; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Vilain E, 2007, GENET MED, V9, P65, DOI 10.1097/GIM.0b013e31802cffcf; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang QD, 2017, CELL DEATH DIFFER, V24, P458, DOI 10.1038/cdd.2016.142; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2013, CURR TOP DEV BIOL, V106, P89, DOI 10.1016/B978-0-12-416021-7.00003-1; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Wolf NI, 2003, EUR J PEDIATR, V162, P279, DOI 10.1007/s00431-002-1110-x; Zschocke J, 2002, J PEDIATR-US, V140, P778, DOI 10.1067/mpd.2002.123854	66	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227411	10.1371/journal.pone.0227411	http://dx.doi.org/10.1371/journal.pone.0227411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910233	Green Published, Green Submitted, gold			2022-12-26	WOS:000534333800046
J	Hwang, S; Greenlee, JJ; Nicholson, EM				Hwang, Soyoun; Greenlee, Justin J.; Nicholson, Eric M.			Role of donor genotype in RT-QuIC seeding activity of chronic wasting disease prions using human and bank vole substrates	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CERVUS-ELAPHUS-NELSONI; WHITE-TAILED DEER; TIME; TRANSMISSION; PROTEIN; ELK; SUSCEPTIBILITY; DISCRIMINATION; BARRIERS	Chronic wasting disease is a transmissible spongiform encephalopathy of cervids. This fatal neurodegenerative disease is caused by misfolding of the cellular prion protein (PrPC) to pathogenic conformers (PrPSc), and the pathogenic forms accumulate in the brain and other tissues. Real-time Quaking Induced Conversion (RT-QuIC) can be used for the detection of prions and for prion strain discrimination in a variety of biological tissues from humans and animals. In this study, we evaluated how either PrPSc from cervids of different genotypes or PrPSc from different sources of CWD influence the fibril formation of recombinant bank vole (BV) or human prion proteins using RT-QuIC. We found that reaction mixtures seeded with PrPSc from different genotypes of white-tailed deer or reindeer brains have similar conversion efficiency with both substrates. Also, we observed similar results when assays were seeded with different sources of CWD. Thus, we conclude that the genotypes of all sources of CWD used in this study do not influence the level of conversion of PrPC to PrPSc.	[Hwang, Soyoun; Greenlee, Justin J.; Nicholson, Eric M.] ARS, USDA, Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, USDA, Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50011 USA.	Eric.Nicholson@ars.usda.gov		Greenlee, Justin/0000-0003-2202-3054	United States Department of Agriculture, Agriculture Research Service	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agriculture Research Service. The funder of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Cheng KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084812; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dassanayake RP, 2016, J GEN VIROL, V97, P803, DOI 10.1099/jgv.0.000367; Davenport KA, 2015, J VIROL, V89, P9524, DOI 10.1128/JVI.01439-15; Department for Environment FaRA Agency APH Monitoring VSPAT-ID, MON VSPAT ID UPD CHR; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P554, DOI 10.1177/1040638712440993; Haley NJ, 2017, J GEN VIROL, V98, P2882, DOI 10.1099/jgv.0.000952; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Hwang S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209106; Hwang S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172391; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Kang HE, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5413936; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2015, J CLIN INVEST, V125, P2548, DOI 10.1172/JCI82647; Masujin K, 2016, J CLIN MICROBIOL, V54, P676, DOI 10.1128/JCM.02731-15; Moore SJ, 2016, VET PATHOL, V53, P1187, DOI 10.1177/0300985816629712; Moore SJ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1400-9; Moore SJ, 2016, EMERG INFECT DIS, V22, P2142, DOI 10.3201/eid2212.160635; Moore SJ, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00078; National Veterinary Institute, MAP CHRON WAST DIS C; Orru CD, 2015, FLUID, V6, P1, DOI DOI 10.1128/MBI0.02451-14; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race B, 2018, J VIROL, V92, DOI [10.1128/JVI.00550-18, 10.1128/jvi.00550-18]; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schmitz M, 2016, NAT PROTOC, V11, P2233, DOI 10.1038/nprot.2016.120; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Vrentas CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-167; Vrentas CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043060; Vrentas CE, 2012, PROTEIN EXPRES PURIF, V82, P380, DOI 10.1016/j.pep.2012.02.008	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227487	10.1371/journal.pone.0227487	http://dx.doi.org/10.1371/journal.pone.0227487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910440	Green Published, gold			2022-12-26	WOS:000534333800048
J	Liu, SW; Li, HT; Wu, SW; Li, LX; Ge, RS; Cheng, CY				Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan			NC1-peptide regulates spermatogenesis through changes in cytoskeletal organization mediated by EB1	FASEB JOURNAL			English	Article						+TIP; collagen alpha 3(IV) chain; cytoskeleton; EB1; microtubules; spermatogenesis; testis	BLOOD-TESTIS BARRIER; GERM CELL-INTERACTIONS; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; PROTEIN TRAFFICKING; ADHERENS JUNCTIONS; PASSIVE TRANSFER; LIFE-HISTORY; COLLAGEN-IV; IN-VITRO	During the epithelial cycle of spermatogenesis, different sets of cellular events take place across the seminiferous epithelium in the testis. For instance, remodeling of the blood-testis barrier (BTB) that facilitates the transport of preleptotene spermatocytes across the immunological barrier and the release of sperms at spermiation take place at the opposite ends of the epithelium simultaneously at stage VIII of the epithelial cycle. These cellular events are tightly coordinated via locally produced regulatory biomolecules. Studies have shown that collagen alpha 3 (IV) chains, a major constituent component of the basement membrane, release the non-collagenous (NC) 1 domain, a 28-kDa peptide, designated NC1-peptide, from the C-terminal region, via the action of MMP-9 (matrix metalloproteinase 9). NC1-peptide was found to be capable of inducing BTB remodeling and spermatid release across the epithelium. As such, the NC1-peptide is an endogenously produced biologically active peptide which coordinates these cellular events across the epithelium in stage VIII tubules. Herein, we used an animal model, wherein NC1-peptide cloned into the pCI-neo mammalian expression vector was overexpressed in the testis, to better understanding the molecular mechanism by which NC1-peptide regulated spermatogenic function. It was shown that NC1-peptide induced considerable downregulation on a number of cell polarity and planar cell polarity (PCP) proteins, and studies have shown these polarity and PCP proteins modulate spermatid polarity and adhesion via their effects on microtubule (MT) and F-actin cytoskeletal organization across the epithelium. More important, NC1-peptide exerted its effects by downregulating the expression of microtubule (MT) plus-end tracking protein (+TIP) called EB1 (end-binding protein 1). We cloned the full-length EB1 cDNA for its overexpression in the testis, which was found to block the NC1-peptide-mediated disruptive effects on cytoskeletal organization in Sertoli cell epithelium and pertinent Sertoli cell functions. These findings thus illustrate that NC1-peptide is working in concert with EB1 to support spermatogenesis.	[Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Peoples R China; [Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA	Wenzhou Medical University; Wenzhou Medical University; Population Council	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Li, Linxi/AFZ-9275-2022	Cheng, C Yan/0000-0003-3117-3791	National Institutes of Health (NICHD) [R01 HD056034]; National Natural Science Foundation of China (NSFC) [81971367, 81730042]	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Institutes of Health (NICHD, R01 HD056034 to CYC), National Natural Science Foundation of China (NSFC, grants 81971367 to L.L., and 81730042 to R.G.).	Ahmad K, 2021, SEMIN CANCER BIOL, V69, P325, DOI 10.1016/j.semcancer.2019.08.030; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Assadin S, 2008, EXPERT OPIN BIOL TH, V8, P941, DOI [10.1517/14712590802184482, 10.1517/14712598.8.7.941 ]; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bogdan Sven, 2013, Commun Integr Biol, V6, pe27634, DOI 10.4161/cib.27634; Bonnet ME, 2013, J CONTROL RELEASE, V170, P183, DOI 10.1016/j.jconrel.2013.05.015; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Burute M, 2019, ANNU REV CELL DEV BI, V35, P2221; Chen HQ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0339-x; Chen HQ, 2017, FASEB J, V31, P3587, DOI 10.1096/fj.201700052R; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; CLERMONT Y, 1987, ANN NY ACAD SCI, V513, P1, DOI 10.1111/j.1749-6632.1987.tb24994.x; de Kretser D.M., 1988, P837; DENDUCHIS B, 1985, J REPROD IMMUNOL, V7, P59, DOI 10.1016/0165-0378(85)90021-X; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Gao Y, 2017, ENDOCRINOLOGY, V158, P963, DOI 10.1210/en.2016-1630; Gao Y, 2017, FASEB J, V31, P584, DOI 10.1096/fj.201600870R; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; Gao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28589; Garcin C, 2019, ESSAYS BIOCHEM, V63, P509, DOI 10.1042/EBC20190016; Goode BL, 2018, TRENDS CELL BIOL, V28, P749, DOI 10.1016/j.tcb.2018.04.008; Gunda Venugopal, 2013, Invest Ophthalmol Vis Sci, V54, P7828, DOI 10.1167/iovs.12-10870; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Lanning LL, 2002, TOXICOL PATHOL, V30, P507, DOI 10.1080/01926230290105695; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Lee NPY, 2004, J ANDROL, V25, P200; Li JCH, 2001, J ANDROL, V22, P266; Li LX, 2019, ASIAN J ANDROL, V21, P365, DOI 10.4103/aja.aja_126_18; Li LX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1394-7; Li Linxi, 2017, F1000Res, V6, P1565, DOI 10.12688/f1000research.11421.1; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Lui WY, 2003, BIOL REPROD, V68, P1597, DOI 10.1095/biolreprod.102.011387; LUSTIG L, 1978, ARCH ANDROLOGY, V1, P333, DOI 10.3109/01485017808988354; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08894; Mao YH, 2011, TRENDS CELL BIOL, V21, P625, DOI 10.1016/j.tcb.2011.08.005; McDonald JA, 2014, INT REV CEL MOL BIO, V312, P169, DOI 10.1016/B978-0-12-800178-3.00006-3; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231; Monboisse JC, 2014, BBA-GEN SUBJECTS, V1840, P2589, DOI 10.1016/j.bbagen.2013.12.029; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Nissen G, 2018, CLIN EXP ALLERGY, V48, P1483, DOI 10.1111/cea.13236; O'Bryan MK, 2008, ADV EXP MED BIOL, V636, P92, DOI 10.1007/978-0-387-09597-4_6; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Oudart JB, 2016, ONCOTARGET, V7, P1516, DOI 10.18632/oncotarget.6399; Patel DF, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0017-2018; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Rajshankar D, 2020, J CELL PHYSIOL, V235, P3096, DOI 10.1002/jcp.29215; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Steinbacher T, 2018, HISTOCHEM CELL BIOL, V150, P341, DOI 10.1007/s00418-018-1691-8; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su WH, 2013, CRIT REV BIOCHEM MOL, V48, P153, DOI 10.3109/10409238.2012.758084; Su WH, 2012, ENDOCRINOLOGY, V153, P6041, DOI 10.1210/en.2012-1670; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; Sudhakar YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04136; Sun C, 2019, MOL PHARMACEUT, V16, P867, DOI 10.1021/acs.molpharmaceut.8b01190; Tang EI, 2016, SEMIN CELL DEV BIOL, V59, P35, DOI 10.1016/j.semcdb.2016.01.004; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; Tang Elizabeth I, 2012, Spermatogenesis, V2, P117; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2013, INT REV CEL MOL BIO, V303, P319, DOI 10.1016/B978-0-12-407697-6.00008-8; Wen Q, 2018, AM J PHYSIOL-ENDOC M, V315, pE924, DOI 10.1152/ajpendo.00114.2018; Wen Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0201-6; Wen Q, 2018, BBA-BIOMEMBRANES, V1860, P141, DOI 10.1016/j.bbamem.2017.04.020; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yasuda J, 2019, J PHARMACOL SCI, V139, P193, DOI 10.1016/j.jphs.2019.01.010; Yasuda J, 2017, N-S ARCH PHARMACOL, V390, P1135, DOI 10.1007/s00210-017-1413-0	86	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3105	3128		10.1096/fj.201901968RR	http://dx.doi.org/10.1096/fj.201901968RR		JAN 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909540				2022-12-26	WOS:000505694700001
J	Relph, S; Ong, M; Vieira, MC; Pasupathy, D; Sandall, J				Relph, Sophie; Ong, Melissa; Vieira, Matias C.; Pasupathy, Dharmintra; Sandall, Jane			Perceptions of risk and influences of choice in pregnant women with obesity. An evidence synthesis of qualitative research	PLOS ONE			English	Article							BODY-MASS INDEX; EQUAL-TO 30; MATERNITY CARE EXPERIENCES; LIVED EXPERIENCES; DECISION-MAKING; OBESE; BIRTH; INTERVENTION; PERSPECTIVES; OVERWEIGHT	Background Between 7-35% of the maternity population are obese in high income countries and 1-40% in lower or middle-income countries. Women with obesity are traditionally limited by the choices available to them during pregnancy and birth because of the higher risk of complications. This evidence synthesis set out to summarise how women with obesity's perceptions of pregnancy and birth risk influence the care choices that they make. Methods A search of medical and health databases for qualitative studies written in the English language, published Jan 1993-April 2019 and reporting on pregnant women with obesity's perception of risk and influence of pregnancy and birth choices. Data was extracted by two reviewers onto a questions framework and then analysed using a thematic synthesis technique. Confidence in the qualitative findings was assessed using GRADE-CERQual. Results 23 full texts were included. The common themes on perception of risk were: 'Self-blame arising from others' stereotyped beliefs', 'Normalisation', 'Lack of preparation', 'Fearful acceptance and inevitability' and 'Baby prioritised over mother'. For influence of choices, the themes were: 'External influences from personal stresses', 'Restrictive guidelines', 'Relationship with healthcare professional' and 'Perception of Risk'. Conclusions Evidence on what influences women with obesity's pregnancy choices is limited. Further research is needed on the best methods to discuss the risks of pregnancy and birth for women with obesity in a sensitive and acceptable manner and to identify the key influences when women with obesity make choices antenatally and for birth planning.	[Relph, Sophie; Vieira, Matias C.; Pasupathy, Dharmintra; Sandall, Jane] Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, Dept Women & Childrens Hlth, London, England; [Ong, Melissa] Kings Coll London, Guys Kings & St Thomas Sch Med Educ, London, England	University of London; King's College London; University of London; King's College London	Relph, S (corresponding author), Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, Dept Women & Childrens Hlth, London, England.	sophie.relph@kcl.ac.uk	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Relph, Sophie/0000-0002-2007-9647; /0000-0002-8076-4275	CAPES [BEX 9571/13-2]; Guy's and St Thomas' charity grant; National Institute for Health Research (NIHR) Applied Research Collaboration South London at King's College Hospital NHS Foundation Trust; Tommy's Charity; NIHR Biomedical Research Centre at Guy's & St Thomas' NHS Foundation Trust and King's College London	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Guy's and St Thomas' charity grant; National Institute for Health Research (NIHR) Applied Research Collaboration South London at King's College Hospital NHS Foundation Trust; Tommy's Charity; NIHR Biomedical Research Centre at Guy's & St Thomas' NHS Foundation Trust and King's College London	MCV is supported by CAPES (BEX 9571/13-2; https://www.capes.gov.br/). SR is supported through a Guy's and St Thomas' charity grant https://www.gsttcharity.org.uk/).JS and SR are supported by the National Institute for Health Research (NIHR) Applied Research Collaboration South London at King's College Hospital NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of, the NIHR or the Department of Health and Social Care. DP is funded by Tommy's Charity (https://www.tommys.org/) and NIHR Biomedical Research Centre at Guy's & St Thomas' NHS Foundation Trust and King's College London (http://www.guysandstthomasbrc.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2017, MIDWIFERY, V49, P54, DOI 10.1016/j.midw.2016.12.008; Booth A., 2016, GUIDANCE CHOOSING QU; Carter W, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1245-4; Chadwick RJ, 2014, HEALTH RISK SOC, V16, P68, DOI 10.1080/13698575.2013.863852; Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938; Coxon K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1279-7; Coxon K, 2016, MIDWIFERY, V38, P1, DOI 10.1016/j.midw.2016.05.012; Coxon K, 2014, HEALTH RISK SOC, V16, P481, DOI 10.1080/13698575.2014.957262; Coxon K, 2014, HEALTH RISK SOC, V16, P51, DOI 10.1080/13698575.2013.859231; Cunningham J.E.R., 2018, BJM, V26, DOI [10.12968/bjom.2018.26.9.598, DOI 10.12968/BJOM.2018.26.9.598, 10.12968/bjom.2018.26.9.5982018]; DeJoy SB, 2016, J MIDWIFERY WOM HEAL, V61, P217, DOI 10.1111/jmwh.12375; Denison FC, 2019, BJOG-INT J OBSTET GY, V126, pE62, DOI 10.1111/1471-0528.15386; Denison FC, 2015, MIDWIFERY, V31, P1163, DOI 10.1016/j.midw.2015.08.006; Department of Health, 1993, CHANGING CHILDBIRTH; Dinsdale S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3289-1; Downe S, 2015, BJOG-INT J OBSTET GY, V122, P1226, DOI 10.1111/1471-0528.13433; Faria-Schutzer DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141879; Fieril KP, 2017, MIDWIFERY, V44, P1, DOI 10.1016/j.midw.2016.10.011; Furber CM, 2011, MIDWIFERY, V27, P437, DOI 10.1016/j.midw.2010.04.001; Furness PJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-69; Hastings-Tolsma M, 2010, QUAL HEALTH RES, V20, P743, DOI 10.1177/1049732310364626; Heslehurst N, 2017, MIDWIFERY, V49, P47, DOI 10.1016/j.midw.2016.11.001; Heslehurst N, 2015, HEALTH EXPECT, V18, P969, DOI 10.1111/hex.12070; Hollowell J, 2014, BJOG-INT J OBSTET GY, V121, P343, DOI 10.1111/1471-0528.12437; Holton S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1538-7; Jarvie R, 2017, MIDWIFERY, V49, P79, DOI 10.1016/j.midw.2016.12.009; Johnson M, 2013, MIDWIFERY, V29, P1287, DOI 10.1016/j.midw.2012.11.016; Jones C, 2017, MIDWIFERY, V53, P87, DOI 10.1016/j.midw.2017.07.011; Keely A, 2011, BR J MIDWIFERY, V19, P364; Keely A, 2017, MIDWIFERY, V49, P87, DOI 10.1016/j.midw.2016.09.016; Keenan J, 2010, HEALTH RISK SOC, V12, P369, DOI 10.1080/13698571003792926; Khazaezadeh N, 2011, BR J MIDWIFERY, V19, P49; Kirk SFL, 2014, QUAL HEALTH RES, V24, P790, DOI 10.1177/1049732314529667; Knight-Agarwal CR, 2016, WOMEN BIRTH, V29, P189, DOI 10.1016/j.wombi.2015.10.008; Kominiarek MA, 2015, MATERN CHILD HLTH J, V19, P1698, DOI 10.1007/s10995-015-1684-3; Lavender T, 2016, HEALTH EXPECT, V19, P222, DOI 10.1111/hex.12339; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Lindhardt CL, 2013, ACTA OBSTET GYN SCAN, V92, P1101, DOI 10.1111/aogs.12186; Mills A, 2013, MATERN CHILD NUTR, V9, P309, DOI 10.1111/j.1740-8709.2011.00386.x; Mitchell M, 2014, HEALTH RISK SOC, V16, P101, DOI 10.1080/13698575.2013.867014; Munthe-Kaas H, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0690-9; National Audit Office National Audit Service, 2017, MENT HLTH PRIS HC 42; National Institute for Health and Care Excellence, 2014, INTR CAR HLTH WOM BA; NHS Litigation Authority, 2013, CLIN NEGL SCHEM TRUS; Nyman VMK, 2010, MIDWIFERY, V26, P424, DOI 10.1016/j.midw.2008.10.008; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Relph S, PROSPERO INT PROSPEC; Smith D, 2011, BJOG-INT J OBSTET GY, V118, P779, DOI 10.1111/j.1471-0528.2011.02924.x; Sui Z, 2013, MATERN CHILD HLTH J, V17, P1879, DOI 10.1007/s10995-012-1211-8; Sui Zhixian, 2013, Australas Med J, V6, P565, DOI 10.4066/AMJ.2013.1881; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Van Wagner V, 2016, MIDWIFERY, V38, P21, DOI 10.1016/j.midw.2016.04.009	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227325	10.1371/journal.pone.0227325	http://dx.doi.org/10.1371/journal.pone.0227325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899773	Green Published, gold			2022-12-26	WOS:000534322000020
J	Stack, J; Romero-Rivas, C				Stack, James; Romero-Rivas, Carlos			Merit overrules theory of mind when young children share resources with others	PLOS ONE			English	Article							THEORY-OF-MIND; PRESCHOOLERS; COOPERATION; BEHAVIOR; COLLABORATION; ALLOCATIONS; RELATE; FAIR	Non-windfall approaches to sharing demonstrate pre-schoolers' sensitivity to merit-based distributions of resources. However, such studies have not considered (1) whether epistemic aspects of task performance, such as the relative accuracy of a co-worker, influences pre-schoolers' rates of sharing; and (2) how children's emerging social understanding may impact resource allocations in high- and low-merit situations. These issues are of theoretical importance as they may provide new information about the scope of pre-schooler's meritbased sharing behaviours. Moreover, as social understanding has been related to both increases and decreases in pre-schoolers' levels of sharing, providing a merit-based assessment of this relationship would allow for a concurrent assessment of recent conflicting findings. In this study, three- and four-year-olds (N = 131) participated in an unexpected transfer task which was followed by a resource generation picture card naming task with a reliable or unreliable (high- or low-merit) co-worker (a hand puppet). The results showed that children engage in more generous rates of sharing with a high-merit co-worker. This suggests that merit-based sharing is apparent in young children and extends to epistemic aspects of task performance. However, such sharing was constrained by a self-serving bias. Finally, we were not able to detect an effect of children's performance on the false belief task on sharing behaviours in the high- or low-merit trials, suggesting that these behaviours may not be modulated by social understanding during early childhood.	[Stack, James] Liverpool Hope Univ, Dept Psychol, Liverpool, Merseyside, England; [Romero-Rivas, Carlos] Univ Autonoma Madrid, Dept Evolut & Educ Psychol, Madrid, Spain	Liverpool Hope University; University of Liverpool; Autonomous University of Madrid	Stack, J (corresponding author), Liverpool Hope Univ, Dept Psychol, Liverpool, Merseyside, England.	stackj@hope.ac.uk	Romero-Rivas, Carlos/S-9775-2019	Romero-Rivas, Carlos/0000-0001-8413-189X; Stack, Jim/0000-0001-7273-3631				ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Burdett ERR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164698; Burford HC, 1996, J SOC BEHAV PERS, V11, P17; Chernyak N, 2017, P COGN SCI SOC, P1764; Cowell JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117947; Engelmann JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048433; Fedra E, 2019, BRIT J DEV PSYCHOL, V37, P130, DOI 10.1111/bjdp.12264; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fusaro M, 2011, J EXP CHILD PSYCHOL, V110, P561, DOI 10.1016/j.jecp.2011.06.008; Hamann K, 2014, DEV PSYCHOL, V50, P121, DOI 10.1037/a0032965; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hermes J, 2018, CHILD DEV PERSPECT, V12, P134, DOI 10.1111/cdep.12274; House B, 2013, EVOL HUM BEHAV, V34, P86, DOI 10.1016/j.evolhumbehav.2012.10.001; Houser D, 2009, J ECON PSYCHOL, V30, P634, DOI 10.1016/j.joep.2009.05.002; Imuta K, 2016, DEV PSYCHOL, V52, P1192, DOI 10.1037/dev0000140; Kanngiesser P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043979; Kelsey C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00698; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Kohler JK., 2022, FRONT PSYCHOL, DOI [DOI 10.3389/FPSYG.2014.00958, 10.3389/fpsyg.2022.906108, DOI 10.3389/FPSYG.2022.906108]; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; Leimgruber KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048292; Li V, 2014, CHILD DEV, V85, P1123, DOI 10.1111/cdev.12198; Liu BY, 2016, J EXP CHILD PSYCHOL, V141, P222, DOI 10.1016/j.jecp.2015.09.010; Malti T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052017; Melis AP, 2013, J EXP CHILD PSYCHOL, V114, P364, DOI 10.1016/j.jecp.2012.08.006; Miller SA, 2009, PSYCHOL BULL, V135, P749, DOI 10.1037/a0016854; Moll H, 2007, DEV PSYCHOL, V43, P309, DOI 10.1037/0012-1649.43.2.309; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Mulvey KL, 2016, J EXP CHILD PSYCHOL, V142, P203, DOI 10.1016/j.jecp.2015.10.002; Olah K, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01399; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; ONeill DK, 1996, CHILD DEV, V67, P659, DOI 10.2307/1131839; Pasquini ES, 2007, DEV PSYCHOL, V43, P1216, DOI 10.1037/0012-1649.43.5.1216; Paulus M, 2017, J EXP CHILD PSYCHOL, V161, P202, DOI 10.1016/j.jecp.2017.03.005; Paulus M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00344; Rizzo MT, 2018, DEV PSYCHOL, V54, P510, DOI 10.1037/dev0000439; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Schafer M, 2015, PSYCHOL SCI, V26, P1252, DOI 10.1177/0956797615586188; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Vonk J, 2020, CHILD DEV, V91, P63, DOI 10.1111/cdev.13112; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Worle M, 2018, J EXP CHILD PSYCHOL, V165, P66, DOI 10.1016/j.jecp.2017.03.016; Wu Z, 2014, J EXP CHILD PSYCHOL, V120, P73, DOI 10.1016/j.jecp.2013.11.007; Yang F, 2018, PSYCHOL SCI, V29, P1598, DOI 10.1177/0956797618779061; Yu J, 2016, CHILD DEV, V87, P1747, DOI 10.1111/cdev.12635; Zmyj N, 2010, J EXP CHILD PSYCHOL, V106, P208, DOI 10.1016/j.jecp.2010.03.002	56	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227375	10.1371/journal.pone.0227375	http://dx.doi.org/10.1371/journal.pone.0227375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899918	Green Published, gold			2022-12-26	WOS:000534322000026
J	Dey, S; Eisa, A; Kline, D; Wagner, FF; Abeysirigunawardena, S; Vijayaraghavan, S				Dey, Souvik; Eisa, Alaa; Kline, Douglas; Wagner, Florence F.; Abeysirigunawardena, Sanjaya; Vijayaraghavan, Srinivasan			Roles of glycogen synthase kinase 3 alpha and calcineurin in regulating the ability of sperm to fertilize eggs	FASEB JOURNAL			English	Article						calcineurin; fertilization; GSK3 alpha; infertile; male contraceptives	TYROSINE PHOSPHORYLATION; MOTILITY INITIATION; PROTEIN; CALCIUM; EPIDIDYMIS; ELEMENTS; PH	Glycogen synthase kinase 3 (GSK3) was identified as an enzyme regulating sperm protein phosphatase. The GSK3 alpha paralog, but not GSK3 beta, is essential for sperm function. Sperm lacking GSK3 alpha display altered motility and are unable to undergo hyperactivation, which is essential for fertilization. Male mice lacking sperm-specific calcineurin (PP2B), a calcium regulated phosphatase, in testis and sperm, are also infertile. Loss of PP2B results in impaired epididymal sperm maturation and motility. The phenotypes of GSK3 alpha and PP2B knockout mice are similar, prompting us to examine the interrelationship between these two enzymes in sperm. High calcium levels must exist to permit catalytically active calcineurin to function during epididymal sperm maturation. Total and free calcium levels are high in immotile compared to motile epididymal sperm. Inhibition of calcineurin by FK506 results in an increase in the net phosphorylation and a consequent decrease in catalytic activity of sperm GSK3. The inhibitor FK506 and an isoform-selective inhibitor of GSK3 alpha, BRD0705, also inhibited fertilization of eggs in vitro. Interrelated functions of GSK3 alpha and sperm PP2B are essential during epididymal sperm maturation and during fertilization. Our results should enable the development of male contraceptives targeting one or both enzymes.	[Dey, Souvik; Kline, Douglas; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Cunningham Hall Annex Rm A301,POB 5190, Kent, OH 44242 USA; [Eisa, Alaa] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Wagner, Florence F.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Abeysirigunawardena, Sanjaya] Kent State Univ, Dept Chem & Biochem, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Dey, S (corresponding author), Kent State Univ, Dept Biol Sci, Cunningham Hall Annex Rm A301,POB 5190, Kent, OH 44242 USA.	sdey4@kent.edu	Kline, Douglas/AAH-5955-2020; Dey, Souvik/AAB-2252-2021	Kline, Douglas/0000-0003-2555-6729; Dey, Souvik/0000-0003-1799-5270	National Institute of Health [R03HD096176, R21HD086839]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health (SV): R03HD096176 and R21HD086839	Alon LT, 2011, FEBS LETT, V585, P1158, DOI 10.1016/j.febslet.2011.03.025; Ando S, 2005, MOL CELL ENDOCRINOL, V245, P1, DOI 10.1016/j.mce.2005.09.011; Aquila S, 2005, J CLIN ENDOCR METAB, V90, P4753, DOI 10.1210/jc.2004-2233; Aquila S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-140; Barford D, 2002, ANNU REV BIOPH BIOM, V27, P133; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bhattacharjee R, 2018, BIOL REPROD, V99, P384, DOI 10.1093/biolre/ioy020; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Chen C, 2016, ASIAN J ANDROL, V18, P600, DOI 10.4103/1008-682X.157650; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; COMHAIRE FH, 1987, INT J ANDROL, V10, P653, DOI 10.1111/j.1365-2605.1987.tb00366.x; da Rocha AM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128181; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Desseyn J-L, 2002, P NATL ACAD SCI USA, V97, P6433; Dey S, 2018, J CELL PHYSIOL, V233, P7239, DOI 10.1002/jcp.26557; Dey S, 2015, MOL REPROD DEV, V82, P1001, DOI 10.1002/mrd.22586; Dey S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110669; du Plessis SS, 2015, ASIAN J ANDROL, V17, P230, DOI 10.4103/1008-682X.135123; Ecroyd H, 2004, DEV BIOL, V268, P53, DOI 10.1016/j.ydbio.2003.12.015; Fardilha M, 2011, MOL HUM REPROD, V17, P466, DOI 10.1093/molehr/gar004; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Freitas MJ, 2017, BIOL REPROD, V96, P2, DOI 10.1095/biolreprod.116.144337; Garzon-Nino J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43468; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Goswami S, 2019, J CELL PHYSIOL, V234, P3105, DOI 10.1002/jcp.27130; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HINSVARK ON, 1953, ANAL CHEM, V25, P320, DOI 10.1021/ac60074a030; Honda Z, 2009, GENES CELLS, V14, P1383, DOI 10.1111/j.1365-2443.2009.01355.x; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 1996, BIOCHEM CELL BIOL, V74, P669, DOI 10.1139/o96-072; JENKINS AD, 1980, BIOL REPROD, V23, P981, DOI 10.1095/biolreprod23.5.981; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kanamaru Yusuke, 2012, J Signal Transduct, V2012, P931215, DOI 10.1155/2012/931215; Kim Y, 2009, J NEUROCHEM, V111, P344, DOI 10.1111/j.1471-4159.2009.06318.x; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Lybaert P, 2009, HISTOL HISTOPATHOL, V24, P999, DOI 10.14670/HH-24.999; MAJUMDER GC, 1990, ARCH ANDROLOGY, V24, P287, DOI 10.3109/01485019008987585; Mannowetz N, 2012, J CELL PHYSIOL, V227, P2154, DOI 10.1002/jcp.22949; Manojlovic Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065897; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; MORTON BE, 1978, FERTIL STERIL, V29, P695; Muramatsu T, 2006, P NATL ACAD SCI USA, V89, P529; Nagy A, 2003, MANIPULATING MOUSE E, P814; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Sinha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047623; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somanath PR, 2004, J ANDROL, V25, P605; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; VIJAYARAGHAVAN S, 1990, MOL REPROD DEV, V25, P186, DOI 10.1002/mrd.1080250212; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wagner FF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam8460; Weissgerber P, 2012, J BIOL CHEM, V287, P17930, DOI 10.1074/jbc.M111.328286; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wuttke M S, 2001, JOP, V2, P154; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yu R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00853-x; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6	71	6	6	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1247	1269		10.1096/fj.201902163R	http://dx.doi.org/10.1096/fj.201902163R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914663	Green Accepted			2022-12-26	WOS:000507308900084
J	Du, HB; Zou, LZ; Ren, R; Li, NN; Li, J; Wang, YF; Sun, JP; Yang, J; Xiong, W; Xu, ZG				Du, Haibo; Zou, Linzhi; Ren, Rui; Li, Nana; Li, Jie; Wang, Yanfei; Sun, Jinpeng; Yang, Jun; Xiong, Wei; Xu, Zhigang			Lack of PDZD7 long isoform disrupts ankle-link complex and causes hearing loss in mice	FASEB JOURNAL			English	Article						ankle links; hair cells; inner ear; PDZD7 long isoform; stereocilia	USHER-SYNDROME TYPE-2; COCHLEAR HAIR-CELLS; INNER-EAR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; WHIRLIN ISOFORMS; PROTEIN COMPLEX; MYOSIN-XVA; GENE; COMPONENT; LOCALIZATION	Usher syndrome (USH) is the most frequent form of combined hereditary deafness-blindness, characterized by hearing loss and retinitis pigmentosa, with or without vestibular dysfunction. PDZD7 is a PDZ domain-containing scaffold protein that was suggested to be a USH modifier and a contributor to digenic USH. In the inner ear hair cells, PDZD7 localizes at the ankle region of the stereocilia and constitutes the so-called ankle-link complex together with three other USH proteins Usherin, WHRN, and ADGRV1. PDZD7 gene is subjected to alternative splicing, which gives rise to two types of PDZD7 isoforms, namely the long and short isoforms. At present, little is known which specific isoform is involved in ankle-link formation and stereocilia development. In this work, we showed that PDZD7 long isoform, but not short isoforms, localizes at the ankle region of the stereocilia. Moreover, we established Pdzd7 mutant mice by introducing deletions into exon 14 of the Pdzd7 gene, which causes potential premature translational stop in the long isoform but leaves short isoforms unaffected. We found that lack of PDZD7 long isoform affects the localization of other ankle-link complex components in the stereocilia. Consequently, Pdzd7 mutant mice showed stereocilia development deficits and hearing loss as well as reduced mechanotransduction (MET) currents, suggesting that PDZD7 long isoform is indispensable for hair cells. Furthermore, by performing yeast two-hybrid screening, we identified a PDZD7 long isoform-specific binding partner PIP5K1C, which has been shown to play important roles in hearing and might participate in the function and/or transportation of PDZD7.	[Du, Haibo; Ren, Rui; Li, Nana; Wang, Yanfei; Xu, Zhigang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao 266237, Shandong, Peoples R China; [Zou, Linzhi; Li, Jie; Xiong, Wei] Tsinghua Univ, IDG McGovern Inst Brain Res Tsinghua, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Jinpeng] Shandong Univ, Dept Biochem & Mol Biol, Key Lab Expt Teratol, Minist Educ,Sch Med, Jinan, Shandong, Peoples R China; [Yang, Jun] Univ Utah, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA; [Xu, Zhigang] Shandong Normal Univ, Shandong Prov Collaborat Innovat Ctr Cell Biol, Jinan, Shandong, Peoples R China	Shandong University; Tsinghua University; Shandong University; Utah System of Higher Education; University of Utah; Shandong Normal University	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao 266237, Shandong, Peoples R China.; Xiong, W (corresponding author), Tsinghua Univ, IDG McGovern Inst Brain Res Tsinghua, Sch Life Sci, Beijing 100084, Peoples R China.	wei_xiong@tsinghua.edu.cn; xuzg@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020; Xiong, Wei/AAY-5944-2020	Xiong, Wei/0000-0002-2784-7696	National Key Basic Research Program of China [2018YFC1003600, 2013CB967700]; National Natural Science Foundation of China [81771001, 31522025, 31571080, 81873703, 3181101148]; Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology [SPKLACDB-2019000]; Fundamental Research Funds of Shandong University [2018JC025]; National Eye Institute [EY020853, EY014800]; Research to Prevent Blindness	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology; Fundamental Research Funds of Shandong University; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the National Key Basic Research Program of China (2018YFC1003600, 2013CB967700), the National Natural Science Foundation of China (81771001, 31522025, 31571080, 81873703, and 3181101148), Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology (SPKLACDB-2019000), the Fundamental Research Funds of Shandong University (2018JC025), the National Eye Institute (EY020853 and EY014800), and Research to Prevent Blindness.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Booth KT, 2015, AM J MED GENET A, V167, P2957, DOI 10.1002/ajmg.a.37274; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chen Q, 2014, J BIOL CHEM, V289, P36070, DOI 10.1074/jbc.M114.610535; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du HB, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2062346; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Ebrahim S, 2016, CELL REP, V15, P935, DOI 10.1016/j.celrep.2016.03.081; Effertz T, 2017, J NEUROSCI, V37, P11632, DOI 10.1523/JNEUROSCI.1351-17.2017; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Mathur PD, 2015, HUM MOL GENET, V24, P7017, DOI 10.1093/hmg/ddv403; Mathur PD, 2015, HUM MOL GENET, V24, P6213, DOI 10.1093/hmg/ddv339; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Rodriguez L, 2012, P NATL ACAD SCI USA, V109, P14013, DOI 10.1073/pnas.1211869109; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Shen J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav071; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Vona B, 2016, EAR HEARING, V37, pE238, DOI 10.1097/AUD.0000000000000278; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Xiong W, 2014, NAT PROTOC, V9, P2438, DOI 10.1038/nprot.2014.168; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zhai XY, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00461; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012; Zou JH, 2017, HUM MOL GENET, V26, P624, DOI 10.1093/hmg/ddw421; Zou JH, 2015, HUM MOL GENET, V24, P6944, DOI 10.1093/hmg/ddv398; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629	45	10	10	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1136	1149		10.1096/fj.201901657RR	http://dx.doi.org/10.1096/fj.201901657RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914662	Green Accepted			2022-12-26	WOS:000507308900077
J	Luo, JQ; Wang, X; Jiang, XH; Liu, C; Li, YZ; Han, XW; Zuo, X; Li, YN; Li, N; Xu, YN; Si, SY				Luo, Jinque; Wang, Xiao; Jiang, Xinhai; Liu, Chao; Li, Yongzhen; Han, Xiaowan; Zuo, Xuan; Li, Yining; Li, Ni; Xu, Yanni; Si, Shuyi			Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport	FASEB JOURNAL			English	Article						ABCA1; IL-1 beta; macrophage; MAPK; NF-kappa B	NF-KAPPA-B; INTERLEUKIN-1 RECEPTOR ANTAGONIST; DOWN-REGULATION; APOE(-/-) MICE; ACTIVATION; MECHANISMS; MACROPHAGES; EXPRESSION; CROSSTALK; PATHWAY	Atherosclerosis is a chronic disease characterized by lipid deposition and inflammatory response. NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome-facilitated inflammatory responses are crucial in the pathogenesis of atherosclerosis, and thus new therapeutic approaches are emerging that target NLRP3 and inflammation. Here, we explored the anti-atherosclerotic effect and mechanisms of a new rutaecarpine derivative, 5-deoxy-rutaecarpine (R3) in vitro and in vivo. R3 treatment attenuated atherosclerosis development and increased plaque stability in Apoe(-/-) mice fed a high-fat diet, and decreased levels of inflammatory mediators, such as interleukin-1 beta, in the serum of Apoe(-/-) mice and in oxidized low-density lipoprotein (ox-LDL)-stimulated murine macrophages. R3 treatment inhibited NLRP3 inflammasome activation in the livers of Apoe(-/-) mice and ox-LDL-stimulated murine macrophages by inhibiting NF-kappa B and MAPK pathways. Additionally, R3 significantly decreased total cholesterol in the serum and livers of Apoe(-/-) mice and promoted cholesterol efflux in murine macrophages through upregulating protein expression of ATP-binding cassette subfamily A member 1 and scavenger receptor class B type I/human CD36 and lysosomal integral membrane protein-II analogous-1. Our results demonstrated that R3 prevented atherosclerotic progression via attenuating NLRP3 inflammasome-related inflammation and modulating cholesterol transport.	[Luo, Jinque; Wang, Xiao; Jiang, Xinhai; Liu, Chao; Li, Yongzhen; Han, Xiaowan; Zuo, Xuan; Li, Yining; Li, Ni; Xu, Yanni; Si, Shuyi] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Natl Ctr Screening Novel Microbial Drugs, NHC Key Lab Biotechnol Antibiot, Beijing, Peoples R China; [Li, Ni] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, YN; Si, SY (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Tiantan Xili 1, Beijing 100050, Peoples R China.	xuyanniwendeng@hotmail.com; sisyimb@hotmail.com			National Natural Science Foundation of China (NSFC) [81573482, 81621064, 81973328]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX09711001003-006, 2018ZX09711001-007-002, 2018ZX09735001-001-002]; CAMS Fundamental Research Funds [2019-RC-HL-009]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; CAMS Fundamental Research Funds; CAMS Innovation Fund for Medical Sciences	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81573482, 81621064 and 81973328; National Science and Technology Major Project of the Ministry of Science and Technology of China, Grant/Award Number: 2018ZX09711001003-006, 2018ZX09711001-007-002, 2018ZX09735001-001-002; CAMS Fundamental Research Funds, Grant/Award Number: 2019-RC-HL-009; CAMS Innovation Fund for Medical Sciences, Grant/Award Number: 2016-I2M-1-011	Abderrazak A, 2015, CIRCULATION, V131, P1061, DOI 10.1161/CIRCULATIONAHA.114.013730; Ahmad F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28056; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Chen H, 2017, CELL HOST MICROBE, V21, P47, DOI 10.1016/j.chom.2016.12.004; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1493, DOI 10.1152/ajpcell.00016.2006; de Jager SCA, 2013, CARDIOVASC RES, V100, P4, DOI 10.1093/cvr/cvt199; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gibson MS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00654; Gomez D, 2018, NAT MED, V24, P1418, DOI 10.1038/s41591-018-0124-5; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo K, 2018, J MOL CELL CARDIOL, V116, P69, DOI 10.1016/j.yjmcc.2018.01.013; Heo SK, 2009, J CELL BIOCHEM, V107, P123, DOI 10.1002/jcb.22109; Hoseini Z, 2018, J CELL PHYSIOL, V233, P2116, DOI 10.1002/jcp.25930; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Jones JG, 2016, DIABETOLOGIA, V59, P1098, DOI 10.1007/s00125-016-3940-5; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200; Ko HC, 2007, EUR J PHARMACOL, V555, P211, DOI 10.1016/j.ejphar.2006.10.002; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Ni WH, 2001, CIRCULATION, V103, P2096; Nie XQ, 2016, ACTA PHARMACOL SIN, V37, P483, DOI 10.1038/aps.2015.167; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Quintans JSS, 2019, FOOD CHEM TOXICOL, V123, P233, DOI 10.1016/j.fct.2018.10.058; Ramji DP, 2015, CYTOKINE GROWTH F R, V26, P673, DOI 10.1016/j.cytogfr.2015.04.003; Reustle A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123761; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen P, 2019, BIOMED PHARMACOTHER, V110, P786, DOI 10.1016/j.biopha.2018.12.033; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tian KM, 2019, PHARMACOL RES, V141, P541, DOI 10.1016/j.phrs.2018.12.019; Tumurkhuu G, 2018, CELL METAB, V28, P432, DOI 10.1016/j.cmet.2018.05.027; Vallurupalli S, 2016, CARDIOVASC INNOV APP, V1, P443, DOI 10.15212/CVIA.2016.0028; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Wang CH, 2017, MOL MED REP, V16, P922, DOI 10.3892/mmr.2017.6631; Wang XQ, 2002, ARTERIOSCL THROM VAS, V22, pE5, DOI 10.1161/01.ATV.0000018287.03856.DD; Xu YN, 2014, J LIPID RES, V55, P1634, DOI 10.1194/jlr.M044198; Zarzycka B, 2015, EXPERT REV CLIN PHAR, V8, P297, DOI 10.1586/17512433.2015.1025052; Zeller I, 2014, CIRC RES, V115, pE83, DOI 10.1161/CIRCRESAHA.114.305641; Zhao Y, 2015, MOLECULES, V20, P2658, DOI 10.3390/molecules20022658	49	14	15	3	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1398	1411		10.1096/fj.201900903RRR	http://dx.doi.org/10.1096/fj.201900903RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914630				2022-12-26	WOS:000507308900093
J	Matos, CO; Passos, YM; do Amaral, MJ; Macedo, B; Tempone, MH; Bezerra, OCL; Moraes, MO; Almeida, MS; Weber, G; Missailidis, S; Silva, JL; Uversky, VN; Pinheiro, AS; Cordeiro, Y				Matos, Carolina O.; Passos, Yulli M.; do Amaral, Mariana J.; Macedo, Bruno; Tempone, Matheus H.; Bezerra, Ohanna C. L.; Moraes, Milton O.; Almeida, Marcius S.; Weber, Gerald; Missailidis, Sotiris; Silva, Jerson L.; Uversky, Vladimir N.; Pinheiro, Anderson S.; Cordeiro, Yraima			Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer	FASEB JOURNAL			English	Article						neurodegenerative diseases; nucleic acid; phase transitions; prions; SELEX	NUCLEIC-ACID; SECONDARY STRUCTURE; CONFORMATION; TRANSITION; BINDING; PRP; DROPLETS; SEQUENCE; COMPLEXITY; PREDICTION	Structural conversion of cellular prion protein (PrP (c)) into scrapie PrP (PrPSc) and subsequent aggregation are key events associated with the onset of transmissible spongiform encephalopathies (TSEs). Experimental evidence supports the role of nucleic acids (NAs) in assisting this conversion. Here, we asked whether PrP undergoes liquid-liquid phase separation (LLPS) and if this process is modulated by NAs. To this end, two 25-mer DNA aptamers, A1 and A2, were selected against the globular domain of recombinant murine PrP (rPrP(90-231)) using SELEX methodology. Multiparametric structural analysis of these aptamers revealed that A1 adopts a hairpin conformation. Aptamer binding caused partial unfolding of rPrP(90-231) and modulated its ability to undergo LLPS and fibrillate. In fact, although free rPrP(90-231) phase separated into large droplets, aptamer binding increased the number of droplets but noticeably reduced their size. Strikingly, a modified A1 aptamer that does not adopt a hairpin structure induced formation of amyloid fibrils on the surface of the droplets. We show here that PrP undergoes LLPS, and that the PrP interaction with NAs modulates phase separation and promotes PrP fibrillation in a NA structure and concentration-dependent manner. These results shed new light on the roles of NAs in PrP misfolding and TSEs.	[Matos, Carolina O.; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Rio De Janeiro, Brazil; [Passos, Yulli M.; Macedo, Bruno; Tempone, Matheus H.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Pharm, Av Carlos Chagas Filho 373,Bl BSs 17, BR-21941902 Rio De Janeiro, Brazil; [do Amaral, Mariana J.; Almeida, Marcius S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil; [Bezerra, Ohanna C. L.; Moraes, Milton O.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil; [Weber, Gerald] Univ Fed Minas Gerais, Dept Phys, Belo Horizonte, MG, Brazil; [Missailidis, Sotiris] Oswaldo Cruz Fdn FIOCRUZ, Inst Technol Immunobiol Biomanguinhos, Rio De Janeiro, Brazil; [Uversky, Vladimir N.] Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Russia	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; State University System of Florida; University of South Florida; Russian Academy of Sciences	Cordeiro, Y (corresponding author), Univ Fed Rio de Janeiro, Fac Pharm, Av Carlos Chagas Filho 373,Bl BSs 17, BR-21941902 Rio De Janeiro, Brazil.; Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Av Athos da Silveira Ramos 149,Bl A,536-B, BR-21941909 Rio De Janeiro, RJ, Brazil.	pinheiro@iq.ufrj.br; yraima@pharma.ufrj.br	Moraes, Milton Ozório/G-9753-2011; Uversky, Vladimir N./F-4515-2011; Silva, Jerson/J-8984-2014; Pinheiro, Anderson/AAL-5299-2021; Weber, Gerald/A-8669-2010; SILVA, JERSON Lima/GRF-1442-2022; Oliveira Matos, Carolina/GNP-7810-2022; Moraes, Milton/AFF-1842-2022; Bezerra, Ohanna Cavalcanti/GXG-0231-2022; Pinheiro, Anderson S/B-6350-2014	Moraes, Milton Ozório/0000-0003-2653-0037; Uversky, Vladimir N./0000-0002-4037-5857; Silva, Jerson/0000-0001-9523-9441; Weber, Gerald/0000-0002-2935-1571; SILVA, JERSON Lima/0000-0001-9523-9441; Pinheiro, Anderson/0000-0001-5118-6931	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [01]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brown University (Brown), Brazil Initiative Collaboration Grant	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brown University (Brown), Brazil Initiative Collaboration Grant	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: Finance Code 01; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brown University (Brown), Grant/Award Number: Brazil Initiative Collaboration Grant	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Balzani E, 2016, CELL REP, V16, P615, DOI 10.1016/j.celrep.2016.06.017; Banerjee A, 2017, ADV PURE APPL MATH, V8, P1, DOI 10.1515/apam-2016-0032; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Biasini E, 2019, NAT BIOMED ENG, V3, P167, DOI 10.1038/s41551-019-0367-6; BRAM S, 1971, J MOL BIOL, V58, P277, DOI 10.1016/0022-2836(71)90246-4; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cavaliere P, 2013, NUCLEIC ACIDS RES, V41, P1; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Cordeiro Y, 2019, BBA-PROTEINS PROTEOM, V1867, P933, DOI 10.1016/j.bbapap.2019.02.006; Dard R, 2017, EUR J MED GENET, V60, P639, DOI 10.1016/j.ejmg.2017.08.015; Darling AL, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11060990; de Oliveira GAP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37990; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dragich JM, 2016, ELIFE, V5, DOI 10.7554/eLife.14810; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Fang XJ, 2017, CHINESE MED J-PEKING, V130, P242, DOI 10.4103/0366-6999.198019; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hamilton MJ, 2018, J MED GENET, V55, P28, DOI 10.1136/jmedgenet-2017-104620; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Kovachev PS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48883-x; Kroschwald S, 2017, CELL, V168, P947, DOI 10.1016/j.cell.2017.02.029; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Langdon EM, 2018, SCIENCE, V7432, P1; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Macedo B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051023; Macedo B, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0361-y; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Sebollela A, 2014, ACS CHEM NEUROSCI, V5, P1238, DOI 10.1021/cn500156r; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2016, J BIOL CHEM, V291, P15482, DOI 10.1074/jbc.R116.733428; Steinberg TH, 1996, ANAL BIOCHEM, V239, P223, DOI 10.1006/abio.1996.0319; Takemura K, 2006, EXP BIOL MED, V231, P204; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Turoverov KK, 2019, TRENDS BIOCHEM SCI, V44, P716, DOI 10.1016/j.tibs.2019.03.005; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; VOORHEES PW, 1992, ANNU REV MATER SCI, V22, P197, DOI 10.1146/annurev.ms.22.080192.001213; Warwicker J, 2000, BIOCHEM BIOPH RES CO, V278, P646, DOI 10.1006/bbrc.2000.3829; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yin S, 2008, J BIOL CHEM, V283, P25446, DOI 10.1074/jbc.M800814200; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang J, 2019, BRIEF BIOINFORM, V20, P1250, DOI 10.1093/bib/bbx168; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	79	24	24	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					365	385		10.1096/fj.201901897R	http://dx.doi.org/10.1096/fj.201901897R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914616				2022-12-26	WOS:000507308900026
J	Quercini, L; Brunetti, J; Riolo, G; Bindi, S; Scali, S; Lampronti, I; D'Aversa, E; Wronski, S; Pollini, S; Gentile, M; Lupetti, P; Rossolini, GM; Falciani, C; Bracci, L; Pini, A				Quercini, Leila; Brunetti, Jlenia; Riolo, Giulia; Bindi, Stefano; Scali, Silvia; Lampronti, Ilaria; D'Aversa, Elisabetta; Wronski, Sabine; Pollini, Simona; Gentile, Mariangela; Lupetti, Pietro; Rossolini, Gian Maria; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro			An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue	FASEB JOURNAL			English	Article						antibacterial agents; antibiotic resistance; antimicrobial peptides; drug development	HOST-DEFENSE PEPTIDES; RESISTANCE	The peptide sequence KKIRVRLSA was synthesized in a dimeric structure (SET-M33DIM) and evaluated as a candidate drug for infections due to multidrug-resistant (MDR) Gram-negative pathogens. SET-M33DIM showed significant antibacterial activity against MDR strains of Klebsiella pneumoniae, Acinetobacter baumannii, and Escherichia coli (Minimal Inhibitory Concentration [MICs], 1.5-11 mu M), and less activity against Pseudomonas aeruginosa (MICs, 11-22 mu M). It showed very low toxicity in vitro, ex vivo, and in vivo; in cytotoxicity tests, its EC50 was as much as 22 times better than that of SET-M33, a peptide with the same amino-acid sequence, but synthesized in tetra-branched form (638 vs 28 mu M). In in vivo and ex vivo experiments, SET-M33DIM cleared P. aeruginosa infection, significantly reducing signs of sepsis in animals, and restoring cell viability in lung tissue after bacterial challenge. It also quelled inflammation triggered by LPS and live bacterial cells, inhibiting expression of inflammatory mediators in lung tissue, cultured macrophages, and bronchial cells from a cystic fibrosis patient.	[Quercini, Leila] SetLance Srl, Siena, Italy; [Brunetti, Jlenia; Riolo, Giulia; Bindi, Stefano; Scali, Silvia; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dept Med Biotechnol, Via A Moro 2, Siena, Italy; [Lampronti, Ilaria; D'Aversa, Elisabetta] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Wronski, Sabine] Fraunhofer Int Consortium AntiInfect Res iCAIR, Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Pollini, Simona; Rossolini, Gian Maria] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Pollini, Simona] Florence Careggi Univ Hosp, Microbiol & Virol Unit, Florence, Italy; [Gentile, Mariangela; Lupetti, Pietro] Univ Siena, Dept Life Sci, Siena, Italy	University of Siena; University of Ferrara; Fraunhofer Gesellschaft; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Siena	Pini, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via A Moro 2, Siena, Italy.	pinia@unisi.it	Riolo, Giulia/AAC-4485-2022; Pini, Alessandro/R-1359-2018; BRACCI, LUISA/V-9913-2018; Falciani, Chiara/R-1330-2018; Brunetti, Jlenia/E-6464-2019	Riolo, Giulia/0000-0003-2888-5755; Pini, Alessandro/0000-0002-3832-8349; BRACCI, LUISA/0000-0002-0738-5746; Falciani, Chiara/0000-0002-1027-8482; Gentile, Mariangela/0000-0002-4928-4652; Brunetti, Jlenia/0000-0001-8144-7186; D'Aversa, Elisabetta/0000-0003-3058-5866	European Union's Seventh Program for Research [604434]; Italian Foundation for Cystic Fibrosis [17/2016]; FAR [60760]	European Union's Seventh Program for Research; Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); FAR	European Union's Seventh Program for Research, Grant/Award Number: 604434 (PNEUMO-NP); Italian Foundation for Cystic Fibrosis, Grant/Award Number: Project FFC#17/2016; FAR 2018, Grant/Award Number: 60760	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andrei Stefan, 2018, Discoveries (Craiova), V6, pe81, DOI 10.15190/d.2018.1; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Brunetti J, 2018, PEPTIDE SCI, V110, DOI 10.1002/pep2.24089; Brunetti J, 2017, CURR TOP MED CHEM, V17, P613, DOI 10.2174/1568026616666160713143017; Brunetti J, 2016, J BIOL CHEM, V291, P25742, DOI 10.1074/jbc.M116.750257; Brunetti J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26077; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falciani C, 2014, AMINO ACIDS, V46, P1403, DOI 10.1007/s00726-014-1686-2; Farha MA, 2019, NAT MICROBIOL, V4, P565, DOI 10.1038/s41564-019-0357-1; Garrido-Mesa J, 2018, BRIT J PHARMACOL, V175, P4353, DOI 10.1111/bph.14494; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Haney EF, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00043; Jiang ZQ, 2014, PHARMACEUTICALS, V7, P366, DOI 10.3390/ph7040366; Lampronti I, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/960603; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Neuhaus V, 2018, JOVE-J VIS EXP, V9, P135; Neuhaus V, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0158-5; Niehof Monika, 2017, BMC Res Notes, V10, P121, DOI 10.1186/s13104-017-2447-6; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Pollini S, 2017, J PEPT SCI, V23, P329, DOI 10.1002/psc.2978; Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308; Silva ON, 2018, DRUG DISCOV TODAY, V23, P1666, DOI 10.1016/j.drudis.2018.05.024; Steckbeck JD, 2014, EXPERT OPIN BIOL TH, V14, P11, DOI 10.1517/14712598.2013.844227; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; van der Weide H, 2017, BBA-BIOMEMBRANES, V1859, P1796, DOI 10.1016/j.bbamem.2017.06.001; World Health Organization, 2014, ANT RES GLOB REP SUR	40	5	5	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					192	207		10.1096/fj.201901896RR	http://dx.doi.org/10.1096/fj.201901896RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914681	Green Published			2022-12-26	WOS:000507308900015
J	Chen, FD; Du, G; Shih, MS; Yuan, HJ; Bao, P; Shi, S; Cang, Y; Zhang, Z				Chen, Fuding; Du, Gang; Shih, Meishu; Yuan, Hongjiang; Bao, Peng; Shi, Sheng; Cang, Yong; Zhang, Zhen			Safe and effective subcutaneous adipolysis in minipigs by a collagenase derivative	PLOS ONE			English	Article							CLOSTRIDIUM-HISTOLYTICUM; INDIVIDUAL COLLAGENASES; FAT; DISEASE; CELLS	Adipocytes attached to the extracellular matrix (ECM) mainly consist of collagen in adipose tissues, while the degradation of ECM by collagenase induces the apoptosis of adipocytes, leading to a decrease in local subcutaneous adipose. To achieve this goal, we are developing a mutant collagenase H (ColH) to remove local subcutaneous fat such as submental fat (SMF). Three vectors were constructed for expressing rColH(FM, mutant for fat melting, with 6xHis tag), rColH(WT, wild-type, with 6xHis tag), and rColH(E451D, E451 D mutant, without 6xHis tag) in Escherichia coll. rColH(FM) & rColH(WT) were purified by Ni Sepharose on a laboratory scale, while rColH(E451 D) was purified by five chromatography purification steps on a large scale. Then, the stability of rColH(FM) and rColH(WT) was tested by SDS-PAGE to investigate the influence of the E451 D mutation on stability. Afterwards, the enzyme kinetics of CoIH (mutant or wild-type, with or without His tag) were investigated and compared. Finally, the adipolysis of rColH(E451 D) at various doses was tested in vitro and in vivo. The ultrasound results in minipigs suggested that effective adipolysis was induced by rColH(E451D) compared with the negative control, and the histological results suggest dose-dependent fibrosis, necrosis, inflammation and cholesterol cleft formation. These findings indicate the possibility of rColH(E451D) becoming a new injectable drug to safely remove subcutaneous adipose.	[Chen, Fuding; Du, Gang; Bao, Peng; Shi, Sheng; Cang, Yong; Zhang, Zhen] Rejuven Dermaceut Co Ltd, Res & Dev Div, Hangzhou, Peoples R China; [Shih, Meishu; Yuan, Hongjiang] PharmaLegacy Labs Shanghai Co Ltd, Shanghai, Peoples R China		Cang, Y; Zhang, Z (corresponding author), Rejuven Dermaceut Co Ltd, Res & Dev Div, Hangzhou, Peoples R China.	ycang@irejuven.com; zzhang@irejuven.com			Rejuven Dermaceutical Co., Ltd.	Rejuven Dermaceutical Co., Ltd.	This work was funded by Rejuven Dermaceutical Co., Ltd. (http://www.irejuven.com/).The funder provided support in the form of salaries for authors F.C., G.D., M.S., H.Y., P.B., S. S., Y.C., Z.Z., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alipour H, 2016, ASIAN PAC J TROP BIO, V6, P975, DOI 10.1016/j.apjtb.2016.07.017; BOND MD, 1984, BIOCHEMISTRY-US, V23, P3077, DOI 10.1021/bi00308a035; BOND MD, 1984, BIOCHEMISTRY-US, V23, P3085, DOI 10.1021/bi00308a036; BOND MD, 1984, BIOCHEMISTRY-US, V23, P3092, DOI 10.1021/bi00308a037; Datta R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122289; Deeks ED, 2016, AM J CLIN DERMATOL, V17, P701, DOI 10.1007/s40257-016-0231-3; Duarte AS, 2016, CRIT REV MICROBIOL, V42, P106, DOI 10.3109/1040841X.2014.904270; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fujio A, 2014, CELL TRANSPLANT, V23, P1187, DOI 10.3727/096368913X668654; GELBARD MK, 1982, UROL RES, V10, P135; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Katz B, 2008, J COSMET LASER THER, V10, P231, DOI 10.1080/14764170802524437; Keramidas E, 2016, PRS-GLOB OPEN, V4, DOI 10.1097/GOX.0000000000000809; MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861; Manstein D, 2008, LASER SURG MED, V40, P595, DOI 10.1002/lsm.20719; Matsushita O, 2001, TOXICON, V39, P1769, DOI 10.1016/S0041-0101(01)00163-5; Moscatello DK, 2008, DERMATOL SURG, V34, P1314, DOI 10.1111/j.1524-4725.2008.34282.x; RODBELL M, 1964, J BIOL CHEM, V239, P375; Schlessinger Joel, 2013, Skinmed, V11, P27; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Tchoukalova YD, 2003, J LIPID RES, V44, P1795, DOI 10.1194/jlr.D300001-JLR200; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Youn S, 2013, DERMATOL SURG, V39, P766, DOI 10.1111/dsu.12140	25	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227202	10.1371/journal.pone.0227202	http://dx.doi.org/10.1371/journal.pone.0227202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891643	gold, Green Published			2022-12-26	WOS:000515096600068
J	Luo, XH; Wang, MK; Hu, GP; Weng, BQ				Luo, Xuhui; Wang, Ming Kuang; Hu, Guiping; Weng, Boqi			Seasonal Change in Microbial Diversity and Its Relationship with Soil Chemical Properties in an Orchard	PLOS ONE			English	Article							BACTERIAL COMMUNITY; APPLE ORCHARD; LAND-USE; DYNAMICS; BIOMASS; FERTILITY; IMPACTS; FOREST	This study aimed to determine the microbial diversity at different soil depths (0-5 and 5-20 cm) in a subtropical orchard during different seasons (i.e., spring, summer and autumn) to advance knowledge of the roles of microbes in orchard ecosystem balance. In tracking experiments conducted in an orchard (established in 1996), the phospholipid fatty acid (PLFA) biomarker method was employed to determine the soil microbial system. The total PLFA concentration did not vary significantly between soil depths but changed between seasons. It peaked in the summer at 258.97 +/- 23.48 mu g g soil(-1) from 0-5 cm and at 270.99 +/- 58.94 mu g g soil(-1) from 5-20 cm. A total of 33 microbial fatty acid biomarkers were observed and identified in the sampled soil. The quantities of PLFAs for 29 microbial groups varied significantly between seasons, except for 15:0 iso 30H, 15:1 iso G, 16:0 20H, and 17:0 iso 30H. The bacterial PLFAs and fungal and actinomycetic PLFAs in the orchard soil collected in summer were significantly more abundant than those collected in the spring or autumn (P < 0.01). The number of soil microorganism species (richness) and the Simpson and Shannon-Wiener indexes were all highest in summer. The total PLFAs, bacterial PLFAs, fungal PLFAs, actinomycetic PLFAs, richness, and Simpson and Shannon-Wiener indexes were all significantly negatively correlated with soil pH, total organic carbon (TOC), total nitrogen (TN) and the cation exchange capacity (CEC) (P < 0.05).	[Luo, Xuhui] Fujian Acad Agr Sci, Agr Ecol Inst, Fuzhou, Fujian, Peoples R China; [Wang, Ming Kuang] Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan; [Hu, Guiping] Jiangxi Sericulture & Tea Res Inst, Nanchang, Jiangxi, Peoples R China; [Weng, Boqi] Minist Agr & Rural Affairs Peoples Republ China, Fuzhou Sci Observing & Expt Stn Agroenvironm, Fuzhou, Fujian, Peoples R China; [Weng, Boqi] Agcy Fujian Sci & Technol, Fujian Key Lab Ecol Proc Hilly Agr Red Soil Reg, Fuzhou, Fujian, Peoples R China	Fujian Academy of Agricultural Sciences; National Taiwan University; Ministry of Agriculture & Rural Affairs	Luo, XH (corresponding author), Fujian Acad Agr Sci, Agr Ecol Inst, Fuzhou, Fujian, Peoples R China.	xuhui22203@163.com	Hu, Guiping/AAT-4414-2020	Hu, Guiping/0000-0001-8392-8442; Luo, Xuhui/0000-0002-1877-8713	basic research project for non-profit research institutes of Fujian Province [2017R1016-3]; fellowship for innovation team of Fujian Academy of Agricultural Sciences [STIT 20173-8]	basic research project for non-profit research institutes of Fujian Province; fellowship for innovation team of Fujian Academy of Agricultural Sciences	This work was financially supported by the basic research project for non-profit research institutes of Fujian Province (No. 2017R1016-3), by the fellowship for innovation team of Fujian Academy of Agricultural Sciences (No. STIT 20173-8).	Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bremner J.M., 1982, METHODS SOIL ANAL AM, V2, P594; Cai MF, 2016, ENVIRON POLLUT, V208, P145, DOI 10.1016/j.envpol.2015.09.050; Chandra U, 2010, INT J ELECTROCHEM SC, V5, P1; Huang PM, 2013, ENVIRON EARTH SCI, V68, P2199, DOI 10.1007/s12665-012-1903-9; Huang PM, 2005, PEDOBIOLOGIA, V49, P609, DOI 10.1016/j.pedobi.2005.06.006; Jackson M.L., 1979, SOIL CHEM ANAL, V2nd; Joa JH, 2014, J MICROBIOL, V52, P995, DOI 10.1007/s12275-014-4129-6; Kim CS, 2016, J MICROBIOL, V54, P14, DOI 10.1007/s12275-016-5521-1; Labriere N, 2015, AGR ECOSYST ENVIRON, V203, P127, DOI 10.1016/j.agee.2015.01.027; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Liu LZ, 2014, J INTEGR AGR, V13, P415, DOI 10.1016/S2095-3119(13)60424-4; Mercier A, 2013, CHEMOSPHERE, V92, P787, DOI 10.1016/j.chemosphere.2013.04.016; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Qi LiangHua, 2013, Journal of Nanjing Forestry University (Natural Sciences Edition), V37, P45; Rowlings DW, 2013, AGR ECOSYST ENVIRON, V179, P168, DOI 10.1016/j.agee.2013.08.013; Shi YC, 2013, BIOL FERT SOILS, V49, P803, DOI 10.1007/s00374-013-0773-y; Shishido M, 2008, SOIL BIOL BIOCHEM, V40, P1460, DOI 10.1016/j.soilbio.2007.12.024; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Soil Survey Staff, 2010, KEYS SOIL TAXONOMY, Veleventh; Yang DW, 2014, EUR J SOIL BIOL, V64, P30, DOI 10.1016/j.ejsobi.2014.07.003; Yao H, 2000, MICROB ECOL, V40, P223; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhu WZ, 2010, J MT SCI-ENGL, V7, P327, DOI 10.1007/s11629-010-1098-z; Zhu YJ, 2012, J INTEGR AGR, V11, P1817, DOI 10.1016/S2095-3119(12)60186-5; Zhuan WM, 2008, MAP FUJIAN PROVINCE	26	11	11	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0215556	10.1371/journal.pone.0215556	http://dx.doi.org/10.1371/journal.pone.0215556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891580	gold, Green Published			2022-12-26	WOS:000515096600002
J	Panyam, V; Layton, A				Panyam, Varuneswara; Layton, Astrid			A quantitative engineering study of ecosystem robustness using thermodynamic power cycles as case studies	PLOS ONE			English	Article							SUSTAINABILITY; PERFORMANCE	Human networks and engineered systems are traditionally designed to maximize efficiency. Ecosystems on the other hand, achieve long-term robustness and sustainability by maintaining a unique balance between pathway efficiency and redundancy, measured in terms of the number of flow pathways available for a given unit of flow at any node in the network. Translating this flow-based ecosystem robustness into an engineering context supports the creation of new robust and sustainable design guidelines for engineered systems. Thermodynamic cycles provide good examples of human systems where simple and clearly defined modifications can be made to increase efficiency. Twenty-three variations on the Brayton and Rankine cycles are used to understand the relationship between design decisions that maximize a system's efficient use of energy (measured by thermodynamic first law efficiency) and ecological measures of robustness and structural efficiency. The results reveal that thermodynamic efficiency and ecological pathway efficiency do not always correlate and that while on average modifications to increase energy efficiency reduce the robustness of the system, the engineering understanding of ecological network design presented here can enable decisions that are able to increase both energy efficiency and robustness.	[Panyam, Varuneswara; Layton, Astrid] Texas A&M Univ, J Mike Walker66 Dept Mech Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Layton, A (corresponding author), Texas A&M Univ, J Mike Walker66 Dept Mech Engn, College Stn, TX 77843 USA.	alayton@tamu.edu		Layton, Astrid/0000-0003-3790-2916	Texas AAMP;M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	Texas AAMP;M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research.	BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Bodini A, 2002, INT J ENVIRON POLLUT, V18, P463, DOI 10.1504/IJEP.2002.002340; Bodini A, 2012, ECOL MODEL, V245, P185, DOI 10.1016/j.ecolmodel.2012.02.022; Borrett SR, 2010, ECOL MODEL, V221, P1710, DOI 10.1016/j.ecolmodel.2010.04.004; BOX G, 1988, TECHNOMETRICS, V30, P1, DOI 10.2307/1270311; Carvalho M, 2019, J BRAZ SOC MECH SCI, V41, DOI 10.1007/s40430-019-2051-x; Chen W, 1996, J MECH DESIGN, V118, P478, DOI 10.1115/1.2826915; Fath BD, 2015, OCEAN COAST MANAGE, V108, P13, DOI 10.1016/j.ocecoaman.2014.06.020; Gallopin G.C, 2003, SYSTEMS APPROACH SUS; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; Hammond GP, 2004, INT J ENERG RES, V28, P613, DOI [10.1002/er.988, 10.1002/cr.988]; Hardy Catherine, 2002, Journal of Industrial Ecology, V6, P29, DOI 10.1162/108819802320971623; Heymans JJ, 2002, NETWORK ANAL S FLORI; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100923; Kharrazi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171184; Kharrazi A, 2013, ECOL ECON, V90, P177, DOI 10.1016/j.ecolecon.2013.03.018; Kuhlman T., 2010, SUSTAINABILITY-BASEL, V2, P3436, DOI [10.3390/su2113436, DOI 10.3390/SU2113436]; Latham LG, 2002, ECOL MODEL, V154, P25, DOI 10.1016/S0304-3800(02)00032-7; Layton A, 2017, INT J SUSTAIN ENG, V10, P250, DOI 10.1080/19397038.2017.1317874; Layton A, 2016, J MANUF SCI E-T ASME, V138, DOI 10.1115/1.4033689; Layton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051841; LEON RV, 1987, TECHNOMETRICS, V29, P253, DOI 10.2307/1269331; MAGHSOODLOO S, 1990, J QUAL TECHNOL, V22, P57, DOI 10.1080/00224065.1990.11979206; Panyam V, 2019, APPL ENERG, V251, DOI 10.1016/j.apenergy.2019.113349; Panyam V, 2019, PROC CIRP, V80, P269, DOI 10.1016/j.procir.2018.12.005; Panyam V, 2019, 2019 IEEE TEXAS POWER AND ENERGY CONFERENCE (TPEC); Panyam VR, 2018, PROCEEDINGS OF THE ASME GAS TURBINE INDIA CONFERENCE, 2017, VOL 1; Parkin S., 2003, P I CIVIL ENG-ENG SU, V156, P19, DOI DOI 10.1680/ensu.2003.156.1.19; Rosen MA, 2012, SUSTAINABILITY-BASEL, V4, P2270, DOI 10.3390/su4092270; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Sonntag R.E., 1998, FUNDAMENTALS THERMOD, V5th ed.; Tsui KL, 2007, IIE T, V24, P44, DOI DOI 10.1080/07408179208964244; Ulanowicz R. E., 1986, GROWTH DEV ECOLOGICA, V1; Ulanowicz RE, 1997, ECOL MODEL, V95, P1, DOI 10.1016/S0304-3800(96)00032-4; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Zhang Y, 2010, ECOL MODEL, V221, P1865, DOI 10.1016/j.ecolmodel.2010.05.006	38	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226993	10.1371/journal.pone.0226993	http://dx.doi.org/10.1371/journal.pone.0226993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891623	gold, Green Published			2022-12-26	WOS:000515096600049
J	Sassu, F; Nikolouli, K; Pereira, R; Vreysen, MJB; Stauffer, C; Caceres, C				Sassu, Fabiana; Nikolouli, Katerina; Pereira, Rui; Vreysen, Marc J. B.; Stauffer, Christian; Caceres, Carlos			Irradiation dose response under hypoxia for the application of the sterile insect technique in Drosophila suzukii	PLOS ONE			English	Article							FRUIT-FLY DIPTERA; SPOTTED WING DROSOPHILA; GAMMA-IRRADIATION; ECONOMIC-ANALYSIS; REVENUE LOSSES; TEPHRITIDAE; QUALITY; PUPAE; COMPETITIVENESS; FERTILITY	Treating insects with a lower oxygen atmosphere before and during exposure to radiation can mitigate some of the negative physiological effects due to the irradiation. The irradiation of pupae under oxygen-reduced environment such as hypoxia or anoxia is routinely used in the sterile insect technique (SIT) of some tephritid species as it provides radiological protection. This treatment allows to have the sterile pupae already in sealed containers facilitating the shipment. SIT is an environment friendly control tactic that could be used to manage populations of Drosophila suzukii in confined areas such as greenhouses. The objectives of this study were to assess the effect of irradiation on the reproductive sterility in D. suzukii males and females under low-oxygen atmosphere (hypoxia) and atmosphere conditions (normoxia). Additionally, we assessed the differences in radiological sensitivity of pupae treated under hypoxia and normoxia conditions. Finally, the effect on emergence rate and flight ability of the irradiated D. suzukii adults exposed to doses that induced >99% of sterility were assessed. Pupae needed a 220 Gy irradiation dose to achieve >99% of egg hatch sterility in males irrespective of the atmosphere condition. For females the same level of sterility was achieved already at 75 Gy and 90 Gy for the normoxia and hypoxia treatments, respectively. Radiation exposure at 170 and 220 Gy under the two atmosphere treatments did not have any effect on the emergence rate and flight ability of D. suzukii males and females. Therefore, hypoxia conditions can be used as part of an area-wide insect pest management program applying SIT to facilitate the protocols of packing, irradiation and shipment of sterile D. suzukii pupae.	[Sassu, Fabiana; Nikolouli, Katerina; Stauffer, Christian] Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Vienna, Austria; [Sassu, Fabiana; Nikolouli, Katerina; Pereira, Rui; Vreysen, Marc J. B.; Caceres, Carlos] Joint FAO IAEA, Div Nucl Tech Food & Agr, Insect Pest Control Subprogramme, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; International Atomic Energy Agency	Sassu, F (corresponding author), Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Vienna, Austria.; Sassu, F (corresponding author), Joint FAO IAEA, Div Nucl Tech Food & Agr, Insect Pest Control Subprogramme, Vienna, Austria.	fabiana.sassu@students.boku.ac.at		Nikolouli, Katerina/0000-0003-4194-0368; Sassu, Fabiana/0000-0002-7871-5933; Stauffer, Christian/0000-0002-2985-8911	French National Research Agency [ANR-15-CE21-0017-01]; Austrian Science Fund [FWF-I2604-B25]	French National Research Agency(French National Research Agency (ANR)); Austrian Science Fund(Austrian Science Fund (FWF))	This research was supported by the French National Research Agency (ANR-15-CE21-0017-01) and the Austrian Science Fund (FWF-I2604-B25). FS and KN are supported by the French National Research Agency (ANR-15-CE21-0017-01) and the Austrian Science Fund (FWF-I2604-B25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; Arthur V., 2015, EVOLUTION IONIZING R, P213, DOI [10.5772/60409, DOI 10.5772/60409]; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Balock JW, 2015, J ECON ENTOMOL, V56, P42; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellamy DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061227; Benito NP, 2016, PESQUI AGROPECU BRAS, V51, P571, DOI 10.1590/S0100-204X2016000500018; Caceres C, 2007, FLA ENTOMOL, V90, P1, DOI 10.1653/0015-4040(2007)90[1:QMSFFF]2.0.CO;2; Caceres C, 2014, INT J TROP INSECT SC, V34, pS1, DOI 10.1017/S1742758414000034; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Condon CH, 2017, J ECON ENTOMOL, V110, P80, DOI 10.1093/jee/tow273; Deutscher AT, 2017, J ECON ENTOMOL, V110, P298, DOI 10.1093/jee/tow262; FAO/IAEA/USDA, 2003, MAN PROD QUAL CONTR; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Farnsworth D, 2017, PEST MANAG SCI, V73, P1083, DOI 10.1002/ps.4497; Fisher K, 1997, J ECON ENTOMOL, V90, P1609, DOI 10.1093/jee/90.6.1609; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hallman GJ, 2010, ACTA HORTIC, V857, P159; Haviland DR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11034; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; HENNEBERRY TJ, 1963, J ECON ENTOMOL, V56, P279, DOI 10.1093/jee/56.3.279; Hooper GHS., 1989, WORLD CROP PESTS A, P153; International Atomic Energy Agency, 2004, DOS SYST SIT MAN GAF; Ioriatti C, 2018, J ECON ENTOMOL, V111, P283, DOI 10.1093/jee/tox292; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kruger AP, 2018, J ECON ENTOMOL, V111, P741, DOI 10.1093/jee/tox349; LANGLEY PA, 1974, ENTOMOL EXP APPL, V17, P97, DOI 10.1007/BF00342569; Lanouette G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180821; Leach H, 2018, J PEST SCI, V91, P219, DOI 10.1007/s10340-017-0873-9; Lopez-Martinez G, 2012, J EXP BIOL, V215, P2150, DOI 10.1242/jeb.065631; Mastrangelo T., 2011, RADIOISOTOPES APPL B, P67, DOI DOI 10.5772/21531; Mazzi D, 2017, INSECTS, V8, DOI 10.3390/insects8010018; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; NATION JL, 1995, ANN ENTOMOL SOC AM, V88, P348, DOI 10.1093/aesa/88.3.348; Nestel D, 2007, FLA ENTOMOL, V90, P80, DOI 10.1653/0015-4040(2007)90[80:EOPCOM]2.0.CO;2; Nikolouli K, 2018, J PEST SCI, V91, P489, DOI 10.1007/s10340-017-0944-y; O'Brien RD, 1964, RAD RADIOACTIVITY IN, DOI DOI 10.1016/C2013-0-12102-2; OHINATA K, 1977, J ECON ENTOMOL, V70, P165, DOI 10.1093/jee/70.2.165; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Robinson AS, 2006, RADIAT RES, V61, P526; Rombaut A, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170117; Ros G. de, 2013, IOBC/WPRS Bulletin, V91, P317; RUHM ME, 1981, ENTOMOL EXP APPL, V29, P237, DOI 10.1007/BF00301727; Schetelig MF, 2018, J APPL ENTOMOL, V142, P3, DOI 10.1111/jen.12469; Sial AA, 2019, J APPL ENTOMOL, V143, P593, DOI 10.1111/jen.12629; Snellings Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23189-6; Stacconi MVR, 2019, BIOCONTROL, V64, P9, DOI 10.1007/s10526-018-09914-0; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; VONSONNTAG C, 1991, BASIC LIFE SCI, V58, P287; Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66; Whitten M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P601, DOI 10.1007/1-4020-4051-2_23; WILLARD WK, 1975, J THEOR BIOL, V52, P149, DOI 10.1016/0022-5193(75)90046-6; WILLIAMSON DL, 1985, ANN ENTOMOL SOC AM, V78, P101, DOI 10.1093/aesa/78.1.101; Younes M. W. F., 2009, Journal of Applied Sciences Research, P305	57	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226582	10.1371/journal.pone.0226582	http://dx.doi.org/10.1371/journal.pone.0226582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891597	Green Published, gold			2022-12-26	WOS:000515096600019
J	Shi, Y; Tong, CY; Zhang, MH; Gao, XL				Shi, Yan; Tong, Chaoyang; Zhang, Minghao; Gao, Xiaoling			Altered functional connectivity density in the brains of hemodialysis end-stage renal disease patients: An in vivo resting-state functional MRI study	PLOS ONE			English	Article							VASCULAR COGNITIVE IMPAIRMENT; CEREBRAL-BLOOD-FLOW; ANTERIOR INSULA; DISORDERS; DEMENTIA; IMPACT; MOCA; MMSE; SENSITIVITY; DEPRESSION	Background End-stage renal disease (ESRD) patients usually suffer from a high prevalence of central nervous system abnormalities, including cognitive impairment and emotional disorders, which severely influence their quality of life. There have been many neuroimaging research developments in ESRD patients with brain function abnormalities; however, the dysfunction of the salience network (SN) of them has received little attention. The purpose of this study was to investigate the changes of global functional connectivity density (gFCD) in brains of ESRD patients undergoing hemodialysis using resting-state functional magnetic resonance imaging (re-fMRI). Methods re-fMRI data were collected from 30 ESRD patients undergoing hemodialysis (14 men, 38.33 +/- 7.44 years old) and 30 matched healthy controls (13 men, 39.17 +/- 5.7 years old). Neuropsychological tests including the Montreal Cognitive Assessment (MoCA) and Beck Depression Inventory (BDI) were used to evaluate the neurocognitive and psychiatric conditions of the subjects. Blood biochemistry tests, including hemoglobin level, serum albumin level, blood urea level, serum phosphate, serum calcium, and parathyroid hormone level, and dialysis-related indicators, including blood pressure fluctuations in dialysis, single-pool KtN(spKtN), and ultrafiltration volume of dialysis were obtained from the ESRD patients. A two-sample t-test was used to examine the group differences in gFCD between ESRD patients and healthy controls after controlling for age, gender and education. Results Compared with healthy controls, ESRD patients exhibited a significantly increased gFCD in the salience network, including the bilateral insula, and dorsal anterior cingulated cortex (dACC), and there was no significant correlation between gFCD and the structural mean grey matter volume in patients for every cluster in the brain regions showing significant different gFCD between the two groups. Furthermore, there were significant negative correlations between the degree of connectivity in the right insula and spKtN. Conclusion Our findings revealed abnormal intrinsic dysconnectivity pattern of salience network-related regions in ESRD patients from the whole brain network perspective. The negative correlation between the right insula and spKtN suggested that increased fractional removal of urea may reduce the pathological activity in the insula.	[Shi, Yan; Gao, Xiaoling] Ninth Peoples Hosp Chongqing, Dept Nephrol, Chongqing, Peoples R China; [Tong, Chaoyang] Ninth Peoples Hosp Chongqing, Dept Med Imaging, Chongqing, Peoples R China; [Zhang, Minghao] Chongqing Med Univ, Ctr Lab Teaching & Management, Chongqing, Peoples R China	Chongqing Medical University	Gao, XL (corresponding author), Ninth Peoples Hosp Chongqing, Dept Nephrol, Chongqing, Peoples R China.	gaoxlcqm@163.com	Gao, xiao ling/GQI-2790-2022					Agganis BT, 2010, AM J KIDNEY DIS, V56, P704, DOI 10.1053/j.ajkd.2010.04.018; Arnold R, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016677687; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Chen C, 2011, ALZHEIMERS DEMENT, V7, pS240; Chen HJ, 2017, MOL NEUROBIOL, V54, P2223, DOI 10.1007/s12035-016-9811-8; Chen HJ, 2015, METAB BRAIN DIS, V30, P1247, DOI 10.1007/s11011-015-9702-0; Chen MC, 2014, BIOL PSYCHOL, V97, P1, DOI 10.1016/j.biopsycho.2013.12.016; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Drew DA, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0628-0; Feinstein JS, 2006, SOC COGN AFFECT NEUR, V1, P136, DOI 10.1093/scan/nsl016; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Fukunishi I, 2002, NEPHRON, V91, P344, DOI 10.1159/000058418; GOTTLIEB D, 1987, J CEREBR BLOOD F MET, V7, P659, DOI 10.1038/jcbfm.1987.119; Hain Debra J, 2008, Nephrol Nurs J, V35, P23; HATA R, 1994, STROKE, V25, P408, DOI 10.1161/01.STR.25.2.408; Hermann DM, 2014, J NEURAL TRANSM, V121, P627, DOI 10.1007/s00702-014-1160-z; HOLZER H, 1981, P EUR DIAL TRANS, V18, P126; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Huang H., 2017, SCHIZOPHR RES; Kim CD, 2007, AM J KIDNEY DIS, V50, P98, DOI 10.1053/j.ajkd.2007.03.019; Kong X, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000313; Li A, 2018, METAB BRAIN DIS, V33; Liang X, 2013, PLOS ONE, V22; Lopes AA, 2002, KIDNEY INT, V62, P199, DOI 10.1046/j.1523-1755.2002.00411.x; Luo S, 2016, RADIOLOGY, V278, P181, DOI 10.1148/radiol.2015141913; Ma XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121085; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; POSTIGLIONE A, 1991, STROKE, V22, P1508, DOI 10.1161/01.STR.22.12.1508; Power A, 2012, AM J KIDNEY DIS, V59, P249, DOI 10.1053/j.ajkd.2011.07.016; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Qiu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098346; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Sozio SM, 2009, AM J KIDNEY DIS, V54, P468, DOI 10.1053/j.ajkd.2009.01.261; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Suzuki M, 1997, STROKE, V28, P2528, DOI 10.1161/01.STR.28.12.2528; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; TESCHAN PE, 1983, KIDNEY INT, pS58; TESCHAN PE, 1975, KIDNEY INT, V7, pS210; Tomasi D, 2016, CEREB CORTEX, V26, P3249, DOI 10.1093/cercor/bhv171; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Watanabe K, 2014, NEUROTOXICOLOGY, V44, P184, DOI 10.1016/j.neuro.2014.06.014; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zhang B, 2016, EUR ARCH PSY CLIN N, V266, P239, DOI 10.1007/s00406-015-0614-0; Zhang JQ, 2015, BEHAV BRAIN RES, V280, P113, DOI 10.1016/j.bbr.2014.12.007; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7; Zhang RJ, 2015, EUR RADIOL, V25, P661, DOI 10.1007/s00330-014-3466-5; Zhang XD, 2015, METAB BRAIN DIS, V30, P1175, DOI 10.1007/s11011-015-9683-z; Zhang XD, 2015, BRAIN RES, V1620, P177, DOI 10.1016/j.brainres.2015.04.046	59	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227123	10.1371/journal.pone.0227123	http://dx.doi.org/10.1371/journal.pone.0227123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891646	Green Published, gold			2022-12-26	WOS:000515096600062
J	Silva, MJ; Holguin, N				Silva, Matthew J.; Holguin, Nilsson			Aging aggravates intervertebral disc degeneration by regulating transcription factors toward chondrogenesis	FASEB JOURNAL			English	Article						biomechanics; genetic animal models; osterix; Wnt; beta-catenin; LRPs	BETA-CATENIN; CHONDROCYTE DIFFERENTIATION; NUCLEUS PULPOSUS; CRE RECOMBINASE; CELLS; BONE; LUMBAR; MICE; CALCIFICATION; ACTIVATION	Osterix is a critical transcription factor of mesenchymal stem cell fate, where its loss or loss of Wnt signaling diverts differentiation to a chondrocytic lineage. Intervertebral disc (IVD) degeneration activates the differentiation of prehypertrophic chondrocyte-like cells and inactivates Wnt signaling, but its interactive role with osterix is unclear. First, compared to young-adult (5 mo), mechanical compression of old (18 mo) IVD induced greater IVD degeneration. Aging (5 vs 12 mo) and/or compression reduced the transcription of osterix and notochordal marker T by 40-75%. Compression elevated the transcription of hypertrophic chondrocyte marker MMP13 and pre-osterix transcription factor RUNX2, but less so in 12 mo IVD. Next, using an Ai9/td reporter and immunohistochemical staining, annulus fibrosus and nucleus pulposus cells of young-adult IVD expressed osterix, but aging and compression reduced its expression. Lastly, in vivo LRP5-deficiency in osterix-expressing cells inactivated Wnt signaling in the nucleus pulposus by 95%, degenerated the IVD to levels similar to aging and compression, reduced the biomechanical properties by 45-70%, and reduced the transcription of osterix, notochordal markers and chondrocytic markers by 60-80%. Overall, these data indicate that age-related inactivation of Wnt signaling in osterix-expressing cells may limit regeneration by depleting the progenitors and attenuating the expansion of chondrocyte-like cells.	[Silva, Matthew J.] Washington Univ, Dept Biomed Engn, Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA; [Holguin, Nilsson] IUPUI, Dept Mech & Energy Engn, Indiana Ctr Musculoskeletal Hlth, 723 W Michigan St,635 Barnhill Dr, Indianapolis, IN 46202 USA; [Holguin, Nilsson] IUPUI, Dept Anat & Cell Biol, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA	Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Holguin, N (corresponding author), IUPUI, Dept Mech & Energy Engn, Indiana Ctr Musculoskeletal Hlth, 723 W Michigan St,635 Barnhill Dr, Indianapolis, IN 46202 USA.	nholguin@iupui.edu			NIH [R01 AR047867, F32 AR064667]; Washington University Musculoskeletal Research Center [P30 AR057235, T32 AR060719]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Musculoskeletal Research Center	NIH, Grant/Award Number: R01 AR047867 and F32 AR064667; Washington University Musculoskeletal Research Center, Grant/Award Number: P30 AR057235 and T32 AR060719	Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Alam I, 2016, ENDOCRINOLOGY, V157, P722, DOI 10.1210/en.2015-1281; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bedore J, 2016, J CELL COMMUN SIGNAL, V10, P137, DOI 10.1007/s12079-016-0329-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Boos N, 1997, HISTOCHEM CELL BIOL, V108, P471, DOI 10.1007/s004180050187; Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen M, 2014, EUR CELLS MATER, V28, P236, DOI 10.22203/eCM.v028a16; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Holguin N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29352-3; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Holguin N, 2014, J APPL PHYSIOL, V116, P1551, DOI 10.1152/japplphysiol.01322.2013; Holguin N, 2013, SPINE J, V13, P428, DOI 10.1016/j.spinee.2013.01.046; Holguin N, 2011, J APPL PHYSIOL, V111, P1846, DOI 10.1152/japplphysiol.00846.2011; Holguin N, 2010, AVIAT SPACE ENVIR MD, V81, P1078, DOI 10.3357/ASEM.2818.2010; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Imuta Y, 2013, GENESIS, V51, P210, DOI 10.1002/dvg.22376; Iwata M, 2015, J CELL PHYSIOL, V230, P180, DOI 10.1002/jcp.24697; Kondo N, 2011, SPINE, V36, pE513, DOI 10.1097/BRS.0b013e3181f52cb5; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma B, 2013, CALCIFIED TISSUE INT, V92, P399, DOI 10.1007/s00223-012-9675-5; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Merceron C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110768; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Mundy C, 2011, DEV BIOL, V351, P70, DOI 10.1016/j.ydbio.2010.12.022; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nalesso G, 2017, ANN RHEUM DIS, V76, P218, DOI 10.1136/annrheumdis-2015-208577; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Richardson SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01567-w; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Shao J, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1015-x; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Tam V, 2018, J ORTHOP RES, V36, P233, DOI 10.1002/jor.23637; Torre OM, 2018, FASEB J, V32, P4753, DOI 10.1096/fj.201701492R; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wang MN, 2012, ARTHRITIS RHEUM-US, V64, P2611, DOI 10.1002/art.34469; Winkler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098444; Wu Q, 2019, JBMR PLUS, V3, P10069; Yurube T, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4460; Zheng YX, 2019, J CELL PHYSIOL, V234, P14422, DOI 10.1002/jcp.28166	54	17	18	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1970	1982		10.1096/fj.201902109R	http://dx.doi.org/10.1096/fj.201902109R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909538	Bronze, Green Accepted, Green Submitted			2022-12-26	WOS:000504269400001
J	Kim, YY; Um, JH; Yoon, JH; Lee, DY; Lee, YJ; Kim, DH; Park, JI; Yun, J				Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Kim, Dong Hyun; Park, Joo-In; Yun, Jeanho			p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence	FASEB JOURNAL			English	Article						cellular senescence; Drp1; mitochondria dynamics; p53; PKA; senescence	WILD-TYPE P53; GIANT MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN; PHOSPHORYLATION; FISSION; BIOLOGY; CELLS; MICE	Cellular senescence acts as an important barrier to tumorigenesis by eliminating precancerous cells. Previous studies have shown an essential role of the tumor suppressor p53 in cellular senescence, but how p53 induces cellular senescence is not fully understood. We found that p53 promoted the formation of highly interconnected and elongated mitochondria prior to the onset of cellular senescence. The inhibition of mitochondrial elongation upon p53 expression suppressed cellular senescence, suggesting that mitochondrial elongation is required for the induction of p53-dependent senescence. p53-induced mitochondrial elongation resulted in mitochondrial dysfunction and subsequent increases in intracellular reactive oxygen species (ROS) levels, an important mediator of cellular senescence. Mechanistically, the inhibitory phosphorylation of Drp1 Ser637 increased upon p53 expression, suppressing the translocation of Drp1 into mitochondria. The transcriptional function of p53 was crucial for controlling the inhibitory phosphorylation of Drp1, whereas p21 was nonessential. Protein kinase A (PKA) activity was responsible for p53-mediated Drp1 Ser637 phosphorylation and mitochondrial dysfunction. Taken together, these results suggest that p53 regulates mitochondrial dynamics through the PKA-Drp1 pathway to induce cellular senescence.	[Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Kim, Dong Hyun; Park, Joo-In; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Busan, South Korea; [Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Park, Joo-In; Yun, Jeanho] Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea; [Kim, Dong Hyun] Dong A Univ, Dept Med Biotechnol, Coll Hlth Sci, Busan, South Korea	Dong A University; Dong A University; Dong A University	Yun, J (corresponding author), Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea.	yunj@dau.ac.kr		Yun, Jeanho/0000-0001-7700-5123				Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Cheng G, 2018, J BIOL CHEM, V293, P10363, DOI 10.1074/jbc.RA118.003044; COLEMAN R, 1987, GERONTOLOGY, V33, P34, DOI 10.1159/000212851; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Kaiser AM, 2018, CELL DEATH DIFFER, V25, P93, DOI 10.1038/cdd.2017.171; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Liu J, 2017, J CELL BIOCHEM, V118, P7, DOI 10.1002/jcb.25609; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; MURAKOSHI M, 1985, Tokai Journal of Experimental and Clinical Medicine, V10, P531; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; SATO T, 1975, ACTA PATHOL JAPON, V25, P403; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	55	20	21	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2451	2464		10.1096/fj.201901747RR	http://dx.doi.org/10.1096/fj.201901747RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908078				2022-12-26	WOS:000514663600036
J	Dineley, B; Munro, S; Norman, WV				Dineley, Brigid; Munro, Sarah; Norman, Wendy V.			Leadership for success in transforming medical abortion policy in Canada	PLOS ONE			English	Article								Objectives Mifepristone was approved for use in medical abortion by Health Canada in 2015. Approval was accompanied by regulations that prohibited pharmacist dispensing of the medication. Reproductive health advocates in Canada recognized this regulation would limit access to medical abortion and successfully worked to have this regulation removed in 2017. The purpose of this study was to assess the leadership involved in changing these regulations so that the success may be replicated by other groups advocating for health policy change. Methods This study involved a mixed methods instrumental design in the context of British Columbia, Canada. Our data collection included: a) interviews with seven key individuals, representing the organizations that worked in concert for change to Canadian mifepristone regulations, and b) document analysis of press articles, correspondence, briefing notes, and meeting minutes. We conducted a thematic analysis of transcripts of audio-recorded interviews. We identified strengths and weaknesses of the team dynamic using the Develop Coalitions, Achieve Results and Systems Transformation domains of the LEADS Framework. Results Our analysis of participant interviews indicates that autonomy, shared values, and clarity in communication were integral to the success of the group's work. Analysis using the LEADS Framework showed that individuals possessed many of the capabilities identified as being necessary for successful health policy leadership. A lack of post-project assessment was identified as a possible limitation and could be incorporated in future work to strengthen dynamics especially when a desired outcome is not achieved. Document analysis provided a clear time-line of the work completed and suggested that strong communication between team members was another key to success. Conclusions The results of our analysis of the interviews and documents provide valuable insight into the workings of a successful group committed to a common goal. The existing collegial and trusting relationships between key stakeholders allowed for interdisciplinary collaboration, rapid mobilization, and identification of issues that facilitated successful Canadian global-first deregulation of mifepristone dispensing.	[Dineley, Brigid; Munro, Sarah] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada; [Munro, Sarah] Ctr Hlth Evaluat & Outcome Sci CHEOS, Vancouver, BC, Canada; [Norman, Wendy V.] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Norman, Wendy V.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of British Columbia; University of British Columbia; University of London; London School of Hygiene & Tropical Medicine	Dineley, B (corresponding author), Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada.	brigid.dineley@cw.bc.ca	Norman, Wendy V./D-6796-2015	Norman, Wendy V./0000-0003-4340-7882	Canadian Institutes for Health Research, CIHR [PHE148161]; Michael Smith Foundation for Health Research [16743, 16603, 18270, 2012-5139 (HSR)]; Canadian Institutes of Health Research [CPP-329455-107837]	Canadian Institutes for Health Research, CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study is supported by grants received by Wendy Norman from Canadian Institutes for Health Research, CIHR (PHE148161), in partnership with Michael Smith Foundation for Health Research (Award #16743). In kind and team infrastructure support was provided by the Women's Health Research Institute of British Columbia Women's Hospital and Health Centre of the Provincial Health Services Authority of British Columbia. SM is supported as a Trainee and a Scholar of the Michael Smith Foundation for Health Research [16603, 18270]. WVN is supported as a Scholar of the Michael Smith Foundation for Health Research [2012-5139 (HSR)], and as an Applied Public Health Research Chair by the Canadian Institutes of Health Research [CPP-329455-107837]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2016, GLOBE MAIL; BC Women's Hospital, VIS MISS VAL; Berer M, 2020, BEST PRACT RES CL OB, V63, P45, DOI 10.1016/j.bpobgyn.2019.07.012; College of Pharmacists of British Columbia, 2016, HLTH PROF ACT 1; College of Physicians and Surgeons of British Columbia, 2009, PROF STAND GUID DISP; Costescu D, 2016, J OBSTET GYNAECOL CA, V38, P366, DOI 10.1016/j.jogc.2016.01.002; Dawson AJ, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0303-8; Dickson G, 2018, LEADERSH HEALTH SERV, V31, P183, DOI 10.1108/LHS-12-2017-0077; Dickson RGB, 1988, MORGENTALER SCC CASE; Dineley B, 2019, COMMUNICATION; Gifford W, 2017, J HEALTHC LEADERSH, V9, P15, DOI 10.2147/JHL.S125558; Gold M, 2015, CONTRACEPTION, V92, P194, DOI 10.1016/j.contraception.2015.06.011; Guilbert E., 2019, PILULE ABORTIVE QUEB; Health Canada, 2015, REG DED SUMM MIF; Health Canada, 2017, MIF CAN DISTR ADM PO; Institute for Health Care Improvement, 2021, PLAN DO STUD ACT WOR; Kingdon John W., 2003, ALTERNATIVES PUBLIC; Kirkey S., 2016, NATL POST; LEADS Collaborative, 2010, DEV COAL EX SUMM; LEADS Collaborative, 2010, SYST TRANSF EX SUMM; LEADS Collaborative, 2010, HLTH LEAD CAP FRAM; LEADS Collaborative, 2010, ACH RES EX SUMM; Munro S, 6 BC WOM CART M CONT; Norman WV, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028443; Norman WV, 2016, CAN MED ASSOC J, V188, pE429, DOI 10.1503/cmaj.160581; Norman WV, 2016, CAN FAM PHYSICIAN, V62, pE209; Oetter H, 2016, COLL CONNECT, V4; Overton AR, 2013, CLIN COLON RECT SURG, V26, P259, DOI 10.1055/s-0033-1356728; Picard A., 2016, GLOBE MAIL; Sethna C, 2013, WOMEN STUD INT FORUM, V38, P52, DOI 10.1016/j.wsif.2013.02.001; Sethna C, 2007, J OBSTET GYNAECOL CA, V29, P640, DOI 10.1016/S1701-2163(16)32560-9; Shaw D, 2020, BEST PRACT RES CL OB, V62, P49, DOI 10.1016/j.bpobgyn.2019.05.010; Watt A, 2012, PROJECT MANAGEMENT B	33	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227216	10.1371/journal.pone.0227216	http://dx.doi.org/10.1371/journal.pone.0227216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914156	gold, Green Published			2022-12-26	WOS:000534337700033
J	Alcaraz, E; Vilardell, J; Borgo, C; Sarro, E; Plana, M; Marin, O; Pinna, LA; Bayascas, JR; Meseguer, A; Salvi, M; Itarte, E; Ruzzene, M				Alcaraz, Estefania; Vilardell, Jordi; Borgo, Christian; Sarro, Eduard; Plana, Maria; Marin, Oriano; Pinna, Lorenzo A.; Bayascas, Jose R.; Meseguer, Anna; Salvi, Mauro; Itarte, Emilio; Ruzzene, Maria			Effects of CK2 beta subunit down-regulation on Akt signalling in HK-2 renal cells	PLOS ONE			English	Article							PROTEIN-KINASE CK2; CENTER STAGE; PHOSPHORYLATION; INHIBITOR; PATHWAYS; CANCER; SITE; INACTIVATION; PROSURVIVAL; DOWNSTREAM	The PI3K/Akt pathway is interconnected to protein kinase CK2, which directly phosphorylates Akt1 at S129. We have previously found that, in HK-2 renal cells, downregulation of the CK2 regulatory subunit beta (shCK2 beta cells) reduces S129 Akt phosphorylation. Here, we investigated in more details how the different CK2 isoforms impact on Akt and other signaling pathways. We found that all CK2 isoforms phosphorylate S129 in vitro, independently of CK2 beta. However, in HK-2 cells the dependence on CK2 beta was confirmed by rescue experiments (CK2 beta re-expression in shCK2 beta HK-2 cells), suggesting the presence of additional components that drive Akt recognition by CK2 in cells. We also found that CK2 beta downregulation altered the phosphorylation ratio between the two canonical Akt activation sites (pT308 strongly reduced, pS473 slightly increased) in HK-2 cells. Similar results were found in other cell lines where CK2 beta was stably knocked out by CRISPR-Cas9 technology. The phosphorylation of rpS6 S235/S236, a downstream effector of Akt, was strongly reduced in shCK2 beta HK-2 cells, while the phosphorylation of two Akt direct targets, PRAS40 T246 and GSK3 beta S9, was increased. Differently to what observed in response to CK2 beta down-regulation, the chemical inhibition of CK2 activity by cell treatment with the specific inhibitor CX-4945 reduced both the Akt canonical sites, pT308 and pS473. In CX-4945-treated cells, the changes in rpS6 pS235/S236 and GSK3 beta pS9 mirrored those induced by CK2 beta knockdown (reduction and slight increase, respectively); on the contrary, the effect on PRAS40 pT246 phosphorylation was sharply different, being strongly reduced by CK2 inhibition; this suggests that this Akt target might be dependent on Akt pS473 status in HK-2 cells. Since PI3K/Akt and ERK1/2/p90rsk pathways are known to be interconnected and both modulated by CK2, with GSK3 beta pS9 representing a convergent point, we investigated if ERK1/2/p90rsk signaling was affected by CK2 beta knock-down and CX-4945 treatment in HK-2 cells. We found that p90rsk was insensitive to any kind of CK2 targeting; therefore, the observation that, similarly, GSK3 beta pS9 was not reduced by CK2 blockade suggests that GSK3 beta phosphorylation is mainly under the control of p90rsk in these cells. However, we found that the PI3K inhibitor LY294002 reduced GSK3 beta pS9, and concomitantly decreased Snail1 levels (a GSK3 beta target and Epithelial-to-Mesenchymal transition marker). The effects of LY294002 were observed also in CK2 beta-downregulated cells, suggesting that reducing GSK3 beta pS9 could be a strategy to control Snail1 levels in any situation where CK2 beta is defective, as possibly occurring in cancer cells.	[Alcaraz, Estefania; Vilardell, Jordi; Plana, Maria; Itarte, Emilio] Univ Autonoma Barcelona, Unitat Bioquim, Dept Bioquim & Biol Mol, Fac Biociencies, Bellaterra, Barcelona, Spain; [Borgo, Christian; Marin, Oriano; Pinna, Lorenzo A.; Salvi, Mauro; Ruzzene, Maria] Univ Padua, Dept Biomed Sci, Padua, Italy; [Sarro, Eduard; Meseguer, Anna] VHIR, Fisiopatol Renal, CIBBIM Nanomed, Barcelona, Spain; [Plana, Maria; Itarte, Emilio] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain; [Pinna, Lorenzo A.; Ruzzene, Maria] CNR, Neurosci Inst, Padua, Italy; [Bayascas, Jose R.; Meseguer, Anna] Univ Autonoma Barcelona, Unitat Bioquim Med, Dept Bioquim & Biol Mol, Bellaterra, Barcelona, Spain; [Bayascas, Jose R.] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain; [Meseguer, Anna] Inst Salud Carlos III FEDER, Red Invest Renal REDINREN, Madrid, Spain	Autonomous University of Barcelona; University of Padua; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consiglio Nazionale delle Ricerche (CNR); Autonomous University of Barcelona; Autonomous University of Barcelona	Itarte, E (corresponding author), Univ Autonoma Barcelona, Unitat Bioquim, Dept Bioquim & Biol Mol, Fac Biociencies, Bellaterra, Barcelona, Spain.; Ruzzene, M (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.; Itarte, E (corresponding author), Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain.; Ruzzene, M (corresponding author), CNR, Neurosci Inst, Padua, Italy.	emili.itarte@uab.cat; maria.ruzzene@unipd.it	Navarro, Anna Meseguer/M-2222-2014; Itarte, Emilio/Q-6246-2019	Navarro, Anna Meseguer/0000-0003-3833-2249; Salvi, Mauro/0000-0003-3448-6048; BORGO, CHRISTIAN/0000-0001-9540-8145	Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad [BFU2009-10189, SAF2014-52813-R, SAF20145994-5-R, SAF2017-89989-R]; REDINREN 2.0 [RD12/0021/0013]; Fundacion Senefro; Kure It-AACR Grant for Kidney Cancer Research; Associazione Italiana per la Ricerca sul Cancro, AIRC [IG 18756]	Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad; REDINREN 2.0; Fundacion Senefro; Kure It-AACR Grant for Kidney Cancer Research; Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by the Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad (BFU2009-10189 to E. I., SAF2014-52813-R to J.R.B. and SAF20145994-5-R and SAF2017-89989-R to A.M.); REDINREN 2.0 Ref: RD12/0021/0013 (A.M.) the Fundacion Senefro (SEN to A.M.) the Kure It-AACR Grant for Kidney Cancer Research (A.M.); the Associazione Italiana per la Ricerca sul Cancro, AIRC (IG 18756 to L.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni G, 2008, J PROTEOME RES, V7, P990, DOI 10.1021/pr070500s; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bischoff N, 2011, J MOL BIOL, V407, P1, DOI 10.1016/j.jmb.2011.01.020; Borgo C, 2017, SCI REPORTS, V7, P1; Borgo C, 2019, FEBS J, V286, P1561, DOI 10.1111/febs.14799; Borgo C, 2013, MOL ONCOL, V7, P1103, DOI 10.1016/j.molonc.2013.08.006; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Chua MMJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188854; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Di Maira G, 2009, CELL MOL LIFE SCI, V66, P3363, DOI 10.1007/s00018-009-0108-1; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Fernandez-Saiz V, 2013, NAT CELL BIOL, V15, P72, DOI 10.1038/ncb2651; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franchin C, 2018, CELL MOL LIFE SCI, V75, P2011, DOI 10.1007/s00018-017-2705-8; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gibson SA, 2017, J IMMUNOL, V198, P4244, DOI 10.4049/jimmunol.1601912; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Lan AP, 2014, CELL PHYSIOL BIOCHEM, V34, P368, DOI 10.1159/000363006; Landesman-Bollag E, 2011, MOL CELL BIOCHEM, V356, P227, DOI 10.1007/s11010-011-0967-2; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Llorens F, 2003, BIOCHEM J, V375, P623, DOI 10.1042/BJ20030915; Lolli G, 2014, ACS CHEM BIOL, V9, P366, DOI 10.1021/cb400771y; Lolli G, 2012, ACS CHEM BIOL, V7, P1158, DOI 10.1021/cb300054n; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Nastainczyk W, 2003, HYBRIDOMA HYBRIDOM, V22, P87, DOI 10.1089/153685903321948003; Olsen BB, 2012, INT J ONCOL, V41, P1967, DOI 10.3892/ijo.2012.1635; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Pal R, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Patsoukis N, 2013, MOL CELL BIOL, V33, P3091, DOI 10.1128/MCB.00319-13; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poletto G, 2008, BIOCHEMISTRY-US, V47, P8317, DOI 10.1021/bi800216d; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruzzene Maria, 2017, Advances in Biological Regulation, V64, P1, DOI 10.1016/j.jbior.2017.03.002; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/S0076-6879(10)84024-8, 10.1016/B978-0-12-381298-8.00024-1]; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vilardell J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193479; Vilardell Jordi, 2018, Oncotarget, V9, P5736, DOI 10.18632/oncotarget.23422; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Xu R, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9379864; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zakharia K, 2019, TRANSL ONCOL, V12, P143, DOI 10.1016/j.tranon.2018.09.005; Zanin S, 2015, BBA-PROTEINS PROTEOM, V1854, P1694, DOI 10.1016/j.bbapap.2015.04.026; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265; Zhou XY, 2014, CELL CYCLE, V13, P3164, DOI 10.4161/15384101.2014.962954	58	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227340	10.1371/journal.pone.0227340	http://dx.doi.org/10.1371/journal.pone.0227340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910234	gold, Green Published			2022-12-26	WOS:000534333800042
J	Gebremichael, TG; Welesamuel, TG				Gebremichael, Tsgehana Gebregyorgis; Welesamuel, Tsehaynesh Gidey			Adherence to iron-folic acid supplement and associated factors among antenatal care attending pregnant mothers in governmental health institutions of Adwa town, Tigray, Ethiopia: Cross-sectional study	PLOS ONE			English	Article							MATERNAL ANEMIA; NUTRITION; BIRTH	Background Iron-folic acid supplementation during pregnancy is among the very effective interventions to prevent iron deficiency anemia, low birth weight, and prematurity. There is a need of having recent studies on adherence to the supplement that consider the very recent interventions targeted to scale up the use of iron-folic acid (IFA) supplement. Therefore we sought to assess adherence to IFA supplement and its associated factors among antenatal care attending pregnant mothers in governmental health institutions of Adwa town. Methods Institution-based cross-sectional study was conducted among 629 antenatal care attending pregnant mothers. Systematic random sampling method was used to select the study subjects. Data were collected through face-to-face interview and chart-review. Bivariable and multivariable binary logistic regression was computed. Variables with P-value < 0.05 were considered statistically significant at 95% confidence interval (CI). Result Only 40.9% (95%CI: 37.0%-44.7%) of participants were adherent (took four or more tablets per week). Women in the age group of 25-29 years [AOR: 2.22(1.21-4.07)] had increased odds of adherence as compared to those in the age group >= 35 years. Women who received nutrition counseling [AOR: 4.12(2.12-8.03)] and partner support [AOR: 2.23 (1.42-3.49)] had increased odds of adherence as compared to those who didn't receive nutrition counseling and partner support respectively. Similarly, women who had satisfactory knowledge on IFA supplement (AOR: 2.16(1.37-3.40)) had increased odds of adherence as compared to those who didn't have satisfactory knowledge on IFA supplement. Conclusion Adherence to the supplement was low. Efforts shall be done to improve awareness of pregnant mothers about IFA supplement through targeted nutrition counseling that includes the engagement of a partner.	[Gebremichael, Tsgehana Gebregyorgis] Axum Univ, Specialized & Compress Hosp, Dept Human Nutr, Axum, Ethiopia; [Welesamuel, Tsehaynesh Gidey] Axum Univ, Specialized & Compress Hosp, Dept Publ Hlth, Axum, Ethiopia		Gebremichael, TG (corresponding author), Axum Univ, Specialized & Compress Hosp, Dept Human Nutr, Axum, Ethiopia.	hanagmichael@gmail.com			Axum University, Axum, Ethiopia	Axum University, Axum, Ethiopia	This study was funded by Axum University, Axum, Ethiopia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ETHIOPIA NATL NUTR P; [Anonymous], 2014, 2025 ANAEMIA POLICY; Arega Sadore A, 2015, J ENV PUBLIC HLTH, V2015; Birhanu Tesfaye Molla, 2018, BMC Res Notes, V11, P345, DOI 10.1186/s13104-018-3433-3; Central statistical agency, ETH DEM HLTH SURV 20; Christian P, 2015, SEMIN PERINATOL, V39, P361, DOI 10.1053/j.semperi.2015.06.009; Ethiopian Public Health Institute (EPHI), 2016, ETH NAT MICR SURV RE, P9; Federal Ministry of Health of Ethiopia, 2016, NAT GUID CONTR PREV; Gebre A., 2015, INT J NUTR FOOD SCI, V4, P161, DOI [10.11648/j.ijnfs.20150402.16, DOI 10.11648/J.IJNFS.20150402.16]; Gebreamlak B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169415; Getachew M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1716-2; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P168, DOI 10.1111/j.1365-3016.2012.01312.x; Jasti S, 2005, J NUTR, V135, P1093, DOI 10.1093/jn/135.5.1093; Kamau MW, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5437-2; Marti-carvaja A.L, 2002, PREVALENCE ANEMIA PR; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mithra P, 2013, Afr Health Sci, V13, P880, DOI 10.4314/ahs.v13i4.3; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Shewasinad S, 2017, J PREGNANCY CHILD HL, DOI [10.4172/2376-127X.1000301, DOI 10.4172/2376-127X.1000301]; Taye B, 2015, J ENV PUBLIC HLTH, V20, P1; Tegegne M., 2017, GLOBAL J MED RES; Tetanus WMIA, 2006, INT MAN PREGN CHILDB; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; World Health Organization, 2013, ESS NUTR ACT IMPR MA	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227090	10.1371/journal.pone.0227090	http://dx.doi.org/10.1371/journal.pone.0227090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910215	Green Published, gold			2022-12-26	WOS:000534333800026
J	Nutini, MFR; Hunter, J; Giron, L; Pires, AFNPC; Kohiyama, IM; Camargo, M; Sucupira, MCA; Benzaken, AS; Ferreira, PA; Truong, HHM; Diaz, RS				Rodrigues Nutini, Mariana Fernanda; Hunter, James; Giron, Leila; Pinto Coelho Pires, Ana Flavia Nacif; Kohiyama, Igor Massaki; Camargo, Michelle; Araripe Sucupira, Maria Cecilia; Benzaken, Adele Schwartz; Ferreira, Paulo Abrao; Truong, Hong-Ha M.; Diaz, Ricardo Sobhie			HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMEPREVIR PLUS SOFOSBUVIR; CHRONIC HEPATITIS-C; PHYLOGENETIC ANALYSIS; FIBROSIS PROGRESSION; PEGINTERFERON; RIBAVIRIN; CIRRHOSIS; TELAPREVIR; SUBTYPES	Introduction To be eligible for government-provided treatment in Brazil, all HCV-infected individuals are required to be genotyped shortly after diagnosis. We describe the HCV genotype (G) profiles by geographic region, gender, age and HIV co-infection. Methods We assessed 29,071 genotypes collected from HCV-infected individuals from March 2016 to March 2018 (Abbott Real-Time HCV Genotype). We randomly selected 12,336 samples for HIV co-infection testing using an EIA rapid test kit (TR DPP HIV 1/2 Bio-Manguinhos). Descriptive statistical analyses were performed using R. Results Overall, HCV genotype distribution was 40.9% G1A, 30.2% G1B, 23.8% G3, 3.8% G2, 0.7% G4, 0.1% G5 and 0.6% with multiples genotypes. G1A prevalence was 44.4% among males and 35.8% among females. G1B and G2 were more prevalent in older individuals than G1A and G3. G3 was more prevalent in the South region. Of samples tested for HIV co-infection, 15% were HIV+. Median age among HCV/HIV co-infected individuals was 50 years old compared to 57 years old among mono-infected individuals. Distinct HCV genotype prevalence between HCV/HIV co-infected and HCV mono-infected individuals were respectively: G1A 60.6% versus 37.8%, G1B 15.2% versus 32.9%, and G3 18.9% versus 24.7%. G4 was detected among co-infected young men (3.5% versus 0.2% among monoinfected). Conclusion The increasing prevalence of G3, as inferred by the younger ages of the HCV-infected individuals, poses an extra challenge with regards to disease progression. Distinct genotypical profiles between HCV mono-infection and HCV/HIV co-infection warrant future research in order to better understand and help mitigate HCV chains of transmission.	[Rodrigues Nutini, Mariana Fernanda; Hunter, James; Camargo, Michelle; Araripe Sucupira, Maria Cecilia; Ferreira, Paulo Abrao; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Giron, Leila] Wistar Inst Philadelphia, Philadelphia, PA USA; [Pinto Coelho Pires, Ana Flavia Nacif] Univ Brasilia, Brasilia, DF, Brazil; [Kohiyama, Igor Massaki] Abbott Mol, Sao Paulo, SP, Brazil; [Benzaken, Adele Schwartz] AIDS Hlth Care Fdn, Global Program, Sao Paulo, SP, Brazil; [Truong, Hong-Ha M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Brasilia; University of California System; University of California San Francisco	Diaz, RS (corresponding author), Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.	rsdiaz@catg.com.br	Giron, Leila/AAO-8299-2021; Giron, Leila B/A-9642-2015; Hunter, James/J-6106-2016	Giron, Leila/0000-0002-3898-5680; Giron, Leila B/0000-0002-3898-5680; Hunter, James/0000-0001-9524-0629	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	HCV genotype is provided by the Brazilian Ministry of Health. HIV rapid tests were donated to the authors by the Brazilian Ministry of Health. MN was supported by grants from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil.	Alves K, 2003, JAIDS-J ACQ IMM DEF, V32, P551, DOI 10.1097/00126334-200304150-00014; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Braun DL, 2018, CLIN INFECT DIS; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cappello JM, 2013, J CLIN VIROL, V58, pE59, DOI 10.1016/j.jcv.2013.08.032; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Ferenci P, 2008, HEPATOLOGY, V47, P1816, DOI 10.1002/hep.22262; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Ingiliz P, 2020, CLIN INFECT DIS, V71, P1248, DOI 10.1093/cid/ciz949; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Kanwal F, 2014, HEPATOLOGY, V60, P98, DOI 10.1002/hep.27095; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Lawitz E, 2016, HEPATOLOGY, V64, P360, DOI 10.1002/hep.28422; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Nakano T, 2012, LIVER INT, V32, P339, DOI 10.1111/j.1478-3231.2011.02684.x; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Nishiya AS, 2015, BRAZ J INFECT DIS, V19, P473, DOI 10.1016/j.bjid.2015.06.010; Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x; Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60; Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009; R Core Team, 2018, R LANG ENV STAT COMP; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; SATO PA, 1994, B WORLD HEALTH ORGAN, V72, P129; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; WICKHAM H, 2017, R PACKAGE VERSION, V1, P1, DOI DOI 10.1590/S0100-204X2017000300003; Wyles DL, 2017, UNDERSTANDING HEPATI, V25	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227082	10.1371/journal.pone.0227082	http://dx.doi.org/10.1371/journal.pone.0227082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905224	Green Published, gold			2022-12-26	WOS:000534327700015
J	Gann, ER; Gainer, PJ; Reynolds, TB; Wilhelm, SW				Gann, Eric R.; Gainer, P. Jackson; Reynolds, Todd B.; Wilhelm, Steven W.			Influence of light on the infection of Aureococcus anophagefferens CCMP 1984 by a "giant virus"	PLOS ONE			English	Article							BROWN TIDE BLOOMS; HETEROSIGMA-AKASHIWO; VIRAL-INFECTION; DARK SURVIVAL; ALGAL VIRUS; GROWTH; CARBON; PHOTOSYNTHESIS; CHRYSOPHYCEAE; PHOSPHORUS	The pelagophyte Aureococcus anophagefferens has caused recurrent brown tide blooms along the northeast coast of the United States since the mid-1980's, and more recently spread to other regions of the globe. These blooms, due to the high cell densities, are associated with severe light attenuation that destroys the sea grass beds which provide the basis for many fisheries. Data collected by transmission electron microscopy, PCR, and metatranscriptomic studies of the blooms, support the hypothesis that large dsDNA viruses play a role in bloom dynamics. While a large (similar to 140 nm) icosahedral virus, with a 371 kbp genome, was first isolated more than a decade ago, the constraints imposed by environmental parameters on bloom infection dynamics by Aureococcus anophagefferens Virus, (AaV) remain unknown. To investigate the role light plays in infection by this virus, we acclimated A. anophagefferens to light intensities of 30 (low), 60 (medium) or 90 mu mol photons m(-2) s(-1) (high) and infected cultures at these irradiance levels. Moreover, we completed light shift experiments where acclimated cultures were exposed to even lower light intensities (0, 5, and 15 mu mol photons m(-2) s(-1)) consistent with irradiance found during the peak of the bloom when cell concentrations are highest. The abundance of viruses produced per lytic event (burst size) was lower in the low irradiance acclimated cultures compared to the medium and high acclimated cultures. Transferring infected cultures to more-limiting light availabilities further decreased burst size and increased the length of time it took for cultures to lyse, regardless of acclimation irradiance level. A hypothetical mechanism for the reduced efficiency of the infection cycle in low light due to ribosome biogenesis was predicted from preexisting transcriptomes. Overall, these studies provide a framework for understanding light effects on infection dynamics over the course of the summer months when A. anophagefferens blooms occur.	[Gann, Eric R.; Reynolds, Todd B.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gainer, P. Jackson] Tennessee Wesleyan Univ, Dept Biol, Athens, TN USA	University of Tennessee System; University of Tennessee Knoxville	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	Wilhelm, Steven/B-8963-2008	Wilhelm, Steven/0000-0001-6283-8077; Reynolds, Todd/0000-0002-2867-7182	National Science Foundation (Division of Integrative Organismal Systems) [1922958]; Gordon & Betty Moore Foundation [4971, EMS4971]; Ken & Blaire Mossman Endowment; National Science Foundation [IOS1922958]; Kenneth & Blaire Mossman Endowment	National Science Foundation (Division of Integrative Organismal Systems)(National Science Foundation (NSF)); Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); Ken & Blaire Mossman Endowment; National Science Foundation(National Science Foundation (NSF)); Kenneth & Blaire Mossman Endowment	The funding agencies are the National Science Foundation (Division of Integrative Organismal Systems grant 1922958 to SWW) the Gordon & Betty Moore Foundation (Award #4971 to SWW) and the Ken & Blaire Mossman Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Robbie Martin, Gary LeCleir, Mohammad Moniruzzaman, and Samantha Coy for discussions about this work. This work was supported by the National Science Foundation IOS1922958, the Gordon & Betty Moore Foundation (Grant EMS4971) and the Kenneth & Blaire Mossman Endowment to the University of Tennessee.	Baudoux AC, 2008, J PHYCOL, V44, P902, DOI 10.1111/j.1529-8817.2008.00543.x; Bratbak G, 1998, AQUAT MICROB ECOL, V16, P1, DOI 10.3354/ame016001; Brown CM, 2014, VIROLOGY, V466, P71, DOI 10.1016/j.virol.2014.07.023; Clasen JL, 2007, FRESHWATER BIOL, V52, P112, DOI 10.1111/j.1365-2427.2006.01677.x; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Frischkorn K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00375; Gann E., PLAQUE ASSAY AUREOCO, DOI [10.17504/protocols.io.g2nbyde, DOI 10.17504/PROTOCOLS.IO.G2NBYDE]; Gann ER, 2016, ASP12A RECIPE CULTUR, DOI [10.17504/protocols.io.f3ybqpw, DOI 10.17504/PROTOCOLS.IO.F3YBQPW]; Gastrich MD, 2004, ESTUARIES, V27, P112, DOI 10.1007/BF02803565; Gastrich MD, 2002, ESTUARIES, V25, P938, DOI 10.1007/BF02691342; Gobler CJ, 2007, AQUAT MICROB ECOL, V47, P25, DOI 10.3354/ame047025; Gobler CJ, 2012, HARMFUL ALGAE, V14, P36, DOI 10.1016/j.hal.2011.10.013; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Jarvis B, 2010, J APPL MICROBIOL, V109, P1660, DOI 10.1111/j.1365-2672.2010.04792.x; Kana TM, 2004, HARMFUL ALGAE, V3, P377, DOI 10.1016/j.hal.2004.06.008; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; Lawrence JE, 2004, AQUAT MICROB ECOL, V37, P1, DOI 10.3354/ame037001; Lomas MW, 1996, J PHYCOL, V32, P907, DOI 10.1111/j.0022-3646.1996.00907.x; Long AM, 2016, ISME J, V10, P1602, DOI 10.1038/ismej.2015.240; Maat DS, 2016, AQUAT MICROB ECOL, V77, P87, DOI 10.3354/ame01791; Meat DS, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00160; Milligan AJ, 1997, MAR ECOL PROG SER, V153, P67, DOI 10.3354/meps153067; Moniruzzaman M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00752; Moniruzzaman M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16054; Moniruzzaman M, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw058; Moniruzzaman M, 2014, VIROLOGY, V466, P60, DOI 10.1016/j.virol.2014.06.031; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Piedade GJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120676; Popels LC, 2003, LIMNOL OCEANOGR-METH, V1, P92, DOI 10.4319/lom.2003.1.92; Popels LC, 2002, J PHYCOL, V38, P738, DOI 10.1046/j.1529-8817.2002.01115.x; Popels LC, 2007, J PHYCOL, V43, P32, DOI 10.1111/j.1529-8817.2006.00303.x; Probyn T, 2001, MAR POLLUT BULL, V42, P405, DOI 10.1016/S0025-326X(00)00170-3; Pustizzi F, 2004, HARMFUL ALGAE, V3, P343, DOI 10.1016/j.hal.2004.06.006; Puxty RJ, 2018, ISME J, V12, P1273, DOI 10.1038/s41396-017-0043-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowe JM, 2008, J PHYCOL, V44, P71, DOI 10.1111/j.1529-8817.2007.00453.x; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; SIEBURTH JM, 1988, J PHYCOL, V24, P416, DOI 10.1111/j.1529-8817.1988.tb00192.x; Simonin D, 1997, J GEN VIROL, V78, P435, DOI 10.1099/0022-1317-78-2-435; Tarutani K, 2006, AQUAT MICROB ECOL, V42, P209, DOI 10.3354/ame042209; Team RC, 2014, LANG ENV STAT COMP; Thamatrakoln K, 2019, NEW PHYTOL, V221, P1289, DOI 10.1111/nph.15459; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Wilhelm SW, 1998, LIMNOL OCEANOGR, V43, P586, DOI 10.4319/lo.1998.43.4.0586; Wu ZJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-564; Wurch LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00136; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Zhang QC, 2012, HARMFUL ALGAE, V19, P117, DOI 10.1016/j.hal.2012.06.007	52	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226758	10.1371/journal.pone.0226758	http://dx.doi.org/10.1371/journal.pone.0226758			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899921	gold, Green Published			2022-12-26	WOS:000534322000006
J	Fatima, R; Yaqoob, A; Qadeer, E; Hinderaker, SG; Ikram, A; Sismanidis, C				Fatima, Razia; Yaqoob, Aashifa; Qadeer, Ejaz; Hinderaker, Sven Gudmund; Ikram, Aamer; Sismanidis, Charalambos			Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children	PLOS ONE			English	Article							CHALLENGES; CONTACTS; BURDEN	Introduction Tuberculosis in children may be difficult to diagnose and is often not reported to routine surveillance systems. Understanding and addressing the tuberculosis (TB) case detection and reporting gaps strengthens national routine TB surveillance systems. Objective The present study aimed to measure the percentage of childhood TB cases that are diagnosed but not reported to the national surveillance system in Pakistan. Design The study design was cross sectional. The study was nationwide in 12 selected districts across Pakistan, each representing a cluster. Health facilities that diagnose and treat childhood TB from all sectors were mapped and invited to participate. Lists of child TB cases were created for the study period (April-June 2016) from all study facilities and compared against the list of child TB cases notified to the national TB surveillance system for the same districts and the same period. Results All public and private health facilities were mapped across 12 sampled districts in Pakistan and those providing health services to child TB cases were included in the study. From all private health facilities, 7,125 children were found with presumptive TB during the study period. Of them, 5,258 were diagnosed with tuberculosis: 11% were bacteriologically-confirmed and 89% clinically-diagnosed; only 4% were notified to National TB Control Program. An additional 1,267 children with TB were also registered in the National TB Control Program. Underreporting was measured to be 78%. Conclusion This is the first nationwide childhood TB inventory study globally and confirmed that childhood TB underreporting is very high in Pakistan. TB surveillance in the country must be strengthened to address this, with particular attention to guiding and supporting general practitioners and pediatricians to notify their TB cases.	[Fatima, Razia; Yaqoob, Aashifa; Ikram, Aamer] Common Management Unit HIV AIDS TB & Malaria, Islamabad, Pakistan; [Yaqoob, Aashifa; Hinderaker, Sven Gudmund] Univ Bergen, Bergen, Norway; [Qadeer, Ejaz] Pakistan Inst Med Sci, Islamabad, Pakistan; [Ikram, Aamer] Natl Inst Hlth, Islamabad, Pakistan; [Sismanidis, Charalambos] WHO, Global TB Programme, Geneva, Switzerland	University of Bergen; Pakistan Institute of Medical Sciences; World Health Organization	Yaqoob, A (corresponding author), Common Management Unit HIV AIDS TB & Malaria, Islamabad, Pakistan.; Yaqoob, A (corresponding author), Univ Bergen, Bergen, Norway.	aashifa.yaqoob@gmail.com		Fatima, Razia/0000-0002-2340-6121	UNITAID, channeled through the STEPTB project	UNITAID, channeled through the STEPTB project	The study was carried out with funding from UNITAID, channeled through the STEPTB project that was led by the TB Alliance and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coghlan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138323; Detjen A, IMPROVING ESTIMATES; Dodd PJ, 2014, LANCET GLOB HLTH, V2; Donald PR, 2004, INT J TUBERC LUNG D, V8, P627; Fatima R, 2014, INT J TUBERC LUNG D, V18, P55, DOI 10.5588/ijtld.13.0198; Fatima R, 2017, J INFECT DIS, V216, pS733, DOI 10.1093/infdis/jix380; Hong SJ, 2012, INT J TUBERC LUNG D, V16, P1221, DOI 10.5588/ijtld.11.0782; Islam Z, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4062-9; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; Lestari T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-784; Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933; Marais BJ, 2016, J PAEDIATR CHILD H, V52, P258, DOI 10.1111/jpc.12647; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; National TB Control Program, 2017, REV DOCT DESK GUID M; National TB Control Program, 2006, NAT GUID DIAGN MAN C; National TB Control Program, 2007, NAT GUID DIAGN MAN T; Onozaki I, 2015, TROP MED INT HLTH; Oshi DC, 2016, INT J MYCOBACT, V5, P44, DOI 10.1016/j.ijmyco.2015.10.007; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Talukder K, 2012, INT J TUBERC LUNG D, V16, P70, DOI 10.5588/ijtld.11.0060; Treatment Action Group, 2017, TUB DIAGN TOOLS; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2014, WHO GUID NAT TUB PRO; World Health Organization, 2018, ROADM END TB CHILDR, V2nd; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; World Health Organization, 2018, EST TB INC CHILDR; World Health Organization, 2012, ASS TUB UND REP INV	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227186	10.1371/journal.pone.0227186	http://dx.doi.org/10.1371/journal.pone.0227186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887208	Green Published, gold			2022-12-26	WOS:000515092200083
J	Fellag, M; Loukil, A; Saad, J; Lepidi, H; Bouzid, F; Bregeon, F; Drancourt, M				Fellag, Mustapha; Loukil, Ahmed; Saad, Jamal; Lepidi, Hubert; Bouzid, Feriel; Bregeon, Fabienne; Drancourt, Michel			Translocation of Mycobacterium tuberculosis after experimental ingestion	PLOS ONE			English	Article							BOVIS INFECTION; LUNG PATHOLOGY; TRANSMISSION; LYMPHADENITIS; DIAGNOSIS; VIRULENCE; RANKING; STRAINS; AFRICA	Human tuberculosis is a life-threatening infection following the inhalation of Mycobacterium tuberculosis, while the closely related bacteria Mycobacterium bovis and Mycobacterium canettii are thought to be transmitted by ingestion. To explore whether M. tuberculosis could also infect individuals by ingestion, male BALBc mice were fed 2 x 10(6) CFUs of M. tuberculosis Beijing or phosphate-buffered saline as a negative control, over a 28-day experiment. While eight negative control mice remained disease-free, M. tuberculosis was identified in the lymph nodes and lungs of 8/14 mice and in the spleens of 4/14 mice by microscopy, PCR-based detection and culture. Whole-genome sequencing confirmed the identity of the inoculum and the tissue isolates. In these genetically identical mice, the dissemination of M. tuberculosis correlated with the results of the culture detection of four intestinal bacteria. These observations indicate that ingested M. tuberculosis mycobacteria can translocate, notably provoking lymphatic tuberculosis.	[Fellag, Mustapha; Saad, Jamal] IHU Mediterranee Infect, Marseille, France; [Fellag, Mustapha; Loukil, Ahmed; Saad, Jamal; Lepidi, Hubert; Bouzid, Feriel; Bregeon, Fabienne; Drancourt, Michel] Aix Marseille Univ, IRD, MEPHI, IHU Mediterranee Infect, Marseille, France; [Bouzid, Feriel] Univ Gafsa, Fac Sci Gafsa, Campus Univ Sidi Ahmed Zarrouk, Gafsa, Tunisia	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Gafsa	Drancourt, M (corresponding author), Aix Marseille Univ, IRD, MEPHI, IHU Mediterranee Infect, Marseille, France.	michel.drancourt@univ-amu.fr	Saad, Jamal/GOP-2737-2022; loukil, ahmed/AAL-1931-2021; Bouzid, Feriel/GPX-1375-2022	loukil, ahmed/0000-0003-3826-3263; Bouzid, Feriel/0000-0001-9285-4297	French Government under the Investissements d'avenir (Investments for the Future) program [10-IAHU-03]; Re gion Le Sud (Provence Alpes Cote d'Azur); European funding FEDER [PA 0000320 PRIMI]	French Government under the Investissements d'avenir (Investments for the Future) program(French National Research Agency (ANR)); Re gion Le Sud (Provence Alpes Cote d'Azur); European funding FEDER(European Commission)	This work was supported by the French Government under the Investissements d'avenir (Investments for the Future) program managed by the Agence Nationale de la Recherche (ANR, fr: National Agency for Research), (reference: Mediterrane e Infection 10-IAHU-03). This work was supported by Re gion Le Sud (Provence Alpes Cote d'Azur) and European funding FEDER PA 0000320 PRIMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bouzid F, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00507-17; Calmette M.A, 1905, REV AGR FISH ANN P D; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Dibbern J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11438-z; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Fox GJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005271; Ghodbane R, 2014, MICROBIOL-SGM, V160, P496, DOI 10.1099/mic.0.073379-0; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Jeon BY, 2012, J MED MICROBIOL, V61, P1373, DOI 10.1099/jmm.0.047027-0; Lagier JC, 2018, NAT REV MICROBIOL, V16, P540, DOI 10.1038/s41579-018-0041-0; Lagier JC, 2015, CLIN MICROBIOL REV, V28, P237, DOI 10.1128/CMR.00014-14; Lefford M.J, 1984, THE MYCOBACTERIA, P947; Loukil A, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00568-18; Luo M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00822; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Osman DA, 2016, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00283; PIERCE C, 1947, J EXP MED, V86, P159, DOI 10.1084/jem.86.2.159; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smaoui S, 2015, INT J MYCOBACT, V4, P196, DOI 10.1016/j.ijmyco.2015.04.004; Smith RMM, 2004, EMERG INFECT DIS, V10, P539, DOI 10.3201/eid1003.020819; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; van Coppenraet ESB, 2004, J CLIN MICROBIOL, V42, P2644, DOI 10.1128/JCM.42.6.2644-2650.2004; Winglee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097048	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227005	10.1371/journal.pone.0227005	http://dx.doi.org/10.1371/journal.pone.0227005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887178	Green Published, gold			2022-12-26	WOS:000515092200061
J	Rodriguez, S; Little, HC; Daneshpajouhnejad, P; Shepard, BD; Tan, SY; Wolfe, A; Cheema, MU; Jandu, S; Woodward, OM; Talbot, CC; Berkowitz, DE; Rosenberg, AZ; Pluznick, JL; Wong, GW				Rodriguez, Susana; Little, Hannah C.; Daneshpajouhnejad, Parnaz; Shepard, Blythe D.; Tan, Stefanie Y.; Wolfe, Andrew; Cheema, Muhammad Umar; Jandu, Sandeep; Woodward, Owen M.; Talbot, C. Conover, Jr.; Berkowitz, Dan E.; Rosenberg, Avi Z.; Pluznick, Jennifer L.; Wong, G. William			Late-onset renal hypertrophy and dysfunction in mice lacking CTRP1	FASEB JOURNAL			English	Article						aging-associated renal physiology; C1q; TNF-related protein 1; kidney function	ADIPOSE-TISSUE INFLAMMATION; FACTOR-RELATED PROTEIN-9; IMPROVES INSULIN ACTION; C1Q/TNF-RELATED PROTEIN-1; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; HEPATIC STEATOSIS; MYOCARDIAL INJURY; FOOD-INTAKE; ADIPOKINE	Local and systemic factors that influence renal structure and function in aging are not well understood. The secretory protein C1q/TNF-related protein 1 (CTRP1) regulates systemic metabolism and cardiovascular function. We provide evidence here that CTRP1 also modulates renal physiology in an age- and sex-dependent manner. In mice lacking CTRP1, we observed significantly increased kidney weight and glomerular hypertrophy in aged male but not female or young mice. Although glomerular filtration rate, plasma renin and aldosterone levels, and renal response to water restriction did not differ between genotypes, CTRP1-deficient male mice had elevated blood pressure. Echocardiogram and pulse wave velocity measurements indicated normal heart function and vascular stiffness in CTRP1-deficient animals, and increased blood pressure was not due to greater salt retention. Paradoxically, CTRP1-deficient mice had elevated urinary sodium and potassium excretion, partially resulting from reduced expression of genes involved in renal sodium and potassium reabsorption. Despite renal hypertrophy, markers of inflammation, fibrosis, and oxidative stress were reduced in CTRP1-deficient mice. RNA sequencing revealed alterations and enrichments of genes in metabolic processes in CTRP1-deficient animals. These results highlight novel contributions of CTRP1 to aging-associated changes in renal physiology.	[Rodriguez, Susana; Little, Hannah C.; Shepard, Blythe D.; Tan, Stefanie Y.; Cheema, Muhammad Umar; Pluznick, Jennifer L.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Rodriguez, Susana; Little, Hannah C.; Tan, Stefanie Y.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Daneshpajouhnejad, Parnaz; Rosenberg, Avi Z.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wolfe, Andrew] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jandu, Sandeep; Berkowitz, Dan E.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Woodward, Owen M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Talbot, C. Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Rosenberg, Avi Z.] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Shepard, Blythe D.] Georgetown Univ, Dept Human Sci, Washington, DC USA; [Tan, Stefanie Y.] Pfizer Inc, Cambridge, MA USA; [Wolfe, Andrew] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA; [Berkowitz, Dan E.] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Georgetown University; Pfizer; National Institutes of Health (NIH) - USA; University of Alabama System; University of Alabama Birmingham	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Daneshpajouhnejad, Parnaz/0000-0002-8845-5813; Jandu, Sandeep/0000-0002-3931-9372; Rosenberg, Avi/0000-0003-2356-950X; Shepard, Blythe/0000-0001-6194-5268; Woodward, Owen M./0000-0001-9514-2180	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK084171, F31DK116537, DK107726]; American Diabetes Association (ADA) [1-18-PMF-022]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL128512]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American Diabetes Association (ADA)(American Diabetes Association); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK084171, F31DK116537 and DK107726; American Diabetes Association (ADA), Grant/Award Number: 1-18-PMF-022; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL128512	Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940; Appari M, 2017, CIRC RES, V120, P66, DOI 10.1161/CIRCRESAHA.116.309398; Arias T, 2013, J AM SOC ECHOCARDIOG, V26, P910, DOI 10.1016/j.echo.2013.04.016; Bai B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172271; Benavides-Vallve C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041691; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; CHO KJ, 2013, KOREAN J PHYS ANTHR, V26, P147, DOI DOI 10.11637/KJPA.2013.26.4.147; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Esteva-Font C, 2012, CELL MOL LIFE SCI, V69, P683, DOI 10.1007/s00018-011-0858-4; Han S, 2018, CIRC RES, V123, pE5, DOI 10.1161/CIRCRESAHA.118.312871; Han S, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5479627; Han S, 2016, J NUTR BIOCHEM, V27, P43, DOI 10.1016/j.jnutbio.2015.08.018; Hoenig MP, 2014, CLIN J AM SOC NEPHRO, V9, P1272, DOI 10.2215/CJN.08860813; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kambara T, 2015, MOL CELL BIOL, V35, P2173, DOI 10.1128/MCB.01518-14; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kanemura N, 2017, ATHEROSCLEROSIS, V257, P138, DOI 10.1016/j.atherosclerosis.2017.01.014; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Knepper MA, 2001, CURR OPIN NEPHROL HY, V10, P655, DOI 10.1097/00041552-200109000-00017; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Lei X, 2015, AM J PHYSIOL-ENDOC M, V308, pE792, DOI 10.1152/ajpendo.00383.2014; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Little HC, 2018, MOL CELL PROTEOMICS, V17, P1546, DOI 10.1074/mcp.RA118.000794; Liu ZH, 2017, BIOCHEM BIOPH RES CO, V490, P580, DOI 10.1016/j.bbrc.2017.06.081; Lu L, 2016, EUR HEART J, V37, P1762, DOI 10.1093/eurheartj/ehv649; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Olson LE, 2003, CANCER RES, V63, P6602; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Petersen PS, 2014, AM J PHYSIOL-REG I, V307, pR1458, DOI 10.1152/ajpregu.00335.2014; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Ramkumar N, 2014, AM J PHYSIOL-RENAL, V307, pF931, DOI 10.1152/ajprenal.00367.2014; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shabani P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118650; Shen Y, 2014, INT J CARDIOL, V174, P203, DOI 10.1016/j.ijcard.2014.03.205; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; Svensson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158716; Tan SY, 2016, PHYSIOL GENOMICS, V48, P936, DOI 10.1152/physiolgenomics.00111.2016; Tang J, 2015, IEEE ICC, P1, DOI 10.1109/ICC.2015.7248289; Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wang HZ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0266-7; Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Weinstein JR, 2010, ADV CHRONIC KIDNEY D, V17, P302, DOI 10.1053/j.ackd.2010.05.002; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu D, 2015, J MOL MED, V93, P1311, DOI 10.1007/s00109-015-1309-8; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557; Yang Y, 2017, CELL PHYSIOL BIOCHEM, V42, P2130, DOI 10.1159/000479915; Yuasa D, 2016, FASEB J, V30, P1065, DOI 10.1096/fj.15-279885; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	85	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2657	2676		10.1096/fj.201900558RR	http://dx.doi.org/10.1096/fj.201900558RR		DEC 2019	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908037	Bronze, Green Accepted			2022-12-26	WOS:000504667600001
J	Komarynets, O; Chassot, A; Bernabeu, E; Czogalla, J; Roth, I; Liaudet, N; Prodon, F; Loffing, J; Feraille, E				Komarynets, Olga; Chassot, Alexandra; Bernabeu, Eva; Czogalla, Jan; Roth, Isabelle; Liaudet, Nicolas; Prodon, Francois; Loffing, Johannes; Feraille, Eric			Aldosterone controls primary cilium length and cell size in renal collecting duct principal cells	FASEB JOURNAL			English	Article						aldosterone; cell volume; collecting duct; primary cilium; sodium	EPITHELIAL NA+ CHANNEL; SODIUM-TRANSPORT; KIDNEY; AUTOPHAGY; DISEASE; INJURY; MTOR; FLOW; HOMEOSTASIS; ABSORPTION	Primary cilia are nonmotile sensory organelles found on the surface of almost all kidney tubule epithelial cells. Being exposed to the tubular lumen, primary cilia are thought to be chemo- and mechanosensors of luminal composition and flux, respectively. We hypothesized that, Na+ transport and primary cilia exist in a sensory functional connection in mature renal tubule epithelial cells. Our results demonstrate that primary cilium length is reduced in mineralocorticoid receptor (MR) knockout (KO) mice in a cell autonomous manner along the aldosterone-sensitive distal nephron (ADSN) compared with wild type (as mu m +/- SEM; 3.1 +/- 0.2 vs 4.0 +/- 0.1). In mouse cortical collecting duct (mCCD)(cl1) cells, which are a model of collecting duct (CD) principal cells, changes in Na+ transport intensity were found to mediate primary cilium length in response to aldosterone (as mu m +/- SEM: control: 2.7 +/- 0.9 vs aldosterone treated: 3.8 +/- 0.8). Cilium length was positively correlated with the availability of IFT88, a major intraflagellar anterograde transport complex B component, which is stabilized in response to exposure to aldosterone treatment. This suggests that the abundance of IFT88 is a regulated, rate limiting factor in the elongation of primary cilia. As previously observed in vivo, aldosterone treatment increased cell volume of cultured CD principal cells. Knockdown of IFT88 prevents ciliogenesis and inhibits the adaptive increase in cell size that was observed in response to aldosterone treatment. In conclusion, our results reveal a functional connection between Na+ transport, primary cilia, and cell size, which may play a key role in the morphological and functional adaptation of the CD to sustained changes in active Na+ reabsorption due to variations in aldosterone secretion.	[Komarynets, Olga; Chassot, Alexandra; Bernabeu, Eva; Roth, Isabelle; Feraille, Eric] Univ Geneva, Univ Med Ctr, Fac Med Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Czogalla, Jan; Loffing, Johannes] Univ Zurich, Inst Anat, Zurich, Switzerland; [Liaudet, Nicolas; Prodon, Francois] Univ Geneva, Serv Bioimaging, Geneva, Switzerland	University of Geneva; University of Zurich; University of Geneva	Feraille, E (corresponding author), Univ Med Ctr, Fac Med Geneva, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@unige.ch	Czogalla, Jan/AAI-9223-2020; Loffing, Johannes/ABG-9973-2020	Feraille, Eric/0000-0003-1656-8365; Loffing, Johannes/0000-0002-9415-6588; Liaudet, Nicolas/0000-0002-0749-5857	Swiss National Science Foundation [31003A_156736/1, 31003A_175471/1]; Fondation Ernst et Lucie Schmidheiny; National Center of Competence in Research Kidney Control of Homeostasis	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Ernst et Lucie Schmidheiny; National Center of Competence in Research Kidney Control of Homeostasis	National Center of Competence in Research Kidney Control of Homeostasis and Swiss National Science Foundation, Grant/Award Number: 31003A_156736/1 and 31003A_175471/1; Fondation Ernst et Lucie Schmidheiny	Atkinson KF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00103; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Barker AR, 2014, ORGANOGENESIS, V10, P96, DOI 10.4161/org.27375; Benmerah Alexandre, 2015, Cilia, V4, P5, DOI 10.1186/s13630-015-0014-0; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boron WF., 2009, MED PHYSL CELLULAR M, V2nd edition; Canonica J, 2016, PFLUG ARCH EUR J PHY, V468, P895, DOI 10.1007/s00424-015-1785-2; Carrisoza-Gaytan R, 2017, AM J PHYSIOL-RENAL, V312, pF143, DOI 10.1152/ajprenal.00256.2016; Chen ZG, 2014, J AM SOC NEPHROL, V25, P534, DOI 10.1681/ASN.2013030225; Czogalla J, 2016, PFLUG ARCH EUR J PHY, V468, P849, DOI 10.1007/s00424-016-1798-5; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Ernandez T, 2018, AM J PHYSIOL-RENAL, V314, pF763, DOI 10.1152/ajprenal.00200.2017; Fantus D, 2016, NAT REV NEPHROL, V12, P587, DOI 10.1038/nrneph.2016.108; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gorelik J, 2005, P NATL ACAD SCI USA, V102, P15000, DOI 10.1073/pnas.0507008102; Han SJ, 2017, BBA-MOL BASIS DIS, V1863, P1817, DOI 10.1016/j.bbadis.2017.05.004; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Ivanova EA, 2016, J INHERIT METAB DIS, V39, P457, DOI 10.1007/s10545-016-9919-z; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kohli P, 2017, EMBO REP, V18, P1521, DOI 10.15252/embr.201643846; Lang F, 2016, NEPHROL DIAL TRANSPL, V31, P200, DOI 10.1093/ndt/gfv270; Malicki J, 2014, ORGANOGENESIS, V10, P138, DOI 10.4161/org.29055; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mounier R, 2011, CELL CYCLE, V10, P2640, DOI 10.4161/cc.10.16.17102; Nag S, 2017, AM J PHYSIOL-RENAL, V313, pF706, DOI 10.1152/ajprenal.00172.2017; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Olteanu D, 2006, AM J PHYSIOL-CELL PH, V290, pC952, DOI 10.1152/ajpcell.00339.2005; Orhon I, 2015, CELL DEATH DIFFER, V22, P389, DOI 10.1038/cdd.2014.171; Orhon I, 2016, NAT CELL BIOL, V18, P657, DOI 10.1038/ncb3360; Pala R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112272; Park Kwon Moo, 2018, Chonnam Med J, V54, P83, DOI 10.4068/cmj.2018.54.2.83; Pluznick JL, 2015, CLIN J AM SOC NEPHRO, V10, P1626, DOI 10.2215/CJN.00730114; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Praetorius HA, 2013, SEMIN CELL DEV BIOL, V24, P3, DOI 10.1016/j.semcdb.2012.10.003; Rafestin-Oblin ME, 2002, MOL PHARMACOL, V62, P1306, DOI 10.1124/mol.62.6.1306; Raghavan V, 2016, AM J PHYSIOL-RENAL, V310, pF1, DOI 10.1152/ajprenal.00373.2015; Rodat-Despoix L, 2009, PFLUG ARCH EUR J PHY, V458, P179, DOI 10.1007/s00424-008-0632-0; Saigusa T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12405; Sanchez I, 2016, NAT CELL BIOL, V18, P711, DOI 10.1038/ncb3370; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Song JP, 2017, HYPERTENSION, V70, P324, DOI 10.1161/HYPERTENSIONAHA.117.09584; Spasic M, 2017, EUR CELLS MATER, V33, P158, DOI 10.22203/eCM.v033a12; Sullivan LM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004142; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Viau A, 2018, EMBO J, V37, DOI 10.15252/embj.201798615; WADE JB, 1990, AM J PHYSIOL, V259, pF88, DOI 10.1152/ajprenal.1990.259.1.F88; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; Wang L, 2015, AM J PHYSIOL-REG I, V309, pR757, DOI 10.1152/ajpregu.00173.2015; Wang SX, 2015, AUTOPHAGY, V11, P607, DOI 10.1080/15548627.2015.1023983; Wang SX, 2013, AM J PHYSIOL-RENAL, V305, pF1085, DOI 10.1152/ajprenal.00399.2013; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443	58	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2625	2640		10.1096/fj.201901947R	http://dx.doi.org/10.1096/fj.201901947R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908048	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000503398300001
J	Ge, QW; Hu, YY; He, JM; Chen, F; Wu, LP; Tu, XT; Qi, YD; Zhang, ZH; Xue, M; Chen, SJ; Zhong, J; Wang, LJ				Ge, Qiwei; Hu, Yingying; He, Jiamin; Chen, Fei; Wu, Lunpo; Tu, Xintao; Qi, Yadong; Zhang, Zizhen; Xue, Meng; Chen, Shujie; Zhong, Jing; Wang, Liangjing			Zic1 suppresses gastric cancer metastasis by regulating Wnt/beta-catenin signaling and epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						EMT; gastric cancer; metastasis; Wnt; beta-catenin; Zic1	GENE-EXPRESSION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; BINDING	Gastric cancer (GC) patients with metastasis had limited treatment options and dismal outcome. We have previously reported the aberrant expression of Zic family member 1 (Zic1) in GC. However, the functional roles and underlying mechanism of Zic1 in GC metastasis remain unknown. Here, we demonstrate that lower expression of Zic1 was correlated with more lymph node metastasis and poor outcome of GC patients. Ectopic expression of Zic1 suppressed both lung metastasis and peritoneal tumor dissemination of GC in mice. The metastatic suppressing ability of Zic1 was mediated by regulating the process of cell invasion, adhesion and epithelial-mesenchymal transition (EMT). Mechanistically, Zic1 could downregulate Wnt targets including c-Myc and Cyclin D1 by inhibiting LEF transcriptional activity in GC cells. Notably, Zic1 was inversely related to the expression of Cyclin D1 in GC tissues tested. In addition, Zic1 could physically interact with beta-catenin/transcription factor 4 (TCF4) and disrupt their complex formation, while not affecting beta-catenin nuclear localization. Collectively, our study indicated that Zic1 suppressed GC metastasis through attenuating Wnt/beta-catenin signaling and the EMT process. Our work may provide novel therapeutic strategies for the metastasis of GC.	[Ge, Qiwei; Chen, Fei; Wu, Lunpo; Zhang, Zizhen; Xue, Meng; Zhong, Jing; Wang, Liangjing] Second Affiliated Hosp Zhejiang Univ Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China; [Ge, Qiwei; Hu, Yingying; He, Jiamin; Chen, Fei; Wu, Lunpo; Qi, Yadong; Zhang, Zizhen; Xue, Meng; Chen, Shujie; Zhong, Jing; Wang, Liangjing] Zhejiang Univ, Institut Gastroenterol, Hangzhou, Peoples R China; [Hu, Yingying; He, Jiamin; Qi, Yadong; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou, Peoples R China; [Tu, Xintao] Univ Texas SW Med Ctr, Dept Immunol, Dallas, TX USA; Second Affiliated Hosp Zhejiang Univ Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhong, J; Wang, LJ (corresponding author), Second Affiliated Hosp Zhejiang Univ Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China.	2512022@zju.edu.cn; wangljzju@zju.edu.cn	Qi, Yadong/GVT-3797-2022; Tu, Xintao/AGW-3112-2022; Zhang, Zizhen/AAA-1539-2022; Hu, Ying/GQZ-8100-2022					Ali RG, 2012, INT J BIOCHEM CELL B, V44, P2065, DOI 10.1016/j.biocel.2012.08.012; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Chen XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115116; Cheng YY, 2013, J THORAC ONCOL, V8, P1317, DOI 10.1097/JTO.0b013e3182a0840a; Chiacchiera F, 2016, CELL STEM CELL, V18, P91, DOI 10.1016/j.stem.2015.09.019; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Degreef I, 2009, SCAND J PLAST RECONS, V43, P36, DOI 10.1080/02844310802489806; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujimi TJ, 2012, DEV BIOL, V361, P220, DOI 10.1016/j.ydbio.2011.10.026; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Han W, 2018, INT J ONCOL, V53, P937, DOI 10.3892/ijo.2018.4450; Howe LR, 2003, CANCER RES, V63, P1906; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Liu LM, 2018, BIOCHEM BIOPH RES CO, V503, P2173, DOI 10.1016/j.bbrc.2018.08.009; Lu Y, 2017, CELL RES, V27, P1422, DOI 10.1038/cr.2017.107; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Pourebrahim R, 2011, J BIOL CHEM, V286, P37732, DOI 10.1074/jbc.M111.242826; Qiang W, 2014, J CLIN ENDOCR METAB, V99, pE1163, DOI 10.1210/jc.2013-3729; Tejpar S, 2005, ACTA GASTRO-ENT BELG, V68, P5; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yang SC, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0700-1; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao ZB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0698; Zhong J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-290	41	11	14	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2161	2172		10.1096/fj.201901372RR	http://dx.doi.org/10.1096/fj.201901372RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909528				2022-12-26	WOS:000514663600017
J	Izquierdo, AG; Carreira, MC; Amil, M; Mosteiro, CS; Garcia-Caballero, T; Fernandez-Quintela, A; Portillo, MP; Casanueva, FF; Crujeiras, AB				Izquierdo, Andrea G.; Carreira, Marcos C.; Amil, Maria; Mosteiro, Carlos S.; Garcia-Caballero, Tomas; Fernandez-Quintela, Alfredo; Portillo, Maria P.; Casanueva, Felipe F.; Crujeiras, Ana B.			An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes	FASEB JOURNAL			English	Article						adipose tissue dysfunction; carcinogenesis; inflammation; NAFLD; NASH; oxidative stress	INFLAMMATION-RELATED GENES; OXIDATIVE STRESS; ADIPOSE-TISSUE; MONONUCLEAR-CELLS; SECRETED FACTORS; FATTY LIVER; CANCER; OVERWEIGHT; SURVIVIN; DISEASE	The epidemiological evidence regarding the association of obesity with liver disease and possibly hepatocellular carcinoma highlights the need for investigations of whether obesity itself could induce the differential expression of genes commonly associated with the initial phase of liver tumorigenesis, and whether such phenomenon could be reversed after a weight loss intervention. In this study, obese Zucker rats were found to have dysregulated cell proliferation, antioxidative defenses, and tumor suppressor gene expression in association with liver dysfunction parameters, as well as oxidative stress and inflammation. Importantly, after a 4-week weight loss protocol of energy restriction and/or exercise, this effect on the liver carcinogenesis-related genes was reversed concomitantly with reductions in the fat mass, hepatic lipid content, oxidative stress, and inflammation. The findings indicate that the oxidative stress and inflammation associated with excess adiposity promote dysregulation of the genes involved in liver tumorigenesis. This is clinically relevant because these effects were detectable in the liver without evidence of a tumoral mass and were reversed after weight loss. Consequently, this study reveals the susceptibility of obese individuals to the initiation of a hepatocarcinogenic process, and how this can be prevented by achieving a healthy body weight.	[Izquierdo, Andrea G.; Crujeiras, Ana B.] Complejo Hospitalario Universitario Santiago Comp, Lab Epign Endocrinol, Instituto Investigac Sanitaria Santiago Compostel, IDIS,CHUS,SERGAS,Nutr, Santiago De Compostela, Spain; [Izquierdo, Andrea G.; Carreira, Marcos C.; Amil, Maria; Fernandez-Quintela, Alfredo; Portillo, Maria P.; Casanueva, Felipe F.; Crujeiras, Ana B.] CIBER Fisiopatol Obes Nutr, CIBERobn, Madrid, Spain; [Carreira, Marcos C.; Amil, Maria; Mosteiro, Carlos S.; Casanueva, Felipe F.] Santiago Compostela Univ, Complejo Hospitalario Universitario Santiago Comp, Lab Mol, Instituto Investigac Sanitaria Santiago Compostel, Santiago De Compostela, Spain; [Garcia-Caballero, Tomas] Univ Santiago Compostela, Sch Med, Dept Morphol Sciences, Santiago De Compostela, Spain; [Fernandez-Quintela, Alfredo; Portillo, Maria P.] Univ Basque Country, Lucio Lascaray Res Inst,Hlth Res Inst BIOARABA, Dept Nutr,UPV,EHU,Nutr,Obes Grp,Food Sci, Vitoria, Spain; Epign Unit, E-15706 Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela; Bioaraba Health Research Institute; University of Basque Country	Crujeiras, AB (corresponding author), Complejo Hospitalario Universitario Santiago Comp, Lab Epign Endocrinol, Instituto Investigac Sanitaria Santiago Compostel, IDIS,CHUS,SERGAS,Nutr, Santiago De Compostela, Spain.	anabelencrujeiras@hotmail.com	Portillo, Maria Puy/ABH-2374-2020; Crujeiras, Ana/ABA-8866-2021; Izquierdo, Andrea G/ABB-9559-2020	Portillo, Maria Puy/0000-0003-0210-6549; Crujeiras, Ana/0000-0003-4392-0301; Izquierdo, Andrea G/0000-0002-0846-8834; Garcia-Caballero, Tomas/0000-0002-7938-1437; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Fernandez-Quintela, Alfredo/0000-0003-2709-4118				Abraham PE, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.178, 10.1038/nplants.2016.178]; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Beltran-Ramirez O, 2010, TRANSL ONCOL, V3, P142, DOI 10.1593/tlo.09298; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Boutari C, 2018, METABOLISM, V81, pA3, DOI 10.1016/j.metabol.2017.12.015; Bultman SJ, 2018, TRENDS ENDOCRIN MET, V29, P529, DOI 10.1016/j.tem.2018.05.004; Cabia B, 2016, OBES REV, V17, P361, DOI 10.1111/obr.12377; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Crujeiras AB, 2008, EUR J CLIN INVEST, V38, P672, DOI 10.1111/j.1365-2362.2008.01998.x; Crujeiras AB, 2017, INT J OBESITY, V41, P1570, DOI 10.1038/ijo.2017.138; Crujeiras AB, 2016, INT J OBESITY, V40, P514, DOI 10.1038/ijo.2015.208; Crujeiras AB, 2016, INT J OBESITY, V40, P403, DOI 10.1038/ijo.2015.206; Crujeiras AB, 2009, EUR J NUTR, V48, P341, DOI 10.1007/s00394-009-0019-9; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gan L, 2018, BBA-REV CANCER, V1869, P97, DOI 10.1016/j.bbcan.2017.12.006; Garces-Rimon M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040441; Gomez-Arbelaez D, 2017, J CLIN ENDOCR METAB, V102, P488, DOI 10.1210/jc.2016-2385; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Halliwell B., 2007, FREE RADICALS BIOL M; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030921; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Li RF, 2018, CELL REP, V22, P624, DOI 10.1016/j.celrep.2017.12.071; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Mi CJ, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431x20198009, 10.1590/1414-431X20198009]; Morgan MM, 2019, FASEB J, V33, P8623, DOI 10.1096/fj.201802347RRR; O'Sullivan J, 2018, NAT REV GASTRO HEPAT, V15, P699, DOI 10.1038/s41575-018-0069-7; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Said A, 2017, WORLD J CLIN ONCOL, V8, P429, DOI 10.5306/wjco.v8.i6.429; Sanchez-Perez Y, 2005, CANCER LETT, V217, P25, DOI 10.1016/j.canlet.2004.07.019; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Upadhyay J, 2018, MED CLIN N AM, V102, P13, DOI 10.1016/j.mcna.2017.08.004; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177	48	9	9	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2312	2325		10.1096/fj.201901147RR	http://dx.doi.org/10.1096/fj.201901147RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908001	Bronze			2022-12-26	WOS:000514663600027
J	Pye, DC				Pye, David C.			A clinical method for estimating the modulus of elasticity of the human cornea in vivo	PLOS ONE			English	Article							DYNAMIC CONTOUR TONOMETRY; GOLDMANN APPLANATION TONOMETRY; INTRAOCULAR-PRESSURE MEASUREMENT; BIOMECHANICAL PROPERTIES; YOUNGS MODULUS; THICKNESS; EYES; CURVATURE; INTACT	Background To develop a method, using current clinical instrumentation, to estimate the Young's modulus of the human cornea in vivo. Methods Central corneal curvature (CCC), central corneal thickness(CCT), intraocular pressure (IOP) was measured with the Goldmann tonometer (IOPG) and the Pascal Dynamic Corneal Tonometer(PDCT) in one eye of 100 normal young human subjects (21.07 +/- 2.94 years) in vivo. The Orssengo and Pye algorithm was used to calculate the Young's modulus of the corneas of these subjects. Results The Young's modulus(E) of the corneas of the subjects using the PDCT and IOPG results (Ecalc) was 0.25 +/- 0.10MPa, and without the PDCT results (Eiopg) was 0.29 +/- 0.06MPa. The difference in these results is due to the difference in tonometry results between the two instruments, as the mean PDCT result for the subjects was 16.89 +/- 2.49mmHg and the IOPG result 15.06 +/- 2.71mmHg. E was affected by the CCC of the subjects but more particularly by the CCT and IOP measurements. Corneal stiffness results are also presented. Conclusion Two methods have been developed to estimate the Young's modulus of the human cornea in vivo using current clinical instrumentation. One method (Ecalc) is applicable to the general corneal condition, and Eiopg to the normal cornea, and these results can be used to calculate corneal stiffness.	[Pye, David C.] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Pye, DC (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	d.pye@unsw.edu.au		Pye, David/0000-0001-5074-5498				Andreanos K, 2016, CLIN OPHTHALMOL, V10, P2477, DOI 10.2147/OPTH.S115203; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cartwright NEK, 2011, INVEST OPHTH VIS SCI, V52, P4324, DOI 10.1167/iovs.09-4798; Chihara E, 2008, SURV OPHTHALMOL, V53, P203, DOI 10.1016/j.survophthal.2008.02.005; Dupps WJ, 2014, J CATARACT REFR SURG, V40, P857, DOI 10.1016/j.jcrs.2014.04.012; Elsheikh A, 2010, EYE VIS RES DEV, P1; Elsheikh Ahmed, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P85, DOI 10.1080/10255840600976013; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Elsheikh A, 2006, ANN BIOMED ENG, V34, P1628, DOI 10.1007/s10439-006-9191-8; Ford MR, 2014, J CATARACT REFR SURG, V40, P1041, DOI 10.1016/j.jcrs.2014.03.017; Girard MJA, 2015, CURR EYE RES, V40, P1, DOI 10.3109/02713683.2014.914543; Hamilton KE, 2008, OPTOMETRY VISION SCI, V85, P445, DOI 10.1097/OPX.0b013e3181783a70; Hamilton KE, 2008, OPTOMETRY VISION SCI, V85, P451, DOI 10.1097/OPX.0b013e3181783a86; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P364; Hon Y, 2017, OPHTHAL PHYSL OPT, V37, P42, DOI 10.1111/opo.12335; HOVDING G, 1983, ACTA OPHTHALMOL, V61, P461; International Organisation for Standardization, 2009, 86122009 ISO; KAUFMAN HE, 1972, INVEST OPHTH VISUAL, V11, P80; Kaufmann C, 2004, INVEST OPHTH VIS SCI, V45, P3118, DOI 10.1167/iovs.04-0018; KIELY PM, 1982, AM J OPTOM PHYS OPT, V59, P976; Kniestedt C, 2005, ARCH OPHTHALMOL-CHIC, V123, P1532, DOI 10.1001/archopht.123.11.1532; Kniestedt C, 2005, GRAEF ARCH CLIN EXP, V243, P359, DOI 10.1007/s00417-004-1024-6; Kniestedt C, 2004, ARCH OPHTHALMOL-CHIC, V122, P1287, DOI 10.1001/archopht.122.9.1287; Kotecha A, 2007, SURV OPHTHALMOL, V52, pS109, DOI 10.1016/j.survophthal.2007.08.004; Kotecha A, 2010, OPHTHALMOLOGY, V117, P730, DOI 10.1016/j.ophtha.2009.09.020; Kwon TH, 2008, J BIOMECH, V41, P1707, DOI 10.1016/j.jbiomech.2008.03.004; Lam AKC, 2015, OPHTHAL PHYSL OPT, V35, P455, DOI 10.1111/opo.12219; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; LOWE RF, 1969, BRIT J OPHTHALMOL, V53, P824, DOI 10.1136/bjo.53.12.824; Luz A, 2016, J CURR OPHTHALMOL, V28, P97, DOI 10.1016/j.joco.2016.07.004; Mahendradas P, 2019, OCUL IMMUNOL INFLAMM, V27, P1127, DOI 10.1080/09273948.2018.1501491; Orssengo GJ, 1999, B MATH BIOL, V61, P551, DOI 10.1006/bulm.1999.0102; Osborne SF, 2007, GRAEF ARCH CLIN EXP, V245, P555, DOI 10.1007/s00417-006-0380-9; Pache M, 2005, GRAEF ARCH CLIN EXP, V243, P763, DOI 10.1007/s00417-005-1124-y; Palko JR, 2016, CORNEAL BIOMECHANICS, P1; Palko JR, 2016, CORNEAL BIOMECHANICS, P7; Ramm L, 2019, CORNEA, V38, P595, DOI 10.1097/ICO.0000000000001879; Sadigh AL, 2013, GRAEF ARCH CLIN EXP, V251, P603, DOI 10.1007/s00417-012-2142-1; Scarcelli G, 2012, OPT EXPRESS, V20, P9197, DOI 10.1364/OE.20.009197; Schneider E, 2006, J GLAUCOMA, V15, P2, DOI 10.1097/01.ijg.0000196655.85460.d6; SCHWARTZ NJ, 1966, B MATH BIOPHYS, V28, P585, DOI 10.1007/BF02476865; Shih PJ, 2015, OPHTHAL PHYSL OPT, V35, P663, DOI 10.1111/opo.12240; Simon G, 1993, Refract Corneal Surg, V9, P110; Sit AJ, 2017, J GLAUCOMA, V26, P967, DOI 10.1097/IJG.0000000000000774; SMOLEK MK, 1994, J CATARACT REFR SURG, V20, P277, DOI 10.1016/S0886-3350(13)80578-0; Tanter M, 2009, IEEE T MED IMAGING, V28, P1881, DOI 10.1109/TMI.2009.2021471; Tomidokoro A, 2007, AM J OPHTHALMOL, V144, P152, DOI 10.1016/j.ajo.2007.02.031; TOMLINSON A, 1972, ACTA OPHTHALMOL, V50, P73; Wan K, 2018, BMJ OPEN OPHTHALMOL, V3, DOI 10.1136/bmjophth-2018-000204; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; WOO SLY, 1972, EXP EYE RES, V14, P29, DOI 10.1016/0014-4835(72)90139-X; Wu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155527; Yun SH, 2018, CURR OPIN OPHTHALMOL, V29, P300, DOI 10.1097/ICU.0000000000000489; Zappone B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197779; Zhao Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00740	57	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0224824	10.1371/journal.pone.0224824	http://dx.doi.org/10.1371/journal.pone.0224824			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914133	gold, Green Published			2022-12-26	WOS:000534337700009
J	Boas, GRV; Lemos, JMR; de Oliveira, MW; dos Santos, RC; da Silveira, APS; Bacha, FB; Ito, CNA; Cornelius, EB; Lima, FB; Rodrigues, AMS; Costa, NB; Bittencourt, FF; de Lima, FF; Paes, MM; Gubert, P; Oesterreich, SA				Villas Boas, Gustavo Roberto; Rodrigues Lemos, Joao Marcos; de Oliveira, Matheus William; dos Santos, Rafael Claudino; Stefanello da Silveira, Ana Paula; Bacha, Flavia Barbieri; Aguero Ito, Caren Naomi; Cornelius, Ediane Bortolotte; Lima, Fernanda Brioli; Sachilarid Rodrigues, Andrea Marisa; Costa, Nathalia Belmal; Bittencourt, Felipe Francisco; de Lima, Fernando Freitas; Paes, Marina Meirelles; Gubert, Priscila; Oesterreich, Silvia Aparecida			Aqueous extract from Mangifera indica Linn. (Anacardiaceae) leaves exerts long-term hypoglycemic effect, increases insulin sensitivity and plasma insulin levels on diabetic Wistar rats	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE; HYPERGLYCEMIA; RESISTANCE; METABOLISM; FISETIN; ROSIGLITAZONE; INHIBITION; VEGETABLES; METFORMIN; GALANGIN	Background Diabetes mellitus is one of the most common todays public health problems. According to a survey by the World Health Organization, this metabolic disorder has reached global epidemic proportions, with a worldwide prevalence of 8.5% in the adult population. Objectives The present study aimed to investigate the hypoglycemic effect of aqueous extract of Mangifera indica (EAMI) leaves in streptozotocin-induced diabetic rats. Methods Sixty male rats were divided into 2 groups: Normoglycemic and Diabetic. Each group was subdivided into negative control, glibenclamide 3 or 10 mg/kg, EAMI 125, 250, 500, and 1000 mg/kg. Intraperitoneal injection of streptozotocin 100 mg/kg was used to DM induction. The hypoglycemic response was assessed acutely after two and four weeks of treatment. After a 6-hour fasting period, the fasting blood glucose of animals was verified, and 2.5 g/kg glucose solution was orally administered. The insulin tolerance test and plasma insulin levels assessment were performed in the morning after fasting of 12 to 14 hours. Results and conclusion The chemical analysis of EAMI showed high levels of phenolic compounds. There was no significant difference in fasting blood glucose between normoglycemic and diabetic groups, and that EAMI did not have an acute effect on diabetes. After two and four weeks of treatment, the extract significantly reduced blood glucose levels, exceeding glibenclamide effects. EAMI was effective in maintaining the long-term hypoglycemic effect, as well as, significantly increased the sensitivity of diabetic animals to insulin and the plasma insulin level.	[Villas Boas, Gustavo Roberto; Paes, Marina Meirelles; Gubert, Priscila] Fed Univ Western Bahia, Res Grp Dev Pharmaceut Prod P&DProFar, Ctr Biol & Hlth Sci, Barreiras, BA, Brazil; [Villas Boas, Gustavo Roberto; dos Santos, Rafael Claudino; de Lima, Fernando Freitas; Oesterreich, Silvia Aparecida] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Rodrigues Lemos, Joao Marcos; de Oliveira, Matheus William; Stefanello da Silveira, Ana Paula; Bacha, Flavia Barbieri; Aguero Ito, Caren Naomi; Cornelius, Ediane Bortolotte; Lima, Fernanda Brioli; Sachilarid Rodrigues, Andrea Marisa; Costa, Nathalia Belmal; Bittencourt, Felipe Francisco] Univ Ctr Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Gubert, Priscila] Univ Fed Pernambuco, Dept Biochem, Lab Imunopathol Keizo Asami, Recife, PE, Brazil	Universidade Federal do Oeste da Bahia; Universidade Federal da Grande Dourados; Universidade Federal de Pernambuco	Boas, GRV (corresponding author), Fed Univ Western Bahia, Res Grp Dev Pharmaceut Prod P&DProFar, Ctr Biol & Hlth Sci, Barreiras, BA, Brazil.; Boas, GRV (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil.	gustavo.villasboas@gmail.com	Gubert, Priscila/ABC-1059-2020	Gubert, Priscila/0000-0002-3598-8050; Villas Boas, Gustavo Roberto/0000-0003-1660-6480; Freitas de Lima, Fernando/0000-0001-5889-8165				Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;504::AID-PTR533&gt;3.0.CO;2-9; Aderibigbe AO, 2001, PHYTOTHER RES, V15, P456, DOI 10.1002/ptr.859; Agostini-Costa T.S., 1999, B CEPPA, V17, P167, DOI DOI 10.5380/CEP.V17I2.13789; Agrawal PK., 1989, CARBON 13 NMR FLAVON; Alkizim FO, 2012, MED CHEM DRUG DISCOV, V2, P9; Aloud AA, 2018, PHARM BIOL, V56, P302, DOI 10.1080/13880209.2018.1474931; Aloud AA, 2017, REDOX REP, V22, P290, DOI 10.1080/13510002.2016.1273437; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Aryaeian N., 2017, MED J ISLAMIC REPUBL, V31, P1, DOI DOI 10.18869/MJIRI.31.1; Ateyyat MA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1501; Barreto JC, 2008, J AGR FOOD CHEM, V56, P5599, DOI 10.1021/jf800738r; Beidokhti MN, 2017, J ETHNOPHARMACOL, V201, P26, DOI 10.1016/j.jep.2017.02.031; Bhandari MR, 2008, FOOD CHEM, V106, P247, DOI 10.1016/j.foodchem.2007.05.077; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; BROADHURST RB, 1978, J SCI FOOD AGR, V29, P788, DOI 10.1002/jsfa.2740290908; BYRNE LT, 1982, AUST J CHEM, V35, P1851, DOI 10.1071/CH9821851; CAMPBELL IW, 1995, DIABETES METAB REV, V11, pS57, DOI 10.1002/dmr.5610110509; Canuto KM, 2009, PROPRIEDADES QUIMICA, P29; Cheong H, 1998, ARCH PHARM RES, V21, P478, DOI 10.1007/BF02974647; Constantin RP, 2010, CELL BIOCHEM FUNCT, V28, P149, DOI 10.1002/cbf.1635; Correia SDJ, 2006, QUIM NOVA, V29, P1287, DOI 10.1590/S0100-40422006000600026; Ngo DH, 2019, SCI PHARM, V87, DOI 10.3390/scipharm87020013; Coria MCD, 2020, INT J NURS STUD, V101, DOI 10.1016/j.ijnurstu.2019.103417; Deepa P, 2018, J ETHNOPHARMACOL, V215, P210, DOI 10.1016/j.jep.2017.12.045; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Dhawan M, 2002, J CLIN GASTROENTEROL, V34, P582, DOI 10.1097/00004836-200205000-00021; Divi RL, 1996, CHEM RES TOXICOL, V9, P16, DOI 10.1021/tx950076m; Fotsis T, 1998, BAILLIERE CLIN ENDOC, V12, P649, DOI 10.1016/S0950-351X(98)80009-8; Gill L.S., 1992, ETHNOMEDICAL USES PL; Gondi M, 2015, J FOOD SCI TECH MYS, V52, P7883, DOI 10.1007/s13197-015-1963-4; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Idris I, 2003, DIABETOLOGIA, V46, P288, DOI 10.1007/s00125-002-1008-1; Ramirez-Espinosa JJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23010067; Kannadasan K, 2019, CLIN EPIDEMIOL GLOB, V7, P530, DOI 10.1016/j.cegh.2018.12.004; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; LALAU JD, 1987, INTENS CARE MED, V13, P383; LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779; Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014; Toledo RCL, 2019, FOOD FUNCT, V10, P4861, DOI [10.1039/c9fo00651f, 10.1039/C9FO00651F]; LUZI L, 1988, DIABETES, V37, P1470, DOI 10.2337/diabetes.37.11.1470; Luzi L, 1997, ACTA DIABETOL, V34, P239, DOI 10.1007/s005920050081; Madhuri A. S., 2017, Biomedical & Pharmacology Journal, V10, P1029, DOI 10.13005/bpj/1200; Madunagu BE., 1990, W AFRICAN J BIOL APP, V35, P25; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Murad MH, 2009, J CLIN ENDOCR METAB, V94, P741, DOI 10.1210/jc.2008-1416; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Mustafa KA, 2005, BIOCHEM SYST ECOL, V33, P1049, DOI 10.1016/j.bse.2005.02.003; NOOR HSM, 2016, J MED PLANTS STUD, V4, P275; Nwinuka N. M., 2008, Pakistan Journal of Nutrition, V7, P663, DOI 10.3923/pjn.2008.663.666; Ojewole JAO, 2005, METHOD FIND EXP CLIN, V27, P547, DOI 10.1358/mf.2005.27.8.928308; Perpetuo G.F., 2003, PLANT FOODS HUM NUTR, V58, P1, DOI [10.1023/B:QUAL.0000040336.38013.83, DOI 10.1023/B:QUAL.0000040336.38013.83]; Prasath GS, 2011, EUR J PHARMACOL, V668, P492, DOI 10.1016/j.ejphar.2011.07.021; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; RIZZA RA, 1979, J CLIN INVEST, V64, P62, DOI 10.1172/JCI109464; Ross I.A., 2005, MED PLANTS WORLD, V3, P155, DOI [10.1007/978-1-59259-887-8_4, DOI 10.1007/978-1-59259-887-8_4, 10.1007/978-1-59259-887-8, DOI 10.1007/978-1-59259-887-8]; Sagbo IJ, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/4170372; Sahoo N, 2010, FITOTERAPIA, V81, P462, DOI 10.1016/j.fitote.2010.02.001; SALEEM M, 2019, MEDICINA LITHUANIA, V0055, DOI [DOI 10.3390/MEDICINA55070353, DOI 10.3390/medicina55070353]; Samanta S., 2019, MOJ BIOEQUIV BIOAVAI, V6, P23; Simoes C.M.O., 2010, FARMACOGNOSIA PLANTA; Solladie G, 1999, EUR J ORG CHEM, V1999, P2309; Sriram Prasath G., 2011, INT J PHARM SCI REV, V6, P68; SRIVASTAVA R, 1995, PHYTOCHEMISTRY, V38, P687, DOI 10.1016/0031-9422(94)00739-G; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Tan C, 2013, INT J MOL SCI, V14, P2551, DOI 10.3390/ijms14022551; Tao ZQ, 2015, CELL BIOCHEM BIOPHYS, V73, P181, DOI 10.1007/s12013-015-0598-4; Thomas CC, 2015, MED CLIN N AM, V99, P1, DOI 10.1016/j.mcna.2014.08.015; Boas GRV, 2018, FOOD FUNCT, V9, P3707, DOI [10.1039/c8fo01017j, 10.1039/C8FO01017J]; Boas GRV, 2018, FOOD CHEM TOXICOL, V118, P1, DOI 10.1016/j.fct.2018.04.063; World Health Organization, 2006, DEF DIAGN DIAB MELL; Xu SQ, 2006, DIABETES, V55, P110, DOI 10.2337/diabetes.55.1.110; Yao Y, 2011, INT J MOL SCI, V12, P6445, DOI 10.3390/ijms12106445; YKIJARVINEN H, 1986, NEW ENGL J MED, V315, P224, DOI 10.1056/NEJM198607243150404; Zang YQ, 2016, BIOSCI BIOTECH BIOCH, V80, P1580, DOI 10.1080/09168451.2015.1116928	76	4	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227105	10.1371/journal.pone.0227105	http://dx.doi.org/10.1371/journal.pone.0227105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914140	gold, Green Published			2022-12-26	WOS:000534337700029
J	Purcell, NL; Goldman, JG; Ouyang, BC; Liu, YQ; Bernard, B; O'Keefeid, JA				Purcell, Nicollette L.; Goldman, Jennifer G.; Ouyang, Bichun; Liu, Yuanqing; Bernard, Bryan; O'Keefeid, Joan A.			The effects of dual-task cognitive interference on gait and turning in Huntington's disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; WALK TEST; BALANCE; RELIABILITY; DEFICITS; IMPAIRMENTS; PERFORMANCE; DYSFUNCTION; PEOPLE; FALLS	Huntington's disease (HD) is characterized by motor, cognitive, and psychiatric dysfunction. HD progression causes loss of automaticity, such that previously automatic tasks require greater attentional resources. Dual-task (DT) paradigms and fast-paced gait may stress the locomotor system, revealing deficits not seen under single-task (ST). However, the impact of gait "stress tests" on HD individuals needs further investigation. Therefore, the aims of this study were to investigate whether: 1) fast-paced and dual-task walking uncover deficits in gait and turning not seen under single-task, 2) cognitive and gait outcomes relate to fall incidence, and 3) gait deficits measured with wearable inertial sensors correlate with motor symptom severity in HD as measured by the Unified Huntington's disease Rating Scaletotal motor score (UHDRS-TMS). Seventeen HD (55 +/- 9.7 years) and 17 age-matched controls (56.5 +/- 9.3 years) underwent quantitative gait testing via a 25m, two-minute walk test with APDM (TM) inertial sensors. Gait was assessed under a 1) ST, self-selected pace, 2) fastas-possible (FAP) pace, and 3) verbal fluency DT. The UHDRS-TMS and a cognitive test battery were administered, and a retrospective fall history was obtained. During ST, DT, and FAP conditions, HD participants demonstrated slower gait, shorter stride length, and greater lateral step and stride length variability compared to controls (p<0.00001 to 0.034). Significant dual-task costs (DTC) were observed for turns; HD participants took more time (p = 0.013) and steps (p = 0.028) to complete a turn under DT compared to controls. Higher UHDRS-TMS correlated with greater stride length variability, less double-support, and more swing-phase time under all conditions. Decreased processing speed was associated with increased gait variability under ST and FAP conditions. Unexpectedly, participant's self-reported falls did not correlate with any gait or turn parameters. HD participants demonstrated significantly greater DTC for turning, which is less automatic than straight walking, requiring coordination of body segments, anticipatory control, and cortical regulation. Turn complexity likely makes it more susceptible to cognitive interference in HD.	[Purcell, Nicollette L.; O'Keefeid, Joan A.] Rush Univ, Med Ctr, Dept Cell & Mol Med, Chicago, IL 60612 USA; [Goldman, Jennifer G.] Shirley Ryan Abil Lab, Chicago, IL USA; [Goldman, Jennifer G.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Ouyang, Bichun; Liu, Yuanqing; Bernard, Bryan; O'Keefeid, Joan A.] Rush Univ, Med Ctr, Dept Neurol Sci, Sect Parkinson Dis & Movement Disorders, Chicago, IL 60612 USA	Rush University; Northwestern University; Feinberg School of Medicine; Rush University	O'Keefeid, JA (corresponding author), Rush Univ, Med Ctr, Dept Cell & Mol Med, Chicago, IL 60612 USA.; O'Keefeid, JA (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Sect Parkinson Dis & Movement Disorders, Chicago, IL 60612 USA.	joan_a_okeefe@rush.edu		O'Keefe, Joan/0000-0003-4018-7212	National Institutes of Health [K01 HD088762]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was support by the National Institutes of Health, K01 HD088762 (JAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amboni M, 2012, MOVEMENT DISORD, V27, P1536, DOI 10.1002/mds.25165; Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/jocn.2003.15.5.629; Beckmann H, 2018, GAIT POSTURE, V62, P451, DOI 10.1016/j.gaitpost.2018.03.039; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bilney B, 2005, MOVEMENT DISORD, V20, P51, DOI 10.1002/mds.20294; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Bohannon RW, 2015, ARCH PHYS MED REHAB, V96, P472, DOI 10.1016/j.apmr.2014.10.006; Callisaya ML, 2012, GAIT POSTURE, V36, P510, DOI 10.1016/j.gaitpost.2012.05.003; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Comber L, 2017, GAIT POSTURE, V51, P25, DOI 10.1016/j.gaitpost.2016.09.026; Cromwell RL, 2004, J AGING PHYS ACTIV, V12, P90, DOI 10.1123/japa.12.1.90; Cruz-Jimenez M, 2017, PHYS MED REH CLIN N, V28, P713, DOI 10.1016/j.pmr.2017.06.005; Fortaleza ACD, 2017, GAIT POSTURE, V56, P76, DOI 10.1016/j.gaitpost.2017.05.006; Delval A, 2008, MOVEMENT DISORD, V23, P684, DOI 10.1002/mds.21896; Freitas S, 2013, ALZ DIS ASSOC DIS, V27, P37, DOI 10.1097/WAD.0b013e3182420bfe; Fritz NE, 2016, GAIT POSTURE, V49, P283, DOI 10.1016/j.gaitpost.2016.07.014; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Gullett JM, 2013, CLIN NEUROPSYCHOL, V27, P1167, DOI 10.1080/13854046.2013.827744; Hamilton F, 2009, MULT SCLER J, V15, P1215, DOI 10.1177/1352458509106712; Hart EP, 2013, MOVEMENT DISORD, V28, P1142, DOI 10.1002/mds.25422; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2011, GERONTOLOGY, V57, P203, DOI 10.1159/000314963; Kertesz A., 2007, WAB R W APHASIA BATT; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; King LA, 2012, J NEUROL PHYS THER, V36, P25, DOI 10.1097/NPT.0b013e31824620d1; Kloos AD, 2017, J HUNTINGTONS DIS, V6, P363, DOI 10.3233/JHD-170279; Kwon MS, 2018, TECHNOL HEALTH CARE, V26, pS427, DOI 10.3233/THC-174736; Lord S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00249; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mancini M, 2011, J BIOENG BIOMED S S1; Maurage P, 2017, NEUROPSYCHOLOGY, V31, P424, DOI 10.1037/neu0000321; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Nocera JR, 2013, J REHABIL RES DEV, V50, P699, DOI 10.1682/JRRD.2012.06.0114; O'Keefe JA, 2016, CEREBELLUM, V15, P475, DOI 10.1007/s12311-015-0714-4; Pal G, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0205-y; Paulsen JS, 2011, CURR NEUROL NEUROSCI, V11, P474, DOI 10.1007/s11910-011-0215-x; Pistacchi M, 2017, FUNCT NEUROL, V32, P28, DOI 10.11138/FNeur/2017.32.1.028; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Purcell NL, 2019, MOV DISORD CLIN PRAC, V6, P202, DOI 10.1002/mdc3.12720; Pyo SJ, 2017, J MOV DISORD, V10, P140, DOI 10.14802/jmd.17041; Rao AK, 2008, MOVEMENT DISORD, V23, P1100, DOI 10.1002/mds.21987; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Schwenk M, 2010, NEUROLOGY, V74, P1961, DOI 10.1212/WNL.0b013e3181e39696; Seo EH, 2010, AM J GERIAT PSYCHIAT, V18, P801, DOI 10.1097/JGP.0b013e3181cab764; Smith A, 1968, SPECIAL CHILD PUBLIC, V83; Termsarasab P, 2018, MOV DISORD CLIN PRAC, V5, P223, DOI 10.1002/mdc3.12586; Thompson JC, 2010, NEUROPSYCHOLOGIA, V48, P171, DOI 10.1016/j.neuropsychologia.2009.09.002; Vaportzis E, 2015, J HUNTINGTONS DIS, V4, P119, DOI 10.3233/JHD-140131; Vuong K, 2018, HAND CLINIC, V159, P251, DOI 10.1016/B978-0-444-63916-5.00016-1; Wajda DA, 2013, J NEUROL SCI, V335, P160, DOI 10.1016/j.jns.2013.09.021; Wechsler D., 2012, WAIS 4 KASIKIRJA; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	54	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226827	10.1371/journal.pone.0226827	http://dx.doi.org/10.1371/journal.pone.0226827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5BZ	31910203	Green Published, gold			2022-12-26	WOS:000534333800017
J	Jacob, S; Kohler, M; Troster, P; Visa, M; Garcia-Prieto, CF; Alanentalo, T; Moede, T; Leibiger, B; Leibiger, IB; Berggren, PO				Jacob, Stefan; Kohler, Martin; Troster, Philip; Visa, Montse; Garcia-Prieto, Concha F.; Alanentalo, Tomas; Moede, Tilo; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per-Olof			In vivo Ca2+ dynamics in single pancreatic beta cells	FASEB JOURNAL			English	Article						calcium dynamics; diabetes mellitus; fluorescence microscopy; in vivo imaging; pancreatic islets	INHIBITS INSULIN-SECRETION; CALCIUM DYNAMICS; ISLETS; GLUCOSE; ISOFLURANE; EXPOSURE; MODEL	The dynamics of cytoplasmic free Ca2+ concentration ([Ca2+](i)) in pancreatic beta cells is central to our understanding of beta-cell physiology and pathology. In this context, there are numerous in vitro studies available but existing in vivo data are scarce. We now critically evaluate the anterior chamber of the eye as an in vivo, non-invasive, imaging site for measuring [Ca2+](i) dynamics longitudinally in three dimensions and at single-cell resolution. By applying a fluorescently labeled glucose analogue 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose in vivo, we followed how glucose almost simultaneously distributes to all cells within the islet volume, resulting in [Ca2+](i) changes. We found that almost all beta cells in healthy mice responded to a glucose challenge, while in hyperinsulinemic, hyperglycemic mice about 80% of the beta cells could not be further stimulated from fasting basal conditions. This finding indicates that our imaging modality can resolve functional heterogeneity within the beta-cell population in terms of glucose responsiveness. Importantly, we demonstrate that glucose homeostasis is markedly affected using isoflurane compared to hypnorm/midazolam anesthetics, which has major implications for [Ca2+](i) measurements. In summary, this setup offers a powerful tool to further investigate in vivo pancreatic beta-cell [Ca2+](i) response patterns at single-cell resolution in health and disease.	[Jacob, Stefan; Kohler, Martin; Troster, Philip; Visa, Montse; Garcia-Prieto, Concha F.; Alanentalo, Tomas; Moede, Tilo; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden	Karolinska Institutet	Troster, P; Berggren, PO (corresponding author), Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Solna L1 03, SE-17176 Stockholm, Sweden.	philip.troster@ki.se; Per-Olof.Berggren@ki.se	Visa, Montse/AAQ-8529-2021	Berggren, Per-Olof/0000-0001-8991-413X; Jacob, Stefan/0000-0001-8456-3924; Moede, Tilo/0000-0002-2045-9244	Svenska Forskningsradet Formas (Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage ERC-2013-AdG [338936]; Swedish Foundation for Strategic Research; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS ERC-2018-AdG [834860]; BETASCREEN ERC-2017-PoC [727306]; Diabetes Research and Wellness Foundation	Svenska Forskningsradet Formas (Swedish Research Council Formas)(Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage ERC-2013-AdG; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS ERC-2018-AdG; BETASCREEN ERC-2017-PoC; Diabetes Research and Wellness Foundation	Svenska Forskningsradet Formas (Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage, Grant/Award Number: ERC-2013-AdG 338936; BETASCREEN, Grant/Award Number: ERC-2017-PoC 727306; Swedish Foundation for Strategic Research; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS, Grant/Award Number: ERC-2018-AdG 834860	Behdad S, 2014, DIABETES METAB J, V38, P311, DOI 10.4093/dmj.2014.38.4.311; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bertram R, 1998, BIOPHYS J, V74, P1722, DOI 10.1016/S0006-3495(98)77883-X; Chen CG, 2016, DIABETES, V65, P2676, DOI 10.2337/db15-1718; de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5; DESBOROUGH JP, 1993, BRIT J ANAESTH, V71, P873, DOI 10.1093/bja/71.6.873; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Irles E, 2015, MOL CELL ENDOCRINOL, V404, P46, DOI 10.1016/j.mce.2015.01.033; JOHANSEN O, 1994, LAB ANIM, V28, P244, DOI 10.1258/002367794780681723; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Kauri LM, 2003, BIOCHEM BIOPH RES CO, V304, P371, DOI 10.1016/S0006-291X(03)00595-3; Kroon D.-J., 2011, SEGMENTATION MANDIBU; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Michau A, 2016, DIABETES, V65, P463, DOI 10.2337/db15-1168; Rodriguez-Diaz R, 2012, P NATL ACAD SCI USA, V109, P21456, DOI 10.1073/pnas.1211659110; Roder PV, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.6; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rutter GA, 2017, DIABETES OBES METAB, V19, P30, DOI 10.1111/dom.12990; Salem V, 2019, NAT METAB, V1, P615, DOI 10.1038/s42255-019-0075-2; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Stoer A, 2013, PLOS COMPUT BIOL, V9, P1; Stoer A, 2013, PLOS ONE, V8; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Torturo CL, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0278-18.2018; Turkyilmaz S, 2011, LANGMUIR, V27, P14380, DOI 10.1021/la2035278; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Westacott MJ, 2017, BIOPHYS J, V113, P1093, DOI 10.1016/j.bpj.2017.07.021; ZAITSEV SV, 1995, P NATL ACAD SCI USA, V92, P9712, DOI 10.1073/pnas.92.21.9712; Zanella R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02523	33	16	16	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					945	959		10.1096/fj.201901302RR	http://dx.doi.org/10.1096/fj.201901302RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914664	hybrid			2022-12-26	WOS:000507308900064
J	Symons, LK; Miller, JE; Tyryshkin, K; Monsanto, SP; Marks, RM; Lingegowda, H; Vanderbeck, K; Childs, T; Young, SL; Lessey, BA; Koti, M; Tayade, C				Symons, Lindsey K.; Miller, Jessica E.; Tyryshkin, Kathrin; Monsanto, Stephany P.; Marks, Ryan M.; Lingegowda, Harshavardhan; Vanderbeck, Kaitlin; Childs, Timothy; Young, Steven L.; Lessey, Bruce A.; Koti, Madhuri; Tayade, Chandrakant			Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model	FASEB JOURNAL			English	Article						angiogenesis; endometrium; immune microenvironment; inflammation; leukocytes	PERITONEAL-FLUID; APOPTOTIC NEUTROPHILS; TNF-ALPHA; T-CELLS; EXPRESSION; WOMEN; CANCER; ANGIOGENESIS; ERADICATION; RESOLUTION	Endometriosis is a chronic inflammatory, gynecological disease characterized by the presence of endometrial-like tissue lesions outside of the uterus. Neutrophils are elevated in the systemic circulation and peritoneal fluid of endometriosis patients; however, whether and how neutrophils contribute to endometriosis pathophysiology remain poorly understood. With emerging roles for neutrophils in chronic and sterile inflammatory conditions, we sought to provide in-depth characterization of neutrophil involvement in endometriosis. We demonstrate that neutrophils reside within patient endometriotic lesions and that patient lesions possess a microenvironment that may influence neutrophil recruitment and function. We also provide the first evidence that systemic circulating neutrophils from endometriosis patients display distinct transcriptomic differences compared neutrophils from healthy control subjects. Time course characterization of our syngeneic, immunocompetent mouse model of endometriosis revealed that neutrophils are rapidly recruited to the peritoneal environment early after endometriotic lesion establishment and remain present in murine lesions long term. In vivo neutrophil depletion altered the systemic and peritoneal immune microenvironment of mice with endometriosis as demonstrated by changes in pro-inflammatory and angiogenic mediators. Taken together, these findings highlight a novel role for neutrophils in early events such as angiogenesis and modulation of the local inflammatory environment associated with endometriosis pathogenesis.	[Symons, Lindsey K.; Miller, Jessica E.; Monsanto, Stephany P.; Marks, Ryan M.; Lingegowda, Harshavardhan; Koti, Madhuri; Tayade, Chandrakant] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Tyryshkin, Kathrin; Vanderbeck, Kaitlin; Childs, Timothy] Kingston Hlth Sci Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Lessey, Bruce A.] Wake Forest Baptist Hlth, Winston Salem, NC USA; [Koti, Madhuri] Kingston Hlth Sci Ctr, Dept Obstet & Gynecol, Kingston, ON, Canada; [Koti, Madhuri] Queens Univ, Div Canc Biol & Genet, Kingston, ON, Canada	Queens University - Canada; McMaster University; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center; Queens University - Canada	Tayade, C (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	tayadec@queensu.ca			Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [394340]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 394340	Ahn SH, 2016, FERTIL STERIL, V106, P1420, DOI 10.1016/j.fertnstert.2016.07.005; Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armstrong GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17565-x; Bai M, 2017, BLOOD, V130, P2092, DOI 10.1182/blood-2017-03-768507; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canis M, 1997, FERTIL STERIL, V67, P817; Cheong YC, 2002, HUM REPROD, V17, P69, DOI 10.1093/humrep/17.1.69; Cho S, 2008, FERTIL STERIL, V90, P2073, DOI 10.1016/j.fertnstert.2008.03.061; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Chung HH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46485; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; Deniset JF, 2017, J EXP MED, V214, P1333, DOI 10.1084/jem.20161621; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Gupta S, 2018, J IMMUNOL, V200, P869, DOI 10.4049/jimmunol.1700905; HALME J, 1984, OBSTET GYNECOL, V64, P151; Jiang KY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0128-7; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Kalu E, 2007, J OBSTET GYNAECOL RE, V33, P490, DOI 10.1111/j.1447-0756.2007.00569.x; Kim HK, 2018, J PSYCHIATR RES, V99, P39, DOI 10.1016/j.jpsychires.2018.01.011; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089742; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Milewski L, 2011, J REPROD IMMUNOL, V91, P64, DOI 10.1016/j.jri.2011.05.008; Miller JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18224-x; Monsanto SP, 2016, FERTIL STERIL, V105, P968, DOI 10.1016/j.fertnstert.2015.11.047; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Neubert E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00012; Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Panarelli N, 2019, ENDOCR-RELAT CANCER, V26, P47, DOI 10.1530/ERC-18-0244; Ren RH, 2017, ONCOTARGET, V8, P70982, DOI 10.18632/oncotarget.20237; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Suryawanshi S, 2014, CLIN CANCER RES, V20, P6163, DOI 10.1158/1078-0432.CCR-14-1338; Symons LK, 2018, TRENDS MOL MED, V24, P748, DOI 10.1016/j.molmed.2018.07.004; Takamura M, 2016, AM J REPROD IMMUNOL, V76, P193, DOI 10.1111/aji.12540; Tariverdian N, 2009, J REPROD IMMUNOL, V80, P80, DOI 10.1016/j.jri.2008.12.005; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Turashvili G, 2018, FASEB J, V32, P5937, DOI 10.1096/fj.201800120R; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Zhou GX, 2018, CARCINOGENESIS, V39, P272, DOI 10.1093/carcin/bgx142; Zhou GX, 2018, GUT, V67, P1052, DOI 10.1136/gutjnl-2016-313535; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	62	19	20	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1558	1575		10.1096/fj.201902272R	http://dx.doi.org/10.1096/fj.201902272R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914688				2022-12-26	WOS:000507308900103
J	Franckowiak, GA; Perdicas, M; Smith, GA				Franckowiak, Gregory A.; Perdicas, Marlo; Smith, Gregory A.			Spatial ecology of coyotes in the urbanizing landscape of the Cuyahoga Valley, Ohio	PLOS ONE			English	Article							HABITAT USE; HOME-RANGE; CANIS-LATRANS; ACTIVITY PATTERNS; BEHAVIORAL-RESPONSES; FOOD-HABITS; GRAY FOXES; SPACE USE; MOVEMENTS; SUBURBAN	Urban landscapes can present ecological challenges for wildlife species, yet many species survive, and even thrive, near dense human populations. Coyotes (Canis latrans), for example, have expanded their geographic range across North America and, as a result of their adaptability and behavioral flexibility, are now a common occupant of many urban areas in the United States. We investigated the spatial ecology of 27 coyotes fitted with Global Positioning System (GPS) telemetry collars radio-collared in the Cuyahoga Valley, Ohio. Our objectives were to quantify coyote space use, evaluate resource selection, and investigate coyote movement and activity patterns. To measure space use, we estimated home range (95%) and core area (50%) size of coyotes using the adaptive local convex hull (a-LoCoH) method. We found the mean (+/- SE) home range size of resident coyotes (4.7 +/- 1.8 km(2)) was significantly smaller than ranges of transient coyotes (67.7 +/- 89.6 km(2)). Similarly, mean (+/- SE) core area size of resident coyotes (0.9 +/- 0.6 km(2)) was significantly smaller than core areas of transient coyotes (11.9 +/- 16.7 km(2)). Home range and core area size of both resident and transient coyotes did not vary by sex, age, or season. For all coyotes, use of natural land cover was significantly greater than use of altered and developed land. When coyotes were using altered and developed land, GPS fixes were most common at night. Coyote movement patterns differed with respect to status, time period, and season; peaking during nighttime hours. A better understanding of coyote space use and movement within anthropogenic landscapes aids management of people, parks, and wildlife by providing the data necessary for research-based management decisions.	[Franckowiak, Gregory A.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Perdicas, Marlo] Summit Metro Pk, Akron, OH USA; [Smith, Gregory A.] Kent State Univ Stark, Dept Biol Sci, N Canton, OH USA	University System of Ohio; University of Akron; University System of Ohio; Kent State University; Kent State University Stark	Franckowiak, GA (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	gfranckowiak@gmail.com		Smith, Greg/0000-0002-8247-559X; Franckowiak, Gregory/0000-0003-1425-8638	Summit Metro Parks	Summit Metro Parks	The study was funded by The Summit Metro Parks. The funder provided support in the form of salaries for authors [MP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adkins CA, 1998, J ZOOL, V244, P335, DOI 10.1111/j.1469-7998.1998.tb00038.x; ALTHOFF DP, 1981, J WILDLIFE MANAGE, V45, P641, DOI 10.2307/3808697; ANDELT WF, 1985, WILDLIFE MONOGR, P1; ANDELT WF, 1979, J WILDLIFE MANAGE, V43, P944, DOI 10.2307/3808278; Atwood TC, 2004, J WILDLIFE MANAGE, V68, P1000, DOI 10.2193/0022-541X(2004)068[1000:SEOCAA]2.0.CO;2; Bates D, 2015, J STAT SOFTWARE; Beyer HL., 2015, GEOSPATIAL MODELING; Bollin-Booth HA, 2007, DIET ANAL COYOTE CAN; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1017/CBO9780511802461.005, DOI 10.1017/CBO9780511802461.005]; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Camenzind F.J., 1978, P267; Cepek JD, 2004, OHIO J SCI, V104, P60; Chamberlain MJ, 2000, CAN J ZOOL, V78, P2087, DOI 10.1139/cjz-78-12-2087; Chavez AS, 2006, J WILDLIFE MANAGE, V70, P1079, DOI 10.2193/0022-541X(2006)70[1079:LUAMOW]2.0.CO;2; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Danner DA, 2009, COYOTE HOME RANGE MO, V44, P484; Ellington EH, 2019, BEHAV ECOL, V30, P821, DOI 10.1093/beheco/arz019; ESRI, 2010, DESKT; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fox J., 2018, R COMPANION APPL REG; Franckowiak GA, 2018, AM MIDL NAT, V180, P233, DOI 10.1674/0003-0031-180.2.233; Gehrt Stanley D., 2010, P79; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; GESE EM, 1988, J WILDLIFE MANAGE, V52, P640, DOI 10.2307/3800923; Gese EM, 2012, J ETHOL, V30, P413, DOI 10.1007/s10164-012-0339-8; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Gier HT, 1968, COYOTES KANSAS KANSA; Grinder M, 2001, J WILDLIFE DIS, V37, P312, DOI 10.7589/0090-3558-37.2.312; Grubbs SE, 2009, SOUTHWEST NAT, V54, P1, DOI 10.1894/MLK-05.1; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Harris Stephen, 2010, P109; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Hennessy CA, 2012, J MAMMAL, V93, P732, DOI 10.1644/11-MAMM-A-184.1; Hidalgo-Mihart MG, 2009, STUD NEOTROP FAUNA E, V44, P77, DOI 10.1080/01650520902941234; HOLZMAN S, 1992, J WILDLIFE MANAGE, V56, P139, DOI 10.2307/3808801; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Kamler JF, 2005, AM MIDL NAT, V153, P396, DOI 10.1674/0003-0031(2005)153[0396:HRAHUO]2.0.CO;2; Larson RN, 2015, WEST N AM NATURALIST, V75, P339, DOI 10.3398/064.075.0311; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Lukasik VM., 2012, CITIES ENV, V4, P8, DOI DOI 10.15365/CATE.4182011; McClennen N, 2001, AM MIDL NAT, V146, P27, DOI 10.1674/0003-0031(2001)146[0027:TEOSAA]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mitchell N, 2015, WILDLIFE RES, V42, P461, DOI 10.1071/WR15020; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Morey PS, 2007, AM MIDL NAT, V158, P147, DOI 10.1674/0003-0031(2007)158[147:SATVIT]2.0.CO;2; Mueller MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190971; National Park Service, 2019, CUYAH VALL NAT PARK; National Weather Service, 2019, WEATH HIST AKR; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; ODOT, 2019, OH TRANSP SYST DAT D; Olson TL, 1998, URSUS-SERIES, V10, P547; PERSON DK, 1991, J WILDLIFE MANAGE, V55, P433, DOI 10.2307/3808971; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Poessel SA, 2017, CAN J ZOOL, V95, P287, DOI 10.1139/cjz-2016-0029; Poessel SA, 2016, J MAMMAL, V97, P1414, DOI 10.1093/jmammal/gyw090; Poessel SA, 2013, J WILDLIFE MANAGE, V77, P297, DOI 10.1002/jwmg.454; Quinn T, 1997, NORTHWEST SCI, V71, P289; Quinn T, 1997, NORTHWEST SCI, V71, P1; Rashleigh RM, 2008, OHIO J SCI, V108, P54; Rempel RS, 1997, J WILDLIFE MANAGE, V61, P525, DOI 10.2307/3802611; Riley SPD, 2006, J WILDLIFE MANAGE, V70, P1425, DOI 10.2193/0022-541X(2006)70[1425:SEOBAG]2.0.CO;2; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; RStudio Team, 2015, INT DEV ENV R; Sacks BN, 1999, J WILDLIFE MANAGE, V63, P593, DOI 10.2307/3802648; Schrecengost JD, 2009, AM MIDL NAT, V162, P346, DOI 10.1674/0003-0031-162.2.346; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Sweanor LL, 2008, J WILDLIFE MANAGE, V72, P1076, DOI 10.2193/2007-024; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; U.S. Census Bureau, 2010, POP FIND; Wallace BF, 2013, COYOTE SPATIAL TEMPO; Way JG, 2004, NORTHEAST NAT, V11, P237, DOI 10.1656/1092-6194(2004)011[0237:MAAPOE]2.0.CO;2; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Zuur A, 2009, J STAT SOFTWARE; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	77	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227028	10.1371/journal.pone.0227028	http://dx.doi.org/10.1371/journal.pone.0227028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887177	gold, Green Published			2022-12-26	WOS:000515092200064
J	Rispoli, LA; Edwards, JL; Pohler, KG; Russell, S; Somiari, RI; Payton, RR; Schrick, FN				Rispoli, Louisa A.; Edwards, J. Lannett; Pohler, Ky G.; Russell, Stephen; Somiari, Richard, I; Payton, Rebecca R.; Schrick, F. Neal			Heat-induced hyperthermia impacts the follicular fluid proteome of the periovulatory follicle in lactating dairy cows	PLOS ONE			English	Article							ELEVATED AMBIENT-TEMPERATURES; HUMAN GRANULOSA-CELLS; TUMOR-NECROSIS-FACTOR; KININ SYSTEM; STRESS; OOCYTE; EXPRESSION; MATURATION; BRADYKININ; PLASMA	We hypothesized that heat-induced perturbations in cumulus cells surrounding the maturing oocyte may extend to the mural granulosa of the periovulatory follicle in the heat-stressed cow to subsequently the follicular fluid proteome. Lactating Holsteins were pharmacologically stimulated to have a dominant follicle that was capable of responding to a gonadotropin releasing hormone-induced luteinizing hormone surge. Following gonadotropin releasing hormone administration, cows were maintained at similar to 67 temperature humidity index (THI; thermoneutral conditions) or exposed to conditions simulating an acute heat stress event (71 to 86 THI; heat stress for similar to 12 h). Dominant follicle collection was conducted in the periovulatory period similar to 16 h after gonadotropin releasing hormone. Follicular fluid proteome from thermoneutral (n = 5) and hyperthermic (n = 5) cows was evaluated by quantitative tandem mass spectrometry (nano LC-MS/MS). We identified 35 differentially-abundant proteins. Functional annotation revealed numerous immune-related proteins. Subsequent efforts revealed an increase in levels of the proinflammatory mediator bradykinin in follicular fluid (P = 0.0456) but not in serum (P = 0.9319) of hyperthermic cows. Intrafollicular increases in transferrin (negative acute phase protein) in hyperthermic cows (P = 0.0181) coincided with a tendency for levels to be increased in the circulation (P = 0.0683). Nine out of 15 cytokines evaluated were detected in follicular fluid. Heat stress increased intrafollicular interleukin 6 levels (P = 0.0160). Whether hyperthermia-induced changes in the heat-stressed cow's follicular fluid milieu reflect changes in mural granulosa, cumulus, other cell types secretions, and/or transudative changes from circulation remains unclear. Regardless of origin, heat stress/hyperthermia related changes in the follicular fluid milieu may have an impact on components important for ovulation and competence of the cumulus-oocyte complex contained within the periovulatory follicle.	[Rispoli, Louisa A.; Edwards, J. Lannett; Pohler, Ky G.; Payton, Rebecca R.; Schrick, F. Neal] Univ Tennessee, Inst Agr, Dept Anim Sci, AgRes, Knoxville, TN 37901 USA; [Russell, Stephen; Somiari, Richard, I] ITSI Biosci LLC, Johnstown, PA USA; [Rispoli, Louisa A.] Cincinnati Zoo & Bot Garden, Lindner Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH USA; [Pohler, Ky G.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Texas A&M University System; Texas A&M University College Station	Edwards, JL (corresponding author), Univ Tennessee, Inst Agr, Dept Anim Sci, AgRes, Knoxville, TN 37901 USA.	jedwards@utk.edu		Rispoli, Louisa/0000-0003-4756-5503	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2016-67015-24899]; state of Tennessee through UT AgResearch; Department of Animal Science; East Tennessee Research and Education Center; USDA National Institute of Food and Agriculture [1015707]; USDANIFA-AFRI competitive grant	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; state of Tennessee through UT AgResearch; Department of Animal Science; East Tennessee Research and Education Center; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDANIFA-AFRI competitive grant	Research including proteomic profiling of follicular fluid samples conducted by ITSI-Biosciences was funded by an Agriculture and Food Research Initiative Competitive Grant no.2016-67015-24899 from the USDA National Institute of Food and Agriculture (https://nifa.usda. gov/program/agriculture-and-food-researchinitiative-afri) and by the state of Tennessee through UT AgResearch, Department of Animal Science, East Tennessee Research and Education Center, and the USDA National Institute of Food and Agriculture, Project No. 1015707. Support in the form of salaries for authors was provided by Agriculture and Food Research Initiative Competitive Grant [LAR], by the state of Tennessee through UT AgResearch, Department of Animal Science, East Tennessee Research and Education Center, and the USDA National Institute of Food and Agriculture, Project No. 1015707 [JLE/KP//RRP/FNS], and ITSI-Biosciences [SR/RIS]. These funders [USDA-NIFA, state of Tennessee through UT AgResearch, Department of Animal Science, East Tennessee Research and Education Center, and the USDA National Institute of Food and Agriculture, Project No. 1015707] did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ITSI-Biosciences performed proteomic profiling of follicular fluid samples and was paid for services using funds from the USDANIFA-AFRI competitive grant. This commercial company did not have a role in the animal study design, data collection, or decision to publish. Two members of this company [SR/RIS] however, provided intellectual contributions beyond contracted paid services by providing important input with sample preparation after collection from animals, invaluable assistance with analysis of proteomic data, and assisted with preparing the manuscript.	Abbott CR, 2018, J THERM BIOL, V78, P247, DOI 10.1016/j.jtherbio.2018.10.003; Altun T, 2011, J ASSIST REPROD GEN, V28, P245, DOI 10.1007/s10815-010-9502-8; ANDERSON KP, 1990, MOL ENDOCRINOL, V4, P543, DOI 10.1210/mend-4-4-543; Arciero C, 2003, INT J BIOL MARKER, V18, P241, DOI 10.1177/172460080301800403; ARMSTRONG DV, 1994, J DAIRY SCI, V77, P2044, DOI 10.3168/jds.S0022-0302(94)77149-6; Ascari IJ, 2017, DOMEST ANIM ENDOCRIN, V60, P50, DOI 10.1016/j.domaniend.2017.03.003; Balboula AZ, 2013, REPRODUCTION, V146, P407, DOI 10.1530/REP-13-0179; Baskind NE, 2014, FERTIL STERIL, V102, P410, DOI 10.1016/j.fertnstert.2014.04.032; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bedaiwy M, 2007, REPROD BIOMED ONLINE, V15, P321, DOI 10.1016/S1472-6483(10)60346-X; BENZEEV A, 1987, DIFFERENTIATION, V34, P222, DOI 10.1111/j.1432-0436.1987.tb00070.x; BENZEEV A, 1989, ENDOCRINOLOGY, V124, P1033, DOI 10.1210/endo-124-2-1033; Bridges PJ, 2005, DOMEST ANIM ENDOCRIN, V29, P508, DOI 10.1016/j.domaniend.2005.02.017; Briggs DA, 1999, MOL HUM REPROD, V5, P1107, DOI 10.1093/molehr/5.12.1107; Bromfield JJ, 2011, ENDOCRINOLOGY, V152, P5029, DOI 10.1210/en.2011-1124; Campen KA, 2018, J REPROD DEVELOP, V64, P385, DOI 10.1262/jrd.2018-029; Cartmill JA, 2001, J DAIRY SCI, V84, P799, DOI 10.3168/jds.S0022-0302(01)74536-5; Constable P.D., 2017, VET MED-US, VVolume 1, P1, DOI [10.2147/VMRR.S91360, DOI 10.2147/VMRR.S91360]; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; De Neubourg D, 2003, GYNECOL OBSTET INVES, V56, P106, DOI 10.1159/000072997; De Rensis F, 2015, THERIOGENOLOGY, V84, P659, DOI 10.1016/j.theriogenology.2015.04.021; Dikmen S, 2009, J DAIRY SCI, V92, P109, DOI 10.3168/jds.2008-1370; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Ducolomb Y, 2013, THERIOGENOLOGY, V79, P896, DOI 10.1016/j.theriogenology.2013.01.024; Duffy DM, 2019, ENDOCR REV, V40, P369, DOI 10.1210/er.2018-00075; EALY AD, 1993, J DAIRY SCI, V76, P2899, DOI 10.3168/jds.S0022-0302(93)77629-8; Edwards JL, 1996, BIOL REPROD, V55, P340, DOI 10.1095/biolreprod55.2.341; El-Bayoumy K, 2012, J PROTEOMICS, V75, P1018, DOI 10.1016/j.jprot.2011.10.013; ENTMAN SS, 1987, J IN VITRO FERTIL EM, V4, P98, DOI 10.1007/BF01555447; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Ferrazza RD, 2017, BIOL REPROD, V97, P835, DOI 10.1093/biolre/iox148; FORTUNE JE, 1985, BIOL REPROD, V32, P1069, DOI 10.1095/biolreprod32.5.1069; GAO XX, 1992, BIOL REPROD, V47, P945, DOI 10.1095/biolreprod47.6.945; Gaughan JB, 2000, ASIAN AUSTRAL J ANIM, V13, P329; Gebremedhin KG, 2008, T ASABE, V51, P2167, DOI 10.13031/2013.25397; Giordano JO, 2013, THERIOGENOLOGY, V79, P1210, DOI 10.1016/j.theriogenology.2013.02.020; Goodwin MR, 2016, J REPROD DEVELOP, V62, P553, DOI 10.1262/jrd.2015-177; HELLBERG P, 1991, BIOL REPROD, V44, P269, DOI 10.1095/biolreprod44.2.269; Hoeben E, 1997, MOL CELL ENDOCRINOL, V132, P149, DOI 10.1016/S0303-7207(97)00132-9; Huleihel M, 2002, MOL CELL ENDOCRINOL, V187, P125, DOI 10.1016/S0303-7207(01)00690-6; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ilha GF, 2011, PEPTIDES, V32, P2122, DOI 10.1016/j.peptides.2011.08.028; IRELAND JJ, 1982, ENDOCRINOLOGY, V111, P2077, DOI 10.1210/endo-111-6-2077; Kawasaki F, 2003, CLIN EXP MED, V3, P27, DOI 10.1007/s102380300012; Khan MM, 2006, ARTERIOSCL THROM VAS, V26, P2260, DOI 10.1161/01.ATV.0000240290.70852.c0; Kihara T, 2000, BIOL REPROD, V62, P1160, DOI 10.1095/biolreprod62.5.1160; Kirby CJ, 1997, J DAIRY SCI, V80, P273, DOI 10.3168/jds.S0022-0302(97)75935-6; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Lawrence JL, 2004, J DAIRY SCI, V87, P2449, DOI 10.3168/jds.S0022-0302(04)73368-8; LEMAIRE W J, 1989, Steroids, V54, P455, DOI 10.1016/0039-128X(89)90040-8; Lewandowska AE, 2017, J PROTEOME RES, V16, P3053, DOI 10.1021/acs.jproteome.7b00366; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Mader TL, 2006, J ANIM SCI, V84, P712, DOI 10.2527/2006.843712x; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Min L, 2016, J PROTEOMICS, V146, P99, DOI 10.1016/j.jprot.2016.06.008; Nivet AL, 2013, REPRODUCTION, V145, P555, DOI 10.1530/REP-13-0032; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Plendl J, 2002, BIOL CHEM, V383, P1917, DOI 10.1515/BC.2002.215; Pohler KG, 2016, J DAIRY SCI, V99, P1584, DOI 10.3168/jds.2015-10192; Poulsen LL, 2019, MOL CELL ENDOCRINOL, V495, DOI 10.1016/j.mce.2019.110522; PUTNEY DJ, 1989, ANIM REPROD SCI, V19, P37, DOI 10.1016/0378-4320(89)90045-6; Rispoli LA, 2013, REPRODUCTION, V146, P193, DOI 10.1530/REP-12-0487; Rispoli LA, 2011, REPRODUCTION, V142, P831, DOI 10.1530/REP-11-0032; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Rutigliano HM, 2008, J DAIRY SCI, V91, P3323, DOI 10.3168/jds.2008-1005; Ryan DP., 1990, THESIS; Samir M, 2017, REPRODUCTION, V154, P35, DOI 10.1530/REP-17-0053; Shen XF, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0277-y; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tsafriri A, 1999, EXP CLIN ENDOCR DIAB, V107, P1, DOI 10.1055/s-0029-1212066; VANDERGRAAF F, 1984, BIOCHEMISTRY-US, V23, P1760, DOI 10.1021/bi00303a027; Wong MKS, 2016, HANDBOOK OF HORMONES: COMPARATIVE ENDOCRINOLOGY FOR BASIC AND CLINICAL RESEARCH, P266, DOI 10.1016/B978-0-12-801028-0.00030-1; YOSHIMURA Y, 1988, ENDOCRINOLOGY, V122, P2540, DOI 10.1210/endo-122-6-2540; Zachut M, 2016, J PROTEOMICS, V139, P122, DOI 10.1016/j.jprot.2016.03.027; Zhandi M, 2009, J ASSIST REPROD GEN, V26, P605, DOI 10.1007/s10815-009-9364-0	79	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227095	10.1371/journal.pone.0227095	http://dx.doi.org/10.1371/journal.pone.0227095			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887207	Green Published, gold			2022-12-26	WOS:000515092200074
J	Pan, HC; Xue, WK; Zhao, WJ; Schachner, M				Pan, Hongchao; Xue, Weikang; Zhao, Weijiang; Schachner, Melitta			Expression and function of chondroitin 4-sulfate and chondroitin 6-sulfate in human glioma	FASEB JOURNAL			English	Article						chondroitin 4-sulfate; chondroitin 6-sulfate; glioma; invasion; migration	SULFATE GLYCOSAMINOGLYCAN; MESENCHYMAL TRANSITION; CELL-MIGRATION; PROTEOGLYCANS; MELANOMA; GLIOBLASTOMA; ADHESION; BRAIN; PROLIFERATION; BIOSYNTHESIS	Key molecules promoting migration and invasion exist in the extracellular matrix, and include chondroitin 4-sulfate (C4S) and chondroitin 6-sulfate (C6S), functionally important carbohydrate chains of chondroitin sulfate proteoglycans that participate in regulating cancer development. Here, we show that C4S and C6S expression is upregulated in human glioma tissues, when compared to normal brain tissue, and that the extent of upregulation positively correlated with glioma malignancy. Treatment of cultured glioma cells with C4S and C6S enhanced cell viability, migration, and invasion, increased MMP-2 and MMP-9 levels, enhanced N-cadherin, but reduced E-cadherin expression. Inhibition of expression of the two CS synthetic enzymes chondroitin 4-O-sulfotransferase-1 (C4ST-1/CHST11) and chondroitin 6-O-sulfotransferase-1 (C6ST-1/CHST3) suppressed cell viability, migration and invasion, reduced MMP-2 and MMP-9 expression, and reduced N-cadherin expression, but increased E-cadherin levels. The C4S- and C6S-enhanced epithelial-to-mesenchymal transition and expression of MMP-2 occurred via activation of the PI3K/AKT signaling pathway, known to be involved in promoting cell migration and invasion. In immune-deficient larval zebrafish, C4S and C6S increased the numbers of viable tumor cells, thereby promoting glioma cell proliferation. The present observations point to a novel role of C4S and C6S in human glioma cell functions, thus possibly representing targets in glioma therapy.	[Pan, Hongchao; Xue, Weikang; Zhao, Weijiang; Schachner, Melitta] Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Lin Rd, Shantou 515041, Peoples R China; [Pan, Hongchao] Shantou Univ Med Coll, Guangdong Prov Key Lab Breast Canc Diag & Treatme, Canc Hosp, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhao, WJ; Schachner, M (corresponding author), Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Lin Rd, Shantou 515041, Peoples R China.	neuromancn@aliyun.com; schachner@stu.edu.cn			Guangdong Provincial Natural Science Foundation [2014A030313469]; National Natural Science Foundation of China [81471279, 81171138, LD030302]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangdong Provincial Natural Science Foundation, Grant/Award Number: 2014A030313469; National Natural Science Foundation of China, Grant/Award Number: 81471279, 81171138 and LD030302	Alexander BM, 2017, J CLIN ONCOL, V35, P2402, DOI 10.1200/JCO.2017.73.0119; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; ALINI M, 1991, CANCER RES, V51, P1443; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; BERTOLOTTO A, 1986, ACTA NEUROPATHOL, V72, P189, DOI 10.1007/BF00685982; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Canas N, 2007, J PHARMACOL EXP THER, V323, P946, DOI 10.1124/jpet.107.123505; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Cheng WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034352; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; de Aguiar CBNM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-31; de Aguiar CBNM, 2002, INT J DEV NEUROSCI, V20, P563, DOI 10.1016/S0736-5748(02)00081-3; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Ferrer VP, 2018, GLIA, V66, P1542, DOI 10.1002/glia.23309; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Fthenou E, 2006, INT J BIOCHEM CELL B, V38, P2141, DOI 10.1016/j.biocel.2006.06.006; Fthenou E, 2009, IN VIVO, V23, P69; GOWDA DC, 1986, J BIOL CHEM, V261, P4926; Heredia A, 1996, ARCH BIOCHEM BIOPHYS, V333, P198, DOI 10.1006/abbi.1996.0381; Hoshiba T, 2018, EXP CELL RES, V370, P571, DOI 10.1016/j.yexcr.2018.07.022; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Kubelt C, 2015, INT J ONCOL, V46, P2515, DOI 10.3892/ijo.2015.2944; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lara-Velazquez M, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120166; Lin RT, 2018, MOL CELL, V69, P923, DOI 10.1016/j.molcel.2018.02.010; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Murai T, 2004, IMMUNOL LETT, V93, P163, DOI 10.1016/j.imlet.2004.03.013; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nadanaka S, 2018, J BIOL CHEM, V293, P444, DOI 10.1074/jbc.M117.814509; NIOKA H, 1994, J NEURO-ONCOL, V21, P233, DOI 10.1007/BF01063772; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Ricciardelli C, 1997, CLIN CANCER RES, V3, P983; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Svensson KJ, 2011, INT J ONCOL, V39, P1421, DOI 10.3892/ijo.2011.1164; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Tysnes BB, 1996, INT J CANCER, V67, P777, DOI 10.1002/(SICI)1097-0215(19960917)67:6<777::AID-IJC5>3.0.CO;2-O; Vallen MJE, 2012, GYNECOL ONCOL, V127, P202, DOI 10.1016/j.ygyno.2012.06.022; Vitucci M, 2013, NEURO-ONCOLOGY, V15, P1317, DOI 10.1093/neuonc/not084; Wilson Taylor A, 2014, Surg Neurol Int, V5, P64, DOI 10.4103/2152-7806.132138	51	14	16	3	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2853	2868		10.1096/fj.201901621RRR	http://dx.doi.org/10.1096/fj.201901621RRR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908019	Bronze			2022-12-26	WOS:000504271100001
J	Liang, RY; Liu, BH; Huang, CJ; Lin, KT; Ko, CC; Huang, LL; Hsu, B; Wu, CY; Chuang, SM				Liang, Ruei-Yue; Liu, Bang-Hung; Huang, Chih-Jou; Lin, Kuan-Ting; Ko, Chih-Chung; Huang, Lin-Lun; Hsu, Bin; Wu, Chun-Ying; Chuang, Show-Mei			MEK2 is a critical modulating mechanism to down-regulate GCIP stability and function in cancer cells	FASEB JOURNAL			English	Article						GCIP; MEK2; tumor suppressor; ubiquitination	LOOP-HELIX PROTEIN; GROWTH; EXPRESSION; KINASE; BREAST; ACTIVATION; CARCINOMA; GENE; MAP; SURVIVAL	Loss of tumor suppressor activity and upregulation of oncogenic pathways simultaneously contribute to tumorigenesis. Expression of the tumor suppressor, GCIP (Grap2- and cyclin D1-interacting protein), is usually reduced or lost in advanced cancers, as seen in both mouse tumor models and human cancer patients. However, no previous study has examined how cancer cells down-regulate GCIP expression. In this study, we first validate the tumor suppressive function of GCIP using clinical gastric cancer tissues and online database analysis. We then reveal a novel mechanism whereby MEK2 directly interacts with and phosphorylates GCIP at its Ser313 and Ser356 residues to promote the turnover of GCIP by ubiquitin-mediated proteasomal degradation. We also reveal that decreased GCIP stability enhances cell proliferation and promotes cancer cell migration and invasion. Taken together, these findings provide a more comprehensive view of GCIP in tumorigenesis and suggest that the oncogenic MEK/ERK signaling pathway negatively regulates the protein level of GCIP to promote cell proliferation and migration.	[Liang, Ruei-Yue; Liu, Bang-Hung; Huang, Chih-Jou; Lin, Kuan-Ting; Ko, Chih-Chung; Huang, Lin-Lun; Hsu, Bin; Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, 145 Xingda Rd, Taichung 402, Taiwan; [Wu, Chun-Ying] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan	National Chung Hsing University; Taipei Veterans General Hospital	Chuang, SM (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, 145 Xingda Rd, Taichung 402, Taiwan.	smchuang@dragon.nchu.edu.tw	Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Chuang, Show-Mei/0000-0003-2986-0736	Ministry of Science and Technology, Taiwan (MOST) [MOST 107-2635-B-005-002]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107-2635-B-005-002	Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang TW, 2008, ONCOGENE, V27, P332, DOI 10.1038/sj.onc.1210651; Chen KY, 2014, ONCOTARGET, V5, P5017, DOI 10.18632/oncotarget.2075; Chen WC, 2008, HISTOPATHOLOGY, V53, P554, DOI 10.1111/j.1365-2559.2008.03154.x; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chuang SM, 2013, BBA-GEN SUBJECTS, V1830, P4960, DOI 10.1016/j.bbagen.2013.06.025; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii R, 2012, EMBO J, V31, P2541, DOI 10.1038/emboj.2012.77; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Ma WB, 2007, J CELL BIOCHEM, V100, P1376, DOI 10.1002/jcb.21140; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Natrajan R, 2003, CANCER RES, V63, P7657; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Seto A, 2009, ACTA CRYSTALLOGR F, V65, P21, DOI 10.1107/S1744309108038219; Sonnenberg-Riethmacher E, 2007, HEPATOLOGY, V45, P404, DOI 10.1002/hep.21461; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Su T, 2007, J EXP THER ONCOL, V6, P117; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Terai S, 2000, HEPATOLOGY, V32, P357, DOI 10.1053/jhep.2000.9092; Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yao Y, 2000, EXP CELL RES, V257, P22, DOI 10.1006/excr.2000.4884; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004	33	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1958	1969		10.1096/fj.201901911R	http://dx.doi.org/10.1096/fj.201901911R		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907980				2022-12-26	WOS:000503398500001
J	Zhang, J; Kong, XM; Zhang, YH; Sun, WQ; Xu, EH; Chen, XB				Zhang, Jin; Kong, Xiangmudong; Zhang, Yanhong; Sun, Wenqiang; Xu, Enshun; Chen, Xinbin			Mdm2 is a target and mediator of IRP2 in cell growth control	FASEB JOURNAL			English	Article						Iron homeostasis; Iron-response element (IRE); IRP2; Mdm2; mRNA stability	IRON REGULATORY PROTEIN-1; P53; MICE; DEGRADATION; DEREPRESSION; EXPRESSION; MULTIPLE; PROMOTES; DELETION; ARREST	Iron is an essential element to all living organisms and plays a vital role in many cellular processes, such as DNA synthesis and energy production. The Mdm2 oncogene is an E3 ligase and known to promote tumor growth. However, the role of Mdm2 in iron homeostasis is not certain. Here, we showed that Mdm2 expression was increased by iron depletion but decreased by iron repletion. We also showed that Iron Regulatory Protein 2 (IRP2) mediated iron-regulated Mdm2 expression. Specifically, Mdm2 expression was increased by ectopic IRP2 but decreased by knockdown or knockout of IRP2 in human cancer cells as well as in mouse embryonic fibroblasts. In addition, we showed that IRP2-regulated Mdm2 expression was independent of tumor suppressor p53. Mechanistically, we found that IRP2 stabilized Mdm2 transcript via binding to an iron response element (IRE) in the 3MODIFIER LETTER PRIMEUTR of Mdm2 mRNA. Finally, we showed that Mdm2 is required for IRP2-mediated cell proliferation and Mdm2 expression is highly associated with IRP2 in both the normal and cancerous liver tissues. Together, we uncover a novel regulation of Mdm2 by IRP2 via mRNA stability and that the IRP2-Mdm2 axis may play a critical role in cell growth.	[Zhang, Jin; Kong, Xiangmudong; Zhang, Yanhong; Sun, Wenqiang; Xu, Enshun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Schools Vet Med, Med, Davis, CA USA; Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Schools Vet Med, Med, Davis, CA USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu			NCI NIH HHS [R01 CA081237, R01 CA224433] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Azer SA, 2018, J CLIN MED, V7, DOI 10.3390/jcm7040064; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Deb Swati Palit, 2014, Subcell Biochem, V85, P215, DOI 10.1007/978-94-017-9211-0_12; Deng ZY, 2017, ONCOTARGET, V8, P82231, DOI 10.18632/oncotarget.19288; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; INOUE S, 1987, CANCER RES, V47, P6522; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Khiroya H, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00711-2016; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muto Y, 2019, J EXP MED, V216, P950, DOI 10.1084/jem.20180900; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Torti SV, 2018, ANNU REV NUTR, V38, P97, DOI 10.1146/annurev-nutr-082117-051732; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhang J, 2018, CANCER RES, V78, P1511, DOI 10.1158/0008-5472.CAN-17-2457; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117	39	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2301	2311		10.1096/fj.201902278RR	http://dx.doi.org/10.1096/fj.201902278RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907996	Green Accepted, Bronze			2022-12-26	WOS:000514663600026
J	Barroso, J; Wakaizumi, K; Reckziegel, D; Pinto-Ramos, J; Schnitzer, T; Galhardo, V; Apkarian, AV				Barroso, Joana; Wakaizumi, Kenta; Reckziegel, Diane; Pinto-Ramos, Joao; Schnitzer, Thomas; Galhardo, Vasco; Apkarian, A. Vania			Prognostics for pain in osteoarthritis: Do clinical measures predict pain after total joint replacement?	PLOS ONE			English	Article							POSTOPERATIVE PAIN; KNEE ARTHROPLASTY; TOTAL HIP; RADIOGRAPHIC SEVERITY; QUESTIONNAIRE; VALIDITY; OUTCOMES; UPDATE; IMPACT; TESTS	A significant proportion of osteoarthritis (OA) patients continue to experience moderate to severe pain after total joint replacement (TJR). Preoperative factors related to pain persistence are mainly studied using individual predictor variables and distinct pain outcomes, thus leading to a lack of consensus regarding the influence of preoperative parameters on post-TJR pain. In this prospective observational study, we evaluated knee and hip OA patients before, 3 and 6 months post-TJR searching for clinical predictors of pain persistence. We assessed multiple measures of quality, mood, affect, health and quality of life, together with radiographic evaluation and performance-based tasks, modeling four distinct pain outcomes. Multivariate regression models and network analysis were applied to pain related biopsychosocial measures and their changes with surgery. A total of 106 patients completed the study. Pre-surgical pain levels were not related to post-surgical residual pain. Although distinct pain scales were associated with different aspects of post-surgical pain, multi-factorial models did not reliably predict post-surgical pain in knee OA (across four distinct pain scales) and did not generalize to hip OA. However, network analysis showed significant changes in biopsychosocial-defined OA personality post-surgery, in both groups. Our results show that although tested clinical and biopsychosocial variables reorganize after TJR in OA, their presurgical values are not predictive of post-surgery pain. Derivation of prognostic markers for pain persistence after TJR will require more comprehensive understanding of underlying mechanisms.	[Barroso, Joana; Galhardo, Vasco] Univ Porto, Dept Biomed, Fac Med, Porto, Portugal; [Barroso, Joana; Galhardo, Vasco] Univ Porto, Inst Invest & Inovacao Saude I3S, Porto, Portugal; [Barroso, Joana; Wakaizumi, Kenta; Schnitzer, Thomas; Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Barroso, Joana; Reckziegel, Diane; Apkarian, A. Vania] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wakaizumi, Kenta] Shirley Ryan Abil Lab, Chicago, IL USA; [Pinto-Ramos, Joao] Ctr Hosp & Univ Sao Joao, Dept Med Fis & Reabilitacao, Porto, Portugal; [Schnitzer, Thomas] Northwestern Univ, Dept Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Apkarian, AV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Apkarian, AV (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu	Wakaizumi, Kenta/AAM-5030-2021; Ramos, João/GSM-7241-2022	Wakaizumi, Kenta/0000-0003-4884-6251; Apkarian, A. Vania/0000-0002-9788-7458; Monteiro, Joana/0000-0002-7826-5354	CCDRN [Norte-08-5369-FSE-000026]; OARSI Collaborative Scholarship 2018; Luso-American Development Foundation R&D@PhD scholarship grant	CCDRN; OARSI Collaborative Scholarship 2018; Luso-American Development Foundation R&D@PhD scholarship grant	J.B. was funded through CCDRN [Norte-08-5369-FSE-000026], OARSI Collaborative Scholarship 2018 and Luso-American Development Foundation R&D@PhD scholarship grant. This research did not receive other specific funding from agencies in the public or commercial sectors.	Azevedo LF, 2007, DOR, V15, P6; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Baert IAC, 2016, OSTEOARTHR CARTILAGE, V24, P213, DOI 10.1016/j.joca.2015.09.002; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; BALKE B, 1963, Rep Civ Aeromed Res Inst US, P1; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; BYRNE M, 1982, PAIN, V13, P193, DOI 10.1016/0304-3959(82)90029-X; Creamer P, 1999, J RHEUMATOL, V26, P1785; Dabare C, 2017, INT J RHEUM DIS, V20, P1350, DOI 10.1111/1756-185X.13083; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Erlenwein J, 2017, J PAIN RES, V10, P2183, DOI 10.2147/JPR.S137892; Ferreira P L, 2000, Acta Med Port, V13, P55; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Forsythe ME, 2008, PAIN RES MANAG, V13, P335, DOI 10.1155/2008/730951; Goncalves RS, 2009, OSTEOARTHR CARTILAGE, V17, P1156, DOI 10.1016/j.joca.2009.01.009; Harden RN, 2005, J PAIN, V6, P364, DOI 10.1016/j.jpain.2005.01.350; Harmelink KEM, 2017, J ARTHROPLASTY, V32, P3840, DOI 10.1016/j.arth.2017.07.011; Hochman JR, 2011, OSTEOARTHR CARTILAGE, V19, P647, DOI 10.1016/j.joca.2011.03.007; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Kim DH, 2018, J ARTHROPLASTY, V33, P3372, DOI 10.1016/j.arth.2018.07.028; Leung YY, 2019, OSTEOARTHR CARTILAGE, V27, P49, DOI 10.1016/j.joca.2018.09.003; Lewis GN, 2015, BRIT J ANAESTH, V114, P551, DOI 10.1093/bja/aeu441; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Petersen KK, 2016, PAIN, V157, P1400, DOI 10.1097/j.pain.0000000000000531; Petersen KK, 2015, PAIN, V156, P55, DOI 10.1016/j.pain.0000000000000022; Pinto PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073917; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; REJESKI WJ, 1995, OSTEOARTHR CARTILAGE, V3, P157, DOI 10.1016/S1063-4584(05)80050-0; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Singh JA, 2008, CLIN ORTHOP RELAT R, V466, P2717, DOI 10.1007/s11999-008-0399-9; Sullivan M, 2011, PAIN, V152, P2287, DOI 10.1016/j.pain.2011.06.014; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Valdes AM, 2012, SEMIN ARTHRITIS RHEU, V41, P568, DOI 10.1016/j.semarthrit.2011.07.002; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; Werner MU, 2014, BRIT J ANAESTH, V113, P1, DOI 10.1093/bja/aeu012; Wylde V, 2012, MUSCULOSKELET CARE, V10, P110, DOI 10.1002/msc.1008; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuo XN, 2019, NAT HUM BEHAV, V3, P768, DOI 10.1038/s41562-019-0655-x	48	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0222370	10.1371/journal.pone.0222370	http://dx.doi.org/10.1371/journal.pone.0222370			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914126	Green Published, Green Submitted, gold			2022-12-26	WOS:000534337700004
J	de Jesus, JG; Wallau, GD; Maia, ML; Xavier, J; Lima, MAO; Fonseca, V; de Abreu, AS; Tosta, SFD; do Amaral, HR; Lima, IAB; Silva, PV; dos Santos, DC; de Oliveira, AS; de Souza, SC; Falcao, MB; Cerqueira, E; Machado, LC; Sobral, MC; Rezende, TMT; Pereira, MR; Pereira, FM; Maia, ZPG; Franca, RFD; de Abreu, AL; Melo, CFCDE; Faria, NR; da Cunha, RV; Giovanetti, M; Alcantara, LCJ				de Jesus, Jaqueline Goes; Wallau, Gabriel da Luz; Maia, Maricelia Lima; Xavier, Joilson; Oliveira Lima, Maria Aparecida; Fonseca, Vagner; de Abreu, Alvaro Salgado; de Oliveira Tosta, Stephane Fraga; do Amaral, Helineide Ramos; Barbosa Lima, Italo Andrade; Silva, Paloma Viana; dos Santos, Daiana Carlos; de Oliveira, Aline Sousa; de Souza, Siane Campos; Falcao, Melissa Barreto; Cerqueira, Erenilde; Machado, Lais Ceschini; Sobral, Mariana Carolina; Teodoro Rezende, Tatiana Maria; Pereira, Mylena Ribeiro; Pereira, Felicidade Mota; Gusmao Maia, Zuinara Pereira; de Oliveira Franca, Rafael Freitas; de Abreu, Andre Luiz; de Albuquerque e Melo, Carlos Frederico Campelo; Faria, Nuno Rodrigues; da Cunha, Rivaldo Venancio; Giovanetti, Marta; Junior Alcantara, Luiz Carlos			Persistence of chikungunya ECSA genotype and local outbreak in an upper medium class neighborhood in Northeast Brazil	PLOS ONE			English	Article							INDIAN-OCEAN; VIRUS; REEMERGENCE; POPULATION; GENOME; ZIKA	The chikungunya East/Central/South/Africa virus lineage (CHIKV-ECSA) was first detected in Brazil in the municipality of Feira de Santana (FS) by mid 2014. Following that, a large number of CHIKV cases have been notified in FS, which is the second-most populous city in Bahia state, northeastern Brazil, and plays an important role on the spread to other Brazilian states due to climate conditions and the abundance of competent vectors. To better understand CHIKV dynamics in Bahia state, we generated 5 complete genome sequences from a local outbreak raised in Serraria Brasil, a neighbourhood in FS, by next-generation sequencing using Illumina approach. Phylogenetic reconstructions revealed that the new FS genomes belongs to the ECSA genotype and falls within a single strongly supported monophyletic clade that includes other older CHIKV sequences from the same location, suggesting the persistence of the virus during distinct epidemic seasons. We also performed minor variants analysis and found a small number of SNPs per sample (b_29L and e_45SR = 16 SNPs, c_29SR = 29 and d_45PL and f_45FL = 21 SNPs). Out of the 93 SNPs found, 71 are synonymous, 21 are non-synonymous and one generated a stop codon. Although those mutations are not related to the increase of virus replication and/or infectivity, some SNPs were found in non-structural proteins which may have an effect on viral evasion from the mammal immunological system. These findings reinforce the needing of further studies on those variants and of continued genomic surveillance strategies to track viral adaptations and to monitor CHIKV epidemics for improved public health control.	[de Jesus, Jaqueline Goes; Barbosa Lima, Italo Andrade; Silva, Paloma Viana; dos Santos, Daiana Carlos; de Oliveira, Aline Sousa; de Souza, Siane Campos] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil; [Wallau, Gabriel da Luz; Machado, Lais Ceschini; Sobral, Mariana Carolina; Teodoro Rezende, Tatiana Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil; [Maia, Maricelia Lima; Oliveira Lima, Maria Aparecida; do Amaral, Helineide Ramos; Cerqueira, Erenilde] Univ Estadual Feira De Santana, Feira De Santana, BA, Brazil; [Maia, Maricelia Lima; Falcao, Melissa Barreto] Minist Saude, Secretaria Sande Feira De Santana, Feira De Santana, BA, Brazil; [Xavier, Joilson; Fonseca, Vagner; de Abreu, Alvaro Salgado; de Oliveira Tosta, Stephane Fraga; Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil; [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa; [Pereira, Mylena Ribeiro; de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil; [Pereira, Felicidade Mota; Gusmao Maia, Zuinara Pereira] Lab Cent Saude Publ Bahia, Salvador, BA, Brazil; [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Labs Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [de Albuquerque e Melo, Carlos Frederico Campelo] Org Mundial Sande OPAS OMS, Org Pan Amer Saude, Brasilia, DF, Brazil; [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England; [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Clin Medica, Fac Med, Campo Grande, MS, Brazil; [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Estadual de Feira de Santana; Universidade Federal de Minas Gerais; University of Kwazulu Natal; Fundacao Oswaldo Cruz; Pan American Health Organization; University of Oxford; Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Giovanetti, M; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.	giovanetti.marta@gmail.com; luiz.alcantara@ioc.fiocruz.br	Campelo de Albuquerque e Melo, Carlos Frederico/DRM-1247-2022; de Jesus, Jaqueline Goes/ABA-3546-2021; Maia, Zuinara/M-7713-2019; Alcantara, Luiz Carlos Júnior/AAK-9468-2021; Freitas de Oliveira Franca, Rafael/ABB-2376-2021; Fonseca, Vagner/R-5813-2019; Faria, Nuno R/I-2975-2012; Wallau, Gabriel Luz/B-5911-2008; Xavier, Joilson/D-7581-2016	Campelo de Albuquerque e Melo, Carlos Frederico/0000-0003-0581-5535; de Jesus, Jaqueline Goes/0000-0002-5404-272X; Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Fonseca, Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798; Wallau, Gabriel Luz/0000-0002-1419-5713; Xavier, Joilson/0000-0003-3916-2018; Andrade Barbosa Lima, Italo/0000-0002-7113-7579	CNPq [440685/2016-8]; CAPES [88887.130716/2016-00]; Horizon 2020 [PRES-005-FEX-17-4-2-33]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Horizon 2020	This research was funded by CNPq grant number (440685/2016-8); CAPES grant number (88887.130716/2016-00), and by Horizon 2020 (PRES-005-FEX-17-4-2-33) to LCJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; [Anonymous], 2016, B EP MON CAS DENG FE, V47, P7; [Anonymous], 2019, B EP ARB BAH 2019; [Anonymous], 2017, IBGE CID FEIR SANT; Brasil. Ministerio da Saude. OPAS, 2015, OPAS DIV DAD LEV; Brasil. Ministerio da Saude. Secretaria de Vigilacia em Saude, 2017, SECR VIG SAUD SECR A; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370; European Centre for Disease Prevention and Control, 2014, GUID SURV NAT MOSQ E, DOI [10.2900/37227, DOI 10.2900/37227]; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8; Fonseca Vagner, 2019, PLoS Negl Trop Dis, V13, pe0007231, DOI 10.1371/journal.pntd.0007231; Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13; Fu JYL, 2019, J GEN VIROL, V100, P1541, DOI 10.1099/jgv.0.001338; Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630; Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lima MM, 2018, ORG YVANNA CARLA SOU, V2; Ministerio da Saude, 2017, B EP MON CAS DENG FE, V48, P4; Morrison CR, 2016, EMERGING INFECTIONS 10, P143, DOI 10.1128/microbiolspec.EI10-0017-2016; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9; Naveca F. G., 2019, PLoS Neglected Tropical Diseases, V13, pe0007065, DOI 10.1371/journal.pntd.0007065; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Pathak H, 2019, CLIN MED, V19, P381, DOI 10.7861/clinmed.2019-0035; Peres RC, 2013, J VECTOR ECOL, V38, P190, DOI 10.1111/j.1948-7134.2013.12027.x; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091; Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Xavier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217871; Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226098	10.1371/journal.pone.0226098	http://dx.doi.org/10.1371/journal.pone.0226098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914137	Green Published, gold			2022-12-26	WOS:000534337700012
J	McGrath, KC; Li, XH; Twigg, SM; Heather, AK				McGrath, Kristine C.; Li, Xiaohong; Twigg, Stephen M.; Heather, Alison K.			Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOA-I; SYSTEMIC INFLAMMATION; SMALL-INTESTINE; IKK-BETA; HDL; DIET; INHIBITION; METABOLISM; PLASMA	Background Apolipoprotein-AI (apo-AI) is the major apolipoprotein found in high density lipoprotein particles (HDLs). We previously demonstrated that apo-AI injected directly into high-fat diet fed mice improved insulin sensitivity associated with decreased hepatic inflammation. While our data provides compelling proof of concept, apoA-I mimetic peptides are more clinically feasible. The aim of this study was to test whether apo-AI mimetic peptide (D-4F and L-5F) treatment will emulate the effects of full-length apo-AI to improve insulin sensitivity. Methods Male C57BL/6 mice were fed a high-fat diet for 16 weeks before receiving D4F mimetic peptide administered via drinking water or L5F mimetic peptide administered by intraperitoneal injection bi-weekly for a total of five weeks. Glucose tolerance and insulin tolerance tests were conducted to assess the effects of the peptides on insulin resistance. Effects of the peptides on inflammation, gluconeogenic enzymes and lipid synthesis were assessed by real-time PCR of key markers involved in the respective pathways. Results Treatment with apo-AI mimetic peptides D-4F and L-5F showed: (i) improved blood glucose clearance (D-4F 1.40-fold AUC decrease compared to HFD, P<0.05; L-4F 1.17-fold AUC decrease compared to HFD, ns) in the glucose tolerance test; (ii) improved insulin tolerance (D-4F 1.63-fold AUC decrease compared to HFD, P<0.05; L-5F 1.39-fold AUC compared to HFD, P<0.05) in the insulin tolerance test. The metabolic test results were associated with (i) decreased hepatic inflammation of SAA1, IL-1 beta IFN-gamma and TNF alpha (2.61-5.97-fold decrease compared to HFD, P<0.05) for both mimetics; (ii) suppression of hepatic mRNA expression of gluconeogenesis-associated genes (PEPCK and G6Pase; 1.66-3.01-fold decrease compared to HFD, P<0.001) for both mimetics; (iii) lipogenic-associated genes, (SREBP1c and ChREBP; 2.15-3.31-fold decrease compared to HFD, P<0.001) for both mimetics and; (iv) reduced hepatic macrophage infiltration (F4/80 and CD68; 1.77-2.15-fold compared to HFD, P<0.001) for both mimetics. Conclusion Apo-AI mimetic peptides treatment led to improved glucose homeostasis. This effect is associated with reduced expression of inflammatory markers in the liver and reduced infiltration of macrophages, suggesting an overall suppression of hepatic inflammation. We also showed altered expression of genes associated with gluconeogenesis and lipid synthesis, suggesting that glucose and lipid synthesis is suppressed. These findings suggest that apoA-I mimetic peptides could be a new therapeutic option to reduce hepatic inflammation that contributes to the development of overnutrition-induced insulin resistance.	[McGrath, Kristine C.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Li, Xiaohong] Shandong Univ, Hlth Management Ctr, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Twigg, Stephen M.] Univ Sydney, Sydney Med Sch Cent, Fac Med & Hlth, Sydney, NSW, Australia; [Twigg, Stephen M.] Univ Sydney, Charles Perkins Ctr, Fac Med & Hlth, Sydney, NSW, Australia; [Heather, Alison K.] Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Heather, Alison K.] Univ Otago, Heart Otago, Dunedin, New Zealand	University of Technology Sydney; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Sydney; University of Sydney; University of Otago; University of Otago	McGrath, KC (corresponding author), Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia.	kristine.mcgrath@uts.edu.au	McGrath, Kristine C/C-7194-2018	McGrath, Kristine C/0000-0002-6244-3929; Li, Xiao-Hong/0000-0002-3190-469X	University of Technology Sydney Chancellor's Postdoctoral Research Fellowship Scheme; Diabetes of Australia Research Trust	University of Technology Sydney Chancellor's Postdoctoral Research Fellowship Scheme; Diabetes of Australia Research Trust	This work was supported by University of Technology Sydney Chancellor's Postdoctoral Research Fellowship Scheme (author KM) and the Diabetes of Australia Research Trust (authors KM, ST, AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Averill MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109252; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dalla-Riva J, 2013, J LIPID RES, V54, P1275, DOI 10.1194/jlr.M032904; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Garber DW, 2001, J LIPID RES, V42, P545; Getz GS, 2011, J INFLAMM RES, V4, P83, DOI 10.2147/JIR.S12983; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Gowri MS, 1999, ARTERIOSCL THROM VAS, V19, P2226, DOI 10.1161/01.ATV.19.9.2226; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; McGrath KCY, 2009, ARTERIOSCL THROM VAS, V29, P877, DOI 10.1161/ATVBAHA.109.184663; McGrath KC, 2014, J LIPID RES, V55, P421, DOI 10.1194/jlr.M043281; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M., 2015, APOLIPOPROTEIN MIMET, P15; Navab M, 2013, J LIPID RES, V54, P3403, DOI 10.1194/jlr.M042051; Navab M, 2012, ARTERIOSCL THROM VAS, V32, P2553, DOI 10.1161/ATVBAHA.112.300282; Navab M, 2012, J LIPID RES, V53, P437, DOI 10.1194/jlr.M023523; Navab M, 2011, J LIPID RES, V52, P1200, DOI 10.1194/jlr.M013144; Navab M, 2010, ARTERIOSCL THROM VAS, V30, P164, DOI 10.1161/ATVBAHA.109.187518; Peterson SJ, 2008, J LIPID RES, V49, P1658, DOI 10.1194/jlr.M800046-JLR200; Reardon CA, 2012, ATHEROSCLEROSIS, V225, P39, DOI 10.1016/j.atherosclerosis.2012.09.020; Siebel AL, 2013, CIRC RES, V113, P167, DOI 10.1161/CIRCRESAHA.113.300689; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Vaziri ND, 2009, KIDNEY INT, V76, P437, DOI 10.1038/ki.2009.177; Williams KJ, 2012, ATHEROSCLEROSIS, V225, P36, DOI 10.1016/j.atherosclerosis.2012.06.023; Zhang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023556	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226931	10.1371/journal.pone.0226931	http://dx.doi.org/10.1371/journal.pone.0226931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914125	gold, Green Published			2022-12-26	WOS:000534337700021
J	Jiang, C; Wang, YL; Hu, QF; Shou, JX; Zhu, L; Tian, N; Sun, L; Luo, H; Zuo, FF; Li, FF; Wang, YY; Zhang, J; Wang, JR; Wang, J; Zhang, JW				Jiang, Chao; Wang, Yali; Hu, Qiangfu; Shou, Jixin; Zhu, Li; Tian, Ning; Sun, Lu; Luo, Huan; Zuo, Fangfang; Li, Fangfang; Wang, Yingying; Zhang, Jing; Wang, Jiarui; Wang, Jian; Zhang, Jiewen			Immune changes in peripheral blood and hematoma of patients with intracerebral hemorrhage	FASEB JOURNAL			English	Article						hematoma; immune changes; intracerebral hemorrhage; outcome; patients	REGULATORY T-CELLS; MINIMALLY INVASIVE SURGERY; TUFTSIN FRAGMENT 1-3; INFLAMMATORY RESPONSE; MICROGLIA/MACROPHAGE POLARIZATION; CEREBRAL-ISCHEMIA; LYMPHOCYTE RATIO; HUMAN MICROGLIA; M1 PHENOTYPE; BRAIN-INJURY	Immunologic changes in the hematoma of patients with intracerebral hemorrhage (ICH) and the contribution of these changes to prognosis are unknown. We collected the blood samples and hematoma fluid from 35 patients with acute ICH (<30 hours from symptom onset) and 55 age-matched healthy controls. Using flow cytometry and ELISA, we found that the percentages of granulocytes, regulatory T cells, helper T (Th) 17 cells, and dendritic cells were higher in the peripheral blood of patients with ICH than in healthy controls, whereas the percentages of lymphocytes, M1-like macrophages, and M2-like macrophages were lower. Levels of IL-6, IL-17, IL-23, TNF-alpha, IL-4, IL-10, and TGF-beta were higher in the peripheral blood of patients with ICH. The absolute counts of white blood cells, lymphocytes, monocytes, and granulocytes in the hematoma tended to be greater at 12-30 hours than they were within 12 hours after ICH, but the percentage of Th cells decreased in peripheral blood. Increased levels of IL-10 in the serum and hematoma, and a reduction in M1-like macrophages in hematoma were independently associated with favorable outcome on day 90. These results indicate that immunocytes present in the hematoma may participate in the acute-phase inflammatory response after ICH.	[Jiang, Chao; Wang, Yali; Zhu, Li; Tian, Ning; Sun, Lu; Luo, Huan; Zuo, Fangfang; Li, Fangfang; Wang, Yingying; Zhang, Jing] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Hu, Qiangfu] Zhengzhou Univ, Affiliated Hosp 5, Dept Anesthesiol, Zhengzhou, Peoples R China; [Shou, Jixin] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurosurg, Zhengzhou, Peoples R China; [Wang, Jiarui] Winston Churchill High Sch, Potomac, MD USA; [Wang, Jian] Zhengzhou Univ, Dept Anat, Coll Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Jiewen] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450000, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Jiang, C (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.; Zhang, JW (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450000, Peoples R China.	chaojzzu@126.com; zhangjiewen9900@126.com	Wang, Jian/I-4874-2019; Zhang, Jiewen/GSE-5744-2022	Wang, Jian/0000-0003-2291-640X; 	National Natural Science Foundation of China [81301006, 81671165]; Excellent Youth Foundation of Henan Scientific Committee [2018JQ0016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Henan Scientific Committee	National Natural Science Foundation of China, Grant/Award Number: 81301006 and 81671165; Excellent Youth Foundation of Henan Scientific Committee, Grant/Award Number: 2018JQ0016	Adachi T, 2017, CEREBROVASC DIS EXTR, V7, P62, DOI 10.1159/000462985; Adeoye O, 2014, J STROKE CEREBROVASC, V23, pE107, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.006; Allam JP, 2011, J CLIN PERIODONTOL, V38, P879, DOI 10.1111/j.1600-051X.2011.01752.x; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Askenase MH, 2016, SEMIN NEUROL, V36, P288, DOI 10.1055/s-0036-1582132; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Benarafa C, 2017, BIOCHEM BIOPH RES CO, V482, P473, DOI 10.1016/j.bbrc.2016.11.086; Bramer D, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-9; Cai YY, 2015, EXP NEUROL, V266, P120, DOI 10.1016/j.expneurol.2015.02.013; Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Dieterlen MT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5946807; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Fam MD, 2017, NEUROLOGY, V89, P1553, DOI 10.1212/WNL.0000000000004493; Feigin VL., 2013, NEUROEPIDEMIOLOGY, V45, P161, DOI DOI 10.1159/000441085; Fiorella D, 2016, STROKE, V47, P1399, DOI 10.1161/STROKEAHA.115.011415; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Gelderblom M, 2012, J CEREBR BLOOD F MET, V32, P835, DOI 10.1038/jcbfm.2011.189; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; Han ZP, 2018, AGING DIS, V9, P235, DOI 10.14336/AD.2017.0328; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; Hu YH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/813045; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jiang C, 2017, ONCOTARGET, V8, P3553, DOI 10.18632/oncotarget.12201; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Koyasu S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00101; Kramer AH, 2015, J CEREBR BLOOD F MET, V35, P1241, DOI 10.1038/jcbfm.2015.47; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; Lan X, 2019, J CEREBR BLOOD F MET, V39, P184, DOI 10.1177/0271678X18805675; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Liang QJ, 2015, IUBMB LIFE, V67, P710, DOI 10.1002/iub.1429; Liotta EM, 2017, NEUROLOGY, V89, P813, DOI [10.1212/WNL.0000000000004249, 10.1212/wnl.0000000000004249]; Liu W, 2016, NEUROSCI LETT, V620, P74, DOI 10.1016/j.neulet.2016.03.047; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Lutz MB, 2016, IMMUNE NETW, V16, P13, DOI 10.4110/in.2016.16.1.13; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; Na SY, 2015, STROKE, V46, P212, DOI 10.1161/STROKEAHA.114.007756; Ohlsson SM, 2014, CLIN IMMUNOL, V152, P10, DOI 10.1016/j.clim.2014.02.016; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Sembill JA, 2017, NEUROLOGY, V89, P423, DOI 10.1212/WNL.0000000000004174; Subramanian S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1187-7; Szulzewsky F, 2018, NEURO-ONCOLOGY, V20, P355, DOI 10.1093/neuonc/nox165; Tapia-Perez JH, 2016, CLIN NEUROL NEUROSUR, V150, P72, DOI 10.1016/j.clineuro.2016.07.010; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Venema E, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1710; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Wilson D, 2016, NEUROLOGY, V86, P360, DOI 10.1212/WNL.0000000000002310; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Yang Z, 2014, INT IMMUNOPHARMACOL, V22, P522, DOI 10.1016/j.intimp.2014.06.037; Yin YT, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0993-4; Yu S, 2016, J NEUROL SCI, V361, P112, DOI 10.1016/j.jns.2015.12.033; Zernecke A, 2015, ARTERIOSCL THROM VAS, V35, P763, DOI 10.1161/ATVBAHA.114.303566; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; Zheng Y, 2015, NEUROSCIENCE, V290, P321, DOI 10.1016/j.neuroscience.2015.01.041; Zhou K, 2017, J CEREBR BLOOD F MET, V37, P967, DOI 10.1177/0271678X16648712; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; Zhu HM, 2019, PROG NEUROBIOL, V178, P6, DOI 10.1016/j.pneurobio.2019.03.003	91	20	21	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2774	2791		10.1096/fj.201902478R	http://dx.doi.org/10.1096/fj.201902478R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912591				2022-12-26	WOS:000506146800001
J	Liu, XD; Zhang, Y; Wu, MH; Ma, ZG; Cao, H				Liu, Xindan; Zhang, Ying; Wu, Menghua; Ma, Zhiguo; Cao, Hui			Color discrimination and gas chromatography-mass spectrometry fingerprint based on chemometrics analysis for the quality evaluation of Schizonepetae Spica	PLOS ONE			English	Article							TENUIFOLIA BRIQUET; VOLATILE OIL; MENTHOFURAN	Schizonepetae Spica (SS), the dried spike of Schizonepeta tenuifolia Briq., is a traditional Chinese medicinal herb. According to the color of persistent calyx, SS is categorized into two classes: the yellowish-green-type and the brownish-type. Based on the chemometrics analysis of gas chromatography-mass spectrometry (GC-MS), a novel model of identifying and evaluating the quality of SS in different colors was constructed for the first time in this work. 20 batches SS samples of different colors were collected and used to extract essential oils. The average essential oils yield of SS in yellowish-green color was significantly higher than that of SS in brownish color from the same origin (p< 0.05). The GC-MS fingerprints of 20 batches SS samples whose correlation coefficients were over 0.964 demonstrated SS samples were consistent to some extent in spite of slightly different chemical indexes. A total of 39 common volatiles compounds were identified. Hierarchical clustering analysis (HCA), principal component analysis (PCA) and partial least-squares discriminate analysis (PLS-DA) were developed to distinguish SS samples characterized by different colors. Consistent results were obtained to show that SS samples could be successfully grouped according to their color. Finally, 4,5,6,7-tetrahydro-3,6-dimethyl-benzofuran and pulegone were detected as the key variables for discriminating SS samples of different colors and for quality control. The obtained results proved that SS of good quality were often yellowishgreen and those of poor quality were often brownish.	[Liu, Xindan; Zhang, Ying; Wu, Menghua; Ma, Zhiguo; Cao, Hui] Jinan Univ, Coll Pharm, Res Ctr Tradit Chinese Med Lingnan, Guangzhou, Peoples R China	Jinan University	Cao, H (corresponding author), Jinan Univ, Coll Pharm, Res Ctr Tradit Chinese Med Lingnan, Guangzhou, Peoples R China.	kovhuicao@aliyun.com		Liu, Xindan/0000-0003-0259-0502	sixth batch of National Academic Experience Inheritance Project of Chinese Medicine Experts [176-2017-XMZC-0166-01]	sixth batch of National Academic Experience Inheritance Project of Chinese Medicine Experts	This work was supported by the sixth batch of National Academic Experience Inheritance Project of Chinese Medicine Experts (No. 176-2017-XMZC-0166-01).	Bertea CM, 2001, ARCH BIOCHEM BIOPHYS, V390, P279, DOI 10.1006/abbi.2001.2378; Chen SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01110-x; Chen Y, 2014, REV BRAS FARMACOGN, V24, P626, DOI 10.1016/j.bjp.2014.11.001; Chun MH, 2011, MICROCHEM J, V97, P274, DOI 10.1016/j.microc.2010.09.015; Chun MH, 2010, MICROCHEM J, V95, P25, DOI 10.1016/j.microc.2009.09.009; Oliveira GLD, 2018, REGUL TOXICOL PHARM, V92, P338, DOI 10.1016/j.yrtph.2017.12.013; Du C.Z., 2014, HUBEI AGR SCI, V53, P188; [段松冷 Duan Songleng], 2015, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V21, P50; Fan Jia-Xin, 2017, Zhongguo Zhong Yao Za Zhi, V42, P1717, DOI 10.19540/j.cnki.cjcmm.20170224.004; Fan Jia-xin, 2017, Yaoxue Xuebao, V52, P126, DOI 10.16438/j.0513-4870.2016-0466; Fung D, 2002, J CLIN PHARMACOL, V42, P30, DOI 10.1177/0091270002042001003; He Ting, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1772; [胡峻 Hu Jun], 2005, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V28, P52; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; [蒋以号 Jiang Yihao], 2016, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V31, P1068; Lassila T, 2016, RAPID COMMUN MASS SP, V30, P917, DOI 10.1002/rcm.7518; Li ZL, 2011, BEN CAO YUAN SHI; Liu CC, 2018, PHYTOCHEMISTRY, V150, P23, DOI 10.1016/j.phytochem.2018.02.018; Liu QT, 2016, J SEP SCI, V39, P2517, DOI 10.1002/jssc.201501275; Liu Yu-ping, 2002, Yaoxue Xuebao, V37, P304; Lv SD, 2015, FOOD ANAL METHOD, V8, P321, DOI 10.1007/s12161-014-9900-0; Ng YC, 2018, J MICROBIOL, V56, P683, DOI 10.1007/s12275-018-8228-7; Ouyang Zhen, 2007, Yaoxue Xuebao, V42, P968; Shan MQ, 2016, J ETHNOPHARMACOL, V194, P580, DOI 10.1016/j.jep.2016.10.045; [石典花 Shi Dianhua], 2018, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V24, P6; State Administration of Traditional Chinese Medicine, 1999, DICT CHIN TRAD MED, P197; State Commission of Chinese Pharmacopoeia, 2015, PHARM PEOPL REP CHIN; Su XJ., 2000, CHIN WILD PLANT RESO, V19, P24; Wang BS, 2012, FOOD CHEM TOXICOL, V50, P526, DOI 10.1016/j.fct.2011.12.010; Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037647, 10.1371/journal.pone.0030209, 10.1371/journal.pone.0047127, 10.1371/journal.pone.0051808]; [王旗 WANG Qi], 2007, [中成药, Chinese Traditional Patent Medicine], V29, P941; Wang Y, 2016, FLAVOUR FRAGRANCE CO, P53; YAMAHARA J, 1980, YAKUGAKU ZASSHI, V100, P713, DOI 10.1248/yakushi1947.100.7_713; Ye DJ, 2005, DICT CHINESE MED PRO, P411; Yu S, 2011, INT J MOL SCI, V12, P6635, DOI 10.3390/ijms12106635; [张丽 Zhang Li], 2012, [中草药, Chinese Traditional and Herbal Drugs], V43, P1767; Zhao ZZ, 2011, J ETHNOPHARMACOL, V134, P556, DOI 10.1016/j.jep.2011.01.018	37	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227235	10.1371/journal.pone.0227235	http://dx.doi.org/10.1371/journal.pone.0227235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910241	Green Published, gold			2022-12-26	WOS:000534333800033
J	Onsorodi, AHH; Korhan, O				Onsorodi, Amir Hosein Habibi; Korhan, Orhan			Application of a genetic algorithm to the keyboard layout problem	PLOS ONE			English	Article							DESIGN	The number of people who use computers for business and personal purposes increases as technology grows. The application of ergonomic practices on computer workstations reduces the musculoskeletal discomfort experienced and increases the overall satisfaction of the users. Keyboards are available in various systems, from computers to mobile devices, and have difference shapes and sizes. The keyboard size and shape is known to influence the user's upper extremities. Alternative keyboard designs help diminish the pain in the arms that occurs due to awkward arm postures. Most previous studies tried to optimize the keyboard layout based on ergonomic typing and the frequency of letters' co-occurrence. This research considers the frequency of the appearance of the most used 3,000 words in the English language. First, the frequency of each letter pair is calculated by the Text Analyzer. Then, a genetic algorithm is applied to design an ergonomically optimized keyboard to minimize the total distance of finger travel among the selected alphanumeric characters. The results showed that the distance travelled obtained by the proposed keyboard layout is less than that for the QWERTY keyboard in all different types of texts, in which an average of 6.04% improvement was achieved. Therefore, the proposed design can be used for keyboards to reduce time and fatigue.	[Onsorodi, Amir Hosein Habibi; Korhan, Orhan] Eastern Mediterranean Univ, Dept Ind Engn, Famagusta, North Cyprus, Turkey	Eastern Mediterranean University	Korhan, O (corresponding author), Eastern Mediterranean Univ, Dept Ind Engn, Famagusta, North Cyprus, Turkey.	orhan.korhan@emu.edu.tr	Korhan, Orhan/B-6800-2013	Korhan, Orhan/0000-0002-9388-8605				Bi XJ, 2012, HUM-COMPUT INTERACT, V27, P352, DOI 10.1080/07370024.2012.678241; Capobianco G, 1999, P HUM FACT ERG SOC 4; Eggers J, 2003, EUR J OPER RES, V148, P672, DOI 10.1016/S0377-2217(02)00489-7; Gerard MJ, 1999, AM IND HYG ASSOC J, V60, P762; Iseri A, 2015, INT J IND ERGONOM, V48, P127, DOI 10.1016/j.ergon.2015.04.006; Karrenbauer A., 2014, P 27 ANN ACM S US IN, P621, DOI [10.1145/2642918.2647382, DOI 10.1145/2642918.2647382]; Korhan O, 2010, SAFETY SCI, V48, P868, DOI 10.1016/j.ssci.2010.03.010; Liao C, 2013, INT J HUM-COMPUT INT, V29, P391, DOI 10.1080/10447318.2013.777827; MacKenzie IS, 1999, BEHAV INFORM TECHNOL, V18, P235, DOI 10.1080/014492999118995; Murali G., 2016, INT J SCI ENG RES, V7, P102; Wagner MO, 2010, ENG DESIGN, V14, P187; Yang N, 2016, PROC INT C TOOLS ART, P165, DOI [10.1109/ICTAI.2016.0034, 10.1109/ICTAI.2016.31]	12	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226611	10.1371/journal.pone.0226611	http://dx.doi.org/10.1371/journal.pone.0226611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KQ9WD	31910214	Green Published, gold			2022-12-26	WOS:000517271400001
J	Perrier, A; Boelle, PY; Chretien, Y; Gligorov, J; Lotz, JP; Brault, D; Comperat, E; Lefevre, G; Boissan, M				Perrier, Alexandre; Boelle, Pierre-Yves; Chretien, Yves; Gligorov, Joseph; Lotz, Jean-Pierre; Brault, Didier; Comperat, Eva; Lefevre, Guillaume; Boissan, Mathieu			An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies	PLOS ONE			English	Article							HER2 EXTRACELLULAR DOMAIN; IN-SITU HYBRIDIZATION; CLINICAL UTILITY; CA 15-3; AMERICAN SOCIETY; CHEMOTHERAPY; HER-2/NEU; SURVIVAL; PROGRESSION; ONCOLOGY	Background The transmembrane receptor tyrosine kinase HER2 is overexpressed in approximately 15% of breast tumors and correlates with poor clinical prognosis. Several treatments that target HER2 are approved for treatment of HER2-positive metastatic breast cancer. The serum biomarkers most widely used to monitor anti-HER2 therapies in patients with HER2-positive metastatic breast cancer currently are CA15.3 and CEA. Nevertheless, their clinical utility in patients with breast cancer remains a subject of discussion and controversy; thus, additional markers may prove useful in monitoring the therapeutic responses of these patients. The extracellular domain of HER2 can be shed by proteolytic cleavage into the circulation and this shed form, sHER2, is reported to be augmented during metastasis of HER2-positive breast tumors. Here, we studied the clinical usefulness of sHER2, CA15.3, and CEA for monitoring treatment for breast cancer. Methods We measured prospectively pretreatment and post-treatment serum levels (day 1, 30, 60 and 90) of these three biomarkers in 47 HER2-positive, metastatic breast cancer patients treated with trastuzumab in combination with paclitaxel. Evaluation of the disease was performed according to the Response Evaluation Criteria in Solid Tumor (RECIST) at day 90. Results Patients with progressive disease at day 90 had smaller relative changes between day 1 and day 30 than those with complete, partial or stable responses at day 90: -9% versus -38% for sHER2 (P = 0.02), +23% versus -17% for CA15.3 (P = 0.005) and +29% versus -26% for CEA (P = 0.02). Patients with progressive disease at day 90 were less likely than the other patients to have a relative decrease of > 20% in their biomarker levels at day 30: 6% vs 33% for sHER2 (P = 0.03), 0% vs 27% for CA15.3 (P = 0.03), 4% vs 29% for CEA (P = 0.04). No patient with progressive disease at day 90 had > 20% reduction of the average combined biomarker levels at day 30 whereas 63% of the other patients had (P = 0.003). Moreover, when we analyzed a > 10% reduction of the average biomarker levels no patient with progressive disease at day 90 had a decrease > 10% at day 30 whereas 78% of other patients had (P<0.001, Se = 100%, Sp = 78%). Conclusion We show that regular measurement of sHER2, CA15.3, and CEA levels is useful for predicting the therapeutic response and for monitoring HER2-targeted therapy in patients with HER2-positive metastatic breast cancer. The average decrease of the three biomarkers with a threshold of > 10% appears to be the best parameter to distinguish patients who go on to have progressive disease from those who will have a complete, partial or stable response.	[Perrier, Alexandre; Brault, Didier; Lefevre, Guillaume; Boissan, Mathieu] Grp Hosp Est Parisien, Hop Tenon, AP HP, Lab Biochim & Hormonol, Paris, France; [Boelle, Pierre-Yves] Sorbonne Univ, Hop St Antoine, AP HP, INSERM,Inst Pierre Louis Epidemiol & Sante Publ I, Paris, France; [Chretien, Yves; Boissan, Mathieu] Sorbonne Univ, INSERM, Ctr Rech St Antoine, Paris, France; [Gligorov, Joseph; Lotz, Jean-Pierre] Sorbonne Univ, AP HP, Inst Univ Cancerol, Serv Oncol Med, Paris, France; [Comperat, Eva] Grp Hosp Est Parisien, Hop Tenon, AP HP, Dept Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Boissan, M (corresponding author), Grp Hosp Est Parisien, Hop Tenon, AP HP, Lab Biochim & Hormonol, Paris, France.; Boissan, M (corresponding author), Sorbonne Univ, INSERM, Ctr Rech St Antoine, Paris, France.	mathieu.boissan@inserm.fr						Ali SM, 2009, J CLIN ONCOL, V27, pe273, DOI 10.1200/JCO.2009.23.4674; Carney Walter P, 2013, Biomark Cancer, V5, P31, DOI 10.4137/BIC.S12389; Christianson TA, 1998, CANCER RES, V58, P5123; Di Gioia D, 2015, CLIN CHIM ACTA, V440, P16, DOI 10.1016/j.cca.2014.11.001; Di Gioia D, 2011, TUMOR BIOL, V32, P777, DOI 10.1007/s13277-011-0180-7; DIXON AR, 1993, BRIT J CANCER, V68, P181, DOI 10.1038/bjc.1993.310; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Esteva FJ, 2005, BREAST CANCER RES, V7, pR436, DOI 10.1186/bcr1020; FLEISHER M, 1984, CLIN CHEM, V30, P200; Fornier MN, 2005, ANN ONCOL, V16, P234, DOI 10.1093/annonc/mdi059; HAYES DF, 1986, J CLIN ONCOL, V4, P1542, DOI 10.1200/JCO.1986.4.10.1542; Hilkens J., 1984, Protides of the Biological Fluids, V31, P1013; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kurebayashi Junichi, 2004, Breast Cancer, V11, P389, DOI 10.1007/BF02968047; Lam L, 2012, BBA-REV CANCER, V1826, P199, DOI 10.1016/j.bbcan.2012.03.012; Leary AF, 2009, J CLIN ONCOL, V27, P1694, DOI 10.1200/JCO.2008.17.3989; Lee CK, 2016, J CLIN ONCOL, V34, P936, DOI 10.1200/JCO.2015.62.4767; Lee HJ, 2014, AM J CLIN PATHOL, V142, P755, DOI 10.1309/AJCPIRL4GUVGK3YX; Lee JS, 2013, ANN ONCOL, V24, P1225, DOI 10.1093/annonc/mds604; Lennon S, 2009, J CLIN ONCOL, V27, P1685, DOI 10.1200/JCO.2008.16.8351; Leyland-Jones B, 2011, LANCET ONCOL, V12, P286, DOI 10.1016/S1470-2045(10)70297-7; Luftner D, 2004, INT J BIOL MARKER, V19, P175; Mariani L, 2009, BIOMARKERS, V14, P130, DOI 10.1080/13547500902770090; Molina R, 2010, CLIN CHEM, V56, P1148, DOI 10.1373/clinchem.2009.135566; Moreno-Aspitia A, 2013, CANCER-AM CANCER SOC, V119, P2675, DOI 10.1002/cncr.28130; Park BW, 2008, ANN ONCOL, V19, P675, DOI 10.1093/annonc/mdm538; Payne RC, 2000, CLIN CHEM, V46, P175; Pedersen AC, 2013, CLIN CHEM LAB MED, V51, P1511, DOI 10.1515/cclm-2012-0488; Perrier A, 2018, LAB INVEST, V98, P696, DOI 10.1038/s41374-018-0033-8; Reix N, 2016, BREAST CANCER RES TR, V160, P249, DOI 10.1007/s10549-016-4000-z; Robertson JFR, 1999, EUR J CANCER, V35, P47, DOI 10.1016/S0959-8049(98)00297-4; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sandri MT, 2004, ANTICANCER RES, V24, P1261; Shah MV, 2016, J CLIN ONCOL, V34, P3502, DOI 10.1200/JCO.2015.61.8983; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stieber P, 2015, CLIN CHIM ACTA, V448, P228, DOI 10.1016/j.cca.2015.06.022; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; TAYLOR-PAPADIMITRIOU J-T, 1988, Cancer Reviews, V11-12, P11; Tchou J, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1015-6; TOBIAS R, 1985, CLIN CHEM, V31, P986; Tse C, 2012, CANCER TREAT REV, V38, P133, DOI 10.1016/j.ctrv.2011.03.008; Van Poznak C, 2015, J CLIN ONCOL, V33, P2695, DOI 10.1200/JCO.2015.61.1459; Wang T, 2016, CLIN CHIM ACTA, V458, P23, DOI 10.1016/j.cca.2016.04.025; Wu SG, 2016, J CANCER, V7, P37, DOI 10.7150/jca.13090; Yang Y, 2017, ONCOL LETT, V14, P7549, DOI 10.3892/ol.2017.7164	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227356	10.1371/journal.pone.0227356	http://dx.doi.org/10.1371/journal.pone.0227356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910438	Green Published, gold			2022-12-26	WOS:000534333800043
J	Wang, JL; Bai, MJ; Elsheikha, HM; Liang, QL; Li, TT; Cao, XZ; Zhu, XQ				Wang, Jin-Lei; Bai, Meng-Jie; Elsheikha, Hany M.; Liang, Qin-Li; Li, Ting-Ting; Cao, Xue-Zhen; Zhu, Xing-Quan			Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection	FASEB JOURNAL			English	Article						dense granule protein 12; immunity-related GTPases; intravacuolar network; rhoptry protein 18; Toxoplasma gondii; virulence	PARASITOPHOROUS VACUOLE; ACUTE VIRULENCE; INTRAVACUOLAR NETWORK; NANOTUBULAR NETWORK; HOST; KINASES; VESICLES; IMMUNITY; GTPASES; PLAYS	Dense granule protein 12 (GRA12) is implicated in a range of processes related to the establishment of Toxoplasma gondii infection, such as the formation of the intravacuolar network (IVN) within the parasitophorous vacuole (PV). This protein is also thought to be important for T. gondii-host interaction, pathogenesis, and immune evasion, but their exact roles remain unknown. In this study, the contributions of GRA12 to the molecular pathogenesis of T. gondii infection were examined in vitro and in vivo. Deletion of GRA12 in type I RH and type II Pru T. gondii strains did not affect the parasite growth and replication in vitro, however, it caused a significant reduction in the parasite virulence and tissue cyst burden in vivo. T. gondii Delta gra12 mutants were more vulnerable to be eliminated by host immunity, without the accumulation of immunity-related GTPase a6 (Irga6) onto the PV membrane. The ultrastructure of IVN in Delta gra12 mutants appeared normal, suggesting that GRA12 is not required for biogenesis of the IVN. Combined deletion of GRA12 and ROP18 induced more severe attenuation of virulence compared to single Delta gra12 or Delta rop18 mutant strains. These data suggest a functional association between GRA12 and ROP18 that is revealed by the severe attenuation of virulence in a double mutant relative to the single individual mutations. Future studies are needed to define the molecular basis of this putative association. Collectively these findings indicate that although GRA12 is not essential for the parasite growth and replication in vitro, it contributes to the virulence and growth of T. gondii in mice.	[Wang, Jin-Lei; Bai, Meng-Jie; Liang, Qin-Li; Li, Ting-Ting; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Cao, Xue-Zhen] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Nottingham; South China Agricultural University	Wang, JL; Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.	wangjinlei90@126.com; xingquanzhu1@hotmail.com	Elsheikha, Hany/G-7573-2011; ZOU, Fengcai/ABE-4598-2021	ZOU, Fengcai/0000-0002-9613-3734	National Natural Science Foundation of China [31802180]; International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program [17JR7WA031]; Agricultural Science and Technology Innovation Program (ASTIP) [CAAS-ASTIP-2016-LVRI-03]; Elite Program of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2016-LVRI-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program; Agricultural Science and Technology Innovation Program (ASTIP); Elite Program of Chinese Academy of Agricultural Sciences	This study was supported by the National Natural Science Foundation of China, Grant/Award Number: 31802180; the International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program, Grant/Award Number: 17JR7WA031; the Elite Program of Chinese Academy of Agricultural Sciences, and the Agricultural Science and Technology Innovation Program (ASTIP), Grant/Award Number: CAAS-ASTIP-2016-LVRI-03	Adjogble KDZ, 2004, INT J PARASITOL, V34, P1255, DOI 10.1016/j.ijpara.2004.07.011; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Bai MJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00300; Behnke MS, 2016, ANNU REV MICROBIOL, V70, P63, DOI 10.1146/annurev-micro-091014-104353; Beraki T, 2019, P NATL ACAD SCI USA, V116, P6361, DOI 10.1073/pnas.1816161116; Blader IJ, 2015, ANNU REV MICROBIOL, V69, P463, DOI 10.1146/annurev-micro-091014-104100; Bohne W, 1997, MOL BIOCHEM PARASIT, V88, P115, DOI 10.1016/S0166-6851(97)00087-X; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Clough B, 2017, TRENDS PARASITOL, V33, P473, DOI 10.1016/j.pt.2017.02.007; Dou ZC, 2014, MBIO, V5, DOI 10.1128/mBio.01188-14; Dubois DJ, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13018; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Fox BA, 2019, MBIO, V10, DOI 10.1128/mBio.00589-19; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Hakimi MA, 2017, CLIN MICROBIOL REV, V30, P615, DOI 10.1128/CMR.00005-17; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Han B, 2019, MBIO, V10, DOI 10.1128/mBio.01944-19; He H, 2018, ELIFE, V7, DOI 10.7554/eLife.39887; Hermanns T, 2016, CELL MICROBIOL, V18, P244, DOI 10.1111/cmi.12499; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Krishnamurthy S, 2016, MBIO, V7, DOI [10.1128/mBio.00754-16, 10.1128/mbio.00754-16]; Labruyere E, 1999, MOL BIOCHEM PARASIT, V102, P311, DOI 10.1016/S0166-6851(99)00092-4; Lei T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099744; Lopez J, 2015, CELL REP, V13, P2273, DOI 10.1016/j.celrep.2015.11.001; Magno RC, 2005, MICROSC RES TECHNIQ, V67, P45, DOI 10.1002/jemt.20182; Mercier C, 1998, INFECT IMMUN, V66, P4176; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Michelin A, 2009, INT J PARASITOL, V39, P299, DOI 10.1016/j.ijpara.2008.07.011; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nadipuram SM, 2016, MBIO, V7, DOI 10.1128/mBio.00808-16; Pan M, 2019, J PROTEOME RES, V18, P319, DOI 10.1021/acs.jproteome.8b00626; Paredes-Santos T, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00321; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Rommereim LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159306; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JP, 2017, CURR OPIN MICROBIOL, V40, P72, DOI 10.1016/j.mib.2017.10.021; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Travier L, 2008, INT J PARASITOL, V38, P757, DOI 10.1016/j.ijpara.2007.10.010; Wang JL, 2018, J INFECT DIS, V218, P768, DOI 10.1093/infdis/jiy211; Wang Jin-Lei, 2017, Front Microbiol, V8, P84, DOI 10.3389/fmicb.2017.00084; Wang JL, 2016, PARASITOL RES, V115, P697, DOI 10.1007/s00436-015-4791-6; Xia NB, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12794; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Young J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11855-w	55	17	18	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3165	3178		10.1096/fj.201901416RR	http://dx.doi.org/10.1096/fj.201901416RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908049	Green Submitted, Bronze			2022-12-26	WOS:000505939800001
J	Han, XY; Na, T; Wu, TT; Yuan, BZ				Han, Xiaoyan; Na, Tao; Wu, Tingting; Yuan, Bao-Zhu			Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells	PLOS ONE			English	Article							IN-VITRO TOXICITY; STROMAL CELLS; INTERNATIONAL-SOCIETY; TRANSITION	BEAS-2B was originally established as an immortalized but non-tumorigenic epithelial cell line from human bronchial epithelium. Because of general recognition for its bronchial epithelial origin, the BEAS-2B cell line has been widely used as an in vitro cell model in a large variety of studies associated with respiratory diseases including lung carcinogenesis. However, very few studies have discussed non-epithelial features of BEAS-2B cells, especially the features associated with mesenchymal stem cells (MSCs), which represent a group of fibroblast-like cells with limited self-renewal and differentiation potential to various cell lineages. In this study, we compared BEAS-2B with a human umbilical cord-derived MSCs (hMSCs) cell line, hMSC1, which served as a representative of hMSCs in terms of expressing common features of hMSCs. It was observed that both BEAS-2B and hMSC1 shared the same expression profile of surface markers of hMSCs and exhibited similar osteogenic and adipogenic differentiation potential. In addition, like hMSC1, the BEAS-2B cell line exhibited suppressive activities on proliferation of mitogen-activated total T lymphocytes as well as Th1 lymphocytes, and IFN gamma-induced expression of IDO1, all thus demonstrating that BEAS-2B cells exhibited an almost identical characteristic profile with hMSCs, even though, there was a clear difference between BEAS-2B and hMSCs in the effects on type 2 macrophage polarization. Most importantly, the hMSCs features of BEAS-2B were unlikely a consequence of epithelial-mesenchymal transition. Therefore, this study provided a set of evidence to provoke reconsideration of epithelial origin of BEAS-2B.	[Han, Xiaoyan; Na, Tao; Wu, Tingting; Yuan, Bao-Zhu] Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Yuan, BZ (corresponding author), Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing, Peoples R China.	yuanbaozhu@nifdc.org.cn	han, xiao/HDN-9782-2022		Nation's Key Strategic Research Program [2016YFA0101501]	Nation's Key Strategic Research Program	This work was supported by the Nation's Key Strategic Research Program (2016YFA0101501).	Batsali AK, 2013, CURR STEM CELL RES T, V8, P144; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Brown C, 2019, J TISSUE ENG REGEN M, V13, P1738, DOI 10.1002/term.2914; Cabrera-Benitez NE, 2012, CRIT CARE MED, V40, P510, DOI 10.1097/CCM.0b013e31822f09d7; Can A, 2017, CYTOTHERAPY, V19, P1351, DOI 10.1016/j.jcyt.2017.08.004; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El Agha E, 2017, CELL STEM CELL, V21, P166, DOI 10.1016/j.stem.2017.07.011; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Galipeau J, 2016, CYTOTHERAPY, V18, P151, DOI 10.1016/j.jcyt.2015.11.008; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gornostaeva A, 2016, CYTOTECHNOLOGY, V68, P565, DOI 10.1007/s10616-015-9906-5; Ha MH, 2007, CHEMOSPHERE, V70, P20, DOI 10.1016/j.chemosphere.2007.07.055; Itoigawa Y, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0207-5; Jiao DL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02085-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Matsuno K, 2018, EXP LUNG RES, V44, P332, DOI 10.1080/01902148.2018.1522558; Na T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118168; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Park YH, 2015, TOXICOL APPL PHARM, V287, P240, DOI 10.1016/j.taap.2015.06.008; Pattarayan D, 2018, J CELL PHYSIOL, V233, P2513, DOI 10.1002/jcp.26127; REDDEL RR, 1988, CANCER RES, V48, P1904; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Sato R, 2016, STEM CELLS, V34, P1997, DOI 10.1002/stem.2406; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Vallabani NVS, 2011, J BIOMED NANOTECHNOL, V7, P106, DOI 10.1166/jbn.2011.1224; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vergaro V, 2016, TOXICOL IN VITRO, V34, P171, DOI 10.1016/j.tiv.2016.04.003; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Yuan BZ, 2015, TISSUE ENG PT A, V21, P2783, DOI [10.1089/ten.tea.2014.0498, 10.1089/ten.TEA.2014.0498]; Yuan BZ, 2014, FRONT MED-PRC, V8, P190, DOI 10.1007/s11684-014-0323-5; Zhang KH, 2014, VACCINE, V32, P6820, DOI 10.1016/j.vaccine.2014.07.071	37	21	21	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227174	10.1371/journal.pone.0227174	http://dx.doi.org/10.1371/journal.pone.0227174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31900469	gold, Green Published			2022-12-26	WOS:000534322000016
J	Nasir, BB; Berha, AB; Gebrewold, MA; Yifru, YM; Engidawork, E; Woldu, MA				Nasir, Beshir Bedru; Berha, Alemseged Beyene; Gebrewold, Meron Awraris; Yifru, Yared Mamushet; Engidawork, Ephrem; Woldu, Minyahil Alebachew			Drug therapy problems and treatment satisfaction among ambulatory patients with epilepsy in a specialized hospital in Ethiopia	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; MEDICATION ADHERENCE; MANAGEMENT; SEIZURES	Objective Epilepsy management especially in developing country is challenging. Seizures recurrence can be caused by both drug and non-drug related problems such as inadequate antiepileptic regimens, adverse drug reaction and poor adherence. Patient treatment satisfaction also affects the treatment out comes by improving medication adherence. This study aimed to assess drug therapy problems (DTPs) and treatment satisfaction among ambulatory epileptic patients at Tikur Anbessa Specialized Hospital. Methods A prospective cross-sectional study was conducted on 291 epileptic patients. Data was collected through patient interview and medical charts review. DTPs were identified based on the standard treatment guidelines and Micromedex (R) was used as drug interaction checker. Cipolle DTPs classification was used to classify the DTPs and Treatment Satisfaction with Medicine Questionnaire (SATMED-Q) was used to assess treatment satisfaction. Binary logistic regressions were utilized to identify the associated factors. Results Phenobarbital 195 (67%) and phenytoin 97 (33.3%) were the most frequently prescribed antiepileptic medications as monotherapy or combination therapy. Only 54 (18.6%) of the study participants had controlled seizure. DTP was found in 205(70.4%) of the study participants. From 352 DTPs identified, adverse drug reaction 146 (41.5%) was the leading DTPs followed by ineffective drugs 98 (27.8%) drug interaction 45 (12.8%) and inappropriate dose 42(11.9%). Headache, depression and epigastric pain were frequently reported adverse drug reaction. Among the study participants 167 (57.3%) were adherent to their medications. The number of medications taken by the patients had significant association with occurrence of DTPs, whereas source of medication and seizure free periods were found to have significant association with poor adherence. The global patient satisfaction was (67.4%) and lower satisfaction rate was found with regard to impact on daily activities (62.0%), treatment effectiveness (64.7%) and medical care (65.9%). Conclusion Prevalence of DTPs among ambulatory epileptic patients was high and about half of the patients were nona-dherent for their medication. The overall treatment satisfaction of the patients was suboptimal.	[Nasir, Beshir Bedru; Berha, Alemseged Beyene; Engidawork, Ephrem; Woldu, Minyahil Alebachew] Addis Ababa Univ AAU, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Gebrewold, Meron Awraris; Yifru, Yared Mamushet] AAU, Dept Neurol, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia		Nasir, BB (corresponding author), Addis Ababa Univ AAU, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	beshir.bedru@aau.edu.et	Woldu, Minyahil/ABD-9452-2020; Engidawork, Ephrem/K-7551-2019	Woldu, Minyahil/0000-0002-3163-0326; Engidawork, Ephrem/0000-0002-9931-6421; , Beshir/0000-0002-8246-9640	Addia Ababa University	Addia Ababa University	This work was supported by Addia Ababa University (Medication therapy management thematic project (https://portal.aau.edu.et/) to BBN, ABB, EE and MAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula T., 2001, Ethiopian Journal of Health Development, V15, P185; Atkinson Mark J, 2004, Health Qual Life Outcomes, V2, P12, DOI 10.1186/1477-7525-2-12; Ayalew MB, 2015, J RES PHARM PRACT, V4, P216, DOI 10.4103/2279-042X.167048; Azar NJ, 2008, SEMIN NEUROL, V28, P305, DOI 10.1055/s-2008-1079335; Blume WT, 2003, CAN MED ASSOC J, V168, P441; Cipolle R.J., 2012, PHARM CAR PRACT PAT, V3rd ed.; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gabr WM, 2015, SAUDI PHARM J, V23, P33, DOI 10.1016/j.jsps.2014.05.003; Getachew H, 2014, EUR J THER, V20, P59, DOI 10.5455/GMJ-30-45904; Gurshaw M, 2014, J YOUNG PHARM, V6, P47, DOI 10.5530/jyp.2014.3.8; Habib M, 2013, BMC RES NOTES, V6, P1; Henry Thomas R., 2012, EPILEPSY BOARD REV M, V1, P1; Hovinga CA, 2008, EPILEPSY BEHAV, V13, P316, DOI 10.1016/j.yebeh.2008.03.009; Hussein M., 2014, CLIN PHARM BIOPHARMA, V3, P2; Jones RM, 2006, SEIZURE-EUR J EPILEP, V15, P504, DOI 10.1016/j.seizure.2006.06.003; Kerr M, 2009, J INTELL DISABIL RES, V53, P687, DOI 10.1111/j.1365-2788.2009.01182.x; Liu JM, 2013, EPILEPTIC DISORD, V15, P289, DOI 10.1684/epd.2013.0588; Manan Mohamed M., 2014, Journal of Pharmacy Practice and Research, V44, P83; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Rishe W, 2015, INDOAMERICAN J PHARM, V5; Rout SK, 2010, INT J PHARM SCI REV, V3, P19; Scott RA, 2001, B WORLD HEALTH ORGAN, V79, P344; Sebastian J, 2013, NEUROL ASIA, V18, P159; Sweileh WM, 2011, EPILEPSY BEHAV, V21, P301, DOI 10.1016/j.yebeh.2011.04.011; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; Wassenaar M, 2013, J NEUROL, V260, P2736, DOI 10.1007/s00415-013-7058-0	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227359	10.1371/journal.pone.0227359	http://dx.doi.org/10.1371/journal.pone.0227359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899779	Green Published, gold			2022-12-26	WOS:000534322000023
J	Lee, YS; Park, JS; Lee, DH; Han, J; Bae, SH				Lee, Yu Seol; Park, Jeong Su; Lee, Da Hyun; Han, Jisu; Bae, Soo Han			Ezetimibe ameliorates lipid accumulation during adipogenesis by regulating the AMPK-mTORC1 pathway	FASEB JOURNAL			English	Article						adipogenesis; AMPK; ezetimibe; mitotic clonal expansion; obesity	MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; HIGH-FAT; INHIBITS ADIPOGENESIS; 3T3-L1 CELLS; IN-VITRO; AMPK; PROTEIN; OBESITY; COMBINATION	Adipogenesis, a critical process that converts adipocyte precursors into adipocytes, is considered a potential therapeutic target for the treatment of obesity. Ezetimibe, a drug approved by the United States Food and Drug Administration, is used for the treatment of hypercholesterolemia. Recently, it was reported to ameliorate high fat diet-induced dyslipidemia in mice and reduce lipid accumulation in hepatocytes through the activation of AMPK. However, the anti-adipogenic effects of ezetimibe and the underlying molecular mechanism have not yet been elucidated. Here, we found that ezetimibe reduced lipid accumulation via activating AMPK during the early phase of adipogenesis. We also observed that ezetimibe inhibited peroxisome proliferator-activated receptor gamma, which is a major transcription factor of adipogenesis. Furthermore, ezetimibe-mediated AMPK activation reduced lipid accumulation by inhibiting mTORC1 signaling, leading to the downregulation of lipogenesis-related genes. Mitotic clonal expansion, required for adipogenesis, accelerates cell cycle progression and cell proliferation. We additionally observed that ezetimibe prevented the progression of mitotic clonal expansion by arresting the cell cycle at the G0/G1 phase, which was followed by the inhibition of cell proliferation. Collectively, ezetimibe-mediated inhibition of adipogenesis is dependent on the AMPK-mTORC1 pathway. Thus, we suggest that ezetimibe might be a promising drug for the treatment of obesity.	[Lee, Yu Seol; Park, Jeong Su; Lee, Da Hyun; Han, Jisu; Bae, Soo Han] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Severance Biomed Sci Inst, 50 Yonsei Ro, Seoul 03722, South Korea; [Lee, Yu Seol; Lee, Da Hyun] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Bae, SH (corresponding author), Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Severance Biomed Sci Inst, 50 Yonsei Ro, Seoul 03722, South Korea.	soohanbae@yuhs.ac		Park, Jeong Su/0000-0003-4551-4294; Lee, Da Hyun/0000-0002-5412-6878; Bae, Soo Han/0000-0002-8007-2906	National Research Foundation of Korea (NRF) [NRF-2017R1A2B4007400, NRF-2017R1D1A1B03032808]; Yonsei University | Yonsei University College of Medicine (YUCM) [6-2019-0068]; Korea Health Industry Development Institute (KHIDI) [HI17C0913, HI16C0257]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Yonsei University | Yonsei University College of Medicine (YUCM); Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1A2B4007400 and NRF-2017R1D1A1B03032808; Yonsei University | Yonsei University College of Medicine (YUCM), Grant/Award Number: 6-2019-0068; Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI17C0913 and HI16C0257	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Cai H, 2016, TRENDS PHARMACOL SCI, V37, P303, DOI 10.1016/j.tips.2015.11.011; Cha JY, 2013, P NATL ACAD SCI USA, V110, P20575, DOI 10.1073/pnas.1320454110; Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157; Choi HS, 2015, MOL NUTR FOOD RES, V59, P1458, DOI 10.1002/mnfr.201500021; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gormand A, 2014, J MOL ENDOCRINOL, V53, P117, DOI 10.1530/JME-13-0296; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Han YH, 2016, J CELL BIOCHEM, V117, P2067, DOI 10.1002/jcb.25509; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heymsfield SB, 2017, NEW ENGL J MED, V376, P1492, DOI 10.1056/NEJMc1701944; Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jung Y, 2018, FASEB J, V32, P3483, DOI 10.1096/fj.201700231RRERR; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kim SH, 2017, AUTOPHAGY, V13, P1767, DOI 10.1080/15548627.2017.1356977; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DH, 2016, FREE RADICAL BIO MED, V99, P520, DOI 10.1016/j.freeradbiomed.2016.09.009; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee HW, 2018, BIOMED PHARMACOTHER, V102, P670, DOI 10.1016/j.biopha.2018.03.124; Li CC, 2018, TOXICOL APPL PHARM, V359, P82, DOI 10.1016/j.taap.2018.09.028; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Nagasu H, 2019, FASEB J, V33, P12253, DOI 10.1096/fj.201900217R; Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004; Nozaki Y, 2009, J HEPATOL, V51, P548, DOI 10.1016/j.jhep.2009.05.017; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Park H, 2011, J GASTROENTEROL, V46, P101, DOI 10.1007/s00535-010-0291-8; Pilch PF, 2006, MOL PHARMACOL, V70, P779, DOI 10.1124/mol.106.026104; Poudel B, 2014, INT J MOL MED, V34, P1401, DOI 10.3892/ijmm.2014.1921; Qin L, 2014, ACTA PHARMACOL SIN, V35, P1129, DOI 10.1038/aps.2014.10; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Tan YQ, 2019, FASEB J, V33, P6526, DOI 10.1096/fj.201801518RR; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Ushio M, 2013, AM J PHYSIOL-ENDOC M, V305, pE293, DOI 10.1152/ajpendo.00442.2012; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Zheng SQ, 2008, EUR J PHARMACOL, V584, P118, DOI 10.1016/j.ejphar.2008.01.045	51	9	9	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					898	911		10.1096/fj.201901569R	http://dx.doi.org/10.1096/fj.201901569R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914598				2022-12-26	WOS:000507308900061
J	de la Sancha, NU; Boyle, SA				de la Sancha, Noe U.; Boyle, Sarah A.			Predictive sampling effort and species-area relationship models for estimating richness in fragmented landscapes	PLOS ONE			English	Article							OVERESTIMATE EXTINCTION RATES; PARAGUAYS ATLANTIC FOREST; SMALL MAMMALS; HABITAT LOSS; DIVERSITY; BIODIVERSITY; GRADIENTS; CURVES; PERSPECTIVES; FRAMEWORK	Loss of habitat, specifically deforestation, is a major driver of biodiversity loss. Species-area relationship (SAR) models traditionally have been used for estimating species richness, species loss as a function of habitat loss, and extrapolation of richness for given areas. Sampling-species relationships (SSRs) are interrelated yet separate drivers for species richness estimates. Traditionally, however, SAR and SSR models have been used independently and not incorporated into a single approach. We developed and compared predictive models that incorporate sampling effort species-area relationships (SESARS) along the entire Atlantic Forest of South America, and then applied the best-fit model to estimate richness in forest remnants of Interior Atlantic Forest of eastern Paraguay. This framework was applied to non-volant small mammal assemblages that reflect different tolerances to forest loss and fragmentation. In order to account for differences in functionality we estimated small mammal richness of 1) the entire non-volant small mammal assemblage, including introduced species; 2) the native species forest assemblage; and 3) the forest-specialist assemblage, with the latter two assemblages being subsets of the entire assemblage. Finally, we geospatially modeled species richness for each of the three assemblages throughout eastern Paraguay to identify remnants with high species richness. We found that multiple regression power-law interaction-term models that only included area and the interactions of area and sampling as predictors, worked best for predicting species richness for the entire assemblage and the native species forest assemblage, while several traditional SAR models (logistic, power, exponential, and ratio) best described forest-specialist richness. Species richness was significantly different between assemblages. We identified obvious remnants with high species richness in eastern Paraguay, and these remnants often were geographically isolated. We also found relatively high predicted species richness (in relation to the entire range of predicted richness values) in several geographically-isolated, medium-size forest remnants that likely have not been considered as possible priority areas for conservation. These findings highlight the importance of using an empirical dataset, created using sources representing diverse sampling efforts, to develop robust predictive models. This approach is particularly important in geographic locations where field sampling is limited yet the geographic area is experiencing rapid and dramatic land cover changes. When combined, area and sampling are powerful modeling predictors for questions of biogeography, ecology, and conservation, especially when addressing habitat loss and fragmentation.	[de la Sancha, Noe U.] Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA; [de la Sancha, Noe U.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Boyle, Sarah A.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA	Chicago State University; Field Museum of Natural History (Chicago)	de la Sancha, NU (corresponding author), Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA.; de la Sancha, NU (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA.	delasancha@msn.com	de la Sancha, Noé U/GZL-8489-2022; de la Sancha, Noé/AAN-3617-2020; Boyle, Sarah/AAQ-6815-2021	de la Sancha, Noé U/0000-0002-1342-5556; de la Sancha, Noé/0000-0002-1342-5556; 	Fulbright Fellowship; Marshall Field Collection Fund; Grainer Bioinformatics Center at The Field Museum; Department of Biological Sciences, Texas Tech University; Mary Rice Foundation; Lewis and Clark Exploration Fund; American Society of Mammalogists; Rhodes College	Fulbright Fellowship; Marshall Field Collection Fund; Grainer Bioinformatics Center at The Field Museum; Department of Biological Sciences, Texas Tech University; Mary Rice Foundation; Lewis and Clark Exploration Fund; American Society of Mammalogists; Rhodes College	Partial financial support to NUD comes from Fulbright Fellowship; The Marshall Field Collection Fund; Grainer Bioinformatics Center at The Field Museum; Department of Biological Sciences, Texas Tech University; the Mary Rice Foundation; The Lewis and Clark Exploration Fund; and American Society of Mammalogists. Funding for the collection of the Tapyta data was provided by Rhodes College to SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce-Pena NP, 2019, BIODIVERS CONSERV, V28, P655, DOI 10.1007/s10531-018-1682-z; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Axelsen JB, 2013, ECOLOGY, V94, P761, DOI 10.1890/12-0047.1; Azovsky AI, 2011, ECOGRAPHY, V34, P18, DOI 10.1111/j.1600-0587.2010.06288.x; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Barret GW, 1999, LANDSCAPE ECOLOGY SM; Beck J., 2011, FRONTIERS BIOGEOGRAP, V3, P81; Benchimol M, 2013, DIVERS DISTRIB, V19, P1339, DOI 10.1111/ddi.12111; Bovendorp R. S., 2018, ECOGRAPHY, V69, P473; Bovendorp RS, 2017, ECOLOGY, P98; Boyle SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086908; Brooks TM, 2011, NATURE, V474, P284, DOI 10.1038/474284b; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cam E, 2002, ECOLOGY, V83, P1118, DOI 10.2307/3071918; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Collins MD, 2002, EVOL ECOL RES, V4, P457; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Costello MJ, 2015, CURR BIOL, V25, pR368, DOI 10.1016/j.cub.2015.03.051; Crawley MJ., 2015, STATISTICS; Da Ponte E, 2017, FORESTS, V8, DOI 10.3390/f8100389; Da Ponte E, 2017, APPL GEOGR, V79, P37, DOI 10.1016/j.apgeog.2016.12.005; la Sancha N, 2009, MAMMALIA, V73, P162, DOI 10.1515/MAMM.2009.026; de la Sancha NU, 2020, MAMMALIA, V84, P366, DOI 10.1515/mammalia-2019-0093; Sancha Noé U. de la, 2017, Therya, V8, P241, DOI 10.12933/therya-17-473; de la Sancha NU, 2014, MAMMALIA, V78, P437, DOI 10.1515/mammalia-2013-0100; de la Sancha NU, 2014, DIVERS DISTRIB, V20, P1058, DOI 10.1111/ddi.12210; de la Sancha NU, 2019, BIOTROPICA; Dengler J, 2008, FOLIA GEOBOT, V43, P269, DOI 10.1007/s12224-008-9014-9; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Desmet P, 2004, ECOLOGY SOC, V2, P1; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Evans M, 2011, NATURE, V474, P284, DOI 10.1038/474284a; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; FAO, 2016, GUID URB PER FOR, V2nd, P1; Fattorini S, 2007, BIODIVERS CONSERV, V16, P2531, DOI 10.1007/s10531-006-9029-6; Fisher JRB, 2018, REMOTE SENS ECOL CON, V4, P137, DOI 10.1002/rse2.61; Fleytas C., 2007, BIODIVERSIDAD PARAGU, V1st, P77; Goncalves F, 2018, ECOLOGY, V99, P498, DOI 10.1002/ecy.2106; Guilhaumon F, 2008, P NATL ACAD SCI USA, V105, P15458, DOI 10.1073/pnas.0803610105; Guilhaumon F, 2010, ECOGRAPHY, V33, P420, DOI 10.1111/j.1600-0587.2010.06304.x; Hanski I, 2013, SPECIES FRAGMENTED A, P2715; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; He FL, 2013, ECOLOGY, V94, P1905, DOI 10.1890/12-1795.1; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Huang CQ, 2007, REMOTE SENS ENVIRON, V106, P460, DOI 10.1016/j.rse.2006.09.016; Huang CQ, 2009, GLOBAL PLANET CHANGE, V67, P1, DOI 10.1016/j.gloplacha.2008.12.009; Kinzig A. P., 2000, ECOLOGY, V12, P3305; Lanzone Cecilia, 2018, Rev. Mus. Argent. Cienc. Nat., V20, P151, DOI 10.22179/REVMACN.20.566; Lawton J., 2000, COMMUNITY ECOLOGY CH; Leal CG, 2003, ATLANTIC FOREST S AM, P1; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Lopez-Gonzalez C, 2015, ECOGRAPHY, V38, P261, DOI 10.1111/ecog.00813; MAC ARTHUR ROBERT H., 1967; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; Pontes ARM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150887; Mittermeier CG, 1999, HOTSPOTS EARTHS BIOL; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Owen Robert D., 2018, Check List, V14, P721; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pereira HM, 2012, NATURE, V482, pE3, DOI 10.1038/nature10857; Pires AS, 2002, BIOL CONSERV, V108, P229, DOI 10.1016/S0006-3207(02)00109-X; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Scheiner SM, 2011, ECOL MONOGR, V81, P195, DOI 10.1890/10-1426.1; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schoener T.W., 1976, P 16 INT ORNITHOLOGI, V1, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Smith AB, 2010, BIOL CONSERV, V143, P555, DOI 10.1016/j.biocon.2009.11.003; Stevens RD, 2004, J BIOGEOGR, V31, P665, DOI 10.1111/j.1365-2699.2003.01042.x; Stevens RD, 2006, OIKOS, V112, P41, DOI 10.1111/j.0030-1299.2006.13167.x; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2019, J MAMMAL, V100, P1069, DOI 10.1093/jmammal/gyz024; Stevens RD, 2015, ECOGRAPHY, V38, P861, DOI 10.1111/ecog.00847; Stiles A, 2007, OIKOS, V116, P1930, DOI 10.1111/j.2007-0030-1299.15703.x; Tanentzap AJ, 2012, CONSERV LETT, V5, P149, DOI 10.1111/j.1755-263X.2011.00221.x; Thomas CD, 2012, NATURE, V482, pE4, DOI 10.1038/nature10858; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Tjorve E, 2009, J BIOGEOGR, V36, P1435, DOI 10.1111/j.1365-2699.2009.02101.x; Tuff KT, 2016, ECOL LETT, V19, P361, DOI 10.1111/ele.12579; Ulrich W, 2005, BIODIVERS CONSERV, V14, P3351, DOI 10.1007/s10531-004-9543-3; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Williams MR, 2009, J BIOGEOGR, V36, P1994, DOI 10.1111/j.1365-2699.2009.02110.x; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	92	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226529	10.1371/journal.pone.0226529	http://dx.doi.org/10.1371/journal.pone.0226529			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891589	Green Published, gold			2022-12-26	WOS:000515096600017
J	Oedin, M; Brescia, F; Boissenin, M; Vidal, E; Cassan, JJ; Hurlin, JC; Millon, A				Oedin, Malik; Brescia, Fabrice; Boissenin, Melanie; Vidal, Eric; Cassan, Jean-Jerome; Hurlin, Jean-Claude; Millon, Alexandre			Monitoring hunted species of cultural significance: Estimates of trends, population sizes and harvesting rates of flying-fox (Pteropus sp.) in New Caledonia	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; KNOWLEDGE; ISLANDS; RISK; SUSTAINABILITY; CONSPICILLATUS; CHIROPTERA; IMPACT	Assessing population trends and their underlying factors is critical to propose efficient conservation actions. This assessment can be particularly challenging when dealing with highly mobile, shy and nocturnal animals such as flying-foxes. Here we investigated the dynamics of hunted populations of Pteropus ornatus and P. tonganus in the Northern Province of New Caledonia. First, an ethno-ecological survey involving 219 local experts identified 494 flying fox roosts. Current status was assessed for 379 of them, among which 125 were no longer occupied, representing a loss of 33% over ca. 40 years. Second, species-specific counts conducted at 35 roosts, and a sample of animals killed by hunters, revealed that the endemic species, P. ornatus, was dominant (68.5%). Between 2010 and 2016, 30 roosts were counted annually during the pre-parturition period. Roosts size averaged 1,425 2,151 individuals (N = 180 counts) and showed high among-year variations (roost-specific CV = 37-162%). If we recorded significant inter-annual variation, we did not detect a significant decline over the 7-yr period, although one roost went possibly extinct. Population size of the two species combined was estimated at 338,000-859,000 individuals distributed over ca. 400 roosts in the Northern Province. Flying-foxes are popular game species and constitute traditional food for all communities of New Caledonia. Annual bags derived from a food survey allowed us to estimate harvesting rates at 5-14%. Such a level of harvesting for species with a 'slow' demography, the occurrence of poaching and illegal trade, suggest the current species use might not be sustainable and further investigations are critically needed.	[Oedin, Malik; Brescia, Fabrice; Boissenin, Melanie; Hurlin, Jean-Claude] Inst Agron Neo Caledonien IAC, Equipe ARBOREAL Agr BiOdiveRsite & vALorisat BP, Paita, Nouvelle Caledo, New Caledonia; [Oedin, Malik; Vidal, Eric] Avignon Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, Aix Marseille Univ, CNRS,IRD,Ctr IRD Noumea, New Caledonia, New Caledonia; [Vidal, Eric] Univ La Reunion, UMR Entropie, IRD, CNRS,Labex Corail, New Caledonia, New Caledonia; [Cassan, Jean-Jerome] DDEE, Serv Impact Environnemental & Conservat, Kone, Nouvelle Caledo, New Caledonia; [Millon, Alexandre] Avignon Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, Aix Marseille Univ, CNRS,IRD, Aix En Provence, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Brescia, F (corresponding author), Inst Agron Neo Caledonien IAC, Equipe ARBOREAL Agr BiOdiveRsite & vALorisat BP, Paita, Nouvelle Caledo, New Caledonia.	brescia@iac.nc	Millon, Alexandre/AAF-8624-2020	Millon, Alexandre/0000-0002-9475-4123; Oedin, Malik/0000-0002-0470-2646	Northern Province of New Caledonia; Southern Province of New Caledonia; Institut Agronomique Caledonien	Northern Province of New Caledonia; Southern Province of New Caledonia; Institut Agronomique Caledonien	FB funded this study thanks to the support of the Northern Province of New Caledonia and Institut Agronomique Caledonien. MO received a PhD fellowship from the Southern Province of New Caledonia.	Aziz SA, 2017, ECOL EVOL, V7, P8670, DOI 10.1002/ece3.3213; Bani Ernest, 1992, U S Fish and Wildlife Service Biological Report, V90, P123; Boissenin M, 2016, VARIATIONS EFF UNPUB; Boissenin M, 2009, UNPUB; Boissenin M, 2015, UNPUB; Boissenin M, 2010, UNPUB; Bourret D, ETUDE ETHNOBOTANIQUE; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Brescia F., 2007, UNPUB; Brook CE, 2019, BIOL CONSERV, V234, P165, DOI 10.1016/j.biocon.2019.03.032; Brook R, 2008, BIODIVERS CONSERV, V17, P3501, DOI 10.1007/s10531-008-9445-x; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Crawford BA, 2018, BIOL CONSERV, V222, P33, DOI 10.1016/j.biocon.2018.03.023; Curt T, 2015, FOREST ECOL MANAG, V337, P48, DOI 10.1016/j.foreco.2014.10.032; Dorrestein A, 2019, BIOTROPICA, V51, P75, DOI 10.1111/btp.12620; Dumas F. Ribadeau, 2013, Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, V53, pP; Eby Peggy, 1999, Australian Zoologist, V31, P240; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Florens FBV, 2019, J NAT CONSERV, V47, P58, DOI 10.1016/j.jnc.2018.11.008; Florens FBV, 2017, J NAT CONSERV, V40, P85, DOI 10.1016/j.jnc.2017.10.002; Forsyth DM, 2006, WILDLIFE RES, V33, P57, DOI 10.1071/WR05029; Fossier C, 2017, UNPUB; Fox S, 2008, WILDLIFE RES, V35, P417, DOI 10.1071/WR07127; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Gomez C, 2015, ECOL EVOL, V5, P377, DOI 10.1002/ece3.1317; Hahn MB, 2014, AM J TROP MED HYG, V90, P247, DOI 10.4269/ajtmh.13-0256; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; Ibanez T, 2019, BIODIVERS CONSERV, V28, P245, DOI 10.1007/s10531-018-1659-y; ISEE, 2014, UNPUB; Jaffre T, 2010, VEGETATION ROCHES UL, P45; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Kunz Thomas H., 2009, P133; Lavery TH, 2019, ORYX, V53, P505, DOI 10.1017/S0030605317001004; Leblic, 2002, J SOCI, P115; Leblic I., 1989, Cahiers des Sciences Humaines, V25, P109; Ling S, 2006, CONSERV BIOL, V20, P1294, DOI 10.1111/j.1523-1739.2006.00414.x; MacKinnon J., 2003, NATURAL HIST MADAGAS, P1299; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; McConkey KR, 2007, BIOTROPICA, V39, P436, DOI 10.1111/j.1744-7429.2007.00269.x; McConkey KR, 2004, J TROP ECOL, V20, P555, DOI 10.1017/S0266467404001804; McIlwee A. P., 2002, Australian Zoologist, V32, P76; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mildenstein Tammy, 2016, P325; Mildenstein TL, 2005, BIOL CONSERV, V126, P93, DOI 10.1016/j.biocon.2005.05.001; Millon A, 2014, GLOBAL CHANGE BIOL, V20, P1770, DOI 10.1111/gcb.12546; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols JD, 2007, J ORNITHOL, V148, pS343, DOI 10.1007/s10336-007-0256-8; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; OEIL, 2019, OBSERVATOIRE ENV NOV; Olival KJ, 2016, ECOHEALTH, V13, P6, DOI 10.1007/s10393-015-1075-7; Palmas P, 2017, BIOL CONSERV, V214, P250, DOI 10.1016/j.biocon.2017.08.003; Parsons JG, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P66; Parsons JG, 2010, ACTA CHIROPTEROL, V12, P301, DOI 10.3161/150811010X537882; Pierson ED, 1996, CONSERV BIOL, V10, P438, DOI 10.1046/j.1523-1739.1996.10020438.x; Pierson Elizabeth D., 1992, U S Fish and Wildlife Service Biological Report, V90, P1; Predavec M, 2018, AUST MAMMAL, V40, P47, DOI 10.1071/AM16059; Primack RB, 2012, BIOLOGIE DE LA CONSE; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Racey Paul A., 2009, P369; Rahaingodrahety Volana N., 2008, Madagascar Conservation & Development, V3, P17; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Sheherazade, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030102; Sinavaiana Caroline, 1992, U S Fish and Wildlife Service Biological Report, V90, P36; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tidemann CR, 2011, ACTA CHIROPTEROL, V13, P419, DOI 10.3161/150811011X624901; Utzurrum RCB, 2003, MONITORING TRENDS BA, P49; Vardon MJ, 2000, AUST J ZOOL, V48, P91, DOI 10.1071/ZO99060; Vincenot CE, 2017, MAMM BIOL, V83, P71, DOI 10.1016/j.mambio.2016.11.006; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Welch JN, 2017, MAMMAL REV, V47, P277, DOI 10.1111/mam.12099; Westcott DA, 2004, WILDLIFE RES, V31, P551, DOI 10.1071/WR03091; Westcott DA, 2015, STATUS TRENDS AUSTRA; Westcott DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22294-w; Westcott DA, 2012, ECOL APPL, V22, P374, DOI 10.1890/11-0132.1; Wiles Gary J., 2004, Pacific Science, V58, P585, DOI 10.1353/psc.2004.0044; WILES GJ, 1986, BIOL CONSERV, V38, P143, DOI 10.1016/0006-3207(86)90070-4; Wodzicki K, 1975, PAC SCI; Ziembicki MR, 2013, BIOL CONSERV, V157, P78, DOI 10.1016/j.biocon.2012.07.004; Zuur Alain F., 2009, P1	85	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0224466	10.1371/journal.pone.0224466	http://dx.doi.org/10.1371/journal.pone.0224466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891573	Green Published, gold			2022-12-26	WOS:000515096600004
J	Orimoloye, OA; Uddin, SMI; Chen, LC; Osei, AD; Mirbolouk, M; Malovichko, MV; Sithu, ID; Dzaye, O; Conklin, DJ; Srivastava, S; Blaha, MJ				Orimoloye, Olusola A.; Uddin, S. M. Iftekhar; Chen, Lung-Chi; Osei, Albert D.; Mirbolouk, Mohammadhassan; Malovichko, Marina, V; Sithu, Israel D.; Dzaye, Omar; Conklin, Daniel J.; Srivastava, Sanjay; Blaha, Michael J.			Electronic cigarettes and insulin resistance in animals and humans: Results of a controlled animal study and the National Health and Nutrition Examination Survey (NHANES 2013-2016)	PLOS ONE			English	Article							NICOTINE; EXPOSURE	Background The popularity of electronic cigarettes (E-cigarettes) has risen considerably. Several studies have suggested that nicotine may affect insulin resistance, however, the impact of E-cigarette exposure on insulin resistance, an early measure of cardiometabolic risk, is not known. Methods and results Using experimental animals and human data obtained from 3,989 participants of the United States National Health and Nutrition Examination Survey (NHANES), respectively, we assessed the association between E-cigarette and conventional cigarette exposures and insulin resistance, as modelled using the homeostatic model assessment of insulin resistance (HOMA-IR) and glucose tolerance tests (GTT). C57BL6/J mice (on standard chow diet) exposed to E-cigarette aerosol or mainstream cigarette smoke (MCS) for 12 weeks showed HOMA-IR and GTT levels comparable with filtered air-exposed controls. In the NHANES cohort, there was no significant association between defined tobacco product use categories (non-users; sole E-cigarette users; cigarette smokers and dual users) and insulin resistance. Compared with non-users of e-cigarettes/conventional cigarettes, sole E-cigarette users showed no significant difference in HOMA-IR or GTT levels following adjustment for age, sex, race, physical activity, alcohol use and BMI. Conclusion E-cigarettes do not appear to be linked with insulin resistance. Our findings may inform future studies assessing potential cardiometabolic harms associated with E-cigarette use.	[Orimoloye, Olusola A.; Uddin, S. M. Iftekhar; Osei, Albert D.; Mirbolouk, Mohammadhassan; Dzaye, Omar; Blaha, Michael J.] Johns Hopkins Univ, Sch Med, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21218 USA; [Orimoloye, Olusola A.; Uddin, S. M. Iftekhar; Chen, Lung-Chi; Osei, Albert D.; Mirbolouk, Mohammadhassan; Malovichko, Marina, V; Sithu, Israel D.; Conklin, Daniel J.; Srivastava, Sanjay; Blaha, Michael J.] Amer Heart Assoc, Tobacco Regulat & Addict Ctr, Dallas, TX 75231 USA; [Chen, Lung-Chi] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Malovichko, Marina, V; Sithu, Israel D.; Conklin, Daniel J.; Srivastava, Sanjay] Univ Louisville, Envirome Inst, Louisville, KY 40292 USA	Johns Hopkins University; Johns Hopkins Medicine; New York University; University of Louisville	Blaha, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21218 USA.; Blaha, MJ (corresponding author), Amer Heart Assoc, Tobacco Regulat & Addict Ctr, Dallas, TX 75231 USA.	mblaha1@jhmi.edu	Mirbolouk, Mohammadhassan/J-5209-2019	Mirbolouk, Mohammadhassan/0000-0001-9612-3352; Malovichko, Marina/0000-0003-2127-5858; Orimoloye, Olusola/0000-0001-6858-1057; Osei, Albert/0000-0002-3901-0471; Chen, Lung Chi/0000-0003-1154-2107	NIH [P54 HL120163, R01 HL120746, R01 HL122676, P30 RR029846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122676, U54HL120163, R01HL120746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM127607] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH grants P54 HL120163, R01 HL120746 and R01 HL122676 and P30 RR029846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in parts by NIH grants P54 HL120163, R01 HL120746 and R01 HL122676 and P30 RR029846.	Alexander LEC, 2018, AM J PHYSIOL-REG I, V314, pR834, DOI 10.1152/ajpregu.00270.2017; Benowitz NL, 2016, TRENDS CARDIOVAS MED, V26, P515, DOI 10.1016/j.tcm.2016.03.001; Chaumont M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28723-0; Coleman BN, 2017, ELECT CIGARETTE USE; Conklin DJ, 2017, TOXICOL SCI, V158, P263, DOI 10.1093/toxsci/kfx095; Conklin DJ, 2017, TOXICOL APPL PHARM; Dinakar C, 2016, NEW ENGL J MED, V375, P1372, DOI 10.1056/NEJMra1502466; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Jaber RM, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.117.008178, 10.1161/jaha.117.008178]; Malovichko M V, 2017, NICOTINE TOB RES; Martin EM, 2016, AM J PHYSIOL-LUNG C, V311, pL135, DOI 10.1152/ajplung.00170.2016; Mirbolouk M, 2018, ANN INTERN MED, V169, P429, DOI 10.7326/M17-3440; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG, V10, P24952; Qasim H, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009264; Sansbury BE, 2012, CIRC RES, V111, P1176, DOI [10.1161/circresaha.112.266395, 10.1161/CIRCRESAHA.112.266395]; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826	20	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226744	10.1371/journal.pone.0226744	http://dx.doi.org/10.1371/journal.pone.0226744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891598	Green Published, gold			2022-12-26	WOS:000515096600025
J	Bakthavatchalam, YD; Babu, P; Munusamy, E; Dwarakanathan, HT; Rupali, P; Zervos, M; Victor, PJ; Veeraraghavan, B				Bakthavatchalam, Yamuna Devi; Babu, Priyanka; Munusamy, Elakkiya; Dwarakanathan, Hariharan Triplicane; Rupali, Priscilla; Zervos, Marcus; Victor, Peter John; Veeraraghavan, Balaji			Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; GLYCOPEPTIDE RESISTANCE; INTERMEDIATE RESISTANCE; REDUCED SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; HETERORESISTANT; BACTEREMIA; EXPRESSION; FAILURE; TCAA	Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important clinical concern in patients, and is often associated with significant disease burden and metastatic infections. There is an increasing evidence of heterogeneous vancomycin-intermediate S. aureus (hVISA) associated treatment failure. In this study, we aim to understand the molecular mechanism of teicop lanin resistant MRSA (TR-MRSA) and hVISA. A total of 482 MRSA isolates were investigated for these phenotypes. Of the tested isolates, 1% were identified as TR-MRSA, and 12% identified as hVISA. A highly diverse amino acid substitution was observed in tcaRAB, vraSR, and graSR genes in TR-MRSA and hVISA strains. Interestingly, 65% of hVISA strains had a D148Q mutation in the graR gene. However, none of the markers were reliable in differentiating hVISA from TR-MRSA. Significant pbp2 upregulation was noted in three TR-MRSA strains, which had teicoplanin MICs of 16 or 32 mu g/ml, whilst significant pbp4 downregulation was not noted in these strains. In our study, multiple mutations were identified in the candidate genes, suggesting a complex evolutionary pathway involved in the development of TR-MRSA and hVISA strains.	[Bakthavatchalam, Yamuna Devi; Babu, Priyanka; Munusamy, Elakkiya; Veeraraghavan, Balaji] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [Dwarakanathan, Hariharan Triplicane] Christian Med Coll & Hosp, Dept Orthopaed, Vellore, Tamil Nadu, India; [Rupali, Priscilla] Christian Med Coll & Hosp, IDTRC, Vellore, Tamil Nadu, India; [Zervos, Marcus] Henry Ford Hlth Syst, Infect Dis, Detroit, MI USA; [Victor, Peter John] Christian Med Coll & Hosp, Dept Crit Care Unit, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Henry Ford Health System; Henry Ford Hospital; Christian Medical College & Hospital (CMCH) Vellore	Veeraraghavan, B (corresponding author), Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India.	vbalaji@cmcvellore.ac.in		Veeraraghavan, Balaji/0000-0002-8662-4257				Alam MT, 2014, GENOME BIOL EVOL, V6, P1174, DOI 10.1093/gbe/evu092; [Anonymous], 2018, M100S28 CLSI; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; BRUNET F, 1990, EUR J CLIN MICROBIOL, V9, P145, DOI 10.1007/BF01963643; Casapao AM, 2013, ANTIMICROB AGENTS CH, V57, P4252, DOI 10.1128/AAC.00380-13; Cepeda J, 2003, J ANTIMICROB CHEMOTH, V52, P533, DOI 10.1093/jac/dkg369; Chang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P736, DOI 10.1093/jac/dkr531; Chaudhari C N, 2015, Med J Armed Forces India, V71, P15, DOI 10.1016/j.mjafi.2014.03.008; Chen CJ, 2015, J ANTIMICROB CHEMOTH, V70, P2965, DOI 10.1093/jac/dkv225; Chen KY, 2013, J MICROBIOL IMMUNOL, V46, P210, DOI 10.1016/j.jmii.2012.06.010; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P428, DOI 10.1128/AAC.50.2.428-438.2006; Deresinski S, 2013, J INFECT DIS, V208, P7, DOI 10.1093/infdis/jit136; Dhand A, 2014, F1000 MED REP, V4, P4; Doddangoudar VC, 2011, CLIN MICROBIOL INFEC, V17, P1268, DOI 10.1111/j.1469-0691.2011.03463.x; Elsaghier AAF, 2002, J ANTIMICROB CHEMOTH, V49, P423, DOI 10.1093/jac/49.2.423; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST, 2018, BREAKP TABL INT MICS; Gao W, 2013, J INFECT DIS, V207, P929, DOI 10.1093/infdis/jis772; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Ghaznavi-Rad E, 2010, J MED MICROBIOL, V59, P1135, DOI 10.1099/jmm.0.021956-0; Gomes DM, 2015, PHARMACOTHERAPY, V35, P424, DOI 10.1002/phar.1577; Goudarzi M, 2017, MICROB PATHOGENESIS, V104, P328, DOI 10.1016/j.micpath.2017.01.055; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 2014, J GLOB ANTIMICROB RE, V2, P213, DOI 10.1016/j.jgar.2014.04.006; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Hu QW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01601; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Kato Y, 2010, J ANTIMICROB CHEMOTH, V65, P37, DOI 10.1093/jac/dkp394; Khatib R, 2015, J CLIN MICROBIOL, V53, P3543, DOI 10.1128/JCM.01620-15; Lin LC, 2018, INFECT DRUG RESIST, V11, P113, DOI 10.2147/IDR.S148335; Liu C, 2003, ANTIMICROB AGENTS CH, V47, P3040, DOI 10.1128/AAC.47.10.3040-3045.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Maki H, 2004, ANTIMICROB AGENTS CH, V48, P1953, DOI 10.1128/AAC.48.6.1953-1959.2004; McCallum N, 2010, INT J MED MICROBIOL, V300, P118, DOI 10.1016/j.ijmm.2009.08.015; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Park C, 2012, J MED MICROBIOL, V61, P345, DOI 10.1099/jmm.0.035204-0; Renzoni A, 2006, ANTIMICROB AGENTS CH, V50, P3048, DOI 10.1128/AAC.00113-06; Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359; Roch M, 2014, ANTIMICROB AGENTS CH, V58, P5306, DOI 10.1128/AAC.02574-14; Rodriguez CA, 2012, ANTIMICROB AGENTS CH, V56, P243, DOI 10.1128/AAC.05129-11; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieradzki K, 1998, ANTIMICROB AGENTS CH, V42, P100, DOI 10.1128/AAC.42.1.100; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; Singh A, 2015, MICROB DRUG RESIST, V21, P545, DOI 10.1089/mdr.2015.0004; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P4926, DOI 10.1128/AAC.48.12.4926-4928.2004; Song KH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01845-16; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szymanek-Majchrzak K, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0397-y; Tille PM., 2014, BAILEY SCOTTS DIAGNO, VThirteenth; van Hal SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021217; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Wang YB, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02163; Watanabe Y, 2011, J CLIN MICROBIOL, V49, P2680, DOI 10.1128/JCM.02144-10; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Wootton M, 2005, BBA-GEN SUBJECTS, V1726, P326, DOI 10.1016/j.bbagen.2005.09.002; Xu J, 2018, OPEN MED-WARSAW, V13, P475, DOI 10.1515/med-2018-0071; Yeh YC, 2012, J MICROBIOL IMMUNOL, V45, P214, DOI 10.1016/j.jmii.2011.11.006; Yoo JI, 2013, J MICROBIOL, V51, P160, DOI 10.1007/s12275-013-3088-7; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136082	74	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227009	10.1371/journal.pone.0227009	http://dx.doi.org/10.1371/journal.pone.0227009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887179	Green Published, gold			2022-12-26	WOS:000515092200062
J	Hajdinak, P; Czobor, A; Szarka, A				Hajdinak, Peter; Czobor, Adam; Szarka, Andras			The potential role of acrolein in plant ferroptosis-like cell death	PLOS ONE			English	Article							LIPID-PEROXIDATION; STRESS; MITOCHONDRIA	The iron dependent, programmed cell death, ferroptosis was described first in tumour cells. It showed distinct features from the already known cell death forms such as apoptosis, necrosis and autophagy. The caspase independent cell death could be induced by the depletion of glutathione by erastin or by the inhibition of the lipid peroxide scavenger enzyme GPX4 by RSL3 and it was accompanied by the generation of lipid reactive oxygen species. Recently, ferroptosis-like cell death associated to glutathione depletion, lipid peroxidation and iron dependency could also be induced in plant cells by heat treatment. Unfortunately, the mediators and elements of the ferroptotic pathway have not been described yet. Our present results on Arabidopsis thaliana cell cultures suggest that acrolein, a lipid peroxide-derived reactive carbonyl species, is involved in plant ferroptosis-like cell death. The acrolein induced cell death could be mitigated by the known ferroptosis inhibitors such as Ferrostatin-1, Deferoxamine, alpha-Tocopherol, and glutathione. At the same time acrolein can be a mediator of ferroptosis-like cell death in plant cells since the known ferroptosis inducer RSL3 induced cell death could be mitigated by the acrolein scavenger carnosine. Finally, on the contrary to the caspase independent ferroptosis in human cells, we found that caspase-like activity can be involved in plant ferroptosis-like cell death.	[Hajdinak, Peter; Czobor, Adam; Szarka, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary	Budapest University of Technology & Economics	Szarka, A (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary.	szarka@mail.bme.hu		Szarka, Andras/0000-0001-6594-254X; Hajdinak, Peter/0000-0002-7705-2074	National Research, Development and Innovation Fund of Hungary by the BME-Biotechnology FIKP grant of EMMI [K 123752, 129593, 20181.2.1-NKP-2018-00005]; MedinProt Protein Excellence foundation	National Research, Development and Innovation Fund of Hungary by the BME-Biotechnology FIKP grant of EMMI; MedinProt Protein Excellence foundation	This work (and A. Sz. as the supervisor) was financially supported by the National Research, Development and Innovation Fund of Hungary under Grant K 123752, 129593, 20181.2.1-NKP-2018-00005 by the BME-Biotechnology FIKP grant of EMMI and MedinProt Protein Excellence foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MS, 2016, PLANT CELL PHYSIOL, V57, P1432, DOI 10.1093/pcp/pcw053; Biswas MS, 2015, PLANT PHYSIOL, V168, P885, DOI 10.1104/pp.115.256834; Castro-Concha Lizbeth A, 2006, Methods Mol Biol, V318, P71; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Czobor A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210592; Czobor A, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2365-1; Dachert J, 2016, ONCOTARGET, V7, P63779, DOI 10.18632/oncotarget.11687; Dangol S, 2019, PLANT CELL, V31, P189, DOI 10.1105/tpc.18.00535; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fearnhead HO, 2017, CELL DEATH DIFFER, V24, P1991, DOI 10.1038/cdd.2017.149; Garcia-Heredia JM, 2008, PLANTA, V228, P89, DOI 10.1007/s00425-008-0721-5; Grosch W., 1987, AUTOXIDATION UNSATUR, P95; Hajdinak P, 2019, PERIOD POLYTECH-CHEM, V63, P1, DOI 10.3311/PPch.11785; Hao SH, 2018, ONCOL LETT, V15, P5405, DOI 10.3892/ol.2018.8066; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Lorincz T, 2015, PATHOL ONCOL RES, V21, P1115, DOI 10.1007/s12253-015-9946-3; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Distefano AM, 2017, J CELL BIOL, V216, P463, DOI 10.1083/jcb.201605110; Pan XF, 2019, ONCOL LETT, V17, P3001, DOI 10.3892/ol.2019.9888; Poborilova Z, 2013, ENVIRON EXP BOT, V91, P1, DOI 10.1016/j.envexpbot.2013.03.002; Qu GQ, 2009, PLANTA, V229, P1269, DOI 10.1007/s00425-009-0908-4; Szarka A, 2012, INT J MOL SCI, V13, P4458, DOI 10.3390/ijms13044458; Van Akent O, 2015, TRENDS PLANT SCI, V20, P754, DOI 10.1016/j.tplants.2015.08.002; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhou DR, 2019, BBA-MOL CELL RES, V1866, P699, DOI 10.1016/j.bbamcr.2018.12.001; Zsigmond L, 2011, PLANT PHYSIOL BIOCH, V49, P809, DOI 10.1016/j.plaphy.2011.04.013	30	12	13	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227278	10.1371/journal.pone.0227278	http://dx.doi.org/10.1371/journal.pone.0227278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887216	Green Published, gold			2022-12-26	WOS:000515092200089
J	Moles, AT; Jagdish, A; Wu, YM; Gooley, S; Dalrymple, RL; Feng, P; Auld, J; Badgery, G; Balding, M; Bell, A; Campbell, N; Clark, M; Clark, M; Crawford, KM; de Lorenzo, O; Fletcher, A; Ford, Z; Fort, H; Gorta, SBZ; Hagan, A; Hemmings, FA; Hoban, GS; Hulme, T; King, K; Kumar, A; Kyriazis, A; Laitly, BA; Markovski, J; Martin, L; McDonnell, G; Pan, C; Paroissien, R; Reeves-Perrin, P; Sano, M; Schwarz, SM; Sipka, A; Sullings, M; Yeong, JW; Cornwell, WK				Moles, Angela T.; Jagdish, Ashika; Wu, Yameng; Gooley, Suzanna; Dalrymple, Rhiannon L.; Feng, Phoebe; Auld, Jennifer; Badgery, Georgia; Balding, Matilda; Bell, Andrew; Campbell, Nora; Clark, Mark; Clark, Michelle; Crawford, Kyle M.; de Lorenzo, Oliver; Fletcher, Amelia; Ford, Zoe; Fort, Haley; Gorta, Simon B. Z.; Hagan, Alexander; Hemmings, Frank A.; Hoban, Gabriella S.; Hulme, Thomasine; King, Kit; Kumar, Anish; Kyriazis, Angelique; Laitly, Beatrice Alexandra; Markovski, Joshua; Martin, Len; McDonnell, Geoffrey; Pan, Cindy; Paroissien, Ruby; Reeves-Perrin, Polly; Sano, Michi; Schwarz, Sebastian M.; Sipka, Alena; Sullings, Michael; Yeong, Jing Wei; Cornwell, William K.			From dangerous branches to urban banyan: Facilitating aerial root growth of Ficus rubiginosa	PLOS ONE			English	Article							FOREST; SURVIVAL; TREE	Large urban trees have many benefits. However, falling branches pose a serious hazard to both people and infrastructure. In several tree species, aerial roots grow down from branches to the ground. These roots are capable of thickening to support the branches, lessening the risk of tree failure. Unfortunately, in urban environments most aerial roots die before reaching the ground. Here, we report a new method for encouraging aerial roots to reach the ground, developed by the second-year botany class at UNSW Sydney. Our class tested three experimental treatments on aerial roots of Ficus rubiginosa Desf. ex Vent. (Port Jackson Fig)-PVC pipes filled with sphagnum moss, PVC pipes filled with potting mix, and PVC pipes filled with sphagnum moss and topped with funnels to catch extra rainwater. All three treatments significantly improved aerial root growth, with 26 of the 30 (87%) treatment roots reaching the ground after one year compared to 0 of the 10 control roots. Our method was successful for roots up to 3 m above the ground, suggesting the potential growth rate of aerial roots is substantial when conditions are favourable. Our novel approach is an attractive and cost-effective alternative to slings and other artificial supports. This project is an example of using undergraduate practical classes to teach science while simultaneously addressing important real-world problems.	[Moles, Angela T.; Jagdish, Ashika; Wu, Yameng; Gooley, Suzanna; Dalrymple, Rhiannon L.; Feng, Phoebe; Auld, Jennifer; Badgery, Georgia; Balding, Matilda; Bell, Andrew; Campbell, Nora; Clark, Michelle; Crawford, Kyle M.; de Lorenzo, Oliver; Fletcher, Amelia; Ford, Zoe; Fort, Haley; Gorta, Simon B. Z.; Hagan, Alexander; Hemmings, Frank A.; Hoban, Gabriella S.; Hulme, Thomasine; King, Kit; Kumar, Anish; Kyriazis, Angelique; Laitly, Beatrice Alexandra; Markovski, Joshua; Martin, Len; McDonnell, Geoffrey; Pan, Cindy; Paroissien, Ruby; Reeves-Perrin, Polly; Sano, Michi; Schwarz, Sebastian M.; Sipka, Alena; Yeong, Jing Wei; Cornwell, William K.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Clark, Mark] UNSW Sydney, Estate Management, Sydney, NSW, Australia; [Sullings, Michael] Sydney Arbor Trees, Botany, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Moles, AT (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	a.moles@unsw.edu.au	Moles, Angela T/C-3083-2008	Moles, Angela T/0000-0003-2041-7762; Crawford, Kyle/0000-0002-4603-2724; Hemmings, Frank/0000-0002-0355-0070; Gorta, Simon/0000-0002-7753-556X; Cornwell, Will/0000-0003-4080-4073; Paroissien, Ruby/0000-0001-6673-6414	Estate Management of UNSW Sydney	Estate Management of UNSW Sydney	This project was funded by Estate Management of UNSW Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2015, INT J HORTICULTURE, V5, P1, DOI DOI 10.5376/IJH.2015.05.0019; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beddie A., 1953, B WELLINGTON BOT SOC, V26, P2; Bengough AG, 2006, J EXP BOT, V57, P437, DOI 10.1093/jxb/erj003; Brookes A., 2007, AUST J OUTDOOR ED, V11, P50, DOI DOI 10.1007/BF03400857; CORNER EJH, 1976, PHILOS T ROY SOC B, V273, P359, DOI 10.1098/rstb.1976.0021; DWYER J F, 1991, Journal of Arboriculture, V17, P276; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fern K., 2018, TROPICAL PLANTS DATA; FETCHER N, 1985, INT J BIOMETEOROL, V29, P145, DOI 10.1007/BF02189035; Fife D, 2017, FIFER BIOSTATISTICIA, P1; Gill A, 1975, DEV FUNCTION ROOTS; Hanchi A, 1997, FOREST ECOL MANAG, V97, P231, DOI 10.1016/S0378-1127(97)00066-2; HENWOOD K, 1973, Biotropica, V5, P83, DOI 10.2307/2989657; Jenik J, 2010, TROPICAL TREES LIVIN, P323; Livesley SJ, 2016, J ENVIRON QUAL, V45, P119, DOI 10.2134/jeq2015.11.0567; Ludwig F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48652-w; Mathews M, 1997, J HORTIC SCI, V72, P27, DOI 10.1080/14620316.1997.11515488; Meineke E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1574; Meyer CFJ, 2004, BIOTROPICA, V36, P483, DOI 10.1111/j.1744-7429.2004.tb00344.x; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Patino S, 1999, J TROP ECOL, V15, P651, DOI 10.1017/S0266467499001078; Paul BK, 2010, NAT HAZARDS, V54, P483, DOI 10.1007/s11069-009-9480-2; Randwick City Council, 2007, SIGN TREES OTH GOV A; Schmidlin TW, 2009, NAT HAZARDS, V50, P13, DOI 10.1007/s11069-008-9314-7; Song XP, 2017, URBAN FOR URBAN GREE; Sutherland WJ, 2009, CONSERVATION SCI ACT; UNSW Sydney, 2016, SUST REP 2016 SUST U; van Noort F, 2019, HANDBOOK OF VANILLA SCIENCE AND TECHNOLOGY, 2ND EDITION, P157; Vogt Jess, 2015, Arboriculture & Urban Forestry, V41, P293; Yang XJ, 2017, PLANTA, V245, P507, DOI 10.1007/s00425-016-2621-4; Zhukovskaya NV, 2018, ANN BOT-LONDON, V122, P811, DOI 10.1093/aob/mcx216; ZIMMERMANN MH, 1968, WOOD SCI TECHNOL, V2, P95, DOI 10.1007/BF00394958	34	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226845	10.1371/journal.pone.0226845	http://dx.doi.org/10.1371/journal.pone.0226845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887183	Green Published, gold			2022-12-26	WOS:000515092200042
J	Vester, K; Santos, KF; Kuropka, B; Weise, C; Wahl, MC				Vester, Karen; Santos, Karine F.; Kuropka, Benno; Weise, Christoph; Wahl, Markus C.			The inactive C-terminal cassette of the dual-cassette RNA helicase BRR2 both stimulates and inhibits the activity of the N-terminal helicase unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein conformation; ATPase; RNA helicase; RNA splicing; dual-cassette Ski2-like helicase; intramolecular regulation; nucleic acid-dependent nucleotide triphosphatase (NTPase); small nuclear ribonucleoprotein U5 subunit 200 (SNRNP200); superfamily 2 helicase; pre-mRNA splicing	PRE-MESSENGER-RNA; CRYO-EM STRUCTURE; SIGNAL COINTEGRATOR 1; BOX ATPASES; TRANSCRIPTION COACTIVATOR; MOLECULAR ARCHITECTURE; ACTIVATED SPLICEOSOME; ATP HYDROLYSIS; PROTEIN; MECHANISM	The RNA helicase bad response to refrigeration 2 homolog (BRR2) is required for the activation of the spliceosome before the first catalytic step of RNA splicing. BRR2 represents a distinct subgroup of Ski2-like nucleic acid helicases whose members comprise tandem helicase cassettes. Only the N-terminal cassette of BRR2 is an active ATPase and can unwind substrate RNAs. The C-terminal cassette represents a pseudoenzyme that can stimulate RNA-related activities of the N-terminal cassette. However, the molecular mechanisms by which the C-terminal cassette modulates the activities of the N-terminal unit remain elusive. Here, we show that N- and C-terminal cassettes adopt vastly different relative orientations in a crystal structure of BRR2 in complex with an activating domain of the spliceosomal Prp8 protein at 2.4 ? resolution compared with the crystal structure of BRR2 alone. Likewise, inspection of BRR2 structures within spliceosomal complexes revealed that the cassettes occupy different relative positions and engage in different intercassette contacts during different splicing stages. Engineered disulfide bridges that locked the cassettes in two different relative orientations had opposite effects on the RNA-unwinding activity of the N-terminal cassette, with one configuration enhancing and the other configuration inhibiting RNA unwinding compared with the unconstrained protein. Moreover, we found that differences in relative positioning of the cassettes strongly influence RNA-stimulated ATP hydrolysis by the N-terminal cassette. Our results indicate that the inactive C-terminal cassette of BRR2 can both positively and negatively affect the activity of the N-terminal helicase unit from a distance.	[Vester, Karen; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Dept Biochem, Struct Biochem Grp, Takustr 6, D-14195 Berlin, Germany; [Kuropka, Benno; Weise, Christoph] Free Univ Berlin, Dept Biochem, Prot Biochem Grp, Thielallee 63, D-14195 Berlin, Germany; [Wahl, Markus C.] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog Grp, Albert Einstein Str 15, D-12489 Berlin, Germany; [Santos, Karine F.] 4TEEN4 Pharmaceut GmbH, Neuendorfstr 15b, D-16761 Hennigsdorf, Germany	Free University of Berlin; Free University of Berlin; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Wahl, MC (corresponding author), Free Univ Berlin, Struct Biochem, Takustr 6, D-14195 Berlin, Germany.	markus.wahl@fu-berlin.de	; Wahl, Markus/D-6365-2017	Kuropka, Benno/0000-0001-5088-6346; Wahl, Markus/0000-0002-2811-5307; Weise, Christoph/0000-0002-5507-4694	Deutsche Forschungsgemeinschaft [TRR186/A15-1]; Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin	This work was supported by Deutsche Forschungsgemeinschaft Grant TRR186/A15-1 (to M. C. W.) and by a Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin (to K. F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Absmeier E, 2017, CELL CYCLE, V16, P100, DOI 10.1080/15384101.2016.1255384; Absmeier E, 2016, CELL CYCLE, V15, P3362, DOI 10.1080/15384101.2016.1249549; Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bowers HA, 2006, RNA, V12, P903, DOI 10.1261/rna.2323406; Brickner JR, 2017, NATURE, V551, P389, DOI 10.1038/nature24484; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cordin O, 2014, NUCLEIC ACIDS RES, V42, P13897, DOI 10.1093/nar/gku1238; Cvackova Z, 2014, HUM MUTAT, V35, P308, DOI 10.1002/humu.22481; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Davignon L, 2016, HUM MOL GENET, V25, P1559, DOI 10.1093/hmg/ddw033; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Henning LM, 2017, NUCLEIC ACIDS RES, V45, P7922, DOI 10.1093/nar/gkx535; Hoskins AA, 2016, ELIFE, V5, DOI 10.7554/eLife.14166; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Knierim E, 2016, AM J HUM GENET, V98, P473, DOI 10.1016/j.ajhg.2016.01.006; Koodathingal P, 2013, RNA BIOL, V10, P1073, DOI 10.4161/rna.25245; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13; Liang WW, 2015, GENE DEV, V29, P81, DOI 10.1101/gad.253708.114; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mojumdar A, 2017, J BIOL CHEM, V292, P4176, DOI 10.1074/jbc.M116.767954; Mozaffari-Jovin S, 2014, RNA BIOL, V11, P298, DOI 10.4161/rna.28353; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Putnam AA, 2015, MOL CELL, V59, P541, DOI 10.1016/j.molcel.2015.06.030; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2001, ACTA CRYSTALLOGR D, V57, P1695, DOI 10.1107/S0907444901013105; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Theuser M, 2016, P NATL ACAD SCI USA, V113, P7798, DOI 10.1073/pnas.1524616113; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; van Nues RW, 2001, GENETICS, V157, P1451; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; WOLFF T, 1993, GENE DEV, V7, P1377, DOI 10.1101/gad.7.7b.1377; Wollenhaupt J, 2018, BIOPHYS J, V114, P788, DOI 10.1016/j.bpj.2017.12.033; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yang F, 2013, NUCLEIC ACIDS RES, V41, P4660, DOI 10.1093/nar/gkt149; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yankiwski V, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-11; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhang X, 2013, EYE, V27, P1204, DOI 10.1038/eye.2013.137; Zhang XF, 2019, CELL RES, V29, P274, DOI 10.1038/s41422-019-0143-x; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033	75	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2097	2112		10.1074/jbc.RA119.010964	http://dx.doi.org/10.1074/jbc.RA119.010964			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31914407	hybrid, Green Published			2022-12-26	WOS:000517128200026
J	Joly, JH; Delfarah, A; Phung, PS; Parrish, S; Graham, NA				Joly, James H.; Delfarah, Alireza; Phung, Philip S.; Parrish, Sydney; Graham, Nicholas A.			A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; cancer biology; redox regulation; Warburg effect; metabolomics; L-cystine; NADPH; SLC7A11	OXIDATIVE STRESS; GLUTAMINE-METABOLISM; INDUCED CYTOTOXICITY; XCT ANTIPORTER; H2O2 MEDIATE; TUMOR-CELLS; DEPENDENCY; SULFOXIMINE; ACTIVATION; INHIBITION	Metabolic reprogramming in cancer cells can increase their dependence on metabolic substrates such as glucose. As such, the vulnerability of cancer cells to glucose deprivation creates an attractive opportunity for therapeutic intervention. Because it is not possible to starve tumors of glucose in vivo, here we sought to identify the mechanisms in glucose deprivation-induced cancer cell death and then designed inhibitor combinations to mimic glucose deprivation-induced cell death. Using metabolomic profiling, we found that cells undergoing glucose deprivation-induced cell death exhibited dramatic accumulation of intracellular L-cysteine and its oxidized dimer, L-cystine, and depletion of the antioxidant GSH. Building on this observation, we show that glucose deprivation-induced cell death is driven not by the lack of glucose, but rather by L-cystine import. Following glucose deprivation, the import of L-cystine and its subsequent reduction to L-cysteine depleted both NADPH and GSH pools, thereby allowing toxic accumulation of reactive oxygen species. Consistent with this model, we found that the glutamate/cystine antiporter (xCT) is required for increased sensitivity to glucose deprivation. We searched for glycolytic enzymes whose expression is essential for the survival of cancer cells with high xCT expression and identified glucose transporter type 1 (GLUT1). Testing a drug combination that co-targeted GLUT1 and GSH synthesis, we found that this combination induces synthetic lethal cell death in high xCT-expressing cell lines susceptible to glucose deprivation. These results indicate that co-targeting GLUT1 and GSH synthesis may offer a potential therapeutic approach for targeting tumors dependent on glucose for survival.	[Joly, James H.; Delfarah, Alireza; Phung, Philip S.; Parrish, Sydney; Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Graham, Nicholas A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Graham, NA (corresponding author), Univ Southern Calif, 3710 McClintock Ave,RTH 509, Los Angeles, CA 90089 USA.	nagraham@usc.edu	Delfarah, Alireza/AAN-2110-2020; Graham, Nicholas A./X-2738-2019; Graham, Nicholas/GYD-5066-2022	Graham, Nicholas A./0000-0002-6811-1941; Graham, Nicholas/0000-0002-6811-1941; Joly, James/0000-0003-3780-9412; Delfarah, Alireza/0000-0002-3192-5941	American Cancer Society [IRG-16-181-57]; Rose Hills Foundation; USC Provost's Office; Viterbi School of Engineering	American Cancer Society(American Cancer Society); Rose Hills Foundation; USC Provost's Office; Viterbi School of Engineering	This work supported by American Cancer Society Grant IRG-16-181-57, the Rose Hills Foundation, the USC Provost's Office, and the Viterbi School of Engineering. The authors declare that they have no conflicts of interest with the contents of this article.	Adams DJ, 2014, ACS CHEM BIOL, V9, P2247, DOI 10.1021/cb500347p; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Andringa KK, 2006, CANCER RES, V66, P1605, DOI 10.1158/0008-5472.CAN-05-3462; Arensman MD, 2019, P NATL ACAD SCI USA, V116, P9533, DOI 10.1073/pnas.1814932116; ARRICK BA, 1982, J BIOL CHEM, V257, P1231; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; Cairns RA, 2016, NAT REV CANCER, V16, P613, DOI 10.1038/nrc.2016.100; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delfarah A, 2019, J BIOL CHEM, V294, P10564, DOI 10.1074/jbc.RA118.005806; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ganapathy-Kanniappan S, 2012, ONCOTARGET, V3, P940, DOI 10.18632/oncotarget.623; Goji T, 2017, J BIOL CHEM, V292, P19721, DOI 10.1074/jbc.M117.814392; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; HAWKINS RA, 1992, J NUCL MED, V33, P339; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HIRONO I, 1961, GANN, V52, P39; Ho SM, 2017, STEM CELL REP, V9, P615, DOI 10.1016/j.stemcr.2017.06.012; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Jae HJ, 2009, KOREAN J RADIOL, V10, P596, DOI 10.3348/kjr.2009.10.6.596; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Krejsa CM, 2010, J BIOL CHEM, V285, P16116, DOI 10.1074/jbc.M110.116210; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Labak CM, 2016, AM J CANCER RES, V6, P1599; Lee HY, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam7893; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Leonard PG, 2016, NAT CHEM BIOL, V12, P1053, DOI [10.1038/NCHEMBIO.2195, 10.1038/nchembio.2195]; Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miwa H, 2013, ONCOL REP, V29, P2053, DOI 10.3892/or.2013.2299; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Ottestad-Hansen S, 2018, GLIA, V66, P951, DOI 10.1002/glia.23294; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Priebe A, 2011, GYNECOL ONCOL, V122, P389, DOI 10.1016/j.ygyno.2011.04.024; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan Michelle, 2017, React Oxyg Species (Apex), V3, P47, DOI 10.20455/ros.2017.801; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Villablanca JG, 2016, PEDIATR BLOOD CANCER, V63, P1349, DOI 10.1002/pbc.25994; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	67	19	19	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1350	1365		10.1074/jbc.RA119.011471	http://dx.doi.org/10.1074/jbc.RA119.011471			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31914417	Bronze, Green Published, Green Submitted			2022-12-26	WOS:000513822300015
J	Giusti, M; Samuelsson, K				Giusti, Matteo; Samuelsson, Karl			The regenerative compatibility: A synergy between healthy ecosystems, environmental attitudes, and restorative experiences	PLOS ONE			English	Article							COMPACT CITY; STRESS RECOVERY; URBAN DENSITY; ENERGY USE; BIODIVERSITY; BENEFITS; EXPOSURE; IMPACT; CONNECTION; GENDER	Urban nature is and will be the most common provider of nature interactions for humankind. The restorative benefits of nature exposure are renown and creating human habitats that simultaneously support people's wellbeing and ecological sustainability is an urgent priority. In this study, we investigate how the relationship between environmental attitudes and healthy ecosystems influences restorative experiences combining a place-based online survey with geographical data on ecosystem health in Stockholm (Sweden). Using spatial regression, we predict the 544 restorative experiences (from 325 respondents), with people's environmental attitudes, natural land covers, ecosystem health, and the statistical interactions among these variables as predictors. Our results show that restorative experiences can happen anywhere in the urban landscape, but when they occur in natural environments, the combined levels of biodiversity and ecological connectivity are better predicting factor than the mere presence of nature. That is, healthy ecosystems seem to be more important than just any nature for restorative experiences. Moreover, the statistical interaction between one's environmental attitudes and natural environments predict almost all restorative experiences better than when these variables are independent predictors. This suggests that there is synergistic compatibility between environmental attitudes and healthy ecosystems that triggers restorative processes. We call this synergy regenerative compatibility. Regenerative compatibility is an unexploited potential that emerges when people's attitudes and ecosystems are aligned in sustainability. We consider regenerative compatibility a valuable leverage point to transform towards ecologically sustainable and healthy urban systems. To this end, we encourage multifaceted policy interventions that regenerate human-nature relationships holistically rather than implement atomistic solutions.	[Giusti, Matteo] Univ Gavle, Dept Bldg Engn Energy Syst & Sustainabil Sci, Gavle, Sweden; [Samuelsson, Karl] Univ Gavle, Dept Geospatial & Comp Sci, Gavle, Sweden	University of Gavle; University of Gavle	Giusti, M (corresponding author), Univ Gavle, Dept Bldg Engn Energy Syst & Sustainabil Sci, Gavle, Sweden.	matteo.giusti@hig.se		Samuelsson, Karl/0000-0002-7936-3722; Giusti, Matteo/0000-0003-0179-2540	Formas supported project ZEUS [2016-01193]	Formas supported project ZEUS	We thank the Formas supported project ZEUS (ref no.: 2016-01193) granted to S.B. for supporting this work. formas.se The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2017, AMBIO, V46, P30, DOI 10.1007/s13280-016-0800-y; Altman I., 1987, HDB ENV PSYCHOL, P7; Alvarsson JJ, 2010, INT J ENV RES PUB HE, V7, P1036, DOI 10.3390/ijerph7031036; Andersson E, 2019, BIOSCIENCE, V69, P566, DOI 10.1093/biosci/biz058; Andersson E, 2014, AMBIO, V43, P445, DOI 10.1007/s13280-014-0506-y; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Barbaro N, 2015, PERS INDIV DIFFER, V75, P220, DOI 10.1016/j.paid.2014.11.032; Barthel S, 2015, KARTLAGGNING ANAL EK; Beatley T, 2010, BIOPHILIC CITIES; Bennett EM, 2017, ECOSYSTEMS, V20, P31, DOI 10.1007/s10021-016-0049-0; Bennett EM, 2015, CURR OPIN ENV SUST, V14, P76, DOI 10.1016/j.cosust.2015.03.007; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Biggs R., 2015, PRINCIPLES BUILDING, DOI [10.1017/CBO9781316014240, DOI 10.1017/CBO9781316014240]; Bivand R., 2017, SPATIAL DEPENDENCE W; Bjerke T., 2006, Managing Leisure, V11, P116, DOI 10.1080/13606710500520197; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Charles C., 2018, HOME US ALL CONNECTI; Chawla L., 1999, J ENVIRON EDUC, V31, P15, DOI [10.1080/00958969909598628, DOI 10.1080/00958969909598628]; Chemero A, 2009, BRADFORD BOOKS, P1; Cheng JCH, 2012, ENVIRON BEHAV, V44, P31, DOI 10.1177/0013916510385082; Clayton S., 2003, IDENTITY NATURAL ENV, P45, DOI [10.7551/mitpress/3644.001.0001, DOI 10.7551/MITPRESS/3644.001.0001]; Cole RJ, 2012, BUILD RES INF, V40, P1, DOI 10.1080/09613218.2012.617516; Collado S, 2016, J ENVIRON PSYCHOL, V48, P24, DOI 10.1016/j.jenvp.2016.08.004; Costanza Robert, 1999, Aquatic Ecology, V33, P105, DOI 10.1023/A:1009930313242; Costanza R, 2012, ECOL ENG, V45, P24, DOI 10.1016/j.ecoleng.2012.03.023; Cox DTC, 2018, LANDSCAPE URBAN PLAN, V179, P72, DOI 10.1016/j.landurbplan.2018.07.013; Davis N., 2013, ECOPSYCHOLOGY, V5, P92, DOI [10.1089/eco.2013.0016, DOI 10.1089/ECO.2013.0016, https://doi.org/10.1089/eco.2013.0016]; Du Plessis C, 2015, J CLEAN PROD, V109, P53, DOI 10.1016/j.jclepro.2014.09.098; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Edwards A., 2005, SUSTAINABILITY REVOL; Ellis RJ, 1997, AM POLIT SCI REV, V91, P885, DOI 10.2307/2952171; Engemann K, 2019, P NATL ACAD SCI USA, V116, P5188, DOI 10.1073/pnas.1807504116; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Foord J., 2010, BUILD ENVIRON, V36, P47; Franco LS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080864; Gatersleben B, 2013, HEALTH PLACE, V20, P91, DOI 10.1016/j.healthplace.2013.01.001; GIBSON James J., 1979, ECOLOGICAL APPROACH; Gifford R, 2014, INT J PSYCHOL, V49, P141, DOI 10.1002/ijop.12034; Gifford R, 2014, ANNU REV PSYCHOL, V65, P541, DOI 10.1146/annurev-psych-010213-115048; Giusti M., 2018, HOME FUTURE EARTH LO; Giusti M., 2014, CHILD YOUTH ENV, V24, P16, DOI 10.7721/chilyoutenvi.24.3.0016; Giusti M, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02283; Grahn P, 2010, LANDSCAPE URBAN PLAN, V94, P264, DOI 10.1016/j.landurbplan.2009.10.012; Guneralp B, 2017, P NATL ACAD SCI USA, V114, P8945, DOI 10.1073/pnas.1606035114; GUTTELING JM, 1993, SEX ROLES, V28, P433, DOI 10.1007/BF00289606; Haga A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01831; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartig T, 1997, SCAND HOUS PLAN RES, V14, P175, DOI 10.1080/02815739708730435; Hartig T, 2016, SCIENCE, V352, P938, DOI 10.1126/science.aaf3759; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Ives CD, 2018, SUSTAIN SCI, V13, P1389, DOI 10.1007/s11625-018-0542-9; Ives CD, 2014, J ENVIRON MANAGE, V144, P67, DOI 10.1016/j.jenvman.2014.05.013; Kahn PH, 2009, CURR DIR PSYCHOL SCI, V18, P37, DOI 10.1111/j.1467-8721.2009.01602.x; Kaiser FG, 2014, EUR REV APPL PSYCHOL, V64, P269, DOI 10.1016/j.erap.2014.09.001; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kennedy CA, 2015, P NATL ACAD SCI USA, V112, P5985, DOI 10.1073/pnas.1504315112; Khan A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000353; Klum Matthias, 2015, BIG WORLD SMALL PLAN; Korpela K, 2017, LANDSCAPE URBAN PLAN, V160, P38, DOI 10.1016/j.landurbplan.2016.12.005; Lee KE, 2015, J ENVIRON PSYCHOL, V42, P182, DOI 10.1016/j.jenvp.2015.04.003; Lin BB, 2017, LANDSCAPE URBAN PLAN, V157, P239, DOI 10.1016/j.landurbplan.2016.07.007; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Luchs MG, 2012, J CONSUM POLICY, V35, P127, DOI 10.1007/s10603-011-9179-0; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Neuman M, 2005, J PLAN EDUC RES, V25, P11, DOI 10.1177/0739456X04270466; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Ohly H, 2016, J TOXICOL ENV HEAL B, V19, P305, DOI 10.1080/10937404.2016.1196155; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Perkins HE, 2010, J ENVIRON PSYCHOL, V30, P455, DOI 10.1016/j.jenvp.2010.05.004; Pyle R. M., 1993, THUNDER TREE LESSONS; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2016, R LANG ENV STAT COMP, P3503, DOI [10.1007/978-3-540-74686-7, DOI 10.1007/978-3-540-74686-7]; Raymond CM, 2018, J ENVIRON PLANN MAN, V61, P778, DOI 10.1080/09640568.2017.1312300; Raymond CM, 2017, ENVIRON SCI POLICY, V77, P15, DOI 10.1016/j.envsci.2017.07.008; Reed Bill., 2006, RETHINKING SUSTAINAB, P1; Resch E, 2016, ENRGY PROCED, V96, P800, DOI 10.1016/j.egypro.2016.09.142; Rockstrom J, 2009, ECOL SOC, V14; Roe J, 2011, LANDSCAPE RES, V36, P535, DOI 10.1080/01426397.2010.543670; Samuelsson K, 2019, LANDSCAPE URBAN PLAN, V187, P70, DOI 10.1016/j.landurbplan.2019.03.015; Samuelsson K, 2018, LANDSCAPE URBAN PLAN, V171, P7, DOI 10.1016/j.landurbplan.2017.11.009; Scannell L, 2013, ENVIRON BEHAV, V45, P60, DOI 10.1177/0013916511421196; Scopelliti M, 2004, J ENVIRON PSYCHOL, V24, P423, DOI 10.1016/j.jenvp.2004.11.002; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soga M, 2014, J APPL ECOL, V51, P1378, DOI 10.1111/1365-2664.12280; Staats H, 2004, J ENVIRON PSYCHOL, V24, P199, DOI 10.1016/j.jenvp.2003.12.005; Stanley MC, 2015, FRONT ECOL ENVIRON, V13, P553, DOI 10.1890/150229; STERN PC, 1993, ENVIRON BEHAV, V25, P322, DOI 10.1177/0013916593255002; Tabrizian P, 2018, J ENVIRON PSYCHOL, V55, P99, DOI 10.1016/j.jenvp.2018.01.001; Tam KP, 2013, J ENVIRON PSYCHOL, V34, P64, DOI 10.1016/j.jenvp.2013.01.004; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; UNHABITAT, 2016, URB DEV EM FUT, DOI DOI 10.1016/S0264-2751(03)00010-6; Van der Waals JFM, 2000, TIJDSCHR ECON SOC GE, V91, P111, DOI 10.1111/1467-9663.00099; van Heezik Y, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01673; von Hertzen L, 2011, EMBO REP, V12, P1089, DOI 10.1038/embor.2011.195; von Lindern E, 2015, J OUTDO RECREAT TOUR, V10, P29, DOI 10.1016/j.jort.2015.06.001; von Lindern E, 2013, LANDSCAPE URBAN PLAN, V118, P90, DOI 10.1016/j.landurbplan.2013.03.001; Wentz EA, 2018, LANDSCAPE URBAN PLAN, V179, P55, DOI 10.1016/j.landurbplan.2018.07.007; White MP, 2013, J ENVIRON PSYCHOL, V35, P40, DOI 10.1016/j.jenvp.2013.04.002; Zylstra M., 2014, SPRINGER SCI REV, V2, P119, DOI [DOI 10.1007/S40362-014-0021-3, 10.1007/s40362-014-0021-3]	106	15	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227311	10.1371/journal.pone.0227311	http://dx.doi.org/10.1371/journal.pone.0227311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5BZ	31910442	Green Published, gold			2022-12-26	WOS:000534333800041
J	Lee, SH; Soh, H; Chung, JH; Cho, EH; Lee, SJ; Ju, JM; Sheen, JH; Kim, H; Oh, SJ; Lee, SJ; Chung, J; Choi, K; Kim, SY; Ryu, JS				Lee, Suk Hyun; Soh, Hyunsu; Chung, Jin Hwa; Cho, Eun Hye; Lee, Sang Ju; Ju, Ji-Min; Sheen, Joong Hyuk; Kim, Hyori; Oh, Seung Jun; Lee, Sang-Jin; Chung, Junho; Choi, Kyungho; Kim, Seog-Young; Ryu, Jin-Sook			Feasibility of real-time in vivo Zr-89-DFO-labeled CAR T-cell trafficking using PET imaging	PLOS ONE			English	Article							ADOPTIVE TRANSFER; IMMUNOTHERAPY; LYMPHOCYTES; TRACKING; TUMORS	Introduction Chimeric antigen receptor (CAR) T-cells have been recently developed and are producing impressive outcomes in patients with hematologic malignancies. However, there is no standardized method for cell trafficking and in vivo CAR T-cell monitoring. We assessed the feasibility of real-time in vivo Zr-89-p-Isothiocyanatobenzyl-desferrioxamine (Df-Bz-NCS, DFO) labeled CAR T-cell trafficking using positron emission tomography (PET). Results The Zr-89-DFO radiolabeling efficiency of Jurkat/CAR and human peripheral blood mononuclear cells (hPBMC)/CAR T-cells was 70%-79%, and cell radiolabeling activity was 98.1-103.6 kBq/10(6) cells. Cell viability after radiolabeling was > 95%. Cell proliferation was not significantly different during the early period after radiolabeling, compared with unlabeled cells; however, the proliferative capacity decreased over time (day 7 after labeling). IL-2 or IFN-. secretion was not significantly different between unlabeled and labeled CAR T-cells. PET/magnetic resonance imaging in the xenograft model showed that most of the (ZrDFO)-Zr-89-labeled Jurkat/CAR T-cells were distributed in the lung (24.4% +/- 3.4%ID) and liver (22.9% +/- 5.6%ID) by one hour after injection. The cells gradually migrated from the lung to the liver and spleen by day 1, and remained stable in these sites until day 7 (on day 7: lung 3.9% +/- 0.3%ID, liver 36.4% +/- 2.7%ID, spleen 1.4% +/- 0.3%ID). No significant accumulation of labeled cells was identified in tumors. A similar pattern was observed in ex vivo biodistributions on day 7 (lung 3.0% +/- 1.0%ID, liver 19.8% +/- 2.2%ID, spleen 2.3% +/- 1.7%ID). Zr-89-DFO-labeled hPBMC/CAR T-cells showed a similar distribution, compared with Jurkat/CAR T-cells, on serial PET images. CAR T cell distribution was cross-confirmed by flow cytometry, Alu polymerase chain reaction, and immunohistochemistry. Conclusion Real-time in vivo cell trafficking is feasible using PET imaging of Zr-89-DFO-labeled CAR T-cells. This can be used to investigate cellular kinetics, initial in vivo biodistribution, and safety profiles in future CAR T-cell development.	[Lee, Suk Hyun; Cho, Eun Hye; Lee, Sang Ju; Oh, Seung Jun; Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Lee, Suk Hyun] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Radiol,Div Nucl Med, Seoul, South Korea; [Soh, Hyunsu; Chung, Jin Hwa] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Chung, Jin Hwa; Kim, Hyori; Kim, Seog-Young] Asan Med Ctr, Convergence Med Res Ctr, Seoul, South Korea; [Ju, Ji-Min; Sheen, Joong Hyuk; Lee, Sang-Jin] Natl Canc Ctr, Res Inst, Gyeonggi Do, South Korea; [Chung, Junho; Choi, Kyungho] Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; Hallym University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); Seoul National University (SNU)	Ryu, JS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea.; Kim, SY (corresponding author), Asan Med Ctr, Convergence Med Res Ctr, Seoul, South Korea.	sykim3@amc.seoul.kr; jsryu2@amc.seoul.kr	LEE, SUK HYUN/GNP-8159-2022	Ju, Ji-MIn/0000-0002-0000-7232; Lee, Suk Hyun/0000-0003-4580-3918	Ministry of Food and Drug Safety [17172MFDS212]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1090]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the grant of Ministry of Food and Drug Safety (grant number: 17172MFDS212) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1090).	Abou DS, 2011, NUCL MED BIOL, V38, P675, DOI 10.1016/j.nucmedbio.2010.12.011; Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Bansal A, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0098-y; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Charoenphun P, 2015, EUR J NUCL MED MOL I, V42, P278, DOI 10.1007/s00259-014-2945-x; Chen YP, 2017, THERANOSTICS, V7, P3585, DOI 10.7150/thno.21471; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; De Oliveira SN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-23; FISHER B, 1989, J CLIN ONCOL, V7, P250, DOI 10.1200/JCO.1989.7.2.250; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Parente-Pereira AC, 2011, J CLIN IMMUNOL, V31, P710, DOI 10.1007/s10875-011-9532-8; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; READ EJ, 1990, J NUCL MED, V31, P999; Roca M, 2010, EUR J NUCL MED MOL I, V37, P835, DOI 10.1007/s00259-010-1393-5; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sato N, 2015, RADIOLOGY, V275, P490, DOI 10.1148/radiol.15142849; SMITH ME, 1983, IMMUNOLOGY, V49, P83; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; WAGSTAFF J, 1981, CLIN EXP IMMUNOL, V43, P443; Wang H, 2018, TRANSPL P, V50, P104, DOI 10.1016/j.transproceed.2017.11.028; Weist MR, 2018, J NUCL MED, V59, P1531, DOI 10.2967/jnumed.117.206714; Zheng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-29	31	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0223814	10.1371/journal.pone.0223814	http://dx.doi.org/10.1371/journal.pone.0223814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910217	gold, Green Submitted, Green Published			2022-12-26	WOS:000534333800005
J	Duan, CW; Fukuda, T; Isaji, T; Qi, F; Yang, J; Wang, YQ; Takahashi, S; Gu, JG				Duan, Chengwei; Fukuda, Tomohiko; Isaji, Tomoya; Qi, Feng; Yang, Jie; Wang, Yuqin; Takahashi, Shinichiro; Gu, Jianguo			Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell system	FASEB JOURNAL			English	Article						acute myeloid leukemia; cellular signaling; core fucosylation; FLT3; Fut8	INTERNAL TANDEM DUPLICATION; GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; CONSTITUTIVE ACTIVATION; N-ACETYLGLUCOSAMINE; ARSENIC TRIOXIDE; KINASE; INHIBITION; MUTATIONS; FUCOSE	Fms-like tyrosine kinase 3 (FLT3) is a glycoprotein, that is a member of the class III receptor tyrosine kinase family. Approximately one-third of acute myeloid leukemia (AML) patients have mutations of this gene, and activation of the FLT3 downstream pathway plays an important role in both normal and malignant hematopoiesis. However, the role of N-glycosylation for FLT3 activation remains unclear. In this study, we showed that the N-glycan structures on wild type (WT), internal tandem duplication (ITD), and tyrosine kinase domain (TKD) mutants of FLT3 were different. Interestingly, expression of either WT or mutant FLT3 in Ba/F3 cells, an interleukin-3 (IL-3)-dependent hematopoietic progenitor cell, greatly induced core fucosylation. To elucidate the function of core fucosylation in FLT3-mediated signaling, we used a CRISPR/Cas9 system to establish alpha 1,6-fucosyltransferase (Fut8) knockout (KO) cells. Surprisingly, the Fut8KO resulted in cell proliferation in an IL-3-independent manner in FLT3-WT cells, which was not observed in the parental cells, and suggested that this proliferation is dependent on FLT3 expression. Fut8KO greatly increased cellular tyrosine phosphorylation levels, together with an activation of STAT5, AKT, and ERK signaling, which could be completely neutralized by restoration with Fut8 in the KO cells. Consistently, a tyrosine kinase inhibitor efficiently inhibited cell proliferation induced by Fut8KO or specific fucosylation inhibitor. Additionally, immunostaining with FLT3 showed that the proteins were mainly expressed on the cell surface in the KO cells, which is similar to FLT3-WT cells, but different from the ITD mutant. Finally, we found that Fut8KO could induce dimer-formation in FLT3 without ligand-stimulation. Taken together, the present study clearly defines the regulatory function of core fucosylation in FLT3, which could provide a valuable direction for development of drugs could be effective in the treatment of AML.	[Duan, Chengwei; Fukuda, Tomohiko; Isaji, Tomoya; Qi, Feng; Yang, Jie; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Wang, Yuqin] Nantong Univ, Dept Pharmacol, Coll Pharm, Nantong, Peoples R China; [Takahashi, Shinichiro] Tohoku Med & Pharmaceut Univ, Div Lab Med, Fac Med, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University; Nantong University; Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.; Takahashi, S (corresponding author), Tohoku Med & Pharmaceut Univ, Fac Med, Div Lab Med, Miyagino Ku, 1-15-1 Fukumuro, Sendai, Miyagi 9838536, Japan.	shintakahashi@tohoku-mpu.ac.jp; jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Japan Society for the Promotion of Science [19H03184, 17K09019, 17K08284]; National Natural Science Foundation of China [31670807]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H04868]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Japan Society for the Promotion of Science, Grant/Award Number: 19H03184, 17K09019 and 17K08284; National Natural Science Foundation of China, Grant/Award Number: 31670807; Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 18H04868	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bacher U, 2008, BLOOD, V111, P2527, DOI 10.1182/blood-2007-05-091215; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Callus BA, 1998, BLOOD, V91, P3182, DOI 10.1182/blood.V91.9.3182.3182_3182_3192; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Daver N, 2019, LEUKEMIA, V33, P299, DOI 10.1038/s41375-018-0357-9; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grafone T, 2012, ONCOL REV, V6, P64, DOI 10.4081/oncol.2012.e8; Gu W, 2015, J BIOL CHEM, V290, P17566, DOI 10.1074/jbc.M114.579938; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kazi JU, 2019, PHYSIOL REV, V99, P1433, DOI 10.1152/physrev.00029.2018; KEENAN RW, 1981, BIOCHEMISTRY-US, V20, P2968, DOI 10.1021/bi00513a039; Kiyoi H, 2002, ONCOGENE, V21, P2555, DOI 10.1038/sj.onc.1205332; Kizuka Y, 2017, CELL CHEM BIOL, V24, P1467, DOI 10.1016/j.chembiol.2017.08.023; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Koch S, 2008, CELLS TISSUES ORGANS, V188, P225, DOI 10.1159/000118788; Larrue C, 2015, MOL CANCER THER, V14, P2364, DOI 10.1158/1535-7163.MCT-15-0163; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Liang W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00078; Liu J, 2013, EUR J MED CHEM, V65, P83, DOI 10.1016/j.ejmech.2013.03.035; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu X, 2019, BBA-GEN SUBJECTS, V1863, P598, DOI 10.1016/j.bbagen.2018.12.008; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nagai Kozo, 2018, Oncotarget, V9, P32885, DOI 10.18632/oncotarget.25972; Nakao M, 1996, LEUKEMIA, V10, P1911; Ng BG, 2018, AM J HUM GENET, V102, P188, DOI 10.1016/j.ajhg.2017.12.009; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okada M, 2017, CELL REP, V20, P1017, DOI 10.1016/j.celrep.2017.07.027; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reiter K, 2018, LEUKEMIA, V32, P313, DOI 10.1038/leu.2017.257; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Steffen B, 2005, CRIT REV ONCOL HEMAT, V56, P195, DOI 10.1016/j.critrevonc.2004.10.012; Takahashi S, 2005, LEUKEMIA RES, V29, P893, DOI 10.1016/j.leukres.2005.01.008; Takahashi S, 2004, BLOOD, V103, P4650, DOI 10.1182/blood-2003-08-2759; Takahashi S, 2006, INT J HEMATOL, V84, P256, DOI 10.1532/IJH97.06076; Takahashi S, 2016, BIOMED REP, V4, P83, DOI 10.3892/br.2015.541; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-13; Takahashi S, 2010, ANTI-CANCER AGENT ME, V10, P504, DOI 10.2174/1871520611009060504; Tse KF, 2000, LEUKEMIA, V14, P1766, DOI 10.1038/sj.leu.2401905; Tsitsipatis D, 2017, ONCOTARGET, V8, P26613, DOI 10.18632/oncotarget.15772; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YQ, 2015, FASEB J, V29, P3217, DOI 10.1096/fj.15-270710; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Wu M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0675-4; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11911-9	79	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3239	3252		10.1096/fj.201902313RR	http://dx.doi.org/10.1096/fj.201902313RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908039	Bronze			2022-12-26	WOS:000505692700001
J	Guri, A; Flaks-Manov, N; Ghilai, A; Hoshen, M; Rimon, OF; Ciobotaro, P; Zimhony, O				Guri, Alex; Flaks-Manov, Natalie; Ghilai, Adi; Hoshen, Moshe; Rimon, Orna Flidel; Ciobotaro, Pnina; Zimhony, Oren			Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; TRACT-INFECTIONS; PREGNANT-WOMEN; PREVALENCE; COMMUNITY; COLONIZATION; TRANSMISSION; BACTERIURIA	Third-generation-cephalosporin resistant Enterobacteriaceae (3GCR-EB) carriage in pregnant women poses challenges for infection control and therapeutic decisions. The factors associated with multidrug resistant Enterobacteriaceae carriage in the gestational period are not well documented. The aim of our study was to identify risk factors associated with 3GCR-EB isolation in gestational urine cultures. The study was designed as retrospective cohort based on centralized electronic health records database. Women delivered in Clalit Health Services hospitals in Israel in 2009-2013 and provided urine culture(s) during pregnancy were included. Multivariable analysis using the Generalized Estimating Equations model was used to assess risk factors for 3GCR-EB isolation in gestational urine cultures. The study included 15,282 pregnant women with urine cultures yielding Enterobacteriaceae (EB). The proportion of 3GCR-EB in EB isolates was 3.9% (n = 603). The following risk factors were associated with 3GCR-EB isolation: multiple hospital admissions during the year before delivery (OR,1.47;95% CI,1.21-1.79), assisted fertilization procedure (OR,1.53; 95% CI,1.12-2.10), Arab ethnicity (OR,1.22; 95% CI,1.03-1.45), multiple antibiotic courses (OR,1.76; 95% CI,1.29-2.40), specifically, cephalosporins (OR,1.56; 95% CI,1.26-1.95), fluoroquinolones (OR,1.34; 95% CI,1.04-1.74), or nitrofurantoin (OR,1.29; 95% CI,1.021.64). The risk factors identified by this study for 3GCR-EB in gestation, can be easily generalized for pregnant women in the Israeli population. Moreover, these risk factors, other than ethnicity, are applicable to pregnant women worldwide. The information of previous antibiotic treatments, hospitalization in the last year and assisted fertilization procedure can be easily accessed and used for appropriate infection control practices and antimicrobial therapy.	[Guri, Alex] Kaplan Med Ctr, Div Pediat, Rehovot, Israel; [Guri, Alex; Rimon, Orna Flidel; Ciobotaro, Pnina; Zimhony, Oren] Hebrew Univ Jerusalem, Sch Med, Jerusalem, Israel; [Guri, Alex; Rimon, Orna Flidel; Ciobotaro, Pnina; Zimhony, Oren] Hadassah Med Ctr, Jerusalem, Israel; [Flaks-Manov, Natalie; Ghilai, Adi; Hoshen, Moshe] Clalit Hlth Serv, Clalit Res Inst, Chief Phys Off, Tel Aviv, Israel; [Rimon, Orna Flidel] Kaplan Med Ctr, Neonatol Dept, Rehovot, Israel; [Ciobotaro, Pnina; Zimhony, Oren] Kaplan Med Ctr, Infect Dis Unit, Rehovot, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center	Guri, A (corresponding author), Kaplan Med Ctr, Div Pediat, Rehovot, Israel.; Guri, A (corresponding author), Hebrew Univ Jerusalem, Sch Med, Jerusalem, Israel.; Guri, A (corresponding author), Hadassah Med Ctr, Jerusalem, Israel.	alexgur@clalit.org.il	Flaks-Manov, Natalie/AAV-9683-2020	Flaks-Manov, Natalie/0000-0002-9163-6295				Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Al-Assil B, 2013, AM J INFECT CONTROL, V41, P597, DOI 10.1016/j.ajic.2012.09.016; Bar-Oz B, 2009, EUR J OBSTET GYN R B, V143, P75, DOI 10.1016/j.ejogrb.2008.12.007; Bidell MR, 2016, ANTIMICROB AGENTS CH, V60, P3170, DOI 10.1128/AAC.02505-15; Chereau F, 2015, ANTIMICROB AGENTS CH, V59, P3652, DOI 10.1128/AAC.00029-15; *CLSI, 2008, M100S18 CLSI S; Danino D, 2018, J HOSP INFECT, V100, P40, DOI 10.1016/j.jhin.2017.12.024; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jorgensen SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173510; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Megged O, 2014, PEDIATR NEPHROL, V29, P1583, DOI 10.1007/s00467-014-2810-y; Mendelson G, 2005, EUR J CLIN MICROBIOL, V24, P17, DOI 10.1007/s10096-004-1264-8; MITTENDORF R, 1992, CLIN INFECT DIS, V14, P927, DOI 10.1093/clinids/14.4.927; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; PHILIPPON A, 1989, ANTIMICROB AGENTS CH, V33, P1131, DOI 10.1128/AAC.33.8.1131; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Rettedal S, 2015, J PERINATOL, V35, P907, DOI 10.1038/jp.2015.82; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Rosen B, 2015, HEALT SYST TRANSIT, V17, P1; Ruppe E, 2013, ANTIMICROB AGENTS CH, V57, P4512, DOI 10.1128/AAC.00238-13; Smaill FM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub3; Sogaard M, 2017, CLIN MICROBIOL INFEC, V23, P952, DOI 10.1016/j.cmi.2017.03.026; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; STENQVIST K, 1989, AM J EPIDEMIOL, V129, P372, DOI 10.1093/oxfordjournals.aje.a115140; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Zaoutis TE, 2005, PEDIATRICS, V115, P942, DOI 10.1542/peds.2004-1289	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226515	10.1371/journal.pone.0226515	http://dx.doi.org/10.1371/journal.pone.0226515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899777	Green Published, gold			2022-12-26	WOS:000534322000004
J	Miller, JC; Shepherd, J; Rinderknecht, D; Cheng, AL; Pahlevan, NM				Miller, Jennifer C.; Shepherd, Jennifer; Rinderknecht, Derek; Cheng, Andrew L.; Pahlevan, Niema M.			Proof-of-concept for a non-invasive, portable, and wireless device for cardiovascular monitoring in pediatric patients	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; 2-DIMENSIONAL ECHOCARDIOGRAPHY; 3-DIMENSIONAL ECHOCARDIOGRAPHY; AMERICAN-SOCIETY; RECOMMENDATIONS; PERFORMANCE; MASS	Measurement of cardiac function is vital for the health of pediatric patients with heart disease. Standard tools to measure function including echocardiogram and magnetic residence imaging are time intensive, costly, and have limited accessibility. The Vivio is a novel, non-invasive, handheld device that screens for cardiac dysfunction by analyzing intrinsic frequencies (IF) omega(1) and omega(2) of carotid artery waveforms. Prior studies demonstrated that left ventricular ejection fraction can be derived from IFs in adults. This study 1) studies whether the Vivio can capture carotid arterial pulse waveform data in children ages 0-19 years old; 2) tests the performance of two sensor head geometries, one larger and smaller than the standard size used in adults, designed for the pediatric population; 3) compares the IFs between pediatric age groups and adults with normal function. The Vivio successfully measured a carotid artery waveform in all children over 5 years old and 28% of children under the age of five. The small head did not accurately measure a waveform in any age group. One-way analysis of variance (ANOVA) demonstrated a difference in the IF omega(1) between the adult and pediatric cohorts (F = 7.3, Prob>F = 0.0001). Post host analysis demonstrated a difference between the adult cohort (omega(1) = 99 +/- 5 bpm) and the cohorts ages 0-4 (omega(1) = 111 +/- 2 bpm; p = 0.0006) and 15-19 years old (omega(1) = 105 +/- 5 bpm; p = 0.02). One-way ANOVA demonstrated a difference in the IF omega(2) between the adult and pediatric cohorts (F = 4.8, Prob>F = 0.003), specifically between the adult (omega(2) = 81 +/- 13 bpm) and age 0-4 cohorts (omega(2) = 48 +/- 8 bpm; p = 0.002). These results suggest that the Vivio can be used to capture carotid pulse waveform data in pediatric populations and that the data produced can be used to measure intrinsic frequencies.	[Miller, Jennifer C.; Cheng, Andrew L.] Childrens Hosp Los Angeles, Div Pediat Cardiol, Los Angeles, CA 90027 USA; [Shepherd, Jennifer] Childrens Hosp Los Angeles, Div Neonatol, Fetal & Neonatal Inst, Los Angeles, CA 90027 USA; [Shepherd, Jennifer; Cheng, Andrew L.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA; [Rinderknecht, Derek] Chief Tech Officer Avicena LLC, Pasadena, CA USA; [Pahlevan, Niema M.] Univ Southern Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90007 USA; [Pahlevan, Niema M.] Univ Southern Calif, Dept Med, Div Cardiovasc Med, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California	Pahlevan, NM (corresponding author), Univ Southern Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90007 USA.; Pahlevan, NM (corresponding author), Univ Southern Calif, Dept Med, Div Cardiovasc Med, Los Angeles, CA 90007 USA.	pahlevan@usc.edu	Pahlevan, Niema/AAY-4299-2020; Pahlevan, Niema M/ABF-7268-2021; Cheng, Andrew L./AAR-8613-2021	Pahlevan, Niema/0000-0001-7498-0396; Cheng, Andrew L./0000-0002-4860-6218; Miller, Jennifer/0000-0002-5356-1675	Atlantic Pediatric Device Consortium (APDC) [RG219-G6]	Atlantic Pediatric Device Consortium (APDC)	This study was partially funded by Atlantic Pediatric Device Consortium (APDC) Subaward No. RG219-G6 (http://atlanticpediatricdeviceconsortium.org/) to NP. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann K, 1997, AM J CARDIOL, V80, P1060, DOI 10.1016/S0002-9149(97)00603-6; Armenian SH, 2018, CLIN CANCER RES, V24, P3119, DOI 10.1158/1078-0432.CCR-17-3599; Banka P, 2016, CURR OPIN PEDIATR, V28, P575, DOI 10.1097/MOP.0000000000000400; Chukwu EO, 2008, J AM SOC ECHOCARDIOG, V21, P990, DOI 10.1016/j.echo.2008.07.009; Lai WW, 2016, ECHOCARDIOGRPAHY PED; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Pahlevan NM, 2017, CRIT CARE MED, V45, P1115, DOI 10.1097/CCM.0000000000002459; Pahlevan NM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0617; Pahlevan NM, 2014, J BIOMECH, V47, P1727, DOI 10.1016/j.jbiomech.2014.02.014; Pahlevan NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087122; Pahlevan NM, 2013, J BIOMECH, V46, P2122, DOI 10.1016/j.jbiomech.2013.07.006; Pahlevan NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023106; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Soleymani S, 2010, J PERINATOL, V30, pS38, DOI 10.1038/jp.2010.101; Tavallali P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150475; Thavendiranathan P, 2013, J AM COLL CARDIOL, V61, P77, DOI 10.1016/j.jacc.2012.09.035	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227145	10.1371/journal.pone.0227145	http://dx.doi.org/10.1371/journal.pone.0227145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899768	Green Published, gold			2022-12-26	WOS:000534322000015
J	Hamraz, M; Abolhassani, R; Andriamihaja, M; Ransy, C; Lenoir, V; Schwartz, L; Bouillaud, F				Hamraz, Minoo; Abolhassani, Raymond; Andriamihaja, Mireille; Ransy, Celine; Lenoir, Veronique; Schwartz, Laurent; Bouillaud, Frederic			Hypertonic external medium represses cellular respiration and promotes Warburg/Crabtree effect	FASEB JOURNAL			English	Article						bioenergetics; cancer; Crabtree effect; inflammation; Krebs cycle; Warburg effect	CANCER; METABOLISM; MECHANISMS; ORIGIN; ANOXIA; TUMORS; CELLS	Hyperosmotic conditions are associated to several pathological states. In this article, we evaluate the consequence of hyperosmotic medium on cellular energy metabolism. We demonstrate that exposure of cells to hyperosmotic conditions immediately reduces the mitochondrial oxidative phosphorylation rate. This causes an increase in glycolysis, which represses further respiration. This is known as the Warburg or Crabtree effect. In addition to aerobic glycolysis, we observed two other cellular responses that would help to preserve cellular ATP level and viability: A reduction in the cellular ATP turnover rate and a partial mitochondrial uncoupling which is expected to enhance ATP production by Krebs cycle. The latter is likely to constitute another metabolic adaptation to compensate for deficient oxidative phosphorylation that, importantly, is not dependent on glucose.	[Hamraz, Minoo; Ransy, Celine; Lenoir, Veronique; Bouillaud, Frederic] Univ Paris, Inst Cochin, CNRS, INSERM, F-75014 Paris, France; [Abolhassani, Raymond] SAS Vaccinopole, Paris, France; [Andriamihaja, Mireille] AgroParisTech, INRA, UMR Physiol Nutr & Comportement Alimentaire 914, Paris, France; [Schwartz, Laurent] AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP)	Bouillaud, F (corresponding author), Univ Paris, Inst Cochin, CNRS, INSERM, F-75014 Paris, France.	frederic.bouillaud@inserm.fr		Bouillaud, Frederic/0000-0002-7518-9237	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes (Paris Descartes University)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes (Paris Descartes University)	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes (Paris Descartes University)	[Anonymous], SEAH XF REAL TIM ATP; Asgari Y, 2015, GENOMICS, V105, P275, DOI 10.1016/j.ygeno.2015.03.001; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brocker Chad, 2012, Biomol Concepts, V3, P345; Buck LT, 2006, RESP PHYSIOL NEUROBI, V154, P226, DOI 10.1016/j.resp.2006.03.004; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Di Paolo Antonello, 2007, Curr Oncol Rep, V9, P109; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; El Kasmi KC, 2015, SEMIN IMMUNOL, V27, P267, DOI 10.1016/j.smim.2015.09.001; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; JAIN RK, 1991, INT J RADIAT BIOL, V60, P85, DOI 10.1080/09553009114551621; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lemus MR, 2018, J BIOL CHEM, V293, P12843, DOI 10.1074/jbc.RA118.003672; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Moreira JD, 2016, METABOLITES, V6, DOI 10.3390/metabo6040033; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Stohrer M, 2000, CANCER RES, V60, P4251; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZWEIBAUM A, 1985, J CELL PHYSIOL, V122, P21, DOI 10.1002/jcp.1041220105	33	2	2	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					222	236		10.1096/fj.201900706RR	http://dx.doi.org/10.1096/fj.201900706RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914644				2022-12-26	WOS:000507308900017
J	Liu, P; Zhu, CC; Luo, JJ; Lan, S; Su, DS; Wang, QJ; Wei, Z; Cui, W; Xu, C; Yang, XJ				Liu, Pei; Zhu, Chenchen; Luo, Juanjuan; Lan, Sheng; Su, Dongsheng; Wang, Qiongjin; Wei, Zhe; Cui, Wei; Xu, Chuan; Yang, Xiaojun			Par6 regulates cell cycle progression through enhancement of Akt/PI3K/GSK-3 beta signaling pathway activation in glioma	FASEB JOURNAL			English	Article						cell proliferation; cyclin D1; glioma; Par6	POLARITY PROTEIN PAR6; MALIGNANT GLIOMA; CANCER; PROLIFERATION; GROWTH; GSK-3-BETA; APOPTOSIS; MIGRATION; INVASION; COMPLEX	As the key factor of the polarity protein complex, Par6 not only regulates polarization processes, but also plays important roles in tumor metastasis and progression in many epithelium malignancy tumors. Here, we showed that Par6 is an essential component in glioma tumorigenesis. Our results indicated the aberrant expression of Par6 in malignant glioma tissues and cell lines. We found that the regulation of Par6 expression induces cell proliferation and tumor growth in vivo and in vitro. Additionally, RNA-seq revealed the effects of Par6 were associated with cyclin D1-regulated cell cycle progression in glioma cells. Moreover, our results demonstrated that the regulation of Par6 can enhance the activation of Akt/PI3K signaling pathway, and subsequently upregulate the expression level of GSK-3 beta protein, which then regulate cyclin D1-mediated cell cycle regulation. Furthermore, we found that TGF-beta-induced the upregulation of Par6 expression may be involved in this process. The pathological analysis confirmed the correlation between Par6 expression and the prognosis in human glioma tissues, suggesting the regulation of Par6 expression regulates glioma tumorigenesis and progression. Thus, our findings showed that Par6 might be a potential biomarker for the diagnosis and providing a therapeutic strategy for the treatment of malignant glioma.	[Liu, Pei; Zhu, Chenchen; Luo, Juanjuan; Lan, Sheng; Su, Dongsheng; Wang, Qiongjin; Yang, Xiaojun] Shantou Univ, Coll Med, Neurosci Ctr, 22 Xinling Rd, Shantou 515041, Peoples R China; [Wei, Zhe] Lishui Univ, Fac Med & Hlth, Lishui, Peoples R China; [Cui, Wei] Shenyang Pharmaceut Univ, Dept Pharmacol, Coll Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Chuan] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, 55 Renmin South Rd, Chengdu 610047, Peoples R China	Shantou University; Lishui University; Shenyang Pharmaceutical University; University of Electronic Science & Technology of China	Yang, XJ (corresponding author), Shantou Univ, Coll Med, Neurosci Ctr, 22 Xinling Rd, Shantou 515041, Peoples R China.; Xu, C (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, 55 Renmin South Rd, Chengdu 610047, Peoples R China.	xuchuan100@163.com; yangx@stu.edu.cn		XU, CHUAN/0000-0002-5320-2277	National Natural Science Foundation of China [81572494, 81872070, 81673652]; Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	National Natural Science Foundation of China, Grant/Award Number: 81572494, 81872070 and 81673652; Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Avery-Cooper G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-19; Bose R, 2006, CURR OPIN CELL BIOL, V18, P206, DOI 10.1016/j.ceb.2006.02.005; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen XH, 2015, EUR REV MED PHARMACO, V19, P3412; Cline EG, 2007, MOL CELL BIOL, V27, P4431, DOI 10.1128/MCB.02235-06; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Gunaratne A, 2013, MOL CELL BIOL, V33, P874, DOI 10.1128/MCB.00837-12; Guo ZF, 2017, BIOMED PHARMACOTHER, V94, P774, DOI 10.1016/j.biopha.2017.07.081; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2017, BIOCHEM BIOPH RES CO, V494, P542, DOI 10.1016/j.bbrc.2017.10.116; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kolsi LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34131-1; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; Li Y, 2017, BIOMED PHARMACOTHER, V93, P435, DOI 10.1016/j.biopha.2017.06.058; Lin JT, 2015, CELL CYCLE, V14, P408, DOI 10.4161/15384101.2014.977103; Liu HJ, 2015, INT J CLIN EXP PATHO, V8, P9140; Liubich L. D., 2017, Experimental Oncology, V39, P258; Marques Elsa, 2015, Oncoscience, V2, P894; Mu Y, 2015, BRIT J CANCER, V112, P1223, DOI 10.1038/bjc.2015.71; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Ramljak D, 2000, CARCINOGENESIS, V21, P1537, DOI 10.1093/carcin/21.8.1537; Renschler FA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam9899; Ruan LL, 2017, CLIN EXP PHARMACOL P, V44, P909, DOI 10.1111/1440-1681.12794; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watts JL, 1996, DEVELOPMENT, V122, P3133; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; Zhu YC, 2017, INT J MOL MED, V40, P1165, DOI 10.3892/ijmm.2017.3100	43	7	7	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1481	1496		10.1096/fj.201901629RR	http://dx.doi.org/10.1096/fj.201901629RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914615	Bronze			2022-12-26	WOS:000507308900098
J	Sorkin, BC; Kuszak, AJ; Bloss, G; Fukagawa, NK; Hoffman, FA; Jafari, M; Barrett, B; Brown, PN; Bushman, FD; Casper, SJ; Chilton, FH; Coffey, CS; Ferruzzi, MG; Hopp, DC; Kiely, M; Lakens, D; MacMillan, JB; Meltzer, DO; Pahor, M; Paul, J; Pritchett-Corning, K; Quinney, SK; Rehermann, B; Setchell, KDR; Sipes, NS; Stephens, JM; Taylor, DL; Tiriac, H; Walters, MA; Xi, D; Zappala, G; Pauli, GF				Sorkin, Barbara C.; Kuszak, Adam J.; Bloss, Gregory; Fukagawa, Naomi K.; Hoffman, Freddie Ann; Jafari, Mahtab; Barrett, Bruce; Brown, Paula N.; Bushman, Frederic D.; Casper, Steven J.; Chilton, Floyd H.; Coffey, Christopher S.; Ferruzzi, Mario G.; Hopp, D. Craig; Kiely, Mairead; Lakens, Daniel; MacMillan, John B.; Meltzer, David O.; Pahor, Marco; Paul, Jeffrey; Pritchett-Corning, Kathleen; Quinney, Sara K.; Rehermann, Barbara; Setchell, Kenneth D. R.; Sipes, Nisha S.; Stephens, Jacqueline M.; Taylor, D. Lansing; Tiriac, Herve; Walters, Michael A.; Xi, Dan; Zappala, Giovanna; Pauli, Guido F.			Improving natural product research translation: From source to clinical trial	FASEB JOURNAL			English	Article						clinical predictive validity; dietary supplements; model systems; rigor and replicability; value of information	HUMAN HEALTH-RISK; IN-VITRO; DROSOPHILA-MELANOGASTER; DRUG DISCOVERY; ANIMAL-MODELS; HUMAN-DISEASE; HYDRASTIS-CANADENSIS; METABOLITE EQUOL; PUBLICATION BIAS; IMMUNE-RESPONSE	While great interest in health effects of natural product (NP) including dietary supplements and foods persists, promising preclinical NP research is not consistently translating into actionable clinical trial (CT) outcomes. Generally considered the gold standard for assessing safety and efficacy, CTs, especially phase III CTs, are costly and require rigorous planning to optimize the value of the information obtained. More effective bridging from NP research to CT was the goal of a . Participants emphasized that replicability and likelihood of successful translation depend on rigor in experimental design, interpretation, and reporting across the continuum of NP research. Discussions spanned good practices for NP characterization and quality control; use and interpretation of models (computational through in vivo) with strong clinical predictive validity; controls for experimental artefacts, especially for in vitro interrogation of bioactivity and mechanisms of action; rigorous assessment and interpretation of prior research; transparency in all reporting; and prioritization of research questions. Natural product clinical trials prioritized based on rigorous, convergent supporting data and current public health needs are most likely to be informative and ultimately affect public health. Thoughtful, coordinated implementation of these practices should enhance the knowledge gained from future NP research.	[Sorkin, Barbara C.; Kuszak, Adam J.] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA; [Bloss, Gregory] NIAAA, NIH, Bethesda, MD USA; [Fukagawa, Naomi K.] ARS, USDA, Beltsville, MD USA; [Hoffman, Freddie Ann] HeteroGeneity LLC, Washington, DC USA; [Jafari, Mahtab] Univ Calif Irvine, Irvine, CA USA; [Barrett, Bruce] Univ Wisconsin, Madison, WI USA; [Brown, Paula N.] British Columbia Inst Technol, Burnaby, BC, Canada; [Bushman, Frederic D.] Univ Penn, Philadelphia, PA 19104 USA; [Casper, Steven J.] US FDA, Off Dietary Supplement Programs, Ctr Food Safety & Appl Nutr, Hyattsville, MD USA; [Chilton, Floyd H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; [Chilton, Floyd H.] Univ Arizona, BIO5 Inst, Tucson, AZ USA; [Coffey, Christopher S.] Univ Iowa, Iowa City, IA USA; [Ferruzzi, Mario G.] North Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA; [Hopp, D. Craig] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Kiely, Mairead] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin D & Nutr Res, Cork, Ireland; [Lakens, Daniel] Eindhoven Univ Technol, Eindhoven, Netherlands; [MacMillan, John B.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Meltzer, David O.] Univ Chicago Med, Chicago, IL USA; [Pahor, Marco] Univ Florida, Gainesville, FL USA; [Paul, Jeffrey] Coll Med, Drexel Grad Coll Biomed Sci, Evanston, IL USA; [Pritchett-Corning, Kathleen] Harvard Univ, Cambridge, MA 02138 USA; [Quinney, Sara K.] Indiana Univ, Indianapolis, IN 46204 USA; [Rehermann, Barbara] NIDDK, NIH, Bethesda, MD 20892 USA; [Setchell, Kenneth D. R.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Sipes, Nisha S.] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Taylor, D. Lansing] Univ Pittsburgh, Pittsburgh, PA USA; [Tiriac, Herve] Univ Calif San Diego, La Jolla, CA 92093 USA; [Walters, Michael A.] Univ Minnesota, Inst Therapeut Discovery & Dev, Minneapolis, MN USA; [Xi, Dan] NCI, Off Canc Complementary & Alternat Med, NIH, Shady Grove, MD USA; [Zappala, Giovanna] NIA, NIH, Bethesda, MD 20892 USA; [Pauli, Guido F.] Univ Illinois, Coll Pharm, CENAPT, Chicago, IL USA; [Pauli, Guido F.] Univ Illinois, Coll Pharm, PCRPS, Chicago, IL USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Agriculture (USDA); University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison; British Columbia Institute of Technology; University of Pennsylvania; US Food & Drug Administration (FDA); University of Arizona; University of Arizona; University of Iowa; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; University College Cork; Eindhoven University of Technology; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; Harvard University; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sorkin, BC (corresponding author), NIH, Off Dietary Supplements, 6100 Execut Blvd,Ste 3B01,MSC 7517, North Bethesda, MD 20892 USA.	barbara.sorkin@nih.gov	Stephens, Jacqueline M/R-5217-2018; Pauli, Guido F/C-1159-2009; Quinney, Sara K/J-5130-2014; Sorkin, Barbara/I-6897-2019; Kiely, Mairead E/ABA-3235-2020; Lakens, Daniel/K-3831-2015	Quinney, Sara K/0000-0002-6554-0695; Sorkin, Barbara/0000-0001-8198-6921; Tiriac, Herve/0000-0001-5039-6750; Lakens, Daniel/0000-0002-0247-239X; Rehermann, Barbara/0000-0001-6832-9951; Chilton, Floyd/0000-0002-3686-0198; Kuszak, Adam/0000-0001-8719-145X	HHS \ National Institutes of Health (NIH)	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NA	Aberle MR, 2018, BRIT J SURG, V105, pE48, DOI 10.1002/bjs.10726; Albers C, 2018, J EXP SOC PSYCHOL, V74, P187, DOI 10.1016/j.jesp.2017.09.004; Applequist WL, 2013, ANAL BIOANAL CHEM, V405, P4419, DOI 10.1007/s00216-012-6595-1; Baden MY, 2019, CIRCULATION, V140, P979, DOI 10.1161/CIRCULATIONAHA.119.041014; Baell JB, 2016, J NAT PROD, V79, P616, DOI 10.1021/acs.jnatprod.5b00947; Baker LA, 2016, TRENDS CANCER, V2, P176, DOI 10.1016/j.trecan.2016.03.004; Barrett B, 2013, MED DECIS MAKING, V33, P869, DOI 10.1177/0272989X13476764; Barrett B, 2011, ANN FAM MED, V9, P312, DOI 10.1370/afm.1250; Barrington WT, 2018, GENETICS, V208, P399, DOI 10.1534/genetics.117.300536; Battiste M., 2018, PALGRAVE HDB ED LAW, P567, DOI DOI 10.1007/978-3-319-77751-1; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Becker KJ, 2016, TRANSL STROKE RES, V7, P303, DOI 10.1007/s12975-016-0455-9; Bell SM, 2018, TOXICOL IN VITRO, V47, P213, DOI 10.1016/j.tiv.2017.11.016; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Berman J, 2011, FITOTERAPIA, V82, P80, DOI 10.1016/j.fitote.2010.07.014; Boudreau A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00018; Box G.E., 1987, EMPIRICAL MODEL BUIL, VVolume 424; Bozin B, 2013, MOLECULES, V18, P11733, DOI 10.3390/molecules181011733; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Brenna JT, 2018, AM J CLIN NUTR, V108, P211, DOI 10.1093/ajcn/nqy089; Britton ER, 2018, J NAT PROD, V81, P484, DOI 10.1021/acs.jnatprod.7b00654; Brown LaVerne L, 2018, BMC Proc, V12, P6, DOI 10.1186/s12919-018-0102-4; Brown NM, 2010, FOOD CHEM TOXICOL, V48, P3042, DOI 10.1016/j.fct.2010.07.042; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Button Katherine S, 2013, Nat Rev Neurosci, V14, P877, DOI 10.1038/nrn3475-c6; Caesar LK, 2019, NAT PROD REP, V36, P869, DOI 10.1039/c9np00011a; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Catlin NR, 2018, FOOD CHEM TOXICOL, V118, P328, DOI 10.1016/j.fct.2018.05.013; Cech NB, 2012, PLANTA MED, V78, P1556, DOI 10.1055/s-0032-1315042; Center for Drug Evaluation and Research, 2016, BOT DRUG DEV GUID IN; Center for Drug Evaluation and Research, 2018, EXP COH US 1 IN HUM; Chen SN, 2009, PLANTA MED, V75, P757, DOI 10.1055/s-0028-1112209; Chen SH, 2016, SCIENCE, V351, P1204, DOI 10.1126/science.aac5610; Chen TY, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700111; Cheng CW, 2017, ANN INTERN MED, V167, P112, DOI [10.7326/M16-2977, 10.7326/IsTranslatedFrom_M17-2977_2, 10.7326/IsTranslatedFrom_M17-2977_1]; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Clark M, 2018, REGUL TOXICOL PHARM, V96, P94, DOI 10.1016/j.yrtph.2018.04.018; Clerici C, 2007, J NUTR, V137, P2270, DOI 10.1093/jn/137.10.2270; Contijoch EJ, 2019, ELIFE, V8, DOI 10.7554/eLife.40553; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Cui Yuanyuan, 2014, BMC Syst Biol, V8, P6, DOI 10.1186/s12918-014-0140-0; Dahlin J. L., 2015, ASSAY GUIDANCE MANUA; Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/FMC.14.60, 10.4155/fmc.14.60]; Das B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22090-6; Davis DJ, 2017, BRAIN BEHAV IMMUN, V59, P38, DOI 10.1016/j.bbi.2016.09.003; Deaton A, 2018, SOC SCI MED, V210, P2, DOI 10.1016/j.socscimed.2017.12.005; Di L, 2013, DRUG METAB DISPOS, V41, P1975, DOI 10.1124/dmd.113.054031; Dotson CD, 2012, CURR NUTR REP, V1, P175, DOI DOI 10.1007/S13668-012-0021-3; Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487; Duric K, 2019, J NAT PROD, V82, P2400, DOI 10.1021/acs.jnatprod.8b00962; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Eisenman S.W., 2012, JAMP, V1, P30, DOI DOI 10.7275/R50K26HC; Elfawal MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052746; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Ewart L, 2017, EXP BIOL MED, V242, P1579, DOI 10.1177/1535370217715441; Fenclova M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47250-0; Ferreira ML, 2013, J CLIN EPIDEMIOL, V66, P1397, DOI 10.1016/j.jclinepi.2013.02.018; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Freedman Leonard P, 2017, F1000Res, V6, P604, DOI 10.12688/f1000research.11334.1; Freedman LP, 2015, BIOTECHNIQUES, V59, P189, DOI 10.2144/000114344; Friesen JB, 2019, J NAT PROD, V82, P621, DOI 10.1021/acs.jnatprod.9b00020; Frolinger T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39994-6; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gagnier JJ, 2011, J CLIN EPIDEMIOL, V64, P760, DOI 10.1016/j.jclinepi.2010.10.005; Gallin J.I., 2017, PRINCIPLES PRACTICE, V4th ed.; Gallo P, 2006, J BIOPHARM STAT, V16, P275, DOI 10.1080/10543400600614742; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gurley BJ, 2018, CLIN PHARMACOL THER, V104, P470, DOI 10.1002/cpt.1131; Gusev PA, CURR DEV NUTR BOST M; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hajirahimkhan A, 2018, J NAT PROD, V81, P966, DOI 10.1021/acs.jnatprod.7b01070; Hansen J, 2013, CLIN PHARMACOL THER, V93, P117, DOI 10.1038/clpt.2012.199; Harrington D, 2019, NEW ENGL J MED, V381, P285, DOI 10.1056/NEJMe1906559; Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; Herati RS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031583; Hildreth J, 2007, ANAL BIOANAL CHEM, V389, P13, DOI 10.1007/s00216-007-1405-x; Hintze KJ, 2014, GUT MICROBES, V5, P183, DOI 10.4161/gmic.28403; Ho L, 2019, J NUTR BIOCHEM, V64, P170, DOI 10.1016/j.jnutbio.2018.10.019; Hoomans T, 2012, VALUE HEALTH, V15, pA2, DOI 10.1016/j.jval.2012.03.014; Hopp C, 2015, HERBALGRAM, V107, P44; Hubbard Troy D, 2019, Appl In Vitro Toxicol, V5, P10, DOI 10.1089/aivt.2018.0020; Ingolfsson HI, 2014, ACS CHEM BIOL, V9, P1788, DOI 10.1021/cb500086e; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Jafari M, 2015, REJUV RES, V18, P573, DOI 10.1089/rej.2015.1774; Jafari M, 2010, FLY, V4, P253, DOI 10.4161/fly.4.3.11997; Jayasekera J, 2018, JNCI-J NATL CANCER I, V110, P1360, DOI 10.1093/jnci/djy059; Jia M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00906; Jones HM, 2015, CLIN PHARMACOL THER, V97, P247, DOI 10.1002/cpt.37; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Justice MJ, 2016, DIS MODEL MECH, V9, P101, DOI 10.1242/dmm.024547; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Karran E, 2014, ANN NEUROL, V76, P185, DOI 10.1002/ana.24188; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x; Kellogg JJ, 2019, NAT PROD REP, V36, P1196, DOI 10.1039/c8np00065d; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Kleerebezem M, 2018, NAT MICROBIOL, V3, P650, DOI 10.1038/s41564-018-0172-0; Klein MA, 1192, J NUTR, V140, p1192S; Klurfeld DM, 2018, AM J PHYSIOL-ENDOC M, V315, pE1087, DOI 10.1152/ajpendo.00058.2018; KNOPF K, 1978, J NUTR, V108, P773, DOI 10.1093/jn/108.5.773; Korach-Rechtman H, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00826-19; Kroeger CM, 2018, AM J CLIN NUTR, V107, P484, DOI 10.1093/ajcn/nqx067; Labachyan KE, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0239-8; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Li WW, 2018, J AGR FOOD CHEM, V66, P11468, DOI 10.1021/acs.jafc.8b04770; Li X, 2018, LAB CHIP, V18, P2614, DOI 10.1039/c8lc00418h; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a; Litichevskiy L, 2018, CELL SYST, V6, P424, DOI 10.1016/j.cels.2018.03.012; Lopez T, 2014, J MED FOOD, V17, P1314, DOI 10.1089/jmf.2013.0190; Low LA, 2017, LAB CHIP, V17, P3026, DOI 10.1039/c7lc00462a; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453; McBurney MI, 2019, J NUTR, V149, P1880, DOI 10.1093/jn/nxz154; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; McManis C. R, 1998, WASH U LQ, V76, P255; Mebane CA, 2019, INTEGR ENVIRON ASSES, V15, P320, DOI 10.1002/ieam.4119; Meltzer DO, 2011, MED DECIS MAKING, V31, pE1, DOI 10.1177/0272989X11412975; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Milanowski DJ, 2002, J NAT PROD, V65, P814, DOI 10.1021/np000270v; Miller J, 2011, PSYCHOL METHODS, V16, P337, DOI 10.1037/a0023347; Minekus M, 1995, ALTERN ANIM; Mirza RD, 2018, JAMA INTERN MED, V178, P1378, DOI 10.1001/jamainternmed.2018.3979; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Morgan SJ, 2013, TOXICOL PATHOL, V41, P508, DOI 10.1177/0192623312457273; Munafo MR, 2018, NATURE, V553, P399, DOI 10.1038/d41586-018-01023-3; Munyangi J, 2019, PHYTOMEDICINE, V57, P49, DOI 10.1016/j.phymed.2018.12.002; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Narayanapillai SC, 2014, CHEM RES TOXICOL, V27, P1871, DOI 10.1021/tx5003194; National Academies of Sciences Engineering and Medicine (NASEM)., 2019, REPRODUCIBILITY REPL, DOI [10.17226/25303, DOI 10.17226/25303]; National Center for Complementary and Integrative Health, NCCIH POL NAT PROD I; National Center for Complementary and Integrative Health, 2012, DAT SAF MON NCCIH FU; National Institutes of Health, ENH REPR RIG TRANSP; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407; Neilson AP, 2011, ANNU REV FOOD SCI T, V2, P125, DOI 10.1146/annurev-food-022510-133725; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Novotny JA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700043; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Ochoa JL, 2015, J NAT PROD, V78, P2242, DOI 10.1021/acs.jnatprod.5b00455; Ortiz D, 2016, J AGR FOOD CHEM, V64, P2727, DOI 10.1021/acs.jafc.5b05698; Peng YS, 2015, J ASIAN NAT PROD RES, V17, P89, DOI 10.1080/10286020.2014.960856; Perry NB, 1999, J AGR FOOD CHEM, V47, P2048, DOI 10.1021/jf981170m; Piper MDW, 2017, CELL METAB, V25, P1206, DOI 10.1016/j.cmet.2017.04.020; Plesser HE, 2018, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00076; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; Ramaiahgari SC, 2019, TOXICOL SCI, V169, P553, DOI 10.1093/toxsci/kfz065; Ramaiahgari SC, 2017, TOXICOL SCI, V160, P189, DOI 10.1093/toxsci/kfx194; Redan BW, 2016, ADV NUTR, V7, P1090, DOI 10.3945/an.116.013029; Rider CV, 2018, CLIN PHARMACOL THER, V104, P429, DOI 10.1002/cpt.1088; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Ruben MD, 2019, SCIENCE, V365, P547, DOI 10.1126/science.aax7621; Salinero AE, 2018, INT J OBESITY, V42, P1088, DOI 10.1038/s41366-018-0023-3; Scargle J. D., 2000, J SCI EXPLORATION, V14, P91; Schinkovitz A, 2008, J NAT PROD, V71, P1604, DOI 10.1021/np800137n; Schmidt CW, 2015, ENVIRON HEALTH PERSP, V123, pA64, DOI 10.1289/ehp.123-A64; Schneider C, 2015, J AGR FOOD CHEM, V63, P7606, DOI 10.1021/acs.jafc.5b00244; Schriner SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063886; Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724; Selvaraj V, 2004, BIOL REPROD, V71, P966, DOI 10.1095/biolreprod.104.029512; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shen L, 2011, HEPATOLOGY, V53, P2139, DOI 10.1002/hep.24296; Sheng BB, 2019, ORG LETT, V21, P6295, DOI 10.1021/acs.orglett.9b02172; Shulman LP, 2011, FITOTERAPIA, V82, P88, DOI 10.1016/j.fitote.2010.10.013; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simmler C, 2018, FITOTERAPIA, V129, P401, DOI 10.1016/j.fitote.2017.11.017; Simmler C, 2014, PHYTOCHEM ANALYSIS, V25, P378, DOI 10.1002/pca.2472; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Sipes NS, 2017, ENVIRON SCI TECHNOL, V51, P10786, DOI 10.1021/acs.est.7b00650; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Smith AJ, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k760; Sorger P. K., 2011, QUANTITATIVE SYSTEMS; Sorkin BC, 2016, ADV NUTR, V7, P383, DOI 10.3945/an.115.010595; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; Stern AM, 2016, J BIOMOL SCREEN, V21, P521, DOI 10.1177/1087057116635818; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; TALAN M, 1984, EXP GERONTOL, V19, P25, DOI 10.1016/0531-5565(84)90028-7; Thomas RS, 2019, TOXICOL SCI, V169, P317, DOI 10.1093/toxsci/kfz058; Thomas RS, 2018, ALTEX-ALTERN ANIM EX, V35, P163, DOI 10.14573/altex.1803011; Tu HB, 2017, EBIOMEDICINE, V23, P125, DOI 10.1016/j.ebiom.2017.08.017; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; US Food and Drug Administration, 2017, CONS DEM INT REF PRO; Vaden RM, 2017, MAR DRUGS, V15, DOI 10.3390/md15030075; Velazquez EM, 2019, NAT MICROBIOL, V4, P1057, DOI 10.1038/s41564-019-0407-8; Vernetti L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42296; Vernetti LA, 2017, CLIN LIVER DIS, V21, P197, DOI 10.1016/j.cld.2016.08.013; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Waidyanatha S, 2018, FOOD CHEM TOXICOL, V121, P194, DOI 10.1016/j.fct.2018.08.062; Wambaugh JF, 2018, TOXICOL SCI, V163, P152, DOI 10.1093/toxsci/kfy020; Wang J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02794-5; Wang ZC, 2018, BIOINFORMATICS, V34, P2150, DOI 10.1093/bioinformatics/bty060; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Williams S., 2019, SCI MAGAZINE    0715; WIRED Staff, 2009, PLAC AR GETT MOR EFF; Wood AC, 2019, JAMA PEDIATR, V173, P311, DOI 10.1001/jamapediatrics.2019.0015; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Yoshihara M, 2018, J NEUROGENET, V32, P53, DOI 10.1080/01677063.2018.1468443; Zarin DA, 2019, JAMA-J AM MED ASSOC, V322, P813, DOI 10.1001/jama.2019.9892; Zeisel SH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00200; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	233	26	26	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					41	65		10.1096/fj.201902143R	http://dx.doi.org/10.1096/fj.201902143R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914647	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000507308900005
J	Titone, R; Robertson, DM				Titone, Rossella; Robertson, Danielle M.			Insulin receptor preserves mitochondrial function by binding VDAC1 in insulin insensitive mucosal epithelial cells	FASEB JOURNAL			English	Article						bronchial epithelial cells; corneal epithelial cells; insulin; mitochondria; receptor tyrosine kinases; VDAC1	LOCALIZED EGFR; CYTOCHROME-C; GSK-3-BETA; MITOPHAGY; KINASE; GROWTH; ROLES; HEXOKINASE; RESISTANCE; REDUCTION	Unlike many epithelial tissues, the corneal epithelium is insulin insensitive, meaning it does not require insulin for glucose uptake. In this study, we show that insulin differentially regulates mitochondrial respiration in two human mucosal epithelial cell types: insulin-insensitive corneal epithelial cells and insulin-sensitive bronchial epithelial cells. In both cell types, insulin blocks glycogen synthase kinase beta (GSK3 beta) activity. In the corneal epithelium however, insulin selectively regulates PTEN-induced kinase 1 (PINK-1)-mediated mitophagy and mitochondrial accumulation of insulin receptor (INSR). While insulin blocked basal levels of PINK-1-mediated mitophagy in bronchial epithelial cells, mitochondrial trafficking of INSR was not detectable. We further show that in corneal epithelia, INSR interacts with the voltage-dependent anion channel-1 (VDAC1) in mitochondria and that INSR knockdown triggers robust mitochondrial fragmentation, alterations in mitochondrial polarization, and blocks the induction of PINK-1-mediated mitophagy. Collectively, these data demonstrate that INSR interacts with VDAC1 to mediate mitochondrial stability. We also demonstrate unique interactions between VDAC1 and other receptor tyrosine kinases, indicating a novel role for this family of receptors in mitochondria.	[Titone, Rossella; Robertson, Danielle M.] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Robertson, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Danielle.Robertson@UTSouthwestern.edu		Titone, Rossella/0000-0002-1528-331X	HHS | NIH | National Eye Institute (NEI) [EY024546, EY029258, EY030413]; Research to Prevent Blindness (RPB); Fight for Sight (FFS)	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Fight for Sight (FFS)	Funding information HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY024546, EY029258 and EY030413; Research to Prevent Blindness (RPB), Grant/Award Number: unrestricted grant; Fight for Sight (FFS)	Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Che TF, 2015, ONCOTARGET, V6, P37349, DOI 10.18632/oncotarget.5736; Cunha DA, 2005, AM J PHYSIOL-ENDOC M, V289, pE768, DOI 10.1152/ajpendo.00469.2004; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Elrod JW, 2018, CURR OPIN PHYSIOL, V3, pIV, DOI 10.1016/j.cophys.2018.05.001; FRIEND J, 1980, INVEST OPHTH VIS SCI, V19, P913; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Henriksen EJ, 2010, CURR DIABETES REV, V6, P285, DOI 10.2174/157339910793360888; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Li HS, 2017, CELL SIGNAL, V35, P223, DOI 10.1016/j.cellsig.2017.04.012; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Lyons A, 2017, J BIOL CHEM, V292, P16983, DOI 10.1074/jbc.M117.792838; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Molina SA, 2017, AM J PHYSIOL-LUNG C, V312, P1688, DOI 10.1152/ajplung.00364.2016; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rocha EM, 2002, INVEST OPHTH VIS SCI, V43, P963; Rocha EM, 2000, CURR EYE RES, V21, P833, DOI 10.1076/ceyr.21.5.833.5535; Shanley LJ, 2004, INVEST OPHTH VIS SCI, V45, P1088, DOI 10.1167/iovs.03-1064; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Takenaka T, 2017, ANTICANCER RES, V37, P4779, DOI 10.21873/anticanres.11884; Titone R, 2019, J CELL PHYSIOL, V234, P1426, DOI 10.1002/jcp.26948; Titone R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21031-7; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Vyssokikh M, 2004, BBA-MOL CELL RES, V1644, P27, DOI 10.1016/j.bbamcr.2003.10.007; Wang TH, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.62; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042483; Yang K, 2017, CELL PHYSIOL BIOCHEM, V44, P1445, DOI 10.1159/000485580; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8402, DOI 10.1002/jcp.27754; Yue XJ, 2008, AUTOPHAGY, V4, P641, DOI 10.4161/auto.5971; Zagon IS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1082, DOI 10.1001/archopht.125.8.1082; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang Y, 2018, BEHAV BRAIN RES, V339, P57, DOI 10.1016/j.bbr.2017.11.015	41	8	8	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					754	775		10.1096/fj.201901316RR	http://dx.doi.org/10.1096/fj.201901316RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914671	Green Accepted			2022-12-26	WOS:000507308900052
J	Abghour, S; Zro, K; Mouahid, M; Tahiri, F; Tarta, M; Berrada, J; Kichou, F				Abghour, Samira; Zro, Khalil; Mouahid, Mohammed; Tahiri, Fatima; Tarta, Meriam; Berrada, Jaouad; Kichou, Faouzi			Isolation and characterization of fowl aviadenovirus serotype 11 from chickens with inclusion body hepatitis in Morocco	PLOS ONE			English	Article							RESTRICTION ENZYME ANALYSIS; AVIAN ADENOVIRUS; MOLECULAR CHARACTERIZATION; HYDROPERICARDIUM SYNDROME; OUTBREAKS; DIFFERENTIATION; IDENTIFICATION; PIGEONS	The present study was conducted in order to isolate, identify and characterize fowl aviadenovirus associated with inclusion body hepatitis (IBH) in three poultry farms (two of broiler chickens and one of breeder broiler chickens) in Morocco during 2015. Liver samples collected from affected three poultry farms were examined by histopathological examination. Tissue samples showing necrosis of hepatocytes associated with basophilic intranuclear inclusion bodies were homogenized and submitted to FAdV isolation in chicken embryo fibroblast (CEF) cell cultures and in SPF embryonated eggs. The cytopathic effect (CPE) was observed in the second passage with swelling and rounding of infected cells. The inoculated embryos were hemorrhagic and showed hepatitis with the presence of basophilic intra-nuclear inclusion bodies within hepatocytes. The presence of the virus was confirmed by conventional polymerase chain reaction based on hexon gene from all investigated samples. Moreover, phylogenetic analysis of the hexon gene revealed that FAdVs isolated from different affected poultry belonged to FAdV 11 serotype of the D genotype group. This work is the first isolation in cell culture and SPF embryonated eggs of FAdV from Moroccan broilers and breeder broiler chickens with IBH.	[Abghour, Samira; Tahiri, Fatima] ONSSA, Div Pharm & Vet Inputs, Rabat, Morocco; [Abghour, Samira; Berrada, Jaouad; Kichou, Faouzi] Hassan 2nd Inst Agron & Vet Med, Rabat, Morocco; [Zro, Khalil] Biopharma, Rabat, Morocco; [Mouahid, Mohammed] Mouahids Vet Clin, Temara, Morocco; [Tarta, Meriam] Hassan II Univ, Fac Sci & Tech Mohammedia, Casablanca, Morocco	Hassan II University of Casablanca	Abghour, S (corresponding author), ONSSA, Div Pharm & Vet Inputs, Rabat, Morocco.; Abghour, S (corresponding author), Hassan 2nd Inst Agron & Vet Med, Rabat, Morocco.	abghour.samira@yahoo.fr	KICHOU, Faouzi/D-6336-2018	KICHOU, Faouzi/0000-0003-1147-9128	veterinary biological and pharmaceutical company (Biopharma)	veterinary biological and pharmaceutical company (Biopharma)	This study was partially funded by veterinary biological and pharmaceutical company (Biopharma). There were no further funders. This Company was provided PCR reagent and sequencing fees and did not have any additional role in the study design, data collection and analysis, decision to publish. We confirm that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Absalon AE, 2016, J VIROL, V501, P63; Alemnesh W, 2012, J COMP PATHOL, V146, P223, DOI 10.1016/j.jcpa.2011.05.001; Anas Said, 2015, THESIS; Asthana M, 2011, J PROTEOM BIOINFORM, V4, P190; Benko M., 2000, 7 INT COMM TAX VIR, P227; Bensassi Y., 2018, POULTRY SCI, P1; Capua I, 1995, AVIAN PATHOL, V24, P717, DOI 10.1080/03079459508419110; Choi KS, 2012, POULTRY SCI, V91, P2502, DOI 10.3382/ps.2012-02296; Dahiya S, 2002, AVIAN DIS, V46, P230, DOI 10.1637/0005-2086(2002)046[0230:FASAWO]2.0.CO;2; Dar A, 2012, AVIAN DIS, V56, P73, DOI 10.1637/9764-041911-Reg.1; Domanska-Blicharz K, 2011, POULTRY SCI, V90, P983, DOI 10.3382/ps.2010-01214; DROUAL R, 1995, J VET DIAGN INVEST, V7, P150, DOI 10.1177/104063879500700125; Ganesh K, 2002, VET RES COMMUN, V26, P73, DOI 10.1023/A:1013361906791; Ghafari P. T., 2017, Iranian Journal of Veterinary Science and Technology, V9, P41; Grafl B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-38; GRIMES TM, 1977, AVIAN DIS, V21, P26, DOI 10.2307/1589361; Gulhane AB, 2016, J PURE APPL MICROBIO, V10, P417; GUY JS, 1988, AVIAN DIS, V32, P587, DOI 10.2307/1590936; Hair-Bejo M., 2005, J VET MALAYSIA, V17, P23; Hemida MG, 2017, TURK J VET ANIM SCI, V41, P506, DOI 10.3906/vet-1612-19; Hess M, 2000, AVIAN PATHOL, V29, P195, DOI 10.1080/03079450050045440; Hess M, 1998, AVIAN PATHOL, V27, P196, DOI 10.1080/03079459808419323; Hess M., 2013, DIS POULTRY, V13th, P290; Hong-Su P, 2001, J VET RES, V51, P209; Kajan GL, 2013, VET MICROBIOL, V167, P357, DOI 10.1016/j.vetmic.2013.09.025; Kaur G, 2003, INDIAN J ANIM SCI, V73, P51; Kim JN, 2008, AVIAN DIS, V52, P526, DOI 10.1637/8178-112207-Case; Kumar V., 2013, ADV ANIM VET SCI, V1, P21; Mase M, 2014, J VET MED SCI, V76, P1535, DOI 10.1292/jvms.14-0312; Mase M, 2012, J VET MED SCI, V74, P1087, DOI 10.1292/jvms.11-0443; Mase M, 2009, J VET MED SCI, V71, P1239, DOI 10.1292/jvms.71.1239; Matos M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0350-0; MCFERRAN J B, 1976, Avian Pathology, V5, P315, DOI 10.1080/03079457608418201; McFerran J.B., 2003, DIS POULTRY, V12th, P214; McFerran JB, 2000, REV SCI TECH OIE, V19, P589, DOI 10.20506/rst.19.2.1238; Mendelson C, 1995, AVIAN PATHOL, V24, P693, DOI 10.1080/03079459508419108; Meulemans G, 2001, AVIAN PATHOL, V30, P655, DOI 10.1080/03079450120092143; Mittal Dinesh, 2014, Indian Journal of Virology, V25, P114, DOI 10.1007/s13337-013-0183-7; Mouahid M, 2013, P 18 WORLD VET POULT, P562; Niczyporuk JS, 2017, ARCH VIROL, V162, P1325, DOI 10.1007/s00705-017-3240-5; Niczyporuk JS, 2015, ARCH VIROL, V160, P1005, DOI 10.1007/s00705-015-2355-9; Niczyporuk JS, 2013, B VET I PULAWY, V57, P305, DOI 10.2478/bvip-2013-0053; Ojkic D, 2008, CAN J VET RES, V72, P236; Ojkic D, 2008, AVIAN PATHOL, V37, P95, DOI 10.1080/03079450701805324; Okuda Y, 2004, J VET MED SCI, V66, P1561, DOI 10.1292/jvms.66.1561; Oliver-Ferrando S, 2017, AVIAN PATHOL, V46, P157, DOI 10.1080/03079457.2016.1232477; Philippe C, 2007, CAN J VET RES, V71, P98; Radwan MM, 2018, POULTRY SCI, P1; Rahul S., 2004, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V25, P1; Raue R, 1998, J VIROL METHODS, V73, P211, DOI 10.1016/S0166-0934(98)00065-2; RIDDELL C, 1984, AVIAN DIS, V28, P774, DOI 10.2307/1590249; Salek M, 2017, P 19 WORLD VET POULT; Schachner A, 2018, AVIAN PATHOL, V47, P111, DOI 10.1080/03079457.2017.1385724; Schachner A, 2016, VET MICROBIOL, V186, P13, DOI 10.1016/j.vetmic.2016.02.008; Shaib H., 2017, ECON MICROBIOL, V3, P92; Soumyalekshmi S., 2014, INDIAN J SCI TECHNOL, V2, P33; Steer-Cope P, 2017, AVIAN DIS, V61, P512, DOI 10.1637/11718-072317-Reg.1; TAKASE K, 1990, JPN J VET SCI, V52, P207; Xie ZX, 1999, AVIAN DIS, V43, P98, DOI 10.2307/1592767; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133073	60	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227004	10.1371/journal.pone.0227004	http://dx.doi.org/10.1371/journal.pone.0227004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891942	gold, Green Published			2022-12-26	WOS:000515096600050
J	Kim, K; Hessl, D; Randol, JL; Espinal, GM; Schneider, A; Protic, D; Aydin, EY; Hagerman, RJ; Hagerman, PJ				Kim, Kyoungmi; Hessl, David; Randol, Jamie L.; Espinal, Glenda M.; Schneider, Andrea; Protic, Dragana; Aydin, Elber Yuksel; Hagerman, Randi J.; Hagerman, Paul J.			Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; MESSENGER-RNA; ABNORMAL METHYLATION; DNA DEMETHYLATION; EXPANDED ALLELES; ELEVATED LEVELS; STEM-CELLS; REACTIVATION; MALES	Fragile X syndrome, the leading heritable form of intellectual disability, is caused by hypermethylation and transcriptional silencing of large (CGG) repeat expansions (> 200 repeats) in the 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene. As a consequence of FMR1 gene silencing, there is little or no production of FMR1 protein (FMRP), an important element in normal synaptic function. Although the absence of FMRP has long been known to be responsible for the cognitive impairment in fragile X syndrome, the relationship between FMRP level and cognitive ability (10) is only imprecisely understood. To address this issue, a high-throughput, fluorescence resonance energy transfer (FRET) assay has been used to quantify FMRP levels in dermal fibroblasts, and the relationship between FMRP and IQ measures was assessed by statistical analysis in a cohort of 184 individuals with CGG-repeat lengths spanning normal (< 45 CGGs) to full mutation (> 200 CGGs) repeat ranges in fibroblasts. The principal findings of the current study are twofold: i) For those with normal CGG repeats, IQ is no longer sensitive to further increases in FMRP above an FMRP threshold of similar to 70% of the mean FMRP level; below this threshold, IQ decreases steeply with further decreases in FMRP; and ii) For the current cohort, a mean IQ of 85 (lower bound for the normal IQ range) is attained for FMRP levels that are only similar to 35% of the mean FMRP level among normal CGG-repeat controls. The current results should help guide expectations for efforts to induce FMR1 gene activity and for the levels of cognitive function expected for a given range of FMRP levels.	[Kim, Kyoungmi; Hessl, David; Schneider, Andrea; Protic, Dragana; Aydin, Elber Yuksel; Hagerman, Randi J.; Hagerman, Paul J.] UC Davis Hlth, UC Davis MIND Inst, Sacramento, CA 95817 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, Davis, CA 95616 USA; [Hessl, David] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Randol, Jamie L.; Espinal, Glenda M.; Hagerman, Paul J.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA; [Schneider, Andrea; Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95616 USA; [Protic, Dragana] Univ Belgrade, Sch Med, Dept Pharmacol Clin Pharmacol & Toxicol, Belgrade, Serbia; [Aydin, Elber Yuksel] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Belgrade; Istanbul University	Hagerman, PJ (corresponding author), UC Davis Hlth, UC Davis MIND Inst, Sacramento, CA 95817 USA.; Hagerman, PJ (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA.	pjhagerman@ucdavis.edu	, WaNgtJ/AAR-7045-2020	Protic, Dragana/0000-0002-2137-5405	NICHD [HD036071]; Azrieli Foundation; MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071, U54HD079125] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Azrieli Foundation; MIND Institute Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was partially supported by NICHD HD036071 (RJH), the Azrieli Foundation (PJH and RJH), and the MIND Institute Intellectual and Developmental Disabilities Research Center U54 HD079125 (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpatov R, 2014, CELL, V157, P869, DOI 10.1016/j.cell.2014.03.040; Arsenault J, 2016, HUM GENE THER, V27, P982, DOI 10.1089/hum.2016.090; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Banerjee A, 2018, BRAIN RES, V1693, P24, DOI 10.1016/j.brainres.2018.04.008; Bar-Nur O, 2012, J MOL CELL BIOL, V4, P180, DOI 10.1093/jmcb/mjs007; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bernard PB, 2013, NEUROBIOL DIS, V59, P1, DOI 10.1016/j.nbd.2013.06.013; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Castagnola S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00342; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Chiurazzi P, 2001, BRAIN RES BULL, V56, P383, DOI 10.1016/S0361-9230(01)00571-8; Chonchaiya W, 2012, HUM GENET, V131, P581, DOI 10.1007/s00439-011-1106-6; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; D'Annessa I, 2019, PROG BIOPHYS MOL BIO, V141, P3, DOI 10.1016/j.pbiomolbio.2018.07.001; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dockendorff TC, 2019, MOL NEUROBIOL, V56, P711, DOI 10.1007/s12035-018-1122-9; Dyer-Friedman J, 2002, J AM ACAD CHILD PSY, V41, P237, DOI 10.1097/00004583-200203000-00002; Fatemi SH, 2011, ANAT REC, V294, P1635, DOI 10.1002/ar.21299; Fatemi SH, 2011, NEUROPHARMACOLOGY, V60, P1221, DOI 10.1016/j.neuropharm.2010.11.011; Fatemi SH, 2010, SCHIZOPHR RES, V124, P246, DOI 10.1016/j.schres.2010.07.017; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fernandez E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00191; Ferron L, 2016, J PHYSIOL-LONDON, V594, P5861, DOI 10.1113/JP270675; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Gholizadeh S, 2014, NEUROPSYCHOPHARMACOL, V39, P3100, DOI 10.1038/npp.2014.167; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Haenfler JM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00282; Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00564; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; HAGERMAN RJ, 1994, AM J MED GENET, V51, P298, DOI 10.1002/ajmg.1320510404; Hessl D, 2004, MENT RETARD DEV D R, V10, P17, DOI 10.1002/mrdd.20004; Hessl D, 2009, J NEURODEV DISORD, V1, P33, DOI 10.1007/s11689-008-9001-8; Hodges SL, 2019, EPILEPSY RES, V157, DOI 10.1016/j.eplepsyres.2019.106193; Holley Andrew J, 2018, Epilepsia Open, V3, P511, DOI 10.1002/epi4.12273; Iwahashi C, 2009, J MOL DIAGN, V11, P281, DOI 10.2353/jmoldx.2009.080118; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jiraanont P, 2017, EXPERT REV MOL DIAGN, V17, P1023, DOI 10.1080/14737159.2017.1377612; Kaufmann WE, 1999, AM J MED GENET, V83, P286, DOI 10.1002/(SICI)1096-8628(19990402)83:4<286::AID-AJMG10>3.0.CO;2-H; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kenny P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060985; Kovacs T, 2013, PSYCHIAT RES, V210, P690, DOI 10.1016/j.psychres.2012.12.022; Kumari D, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9020039; Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278; Lachiewicz AM, 1996, AM J MED GENET, V64, P278, DOI 10.1002/(SICI)1096-8628(19960809)64:2<278::AID-AJMG9>3.0.CO;2-Q; LaFauci G, 2013, J MOL DIAGN, V15, P508, DOI 10.1016/j.jmoldx.2013.02.006; Leboucher A, 2019, MOL METAB, V21, P22, DOI 10.1016/j.molmet.2019.01.002; Lessard M, 2012, CLIN GENET, V82, P472, DOI 10.1111/j.1399-0004.2011.01798.x; Li M, 2017, STEM CELLS, V35, P158, DOI 10.1002/stem.2463; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Loesch DZ, 2003, AM J MED GENET A, V122A, P13, DOI 10.1002/ajmg.a.20214; Ludwig AL, 2014, HUM MOL GENET, V23, P3228, DOI 10.1093/hmg/ddu032; Maurin T, 2018, NUCLEIC ACIDS RES, V46, P6344, DOI 10.1093/nar/gky267; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MERENSTEIN SA, 1994, J AM ACAD CHILD PSY, V33, P1316, DOI 10.1097/00004583-199411000-00014; Mila M, 2018, CLIN GENET, V93, P197, DOI 10.1111/cge.13075; Musumeci SA, 2007, EXP NEUROL, V203, P233, DOI 10.1016/j.expneurol.2006.08.007; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pietrobono R, 2002, NUCLEIC ACIDS RES, V30, P3278, DOI 10.1093/nar/gkf434; Plomin R, 2015, MOL PSYCHIATR, V20, P98, DOI 10.1038/mp.2014.105; Pretto D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00318; Pretto DI, 2014, J MED GENET, V51, P309, DOI 10.1136/jmedgenet-2013-102021; Ramirez-Cheyne JA, 2019, CLIN GENET, V95, P262, DOI 10.1111/cge.13469; ROUSSEAU F, 1994, HUM MOL GENET, V3, P927, DOI 10.1093/hmg/3.6.927; Sansone SM, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-16; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schutzius G, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-8; Sears JC, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00440; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sitzmann AF, 2018, AM J MED GENET A, V176, P11, DOI 10.1002/ajmg.a.38504; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; Steyaert J, 1996, AM J MED GENET, V64, P274, DOI 10.1002/(SICI)1096-8628(19960809)64:2<274::AID-AJMG8>3.0.CO;2-U; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Swanson MR, 2018, JAMA PSYCHIAT, V75, P505, DOI 10.1001/jamapsychiatry.2018.0180; Tabolacci E, 2008, PHARMACOGENET GENOM, V18, P738, DOI 10.1097/FPC.0b013e32830500a1; Tabolacci E, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080049; Tassone F, 2000, AM J MED GENET, V94, P232, DOI 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2001, J MED GENET, V38, P453, DOI 10.1136/jmg.38.7.453; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; Wang ZM, 1996, J MED GENET, V33, P376, DOI 10.1136/jmg.33.5.376; Wegiel J, 2018, AUTISM RES, V11, P1316, DOI 10.1002/aur.2003; Wheeler A, 2017, PEDIATRICS, V139, pS172, DOI 10.1542/peds.2016-1159D; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Winarni Tri Indah, 2012, Case Rep Genet, V2012, P280813, DOI 10.1155/2012/280813; Wohrle D, 1998, J MED GENET, V35, P103, DOI 10.1136/jmg.35.2.103; Xie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165499; Yrigollen CM, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-24; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	94	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226811	10.1371/journal.pone.0226811	http://dx.doi.org/10.1371/journal.pone.0226811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891607	Green Published, gold			2022-12-26	WOS:000515096600030
J	Rajar, P; Asegg-Atneosen, M; Saugstad, OD; Solberg, R; Baumbusch, LO				Rajar, Polona; Asegg-Atneosen, Monica; Saugstad, Ola Didrik; Solberg, Ronnaug; Baumbusch, Lars Oliver			Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet model of asphyxia	PLOS ONE			English	Article							NUCLEIC-ACIDS; CLINICAL-APPLICATIONS; PLASMA; HYPOXIA; SERUM; TIME	Cell free DNA (cfDNA) in plasma has been described as a potential diagnostic indicator for a variety of clinical conditions, including neonatal hypoxia. Neonatal hypoxia or perinatal asphyxia is a severe medical condition caused by a temporary interruption in oxygen availability during birth. Previously, we have reported temporal changes of cfDNA detected in blood in a newborn piglet model of perinatal asphyxia. However, cfDNA can also be found in other body liquids, opening for a less invasive diagnostic prospective. The objective of this study was to test and establish a reliable method for the isolation and quantification of cfDNA from urine and to explore changes in the quantities of cfDNA using a newborn piglet model of asphyxia. Animals were exposed to hypoxia-reoxygenation (n = 6), hypoxia-reoxygenation + hypothermia (n = 6) or were part of the sham-operated control group (n = 6) and urine samples (n = 18) were collected at 570 minutes post-intervention. Two alternative applications of cfDNA measurement were tested, an indirect method comprising a centrifugation step together with DNA extraction with magnetic beads versus a direct assessment based on two centrifugation steps. CfDNA concentrations were determined by a fluorescent assay using PicoGreen and by qRT-PCR. Genomic (gDNA) and mitochondrial DNA (mtDNA) cfDNA were determined in parallel, taking into account potential differences in the rates of damages caused by oxidative stress. In contrast to previous publications, our results indicate that the direct method is insufficient. Application of the indirect method obtained with the fluorescence assay revealed mean cfDNA levels (SD) of 1.23 (1.76) ng/ml for the hypoxia samples, 4.47 (6.15) ng/ml for the samples exposed to hypoxia + hypothermia and 2.75 (3.62) ng/ml for the control animals. The mean cfDNA levels in piglets exposed to hypoxia + hypothermia revealed significantly higher cfDNA amounts compared to mean cfDNA levels in the samples purely exposed to hypoxia (p < 0.05); however, no significant difference could be determined when compared to the control group (p = 0.09). Application of the indirect method by qRT-PCR revealed mean cfDNA levels of mtDNA and gDNA at the detection limit of the technique and thus no reliable statistics could be performed between the observed cfDNA levels in the investigated groups. The methodology for detection and monitoring of cfDNA in urine has to be further optimized before it can be applied in a clinical setting in the future.	[Rajar, Polona; Asegg-Atneosen, Monica; Saugstad, Ola Didrik; Solberg, Ronnaug; Baumbusch, Lars Oliver] Oslo Univ Hosp, Dept Pediat Res, Div Pediat & Adolescent Med, Rikshosp, Oslo, Norway; [Rajar, Polona; Asegg-Atneosen, Monica; Saugstad, Ola Didrik] Univ Oslo, Oslo, Norway; [Solberg, Ronnaug] Vestfold Hosp Trust, Dept Pediat, Tonsberg, Norway	University of Oslo; National Hospital Norway; University of Oslo	Baumbusch, LO (corresponding author), Oslo Univ Hosp, Dept Pediat Res, Div Pediat & Adolescent Med, Rikshosp, Oslo, Norway.	lars.o.baumbusch@rr-research.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254; Baumbusch, Lars O./0000-0003-1290-312X; Rajar, Polona/0000-0002-0986-3510				Akhter W, 2001, BIOL NEONATE, V79, P187; ANKER P, 1975, CANCER RES, V35, P2375; [Anonymous], 2016, INFORMATION NC FOR B; Aucamp J, 2018, BIOL REV, V93, P1649, DOI 10.1111/brv.12413; Benterud T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140966; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Bratz M, AUTOMATED CIRCULATIN, P1; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Bryzgunova OE, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-3-48-54; Chang Y, 2017, THER CLIN RISK MANAG, V13, P1363, DOI 10.2147/TCRM.S141991; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; El Bali Latifa, 2014, J Biomol Tech, V25, P96, DOI 10.7171/jbt.14-2504-002; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Gahan Peter B., 2008, Infectious Disorders - Drug Targets, V8, P100; Garberg HT, 2017, NEONATOLOGY, V111, P133, DOI 10.1159/000449032; Gillam-Krakauer M., 2019, BIRTH ASPHYXIA; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Herrera-Marschitz M, 2011, NEUROTOX RES, V19, P603, DOI 10.1007/s12640-010-9208-9; Huang DJ, 2005, CLIN CHEM, V51, P2419, DOI 10.1373/clinchem.2005.056010; Lu T, 2017, AM J CANCER RES, V7, P2318; Manueldas S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206601; Nakashima Chiho, 2018, Oncotarget, V9, P25181, DOI 10.18632/oncotarget.25388; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Saugstad OD, 2012, NEONATOLOGY, V101, P315, DOI 10.1159/000337345; Sharma VK, 2011, INT J MASS SPECTROM, V304, P172, DOI 10.1016/j.ijms.2010.10.003; Siddiqui H, 2009, CLIN BIOCHEM, V42, P1128, DOI 10.1016/j.clinbiochem.2009.03.010; Singh Gyanesh, 2015, F1000Res, V4, P176, DOI 10.12688/f1000research.6665.1; Su YH, 2008, ANN NY ACAD SCI, V1137, P82, DOI 10.1196/annals.1448.019; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Tnaeva NO, 2008, ANN NY ACAD SCI, V1137, P27, DOI 10.1196/annals.1448.043; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Vlassov VV, 2010, CURR MOL MED, V10, P142, DOI 10.2174/156652410790963295; Wagner J, 2012, BIOCHEM MEDICA, V22, P24; Wang MJ, 2004, CLIN CHEM, V50, P211, DOI 10.1373/clinchem.2003.026914	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227066	10.1371/journal.pone.0227066	http://dx.doi.org/10.1371/journal.pone.0227066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891615	Green Published, gold, Green Submitted			2022-12-26	WOS:000515096600056
J	Yan, SX; Wang, YL; Zhang, YJ; Wang, L; Zhao, XF; Du, CL; Gao, P; Yan, F; Liu, FW; Gong, XL; Guan, Y; Cui, XY; Wang, XM; Zhang, CX				Yan, Shuxin; Wang, Yalong; Zhang, Yujia; Wang, Le; Zhao, Xiaofang; Du, Cuilian; Gao, Pei; Yan, Feng; Liu, Fengwei; Gong, Xiaoli; Guan, Yuan; Cui, Xiuyu; Wang, Xiaomin; Zhang, Claire Xi			Synaptotagmin-11 regulates the functions of caveolae and responds to mechanical stimuli in astrocytes	FASEB JOURNAL			English	Article						astrocyte swelling; endocytosis; hypoosmotic stress; mechanoprotection	PLASMA-MEMBRANE; CAVIN FAMILY; PARKINSONS-DISEASE; CYTOKINE SECRETION; EXPRESSION; GENE; PROTEIN; XI; ENDOCYTOSIS; CELLS	Caveolae play crucial roles in intracellular membrane trafficking and mechanosensation. In this study, we report that synaptotagmin-11 (Syt11), a synaptotagmin isoform associated with Parkinson's disease and schizophrenia, regulates both caveolae-mediated endocytosis and the caveolar response to mechanical stimuli in astrocytes. Syt11-knockout (KO) accelerated caveolae-mediated endocytosis. Interestingly, the caveolar structures on the cell surface were markedly fewer in the absence of Syt11. Caveolar disassembly in response to hypoosmotic stimuli and astrocyte swelling were both impaired in Syt11-KO astrocytes. Live imaging revealed that Syt11 left caveolar structures before cavin1 during hypoosmotic stress and returned earlier than cavin1 after isoosmotic recovery. Chronic hypoosmotic stress led to proteasome-mediated Syt11 degradation. In addition, Syt11-KO increased the turnover of cavin1 and EH domain-containing protein 2 (EHD2), accompanied by compromised membrane integrity, suggesting a mechanoprotective role of Syt11. Direct interactions between Syt11 and cavin1 and EHD2, but not caveolin-1, are found. Altogether, we propose that Syt11 stabilizes caveolar structures on the cell surface of astrocytes and regulates caveolar functions under physiological and pathological conditions through cavin1 and EHD2.	[Yan, Shuxin; Wang, Yalong; Zhang, Yujia; Zhao, Xiaofang; Du, Cuilian; Gao, Pei; Yan, Feng; Liu, Fengwei; Guan, Yuan; Cui, Xiuyu; Wang, Xiaomin; Zhang, Claire Xi] Capital Med Univ, Collaborat Innovat Ctr Brain Disorders, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Wang, Le; Wang, Xiaomin] Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Key Lab Parkinson Dis, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, Beijing, Peoples R China; [Du, Cuilian] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Clin Neuroimmunol, Munich, Germany; [Du, Cuilian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Munich, Germany; [Gong, Xiaoli; Wang, Xiaomin] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Guan, Yuan] Tsinghua Univ, Hosp 1, Dept Anesthesiol, Huaxin Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; University of Munich; University of Munich; Capital Medical University; Tsinghua University	Wang, XM; Zhang, CX (corresponding author), Capital Med Univ, Collaborat Innovat Ctr Brain Disorders, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	xmwang@ccmu.edu.cn; clairexizhang@ccmu.edu.cn		yan, feng/0000-0001-8663-6859	National Natural Science Foundation of China (NSFC) [31471085]; Beijing Natural Science Foundation Program; Scientific Research Key Program of Beijing Municipal Commision of Education [KM201610025014]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201610025014]; Chaoyang District Science and Technology Plan Project [CYSF-1933]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Scientific Research Key Program of Beijing Municipal Commision of Education; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Chaoyang District Science and Technology Plan Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31471085; Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commision of Education, Grant/Award Number: KZ201510025023; Scientific Research Common Program of Beijing Municipal Commission of Education, Grant/Award Number: KM201610025014; Chaoyang District Science and Technology Plan Project, Grant/Award Number: CYSF-1933	Albinsson S, 2008, AM J PHYSIOL-CELL PH, V294, pC271, DOI 10.1152/ajpcell.00297.2007; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bento CF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11803; Cameron PL, 1997, J NEUROSCI, V17, P9520; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Du CL, 2017, GLIA, V65, P1656, DOI 10.1002/glia.23186; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Duque GA, 2014, J IMMUNOL, V193, P2363, DOI 10.4049/jimmunol.1303043; Duque GA, 2013, J IMMUNOL, V190, P1737, DOI 10.4049/jimmunol.1202500; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hoernke M, 2017, P NATL ACAD SCI USA, V114, pE4360, DOI 10.1073/pnas.1614066114; Hsiao IL, 2017, ENVIRON TOXICOL, V32, P1742, DOI 10.1002/tox.22397; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Inoue S, 2007, AM J MED GENET B, V144B, P332, DOI 10.1002/ajmg.b.30465; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lafrenaye AD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020330; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014; Lisjak M, 2017, J NEUROSCI, V37, P10748, DOI 10.1523/JNEUROSCI.0776-17.2017; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MASSA PT, 1982, AM J ANAT, V165, P69, DOI 10.1002/aja.1001650107; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mittelsteadt T, 2009, J COMP NEUROL, V512, P514, DOI 10.1002/cne.21908; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Niesman IR, 2013, MOL CELL NEUROSCI, V56, P283, DOI 10.1016/j.mcn.2013.07.002; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Parton RG, 2018, CURR BIOL, V28, pR402, DOI 10.1016/j.cub.2017.11.075; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rewatkar PV, 2015, ADV DRUG DELIVER REV, V91, P92, DOI 10.1016/j.addr.2015.01.003; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sesar A, 2016, J NEUROL SCI, V362, P321, DOI 10.1016/j.jns.2016.02.014; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shimojo M, 2019, GENE DEV, V33, P365, DOI 10.1101/gad.320077.118; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sreetama SC, 2016, CELL DEATH DIFFER, V23, P596, DOI 10.1038/cdd.2015.124; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Torrino S, 2018, J CELL BIOL, V217, P4092, DOI 10.1083/jcb.201801122; Volynski KE, 2018, CURR OPIN NEUROBIOL, V51, P154, DOI 10.1016/j.conb.2018.05.006; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wang CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02593-y; Wang CH, 2016, EMBO REP, V17, P47, DOI 10.15252/embr.201540689; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047; Yokota H, 2003, DNA RES, V10, P287, DOI 10.1093/dnares/10.6.287; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	69	6	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2609	2624		10.1096/fj.201901715R	http://dx.doi.org/10.1096/fj.201901715R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908017				2022-12-26	WOS:000503756600001
J	Bhopatkar, AA; Uversky, VN; Rangachari, V				Bhopatkar, Anukool A.; Uversky, Vladimir N.; Rangachari, Vijayaraghavan			Granulins modulate liquid?liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43; TARDBP); ALS (Lou Gehrig disease); stress granule; protein?protein interaction; protein dynamic; intrinsically disordered protein; ALS; FTLD; Granulins; liquid?liquid phase separation; progranulin	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; DNA-BINDING PROTEIN; INTRINSIC DISORDER; EPITHELIN PRECURSOR; WEB SERVER; PROGRANULIN; RNA; PREDICTION; SEQUENCE	TAR DNA-binding protein 43 (TDP-43) has emerged as a key player in many neurodegenerative pathologies, including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Hallmarks of both FTLD and ALS are the toxic cytoplasmic inclusions of the prion-like C-terminal fragments of TDP-43 CTD (TDP-43 C-terminal domain), formed upon proteolytic cleavage of full-length TDP-43 in the nucleus and subsequent transport to the cytoplasm. Both full-length TDP-43 and its CTD are also known to form stress granules by coacervating with RNA in the cytoplasm during stress and may be involved in these pathologies. Furthermore, mutations in the PGRN gene, leading to haploinsufficiency and diminished function of progranulin (PGRN) protein, are strongly linked to FTLD and ALS. Recent reports have indicated that proteolytic processing of PGRN to smaller protein modules called granulins (GRNs) contributes to FTLD and ALS progression, with specific GRNs exacerbating TDP-43?induced cytotoxicity. Here we investigated the interactions between the proteolytic products of both TDP-43 and PGRN. Based on structural disorder and charge distributions, we hypothesized that GRN-3 and GRN-5 could interact with the TDP-43 CTD. We show that, under both reducing and oxidizing conditions, GRN-3 and GRN-5 interact with and differentially modulate TDP-43 CTD aggregation and/or liquid?liquid phase separation in vitro. GRN-3 promoted insoluble aggregates of the TDP-43 CTD while GRN-5 mediated liquid?liquid phase separation. These results constitute the first observation of an interaction between GRNs and TDP-43, suggesting a mechanism by which attenuated PGRN function could lead to familial FTLD or ALS.	[Bhopatkar, Anukool A.; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Lab New Methods Biol, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	University of Southern Mississippi; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Rangachari, V (corresponding author), Univ Southern Mississippi, 118 Coll Dr 5043, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	NIA, National Institutes of Health [1R56AG062292-01, RF1AG055088]; NIGMS, National Institutes of Health [R01GM120634, 8 P20 GM-103476-11]; National Science Foundation [CBET 1802793]; National Center for Research Resources, National Institutes of Health [5P20RR01647-11]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIA, National Institutes of Health Grants 1R56AG062292-01 (to V. R.) and RF1AG055088 (to V. N. U.), NIGMS, National Institutes of Health Grants R01GM120634 and 8 P20 GM-103476-11 (to V. R.), National Science Foundation Grant CBET 1802793 (to V. R.), and National Center for Research Resources, National Institutes of Health Grant 5P20RR01647-11 (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Babinchak WM, 2019, J BIOL CHEM, V294, P6306, DOI 10.1074/jbc.RA118.007222; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Bhopatkar AA, 2019, BIOCHEM J, V476, P859, DOI 10.1042/BCJ20180916; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bocti C, 2006, DEMENT GERIATR COGN, V21, P364, DOI 10.1159/000091838; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Butler VJ, 2019, BIOCHEMISTRY-US, V58, P2670, DOI 10.1021/acs.biochem.9b00275; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cascella R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153685; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; Chornenkyy Y, 2019, LAB INVEST, V99, P993, DOI 10.1038/s41374-019-0196-y; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Cooper PN, 1996, NEUROPATH APPL NEURO, V22, P17, DOI 10.1046/j.1365-2990.1996.2398023.x; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; Das RK, 2015, CURR OPIN STRUC BIOL, V32, P102, DOI 10.1016/j.sbi.2015.03.008; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Dine E, 2018, CELL SYST, V6, P655, DOI 10.1016/j.cels.2018.05.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Elhaddaoui A, 1995, BIOSPECTROSCOPY, V1, P351, DOI 10.1002/bspy.350010506; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Fei JY, 2017, J CELL SCI, V130, P4180, DOI 10.1242/jcs.206854; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fukui T, 2000, J NEUROL SCI, V174, P111, DOI 10.1016/S0022-510X(00)00261-6; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Ghag G, 2017, PROTEIN SCI, V26, P1759, DOI 10.1002/pro.3212; Ghag G, 2016, PROTEIN ENG DES SEL, V29, P177, DOI 10.1093/protein/gzw005; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Guo L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024554; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00680; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; HULETTE CM, 1992, CLIN NEUROPATHOL, V11, P151; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Irwin DJ, 2015, ACTA NEUROPATHOL, V129, P469, DOI 10.1007/s00401-014-1380-1; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Khalfallah Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25767-0; Kitamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19230; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Mann JR, 2019, NEURON, V102, P321, DOI 10.1016/j.neuron.2019.01.048; Mao QW, 2017, J NEUROPATH EXP NEUR, V76, P957, DOI 10.1093/jnen/nlx085; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meng FC, 2017, CELL MOL LIFE SCI, V74, P3069, DOI 10.1007/s00018-017-2555-4; Meng Fanchi, 2017, Curr Protoc Protein Sci, V88, DOI 10.1002/cpps.28; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, BIOCOMPUT-PAC SYM, P176; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025; Prather LJ, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11040649; Rao BS, 2017, P NATL ACAD SCI USA, V114, pE9569, DOI 10.1073/pnas.1712396114; Robert PH, 1999, ENCEPHALE, V25, P612; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Santamaria N, 2017, CELL MOL LIFE SCI, V74, P1297, DOI 10.1007/s00018-016-2416-6; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uversky VN, 2017, AUTOPHAGY, V13, P2115, DOI 10.1080/15548627.2017.1384889; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	108	15	15	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2506	2519		10.1074/jbc.RA119.011501	http://dx.doi.org/10.1074/jbc.RA119.011501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31911437	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000517330200030
J	Wang, X; Gan, GH; Wu, LY				Wang, Xu; Gan, Guohua; Wu, Ling-Yun			Framework and algorithms for identifying honest blocks in blockchain	PLOS ONE			English	Article							CHALLENGES	Blockchain technology gains more and more attention in the past decades and has been applied in many areas. The main bottleneck for the development and application of blockchain is its limited scalability. Blockchain with directed acyclic graph structure (BlockDAG) is proposed in order to alleviate the scalability problem. One of the key technical problems in BlockDAG is the identification of honest blocks which are very important for establishing a stable and invulnerable total order of all the blocks. The stability and security of BlockDAG largely depends on the precision of honest block identification. This paper presents a novel universal framework based on graph theory, called MaxCord, for identifying the honest blocks in BlockDAG. By introducing the concept of discord, the honest block identification is modelled as a generalized maximum independent set problem. Several algorithms are developed, including exact, greedy and iterative filtering algorithms. The extensive comparisons between proposed algorithms and the existing method were conducted on the simulated BlockDAG data to show that the proposed iterative filtering algorithm identifies the honest blocks both efficiently and effectively. The proposed MaxCord framework and algorithms can set the solid foundation for the BlockDAG technology.	[Wang, Xu; Wu, Ling-Yun] Chinese Acad Sci, Key Lab Management Decis & Informat Syst, Inst Appl Math, Acad Math & Syst Sci, Beijing, Peoples R China; [Wang, Xu; Wu, Ling-Yun] Univ Chinese Acad Sci, Sch Math Sci, Beijing, Peoples R China; [Wang, Xu; Gan, Guohua; Wu, Ling-Yun] Chinese Acad Sci, Lab Big Data & Blockchain, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Gan, Guohua] Beijing Taiyiyun Technol Co Ltd, Beijing, Peoples R China; [Gan, Guohua] Univ Sci & Technol Beijing, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology Beijing	Wu, LY (corresponding author), Chinese Acad Sci, Key Lab Management Decis & Informat Syst, Inst Appl Math, Acad Math & Syst Sci, Beijing, Peoples R China.; Wu, LY (corresponding author), Univ Chinese Acad Sci, Sch Math Sci, Beijing, Peoples R China.; Wu, LY (corresponding author), Chinese Acad Sci, Lab Big Data & Blockchain, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	lywu@amss.an.cn	Wu, Ling-Yun/C-4222-2008	Wu, Ling-Yun/0000-0001-9487-0215	Laboratory of Big Data and Blockchain, National Centerfor Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences	Laboratory of Big Data and Blockchain, National Centerfor Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences	LYW was supported by the Laboratory of Big Data and Blockchain, National Centerfor Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences. GG received salary from Beijing Taiyiyun Technology Co., Ltd. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apte S., 2016, J EXCIPIENTS FOOD CH, V7, P910; Bahga A., 2016, J SOFTWARE ENG APPL, V9, P533, DOI [10.4236/jsea.2016.910036, DOI 10.4236/JSEA.2016.910036]; Bai C., 2018, STRUCTURED OBJECT OR, P183; Biais B, 2019, REV FINANC STUD, V32, P1662, DOI 10.1093/rfs/hhy095; Crosby M., 2016, APPL INNOVATION REV, V2, P1; Decker C, 2013, IEEE INT CONF PEER, DOI 10.1109/p2p.2013.6688704; Feng Q, 2019, J NETW COMPUT APPL, V126, P45, DOI 10.1016/j.jnca.2018.10.020; FEO TA, 1994, OPER RES, V42, P860, DOI 10.1287/opre.42.5.860; Nguyen GT, 2018, J INF PROCESS SYST, V14, P101, DOI 10.3745/JIPS.01.0024; Huh S, 2017, INT CONF ADV COMMUN, P464, DOI 10.23919/ICACT.2017.7890132; Juhasz PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207000; Kim YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177630; Kristoufek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123923; Lansiti M, 2017, HARVARD BUS REV, V95, P119; Lewenberg Y, 2015, LECT NOTES COMPUT SC, V8975, P528, DOI 10.1007/978-3-662-47854-7_33; Li X., 2017, FUTURE GENER COMPUT; Liao Tzu-Chun, 2017, IJ NETWORK SECURITY, V19, P653, DOI [DOI 10.6633/IJNS.201709.19(5).01, 10.6633/IJNS.201709.19(5).01]; Mettler M, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P520; Nakamoto S., 2019, BITCOIN PEER TO PEER, P21260; Pervez H, 2018, 2018 12TH INTERNATIONAL CONFERENCE ON OPEN SOURCE SYSTEMS AND TECHNOLOGIES (ICOSST), P27, DOI 10.1109/ICOSST.2018.8632193; Reyna A, 2018, FUTURE GENER COMP SY, V88, P173, DOI 10.1016/j.future.2018.05.046; Serguei Popov, 2016, THE TANGLE; Sompolinsky Y., 2018, IACR CRYPTOL EPRINT, V2018, P104; Sompolinsky Y, 2015, LECT NOTES COMPUT SC, V8975, P507, DOI 10.1007/978-3-662-47854-7_32; Swan M., 2015, BLOCKCHAIN BLUEPRINT; Tapscott A., 2017, HARVARD BUS REV, V1, P2; Tarjan R. E., 1977, SIAM Journal on Computing, V6, P537, DOI 10.1137/0206038; Treleaven P, 2017, COMPUTER, V50, P14, DOI 10.1109/MC.2017.3571047; Tsukiyama S., 1977, SIAM Journal on Computing, V6, P505, DOI 10.1137/0206036; Xiao MY, 2016, DISCRETE APPL MATH, V199, P137, DOI 10.1016/j.dam.2014.07.009; Yli-Huumo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163477; Zhang Y, 2017, PEER PEER NETW APPL, V10, P983, DOI 10.1007/s12083-016-0456-1; Zheng ZB, 2018, INT J WEB GRID SERV, V14, P352, DOI 10.1504/IJWGS.2018.095647	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227531	10.1371/journal.pone.0227531	http://dx.doi.org/10.1371/journal.pone.0227531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914455	Green Published, gold			2022-12-26	WOS:000534337700049
J	Wang, YX; Xiong, GH; He, Z; Yan, MF; Zou, MF; Jiang, JX				Wang, Yuanxiu; Xiong, Guihong; He, Zhe; Yan, Mingfeng; Zou, Manfei; Jiang, Junxi			Transcriptome analysis of Actinidia chinensis in response to Botryosphaeria dothidea infection	PLOS ONE			English	Article							DISEASE RESISTANCE; 1ST REPORT; DEFENSE RESPONSES; BINDING PROTEIN; GENE-EXPRESSION; FATTY-ACID; FRUIT ROT; CALCIUM; PLANTS; KIWIFRUIT	Ripe rot caused by Botryosphaeria dothidea causes extensive production losses in kiwifruit (Actinidia chinensis Planch.). Our previous study showed that kiwifruit variety "Jinyan" is resistant to B. dothidea while "Hongyang" is susceptible. For a comparative analysis of the response of these varieties to B. dothidea infection, we performed a transcriptome analysis by RNA sequencing. A total of 305.24 Gb of clean bases were generated from 36 libraries of which 175.76 Gb was from the resistant variety and 129.48 Gb from the susceptible variety. From the libraries generated, we identified 44,656 genes including 39,041 reference genes, 5,615 novel transcripts, and 13,898 differentially expressed genes (DEGs). Among these, 2,373 potentially defense-related genes linked to calcium signaling, mitogen-activated protein kinase (MAPK), cell wall modification, phytoalexin synthesis, transcription factors, pattern-recognition receptors, and pathogenesis-related proteins may regulate kiwifruit resistance to B. dothidea. DEGs involved in calcium signaling, MAPK, and cell wall modification in the resistant variety were induced at an earlier stage and at higher levels compared with the susceptible variety. Thirty DEGs involved in plant defense response were strongly induced in the resistant variety at all three time points. This study allowed the first comprehensive understanding of kiwifruit transcriptome in response to B. dothidea and may help identify key genes required for ripe rot resistance in kiwifruit.	[Wang, Yuanxiu; Xiong, Guihong; He, Zhe; Yan, Mingfeng; Zou, Manfei; Jiang, Junxi] Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China; [Wang, Yuanxiu] Jiangxi Agr Univ, Coll Biosci & Bioengn, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University	Jiang, JX (corresponding author), Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China.	jxau2011@126.com			National Natural Science Foundation of China [31460452]; Jiangxi Provincial Science and Technology Plan Project [20181ACF60017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Science and Technology Plan Project	This study was supported by the National Natural Science Foundation of China (Grant No. 31460452) and Jiangxi Provincial Science and Technology Plan Project (Grant No. 20181ACF60017)	Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bai SH, 2015, PLANT SCI, V231, P11, DOI 10.1016/j.plantsci.2014.11.003; Bai SH, 2013, PLANT PHYSIOL BIOCH, V62, P23, DOI 10.1016/j.plaphy.2012.10.016; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonthala VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148771; Choi IY, 2011, PLANT DIS, V95, P227, DOI 10.1094/PDIS-05-10-0371; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Duarte KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40623-5; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Eva M, 2007, J AGR FOOD CHEM, V55, P9021, DOI [10.1021/jf0718244, DOI 10.1021/JF0718244]; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Garibaldi A, 2012, PLANT DIS, V96, P910, DOI 10.1094/PDIS-02-12-0130-PDN; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Hamdoun S, 2016, PLANT PHYSIOL, V170, P515, DOI 10.1104/pp.15.01466; Hosseini S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1829-1; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurick WM, 2013, PLANT DIS, V97, P999, DOI 10.1094/PDIS-01-13-0053-PDN; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kishimoto K, 2010, PLANT J, V64, P343, DOI 10.1111/j.1365-313X.2010.04328.x; Koh YJ, 2005, NEW ZEAL J CROP HORT, V33, P303, DOI 10.1080/01140671.2005.9514363; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Li Cheng, 2014, Acta Agriculturae Universitatis Jiangxiensis, V36, P1061; Li Cheng, 2012, Acta Agriculturae Universitatis Jiangxiensis, V34, P259; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Lu GY, 2011, EUR J PLANT PATHOL, V131, P585, DOI 10.1007/s10658-011-9833-z; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Moscatiello R, 2006, J EXP BOT, V57, P2847, DOI 10.1093/jxb/erl043; Nagano Y, 2001, NUCLEIC ACIDS RES, V29, P4097, DOI 10.1093/nar/29.20.4097; Pathak RK, 2013, BIOINFORMATION, V9, P443, DOI 10.6026/97320630009443; PENNYCOOK SR, 1985, MYCOTAXON, V24, P445; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4, P94, DOI 10.4161/psb.4.2.7580; Ramirez V, 2011, PLANT SIGNAL BEHAV, V6, P911, DOI 10.4161/psb.6.6.15354; Reddy VS, 2003, PLANT MOL BIOL, V52, P143, DOI 10.1023/A:1023993713849; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Seo JK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05905; So Hyun-A, 2015, Plant Omics, V8, P479; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang WM, 2012, MOL PLANT, V5, P1125, DOI 10.1093/mp/sss008; Wei G, 2006, MOL PLANT PATHOL, V7, P579, DOI [10.1111/j.1364-3703.2006.00363.x, 10.1111/j.1364-3703.2006.00363.X]; Wunderlich N, 2012, AUSTRALAS PLANT DIS, V7, P47, DOI 10.1007/s13314-012-0045-y; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang SP, 2013, MOL GENET GENOMICS, V288, P21, DOI 10.1007/s00438-012-0727-3; Zhang WW, 2018, PLANT SCI, V269, P94, DOI 10.1016/j.plantsci.2018.01.009; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou WL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00011	63	7	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227303	10.1371/journal.pone.0227303	http://dx.doi.org/10.1371/journal.pone.0227303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914162	Green Published, gold			2022-12-26	WOS:000534337700037
J	Chiavari-Frederico, MO; Barbosa, LN; dos Santos, IC; da Silva, GR; de Castro, AF; Bortolucci, WD; Barboza, LN; Campos, CFDA; Goncalves, JE; Menetrier, JV; Jacomassi, E; Gazim, ZC; Wietzikoski, S; Livero, FAD; Lovato, ECW				Chiavari-Frederico, Marcela Oliveira; Barbosa, Lidiane Nunes; dos Santos, Isabela Carvalho; da Silva, Gustavo Ratti; de Castro, Alanna Fernandes; Bortolucci, Wanessa de Campos; Barboza, Lorena Neris; de Araujo Almeida Campos, Caio Franco; Eduardo Goncalves, Jose; Menetrier, Jacqueline Vergutz; Jacomassi, Ezilda; Gazim, Zilda Cristiani; Wietzikoski, Samantha; dos Reis Livero, Francislaine Aparecida; Wietzikoski Lovato, Evellyn Claudia			Antimicrobial activity of Asteraceae species against bacterial pathogens isolated from postmenopausal women	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIBACTERIAL ACTIVITY; CHEMICAL-COMPOSITION; ESCHERICHIA-COLI; PLANT-EXTRACTS; L.; EPIDEMIOLOGY; MENOPAUSE; PRODUCTS; HEALTH	Purpose Investigation of the antibacterial action of aqueous extracts of Bidens sulphurea, Bidens pilosa, and Tanacetum vulgare, species of Asteraceae family that are popularly used for the treatment of genito-urinary infection. Methods The minimum inhibitory concentration (MIC) and minimal bacterial concentration (MBC) of the extracts against standard strains of Staphylococcus aureus (ATCC25923), Enterococcus faecalis (ATCC29212), Escherichia coli (ATCC25922), and Pseudomonas aeruginosa (ATCC27853) and against bacteria that were isolated from cultures of vaginal secretions and urine from menopausal women with a diagnosis of recurrent urinary tract infections (rUTI) were determined by broth microdilution. Results The MIC values of the three extracts against Gram-positive and Gram-negative standard bacterial strains ranged from 7.81 to 125.00 mg ml(-1), and the MBC values ranged from 7.81 to 500.00 mg ml(-1). However, B. sulphurea was more efficient. In the urine samples, the three extracts inhibited the growth of coagulase-negative Staphylococcus spp., and the B. pilosa was the most active extract against E. coli compared with the other ones. For the vaginal secretion samples, no significant differences in the inhibition of coagulase-positive Staphylococcus spp. and P. mirabilis were found among the extracts. T. vulgare and B. sulphurea were more effective in inhibiting coagulase-negative Staphylococcus spp. compared with B. pilosa. E. coli was more susceptible to the B. sulphurea extract compared with the B. pilosa and T. vulgare extracts. Conclusion The present results suggested the potential medicinal use of Asteraceae species, especially B. sulphurea, as therapeutic agents against rUTI-related bacteria.	[Chiavari-Frederico, Marcela Oliveira; de Castro, Alanna Fernandes; Barboza, Lorena Neris; Wietzikoski, Samantha; Wietzikoski Lovato, Evellyn Claudia] Univ Paranaense, Lab Preclin Res Nat Prod, Umuarama, PR, Brazil; [Chiavari-Frederico, Marcela Oliveira; Menetrier, Jacqueline Vergutz; Jacomassi, Ezilda; dos Reis Livero, Francislaine Aparecida; Wietzikoski Lovato, Evellyn Claudia] Univ Paranaense, Med Plants & Phytotherap Basic Attent, Umuarama, PR, Brazil; [Barbosa, Lidiane Nunes; dos Santos, Isabela Carvalho; da Silva, Gustavo Ratti] Univ Paranaense, Lab Prevent Vet Med & Publ Hlth, Umuarama, PR, Brazil; [Barbosa, Lidiane Nunes; dos Reis Livero, Francislaine Aparecida] Univ Paranaense, Anim Sci Emphasis Bioact Prod, Umuarama, PR, Brazil; [Bortolucci, Wanessa de Campos; Gazim, Zilda Cristiani] Univ Paranaense, Biotechnol Appl Agr, Chem Lab Nat Prod, Umuarama, PR, Brazil; [de Araujo Almeida Campos, Caio Franco; Eduardo Goncalves, Jose] Univ Ctr Maringa, Clean Technol, Maringa, PR, Brazil; [Eduardo Goncalves, Jose] Univ Ctr Maringa, Technol & Food Safety & Cesumar Inst Sci Technol, Maringa, PR, Brazil	Universidade Paranaense; Universidade Paranaense; Universidade Paranaense; Universidade Paranaense; Universidade Paranaense	Lovato, ECW (corresponding author), Univ Paranaense, Lab Preclin Res Nat Prod, Umuarama, PR, Brazil.; Lovato, ECW (corresponding author), Univ Paranaense, Med Plants & Phytotherap Basic Attent, Umuarama, PR, Brazil.	evellyn@prof.unipar.br	Barbosa, Lidiane Nunes/AFO-3012-2022; Santos, Isabela Carvalho/GLQ-6273-2022; Wietzikoski, E.C./N-8166-2015; de Campos Bortolucci, Wanessa/AAK-9897-2020; Goncalves, Jose Eduardo/Y-1015-2018	de Campos Bortolucci, Wanessa/0000-0002-7233-8313; Goncalves, Jose Eduardo/0000-0002-2505-0536; Gazim, Zilda Cristiani/0000-0003-0392-5976; Carvalho Dos Santos, Isabela/0000-0002-7971-5126	Universidade Paranaense; Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention; Graduate Program in Animal Science with Emphasis on Bioactive Products; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [800435/2018-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PNPD20132409-40028011002P4]; Fundacao Araucaria (FUNDACAO ARAUCARIA) [47661.491.48325.12122016]	Universidade Paranaense; Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention; Graduate Program in Animal Science with Emphasis on Bioactive Products; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FUNDACAO ARAUCARIA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	The authors are grateful to Universidade Paranaense, Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention, and Graduate Program in Animal Science with Emphasis on Bioactive Products for financial support. This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; no. 800435/2018-4), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; no. PNPD20132409-40028011002P4) and Fundacao Araucaria (FUNDACAO ARAUCARIA; no. 47661.491.48325.12122016).	Adams R.P., 2012, IDENTIFICATION ESSEN; Alaagib R.M.O., 2015, TPI, V4, P73; [Anonymous], 2012, SCI SECURE J BIOTECH; Baranauskiene R, 2014, IND CROP PROD, V60, P113, DOI 10.1016/j.indcrop.2014.05.047; Bartolome AP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/340215; Bessada SMP, 2015, IND CROP PROD, V76, P604, DOI 10.1016/j.indcrop.2015.07.073; Blake J, 2006, BEST PRACT RES CL OB, V20, P799, DOI 10.1016/j.bpobgyn.2006.07.001; Borges C.C., 2013, Rev. bras. plantas med., V15, P34, DOI 10.1590/S1516-05722013000100004; Caretto M, 2017, MATURITAS, V99, P43, DOI 10.1016/j.maturitas.2017.02.004; Chattopadhyay D, 2002, J ETHNOPHARMACOL, V82, P229, DOI 10.1016/S0378-8741(02)00165-4; Choi K, 2016, INT J VET HLTH SCI R, V4, P88, DOI [10.19070/2332-2748-1600022, DOI 10.19070/2332-2748-1600022]; CLSI, 2015, PERFORMANCE STANDARD, V3rd ed.; Costa LC., 2010, REV BRAS ANAL CLIN, V42, P175; da Silva BP, 2017, J AGR FOOD CHEM, V65, P5161, DOI 10.1021/acs.jafc.7b01922; de Souza GC, 2004, J ETHNOPHARMACOL, V90, P135, DOI 10.1016/j.jep.2003.09.039; Deba F, 2007, WEED BIOL MANAG, V7, P77, DOI 10.1111/j.1445-6664.2007.00239.x; Dias H. J., 2017, INT J COMPLEM ALT ME, V6, P188; Oliveira SGD, 2012, J ETHNOPHARMACOL, V140, P428, DOI 10.1016/j.jep.2012.01.054; Duarte MCT, 2005, J ETHNOPHARMACOL, V97, P305, DOI 10.1016/j.jep.2004.11.016; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Hernandez MM, 1999, J ETHNOPHARMACOL, V67, P37, DOI 10.1016/S0378-8741(99)00041-0; Jhang JF, 2017, TZU CHI MED J, V29, P131, DOI 10.4103/tcmj.tcmj_53_17; Kannan RRR, 2012, FOOD CHEM, V135, P2470, DOI 10.1016/j.foodchem.2012.07.070; Knight JA, 2000, ANN CLIN LAB SCI, V30, P145; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Koneman EK, 2008, DIAGNOSTICO MICROBIO; Kostakioti M, 2012, VIRULENCE, V3, P592, DOI 10.4161/viru.22364; KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165, DOI 10.1128/AEM.46.1.165-170.1983; Martino MDV, 2002, J BRAS NEFROL, V24, P71; Mazili P. M. L., 2011, Revista Brasileira de Medicina, V68, P74; Medeiros S, 2017, ELLIPSIS, V2, P7; Miah, 2012, INT CURRENT PHARM J, V1, DOI [https://doi.org/10.3329/icpj.v1i6.10534, DOI 10.3329/ICPJ.V1I6.10534]; Moore KN, 2002, J CLIN NURS, V11, P568, DOI 10.1046/j.1365-2702.2002.00629.x; Neilson JP, 2008, OBSTET GYNECOL, V112, P689, DOI 10.1097/AOG.0b013e318185f7a5; Oliveira DF, 2007, FITOTERAPIA, V78, P142, DOI 10.1016/j.fitote.2006.09.027; Persu C, 2011, J Med Life, V4, P75; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Raz R, 2011, KOREAN J UROL, V52, P801, DOI 10.4111/kju.2011.52.12.801; Rosselli S, 2012, MOLECULES, V17, P8186, DOI 10.3390/molecules17078186; Silva DR, 2009, MOLECULES, V14, P1171, DOI 10.3390/molecules14031171; Sribalan R, 2016, SAUDI PHARM J, V24, P658, DOI 10.1016/j.jsps.2015.05.003; Sridevi VK, 2012, NAT PROD RES, V26, P1135, DOI 10.1080/14786419.2011.560849; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Tsuchiya H, 1996, J ETHNOPHARMACOL, V50, P27, DOI 10.1016/0378-8741(96)85514-0; Xie G, 2007, INT IMMUNOPHARMACOL, V7, P1639, DOI 10.1016/j.intimp.2007.08.013; Zeeuwen PLJM, 2013, CURR OPIN ALLERGY CL, V13, P514, DOI 10.1097/ACI.0b013e328364ebeb	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227023	10.1371/journal.pone.0227023	http://dx.doi.org/10.1371/journal.pone.0227023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905207	Green Published, gold			2022-12-26	WOS:000534327700014
J	Furuhata, Y; Sakai, A; Murakami, T; Nagasaki, A; Kato, Y				Furuhata, Yuichi; Sakai, Ayako; Murakami, Tomi; Nagasaki, Akira; Kato, Yoshio			Bioluminescent imaging of Arabidopsis thaliana using an enhanced Nano-lantern luminescence reporter system	PLOS ONE			English	Article							SINGLE-CELL; LUCIFERASE; EXPRESSION; EMISSION; SPECTRA; ALGAE; GENE	Bioluminescent detection has become a powerful method that is used extensively in numerous areas in life science research. Given that fluorescence detection in plant cells is difficult owing to the autofluorescence of chlorophyll, the use of a luciferin-luciferase system should be effective in plant biology. However, the suitable optical window for a luminescence system in plants remains unexplored. In this study, we sought to determine the optical window and optimal luciferase reporter system for terrestrial plant analyses using Arabidopsis thaliana as a model organism. We compared six different luciferase systems and found the green enhanced Nano-lantern (GeNL)-furimazine combination to be the optimal luciferase reporter. Spectral measurements of GeNL-furimazine showed that its luminescence peak falls within the range of optical transparency for chlorophyll and, therefore, enables greater penetration through a layer of cultured A. thaliana cells. Moreover, A. thaliana plants expressing GeNL with furimazine emitted strong luminescence, which could be detected even with the naked eye. Thus, the GeNL-furimazine combination should facilitate biological analyses of genes and cellular functions in A. thaliana and all other terrestrial plants.	[Furuhata, Yuichi; Sakai, Ayako; Murakami, Tomi; Nagasaki, Akira; Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kato, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	y-kato@aist.go.jp	Furuhata, Yuichi/L-6937-2018; Nagasaki, Akira/M-4892-2018; Kato, Yoshio/M-1093-2018	Furuhata, Yuichi/0000-0003-4299-4819; Nagasaki, Akira/0000-0002-1468-4592; Kato, Yoshio/0000-0001-8584-367X	New Energy and Industrial Technology Development Organization (NEDO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) to YK.	BERKALOFF C, 1990, PHOTOSYNTH RES, V23, P181, DOI 10.1007/BF00035009; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Fleiss A, 2019, CURR GENET, V65, P877, DOI 10.1007/s00294-019-00951-5; FRENCH CS, 1952, J GEN PHYSIOL, V35, P873, DOI 10.1085/jgp.35.6.873; Furuhata Y, 2019, PROTOC EXCH, DOI [10.1038/protex.2019.027, DOI 10.1038/PROTEX.2019.027]; Furuhata Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38119-9; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Horecker BL, 1943, J BIOL CHEM, V148, P173; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Khakhar A, 809533 BIORXIV, DOI [10.1101/809533v1, DOI 10.1101/809533V1]; Kotlobay AA, 2018, P NATL ACAD SCI USA, V115, P12728, DOI 10.1073/pnas.1803615115; Kuchimaru T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11856; Markova SV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P714, DOI 10.1134/S0006297915060073; Mitiouchkina T, 809376 BIORXIV, DOI [10.1101/809376v1, DOI 10.1101/809376V1]; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Shakhmin A, 2017, ORG BIOMOL CHEM, V15, P8559, DOI [10.1039/c7ob01985hrsc.li/obc, 10.1039/c7ob01985h]; Shimomura O, 2012, BIOLUMINESCENCE CHEM, DOI [10.1142/8239, DOI 10.1142/8239]; Suzuki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13718; Taiz L., PLANT PHYSL DEV; Takai A, 2015, P NATL ACAD SCI USA, V112, P4352, DOI 10.1073/pnas.1418468112; Tomabechi Y, 2016, BIOCHEM BIOPH RES CO, V470, P88, DOI 10.1016/j.bbrc.2015.12.123; Urquiza-Garcia U, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0454-4	27	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227477	10.1371/journal.pone.0227477	http://dx.doi.org/10.1371/journal.pone.0227477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899919	Green Published, gold			2022-12-26	WOS:000534322000029
J	Kumla, J; Suwannarach, N; Matsui, K; Lumyong, S				Kumla, Jaturong; Suwannarach, Nakarin; Matsui, Kenji; Lumyong, Saisamorn			Biosynthetic pathway of indole-3-acetic acid in ectomycorrhizal fungi collected from northern Thailand	PLOS ONE			English	Article							IAA BIOSYNTHESIS; PSEUDOMONAS-FLUORESCENS; PLANT-GROWTH; ROOT; AUXIN; IDENTIFICATION; BACTERIA; COLONIZATION; TOLERANCE; TRANSPORT	Indole-3-acetic acid (IAA) is an imperative phytohormone for plant growth and development. Ectomycorrhizal fungi (ECM) are able to produce IAA. However, only a few studies on IAA biosynthesis pathways in ECM fungi have been reported. This study aimed to investigate the IAA biosynthesis pathway of six ECM cultures including Astraeus odoratus, Gyrodon suthepensis, Phlebopus portentosus, Pisolithus albus, Pisolithus orientalis and Scleroderma suthepense. The results showed that all ECM fungi produced IAA in liquid medium that had been supplemented with L-tryptophan. Notably, fungal IAA levels vary for different fungal species. The detection of indole-3-lactic acid and indole-3-ethanol in the crude culture extracts of all ECM fungi indicated an enzymatic reduction of indole-3-pyruvic acid and indole-3-acetaldehyde, respectively in the IAA biosynthesis via the indole-3-pyruvic acid pathway. Moreover, the tryptophan aminotransferase activity confirmed that all ECM fungi synthesize IAA through the indole-3-pyruvic acid pathway. Additionally, the elongation of rice and oat coleoptiles was stimulated by crude culture extract. This is the first report of the biosynthesis pathway of IAA in the tested ECM fungi.	[Kumla, Jaturong; Suwannarach, Nakarin; Lumyong, Saisamorn] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Kumla, Jaturong; Suwannarach, Nakarin; Lumyong, Saisamorn] Chiang Mai Univ, Ctr Excellence Microbial Divers & Sustainable Uti, Chiang Mai, Thailand; [Matsui, Kenji] Yamaguchi Univ, Fac Agr, Grad Sch Sci & Technol Innovat, Yamaguchi 7, Japan; [Lumyong, Saisamorn] Royal Soc Thailand, Acad Sci, Bangkok, Thailand	Chiang Mai University; Chiang Mai University	Lumyong, S (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.; Lumyong, S (corresponding author), Chiang Mai Univ, Ctr Excellence Microbial Divers & Sustainable Uti, Chiang Mai, Thailand.; Lumyong, S (corresponding author), Royal Soc Thailand, Acad Sci, Bangkok, Thailand.	saisamorn.l@cmu.ac.th	Suwannarach, Nakarin/P-6078-2019	Suwannarach, Nakarin/0000-0002-2653-1913	Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission [BDC-PG4-161008]; Chiang Mai University, Thailand; Japan Society for the Promotion of Science (JSPS) in Core-to-Core Program	Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission; Chiang Mai University, Thailand; Japan Society for the Promotion of Science (JSPS) in Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funded by 1. Center of Excellence on Biodiversity (BDC), The Office of The Higher Education Commission, (BDC-PG4-161008). (www.bdc-perdo.com).2.Chiang Mai University, Thailand (https://www.cmu.ac.th).3.Japan Society for the Promotion of Science (JSPS) in Core-to-Core Program. (http://www.jsps.go.jp/english/ecore_to_core).	Ahmad Farah, 2005, Turkish Journal of Biology, V29, P29; Anjali Bose, 2013, Mycology - An International Journal on Fungal Biology, V4, P103, DOI 10.1080/21501203.2013.823891; [Anonymous], 1996, ACIAR MONOGRAPH; Apine OA, 2011, J APPL MICROBIOL, V110, P1235, DOI 10.1111/j.1365-2672.2011.04976.x; Barker SJ, 2000, J PLANT GROWTH REGUL, V19, P144; Bartel B, 1997, ANNU REV PLANT PHYS, V48, P49; Carreno-Lopez R, 2000, MOL GEN GENET, V264, P521, DOI 10.1007/s004380000340; Chung KR, 2003, FEMS MICROBIOL LETT, V226, P23, DOI 10.1016/S0378-1097(03)00605-0; Chung KR, 2004, J BIOL SCI, V4, P744, DOI DOI 10.3923/JBS.2004.744.750; Chutima R, 2012, SYMBIOSIS, V56, P35, DOI 10.1007/s13199-012-0158-2; COSTACURTA A, 1994, MOL GEN GENET, V243, P463, DOI 10.1007/BF00280477; Ditengou FA, 2000, PLANTA, V211, P722, DOI 10.1007/s004250000342; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; FRANKENBERGER WT, 1987, APPL ENVIRON MICROB, V53, P2908, DOI 10.1128/AEM.53.12.2908-2913.1987; GAY G, 1994, NEW PHYTOL, V128, P645, DOI 10.1111/j.1469-8137.1994.tb04029.x; GAY G, 1987, APPL MICROBIOL BIOT, V26, P141, DOI 10.1007/BF00253898; GAY G, 1989, CAN J BOT, V67, P2235, DOI 10.1139/b89-285; Hilbert M., 2012, NEW PHYTOL, V196, P520, DOI DOI 10.1111/j.1469-8137.2012.04275.x; Imada EL, 2017, RES MICROBIOL, V168, P283, DOI 10.1016/j.resmic.2016.10.010; Karabaghli C, 1998, TREE PHYSIOL, V18, P103; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Kumla J, 2014, ANN MICROBIOL, V64, P707, DOI 10.1007/s13213-013-0706-x; LIBBERT E, 1969, PHYSIOL PLANTARUM, V22, P51, DOI 10.1111/j.1399-3054.1969.tb07840.x; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Makita N, 2012, J PLANT NUTR SOIL SC, V175, P900, DOI 10.1002/jpln.201100417; Minamisawa K, 1996, PLANT CELL PHYSIOL, V37, P449, DOI 10.1093/oxfordjournals.pcp.a028966; Niemi K, 2002, TREE PHYSIOL, V22, P1231, DOI 10.1093/treephys/22.17.1231; Numponsak T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205070; Nutaratat P, 2016, ARCH MICROBIOL, V198, P429, DOI 10.1007/s00203-016-1202-z; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; Ramachela K, 2010, SOUTH FORESTS, V72, P37, DOI 10.2989/20702620.2010.482343; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Rodrigues EP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01572; Rudawska ML, 1997, NEW PHYTOL, V137, P509, DOI 10.1046/j.1469-8137.1997.00838.x; Sardar P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192293; Sarjala T, 2010, PLANT PHYSIOL BIOCH, V48, P596, DOI 10.1016/j.plaphy.2010.01.022; Shilts T., 2005, Journal of Biological Sciences, V5, P205; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Strelczyck E, 1984, PLANT SOIL, V81, P185; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Suwannarach N, 2015, BIOL CONTROL, V90, P25, DOI 10.1016/j.biocontrol.2015.05.008; Szkop M, 2013, ANTON LEEUW INT J G, V103, P683, DOI 10.1007/s10482-012-9838-4; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tomaszewski M, 1975, ROLE GROWTH REGULATO; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Tsavkelova EA, 2007, MICROBIOL RES, V162, P69, DOI 10.1016/j.micres.2006.07.014; Yan XM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01848; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	53	15	15	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227478	10.1371/journal.pone.0227478	http://dx.doi.org/10.1371/journal.pone.0227478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899917	gold, Green Published			2022-12-26	WOS:000534322000030
J	Lv, Y; He, XY; Li, DG; Liu, T; Wen, GQ; Li, JF				Lv, Yan; He, X. Y.; Li, Dongguo; Liu, Tao; Wen, G. Q.; Li, Junfa			Sex-specific and opposite modulatory aspects revealed by PPI network and pathway analysis of ischemic stroke in humans	PLOS ONE			English	Article							GENDER; RISK; INFARCTION; MICROGLIA; CYTOSCAPE; SIZE	Background Ischemic Stroke (IS) is a major disease which greatly threatens human health. Recent studies showed sex-specific outcomes and mechanisms of cerebral ischemic stroke. This study aimed to identify the key changes of gene expression between male and female IS in humans. Methods Gene expression dataset GSE22255, including peripheral blood samples, was downloaded from the Gene Expression Omnibus (GEO) dataset. Differentially Expressed Genes (DEGs) with a LogFC>1, and a P-value <0.05 were screened by BioConductor R package and grouped in female, male and overlap DEGs for further bioinformatic analysis. Gene Ontology (GO) functional annotation, Protein-Protein Interaction (PPI) network, "Molecular Complex Detection" (MCODE) modules, CytoNCA (cytoscape network centrality analysis) essential genes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway interrelation analysis were performed. Results In a total of 54,665 genes, 185 (73 ups and 112 downs) DEGs in the female dataset, 461 DEGs (297 ups and 164 downs) in the male dataset, within which 118 DEGs overlapped (7 similar changes in female and male, 111 opposite changes in female and male) were obtained from the GSE22255 dataset. Female, male and overlapping DEGs enriched for similar cellular components and molecular function. Male DEGs enriched for divergent biological processes from female and overlapping DEGs. Sex-specific and overlapping DEGs were put into the PPI network. Overlapping genes such as IL6, presented opposite changes and were mainly involved in cytokine-cytokine receptor interactions, the TNF-signalling pathway, etc. Conclusion The analysis of sex-specific DEGs from GEO human blood samples showed that not only specific but also opposite DEG alterations in the female and male stroke genome wide dataset. The results provided an overview of sex-specific mechanisms, which might provide insight into stroke and its biomarkers and lead to sex-specific prognosis and treatment strategies in future clinical practice.	[Lv, Yan; Li, Junfa] Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Lv, Yan; He, X. Y.; Liu, Tao; Wen, G. Q.] Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China; [Li, Dongguo] Capital Med Univ, Sch Basic Med Sci, Dept Bioinformat & Engn, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, JF (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.; Wen, GQ (corresponding author), Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China.	wengq9119@126.com; junfali@ccmu.edu.cn			Key Science and Technology Project of Hainan Province [ZDYF2018141, SQ2018SHFZ0095]	Key Science and Technology Project of Hainan Province	This work was supported by grants from the Key Science and Technology Project of Hainan Province (ZDYF2018141) and (SQ2018SHFZ0095). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Asdaghi N, 2016, STROKE, V47, P2618, DOI 10.1161/STROKEAHA.116.013059; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Banerjee A, 2013, TRANSL STROKE RES, V4, P554, DOI 10.1007/s12975-013-0268-z; Black M, 2015, OMICS, V19, P451, DOI 10.1089/omi.2015.0083; Bodhankar S, 2015, METAB BRAIN DIS, V30, P1515, DOI 10.1007/s11011-015-9714-9; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chauhan A, 2017, CLIN SCI, V131, P533, DOI 10.1042/CS20160841; Colbert JF, 2016, J STROKE CEREBROVASC, V25, P2399, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.008; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Etherton MR, 2017, STROKE, V48, P3387, DOI 10.1161/STROKEAHA.117.019258; Fahmi RM, 2016, J STROKE CEREBROVASC, V25, P2475, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.021; Feng J, 2013, J THROMB THROMBOLYS, V36, P307, DOI 10.1007/s11239-012-0849-9; Gibson CL, 2016, NEUROSCI BIOBEHAV R, V67, P119, DOI 10.1016/j.neubiorev.2015.08.020; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin G, 2017, EUR REV MED PHARMACO, V21, P3911; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Krug T, 2012, J CEREBR BLOOD F MET, V32, P1061, DOI 10.1038/jcbfm.2012.24; Li WZ, 2016, GENET MOL RES, V15; Li YW, 2017, J NEUROL SCI, V373, P107, DOI 10.1016/j.jns.2016.12.036; Madsen TE, 2017, NEUROLOGY, V89, P990, DOI 10.1212/WNL.0000000000004325; Marsh JD, 2010, J AM COLL CARDIOL, V56, P683, DOI 10.1016/j.jacc.2009.12.072; McCullough LD, 2016, AGING-US, V8, P1432, DOI 10.18632/aging.100997; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nguyen TVV, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0371-y; Ong CT, 2017, PLOS ONE, V12; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spaander FH, 2017, STROKE, V48, P699, DOI 10.1161/STROKEAHA.116.014739; Srivastava MVP, 2014, J STROKE CEREBROVASC, V23, P2391, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.016; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tan XW, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4323496; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Tatusova TA, 1999, BIOINFORMATICS, V15, P536, DOI 10.1093/bioinformatics/15.7.536; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Ye Z, 2018, NEUROMOLECULAR MED; Zaninovich OA, 2017, WORLD NEUROSURG, V106, P953, DOI [10.1016/J.WNEU.2017.07.084, 10.1016/j.wneu.2017.07.084]	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227481	10.1371/journal.pone.0227481	http://dx.doi.org/10.1371/journal.pone.0227481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899762	Green Published, gold			2022-12-26	WOS:000534322000031
J	Maria, DS; Daundasekara, SS; Hernandez, DC; Zhang, W; Narendorf, SC				Maria, Diane Santa; Daundasekara, Saumali S.; Hernandez, Daphne C.; Zhang, Wei; Narendorf, Sarah C.			Sexual risk classes among youth experiencing homelessness: Relation to childhood adversities, current mental symptoms, substance use, and HIV testing	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; YOUNG-ADULTS; FOSTER-CARE; STRESS; RUNAWAY; BEHAVIOR; ABUSE; VICTIMIZATION; PREDICTORS; ILLNESS	The aim of this study was to determine whether there are meaningful subgroups with different types of sexual risk behaviors among youth experiencing homelessness and examine the associations between potential classes and other risk variables. A latent class analysis was used to identify classes of youth according to sexual risk behaviors and sexual assault. A two-class solution was found to be the best fit for the data-Lower and Higher Risk groups. The Higher Risk class had significantly higher levels of synthetic marijuana and alcohol use, mental health diagnoses, and were more likely to have been tested for HIV than the Lower Risk group. Youth were more likely to be in the Higher Risk group if they were cisgender female or lesbian, gay, bisexual, or questioning (LGBQ). Nearly all youth (10/11) who reported having HIV infection were in the Higher Risk group. The Lower Risk group were sexually active but had lower rates of risk behaviors and sexual assault. Youth who were not sexually active had the lowest rates of marijuana and alcohol use as well as HIV testing. Health and social service providers should be aware of the added risks for stress, mental distress, mental health diagnoses, and substance use among youth who also report higher risk sexual behaviors and treat as needed.	[Maria, Diane Santa; Hernandez, Daphne C.] Univ Texas Hlth Sci Ctr Houston, Cizik Sch Nursing, Dept Res, Houston, TX 77030 USA; [Daundasekara, Saumali S.] Univ Houston, Dept Hlth & Human Performance, Houston, TX USA; [Zhang, Wei] Univ Texas Hlth Sci Ctr Houston, Dept Biostat & Data Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Narendorf, Sarah C.] Univ Houston, Grad Coll Social Work, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Houston System; University of Houston	Maria, DS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Cizik Sch Nursing, Dept Res, Houston, TX 77030 USA.	diane.m.santamaria@uth.tmc.edu	Daundasekara, Sajeevika/GLT-0050-2022	Santa Maria, Diane/0000-0001-8202-226X; Daundasekara, Sajeevika/0000-0002-9913-1937	Greater Houston Community Foundation; Funders Together to End Homelessness; Child and Family Center for Innovative Research	Greater Houston Community Foundation; Funders Together to End Homelessness; Child and Family Center for Innovative Research	This study was supported by the Greater Houston Community Foundation, Funders Together to End Homelessness, and the Child and Family Center for Innovative Research. The authors have no conflicts of interest, financial or otherwise, relevant to this article to disclose.; This study was supported by the Greater Houston Community Foundation, Funders Together to End Homelessness, and the Child and Family Center for Innovative Research. The authors have no conflicts of interest, financial or otherwise, relevant to this article to disclose.	Abramovich A, 2017, J HOMOSEXUAL, V64, P1484, DOI 10.1080/00918369.2016.1244449; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 1999, NOWHERE GROW HOMELES, DOI DOI 10.4324/9781315125398; Avenevoli S, 2015, J AM ACAD CHILD PSY, V54, P37, DOI 10.1016/j.jaac.2014.10.010; Beech BM, 2003, SEMIN PEDIAT INFECT; Begun S, 2016, J GAY LESBIAN SOC SE, V28, P54, DOI 10.1080/10538720.2016.1125821; Bender K, 2014, J ADOLESCENCE, V37, P155, DOI 10.1016/j.adolescence.2013.11.007; Bender K, 2010, J TRAUMA STRESS, V23, P161, DOI 10.1002/jts.20501; Brezing C, 2015, PSYCHOSOMATICS, V56, P107, DOI 10.1016/j.psym.2014.10.006; Buttram ME, 2018, SEX TRANSM INFECT; Caccamo A, 2017, SEX TRANSM DIS, V44, P466, DOI 10.1097/OLQ.0000000000000633; Carmona J, 2014, CHILDREN YOUTH SERVI; Castro AL, 2014, J HEALTH CARE POOR U, V25, P1201, DOI 10.1353/hpu.2014.0124; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, PERCEIVED STRESS PRO; Cutrona CE, 2006, CURR DIR PSYCHOL SCI, V15, P188, DOI 10.1111/j.1467-8721.2006.00433.x; Delker BC, 2014, J TRAUMA STRESS, V27, P576, DOI 10.1002/jts.21959; Dembo R, 2015, J ALCOHOLISM DRUG DE, V3, DOI [10.1016/j.acap.2018.04.011, DOI 10.1016/J.ACAP.2018.04.011]; Dermen KH, 2011, PSYCHOL ADDICT BEHAV, V25, P583, DOI 10.1037/a0025472; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Edidin JP, 2012, CHILD PSYCHIAT HUM D, V43, P354, DOI 10.1007/s10578-011-0270-1; Gangamma R, 2008, J YOUTH ADOLESCENCE, V37, P456, DOI 10.1007/s10964-007-9171-9; Gattis MN, 2016, AM J ORTHOPSYCHIAT, V86, P79, DOI 10.1037/ort0000096; Goldberg SK, 2017, PERSPECT SEX REPRO H, V49, P55, DOI 10.1363/psrh.12020; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.2307/2334349; Goodman LA, 2007, SOCIOL METHODOL, V37, P1, DOI 10.1111/j.1467-9531.2007.00184.x; Green KM, 2018, SEXUALLY TRANSMITTED; Gwadz MV, 2010, AIDS EDUC PREV, V22, P312, DOI 10.1521/aeap.2010.22.4.312; Halcon LL, 2004, J YOUTH ADOLESCENCE, V33, P71, DOI 10.1023/A:1027338514930; Hall KS, 2013, CONTRACEPTION; Hall KS, 2014, J SEXUAL MED; Heerde JA, 2015, TRAUMA VIOLENCE ABUS; Heerde JA, 2017, J INVEST PSYCHOL OFF, V14, P150, DOI 10.1002/jip.1473; Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204; Homelessness NAtE, 2016, STAT HOM AM; Hudson AL, 2012, CONTEMP NURSE, V42, P178, DOI 10.5172/conu.2012.42.2.178; Hulland EN, 2014, PSYCHOL HEALTH MED, V20, P1; James S, 2013, ADDICT BEHAV, V38, P1804, DOI 10.1016/j.addbeh.2012.09.002; Jung I, 2015, ROUT INT HANDB, P115; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kattari SK, 2017, J SOC WORK DISABIL R, V16, P116, DOI 10.1080/1536710X.2017.1299661; Kattari SK, 2017, AFFILIA J WOM SOC WO, V32, P92, DOI 10.1177/0886109916651904; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Khurana S., 2004, Indian Journal of Pediatrics, V71, P405, DOI 10.1007/BF02725627; Kidd SA, 2006, YOUTH SOC, V37, P393, DOI 10.1177/0044118X05282763; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Krause KD, 2016, J URBAN HEALTH, V93, P511, DOI 10.1007/s11524-016-0049-6; Kulik DM, 2011, PAED CHILD HEALT-CAN, V16, pE43, DOI 10.1093/pch/16.6.e43; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Maria DS, 2018, JMIR PUBLIC HLTH SUR, V4, P185, DOI 10.2196/publichealth.9020; Marshall BDL, 2009, HEALTH PLACE, V15, P783, DOI 10.1016/j.healthplace.2008.12.005; McMorris BJ, 2002, FAMILIAL STREET RISK; Muthen L, 2015, COMPREHENSIVE MODELL, V5; Narendorf SC, 2016, J COMMUNITY HLTH, P1, DOI [10.1007/s10900-015-0055-8, DOI 10.1007/S10900-015-0055-8]; Nylund-Gibson K., 2018, TRANSL ISS PSYCH SCI, V4, P440, DOI [DOI 10.1037/TPS0000176, 10.1037/tps0000176]; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Olivet J, 2016, TRUE COLORS FUND NAT; Pabst S, 2013, BEHAV BRAIN RES; Pabst S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00142; Parsons JT, 2013, AIDS BEHAV, V17, P1465, DOI 10.1007/s10461-012-0206-1; Parsons JT, 2012, AIDS BEHAV, P1, DOI [10.1007/s10461-011-9920-3, DOI 10.1007/S10461-011-9920-3]; Patterson ML, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0411-3; Pfeifer RW, 1997, J ADOLESCENT HEALTH, V20, P339, DOI 10.1016/S1054-139X(97)00038-4; Plessow F, 2012, EXP BRAIN RES, V216, P397, DOI 10.1007/s00221-011-2943-1; Ray N, 2006, GAY BISEXUAL TRANSGE; Rebbe R, 2018, ACAD PEDIATR, V18, P502, DOI 10.1016/j.acap.2018.04.011; Rew L, 2001, J NURS SCHOLARSHIP, V33, P33, DOI 10.1111/j.1547-5069.2001.00033.x; Rew L, 2016, J SOCIAL DISTRESS HO, P1, DOI [10.1179/1573658X15Y.0000000004, DOI 10.1179/1573658X15Y.0000000004]; Ringwalt CL, 1998, J ADOLESCENCE, V21, P241, DOI 10.1006/jado.1998.0150; Robinson AC, 2016, J BEHAV MED, V39, P1, DOI 10.1007/s10865-015-9670-1; Rohde P, 2001, J ADOLESCENCE, V24, P447, DOI 10.1006/jado.2001.0382; Rotheram-Borus Mary Jane, 2003, Prev Sci, V4, P173, DOI 10.1023/A:1024697706033; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Sandro Galea Md D, 2003, J URBAN HEALTH, V80, piii50; Santa Maria D, 2018, J ADOLESCENT HLTH; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Scholz U, 2009, NEUROBIOL LEARN MEM, V91, P89, DOI 10.1016/j.nlm.2008.09.002; Schulenberg JE., 2018, MONITORING FUTURE NA, DOI [10.3998/2027.42/146531, DOI 10.3998/2027.42/146531]; Shiffman S, 2009, PSYCHOL ASSESSMENT, V21, P486, DOI 10.1037/a0017074; Slesnick N, 2005, AM J DRUG ALCOHOL AB, V31, P179, DOI 10.1081/ADA-200047916; Starcke K, 2012, NEUROSCI BIOBEHAV R, V36, P1228, DOI 10.1016/j.neubiorev.2012.02.003; Stone AA, 2007, SCI REAL TIME DATA C; Tevendale HD, 2009, AIDS BEHAV, V13, P154, DOI 10.1007/s10461-008-9395-z; Thompson SJ, 2006, INT J SOC WELF, V15, P142, DOI 10.1111/j.1468-2397.2006.00370.x; Tucker JS, 2012, J ADOLESCENT HEALTH, V51, P386, DOI 10.1016/j.jadohealth.2012.01.015; Tyler KA, 2000, J INTERPERS VIOLENCE, V15, P235, DOI 10.1177/088626000015003001; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Votta E, 2009, J CAN ACAD CHILD ADO, V18, P126; Walls NE, 2011, J SEX RES, V48, P423, DOI 10.1080/00224499.2010.501916; Warttig SL, 2013, J HEALTH PSYCHOL, V18, P1617, DOI 10.1177/1359105313508346; Whitbeck LB, 1999, AM J COMMUN PSYCHOL, V27, P273, DOI 10.1023/A:1022891802943; Whitbeck LB, 2000, CHILD DEV, V71, P721, DOI 10.1111/1467-8624.00181; Whitbeck LB, 2004, J SEX RES, V41, P329, DOI 10.1080/00224490409552240; Wong CF, 2010, J ADOLESCENCE, V33, P463, DOI 10.1016/j.adolescence.2009.06.004; Yu V, 2010, J GAY LESBIAN MENT H, V14, P340, DOI 10.1080/19359705.2010.504476	96	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227331	10.1371/journal.pone.0227331	http://dx.doi.org/10.1371/journal.pone.0227331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899781	gold, Green Published			2022-12-26	WOS:000534322000021
J	Motiei, A; Brindefalk, B; Ogonowski, M; El-Shehawy, R; Pastuszek, P; Ek, K; Liewenborg, B; Udekwu, K; Gorokhova, E				Motiei, Asa; Brindefalk, Bjorn; Ogonowski, Martin; El-Shehawy, Rehab; Pastuszek, Paulina; Ek, Karin; Liewenborg, Birgitta; Udekwu, Klas; Gorokhova, Elena			Disparate effects of antibiotic-induced microbiome change and enhanced fitness in Daphnia magna	PLOS ONE			English	Article							OXIDATIVE STATUS; CIPROFLOXACIN; TOXICITY; BACTERIAL; REPRODUCTION; EXPRESSION; RESISTANCE; CRUSTACEAN; SURVIVAL; GROWTH	It is a common view that an organism's microbiota has a profound influence on host fitness; however, supporting evidence is lacking in many organisms. We manipulated the gut microbiome of Daphnia magna by chronic exposure to different concentrations of the antibiotic Ciprofloxacin (0.01-1 mg L-1), and evaluated whether this affected the animals fitness and antioxidant capacity. In line with our expectations, antibiotic exposure altered the microbiome in a concentration-dependent manner. However, contrary to these expectations, the reduced diversity of gut bacteria was not associated with any fitness detriment. Moreover, the growth-related parameters correlated negatively with microbial diversity; and, in the daphnids exposed to the lowest Ciprofloxacin concentrations, the antioxidant capacity, growth, and fecundity were even higher than in control animals. These findings suggest that Ciprofloxacin exerts direct stimulatory effects on growth and reproduction in the host, while microbiome- mediated effects are of lesser importance. Thus, although microbiome profiling of Daphnia may be a sensitive tool to identify early effects of antibiotic exposure, disentangling direct and microbiome-mediated effects on the host fitness is not straightforward.	[Motiei, Asa; Ogonowski, Martin; El-Shehawy, Rehab; Ek, Karin; Liewenborg, Birgitta; Gorokhova, Elena] Stockholm Univ, Dept Environm Sci & Analyt Chem ACES, Stockholm, Sweden; [Brindefalk, Bjorn; Pastuszek, Paulina; Udekwu, Klas] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Ogonowski, Martin] Aquabiota Water Res AB, Stockholm, Sweden; [Ogonowski, Martin] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Freshwater Res, Drottningholm, Sweden	Stockholm University; Stockholm University; Swedish University of Agricultural Sciences	Gorokhova, E (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem ACES, Stockholm, Sweden.	elena.gorokhova@aces.su.se		Gorokhova, Elena/0000-0002-4192-6956; El Shehawy, Rehab/0000-0003-4091-0810; Ogonowski, Martin/0000-0002-7082-0990	Stockholm County Council (SLL) [20160933]; Swedish Research Council (Vetenskapsradet) [2018-05213]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS);  [2018-01010]	Stockholm County Council (SLL)(Stockholm County Council); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); 	Sequencing and analysis of microbiome results were made possible by grant #20160933 from the Stockholm County Council (SLL) to KU. Funding from The Swedish Research Council (Vetenskapsradet, grant number 2018-05213) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, grant number 2018-01010) to EG and RE is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, R LANG ENV STAT COMP; Bona MD, 2015, ECOTOX ENVIRON SAFE, V113, P152, DOI 10.1016/j.ecoenv.2014.11.018; Borgan O, 2001, STAT MED, V20, P2053, DOI DOI 10.1002/SIM.956; Bowman J., 2005, GENUS 13 SHEWANELLA, P180; Brennan SJ, 2006, CHEMOSPHERE, V64, P49, DOI 10.1016/j.chemosphere.2005.11.046; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Callens M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0444-1; Castiglioni S, 2006, ENVIRON SCI TECHNOL, V40, P357, DOI 10.1021/es050991m; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; CHERRINGTON CA, 1991, J APPL BACTERIOL, V70, P161, DOI 10.1111/j.1365-2672.1991.tb04442.x; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CRUMPLIN GC, 1975, ANTIMICROB AGENTS CH, V8, P251, DOI 10.1128/AAC.8.3.251; De Liguoro M, 2009, CHEMOSPHERE, V75, P1519, DOI 10.1016/j.chemosphere.2009.02.002; Dietrich S, 2010, CHEMOSPHERE, V79, P60, DOI 10.1016/j.chemosphere.2009.12.069; Eckert EM, 2014, ISME J, V8, P1808, DOI 10.1038/ismej.2014.39; Edlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033107; Fink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028498; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Furuhagen S, 2014, ENVIRON SCI TECHNOL, V48, P12886, DOI 10.1021/es5044722; Gorokhova E, 2015, ENVIRON SCI TECHNOL, V49, P5779, DOI 10.1021/acs.est.5b00833; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Grillon A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156690; Gurbay A, 2004, DRUG CHEM TOXICOL, V27, P233, DOI 10.1081/DCT-120037504; Gurbay A, 2001, FREE RADICAL BIO MED, V30, P1118, DOI 10.1016/S0891-5849(01)00508-1; Gyuraszova M, 2017, MED HYPOTHESES, V103, P81, DOI 10.1016/j.mehy.2017.04.011; Harris KD, 2012, GENETICS RES INT, DOI DOI 10.1155/2012/147892; Hincal Filiz, 2003, Nonlinearity Biol Toxicol Med, V1, P481, DOI 10.1080/15401420390271083; Huang DJ, 2014, ENVIRON TOXICOL PHAR, V38, P874, DOI 10.1016/j.etap.2014.09.006; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Lien LTQ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060588; LEBEL M, 1988, PHARMACOTHERAPY, V8, P3; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Logares R, 2010, QUANT IT PICOGREEN A; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oliveira MF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00945; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Ouattara AS, 2003, INT J SYST EVOL MICR, V53, P1247, DOI 10.1099/ijs.0.02540-0; Peerakietkhajorn S, 2016, ENVIRON MICROBIOL, V18, P2366, DOI 10.1111/1462-2920.12919; Peerakietkhajorn S, 2015, ENV MICROBIOL REP, V7, P364, DOI 10.1111/1758-2229.12260; Purswani MU, 2002, J ANTIMICROB CHEMOTH, V50, P51, DOI 10.1093/jac/dkf091; Qi WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-172; Robinson AA, 2005, ENVIRON TOXICOL CHEM, V24, P423, DOI 10.1897/04-210R.1; Rosenfeld CS, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00396; Shin R, 2002, MOL PLANT MICROBE IN, V15, P983, DOI 10.1094/MPMI.2002.15.10.983; Shivlata L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01014; Sison-Mangus MP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27681-x; Sison-Mangus MP, 2015, ISME J, V9, P59, DOI 10.1038/ismej.2014.116; Stollewerk Angelika, 2010, J Biol, V9, P21, DOI 10.1186/jbiol212; Straughan DJ, 2000, J HERED, V91, P8, DOI 10.1093/jhered/91.1.8; Taipale SJ, 2012, FEMS MICROBIOL ECOL, V82, P50, DOI 10.1111/j.1574-6941.2012.01406.x; Tanaka Y, 2002, ENVIRON TOXICOL, V17, P487, DOI 10.1002/tox.10083; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wollenberger L, 2000, CHEMOSPHERE, V40, P723, DOI 10.1016/S0045-6535(99)00443-9; Yan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40610	62	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0214833	10.1371/journal.pone.0214833	http://dx.doi.org/10.1371/journal.pone.0214833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899775	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000534322000001
J	Hosonuma, M; Yajima, N; Takahashi, R; Yanai, R; Matsuyama, T; Toyosaki, E; Saito, J; Kusano, K; Morita, H				Hosonuma, Masahiro; Yajima, Nobuyuki; Takahashi, Ryo; Yanai, Ryo; Matsuyama, Takaaki; Toyosaki, Eiji; Saito, Jumpei; Kusano, Kengo; Morita, Hiroshi			Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; ALPHA-ACTININ; 12-LEAD ECG; HEART; RISK; MARKER; CONDUCTION; FREQUENCY; FIBROSIS	Objective Cardiovascular disease is an important contributor to the mortality rate of patients with systemic lupus erythematosus (SLE), which is related to SLE disease activity. Fragmented QRS (fQRS) complexes, defined by additional spikes in the QRS complex, are useful for identifying myocardial scars on electrocardiography and can be an independent predictor of cardiac events. We aimed to assess the relationship between disease activity in patients with SLE and fQRS at the time of diagnosis. Methods Forty-four patients with SLE were included. Patients with cardiac diseases, other rheumatic diseases, and prior treatment at the time of electrocardiography measurement were excluded. The appearance of fQRS represented exposure. The primary outcome was SLE Disease Activity Index 2000 (SLEDAI-2K). Multiple regression analysis was conducted to assess the association between fQRS and SLEDAI-2K adjusted for age, sex, and time from the estimated onset date to the date of diagnosis. Results Among patients with SLE at diagnosis, 26 (59.1%) had fQRS. The median SLEDAI-2K was 18 (interquartile range [IQR], 12-22) and 9 (IQR, 8-15) in the fQRS(+) and fQRS(-) groups, respectively. SLEDAI-2K was significantly higher in the fQRS(+) group than in the fQRS(-) group (regression coefficient, 2.69; 95% confidence interval, 0.76-4.61; p = 0.008). Conclusion Our results suggested that fQRS(+) patients with SLE had high disease activity. fQRS could likely detect subclinical myocardial involvement in patients with SLE and predict long-term occurrence of cardiac events.	[Hosonuma, Masahiro; Yajima, Nobuyuki; Takahashi, Ryo; Yanai, Ryo] Showa Univ, Sch Med, Dept Med, Div Rheumatol, Tokyo, Japan; [Yajima, Nobuyuki] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Yajima, Nobuyuki] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan; [Matsuyama, Takaaki] Showa Univ, Sch Med, Dept Legal Med, Tokyo, Japan; [Toyosaki, Eiji] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan; [Saito, Jumpei] Showa Univ, Northern Yokohama Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Kusano, Kengo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Osaka, Japan; [Morita, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Therapeut, Okayama, Japan	Showa University; Kyoto University; Fukushima Medical University; Showa University; Showa University; Showa University; National Cerebral & Cardiovascular Center - Japan; Okayama University	Yajima, N (corresponding author), Showa Univ, Sch Med, Dept Med, Div Rheumatol, Tokyo, Japan.; Yajima, N (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.; Yajima, N (corresponding author), Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan.	n.yajima@med.showa-u.ac.jp	Yanai, Ryo/HGF-2776-2022	Yajima, Nobuyuki/0000-0002-8292-3962; Hosonuma, Masahiro/0000-0002-5861-7543				Abdel-Aty H, 2008, LUPUS, V17, P561, DOI 10.1177/0961203308089401; Apte M, 2008, RHEUMATOLOGY, V47, P362, DOI 10.1093/rheumatology/kem371; Basaran Y, 2011, ECHOCARDIOGR-J CARD, V28, P62, DOI 10.1111/j.1540-8175.2010.01242.x; Bayar N, 2015, ANATOL J CARDIOL, V15, P209, DOI 10.5152/akd.2014.5191; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BIDANI AK, 1980, AM J MED, V69, P849, DOI 10.1016/S0002-9343(80)80010-6; Bjornadal L, 2004, J RHEUMATOL, V31, P713; Bulut M, 2015, J CARDIOVASC THORAC, V7, P96, DOI 10.15171/jcvtr.2015.21; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Demir K, 2014, SCAND CARDIOVASC J, V48, P197, DOI 10.3109/14017431.2014.935801; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Goovaerts G, 2019, IEEE J BIOMED HEALTH, V23, P1980, DOI 10.1109/JBHI.2018.2878492; Gungor B, 2016, ANN NONINVAS ELECTRO, V21, P604, DOI 10.1111/anec.12357; Gustafsson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174572; Hermansen ML, 2017, RHEUMATOLOGY, V56, P709, DOI 10.1093/rheumatology/kew475; Homsi M, 2009, ANN NONINVAS ELECTRO, V14, P319, DOI 10.1111/j.1542-474X.2009.00320.x; Inanir A, 2013, Z RHEUMATOL, V72, P468, DOI 10.1007/s00393-012-1102-9; Jain D, 2009, J CLIN PATHOL, V62, P584, DOI 10.1136/jcp.2009.064311; Kadi H, 2012, MOD RHEUMATOL, V22, P238, DOI 10.1007/s10165-011-0493-9; Kanitsoraphan C, 2019, ANN NONINVAS ELECTRO, V24, DOI 10.1111/anec.12597; Kim CH, 2017, HEART, V103, P227, DOI 10.1136/heartjnl-2016-309561; Konno T, 2015, J CARDIOVASC ELECTR, V26, P1081, DOI 10.1111/jce.12742; LIM KL, 1994, ANN RHEUM DIS, V53, P178, DOI 10.1136/ard.53.3.178; Lorgis L, 2013, HEART LUNG, V42, P326, DOI 10.1016/j.hrtlng.2013.05.005; Mavrogeni S, 2018, LUPUS, V27, P564, DOI 10.1177/0961203317731533; Mavrogeni S, 2017, INT J CARDIOL, V236, P151, DOI 10.1016/j.ijcard.2017.01.104; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Mostoslavsky G, 2001, EUR J IMMUNOL, V31, P1221, DOI 10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3473; Sadeghi R, 2016, KARDIOL POL, V74, P331, DOI 10.5603/KP.a2015.0193; Sayin MR, 2013, CORONARY ARTERY DIS, V24, P398, DOI 10.1097/MCA.0b013e328361a978; Singh J. A., 2005, Lupus, V14, P137, DOI 10.1191/0961203305lu2050oa; Take Yutaka, 2012, Indian Pacing Electrophysiol J, V12, P213; Vogels RJ, 2017, AM J CARDIOL, V119, P126, DOI 10.1016/j.amjcard.2016.09.021; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhang Y, 2015, INT J CARDIOVAS IMAG, V31, P389, DOI 10.1007/s10554-014-0560-3	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0227022	10.1371/journal.pone.0227022	http://dx.doi.org/10.1371/journal.pone.0227022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895922	Green Published, gold			2022-12-26	WOS:000534267300013
J	Park, JS; Yoo, SH; Lim, MA; Ryu, JG; Oh, HJ; Hwang, SH; Yang, S; Jung, KA; Yoon, S; Park, BC; Park, SH; Kim, HY; Cho, ML; Park, YW				Park, Jin-Sil; Yoo, Seok-Ho; Lim, Mi-Ae; Ryu, Jun-Geol; Oh, Hye-Joa; Hwang, Sun-Hee; Yang, SeungCheon; Jung, Kyung-Ah; Yoon, Sunha; Park, Bum-Chan; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La; Park, Young-woo			A bispecific soluble receptor fusion protein that targets TNF-alpha and IL-21 for synergistic therapy in inflammatory arthritis	FASEB JOURNAL			English	Article						bispecific fusion protein; cytokine; IL-17-producing T cells; rheumatoid arthritis; osteoclastogenesis	TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; PROMOTES OSTEOCLASTOGENESIS; AUTOIMMUNE ARTHRITIS; INCREASED RISK; ANIMAL-MODELS; TH17 CELLS; B-CELLS; INTERLEUKIN-21; GENERATION	This study was aimed at investigating the therapeutic effects of BITRAP, a bispecific fusion protein targeting TNF-alpha and IL-21, on the development of autoimmune arthritis in humans and mice. To verify the effects of BITRAP in human, peripheral blood mononuclear cells were cultured with BITRAP under IL-17-producing T (Th17) cell-polarizing conditions or osteoclast differentiation conditions. BITRAP treatment inhibited the production of IL-17 and vascular endothelial growth factor but increased the production of IL-10 in CD4(+) T cells, as well as directly suppressed osteoclastogenesis. Collagen-induced arthritis (CIA) and IL-1R antagonist (IL-1Ra) knockout mice were treated with BITRAP. Following injection in CIA mice, BITRAP rapidly migrated into the inflamed joints and remained there for 72 hours. Application of BITRAP attenuated the severity of autoimmune arthritis in CIA and IL-1Ra knockout mice by reducing the numbers of inflammatory cytokine-expressing cells and Th17 cells and antibody secretion. Finally, BITRAP suppressed STAT3 phosphorylation, as well as production of IL-17 and TNF-alpha, in murine splenic CD4(+) T cells. These findings suggest that BITRAP, a bispecific fusion protein targeting TNF-alpha and IL-21, may be an effective treatment to overcome the limitations of anti-TNF therapy for patients with rheumatoid arthritis.	[Park, Jin-Sil; Lim, Mi-Ae; Ryu, Jun-Geol; Oh, Hye-Joa; Hwang, Sun-Hee; Yang, SeungCheon; Jung, Kyung-Ah; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Yoo, Seok-Ho; Yoon, Sunha; Park, Bum-Chan; Park, Young-woo] Y Biol, Daejeon, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 06591, South Korea.	iammila@catholic.ac.kr			National Research Foundation of Korea (NRF) [20100029601]; Ministry for health and welfare, Republic of Korea [HI14C3417]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry for health and welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 20100029601; Ministry for health and welfare, Republic of Korea, Grant/Award Number: HI14C3417	Ali T, 2013, DRUG HEALTHC PATIENT, V5, P79, DOI 10.2147/DHPS.S28801; Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Buch MH, 2007, RHEUMATOLOGY, V46, P1153, DOI 10.1093/rheumatology/kem075; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Cho ML, 2002, ARTHRITIS RHEUM-US, V46, P42, DOI 10.1002/1529-0131(200201)46:1<42::AID-ART10026>3.0.CO;2-A; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Genovese MC, 2018, ARTHRITIS RHEUMATOL, V70, P1710, DOI 10.1002/art.40580; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Jablonska-Trypuc A, 2016, J ENZYM INHIB MED CH, V31, P177, DOI 10.3109/14756366.2016.1161620; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Kalden JR, 2017, NAT REV RHEUMATOL, V13, P707, DOI 10.1038/nrrheum.2017.187; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20150; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu ZH, 2018, INT J PHARMACEUT, V547, P72, DOI 10.1016/j.ijpharm.2018.05.058; Lloyd S, 2010, RHEUMATOLOGY, V49, P2313, DOI 10.1093/rheumatology/keq169; Long D, 2019, J AUTOIMMUN, V99, P1, DOI 10.1016/j.jaut.2019.01.013; Mease PJ, 2018, ARTHRITIS RHEUMATOL, V70, P1778, DOI 10.1002/art.40579; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Park JS, 2017, AM J PATHOL, V187, P2034, DOI 10.1016/j.ajpath.2017.05.008; Park JS, 2013, AM J PATHOL, V183, P857, DOI 10.1016/j.ajpath.2013.05.027; Park JS, 2013, ARTHRITIS RHEUM-US, V65, P949, DOI 10.1002/art.37841; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Rosloniec EF, 2001, CURR PROTOC IMMUNOL; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Xing R, 2016, SCAND J IMMUNOL, V83, P64, DOI 10.1111/sji.12396; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	49	3	3	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					248	262		10.1096/fj.201900816RR	http://dx.doi.org/10.1096/fj.201900816RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914604				2022-12-26	WOS:000507308900019
J	Mougi, A				Mougi, Akihiko			Rapid evolution of prey maintains predator diversity	PLOS ONE			English	Article							GENETIC-VARIATION; COEXISTENCE; MAINTENANCE; COEVOLUTION; COMPETITION; COMMUNITY; FEEDBACKS; STABILITY; DYNAMICS; ECOLOGY	Factors maintaining the populations of diverse species that share limited resources or prey remain important issues in ecology. In the present study, I propose that heritable intraspecific variation in prey, which facilitates natural selection, is a key to solve this issue. A mathematical model reveals that diverse genotypes in a prey promote the coexistence of multiple predator species. When two predators share a prey with multiple genotypes, evolution nearly selects the two prey genotypes. Through analysis, I establish a condition of coexistence of such multiple predator-one prey interaction with two genotypes. If each prey type has high defensive capacity against different predator species, stable coexistence is likely to occur. Particularly, interspecific variations of life-history parameters allow the coexistence equilibrium to be stable. In addition, rapid evolution in a prey allows more than two predator species to coexist. Furthermore, mutation tends to stabilize otherwise unstable systems. These results suggest that intraspecific variation in a prey plays a key role in the maintenance of diverse predator species by driving adaptive evolution.	[Mougi, Akihiko] Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Nishikawatsu Cho, Matsue, Shimane, Japan	Shimane University	Mougi, A (corresponding author), Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Nishikawatsu Cho, Matsue, Shimane, Japan.	amougi@gmail.com			Japan Society for the Promotion of Science [16K18621]; Faculty of Life and Environmental Science at Shimane University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Faculty of Life and Environmental Science at Shimane University	This work was supported by a Grant-inAid for Young Scientists (B) from the Japan Society for the Promotion of Science (num. #16K18621) and the Faculty of Life and Environmental Science at Shimane University to AM.	Abrams PA, 2006, AM NAT, V167, P329, DOI 10.1086/499382; Abrams PA, 2002, THEOR POPUL BIOL, V62, P281, DOI 10.1006/tpbi.2002.1614; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cortez MH, 2014, P NATL ACAD SCI USA, V111, P7486, DOI 10.1073/pnas.1317693111; Cortez MH, 2010, AM NAT, V176, pE109, DOI 10.1086/656485; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Gause G. F., 1934, STRUGGLE EXISTENCE; GILLESPIE JH, 1989, GENETICS, V121, P129; GILLESPIE JH, 1984, GENETICS, V107, P321; HAIGH J, 1972, THEOR POPUL BIOL, V3, P290, DOI 10.1016/0040-5809(72)90005-6; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Klauschies T, 2018, ECOL MODEL, V381, P46, DOI 10.1016/j.ecolmodel.2018.02.001; Klauschies T, 2016, ECOL EVOL, V6, P4141, DOI 10.1002/ece3.2172; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; LEVINS R, 1979, AM NAT, V114, P765, DOI 10.1086/283527; LEVINS RICHARD, 1968; Lynch M., 1998, GENETICS ANAL QUANTI; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Menden-Deuer S, 2019, THEOR ECOL-NETH, V12, P1, DOI 10.1007/s12080-018-0384-1; Menden-Deuer S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0031; Mougi A, 2012, THEOR POPUL BIOL, V81, P113, DOI 10.1016/j.tpb.2011.12.005; Mougi A, 2011, J THEOR BIOL, V277, P83, DOI 10.1016/j.jtbi.2011.02.015; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; RESCIGNO A, 1965, B MATH BIOPHYS, V27, P85, DOI 10.1007/BF02477264; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Schreiber SJ, 2018, AM NAT, V191, P407, DOI 10.1086/695832; Schreiber SJ, 2011, ECOLOGY, V92, P1582; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TILMAN D, 1980, AM NAT, V116, P362, DOI 10.1086/283633; Volterra V., 1928, Journal du Conseil Copenhague, P3; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	48	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227111	10.1371/journal.pone.0227111	http://dx.doi.org/10.1371/journal.pone.0227111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891629	Green Published, gold			2022-12-26	WOS:000515096600061
J	Oliveira, A; Selvaraj, K; Tripathy, JP; Betodkar, U; Cacodcar, J; Wadkar, A				Oliveira, Annet; Selvaraj, Kalaiselvi; Tripathy, Jaya Prasad; Betodkar, Utkarsh; Cacodcar, Jagadish; Wadkar, Abhijit			Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research	PLOS ONE			English	Article							OUTBREAK	Background Kyasanur Forest Disease (KFD) is a highly infectious viral illness transmitted by infected ticks through contact with monkeys and other forest animals. Till date there is no definite treatment available for KFD. Hence, vaccination is considered to be an important public health intervention to control KFD. This study aimed at estimating the vaccination coverage for primary and booster doses of KFD vaccine and exploring the perceived barriers to vaccination in the affected villages of Goa, India during 2015-18. Methodology & principal findings In this explanatory mixed methods study, vaccine coverage was estimated bydata obtained from the KFD vaccination registers maintained at the health centers catering to the KFD affected villages. To understand the barriers to vaccination,key informant interviews were conducted among implementing health officers, medical officers and nurses involved in vaccination. Perceptions of vaccinees and community members were studied through in-depth interviews and focus group discussions. Out of the 35,500 targeted population (6-65 years)for KFD vaccination, 32% received one dose and 13.2% received two doses. The coverage for first booster and annual booster was 4.9% and 0.5% respectively. The drop out from first to second and third doses was 57% and 85% respectively. 69% of doses were delivered during community outreach programmes and remaining at health facilities. Inadequate vaccine stock, inappropriate timing of vaccination campaign, lack of awareness and misconceptions related to indications of vaccines, travel distance for follow up doses given at community health centre and pain due to injection were perceived as reasons for poor vaccination coverage. Conclusions KFD vaccination coverage was poor in the villages affected by KFD in Goa. Both left-out and drop-out phenomena were observed in KFD vaccination. Vaccine implementation plan has to consider suitable time for the local people, maintain adequate vaccine stock and encourage community-based vaccination campaigns instead of facility-based to achieve optimal vaccine coverage.	[Oliveira, Annet] Directorate Hlth Serv, Integrated Dis Surveillance Programme, Panaji, Goa, India; [Selvaraj, Kalaiselvi; Tripathy, Jaya Prasad] All India Inst Med Sci, Nagpur, Maharashtra, India; [Tripathy, Jaya Prasad] Int Union TB & Lung Dis, Paris, France; [Betodkar, Utkarsh; Wadkar, Abhijit] Directorate Hlth Serv, Panaji, Goa, India; [Cacodcar, Jagadish] Goa Med Coll, Dept Prevent & Social Med, Bambolim, Goa, India	All India Institute of Medical Sciences (AIIMS) Nagpur; Goa Medical College & Hospital	Oliveira, A (corresponding author), Directorate Hlth Serv, Integrated Dis Surveillance Programme, Panaji, Goa, India.	oliveiraannet@ymail.com		Oliveira, Annet/0000-0003-2889-2410	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The training program, within which this paper was developed, was funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, CD AL KFD; Awate P, 2016, J INFECTION, V72, P759, DOI 10.1016/j.jinf.2016.03.006; Directorate of Census Operations, 2011, CENS IND 2011; Directorate of Health and Family Welfare Services Govt of Karnataka, 2005, MAN KYAS FOR DIS; International Institute for Population Sciences, 2016, NAT FAM HLTH SURV 20; Kasabi GS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002025; Kiran SK, 2015, EMERG INFECT DIS, V21, P146, DOI 10.3201/eid2101.141227; Mehla R, 2009, EMERG INFECT DIS, V15, P1431, DOI 10.3201/eid1509.080759; Murhekar MV, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0066-9; Plano Clark V. L., 2010, DESIGNING CONDUCTING, V2nd; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Yadav Pragya D., 2014, INT J INFECT DIS	12	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226141	10.1371/journal.pone.0226141	http://dx.doi.org/10.1371/journal.pone.0226141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891608	Green Published, gold			2022-12-26	WOS:000515096600011
J	Sichali, JM; Khan, JAK; Gama, EM; Banda, HT; Namakhoma, I; Bongololo, G; Thomson, R; Stenberg, B; Squire, SB				Sichali, Junious M.; Khan, Jahangir A. K.; Gama, Elvis M.; Banda, Hastings T.; Namakhoma, Ireen; Bongololo, Grace; Thomson, Rachael; Stenberg, Berthe; Squire, S. Bertel			Direct costs of illness of patients with chronic cough in rural Malawi-Experiences from Dowa and Ntchisi districts	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ECONOMIC BURDEN; TUBERCULOSIS PATIENTS; HEALTH-CARE; INCOME; DETERMINANTS; SYMPTOMS	Introduction Chronic cough is a distressing symptom and a common reason for people to seek health care services. It is a symptom that can indicate underlying tuberculosis (TB) and/or chronic airways diseases (CAD) including asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis. In developing countries including Malawi, provision of diagnostic services and clinical management of CAD is rudimentary, so it is thought that patients make costly and unyielding repeated care-seeking visits. There is, however, a lack of information on cost of illness, both direct and indirect, to patients with chronic cough symptom. Such data are needed to inform policy-makers in making decisions on allocating resources for designing and developing the relevant health care services to address universal coverage programmes for CAD. This paper therefore explores health seeking costs associated with chronic cough and explores information on usage of the coping mechanisms which indicate financial hardship, such as borrowing and selling household assets. Methods This economic study was nested within a community-based, population-proportional cross-sectional survey of 15,795 individuals aged 15 years and above, in Dowa and Ntchisi districts. The study sought to identify individuals with symptoms of chronic airways disease whose health records documented at least one of the following diagnoses within the previous year: TB, Asthma, COPD, Bronchitis and Lower Respiratory Tract Infection (LRTI). We interviewed these chronic coughers to collect information on socioeconomic and socio-demographic characteristics, health care utilization, and associated costs of care in 2015. We also collected information on how they funded their health seeking costs. Results We identified 608 chronic coughers who reported costs in relation to their latest confirmed diagnosis in their hand-held health record. The mean care-seeking cost per patient was US $ 3.9 (95% CI: 3.00-5.03); 2.3 times the average per capita expenditure on health of US$ 1.69. The largest costs were due to transport (US$ 1.4), followed by drugs (US$ 1.3). The costs of non-medical inputs (US$ 2.09) was considerable (52.3%). Nearly a quarter (24.4%) of all the patients reportedly borrowed or/and sold assets/property to finance their healthcare. CCs with COPD and LRTI had 85.6% and 62.0% lower chance of incurring any costs compared with the TB patients and any patients with comorbidity had 2.9 times higher chance to incur any costs than the patients with single disease. COPD, Bronchitis and LRTI patients had 123.9%, 211.4% and 87.9% lower costs than the patients with TB. The patients with comorbidity incurred 53.9% higher costs than those with single disease. Conclusions The costs of healthcare per chronic cougher was mainly influenced by the transport and drugs costs. Types of diseases and comorbidity led to significantly different chances of incurring costs as well as difference in magnitude of costs. The costs appeared to be unaffordable for many patients.	[Sichali, Junious M.; Banda, Hastings T.; Namakhoma, Ireen; Bongololo, Grace] Res Equ & Community Hlth REACH Trust, Lilongwe, Malawi; [Khan, Jahangir A. K.; Gama, Elvis M.; Thomson, Rachael; Squire, S. Bertel] Univ Liverpool Liverpool Sch Trop Med, CAHRD, Liverpool, Merseyside, England; [Stenberg, Berthe] LHLs Int TB Fdn LHL Int, Oslo, Norway	Liverpool School of Tropical Medicine	Sichali, JM (corresponding author), Res Equ & Community Hlth REACH Trust, Lilongwe, Malawi.	sichalimj@gmail.com		Squire, Stephen/0000-0001-7173-9038	LHL International; NIHR Global Health Research Unit on Lung Health [16/136/35]; National Institute of Health Research using Official Development Assistance (ODA)	LHL International; NIHR Global Health Research Unit on Lung Health; National Institute of Health Research using Official Development Assistance (ODA)	The full name of the primary funder is LHL International. The funder provided support in the form of salaries for author BS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. "We also thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM -"IMPALA" for helping to make this work possible. In relation to IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National Institute of Health Research using Official Development Assistance (ODA) funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Accordini S, 2008, ALLERGY, V63, P116, DOI 10.1111/j.1398-9995.2007.01523.x; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; de Cuevas RMA, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0117-x; [Anonymous], 2008, ANAL HLTH EQUITY USI; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Banda HT, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1068-4; Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Blanchette CM, 2011, INT J CHRONIC OBSTR, V6, P73, DOI 10.2147/COPD.S15882; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Guarascio AJ, 2013, CLINICOECONOMIC OUTC, V5, P235, DOI 10.2147/CEOR.S34321; JONES AM, 1989, J APPL ECONOM, V4, P23, DOI 10.1002/jae.3950040103; Jordan TS, 2010, RESPIROLOGY, V15, P623, DOI 10.1111/j.1440-1843.2010.01749.x; Khan JAM, 2019, INT HLTH; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Laokri S, 2014, TROP MED INT HEALTH, V19, P1249, DOI 10.1111/tmi.12365; Laokri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096912; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Madan J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1138-z; Malawi National Statistics Office, 2012, INT HOUS SURV HIS 20; Martins P, 2009, ALLERGY, V64, P1061, DOI 10.1111/j.1398-9995.2009.01956.x; Menzin J, 2008, RESP MED, V102, P1248, DOI 10.1016/j.rmed.2008.04.009; Okunade AA, 2010, HEALTH ECON, V19, P365, DOI 10.1002/hec.1471; Ramsay A, 2010, INT J TUBERC LUNG D, V14, P165; Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009; Shete PB, 2015, INT J TUBERC LUNG D, V19, P912, DOI 10.5588/ijtld.14.0166; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Stop TB Partnership, 2008, TOOL EST PAT COSTS; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Ukwaja KN, 2012, INT J TUBERC LUNG D, V16, P733, DOI 10.5588/ijtld.11.0193; United Nations Statistics, CLASS IND CONS ACC P; van den Boom M, 2010, EUR RESPIR J, V36, P979, DOI 10.1183/09031936.00116810; World Health Organisation, BURD COPD; World Health Organization, 2008, GLOB BURD DIS 2004 U	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0225712	10.1371/journal.pone.0225712	http://dx.doi.org/10.1371/journal.pone.0225712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891576	Green Accepted, Green Published, gold			2022-12-26	WOS:000515096600006
J	Tao, Y; Yue, MF; Lv, CJ; Yun, XM; Qiao, SM; Fang, YL; Wei, ZF; Xia, YF; Dai, Y				Tao, Yu; Yue, Mengfan; Lv, Changjun; Yun, Xinming; Qiao, Simiao; Fang, Yulai; Wei, Zhifeng; Xia, Yufeng; Dai, Yue			Pharmacological activation of ER beta by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases	FASEB JOURNAL			English	Article						arctigenin; ER beta; inflammatory bowel diseases; MLCK; tight junction	LIGHT-CHAIN KINASE; TIGHT JUNCTION; TNF-ALPHA; PATHOGENESIS; EXPRESSION; PERMEABILITY; DYSFUNCTION; PROTEINS; STRESS	Intestinal epithelial barrier dysfunction is deeply involved in the pathogenesis of inflammatory bowel diseases (IBD). Arctigenin, the main active constituent in Fructus Arctii (a traditional Chinese medicine), has previously been found to attenuate colitis induced by dextran sulfate sodium (DSS) in mice. The present study investigated whether and how arctigenin protects against the disruption of the intestinal epithelial barrier in IBD. Arctigenin maintained the intestinal epithelial barrier function of mice with DSS- and TNBS-induced colitis. In Caco-2 and HT-29 cells, arctigenin lowered the monolayer permeability, increased TEER, reversed the abnormal expression of tight junction proteins, and restored the altered localization of F-actin induced by TNF-alpha and IL-1 beta. The specific antagonist PHTPP or shRNA of ER beta largely weakened the protective effect of arctigenin on the epithelial barrier function of Caco-2 and HT-29 cells. Molecular docking demonstrated that arctigenin had high affinity for ER beta mainly through hydrogen bonds as well as hydrophobic effects, and the protective effect of arctigenin on the intestinal barrier function was largely diminished in ER beta-mutated (ARG346 and/or GLU305) Caco-2 cells. Moreover, arctigenin-blocked TNF-alpha induced increase of the monolayer permeability in Caco-2 and HT-29 cells and the activation of myosin light chain kinase (MLCK)/myosin light chain (MLC) pathway in an ER beta-dependent manner. ER beta deletion in colons of mice with DSS-induced colitis resulted in a significant attenuation of the protective effect of arctigenin on the barrier integrity and colon inflammation. Arctigenin maintained the integrity of the intestinal epithelial barrier under IBD by upregulating the expression of tight junction proteins through the ER beta-MLCK/MLC pathway.	[Tao, Yu; Yue, Mengfan; Lv, Changjun; Yun, Xinming; Qiao, Simiao; Fang, Yulai; Wei, Zhifeng; Xia, Yufeng; Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Xia, YF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China.	yfxiacpu@126.com; yuedaicpu@hotmail.com			China National Natural Science Foundation [81673666, CPU2018GY10]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	China National Natural Science Foundation, Grant/Award Number: 81673666 and CPU2018GY10	Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Baumert TF, 2018, GUT; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Belibasakis GN, 2015, VIRULENCE, V6, P704, DOI 10.1080/21505594.2015.1081731; Bohringer M, 2016, CELL MICROBIOL, V18, P889, DOI 10.1111/cmi.12566; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Chen SW, 2019, J CROHNS COLITIS, V13, P1067, DOI 10.1093/ecco-jcc/jjz027; Du J, 2015, INFLAMM BOWEL DIS, V21, P2495, DOI 10.1097/MIB.0000000000000526; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Genser L, 2018, J PATHOL, V246, P217, DOI 10.1002/path.5134; Gentile C, 2015, EUR J NUTR, V54, P811, DOI 10.1007/s00394-014-0760-6; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Goggins BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00272; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gu Y, 2012, ACTA PHARMACOL SIN, V33, P941, DOI 10.1038/aps.2012.60; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Jacenik D, 2018, MOL CELL ENDOCRINOL, V471, P89, DOI 10.1016/j.mce.2017.07.036; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Keszthelyi D, 2014, ALIMENT PHARM THER, V40, P392, DOI 10.1111/apt.12842; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Krug SM, 2014, SEMIN CELL DEV BIOL, V36, P166, DOI 10.1016/j.semcdb.2014.09.002; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Li X, 2006, ENDOCRINOLOGY, V147, P5236, DOI 10.1210/en.2006-0779; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; Lopez-Posadas R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01240; Luettig J, 2016, MOL NUTR FOOD RES, V60, P2576, DOI 10.1002/mnfr.201600274; Manthari RK, 2018, ARCH TOXICOL, V92, P3255, DOI 10.1007/s00204-018-2304-y; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Park CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043282; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Scaldaferri F, 2012, J CLIN GASTROENTEROL, V46, pS12, DOI 10.1097/MCG.0b013e31826ae849; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shouval DS, 2017, JAMA PEDIATR, V171, P999, DOI 10.1001/jamapediatrics.2017.2571; Sun Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00268; Tao Y, 2017, CELL PHYSIOL BIOCHEM, V44, P1106, DOI 10.1159/000485416; Thatcher SE, 2011, J PHARMACOL SCI, V116, P116, DOI 10.1254/jphs.10296FP; Triplett KD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37951-3; Turner JR, 2014, SEMIN CELL DEV BIOL, V36, P204, DOI 10.1016/j.semcdb.2014.09.022; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2017, MOL BIOL CELL, V28, P524, DOI 10.1091/mbc.E16-10-0698; Wang K, 2018, BIOCHEM PHARMACOL, V155, P494, DOI 10.1016/j.bcp.2018.07.039; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Wu X, 2016, ONCOTARGET, V7, P83893, DOI 10.18632/oncotarget.13338; Wu X, 2014, INT IMMUNOPHARMACOL, V23, P505, DOI 10.1016/j.intimp.2014.09.026; Yano T, 2017, ANN NY ACAD SCI, V1405, P32, DOI 10.1111/nyas.13432; Zhang N, 2013, INT J MOL SCI, V14, P18657, DOI 10.3390/ijms140918657	53	16	16	3	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3069	3090		10.1096/fj.201901638RR	http://dx.doi.org/10.1096/fj.201901638RR		DEC 2019	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908053				2022-12-26	WOS:000505009000001
J	Yang, HL; Yang, L; Zhang, J; Li, H; Tu, ZC; Wang, XL				Yang, Huilin; Yang, Lin; Zhang, Ju; Li, Hao; Tu, Zongcai; Wang, Xiaolan			Exploring functional core bacteria in fermentation of a traditional Chinese food, Aspergillus-type douchi	PLOS ONE			English	Article							AROMA IMPACT COMPOUNDS; MICROBIAL COMMUNITY; DYNAMICS; IDENTIFICATION; KIMCHI; SALT; SP.	Douchi is a type of traditional Chinese flavoring food that has been used for thousands of years and is produced by multispecies solid-state fermentation. However, the correlation between the flavor, the microbiota, and the functional core microbiota in Aspergillus-type douchi fermentation remains unclear. In this study, Illumina MiSeq sequencing and chromatography were used to investigate the bacterial community and flavor components in Aspergillus-type douchi fermentation. The dominant phyla were Firmicutes, Proteobacteria, and Actinobacteria, and the dominant genera were Weissella, Bacillus, Anaerosalibacter, Lactobacillus, Staphylococcus, and Enterococcus. A total of 58 flavor components were detected during fermentation, including two alcohols, 14 esters, five pyrazines, three alkanes, four aldehydes, three phenols, six acids, and five other compounds. Bidirectional orthogonal partial least square modeling showed that Corynebacterium_1, Lactococcus, Atopostipes, Peptostreptococcus, norank_o_AKYG1722, Truepera, Gulosibacter, norank_f_Actinomycetaceae, and unclassified_f_Rhodobacteraceae are the functional core microbiota responsible for the formation of the flavor components during douchi fermentation. This is the first study to investigate the functional core microbiota in douchi fermentation using Illumina MiSeq sequencing and chromatographic techniques. Our findings extend our understanding of the relationships between flavor, the microbiota, and the functional core microbiota during Aspergillus-type douchi fermentation.	[Yang, Huilin; Yang, Lin; Zhang, Ju; Li, Hao; Tu, Zongcai; Wang, Xiaolan] Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China	Jiangxi Normal University	Wang, XL (corresponding author), Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China.	xlwang08@aliyun.com			National Natural Science Foundation of China [31760449]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant nos. 31760449). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen C, 2015, J APPL MICROBIOL, V119, P1324, DOI 10.1111/jam.12917; Chen QC, 2011, INT J FOOD SCI TECH, V46, P1823, DOI 10.1111/j.1365-2621.2011.02687.x; Chen TT, 2014, J FOOD SCI, V79, pM653, DOI 10.1111/1750-3841.12417; Chen TT, 2011, INT J FOOD SCI TECH, V46, P1878, DOI 10.1111/j.1365-2621.2011.02696.x; Cho J, 2006, FEMS MICROBIOL LETT, V257, P262, DOI 10.1111/j.1574-6968.2006.00186.x; Cretenet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1054; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; Gao XL, 2010, FOOD SCI BIOTECHNOL, V19, P889, DOI 10.1007/s10068-010-0126-7; Garruti DS, 2006, LWT-FOOD SCI TECHNOL, V39, P373, DOI 10.1016/j.lwt.2005.02.006; Giri A, 2010, FOOD RES INT, V43, P1027, DOI 10.1016/j.foodres.2010.01.012; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; HEINEN W, 1982, A VAN LEEUW J MICROB, V48, P265, DOI 10.1007/BF00400386; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Igarashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107909; JOHNSON JA, 1969, J AGR FOOD CHEM, V17, P740, DOI 10.1021/jf60164a029; Kim JH, 2005, FOOD CONTROL, V16, P43, DOI 10.1016/j.foodcont.2003.11.004; Lambert JE, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-69; Li P, 2015, APPL ENVIRON MICROB, V81, P5144, DOI 10.1128/AEM.01325-15; Li YM, 2015, RSC ADV, V5, P79329, DOI 10.1039/c5ra16338b; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Liu SP, 2015, WORLD J MICROB BIOT, V31, P1907, DOI 10.1007/s11274-015-1931-1; Loizou C, 2008, 2008 INT C INF TECHN; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; McFeeters RF, 2004, J FOOD SCI, V69, pM35, DOI 10.1111/j.1365-2621.2004.tb17876.x; Niamsup P, 2003, INT J SYST EVOL MICR, V53, P263, DOI 10.1099/ijs.0.02347-0; Ott A, 1997, J AGR FOOD CHEM, V45, P850, DOI 10.1021/jf960508e; Panda MK, 2013, IRAN J MICROBIOL, V5, P159; Park SE, 2016, LWT-FOOD SCI TECHNOL, V68, P313, DOI 10.1016/j.lwt.2015.12.046; Piao HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00809; RCore Team, 2020, R LANG ENV STAT COMP; Rencher AC, 2005, REV METHODS MULTIVAR, DOI 10.1080/07408170500232784; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seck EH, 2017, ETUDE DIVERSITE PROC; STANOJLOVIC OP, 2000, INDIAN J PHYSL PHARM, V44; Tang J, 2015, J IMMUNOL METHODS, V421, P112, DOI 10.1016/j.jim.2015.04.004; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WANG ZG, 2016, SCI REP UK, V6; Williams, 2001, AMINO ACID ANAL PROT; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Yang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168166; Ye MQ, 2014, EUR FOOD RES TECHNOL, V239, P67, DOI 10.1007/s00217-014-2204-1; You J, 2016, APPL MICROBIOL BIOT, V100, P1469, DOI 10.1007/s00253-015-7073-4	44	11	16	13	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226965	10.1371/journal.pone.0226965	http://dx.doi.org/10.1371/journal.pone.0226965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887171	Green Published, gold			2022-12-26	WOS:000515092200055
J	Xia, B; Yu, J; He, T; Liu, X; Su, JH; Wang, MJ; Wang, JF; Zhu, YH				Xia, Bing; Yu, Jiao; He, Ting; Liu, Xiao; Su, Jinhui; Wang, Meijun; Wang, Jiufeng; Zhu, Yaohong			Lactobacillus johnsonii L531 ameliorates enteritis via elimination of damaged mitochondria and suppression of SQSTM1-dependent mitophagy in a Salmonella infantis model of piglet diarrhea	FASEB JOURNAL			English	Article						autophagy; inflammasome; IPEC-J2; pig; probiotic	INDUCED AUTOPHAGY; SECRETORY IGA; RHAMNOSUS GG; INFLAMMASOME; NLRP3; PIGS; ACTIVATION; EXPRESSION; PROBIOTICS; MICROBIOTA	Newly weaned piglets challenged with Salmonella infantis were particularly susceptible, whereas oral preadministration of Lactobacillus johnsonii L531 alleviated enteritis and promoted intestinal secretory IgA production. Salmonella infantis-induced activation of NLRC4 and NLRP3 inflammasomes and (nuclear factor kappa B) NF-kappa B signaling in the small intestine was also inhibited by L. johnsonii L531 pretreatment, thus limiting inflammation. An IPEC-J2 cell model of S. infantis infection yielded similar results. Salmonella infantis infection also resulted in mitochondrial damage and impaired mitophagy in the ileum and IPEC-J2 cells, as demonstrated by immunofluorescence colocalization of mitochondria with microtubule-binding protein light chain 3 (LC3) and high expression of autophagy-related proteins PTEN-induced putative kinase 1 (PINK1), sequestosome 1 (SQSTM1/p62), optineurin (OPTN), and LC3 by Western blotting analysis. However, L. johnsonii L531 pretreatment reduced both the extent of mitochondrial damage and autophagy-related protein expression. Our findings suggest that the amelioration of S. infantis-associated enteritis by L. johnsonii L531 is associated with regulation of NLRC4 and NLRP3 inflammasomes and NF-kappa B signaling pathway activation and suppression of mitochondrial damage. Amelioration of impaired mitophagy by L. johnsonii L531 could involve eliminating damaged mitochondria and regulating S. infantis-induced activation of the NF-kappa B-SQSTM1mitophagy signaling pathway in host cells to prevent the further mitochondrial damage and S. infantis dissemination.	[Xia, Bing; Yu, Jiao; He, Ting; Liu, Xiao; Su, Jinhui; Wang, Meijun; Wang, Jiufeng; Zhu, Yaohong] China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Zhu, YH (corresponding author), China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	zhu_yaohong@hotmail.com			National Key R&D Program of China [2017YFD0502200]; National Natural Science Foundation of China (NSFC) [31672613]; National Natural Science Foundation of China [31672613, 31873034]	National Key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2017YFD0502200; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31873034; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31672613; National Natural Science Foundation of China, Grant/Award Number: 31873034 and 31672613	Bereswill S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02436-2; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Corthesy B, 2013, AUTOIMMUN REV, V12, P661, DOI 10.1016/j.autrev.2012.10.012; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Dore K, 2004, EPIDEMIOL INFECT, V132, P485, DOI 10.1017/S0950268803001924; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Gresse R, 2017, TRENDS MICROBIOL, V25, P851, DOI 10.1016/j.tim.2017.05.004; Han CQ, 2016, CELL PHYSIOL BIOCHEM, V38, P2464, DOI 10.1159/000445597; He T, 2019, VET MICROBIOL, V230, P187, DOI 10.1016/j.vetmic.2019.02.003; Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lazarou M, 2015, IMMUNOL CELL BIOL, V93, P3, DOI 10.1038/icb.2014.75; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Lopez-Perez O, 2019, VET MICROBIOL, V233, P78, DOI 10.1016/j.vetmic.2019.04.026; Masud S, 2019, AUTOPHAGY, V15, P796, DOI 10.1080/15548627.2019.1569297; Mathias A, 2014, GUT MICROBES, V5, P688, DOI 10.4161/19490976.2014.983763; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Petibone DM, 2017, J APPL TOXICOL, V37, P23, DOI 10.1002/jat.3393; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Ramakrishnan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08581-8; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Su JH, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040117; Sun YX, 2018, CIRCULATION, V138, P2247, DOI 10.1161/CIRCULATIONAHA.117.032821; Tohno M, 2011, VET IMMUNOL IMMUNOP, V144, P410, DOI 10.1016/j.vetimm.2011.09.010; van Wijk SJL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.66; Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Wang YP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02987; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Yang GY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00323; Yu J, 2017, VET MICROBIOL, V210, P91, DOI 10.1016/j.vetmic.2017.08.008; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zhang Wei, 2017, Front Microbiol, V8, P2705, DOI 10.3389/fmicb.2017.02705; Zheng W, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0353-3; Zhong Z, 2016, CLIN EXP RHEUMATOL, V34, pS12; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13	50	20	22	1	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2821	2839		10.1096/fj.201901445RRR	http://dx.doi.org/10.1096/fj.201901445RRR		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908018				2022-12-26	WOS:000504667300001
J	Scott, HL; Buckner, N; Fernandez-Albert, F; Pedone, E; Postiglione, L; Shi, GY; Allen, N; Wong, LF; Magini, L; Marucci, L; O'Sullivan, GA; Cole, S; Powell, J; Maycox, P; Uney, JB				Scott, Helen L.; Buckner, Nicola; Fernandez-Albert, Francesc; Pedone, Elisa; Postiglione, Lorena; Shi, Gongyu; Allen, Nicholas; Wong, Liang-Fong; Magini, Lorenzo; Marucci, Lucia; O'Sullivan, Gregory A.; Cole, Sarah; Powell, Justin; Maycox, Peter; Uney, James B.			A dual druggable genome-wide siRNA and compound library screening approach identifies modulators of parkin recruitment to mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; parkin; ubiquitin; Parkinson disease; mitophagy; kenpaullone; genome screen; neurodegeneration; ubiquitin proteasome system (UPS)	CYCLIN-DEPENDENT KINASE-5; HIT SELECTION; UBIQUITIN; DISEASE; PINK1; PHOSPHORYLATION; ASSOCIATION; DYSFUNCTION; ACTIVATION; IMPORT	Genetic and biochemical evidence points to an association between mitochondrial dysfunction and Parkinson's disease (PD). PD-associated mutations in several genes have been identified and include those encoding PTEN-induced putative kinase 1 (PINK1) and parkin. To identify genes, pathways, and pharmacological targets that modulate the clearance of damaged or old mitochondria (mitophagy), here we developed a high-content imaging-based assay of parkin recruitment to mitochondria and screened both a druggable genome-wide siRNA library and a small neuroactive compound library. We used a multiparameter principal component analysis and an unbiased parameter-agnostic machine-learning approach to analyze the siRNA-based screening data. The hits identified in this analysis included specific genes of the ubiquitin proteasome system, and inhibition of ubiquitin-conjugating enzyme 2 N (UBE2N) with a specific antagonist, Bay 11-7082, indicated that UBE2N modulates parkin recruitment and downstream events in the mitophagy pathway. Screening of the compound library identified kenpaullone, an inhibitor of cyclin-dependent kinases and glycogen synthase kinase 3, as a modulator of parkin recruitment. Validation studies revealed that kenpaullone augments the mitochondrial network and protects against the complex I inhibitor MPP+. Finally, we used a microfluidics platform to assess the timing of parkin recruitment to depolarized mitochondria and its modulation by kenpaullone in real time and with single-cell resolution. We demonstrate that the high-content imaging-based assay presented here is suitable for both genetic and pharmacological screening approaches, and we also provide evidence that pharmacological compounds modulate PINK1-dependent parkin recruitment.	[Scott, Helen L.; Buckner, Nicola; Shi, Gongyu; Wong, Liang-Fong; Magini, Lorenzo; Uney, James B.] Univ Bristol, Bristol Med Sch, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England; [Pedone, Elisa; Postiglione, Lorena; Marucci, Lucia] Univ Bristol, Dept Engn & Math, Bristol BS8 1TD, Avon, England; [Pedone, Elisa; Postiglione, Lorena] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Fernandez-Albert, Francesc; O'Sullivan, Gregory A.; Powell, Justin] Takeda Cambridge Ltd, Cambridge Sci Pk, Cambridge CB4 0PZ, England; [Allen, Nicholas] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, Wales; [Marucci, Lucia] BrisSynBio, Bristol BS8 1QU, Avon, England; [Cole, Sarah; Maycox, Peter] Takeda Ventures Inc, 61 Aldwych, London WC2B 4A, England	University of Bristol; University of Bristol; University of Bristol; Cardiff University	Uney, JB (corresponding author), Univ Bristol, Bristol Med Sch, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	James.uney@bristol.ac.uk	Pedone, Elisa/AAP-7448-2020; Marucci, Lucia/P-1582-2016; Scott, Helen/A-6307-2009; O'Sullivan, Gregory/F-8355-2011	Pedone, Elisa/0000-0001-9467-8207; Marucci, Lucia/0000-0002-7553-6358; Fernandez-Albert, Francesc/0000-0001-5561-0701; Allen, Nicholas/0000-0003-4009-186X; Scott, Helen/0000-0003-2656-4034; O'Sullivan, Gregory/0000-0003-0428-041X; Buckner, Nikki/0000-0003-2842-9928	Takeda Cambridge Ltd.; Parkinson'sUK [K1411]; Biotechnology and Biological Sciences Research Council [BB/J016489/1, BB/R017883/1]; Medical Research Council [MR/N021444/1]; Engineering and Physical Sciences Research Council [EP/R041695/1]; BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre [BB/L01386X/1]; BBSRC [BB/J016489/1, BB/L01386X/1, BB/M017532/1, BB/R017883/1] Funding Source: UKRI; EPSRC [EP/R041695/1, EP/S01876X/1] Funding Source: UKRI; MRC [MR/N021444/1, 1813362] Funding Source: UKRI	Takeda Cambridge Ltd.; Parkinson'sUK(Parkinson's UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Takeda Cambridge Ltd., Parkinson'sUKGrant K1411 (to J. B. U.), Biotechnology and Biological Sciences Research Council Grants BB/J016489/1 and BB/R017883/1 (to J. B. U.), Medical Research Council Grant MR/N021444/1 (to L. M.), Engineering and Physical Sciences Research Council Grant EP/R041695/1 (to L. M.), and BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre, Grant BB/L01386X/1 (to L. M.). This work was funded in part by Takeda Cambridge Ltd. Francesc Fernandez-Albert, Gregory O'Sullivan, Sarah Cole, Justin Powell, and Peter Maycox were employees of Takeda Cambridge Ltd. at the time of the study.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; BRION JP, 1995, AM J PATHOL, V147, P1465; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Datler C, 2014, J CELL SCI, V127, P1816, DOI 10.1242/jcs.140467; Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Fracassi C, 2016, ACS SYNTH BIOL, V5, P296, DOI 10.1021/acssynbio.5b00141; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2012, MCLUST VERSION 4 R N; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Ivatt RM, 2014, P NATL ACAD SCI USA, V111, P8494, DOI 10.1073/pnas.1321207111; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kolnik M, 2012, LAB CHIP, V12, P4732, DOI 10.1039/c2lc40569e; Koyano F, 2019, EMBO REP, V20, DOI 10.15252/embr.201947728; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Langston JW, 2017, J PARKINSON DIS, V7, pS11, DOI 10.3233/JPD-179006; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Lesage Suzanne, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS66, DOI 10.1016/S1353-8020(11)70022-0; Levine AJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-4; Li DW, 2014, MOL MED REP, V9, P2043, DOI 10.3892/mmr.2014.2080; Liu YH, 2017, CELL REP, V20, P30, DOI 10.1016/j.celrep.2017.06.022; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; Mezzaroba L, 2019, NEUROTOXICOLOGY, V74, P230, DOI 10.1016/j.neuro.2019.07.007; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pedone E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12329-9; Peng J, 2016, MITOCHONDRION, V28, P49, DOI 10.1016/j.mito.2016.03.007; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Postiglione L, 2018, ACS SYNTH BIOL, V7, P2558, DOI 10.1021/acssynbio.8b00235; R Development Core Team, 2016, R LANG ENV STAT COMP; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Scott H, 2012, J BIOL CHEM, V287, P14726, DOI 10.1074/jbc.M111.326041; Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Villace P, 2017, SLAS DISCOV, V22, P67, DOI 10.1177/1087057116671498; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Yin Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00171; Yuan LM, 2017, NEUROSCI BULL, V33, P510, DOI 10.1007/s12264-017-0122-5; Yuan YS, 2013, GENE, V524, P133, DOI 10.1016/j.gene.2013.04.045; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zhang XD, 2011, OPTIMAL HIGH THROUGH; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	68	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3285	3300		10.1074/jbc.RA119.009699	http://dx.doi.org/10.1074/jbc.RA119.009699			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31911436	hybrid, Green Published			2022-12-26	WOS:000519597300032
J	Lyons, CE; Razzoli, M; Larson, E; Svedberg, D; Frontini, A; Cinti, S; Vulchanova, L; Sanders, M; Thomas, M; Bartolomucci, A				Lyons, Carey E.; Razzoli, Maria; Larson, Erin; Svedberg, Daniel; Frontini, Andrea; Cinti, Saverio; Vulchanova, Lucy; Sanders, Mark; Thomas, Mark; Bartolomucci, Alessandro			Optogenetic-induced sympathetic neuromodulation of brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						AAV6; CLARITY; opsin; peripheral nervous system; UCP1	MICE; ACTIVATION; PEPTIDE; STRESS; VECTOR; NERVES; WHITE	The brown adipose tissue (BAT) is a thermogenic organ that plays a major role in energy balance, obesity, and diabetes due to the potent glucose and lipid clearance that fuels its thermogenesis, which is largely mediated via sympathetic nervous system activation. However, thus far there has been little experimental validation of the hypothesis that selective neuromodulation of the sympathetic nerves innervating the BAT is sufficient to elicit thermogenesis in mice. We generated mice expressing blue light-activated channelrhodopsin-2 (ChR2) in the sympathetic nerves innervating the BAT using two different strategies: injecting the BAT of C57Bl/6J mice with AAV6-hSyn-ChR2 (H134R)-EYFP; crossbreeding tyrosine hydroxylase-Cre mice with floxed-stop ChR2-EYFP mice. The nerves in the BAT expressing ChR2 were selectively stimulated with a blue LED light positioned underneath the fat pad of anesthetized mice, while the BAT and core temperatures were simultaneously recorded. Using immunohistochemistry we confirmed the selective expression of EYFP in TH positive nerves fibers. In addition, local optogenetic stimulation of the sympathetic nerves induced significant increase in the BAT temperature followed by an increase in core temperature in mice expressing ChR2, but not in the respective controls. The BAT activation was also paralleled by increased levels of pre-UCP1 transcript. Our results demonstrate that local optogenetic stimulation of the sympathetic nerves is sufficient to elicit BAT and core thermogenesis, thus suggesting that peripheral neuromodulation has the potential to be exploited as an alternative to pharmacotherapies to elicit organ activation and thus ameliorate type 2 diabetes and/or obesity.	[Lyons, Carey E.; Razzoli, Maria; Svedberg, Daniel; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol, Physiology, Minneapolis, MN USA; [Lyons, Carey E.] Univ Minnesota, Grad Program Neuroscience, Minneapolis, MN USA; [Larson, Erin; Vulchanova, Lucy; Thomas, Mark] Univ Minnesota, Dept Neuroscience, Minneapolis, MN USA; [Frontini, Andrea] Univ Pavia, Dept Publ Hlth, Expt, Forens Med, Pavia, Italy; [Cinti, Saverio] Univ Politecn Marche, Dept Expt, Clin Med, Ancona, Italy; [Sanders, Mark] Univ Minnesota, Univ Imaging Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Integrat Biol, Alessandro Bartolomucci, Physiology, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pavia; Marche Polytechnic University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bartolomucci, A (corresponding author), Univ Minnesota, Dept Integrat Biol, Physiology, Minneapolis, MN USA.	abartolo@umn.edu	Thomas, Mark John/HHC-7509-2022	Thomas, Mark John/0000-0001-5721-5350; CINTI, Saverio/0000-0003-0362-5017; Lyons, Carey/0000-0002-9858-5021; Lind, Erin/0000-0003-2198-9922; Svedberg, Daniel/0000-0002-4605-9572	NIA NIH HHS [T32 AG029796] Funding Source: Medline; NIDDK NIH HHS [R01 DK117504, R01 DK102496, R56 DK118150] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bell BB, 2018, MOL METAB, V8, P1, DOI 10.1016/j.molmet.2017.12.006; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano Antonio, 2008, V456, P83, DOI 10.1007/978-1-59745-245-8_6; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jeong JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25265-3; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Montgomery KL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7577; Morrison SF, 2018, HAND CLINIC, V156, P281, DOI 10.1016/B978-0-444-63912-7.00017-5; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X; Razzoli M, 2018, FASEB J, V32, P5640, DOI 10.1096/fj.201800452R; Razzoli M, 2016, TRENDS ENDOCRIN MET, V27, P504, DOI 10.1016/j.tem.2016.04.007; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Rondini EA, 2017, J PHARMACOL EXP THER, V363, P367, DOI 10.1124/jpet.117.243253; Rooks CR, 2005, AM J PHYSIOL-REG I, V289, pR92, DOI 10.1152/ajpregu.00858.2004; Sack BK, 2009, CURR OPIN MOL THER, V11, P493; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Swindle MM, 2002, LAB ANIMAL MED, P955, DOI DOI 10.1016/B978-012263951-7/50025-9; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Uhrig-Schmidt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116288; Xiao CY, 2015, OBESITY, V23, P1450, DOI 10.1002/oby.21124; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	43	8	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2765	2773		10.1096/fj.201901361RR	http://dx.doi.org/10.1096/fj.201901361RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908033	Green Accepted			2022-12-26	WOS:000514663600057
J	Watanabe, S				Watanabe, Seiya			Characterization of L-2-keto-3-deoxyfuconate aldolases in a nonphosphorylating L-fucose metabolism pathway in anaerobic bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stereoselectivity; molecular evolution; substrate specificity; enzyme catalysis; enzyme mechanism; 2-keto-3-deoxysugar acid; aldolase; gene cluster; L-fucose metabolism; Veillonella ratti	ARCHAEON SULFOLOBUS-SOLFATARICUS; L-RHAMNOSE; ALTERNATIVE PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; L-LACTALDEHYDE; IDENTIFICATION; DEHYDROGENASE; PROMISCUITY; DEHYDRATASE	The genetic context in bacterial genomes and screening for potential substrates can help identify the biochemical functions of bacterial enzymes. The Gram-negative, strictly anaerobic bacterium Veillonella ratti possesses a gene cluster that appears to be related to L-fucose metabolism and contains a putative dihydrodipicolinate synthase/N-acetylneuraminate lyase protein (FucH). Here, screening of a library of 2-keto-3-deoxysugar acids with this protein and biochemical characterization of neighboring genes revealed that this gene cluster encodes enzymes in a previously unknown "route I" nonphosphorylating L-fucose pathway. Previous studies of other aldolases in the dihydrodipicolinate synthase/N-acetylneuraminate lyase protein superfamily used only limited numbers of compounds, and the approach reported here enabled elucidation of the substrate specificities and stereochemical selectivities of these aldolases and comparison of them with those of FucH. According to the aldol cleavage reaction, the aldolases were specific for (R)- and (S)-stereospecific groups at the C4 position of 2-keto-3-deoxysugar acid but had no structural specificity or preference of methyl groups at the C5 and C6 positions, respectively. This categorization corresponded to the (Re)- or (Si)-facial selectivity of the pyruvate enamine on the (glycer)aldehyde carbonyl in the aldol-condensation reaction. These properties are commonly determined by whether a serine or threonine residue is positioned at the equivalent position close to the active site(s), and site-directed mutagenesis markedly modified C4-OH preference and selective formation of a diastereomer. I propose that substrate specificity of 2-keto-3-deoxysugar acid aldolases was convergently acquired during evolution and report the discovery of another L-2-keto-3-deoxyfuconate aldolase involved in the same nonphosphorylating L-fucose pathway in Campylobacter jejuni.	[Watanabe, Seiya] Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan; [Watanabe, Seiya] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Watanabe, Seiya] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan	Ehime University; Ehime University; Ehime University	Watanabe, S (corresponding author), Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan.; Watanabe, S (corresponding author), Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan.; Watanabe, S (corresponding author), Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan.	irab@agr.ehime-u.ac.jp		Watanabe, Seiya/0000-0002-6530-9047				BALDOMA L, 1988, J BACTERIOL, V170, P416, DOI 10.1128/jb.170.1.416-421.1988; Bhaskar V, 2011, PROTEINS, V79, P1132, DOI 10.1002/prot.22949; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; DAHMS AS, 1974, BIOCHEM BIOPH RES CO, V60, P1433; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DAHMS AS, 1972, J BIOL CHEM, V247, P2238; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Hilditch S, 2007, J BIOL CHEM, V282, P26195, DOI 10.1074/jbc.M704401200; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lamble HJ, 2005, CHEM COMMUN, P124, DOI 10.1039/b413255f; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; MACGEE J, 1954, J BIOL CHEM, V210, P617; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Moore S, 1940, J BIOL CHEM, V133, P293; Nunn CEM, 2010, J BIOL CHEM, V285, P33701, DOI 10.1074/jbc.M110.146332; Royer SF, 2010, J AM CHEM SOC, V132, P11753, DOI 10.1021/ja104412a; Shimada T, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx220; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; Watanabe S, 2008, J BIOL CHEM, V283, P20372, DOI 10.1074/jbc.M801065200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2019, MOL MICROBIOL, V112, P147, DOI 10.1111/mmi.14259; Watanabe S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36774-6; Watanabe S, 2009, FEBS J, V276, P1554, DOI 10.1111/j.1742-4658.2009.06885.x; Williams GJ, 2006, J AM CHEM SOC, V128, P16238, DOI 10.1021/ja065233q; Windle CL, 2014, CURR OPIN CHEM BIOL, V19, P25, DOI 10.1016/j.cbpa.2013.12.010; Wolf J, 2016, MOL MICROBIOL, V102, P882, DOI 10.1111/mmi.13498; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o	29	5	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1338	1349		10.1074/jbc.RA119.011854	http://dx.doi.org/10.1074/jbc.RA119.011854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31914410	Green Published, Bronze			2022-12-26	WOS:000513822300014
J	Kovacevic, S; Ivanov, M; Miloradovic, Z; Brkic, P; Vajic, UJ; Zivotic, M; Mihailovic-Stanojevic, N; Jovovic, D; Karanovic, D; Jeremic, R; Nesovic-Ostojic, J				Kovacevic, Sanjin; Ivanov, Milan; Miloradovic, Zoran; Brkic, Predrag; Vajic, Una Jovana; Zivotic, Maja; Mihailovic-Stanojevic, Nevena; Jovovic, Djurdjica; Karanovic, Danijela; Jeremic, Rada; Nesovic-Ostojic, Jelena			Hyperbaric oxygen preconditioning and the role of NADPH oxidase inhibition in postischemic acute kidney injury induced in spontaneously hypertensive rats	PLOS ONE			English	Article							RENAL ISCHEMIA-REPERFUSION; BLOOD-PRESSURE; OXIDATIVE STRESS; APOCYNIN; EXPRESSION; ACTIVATION; TOLERANCE; CATALASE; BALANCE; TISSUES	Renal ischemia/reperfusion injury is a common cause of acute kidney injury (AKI) and hypertension might contribute to the increased incidence of AKI. The purpose of this study was to investigate the effects of single and combined hyperbaric oxygen (HBO) preconditioning and NADPH oxidase inhibition on oxidative stress, kidney function and structure in spontaneously hypertensive rats (SHR) after renal ischemia reperfusion injury. HBO preconditioning was performed by exposing to pure oxygen (2.026 bar) twice a day for two consecutive days for 60 minutes, and 24h before AKI induction. For AKI induction, the right kidney was removed and ischemia was performed by clamping the left renal artery for 45 minutes. NADPH oxidase inhibition was induced by apocynin (40 mg/kg b.m., intravenously) 5 minutes before reperfusion. AKI significantly increased renal vascular resistance and reduced renal blood flow, which were significantly improved after apocynin treatment. Also, HBO preconditioning, with or without apocynin treatment showed improvement on renal hemodynamics. AKI significantly increased plasma creatinine, urea, phosphate levels and lipid peroxidation in plasma. Remarkable improvement, with decrease in creatinine, urea and phosphate levels was observed in all treated groups. HBO preconditioning, solitary or with apocynin treatment decreased lipid peroxidation in plasma caused by AKI induction. Also, combined with apocynin, it increased catalase activity and solitary, glutathione reductase enzyme activity in erythrocytes. While AKI induction significantly increased plasma KIM- 1 levels, HBO preconditioning, solitary or with apocynin decreased its levels. Considering renal morphology, significant morphological alterations present after AKI induction were significantly improved in all treated groups with reduced tubular dilatation, tubular necrosis in the cortico-medullary zone and PAS positive cast formation. Our results reveal that NADPH oxidase inhibition and hyperbaric oxygen preconditioning, with or without NADPH oxidase inhibition may have beneficial effects, but their protective role should be evaluated in further studies.	[Kovacevic, Sanjin; Nesovic-Ostojic, Jelena] Univ Belgrade, Fac Med, Dept Pathophysiol, Belgrade, Serbia; [Ivanov, Milan; Miloradovic, Zoran; Vajic, Una Jovana; Mihailovic-Stanojevic, Nevena; Jovovic, Djurdjica; Karanovic, Danijela] Univ Belgrade, Inst Med Res, Dept Cardiovasc Physiol, Belgrade, Serbia; [Brkic, Predrag; Jeremic, Rada] Univ Belgrade, Fac Med, Dept Med Physiol, Belgrade, Serbia; [Zivotic, Maja] Univ Belgrade, Fac Med, Dept Pathol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Kovacevic, S; Nesovic-Ostojic, J (corresponding author), Univ Belgrade, Fac Med, Dept Pathophysiol, Belgrade, Serbia.	sanjin.kovacevic@med.bg.ac.rs; jelena.nesovic-ostojic@med.bg.ac.rs	Karanovic, Danijela/GVT-7443-2022; Kovacevic, Sanjin/S-9564-2019; Ivanov, Milan/ABD-4357-2021	Kovacevic, Sanjin/0000-0001-5905-7173; Karanovic, Danijela/0000-0001-5746-746X; Brkic, Predrag/0000-0001-7541-4986; Mihailovic-Stanojevic, Nevena/0000-0001-5356-8706; Ivanov, Milan/0000-0001-8683-5751	Ministry of Education, Science and Technological Development, Republic of Serbia [175096]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was carried out with funding from Ministry of Education, Science and Technological Development, Republic of Serbia, Grant number 175096. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grant 175096 from the Ministry of Education and Science of Republic of Serbia. Also, authors would like to thank Center for Hyperbaric Medicine, Belgrade, Serbia for their continuous support.	Abdelrahman RS, 2018, HUM EXP TOXICOL, V37, P27, DOI 10.1177/0960327116689716; Altintas R, 2013, J ENDOUROL, V27, P617, DOI 10.1089/end.2012.0556; Baumer AT, 2007, CLIN EXP HYPERTENS, V29, P287, DOI 10.1080/10641960701500398; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; BOWMER CJ, 1983, BRIT J PHARMACOL, V79, P471, DOI 10.1111/j.1476-5381.1983.tb11020.x; Brkic Predrag, 2007, Srp Arh Celok Lek, V135 11-12, P669; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Cartin-Ceba R, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/691013; Choi HM, 2015, KIDNEY RES CLIN PRAC, V34, P13, DOI 10.1016/j.krcp.2014.11.002; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Drenjancevic I, 2013, UNDERSEA HYPERBAR M, V40, P319; He XZ, 2011, J SURG RES, V170, pE271, DOI 10.1016/j.jss.2011.06.008; Hentia C, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.959; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Ivanov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096353; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Kim CH, 2001, PFLUG ARCH EUR J PHY, V442, P519, DOI 10.1007/s004240100571; Kim SY, 2012, IMMUNOL CELL BIOL, V90, P441, DOI 10.1038/icb.2011.60; Kinsey GR, 2012, CRIT CARE, V16, DOI 10.1186/cc11228; Klemetti E, 2005, LAB ANIM-UK, V39, P116, DOI 10.1258/0023677052886529; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; Lavrnja I, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/498405; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Li ZM, 2015, TOXICOL REP, V2, P1111, DOI 10.1016/j.toxrep.2015.07.019; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Mas-Font S, 2017, MED INTENSIVA, V41, P116, DOI 10.1016/j.medin.2016.12.004; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Mihaljevic Z, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7406027; Miloradovic Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/512619; Mohamed NSE, 2011, LIFE SCI J, V8, P204; MORENO S, 1995, J HISTOCHEM CYTOCHEM, V43, P1253, DOI 10.1177/43.12.8537642; Parabucki AB, 2012, CROAT MED J, V53, P586, DOI 10.3325/cmj.2012.53.586; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Park YM, 2004, BIOCHEM BIOPH RES CO, V313, P812, DOI 10.1016/j.bbrc.2003.11.173; Rabb Hamid, 1996, Frontiers in Bioscience (online), V1, pE9; Ratliff BB, 2016, ANTIOXID REDOX SIGN, V25, P119, DOI 10.1089/ars.2016.6665; Rubinger Dvora, 2005, Nephron Physiology, V100, P1; Rubinstein I, 2009, NEPHROL DIAL TRANSPL, V24, P428, DOI 10.1093/ndt/gfn511; Rybka J, 2011, CARDIOVASC TOXICOL, V11, P1, DOI 10.1007/s12012-010-9096-5; Sabbisetti VS, 2014, J AM SOC NEPHROL, V25, P2177, DOI 10.1681/ASN.2013070758; Schluter T, 2008, CARDIOVASC RES, V80, P271, DOI 10.1093/cvr/cvn185; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Sureda A, 2009, MED SCI SPORT EXER, V41, P1271, DOI 10.1249/MSS.0b013e3181951069; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; Tajra LCF, 1999, J SURG RES, V87, P32, DOI 10.1006/jsre.1999.5724; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; TOKUDA Y, 1993, NEUROCHEM INT, V23, P107, DOI 10.1016/0197-0186(93)90087-L; Vajic UJ, 2018, PHYTOMEDICINE, V46, P39, DOI 10.1016/j.phymed.2018.04.037; Virdis A, 2016, VASC PHARMACOL, V87, P1, DOI 10.1016/j.vph.2016.08.006; Weaver L.K., 2014, HYPERBARIC OXYGEN TH; Welch WJ, 2001, KIDNEY INT, V59, P230, DOI 10.1046/j.1523-1755.2001.00483.x	53	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226974	10.1371/journal.pone.0226974	http://dx.doi.org/10.1371/journal.pone.0226974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914135	Green Published, Green Submitted, gold			2022-12-26	WOS:000534337700023
J	Velandia-Romero, ML; Calderon-Pelaez, MA; Balbas-Tepedino, A; Marquez-Ortiz, RA; Madronero, LJ; Prieto, AB; Castellanos, JE				Lucia Velandia-Romero, Myriam; Angelica Calderon-Pelaez, Maria; Balbas-Tepedino, Arturo; Alejandro Marquez-Ortiz, Ricaurte; Johana Madronero, L.; Barreto Prieto, Alfonso; Castellanos, Jaime E.			Extracellular vesicles of U937 macrophage cell line infected with DENV-2 induce activation in endothelial cells EA.hy926	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CD8(+) T-LYMPHOCYTES; MEMBRANE-VESICLES; APOPTOTIC BODIES; EXOSOMES; EXPRESSION; SECRETION; MOLECULES; PROTEINS; LEAKAGE	Endothelial activation and alteration during dengue virus (DENV) infection are multifactorial events; however, the role of extracellular vesicles (EVs) in these phenomena is not known. In the present study, we characterized the EVs released by DENV-2 infected U937 macrophage cell line and evaluated the changes in the physiology and integrity of the EA.hy926 endothelial cells exposed to them. U937 macrophages were infected, supernatants were collected, and EVs were purified and characterized. Then, polarized endothelial EA.hy926 cells were exposed to the EVs for 24 h, and the transendothelial electrical resistance (TEER), monolayer permeability, and the expression of tight junction and adhesion proteins and cytokines were evaluated. The isolated EVs from infected macrophages corresponded to exosomes and apoptotic bodies, which contained the viral NS3 protein and different miRs, among other products. Exposure of EA.hy926 cells to EVs induced an increase in TEER, as well as changes in the expression of VE-cadherin and ICAM in addition leads to an increase in TNF-alpha, IP-10, IL-10, RANTES, and MCP-1 secretion. These results suggest that the EVs of infected macrophages transport proteins and miR that induce early changes in the physiology of the endothelium, leading to its activation and eliciting a defense program against damage during first stages of the disease, even in the absence of the virus.	[Lucia Velandia-Romero, Myriam; Angelica Calderon-Pelaez, Maria; Balbas-Tepedino, Arturo; Castellanos, Jaime E.] Univ El Bosque, Grp Virol, Vicerrectoria Invest, Bogota, Colombia; [Alejandro Marquez-Ortiz, Ricaurte; Johana Madronero, L.] Univ El Bosque, Lab Genet Mol Bacteriana, Vicerrectoria Invest, Bogota, Colombia; [Barreto Prieto, Alfonso] Pontificia Univ Javeriana, Fac Ciencias, Grp Inmunobiol & Biol Celular, Bogota, Colombia	Universidad El Bosque; Universidad El Bosque; Pontificia Universidad Javeriana	Velandia-Romero, ML (corresponding author), Univ El Bosque, Grp Virol, Vicerrectoria Invest, Bogota, Colombia.	mlvelandiaro@gmail.com	Márquez-Ortiz, Ricaurte Alejandro/AHC-5399-2022; Barreto, Alfonso/AAF-2963-2019	Velandia-Romero, Myriam Lucia/0000-0002-3340-7304; Madronero, Leidy Johana/0000-0002-0886-4677; Castellanos, Jaime/0000-0003-1596-8383	Departamento Administrativo de Ciencia y Tecnologia COLCIENCIAS [130865842863]; Universidad El Bosque [623-2014]	Departamento Administrativo de Ciencia y Tecnologia COLCIENCIAS; Universidad El Bosque	MLVR: Departamento Administrativo de Ciencia y Tecnologia COLCIENCIAS, project number 130865842863 MLVR and JC: Universidad El Bosque, contract number 623-2014. Funders website: www.colciencias.gov.co and www.uelbosque.edu.co.The sponsors did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Atkin-Smith GK, 2017, SCI REP-UK, V7, DOI 10.1038/srep39846; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Barreto A, 2010, VIRAL IMMUNOL, V23, P595, DOI 10.1089/vim.2009.0113; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; Bautista D, 2015, CELL STRESS CHAPERON, V20, P697, DOI 10.1007/s12192-015-0597-9; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Braciale TJ, 2013, IMMUNOL REV, V255, P5, DOI 10.1111/imr.12109; Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424; Carmona A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00666; Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770; Chen YZ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2159; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dalvi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10449-0; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Goswami S, 2017, MOL NEUROBIOL, V54, P1541, DOI 10.1007/s12035-016-9764-y; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu Y, 2017, FASEB J, V31, P3321, DOI 10.1096/fj.201601263R; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hamlin RE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92424; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Hauser P, 2017, METHODS MOL BIOL, V1554, P193, DOI 10.1007/978-1-4939-6759-9_12; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jiang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14305-z; Kapoor N, 2014, INT J BIOCH REREV, V4, P653, DOI [10.9734/IJBcRR/2014/9370, DOI 10.9734/IJBCRR/2014/9370]; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lai CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099022; Lin Z, 2016, J VIROL, V90, P3469, DOI 10.1128/JVI.02830-15; Liu ZJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0695-7; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Malik S, 2016, CURR HIV RES, V14, P400, DOI 10.2174/1570162X14666160324124558; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; Mehta JL, 2015, J CARDIOVASC PHARM, V65, P123, DOI 10.1097/FJC.0000000000000118; Mladinich KM, 2012, IMMUNOGENETICS, V64, P111, DOI 10.1007/s00251-011-0566-0; Alvarez-Rodriguez LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/956875; Morales L, 2017, BIOMEDICA, V37, P131, DOI 10.7705/biomedica.v37i1.3249; Ong S.S., 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0041932; PEARLMAN E, 1988, MICROB PATHOGENESIS, V5, P87, DOI 10.1016/0882-4010(88)90011-3; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Revenfeld ALS, 2014, CLIN THER, V36, P830, DOI 10.1016/j.clinthera.2014.05.008; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Schmidt A, 2016, TOXICOL LETT, V244, P88, DOI 10.1016/j.toxlet.2015.10.002; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tokarev A, 2000, MADAME CURIE BIOSCIE; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Velandia Myriam L, 2011, Infect., V15, P33; Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786; Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243; Yang CF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003885; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164; Zhu J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12492-3; Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339	71	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227030	10.1371/journal.pone.0227030	http://dx.doi.org/10.1371/journal.pone.0227030			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910224	gold, Green Published, Green Submitted			2022-12-26	WOS:000534333800024
J	Nwaroh, C; Giuffre, A; Cole, L; Bell, T; Carlson, HL; MacMaster, FP; Kirton, A; Harris, AD				Nwaroh, Chidera; Giuffre, Adrianna; Cole, Lauran; Bell, Tiffany; Carlson, Helen L.; MacMaster, Frank P.; Kirton, Adam; Harris, Ashley D.			Effects of Transcranial Direct Current Stimulation on GABA and Glx in Children: A pilot study	PLOS ONE			English	Article							NONINVASIVE CORTICAL STIMULATION; PRIMARY MOTOR CORTEX; BRAIN-STIMULATION; SENSORIMOTOR CORTEX; SKILL ACQUISITION; PERINATAL STROKE; HD-TDCS; SPECTROSCOPY; EXCITABILITY; MODULATION	Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that safely modulates brain excitability and has therapeutic potential for many conditions. Several studies have shown that anodal tDCS of the primary motor cortex (M1) facilitates motor learning and plasticity, but there is little information about the underlying mechanisms. Using magnetic resonance spectroscopy (MRS), it has been shown that tDCS can affect local levels of gamma-aminobutyric acid (GABA) and Glx (a measure of glutamate and glutamine combined) in adults, both of which are known to be associated with skill acquisition and plasticity; however this has yet to be studied in children and adolescents. This study examined GABA and Glx in response to conventional anodal tDCS (a-tDCS) and high definition tDCS (HD-tDCS) targeting the M1 in a pediatric population. Twenty-four typically developing, right-handed children ages 12-18 years participated in five consecutive days of tDCS intervention (sham, a-tDCS or HD-tDCS) targeting the right M1 while training in a fine motor task (Purdue Pegboard Task) with their left hand. Glx and GABA were measured before and after the protocol (at day 5 and 6 weeks) using a PRESS and GABA-edited MEGA-PRESS MRS sequence in the sensorimotor cortices. Glx measured in the left sensorimotor cortex was higher in the HD-tDCS group compared to a-tDCS and sham at 6 weeks (p = 0.001). No changes in GABA were observed in either sensorimotor cortex at any time. These results suggest that neither a-tDCS or HD-tDCS locally affect GABA and Glx in the developing brain and therefore it may demonstrate different responses in adults.	[Nwaroh, Chidera; Bell, Tiffany; Harris, Ashley D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Nwaroh, Chidera; Giuffre, Adrianna; Cole, Lauran; Bell, Tiffany; Carlson, Helen L.; MacMaster, Frank P.; Kirton, Adam; Harris, Ashley D.] Alberta Childrens Hosp ACHRI, Calgary, AB, Canada; [Nwaroh, Chidera; Giuffre, Adrianna; Cole, Lauran; Bell, Tiffany; Carlson, Helen L.; MacMaster, Frank P.; Kirton, Adam; Harris, Ashley D.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Nwaroh, Chidera; Bell, Tiffany; MacMaster, Frank P.; Harris, Ashley D.] Child & Adolescent Imaging Res CAIR Program, Calgary, AB, Canada; [Giuffre, Adrianna; Cole, Lauran] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Giuffre, Adrianna; Cole, Lauran; Kirton, Adam] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Carlson, Helen L.; MacMaster, Frank P.; Kirton, Adam] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada; [MacMaster, Frank P.] Addict & Mental Hlth Strateg Clin Network, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Harris, AD (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.; Harris, AD (corresponding author), Alberta Childrens Hosp ACHRI, Calgary, AB, Canada.; Harris, AD (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.; Harris, AD (corresponding author), Child & Adolescent Imaging Res CAIR Program, Calgary, AB, Canada.	ashley.harris2@ucalgary.ca	Bell, Tiffany/AAB-4896-2019	Bell, Tiffany/0000-0002-9591-706X; Giuffre, Dr. Adrianna/0000-0001-9632-0612; MacMaster, Frank/0000-0002-7159-7583	Behaviour and the Developing Brain Theme of the Alberta Children's Hospital Research Institute the Hotchkiss Brain Institute, University of Calgary; Canadian Institute of Health Research	Behaviour and the Developing Brain Theme of the Alberta Children's Hospital Research Institute the Hotchkiss Brain Institute, University of Calgary; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this project was received from the Behaviour and the Developing Brain Theme of the Alberta Children's Hospital Research Institute the Hotchkiss Brain Institute, University of Calgary and the Canadian Institute of Health Research.	Ambrus GG, BRAIN STIMUL; Anguera JA, 2007, BRAIN RES, V1185, P136, DOI 10.1016/j.brainres.2007.09.088; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2008, CEREB CORTEX, V18, P2701, DOI 10.1093/cercor/bhn032; Auvichayapat P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00366; Bachtiar V, 2015, ELIFE, V4, DOI 10.7554/eLife.08789; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Boissy P, 1997, ARCH PHYS MED REHAB, V78, P1117, DOI 10.1016/S0003-9993(97)90138-6; Borckardt JJ, 2012, J PAIN, V13, P112, DOI 10.1016/j.jpain.2011.07.001; Caparelli-Daquer EM, 2017, PILOT STUDY EFFECTS, V20, P48, DOI [10.1007/s00221-005-2334-6, DOI 10.1007/S00221-005-2334-6]; Carlson HL, 2018, BRAIN STIMUL, V11, P94, DOI 10.1016/j.brs.2017.09.007; Ciechanski P, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00268; Ciechanski P, 2017, J NEUROPHYSIOL, V118, P140, DOI 10.1152/jn.00076.2017; Ciechanski P, 2017, CEREB CORTEX, V27, P2758, DOI 10.1093/cercor/bhw114; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; Cole L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00787; Datta A, 2010, NIH PUBLIC ACCESS, V2, P201, DOI DOI 10.1016/j.brs.2009.03.005.Gyri; Davis NJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00600; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Dwyer GE, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01145; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Foerster BR, 2015, ARTHRITIS RHEUMATOL, V67, P576, DOI 10.1002/art.38945; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Hameed MQ, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0719-0; Harris AD, 2019, BRAIN STIMUL; Harris AD, 2019, NEUROBIOL AGING, V79, P75, DOI 10.1016/j.neurobiolaging.2019.03.011; Harris AD, 2017, MAGN RESON MED, V77, P1377, DOI 10.1002/mrm.26619; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Hone-Blanchet A, 2016, BIOL PSYCHIAT, V80, P432, DOI 10.1016/j.biopsych.2015.11.008; Hunter MA, 2015, BRAIN RES, V1594, P92, DOI 10.1016/j.brainres.2014.09.066; Kadosh KC, 2015, HUM BRAIN MAPP, V36, P4334, DOI 10.1002/hbm.22921; Kessler SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076112; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; Kirton A, 2017, NEUROLOGY, V88, P259, DOI 10.1212/WNL.0000000000003518; Kirton A, 2013, PEDIATR NEUROL, V48, P81, DOI 10.1016/j.pediatrneurol.2012.08.001; Kirton A, 2010, CLIN NEUROPHYSIOL, V121, P1922, DOI 10.1016/j.clinph.2010.04.021; Kolasinski J, 2019, J PHYSIOL-LONDON, V597, P271, DOI 10.1113/JP276626; Krause B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00602; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Near J, 2015, MAGN RESON MED, V73, P44, DOI 10.1002/mrm.25094; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Oldfield RC, 1971, NEUROPSYCHOLOGIA; Patel HJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39262-7; Prichard G, 2014, BRAIN STIMUL, V7, P532, DOI 10.1016/j.brs.2014.04.005; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rajapakse T, 2013, TRANSL NEUROSCI, V4, P217, DOI 10.2478/s13380-013-0116-3; Reis J, 2011, CURR OPIN NEUROL, V24, P590, DOI 10.1097/WCO.0b013e32834c3db0; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Richardson J, 2015, NEUROREHABILITATION, V36, P115, DOI 10.3233/NRE-141199; Ryan K, 2018, PLOS ONE, V13, P1; Schambra HM, 2011, J NEUROPHYSIOL, V106, P652, DOI 10.1152/jn.00210.2011; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Villamar MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50309; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhao HC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00685	75	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0222620	10.1371/journal.pone.0222620	http://dx.doi.org/10.1371/journal.pone.0222620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910218	Green Submitted, Green Published, gold			2022-12-26	WOS:000534333800004
J	Dalton, AM; Jones, AP				Dalton, Alice M.; Jones, Andrew P.			Residential neighbourhood greenspace is associated with reduced risk of cardiovascular disease: A prospective cohort study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; HEALTH-BENEFITS; EPIC-NORFOLK; SPACE; QUESTIONNAIRE; CANCER; ACCESSIBILITY; NUTRITION; GREENERY	Background Living in a greener neighbourhood may reduce the risk of developing incident cardiovascular disease, but evidence is limited by reliance on cross-sectional comparisons. We use data from a longitudinal study with a time-independent measure of risk to explore the association between exposure to greenspace and cardiovascular disease. Methods Data was from the European Prospective Investigation of Cancer Norfolk UK cohort, baseline 1993-1997 (n = 24,420). Neighbourhoods were defined as 800m radius zones around participants' home, according to their home postcode (zip code) in the year 2000. Green-space exposure was identified using classified satellite imagery. Adjusted Cox proportional hazards regression examined associations between greenspace and incident cardiovascular disease. Mediation analysis assessed if physical activity mediated associations, whilst modification by rurality, socio-economic status and age was explored. Results The mean age of participants was 59.2 years at baseline, 54.7% were female, and mean follow-up time was 14.5 years. Individuals living in the greenest neighbourhood quartile had a 7% lower relative hazard of developing cardiovascular disease than other neighbourhoods (HR 0.93; 95% CI 0.88, 0.97; p = 0.003) after adjusting for age, sex, BMI, prevalent diabetes and socio-economic status (SES). Physical activity did not mediate the relationship (greenest compared to the least green quartile HR 0.99; 95% CI 0.97, 1.01; p = 0.416). Models predicted incidence of cardiovascular disease in the least green neighbourhoods (19.4% greenspace on average) would fall by 4.8% (95% CI 1.6%, 8.2% p = 0.003) if they were as green as the average neighbourhood (59.0% greenspace). Occupation moderated the relationship, whereby exposure to greenspace was not associated with incident CVD for participants engaged in manual occupations. Conclusions Greener home neighbourhoods may protect against risk of cardiovascular disease even after accounting for SES, whilst the mechanism does not appear to be strongly associated with physical activity. Putative causal mechanisms require investigation.	[Dalton, Alice M.; Jones, Andrew P.] Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich, Norfolk, England; [Dalton, Alice M.; Jones, Andrew P.] Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res CEDAR, Cambridge, England	University of East Anglia; University of Cambridge	Jones, AP (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich, Norfolk, England.; Jones, AP (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res CEDAR, Cambridge, England.	a.p.jones@uea.ac.uk	Jones, Andy/ABB-9742-2021	Jones, Andy/0000-0002-3130-9313	Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; Cancer Research UK; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration;  [MR/K025147/1]; MRC [MR/K023187/1, MR/K025147/1] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from Cancer Research UK, the British Heart Foundation, the Economic and Social Research Council, the Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The corresponding and lead authors were supported by MR/K025147/1. The views and opinions expressed herein are those of the authors. The funders had no role in study design, data analysis, the decision to publish, or the preparation of the manuscript.	Aerts R, 2018, BRIT MED BULL, V127, P5, DOI 10.1093/bmb/ldy021; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; [Anonymous], 2015, CARD DIS CVDS; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bassuk SS, 2010, NUTR METAB CARDIOVAS, V20, P467, DOI 10.1016/j.numecd.2009.12.015; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Bhopal R, 2002, J PUBLIC HEALTH MED, V24, P95, DOI 10.1093/pubmed/24.2.95; Bixby H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119495; Boruff B, 2014, INT J HEALTH GEOGR, V11, P1; British Heart Foundation, 2017, BHF CVD STAT COMP 20; British Heart Foundation, 2017, CVD STAT BHF UK FACT; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Centre for Ecology and Hydrology (CEH), 2013, LAND COV MAP 2007 LC; Chum A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1788-0; Collett, 2003, MODELLING SURVIVAL D; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Coutts C, 2010, GEOCARTO INT, V25, P471, DOI 10.1080/10106049.2010.505302; Dadvand P, 2016, ENVIRON INT, V91, P161, DOI 10.1016/j.envint.2016.02.029; Dalton AM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3833-z; Day N, 1999, BRIT J CANCER, V80, P95; de Vries S, 2013, SOC SCI MED, V94, P26, DOI 10.1016/j.socscimed.2013.06.030; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Ellaway A, 2005, BMJ-BRIT MED J, V331, P611, DOI 10.1136/bmj.38575.664549.F7; ESRI, 2015, ARCGIS 10 4 1; Frumkin H, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1663; Gascon M, 2016, ENVIRON INT, V86, P60, DOI 10.1016/j.envint.2015.10.013; Haahtela T, 2019, ALLERGY, V74, P1445, DOI 10.1111/all.13763; Hurvitz PM, 2012, AM J PREV MED, V42, P411, DOI 10.1016/j.amepre.2011.11.015; James Peter, 2015, Curr Epidemiol Rep, V2, P131; Jones A, 2009, PREV MED, V49, P500, DOI 10.1016/j.ypmed.2009.10.012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Lachman S, 2016, EUR J PREV CARDIOL, V23, P986, DOI 10.1177/2047487315602015; Lachowycz K, 2013, LANDSCAPE URBAN PLAN, V118, P62, DOI 10.1016/j.landurbplan.2012.10.012; Lai H, 2019, FRONT ECOL ENVIRON, V17, P383, DOI 10.1002/fee.2077; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Lange T, 2011, EPIDEMIOLOGY, V22, P575, DOI 10.1097/EDE.0b013e31821c680c; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Leung FP, 2008, SPORTS MED, V38, P1009, DOI 10.2165/00007256-200838120-00005; Maas J, 2009, J EPIDEMIOL COMMUN H, V63, P967, DOI 10.1136/jech.2008.079038; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; Markevych I, 2017, ENVIRON RES, V158, P301, DOI 10.1016/j.envres.2017.06.028; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Ngom R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040423; Nieuwenhuijsen MJ, 2017, EPIDEMIOLOGY, V28, P63, DOI 10.1097/EDE.0000000000000549; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Nomis, 2011, POSTC HEADC HOUS EST; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Ord K, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-127; Ordnance Survey, 2014, COD POINT SOUTH ORDN; Paquet C, 2013, LANDSCAPE URBAN PLAN, V118, P70, DOI 10.1016/j.landurbplan.2012.11.011; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Development Core Team, 2014, R LANG ENV STAT COMP; Richardson EA, 2013, PUBLIC HEALTH, V127, P318, DOI 10.1016/j.puhe.2013.01.004; Richardson E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-240; Richardson EA, 2012, J EPIDEMIOL COMMUN H, V66, P160, DOI 10.1136/jech.2011.137240; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Rochon J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-9; Schipperijn J, 2010, LANDSCAPE URBAN PLAN, V95, P130, DOI 10.1016/j.landurbplan.2009.12.010; Seo S, 2019, ENVIRON INT, V125, P51, DOI 10.1016/j.envint.2019.01.038; Stare J, 2016, ADV METHODOL STAT, V13, P59, DOI DOI 10.51936/UWAH2960; Stata Corp, 2013, STAT SE 13 0 UN; Tamosiunas A, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-20; Taylor L, 2017, LANDSCAPE URBAN PLAN, V158, P25, DOI 10.1016/j.landurbplan.2016.09.024; Townsend PP., 1988, HLTH DEPRIVATION INE; Tsao Tsung-Ming, 2018, Oncotarget, V9, P16501, DOI 10.18632/oncotarget.24741; van den Berg M, 2015, URBAN FOR URBAN GREE, V14, P806, DOI 10.1016/j.ufug.2015.07.008; Villeneuve PJ, 2012, ENVIRON RES, V115, P51, DOI 10.1016/j.envres.2012.03.003; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wheeler BW, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0009-5; Wilker EH, 2014, ENVIRON RES, V133, P42, DOI 10.1016/j.envres.2014.05.005; Wilkins E., 2017, EUROPEAN CARDIOVASCU; Woodfield R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137538; World Health Organization, 2016, INT STAT CLASS DIS R, V10th	80	29	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226524	10.1371/journal.pone.0226524	http://dx.doi.org/10.1371/journal.pone.0226524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899764	Green Published, gold			2022-12-26	WOS:000534322000005
J	Dukpa, T; Dorji, N; Thinley, S; Wangchuk; Tshering, K; Gyem, K; Wangmo, D; Sherpa, PL; Dorji, T; Montresor, A				Dukpa, Tshering; Dorji, Nidup; Thinley, Sangay; Wangchuk; Tshering, Karma; Gyem, Kinley; Wangmo, Diki; Sherpa, Passang Lhamo; Dorji, Tshering; Montresor, Antonio			Soil-Transmitted Helminth infections reduction in Bhutan: A report of 29 years of deworming	PLOS ONE			English	Article								Soil Transmitted Helminth (STH) infections affect over 1.5 billion people worldwide. Although prevalent in all age groups, school aged children are a high-risk groups for STH infections. In Bhutan, epidemiological data on STH were collected from western Bhutan in 2003, which found a prevalence of 16.5%. However, little evidence is available on the prevalence of infection at national level. Therefore, this study was conducted with the aim to assess the prevalence and intensity of STH infections, and identify significant correlates of STH among students. A school-based survey was conducted in three regions of Bhutan. Two-stage cluster sampling was adopted to select a sample of 1500 students from 24 schools, in equal proportion from three regions of the country. A total of 1456 (97%) students were interviewed and their stool sample examined for the presence of parasites. Mini-FLOTAC technique was used to detect the parasite eggs/ova. The prevalence of any STH infection was 1.4%, with 0.8% Ascaris lumbricoides, 0.5% Trichuris trichiura and 0.2% hookworms. The eastern region had the highest prevalence at 2.3%. Except for one student who had moderate intensity of A. lumbricoides, the rest had light infection. Any STH presence was significantly associated with father's occupation, father's education level, type of house and the flooring of the house in which students reported to live. No significant associations were observed between water, sanitation and hygiene (WASH) variables measured and presence of any STH infection. The prevalence of STH was found to be very low with primarily light intensity in this study. Nonetheless, it was also found that the sanitation situation is not ideal in the country, with several students reporting constant or partial open defecation leading to environmental contamination. Based on this prevalence and in line with the WHO guideline, it is recommended that deworming be reduced to once a year in combination with concerted health education on proper hygiene and sanitation practice.	[Dukpa, Tshering; Dorji, Nidup; Wangchuk; Wangmo, Diki; Sherpa, Passang Lhamo] Khesar Gyalpo Univ Med Sci Bhutan, Fac Nursing & Publ Hlth, Thimphu, Bhutan; [Thinley, Sangay] Minist Hlth, Comprehens Sch Hlth Programme, Dept Publ Hlth, Thimphu, Bhutan; [Tshering, Karma] Jigme Dorji Wangchuk Natl Referral Hosp, Dept Microbioloy, Thimphu, Bhutan; [Gyem, Kinley] Royal Ctr Dis Control, Thimphu, Bhutan; [Dorji, Tshering] Trashigang Dist Hosp, Lab Unit, Trashigang, Bhutan; [Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland	World Health Organization	Dukpa, T (corresponding author), Khesar Gyalpo Univ Med Sci Bhutan, Fac Nursing & Publ Hlth, Thimphu, Bhutan.	tshering@fnph.edu.bt	Montresor, Antonio/J-3137-2019	Montresor, Antonio/0000-0003-3103-8872; Dukpa, Tshering/0000-0002-7945-0228; sherpa, Passang Lhamo/0000-0002-4059-4793; Wangmo, Diki/0000-0002-1378-7733; Gyem, Kinley/0000-0003-3280-2916; Thinley, Sangay/0000-0002-0022-8465; Dorji, Tshering/0000-0001-7125-572X	World Health Organization, country office, Bhutan [GNHC/DCD/WHO/2017/2073]	World Health Organization, country office, Bhutan	This work was supported by the World Health Organization, country office, Bhutan, GNHC/DCD/WHO/2017/2073 (https://www.who.int/countries/btn/en/) to TD. The funder had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; Allen Henrietta, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P777; Assefa LM, DIAGNOSTIC ACCURACY, P1935; Barda B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-220; Barda BD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002344; Benjamin-Chung J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004256; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Campbell SJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002651; Casey GJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005446; Dreyer G, 1996, J CLIN MICROBIOL, V34, P2569, DOI 10.1128/JCM.34.10.2569-2571.1996; Ganguly S, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0354-7; Greenland K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003790; Horton J, 2003, TRENDS PARASITOL, V19, P527, DOI 10.1016/j.pt.2003.09.007; Jourdan PM, 2018, LANCET, V391, P252, DOI 10.1016/S0140-6736(17)31930-X; Kattula D, 2014, INDIAN J MED RES, V139, P76; Kirwan P, SOIL TRANSMITTED HEL, P1475; Knopp S, DIAGNOSIS SOIL TRANS, P1935; Kunwar R, 2016, TROP MED INT HEALTH, V21, P1365; Montresor A, 2017, T ROY SOC TROP MED H, V111, P457, DOI 10.1093/trstmh/trx082; Montresor A, ACHIEVEMENTS DEWORMI, P2214; Mupfasoni DA-Ohoo, SUSTAINED PREVENTIVE, P2049; Passerini L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001608; Patil SR, 2014, EFFECT INDIAS TOTAL, P1549; Phommasack B, 2008, T ROY SOC TROP MED H, V102, P1201, DOI 10.1016/j.trstmh.2008.04.036; Ranjan S, 2015, J PARASITIC DIS, P971; Safi N, 2019, ACTA TROP, V197, DOI 10.1016/j.actatropica.2019.05.026; Salawu SA, 2015, FUTA J RES SCI, V11, P139; Sanchez AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002378; Shumbej T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136342; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub6; Tun A, 2013, TROP MED INT HEALTH, V18, P1017, DOI 10.1111/tmi.12130; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2015, WAT SAN HYG ACC SUST; World Health Organization, 2012, EL SOIL TRANM HELM P; World Health Organization, 2015, ASS EP SOIL TRANM HE; World Health Organization, FACT SHEET SOIL TRAN; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	39	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227273	10.1371/journal.pone.0227273	http://dx.doi.org/10.1371/journal.pone.0227273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KB6PZ	31899772	gold, Green Published			2022-12-26	WOS:000506616000001
J	Qiu, JY; Wang, B; Zhou, CJ				Qiu, Jiayu; Wang, Bin; Zhou, Changjun			Forecasting stock prices with long-short term memory neural network based on attention mechanism	PLOS ONE			English	Article								The stock market is known for its extreme complexity and volatility, and people are always looking for an accurate and effective way to guide stock trading. Long short-term memory (LSTM) neural networks are developed by recurrent neural networks (RNN) and have significant application value in many fields. In addition, LSTM avoids long-term dependence issues due to its unique storage unit structure, and it helps predict financial time series. Based on LSTM and an attention mechanism, a wavelet transform is used to denoise historical stock data, extract and train its features, and establish the prediction model of a stock price. We compared the results with the other three models, including the LSTM model, the LSTM model with wavelet denoising and the gated recurrent unit(GRU) neural network model on S&P 500, DJIA, HSI datasets. Results from experiments on the S&P 500 and DJIA datasets show that the coefficient of determination of the attention-based LSTM model is both higher than 0.94, and the mean square error of our model is both lower than 0.05.	[Qiu, Jiayu; Wang, Bin] Dalian Univ, Minist Educ, Key Lab Adv Design & Intelligent Comp, Dalian, Peoples R China; [Zhou, Changjun] Dalian Minzu Univ, Coll Comp Sci & Engn, Dalian, Peoples R China	Dalian University; Dalian Minzu University	Wang, B (corresponding author), Dalian Univ, Minist Educ, Key Lab Adv Design & Intelligent Comp, Dalian, Peoples R China.; Zhou, CJ (corresponding author), Dalian Minzu Univ, Coll Comp Sci & Engn, Dalian, Peoples R China.	wangbinpaper@gmail.com; zhou-chang231@163.com	wang, bin/B-5533-2011	wang, bin/0000-0002-8800-000X	National Natural Science Foundation of China [61672121, 61425002, 61751203, 61772100, 61972266, 61802040, 61572093]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R07]; Program for Liaoning Innovative Research Team in University [LT2017012]; Natural Science Foundation of Liaoning Province [20180551241, 2019-ZD-0567]; High-level Talent Innovation Support Program of Dalian City [2017RQ060, 2018RQ75]; Dalian Outstanding Young Science and Technology Talent Support Program [2017RJ08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Liaoning Innovative Research Team in University; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); High-level Talent Innovation Support Program of Dalian City; Dalian Outstanding Young Science and Technology Talent Support Program	This work is supported by the National Natural Science Foundation of China(Nos. 61672121, 61425002, 61751203, 61772100, 61972266, 61802040, 61572093), Program for Changjiang Scholars and Innovative Research Team in University (No.IRT_15R07), the Program for Liaoning Innovative Research Team in University (No.LT2017012), the Natural Science Foundation of Liaoning Province (No.20180551241, 2019-ZD-0567), the High-level Talent Innovation Support Program of Dalian City (No.2017RQ060, 2018RQ75), and the Dalian Outstanding Young Science and Technology Talent Support Program No. 2017RJ08.	Abedinia O, 2017, IEEE T POWER SYST, V32, P62, DOI 10.1109/TPWRS.2016.2556620; Ardila D, 2016, FINANCE RES LETT; Bahdanau D., 2014, INT C LEARN REPR; Chang S, 2018, WORKING PAPERS; Dessaint O, 2018, NOISY STOCK PRICES C; Graves A., 2014, ADV NEURAL INFORM PR; Jiang Q, 2018, STOCK PRICE FORECAST; Kim Ha Young, 2018, EXPERT SYSTEMS APPL, V103; Kim J., 2017, RESIDUAL LSTM DESIGN; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Lin Y, 2013, 2013 INT JOINT C NEU; Liu H, 2018, LEVERAGING FINANCIAL; Liu S., 2017, INT C NEUR INF PROC; LOPES M, 2013, EUROPEAN BUSINESS IN, V4, DOI DOI 10.3389/FGENE.2013.00303; Mao FF, 2019, AIP ADV, V9, DOI 10.1063/1.5112078; Ramsey JB, 1999, PHILOS T R SOC A, V357, P2593, DOI 10.1098/rsta.1999.0450; Shih C H, 2017, AS PAC SIGN INF PROC; Simistira F, 2015, 13 INT C DOC AN REC; Song T, 2016, IEEE T NANOBIOSCI, V15, P1; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Sun Y, 2017, INT J PATTERN RECOGN, V32, P1790; Tay F E H, 2007, J U ELECT SCI TECHNO, V29, P309; Wang QJ, 2018, INT J PATTERN RECOGN, V32, DOI 10.1142/S021800141854023X; Wanjawa B W, 2014, PAPERS; Weng B, 2017, EXPERT SYST APPL, V79, P153, DOI 10.1016/j.eswa.2017.02.041; Xu T, 2017, DEEP LSTM LARGE VOCA; Zhang R, 2018, 2018 IEEE 42 ANN COM; Zhao Z, 2017, 2017 IEEE 29 INT C T; Zhi S U, 2017, J FINANCIAL RES	30	61	62	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227222	10.1371/journal.pone.0227222	http://dx.doi.org/10.1371/journal.pone.0227222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899770	gold, Green Published			2022-12-26	WOS:000534322000017
J	Taghian, T; Metelev, VG; Zhang, SR; Bogdanov, AA				Taghian, Toloo; Metelev, Valeriy G.; Zhang, Surong; Bogdanov, Alexei A., Jr.			Imaging NF-kappa B activity in a murine model of early stage diabetes	FASEB JOURNAL			English	Article						beta cells; imaging probes; NF-kappa B; oligodeoxyribonucleotide duplex; type 1 diabetes	BETA-CELL DEATH; CRYSTAL-STRUCTURE; HUMAN ISLETS; TYPE-1; FLUORESCENCE; RECEPTOR; MICE; INFLAMMATION; INHIBITION; ACTIVATION	Early pro-inflammatory signaling in the endocrine pancreas involves activation of NF-kappa B, which is believed to be important for determining the ultimate fate of beta-cells and hence progression of type 1 diabetes (T1D). Thus, early non-invasive detection of NF-kappa B in pancreatic islets may serve as a potential strategy for monitoring early changes in pancreatic endocrine cells eventually leading to T1D. We investigated the feasibility of optical imaging of NF-kappa B transcription factor activation induced by low-dose streptozocin (LD-STZ) treatment in the immunocompetent SKH1 mouse model of early stage diabetes. In this model, we showed that the levels of NF-kappa B may be visualized and measured by fluorescence intensity of specific near-infrared (NIR) fluorophore-labeled oligodeoxyribonucleotide duplex (ODND) probes. In addition, NF-kappa B activation following LD-STZ treatment was validated using immunofluorescence and transgenic animals expressing NF-kappa B inducible imaging reporter. We showed that LD-STZ-treated SKH1 mice had significantly higher (2-3 times, P < .01) specific NIR FI in the nuclei and cytoplasm of islets cells than in non-treated control mice and this finding was corroborated by immunoblotting and electrophoretic mobility shift assays. Finally, using semi-quantitative confocal analysis of non-fixed pancreatic islet microscopy we demonstrated that ODND probes may be used to distinguish between the islets with high levels of NF-kappa B transcription factor and control islet cells.	[Taghian, Toloo; Metelev, Valeriy G.; Zhang, Surong; Bogdanov, Alexei A., Jr.] Univ Massachusetts, Sch Med, Dept Radiol, 55 Lake Ave North, Worcester, MA 01655 USA; [Metelev, Valeriy G.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia	University of Massachusetts System; University of Massachusetts Worcester; Lomonosov Moscow State University	Bogdanov, AA (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, 55 Lake Ave North, Worcester, MA 01655 USA.	alexei.bogdanov@umassmed.edu	Bogdanov, Alexei A/K-4946-2017	Bogdanov, Alexei A/0000-0003-4806-5869	NIH [1R01DK095728, 2R01EB000858]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: 1R01DK095728 and 2R01EB000858	Adenis A, 2005, B CANCER, V92, pS21; Bogdanov AA, 2012, MOL BIOSYST, V8, P2166, DOI 10.1039/c2mb25057h; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Gaglia JL, 2015, P NATL ACAD SCI USA, V112, P2139, DOI 10.1073/pnas.1424993112; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; KOLB H, 1990, Journal of Autoimmunity, V3, P117; Laurent D, 2016, DIABETES OBES METAB, V18, P6, DOI 10.1111/dom.12544; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Medarova Z, 2011, DIABETES-METAB RES, V27, P767, DOI 10.1002/dmrr.1249; Metelev V, 2013, MOL BIOSYST, V9, P2447, DOI 10.1039/c3mb70108e; Metelev V, 2011, BIOCONJUGATE CHEM, V22, P759, DOI 10.1021/bc100553e; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; PAPACCIO G, 1993, HISTOL HISTOPATHOL, V8, P751; Pirot P, 2008, ARQ BRAS ENDOCRINOL, V52, P156, DOI 10.1590/S0004-27302008000200003; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schott-Ohly P, 2004, EXP BIOL MED, V229, P1177, DOI 10.1177/153537020422901113; Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3; Shehata AM, 2011, PHYTOMEDICINE, V18, P1037, DOI 10.1016/j.phymed.2011.06.035; Signore A, 1996, CLIN EXP RHEUMATOL, V14, pS41; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Tabatadze D, 2008, NUCLEOS NUCLEOT NUCL, V27, P157, DOI 10.1080/15257770701795938; Wang P, 2014, DIABETES, V63, P1465, DOI 10.2337/db13-1543; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zhang S, 2008, OLIGONUCLEOTIDES, V18, P235, DOI 10.1089/oli.2008.0135; Zhang S, 2008, P NATL ACAD SCI USA, V105, P4156, DOI 10.1073/pnas.0800162105	43	1	1	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1198	1210		10.1096/fj.201801147R	http://dx.doi.org/10.1096/fj.201801147R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914655	Green Accepted			2022-12-26	WOS:000507308900081
J	Teng, YS; Zhao, YL; Li, MS; Liu, YG; Cheng, P; Lv, YP; Mao, FY; Chen, W; Yang, SM; Hao, CJ; Peng, LS; Zhang, JY; Zhang, WJ; Zou, QM; Zhuang, Y				Teng, Yong-Sheng; Zhao, Yong-Liang; Li, Mao-Shi; Liu, Yu-Gang; Cheng, Ping; Lv, Yi-Pin; Mao, Fang-Yuan; Chen, Weisan; Yang, Shi-Ming; Hao, Chuan-Jie; Peng, Liu-Sheng; Zhang, Jin-Yu; Zhang, Wei-Jun; Zou, Quan-Ming; Zhuang, Yuan			Upexpression of BHLHE40 in gastric epithelial cells increases CXCL12 production through interaction with p-STAT3 in Helicobacter pylori-associated gastritis	FASEB JOURNAL			English	Article						BHLHE40; cagA; CXCL12; Helicobacter pylori; p-STAT3	TRANSCRIPTION FACTOR DEC1; TH17 RESPONSES; H. PYLORI; EXPRESSION; REGULATOR; CHEMOKINE; HYPOXIA; MUCOSA; STRA13; STAT3	BHLHE40, a member of the basic helix-loop-helix transcription factor family, has been reported to play an important role in inflammatory diseases. However, the regulation and function of BHLHE40 in Helicobacter pylori (H pylori)-associated gastritis is unknown. We observed that gastric BHLHE40 was significantly elevated in patients and mice with H pylori infection. Then, we demonstrate that H pylori-infected GECs express BHLHE40 via cagA-ERK pathway. BHLHE40 translocates to cell nucleus, and then binds to cagA protein-activated p-STAT3 (Tyr705). The complex increases chemotactic factor CXCL12 expression (production). Release of CXCL12 from GECs fosters CD4(+) T cell infiltration in the gastric mucosa. Our results identify the cagA-BHLHE40-CXCL12 axis that contributes to inflammatory response in gastric mucosa during H pylori infection.	[Teng, Yong-Sheng; Liu, Yu-Gang; Cheng, Ping; Lv, Yi-Pin; Mao, Fang-Yuan; Hao, Chuan-Jie; Peng, Liu-Sheng; Zhang, Jin-Yu; Zhang, Wei-Jun; Zou, Quan-Ming; Zhuang, Yuan] Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm & Lab Med, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Zhao, Yong-Liang] Third Mil Med Univ, Dept Gen Surg, Chongqing, Peoples R China; [Zhao, Yong-Liang] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China; [Li, Mao-Shi] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Yang, Shi-Ming] Third Mil Med Univ, XinQiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; La Trobe University; Army Medical University	Zou, QM; Zhuang, Y (corresponding author), Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm & Lab Med, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	qmzou@tmmu.edu.cn; yuanzhuang1983@yahoo.com	Mao, Fangyuan/CAF-1614-2022; Teng, Yong-sheng/CAG-8033-2022; lv, yipin/CAI-9979-2022	/0000-0003-4634-1460	National Key Research and Development Program of China [2016YFC1302200]; National Natural Science Foundation of China (NSFC) [81870394, 81372560]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2016YFC1302200; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870394 and 81372560	Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004; Bagheri V, 2016, CYTOKINE, V85, P1, DOI 10.1016/j.cyto.2016.05.025; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Bodger K, 1998, BRIT MED BULL, V54, P139; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dotan I, 2010, INFLAMM BOWEL DIS, V16, P583, DOI 10.1002/ibd.21106; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Fakhari Shohreh, 2014, Adv Biomed Res, V3, P19, DOI 10.4103/2277-9175.124650; Fallone CA, 2019, GASTROENTEROLOGY, V157, P44, DOI 10.1053/j.gastro.2019.04.011; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jia YF, 2018, GASTRIC CANCER, V21, P632, DOI 10.1007/s10120-017-0780-z; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kandulski A, 2010, ANTICANCER RES, V30, P1093; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Legler DF, 2016, CHIMIA, V70, P856, DOI 10.2533/chimia.2016.856; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lina TT, 2013, J IMMUNOL, V191, P3838, DOI 10.4049/jimmunol.1300524; Liu H, 2018, EXP NEUROL, V306, P55, DOI 10.1016/j.expneurol.2018.04.013; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; Mejias-Luque R, 2017, GUT, V66, P1369, DOI 10.1136/gutjnl-2015-310783; Menheniott TR, 2015, CELL MICROBIOL, V17, P1570, DOI 10.1111/cmi.12518; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Roussel Y, 2005, J MICROBIOL METH, V62, P71, DOI 10.1016/j.mimet.2005.01.011; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Shibata W, 2013, GUT, V62, P192, DOI 10.1136/gutjnl-2011-301824; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zhang W, 2015, GUT, V64, P1715, DOI 10.1136/gutjnl-2015-309900; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014; Zhuang Y, 2015, GUT, V64, P1368, DOI 10.1136/gutjnl-2014-307020	37	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1169	1181		10.1096/fj.201900464RR	http://dx.doi.org/10.1096/fj.201900464RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914631				2022-12-26	WOS:000507308900079
J	Tolson, KP; Marooki, N; De Bond, JAP; Walenta, E; Stephens, SBZ; Liaw, RB; Savur, R; Wolfe, A; Oh, DY; Smith, JT; Kauffman, AS				Tolson, Kristen P.; Marooki, Nuha; De Bond, Julie-Ann P.; Walenta, Evelyn; Stephens, Shannon B. Z.; Liaw, Reanna B.; Savur, Rishi; Wolfe, Andrew; Oh, Da Young; Smith, Jeremy T.; Kauffman, Alexander S.			Conditional knockout of kisspeptin signaling in brown adipose tissue increases metabolic rate and body temperature and lowers body weight	FASEB JOURNAL			English	Article						adipose; BAT; fat; GPR54; Kiss1; Kiss1r; kisspeptin; metabolism; obesity; temperature	PROTEIN-COUPLED RECEPTOR; TRANSCRIPTIONAL CONTROL; EXPRESSION; CORTEX; FAT	The peptide kisspeptin and its receptor, Kiss1r, act centrally to stimulate reproduction. Evidence indicates that kisspeptin signaling is also important for body weight (BW) and metabolism. We recently reported that Kiss1r KO mice develop obesity, along with reduced metabolism and energy expenditure, independent of estradiol levels. Outside the brain, Kiss1r is expressed in several metabolic tissues, including brown adipose tissue (BAT), but it is unknown which specific tissue is responsible for the metabolic phenotype in Kiss1r KOs. We first determined that global Kiss1r KO mice have significant alterations in body temperature and BAT thermogenic gene expression, perhaps contributing to their obesity. Next, to test whether kisspeptin signaling specifically in BAT influences BW, metabolism, or body temperature, we used Cre/lox technology to generate conditional Kiss1r knockout exclusively in BAT (BAT-Kiss1r KO). Unlike global Kiss1r KOs, BAT-Kiss1r KOs (lacking Kiss1r in just BAT) were not hypogonadal, as expected. Surprisingly, however, BAT-Kiss1r KOs of both sexes displayed significantly lower BW and adiposity than controls. This novel BAT-Kiss1r KO phenotype was of greater magnitude in females and was associated with improved glucose tolerance, increased metabolism, energy expenditure, and locomotor activity, along with increased body temperature and BAT gene expression, specifically Cox8b. Our findings suggest that the previously observed obesity and decreased metabolism in global Kiss1r KOs reflect impaired kisspeptin signaling in non-BAT tissues. However, the novel finding of increased metabolism and body temperature and lower BW in BAT-Kiss1r KOs reveal a previously unidentified role for endogenous kisspeptin signaling in BAT in modulating metabolic and thermogenic physiology.	[Tolson, Kristen P.; Marooki, Nuha; Stephens, Shannon B. Z.; Liaw, Reanna B.; Savur, Rishi; Kauffman, Alexander S.] Univ Calif San Diego, Dept OBGYN & Reprod Sci, 9500 Gilman Dr,0674, La Jolla, CA 92093 USA; [De Bond, Julie-Ann P.; Smith, Jeremy T.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia; [Walenta, Evelyn; Oh, Da Young] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wolfe, Andrew] Johns Hopkins Univ, Dept Pediat & Physiol, Baltimore, MD USA; [Wolfe, Andrew] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of Western Australia; University of California System; University of California San Diego; Johns Hopkins University; National Institutes of Health (NIH) - USA	Kauffman, AS (corresponding author), Univ Calif San Diego, Dept OBGYN & Reprod Sci, 9500 Gilman Dr,0674, La Jolla, CA 92093 USA.	akauffman@ucsd.edu		Stephens, Shannon/0000-0002-4645-4214	NIH [R01 HD082567, R01 HD090161, R01 HD068777, R01 DK108773, P30 DK063491, U01 HD066432, K99 HD092894, P50 HD012303, F32 HD076606, T32 HD007203]; American Heart Association [14SDG19880020]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	NIH, Grant/Award Number: R01 HD082567, R01 HD090161, R01 HD068777, R01 DK108773, P30 DK063491, U01 HD066432, K99 HD092894, P50 HD012303, F32 HD076606 and T32 HD007203; American Heart Association, Grant/Award Number: 14SDG19880020	Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Colledge WH, 2009, PEPTIDES, V30, P34, DOI 10.1016/j.peptides.2008.05.006; De Bond JAP, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12430; Dror T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108555; Dudek M, 2016, NEUROPEPTIDES, V56, P41, DOI 10.1016/j.npep.2016.01.005; Herbison AE, 2018, ENDOCRINOLOGY, V159, P3723, DOI 10.1210/en.2018-00653; Herbison AE, 2016, NAT REV ENDOCRINOL, V12, P452, DOI 10.1038/nrendo.2016.70; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Kauffman AS, 2010, MOL CELL ENDOCRINOL, V324, P51, DOI 10.1016/j.mce.2010.01.017; Koemeter-Cox AI, 2014, P NATL ACAD SCI USA, V111, P10335, DOI 10.1073/pnas.1403286111; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Laursen WJ, 2015, P NATL ACAD SCI USA, V112, P1607, DOI 10.1073/pnas.1421419112; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Mehler-Wex C, 2006, J NEURAL TRANSM, V113, P1383, DOI 10.1007/s00702-005-0425-y; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Novaira HJ, 2014, MOL ENDOCRINOL, V28, P225, DOI 10.1210/me.2013-1319; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pruszynska-Oszmaek E, 2017, ENDOCRINE, V56, P54, DOI 10.1007/s12020-017-1248-y; Seale P, 2010, INT J OBESITY, V34, pS17, DOI 10.1038/ijo.2010.178; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Tolson KP, 2019, MOL CELL ENDOCRINOL, V498, DOI 10.1016/j.mce.2019.110559; Tolson KP, 2016, ENDOCRINOLOGY, V157, P4192, DOI 10.1210/en.2016-1501; Tolson KP, 2014, J CLIN INVEST, V124, P3075, DOI 10.1172/JCI71075	27	21	21	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					107	121		10.1096/fj.201901600R	http://dx.doi.org/10.1096/fj.201901600R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914628	Green Accepted, Green Published			2022-12-26	WOS:000507308900009
J	Yu, HT; Wang, YM; Zeng, XF; Cai, S; Wang, G; Liu, L; Huang, S; Li, N; Liu, HB; Ding, XL; Song, QL; Qiao, SY				Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan			Therapeutic administration of the recombinant antimicrobial peptide microcin J25 effectively enhances host defenses against gut inflammation and epithelial barrier injury induced by enterotoxigenic Escherichia coli infection	FASEB JOURNAL			English	Article						gut microbiota; inflamed gut; inflammation diseases; intestinal barrier injury; mice; pathogens infection	ENCODED ANTIBACTERIAL PEPTIDES; TIGHT JUNCTION PERMEABILITY; CHAIN FATTY-ACIDS; GROWTH-PERFORMANCE; CATHELICIDIN-WA; MICROBIOTA; EXPRESSION; IMPROVES; BACTERIA; DIARRHEA	Recombinant antimicrobial peptide microcin J25 (MccJ25) causes potent antimicrobial activity against enterotoxigenic Escherichia coli (ETEC) in vitro; however, independently of this activity, its role in suppressing intestinal inflammation and epithelial barrier injury in vivo remains unclear. We investigated the therapeutic effects of MccJ25 on intestinal inflammation and epithelial barrier dysfunction and the underlying mechanism, using gentamicin for comparison. In a mouse model of intestinal inflammation, therapeutic administration of either MccJ25 or gentamicin after ETEC K88 infection attenuated clinical symptoms, reduced intestinal pathogen colonization, improved intestinal morphology, and decreased inflammatory pathologies and intestinal permeability, ultimately improving the hosts' health. MccJ25 also attenuated ETEC-induced mouse intestinal barrier dysfunction by enhancing tight junction proteins (TJPs). Using the human epithelial cell line Caco-2, we verified the epithelial barrier-strengthening and mucosal injury-alleviating effects of MccJ25 on ETEC infection: increased expression of TJPs by activating the p38/MAPK pathway, balancing the microbiota, and improving short-chain fatty acid concentrations in the cecum of ETEC-infected mice. Although gentamicin and MccJ25 had similar effects in the inflamed gut, MccJ25 was superior to gentamicin with regard to defending the host from ETEC infection. Overall, MccJ25 may be a promising therapeutic drug for treating enteric pathogen-induced intestinal inflammation diseases.	[Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan] China Agr Univ, Feed Ind Ctr, Minist Agr & Rural Affairs, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan] Beijing Key Lab Biofeed Addit, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Qiao, SY (corresponding author), China Agr Univ, Feed Ind Ctr, Minist Agr & Rural Affairs, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qiaoshiyan@cau.edu.cn	Wang, Yu/GZL-9655-2022; hongbin, Liu/GPC-5156-2022	hongbin, Liu/0000-0002-5840-2374	National Key Research and Development Program of China [2016YFD0501308]; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China) [201403047]; Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China); Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	National Key Research and Development Program of China, Grant/Award Number: 2016YFD0501308; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China), Grant/Award Number: 201403047; the Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Agus A, 2015, GASTROENTEROLOGY, V148, pS706; Ahmed I., 2016, MICROBIOME METABOLOM, V4, P20, DOI [10.3390/microorganisms402002027681914, DOI 10.3390/MICROORGANISMS402002027681914]; Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Blond A, 1999, EUR J BIOCHEM, V259, P747, DOI 10.1046/j.1432-1327.1999.00085.x; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Cao JC, 2018, ACS SYNTH BIOL, V7, P896, DOI 10.1021/acssynbio.7b00396; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; de la Fuente-Nunez C, 2017, CURR OPIN MICROBIOL, V37, P95, DOI 10.1016/j.mib.2017.05.014; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Falagas ME, 2012, ANTIMICROB AGENTS CH, V56, P4214, DOI 10.1128/AAC.00663-12; Faure M, 2003, DIGEST DIS SCI, V48, P1366, DOI 10.1023/A:1024175629909; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Forkus B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40695; Frick JS, 2013, CURR TOP MICROBIOL, V358, P273, DOI 10.1007/82_2012_217; Furter M, 2019, CELL REP, V27, P2665, DOI 10.1016/j.celrep.2019.04.106; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Han FF, 2015, J IMMUNOL, V194, P1882, DOI 10.4049/jimmunol.1402300; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jiang Q, 2016, INT IMMUNOPHARMACOL, V39, P181, DOI 10.1016/j.intimp.2016.07.029; Johnson AM, 2010, VET MICROBIOL, V141, P115, DOI 10.1016/j.vetmic.2009.08.020; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kiatsurayanon C, 2014, J INVEST DERMATOL, V134, P2163, DOI 10.1038/jid.2014.143; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Ling KH, 2016, CHEM RES TOXICOL, V29, P823, DOI 10.1021/acs.chemrestox.6b00001; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lopez FE, 2007, J ANTIMICROB CHEMOTH, V59, P676, DOI 10.1093/jac/dkm009; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Ma X, 2015, J CELL PHYSIOL, V230, P752, DOI 10.1002/jcp.24838; Ma ZX, 2018, J HAZARD MATER, V341, P248, DOI 10.1016/j.jhazmat.2017.07.071; Markey L, 2018, GUT MICROBES, V9, P497, DOI 10.1080/19490976.2018.1465158; Mondal D, 2009, AM J TROP MED HYG, V80, P824, DOI 10.4269/ajtmh.2009.80.824; Myerscough N, 1995, BIOCHEM SOC T, V23, pS536, DOI 10.1042/bst023536s; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Pizarro-Guajardo M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00365; Rabanal F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10558; Rebuffat S, 2004, CURR PROTEIN PEPT SC, V5, P383, DOI 10.2174/1389203043379611; Ren WK, 2014, MICROBES INFECT, V16, P954, DOI 10.1016/j.micinf.2014.09.005; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; Sam QH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020330; Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Wang S, 2015, J ANIM SCI, V93, P4750, DOI 10.2527/jas.2015-9284; Wang S, 2017, J AGR FOOD CHEM, V65, P8595, DOI 10.1021/acs.jafc.7b02592; Wang YZ, 2007, ANIM FEED SCI TECH, V135, P263, DOI 10.1016/j.anifeedsci.2006.07.013; Wilson JC, 2016, J CROHNS COLITIS, V10, P186, DOI 10.1093/ecco-jcc/jjv193; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu YP, 2016, VET IMMUNOL IMMUNOP, V172, P55, DOI 10.1016/j.vetimm.2016.03.005; Xia X, 2015, MICROBIOL RES, V171, P45, DOI 10.1016/j.micres.2014.12.009; Xiao L, 2016, MOL BIOL CELL, V27, P617, DOI 10.1091/mbc.E15-10-0703; Yi HB, 2017, J IMMUNOL, V198, P1696, DOI 10.4049/jimmunol.1601221; Yi HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25679; Yu HT, 2017, J ANIM SCI, V95, P5064, DOI 10.2527/jas2017.1494; Yu HT, 2018, J AGR FOOD CHEM, V66, P11301, DOI 10.1021/acs.jafc.8b03405; Yu HT, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00242; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zhu HL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700814; Zong X, 2016, BIOCHEM PHARMACOL, V104, P74, DOI 10.1016/j.bcp.2016.01.009	85	27	29	3	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1018	1037		10.1096/fj.201901717R	http://dx.doi.org/10.1096/fj.201901717R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914603				2022-12-26	WOS:000507308900069
J	Kiefer, AM; Seney, CS; Boyd, EA; Smith, C; Shivdat, DS; Matthews, E; Hull, MW; Bridges, CC; Castleberry, A				Kiefer, Adam M.; Seney, Caryn S.; Boyd, Evelyn A.; Smith, Caroline; Shivdat, Darran S.; Matthews, Elaina; Hull, Michael W.; Bridges, Christy C.; Castleberry, Amber			Chemical analysis of Hg-0-containing Hindu religious objects	PLOS ONE			English	Article							MERCURY EXPOSURE; MINAMATA CONVENTION; MEDICINES; COMMUNITY; TOXICITY; PRODUCTS; CHILDREN; DRUG; XRF; EDS	Parad items used in Hindu practices and Ayurvedic medicines contain elemental mercury (Hg-0) and have traditionally been used in prayer and to treat a variety of diseases including diabetes, heart conditions, and sexual dysfunction. These items are often referred to as amalgams of silver, and take the form of shivlings, statues of gods, necklaces, and other jewelry. Fourteen parad items were purchased from online vendors in India and the United States and analyzed. All items produced copious amounts of Hg-0 vapor, with Hg-0 concentrations exceeding 1,000,000 ng/m(3) as measured using a Mercury Instruments Mercury Tracker 3000 IP atomic absorption spectrometer. Measured concentrations were highly variable, so a simple qualitative experiment employing a UV-C light source and a thin-layer chromatography plate impregnated with a fluorescent dye that glows green when irradiated at 254 nm allowed for the indirect visualization of the Hg-0 being evolved. In addition, all items were screened using a hand-held X-ray fluorescence analyzer to estimate the concentration of Hg, Sn, Pb, As, and Cd on the surface of the item. Select samples were then digested in aqua regia and analyzed for Hg content using a direct mercury analyzer. All samples were found to exceed 20% by mass Hg. The digestates were analyzed using inductively-coupled plasma-optical emission spectrometry and were determined to be between 10-55% by mass Pb and contain up to 0.3% by mass As. While Article 4 of the Minamata Convention on Mercury specifically requires parties to stop importing, exporting, and manufacturing Hg-added products, products used in traditional and religious practices are excluded.	[Kiefer, Adam M.; Seney, Caryn S.; Boyd, Evelyn A.; Smith, Caroline; Shivdat, Darran S.; Matthews, Elaina; Castleberry, Amber] Mercer Univ, Dept Chem, Macon, GA 31207 USA; [Hull, Michael W.] Olympus Corp Amer, Analyt Instrumentat, Webster, TX USA; [Bridges, Christy C.] Mercer Univ, Sch Med, Dept Biomed Sci, Macon, GA 31207 USA	Mercer University; Olympus Corporation; Mercer University	Kiefer, AM (corresponding author), Mercer Univ, Dept Chem, Macon, GA 31207 USA.	kiefer_am@mercer.edu		Kiefer, Adam/0000-0002-3277-7135; Boyd, Evelyn/0000-0003-2478-3284				Ali MA, 2018, J PHARM BIOALLIED SC, V10, P144, DOI 10.4103/jpbs.JPBS_25_17; [Anonymous], 2013, MIN CONV MERC TEXT A; [Anonymous], 2005, CREAT NETW INF MERC; [Anonymous], 1991, WASHINGTON POST; Arizio E, 2014, ENVIRON SCI POLLUT R, V21, P13243, DOI 10.1007/s11356-013-2129-4; Arizio E, 2013, APPL PHYS A-MATER, V111, P733, DOI 10.1007/s00339-013-7640-4; Basu N, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP3904; Basu N, 2015, INT J ENV RES PUB HE, V12, P5143, DOI 10.3390/ijerph120505143; Bose-O'Reilly S, 2008, ENVIRON RES, V107, P89, DOI 10.1016/j.envres.2008.01.009; Bose-O'Reilly S, 2017, INT J OCCUP MED ENV, V30, P249, DOI 10.13075/ijomeh.1896.00715; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clifford MJ, 2014, FUTURES, V62, P106, DOI 10.1016/j.futures.2014.05.001; Copan L, 2015, INT J ENV RES PUB HE, V12, P10943, DOI 10.3390/ijerph120910943; Copan Lori, 2012, Morbidity and Mortality Weekly Report, V61, P33; Donohue A, 2018, J EXPO SCI ENV EPID, V28, P494, DOI 10.1038/s41370-018-0033-1; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Elam WT, 2006, POWDER DIFFR, V21, DOI [10.1154/1.2219811, DOI 10.1154/1.2219811]; Eriksen HH, 2014, REV EUR COMP INT ENV, V23, P195, DOI 10.1111/reel.12079; Ernst E, 2001, CLIN PHARMACOL THER, V70, P497, DOI 10.1067/mcp.2001.120249; Evers DC, 2016, SCI TOTAL ENVIRON, V569, P888, DOI 10.1016/j.scitotenv.2016.05.001; Feret F.R., 2003, ADV X-RAY ANAL, V46, P381; FERRACANE JL, 1992, J DENT RES, V71, P1151, DOI 10.1177/00220345920710050401; Forman J, 2000, ENVIRON HEALTH PERSP, V108, P575, DOI 10.2307/3454622; Gallhofer D, 2018, MINERALS-BASEL, V8, DOI 10.3390/min8080320; Garcia-Hernandez J, 2018, FOOD CHEM TOXICOL, V120, P367, DOI 10.1016/j.fct.2018.07.029; Garetano G, 2006, ENVIRON HEALTH PERSP, V114, P59, DOI 10.1289/ehp.8410; Geer LA, 2012, J ENVIRON MONITOR, V14, P1035, DOI 10.1039/c2em10835f; Gustin MS, 2016, ENVIRON SCI TECHNOL, V50, P2767, DOI 10.1021/acs.est.6b00573; Hamann CR, 2014, J AM ACAD DERMATOL, V70, P281, DOI 10.1016/j.jaad.2013.09.050; Huang CF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254582; Hylander LD, 2011, ENCY ENV HLTH BURLIN; Jenkins R., 2006, XRAY TECHNIQUES OVER, DOI [10.1002/9780470027318.a6801, DOI 10.1002/9780470027318.A6801]; Kiefer Adam, PARAD ITEMS READILY; Lerf A, 2016, HYPERFINE INTERACT, V237, DOI 10.1007/s10751-016-1279-4; Lynch Emma, 2005, Expert Opin Drug Saf, V4, P769, DOI 10.1517/14740338.4.4.769; Malm O, 1997, WATER AIR SOIL POLL, V97, P45, DOI 10.1023/A:1018340619475; Masur LC, 2011, ALTERN MED REV, V16, P314; MILNE J, 1970, BRIT J IND MED, V27, P334; Mohammed T, 2017, J PUBLIC HEALTH RES, V6, P184, DOI 10.4081/jphr.2017.1097; Mukhi P, 2017, J AYURVEDA INTEGR ME, V8, P93, DOI 10.1016/j.jaim.2017.01.009; Newby CA, 2006, ETHNIC HEALTH, V11, P287, DOI 10.1080/13557850600565616; Obrist D, 2018, AMBIO, V47, P116, DOI 10.1007/s13280-017-1004-9; Ohmoto K, 2000, Dent Mater J, V19, P211; Okabe T, 1997, Dent Mater J, V16, P191; Riley DM, 2006, RISK ANAL, V26, P1205, DOI 10.1111/j.1539-6924.2006.00809.x; Risher J, 2003, EL MERC IN MERC COMP; Rogers HS, 2008, J URBAN HEALTH, V85, P39, DOI 10.1007/s11524-007-9230-2; ROUSSEAU N, 2009, OPEN SPECTROSC J, P3, DOI DOI 10.2174/1874383800903010058; Rousseau R. M, 2013, J GEOSCIENCES GEOMAT, V1, P1, DOI DOI 10.12691/JGG-1-1-1; Rousseau R.M, 1998, RIGAKU J, V15, P13, DOI DOI 10.12691/JGG-1-1-1; Saper RB, 2008, JAMA-J AM MED ASSOC, V300, P915, DOI 10.1001/jama.300.8.915; Selin H, 2014, GLOBAL ENVIRON POLIT, V14, P1, DOI 10.1162/GLEP_a_00208; Sharma V, 2018, CURR SCI INDIA, V115, P1174, DOI 10.18520/cs/v115/i6/1174-1178; Singh A, 2018, IJTK, V171; Son HY, 2010, IMMUNOPHARM IMMUNOT, V32, P277, DOI 10.3109/08923970903305499; Steckling N, 2017, ANN GLOB HEALTH, V83, P234, DOI 10.1016/j.aogh.2016.12.005; Thomsen V, 2007, SPECTROSCOPY, V22, P46; UN Environment, 2019, GLOBAL MERCURY ASSES; US EPA, 2014, MERC VAP RES AEGL PR; van Sprang H A., 2000, ADV XRAY ANAL, V42; Winter TG, 2003, AM J PHYS, V71, P783, DOI 10.1119/1.1568971; Yadav KD, 2018, CURR SCI INDIA, V114, P1650, DOI 10.18520/cs/v114/i08/1650-1655; Yadav KD, 2016, IJTK, V153	63	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226855	10.1371/journal.pone.0226855	http://dx.doi.org/10.1371/journal.pone.0226855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887195	Green Published, gold			2022-12-26	WOS:000515092200044
J	Cai, J; Shao, X; Yan, ZD; Liu, XY; Yang, YQ; Luo, EP; Jing, D				Cai, Jing; Shao, Xi; Yan, Zedong; Liu, Xiyu; Yang, Yongqing; Luo, Erping; Jing, Da			Differential skeletal response in adult and aged rats to independent and combinatorial stimulation with pulsed electromagnetic fields and mechanical vibration	FASEB JOURNAL			English	Article						age-related osteopenia; osteoporosis; bone anabolism; bone quality; canonical Wnt signaling; pulsed electromagnetic fields; whole-body vibration	WHOLE-BODY VIBRATION; PROMOTING BONE-FORMATION; LOW-MAGNITUDE; THERAPY; OSTEOPOROSIS; FRACTURE; STRENGTH; WOMEN; ACTIVATION; PREVENTION	Pulsed electromagnetic fields (PEMFs) and whole-body vibration (WBV) are proved to partially preserve bone mass/strength in hindlimb-unloaded and ovariectomized animals. However, the potential age-dependent skeletal response to either PEMF or WBV has not been fully investigated. Moreover, whether the coupled "mechano-electro-magnetic" signals can induce greater osteogenic potential than single stimulation remains unknown. Herein, 5-month-old or 20-month-old rats were assigned to the Control, PEMF, WBV, and PEMF + WBV groups. After 8-week treatment, single PEMF/WBV enhanced bone mass, strength, and anabolism in 5-month-old rats, but not in 20-month-old rats. PEMF + WBV induced greater increase of bone quantity, quality, and anabolism than single PEMF/WBV in young adult rats. PEMF + WBV also inhibited bone loss in elderly rats by primarily improving osteoblast and osteocyte activity, but had no effects on bone resorption. PEMF + WBV upregulated the expression of various canonical Wnt ligands and downstream molecules (p-GSK-3 beta and beta-catenin), but had no impacts on noncanonical Wnt5a expression in aged skeleton, revealing the potential involvement of canonical Wnt signaling in bone anabolism of PEMF + WBV. This study not only reveals much weaker responsiveness of aged skeleton to single PEMF/WBV relative to young adult skeleton, but also presents a novel noninvasive approach based on combinatorial treatment with PEMF + WBV for improving bone health and preserving bone quantity/quality (especially for age-related osteoporosis) with stronger anabolic effects.	[Cai, Jing] Shaanxi Univ Chinese Med, Coll Basic Med, Xianyang, Peoples R China; [Cai, Jing; Shao, Xi; Yan, Zedong; Liu, Xiyu; Yang, Yongqing; Luo, Erping; Jing, Da] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China	Shaanxi University of Chinese Medicine; Air Force Military Medical University	Jing, D (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	jingdaasq@126.com			National Natural Science Foundation of China [31500760, 51777211, 11972366, 51907111]; Young Talent Supporting Project in Military Technology of China [17-JCJQ-QT-038]; Shaanxi Provincial Natural Science Foundation of China [2018JQ8056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Supporting Project in Military Technology of China; Shaanxi Provincial Natural Science Foundation of China	National Natural Science Foundation of China, Grant/Award Number: 31500760, 51777211, 11972366 and 51907111; Young Talent Supporting Project in Military Technology of China, Grant/Award Number: 17-JCJQ-QT-038; Shaanxi Provincial Natural Science Foundation of China, Grant/Award Number: 2018JQ8056	ANDERSON JC, 1970, NATURE, V227, P491, DOI 10.1038/227491a0; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Bala Y, 2012, J BONE MINER RES, V27, P825, DOI 10.1002/jbmr.1501; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BASSETT CAL, 1974, SCIENCE, V184, P575; Benhaj K, 2006, ONCOL REP, V15, P701; Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cai J, 2018, OSTEOPOROSIS INT, V29, P1177, DOI 10.1007/s00198-018-4392-1; Catalano A, 2018, BONE, V116, P42, DOI 10.1016/j.bone.2018.07.010; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chan ME, 2013, CURR OSTEOPOROS REP, V11, P36, DOI 10.1007/s11914-012-0132-1; Chan ME, 2012, FASEB J, V26, P4855, DOI 10.1096/fj.12-209841; Clarke BL, 1996, J CLIN ENDOCR METAB, V81, P2264, DOI 10.1210/jc.81.6.2264; De Laet CEDH, 2000, BEST PRACT RES CL EN, V14, P171, DOI 10.1053/beem.2000.0067; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Gabel L, 2017, J BONE MINER RES, V32, P1525, DOI 10.1002/jbmr.3115; Ganesan K, 2009, INDIAN J EXP BIOL, V47, P939; Gao JZ, 2016, ANN BIOMED ENG, V44, P2489, DOI 10.1007/s10439-015-1532-z; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Grace KLR, 1998, ORTHOPEDICS, V21, P297; Gruntmanis U, 2007, AM J MED SCI, V333, P85, DOI 10.1097/00000441-200702000-00004; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2018, BONE, V106, P11, DOI 10.1016/j.bone.2017.10.001; Jing D, 2016, J BONE MINER RES, V31, P1713, DOI 10.1002/jbmr.2837; Jing D, 2014, J BONE MINER RES, V29, P2250, DOI 10.1002/jbmr.2260; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Jing D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079377; Jing D, 2010, BONE, V46, P487, DOI 10.1016/j.bone.2009.09.021; Khosla S, 2008, ENDOCR REV, V29, P441, DOI 10.1210/er.2008-0002; Kiel DP, 2015, J BONE MINER RES, V30, P1319, DOI 10.1002/jbmr.2448; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lambert Jessica K, 2011, Curr Osteoporos Rep, V9, P229, DOI 10.1007/s11914-011-0066-z; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Lynch MA, 2010, J ORTHOP RES, V28, P241, DOI 10.1002/jor.20965; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Musette P, 2010, OSTEOPOROSIS INT, V21, P723, DOI 10.1007/s00198-009-1097-5; Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Razi H, 2015, J BONE MINER RES, V30, P1864, DOI 10.1002/jbmr.2528; Rizzoli R, 2011, CALCIFIED TISSUE INT, V89, P91, DOI 10.1007/s00223-011-9499-8; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sanudo B, 2017, MENOPAUSE, V24, P1208, DOI 10.1097/GME.0000000000000872; Sehmisch S, 2009, OSTEOPOROSIS INT, V20, P1999, DOI 10.1007/s00198-009-0892-3; Shen WW, 2010, BIOELECTROMAGNETICS, V31, P113, DOI 10.1002/bem.20535; Sherk VD, 2013, J CLIN DENSITOM, V16, P104, DOI 10.1016/j.jocd.2012.07.009; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Wang P, 2019, J CELL PHYSIOL, V234, P10588, DOI 10.1002/jcp.27734; Wang T, 2019, OSTEOPOROSIS INT, V30, P267, DOI 10.1007/s00198-018-04822-6; Zhai MM, 2016, BIOELECTROMAGNETICS, V37, P152, DOI 10.1002/bem.21961; Zhu SY, 2017, BIOELECTROMAGNETICS, V38, P406, DOI 10.1002/bem.22065	61	8	8	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3037	3050		10.1096/fj.201902779R	http://dx.doi.org/10.1096/fj.201902779R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908035	Bronze			2022-12-26	WOS:000504854800001
J	Chen, JR; Zhao, HJ; Lazarenko, OP; Blackburn, ML; Shankar, K				Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik			Maternal regulation of SATB2 in osteo-progeniters impairs skeletal development in offspring	FASEB JOURNAL			English	Article						bone; epigenetic; high fat diet; osteoblast	TRANSCRIPTION FACTOR OSTERIX; ADIPOGENIC DIFFERENTIATION; BONE-FORMATION; OBESITY; EZH2; METHYLATION; INHIBITION; ORIGINS; OSTEOPOROSIS; EPIGENETICS	Nutritional status during intrauterine and/or early postnatal life has substantial influence on adult offspring health. Along these lines, there is a growing body of evidence illustrating that high fat diet (HFD)-induced maternal obesity can regulate fetal bone development. Thus, we investigated the effects of maternal obesity on both fetal skeletal development and mechanisms linking maternal obesity to osteoblast differentiation in offspring. Embryonic osteogenic calvarial cells (EOCCs) were isolated from fetuses at gestational day 18.5 (E18.5) of HFD-induced obese rat dams. We observed impaired differentiation of EOCCs to mature osteoblasts from HFD obese dams. ChIP-seq-based genome-wide localization of the repressive histone mark H3K27me3 (mediated via the polycomb histone methyltransferase, enhancer of zeste homologue 2 [Ezh2]) showed that this phenotype was associated with increased enrichment of H3K27me3 on the gene of SATB2, a critical transcription factor required for osteoblast differentiation. Knockdown of Ezh2 in EOCCs and ST2 cells increased SATB2 expression; while Ezh2 overexpression in EOCCs and ST2 cells decreased SATB2 expression. These data were consistent with experimental results showing strong association between H3K27me3, Ezh2, and SATB2 in cells from rats and humans. We have further presented that SATB2 mRNA and protein expression were increased in bones, and increased trabecular bone mass from pre-osteoblast specific Ezh2 deletion (Ezh2(flox/flox) Osx-Cre(+) cko) mice compared with those from control Cre(+) mice. These findings indicate that maternal HFD-induced obesity may be associated with decreasing fetal pre-osteoblastic cell differentiation, under epigenetic control of SATB2 expression via Ezh2-dependent mechanisms.	[Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA.	chenjinran@uams.edu			United States Department of Agriculture [6026-51000-010-05S]; Agricultural Research Service	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	United States Department of Agriculture, Grant/Award Number: 6026-51000-010-05S; Agricultural Research Service	Adamik J, 2017, MOL CANCER RES, V15, P405, DOI 10.1158/1541-7786.MCR-16-0242-T; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bengani H, 2017, GENET MED, V19, P900, DOI 10.1038/gim.2016.211; Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JR, 2018, J ENDOCRINOL, V239, P33, DOI 10.1530/JOE-18-0244; Chen JR, 2016, ENDOCRINOLOGY, V157, P4172, DOI 10.1210/en.2016-1408; Chen JR, 2015, ENDOCRINOLOGY, V156, P475, DOI 10.1210/en.2014-1427; Chen JR, 2013, FASEB J, V27, P3514, DOI 10.1096/fj.12-226464; Chen JR, 2012, FASEB J, V26, P1131, DOI 10.1096/fj.11-197822; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; Dennison EM, 2013, CLIN OBSTET GYNECOL, V56, P549, DOI 10.1097/GRF.0b013e31829cb9b0; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kawai M, 2012, ENDOCRIN METAB CLIN, V41, P323, DOI 10.1016/j.ecl.2012.04.013; Kereliuk SM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071451; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Liang C, 2009, BIRTH DEFECTS RES B, V86, P362, DOI 10.1002/bdrb.20204; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Moritz LE, 2018, J BIOL CHEM, V293, P13805, DOI 10.1074/jbc.R117.800367; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Petersen SB, 2015, NUTRIENTS, V7, P2382, DOI 10.3390/nu7042382; Saben J, 2014, EXP BIOL MED, V239, P1340, DOI 10.1177/1535370214539225; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2015, PLACENTA, V36, P1342, DOI 10.1016/j.placenta.2015.10.010; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yang QY, 2013, DIABETES, V62, P3727, DOI 10.2337/db13-0433; Yu Fangtang, 2017, Bone Rep, V6, P109, DOI 10.1016/j.bonr.2017.04.001; Zhang YF, 2015, GENOM DATA, V6, P12, DOI 10.1016/j.gdata.2015.07.024; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078	43	6	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2511	2523		10.1096/fj.201901901R	http://dx.doi.org/10.1096/fj.201901901R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908011	hybrid			2022-12-26	WOS:000504225100001
J	Javed, E; Thangavel, C; Frara, N; Singh, J; Mohanty, I; Hypolite, J; Birbe, R; Braverman, AS; Den, RB; Rattan, S; Zderic, SA; Deshpande, DA; Penn, RB; Ruggieri, MR; Chacko, S; Boopathi, E				Javed, Elham; Thangavel, Chellappagounder; Frara, Nagat; Singh, Jagmohan; Mohanty, Ipsita; Hypolite, Joseph; Birbe, Ruth; Braverman, Alan S.; Den, Robert B.; Rattan, Satish; Zderic, Stephen A.; Deshpande, Deepak A.; Penn, Raymond B.; Ruggieri, Michael R., Sr.; Chacko, Samuel; Boopathi, Ettickan			Increased expression of desmin and vimentin reduces bladder smooth muscle contractility via JNK2	FASEB JOURNAL			English	Article						bladder; carbachol; cholinergic agonist; intermediate filaments; KCl	INTERMEDIATE-FILAMENTS; SIGNAL-TRANSDUCTION; MECHANICAL STRETCH; OUTLET OBSTRUCTION; MAP KINASE; G-PROTEINS; CELL; ACTIN; CYTOSKELETAL; GENE	Bladder dysfunction is associated with the overexpression of the intermediate filament (IF) proteins desmin and vimentin in obstructed bladder smooth muscle (BSM). However, the mechanisms by which these proteins contribute to BSM dysfunction are not known. Previous studies have shown that desmin and vimentin directly participate in signal transduction. In this study, we hypothesized that BSM dysfunction associated with overexpression of desmin or vimentin is mediated via c-Jun N-terminal kinase (JNK). We employed a model of murine BSM tissue in which increased expression of desmin or vimentin was induced by adenoviral transduction to examine the sufficiency of increased IF protein expression to reduce BSM contraction. Murine BSM strips overexpressing desmin or vimentin generated less force in response to KCl and carbachol relative to the levels in control murine BSM strips, an effect associated with increased JNK2 phosphorylation and reduced myosin light chain (MLC20) phosphorylation. Furthermore, desmin and vimentin overexpressions did not alter BSM contractility and MLC20 phosphorylation in strips isolated from JNK2 knockout mice. Pharmacological JNK2 inhibition produced results qualitatively similar to those caused by JNK2 knockout. These findings suggest that inhibition of JNK2 may improve diminished BSM contractility associated with obstructive bladder disease.	[Javed, Elham; Hypolite, Joseph; Deshpande, Deepak A.; Penn, Raymond B.; Boopathi, Ettickan] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA USA; [Thangavel, Chellappagounder; Den, Robert B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA USA; [Frara, Nagat; Braverman, Alan S.; Ruggieri, Michael R., Sr.] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, Philadelphia, PA USA; [Singh, Jagmohan; Mohanty, Ipsita; Rattan, Satish] Thomas Jefferson Univ, Dept Med, Div Gastroenterol & Hepatol, Philadelphia, PA USA; [Birbe, Ruth] Cooper Univ Hlth Care, Dept Pathol & Lab Med, Camden, NJ USA; [Zderic, Stephen A.] Childrens Hosp Philadelphia, Dept Urol, Philadelphia, PA USA; [Chacko, Samuel; Boopathi, Ettickan] Univ Penn, Div Urol, Philadelphia, PA USA; [Chacko, Samuel] Univ Penn, Dept Pathobiol, Philadelphia, PA USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Boopathi, E (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA USA.	boopathi.ettickan@jefferson.edu	MOHANTY, IPSITA/AAB-3667-2020	MOHANTY, IPSITA/0000-0003-0894-4770; Javed, Elham/0000-0002-8867-0724	NIDDK NIH HHS [R01 DK035385, R01 DK100483] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amini N, 2014, ATHEROSCLEROSIS, V235, P613, DOI 10.1016/j.atherosclerosis.2014.05.950; ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Arner A, 1999, Rev Physiol Biochem Pharmacol, V134, P63; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; DARBY I, 1990, LAB INVEST, V63, P21; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; DRAEGER A, 1990, J CELL BIOL, V111, P2463, DOI 10.1083/jcb.111.6.2463; Drake MJ, 2014, NAT REV UROL, V11, P454, DOI 10.1038/nrurol.2014.156; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GABBIANI G, 1981, P NATL ACAD SCI-BIOL, V78, P298, DOI 10.1073/pnas.78.1.298; Gianni D, 2010, CIRCULATION, V121, P1216, DOI 10.1161/CIRCULATIONAHA.109.879510; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Hypolite JA, 2001, AM J PHYSIOL-CELL PH, V280, pC254, DOI 10.1152/ajpcell.2001.280.2.C254; Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kim HD, 1996, ANAT RECORD, V246, P271, DOI 10.1002/(SICI)1097-0185(199610)246:2<271::AID-AR13>3.0.CO;2-L; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Kushida N, 2001, AM J PHYSIOL-CELL PH, V281, pC1165, DOI 10.1152/ajpcell.2001.281.4.C1165; Lamarre NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109314; Laukeviciene A, 2006, EUR J PHARM SCI, V29, P335, DOI 10.1016/j.ejps.2006.06.012; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; MALMQVIST U, 1991, SCAND J UROL NEPHROL, V25, P261, DOI 10.3109/00365599109024556; NAGAI R, 1989, J BIOL CHEM, V264, P9734; Nguyen HT, 2000, AM J PHYSIOL-CELL PH, V279, pC1155, DOI 10.1152/ajpcell.2000.279.4.C1155; OSBORN M, 1981, DIFFERENTIATION, V20, P196, DOI 10.1111/j.1432-0436.1981.tb01176.x; Osman NI, 2018, EUR UROL FOCUS, V4, P6, DOI 10.1016/j.euf.2018.03.012; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; OWENS GK, 1995, PHYSIOL REV, V75, P487; Palmisano MG, 2015, J CELL SCI, V128, P219, DOI 10.1242/jcs.142463; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Polyak E, 2009, J UROLOGY, V182, P2497, DOI 10.1016/j.juro.2009.07.011; QUINLAN RA, 1982, P NATL ACAD SCI-BIOL, V79, P3452, DOI 10.1073/pnas.79.11.3452; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Ridge KM, 2016, METHOD ENZYMOL, V568, P389, DOI 10.1016/bs.mie.2015.09.036; SCHMID E, 1982, EXP CELL RES, V137, P329, DOI 10.1016/0014-4827(82)90034-9; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; Sjuve R, 1998, J MUSCLE RES CELL M, V19, P415, DOI 10.1023/A:1005353805699; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; van der Velden JLJ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0117-2; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang TC, 2012, AM J PHYSIOL-RENAL, V303, pF1382, DOI 10.1152/ajprenal.00261.2011; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Zhang EY, 2004, AM J PATHOL, V164, P601, DOI 10.1016/S0002-9440(10)63149-5; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	67	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2126	2146		10.1096/fj.201901301R	http://dx.doi.org/10.1096/fj.201901301R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909533	Green Accepted			2022-12-26	WOS:000514663600015
J	Ren, SQ; Pan, XY; Gao, F; Sangild, PT; Nguyen, DN				Ren, Shuqiang; Pan, Xiaoyu; Gao, Fei; Sangild, Per T.; Nguyen, Duc Ninh			Prenatal inflammation suppresses blood Th1 polarization and gene clusters related to cellular energy metabolism in preterm newborns	FASEB JOURNAL			English	Article						chorioamnionitis; immune development; lipopolysaccharide; neonatal sepsis; preterm infants	INNATE IMMUNE-RESPONSES; MITOCHONDRIAL DYSFUNCTION; CHORIOAMNIONITIS; MODEL; ASSOCIATION; SEPSIS; GROWTH; CELLS; BIRTH; RISK	Chorioamnionitis (CA, fetal membrane inflammation) predisposes to preterm birth and is associated with increased neonatal infection risk, but the separate effects of prematurity, CA, and postnatal adaptations on this risk are unclear. Using pigs as models for infants, we examined the systemic immune-metabolic status in cesarean-delivered preterm pigs, with and without CA induced by intra-amniotic (IA) LPS exposure. At birth, cord blood of preterm pigs showed neutropenia and low expressions of innate and adaptive immune genes, relative to term pigs. IA LPS induced CA and fetal systemic innate immune activation via complement and neutrophil-related pathways. These were mainly modulated via cellular regulations rather than granulopoiesis, as validated by the in vitro LPS stimulation of cord blood. After birth, IA LPS-exposed preterm pigs did not follow normal immune-metabolic ontogenies found in fetuses or newborns without prenatal insults, but showed consistently high levels of Treg, impaired Th1 polarization, and reduced expressions of multiple genes related to cellular oxidative phosphorylation and ribosomal activities. In conclusion, our results provide cellular and molecular evidence for CA-induced distinct neonatal immune-metabolic status with increased disease tolerance strategy, suggesting mechanisms for the clinical observation of elevated sepsis risks in immune-compromised preterm infants born with CA.	[Ren, Shuqiang; Pan, Xiaoyu; Gao, Fei; Sangild, Per T.; Nguyen, Duc Ninh] Univ Copenhagen, Sect Comparat Pediat & Nutr, Dept Vet & Anim Sci, Dyrlaegevej 68, DK-1870 Frederiksberg C, Denmark; [Gao, Fei] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Guangdong, Peoples R China; [Sangild, Per T.] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Sangild, Per T.] Univ Southern Denmark, Odense, Denmark	University of Copenhagen; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Nguyen, DN (corresponding author), Univ Copenhagen, Sect Comparat Pediat & Nutr, Dept Vet & Anim Sci, Dyrlaegevej 68, DK-1870 Frederiksberg C, Denmark.	dnn@sund.ku.dk	Pan, Xiaoyu/AAT-9002-2021; Nguyen, Duc Ninh/AAX-1131-2020	Pan, Xiaoyu/0000-0002-0282-6047; Nguyen, Duc Ninh/0000-0002-4997-555X				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunse A, 2019, SHOCK, V51, P337, DOI 10.1097/SHK.0000000000001131; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; de Jong E, 2018, IMMUNOL CELL BIOL, V96, P792, DOI 10.1111/imcb.12037; Nguyen DN, 2018, AM J PATHOL, V188, P2629, DOI 10.1016/j.ajpath.2018.07.020; Nguyen DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep36816; Nguyen DN, 2016, INNATE IMMUN-LONDON, V22, P51, DOI 10.1177/1753425915615195; Duvigneau JC, 2008, LAB INVEST, V88, P70, DOI 10.1038/labinvest.3700691; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01918; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01077; Hibbert JE, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00357; Kallapur SG, 2005, AM J RESP CRIT CARE, V172, P1315, DOI 10.1164/rccm.200506-1007OC; Kallapur SG, 2014, SEMIN REPROD MED, V32, P56, DOI 10.1055/s-0033-1361823; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kan B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07215-9; Kramer BW, 2011, NEONATOLOGY, V99, P320, DOI 10.1159/000326620; Kuypers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081644; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Lee I, 2014, BBA-MOL BASIS DIS, V1842, P1579, DOI 10.1016/j.bbadis.2014.05.031; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luciano AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095867; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Maerkedahl RB, 2015, CLIN CHEM LAB MED, V53, P1181, DOI 10.1515/cclm-2014-1054; Matsuoka T, 2001, PEDIATR INT, V43, P453, DOI 10.1046/j.1442-200X.2001.01445.x; Miller JE, 2016, LANCET INFECT DIS, V16, P952, DOI 10.1016/S1473-3099(16)00150-X; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pagel J, 2016, CLIN EXP IMMUNOL, V185, P219, DOI 10.1111/cei.12810; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; Shen RL, 2015, AM J PHYSIOL-GASTR L, V309, pG310, DOI 10.1152/ajpgi.00163.2015; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Snyder CC, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.018; Soler-Rodriguez AM, 2000, J IMMUNOL, V164, P2674, DOI 10.4049/jimmunol.164.5.2674; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Weitkamp JH, 2016, EARLY HUM DEV, V98, P1, DOI 10.1016/j.earlhumdev.2016.06.001; Wolfs TGAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018355	48	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2896	2911		10.1096/fj.201902629R	http://dx.doi.org/10.1096/fj.201902629R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908027	Bronze			2022-12-26	WOS:000514663600066
J	Shinohara, M; Tashiro, Y; Shinohara, M; Hirokawa, J; Suzuki, K; Onishi-Takeya, M; Mukouzono, M; Takeda, S; Saito, T; Fukumori, A; Saido, TC; Morishita, R; Sato, N				Shinohara, Mitsuru; Tashiro, Yoshitaka; Shinohara, Motoko; Hirokawa, Junko; Suzuki, Kaoru; Onishi-Takeya, Miyuki; Mukouzono, Masahiro; Takeda, Shuko; Saito, Takashi; Fukumori, Akio; Saido, Takaomi C.; Morishita, Ryuichi; Sato, Naoyuki			Increased levels of A beta 42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes	FASEB JOURNAL			English	Article						Alzheimer's disease; astrocytes; diabetes; lifespan; microglia; obesity	ALZHEIMERS-DISEASE PATIENTS; INSULIN-RESISTANCE; A-BETA; MOUSE MODEL; EXPECTANCY; PATHOLOGY; OBESITY; ACCUMULATION; DEMENTIA; MEMORY	Clinical studies have indicated that obesity and diabetes are associated with Alzheimer's disease (AD) and neurodegeneration. Although the mechanisms underlying these associations remain elusive, the bidirectional interactions between obesity/diabetes and Alzheimer's disease (AD) may be involved in them. Both obesity/diabetes and AD significantly reduce life expectancy. We generated App(NL-F/wt) knock-in; ob/ob mice by crossing App(NL-F/wt) knock-in mice and ob/ob mice to investigate whether amyloid-beta (A beta) affects the lifespan of ob/ob mice. App(NL-F/wt) knock-in; ob/ob mice displayed the shortest lifespan compared to wild-type mice, App(NL-F/wt) knock-in mice, and ob/ob mice. Notably, the A beta 42 levels were increased at minimum levels before deposition in App(NL-F/wt) knock-in mice and App(NL-F/wt) knock-in; ob/ob mice at 18 months of age. No differences in the levels of several neuronal markers were observed between mice at this age. However, we observed increased levels of glial fibrillary acidic protein (GFAP), an astrocyte marker, in App(NL-F/wt) knock-in; ob/ob mice, while the levels of several microglial markers, including CD11b, TREM2, and DAP12, were decreased in both ob/ob mice and App(NL-F/wt) knock-in; ob/ob mice. The increase in GFAP levels was not observed in young App(NL-F/wt) knock-in; ob/ob mice. Thus, the increased A beta 42 levels may decrease the lifespan of ob/ob mice, which is associated with the dysregulation of microglia and astrocytes in an age-dependent manner. Based on these findings, the imbalance in these neuroinflammatory cells may provide a clue to the mechanisms by which the interaction between obesity/diabetes and early AD reduces life expectancy.	[Shinohara, Mitsuru; Tashiro, Yoshitaka; Shinohara, Motoko; Hirokawa, Junko; Suzuki, Kaoru; Fukumori, Akio; Sato, Naoyuki] Natl Ctr Geriatr, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Gerontology, Morioka, Japan; [Shinohara, Mitsuru; Fukumori, Akio; Sato, Naoyuki] Osaka Univ, Grad Sch Med, Dept Aging Neurobiol, Suita, Japan; [Onishi-Takeya, Miyuki] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Japan; [Mukouzono, Masahiro; Takeda, Shuko; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Japan; [Saito, Takashi; Saido, Takaomi C.] RIKEN Ctr Brain Sci, Lab Proteolyt Neuroscience, Wako, Japan; [Saito, Takashi] Nagoya City Univ Grad Sch Med Sci, Dept Neurocognit Sci, Nagoya, Japan; Ctr Dev Adv Med Dementia, Morioka, Japan	Osaka University; Osaka University; Osaka University; RIKEN; Nagoya City University	Sato, N (corresponding author), Natl Ctr Geriatr, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Gerontology, Morioka, Japan.	nsato@ncgg.go.jp	Suzuki, Kaoru/AHC-0437-2022; Saito, Takashi/G-2563-2015	Saito, Takashi/0000-0002-9659-9251; Suzuki, Kaoru/0000-0002-5168-9018				Adebakin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045179; Akintola AA, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00013; Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; AUSTIN BP, 1984, EXP GERONTOL, V19, P121, DOI 10.1016/0531-5565(84)90015-9; Buckley RF, 2019, NEUROBIOL AGING, V78, P178, DOI 10.1016/j.neurobiolaging.2019.02.019; Carmona S, 2018, LANCET NEUROL, V17, P721, DOI 10.1016/S1474-4422(18)30232-1; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hiller AJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00471; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kalaria RN, 2009, NAT REV NEUROL, V5, P305, DOI 10.1038/nrneurol.2009.72; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kojima G, 2017, CURR ALZHEIMER RES, V14, P1256, DOI 10.2174/1567205014666170417104236; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; MENAHAN LA, 1983, METABOLISM, V32, P172, DOI 10.1016/0026-0495(83)90225-1; Oveisgharan S, 2018, ACTA NEUROPATHOL, V136, P887, DOI 10.1007/s00401-018-1920-1; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Perez-Nievas BG, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00114; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Ratter JM, 2018, TRENDS ENDOCRIN MET, V29, P468, DOI 10.1016/j.tem.2018.04.008; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Roberts RO, 2014, J NUCL MED, V55, P759, DOI 10.2967/jnumed.113.132647; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sato N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00143; Sato N, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00064; Sato N, 2013, DIABETES, V62, P1005, DOI 10.2337/db12-1549; Shinohara M, 2017, NEUROCHEM INT, V108, P296, DOI 10.1016/j.neuint.2017.04.020; Shinohara M, 2014, BRAIN, V137, P1533, DOI 10.1093/brain/awu046; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; SHULTZ LD, 1995, J IMMUNOL, V154, P180; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Starks EJ, 2015, J ALZHEIMERS DIS, V46, P525, DOI 10.3233/JAD-150072; Sutherland GT, 2017, J ALZHEIMERS DIS, V59, P393, DOI 10.3233/JAD-161194; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Takeda S, 2012, DEMENT GERIATR COGN, V34, P25, DOI 10.1159/000338704; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Dinh T, 2012, DIABETES, V61, P2937, DOI 10.2337/db12-0227; Tomita N, 2013, GERIATR GERONTOL INT, V13, P215, DOI 10.1111/j.1447-0594.2012.00880.x; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Vemuri P, 2017, JAMA NEUROL, V74, P718, DOI 10.1001/jamaneurol.2017.0244; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Wallace LMK, 2019, LANCET NEUROL, V18, P177, DOI 10.1016/S1474-4422(18)30371-5; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Wright AK, 2017, DIABETES CARE, V40, P338, DOI 10.2337/dc16-1616; Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499	51	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2425	2435		10.1096/fj.201901028RR	http://dx.doi.org/10.1096/fj.201901028RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907998	hybrid			2022-12-26	WOS:000514663600034
J	Mohamed, A; Collins, J; Jiang, H; Molendijk, J; Stoll, T; Torta, F; Wenk, MR; Bird, RJ; Marlton, P; Mollee, P; Markey, KA; Hill, MM				Mohamed, Ahmed; Collins, Joel; Jiang, Hui; Molendijk, Jeffrey; Stoll, Thomas; Torta, Federico; Wenk, Markus R.; Bird, Robert J.; Marlton, Paula; Mollee, Peter; Markey, Kate A.; Hill, Michelle M.			Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome	PLOS ONE			English	Article							IDENTIFICATION; CANCER; ACID	Background Multiple myeloma (MM) is a hematological malignancy characterized by the clonal expansion of malignant plasma cells. Though durable remissions are possible, MM is considered incurable, with relapse occurring in almost all patients. There has been limited data reported on the lipid metabolism changes in plasma cells during MM progression. Here, we evaluated the feasibility of concurrent lipidomics and proteomics analyses from patient plasma cells, and report these data on a limited number of patient samples, demonstrating the feasibility of the method, and establishing hypotheses to be evaluated in the future. Methods Plasma cells were purified from fresh bone marrow aspirates using CD138 microbeads. Proteins and lipids were extracted using a bi-phasic solvent system with methanol, methyl tertbutyl ether, and water. Untargeted proteomics, untargeted and targeted lipidomics were performed on 7 patient samples using liquid chromatography-mass spectrometry. Two comparisons were conducted: high versus low risk; relapse versus newly diagnosed. Proteins and pathways enriched in the relapsed group was compared to a public transcriptomic dataset from Multiple Myeloma Research Consortium reference collection (n = 222) at gene and pathways level. Results From one million purified plasma cells, we were able to extract material and complete untargeted (similar to 6000 and similar to 3600 features in positive and negative mode respectively) and targeted lipidomics (313 lipids), as well as untargeted proteomics analysis (similar to 4100 reviewed proteins). Comparative analyses revealed limited differences between high and low risk groups (according to the standard clinical criteria), hence we focused on drawing comparisons between the relapsed and newly diagnosed patients. Untargeted and targeted lipidomics indicated significant down-regulation of phosphatidylcholines (PCs) in relapsed MM. Although there was limited overlap of the differential proteins/transcripts, 76 significantly enriched pathways in relapsed MM were common between proteomics and transcriptomics data. Further evaluation of transcriptomics data for lipid metabolism network revealed enriched correlation of PC, ceramide, cardiolipin, arachidonic acid and cholesterol metabolism pathways to be exclusively correlated among relapsed but not in newly-diagnosed patients. Conclusions This study establishes the feasibility and workflow to conduct integrated lipidomics and proteomics analyses on patient-derived plasma cells. Potential lipid metabolism changes associated with MM relapse warrant further investigation.	[Mohamed, Ahmed; Jiang, Hui; Molendijk, Jeffrey; Stoll, Thomas; Hill, Michelle M.] Univ Queensland, Diamantina Inst, Fac Med, Brisbane, Qld, Australia; [Mohamed, Ahmed; Molendijk, Jeffrey; Stoll, Thomas; Hill, Michelle M.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Collins, Joel; Bird, Robert J.; Marlton, Paula; Mollee, Peter; Markey, Kate A.] Princess Alexandra Hosp, Div Canc Care Serv, Dept Haematol, Brisbane, Qld, Australia; [Collins, Joel] Toowoomba Hosp, Canc Care Serv, Toowoomba, Qld, Australia; [Collins, Joel; Marlton, Paula; Mollee, Peter; Markey, Kate A.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, SLING, Dept Biochem, Singapore, Singapore; [Markey, Kate A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; National University of Singapore; Memorial Sloan Kettering Cancer Center	Hill, MM (corresponding author), Univ Queensland, Diamantina Inst, Fac Med, Brisbane, Qld, Australia.; Hill, MM (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Michelle.Hill@qimrberghofer.edu.au	Molendijk, Jeffrey/AAZ-9494-2021; Mohamed, Ahmed/L-4998-2016; Hill, Michelle Mei Chih/G-4417-2010; Markey, Kate/A-5385-2016	Molendijk, Jeffrey/0000-0001-6575-504X; Mohamed, Ahmed/0000-0001-6507-5300; Hill, Michelle Mei Chih/0000-0003-1134-0951; Bird, Robert/0000-0002-3110-1424; Markey, Kate/0000-0002-7064-2362; Stoll, Thomas/0000-0002-6275-3433; Collins, Joel/0000-0001-8570-4338	Australian Cancer Research Foundation Grant "Diamantina Individualized Oncology Care Centre"; Australian Research Council [FT120100251, DP160100224]	Australian Cancer Research Foundation Grant "Diamantina Individualized Oncology Care Centre"; Australian Research Council(Australian Research Council)	This project was funded, in part, by an Australian Cancer Research Foundation Grant "Diamantina Individualized Oncology Care Centre" (to MMH, P Marlton and P Mollee). Lipidomics method development and analyses were enabled by a Translational Research Institute Spore Grant to MMH, Australian Research Council Discovery Project (DP160100224, to MMH and MRW). MMH was supported by an Australian Research Council Future Fellowship (FT120100251). KAM and JC are Queensland Health Junior Research Fellows. The funders played no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Cajka T, 2017, METHODS MOL BIOL, V1609, P149, DOI 10.1007/978-1-4939-6996-8_14; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0929-x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dave KA, 2014, MOL CELL PROTEOMICS, V13, P3250, DOI 10.1074/mcp.M114.041129; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fonseca R, 2017, LEUKEMIA, V31, P1915, DOI 10.1038/leu.2016.380; Franco D, 2017, SPECTROCHIM ACTA A, V187, P15, DOI 10.1016/j.saa.2017.06.020; Guang MHZ, 2018, LEUKEMIA LYMPHOMA, V59, P542, DOI 10.1080/10428194.2017.1337115; Hanna VS, 2018, J ADV RES, V11, P23, DOI 10.1016/j.jare.2018.03.005; Jurczyszyn A, 2015, LEUKEMIA RES, V39, P400, DOI 10.1016/j.leukres.2014.12.010; Koenig AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21763-6; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mancini R, 2018, ONCOGENE, V37, P2367, DOI 10.1038/s41388-018-0141-3; Mohamed A, 2014, BIOINFORMATICS, V30, P3139, DOI 10.1093/bioinformatics/btu501; Morris EV, 2018, J CELL PHYSIOL, V233, P9159, DOI 10.1002/jcp.26884; Nagata Y, 2015, LEUKEMIA RES, V39, P638, DOI 10.1016/j.leukres.2015.02.011; Nikesitch N, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1007; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sergushichev AA, ALGORITHM FAST PRERA, DOI 10.1101/060012v1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steiner N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202045; Teras LR, 2014, BRIT J HAEMATOL, V166, P667, DOI 10.1111/bjh.12935; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Valikangas T, 2017, BRIEFINGS BIOINFORMA; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Zub KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119857	31	10	10	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227455	10.1371/journal.pone.0227455	http://dx.doi.org/10.1371/journal.pone.0227455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914155	Green Published, Green Submitted, gold			2022-12-26	WOS:000534337700046
J	Liu, BD; Pan, XH; Liu, ZH; Han, ML; Xu, GH; Dai, XS; Wang, W; Zhang, HB; Xie, LW				Liu, Bingdong; Pan, Xiaohan; Liu, Zhihong; Han, Mulan; Xu, Guohuan; Dai, Xiaoshuang; Wang, Wei; Zhang, Huabing; Xie, Liwei			Fecal microbiota as a noninvasive biomarker to predict the tissue iron accumulation in intestine epithelial cells and liver	FASEB JOURNAL			English	Article						ferritin assay; iron; LASSO; ramdom forest; RDA; microbiota	NEONATAL GUT FLORA; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; FORTIFICATION; FAMILY; GROWTH	Iron is an essential trace mineral required for growth, metabolism, and immune response. Dysregulation of iron homeostasis is linked with the development and progression of various diseases. Iron accumulation is associated with inflammatory diseases and cancer, while iron deficiency leads to the growth retardation. Several studies have suggested that iron imbalance results in alteration of gut microbiota, leading to the disruption of microbial diversity, the increase of pathogen abundance, and the induction of intestinal inflammation. However, in screening studies done in the past decades, the association between the iron availability and gut microbiota has not been systemically explored. Furthermore, a noninvasive and convenient approach to determine the iron levels in tissues is lacking. In the present study, a murine model for iron dysregulation was established. 16S rRNA amplicon sequencing and bioinformatic algorithms were used to identify the key taxa. Using the key taxa identified and machine learning models, we established an easily accessible prediction model, which could accurately distinguish between iron-deprived or iron-fortified condition. This prediction model could precisely predict the iron level of the intestinal epithelial cells and the liver and could be used for early diagnosis of iron dysbiosis-related diseases, in a noninvasive manner, in the future.	[Liu, Bingdong; Pan, Xiaohan; Liu, Zhihong; Han, Mulan; Xu, Guohuan; Xie, Liwei] Guangdong Acad Sci, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol,Guangdong Inst, Guangzhou 510070, Guangdong, Peoples R China; [Liu, Bingdong] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Dai, Xiaoshuang] BGI Shenzhen, BGI Inst Appl Agr, Shenzhen, Guangdong, Peoples R China; [Wang, Wei] Jilin Univ, Coll Vet Med, Changchun 130062, Jilin, Peoples R China; [Zhang, Huabing] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China; [Xie, Liwei] Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Wei] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Jinan University; Beijing Genomics Institute (BGI); Jilin University; Anhui Medical University; Southern Medical University - China; Zhongkai University of Agriculture & Engineering	Xie, LW (corresponding author), Guangdong Acad Sci, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol,Guangdong Inst, Guangzhou 510070, Guangdong, Peoples R China.; Wang, W (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130062, Jilin, Peoples R China.; Zhang, HB (corresponding author), Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China.	wang_wei99@jlu.edu.cn; slzhang1977@163.com; xielw@gdim.cn	Dai, Xiaoshuang/AAP-2367-2021	Dai, Xiaoshuang/0000-0001-6563-7756; zhang, huabing/0000-0001-8402-7830; Liu, Zhihong/0000-0001-8370-2419	"GDAS" Project of Science and Technology Development [2018GDASCX-0806]; National Natural Science Foundation of China [81900797]	"GDAS" Project of Science and Technology Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "GDAS" Project of Science and Technology Development (Grant No. 2018GDASCX-0806) to Liwei Xie and by National Natural Science Foundation of China (Grant No. 81900797) to Liwei Xie	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ARTEMENKO VD, 1984, ZH MIKROB EPID IMMUN, P20; Atarashi M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020175; Bian XM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00487; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doherty MK, 2018, MBIO, V9, DOI [10.1128/mBio.02120-17, 10.1128/mbio.02120-17]; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Elli M, 2000, J APPL MICROBIOL, V88, P695, DOI 10.1046/j.1365-2672.2000.01013.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Hansen LBS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07019-x; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liang DC, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0230-4; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Lozano R, 2017, ACONTEC MUND, P117; MELBY CL, 1993, J AM COLL NUTR, V12, P262; MELBY CL, 1994, AM J CLIN NUTR, V59, P103, DOI 10.1093/ajcn/59.1.103; MEVISSENVERHAGE EAE, 1985, EUR J CLIN MICROBIOL, V4, P14, DOI 10.1007/BF02148653; MEVISSENVERHAGE EAE, 1985, EUR J CLIN MICROBIOL, V4, P273, DOI 10.1007/BF02013651; Parmanand BA, 2019, J NUTR BIOCHEM, V67, P20, DOI 10.1016/j.jnutbio.2019.01.010; Pfeiffer CM, 2017, AM J CLIN NUTR, V106, p1606S, DOI 10.3945/ajcn.117.155887; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084; Rocha ER, 2013, BIOMETALS, V26, P577, DOI 10.1007/s10534-013-9650-2; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Sjodin KS, 2019, GUT, V68, DOI 10.1136/gutjnl-2018-316988; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Toohey ML, 1998, J AM COLL NUTR, V17, P425, DOI 10.1080/07315724.1998.10718789; Triner D, 2019, GASTROENTEROLOGY, V156, P1467, DOI 10.1053/j.gastro.2018.12.003; Ward T, 2017, BUGBASE PREDICTS ORG; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Wood JC, 2015, BRIT J HAEMATOL, V170, P15, DOI 10.1111/bjh.13374; Yao XP, 2019, BIOCHEM BIOPH RES CO, V509, P125, DOI 10.1016/j.bbrc.2018.12.082; Zhu J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0515-3; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	57	8	8	12	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3006	3020		10.1096/fj.201901635RR	http://dx.doi.org/10.1096/fj.201901635RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912587	Green Submitted			2022-12-26	WOS:000506146700001
J	Moraski, GC; Deboosere, N; Marshall, KL; Weaver, HA; Vandeputte, A; Hastings, C; Woolhiser, L; Lenaerts, AJ; Brodin, P; Miller, MJ				Moraski, Garrett C.; Deboosere, Nathalie; Marshall, Kate L.; Weaver, Heath A.; Vandeputte, Alexandre; Hastings, Courtney; Woolhiser, Lisa; Lenaerts, Anne J.; Brodin, Priscille; Miller, Marvin J.			Intracellular and in vivo evaluation of imidazo [2,1-b]thiazole-5-carboxamide antituberculosis compounds	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CLINICAL CANDIDATE; VITRO; DERIVATIVES; DISCOVERY; SERIES; Q203	The imidazo[2,1-b]thiazole-5-carboxamides (ITAs) are a promising class of anti-tuberculosis agents shown to have potent activity in vitro and to target QcrB, a key component of the mycobacterial cytochrome bcc-aa3 super complex critical for the electron transport chain. Herein we report the intracellular macrophage potency of nine diverse ITA analogs with MIC values ranging from 0.0625-2.5 mu M and mono-drug resistant potency ranging from 0.0017 to 7 mu M. The in vitro ADME properties (protein binding, CaCo-2, human microsomal stability and CYP450 inhibition) were determined for an outstanding compound of the series, ND11543. ND-11543 was tolerable at > 500 mg/kg in mice and at a dose of 200 mg/kg displayed good drug exposure in mice with an AUC(0-24h) > 11,700 ng.hr/mL and a >= 24 hr half-life. Consistent with the phenotype observed with other QcrB inhibitors, compound ND-11543 showed efficacy in a chronic murine TB infection model when dosed at 200 mg/kg for 4 weeks. The efficacy was not dependent upon exposure, as pre-treatment with a known CYP450-inhibitor did not substantially improve efficacy. The ITAs are an interesting scaffold for the development of new anti-TB drugs especially in combination therapy based on their favorable properties and novel mechanism of action.	[Moraski, Garrett C.; Marshall, Kate L.; Weaver, Heath A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Deboosere, Nathalie; Vandeputte, Alexandre; Brodin, Priscille] Univ Lille, CNRS, Inst Pasteur Lille, Inserm,CHU Lille,U1019,UMR 8204,CIIL Ctr Infect &, Lille, France; [Hastings, Courtney; Woolhiser, Lisa; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Miller, Marvin J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Montana State University System; Montana State University Bozeman; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Colorado State University; University of Notre Dame	Brodin, P (corresponding author), Univ Lille, CNRS, Inst Pasteur Lille, Inserm,CHU Lille,U1019,UMR 8204,CIIL Ctr Infect &, Lille, France.; Miller, MJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	priscille.brodin@inserm.fr; mmiller1@nd.edu	Moraski, Garrett/AAH-3616-2021; Brodin, Priscille/E-5802-2014	Brodin, Priscille/0000-0003-0991-7344	National Institutes of Health [R37AI054193]; National Institute of Allergy and Infectious Diseases [HHSN272201100009I]; MJ Murdock Charitable Trust; NIH [P20GM103474]; NSF-Major Research Instrumentation program (NSF-MRI) [DBI1532078]; Murdock Charitable Trust Foundation [015066:MNL]; MSU Vice-President for Research and Economic Development office; European Community (ERC-STG INTRACELLTB) [260901, 260872]; Agence Nationale de la Recherche [ANR-10-EQPX-04-01, ANR-14-CE08-0017, ANR16-CE35-0009]; Feder [12001407]; Region Nord Pas de Calais [12000080]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MJ Murdock Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-Major Research Instrumentation program (NSF-MRI)(National Science Foundation (NSF)); Murdock Charitable Trust Foundation; MSU Vice-President for Research and Economic Development office; European Community (ERC-STG INTRACELLTB); Agence Nationale de la Recherche(French National Research Agency (ANR)); Feder(European Commission); Region Nord Pas de Calais(Region Hauts-de-FranceEuropean Commission)	This study was financially supported in part by the National Institutes of Health by grant R37AI054193 (M.J.M., G.C.M) and the National Institute of Allergy and Infectious Diseases, Contract No. HHSN272201100009I. Funding for Proteomics, Metabolomics and Mass Spectrometry Facility (at MSU) was made possible by the MJ Murdock Charitable Trust and NIH P20GM103474. Funding for the 500 NMR (at MSU) was provided by the NSF-Major Research Instrumentation program (NSF-MRI: DBI1532078), the Murdock Charitable Trust Foundation (015066:MNL), and support from the MSU Vice-President for Research and Economic Development office. Work in Priscille Brodin's lab was also supported from the European Community (ERC-STG INTRACELLTB no 260901, MM4TB no 260872), the Agence Nationale de la Recherche (ANR-10-EQPX-04-01, ANR-14-CE08-0017, ANR16-CE35-0009), and the Feder (12001407 (D-AL) Equipex Imaginex BioMed) and the Region Nord Pas de Calais (convention no 12000080).	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Arora K, 2014, ANTIMICROB AGENTS CH, V58, P6962, DOI 10.1128/AAC.03486-14; Berube BJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01677-17; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Chandrasekera NS, 2017, ACS INFECT DIS, V3, P898, DOI 10.1021/acsinfecdis.7b00112; Cheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087483; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Cleghorn LAT, 2018, J MED CHEM, V61, P6592, DOI 10.1021/acs.jmedchem.8b00172; Converse PJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00426-19, 10.1128/aac.00426-19]; Cook GM, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0014-2016; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Foo CS, 2018, MBIO, V9, DOI [10.1128/mBio.01276-18, 10.1128/mbio.01276-18]; Foti RS, 2010, DRUG METAB DISPOS, V38, P981, DOI 10.1124/dmd.110.032094; Hu XL, 2019, ACS MED CHEM LETT, V10, P295, DOI 10.1021/acsmedchemlett.8b00410; Kalia NP, 2017, P NATL ACAD SCI USA, V114, P7426, DOI 10.1073/pnas.1706139114; Kang S, 2014, J MED CHEM, V57, P5293, DOI 10.1021/jm5003606; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Liu Y, 2019, CHIN J URBAN ENV STU, V7, DOI 10.1142/S2345748119500106; Lu P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20989-8; Lu XY, 2019, ACS INFECT DIS, V5, P239, DOI 10.1021/acsinfecdis.8b00225; Lu XY, 2016, BIOORG MED CHEM LETT, V26, P5916, DOI 10.1016/j.bmcl.2016.11.003; Mahajan Rajiv, 2013, Int J Appl Basic Med Res, V3, P1, DOI 10.4103/2229-516X.112228; Maxmen Amy, 2019, Nature, DOI 10.1038/d41586-019-02464-0; Moraski GC, 2017, CHEMMEDCHEM, V12, P1108, DOI 10.1002/cmdc.201700170; Moraski GC, 2016, ANTIMICROB AGENTS CH, V60, P5018, DOI 10.1128/AAC.00618-16; Moraski GC, 2016, ACS INFECT DIS, V2, P393, DOI 10.1021/acsinfecdis.5b00154; Moraski GC, 2015, ACS INFECT DIS, V1, P85, DOI 10.1021/id500008t; Moraski GC, 2014, BIOORG MED CHEM LETT, V24, P3493, DOI 10.1016/j.bmcl.2014.05.062; Moraski GC, 2013, ACS MED CHEM LETT, V4, P110, DOI 10.1021/ml400088y; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; O'Malley T, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02439-17; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Pontali E, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0035-2019; Queval CJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51114; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rybniker J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8659; Sahu S, 2019, LANCET GLOB HEALTH, V7, pE558, DOI 10.1016/S2214-109X(19)30068-3; Scherr N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07804-8; Song OR, 2017, CYTOM PART A, V91A, P983, DOI 10.1002/cyto.a.23129; Sotgiu G, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017822; Sprouffske K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1016-7; Tang J, 2015, ACS MED CHEM LETT, V6, P814, DOI 10.1021/acsmedchemlett.5b00176; Tiwari R, 2013, J AM CHEM SOC, V135, P3539, DOI 10.1021/ja311058q; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	47	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0227224	10.1371/journal.pone.0227224	http://dx.doi.org/10.1371/journal.pone.0227224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905374	Green Published, gold			2022-12-26	WOS:000534327700019
J	Kasahara, T; Kubota-Sakashita, M; Nagatsuka, Y; Hirabayashi, Y; Hanasaka, T; Tohyama, K; Kato, T				Kasahara, Takaoki; Kubota-Sakashita, Mie; Nagatsuka, Yasuko; Hirabayashi, Yoshio; Hanasaka, Tomohito; Tohyama, Koujiro; Kato, Tadafumi			Cardiolipin is essential for early embryonic viability and mitochondrial integrity of neurons in mammals	FASEB JOURNAL			English	Article						Crls1; mitochondrial cristae; calcium retention capacity; peri-implantation lethality; Camk2 alpha-Cre mice	GENOME-WIDE ASSOCIATION; SYNTHASE; GENE; PERMEABILITY; DISCOVERY; MEMBRANE; ROLES; CELLS; LOCI	Cardiolipin (CL) is a hallmark phospholipid of mitochondria and plays a significant role in maintaining the mitochondrial structure and functions. Despite the physiological importance of CL, mutant organisms, yeast, Arabidopsis, C elegans, and Drosophila, which lack CL synthase (Crls1) gene and consequently are deprived of CL, are viable. Here we report conditional Crls1-deficient mice using targeted insertion of loxP sequences flanking the functional domain of CRLS1 enzyme. Homozygous null mutant mice exhibited early embryonic lethality at the peri-implantation stage. We generated neuron-specific Crls1 knockout (cKO) mice by crossing with Camk2 alpha-Cre mice. Neuronal loss and gliosis were gradually manifested in the forebrains, where CL levels were significantly decreased. In the surviving neurons, malformed mitochondria with bubble-like or onion-like inner membrane structures were observed. We showed decreased supercomplex assembly and reduced enzymatic activities of electron transport chain complexes in the forebrain of cKO mice, resulting in affected mitochondrial calcium dynamics, a slower rate of Ca2+ uptake and a smaller calcium retention capacity. These observations clearly demonstrate indispensable roles of CL as well as of Crls1 gene in mammals.	[Kasahara, Takaoki; Kubota-Sakashita, Mie; Kato, Tadafumi] RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; [Nagatsuka, Yasuko] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol,Itabashi Ku, Tokyo, Japan; [Hirabayashi, Yoshio] RIKEN, Cellular Informat Lab, Cluster Pioneering Res, Wako, Saitama, Japan; [Hirabayashi, Yoshio] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan; [Hanasaka, Tomohito; Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Sch Dent, Dept Physiol, Yahaba, Iwate, Japan	RIKEN; Nihon University; RIKEN; Juntendo University; Iwate Medical University	Kasahara, T; Kato, T (corresponding author), RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.	takaoki.kasahara@riken.jp; tadafumi.kato@riken.jp	Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020; Kubota-Sakashita, Mie/AAM-4064-2021	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146; Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN; MEXT	RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	RIKEN; MEXT	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi CI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.14; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEBOLAND AR, 1975, J BIOL CHEM, V250, P7501; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Fajardo VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02089-1; Govindarajan S, 2012, FEMS MICROBIOL REV, V36, P1005, DOI 10.1111/j.1574-6976.2012.00348.x; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156; Katayama K, 2004, FEBS LETT, V577, P193, DOI 10.1016/j.febslet.2004.10.009; Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037; Kato TM, 2018, MOL PSYCHIATR, V23, P2039, DOI 10.1038/s41380-018-0074-9; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Lu B, 2006, J LIPID RES, V47, P1140, DOI 10.1194/jlr.C600004-JLR200; Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P599, DOI 10.1016/j.bbabio.2015.03.005; Lynch M, 2017, ELIFE, V6, DOI 10.7554/eLife.20437; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Miettinen TP, 2016, DEV CELL, V39, P370, DOI 10.1016/j.devcel.2016.09.004; Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055; Munoz-Gomez SA, 2017, MOL BIOL EVOL, V34, P943, DOI 10.1093/molbev/msw298; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Saunders CJ, 2015, HUM MUTAT, V36, P301, DOI 10.1002/humu.22743; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Sigitova E, 2017, PSYCHIAT CLIN NEUROS, V71, P77, DOI 10.1111/pcn.12476; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	59	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1465	1480		10.1096/fj.201901598R	http://dx.doi.org/10.1096/fj.201901598R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914590	Bronze			2022-12-26	WOS:000507308900097
J	Xiong, W; Huang, J; Li, XY; Zhang, Z; Jin, ML; Wang, J; Xu, YW; Wang, ZL				Xiong, Wen; Huang, Jing; Li, Xueying; Zhang, Zhu; Jin, Meilan; Wang, Jian; Xu, Yuwei; Wang, Zili			Icariin and its phosphorylated derivatives alleviate intestinal epithelial barrier disruption caused by enterotoxigenic Escherichia coli through modulate p38 MAPK in vivo and in vitro	FASEB JOURNAL			English	Article						enterotoxigenic Escherichia coli K88; icariin; intestinal barrier function; p38 MAPK; phosphorylated icariin	TIGHT JUNCTION DISRUPTION; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; WEANED PIGS; ZINC-OXIDE; PROTECTION; CELLS; PIGLETS; K88; SUPPLEMENTATION	The natural product icariin (ICA) and its phosphorylated derivatives (pICA) have been shown to have outstanding anti-inflammatory and antioxidant properties. This study was to explore the protective effects of ICA and pICA on the intestinal epithelium of enterotoxigenic Escherichia coli (ETEC)-induced piglet diarrhea and its underlying mechanisms in vivo and in vitro. ETEC K88 increased pro-inflammatory cytokine expression, activated oxidative stress and inhibited antioxidant enzyme activity, induced phosphorylated p38 MAPK gene and protein expression, disrupted intestinal barrier function, and led to diarrhea in piglets. Pretreatment with ICA and pICA effectively alleviated ETEC-induced intestinal barrier dysfunction in vivo and in vitro. Pretreatment with p38 MAPK inhibitor (SB203580) significantly rescued the IPEC-J2 cells barrier function damaged by ETEC challenge. However, pretreatment with p38 MAPK activator (anisomycin) did not alleviated the IPEC-J2 cells barrier function damaged by ETEC challenge. Our data demonstrated that ICA and pICA regulate the inflammatory response and oxidative stress of intestinal epithelial cells by inhibiting the expression of p38 MAPK, thereby alleviating ETEC K88-induced disruption of intestinal barrier function and intestinal permeability. These findings provide new insights into the prevention and treatment of intestinal barrier dysfunction induced by ETEC K88.	[Xiong, Wen; Huang, Jing; Li, Xueying; Zhang, Zhu; Jin, Meilan; Wang, Jian; Xu, Yuwei; Wang, Zili] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Southwest University - China	Wang, ZL (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	wzl9698@126.com	xiong, wen/Q-4069-2017	xiong, wen/0000-0003-0217-2992	National Nature Science Foundation of China [31902313]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Nature Science Foundation of China, Grant/Award Number: 31902313	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Che LQ, 2017, BRIT J NUTR, V118, P949, DOI [10.1017/s0007114517003051, 10.1017/S0007114517003051]; Chen TT, 2017, FOOD FUNCT, V8, P1166, DOI [10.1039/c6fo01532h, 10.1039/C6FO01532H]; Deng YL, 2017, CURR TOP MED CHEM, V17, P2977, DOI 10.2174/1568026617666170821130315; de Barboza GD, 2017, WORLD J GASTROENTERO, V23, P2841, DOI 10.3748/wjg.v23.i16.2841; Dors A, 2016, VET REC, V179, P598, DOI 10.1136/vr.103811; Enaud R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050645; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Gangwar R, 2017, BIOCHEM J, V474, P731, DOI 10.1042/BCJ20160679; Guan GP, 2019, SCI CHINA LIFE SCI, V62, P1019, DOI 10.1007/s11427-018-9494-6; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hua WB, 2017, CURR PHARM DESIGN, V23, P6071, DOI 10.2174/1381612823666170615112158; Ji JJ, 2018, INT J MOL MED, V41, P137, DOI 10.3892/ijmm.2017.3229; Johnson AM, 2010, VET MICROBIOL, V141, P115, DOI 10.1016/j.vetmic.2009.08.020; Kim KY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5718396; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lee CY, 2017, J ANIM PHYSIOL AN N, V101, P88, DOI 10.1111/jpn.12513; Li HF, 2012, FITOTERAPIA, V83, P44, DOI 10.1016/j.fitote.2011.09.010; Lin J, 2013, VET MICROBIOL, V162, P731, DOI 10.1016/j.vetmic.2012.09.025; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Minamiyama Y, 2010, FREE RADICAL RES, V44, P1398, DOI 10.3109/10715762.2010.510523; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Palatinus JA, 2011, AM J PHYSIOL-HEART C, V300, pH583, DOI 10.1152/ajpheart.00999.2010; Roselli M, 2003, J NUTR, V133, P4077, DOI 10.1093/jn/133.12.4077; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Sargeant HR, 2011, MOL IMMUNOL, V48, P2113, DOI 10.1016/j.molimm.2011.07.002; Saxena A, 2018, INFLAMM RES, V67, P829, DOI 10.1007/s00011-018-1172-5; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Song YH, 2016, BIOMED PHARMACOTHER, V83, P1089, DOI 10.1016/j.biopha.2016.08.016; Tao SY, 2019, J CELL PHYSIOL, V234, P3621, DOI 10.1002/jcp.27132; Tao SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28778; Tao SY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0235-2; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uwada J, 2017, CELL SIGNAL, V35, P188, DOI 10.1016/j.cellsig.2017.04.007; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang SD, 2017, J CELL MOL MED, V21, P1182, DOI 10.1111/jcmm.13050; Wu YP, 2016, VET IMMUNOL IMMUNOP, V172, P55, DOI 10.1016/j.vetimm.2016.03.005; Xiao DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104192; Xiong W, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01850; Xiong W, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0226-3; Xu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104183; Yu HT, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00242; Yu L, 2017, RENAL FAILURE, V39, P440, DOI 10.1080/0886022X.2017.1305968; Zeng Q, 2019, TOXICOLOGY, V411, P122, DOI 10.1016/j.tox.2018.09.010; Zhu H, 2017, EUR REV MED PHARMACO, V21, P5239, DOI 10.26355/eurrev_201711_13847	49	23	25	6	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1783	1801		10.1096/fj.201902265R	http://dx.doi.org/10.1096/fj.201902265R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914584	hybrid			2022-12-26	WOS:000507308900118
J	Zhang, P; Ha, M; Li, LB; Huang, X; Liu, CJ				Zhang, Pei; Ha, Mei; Li, Lianbing; Huang, Xu; Liu, Changjiang			MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway	FASEB JOURNAL			English	Article						ceRNA; FOXA1; CD24; Src pathway; HCC angiogenesis; lncRNA MALAT1; miR-3064-5p	LONG NONCODING RNA; PROMOTES TUMOR ANGIOGENESIS; FOXA1; EXPRESSION; PROLIFERATION; PROGRESSION; CD24; SRC	Angiogenesis is critical for the development, progression, and metastasis of hepatocellular carcinoma (HCC), but the roles of miR-3064-5p in HCC angiogenesis are still unknown. In this study, the roles of miR-3064-5p in HCC angiogenesis were studied in 192 HCC patients, xenograft mouse models, and HCC cell lines. The results showed that miR-3064-5p expression was significantly decreased in HCC tissues and cells, and downregulated miR-3064-5p was associated with upregulated angiogenic potential of HCC. MiR-3064-5p inhibited proangiogenic VEGFA and angiogenin expressions but induced antiangiogenic endostatin and MMP12 expressions, finally leading to suppression of HCC angiogenesis, as shown by the decline in intratumoral microvessel density (MVD). Moreover, miR-3064-5p was inversely correlated with lncRNA MALAT1 and FOXA1. FOXA1 bound to and interacted with CD24 and then regulated Src phosphorylation. MiR-3064-5p played an antiangiogenic role by inhibiting the FOXA1/CD24/Src pathway, whereas oncogenic MALAT1 functioned as a competing endogenous RNA (ceRNA) by sponging miR-3064-5p to alleviate the suppressive effect on the FOXA1 pathway. HCC patients with high miR-3064-5p, low MALAT1, or low FOXA1 expression had a better prognosis with longer overall survival and recurrence-free survival. In univariate and multivariate analyses, miR-3064-5p was identified as the independent prognostic predicator for HCC progression and patient survival. Taken together, miR-3064-5p exerts an antiangiogenic role by targeting the FOXA1/CD24/Src pathway but oncogenic lncRNA MALAT1 acts as a ceRNA to sponge miR-3064-5p. MiR-3064-5p is of great clinical significance and is a novel prognostic indicator and an attractive therapeutic target for HCC.	[Zhang, Pei] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan, Peoples R China; [Ha, Mei] Chongqing Med & Pharmaceut Coll, Sch Nursing, Chongqing, Peoples R China; [Li, Lianbing; Huang, Xu; Liu, Changjiang] Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China	Huazhong University of Science & Technology	Liu, CJ (corresponding author), Chongqing Populat & Family Planning Sci & Technol, 18 Honghuang Rd, Chongqing 400020, Peoples R China.	cj_514@163.com			Chongqing Science and Technology Bureau [cstc2018jcyjAX0380]	Chongqing Science and Technology Bureau	Chongqing Science and Technology Bureau, Grant/Award Number: cstc2018jcyjAX0380	Amata I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00181; Baumann P, 2012, CELL MOL LIFE SCI, V69, P435, DOI 10.1007/s00018-011-0756-9; Bretz N, 2012, CLIN EXP METASTAS, V29, P27, DOI 10.1007/s10585-011-9426-4; Bretz NP, 2012, CELL MOL LIFE SCI, V69, P3863, DOI 10.1007/s00018-012-1055-9; Cao C, 2017, ONCOGENE, V36, P1112, DOI 10.1038/onc.2016.278; Chang RM, 2017, CLIN CANCER RES, V23, P2593, DOI 10.1158/1078-0432.CCR-16-0851; Cheng SU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35786-6; Dou CW, 2015, ONCOTARGET, V6, P13216, DOI 10.18632/oncotarget.3916; Du CL, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0182-1; Guo PY, 2018, ONCOGENE, V37, P1220, DOI 10.1038/s41388-017-0017-y; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hu YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0978-y; Li W, 2019, EUR J PHARMACOL, V849, P106, DOI 10.1016/j.ejphar.2019.01.049; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin L, 2002, CANCER RES, V62, P5273; Malakar P, 2017, CANCER RES, V77, P1155, DOI 10.1158/0008-5472.CAN-16-1508; Moon WS, 2003, MODERN PATHOL, V16, P552, DOI 10.1097/01.MP.0000071841.17900.69; Musso O, 2001, CANCER RES, V61, P45; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Wang LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20859-3; Yang C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.356; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Yu WW, 2019, ONCOGENE, V38, P1225, DOI 10.1038/s41388-018-0463-1; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhuang M, 2019, EBIOMEDICINE, V41, P286, DOI 10.1016/j.ebiom.2018.12.049	30	32	33	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					66	81		10.1096/fj.201901834R	http://dx.doi.org/10.1096/fj.201901834R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914639				2022-12-26	WOS:000507308900006
J	Fujita, K; Yamada, H; Iijima, M; Ichida, K				Fujita, Kyoko; Yamada, Hiroki; Iijima, Masahiro; Ichida, Kimiyoshi			Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels	PLOS ONE			English	Article							URATE TRANSPORT; IDENTIFICATION; ABCG2	Recently, extensive efforts have been made to understand the importance of the extra-renal uric acid (UA) excretion pathways and their contribution to UA-related diseases. However, the method typically used to measure UA concentrations in the intestinal lumen is difficult to real time and dynamic analysis. In this study, UA excretion in the rat intestinal lumen was measured in real time using an electrochemical method. A sensitive electrode to detect UA was constructed using a gold electrode modified with a mixed self-assembled monolayer. Excretion rate of UA in the intestine was calculated using time course data. A decrease in UA excretion rate was observed in the intestine after administration of serum UA-lowering drugs (benzbromarone, febuxostat, and topiroxostat). Inhibition of ATP-binding cassette transporter G2 (ABCG2) which has been reported as an important exporter of UA was suggested by administration of these drugs. On the other hand, an increase in excretion rate of UA was observed in the intestine of 5/6 nephrectomy rats. Upregulation of mRNA expression of the UA transporter organic anion transporter OAT3, which is related to the secretion at the basal membrane, suggested an enhancement of UA excretion by ABCG2, a high-capacity UA exporter. Observed urate excretion dynamics and mRNA expression of UA transporters in the intestine upon administration of serum UA-lowering drugs and 5/6 nephrectomy improve our understanding of the underlying mechanisms of intestinal UA excretion.	[Fujita, Kyoko; Yamada, Hiroki; Iijima, Masahiro; Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Fujita, K (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Hachioji, Tokyo, Japan.	kyokof@toyaku.ac.jp			Japan Society for the Promotion of Science, KAKENHI [17K05937, 18K08224]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research, KAKENHI, (https://www.jsps.go.jp/j-grantsinaid/index.html) grant #17K05937 to KF and grant#18K08224 to KI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa T, 2016, MOL PHARMACEUT, V13, P2443, DOI 10.1021/acs.molpharmaceut.6b00196; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Endou H, 2008, NUCLEOS NUCLEOT NUCL, V27, P578, DOI 10.1080/15257770802136024; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fujita K, 2004, J AM CHEM SOC, V126, P13954, DOI 10.1021/ja047875o; GANEVAL D, 1973, KIDNEY INT, V3, P222, DOI 10.1038/ki.1973.35; Ichida K, 2003, KIDNEY INT, V63, P143, DOI 10.1046/j.1523-1755.2003.00710.x; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Kawashima M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-31; Liu HC, 2016, J PHARMACOL EXP THER, V359, P215, DOI 10.1124/jpet.116.232660; Matsuo H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03755; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Miyata Hiroshi, 2016, Front Pharmacol, V7, P518, DOI 10.3389/fphar.2016.00518; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Paganoni S, 2017, NEUROTHERAPEUTICS, V14, P148, DOI 10.1007/s13311-016-0497-4; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Tan PK, 2017, ADMET DMPK, V5, P59, DOI 10.5599/admet.5.2.387; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; VAZIRI ND, 1995, J AM SOC NEPHROL, V6, P1313; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Xu LQ, 2017, ONCOTARGET, V8, P100852, DOI 10.18632/oncotarget.20135; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8; Zhong LL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010967	29	8	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226918	10.1371/journal.pone.0226918	http://dx.doi.org/10.1371/journal.pone.0226918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891613	Green Published, gold			2022-12-26	WOS:000515096600044
J	Khan, N; Schoenike, B; Basu, T; Grabenstatter, H; Rodriguez, G; Sindic, C; Johnson, M; Wallace, E; Maganti, R; Dingledine, R; Roopra, A				Khan, Nadia; Schoenike, Barry; Basu, Trina; Grabenstatter, Heidi; Rodriguez, Genesis; Sindic, Caleb; Johnson, Margaret; Wallace, Eli; Maganti, Rama; Dingledine, Raymond; Roopra, Avtar			A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy	PLOS ONE			English	Article							GENE-EXPRESSION; STATUS EPILEPTICUS; WEAVER SYNDROME; POLYCOMB; MUTATIONS; SEIZURE; METHYLATION; INHIBITION; MECHANISMS; PATTERNS	Complex neurological conditions can give rise to large scale transcriptomic changes that drive disease progression. It is likely that alterations in one or a few transcription factors or cofactors underlie these transcriptomic alterations. Identifying the driving transcription factors/cofactors is a non-trivial problem and a limiting step in the understanding of neurological disorders. Epilepsy has a prevalence of 1% and is the fourth most common neurological disorder. While a number of anti-seizure drugs exist to treat seizures symptomatically, none is curative or preventive. This reflects a lack of understanding of disease progression. We used a novel systems approach to mine transcriptome profiles of rodent and human epileptic brain samples to identify regulators of transcriptional networks in the epileptic brain. We find that Enhancer of Zeste Homolog 2 (EZH2) regulates differentially expressed genes in epilepsy across multiple rodent models of acquired epilepsy. EZH2 undergoes a prolonged upregulation in the epileptic brain. A transient inhibition of EZH2 immediately after status epilepticus (SE) robustly increases spontaneous seizure burden weeks later. This suggests that EZH2 upregulation is a protective. These findings are the first to characterize a role for EZH2 in opposing epileptogenesis and debut a bioinformatic approach to identify nuclear drivers of complex transcriptional changes in disease.	[Khan, Nadia] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI USA; [Khan, Nadia; Schoenike, Barry; Basu, Trina; Johnson, Margaret; Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Basu, Trina] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Grabenstatter, Heidi] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Rodriguez, Genesis; Sindic, Caleb] Univ Wisconsin, Coll Letters & Sci, Madison, WI USA; [Wallace, Eli] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI USA; [Wallace, Eli; Maganti, Rama] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Dingledine, Raymond] Emory Univ, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Emory University	Roopra, A (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	asroopra@wisc.edu		Khan, Nadia/0000-0003-3383-9876; Rodriguez, Genesis/0000-0001-5159-533X; Wallace, Eli/0000-0003-2119-1056	NIH National Research Service Award T32; NIH NINDS Blueprint Diversity Specialized Pre-Doctoral Award [F99]; NIH [R21NS093364]; CURE Challenge award; Spark award from Lily's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093364, R01NS108756] Funding Source: NIH RePORTER	NIH National Research Service Award T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NINDS Blueprint Diversity Specialized Pre-Doctoral Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE Challenge award; Spark award from Lily's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	During the course of this study, NK was supported by NIH National Research Service Award T32 and the NIH NINDS Blueprint Diversity Specialized Pre-Doctoral Award F99. AR and RD were supported by NIH R21NS093364. AR was supported by a CURE Challenge award and a Spark award from Lily's Fund (https://lilysfund.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; Blumcke I, 1999, EPILEPSY RES, V36, P205, DOI 10.1016/S0920-1211(99)00052-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borges K, 2007, NEUROBIOL DIS, V26, P66, DOI 10.1016/j.nbd.2006.12.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carvill GL, 2015, AM J HUM GENET, V96, P808, DOI 10.1016/j.ajhg.2015.02.016; Cohen ASA, 2016, HUM MUTAT, V37, P301, DOI 10.1002/humu.22946; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Dingledine R, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.61; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Hansen KF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06930; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Johnson MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7031; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Levin MF, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P2, DOI 10.1109/ICVR.2015.7358630; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; Na J, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt33; Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2; Noebels JL, 2010, EPILEPSIA, V51, P1, DOI 10.1111/j.1528-1167.2010.02792.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tatton-Brown K, 2013, AM J MED GENET A, V161, P2972, DOI 10.1002/ajmg.a.36229; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Williams-Karnesky RL, 2013, J CLIN INVEST, V123, P3552, DOI 10.1172/JCI65636; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	55	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226733	10.1371/journal.pone.0226733	http://dx.doi.org/10.1371/journal.pone.0226733			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891591	gold, Green Submitted, Green Published			2022-12-26	WOS:000515096600024
J	Tozan, Y; Sun, SC; Capasso, A; Wang, JSH; Neilands, TB; Bahar, OS; Damulira, C; Ssewamala, FM				Tozan, Yesim; Sun, Sicong; Capasso, Ariadna; Wang, Julia Shu-Huah; Neilands, Torsten B.; Bahar, Ozge Sensoy; Damulira, Christopher; Ssewamala, Fred M.			Evaluation of a savings-led family-based economic empowerment intervention for AIDS-affected adolescents in Uganda: A four-year follow-up on efficacy and cost-effectiveness	PLOS ONE			English	Article							HEALTH-RELATED OUTCOMES; SEXUAL RISK-TAKING; SUB-SAHARAN AFRICA; ORPHANED ADOLESCENTS; RANDOMIZED EXPERIMENT; IMPACTED COMMUNITIES; CASH TRANSFERS; CHILDREN; ATTITUDES; EDUCATION	Background Children who have lost a parent to HIV/AIDS, known as AIDS orphans, face multiple stressors affecting their health and development. Family economic empowerment (FEE) interventions have the potential to improve these outcomes and mitigate the risks they face. We present efficacy and cost-effectiveness analyses of the Bridges study, a savings-led FEE intervention among AIDS-orphaned adolescents in Uganda at four-year follow-up. Methods Intent-to-treat analyses using multilevel models compared the effects of two savings-led treatment arms: Bridges (1:1 matched incentive) and BridgesPLUS (2:1 matched incentive) to a usual care control group on the following outcomes: self-rated health, sexual health, and mental health functioning. Total per-participant costs for each arm were calculated using the treatment-on-the-treated sample. Intervention effects and per-participant costs were used to calculate incremental cost-effectiveness ratios (ICERs). Findings Among 1,383 participants, 55% were female, 20% were double orphans. Mean age was 12 years at baseline. At 48-months, BridgesPLUS significantly improved self-rated health, (0.25, 95% CI 0.06, 0.43), HIV knowledge (0.21, 95% CI 0.01, 0.41), self-concept (0.26, 95% CI 0.09, 0.44), and self-efficacy (0.26, 95% CI 0.09, 0.43) and lowered hopelessness (-0.28, 95% CI-0.43, -0.12); whereas Bridges improved self-rated health (0.26, 95% CI 0.08, 0.43) and HIV knowledge (0.22, 95% CI 0.05, 0.39). ICERs ranged from $224 for hopelessness to $298 for HIV knowledge per 0.2 standard deviation change. Conclusions Most intervention effects were sustained in both treatment arms at two years post-intervention. Higher matching incentives yielded a significant and lasting effect on a greater number of outcomes among adolescents compared to lower matching incentives at a similar incremental cost per unit effect. These findings contribute to the evidence supporting the incorporation of FEE interventions within national social protection frameworks.	[Tozan, Yesim; Capasso, Ariadna] NYU, Coll Global Publ Hlth, New York, NY USA; [Sun, Sicong; Bahar, Ozge Sensoy; Damulira, Christopher; Ssewamala, Fred M.] Washington Univ, Int Ctr Child Hlth & Dev, Brown Sch, St Louis, MO 63110 USA; [Wang, Julia Shu-Huah] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China; [Neilands, Torsten B.] Univ Calif San Francisco, Sch Med, Ctr AIDS Prevent Studies, San Francisco, CA USA	New York University; Washington University (WUSTL); University of Hong Kong; University of California System; University of California San Francisco	Ssewamala, FM (corresponding author), Washington Univ, Int Ctr Child Hlth & Dev, Brown Sch, St Louis, MO 63110 USA.	fms1@wustl.edu	Wang, Julia Shu-Huah/ABB-7928-2021	Wang, Julia Shu-Huah/0000-0002-6128-8242; Ssewamala, Fred/0000-0002-4849-5650; Tozan, Yesim/0000-0001-8997-8897; Capasso, Ariadna/0000-0001-5462-7800; Sun, Sicong/0000-0003-4508-604X	National Institute of Child Health and Development at the National Institutes of Health [1 R01-HD070727-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH067127] Funding Source: NIH RePORTER	National Institute of Child Health and Development at the National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by FMS. Grant #1 R01-HD070727-01. National Institute of Child Health and Development at the National Institutes of Health, https://www.nichd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EV CHILD END AIDS 7; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Bryant M, 2016, PEDIATR CLIN N AM, V63, P131, DOI 10.1016/j.pcl.2015.08.007; Cluver L, 2013, LANCET GLOB HEALTH, V1, pE362, DOI 10.1016/S2214-109X(13)70115-3; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Cohen J.E., 1988, STAT POWER ANAL BEHA; Drummond MF, 2015, METHODS EC EVALUATIO; Earls F., 1997, PROJECT HUMAN DEV CH; Fieno J, 2014, AJAR-AFR J AIDS RES, V13, P153, DOI 10.2989/16085906.2014.943251; Fitts WH., 1996, TENNESSEE SELF CONCE, V2nd Edn; Frankenberg E, 2004, J HEALTH SOC BEHAV, V45, P441, DOI 10.1177/002214650404500406; Glewwe P, 2015, RISEWP15001; Goldberg RE, 2016, AIDS CARE, V28, P130, DOI 10.1080/09540121.2016.1176684; Han CK, 2013, J EPIDEMIOL COMMUN H, V67, P225, DOI 10.1136/jech-2012-201601; Handa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085473; Harris DN, 2009, EDUC EVAL POLICY AN, V31, P3, DOI 10.3102/0162373708327524; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Ismayilova L, 2012, J ADOLESCENT HEALTH, V50, P228, DOI 10.1016/j.jadohealth.2011.06.008; Jennings L, 2016, AIDS CARE, V28, P273, DOI 10.1080/09540121.2015.1109585; Karimli L, 2015, J ADOLESCENT HEALTH, V57, P425, DOI 10.1016/j.jadohealth.2015.06.011; Karlan D, 2014, REV INCOME WEALTH, V60, P36, DOI 10.1111/roiw.12101; Kilburn K, 2017, ECON EDUC REV, V59, P63, DOI 10.1016/j.econedurev.2017.06.002; Madrian BC, 2012, NBER WORKING PAPER S; McEwan PJ, 2012, J DEV EFFECT, V4, P189, DOI 10.1080/19439342.2011.649044; Mkandawire P, 2013, AIDS BEHAV, V17, P939, DOI 10.1007/s10461-011-0120-y; Mokdad AH, 2013, GLOBAL BURDEN DIS IN; Nabunya P, 2014, CHILD YOUTH SERV REV, V43, P131, DOI 10.1016/j.childyouth.2014.05.011; Operario D, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-25; Raymond JM, 2018, AIDS BEHAV, V22, P3429, DOI 10.1007/s10461-018-2134-1; Remme M, 2014, AIDS, V28, P425, DOI 10.1097/QAD.0000000000000076; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Sarkar S, 2019, ECLINICALMEDICINE, V10, P10, DOI 10.1016/j.eclinm.2019.04.006; Schreiner Mark, 2007, CAN POOR SAVE SAVING; Ssewamala FM, 2008, J ADOLESCENT HEALTH, V42, P102, DOI 10.1016/j.jadohealth.2007.08.011; Ssewamala FM, 2018, J ADOLESCENT HEALTH, V62, pS29, DOI 10.1016/j.jadohealth.2017.09.026; Ssewamala FM, 2016, PREV SCI, V17, P134, DOI 10.1007/s11121-015-0580-9; Ssewamala FM, 2012, J ADOLESCENT HEALTH, V50, P346, DOI 10.1016/j.jadohealth.2011.08.008; Ssewamala FM, 2010, J ADOLESCENT HEALTH, V46, P372, DOI 10.1016/j.jadohealth.2009.08.010; Ssewamala FM, 2009, SOC SERV REV, V83, P453, DOI 10.1086/605941; Uganda AIDS Commission Ministry of Health of Uganda, 2015, 2014 UG HIV AIDS COU; Uganda Bureau of Statistics, 2015, CONS PRIC IND; UNAIDS, 2014, GAP REP; UNICEF-ESARO/Transfer Project, 2015, SOC CASH TRANSF CHIL; United Nations Children's Fund, 2018, WOM HEART HIV RESP C; Wang JSH, 2018, J POLICY ANAL MANAG, V37, P602, DOI 10.1002/pam.22065; WHO, 2014, HLTH WORLDS AD 2 CHA	49	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226809	10.1371/journal.pone.0226809	http://dx.doi.org/10.1371/journal.pone.0226809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891601	Green Published, gold			2022-12-26	WOS:000515096600028
J	Huang, YF; Gu, CJ; Wang, Q; Xu, L; Chen, J; Zhou, W; Zhou, Z; Zhao, SJ; Li, LW; Kong, FQ; Qian, DF; Zhao, X; Fan, J; Li, QQ; Yin, GY				Huang, Yi-Fan; Gu, Chang-Jiang; Wang, Qian; Xu, Lin; Chen, Jian; Zhou, Wei; Zhou, Zheng; Zhao, Shu-Jie; Li, Lin-Wei; Kong, Fan-Qi; Qian, Ding-Fei; Zhao, Xuan; Fan, Jin; Li, Qing-Qing; Yin, Guo-Yong			The protective effort of GPCR kinase 2-interacting protein-1 in neurons via promoting Beclin1-Parkin induced mitophagy at the early stage of spinal cord ischemia-reperfusion injury	FASEB JOURNAL			English	Article						GIT1; mitophagy; neuron; spinal cord injury	IN-VITRO; APOPTOSIS; MITOCHONDRIA; UBIQUITIN; PARKIN; PINK1; INHIBITION; AUTOPHAGY; DEGRADATION; BECN1	In spinal cord ischemia-reperfusion (I/R) injury, large amounts of reactive oxygen species can cause mitochondrial damage. Therefore, mitophagy acts as the main mechanism for removing damaged mitochondria and protects nerve cells. This study aimed to illustrate the important role of GPCR kinase 2-interacting protein-1 (GIT1) in mitophagy in vivo and in vitro. The level of mitophagy in the neurons of Git1 knockout mice was significantly reduced after ischemia-reperfusion. However, the overexpression of adeno-associated virus with Git1 promoted mitophagy and inhibited the apoptosis of neurons. GIT1 regulated the phosphorylation of Beclin-1 in Thr119, which could promote the translocation of Parkin to the mitochondrial outer membrane. This process was independent of PTEN-induced kinase 1 (PINK1), but it could not rescue the role in the absence of PINK1. Overall, GIT1 enhanced mitophagy and protected neurons against ischemia-reperfusion injury and, hence, might serve as a new research site for the protection of ischemia-reperfusion injury.	[Huang, Yi-Fan; Gu, Chang-Jiang; Wang, Qian; Xu, Lin; Chen, Jian; Zhou, Wei; Zhou, Zheng; Zhao, Shu-Jie; Li, Lin-Wei; Kong, Fan-Qi; Qian, Ding-Fei; Zhao, Xuan; Fan, Jin; Li, Qing-Qing; Yin, Guo-Yong] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Lin] Wuxi Xishan Peoples Hosp, Dept Orthoped, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University	Fan, J; Li, QQ; Yin, GY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	fanjin@njmu.edu.cn; liqingqing_1999@163.com; guoyong_yin@sina.com			National Natural Science Foundation of China (NSFC) [81772351, 81520108018, 81472080, 81772352, 81902211, 81401800]; Jiangsu Committee of Science and Technology-Social Development Plan [BE2017755]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX19_1161]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Committee of Science and Technology-Social Development Plan; Postgraduate Research & Practice Innovation Program of Jiangsu Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772351, 81520108018, 81520108018, 81472080, 81772352, 81902211 and 81401800; Jiangsu Committee of Science and Technology-Social Development Plan, Grant/Award Number: BE2017755; Postgraduate Research & Practice Innovation Program of Jiangsu Province, Grant/Award Number: KYCX19_1161	Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; Balsam LB, 2017, J THORAC CARDIOV SUR, V154, P1509, DOI 10.1016/j.jtcvs.2017.06.010; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Chen J, 2018, FASEB J, V32, P6833, DOI 10.1096/fj.201800548; Choubey V, 2014, AUTOPHAGY, V10, P1105, DOI 10.4161/auto.28615; Feng JH, 2018, MOL NEUROBIOL, V55, P6369, DOI 10.1007/s12035-017-0859-x; Gelmetti V, 2017, AUTOPHAGY, V13, P654, DOI 10.1080/15548627.2016.1277309; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Jiang X, 2006, ANN SURG, V244, P148, DOI 10.1097/01.sla.0000217608.08582.35; Jin SH, 2016, EMBO J, V35, P866, DOI 10.15252/embj.201593596; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Kong H, 2019, J MOL CELL BIOL, V11, P1056, DOI 10.1093/jmcb/mjz002; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2018, SCI REP, V8, P1; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Li Q, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00865; Liu K, 2017, J THORAC CARDIOV SUR, V154, P1498, DOI 10.1016/j.jtcvs.2017.05.046; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Matsuda N, 2016, J BIOCHEM, V159, P379, DOI 10.1093/jb/mvv125; McIlwain DL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-19; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pang JJ, 2011, J MOL CELL CARDIOL, V51, P769, DOI 10.1016/j.yjmcc.2011.06.020; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Perelman A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.171; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; Tenorio ER, 2019, J CARDIOVASC SURG, V60, P54, DOI 10.23736/S0021-9509.18.10739-7; Wang LP, 2009, J NEUROTRAUM, V26, P55, DOI 10.1089/neu.2008.0538; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Yin GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089127; Yoshii SR, 2015, BBA-MOL CELL RES, V1853, P2797, DOI 10.1016/j.bbamcr.2015.01.013; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu DT, 2013, NEUROTOX RES, V24, P512, DOI 10.1007/s12640-013-9397-0; Zhang Y, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12542; Zhang ZR, 2019, J NEURORESTORATOLOGY, V7, P55, DOI 10.26599/JNR.2019.9040011; Zhao S., 2018, FRONT MICROBIAL, V9, P1; Zhou H, 2017, REDOX BIOL, V13, P498, DOI 10.1016/j.redox.2017.07.007; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	54	12	13	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2055	2074		10.1096/fj.201902047R	http://dx.doi.org/10.1096/fj.201902047R		DEC 2019	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908016	hybrid			2022-12-26	WOS:000504677200001
J	Thibeault, PE; LeSarge, JC; Arends, D; Fernandes, M; Chidiac, P; Stathopulos, PB; Luyt, LG; Ramachandran, R				Thibeault, Pierre E.; LeSarge, Jordan C.; Arends, D'Arcy; Fernandes, Michaela; Chidiac, Peter; Stathopulos, Peter B.; Luyt, Leonard G.; Ramachandran, Rithwik			Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein?coupled receptor (GPCR); bioluminescence; bioluminescence resonance energy transfer (BRET); mitogen-activated protein kinase (MAPK); arrestin; docking; platelet; biased signaling; G-protein; peptide; protease-activated receptor-4 (PAR4)	SECONDARY PREVENTION; TETHERED LIGAND; AGONIST RECOGNITION; COUPLED RECEPTORS; SPECIFICITY; PEPTIDE; MECHANISM; CLONING; REQUIREMENTS; ASSOCIATION	Proteinase-activated receptor (PAR)-4 is a member of the proteolytically-activated PAR family of G-protein?coupled receptors (GPCR) that represents an important target in the development of anti-platelet therapeutics. PARs are activated by proteolytic cleavage of their receptor N terminus by enzymes such as thrombin, trypsin, and cathepsin-G. This reveals the receptor-activating motif, termed the tethered ligand that binds intramolecularly to the receptor and triggers signaling. However, PARs are also activated by exogenous application of synthetic peptides derived from the tethered-ligand sequence. To better understand the molecular basis for PAR4-dependent signaling, we examined PAR4-signaling responses to a peptide library derived from the canonical PAR4-agonist peptide, AYPGKF-NH2, and we monitored activation of the G?(q/11)-coupled calcium-signaling pathway, ?-arrestin recruitment, and mitogen-activated protein kinase (MAPK) pathway activation. We identified peptides that are poor activators of PAR4-dependent calcium signaling but were fully competent in recruiting ?-arrestin-1 and -2. Peptides that were unable to stimulate PAR4-dependent calcium signaling could not trigger MAPK activation. Using in silico docking and site-directed mutagenesis, we identified Asp(230) in the extracellular loop-2 as being critical for PAR4 activation by both agonist peptide and the tethered ligand. Probing the consequence of biased signaling on platelet activation, we found that a peptide that cannot activate calcium signaling fails to cause platelet aggregation, whereas a peptide that is able to stimulate calcium signaling and is more potent for ?-arrestin recruitment triggered greater levels of platelet aggregation compared with the canonical PAR4 agonist peptide. These findings uncover molecular determinants critical for agonist binding and biased signaling through PAR4.	[Thibeault, Pierre E.; Arends, D'Arcy; Chidiac, Peter; Stathopulos, Peter B.; Ramachandran, Rithwik] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [LeSarge, Jordan C.; Fernandes, Michaela; Luyt, Leonard G.] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Luyt, Leonard G.] Univ Western Ontario, Dept Oncol, London, ON N6A 5C1, Canada; [Luyt, Leonard G.] Lawson Hlth Res Inst, London Reg Canc Program, London, ON N6C2R5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Ramachandran, R (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	rramach@uwo.ca	Ramachandran, Rithwik/N-7815-2015; Chidiac, Peter/L-5906-2015	Ramachandran, Rithwik/0000-0001-9557-9905; Chidiac, Peter/0000-0001-8365-6109; Thibeault, Pierre/0000-0002-3867-9819; Stathopulos, Peter B./0000-0002-0536-6656	Canadian Institutes of Health Research (CIHR) [376560]; Natural Sciences and Engineering Research Council of Canada; Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology; Canada Graduate Scholarship; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology; Canada Graduate Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by a Canadian Institutes of Health Research (CIHR) grant 376560 (to R. R.) and by grants from the Natural Sciences and Engineering Research Council of Canada (to L. G. L. and P. B. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology.; Recipient of a Canada Graduate Scholarship and an Ontario Graduate Scholarship.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2002, J PHARMACOL EXP THER, V302, P1046, DOI 10.1124/jpet.302.3.1046; Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Bar-Shavit R, 2016, METHOD CELL BIOL, V132, P341, DOI 10.1016/bs.mcb.2015.11.006; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Boitano S, 2011, J MED CHEM, V54, P1308, DOI 10.1021/jm1013049; Centellas DS, 2017, THROMB RES, V154, P84, DOI 10.1016/j.thromres.2017.04.006; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Chidiac P, 2016, METHODS, V92, P87, DOI 10.1016/j.ymeth.2015.08.011; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edelstein LC, 2014, BLOOD, V124, P3450, DOI 10.1182/blood-2014-04-572479; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Ferguson Stephen S. G., 2003, V237, P121; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; French SL, 2016, BRIT J PHARMACOL, V173, P2952, DOI 10.1111/bph.13455; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hoffmann W, 2019, ANGEW CHEM INT EDIT, V58, P8216, DOI 10.1002/anie.201813954; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Hollenberg MD, 2003, DRUG DEVELOP RES, V59, P336, DOI 10.1002/ddr.10301; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Kim BH, 2019, ACS PHARMACOL TRANSL, V2, P155, DOI 10.1021/acsptsci.8b00053; Lee H, 2015, NUCLEIC ACIDS RES, V43, pW431, DOI 10.1093/nar/gkv495; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; LIU LW, 1991, J BIOL CHEM, V266, P16977; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Miller MM, 2019, J MED CHEM, V62, P7400, DOI 10.1021/acs.jmedchem.9b00186; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Morrow DA, 2009, AM HEART J, V158, P335, DOI 10.1016/j.ahj.2009.06.027; Moschonas IC, 2017, PLATELETS, V28, P812, DOI 10.1080/09537104.2017.1282607; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ramachandran R, 2017, MOL PHARMACOL, V91, P287, DOI 10.1124/mol.116.106526; Rudinga GR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020573; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Seyedabadi M, 2019, PHARMACOL THERAPEUT, V200, P148, DOI 10.1016/j.pharmthera.2019.05.006; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tourdot BE, 2018, ARTERIOSCL THROM VAS, V38, P1632, DOI 10.1161/ATVBAHA.118.311112; Vanderboor C. M., 2019, PROTEINASE ACTIVATED, DOI [10.1101/746677, DOI 10.1101/746677]; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wilson SJ, 2018, ARTERIOSCL THROM VAS, V38, P448, DOI 10.1161/ATVBAHA.117.310104; Wong PC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5294; Woolley MJ, 2017, MOL CELL ENDOCRINOL, V449, P3, DOI 10.1016/j.mce.2016.11.023; Wu CC, 2000, BRIT J PHARMACOL, V130, P1289, DOI 10.1038/sj.bjp.0703437; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Young S. E., 2010, PROBE REPORTS NIH MO	73	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2520	2540		10.1074/jbc.RA119.011461	http://dx.doi.org/10.1074/jbc.RA119.011461			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31892516	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000517330200031
J	Zhuang, NN; Zhang, H; Li, LT; Wu, XX; Yang, C; Zhang, Y				Zhuang, Ningning; Zhang, Hao; Li, Lingting; Wu, Xiaoxian; Yang, Chen; Zhang, Yu			Crystal structures and biochemical analyses of the bacterial arginine dihydrolase ArgZ suggests a ?bond rotation? catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; nitrogen metabolism; enzyme structure; cyanobacteria; hydrolase; enzyme mechanism; arginine; arginine dihydrolase; arginine metabolism; cyanobacteria; ornithine?ammonia cycle	ENZYME; METABOLISM; PATHWAY; INTERMEDIATE; DIVERSITY; DEIMINASE; SUBSTRATE; COMPLEX	A recently discovered ornithine?ammonia cycle (OAC) serves as a conduit in the nitrogen storage and remobilization machinery in cyanobacteria. The OAC involves an arginine catabolic reaction catalyzed by the arginine dihydrolase ArgZ whose catalytic mechanism is unknown. Here we determined the crystal structures at 1.2?3.0 ? of unliganded ArgZ from the cyanobacterium Synechocystis sp. PCC6803 and of ArgZ complexed with its substrate arginine, a covalently linked reaction intermediate, or the reaction product ornithine. The structures reveal that a key residue, Asn(71), in the ArgZ active center functions as the determinant distinguishing ArgZ from other members of the guanidino group?modifying enzyme superfamily. The structures, along with biochemical evidence from enzymatic assays coupled with electrospray ionization MS techniques, further suggest that ArgZ-catalyzed conversion of arginine to ornithine, ammonia, and carbon dioxide consists of two successive cycles of amine hydrolysis. Finally, we show that arginine dihydrolases are broadly distributed among bacteria and metazoans, suggesting that the OAC may be frequently used for redistribution of nitrogen from arginine catabolism or nitrogen fixation.	[Zhuang, Ningning; Zhang, Hao; Li, Lingting; Wu, Xiaoxian; Yang, Chen; Zhang, Yu] Chinese Acad Sci, Key Lab Synthet Biol, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Zhang, Hao; Li, Lingting; Wu, Xiaoxian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, C; Zhang, Y (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.	chenyang@sibs.ac.cn; yzhang@sippe.ac.cn	Zhang, Yu/AAV-5722-2021	Zhang, Yu/0000-0002-1778-8389	National Key Research and Development Program of China [2018YFA0900700]; National Natural Science Foundation of China [31822001]; Leading Science Key Research Program of the Chinese Academy of Sciences [QYZDB-SSW-SMC005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Science Key Research Program of the Chinese Academy of Sciences	This work was supported by National Key Research and Development Program of China Grant 2018YFA0900700, National Natural Science Foundation of China Grant 31822001, and Leading Science Key Research Program of the Chinese Academy of Sciences Grant QYZDB-SSW-SMC005. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berthold CL, 2007, STRUCTURE, V15, P853, DOI 10.1016/j.str.2007.06.001; Botas A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00361; Burnat M, 2019, MOL MICROBIOL, V111, P883, DOI 10.1111/mmi.14203; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Kemper EL, 1998, EUR J BIOCHEM, V253, P720, DOI 10.1046/j.1432-1327.1998.2530720.x; Liao DI, 1998, STRUCTURE, V6, P23, DOI 10.1016/S0969-2126(98)00004-5; Linsky T, 2010, BBA-PROTEINS PROTEOM, V1804, P1943, DOI 10.1016/j.bbapap.2010.07.016; Linsky TW, 2008, CHEM BIOL, V15, P467, DOI 10.1016/j.chembiol.2008.03.012; Ma H, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13100969; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; SIMON JP, 1982, J BACTERIOL, V150, P1085, DOI 10.1128/JB.150.3.1085-1090.1982; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Stone EA, 2005, BIOCHEMISTRY-US, V44, P7069, DOI 10.1021/bi047407r; Stone EM, 2006, BIOCHEMISTRY-US, V45, P5618, DOI 10.1021/bi052595m; Tocilj A, 2005, J BIOL CHEM, V280, P15800, DOI 10.1074/jbc.M413833200; Wall LG, 2000, J PLANT GROWTH REGUL, V19, P167; Wang BH, 2015, J IND MICROBIOL BIOT, V42, P949, DOI 10.1007/s10295-015-1611-z; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wang Y, 2017, NUCLEIC ACIDS RES, V45, pW429, DOI 10.1093/nar/gkx349; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhang H, 2018, NAT CHEM BIOL, V14, P575, DOI 10.1038/s41589-018-0038-z	32	4	4	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2113	2124		10.1074/jbc.RA119.011752	http://dx.doi.org/10.1074/jbc.RA119.011752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31914412	Green Published, hybrid			2022-12-26	WOS:000517128200027
J	Lee, J; Jeon, J; Im, J; Jang, J; Lee, J; Choi, HJ; Noh, BR; Kim, KK; Cho, S				Lee, Jeongjun; Jeon, Jihyun; Im, Jaehyuk; Jang, Junhwan; Lee, Jaegun; Choi, Hee-Jung; Noh, Beom-Rae; Kim, Kyoung-Kook; Cho, Soohaeng			Quantitative analysis of adsorption and desorption of volatile organic compounds on reusable zeolite filters using gas chromatography	PLOS ONE			English	Article							REMOVAL; VOCS	In this study, we propose a method to quantitatively analyze the concentration of VOCs adsorbed on zeolite filters via gas chromatography (GC). The sampled VOCs from the filters with ethanol as a solution were characterized using GC to determine the concentration of the adsorbed VOCs by comparing the areas of GC peaks of the detected VOCs and ethanol. The proposed method also enabled determination of the desorption (regeneration) conditions of the zeolite filters according to heating temperature and time for various VOCs. Repeated adsorption and desorption of VOCs on zeolite filters and GC analyses allow us to evaluate the durability and reusability of the filter and could help predict the lifetime of zeolite filters in practice.	[Lee, Jeongjun; Jeon, Jihyun; Im, Jaehyuk; Jang, Junhwan; Lee, Jaegun; Cho, Soohaeng] Yonsei Univ, Dept Phys, Wonju, South Korea; [Choi, Hee-Jung; Noh, Beom-Rae; Kim, Kyoung-Kook] Korea Polytech Univ, Dept Nanoopt Engn, Shihung, South Korea	Yonsei University; Korea Polytechnic University	Cho, S (corresponding author), Yonsei Univ, Dept Phys, Wonju, South Korea.	shcho@yonsei.ac.kr		Cho, Soohaeng/0000-0003-0749-3891	Technology Innovation Program [10053374]; Industrial Strategic Technology Development Program [20002694]; Ministry of Trade, Industry Energy (Korea)	Technology Innovation Program; Industrial Strategic Technology Development Program; Ministry of Trade, Industry Energy (Korea)	This work was supported by the Technology Innovation Program (Grant No. 10053374) and the Industrial Strategic Technology Development Program (Grant No. 20002694) funded by the Ministry of Trade, Industry & Energy (Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldararu F, 2012, J ENVIRON MONITOR, V14, P2616, DOI 10.1039/c2em30224a; Duan F, 2015, BIORESOURCE TECHNOL, V183, P195, DOI 10.1016/j.biortech.2015.02.044; Guo H, 2004, ENVIRON RES, V94, P57, DOI 10.1016/S0013-9351(03)00035-5; Jae J, 2011, J CATAL, V279, P257, DOI 10.1016/j.jcat.2011.01.019; Kim KJ, 2012, MICROPOR MESOPOR MAT, V152, P78, DOI 10.1016/j.micromeso.2011.11.051; Kimura M, 2012, ADV FUNCT MATER, V22, P469, DOI 10.1002/adfm.201101953; Kohno H, 1998, IEEE T IND APPL, V34, P953, DOI 10.1109/28.720435; Lim JS, 2006, CHARACTERISTIC APPL; Mirji SA, 2006, COLLOID SURFACE A, V272, P220, DOI 10.1016/j.colsurfa.2005.07.019; Moghaddam S, 2018, INT J NANO DIMENS, V9, P89; Mustafa MF, 2018, J HAZARD MATER, V347, P317, DOI 10.1016/j.jhazmat.2018.01.021; Paknahad M, 2018, ANAL CHIM ACTA, V1021, P103, DOI 10.1016/j.aca.2018.03.021; Quan Y, 2018, BIORESOURCE TECHNOL, V259, P365, DOI 10.1016/j.biortech.2018.03.031; Tripathi KM, 2018, SUSTAIN MATER TECHNO, V16, P1, DOI 10.1016/j.susmat.2018.01.001; Tung TT, 2018, CARBON NANOMATERIAL; Urashima K, 2000, IEEE T DIELECT EL IN, V7, P602, DOI 10.1109/94.879356; Vercammen KLL, 1997, J ADV OXIDATION TECH, V2; Yi HH, 2018, PLASMA CHEM PLASMA P, V38, P331, DOI 10.1007/s11090-017-9863-1; Zhao XS, 1998, ENERG FUEL, V12, P1051, DOI 10.1021/ef980113s	19	1	1	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227430	10.1371/journal.pone.0227430	http://dx.doi.org/10.1371/journal.pone.0227430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914142	Green Published, gold			2022-12-26	WOS:000534337700043
J	Mbada, CE; Oguntoyinbo, OE; Fasuyi, FO; Idowu, OA; Odole, AC; Ayanniyi, O; Johnson, OE; Orimolade, EA; Oladiran, AB; Fatoye, F				Mbada, Chidozie Emmanuel; Oguntoyinbo, Oluwabunmi Esther; Fasuyi, Francis Oluwafunso; Idowu, Opeyemi Ayodiipo; Odole, Adesola Christiana; Ayanniyi, Olusola; Johnson, Olubusola Esther; Orimolade, Elkanah Ayodele; Oladiran, Ajibola Babatunde; Fatoye, Francis			Cross-cultural adaptation and psychometric evaluation of the Yoruba version of Oswestry disability index	PLOS ONE			English	Article							LOW-BACK-PAIN; OUTCOME MEASURES; PART 1; QUESTIONNAIRE; VALIDATION; RELIABILITY; VALIDITY; ASSOCIATION; CRITERIA; SCALE	Introduction Low-Back Pain (LBP) is a common public health problem that is often worsened by maladaptive beliefs and disability. Thus, necessitating the need for availability of outcome measures to assess these sequelae among patients with chronic LBP. This study aimed to cross-culturally adapt and determine the psychometric properties of the Yoruba version of the ODI (ODI-Y). Methods The ODI-Y was cross-culturally adapted following the process involving forward translation, synthesis, backward translation, expert review, and pilot testing. Internal consistency and test-retest reliability of the ODI-Y were determined using the Cronbach's alpha and intraclass correlation. Other psychometric properties explored included the factor structure, convergent validity, standard error of measurement and the minimal detectable change. Results One hundred and thirty-six patients with chronic LBP took part in the validation of the ODI-Y; 86 of these individuals took part in the test-retest reliability (within 1-week interval) of the translated instrument. The mean age of the respondents was 50.5 +/- 10.6years. The ODI-Y showed a high internal consistency, with a Cronbach's alpha (alpha) of 0.81. Test-retest of the Yoruba version of the ODI within 1-week interval yielded an Intra-Class Correlation coefficient of 0.89. The ODI-Y yielded a three-factor structure which accounted for 61.56% of the variance. Correlation of ODI-Y with the visual analogue scale was moderate (r = 0.30; p = 0.001). The standard error of measurement and minimal detectable change of the ODI-Y were 2.0 and 5.5. Conclusions The ODI was adapted into the Yoruba language and proved to have good psychometric properties that replicated the results of other obtainable versions. We recommend it for use among Yoruba speaking patients with LBP.	[Mbada, Chidozie Emmanuel; Oguntoyinbo, Oluwabunmi Esther; Johnson, Olubusola Esther] Obafemi Awolowo Univ, Dept Med Rehabil, Coll Hlth Sci, Ife, Nigeria; [Mbada, Chidozie Emmanuel; Odole, Adesola Christiana; Ayanniyi, Olusola] Univ Ibadan, Fac Clin Sci, Dept Physiotherapy, Coll Med, Ibadan, Nigeria; [Fasuyi, Francis Oluwafunso] Univ Med Sci, Fac Allied Hlth Sci, Dept Physiotherapy, Ondo, Nigeria; [Idowu, Opeyemi Ayodiipo] Univ Benin, Sch Basic Med Sci, Dept Physiotherapy, Coll Med Sci, Benin, Nigeria; [Orimolade, Elkanah Ayodele] Obafemi Awolowo Univ, Dept Orthopaed Surg & Traumatol, Coll Hlth Sci, Ife, Nigeria; [Oladiran, Ajibola Babatunde] Univ Ibadan, Dept Orthopaed Surg & Traumatol, Coll Med, Ibadan, Nigeria; [Fatoye, Francis] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Dept Hlth Profess, Manchester, Lancs, England	Obafemi Awolowo University; University of Ibadan; University of Benin; Obafemi Awolowo University; University of Ibadan; Manchester Metropolitan University	Idowu, OA (corresponding author), Univ Benin, Sch Basic Med Sci, Dept Physiotherapy, Coll Med Sci, Benin, Nigeria.	opeyemi.idowu@uniben.edu	Mbada, Chidozie/AAD-5893-2021; Idowu, Opeyemi/ABI-8135-2020	Mbada, Chidozie/0000-0003-3666-7432; Odole, Adesola/0000-0003-1517-9499; Idowu, Opeyemi Ayodiipo/0000-0003-0855-932X				Adamu AS, 2019, SPINE, V44, pE1092, DOI 10.1097/BRS.0000000000003068; Adeuyan JO, 2011, CONTRIBUTIONS YORUBA; Akinpelu A O, 2006, Afr J Med Med Sci, V35, P417; Akinpelu AO., 2009, INTERNET J ALLIED HL, V7, P13; Algarni A. S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P653, DOI 10.1016/j.rehab.2014.06.006; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Ayanniyi O, 2016, ARCH PHYSIOTHER GLOB, V20, P7; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boscainos P, 2003, CLIN ORTHOP RELAT R, V41, P40; Chiarotto A, 2016, PHYS THER, V96, P1620, DOI 10.2522/ptj.20150420; Conn DA, 2005, ANAEST INTENS CARE M, V6, P14, DOI 10.1383/anes.6.1.14.57132; Crichton N, 2001, J CLIN NURS, V10, P706; Davies CC, 2009, PHYS THER REV, V14, P399, DOI 10.1179/108331909X12540993898134; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Di Iorio A, 2007, SPINE, V32, pE809, DOI 10.1097/BRS.0b013e31815cd422; Domazet I, 2018, EUR SPINE J, V27, P2814, DOI 10.1007/s00586-018-5757-z; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fayad F., 2004, Annales de Readaptation et de Medecine Physique, V47, P179, DOI 10.1016/j.annrmp.2004.01.005; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Gabel CP, 2017, EUR SPINE J, V26, P2007, DOI 10.1007/s00586-017-5179-3; Gamus Dorit, 2016, J Back Musculoskelet Rehabil; Grabovac I, 2019, WIEN KLIN WOCHENSCHR, P1; Grotle M, 2003, J REHABIL MED, V35, P241, DOI 10.1080/16501970306094; Guermazi M., 2005, Annales de Readaptation et de Medecine Physique, V48, P1, DOI 10.1016/j.annrmp.2004.06.055; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Igwesi-Chidobe CN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216482; Kim DY, 2005, SPINE, V30, P123, DOI 10.1097/01.brs.0000148999.21492.53; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Lauridsen HH, 2006, EUR SPINE J, V15, P1705, DOI 10.1007/s00586-006-0117-9; Le May S, 2018, PAIN, P1; Lue YJ, 2008, SPINE, V33, P2354, DOI 10.1097/BRS.0b013e31818018d8; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Marco M, 2009, SPINE, V34, P2090, DOI [10.1097/BRS.0b013e3181aa1e6b, DOI 10.1097/BRS.0B013E3181AA1E6B]; Maughan EF, 2010, EUR SPINE J, V19, P1484, DOI 10.1007/s00586-010-1353-6; Mbada CE, 2017, SPINE, V42, P497, DOI 10.1097/BRS.0000000000001899; Miekisiak G, 2013, SPINE, V38, pE237, DOI 10.1097/BRS.0b013e31827e948b; Mousavi SJ, 2006, SPINE, V31, pE454, DOI 10.1097/01.brs.0000222141.61424.f7; Muller U, 2004, EUR SPINE J, V13, P301, DOI 10.1007/s00586-003-0665-1; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Payares K, 2011, SPINE, V36, pE1730, DOI 10.1097/BRS.0b013e318219d184; Pekkanen L, 2011, SPINE, V36, P332, DOI 10.1097/BRS.0b013e3181cdd702; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Salvetti MD, 2012, REV ESC ENFERM USP, V46, P16; Shah S, 2017, J BACK MUSCULOSKELET, V30, P1103, DOI 10.3233/BMR-169728; Stevens Matthew L, 2016, J Physiother, V62, P116, DOI 10.1016/j.jphys.2015.10.003; Sullivan MJL, 2013, HDB WORK DISABILITY; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P219, DOI 10.1177/875647939000600404; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; Turner JA, 2004, PAIN, V112, P307, DOI 10.1016/j.pain.2004.09.010; Valasek T, 2013, EUR SPINE J, V22, P1010, DOI 10.1007/s00586-012-2645-9; Vianin M, 2008, J CHIROPR MED, V7, P161, DOI 10.1016/j.jcm.2008.07.001; Vigatto R, 2007, SPINE, V32, P481, DOI 10.1097/01.brs.0000255075.11496.47; Vincent Joshua Israel, 2014, Open Orthop J, V8, P11, DOI 10.2174/1874325001408010011; Yakut E, 2004, SPINE, V29, P581, DOI 10.1097/01.BRS.0000113869.13209.03; Yao M, 2016, SPINE, V41, pE1470, DOI 10.1097/BRS.0000000000001891; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079	60	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0221138	10.1371/journal.pone.0221138	http://dx.doi.org/10.1371/journal.pone.0221138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914157	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000534337700002
J	Lamp, K; McGovern, S; Fong, Y; Atem, CD; Nfetam, JBE; Nzuobontane, D; Bollinger, T; Jani, I; Sitoe, N; Kiyaga, C; Senyama, G; Mangwendeza, PM; Mtapuri-Zinyowera, S; Doi, N; Peter, T; Sacks, JA; Vojnovi, L				Lamp, Katherine; McGovern, Seth; Fong, Youyi; Atem, Charles Diko; Nfetam, Jean Bosco Elat; Nzuobontane, Divine; Bollinger, Timothy; Jani, Ilesh; Sitoe, Nadia; Kiyaga, Charles; Senyama, George; Mangwendeza, Phibeon M.; Mtapuri-Zinyowera, Sekesai; Doi, Naoko; Peter, Trevor; Sacks, Jilian A.; Vojnovi, Lara			Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; INFECTED ADULTS; MORTALITY; PEOPLE	Background Globally, nearly 22 million HIV-infected patients are currently accessing antiretroviral treatment; however, almost one million people living with HIV died of AIDS-related illnesses in 2018. Advanced HIV disease remains a significant issue to curb HIV-related mortality. Methods We analyzed 864,389 CD4 testing records collected by 1,016 Alere Pima Analyzers implemented at a variety of facilities, including peripheral facilities, between January 2012 and December 2016 across four countries in sub-Saharan Africa. Routinely collected data and programmatic records were used to analyze the median CD4 counts and proportions of patients with advanced HIV disease by country, facility type, and year. Results Median CD4 counts were between 409-444 cells/ul each year since 2012 with a median in 2016 of 444 cells/ul (n = 319,829). The proportion of test results returning CD4 counts above 500 cells/ul has increased slowly each year with 41.8% (95% CI: 41.6-41.9%) of tests having a CD4 count above 500 cells/ul in 2016. Median CD4 counts were similar across facility types. The proportion of test results indicating advanced HIV disease has remained fairly consistent: 19.4% (95% CI: 18.8-20.1%) in 2012 compared to 16.1% (95% CI: 16.0-16.3%) in 2016. The proportion of test results indicating advanced HIV disease annually ranged from 14.5% in Uganda to 29.8% in Cameroon. 6.9% (95% CI: 6.8-7.0%) of test results showed very advanced HIV disease (CD4<100 cells/ul) in 2016. Conclusions The proportion of CD4 test results indicating advanced disease was relatively high and consistent across four high HIV burden countries.	[Lamp, Katherine; McGovern, Seth; Doi, Naoko; Peter, Trevor; Sacks, Jilian A.; Vojnovi, Lara] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Fong, Youyi] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Atem, Charles Diko; Nzuobontane, Divine] Clinton Hlth Access Initiat, Yaounde, Cameroon; [Nfetam, Jean Bosco Elat] Natl AIDS Control Comm, Yaounde, Cameroon; [Bollinger, Timothy] Clinton Hlth Access Initiat, Maputo, Mozambique; [Jani, Ilesh; Sitoe, Nadia] Inst Nacl Saude, Maputo, Mozambique; [Kiyaga, Charles] Cent Publ Hlth Lab, Kampala, Uganda; [Senyama, George] Clinton Hlth Access Initiat, Kampala, Uganda; [Mangwendeza, Phibeon M.] Clinton Hlth Access Initiat, Harare, Zimbabwe; [Mtapuri-Zinyowera, Sekesai] Minist Hlth & Child Care, Harare, Zimbabwe	Fred Hutchinson Cancer Center	Vojnovi, L (corresponding author), Clinton Hlth Access Initiat, Boston, MA 02127 USA.	lvojnov.IC@clintonhealthaccess.org		Sitoe, Nadia/0000-0001-7310-8221; Vojnov, Lara/0000-0003-0488-1012	DFID [300380]	DFID	The DFID grant (#300380) was awarded to all authors of the Clinton Health Access Initiative. The Unitaid grant also, but the grant number unknown.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg N, 2018, CLIN INFECT DIS, V66, P893, DOI 10.1093/cid/cix915; Calmy A, 2018, CLIN INFECT DIS, V66, pS103, DOI 10.1093/cid/cix1138; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Clinton Health Access Initiative, 2018 HIV MARK REP; Doherty M, 2018, 22 INT AIDS C AMST N; Ford N, 2018, CLIN INFECT DIS, V66, pS106, DOI 10.1093/cid/cix1139; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Habiyambere V, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002088; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Low A, 2016, CLIN INFECT DIS, V62, P1595, DOI 10.1093/cid/ciw125; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Osler M, 2018, CLIN INFECT DIS, V66, pS118, DOI 10.1093/cid/cix1140; Ousley J, 2018, CLIN INFECT DIS, V66, pS126, DOI 10.1093/cid/ciy103; Post FA, 2018, CLIN INFECT DIS, V66, pS132, DOI 10.1093/cid/cix1141; UNAIDS, 2018, GLOB AIDS UPD 2018 M; Unitaid, 2015, HIV AIDS DIAGN LANDS; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization, 2016, CONS GUID US ANT TRE; World Health Organization, 2017, HIV TREAT CARE; World Health Organization, 2018, UPD REC 1 LIN 2 LIN	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226987	10.1371/journal.pone.0226987	http://dx.doi.org/10.1371/journal.pone.0226987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910221	Green Published, gold			2022-12-26	WOS:000534333800022
J	Kubesch, A; Boulahrout, P; Filmann, N; Blumenstein, I; Hausmann, J				Kubesch, Alica; Boulahrout, Patric; Filmann, Natalie; Blumenstein, Irina; Hausmann, Johannes			Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; SICK LEAVE; ATTENDANCE; ADHERENCE; IMPACT; RISK	To date, there is insufficient insight into inflammatory bowel disease (IBD)-associated stress, recognized disability, and contact with the social care system. We aimed to assess these parameters in IBD patients and a non-IBD control group, who were invited to participate in an online survey developed specifically for this study (www.soscisurvey.de) with the help of IBD patients. 505 IBD patients and 166 volunteers (i.e., control group) participated in the survey. IBD patients reported significantly increased levels of stress within the last six months and five years (p<0.0001) and were more likely to have a recognized disability (p<0.0001). A low academic status was the strongest indicator of a disability (p = 0.006). Only 153 IBD patients (30.3%) reported contact with the social care system, and a disability was the strongest indicator for this (p<0.0001). Our study provides data on stress and disability in a large unselected German IBD cohort. We showed that patients with IBD suffer more often from emotional stress and more often have a recognized disability. As only about 1/3 of the patients had come into contact with the social care system and the corresponding support, this patient group is undersupplied in this area.	[Kubesch, Alica; Blumenstein, Irina; Hausmann, Johannes] Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Boulahrout, Patric] Frankfurt Univ Appl Sci, Dept Social Work & Hlth 4, Frankfurt, Germany; [Filmann, Natalie] Goethe Univ Hosp, Inst Biostat & Math Modeling, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Hausmann, J (corresponding author), Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	Johannes.Hausmann@kgu.de	Blumenstein, Irina/AGG-9266-2022	Filmann, Natalie/0000-0003-0424-2317				Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Assa A, 2015, J PEDIATR GASTR NUTR, V61, P553, DOI 10.1097/MPG.0000000000000850; Belfer I, 2017, AGRI, V29, P51, DOI 10.5505/agri.2017.87369; Busch K, 2014, J CROHNS COLITIS, V8, P1362, DOI 10.1016/j.crohns.2014.06.006; Carreon SA, 2018, INFLAMM BOWEL DIS, V24, P1624, DOI 10.1093/ibd/izy026; Choi K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050654; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Freckmann M, 2018, BMJ OPEN GASTROENTER, V5, DOI 10.1136/bmjgast-2018-000236; Ghosh S, 2007, J CROHNS COLITIS, V1, P10, DOI 10.1016/j.crohns.2007.06.005; Haapamaki J, 2010, QUAL LIFE RES, V19, P919, DOI 10.1007/s11136-010-9650-4; Helbig S, 2017, PHYSIOL BEHAV, V179, P67, DOI 10.1016/j.physbeh.2017.05.027; Hoivik ML, 2013, GUT, V62, P368, DOI 10.1136/gutjnl-2012-302311; Hommel KA, 2010, J PEDIATR PSYCHOL, V35, P1005, DOI 10.1093/jpepsy/jsp126; Irvine EJ, 2008, INFLAMM BOWEL DIS, V14, P554, DOI 10.1002/ibd.20301; Lewis K, 2019, INFLAMM BOWEL DIS, V25, P1674, DOI 10.1093/ibd/izz045; Lonnfors S, 2014, J CROHNS COLITIS, V8, P1281, DOI 10.1016/j.crohns.2014.03.005; Louis E, 2015, J CROHNS COLITIS, V9, P685, DOI 10.1093/ecco-jcc/jjv085; Mackner LM, 2012, J DEV BEHAV PEDIATR, V33, P106, DOI 10.1097/DBP.0b013e318240cf68; Muller KR, 2010, INFLAMM BOWEL DIS, V16, P657, DOI 10.1002/ibd.21090; Plevinsky JM, 2016, CLIN EXP GASTROENTER, V9, DOI 10.2147/CEG.S106302; Ramos A, 2015, UNITED EUR GASTROENT, V3, P335, DOI 10.1177/2050640615577532; Romberg-Camps MJL, 2010, INFLAMM BOWEL DIS, V16, P2137, DOI 10.1002/ibd.21285; Rubin DT, 2010, DIGEST DIS SCI, V55, P1044, DOI 10.1007/s10620-009-0953-7; Sainsbury A, 2005, ALIMENT PHARM THER, V21, P499, DOI 10.1111/j.1365-2036.2005.02380.x; Sellin J, 2010, INFLAMM BOWEL DIS, V16, P23, DOI 10.1002/ibd.21014; Spekhorst LM, 2017, WORLD J GASTROENTERO, V23, P8182, DOI 10.3748/wjg.v23.i46.8182; Stjernman H, 2010, SCAND J GASTROENTERO, V45, P696, DOI 10.3109/00365521003734141; Taft TH, 2016, CLIN EXP GASTROENTER, V9, P49, DOI 10.2147/CEG.S83533; van den Brink G, 2018, ALIMENT PHARM THER, V48, P358, DOI 10.1111/apt.14832; van der Eijk I, 2004, INFLAMM BOWEL DIS, V10, P392, DOI 10.1097/00054725-200407000-00010; Vester-Andersen MK, 2015, INFLAMM BOWEL DIS, V21, P2296, DOI 10.1097/MIB.0000000000000493; WHO, 2001, WHO INT CLASS FUNCT	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227309	10.1371/journal.pone.0227309	http://dx.doi.org/10.1371/journal.pone.0227309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4XM	31899780	Green Published, gold			2022-12-26	WOS:000534322000019
J	Poddighe, D; Turganbekova, A; Baymukasheva, D; Saduakas, Z; Zhanzakova, Z; Abdrakhmanova, S				Poddighe, Dimitri; Turganbekova, Aida; Baymukasheva, Dana; Saduakas, Zhazira; Zhanzakova, Zhuldyz; Abdrakhmanova, Saniya			Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia	PLOS ONE			English	Article							HLA-DQ; RISK	Background Celiac disease (CD) is a systemic immune-mediated disorder developing in HLA genetically predisposed individuals carrying HLA-DQ2 and/or HLA-DQ8 molecules. Recent evidences supported a predominant importance of HLA-DQB1 locus and, in particular, HLA-DQB1* 02 alleles. This diagnosis is poorly considered in Kazakhstan, because of the assumption that CD is not prevalent in this population. Objective To demonstrate that the genetic predisposition to CD in Kazakhstan is not negligible and is actually comparable to Western populations. Methods Through the analysis of HLA-DQ genotypes of healthy bone marrow donors from Kazakhstan's national registry, we estimated the HLA-related genetic predisposition to CD in the country. Results We demonstrated that the frequency of CD-related HLA-DQB1 alleles and, as a consequence, of predisposed individuals to CD in Kazakhstan is significant and comparable to countries with the highest disease prevalence. Conclusion Considering the dietary style in Kazakhstan, including wheat as a staple food, these results provided a preliminary background of knowledge to expect a significant CD prevalence in Kazakhstan and Central Asia by implementing appropriate and cost-effective diagnostic strategies.	[Poddighe, Dimitri] Nazarbayev Univ, Sch Med, Dept Med, Nur Sultan City, Kazakhstan; [Turganbekova, Aida; Baymukasheva, Dana; Saduakas, Zhazira; Zhanzakova, Zhuldyz; Abdrakhmanova, Saniya] Minist Hlth Republ Kazakhstan, RSE REM Res & Prod Ctr Transfus, Nur Sultan City, Kazakhstan	Nazarbayev University	Poddighe, D (corresponding author), Nazarbayev Univ, Sch Med, Dept Med, Nur Sultan City, Kazakhstan.	dimitri.poddighe@nu.edu.kz	Abdrakhmanova, Saniya/AAB-2533-2020; Poddighe, Dimitri/AAI-5712-2020; Abdrakhmanova, Saniya/I-3942-2018	Abdrakhmanova, Saniya/0000-0003-0782-1795; Poddighe, Dimitri/0000-0001-6431-9334; Abdrakhmanova, Saniya/0000-0003-0782-1795				Al-Hussaini A, 2018, SAUDI J GASTROENTERO, V24, P268, DOI 10.4103/sjg.SJG_551_17; Blasczyk R., 2003, J LAB MED, V27, P359; Capittini C, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050190; Catassi C, 2018, SAUDI J GASTROENTERO, V24, P257, DOI 10.4103/sjg.SJG_388_18; De Silvestri A, 2018, PEDIATR RES, V83, P564, DOI 10.1038/pr.2017.307; Kuranov AB, 2014, TISSUE ANTIGENS, V83, P106, DOI 10.1111/tan.12279; Kuranov AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115265; Lebwohl B, 2018, LANCET, V391, P70, DOI 10.1016/S0140-6736(17)31796-8; Lindfors K, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-018-0054-z; Makharia GK, 2019, GASTROENTEROL CLIN N, V48, P101, DOI 10.1016/j.gtc.2018.09.007; Megiorni F, 2009, HUM IMMUNOL, V70, P55, DOI 10.1016/j.humimm.2008.10.018; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Moore E, 2018, HUM IMMUNOL, V79, P821, DOI 10.1016/j.humimm.2018.09.008; Pietzak MM, 2009, CLIN GASTROENTEROL H, V7, P966, DOI 10.1016/j.cgh.2009.05.028; Poddighe D, 2019, INT J IMMUNOGENET, V46, P342, DOI 10.1111/iji.12441; Poddighe D, 2019, INT J IMMUNOGENET, V46, P274, DOI 10.1111/iji.12427; Poddighe D, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55010011; Poddighe D, 2018, EUR J PEDIATR, V177, P1871, DOI 10.1007/s00431-018-3251-6; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rostami Nejad M, 2011, Middle East J Dig Dis, V3, P5; Singh P, 2018, CLIN GASTROENTEROL H, V16, P823, DOI 10.1016/j.cgh.2017.06.037; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01	22	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226546	10.1371/journal.pone.0226546	http://dx.doi.org/10.1371/journal.pone.0226546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895924	Green Published, gold			2022-12-26	WOS:000534267300006
J	Jacobs, DT; Allard, BA; Pottorf, TS; Silva, LM; Wang, W; Al-Naamani, A; Agborbesong, E; Wang, T; Carr, DA; Tran, PV				Jacobs, Damon T.; Allard, Bailey A.; Pottorf, Tana S.; Silva, Luciane M.; Wang, Wei; Al-Naamani, Aisha; Agborbesong, Ewud; Wang, Tao; Carr, Dajanae A.; Tran, Pamela V.			Intraflagellar-transport A dysfunction causes hyperphagia-induced systemic insulin resistance in a pre-obese state	FASEB JOURNAL			English	Article						adipogenesis; liver; metabolism; mouse model; primary cilia	BIEDL SYNDROME PROTEINS; IFT-A COMPLEX; PRIMARY-CILIUM; OBESITY; DIFFERENTIATION; ADIPOGENESIS; BBSOME; TRAFFICKING; MUTATION; DISEASE	Deletion of murine Thm1, an intraflagellar transport A (IFT-A) component that mediates ciliary protein trafficking, causes hyperphagia, obesity, and metabolic syndrome. The role of Thm1 or IFT-A in adipogenesis and insulin sensitivity is unknown. Here, we report that Thm1 knockdown in 3T3-L1 pre-adipocytes promotes adipogenesis and enhances insulin sensitivity in vitro. Yet, pre-obese Thm1 conditional knockout mice show systemic insulin resistance. While insulin-induced AKT activation in Thm1 mutant adipose depots and skeletal muscle are similar to those of control littermates, an attenuated insulin response arises in the mutant liver. Insulin treatment of control and Thm1 mutant primary hepatocytes results in similar AKT activation. Moreover, pair-feeding Thm1 conditional knockout mice produces a normal insulin response, both in the liver and systemically. Thus, hyperphagia caused by a cilia defect, induces hepatic insulin resistance via a non-cell autonomous mechanism. In turn, hepatic insulin resistance drives systemic insulin resistance prior to an obese phenotype. These data demonstrate that insulin signaling across cell types is regulated differentially, and that the liver is particularly susceptible to hyperphagia-induced insulin resistance and a critical determinant of systemic insulin resistance.	[Jacobs, Damon T.; Allard, Bailey A.; Pottorf, Tana S.; Silva, Luciane M.; Wang, Wei; Al-Naamani, Aisha; Agborbesong, Ewud; Wang, Tao; Carr, Dajanae A.; Tran, Pamela V.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Tran, PV (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA.; Tran, PV (corresponding author), Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA.	ptran@kumc.edu	Pottorf, Tana/AAP-2801-2021	Pottorf, Tana/0000-0001-9410-6110; Wang, Tao/0000-0003-4832-1148	Department of Education, GEAR-UP Washington Cluster [DED0068469]; HHS | National Institutes of Health (NIH) [P20GM103418, P30DK106912, R01DK103033, P30GM118247]	Department of Education, GEAR-UP Washington Cluster; HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Department of Education, GEAR-UP Washington Cluster, Grant/Award Number: DED0068469; HHS | National Institutes of Health (NIH), Grant/Award Number: P20GM103418, P30DK106912, R01DK103033 and P30GM118247	Benzinou M, 2006, DIABETES, V55, P2876, DOI 10.2337/db06-0337; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Fu WX, 2016, CELL REP, V17, P1505, DOI 10.1016/j.celrep.2016.10.018; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; Jacobs DT, 2016, DIS MODEL MECH, V9, P789, DOI 10.1242/dmm.025791; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Machado MV, 2018, J HEPATOL, V68, P550, DOI 10.1016/j.jhep.2017.10.017; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Melvin A, 2018, CURR OPIN GENET DEV, V50, P60, DOI 10.1016/j.gde.2018.02.002; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; Ritter A, 2018, STEM CELL REP, V10, P583, DOI 10.1016/j.stemcr.2017.12.022; Scheidecker S, 2014, J MED GENET, V51, P132, DOI 10.1136/jmedgenet-2013-101785; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Starks RD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005311; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Xu QW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11855; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	41	1	1	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					148	160		10.1096/fj.201900751R	http://dx.doi.org/10.1096/fj.201900751R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914634	Green Accepted			2022-12-26	WOS:000507308900012
J	Jang, HJ; Lim, S; Kim, JM; Yoon, S; Lee, CY; Hwang, HJ; Shin, JW; Shin, KJ; Kim, HY; Park, KI; Nam, D; Lee, JY; Yea, K; Hirabayashi, Y; Lee, YJ; Chae, YC; Suh, PG; Choi, JH				Jang, Hyun-Jun; Lim, Seyoung; Kim, Jung-Min; Yoon, Sora; Lee, Chae Young; Hwang, Hyeon-Jeong; Shin, Jeong Woo; Shin, Kyeong Jin; Kim, Hye Yun; Park, Kwang Il; Nam, Dougu; Lee, Ja Yil; Yea, Kyungmoo; Hirabayashi, Yoshio; Lee, Yu Jin; Chae, Young Chan; Suh, Pann-Ghill; Choi, Jang Hyun			Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPAR gamma with GlcCer	FASEB JOURNAL			English	Article						adipogenesis; glucosylceramide; glucosylceramide synthase; mesenchymal stem cells; osteogenesis; PDMP; peroxisome proliferator-activated receptor gamma	GAUCHER-DISEASE; FATE DECISION; CELLS; INHIBITION; METABOLISM; OSTEOBLAST; CERAMIDE; MARKERS; MOUSE	Dysregulation of the adipo-osteogenic differentiation balance of mesenchymal stem cells (MSCs), which are common progenitor cells of adipocytes and osteoblasts, has been associated with many pathophysiologic diseases, such as obesity, osteopenia, and osteoporosis. Growing evidence suggests that lipid metabolism is crucial for maintaining stem cell homeostasis and cell differentiation; however, the detailed underlying mechanisms are largely unknown. Here, we demonstrate that glucosylceramide (GlcCer) and its synthase, glucosylceramide synthase (GCS), are key determinants of MSC differentiation into adipocytes or osteoblasts. GCS expression was increased during adipogenesis and decreased during osteogenesis. Targeting GCS using RNA interference or a chemical inhibitor enhanced osteogenesis and inhibited adipogenesis by controlling the transcriptional activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). Treatment with GlcCer sufficiently rescued adipogenesis and inhibited osteogenesis in GCS knockdown MSCs. Mechanistically, GlcCer interacted directly with PPAR gamma through A/B domain and synergistically enhanced rosiglitazone-induced PPAR gamma activation without changing PPAR gamma expression, thereby treatment with exogenous GlcCer increased adipogenesis and inhibited osteogenesis. Animal studies demonstrated that inhibiting GCS reduced adipocyte formation in white adipose tissues under normal chow diet and high-fat diet feeding and accelerated bone repair in a calvarial defect model. Taken together, our findings identify a novel lipid metabolic regulator for the control of MSC differentiation and may have important therapeutic implications.	[Jang, Hyun-Jun; Lim, Seyoung; Kim, Jung-Min; Yoon, Sora; Lee, Chae Young; Hwang, Hyeon-Jeong; Shin, Jeong Woo; Shin, Kyeong Jin; Kim, Hye Yun; Nam, Dougu; Lee, Ja Yil; Lee, Yu Jin; Chae, Young Chan; Suh, Pann-Ghill; Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Park, Kwang Il] Korea Inst Oriental Med, Korean Med KM Applicat Ctr, Daegu, South Korea; [Yea, Kyungmoo] DGIST, Dept New Biol, Daegu, South Korea; [Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Hirabayashi Res Unit, Wako, Saitama, Japan	Ulsan National Institute of Science & Technology (UNIST); Korea Institute of Oriental Medicine (KIOM); Daegu Gyeongbuk Institute of Science & Technology (DGIST); RIKEN	Suh, PG; Choi, JH (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.	pgsuh@unist.ac.kr; janghchoi@unist.ac.kr	Kim, Jung Min/AAL-8604-2021; Nam, Dougu/AAC-7173-2019; Nam, Dougu/F-5057-2010	Kim, Jung Min/0000-0002-9072-4293; Nam, Dougu/0000-0003-0239-2899; Yoon, Sora/0000-0002-0107-0057; Hirabayashi, Yoshio/0000-0002-5774-7354	Korea Mouse Phenotyping Project [2016M3A9D5A01952411]; Ministry of Science and ICT through the National Research Foundation (NRF); Bio AMP; Medical Technology Development Program of the NRF [2014M3A9D8034459, 2017R1A2B2007378]	Korea Mouse Phenotyping Project; Ministry of Science and ICT through the National Research Foundation (NRF); Bio AMP; Medical Technology Development Program of the NRF	This work was supported by Korea Mouse Phenotyping Project (NO. 2016M3A9D5A01952411) of the Ministry of Science and ICT through the National Research Foundation (NRF) and Bio & Medical Technology Development Program of the NRF (NO. 2014M3A9D8034459, 2017R1A2B2007378).	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bergante S, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4706943; Bergante S, 2014, J LIPID RES, V55, P549, DOI 10.1194/jlr.M046672; Bondar C, 2017, BONE, V103, P262, DOI 10.1016/j.bone.2017.07.020; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Choi JS, 2015, CELL SIGNAL, V27, P614, DOI 10.1016/j.cellsig.2014.11.035; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Deegan PB, 2011, MEDICINE, V90, P52, DOI 10.1097/MD.0b013e3182057be4; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Ersek A, 2015, J CLIN INVEST, V125, P2279, DOI 10.1172/JCI59987; Ficicioglu Can, 2008, Ther Clin Risk Manag, V4, P425; Futerman AH, 2017, MOL GENET METAB, V120, P22, DOI 10.1016/j.ymgme.2016.11.390; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Hagberg CE, 2018, CELL REP, V24, P2746, DOI 10.1016/j.celrep.2018.08.006; Hu LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020360; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Lacava G, 2019, J CELL PHYSIOL, V234, P16338, DOI 10.1002/jcp.28299; Lee SY, 2017, DIABETES, V66, P2596, DOI 10.2337/db16-1232; Levental KR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1193; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Lim S, 2012, J CELL BIOCHEM, V113, P3436, DOI 10.1002/jcb.24220; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marycz K, 2015, CELL MOL BIOL LETT, V20, P510, DOI 10.1515/cmble-2015-0029; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mikosch P, 2011, BEST PRACT RES CL RH, V25, P665, DOI 10.1016/j.berh.2011.10.015; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Norris-Cervetto E, 2004, J BIOL CHEM, V279, P40412, DOI 10.1074/jbc.M404466200; Nuttall ME, 2014, CALCIFIED TISSUE INT, V94, P78, DOI 10.1007/s00223-013-9807-6; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Picke AK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6806; Rocca-Serra P, 2003, CR BIOL, V326, P1075, DOI 10.1016/j.crvi.2003.09.026; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; STOWENS DW, 1985, MEDICINE, V64, P310, DOI 10.1097/00005792-198509000-00003; van Dussen L, 2011, J CLIN ENDOCR METAB, V96, P2194, DOI 10.1210/jc.2011-0162; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; van Zoelen EJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0375-3; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zhu HH, 2015, GENE DEV, V29, P1218, DOI 10.1101/gad.263483.115	45	6	6	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1270	1287		10.1096/fj.201901437R	http://dx.doi.org/10.1096/fj.201901437R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914593				2022-12-26	WOS:000507308900085
J	Kl'uckova, K; Thakker, A; Vettore, L; Escribano-Gonzalez, C; Hindshaw, RL; Tearle, JLE; Goncalves, J; Kaul, B; Lavery, GG; Favier, J; Tennant, DA				Kl'uckova, Katarina; Thakker, Alpesh; Vettore, Lisa; Escribano-Gonzalez, Cristina; Hindshaw, Rebecca L.; Tearle, Jacqueline L. E.; Goncalves, Judith; Kaul, Baksho; Lavery, Gareth G.; Favier, Judith; Tennant, Daniel A.			Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase function	FASEB JOURNAL			English	Article						electron transport chain; metabolism; mitochondria; pheochromocytoma; succinate dehydrogenase	RESPIRATORY-CHAIN; SDH MUTATIONS; COMPLEX-II; GENE; PHEOCHROMOCYTOMA; PHENOTYPE; MUSCLE	Mutations in succinate dehydrogenase (SDH) lead to the development of tumors in a restricted subset of cell types, including chromaffin cells and paraganglia. The molecular basis for this specificity is currently unknown. We show that loss of SDH activity in a chromaffin cell model does not perturb complex I function, retaining the ability to oxidize NADH within the electron transport chain. This activity supports continued oxidation of substrates within the tricarboxylic acid (TCA) cycle. However, due to the block in the TCA cycle at SDH, the high glutamine oxidation activity is only maintained through an efflux of succinate. We also show that although the mitochondria of SDH-deficient cells are less active per se, their higher mass per cell results in an overall respiratory rate that is comparable with wild-type cells. Finally, we observed that when their mitochondria are uncoupled, SDH-deficient cells are unable to preserve their viability, suggesting that the mitochondrial metabolic network is unable to compensate when exposed to additional stress. We therefore show that in contrast to models of SDH deficiency based on epithelial cells, a chromaffin cell model retains aspects of metabolic "health," which could form the basis of cell specificity of this rare tumor type.	[Kl'uckova, Katarina; Thakker, Alpesh; Vettore, Lisa; Escribano-Gonzalez, Cristina; Hindshaw, Rebecca L.; Tearle, Jacqueline L. E.; Kaul, Baksho; Lavery, Gareth G.; Tennant, Daniel A.] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Goncalves, Judith; Favier, Judith] Univ Paris, PARCC, INSERM, Equipe Labellisee Ligue Canc, Paris, France; [Kl'uckova, Katarina] Queen Mary Univ London, Barts Canc Inst, London, England; [Tearle, Jacqueline L. E.] UNSW, Lowy Canc Res Ctr, Sch Med Sci, EMBL Australia Single Mol Sci, Sydney, NSW, Australia	University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; University of New South Wales Sydney	Tennant, DA (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.; Favier, J (corresponding author), Hop Europeen Georges Pompidou, PARCC, 56 Rue Leblanc, F-75015 Paris, France.	judith.favier@inserm.fr; d.tennant@bham.ac.uk	Kluckova, Katarina/ABF-2155-2020; Tennant, Daniel/ABE-8145-2021; Thakker, Alpesh/K-8529-2017; Favier, Judith/M-7601-2017	Tennant, Daniel/0000-0003-0499-2732; Thakker, Alpesh/0000-0003-3901-0479; Favier, Judith/0000-0001-8190-5853; Escribano-Gonzalez, Cristina/0000-0001-8696-6049; Tearle, Jacqueline/0000-0001-7464-6187; Vettore, Lisa A./0000-0001-8396-5358; Lavery, Gareth/0000-0001-5794-748X	Paradifference Foundation; Cancer Research UK [C42109/A26982, C42109/A24891]; Wellcome Trust [104612/Z/14/Z]	Paradifference Foundation; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank Professor Mark Viant and Dr Stefan Schade for the use and assistance with the CASY cell counter. We thank Professors Ed Rainger and David Hodson and Mr Nick Fine for kindly providing reagents. KK, AT, and JG are supported by the Paradifference Foundation, LV, CEG, and BK are supported by Cancer Research UK (C42109/A26982 and C42109/A24891) and GGL holds a Wellcome Trust Senior Fellowship (104612/Z/14/Z).	Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Ben Aim L, 2019, J MED GENET, V56, P513, DOI 10.1136/jmedgenet-2018-105714; Bezawork-Geleta A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04603-z; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Christen S, 2016, CELL REP, V17, P837, DOI 10.1016/j.celrep.2016.09.042; D'Antongiovanni V, 2017, ENDOCR-RELAT CANCER, V24, P555, DOI 10.1530/ERC-17-0212; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GARLICK PB, 1979, BIOCHEM J, V184, P547, DOI 10.1042/bj1840547; Housley SL, 2010, HISTOPATHOLOGY, V56, P405, DOI 10.1111/j.1365-2559.2010.03482.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Laurenti G, 2016, BIOCHEM SOC T, V44, P1111, DOI 10.1042/BST20160099; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lorendeau D, 2017, METAB ENG, V43, P187, DOI 10.1016/j.ymben.2016.11.005; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Nonnenmacher Y, 2017, METAB ENG, V43, P147, DOI 10.1016/j.ymben.2016.12.005; Pang Y, 2018, CLIN CANCER RES, V24, P3423, DOI 10.1158/1078-0432.CCR-17-3406; ROUSLIN W, 1983, J BIOL CHEM, V258, P9657; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Szarek E, 2015, ENDOCR-RELAT CANCER, V22, P345, DOI 10.1530/ERC-15-0069	27	13	13	6	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					303	315		10.1096/fj.201901456R	http://dx.doi.org/10.1096/fj.201901456R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914648	Green Published, hybrid			2022-12-26	WOS:000507308900022
J	Watanabe, H; Higashimoto, K; Miyake, N; Morita, S; Horii, T; Kimura, M; Suzuki, T; Maeda, T; Hidaka, H; Aoki, S; Yatsuki, H; Okamoto, N; Uemura, T; Hatada, I; Matsumoto, N; Soejima, H				Watanabe, Hidetaka; Higashimoto, Ken; Miyake, Noriko; Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Suzuki, Takayuki; Maeda, Toshiyuki; Hidaka, Hidenori; Aoki, Saori; Yatsuki, Hitomi; Okamoto, Nobuhiko; Uemura, Tetsuji; Hatada, Izuho; Matsumoto, Naomichi; Soejima, Hidenobu			DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer	FASEB JOURNAL			English	Article						Beckwith-Wiedemann syndrome; epigenome editing; genomic imprinting; histone modifications; NSD1	BECKWITH-WIEDEMANN-SYNDROME; TEMPLE SYNDROME; OVERGROWTH SYNDROME; NSD1 MUTATIONS; HISTONE 3; METHYLTRANSFERASE; DNMT3A; GROWTH; MOUSE; IDENTIFICATION	Haploinsufficiency of NSD1, which dimethylates histone H3 lysine 36 (H3K36), causes Sotos syndrome (SoS), an overgrowth syndrome. DNMT3A and DNMT3B recognizes H3K36 trimethylation (H3K36me3) through PWWP domain to exert de novo DNA methyltransferase activity and establish imprinted differentially methylated regions (DMRs). Since decrease of H3K36me3 and genome-wide DNA hypomethylation in SoS were observed, hypomethylation of imprinted DMRs in SoS was suggested. We explored DNA methylation status of 28 imprinted DMRs in 31 SoS patients with NSD1 defect and found that hypomethylation of IGF2-DMR0 and IG-DMR in a substantial proportion of SoS patients. Luciferase assay revealed that IGF2-DMR0 enhanced transcription from the IGF2 P0 promoter but not the P3 and P4 promoters. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) revealed active enhancer histone modifications at IGF2-DMR0, with high enrichment of H3K4me1 and H3 lysine 27 acetylation (H3K27ac). CRISPR-Cas9 epigenome editing revealed that specifically induced hypomethylation at IGF2-DMR0 increased transcription from the P0 promoter but not the P3 and P4 promoters. NSD1 knockdown suggested that NSD1 targeted IGF2-DMR0; however, IGF2-DMR0 DNA methylation and IGF2 expression were unaltered. This study could elucidate the function of IGF2-DMR0 as a DNA methylation dependent, P0 promoter-specific enhancer. NSD1 may play a role in the establishment or maintenance of IGF2-DMR0 methylation during the postimplantation period.	[Watanabe, Hidetaka; Higashimoto, Ken; Aoki, Saori; Yatsuki, Hitomi; Soejima, Hidenobu] Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Watanabe, Hidetaka; Uemura, Tetsuji] Saga Univ Hosp, Dept Plast & Reconstruct Surg, Saga, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan; [Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma, Japan; [Suzuki, Takayuki] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Maeda, Toshiyuki] Saga Univ, Dept Pediat, Fac Med, Saga, Japan; [Hidaka, Hidenori] Saga Univ, Dept Internal Med & Gastrointestinal Endoscopy, Fac Med, Saga, Japan; [Okamoto, Nobuhiko] Osaka Womens & Childrens Hosp, Dept Med Genet, Izumi, Japan	Saga University; Saga University; Yokohama City University; Gunma University; Nagoya University; Saga University; Saga University	Higashimoto, K; Soejima, H (corresponding author), Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan.	higashim@cc.saga-u.ac.jp; soejimah@cc.saga-u.ac.jp			MEXT \ Japan Society for the Promotion of Science (JSPS) [16K09970, 17K08687, 19H03621, 17H01539]; Japan Agency for Medical Research and Development (AMED) [17ek0109280h0001, 17ek0109234h0001, 17ek0109205h0001, JP19ek0109280, JP19dm0107090, JP19ek0109301]; Ministry of Health, Labour and Welfare (MHLW) [H29-nanchitou(nan)-ippan-025]; National Center for Child Health and Development (NCCHD) [26-13]; Gunma University [16029]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); National Center for Child Health and Development (NCCHD); Gunma University	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K09970, 17K08687, 19H03621 and 17H01539; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 17ek0109280h0001, 17ek0109234h0001, 17ek0109205h0001, JP19ek0109280, JP19dm0107090 and JP19ek0109301; Ministry of Health, Labour and Welfare (MHLW), Grant/Award Number: H29-nanchitou(nan)-ippan-025; National Center for Child Health and Development (NCCHD), Grant/Award Number: 26-13; Gunma University, Grant/Award Number: 16029	Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Ayesh B, 2003, MOL THER, V7, P535, DOI 10.1016/S1525-0016(03)00056-X; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Baujat G, 2004, AM J HUM GENET, V74, P715, DOI 10.1086/383093; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Brioude F, 2018, NAT REV ENDOCRINOL, V14, P229, DOI 10.1038/nrendo.2017.166; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; COLE TRP, 1990, J MED GENET, V27, P571, DOI 10.1136/jmg.27.9.571; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2002, CANCER RES, V62, P6442; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hidaka H, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0578-9; Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396; Kagami M, 2017, GENET MED, V19, P1356, DOI 10.1038/gim.2017.53; Kagami M, 2017, GENET MED, V19, P476, DOI 10.1038/gim.2016.123; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kamimura J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e126; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lee SC, 2016, ONCOGENE, V35, P5515, DOI 10.1038/onc.2016.92; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lewis MP, 1996, PLACENTA, V17, P137, DOI 10.1016/S0143-4004(96)80006-3; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Maeda T, 2014, GENET MED, V16, P903, DOI 10.1038/gim.2014.46; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; SOTOS JF, 1964, NEW ENGL J MED, V271, P109, DOI 10.1056/NEJM196407162710301; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Sun FF, 2019, J HUM GENET, V64, P937, DOI 10.1038/s10038-019-0634-0; Tatton-Brown K, 2007, EUR J HUM GENET, V15, P264, DOI 10.1038/sj.ejhg.5201686; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tlemsani C, 2016, J MED GENET, V53, P743, DOI 10.1136/jmedgenet-2015-103638; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106	54	5	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					960	973		10.1096/fj.201901757R	http://dx.doi.org/10.1096/fj.201901757R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914674	Green Published, hybrid			2022-12-26	WOS:000507308900065
J	Ganan, M; Lorentzen, SB; Aam, BB; Eijsink, VGH; Gaustad, P; Sorlie, M				Ganan, Monica; Lorentzen, Silje B.; Aam, Berit B.; Eijsink, Vincent G. H.; Gaustad, Peter; Sorlie, Morten			Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts	PLOS ONE			English	Article							CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; AMPHOTERICIN-B; EFFECT PAFE; TIME-KILL; IN-VITRO; FLUCONAZOLE; INFECTIONS; RESISTANCE; EXPOSURE	Combination therapies can be a help to overcome resistance to current antifungals in humans. The combined activity of commercial antifungals and soluble and well-defined low molecular weight chitosan with average degrees of polymerization (DPn) of 17-62 (abbreviated C17-C62) and fraction of acetylation (F-A) of 0.15 against medically relevant yeast strains was studied. The minimal inhibitory concentration (MIC) of C32 varied greatly among strains, ranging from > 5000 mu g mL(-1) (Candida albicans and C. glabrata) to < 4.9 (C. tropicalis). A synergistic effect was observed between C32 and the different antifungals tested for most of the strains. Testing of several CHOS preparations indicated that the highest synergistic effects are obtained for fractions with a DPn in the 30-50 range. Pre-exposure to C32 enhanced the antifungal effect of fluconazole and amphotericin B. A concentration-dependent post-antifungal effect conserved even 24 h after C32 removal was observed. The combination of C32 and commercial antifungals together or as part of a sequential therapy opens new therapeutic perspectives for treating yeast infections in humans.	[Ganan, Monica; Lorentzen, Silje B.; Aam, Berit B.; Eijsink, Vincent G. H.; Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Ganan, Monica; Gaustad, Peter] Univ Oslo, Inst Clin Med, Dept Microbiol, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Sorlie, M (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	morten.sorlie@nmbu.no		Sorlie, Morten/0000-0001-7259-6710; Ganan, Monica/0000-0001-7277-0029	Norwegian Research Council [226280]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council, 226280 (www.nfr.no) to MG, SBL, BBA, VGHE, PG, and MS. The funding agency din not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Alburquenque C, 2010, MED MYCOL, V48, P1018, DOI 10.3109/13693786.2010.486412; [Anonymous], 1979, MECH ACTION ANTIEUKA; Baddley JW, 2005, DRUGS, V65, P1461, DOI 10.2165/00003495-200565110-00002; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Beer KD, 2018, MMWR-MORBID MORTAL W, V67, P1064, DOI 10.15585/mmwr.mm6738a5; Ben-Ami R, 2018, J FUNGI, V4, DOI 10.3390/jof4030097; Calamari SE, 2011, MED ORAL PATOL ORAL, V16, pE23, DOI 10.4317/medoral.16.e23; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; D'Arrigo M, 2010, PHYTOMEDICINE, V17, P317, DOI 10.1016/j.phymed.2009.07.008; Egusa H, 2000, J ORAL PATHOL MED, V29, P206, DOI 10.1034/j.1600-0714.2000.290503.x; El-Sharif AA, 2011, CURR MICROBIOL, V62, P739, DOI 10.1007/s00284-010-9777-0; Ernst EJ, 2000, ANTIMICROB AGENTS CH, V44, P1108, DOI 10.1128/AAC.44.4.1108-1111.2000; Ganan M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210208; Gratieri T, 2011, EUR J PHARM BIOPHARM, V79, P320, DOI 10.1016/j.ejpb.2011.05.006; Healey KR, 2018, J FUNGI, V4, DOI 10.3390/jof4030105; Jaime MDLA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-267; Kontoyiannis DP, 2003, DRUG RESIST UPDATE, V6, P257, DOI 10.1016/j.drup.2003.08.003; Lamb DC, 1997, J BIOL CHEM, V272, P5682, DOI 10.1074/jbc.272.9.5682; Louie A, 2001, ANTIMICROB AGENTS CH, V45, P485, DOI 10.1128/AAC.45.2.485-494.2001; MACKENZIE FM, 1993, J ANTIMICROB CHEMOTH, V32, P519, DOI 10.1093/jac/32.4.519; Manavathu EK, 2004, J ANTIMICROB CHEMOTH, V53, P386, DOI 10.1093/jac/dkh066; Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558; Palmeira-de-Oliveira A, 2010, GYNECOL OBSTET INVES, V70, P322, DOI 10.1159/000314023; Park Y, 2008, J MICROBIOL BIOTECHN, V18, P1729; Pristov KE, 2019, CLIN MICROBIOL INFEC, V25, P792, DOI 10.1016/j.cmi.2019.03.028; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rahman MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093192; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Senel S, 2000, INT J PHARM, V193, P197, DOI 10.1016/S0378-5173(99)00334-8; Singh K, 2013, INT J BIOL MACROMOL, V58, P310, DOI 10.1016/j.ijbiomac.2013.04.053; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Tiyaboonchai W, 2007, INT J PHARMACEUT, V329, P142, DOI 10.1016/j.ijpharm.2006.08.013; Uppuluri P, 2008, ANTIMICROB AGENTS CH, V52, P1127, DOI 10.1128/AAC.01397-07; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885; Wang Y, 2012, FOOD CHEM, V132, P419, DOI 10.1016/j.foodchem.2011.11.015; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Yehia Soad A., 2009, Current Drug Delivery, V6, P17	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227098	10.1371/journal.pone.0227098	http://dx.doi.org/10.1371/journal.pone.0227098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891619	Green Published, gold			2022-12-26	WOS:000515096600059
J	Hara, Y; Teshima, K; Yamaya, Y				Hara, Yohei; Teshima, Kenji; Yamaya, Yoshiki			Arterial blood gas analysis in dogs with bronchomalacia	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; CLINICAL-FEATURES; TRACHEAL COLLAPSE; CHILDREN; TRACHEOBRONCHOMALACIA; MALACIA	Canine bronchomalacia (CBM) is a structural airway disease leading to chronic cough and intermittent respiratory distress, primarily affecting elderly dogs of small breeds. Results of blood gas analysis have been reported in dogs with several diseases, but not yet in those with CBM. Eleven dogs with CBM were recruited in this study. Most dogs presented with mild hypoxemia and normocapnia, and all with increased alveolar-arterial difference for O-2 (A-aDO(2)). In computed tomography, abnormal lung patterns, such as atelectasis and parenchymal band, were detected in all dogs, consistent with the regions affected by CBM. We conclude that CBM causes abnormal lung patterns and results in impaired oxygenation. Blood gas analysis is a useful tool for detecting mild pulmonary lesions and concurrent CBM.	[Hara, Yohei; Teshima, Kenji; Yamaya, Yoshiki] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Anesthesiol & Resp Res Lab, Fujisawa, Kanagawa, Japan	Nihon University	Yamaya, Y (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Anesthesiol & Resp Res Lab, Fujisawa, Kanagawa, Japan.	yamaya.yoshiki@nihon-u.ac.jp		Yamaya, Yoshiki/0000-0002-0625-7670	Individual Research Grant from Nihon University	Individual Research Grant from Nihon University	This work was supported by Individual Research Grant from Nihon University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamama-Moraitou KK, 2012, VET J, V191, P261, DOI 10.1016/j.tvjl.2010.11.021; Aguilera-Tejero E, 1997, RES VET SCI, V63, P253, DOI 10.1016/S0034-5288(97)90029-1; Bach JF, 2007, AM J VET RES, V68, P670, DOI 10.2460/ajvr.68.6.670; Bottero E, 2013, J VET INTERN MED, V27, P840, DOI 10.1111/jvim.12096; Buitrago DH, 2017, J THORAC DIS, V9, pE57, DOI 10.21037/jtd.2017.01.13; Burden RJ, 1999, THORAX, V54, P511, DOI 10.1136/thx.54.6.511; Corcoran BM, 2011, VET REC, V168, DOI 10.1136/vr.c6519; De Lorenzi D, 2009, JAVMA-J AM VET MED A, V235, P835, DOI 10.2460/javma.235.7.835; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Heidinger BH, 2015, AM J ROENTGENOL, V205, P41, DOI 10.2214/AJR.14.13857; Hoareau GL, 2012, J VET INTERN MED, V26, P897, DOI 10.1111/j.1939-1676.2012.00941.x; Johnson LR, 2010, J VET INTERN MED, V24, P298, DOI 10.1111/j.1939-1676.2009.0451.x; Kim H, 2018, VET RADIOL ULTRASOUN, V59, P551, DOI 10.1111/vru.12625; Kligerman SJ, 2015, RADIOGRAPHICS, V35, P1360, DOI 10.1148/rg.2015140308; Macready DM, 2007, JAVMA-J AM VET MED A, V230, P1870, DOI 10.2460/javma.230.12.1870; Meler E, 2010, CAN VET J, V51, P753; Oh D, 2019, VET RADIOL ULTRASOUN, V60, P28, DOI 10.1111/vru.12692; Pan W, 2014, INT J CLIN EXP MED, V7, P3005; Puighibet Z, 2015, VET ANAESTH ANALG, V42, P590, DOI 10.1111/vaa.12256; Roels E, 2017, VET RADIOL ULTRASOUN, V58, P284, DOI 10.1111/vru.12481; Sarkar M, 2017, LUNG INDIA, V34, P47, DOI 10.4103/0970-2113.197116; Scrivani PV, 2012, VET RADIOL ULTRASOUN, V53, P1, DOI 10.1111/j.1740-8261.2011.01881.x; SORBINI CA, 1968, RESPIRATION, V25, P3, DOI 10.1159/000192549; Stadler K, 2011, VET RADIOL ULTRASOUN, V52, P377, DOI 10.1111/j.1740-8261.2011.01816.x; Tan JZY, 2012, PEDIATR RADIOL, V42, P906, DOI 10.1007/s00247-012-2367-5; Thierry F, 2017, VET RADIOL ULTRASOUN, V58, P381, DOI 10.1111/vru.12491; Ullmann N, 2018, PEDIATR PULM, V53, P73, DOI 10.1002/ppul.23831; Viitanen SJ, 2014, J VET INTERN MED, V28, P84, DOI 10.1111/jvim.12262; Wagner PD, 2015, EUR RESPIR J, V45, P227, DOI 10.1183/09031936.00039214	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227194	10.1371/journal.pone.0227194	http://dx.doi.org/10.1371/journal.pone.0227194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891639	gold, Green Published			2022-12-26	WOS:000515096600065
J	Woldegiorgis, AE; Erku, W; Medhin, G; Berhe, N; Legesse, M				Woldegiorgis, Adugna Endale; Erku, Woldearegay; Medhin, Girmay; Berhe, Nega; Legesse, Mengistu			Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia	PLOS ONE			English	Article							VIRAL-HEPATITIS; VIRUS-INFECTION; UNITED-STATES; EPIDEMIOLOGY; HEALTH; COINFECTION; FATIGUE; DELTA	Background Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are the leading causes of liver-related morbidity and mortality throughout the world. The magnitude of HBV and HCV infections in Ethiopia has not been well studied at community level. This study aimed at investigating the sero-prevalence and associated risk factors of HBV and HCV among HBV unvaccinated community members in South Omo Zone, Southern Ethiopia. Methods A community-based cross-sectional study was conducted in three districts from March to May 2018. Structured questionnaire was used to collect relevant clinical and socio-demographic data. Three milliliter of blood sample was collected from each study participant and screened for HBV and HCV using one step hepatitis B surface antigen (HBsAg) test strip and one step HCV test strip, respectively. Samples found positive for HBsAg were further tested using immunoassay of Alere Determine (TM) HBsAg (Alere Inc., USA). Data were analyzed using SPSS version 25.0. Results A total of 625 (51.4% males, age 680 years, mean age +/- SD = 30.83 +/- 13.51 years) individuals participated in the study. The sero-prevalence for HBV infection was 8.0% as detected using one step HBsAg test strip, while it was 7.2% using Alere Determine (TM) HBsAg test. The sero-prevalence for HCV infection was 1.9%. Two (0.3%) of the participants were seropositive for both HBV and HCV infections. High sero-prevalence for HBV infection was associated with weakness and fatigue (AOR = 5.20; 95% CI: 1.58, 17.15), while high sero-prevalence of HCV infection was associated with age group between 46 and 65 years (AOR = 13.02; 95% CI: 1.11, 152.41). Conclusion This study revealed higher-intermediate endemicity level of HBV infection and low to intermediate endemicity level of HCV infection in the study area. Clinical symptoms like weakness and fatigue were found to be indictors for HBV infection, while individuals in the age group between 46 and 65 years were at higher risk for HCV infection. Provision of community- based health education; vaccination, mass screening and providing treatment would have utmost importance in reducing the transmission of these diseases in the present study area.	[Woldegiorgis, Adugna Endale; Medhin, Girmay; Berhe, Nega; Legesse, Mengistu] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Woldegiorgis, Adugna Endale] Dire Dawa Univ, Coll Med & Hlth Sci, Sch Med, Dire Dawa, Ethiopia; [Erku, Woldearegay] Addis Ababa Univ, Tikur Anbessa Hosp, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol,Sch Med, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Woldegiorgis, AE (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.; Woldegiorgis, AE (corresponding author), Dire Dawa Univ, Coll Med & Hlth Sci, Sch Med, Dire Dawa, Ethiopia.	adugna.endale@aau.edu.et		Medhin, Girmay/0000-0003-2146-4261; Woldegiorgis, Adugna Endale/0000-0001-6030-4012	Office of Vice President for Research and Technology Transfer, Addis Ababa University [RD/PY 662/2016]	Office of Vice President for Research and Technology Transfer, Addis Ababa University	The study was financially supported by the Office of Vice President for Research and Technology Transfer, Addis Ababa University (Ref No. RD/PY 662/2016). Dr Mengistu Legesse received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Bane, 2014, International Journal of Innovation and Applied Studies, V9, P1718; Abdel-Aziz F, 2000, HEPATOLOGY, V32, P111, DOI 10.1053/jhep.2000.8438; Abera B, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0696-6; Adoga MP, 2009, J INFECT DEV COUNTR, V3, P539, DOI 10.3855/jidc.472; Ashrafi M, 2012, J PSYCHOSOM RES, V73, P218, DOI 10.1016/j.jpsychores.2012.06.006; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Birku Tigist, 2015, BMC Res Notes, V8, P737, DOI 10.1186/s13104-015-1719-2; Chaabna K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149966; Chisenga CC, 2018, J CLIN VIROL, V98, P5, DOI [10.1016/j.jcv.2017.11.005, 10.101]; CSAE, 2008, CENTR STAT AG ETH 20; El Khoury Antoine C, 2012, J Med Econ, V15, P887, DOI 10.3111/13696998.2012.681332; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Evon DM, 2016, DIGEST DIS SCI, V61, P1186, DOI 10.1007/s10620-015-4006-0; Gelaw B, 2007, ETHIOP J HEALTH DEV, V2, P3; Hann HW, 2008, J VIRAL HEPATITIS, V15, P42, DOI 10.1111/j.1365-2893.2007.00895.x; Karaivazoglou K, 2010, ANN HEPATOL, V9, P419, DOI 10.1016/S1665-2681(19)31618-7; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lilay A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2435-4; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Malhotra Rubina, 2016, J Nat Sci Biol Med, V7, P72, DOI 10.4103/0976-9668.175076; Martin P, 2015, CLIN GASTROENTEROL H, V13, P2071, DOI 10.1016/j.cgh.2015.07.007; Molla S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0437-7; Mora N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1584-1; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Nerrienet E, 2005, J MED VIROL, V76, P208, DOI 10.1002/jmv.20343; ONM, 2017, ORG NAT MED ONM LOW; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Ramarokoto CE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-25; Rao M. R., 2002, BMC Infectious Diseases, V2; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Saravanan S, 2009, J MICROBIOL IMMUNOL, V42, P122; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shire NJ, 2015, GASTROENTEROL CLIN N, V44, P699, DOI 10.1016/j.gtc.2015.07.002; Shivkumar S, 2012, AM J GASTROENTEROL, V107, P1306, DOI 10.1038/ajg.2012.141; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203; Taye Solomon, 2014, BMC Res Notes, V7, P272, DOI 10.1186/1756-0500-7-272; Tsatsralt-Od B, 2005, J MED VIROL, V77, P491, DOI 10.1002/jmv.20482; Umumararungu E, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5841272; WHO, 2018, WHO HEP C VIR PREV 2; WHO, 2013, GLOB POL REP PREV CO, P536; WHO, 2016, WHO COMB HEP B C REA; WHO, 2017, WHO PUBLISHES LIST B; who, WHO HEP B FACT SHEET; WHO b, 2001, HEP B SURF ANT ASS O; WHO/PAHO, 2005, SCI TECHNICAL PUBLIC, V603; WHOa, 2016, WHO HEP 2016; WHOa, 2011, WHO HEP C 2011	49	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226890	10.1371/journal.pone.0226890	http://dx.doi.org/10.1371/journal.pone.0226890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887192	Green Submitted, gold, Green Published			2022-12-26	WOS:000515092200048
J	Angelini, A; Gorey, MA; Dumont, F; Mougenot, N; Chatzifrangkeskou, M; Muchir, A; Li, ZL; Mericskay, M; Decaux, JF				Angelini, Aude; Gorey, Mark-Alexander; Dumont, Florent; Mougenot, Nathalie; Chatzifrangkeskou, Maria; Muchir, Antoine; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois			Cardioprotective effects of alpha-cardiac actin on oxidative stress in a dilated cardiomyopathy mouse model	FASEB JOURNAL			English	Article						cardiac remodeling; dilated cardiomyopathy; oxidative stress; alpha-cardiac actin	SERUM RESPONSE FACTOR; NADPH OXIDASES; SKELETAL-MUSCLE; GENE-EXPRESSION; NUCLEAR ACTIN; HUMAN HEART; NOX FAMILY; MUTATIONS; RNA; SUPEROXIDE	The expression of alpha-cardiac actin, a major constituent of the cytoskeleton of cardiomyocytes, is dramatically decreased in a mouse model of dilated cardiomyopathy triggered by inducible cardiac-specific serum response factor (Srf) gene disruption that could mimic some forms of human dilated cardiomyopathy. To investigate the consequences of the maintenance of alpha-cardiac actin expression in this model, we developed a new transgenic mouse based on Cre/LoxP strategy, allowing together the induction of SRF loss and a compensatory expression of alpha-cardiac actin. Here, we report that maintenance of alpha-cardiac actin within cardiomyocytes temporally preserved cytoarchitecture from adverse cardiac remodeling through a positive impact on both structural and transcriptional levels. These protective effects were accompanied in vivo by the decrease of ROS generation and protein carbonylation and the downregulation of NADPH oxidases NOX2 and NOX4. We also show that ectopic expression of alpha-cardiac actin protects HEK293 cells against oxidative stress induced by H2O2. Oxidative stress plays an important role in the development of cardiac remodeling and contributes also to the pathogenesis of heart failure. Taken together, these findings indicate that alpha-cardiac actin could be involved in the regulation of oxidative stress that is a leading cause of adverse remodeling during dilated cardiomyopathy development.	[Angelini, Aude; Gorey, Mark-Alexander; Li, Zhenlin; Decaux, Jean-Francois] Sorbonne Univ, Inst Biol Paris Seine IBPS, Biol Adaptat & Ageing, CNRS UMR 8256,INSERM ERL U1164, Paris, France; [Dumont, Florent; Mericskay, Mathias] Univ Paris Saclay, Signalling & Cardiovasc Pathophysiol, INSERM UMR S 1180, Chatenay Malabry, France; [Mougenot, Nathalie] Sorbonne Univ, Fac Med Pierre & Marie Curie, INSERM UMS 28 Phenotypage Petit Anim, Paris, France; [Chatzifrangkeskou, Maria; Muchir, Antoine] Sorbonne Univ, Inst Myol, Ctr Res Myol, INSERM UMRS 974, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Li, ZL (corresponding author), Sorbonne Univ, Inst Biol Paris Seine IBPS, Biol Adaptat & Ageing, CNRS UMR 8256,INSERM ERL U1164, Paris, France.	zhenlin.li@sorbonne-universite.fr	MERICSKAY, Mathias/M-3477-2018	MERICSKAY, Mathias/0000-0002-6779-092X; Angelini, Aude/0000-0001-5339-5315; LI, Zhenlin/0000-0002-3706-4505; DECAUX, Jean-Francois/0000-0003-0014-4197	l'Association Francaise contre les Myopathies (AFM) [19814]; PhD fellowship of Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC); Fondation de la Recherche Medicale (FRM)	l'Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); PhD fellowship of Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by l'Association Francaise contre les Myopathies (AFM#19814). AA was supported by a PhD fellowship of Universite Paris 05, a fellowship of Fondation de la Recherche Medicale (FRM), and a fellowship of Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC) and Societe Francaise de Cardiologie (SFC).	Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; Agbulut O, 2001, CELL MOTIL CYTOSKEL, V49, P51, DOI 10.1002/cm.1020; Angelini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139858; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33; Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099; Diguet N, 2011, J BIOL CHEM, V286, P35007, DOI 10.1074/jbc.M111.252395; Farah ME, 2007, MOL BIOL CELL, V18, P1359, DOI 10.1091/mbc.E06-08-0718; Farah ME, 2011, CYTOSKELETON, V68, P340, DOI 10.1002/cm.20516; GARNER I, 1986, EMBO J, V5, P2559, DOI 10.1002/j.1460-2075.1986.tb04535.x; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Ichihara S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08546-1; Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lamon S, 2014, PFLUG ARCH EUR J PHY, V466, P1659, DOI 10.1007/s00424-014-1475-5; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5; Mundia MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036821; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Suzuki M, 2005, BIOPHYS J, V89, P321, DOI 10.1529/biophysj.104.054957; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VANDEKERCKHOVE J, 1986, J BIOL CHEM, V261, P1838; Victorino VJ, 2015, LIFE SCI, V129, P42, DOI 10.1016/j.lfs.2014.11.008; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	72	3	3	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2987	3005		10.1096/fj.201902389R	http://dx.doi.org/10.1096/fj.201902389R		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908029	Green Submitted			2022-12-26	WOS:000504854600001
J	Liverani, E; Tursi, SA; Cornwell, WD; Mondrinos, MJ; Sun, S; Buttaro, BA; Wolfson, MR; Rogers, TJ; Tukel, C; Kilpatrick, LE				Liverani, Elisabetta; Tursi, Sarah A.; Cornwell, William D.; Mondrinos, Mark J.; Sun, Shuang; Buttaro, Bettina A.; Wolfson, Marla R.; Rogers, Thomas J.; Tuekel, Cagla; Kilpatrick, Laurie E.			Protein kinase C-delta inhibition is organ-protective, enhances pathogen clearance, and improves survival in sepsis	FASEB JOURNAL			English	Article						cecal ligation and puncture; inflammation; macrophages; organ injury; phagocytosis	SEPTIC SHOCK; LUNG INJURY; PKC-DELTA; NEUTROPHILS; BIODISTRIBUTION; INFLAMMATION; PI-3-KINASE; EXPRESSION; MORTALITY; DELIVERY	Sepsis is a leading cause of morbidity and mortality in intensive care units. Previously, we identified Protein Kinase C-delta (PKC delta) as an important regulator of the inflammatory response in sepsis. An important issue in development of anti-inflammatory therapeutics is the risk of immunosuppression and inability to effectively clear pathogens. In this study, we investigated whether PKC delta inhibition prevented organ dysfunction and improved survival without compromising pathogen clearance. Sprague Dawley rats underwent sham surgery or cecal ligation and puncture (CLP) to induce sepsis. Post-surgery, PBS or a PKC delta inhibitor (200 mu g/kg) was administered intra-tracheally (IT). At 24 hours post-CLP, there was evidence of lung and kidney dysfunction. PKC delta inhibition decreased leukocyte influx in these organs, decreased endothelial permeability, improved gas exchange, and reduced blood urea nitrogen/creatinine ratios indicating organ protection. PKC delta inhibition significantly decreased bacterial levels in the peritoneal cavity, spleen and blood but did not exhibit direct bactericidal properties. Peritoneal chemokine levels, neutrophil numbers, or macrophage phenotypes were not altered by PKC delta inhibition. Peritoneal macrophages isolated from PKC delta inhibitor-treated septic rats demonstrated increased bacterial phagocytosis. Importantly, PKC delta inhibition increased survival. Thus, PKC delta inhibition improved survival and improved survival was associated with increased phagocytic activity, enhanced pathogen clearance, and decreased organ injury.	[Liverani, Elisabetta; Cornwell, William D.; Mondrinos, Mark J.; Sun, Shuang; Wolfson, Marla R.; Rogers, Thomas J.; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Clin & Translat Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Liverani, Elisabetta; Mondrinos, Mark J.; Kilpatrick, Laurie E.] Temple Univ, Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Tursi, Sarah A.; Buttaro, Bettina A.; Tuekel, Cagla] Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Wolfson, Marla R.; Kilpatrick, Laurie E.] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kilpatrick, LE (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, 3500 North Broad St,Rm 1153 MERB, Philadelphia, PA 19140 USA.	laurie.kilpatrick@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456	National Institute of General Medical Sciences of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Institute on Drug Abuse of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Heart, Lung; Blood Institute of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]	National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse of the National Institutes of Health (NIH); National Heart, Lung; Blood Institute of the National Institutes of Health (NIH)	National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Heart, Lung; Blood Institute of the National Institutes of Health (NIH), Grant/Award Number: HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996 and AI125429	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Bhargava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079037; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chichger H, 2012, AM J PHYSIOL-LUNG C, V303, pL880, DOI 10.1152/ajplung.00169.2012; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Craciun FL, 2014, SHOCK, V41, P97, DOI 10.1097/SHK.0000000000000073; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hazeki K, 2009, J BIOCHEM, V145, P87, DOI 10.1093/jb/mvn142; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Liverani E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195379; Medzhitov R, 2013, IMMUNITY, V39, P799, DOI 10.1016/j.immuni.2013.10.012; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Mestry N, 2009, THORAX, V64, P532, DOI 10.1136/thx.2008.099143; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a; Neumann B, 1999, INT IMMUNOL, V11, P217, DOI 10.1093/intimm/11.2.217; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Perl M, 2010, CRIT CARE MED, V38, P1179, DOI 10.1097/CCM.0b013e3181d4563f; Poston JT, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4891; Ramnath R, 2010, J MOL MED BERL, V88, P1; Shukla A, 2007, AM J PATHOL, V170, P140, DOI 10.2353/ajpath.2007.060381; Castanheira FVES, 2018, SHOCK, V49, P682, DOI 10.1097/SHK.0000000000000969; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slutsky AS, 2002, J CLIN INVEST, V110, P737, DOI 10.1172/JCI200216551; Soroush F, 2019, SHOCK, V51, P538, DOI 10.1097/SHK.0000000000001247; Soroush F, 2016, J LEUKOCYTE BIOL, V100, P1027, DOI 10.1189/jlb.3MA0216-087R; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Tang Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1342-y; Tao XT, 2017, J INFECT DIS, V215, P321, DOI 10.1093/infdis/jiw535; Toledo-Rodriguez M, 2012, TOXICOL LETT, V213, P228, DOI 10.1016/j.toxlet.2012.06.009; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013	56	6	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2497	2510		10.1096/fj.201900897R	http://dx.doi.org/10.1096/fj.201900897R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908004	Green Accepted, Bronze			2022-12-26	WOS:000504090700001
J	Namuduri, AV; Heras, G; Lauschke, VM; Vitadello, M; Traini, L; Cacciani, N; Gorza, L; Gastaldello, S				Namuduri, Arvind Venkat; Heras, Gabriel; Lauschke, Volker M.; Vitadello, Maurizio; Traini, Leonardo; Cacciani, Nicola; Gorza, Luisa; Gastaldello, Stefano			Expression of SUMO enzymes is fiber type dependent in skeletal muscles and is dysregulated in muscle disuse	FASEB JOURNAL			English	Article						atrophy; muscle inactivity; PAX6; skeletal muscles; SUMO cycle; UBC9	SIGNALING PATHWAYS; SUMOYLATION; CONJUGATION; DIAPHRAGM; ATROPHY	SUMOylation is a dynamic, reversible, enzymatic drug-targetable post-translational modification (PTM) reaction where the Small Ubiquitin-like Modifier (SUMO) moieties are attached to proteins. This reaction regulates various biological functions like cell growth, differentiation, and it is crucial for maintaining organ homeostasis. However, the actions of SUMO in skeletal muscle pathophysiology are still not investigated. In this study, we quantified the abundance of the SUMO enzymes and determined the distribution of SUMOylated proteins along the fibers of nine different muscles. We find that skeletal muscles contain a distinctive group of SUMO enzymes and SUMOylated proteins in relation to their different metabolism, functions, and fiber type composition. In addition, before the activation of protein degradation pathways, this unique set is quickly altered in response to muscle sedentariness. Finally, we demonstrated that PAX6 acts as an upstream regulator of the SUMO conjugation reaction, which can become a potential therapeutic marker to prevent muscle diseases generated by inactivity.	[Namuduri, Arvind Venkat; Heras, Gabriel; Lauschke, Volker M.; Cacciani, Nicola; Gastaldello, Stefano] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Vitadello, Maurizio; Gorza, Luisa] Univ Padua, Dept Biomed Sci, Padua, Italy; [Traini, Leonardo] German Canc Res Ctr, Helmholtz Univ Grp Cell Plast & Epigenet Remodeli, Heidelberg, Germany; [Traini, Leonardo] Univ Hosp, Inst Pathol, Heidelberg, Germany; [Cacciani, Nicola] Karolinska Inst, Dept Clin Neurosci, Clin Neurophysiol, Stockholm, Sweden; [Gastaldello, Stefano] Binzhou Med Univ, Precis Med Res Ctr, Yantai, Peoples R China	Karolinska Institutet; University of Padua; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Karolinska Institutet; Binzhou Medical University	Gastaldello, S (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Solnavagen 9, S-17165 Solna, Sweden.	stefano.gastaldello@ki.se	Gastaldello, Stefano/AAM-6768-2020; Lauschke, Volker/O-3014-2017	Gastaldello, Stefano/0000-0001-7369-8452; Lauschke, Volker/0000-0002-1140-6204				Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chopard A, 2009, J CELL MOL MED, V13, P3032, DOI 10.1111/j.1582-4934.2009.00864.x; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Da Silva-Ferrada E, 2016, INT J BIOCHEM CELL B, V79, P443, DOI 10.1016/j.biocel.2016.09.015; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Grichko VP, 2000, J APPL PHYSIOL, V88, P473, DOI 10.1152/jappl.2000.88.2.473; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Heras G, 2019, J MOL CELL BIOL, V11, P356, DOI 10.1093/jmcb/mjy036; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Hirasawa T, 2013, J ANAT, V222, P504, DOI 10.1111/joa.12037; Hu YH, 2014, J BIOL CHEM, V289, P21289, DOI 10.1074/jbc.C114.582122; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Terradas ALI, 2018, J PATHOL, V246, P433, DOI 10.1002/path.5149; Liang YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26509; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mendler L, 2016, CIRC RES, V118, P132, DOI 10.1161/CIRCRESAHA.115.307730; Merrell AJ, 2013, FEBS J, V280, P4026, DOI 10.1111/febs.12274; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Namuduri AV, 2017, MOL CELL PROTEOMICS, V16, P1081, DOI 10.1074/mcp.M116.066159; Nikolic M, 2001, COLLEGIUM ANTROPOL, V25, P545; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salah H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7099; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sinha N, 2016, MOL BIOL REP, V43, P345, DOI 10.1007/s11033-016-3979-x; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Taherbhoy AM, 2012, ESSAYS BIOCHEM, V52, P51, DOI [10.1042/BSE0520051, 10.1042/bse0520051]; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Wang J, 2009, FRONT BIOSCI-LANDMRK, V14, P1219, DOI 10.2741/3304; Wei LM, 2018, MOL CELL PROTEOMICS, V17, P148, DOI 10.1074/mcp.RA117.000124; Widmer CG, 2010, PROG BRAIN RES, V187, P63, DOI [10.1016/S0079-6123(10)87005-0, 10.1016/B978-0-444-53613-6.00005-8]; Xiong DZ, 2017, P NATL ACAD SCI USA, V114, pE6686, DOI 10.1073/pnas.1706267114; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yang W, 2016, STROKE VASC NEUROL, V1, P101, DOI 10.1136/svn-2016-000031	46	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2269	2286		10.1096/fj.201901913R	http://dx.doi.org/10.1096/fj.201901913R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908008	Bronze			2022-12-26	WOS:000514663600024
J	Good, SS; Moussa, A; Zhou, XJ; Pietropaolo, K; Sommadossi, JP				Good, Steven S.; Moussa, Adel; Zhou, Xiao-Jian; Pietropaolo, Keith; Sommadossi, Jean-Pierre			Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus	PLOS ONE			English	Article							METABOLIC-ACTIVATION; POLYMERASE; INHIBITOR; INDUCTION	Despite the availability of highly effective direct-acting antiviral (DAA) regimens for the treatment of hepatitis C virus (HCV) infections, sustained viral response (SVR) rates remain suboptimal for difficult-to-treat patient populations such as those with HCV genotype 3, cirrhosis or prior treatment experience, warranting development of more potent HCV replication antivirals. AT-527 is the hemi-sulfate salt of AT-511, a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV. The EC50 of AT-511, determined using HCV laboratory strains and clinical isolates with genotypes 1-5, ranged from 5-28 nM. The active 5'-triphosphate metabolite, AT-9010, specifically inhibited the HCV RNA-dependent RNA polymerase. AT-511 did not inhibit the replication of other selected RNA or DNA viruses in vitro. AT-511 was approximately 10-fold more active than sofosbuvir (SOF) against a panel of laboratory strains and clinical isolates of HCV genotypes 1-5 and remained fully active against S282T resistance-associated variants, with up to 58-fold more potency than SOF. In vitro, AT-511 did not inhibit human DNA polymerases or elicit cytotoxicity or mitochondrial toxicity at concentrations up to 100 mu M. Unlike the other potent guanosine analogs PSI-938 and PSI-661, no mutagenic O6 -alkylguanine bases were formed when incubated with cytochrome P450 (CYP) 3A4, and AT-511 had IC50 values >= 25 mu M against a panel of CYP enzymes. In hepatocytes from multiple species, the active triphosphate was the predominant metabolite produced from the prodrug, with a half-life of 10 h in human hepatocytes. When given orally to rats and monkeys, AT527 preferentially delivered high levels of AT-9010 in the liver in vivo. These favorable preclinical attributes support the ongoing clinical development of AT-527 and suggest that, when used in combination with an HCV DAA from a different class, AT-527 may increase SVR rates, especially for difficult-to-treat patient populations, and could potentially shorten treatment duration for all patients.	[Good, Steven S.; Moussa, Adel; Zhou, Xiao-Jian; Pietropaolo, Keith; Sommadossi, Jean-Pierre] Atea Pharmaceut Inc, Boston, MA 02110 USA		Good, SS (corresponding author), Atea Pharmaceut Inc, Boston, MA 02110 USA.	good.steven@ateapharma.com		Good, Steven/0000-0003-1476-9892				AASLD-IDSA, REC TEST MAN TREAT H; Ahmad T, 2015, HEPATOLOGY, V62, P409, DOI 10.1002/hep.27488; Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Berry Loren M, 2009, Drug Metab Lett, V3, P70; Bonatti S, 2000, MUTAGENESIS, V15, P361, DOI 10.1093/mutage/15.4.361; BONATTI S, 1986, MUTAGENESIS, V1, P99, DOI 10.1093/mutage/1.2.99; Chang W, 2011, ACS MED CHEM LETT, V2, P130, DOI 10.1021/ml100209f; Feld JJ, 2017, LIVER INT, V37, P5, DOI 10.1111/liv.13212; Feng Joy Y., 2018, Antiviral Chemistry & Chemotherapy, V26, p2040206618758524, DOI 10.1177/2040206618758524; Feng JY, 2016, ANTIMICROB AGENTS CH, V60, P806, DOI 10.1128/AAC.01922-15; Furman PA, 2011, ANTIVIR RES, V91, P120, DOI 10.1016/j.antiviral.2011.05.003; Hosein S, HCV TREATMENT ADV LI; Lalezari J, 2013, ONCE DAILY SOFOSBUVI, DOI [10.1053/j.gastro.2013.11.007, DOI 10.1053/J.GASTRO.2013.11.007]; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Murakami E, 2011, J MED CHEM, V54, P5902, DOI 10.1021/jm200650j; Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802; Niu CR, 2012, ANTIMICROB AGENTS CH, V56, P3767, DOI 10.1128/AAC.00530-12; SIMILI M, 1995, MUTAGENESIS, V10, P105, DOI 10.1093/mutage/10.2.105; Walsky R, 2004, DRUG METAB DISPOS, V32; World Health Organization, 2019, HEP C FACT SHEET	21	21	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227104	10.1371/journal.pone.0227104	http://dx.doi.org/10.1371/journal.pone.0227104			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914458	Green Published, gold			2022-12-26	WOS:000534337700028
J	Zhang, J; Tsai, PW; Xue, XS; Ye, XC; Zhang, SM				Zhang, Jing; Tsai, Pei-Wei; Xue, Xingsi; Ye, Xiucai; Zhang, Shunmiao			A Comprehensive Data Gathering Network Architecture in Large-Scale Visual Sensor Networks	PLOS ONE			English	Article							DISTRIBUTED ALGORITHMS; LOCALIZATION; LIFETIME	The fundamental utility of the Large-Scale Visual Sensor Networks (LVSNs) is to monitor specified events and to transmit the detected information back to the sink for achieving the data aggregation purpose. However, the events of interest are usually not uniformly distributed but frequently detected in certain regions in real-world applications. It implies that when the events frequently picked up by the sensors in the same region, the transmission load of LVSNs is unbalanced and potentially cause the energy hole problem. To overcome this kind of problem for network lifetime, a Comprehensive Visual Data Gathering Network Architecture (CDNA), which is the first comparatively integrated architecture for LVSNs is designed in this paper. In CDNA, a novel alpha-hull based event location algorithm, which is oriented from the geometric model of alpha-hull, is designed for accurately and efficiently detect the location of the event. In addition, the Chi-Square distribution event-driven gradient deployment method is proposed to reduce the unbalanced energy consumption for alleviating energy hole problem. Moreover, an energy hole repairing method containing an efficient data gathering tree and a movement algorithm is proposed to ensure the efficiency of transmitting and solving the energy hole problem. Simulations are made for examining the performance of the proposed architecture. The simulation results indicate that the performance of CDNA is better than the previous algorithms in the realistic LVSN environment, such as the significant improvement of the network lifetime.	[Zhang, Jing; Xue, Xingsi; Zhang, Shunmiao] Fujian Univ Technol, Sch Informat Sci & Engn, Fuzhou, Peoples R China; [Zhang, Jing; Xue, Xingsi; Zhang, Shunmiao] Fujian Prov Key Lab Big Data Min & Applicat, Fuzhou, Peoples R China; [Tsai, Pei-Wei] Swinburne Univ Technol, Dept Comp Sci & Software Engn, Hawthorn, Vic, Australia; [Ye, Xiucai] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan	Fujian University of Technology; Swinburne University of Technology; University of Tsukuba	Zhang, J (corresponding author), Fujian Univ Technol, Sch Informat Sci & Engn, Fuzhou, Peoples R China.; Zhang, J (corresponding author), Fujian Prov Key Lab Big Data Min & Applicat, Fuzhou, Peoples R China.	jing165455@126.com	zhang, shunmiao/AAU-3852-2021		National Natural Science Foundation of China [61902069]; Natural Science Foundation of Fujian Province of China [2017J05098]; Education Department of Fujian Province science and technology project [JZ160461]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Education Department of Fujian Province science and technology project	This work was supported by National Natural Science Foundation of China (Grant No.: 61902069), Jing Zhang is the project leader, the URL of the project is as follows: http://output.nsfc.gov.cn/fundingQuery; Natural Science Foundation of Fujian Province of China (2017J05098), Jing Zhang is the project leader, the URL of the project is as follows: http://xmgl.fjkjt.gov.cn/p_itemsearch.pr.pr_ iteminfo_public_index.do?I_ITEMID=73203&I_ ITEMTYPEID=4; and The Education Department of Fujian Province science and technology project (JZ160461), Jing Zhang is the project leader, the URL of the project is as follows: http://59.77.139.101/project/project.do?actionType= view&pageModeId=view&bean.id= 3639&pageFrom=commonList.	Altahir AA, 2018, IEEE SENS J, V18, P4544, DOI 10.1109/JSEN.2018.2825781; Amodu MOA, 2018, WIREL NETW, V25, P1379; Castano F, 2018, INFORM SCIENCES, V433, P274, DOI 10.1016/j.ins.2017.12.028; Chaurasiya VK, 2014, INFORM FUSION, V15, P5, DOI 10.1016/j.inffus.2013.06.003; Cheng Long, 2011, Journal on Communications, V32, P158; Dieber B, 2011, IEEE T CIRC SYST VID, V21, P1424, DOI 10.1109/TCSVT.2011.2162770; Ding SG, 2018, IEEE T NEUR NET LEAR, V29, P792, DOI 10.1109/TNNLS.2017.2648038; Eriksson E, 2018, IEEE T CIRC SYST VID, V28, P3288, DOI 10.1109/TCSVT.2017.2745102; He YF, 2009, IEEE T CIRC SYST VID, V19, P704, DOI 10.1109/TCSVT.2009.2017411; He ZH, 2006, IEEE T CIRC SYST VID, V16, P590, DOI 10.1109/TCSVT.2006.873154; Jiang XY, 2018, IEEE ACCESS, V6, P13716, DOI 10.1109/ACCESS.2018.2812794; Kar P, 2018, IEEE SYST J, V12, P2048, DOI 10.1109/JSYST.2016.2606459; Kumar KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206027; Li W, 2015, J NETW COMPUT APPL, V57, P119, DOI 10.1016/j.jnca.2015.07.013; LIU X, 2017, IEEE T CYBERNETICS, V45, P2364, DOI DOI 10.1109/TCYB.2015.2443062; Madan R, 2006, IEEE T WIREL COMMUN, V5, P2185, DOI [10.1109/TWC.2006.1687734, 10.1109/TWC.2006.04667]; Moradi M, 2012, SENSORS-BASEL, V12, P4352, DOI 10.3390/s120404352; Nasseri M, 2017, IEEE T VEH TECHNOL, V66, P344, DOI 10.1109/TVT.2016.2535438; Pan JS, 2019, IEEE T VLSI SYST, V27, P1614, DOI 10.1109/TVLSI.2019.2903289; Pan JS, 2018, J INTERNET TECHNOL, V19, P1717, DOI 10.3966/160792642018111906009; Rahman Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197087; Ren J, 2016, IEEE T IND INFORM, V12, P788, DOI 10.1109/TII.2015.2411231; Wang WP, 2008, IEEE ICC, P1630, DOI 10.1109/ICC.2008.315; Xu KA, 2010, IEEE T MOBILE COMPUT, V9, P145, DOI 10.1109/TMC.2009.105; Yao YJ, 2015, IEEE ACM T NETWORK, V23, P810, DOI 10.1109/TNET.2014.2306592; Yildiz HU, 2019, IEEE T IND INFORM, V15, P719, DOI 10.1109/TII.2018.2841830; Zhang J, 2020, INFORM FUSION, V56, P103, DOI 10.1016/j.inffus.2019.10.008; Zhang J, 2019, WIREL NETW, V25, P1875, DOI 10.1007/s11276-017-1653-4; Zhang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196705; Zhang J, 2017, J NETW COMPUT APPL, V91, P75, DOI 10.1016/j.jnca.2017.05.001; Zhang J, 2015, ADV INTELL SYST, V370, P361, DOI 10.1007/978-3-319-21206-7_30; Zhou BP, 2017, IEEE T MOBILE COMPUT, V16, P2955, DOI 10.1109/TMC.2016.2640294	32	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226649	10.1371/journal.pone.0226649	http://dx.doi.org/10.1371/journal.pone.0226649			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910202	Green Published, gold			2022-12-26	WOS:000534333800013
J	Draper, ACE; Wilson, Z; Maile, C; Faccenda, D; Campanella, M; Piercy, RJ				Draper, Alexandra C. E.; Wilson, Zoe; Maile, Charlotte; Faccenda, Danilo; Campanella, Michelangelo; Piercy, Richard J.			Species-specific consequences of an E40K missense mutation in superoxide dismutase 1 (SOD1)	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; degenerative myelopathy; dog; horse; superoxide dismutase 1	CANINE DEGENERATIVE MYELOPATHY; COMPLEX-I; SELECTIVE VULNERABILITY; MOTOR-NEURONS; WILD-TYPE; ALS; PROTEIN; AGGREGATION; DISEASE; RNA	A glutamic acid to lysine (E40K) residue substitution in superoxide dismutase 1 (SOD1) is associated with canine degenerative myelopathy: the only naturally occurring large animal model of amyotrophic lateral sclerosis (ALS). The E40 residue is highly conserved across mammals, except the horse, which naturally carries the (dog mutant) K40 residue. Here we hypothesized that in vitro expression of mutant dog SOD1 would recapitulate features of human ALS (ie, SOD1 protein aggregation, reduced cell viability, perturbations in mitochondrial morphology and membrane potential, reduced ATP production, and increased superoxide ion levels); further, we hypothesized that an equivalent equine SOD1 variant would share similar perturbations in vitro, thereby explain horses' susceptibility to certain neurodegenerative diseases. As in human ALS, expression of mutant dog SOD1 was associated with statistically significant increased aggregate formation, raised superoxide levels (ROS), and altered mitochondrial morphology (increased branching (form factor)), when compared to wild-type dog SOD1-expressing cells. Similar deficits were not detected in cells expressing the equivalent horse SOD1 variant. Our data helps explain the ALS-associated cellular phenotype of dogs expressing the mutant SOD1 protein and reveals that species-specific sequence conservation does not necessarily predict pathogenicity. The work improves understanding of the etiopathogenesis of canine degenerative myelopathy.	[Draper, Alexandra C. E.; Wilson, Zoe; Maile, Charlotte; Piercy, Richard J.] Univ London, Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Faccenda, Danilo; Campanella, Michelangelo] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, Mitochondrial Cell Biol & Pharmaceut Res Unit, London, England; [Campanella, Michelangelo] Univ London, Univ Coll London, Univ Coll London Consortium Mitochondrial Res, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University College London	Piercy, RJ (corresponding author), Royal Vet Coll, Comparat Neuromuscular Dis Lab, 4 Royal Coll St, London NW1 0TU, England.	rpiercy@rvc.ac.uk	Campanella, Michelangelo/K-8172-2016	Campanella, Michelangelo/0000-0002-6948-4184	Horserace Betting Levy Board [RS251]; BBSRC [BB/I013695/1, BB/N007042/1] Funding Source: UKRI	Horserace Betting Levy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Alex Draper's PhD was kindly funded by the Horserace Betting Levy Board (RS251).	Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Abu-Hamad S, 2017, ACS CHEM NEUROSCI, V8, P2225, DOI 10.1021/acschemneuro.7b00140; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Berglund AC, 2018, RBPDB DATABASE RNA B; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chung CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06543-0; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; Coussee E, 2011, CELL CALCIUM, V49, P217, DOI 10.1016/j.ceca.2011.02.004; Crisp MJ, 2013, EXP NEUROL, V248, P1, DOI 10.1016/j.expneurol.2013.05.009; Crown AM, 2019, G3-GENES GENOM GENET, V9, P719, DOI 10.1534/g3.118.200787; Deheshi S, 2015, J NEUROCHEM, V133, P684, DOI 10.1111/jnc.13090; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Draper ACE, 2018, J VET INTERN MED, V32, P1397, DOI 10.1111/jvim.15142; Finno CJ, 2012, J VET INTERN MED, V26, P1251, DOI 10.1111/j.1939-1676.2012.00994.x; Ge WW, 2006, NEUROBIOL DIS, V23, P342, DOI 10.1016/j.nbd.2006.03.007; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Goodwin M, 2015, CELL REP, V12, P1159, DOI 10.1016/j.celrep.2015.07.029; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Green SL, 2002, J HERED, V93, P119, DOI 10.1093/jhered/93.2.119; Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407; Henriques SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191274; Hildyard John C W, 2018, J Neuromuscul Dis, V5, P177, DOI 10.3233/JND-170267; Hildyard John C W, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.faafdde4bea8df4aa7d06cd5553119a6; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Innovagen, 2015, INN PROT CALC; Ivansson EL, 2016, P NATL ACAD SCI USA, V113, pE3091, DOI 10.1073/pnas.1600084113; Katz ML, 2017, J NEUROL SCI, V378, P193, DOI 10.1016/j.jns.2017.05.009; Kaufmann W, 2012, TOXICOL PATHOL, V40, P87, DOI 10.1177/0192623312439125; Keskin I, 2017, AMYOTROPH LAT SCL FR, V18, P457, DOI 10.1080/21678421.2017.1301481; Keskin I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150133; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kobatake Y, 2017, J NEUROL SCI, V372, P369, DOI 10.1016/j.jns.2016.10.034; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Lee DY, 2015, EXP NEUROBIOL, V24, P226, DOI 10.5607/en.2015.24.3.226; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Librado P, 2017, SCIENCE, V356, P442, DOI 10.1126/science.aam5298; Maile CA, 2017, BBA-GEN SUBJECTS, V1861, P3388, DOI 10.1016/j.bbagen.2016.08.021; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; MOHAMMED HO, 1994, VET RES, V25, P275; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nakamae S, 2015, NEUROSCIENCE, V303, P229, DOI 10.1016/j.neuroscience.2015.06.066; Naylor RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042317; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Raimondi A, 2006, EUR J NEUROSCI, V24, P387, DOI 10.1111/j.1460-9568.2006.04922.x; Richardson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068256; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi Y, 2014, PROTEIN SCI, V23, P1417, DOI 10.1002/pro.2526; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; Wang H, 2018, BONE, V106, P126, DOI 10.1016/j.bone.2017.10.010; Windley Z, 2012, COMP BIOMEDICAL SCI, P94; Zimmennan MC, 2007, J NEUROCHEM, V102, P609, DOI 10.1111/j.1471-4159.2007.04502.x	70	1	1	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					458	473		10.1096/fj.201901455R	http://dx.doi.org/10.1096/fj.201901455R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914665	Green Accepted			2022-12-26	WOS:000507308900032
J	Maller, SM; Cagnoni, AJ; Bannoud, N; Sigaut, L; Saez, JMP; Pietrasanta, LI; Yang, RY; Liu, FT; Croci, DO; Di Lella, S; Sundblad, V; Rabinovich, GA; Marino, KV				Maller, Sebastian M.; Cagnoni, Alejandro J.; Bannoud, Nadia; Sigaut, Lorena; Perez Saez, Juan M.; Pietrasanta, Lia I.; Yang, Ri-Yao; Liu, Fu-Tong; Croci, Diego O.; Di Lella, Santiago; Sundblad, Victoria; Rabinovich, Gabriel A.; Marino, Karina V.			An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans	FASEB JOURNAL			English	Article						adipose tissue; angiogenesis; galectins; glycosylation	HYPOXIA-DRIVEN ANGIOGENESIS; INSULIN SENSITIVITY; MOLECULAR-DYNAMICS; OBESITY; PROTEIN; INFLAMMATION; SPECIFICITY; MODULATION; MECHANISMS; EXPRESSION	Upon overnutrition, adipocytes activate a homeostatic program to adjust anabolic pressure. An inflammatory response enables adipose tissue (AT) expansion with concomitant enlargement of its capillary network, and reduces energy storage by increasing insulin resistance. Galectin-12 (Gal-12), an endogenous lectin preferentially expressed in AT, plays a key role in adipocyte differentiation, lipolysis, and glucose homeostasis. Here, we reveal biochemical and biophysical determinants of Gal-12 structure, including its preferential recognition of 3-fucosylated structures, a unique feature among members of the galectin family. Furthermore, we identify a previously unanticipated role for this lectin in the regulation of angiogenesis within AT. Gal-12 showed preferential localization within the inner side of lipid droplets, and its expression was upregulated under hypoxic conditions. Through glycosylation-dependent binding to endothelial cells, Gal-12 promoted in vitro angiogenesis. Moreover, analysis of in vivo AT vasculature showed reduced vascular networks in Gal-12-deficient (Lgals12(-/-)) compared to wild-type mice, supporting a role for this lectin in AT angiogenesis. In conclusion, this study unveils biochemical, topological, and functional features of a hypoxia-regulated galectin in AT, which modulates endothelial cell function through recognition of 3-fucosylated glycans. Thus, glycosylation-dependent programs may control AT homeostasis by modulating endothelial cell biology with critical implications in metabolic disorders and inflammation.	[Maller, Sebastian M.; Cagnoni, Alejandro J.; Marino, Karina V.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Glicom Func & Mol, C1428ADN, Buenos Aires, DF, Argentina; [Maller, Sebastian M.; Perez Saez, Juan M.; Sundblad, Victoria; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, C1428ADN, Buenos Aires, DF, Argentina; [Bannoud, Nadia; Croci, Diego O.] Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Lab Inmunopatol,IHEM, Mendoza, Argentina; [Sigaut, Lorena; Pietrasanta, Lia I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Pietrasanta, Lia I.] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires IFIBA, Buenos Aires, DF, Argentina; [Pietrasanta, Lia I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CMA, Buenos Aires, DF, Argentina; [Yang, Ri-Yao] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Croci, Diego O.] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Mendoza, Argentina; [Di Lella, Santiago] Consejo Nacl Invest Cient & Tecn, Inst Quim Biol Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Di Lella, Santiago; Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Marino, KV (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Glicom Func & Mol, C1428ADN, Buenos Aires, DF, Argentina.; Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, C1428ADN, Buenos Aires, DF, Argentina.	gabriel.r@ibyme.conicet.gov.ar; kmarino@ibyme.conicet.gov.ar	Liu, FU-TONG/A-5749-2019; Croci, Diego/AAJ-5709-2021; Yang, Riyao/R-7593-2019	Liu, FU-TONG/0000-0002-3354-1001; Croci, Diego/0000-0002-8623-0645; Yang, Riyao/0000-0002-0278-4385; Sigaut, Lorena/0000-0001-9417-9600; Marino, Karina Valeria/0000-0002-0581-8640; PIETRASANTA, LIA/0000-0002-2714-3162; Maller, Sebastian M./0000-0001-5536-7596	CONICET; Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-0564, PICT V 2014-3687, PICT 2016-0205]; University of Buenos Aires [20020120100276]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires)	CONICET; Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; The Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica, Grant/Award Number: PICT 2015-0564, PICT V 2014-3687 and PICT 2016-0205; The University of Buenos Aires, Grant/Award Number: 20020120100276; 2013-2015	Aanhane E, 2018, ANGIOGENESIS, V21, P545, DOI 10.1007/s10456-018-9607-8; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Bum-Erdene K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20289; Cagnoni AJ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00109; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Case D.A., 2014, AMBER, V14, P29; Cerliani JP, 2017, TRENDS BIOCHEM SCI, V42, P255, DOI 10.1016/j.tibs.2016.11.003; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Croci DO, 2014, GLYCOBIOLOGY, V24, P1283, DOI 10.1093/glycob/cwu083; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; Dam TK, 2010, GLYCOBIOLOGY, V20, P1061, DOI 10.1093/glycob/cwq084; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Fasshauer M, 2002, EUR J ENDOCRINOL, V147, P553, DOI 10.1530/eje.0.1470553; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garcia-Vallejo JJ, 2015, IMMUNITY, V42, P983, DOI 10.1016/j.immuni.2015.05.021; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Guardia CMA, 2011, J CHEM INF MODEL, V51, P1918, DOI 10.1021/ci200180h; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hefti MH, 2001, ANAL BIOCHEM, V295, P180, DOI 10.1006/abio.2001.5214; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hotta K, 2001, J BIOL CHEM, V276, P34089, DOI 10.1074/jbc.M105097200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; Katiyar A., 2009, Genomics Proteomics & Bioinformatics, V7, P185, DOI 10.1016/S1672-0229(08)60048-0; Kumar J, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00437-18; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meynier C, 2009, J BIOMOL STRUCT DYN, V27, P49, DOI 10.1080/07391102.2009.10507295; Nio-Kobayashi J, 2017, ANAT SCI INT, V92, P25, DOI 10.1007/s12565-016-0366-6; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Nugroho DB, 2018, BIOCHEM BIOPH RES CO, V503, P378, DOI 10.1016/j.bbrc.2018.06.043; Rabinovich G, 1996, J LEUKOCYTE BIOL, V59, P363, DOI 10.1002/jlb.59.3.363; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rapoport EM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P310, DOI 10.1134/S0006297910030077; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rodrigues T, 2014, ARCH PHYSIOL BIOCHEM, V120, P1, DOI 10.3109/13813455.2013.838971; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Rubio Ivonne, 2005, Biomed., V25, P34; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sundblad V, 2017, J IMMUNOL, V199, P3721, DOI 10.4049/jimmunol.1701172; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wan L, 2016, GLYCOBIOLOGY, V26, P732, DOI 10.1093/glycob/cww013; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153534; Yang RY, 2011, P NATL ACAD SCI USA, V108, P18696, DOI 10.1073/pnas.1109065108; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200	75	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					735	753		10.1096/fj.201901817R	http://dx.doi.org/10.1096/fj.201901817R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914594				2022-12-26	WOS:000507308900051
J	Qi, F; Isaji, T; Duan, CW; Yang, J; Wang, YQ; Fukuda, T; Gu, JG				Qi, Feng; Isaji, Tomoya; Duan, Chengwei; Yang, Jie; Wang, Yuqin; Fukuda, Tomohiko; Gu, Jianguo			ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the alpha 2,3-sialylation of target proteins	FASEB JOURNAL			English	Article						EGFR; glycoproteins; N-glycan; integrin beta 1; alpha 2; 3-sialyltransferase	GROWTH-FACTOR RECEPTOR; BETA-PROPELLER DOMAIN; SIALYL-LEWIS-X; N-GLYCOSYLATION; EXPRESSION PROFILES; CELL-PROLIFERATION; MOLECULAR-CLONING; ACID; CARCINOMA; SIALYLTRANSFERASES	The alpha 2,3-sialylation of N-glycans is considered important but complicated because the functions of the three beta-galactoside alpha 2,3-sialyltransferases, ST3GAL3, ST3GAL4, and ST3GAL6, could be compensating for one another. To distinguish their specific functions, we established each individual knockout (KO) cell line. Loss of either the ST3GAL3 or ST3GAL6 genes decreased cell proliferation and colony formation, as opposed to the effect in the ST3GAL4 KO cells. The phosphorylation levels of ERK and AKT were significantly suppressed in the ST3GAL6 KO and ST3GAL3 KO cells, respectively. The cell aggregations were clearly observed in the KO cells, particularly the ST3GAL3 KO and ST3GAL6 KO cells, and the expression levels of E-cadherin and claudin-1 were enhanced in both those cell lines, but were suppressed in the ST3GAL4 KO cells. Those alterations were reversed with an overexpression of each corresponding gene in rescued cells. Of particular interest, the alpha 2,3-sialylation levels of beta 1 integrin were clearly suppressed in the ST3GAL4 KO cells, but these were increased in the ST3GAL3 KO and ST3GAL6 KO cells, whereas the alpha 2,3-sialylation levels of EGFR were significantly decreased in the ST3GAL6 KO cells. The decrease in alpha 2,3-sialylation increased the alpha 2,6-sialylation on beta 1, but not EGFR. Furthermore, a cross-restoration of each of the three genes in ST3GAL6 KO cells showed that overexpression of ST3GAL6 sufficiently rescued the total alpha 2,3-sialylation levels, cell morphology, and alpha 2,3-sialylation of EGFR, whereas the alpha 2,3-sialylation levels of beta 1 were greatly enhanced by an overexpression of ST3GAL4. These results clearly demonstrate that the three alpha 2,3-sialyltransferases modify characteristic target proteins and regulate cell biological functions in different ways.	[Qi, Feng; Isaji, Tomoya; Duan, Chengwei; Yang, Jie; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Qi, Feng] Nantong Univ, Affiliated Hosp 4, Dept Pharm, Yancheng, Peoples R China; [Wang, Yuqin] Nantong Univ, Coll Pharm, Dept Pharmacol, Nantong, Peoples R China	Tohoku Medical & Pharmaceutical University; Nantong University; Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		MEXT | Japan Society for the Promotion of Science (JSPS) [15H04354, 19H03184, 19K07049]; National Natural Science Foundation of China (NSFC) [31670807]; Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau [YB2017072]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18H04868]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H04354, 19H03184 and 19K07049; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31670807; Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau, Grant/Award Number: YB2017072; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 18H04868	Aco-Tlachi M, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0197-2; Arike L, 2017, GLYCOBIOLOGY, V27, P318, DOI 10.1093/glycob/cww134; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; Chachadi VB, 2015, GLYCOBIOLOGY, V25, P963, DOI 10.1093/glycob/cwv030; Chung CY, 2015, BIOCHEM BIOPH RES CO, V463, P211, DOI 10.1016/j.bbrc.2015.05.023; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Dall'Olio F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050998; Dewald JH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5040043; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Engelstaedter V, 2012, HISTOL HISTOPATHOL, V27, P507, DOI 10.14670/HH-27.507; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hatcher BL, 2016, INFECT IMMUN, V84, P2607, DOI 10.1128/IAI.01514-15; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inokuchi J, 2018, PROG MOL BIOL TRANSL, V156, P151, DOI 10.1016/bs.pmbts.2017.10.004; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jahangiri A, 2014, CANCER RES, V74, P3, DOI 10.1158/0008-5472.CAN-13-1742; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Jin Xiao-Ling, 2004, Hepatobiliary Pancreat Dis Int, V3, P292; Jin Y, 2016, CLIN CHEM LAB MED, V54, P1811, DOI 10.1515/cclm-2015-1014; Kawamura YI, 2014, CANCER GENE THER, V21, P427, DOI 10.1038/cgt.2014.46; Kim HS, 2017, J BIOL CHEM, V292, P10664, DOI 10.1074/jbc.M117.782425; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kolasinska E, 2016, ACTA BIOCHIM POL, V63, P533, DOI 10.18388/abp.2015_1221; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kudo T, 1998, LAB INVEST, V78, P797; Kurokawa K, 2019, J CELL BIOL, V218, P1602, DOI 10.1083/jcb.201807194; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lopez-Morales D, 2009, INVEST CLIN, V50, P45; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085113; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Perez-Garay M, 2013, INT J BIOCHEM CELL B, V45, P1748, DOI 10.1016/j.biocel.2013.05.015; Perez-Garay M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012524; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Recchi MA, 1998, CANCER RES, V58, P4066; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Sasaki K, 2019, CELL STRUCT FUNCT, V44, P85, DOI 10.1247/csf.19010; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shimizu S, 2019, J BIOCHEM, V165, P101, DOI 10.1093/jb/mvy068; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Suzuki O, 2015, INT J ONCOL, V46, P973, DOI 10.3892/ijo.2015.2818; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Takahashi T, 2008, PROTEOM CLIN APPL, V2, P1246, DOI 10.1002/prca.200700119; Teppa RE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081286; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Van Slambrouck S, 2014, BIOSCIENCE REP, V34, P546, DOI 10.1042/BSR20140096; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Velazquez-Marquez N, 2012, J BIOSCIENCES, V37, P999, DOI 10.1007/s12038-012-9261-z; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Yuan Y, 2016, LIFE SCI, V149, P138, DOI 10.1016/j.lfs.2016.02.071; Zhang GW, 2019, FASEB J, V33, P2823, DOI 10.1096/fj.201801478R; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhou XX, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122475	82	25	25	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					881	897		10.1096/fj.201901793R	http://dx.doi.org/10.1096/fj.201901793R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914669	Bronze			2022-12-26	WOS:000507308900060
J	Zhang, CJ; Wang, Y; Peng, YN; Xu, HJ; Zhou, XL				Zhang, Chenjing; Wang, Yin; Peng, Yunan; Xu, Hongjiao; Zhou, Xuelong			METTL3 regulates inflammatory pain by modulating m(6)A-dependent pri-miR-365-3p processing	FASEB JOURNAL			English	Article						central sensitization; inflammatory pain; METTL3; N-6-methyladenosine; spinal cord	RNA MODIFICATIONS; N-6-METHYLADENOSINE; M(6)A; GENE; HYPERSENSITIVITY; MECHANISMS; LANDSCAPE; MICRORNA; RAT; FTO	N-6-methyladenosine (m(6)A) modification in RNA has been implicated in diverse biological processes. However, very little is currently known about its role in nociceptive modulation. Here, we found that the level of spinal m(6)A modification was significantly increased in a mouse model of Complete Freund's Adjuvant (CFA)-induced chronic inflammatory pain, which was accompanied with the augmentation of methyltransferase-like 3 (METTL3) expression in the spinal cord. Knockdown of spinal METTL3 prevented and reversed CFA-induced pain behaviors and spinal neuronal sensitization. In contrast, overexpression of spinal METTL3 produced pain behaviors and neuronal sensitization in naive mice. Moreover, we found that METTL3 positively modulated the pri-miR-65-3p processing in a microprocessor protein DiGeorge critical region 8-dependent manner. Collectively, our findings reveal an important role of METTL3-mediated m(6)A modification in nociceptive sensitization and provide a novel perspective on m(6)A modification in the development of pathological pain.	[Zhang, Chenjing] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Peoples R China; [Wang, Yin] Taizhou Peoples Hosp, Dept Anesthesiol, Taizhou, Peoples R China; [Peng, Yunan] Nanjing Univ, Dept Anesthesiol, Affiliated Drum Tower Hosp, Sch Med, Nanjing, Peoples R China; [Xu, Hongjiao] Shanghai Transportat Univ, Peoples Hosp 1, Dept Anesthesiol, Shanghai, Peoples R China; [Zhou, Xuelong] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China	Zhejiang Provincial People's Hospital; Nanjing University; Shanghai Jiao Tong University; Nanjing Medical University	Zhou, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China.	zhouxuelong0258@126.com			 [81701101]		Xuelong Zhou, Grant/Award Number: 81701101	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Engel M, 2018, NEURON, V99, P389, DOI 10.1016/j.neuron.2018.07.009; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fry Nate J, 2018, Oncotarget, V9, P31231, DOI 10.18632/oncotarget.25782; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Koranda JL, 2018, NEURON, V99, P283, DOI 10.1016/j.neuron.2018.06.007; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Gonzalez MJ, 2017, PHARMACOL THERAPEUT, V180, P1, DOI 10.1016/j.pharmthera.2017.06.001; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pan ZQ, 2016, J NEUROSCI, V36, P2769, DOI 10.1523/JNEUROSCI.3474-15.2016; Rowles J, 2012, EPIGENETICS-US, V7, P1094, DOI 10.4161/epi.21977; Satterlee JS, 2014, J NEUROSCI, V34, P15170, DOI 10.1523/JNEUROSCI.3236-14.2014; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Sun WJ, 2016, NUCLEIC ACIDS RES, V44, pD259, DOI 10.1093/nar/gkv1036; Wang SY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0847-4; Wang Y, 2018, NAT NEUROSCI, V21, P195, DOI 10.1038/s41593-017-0057-1; Zhang JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09712-x; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou XL, 2017, ANESTHESIOLOGY, V126, P967, DOI 10.1097/ALN.0000000000001588	33	21	21	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					122	132		10.1096/fj.201901555R	http://dx.doi.org/10.1096/fj.201901555R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914601				2022-12-26	WOS:000507308900010
J	Zheng, C; Lin, XS; Liu, H; Lu, WG; Xu, XL; Wang, D; Gao, B; Wang, C; Zhou, JR; Fan, J; Hu, YQ; Jie, Q; Chen, D; Yang, L; Luo, ZJ				Zheng, Chao; Lin, Xisheng; Liu, He; Lu, Weiguang; Xu, Xiaolong; Wang, Di; Gao, Bo; Wang, Cheng; Zhou, Jinru; Fan, Jing; Hu, Yaqian; Jie, Qiang; Chen, Di; Yang, Liu; Luo, Zhuojing			Phenotypic characterization of Slc26a2 mutant mice reveals a multifactorial etiology of spondylolysis	FASEB JOURNAL			English	Article						bone loss; isthmic defect; spondylolysis; vertebral development	FINITE-ELEMENT-ANALYSIS; PEDIATRIC LUMBAR SPINE; NATURAL-HISTORY; RADIOGRAPHIC ASSESSMENT; CHONDROCYTE DEVELOPMENT; FOLLOW-UP; SPONDYLOLISTHESIS; GROWTH; SULFATION; PATHOMECHANISM	Confusion persists over pathogenesis of spondylolysis. To confirm pathogenicity of the previously identified causative mutation of spondylolysis and investigate the genetic etiology, we generate a new mouse line harboring D673V mutation in the Slc26a2 gene. D673V mutation induces delayed endochondral ossification characterized by transiently reduced chondrocyte proliferation in mice at the early postnatal stage. Adult D673V homozygotes exhibit dysplastic isthmus and reduced bone volume of the dorsal vertebra resembling the detached vertebral bony structure when spondylolysis occurs, including the postzygopophysis, vertebral arch, and spinous process, which causes biomechanical alterations around the isthmic region of L4-5 vertebrae indicated by finite element analysis. Consistently, partial ablation of Slc26a2 in vertebral skeletal cells using Col1a1-Cre; Slc26a2 (fl/fl) mouse line recapitulates a similar but worsened vertebral phenotype featured by lamellar isthmus. In addition, when reaching late adulthood, D673V homozygotes develop an evident bone-loss phenotype and show impaired osteogenesis. These findings support a multifactorial etiology, involving congenitally predisposed isthmic conditions, altered biomechanics, and age-dependent bone loss, which leads to SLC26A2-related spondylolysis.	[Zheng, Chao; Lin, Xisheng; Liu, He; Lu, Weiguang; Xu, Xiaolong; Wang, Di; Gao, Bo; Zhou, Jinru; Fan, Jing; Hu, Yaqian; Yang, Liu; Luo, Zhuojing] Fourth Mil Med Univ, Inst Orthoped Surg, Xijing Hosp, Xian, Peoples R China; [Wang, Cheng] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Jie, Qiang] Xi An Jiao Tong Univ, Hong Hui Hosp, Dept Orthoped Surg, Coll Med, Xian, Peoples R China; [Chen, Di] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Yang, Liu; Luo, Zhuojing] Northwestern Polytech Univ, Med Res Inst, Xian, Peoples R China	Air Force Military Medical University; University of Hong Kong; Xi'an Jiaotong University; Rush University; Northwestern Polytechnical University	Yang, L; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Inst Orthoped Surg, Xijing Hosp, Xian, Peoples R China.	yangliu@fmmu.edu.cn; zjluo@fmmu.edu.cn		Yang, Liu/0000-0002-6498-4702; Zheng, Chao/0000-0001-8530-0923	National Natural Science Foundation of China [81972032, 81730065, 81871743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81972032, 81730065 and 81871743	ALBANESE M, 1982, J PEDIATR ORTHOPED, V2, P496, DOI 10.1097/01241398-198212000-00006; Bajwa NS, 2012, CLIN ORTHOP RELAT R, V470, P3202, DOI 10.1007/s11999-012-2439-8; Belfi LM, 2006, SPINE, V31, pE907, DOI 10.1097/01.brs.0000245947.31473.0a; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Cai T, 2015, P NATL ACAD SCI USA, V112, P8064, DOI 10.1073/pnas.1502454112; Cavalier R, 2006, J AM ACAD ORTHOP SUR, V14, P417, DOI 10.5435/00124635-200607000-00004; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Dwyer E, 2010, AM J MED GENET A, V152A, P3043, DOI 10.1002/ajmg.a.33736; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Fagan MJ, 2002, P I MECH ENG H, V216, P281, DOI 10.1243/09544110260216568; Foreman P, 2013, CHILD NERV SYST, V29, P209, DOI 10.1007/s00381-012-1942-2; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699, DOI 10.2106/00004623-198466050-00008; Gao B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099137; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; GOLDSTEIN JD, 1991, AM J SPORT MED, V19, P463, DOI 10.1177/036354659101900507; Gualeni B, 2013, BONE, V54, P83, DOI 10.1016/j.bone.2013.01.036; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Hajjioui A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P53, DOI 10.1016/j.rehab.2010.12.001; Hammerberg KW, 2005, SPINE, V30, pS4, DOI 10.1097/01.brs.0000155576.62159.1c; He LC, 2014, EUR RADIOL, V24, P441, DOI 10.1007/s00330-013-3041-5; Ivo R, 2007, EUR SPINE J, V16, P1636, DOI 10.1007/s00586-006-0293-7; Kang HJ, 2014, J ORTHOP SCI, V19, P682, DOI 10.1007/s00776-012-0324-7; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Kumar N, 2000, ANAT RECORD, V260, P189, DOI 10.1002/1097-0185(20001001)260:2<189::AID-AR80>3.0.CO;2-N; Lawrence KJ, 2016, PHYS THER SPORT, V20, P56, DOI 10.1016/j.ptsp.2016.04.003; Leone A, 2011, SKELETAL RADIOL, V40, P683, DOI 10.1007/s00256-010-0942-0; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; OGILVIE JW, 1987, SPINE, V12, P251, DOI 10.1097/00007632-198704000-00010; Remes VM, 2002, EUR SPINE J, V11, P327, DOI 10.1007/s00586-002-0413-y; Rossi A, 1996, J BIOL CHEM, V271, P18456, DOI 10.1074/jbc.271.31.18456; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; ROSSI F, 1978, J SPORT MED PHYS FIT, V18, P317; ROWE GG, 1953, J BONE JOINT SURG AM, V35-A, P102, DOI 10.2106/00004623-195335010-00010; Sairyo K, 2006, EUR SPINE J, V15, P930, DOI 10.1007/s00586-005-1033-0; Sairyo K, 2006, EUR SPINE J, V15, P923, DOI 10.1007/s00586-005-1026-z; Sairyo K, 2015, J MED INVESTIG, V62, P11, DOI 10.2152/jmi.62.11; Sakai T, 2010, J ORTHOP SCI, V15, P281, DOI 10.1007/s00776-010-1454-4; SARASTE H, 1987, J PEDIATR ORTHOPED, V7, P631; SIMPER LB, 1986, ACTA ORTHOP SCAND, V57, P78, DOI 10.3109/17453678608993222; Tabrizi P, 2001, SPINE, V26, P1482, DOI 10.1097/00007632-200107010-00020; TURNER RH, 1971, J BONE JOINT SURG AM, VA 53, P1298, DOI 10.2106/00004623-197153070-00005; Vogt MT, 1999, SPINE, V24, P2536, DOI 10.1097/00007632-199912010-00016; Walter JD, 2019, ELIFE, P8; Wang C, 2018, ELIFE, V7, DOI 10.7554/eLife.37673; Ward CV, 2007, SPINE, V32, pE85, DOI 10.1097/01.brs.0000252200.66545.43; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; WYNNEDAVIES R, 1979, J BONE JOINT SURG BR, V61, P301, DOI 10.1302/0301-620X.61B3.383720; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yue R, 2016, ELIFE, V5, DOI 10.7554/eLife.18782; Zehnder SW, 2009, SPINE, V34, P285, DOI 10.1097/BRS.0b013e3181956053; Zhang ST, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0723-3; Zheng C, 2019, EBIOMEDICINE, V40, P695, DOI 10.1016/j.ebiom.2019.01.010; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570	57	3	3	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					720	734		10.1096/fj.201901040RR	http://dx.doi.org/10.1096/fj.201901040RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914611				2022-12-26	WOS:000507308900050
J	Hector, A; McAnulty, C; Piche-Lemieux, ME; Alves-Pires, C; Buee-Scherrer, V; Buee, L; Brouillette, J				Hector, Audrey; McAnulty, Christina; Piche-Lemieux, Maude-Eloise; Alves-Pires, Claire; Buee-Scherrer, Valerie; Buee, Luc; Brouillette, Jonathan			Tau hyperphosphorylation induced by the anesthetic agent ketamine/xylazine involved the calmodulin-dependent protein kinase II	FASEB JOURNAL			English	Article						anesthesia; CaMKII; ketamine; tau; xylazine	KETAMINE; PHOSPHORYLATION; INHIBITION; RECEPTOR; HIPPOCAMPUS; PROPOFOL; XYLAZINE; CHANNELS; NEURONS; MODELS	Tau hyperphosphorylation is a major neuropathological hallmark of many neurodegenerative disorders such as Alzheimer's disease. Several anesthetics have been shown previously to induced marked tau hyperphosphorylation. Although the ketamine/xylazine mixture is one of the most commonly used anesthetic agents in animal research and veterinary practice, the effect of this anesthetic agent on tau phosphorylation still remains to be determined. Here, we found that ketamine-/xylazine-induced a rapid and robust hyperphosphorylation of tau in a dose-dependent manner under normothermic and hypothermic conditions in mice. When used together, ketamine and xylazine exerted a synergistic action on tau phosphorylation most strongly not only on epitopes S396 and S262, but also on other residues (T181, and S202/T205). We observed that activation of the calmodulin-dependent protein kinase II (CaMKII) is the major upstream molecular event leading to tau hyperphosphorylation following ketamine/xylazine anesthesia in mice. Moreover, we observed that intracerebroventricular injection of the selective CaMKII inhibitor KN93 attenuated tau hyperphosphorylation. Since ketamine/xylazine also had a marked impact on other key molecular signaling pathways involving the MAP/microtubule affinity-regulating kinase (MARK), extracellular signal-regulated kinase (ERK), and glycogen synthase kinase-3 (GSK3), our study calls for high caution and careful monitoring when using this anesthetic agent in laboratory animal settings across all fields of biological sciences in order to avoid artifactual results.	[Hector, Audrey; McAnulty, Christina; Piche-Lemieux, Maude-Eloise; Brouillette, Jonathan] Univ Montreal, Hop Sacre Coeur, Montreal Res Ctr, Dept Pharmacol & Physiol,CIUSSS NIM, Montreal, PQ, Canada; [Alves-Pires, Claire; Buee-Scherrer, Valerie; Buee, Luc] Univ Lille, INSERM, CHU Lille, Alzheimer & Tauopathies, F-59000 Lille, France	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Brouillette, J (corresponding author), Univ Montreal, Hop Sacre Coeur, Montreal Res Ctr, Dept Pharmacol & Physiol,CIUSSS NIM, Montreal, PQ, Canada.; Buee, L (corresponding author), Univ Lille, INSERM, CHU Lille, Alzheimer & Tauopathies, F-59000 Lille, France.	luc.buee@inserm.fr; jonathan.brouillette@umontreal.ca	BUEE, Luc/B-3126-2010; Brouillette, Jonathan/AAF-6735-2020	BUEE, Luc/0000-0002-6261-4230; Brouillette, Jonathan/0000-0003-1058-1892; McAnulty, Christina/0000-0003-2787-2792	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency(French National Research Agency (ANR))	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ando K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005917; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Cui X, 2009, J NEUROSURG ANESTH, V21, P145, DOI 10.1097/ANA.0b013e31819ac2c0; Dujardin S, 2015, NEUROPATH APPL NEURO, V41, P59, DOI 10.1111/nan.12200; Friederich P, 2001, EUR J ANAESTH, V18, P177, DOI 10.1046/j.0265-0215.2000.00807.x; GAGE PW, 1985, BRIT J PHARMACOL, V85, P675, DOI 10.1111/j.1476-5381.1985.tb10563.x; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hatakeyama N, 2001, J Anesth, V15, P149, DOI 10.1007/s005400170017; Hirota K, 1996, BRIT J ANAESTH, V77, P441, DOI 10.1093/bja/77.4.441; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; Jin HY, 2013, NEURAL REGEN RES, V8, P1590, DOI 10.3969/j.issn.1673-5374.2013.17.007; Kitayama M, 2002, N-S ARCH PHARMACOL, V366, P246, DOI 10.1007/s00210-002-0590-6; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Lebouvier T, 2017, CURR OPIN NEUROL, V30, P589, DOI 10.1097/WCO.0000000000000502; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Schnoebel R, 2005, BRIT J PHARMACOL, V146, P826, DOI 10.1038/sj.bjp.0706385; SCHOLFIELD CN, 1980, PFLUG ARCH EUR J PHY, V383, P249, DOI 10.1007/BF00587527; Schwartz DD, 1998, J VET PHARMACOL THER, V21, P107, DOI 10.1046/j.1365-2885.1998.00113.x; Tan WF, 2010, EUR J ANAESTH, V27, P835, DOI 10.1097/EJA.0b013e32833a6561; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wen GH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00287; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Yamakura T, 2000, ANESTHESIOLOGY, V92, P1144, DOI 10.1097/00000542-200004000-00033; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008	40	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2968	2977		10.1096/fj.201902135R	http://dx.doi.org/10.1096/fj.201902135R		DEC 2019	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908108				2022-12-26	WOS:000504668000001
J	Park, D; Yoon, HJ; Lee, KY; Park, SJ; Cheon, SH; Lee, HH; Lee, SJ; Lee, BJ				Park, DongWon; Yoon, Hye-Jin; Lee, Ki-Young; Park, Sung-Jean; Cheon, Seung-Ho; Lee, Hyung Ho; Lee, Sang Jae; Lee, Bong-Jin			Crystal structure of proteolyzed VapBC and DNA-bound VapBC from Salmonella enterica Typhimurium LT2 and VapC as a putative Ca2+-dependent ribonuclease	FASEB JOURNAL			English	Article						DNA-free and -bound VapBC complex; toxin-antitoxin; VapC	TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; PIN-DOMAIN; TUBERCULOSIS REVEALS; INHIBITS TRANSLATION; STATISTICAL-ANALYSIS; STRESS-RESPONSE; MESSENGER-RNA; BINDING; COMPLEX	Bacterial toxin-antitoxin (TA) system has gained attention for its essential roles in cellular maintenance and survival under harsh environmental conditions such as nutrient deficiency and antibiotic treatment. There are at least 14 TA systems in Salmonella enterica serovar Typhimurium LT2, a pathogenic bacterium, and none of the structures of these TA systems have been determined. We determined the crystal structure of the VapBC TA complex from S. Typhimurium LT2 in proteolyzed and DNA-bound forms at 2.0 angstrom and 2.8 angstrom resolution, respectively. The VapC toxin possesses a pilT N-terminal domain (PIN-domain) that shows ribonuclease activity, and the VapB antitoxin has an AbrB-type DNA binding domain. In addition, the structure revealed details of interaction mode between VapBC and the cognate promoter DNA, including the inhibition of VapC by VapB and linear conformation of bound DNA in the VapBC complex. The complexation of VapBC with the linear DNA is not consistent with known structures of VapBC homologs in complex with bent DNA. We also identified VapC from S. Typhimurium LT2 as a putative Ca2+-dependent ribonuclease, which differs from previous data showing that VapC homologs have Mg2+ or Mn2+-dependent ribonuclease activities. The present studies could provide structural understanding of the physiology of VapBC systems and foundation for the development of new antibiotic drugs against Salmonella infection.	[Park, DongWon; Cheon, Seung-Ho; Lee, Bong-Jin] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 08826, South Korea; [Yoon, Hye-Jin; Lee, Hyung Ho] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea; [Lee, Ki-Young] Univ Toronto, Dept Med Biophys, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Park, Sung-Jean] Gachon Univ, Coll Pharm, Incheon, South Korea; [Lee, Sang Jae] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Gachon University; Pohang University of Science & Technology (POSTECH)	Lee, BJ (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 08826, South Korea.	lbj@nmr.snu.ac.kr	Lee, Sang Jae/AAX-7611-2021; Lee, Bong-Jin/AAQ-1609-2020	Lee, Sang Jae/0000-0002-5366-2900; Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea (NRF) [2018R1A2A1A19018526, 2018R1A5A2024425]; 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea (NRF), Grant/Award Number: 2018R1A2A1A19018526 and 2018R1A5A2024425; 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	Aakre CD, 2013, MOL CELL, V52, P617, DOI 10.1016/j.molcel.2013.10.014; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bendtsen KL, 2017, NUCLEIC ACIDS RES, V45, P2875, DOI 10.1093/nar/gkw1266; Brielle R, 2016, CURR OPIN MICROBIOL, V30, P114, DOI 10.1016/j.mib.2016.01.009; Cates MS, 2002, BIOPHYS J, V82, P1133, DOI 10.1016/S0006-3495(02)75472-6; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Cooper CR, 2009, BIOCHEM SOC T, V37, P123, DOI 10.1042/BST0370123; Corona RI, 2016, PROTEINS, V84, P1147, DOI 10.1002/prot.25061; Coussens NP, 2016, EXP BIOL MED, V241, P1332, DOI 10.1177/1535370216651938; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Das U, 2014, J STRUCT BIOL, V188, P249, DOI 10.1016/j.jsb.2014.10.002; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kang SM, 2017, NUCLEIC ACIDS RES, V45, P8564, DOI 10.1093/nar/gkx489; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee IG, 2015, NUCLEIC ACIDS RES, V43, P7624, DOI 10.1093/nar/gkv689; Lee KY, 2016, TOXINS, V8, DOI 10.3390/toxins8100305; MAKAROVA KS, 2009, BIOL DIRECT, V4; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1155, DOI 10.1016/j.bbapap.2013.02.027; Perticaroli S, 2014, BIOPHYS J, V106, P2667, DOI 10.1016/j.bpj.2014.05.009; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	63	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3051	3068		10.1096/fj.201901989R	http://dx.doi.org/10.1096/fj.201901989R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908032				2022-12-26	WOS:000504067300001
J	Sekulovski, N; Whorton, AE; Shi, MX; Hayashi, K; MacLean, JA				Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II			Periovulatory insulin signaling is essential for ovulation, granulosa cell differentiation, and female fertility	FASEB JOURNAL			English	Article						female reproduction; insulin signaling; knockout mouse; ovary	GROWTH-FACTOR RECEPTOR; OVARIAN GRANULOSA; TARGETED DISRUPTION; MICE; GENES; EXPRESSION; PROGESTERONE; ACTIVATION; FOLLICLE; E2A	Recent studies have demonstrated an essential role for insulin signaling in folliculogenesis as conditional ablation of Igf1r in primary follicles elicits defective follicle-stimulating hormone responsiveness blocking development at the preantral stage. Thus the potential role of insulin action in the periovulatory window and in the corpus luteum is unknown. To examine this, we generated conditional Insr,Igf1r, and double receptor knockout mice driven by Pgr-Cre. These models escape the preantral follicle block and in response to superovulatory gonadotropins exhibit normal distribution of ovarian follicles and corpora lutea. However, single ablation of Igf1r leads to subfertility and mice lacking both receptors are infertile. Double knockout mice have impaired oocyte development and ovulation. While some oocytes are released and fertilized, subsequent embryo development is retarded, and the embryos potentially fail to thrive due to lack of luteal support. In support of this, we found reduced expression of key enzymes in the steroid synthesis pathway and reduced serum progesterone. In addition to metabolic and steroidogenic pathways, RNA-sequencing analysis revealed transcription factor-3 as an important transcription factor downstream of insulin signaling. Collectively, these results highlight the importance of growth factors of the insulin family during two distinct windows of follicular development, ovulation, and luteinization.	[Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II] Southern Illinois Univ, Sch Med, Dept Physiol, Life Sci 3, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University	MacLean, JA (corresponding author), Southern Illinois Univ, Dept Physiol, Life Sci 3,Room 2071,1135 Lincoln Dr, Carbondale, IL 62901 USA.	jmaclean@siumed.edu		Whorton, Allison/0000-0003-2983-401X; Hayashi, Kanako/0000-0002-5028-799X				Abazari-Kia AH, 2014, J ASSIST REPROD GEN, V31, P313, DOI 10.1007/s10815-013-0159-y; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bassuk AG, 1998, MOL MED, V4, P392, DOI 10.1007/BF03401746; Baumgarten SC, 2017, ENDOCRINOLOGY, V158, P2309, DOI 10.1210/en.2017-00146; Baumgarten SC, 2014, J CLIN ENDOCR METAB, V99, P2995, DOI 10.1210/jc.2014-1139; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Bhalla S, 2008, J IMMUNOL, V180, P1694, DOI 10.4049/jimmunol.180.3.1694; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buensuceso AV, 2016, ENDOCRINOLOGY, V157, P942, DOI 10.1210/en.2015-1216; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Choi Y, 2018, J CLIN ENDOCR METAB, V103, P4241, DOI 10.1210/jc.2017-02532; Choi Y, 2017, J CLIN ENDOCR METAB, V102, P1971, DOI 10.1210/jc.2016-3153; Davis BJ, 1999, ENDOCRINOLOGY, V140, P2685, DOI 10.1210/en.140.6.2685; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dunning KR, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127274; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Dupont J, 2016, BIOCHEM J, V473, P1483, DOI 10.1042/BCJ20160124; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Hannon PR, 2018, ENDOCRINOLOGY, V159, P2447, DOI 10.1210/en.2018-00020; Hannon PR, 2016, TOXICOL SCI, V150, P97, DOI 10.1093/toxsci/kfv317; Haywood NJ, 2019, MOL METAB, V19, P86, DOI 10.1016/j.molmet.2018.10.008; Hoang YD, 2009, BIOL REPROD, V81, P636, DOI 10.1095/biolreprod.109.078378; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kim J, 2009, MOL HUM REPROD, V15, P821, DOI 10.1093/molehr/gap082; King AM, 2009, MECH AGEING DEV, V130, P384, DOI 10.1016/j.mad.2009.03.002; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kong C, 1998, J NEUROIMMUNOL, V88, P91, DOI 10.1016/S0165-5728(98)00094-0; KRASNOW JS, 1990, MOL ENDOCRINOL, V4, P13, DOI 10.1210/mend-4-1-13; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li RT, 2016, BIOCHEM CELL BIOL, V94, P247, DOI 10.1139/bcb-2015-0162; Lim J, 2015, ENDOCRINOLOGY, V156, P3329, DOI 10.1210/en.2015-1206; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu QW, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9846274; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Luo C, 2011, J AM ASSOC LAB ANIM, V50, P471; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Munir I, 2004, ENDOCRINOLOGY, V145, P175, DOI 10.1210/en.2003-0329; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Nandi A, 2010, ENDOCRINOLOGY, V151, P1863, DOI 10.1210/en.2009-0788; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Pan YY, 2020, J CELL BIOCHEM, V121, P1087, DOI 10.1002/jcb.29345; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Prather GR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140236; Richards JS, 2018, TRENDS ENDOCRIN MET, V29, P313, DOI 10.1016/j.tem.2018.02.012; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Segales J, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0074-x; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stodden GR, 2015, ONCOGENE, V34, P2471, DOI 10.1038/onc.2014.193; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Titone R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21031-7; Walusimbi SS, 2013, J ANIM SCI, V91, P1650, DOI 10.2527/jas.2012-6179; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Welborn JP, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124834; Zhang GQ, 2000, ENDOCRINOLOGY, V141, P2735, DOI 10.1210/en.141.8.2735; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712; Zhou J, 1997, MOL ENDOCRINOL, V11, P1924, DOI 10.1210/me.11.13.1924; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307	79	15	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2376	2391		10.1096/fj.201901791R	http://dx.doi.org/10.1096/fj.201901791R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908002	Bronze, Green Accepted			2022-12-26	WOS:000514663600031
J	Skedsmo, FS; Malachin, G; Vage, DI; Hammervold, MM; Salvesen, O; Ersdal, C; Ranheim, B; Stafsnes, MH; Bartosova, Z; Bruheim, P; Jaderlund, KH; Matiasek, K; Espenes, A; Tranulis, MA				Skedsmo, Fredrik S.; Malachin, Giulia; Vage, Dag Inge; Hammervold, Mie Marie; Salvesen, Oyvind; Ersdal, Cecilie; Ranheim, Birgit; Stafsnes, Marit H.; Bartosova, Zdenka; Bruheim, Per; Jaderlund, Karin H.; Matiasek, Kaspar; Espenes, Arild; Tranulis, Michael A.			Demyelinating polyneuropathy in goats lacking prion protein	FASEB JOURNAL			English	Article						lipidomic; myelin; neuropathy; PRNP haplotype	PERIPHERAL-NERVE; MICE; PRP; INJURY; ONSET; GENE	Studies in mice with ablation of Prnp, the gene that encodes the cellular prion protein (PrP (c)), have led to the hypothesis that PrP (c) is important for peripheral nerve myelin maintenance. Here, we have used a nontransgenic animal model to put this idea to the test; namely, goats that, due to a naturally occurring nonsense mutation, lack PrP (c). Teased nerve fiber preparation revealed a demyelinating pathology in goats without PrP (c). Affected nerves were invaded by macrophages and T cells and displayed vacuolated fibers, shrunken axons, and onion bulbs. Peripheral nerve lipid composition was similar in young goats with or without PrP (c), but markedly different between corresponding groups of adult goats, reflecting the progressive nature of the neuropathy. This is the first report of a subclinical demyelinating polyneuropathy caused by loss of Pr (c) function in a nontransgenic mammal.	[Skedsmo, Fredrik S.; Jaderlund, Karin H.] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Malachin, Giulia; Espenes, Arild; Tranulis, Michael A.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Ullevalsveien 72, N-0454 Oslo, Norway; [Vage, Dag Inge; Hammervold, Mie Marie] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway; [Salvesen, Oyvind; Ersdal, Cecilie; Ranheim, Birgit] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Stafsnes, Marit H.; Bartosova, Zdenka; Bruheim, Per] Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Fac Nat Sci, Trondheim, Norway; [Matiasek, Kaspar] Ludwig Maximilians Univ Munchen, Sect Clin & Comparat Neuropathol, Ctr Clin Vet Med, Munich, Germany	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Science & Technology (NTNU); University of Munich	Tranulis, MA (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Ullevalsveien 72, N-0454 Oslo, Norway.	Michael.Tranulis@nmbu.no	Jäderlund, Karin Hultin/AAL-8211-2020; Våge, Dag Inge/AAD-5178-2020; Ranheim, Birgit/AAB-8345-2021	Våge, Dag Inge/0000-0003-2568-1554; Bartosova, Zdenka/0000-0001-5644-1903; Malachin, Giulia/0000-0003-1888-6850; Bruheim, Per/0000-0002-7851-8083	The Research Council of Norway [227386/E40] Funding Source: Medline	The Research Council of Norway(Research Council of Norway)		BRECHENMACHER C, 1987, CLIN NEUROPATHOL, V6, P19; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Dyck PJ, 1984, PERIPHERAL NEUROPATH, V1, P790; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Holcapek M, 2015, J CHROMATOGR A, V1377, P85, DOI 10.1016/j.chroma.2014.12.023; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kouadri A, 2019, ANTIOXID REDOX SIGN, V31, P59, DOI 10.1089/ars.2018.7500; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Lisa M, 2015, ANAL CHEM, V87, P7187, DOI 10.1021/acs.analchem.5b01054; Malachin G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179881; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mizisin AP, 1998, ACTA NEUROPATHOL, V95, P171, DOI 10.1007/s004010050783; Mogha A, 2016, J NEUROSCI, V36, P12351, DOI 10.1523/JNEUROSCI.3854-15.2016; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; Nishida N, 1999, LAB INVEST, V79, P689; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Petit CSV, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24377; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodionova NN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185170; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Salvesen O, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0879-5; Salvesen O, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01722; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Weller RO, 1977, PATHOLOGY PERIPHERAL, P61; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	36	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2359	2375		10.1096/fj.201902588R	http://dx.doi.org/10.1096/fj.201902588R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907995	Green Published, hybrid			2022-12-26	WOS:000514663600030
J	Nakamura, A; Kohno, A; Noguchi, N; Kawa, K; Ohno, Y; Komatsu, M; Yamanishi, H				Nakamura, Akihiro; Kohno, Aya; Noguchi, Nobuyoshi; Kawa, Kenji; Ohno, Yuki; Komatsu, Masaru; Yamanishi, Hachiro			Prediction of Uropathogens by Flow Cytometry and Dip-stick Test Results of Urine Through Multivariable Logistic Regression Analysis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ESCHERICHIA-COLI; BACTERIAL	Purpose Multidrug-resistant Enterobacteriaceae in urinary tract infection (UTI) has spread worldwide; one cause is overuse of broad-spectrum antimicrobial agents such as fluoroquinolone antibacterials. To improve antimicrobial agent administration, this study aimed to calculate a probability prediction formula to predict the organism strain causing UTI in real time from dip-stick testing and flow cytometry. Methodology We examined 372 outpatient spot urine samples with observed pyuria and bacteriuria using dip-stick testing and flow cytometry. We performed multiple logistic-regression analysis on the basis of 11 measurement items and BACT scattergram analysis with age and sex as explanatory variables and each strain as the response variable and calculated a probability prediction formula. Results The best prediction formula for discrimination of the bacilli group and cocci or polymicrobial group was a model with 5 explanatory variables that included percentage of scattergram dots in an angular area of 0-25 degrees (P< 0.001), sex (P< 0.001), nitrite (P = 0.002), and ketones (P = 0.133). For a predicted cut-off value of Y = 0.395, sensitivity was 0.867 and specificity was 0.775 (cross-validation group: sensitivity = 0.840, specificity = 0.760). The best prediction formula for P. mirabilis and other bacilli was a model with percentage of scattergram dots in an angular area of 0-20 degrees (P< 0.001) and nitrite (P = 0.090). For a predicted cut-off value of Y = 0.064, sensitivity was 0.889 and specificity was 0.788 (cross-validation group: sensitivity = 1.000, specificity = 0.766). Conclusion Simultaneous use of the calculated probability prediction formula with urinalysis results facilitates real-time prediction of organisms causing UTI, thus providing helpful information for empiric therapy.	[Nakamura, Akihiro; Noguchi, Nobuyoshi; Komatsu, Masaru; Yamanishi, Hachiro] Tenri Hlth Care Univ, Fac Hlth Care, Dept Clin Lab Sci, Tenri, Nara, Japan; [Kohno, Aya; Noguchi, Nobuyoshi; Kawa, Kenji; Ohno, Yuki] Tenri Hosp, Dept Clin Bacteriol, Clin Lab Med, Tenri, Nara, Japan	Tenri Hospital	Nakamura, A (corresponding author), Tenri Hlth Care Univ, Fac Hlth Care, Dept Clin Lab Sci, Tenri, Nara, Japan.	a.nakamura@tenriyorozu-u.ac.jp		Nakamura, Akihiro/0000-0003-2065-6720	Tenri Health Care University	Tenri Health Care University	This work was supported by internal funding of Tenri Health Care University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the funders.	Ahn JY, 2014, AM J INFECT CONTROL, V42, P621, DOI 10.1016/j.ajic.2014.02.024; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; De Rosa R, 2018, CLIN CHIM ACTA, V484, P171, DOI 10.1016/j.cca.2018.05.047; Hayami H, 2013, J INFECT CHEMOTHER, V19, P393, DOI 10.1007/s10156-013-0606-9; Henry FC, 2019, SANFORD GUIDE INFECT; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kim SY, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.02004-17, 10.1128/jcm.02004-17]; Matsumoto T, 2011, INT J ANTIMICROB AG, V37, P210, DOI 10.1016/j.ijantimicag.2010.10.032; Monsen T, 2015, J CLIN MICROBIOL, V53, P539, DOI 10.1128/JCM.01974-14; Muratani T., 2013, SYSMEX J INT, V23, P1; Nakamura A, 2015, DIAGN MICR INFEC DIS, V83, P237, DOI 10.1016/j.diagmicrobio.2015.06.024; Ohno Y, 2017, J INFECT CHEMOTHER, V23, P224, DOI 10.1016/j.jiac.2016.12.013; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schechner V, 2013, CLIN MICROBIOL INFEC, V19, P451, DOI 10.1111/j.1469-0691.2012.03888.x; SINHA B, 1984, J UROLOGY, V131, P330, DOI 10.1016/S0022-5347(17)50366-3; Sun SJ, 2018, CLIN LAB, V64, P1395, DOI 10.7754/Clin.Lab.2018.180210; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Wang XH, 2013, J MICROBIOL METH, V92, P231, DOI 10.1016/j.mimet.2012.12.016	20	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227257	10.1371/journal.pone.0227257	http://dx.doi.org/10.1371/journal.pone.0227257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910242	gold, Green Published			2022-12-26	WOS:000534333800035
J	Thielen, D; Schuchmann, KL; Ramoni-Perazzi, P; Marquez, M; Rojas, W; Quintero, JI; Marques, MI				Thielen, Dirk; Schuchmann, Karl-Ludwig; Ramoni-Perazzi, Paolo; Marquez, Marco; Rojas, Wilmer; Quintero, Jose Isrrael; Marques, Marinez Isaac			Quo vadis Pantanal? Expected precipitation extremes and drought dynamics from changing sea surface temperature	PLOS ONE			English	Article							CLIMATE-CHANGE; SOUTH-AMERICA; RAINFALL VARIABILITY; DECADAL VARIABILITY; SUMMER RAINFALL; AMAZON; WETLAND; PACIFIC; IMPACT; ENSO	Climate change poses a critical threat to the Pantanal, the largest wetland in the world. Models indicate an increase in the frequency of extreme precipitation events and extended periods of drought. These changes can amplify consequences for Pantanal's ecological functioning, which has already experienced intensive human modification of its hydrological system and environmental health. The present study analyzed the spatial and temporal dynamics of rainfall and resulting extremes in the Brazilian area of the Upper Paraguay River Basin (UPRB) along with a co-evaluation of the global Sea Surface Temperature data (SST). The predicted results indicate that wet extreme precipitation events will become more frequent in the highlands, while severe and prolonged droughts triggered by warming SSTs in the Northern Hemisphere (North Atlantic and North Pacific oceans) will affect the Pantanal. The linear relations between precipitation with SST of very specific oceanic regions and even from specific oceanic indexes obtained in the present study significantly improve the forecasting capacity, mainly from a resulting reduction to two months of the lead-time between SST warming to concomitant precipitation impacts, and by explaining 80% of Pantanal's precipitation variation from major oceanic indexes (e.g., ENSO, PDO, NAO, ATL3). Current SST trends will result in inter- and intra-annual flooding dynamic alterations, drastically affecting the Pantanal ecosystem functioning, with consequences for wildlife diversity and distribution. Regarding the foreseeable global climate and land use change scenarios, the results from the present study provide solid evidence that can be used at different decision-making levels (from local to global) for identifying the most appropriate management practices and effectively achieving sustainability of the anthropic activity occurring in the Pantanal.	[Thielen, Dirk; Marquez, Marco; Rojas, Wilmer; Quintero, Jose Isrrael] Venezuelan Inst Sci Res IVIC, Lab Landscape Ecol & Climate, Caracas, Venezuela; [Schuchmann, Karl-Ludwig; Marques, Marinez Isaac] Univ Fed Mato Grosso, Natl Inst Sci & Technol Wetlands INAU, Computat Bioacoust Res Unit CO BRA, Cuiaba, MG, Brazil; [Schuchmann, Karl-Ludwig; Marques, Marinez Isaac] Univ Fed Mato Grosso, Inst Biosci, Postgrad Program Zool, Cuiaba, MG, Brazil; [Schuchmann, Karl-Ludwig] Zool Res Museum A Koenig, Dept Vertebrates, Bonn, Germany; [Schuchmann, Karl-Ludwig] Univ Bonn, Fac Math & Nat Sci, Bonn, Germany; [Ramoni-Perazzi, Paolo] Univ Fed Lavras, Lavras, MG, Brazil; [Ramoni-Perazzi, Paolo] Univ Los Andes, Ctr Model Simulat, Merida, Venezuela; [Marques, Marinez Isaac] Univ Fed Mato Grosso, Inst Biosci, Postgrad Program Ecol & Biodivers Conservat, Cuiaba, MG, Brazil	Venezuelan Institute Science Research; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; University of Bonn; Universidade Federal de Lavras; University of Los Andes Venezuela; Universidade Federal de Mato Grosso	Schuchmann, KL (corresponding author), Univ Fed Mato Grosso, Natl Inst Sci & Technol Wetlands INAU, Computat Bioacoust Res Unit CO BRA, Cuiaba, MG, Brazil.; Schuchmann, KL (corresponding author), Univ Fed Mato Grosso, Inst Biosci, Postgrad Program Zool, Cuiaba, MG, Brazil.; Schuchmann, KL (corresponding author), Zool Res Museum A Koenig, Dept Vertebrates, Bonn, Germany.; Schuchmann, KL (corresponding author), Univ Bonn, Fac Math & Nat Sci, Bonn, Germany.	klschuchmann@googlemail.com	Thielen, Dirk R/X-2307-2018; Ramoni Perazzi, Paolo/ABA-7060-2021; Schuchmann, Karl-L/GON-8135-2022	Thielen, Dirk R/0000-0003-4102-1927; Ramoni Perazzi, Paolo/0000-0001-9182-3798; Schuchmann, Karl-L/0000-0002-3233-8917; Quintero Delgado, Jose Isrrael/0000-0002-7944-0345	Brazilian Science Council (CNPq); National Institute for Science and Technology in Wetlands (INAU/UFMT/CNPq); Brehm Funds for International Bird Conservation (BF), Germany; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES - INCT/MCTI/CNPq/CAPES/FAPs) [16/2014]; Secretaria de Relacoes Internacionais (SECRI/UFMT) [SECRI 001/2018]; Organization of American States through its Partnerships Program for Education and Training of the Coimbra Group of Brazilian Universities (OAS/PAEC/GCUB, PRP)	Brazilian Science Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Science and Technology in Wetlands (INAU/UFMT/CNPq); Brehm Funds for International Bird Conservation (BF), Germany; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES - INCT/MCTI/CNPq/CAPES/FAPs); Secretaria de Relacoes Internacionais (SECRI/UFMT); Organization of American States through its Partnerships Program for Education and Training of the Coimbra Group of Brazilian Universities (OAS/PAEC/GCUB, PRP)	This work was funded by the Brazilian Science Council (CNPq), the National Institute for Science and Technology in Wetlands (INAU/UFMT/CNPq), and the Brehm Funds for International Bird Conservation (BF), Germany. A research grant for DT was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES - INCT/MCTI/CNPq/CAPES/FAPs no.16/2014.). The Secretaria de Relacoes Internacionais (SECRI/UFMT) Edital SECRI 001/2018 provided funds for DT for international researcher visitor. A scholarship for PRP was provided by the Organization of American States through its Partnerships Program for Education and Training of the Coimbra Group of Brazilian Universities (OAS/PAEC/GCUB, PRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Alfaro E.J., 2005, ENCY WORLD CLIMATOLO, DOI 10.1007/1-4020-3266-8_37; ALHO C.J.R., 2012, OECOL AUST, V16, P958, DOI [10.4257/oeco.2012.1604.17, DOI 10.4257/OECO.2012.1604.17]; ALHO CJR, 1988, BIOSCIENCE, V38, P164, DOI 10.2307/1310449; Alho Cleber J.R., 2012, Animals, V2, P591, DOI 10.3390/ani2040591; Allasia DG, 2006, IAHS-AISH P, V303, P360; Allasia Piccilli DG, 2007, THESIS; Andreoli RV, 2012, INT J CLIMATOL, V32, P1193, DOI 10.1002/joc.2345; Annamalai H, 2005, J CLIMATE, V18, P302, DOI 10.1175/JCLI-3268.1; Araujo AGD, 2018, WETL ECOL MANAG, V26, P829, DOI 10.1007/s11273-018-9612-0; ASSINE ML, 2016, DYNAMICS PANTANAL WE, V37, P23, DOI [10.1007/698_2015_349, DOI 10.1007/698_2015_349]; Baker PA, 2015, QUATERNARY SCI REV, V124, P31, DOI 10.1016/j.quascirev.2015.06.011; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P6201, DOI 10.5194/hess-21-6201-2017; Behera SK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034122; Bergier, 2010, AN 3 S GEOTCN PANT C, DOI DOI 10.13140/2.1.4754.0809; Bergier I, 2018, SCI TOTAL ENVIRON, V619, P1116, DOI 10.1016/j.scitotenv.2017.11.163; Bergier I, 2013, SCI TOTAL ENVIRON, V463, P1060, DOI 10.1016/j.scitotenv.2013.06.036; Bravo JM, 2012, J HYDROL ENG, V17, P635, DOI 10.1061/(ASCE)HE.1943-5584.0000494; Bravo JM, 2014, CLIMATIC CHANGE, V127, P27, DOI 10.1007/s10584-013-0816-2; Bunker DE, 2005, J ECOL, V93, P794, DOI 10.1111/j.1365-2745.2005.01019.x; Chan SC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034204; Cherchi A, 2014, CLIM DYNAM, V42, P219, DOI 10.1007/s00382-013-1768-y; Clarke RT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021742; Da Silva JD, 1998, PESQUI AGROPECU BRAS, V33, P1703; Skansi MD, 2013, GLOBAL PLANET CHANGE, V100, P295, DOI 10.1016/j.gloplacha.2012.11.004; Deser C, 2017, J CLIMATE, V30, P5059, DOI 10.1175/JCLI-D-16-0844.1; Deser C, 2012, J CLIMATE, V25, P2622, DOI 10.1175/JCLI-D-11-00301.1; Doyle ME, 2002, J CLIMATE, V15, P3394, DOI 10.1175/1520-0442(2002)015&lt;3394:MLLCAP&gt;2.0.CO;2; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Espinoza JC, 2019, J HYDROL-REG STUD, V26, DOI 10.1016/j.ejrh.2019.100637; Esquivel-Muelbert A, 2017, ECOGRAPHY, V40, P618, DOI 10.1111/ecog.01904; Fortes CF, 2018, BRAZ J BOT, V41, P167, DOI 10.1007/s40415-017-0434-8; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Garcia NO, 2005, HYDROLOG SCI J, V50, P459, DOI 10.1623/hysj.50.3.459.65030; Girard P, 2012, ASH STUD ENV POL PR, P7; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hirabayashi Y, 2013, NAT CLIM CHANGE, V3, P816, DOI [10.1038/nclimate1911, 10.1038/NCLIMATE1911]; Ioris AAR, 2014, CLIMATIC CHANGE, V127, P139, DOI 10.1007/s10584-014-1134-z; Izumo T, 2008, J CLIMATE, V21, P5603, DOI 10.1175/2008JCLI2158.1; Jones C, 2013, J CLIMATE, V26, P6660, DOI 10.1175/JCLI-D-12-00412.1; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk WJ, 2018, WETLAND, VII; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Krepper CM, 2010, THEOR APPL CLIMATOL, V102, P13, DOI 10.1007/s00704-009-0234-6; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Liebmann B., 2011, GLOBAL MONSOON SYSTE, P137, DOI DOI 10.1142/9789814343411_0009; Marcuzzo F.F.N., 2010, P 3 S GEOT PANT, P170; Marcuzzo FFN, 2011, GEOAMBIENTE ON LINE, V16, P66, DOI [10.5216/revgeoamb.v0i16.26021, DOI 10.5216/REVGEOAMB.V0I16.26021]; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Marengo JA, 2016, CLIM RES, V68, P201, DOI 10.3354/cr01324; Marengo JA, 2010, CLIM DYNAM, V35, P1089, DOI 10.1007/s00382-009-0721-6; Marengo JA, 2009, HYDROL PROCESS, V23, P3236, DOI 10.1002/hyp.7396; Marengo Jose A., 2015, HDB ENV CHEM, V37, P227, DOI DOI 10.1007/698_2015_357; Marengo José Antônio, 2008, Estud. av., V22, P83, DOI 10.1590/S0103-40142008000200006; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Mechoso C. R., 2005, GLOBAL MONSOON SYSTE, V13, P197; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mittermeier RA., 1990, ORYX, V24, P103, DOI [10.1017/S003060530003475X, DOI 10.1017/S003060530003475X]; Nobre A.D., 2014, FUTURO CLIM TICO AMA; Nobre P, 2006, J CLIMATE, V19, P5988, DOI 10.1175/JCLI3946.1; Novello VF, 2017, SCI REP-UK, V7, DOI 10.1038/srep44267; Paegle JN, 2002, J CLIMATE, V15, P1389, DOI [10.1175/1520-0442(2002)015<1389:LBSRVO>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;1389:LBSRVO&gt;2.0.CO;2]; Paredes-Trejo FJ, 2017, J ARID ENVIRON, V139, P26, DOI 10.1016/j.jaridenv.2016.12.009; PBMC (Painel Brasileiro de Mudancas Climaticas), 2013, CONTR GRUP TRAB 1 PA; Pita Lopez M.F, 2001, PUBL ASS INT CLIM, V13, P225; Por F. D., 1995, PANTANAL MATO GROSSO; Robertson AW, 1998, J CLIMATE, V11, P2570, DOI 10.1175/1520-0442(1998)011<2570:IADCIR>2.0.CO;2; Robertson AW, 2000, MON WEATHER REV, V128, P2947, DOI 10.1175/1520-0493(2000)128<2947:IAIVOT>2.0.CO;2; Ronchail J, 2005, J HYDROL, V302, P223, DOI 10.1016/j.jhydrol.2004.07.005; Ronchail J, 2002, INT J CLIMATOL, V22, P1663, DOI 10.1002/joc.815; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Schwerdtfeger J, 2015, REMOTE SENS-BASEL, V7, P9769, DOI 10.3390/rs70809769; Silva CB, 2017, THEOR APPL CLIMATOL, V129, P97, DOI 10.1007/s00704-016-1760-7; Taschetto AS, 2012, CLIM DYNAM, V38, P1615, DOI 10.1007/s00382-011-1165-3; Torralba V, 2015, FRONT EARTH SCI, V3, DOI 10.3389/feart.2015.00055; Valeriano M.M., 2012, AN 4 S GEO PANT BON, P289; Zhou JY, 2001, INT J CLIMATOL, V21, P1623, DOI 10.1002/joc.700	79	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227437	10.1371/journal.pone.0227437	http://dx.doi.org/10.1371/journal.pone.0227437			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910441	gold, Green Published			2022-12-26	WOS:000534333800052
J	Wieschowski, S; Laser, H; Sena, ES; Bleich, A; Tolba, R; Strech, D				Wieschowski, Susanne; Laser, Hans; Sena, Emily S.; Bleich, Andre; Tolba, Rene; Strech, Daniel			Attitudes towards animal study registries and their characteristics: An online survey of three cohorts of animal researchers	PLOS ONE			English	Article								Objectives Prospective registration of animal studies has been suggested as a new measure to increase value and reduce waste in biomedical research. We sought to further explore and quantify animal researchers' attitudes and preferences regarding animal study registries (ASRs). Design Cross-sectional online survey. Setting and participants We conducted a survey with three different samples representing animal researchers: i) corresponding authors from journals with high Eigenfactor, ii) a random Pubmed sample and iii) members of the CAMARADES network. Main outcome measures Perceived level of importance of different aspects of publication bias, the effect of ASRs on different aspects of research as well as the importance of different research types for being registered. Results The survey yielded responses from 413 animal researchers (response rate 7%). The respondents indicated, that some aspects of ASRs can increase administrative burden but could be outweighed by other aspects decreasing this burden. Animal researchers found it more important to register studies that involved animal species with higher levels of cognitive capabilities. The time frame for making registry entries publicly available revealed a strong heterogeneity among respondents, with the largest proportion voting for "access only after consent by the principal investigator" and the second largest proportion voting for "access immediately after registration". Conclusions The fact that the more senior and experienced animal researchers participating in this survey clearly indicated the practical importance of publication bias and the importance of ASRs underscores the problem awareness across animal researchers and the willingness to actively engage in study registration if effective safeguards for the potential weaknesses of ASRs are put into place. To overcome the first-mover dilemma international consensus statements on how to deal with prospective registration of animal studies might be necessary for all relevant stakeholder groups including animal researchers, academic institutions, private companies, funders, regulatory agencies, and journals.	[Wieschowski, Susanne; Strech, Daniel] Hannover Med Sch, Inst Eth Hist & Philosophy Med, Hannover, Germany; [Laser, Hans] Hannover Med Sch, Ctr Informat Management ZIMt, Hannover, Germany; [Sena, Emily S.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Tolba, Rene] Rhein Westfal TH Aachen, Fac Med, Inst Lab Anim Sci, Aachen, Germany; [Strech, Daniel] Berlin Inst Hlth, QUEST Ctr Transforming Biomed Res, Berlin, Germany; [Strech, Daniel] Charite Univ Med Berlin, Berlin, Germany	Hannover Medical School; Hannover Medical School; University of Edinburgh; Hannover Medical School; RWTH Aachen University; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Strech, D (corresponding author), Hannover Med Sch, Inst Eth Hist & Philosophy Med, Hannover, Germany.; Strech, D (corresponding author), Berlin Inst Hlth, QUEST Ctr Transforming Biomed Res, Berlin, Germany.; Strech, D (corresponding author), Charite Univ Med Berlin, Berlin, Germany.	daniel.strech@charite.de		Laser, Hans/0000-0002-0958-8600; Wieschowski, Susanne/0000-0003-0128-2938; Strech, Daniel/0000-0002-9153-079X	German Research Foundation (DFG) [STR 1070/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG), http://gepris.dfg.de/gepris/projekt/260525081 (grant number STR 1070/4-1). DS applied for and received the grant. SW was paid by this funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; BfR, STRENGTH SCI AV UNN; Carroll HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186472; Chambers CD, 2019, EUR J NEUROSCI, V49, P4, DOI 10.1111/ejn.14319; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K, 2012, JAMA-J AM MED ASSOC, V307, P1861, DOI 10.1001/jama.2012.4230; Dillman D. R., 2007, MAIL INTERNET SURVEY; Hardwicke TE, 2018, NAT HUM BEHAV, V2, P793, DOI 10.1038/s41562-018-0444-y; International Cf (CIOMS) OoMS the icw (WHO) WHO, INT ETH GUID HLTH RE; Kimmelman J, 2012, NAT BIOTECHNOL, V30, P488, DOI 10.1038/nbt.2261; Laser H, E MAIL EXTRACTOR; Mayring P, 2014, QUALITATIVE CONTENT; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; ter Riet G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043404; Utrecht RM, 2017, ONLINE REGISTER PREC; Wieschowski S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000391	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226443	10.1371/journal.pone.0226443	http://dx.doi.org/10.1371/journal.pone.0226443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905203	gold, Green Published, Green Submitted			2022-12-26	WOS:000534327700007
J	Britto, FA; Gnimassou, O; De Groote, E; Balan, E; Warnier, G; Everard, A; Cani, PD; Deldicque, L				Britto, Florian A.; Gnimassou, Olouyoumi; De Groote, Estelle; Balan, Estelle; Warnier, Geoffrey; Everard, Amandine; Cani, Patrice D.; Deldicque, Louise			Acute environmental hypoxia potentiates satellite cell-dependent myogenesis in response to resistance exercise through the inflammation pathway in human	FASEB JOURNAL			English	Article						exercise; hypoxia; inflammation; muscle; myogenesis	MUSCLE HYPERTROPHY; UP-REGULATION; DIFFERENTIATION; INTERLEUKIN-6; PROLIFERATION; TRANSCRIPTION; ACTIVATION; EXPRESSION; AUTOCRINE; REGULATOR	Acute environmental hypoxia may potentiate muscle hypertrophy in response to resistance training but the mechanisms are still unknown. To this end, twenty subjects performed a 1-leg knee extension session (8 sets of 8 repetitions at 80% 1 repetition maximum, 2-min rest between sets) in normoxic or normobaric hypoxic conditions (FiO2 14%). Muscle biopsies were taken 15 min and 4 hours after exercise in the vastus lateralis of the exercised and the non-exercised legs. Blood samples were taken immediately, 2h and 4h after exercise. In vivo, hypoxic exercise fostered acute inflammation mediated by the TNF alpha/NF-kappa B/IL-6/STAT3 (+333%, +194%, + 163% and +50% respectively) pathway, which has been shown to contribute to satellite cells myogenesis. Inflammation activation was followed by skeletal muscle invasion by CD68 (+63%) and CD197 (+152%) positive immune cells, both known to regulate muscle regeneration. The role of hypoxia-induced activation of inflammation in myogenesis was confirmed in vitro. Acute hypoxia promoted myogenesis through increased Myf5 (+300%), MyoD (+88%), myogenin (+1816%) and MRF4 (+489%) mRNA levels in primary myotubes and this response was blunted by siRNA targeting STAT3. In conclusion, our results suggest that hypoxia could improve muscle hypertrophic response following resistance exercise through IL-6/STAT3-dependent myogenesis and immune cells-dependent muscle regeneration.	[Britto, Florian A.; Gnimassou, Olouyoumi; De Groote, Estelle; Balan, Estelle; Warnier, Geoffrey; Deldicque, Louise] Catholic Univ Louvain, UCLouvain, Inst Neurosci, Louvain La Neuve, Belgium; [Everard, Amandine; Cani, Patrice D.] Catholic Univ Louvain, WELBIO Walloon Excellence Life Sci & Biotechnol, UCLouvain, LDRI,Metab & Nutr Res Grp, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Deldicque, L (corresponding author), Catholic Univ Louvain, Inst Neurosci, Pl Pierre de Coubertin 1,Box L08-10-01, B-1348 Louvain La Neuve, Belgium.	louise.deldicque@uclouvain.be	D., Cani Patrice/M-8055-2016; Warnier, Geoffrey/AEK-2389-2022; Britto, Florian/ABE-1255-2021	D., Cani Patrice/0000-0003-2040-2448; Britto, Florian Alexis/0000-0002-7223-6341; Deldicque, Louise/0000-0003-3393-5278; Warnier, Geoffrey/0000-0002-2438-0875; Everard, Amandine/0000-0001-8925-8144	Fonds De La Recherche Scientifique FNRS (FNRS) [J.0050.16, F.4504.17]; Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Fonds De La Recherche Scientifique FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Fonds De La Recherche Scientifique FNRS (FNRS), Grant/Award Number: J.0050.16 and F.4504.17; Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Adi S, 2002, ENDOCRINOLOGY, V143, P511, DOI 10.1210/en.143.2.511; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Bazgir B, 2017, CELL J, V18, P473; Begue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057141; BIGARD AX, 1991, J APPL PHYSIOL, V71, P2114, DOI 10.1152/jappl.1991.71.6.2114; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Chycki J, 2016, J HUM KINET, V53, P91, DOI 10.1515/hukin-2016-0013; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; Filopoulos D, 2017, EUR J SPORT SCI, V17, P821, DOI 10.1080/17461391.2017.1317834; Fischer M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00041; Francaux M, 2018, PFLUGERS ARCH, V471, P397; Friedmann B, 2003, PFLUG ARCH EUR J PHY, V446, P742, DOI 10.1007/s00424-003-1133-9; Gnimassou O, 2018, FASEB J, V32, P5272, DOI 10.1096/fj.201800049RR; Gnimassou O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00190; Goldberg A.L., 1972, Muscle Biol, V1, P89; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Inness MWH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00502; Ito T, 2010, NEUROSCI LETT, V472, P104, DOI 10.1016/j.neulet.2010.01.061; JAHN L, 1994, EXP CELL RES, V212, P297, DOI 10.1006/excr.1994.1147; Kon M, 2012, J STRENGTH COND RES, V26, P611, DOI 10.1519/JSC.0b013e3182281c69; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Launay T, 2010, CELL PROLIFERAT, V43, P1, DOI 10.1111/j.1365-2184.2009.00648.x; Liu J, 2018, ACTA BIOCH BIOPH SIN, V50, P1200, DOI 10.1093/abbs/gmy131; Manimmanakorn A, 2013, J SCI MED SPORT, V16, P337, DOI 10.1016/j.jsams.2012.08.009; Nagahisa H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207040; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pallafacchina G, 2013, NUTR METAB CARDIOVAS, V23, pS12, DOI 10.1016/j.numecd.2012.02.002; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rossi FE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01376; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sun CS, 2017, STEM CELLS, V35, P1958, DOI 10.1002/stem.2652; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; von Horn H, 2002, J ENDOCRINOL, V172, P457, DOI 10.1677/joe.0.1720457; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wei HL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691684; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Yan B, 2016, J STRENGTH COND RES, V30, P184, DOI 10.1519/JSC.0000000000001056; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang J, 2014, ANIMAL, V8, P800, DOI 10.1017/S1751731114000469	46	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1885	1900		10.1096/fj.201902244R	http://dx.doi.org/10.1096/fj.201902244R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914659				2022-12-26	WOS:000507308900125
J	Byskov, K; Le Gall, SM; Thiede, B; Camerer, E; Kanse, SM				Byskov, Kristina; Le Gall, Sylvain M.; Thiede, Bernd; Camerer, Eric; Kanse, Sandip M.			Protease activated receptors (PAR)-1 and-2 mediate cellular effects of factor VII activating protease (FSAP)	FASEB JOURNAL			English	Article						apoptosis; FSAP; HABP2; mutations; PARs; vascular	VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; PROTEOLYSIS; DEFICIENCY; APOPTOSIS; PROMOTES; STROKE; MICE	Factor VII activating protease (FSAP) is a circulating serine protease implicated in thrombosis, atherosclerosis, stroke, and cancer. Using an overexpression strategy, we have systematically investigated the role of protease activated receptors (PAR)-1, -2, -3, and -4 on FSAP-mediated signaling in HEK293T and A549 cells. Cleavage of PAR-reporter constructs and MAPK phosphorylation was used to monitor receptor activation. FSAP cleaved PAR-2 and to a lesser degree PAR-1, but not PAR-3 or PAR-4 in both cell types. Robust MAPK activation in response to FSAP was observed after PAR-2, but not PAR-1 overexpression in HEK293T. Recombinant serine protease domain of wild type FSAP, but not the Marburg I isoform of FSAP, could reproduce the effects of plasma purified FSAP. Canonical cleavage of both PARs was suggested by mass spectrometric analysis of synthetic peptide substrates from the N-terminus of PARs and site directed mutagenesis studies. Surprisingly, knockdown of endogenous PAR-1, but not PAR-2, prevented the apoptosis-inhibitory effect of FSAP, suggesting that PAR1 is nevertheless a direct or indirect target in some cell types. This molecular characterization of PAR-1 and -2 as cellular receptors of FSAP will help to define the actions of FSAP in the context of cancer and vascular biology.	[Byskov, Kristina; Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway; [Le Gall, Sylvain M.; Camerer, Eric] Univ Paris, Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France; [Thiede, Bernd] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway; [Kanse, Sandip M.] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway	University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oslo; University of Oslo	Kanse, SM (corresponding author), Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway.	sandip.kanse@medisin.uio.no	Camerer, Eric/K-4161-2017	Kanse, Sandip/0000-0003-0782-9957; Camerer, Eric/0000-0002-6271-7125	Research Council of Norway; Helse Sor-Ost	Research Council of Norway(Research Council of Norway); Helse Sor-Ost	This work was supported by grants from Research Council of Norway as well as Helse Sor-Ost to SMK.	Bae JS, 2009, J CELL PHYSIOL, V219, P744, DOI 10.1002/jcp.21718; Borkham-Kamphorst E, 2013, J HEPATOL, V58, P104, DOI 10.1016/j.jhep.2012.09.007; Bulani Y, 2015, CURR PHARM DESIGN, V21, P4392, DOI 10.2174/138161282130151007144725; Byskov K, 2017, ATHEROSCLEROSIS, V265, P133, DOI 10.1016/j.atherosclerosis.2017.08.029; Daniel JM, 2016, J THROMB HAEMOST, V14, P2058, DOI 10.1111/jth.13417; Flaumenhaft R, 2017, TRENDS PHARMACOL SCI, V38, P701, DOI 10.1016/j.tips.2017.05.001; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; Griffin JH, 2016, ARTERIOSCL THROM VAS, V36, P2143, DOI 10.1161/ATVBAHA.116.308038; Hamilton JR, 2017, ANNU REV PHARMACOL, V57, P349, DOI 10.1146/annurev-pharmtox-011613-140016; Herold J, 2017, AM J TRANSL RES, V9, P3084; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Huang SH, 2013, CANCER INVEST, V31, P578, DOI 10.3109/07357907.2013.845674; Iablokov V, 2014, J BIOL CHEM, V289, P34366, DOI 10.1074/jbc.M114.610485; Joshi AU, 2015, EUR J NEUROSCI, V41, P963, DOI 10.1111/ejn.12830; Kannemeier C, 2004, FASEB J, V18, P728, DOI 10.1096/fj.03-0898fje; Kanse SM, 2012, J IMMUNOL, V188, P2858, DOI 10.4049/jimmunol.1103029; Kanse SM, 2012, ARTERIOSCL THROM VAS, V32, P427, DOI 10.1161/ATVBAHA.111.238394; Kara E, 2017, THROMB HAEMOSTASIS, V117, P1750, DOI 10.1160/TH17-02-0081; Kress JA, 2006, BIOL CHEM, V387, P1275, DOI 10.1515/BC.2006.158; Le Gall SM, 2016, BLOOD, V127, P3260, DOI 10.1182/blood-2015-11-683110; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Mirzapoiazova T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00164; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Nieman MT, 2016, BLOOD, V128, P169, DOI 10.1182/blood-2015-11-636472; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Subramaniam S, 2015, THROMB HAEMOSTASIS, V113, P870, DOI 10.1160/TH14-06-0519; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Yau MK, 2016, EXPERT OPIN THER PAT, V26, P471, DOI 10.1517/13543776.2016.1154540	30	8	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1079	1090		10.1096/fj.201801986RR	http://dx.doi.org/10.1096/fj.201801986RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914657	hybrid, Green Published			2022-12-26	WOS:000507308900073
J	Mahizir, D; Briffa, JF; Wood, JL; Anevska, K; Hill-Yardin, EL; Jefferies, AJ; Gravina, S; Mazzarino, G; Franks, AE; Moritz, KM; Wadley, GD; Wlodek, ME				Mahizir, Dayana; Briffa, Jessica F.; Wood, Jennifer L.; Anevska, Kristina; Hill-Yardin, Elisa L.; Jefferies, Andrew J.; Gravina, Sogand; Mazzarino, Gisella; Franks, Ashley E.; Moritz, Karen M.; Wadley, Glenn D.; Wlodek, Mary E.			Exercise improves metabolic function and alters the microbiome in rats with gestational diabetes	FASEB JOURNAL			English	Article						exercise training; fetal programming; gestational diabetes; microbiome; obesity; pregnancy adaptations	BETA-CELL FUNCTION; BODY-COMPOSITION; PHYSICAL-ACTIVITY; BORN SMALL; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; MATERNAL OBESITY; REGULAR EXERCISE; PREGNANCY; MELLITUS	Gestational diabetes mellitus (GDM) is a common pregnancy complication, particularly prevalent in obese women. Importantly, exercise has beneficial impacts on maternal glucose control and may prevent GDM in "at-risk" women. We aimed to determine whether a high-fat diet (HFD) exacerbates metabolic dysfunction and alters gut microbiome in GDM and whether endurance exercise prevents these changes. Uteroplacental insufficiency was induced by bilateral uterine vessel ligation (Restricted) or sham (Control) surgery on E18 in Wistar-Kyoto rats. Female offspring were fed a Chow or HFD (23% fat) from weaning (5 weeks) and at 16 weeks randomly allocated to remain Sedentary or to an exercise protocol of either Exercise prior to and during pregnancy (Exercise); or Exercise during pregnancy only (PregEx). Females were mated (20 weeks) and underwent indirect calorimetry (embryonic day 16; E16), glucose tolerance testing (E18), followed by 24-hr feces collection at E19 (n = 8-10/group). HFD consumption in female rats with GDM exacerbated the adverse metabolic adaptations to pregnancy and altered gut microbial populations. Specifically, the Firmicutes-to-Bacteroidetes ratio was increased, due to an underlying change in abundance of the orders Clostridiales and Bacteroidales. Maternal Exercise, but not PregEx, prevented the development of metabolic dysfunction, increased pancreatic beta-cell mass, and prevented the alteration of the gut microbiome in GDM females. Our findings suggest that maternal exercise and diet influence metabolic and microbiome dysfunction in females with GDM, which may impact long-term maternal and offspring health.	[Mahizir, Dayana; Briffa, Jessica F.; Hill-Yardin, Elisa L.; Jefferies, Andrew J.; Gravina, Sogand; Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia; [Wood, Jennifer L.; Anevska, Kristina; Franks, Ashley E.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Wood, Jennifer L.; Franks, Ashley E.] La Trobe Univ, Ctr Future Landscapes, Bundoora, Vic, Australia; [Hill-Yardin, Elisa L.] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Mazzarino, Gisella; Wadley, Glenn D.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Moritz, Karen M.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia	University of Melbourne; La Trobe University; La Trobe University; Royal Melbourne Institute of Technology (RMIT); University of Queensland; Deakin University	Wlodek, ME (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia.	m.wlodek@unimelb.edu.au	Wood, Jen/AAA-7907-2020; Mahizir, Dayana/AAK-8025-2020; Briffa, Jessica F/H-9059-2019; Wlodek, Mary/A-8939-2019; Moritz, Karen/G-2508-2015	Wood, Jen/0000-0002-7313-5681; Briffa, Jessica F/0000-0001-5173-4790; Mahizir, Nurul Dayana/0000-0003-3617-1496; Wadley, Glenn/0000-0002-6617-4359; Franks, Ashley/0000-0003-1664-6060; Hill-Yardin, Elisa/0000-0002-4146-7198; Wlodek, Mary/0000-0002-8490-9099; Moritz, Karen/0000-0002-8085-0034	Medical Research Council [APP1025426, APP1045602]; Diabetes Australia Research Trust [FT160100126, APP1078164]; University of Melbourne; La Trobe University	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes Australia Research Trust; University of Melbourne(University of Melbourne); La Trobe University	Medical Research Council, Grant/Award Number: APP1025426 and APP1045602; Diabetes Australia Research Trust, Grant/Award Number: FT160100126 and APP1078164; University of Melbourne; La Trobe University	Agha-Jaffar R, 2016, NAT REV ENDOCRINOL, V12, P533, DOI 10.1038/nrendo.2016.88; Artal R, 2003, BRIT J SPORT MED, V37, P6, DOI 10.1136/bjsm.37.1.6; Asif Y, 2018, J PHYSIOL-LONDON, V596, P163, DOI 10.1113/JP275339; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01408; Choi SB, 2006, J ENDOCRINOL, V190, P471, DOI 10.1677/joe.1.06400; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chu DM, 2016, GUT MICROBES, V7, P459, DOI 10.1080/19490976.2016.1241357; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferrocino I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30735-9; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Kim SY, 2013, OBESITY, V21, pE33, DOI 10.1002/oby.20025; Laker RC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1221, DOI 10.1152/ajpendo.00583.2011; Laker RC, 2011, AM J PHYSIOL-ENDOC M, V301, pE931, DOI 10.1152/ajpendo.00114.2011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahizir D, 2016, MOL NUTR FOOD RES, V60, P8, DOI 10.1002/mnfr.201500289; Mangwiro YTM, 2018, J PHYSIOL-LONDON, V596, P5947, DOI 10.1113/JP275758; Martin A, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12297; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendelson M, 2015, PEDIATR OBES, V10, P311, DOI 10.1111/ijpo.255; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Narendran P, 2015, DIABETOLOGIA, V58, P10, DOI 10.1007/s00125-014-3412-8; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Nobles C, 2015, OBSTET GYNECOL, V125, P1195, DOI 10.1097/AOG.0000000000000738; Oksanen J, 2013, COMMUNITY ECOL PACKA, V2, P7; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Ronsen O, 2002, J APPL PHYSIOL, V92, P2547, DOI 10.1152/japplphysiol.01263.2001; Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691; Singh S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0836-9; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van den Hoek AM, 2008, J NEUROENDOCRINOL, V20, P120, DOI 10.1111/j.1365-2826.2007.01626.x; Wadley GD, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12720; Wang C, 2017, AM J OBSTET GYNECOL, V216, P340, DOI 10.1016/j.ajog.2017.01.037; Weyer C, 1999, INT J OBESITY, V23, P715, DOI 10.1038/sj.ijo.0800910; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	49	14	14	4	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1728	1744		10.1096/fj.201901424R	http://dx.doi.org/10.1096/fj.201901424R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914625	Green Published, Bronze			2022-12-26	WOS:000507308900114
J	Nath, AK; Ma, JY; Chen, ZZ; Li, ZY; Vitery, MD; Kelley, ML; Peterson, RT; Gerszten, RE; Yeh, JRJ				Nath, Anjali K.; Ma, Junyan; Chen, Zsu-Zsu; Li, Zhuyun; Vitery, Maria del Carmen; Kelley, Michelle L.; Peterson, Randall T.; Gerszten, Robert E.; Yeh, Jing-Ruey J.			Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish	FASEB JOURNAL			English	Article						carnitine palmitoyltransferase I; G protein-coupled receptors; insulin resistance; lipid metabolism; metabolomic profiling	PROTEIN-COUPLED RECEPTORS; THERAPEUTIC TARGETS; DIABETES-MELLITUS; DRUG DISCOVERY; BETA-OXIDATION; RESISTANCE; DISEASE; IDENTIFICATION; PROFILES; INSIGHTS	G protein-coupled receptors (GPCRs) comprise the largest group of membrane receptors in eukaryotic genomes and collectively they regulate nearly all cellular processes. Despite the widely recognized importance of this class of proteins, many GPCRs remain understudied. G protein-coupled receptor 27 (Gpr27) is an orphan GPCR that displays high conservation during vertebrate evolution. Although, GPR27 is known to be expressed in tissues that regulate metabolism including the pancreas, skeletal muscle, and adipose tissue, its functions are poorly characterized. Therefore, to investigate the potential roles of Gpr27 in energy metabolism, we generated a whole body gpr27 knockout zebrafish line. Loss of gpr27 potentiated the elevation in glucose levels induced by pharmacological or nutritional perturbations. We next leveraged a mass spectrometry metabolite profiling platform to identify other potential metabolic functions of Gpr27. Notably, genetic deletion of gpr27 elevated medium-chain acylcarnitines, in particular C6-hexanoylcarnitine, C8-octanoylcarnitine, C9-nonanoylcarnitine, and C10-decanoylcarnitine, lipid species known to be associated with insulin resistance in humans. Concordantly, gpr27 deletion in zebrafish abrogated insulin-dependent Akt phosphorylation and glucose utilization. Finally, loss of gpr27 increased the expression of key enzymes in carnitine shuttle complex, in particular the homolog to the brain-specific isoform of CPT1C which functions as a hypothalamic energy senor. In summary, our findings shed light on the biochemical functions of Gpr27 by illuminating its role in lipid metabolism, insulin signaling, and glucose homeostasis.	[Nath, Anjali K.; Chen, Zsu-Zsu; Gerszten, Robert E.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 3 Blackfan Circle,CLS 917, Boston, MA 02215 USA; [Nath, Anjali K.; Gerszten, Robert E.] Broad Inst, Cambridge, MA USA; [Ma, Junyan; Li, Zhuyun; Vitery, Maria del Carmen; Kelley, Michelle L.; Yeh, Jing-Ruey J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA; [Ma, Junyan; Yeh, Jing-Ruey J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Peterson, Randall T.] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	Nath, AK (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 3 Blackfan Circle,CLS 917, Boston, MA 02215 USA.; Yeh, JRJ (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.	anath1@bidmc.harvard.edu; jyeh1@mgh.harvard.edu		Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Peterson, Randall/0000-0003-0727-3469	NIH [U01 MH105027, R21 HG010392, R01 HL132320-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: U01 MH105027, NIH R21 HG010392 and NIH R01 HL132320-01	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Avgerinos KI, 2019, METABOLISM, V92, P121, DOI 10.1016/j.metabol.2018.11.001; Batchuluun B, 2018, DIABETES, V67, P885, DOI 10.2337/db17-1150; Chow L, 2010, METABOLISM, V59, P70, DOI 10.1016/j.metabol.2009.07.009; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; den Broeder MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040894; Dupuis N, 2017, MOL PHARMACOL, V91, P595, DOI 10.1124/mol.116.107714; Foster Simon R, 2015, Biophys Rev, V7, P77, DOI 10.1007/s12551-014-0154-2; Friesen M, 2019, TRENDS ENDOCRIN MET, V30, P396, DOI 10.1016/j.tem.2019.03.002; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Gut P, 2017, PHYSIOL REV, V97, P889, DOI 10.1152/physrev.00038.2016; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang W, 2014, DEV BIOL, V394, P83, DOI 10.1016/j.ydbio.2014.07.021; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; LECOCO FR, 1964, J CLIN INVEST, V43, P237, DOI 10.1172/JCI104908; Liu LY, 2013, DIS MODEL MECH, V6, P1271, DOI 10.1242/dmm.011726; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maddison LA, 2015, AM J PHYSIOL-ENDOC M, V308, pE662, DOI 10.1152/ajpendo.00441.2014; Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459; Marin-Juez R, 2014, J ENDOCRINOL, V222, P229, DOI 10.1530/JOE-14-0178; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Matsumoto M, 2000, BIOCHEM BIOPH RES CO, V272, P576, DOI 10.1006/bbrc.2000.2829; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Nath AK, 2015, CELL REP, V10, P694, DOI 10.1016/j.celrep.2015.01.010; Nevis K, 2013, DEV DYNAM, V242, P550, DOI 10.1002/dvdy.23928; Nowak C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26701-0; Oprea TI, 2018, NAT REV DRUG DISCOV, V17, P317, DOI [10.1038/nrd.2018.14, 10.1038/nrd.2018.52]; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Prince VE, 2017, CURR TOP DEV BIOL, V124, P235, DOI 10.1016/bs.ctdb.2016.10.005; Quinlivan VH, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00319; Reimann F, 2016, DIABETOLOGIA, V59, P229, DOI 10.1007/s00125-015-3825-z; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schlegel A, 2015, CELL MOL LIFE SCI, V72, P2249, DOI 10.1007/s00018-014-1816-8; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Shim H, 2016, NUCLEIC ACIDS RES, V44, P9611, DOI 10.1093/nar/gkw897; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Wagner BK, 2011, ACS CHEM BIOL, V6, P900, DOI 10.1021/cb200206w; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wolf M, 2013, J CLIN ENDOCR METAB, V98, pE1137, DOI 10.1210/jc.2012-3976; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Yanai T, 2016, GENES CELLS, V21, P717, DOI 10.1111/gtc.12378; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Zang LQ, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00091	54	7	7	4	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1546	1557		10.1096/fj.201901466R	http://dx.doi.org/10.1096/fj.201901466R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914600	Green Accepted, hybrid			2022-12-26	WOS:000507308900102
J	Tettweiler, G; Blaquiere, JA; Wray, NB; Verheyen, EM				Tettweiler, Gritta; Blaquiere, Jessica A.; Wray, Nathan B.; Verheyen, Esther M.			Hipk is required for JAK/STAT activity during development and tumorigenesis	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASES; DROSOPHILA; PATHWAY; MUTATION; COMPLEX; JAK2; DETERMINANT; ACTIVATION; SEQUENCE	Drosophila has been instrumental as a model system in studying signal transduction and revealing molecular functions in development and human diseases. A point mutation in the Drosophila Janus kinase JAK (called hop) causes constitutive activation of the JAK/STAT pathway. We provide robust genetic evidence that the Homeodomain interacting protein kinase (Hipk) is required for endogenous JAK/STAT activity. Overexpression of Hipk can phenocopy the effects of overactive JAK/STAT mutations and lead to melanized tumors, and loss of Hipk can suppress the effects of hyperactive JAK/STAT. Further, the loss of the pathway effector Stat92E can suppress Hipk induced overgrowth. Interaction studies show that Hipk can physically interact with Stat92E and regulate Stat92E subcellular localization. Together our results show that Hipk is a novel factor required for effective JAK/STAT signaling.	[Tettweiler, Gritta; Blaquiere, Jessica A.; Wray, Nathan B.; Verheyen, Esther M.] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Dept Mol Biol & Biochem, Burnaby, BC, Canada	Simon Fraser University	Verheyen, EM (corresponding author), Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Dept Mol Biol & Biochem, Burnaby, BC, Canada.	everheye@sfu.ca		Verheyen, Esther/0000-0002-9795-5094	Natural Sciences and Engineering Council of Canada (NSERC) [RGPIN/2014-05479]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a research grant to Esther Verheyen from the Natural Sciences and Engineering Council of Canada (NSERC), grant number RGPIN/2014-05479. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-de-Prado S, 2018, DEV BIOL, V441, P31, DOI 10.1016/j.ydbio.2018.05.021; Amoyel M, 2014, SEMIN CELL DEV BIOL, V28, P96, DOI 10.1016/j.semcdb.2014.03.023; Arbouzova N, 2006, DEVELOPMENT; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blaquiere JA, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031146; Blaquiere JA, 2017, CURR TOP DEV BIOL, V123, P73, DOI 10.1016/bs.ctdb.2016.10.002; Brown S, 2006, DEV DYNAM, V235, P958, DOI 10.1002/dvdy.20709; Chen J, 2012, CURR BIOL, V22, P1582, DOI 10.1016/j.cub.2012.06.074; Chen Q, 2014, METHODS, V68, P160, DOI 10.1016/j.ymeth.2014.03.023; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989; Fleischmann KK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-27; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HANRATTY WP, 1981, DEV BIOL, V83, P238, DOI 10.1016/0012-1606(81)90470-X; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jaszczak JS, 2016, CURR OPIN GENET DEV, V40, P87, DOI 10.1016/j.gde.2016.06.008; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Ohtsu N, 2007, EXP CELL RES, V313, P88, DOI 10.1016/j.yexcr.2006.09.022; Poon CLC, 2012, CURR BIOL, V22, P1587, DOI 10.1016/j.cub.2012.06.075; Rawlings JS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-38; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sotillos S, 2008, CURR BIOL, V18, P624, DOI 10.1016/j.cub.2008.03.055; Sotillos S, 2013, DEVELOPMENT, V140, P1507, DOI 10.1242/dev.092320; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Swarup S, 2011, P NATL ACAD SCI USA, V108, P9887, DOI 10.1073/pnas.1017548108; Trivedi S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124056; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Wang SJH, 2014, BIOL OPEN, V3, P1196, DOI 10.1242/bio.20148342; Wong KKL, 2019, ELIFE, V8, DOI 10.7554/eLife.46315; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842	46	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226856	10.1371/journal.pone.0226856	http://dx.doi.org/10.1371/journal.pone.0226856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891940	Green Submitted, gold, Green Published			2022-12-26	WOS:000515096600037
J	Young, D; Malone, S; Collins, K; Mourot, L; Beato, M; Coratella, G				Young, Damien; Malone, Shane; Collins, Kieran; Mourot, Laurent; Beato, Marco; Coratella, Giuseppe			Metabolic power in hurling with respect to position and halves of match-play	PLOS ONE			English	Article							ESTIMATED ENERGY-COST; ELITE SOCCER PLAYERS; GAELIC FOOTBALL; DEMANDS; EXPENDITURE; DISTANCE	The current investigation compared the metabolic power and energetic characteristics in team sports with respect to positional lines and halves of match-play. Global positioning system (GPS) technology data were collected from 22 elite competitive hurling matches over a 3-season period. A total of 250 complete match-files were recorded with players split into positional groups of full-back; half-back; midfield; half-forward; full-forward. Raw GPS data were exported into a customized spreadsheet that provided estimations of metabolic power and speed variables across match-play events (average metabolic power [P-met], high metabolic load distance [HMLD], total distance, relative distance, high-speed distance, maximal speed, accelerations, and deceleration). P-met, HMLD, total, relative and high-speed distance were 8.9 +/- 1.6 W.kg(-1), 1457 +/- 349 m, 7506 +/- 1364 m, 107 +/- 20 m.min(-1) and 1169 +/- 260 m respectively. Half-backs, midfielders and half-forwards outperformed full-backs (Effect Size [ES] = 1.03, 1.22 and 2.07 respectively), and full-forwards in P-met (Effect Size [ES] = 1.70, 2.07 and 1.28 respectively), and HMLD (full-backs: ES = -1.23, -1.37 and -0.84 respectively, and full-forwards: ES = -1.77, -2.00 and -1.38 respectively). Half-backs (ES = -0.60), midfielders (ES = -0.81), and half-forwards (ES = -0.74) experienced a second-half temporal decrement in HMLD. The current investigation demonstrates that metabolic power may increase our understanding of the match-play demands placed on elite hurling players. Coaches may utilize these findings to construct training drills that replicate match-play demands.	[Young, Damien] Limerick Inst Technol, Thurles Campus, Thurles, Tipperary, Ireland; [Malone, Shane; Collins, Kieran] Technol Univ Dublin, Gael Sports Res Ctr, Dublin, Ireland; [Malone, Shane; Collins, Kieran] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Tom Reilly Bldg, Liverpool, Merseyside, England; [Mourot, Laurent] Univ Bourgogne Franche Comte, Prognost Markers & Regulatory Factors Cardiovasc, Exercise Performance Hlth, Res Unit,EA3920,Innovat Platform, Besancon, France; [Mourot, Laurent] Tomsk Polytech Univ, Tomsk, Russia; [Beato, Marco] Univ Suffolk, Sch Hlth & Sports Sci, Ipswich, Suffolk, England; [Coratella, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Liverpool John Moores University; Universite de Franche-Comte; Tomsk Polytechnic University; University of Milan	Young, D (corresponding author), Limerick Inst Technol, Thurles Campus, Thurles, Tipperary, Ireland.	damien.young@hotmail.com	Collins, Kieran/AAW-5613-2021; Young, Damien/AAU-3590-2020; Mourot, Laurent/M-2114-2019; Mourot, Laurent/ABE-1867-2021	Collins, Kieran/0000-0003-1653-2071; Young, Damien/0000-0002-7725-8267; Mourot, Laurent/0000-0001-9486-3090; CORATELLA, GIUSEPPE/0000-0001-7523-9102; Beato, Marco/0000-0001-5373-2211				Beato M, 2018, J STRENGTH COND RES, V32, P2831, DOI 10.1519/JSC.0000000000002778; Beato M, 2017, BIOL SPORT, V34, P227, DOI 10.5114/biolsport.2017.65998; Beato M, 2016, J HUM KINET, V54, P15, DOI 10.1515/hukin-2016-0031; Brown DM, 2016, INT J SPORT PHYSIOL, V11, P1067, DOI 10.1123/ijspp.2016-0021; Buchheit M, 2015, INT J SPORTS MED, V36, P1149, DOI 10.1055/s-0035-1555927; Carling CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186874; Collins DK, 2018, J STRENGTH COND RES, V32, P805, DOI 10.1519/JSC.0000000000001822; Coutts AJ, 2015, J SCI MED SPORT, V18, P219, DOI 10.1016/j.jsams.2014.02.003; Cummins C, 2016, INT J SPORTS MED, V37, P552, DOI 10.1055/s-0042-101795; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Duffield R, 2010, J SCI MED SPORT, V13, P523, DOI 10.1016/j.jsams.2009.07.003; Gaudino P, 2013, INT J SPORTS MED, V34, P963, DOI 10.1055/s-0033-1337943; Hopkins WG, 2006, SPORTS SCI; Jennings D, 2010, INT J SPORT PHYSIOL, V5, P565, DOI 10.1123/ijspp.5.4.565; Johnston RJ, 2015, J STRENGTH COND RES, V29, P2738, DOI 10.1519/JSC.0000000000000936; Kempton T, 2015, J SPORT SCI, V33, P39, DOI 10.1080/02640414.2014.921832; Kempton T, 2015, INT J SPORT PHYSIOL, V10, P23, DOI 10.1123/ijspp.2013-0540; Maddison R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-73; Malone S, 2017, J SPORT MED PHYS FIT, V57, P543, DOI 10.23736/S0022-4707.16.06233-2; Malone S, 2016, INT J SPORTS SCI COA, V11, P853, DOI 10.1177/1747954116676112; Manzi V, 2014, J STRENGTH COND RES, V28, P914, DOI 10.1519/JSC.0000000000000239; Morgans R, 2018, INT J SPORT PHYSIOL, V13, P665, DOI 10.1123/ijspp.2016-0412; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Polglaze T, 2019, INT J SPORT PHYSIOL, V14, P407, DOI 10.1123/ijspp.2018-0661; Polglaze T, 2018, J SPORT SCI, V36, P140, DOI 10.1080/02640414.2017.1287933; Reilly T, 2008, EUR J SPORT SCI, V8, P231, DOI 10.1080/17461390802251851; Stevens TGA, 2015, MED SCI SPORT EXER, V47, P1219, DOI 10.1249/MSS.0000000000000515; Young D., 2018, SPORTS SCI HLTH, V14, P201, DOI DOI 10.1007/S11332-018-0441-6; Young D, 2018, J STRENGTH COND RES; Young D, 2019, SPORT SCI HLTH, V15, P351, DOI 10.1007/s11332-018-00523-z; Young D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215156; Young D, 2018, J STRENGTH COND RES, V32, P2925, DOI 10.1519/JSC.0000000000002558; Zamparo P, 2014, INT J SPORT PHYSIOL, V9, P1033, DOI 10.1123/ijspp.2013-0258	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0225947	10.1371/journal.pone.0225947	http://dx.doi.org/10.1371/journal.pone.0225947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891945	Green Published, Green Accepted, gold			2022-12-26	WOS:000515096600009
J	Ayana, DA; Mulu, A; Mihret, A; Seyoum, B; Aseffa, A; Howe, R				Ayana, Desalegn Admassu; Mulu, Andargachew; Mihret, Adane; Seyoum, Berhanu; Aseffa, Abraham; Howe, Rawleigh			Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTI-HBC; ANTIRETROVIRAL THERAPY; ADDIS-ABABA; C VIRUS; PREVALENCE; COINFECTION; COHORT; RECOMMENDATIONS; TRANSMISSION	Progression of chronic HBV to cirrhosis, end-stage liver disease (ESLD), and hepatocellular carcinoma (HCC) is more rapid in HIV positive individuals than those with HBV alone; however, the distribution of HBV seromarkers in HIV infected individuals on antiretroviral therapy (ART) is not well described. To address this problem, we assessed the distribution of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc) and hepatitis B surface antibody (anti-HBs) among HIV infected adults on ART in Eastern Ethiopia. A cross-sectional study was conducted from September 2017 to February 2018. Socio-demographic, behavioral and health related factors, and clinical data were collected using questionnaire and checklist. Plasma samples were tested for HBsAg, anti-HBc and anti-HBs seromarkers using ELISA. Data were double entered into EpiData 3.1, cleaned, exported to and analyzed using STATA 13. Descriptive and logistic regression analysis were conducted and statistical significance was decided at p <= 0.05. A total of 901 participants were included and the prevalence of HBsAg was found to be 11.7% [95%CI (10, 14)]. Among the co-infected, 47.6% were also positive for anti-HBc, of which 58% were on an ART containing tenofovir (TDF). Among those screened for the three seromarkers, 38.1% were negative for all and 21% were positive only for anti-HBc (IAHBc). Being single, history of genital discharge and taking ART with TDF combination were significantly associated with HBV co-infection (p <= 0.05). There is high burden HBV co-infection among individuals on ART. The unmet need of HBV screening prior to ART initiation leaves many co-infected individuals without appropriate management including therapy, close monitoring or vaccination when indicated, impacting disease prevention.	[Ayana, Desalegn Admassu; Mulu, Andargachew; Mihret, Adane; Seyoum, Berhanu; Aseffa, Abraham; Howe, Rawleigh] Haramaya Univ, Coll Hlth & Med Sci, Oromia, Ethiopia; [Ayana, Desalegn Admassu; Mulu, Andargachew; Mihret, Adane; Seyoum, Berhanu; Aseffa, Abraham; Howe, Rawleigh] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Haramaya University	Ayana, DA (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Oromia, Ethiopia.; Ayana, DA (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	desadmassu@gmail.com	Mulu, Andargachew/GMW-4823-2022; Aseffa, Abraham/J-3248-2016	Mulu, Andargachew/0000-0003-2862-0175; Aseffa, Abraham/0000-0002-8028-1150; Ayana, Desalegn Admassu/0000-0002-1544-7492; Mihret, Adane/0000-0003-3183-4772	AHRI; Haramaya University	AHRI; Haramaya University	This study was supported by AHRI and Haramaya University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abebe A, 2003, EPIDEMIOL INFECT, V131, P757, DOI 10.1017/S0950268803008574; Allain JP, 2004, TRANSFUS CLIN BIOL, V11, P18, DOI 10.1016/j.tracli.2003.11.007; [Anonymous], 2006, MMWR MORBID MORTAL W; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Belayneh F., 2015, OALIB, V02, P1, DOI [DOI 10.4236/0ALIB.1101490, 10.4236/oalib.1101490, DOI 10.4236/OALIB.1101490]; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Bezabeh YH, 2015, J HIV ADIS RES, V71, P10, DOI [10.5897/jahr2014.0313, DOI 10.5897/JAHR]; Bozdayi AM, 2003, J VIRAL HEPATITIS, V10, P256, DOI 10.1046/j.1365-2893.2003.00435.x; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Busch MP, 2004, TRANSFUS CLIN BIOL, V11, P26, DOI 10.1016/j.tracli.2003.12.003; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Chung Raymond T, 2006, Top HIV Med, V14, P78; Coffin CS, 2014, J CLIN VIROL, V60, P347, DOI 10.1016/j.jcv.2014.04.021; Deressa T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190149; EPHI, 2018, ETH POP BAS HIV IMP; FMOH, 2016, 2016 FMOH GUID PREV; FMOH, 2017, NAT GUID COMPR HIV P; FMOH, 2016, GUID PREV CONTR VIR; Habte Y., 2016, J ANTIVIRALS ANTIRET, V8, P103, DOI [10.4172/jaa.1000144, DOI 10.4172/JAA.1000144]; Hollinger FB, 2008, TRANSFUSION, V48, P1001, DOI 10.1111/j.1537-2995.2008.01701.x; Isaakidis P, 2012, INT HEALTH, V4, P239, DOI 10.1016/j.inhe.2012.04.002; Iser DM, 2011, AIDS, V25, P197, DOI 10.1097/QAD.0b013e3283410ccb; Iser DM, 2010, J VIROLOGY; Kang SY, 2010, J MED VIROL, V82, P1508, DOI 10.1002/jmv.21862; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Luetkemeyer Anne F, 2010, Top HIV Med, V18, P143; Lule N, 2012, GUIDELINES TREATMENT; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Manyazewal T, 2014, J MED MICROBIOL, V63, P742, DOI 10.1099/jmm.0.063321-0; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Melashu Balew, 2014, Asian Pacific Journal of Tropical Disease, V4, P1; MELEGARI M, 1994, VIROLOGY, V199, P292, DOI 10.1006/viro.1994.1127; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Negero Asfaw, 2011, BMC Res Notes, V4, P35, DOI 10.1186/1756-0500-4-35; Ocana S, 2011, WORLD J GASTROENTERO, V17, P1553, DOI 10.3748/wjg.v17.i12.1553; Ponde RAA, 2010, ARCH VIROL, V155, P149, DOI 10.1007/s00705-009-0559-6; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Saha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073613; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Shimelis T, 2007, SEX TRANSM INFECT, V84, P37, DOI 10.1136/sti.2007.027326; Shimelis T, 2017, HIV AIDS-RES PALLIAT, V9, P203, DOI 10.2147/HIV.S150795; Shire NJ, 2007, JAIDS-J ACQ IMM DEF, V44, P309, DOI 10.1097/QAI.0b013e31802e29a9; Singh A. E, 2009, BACKGROUND DOCUMENT; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; Tsui JI, 2007, CLIN INFECT DIS, V45, P736, DOI 10.1086/520989; UNAIDS, 2019, GLOB AIDS UPD 2019 F; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Weldemhret L, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0090-2; Wondimeneh Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-171; World Health Organization, 2017, GUID HEP B C TEST, V66; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2017, GLOB HEP REP 2017 WH; Wu JF, 2014, J INFECT DIS, V209, P1374, DOI 10.1093/infdis/jit638; Yemanebrhane N, 2017, J AIDS CLIN RES, V8, DOI [10.4172/2155-6113.1000702, DOI 10.4172/2155-6113.1000702]	55	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226922	10.1371/journal.pone.0226922	http://dx.doi.org/10.1371/journal.pone.0226922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887187	Green Published, gold			2022-12-26	WOS:000515092200051
J	Kim, JM; Stewart, R; Kim, SY; Kim, JW; Kang, HJ; Lee, JY; Kim, SW; Shin, IS; Kim, MC; Hong, YJ; Ahn, Y; Jeong, MH; Yoon, JS				Kim, Jae-Min; Stewart, Robert; Kim, Seon-Young; Kim, Ju-Wan; Kang, Hee-Ju; Lee, Ju-Yeon; Kim, Sung-Wan; Shin, Il-Seon; Kim, Min Chul; Hong, Young Joon; Ahn, Youngkeun; Jeong, Myung Ho; Yoon, Jin-Sang			Interaction between BDNF val66met polymorphism and personality on long-term cardiac outcomes in patients with acute coronary syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; NEUROTROPHIC FACTOR GENE; HEART-DISEASE; DEPRESSION; MORTALITY; ANXIETY; EVENTS; RISK; ASSOCIATION; 5-HTTLPR	Background The prognostic role of BDNF val66met polymorphism on long-term cardiac outcomes in acute coronary syndrome (ACS) has been unclear. Environmental factors may modify the association, but these have not been investigated to date. This study aimed to investigate the potential interactive effects of BDNF val66met polymorphism and personality traits, one of the main environmental prognostic factors of ACS, on major adverse cardiac events (MACEs) in patients with ACS. Methods A total of 611 patients with recent ACS were recruited at a university hospital in Korea. Baseline evaluations from 2007 to 2012 assessed BDNF val66met polymorphism and personality using the Big Five Inventory, which yielded two personality clusters (resilient and vulnerable) and five dimensions (extraversion, agreeableness, conscientiousness, neuroticism, and openness). Over a 5 similar to 12 year follow-up after the index ACS, times to MACE were investigated using Cox regression models after adjustment for a range of covariates. Results The BDNF val66met polymorphism modified the associations between vulnerable personality type and worse long-term cardiac outcomes in ACS patients with significant interaction terms, in that the associations were statistically significant in the presence met allele. Similar findings were observed for the individual personality dimensions of agreeableness and neuroticism. Conclusions Gene (BDNF val66met polymorphism) x environment (personality traits) interactions on long-term cardiac outcomes were found in ACS.	[Kim, Jae-Min; Kim, Seon-Young; Kim, Ju-Wan; Kang, Hee-Ju; Lee, Ju-Yeon; Kim, Sung-Wan; Shin, Il-Seon; Yoon, Jin-Sang] Chonnam Natl Univ, Dept Psychiat, Med Sch, Gwangju, South Korea; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Stewart, Robert] South London & Maudsley NHS Fdn Trust, London, England; [Kim, Min Chul; Hong, Young Joon; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Dept Cardiol, Med Sch, Gwangju, South Korea	Chonnam National University; University of London; King's College London; South London & Maudsley NHS Trust; Chonnam National University	Kim, JM (corresponding author), Chonnam Natl Univ, Dept Psychiat, Med Sch, Gwangju, South Korea.	jmkim@chonnam.ac.kr	KIM, Jae-Min/S-7637-2019	Jeong, Myung Ho/0000-0003-2424-810X; KIM, JAE-MIN/0000-0001-7409-6306	National Research Foundation of Korea [NRF-2015M3C7A1028899]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2016R1A2A2A05919518]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; EPSRC [EP/N027280/1] Funding Source: UKRI; MRC [MC_PC_17214] Funding Source: UKRI	National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by a grant of National Research Foundation of Korea Grant (NRF-2015M3C7A1028899), and was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2016R1A2A2A05919518). RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design and conduct of the study; in the collection, management, analysis, and interpretation of data; in the preparation, review, or approval of the manuscript; and in the decision to submit the manuscript for publication.	Amadio P, 2017, EUR HEART J, V38, P1426, DOI 10.1093/eurheartj/ehv655; Asendorpf JB, 2002, EUR J PERSONALITY, V16, pS1, DOI 10.1002/per.446; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Costa PT, 2002, EUR J PERSONALITY, V16, pS73, DOI 10.1002/per.448; De Fruyt F, 2002, J VOCAT BEHAV, V60, P73, DOI 10.1006/jvbe.2001.1816; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eggers KM, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0840-3; Erasmus RT, 2009, CLIN CHIM ACTA, V400, P1, DOI 10.1016/j.cca.2008.10.024; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jaffe AS, 2006, AM HEART J, V152, P126, DOI 10.1016/j.ahj.2005.10.004; Jiang H, 2009, CLIN CHIM ACTA, V400, P3, DOI 10.1016/j.cca.2008.10.017; Jiang R, 2017, AM HEART J, V190, P40, DOI 10.1016/j.ahj.2017.05.002; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jokela M, 2014, BRIT J CANCER, V110, P1820, DOI 10.1038/bjc.2014.58; Jokela M, 2014, J BEHAV MED, V37, P881, DOI 10.1007/s10865-013-9548-z; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kazantseva A, 2015, PROG NEURO-PSYCHOPH, V56, P58, DOI 10.1016/j.pnpbp.2014.08.001; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kim JM, 2018, JAMA-J AM MED ASSOC, V320, P350, DOI 10.1001/jama.2018.9422; Kim JM, 2018, J AM COLL CARDIOL, V71, P2706, DOI 10.1016/j.jacc.2018.04.006; Kim JM, 2017, PSYCHOTHER PSYCHOSOM, V86, P62, DOI 10.1159/000449469; Kim JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051280; Kim JM, 2012, PSYCHOSOM MED, V74, P8, DOI 10.1097/PSY.0b013e318241530c; 김선영, 2010, [Journal of Korean Society of Biological Psychiatry, 생물정신의학], V17, P15; Kunugi H, 2004, BIOL PSYCHIAT, V56, P376, DOI 10.1016/j.biopsych.2004.06.017; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lee YC, 2011, J DATA MINING GENOMI, V2; McCrae RR, 2001, J RES PERS, V35, P108, DOI 10.1006/jrpe.2000.2294; Pedersen SS, 2004, J AM COLL CARDIOL, V44, P997, DOI 10.1016/j.jacc.2004.05.064; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stahelova A, 2011, CYTOKINE, V53, P13, DOI 10.1016/j.cyto.2010.08.007; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213; Wardenaar KJ, 2014, J CLIN PSYCHIAT, V75, pE916, DOI 10.4088/JCP.13m08855	43	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226802	10.1371/journal.pone.0226802	http://dx.doi.org/10.1371/journal.pone.0226802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8JV	31887219	Green Published, gold			2022-12-26	WOS:000515092200037
J	Wang, HA; Wang, LF; Wang, ZZC; Dang, YN; Shi, Y; Zhao, PP; Zhang, K				Wang, Huanan; Wang, Lefeng; Wang, Zizengchen; Dang, Yanna; Shi, Yan; Zhao, Panpan; Zhang, Kun			The nucleolar protein NOP2 is required for nucleolar maturation and ribosome biogenesis during preimplantation development in mammals	FASEB JOURNAL			English	Article						cattle; embryo; NOP2; nucleolus; preimplantation; ribosome	MATERNAL NUCLEOLUS; RNA; PROVIDES; OOCYTE	The maternal nucleolus plays an indispensable role in zygotic genome activation (ZGA) and early embryonic development in mice. During oocyte-to-embryo transition, the nucleolus is subject to substantial transformation. Despite the primary role of the nucleolus is ribosome biogenesis, accumulating evidence has uncovered its functions in various other cell processes. However, the regulation of nucleolar maturation and ribosome biogenesis and the molecules involved remain unclear during early embryonic development. In this study, we observed that nucleolar protein 2 (NOP2) is restrictedly localized within the nucleolus, first detected in the late two-cell embryos, and increases to a peak level at the eight-cell stage in mice. RNAi-mediated NOP2 depletion leads to a developmental arrest during the morula-to-blastocyst transition. RNA-seq analyses reveal that 208 genes are differentially expressed, including multiple lineage-specific genes and several genes encoding ribosome proteins. Indeed, we observe a failure of the first lineage specification with reduced TEA domain transcription factor 4(TEAD4) (trophectoderm-specific), tir na nog (NANOG), and kruppel-like factor 4 (KLF4) (inner cell mass-specific). Importantly, by Transmission Electron Microscopy (TEM), we noted a decrease in the ratio of the nucleolus size and an increase in the ratio of the size of the nucleolus precursor body, suggesting the nucleolar maturation is disrupted. Moreover, both qPCR and Fluorescence In Situ Hybridization (FISH) data showcase a significant decrease in the abundance of ribosome RNAs. Similarly, NOP2 depletion causes reduced developmental potential and decreased rRNA level in bovine early embryos, suggesting a functional conservation of NOP2 in mammals. Taken together, these results suggest that NOP2 is required for mammalian preimplantation development, presumably by regulating nucleolar maturation and ribosome biogenesis.	[Wang, Huanan; Wang, Lefeng; Wang, Zizengchen; Dang, Yanna; Shi, Yan; Zhao, Panpan; Zhang, Kun] Zhejiang Univ, Assisted Reprod Unit, Lab Mammalian Mol Embryol,Coll Anim Sci, Dept Obstet & Gynecol,Sir Run Run Shaw Hosp,Sch M, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, K (corresponding author), Zhejiang Univ, Assisted Reprod Unit, Lab Mammalian Mol Embryol,Coll Anim Sci, Dept Obstet & Gynecol,Sir Run Run Shaw Hosp,Sch M, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	kzhang@zju.edu.cn		Zhang, Kun/0000-0002-2324-9381	National Natural Science Foundation of China (NSFC) [31872348]; Zhejiang Provincial Natural Science Foundation of China [LY19C180002]; Foundation of Key Laboratory of Veterinary Biotechnology [klab201708]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Key Laboratory of Veterinary Biotechnology	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31672416; National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31872348; Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LY19C180002; the Foundation of Key Laboratory of Veterinary Biotechnology, Grant/Award Number: No. klab201708	Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Bohnsack KE, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020102; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bourgeois G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133321; Chen H, 2008, BIOCHEM BIOPH RES CO, V365, P636, DOI 10.1016/j.bbrc.2007.11.019; Cui W, 2016, MOL REPROD DEV, V83, P124, DOI 10.1002/mrd.22600; Forloni Matteo, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot097758; Fulka H, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136093; Fulka H, 2014, DEVELOPMENT, V141, P1694, DOI 10.1242/dev.105940; Hamdane N, 2019, TRENDS GENET, V35, P868; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Kone MC, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136366; Kresoja-Rakic J, 2019, TRENDS GENET, V35, P868, DOI 10.1016/j.tig.2019.06.005; Kressler D, 2017, TRENDS BIOCHEM SCI, V42, P640, DOI 10.1016/j.tibs.2017.05.005; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; Nelson MD, 2011, METHODS MOL BIOL, V772, P459, DOI 10.1007/978-1-61779-228-1_27; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; OCHS RL, 1988, CANCER RES, V48, P6523; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Ogushi S, 2010, J REPROD DEVELOP, V56, P495, DOI 10.1262/jrd.09-184H; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Romanova LG, 2006, BIOL REPROD, V75, P690, DOI 10.1095/biolreprod.106.054072; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Sahraeian SME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00050-4; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Tiku V, 2018, TRENDS CELL BIOL, V28, P662, DOI 10.1016/j.tcb.2018.03.007; Trere D, 2000, J PATHOL, V192, P216, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH695>3.0.CO;2-L; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Zhang K, 2013, DEV BIOL, V383, P15, DOI 10.1016/j.ydbio.2013.09.005; Zhang K, 2013, DEV BIOL, V373, P359, DOI 10.1016/j.ydbio.2012.10.026; Zhao PP, 2019, FASEB J, V33, P12541, DOI 10.1096/fj.201901213R	40	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2715	2729		10.1096/fj.201902623R	http://dx.doi.org/10.1096/fj.201902623R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908012				2022-12-26	WOS:000504269800001
J	Grailey, KE; Murray, EJ; Billings, J; Brett, SJ				Grailey, K. E.; Murray, E. J.; Billings, J.; Brett, S. J.			How do critical care staff respond to organisational challenge? A qualitative exploration into personality types and cognitive processing in critical care	PLOS ONE			English	Article								Critical care staff are frequently required to respond to stressful scenarios. The way staff counter organisational challenge may be influenced by their underlying personality type, preferred style of cognitive processing and previous clinical experience. Our objective was to explore the personality types of a sample of critical care workers, and the potential relationship of this with cognitive processing. This was achieved through a qualitative interview study in which participants were presented with difficult but realistic scenarios pertaining to staffing. Data on individual's personality were captured using the '16 Personality Factor' assessment, a tool that produces scores for 16 different elements of an individual's personality. The existence of perfectionist and pragmatic cognitive processing styles were identified as one theme emerging from a prior analysis of these interview transcripts. We aimed to validate this, explore our ability to categorise individuals into groups based upon their cognitive processing. We identified that some individuals strongly tended to either a perfectionist or pragmatic style of cognitive processing for the majority of their decisions; however most adapted their style of processing according to the nature of the decision. Overall participants generally demonstrated average scores for all 16 personality factors tested. However, we observed that some factors tended to higher scores than others, indicating a pattern within the personalities of our sample cohort. Whilst a small sample size, our data suggests that individuals working within the same critical care environment may have clear differences in their approach to problem solving as a consequence of both their personality type and preferred style of cognitive processing. Thus there may be individuals within this environment who would benefit from increased support to minimise their risk of cognitive dissonance and stress in times of challenge.	[Grailey, K. E.; Brett, S. J.] Imperial Coll London, Dept Surg & Canc, London, England; [Murray, E. J.] Univ Oxford, Said Business Sch, Oxford, England; [Billings, J.] UCL, London, England	Imperial College London; University of Oxford; University of London; University College London	Grailey, KE (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.	k.grailey18@imperial.ac.uk	Billings, Jo/ABA-4690-2020	Billings, Jo/0000-0003-1238-2440; Grailey, Kate/0000-0002-4104-8444	BUPA Cromwell Hospital; Health Foundation; National Institute for Health Research Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London; National Institute for Health Research (NIHR), Imperial Biomedical Research Centre (BRC)	BUPA Cromwell Hospital; Health Foundation; National Institute for Health Research Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London(General Electric); National Institute for Health Research (NIHR), Imperial Biomedical Research Centre (BRC)	KG received an unrestricted educational grant from BUPA Cromwell Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study analyses data originally collected in a previous qualitative study by the authors (EM, SJB). EM's institution received funding from The Health Foundation. SJB's institution received funding from The Health Foundation. In addition, he received general support for research from the National Institute for Health Research Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; This work was originally supported by the Health Foundation. In addition, the work was supported by the National Institute for Health Research (NIHR), Imperial Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NIHR, the UK Department of Health or the UK National Health Service.	[Anonymous], 2016, 16PF COMPR INS REP; Cattell H, 2008, SAGE HDB PERSONALITY, P135, DOI DOI 10.4135/9781849200479.N7; Cattell R, 1980, HDB 16 PERSONALITY F; Chuang CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005629; D'Lima DM, 2018, CRIT CARE MED, V46, P60, DOI 10.1097/CCM.0000000000002773; Epp Kirstin, 2012, Dynamics, V23, P25; Flett G.L., 2002, PERFECTIONISM MALADJ, DOI DOI 10.1037/10458-001; GERBING DW, 1991, MULTIVAR BEHAV RES, V26, P271, DOI 10.1207/s15327906mbr2602_5; Khatibi M, J ED MANAGE STUD, V6, P13; Kluger MT, 1999, ANAESTH INTENS CARE, V27, P282, DOI 10.1177/0310057X9902700310; Meit SS, 2005, PSYCHOL REP, V96, P1029; Oxford Dictionaries | English, 2018, DEFINITION REASONING; Rieke, 1994, 16PF TECHNICAL MANUA; Russell MT, 2002, 16PF ADM MANUAL; Stoeber J, 2010, J PERS ASSESS, V92, P577, DOI 10.1080/00223891.2010.513306; Wilhite A, 2016, COMPUTING EC FINANCE, V103; Zhang L, 2013, CONTEMP NURSE, V43, P219, DOI 10.5172/conu.2013.43.2.219	17	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226800	10.1371/journal.pone.0226800	http://dx.doi.org/10.1371/journal.pone.0226800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914163	Green Published, gold, Green Submitted			2022-12-26	WOS:000534337700017
J	Schafermann, S; Neci, R; Ndze, EN; Nyaah, F; Pondo, VB; Heide, L				Schaefermann, Simon; Neci, Richard; Ndze, Edward Ngah; Nyaah, Fidelis; Pondo, Valentin Basolanduma; Heide, Lutz			Availability, prices and affordability of selected antibiotics and medicines against non-communicable diseases in western Cameroon and northeast DR Congo	PLOS ONE			English	Article								Access to safe, effective and affordable medicines of good quality is included into the Sustainable Development Goals of the United Nations. Furthermore, WHO has developed a Global Action Plan with the aim to raise access to essential medicines against non-communicable diseases (NCDs) to 80%, and to improve their affordability. In order to contribute to the monitoring of progress towards these goals, the present study investigated the availability and affordability of seven antibiotics and six medicines against non-communicable diseases in the northeast of the Democratic Republic of Congo and the west of the Republic of Cameroon. Data on availability and prices of these medicines were collected in 60 different sites (34 in the DR Congo, 26 in Cameroon), including government health facilities, church health facilities, private pharmacies and informal vendors, as part of a study on medicine quality. The data were analyzed using a standardized procedure developed by WHO and Health Action International (HAI). Average availability of the investigated antibiotics ranged from 62% to 98% in the different types of facilities in both countries, including the informal vendors. Average availability for medicines against NCDs in the different types of facilities showed a higher variation in both countries, ranging from 11% up to 87%. The average availability of medicines against NCDs in government health facilities was only 33% in Cameroon, and as low as 11% in the DR Congo. In contrast, availability of medicines against NCDs in church health facilities in Cameroon was 70%, not far from the 80% availability goal set by WHO. Medicine prices were clearly higher in Cameroon than in the DR Congo, with median price ratios to an international reference price of 5.69 and 2.17, respectively (p < 0.001). In relation to the daily minimum wages in both countries, treatment courses with five of the seven investigated antibiotics could be considered as affordable, while in each country only one out of the five investigated medicines against NCDs could be considered as affordable. Especially generic medicines provided by government and church health facilities showed reasonable affordability in most cases, while originator medicines offered by private pharmacies were clearly unaffordable to a major part of the population. Despite some encouraging findings on the availability of antibiotics in both countries, the availability and affordability of medicines against NCDs urgently requires further improvements.	[Schaefermann, Simon; Heide, Lutz] Eberhard Karls Univ Tuebingen, Pharmaceut Inst, Tubingen, Germany; [Neci, Richard] Depot Cent Med Pharmaceut 8e CEPAC DCMP, Bukavu, DEM REP CONGO; [Ndze, Edward Ngah] Cameroon Baptist Convent CBC, Cent Pharm, Mutengene, Cameroon; [Nyaah, Fidelis] Presbyterian Church Cameroon PCC, Cent Pharm, Limbe, Cameroon; [Pondo, Valentin Basolanduma] Cent Approvisionnnement & Distribut Medicaments E, Bunia, DEM REP CONGO	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heide, L (corresponding author), Eberhard Karls Univ Tuebingen, Pharmaceut Inst, Tubingen, Germany.	heide@uni-tuebingen.de		Heide, Lutz/0000-0001-7809-7453	Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft; University of Tubingen	Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was funded by the Eberhard Karls University Tubingen. We furthermore acknowledge support for open access publication by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminde LN, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0360-9; [Anonymous], 2016, WHO TECHN REP SER, V996; [Anonymous], 2012, UN MILLENIUM DEV GOA; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Becker J, 2002, LANCET INFECT DIS, V2, P325, DOI 10.1016/S1473-3099(02)00285-2; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Ewen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171284; Gostin LO, 2019, JAMA-J AM MED ASSOC, V321, P243, DOI 10.1001/jama.2018.19743; Health Action International, 2008, HLTH ACTION INT MEAS; Hunter-Adams J, 2017, LANCET DIABETES ENDO, V5, P932, DOI 10.1016/S2213-8587(17)30220-6; Jingi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111812; Laokri S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3211-x; Ministere de la Sante Publique, REP DEM CONG LIST NA; Ministere de la Sante Publique (MSP), 2014, ENQ DISP CAP OP SERV; Ministeres de la Sante Publique, 2017, REP CAM LIST NAT MED; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Ntangsi J, 1998, ANAL HLTH SECTOR EXP; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Peyraud N, 2017, LANCET GLOB HEALTH, V5, pE137, DOI 10.1016/S2214-109X(16)30287-X; Preux PM, 2000, EPILEPSIA, V41, P432, DOI 10.1111/j.1528-1157.2000.tb00185.x; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Tsabang N, 2016, J FOR RES, V5; UN-DESA, SUST DEV GOAL 3 PROG; United Nations Development Programme, 2018, HUM DEV REP DEM REP, DOI DOI 10.1001/JAMA.2018.19743; United Nations Development Programme, 2018, HUM DEV REP CAM 2018; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2009, WHO MOD FORM 2008; World Health Organization, 2019, WHO MOD LIST ESS MED	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227515	10.1371/journal.pone.0227515	http://dx.doi.org/10.1371/journal.pone.0227515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910444	Green Published, gold			2022-12-26	WOS:000534333800049
J	Slayton, MA; Romero-Sosa, JL; Shore, K; Buonomano, DV; Viskontas, IV				Slayton, Matthew A.; Romero-Sosa, Juan L.; Shore, Katrina; Buonomano, Dean V.; Viskontas, Indre V.			Musical expertise generalizes to superior temporal scaling in a Morse code tapping task	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; MOTOR-PERFORMANCE; NEURAL BASIS; TIME; PERCEPTION; MECHANISMS; MUSICIANS; NETWORK; EXPERIENCE; INTERVALS	A key feature of the brain's ability to tell time and generate complex temporal patterns is its capacity to produce similar temporal patterns at different speeds. For example, humans can tie a shoe, type, or play an instrument at different speeds or tempi-a phenomenon referred to as temporal scaling. While it is well established that training improves timing precision and accuracy, it is not known whether expertise improves temporal scaling, and if so, whether it generalizes across skill domains. We quantified temporal scaling and timing precision in musicians and non-musicians as they learned to tap a Morse code sequence. We found that non-musicians improved significantly over the course of days of training at the standard speed. In contrast, musicians exhibited a high level of temporal precision on the first day, which did not improve significantly with training. Although there was no significant difference in performance at the end of training at the standard speed, musicians were significantly better at temporal scaling-i.e., at reproducing the learned Morse code pattern at faster and slower speeds. Interestingly, both musicians and non-musicians exhibited a Weber-speed effect, where temporal precision at the same absolute time was higher when producing patterns at the faster speed. These results are the first to establish that the ability to generate the same motor patterns at different speeds improves with extensive training and generalizes to non-musical domains.	[Slayton, Matthew A.; Shore, Katrina; Viskontas, Indre V.] San Francisco Conservatory Mus, San Francisco, CA 94102 USA; [Romero-Sosa, Juan L.; Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Romero-Sosa, Juan L.; Buonomano, Dean V.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Viskontas, Indre V.] Univ San Francisco, Dept Psychol, San Francisco, CA 94117 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of San Francisco	Viskontas, IV (corresponding author), San Francisco Conservatory Mus, San Francisco, CA 94102 USA.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA.; Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.; Viskontas, IV (corresponding author), Univ San Francisco, Dept Psychol, San Francisco, CA 94117 USA.	dbuono@ucla.edu; ivviskontas@usfca.edu		Slayton, Matthew/0000-0003-3561-7660				Bakhurin KI, 2017, J NEUROSCI, V37, P854, DOI 10.1523/JNEUROSCI.1789-16.2016; Bueti D., 2014, TIMING TIME PERCEPT, V2, P261, DOI [10.1163/22134468-00002023, DOI 10.1163/22134468-00002023]; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Dowling WJ, 2008, PERCEPT PSYCHOPHYS, V70, P496, DOI 10.3758/PP.70.3.496; Furuya S, 2012, J NEUROPHYSIOL, V108, P2060, DOI 10.1152/jn.00378.2012; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P993, DOI 10.1037/0096-1523.25.4.993; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Grondin S, 2009, ATTEN PERCEPT PSYCHO, V71, P1649, DOI 10.3758/APP.71.7.1649; Hardy NF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07161-6; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hinton SC, 2004, COGNITIVE BRAIN RES, V21, P183, DOI 10.1016/j.cogbrainres.2004.04.009; Hosoda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37632; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krause V, 2010, NEUROIMAGE, V52, P245, DOI 10.1016/j.neuroimage.2010.03.081; Laje R, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00061; Lerner Y, 2014, J NEUROPHYSIOL, V111, P2433, DOI 10.1152/jn.00497.2013; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Namboodiri VMK, 2015, NEURON, V86, P319, DOI 10.1016/j.neuron.2015.02.043; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Paton JJ, 2018, NEURON, V98, P687, DOI 10.1016/j.neuron.2018.03.045; Penhune V, 2018, TAPPING RATE FLEXIBI; Rammsayer TH, 2012, MUSIC PERCEPT, V30, P85, DOI 10.1525/MP.2012.30.1.85; Remington ED, 2018, NEURON, V98, P1005, DOI 10.1016/j.neuron.2018.05.020; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Shankar KH, 2012, NEURAL COMPUT, V24, P134, DOI 10.1162/NECO_a_00212; Stupacher J, 2017, FRONT NEUROSCI-SWITZ, V11, P1, DOI 10.3389/fnins.2017.00208; Wang J, 2018, NAT NEUROSCI, V21, P102, DOI 10.1038/s41593-017-0028-6; Watanabe D, 2007, EXP BRAIN RES, V176, P332, DOI 10.1007/s00221-006-0619-z; Wright BA, 2010, J NEUROSCI, V30, P11635, DOI 10.1523/JNEUROSCI.1441-10.2010	45	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0221000	10.1371/journal.pone.0221000	http://dx.doi.org/10.1371/journal.pone.0221000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4ZR	31905200	Green Published, gold, Green Submitted			2022-12-26	WOS:000534327700002
J	Middleton, BA				Middleton, Beth A.			Trends of litter decomposition and soil organic matter stocks across forested swamp environments of the southeastern US	PLOS ONE			English	Article							STANDARD PLANT-MATERIAL; LEAF-LITTER; NUTRIENT ACCUMULATION; CARBON SEQUESTRATION; CONIFEROUS FORESTS; WETLAND SOILS; CLIMATE; COASTAL; SALINITY; GRADIENT	A common idea in the discussion of soil carbon processes is that litter decomposition rates and soil carbon stocks are inversely related. To test this overall hypothesis, simultaneous studies were conducted of the relationship of environmental gradients to leaf and wood decomposition, buried cloth decomposition and percent soil organic matter in Taxodium distichum swamps across the Mississippi River Alluvial Valley (MRAV) and northern Gulf of Mexico (GOM) of the US. Decomposition of leaf tissue was 6.2 to 10.9 times faster than wood tissue. Both precipitation and flooding gradients were negatively related to leaf and wood litter decomposition rates based on models developed using Stepwise General Model Selection (MRAV vs. GOM, respectively). Cotton cloth should not be used as a proxy for plant litter without prior testing because cloth responded differently than plant litter to regional environmental gradients in T. distichum swamps. The overall hypothesis was supported in the MRAV because environments with higher precipitation (climate normal) had lower rates of decomposition and higher percent soil organic matter. In the MRAV, higher levels of percent soil organic matter were related to increased 30-year climate normals (30 year averages of precipitation and air temperature comprising southward increasing Prin-Comp1). Soil organic carbon % in inland vs. coastal T. distichum forests of the MRAV were comparable (range = 1.5% to 26.9% vs. 9.8 to 31.5%, respectively). GOM swamps had lower rates of litter decomposition in more flooded environments. Woody T. distichum detritus had a half-life of up to 300 years in the MRAV, which points to its likely role in the maintenance of inland "teal" soil organic carbon. This unique study can contribute to the discussion of approaches to maintain environments conducive to soil carbon stock maximization.	[Middleton, Beth A.] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA	United States Department of the Interior; United States Geological Survey	Middleton, BA (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA.	middletonb@usgs.gov	Middleton, Beth/D-1778-2014	Middleton, Beth/0000-0002-1220-2326	U.S. Geological Survey Ecosystem Program; National Science Foundation [DEB-1049838]	U.S. Geological Survey Ecosystem Program; National Science Foundation(National Science Foundation (NSF))	Funding came from the U.S. Geological Survey Ecosystem Program and the National Science Foundation (DEB-1049838).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Akanil N, 1997, CAN J BOT, V75, P1394, DOI 10.1139/b97-853; Allen S.E., 1974, CHEM ANAL ECOLOGICAL; Allen Y, 2016, RIVER RES APPL, V32, P1609, DOI 10.1002/rra.2987; Alongi DM, 2014, ANNU REV MAR SCI, V6, P195, DOI 10.1146/annurev-marine-010213-135020; [Anonymous], 2019, GOOGL EARTH PRO 6 3; [Anonymous], 1992, HDB REFERENCE METHOD; [Anonymous], 1989, APPL LINEAR REGRESSI; [Anonymous], [No title captured]; Barlocher Felix, 2005, P37, DOI 10.1007/1-4020-3466-0_6; Battle JM, 2001, AM MIDL NAT, V146, P128, DOI 10.1674/0003-0031(2001)146[0128:HIOBOL]2.0.CO;2; BRINSON MM, 1981, ANNU REV ECOL SYST, V12, P123, DOI 10.1146/annurev.es.12.110181.001011; Chadwick OA, 2003, CHEM GEOL, V202, P195, DOI 10.1016/j.chemgeo.2002.09.001; Chen H, 2002, CAN J FOREST RES, V32, P320, DOI 10.1139/X01-202; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Couteaux MM, 2002, SOIL BIOL BIOCHEM, V34, P69, DOI 10.1016/S0038-0717(01)00155-9; Couteaux MM, 2001, BIOGEOCHEMISTRY, V54, P147, DOI 10.1023/A:1010613524551; Craft CB, 2000, WETLANDS, V20, P323, DOI 10.1672/0277-5212(2000)020[0323:SANAIF]2.0.CO;2; Craft C, 2008, WASTEWATER TREATMENT, PLANT DYNAMICS AND MANAGEMENT IN CONSTRUCTED AND NATURAL WETLANDS, P23, DOI 10.1007/978-1-4020-8235-1_3; Craft C, 2007, LIMNOL OCEANOGR, V52, P1220, DOI 10.4319/lo.2007.52.3.1220; Dale SE, 2015, PLANT SOIL, V394, P225, DOI 10.1007/s11104-015-2511-8; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Day JW, 2011, ECOL ENG, V37, P229, DOI 10.1016/j.ecoleng.2010.11.021; Fritz KM, 2011, ECOHYDROLOGY, V4, P469, DOI 10.1002/eco.128; Giese LA, 2000, ECOL ENG, V15, pS157, DOI 10.1016/S0925-8574(99)00081-6; Hansen VD, 2014, WETL ECOL MANAG, V22, P289, DOI 10.1007/s11273-013-9330-6; Hernes PJ, 2004, GEOCHIM COSMOCHIM AC, V68, P1293, DOI 10.1016/j.gca.2003.09.015; Howard J, 2017, FRONT ECOL ENVIRON, V15, P42, DOI 10.1002/fee.1451; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Little E., 1971, CONIFERS IMPORTANT H, V1; Mackey AP, 1996, HYDROBIOLOGIA, V332, P93, DOI 10.1007/BF00016688; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Markewich H.W, 2007, 1686B US GEOL SURV; Mendelssohn IA, 1999, AQUAT BOT, V64, P381, DOI 10.1016/S0304-3770(99)00065-0; Middleton BA, 2004, GLOBAL ECOL BIOGEOGR, V13, P247, DOI 10.1111/j.1466-822X.2004.00088.x; MIDDLETON BA, 1992, WETLANDS, V12, P37, DOI 10.1007/BF03160542; Middleton BA, 2001, J ECOL, V89, P818, DOI 10.1046/j.0022-0477.2001.00602.x; Middleton BA, 2015, ECOHYDROLOGY, V8, P838, DOI 10.1002/eco.1625; Middleton BA, 2009, PLANT ECOL, V202, P257, DOI 10.1007/s11258-008-9480-4; Miller J., 1992, FLUVIAL PROCESSES GE; Moomaw WR, 2018, WETLANDS, V38, P183, DOI 10.1007/s13157-018-1023-8; Moore TR, 2017, PLANT SOIL, V416, P419, DOI 10.1007/s11104-017-3228-7; Morrissey EM, 2014, GLOBAL CHANGE BIOL, V20, P1351, DOI 10.1111/gcb.12431; Nahlik AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13835; Nelson Institute for Environmental Studies, 2017, ATL BIOSPH; Olsen MW, 1996, PLANT SOIL, V179, P183, DOI 10.1007/BF00009327; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Osland MJ, 2018, GLOBAL CHANGE BIOL, V24, P5361, DOI 10.1111/gcb.14376; Osland MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183431; Ricker MC, 2016, BIOGEOCHEMISTRY, V127, P323, DOI 10.1007/s10533-016-0183-y; Russell MB, 2014, ECOSYSTEMS, V17, P765, DOI 10.1007/s10021-014-9757-5; Salinas N, 2011, NEW PHYTOL, V189, P967, DOI 10.1111/j.1469-8137.2010.03521.x; SAS Institute Inc, 2002, SAS 9 3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCOTT RM, 1962, J SOIL SCI, V13, P1, DOI 10.1111/j.1365-2389.1962.tb00674.x; Siocum MG, 2009, J PLANT NUTR SOIL SC, V172, P71, DOI 10.1002/jpln.200800179; Sokal RR, 1998, BIOMETRY; Stahle DW, 2012, QUATERNARY SCI REV, V34, P1, DOI 10.1016/j.quascirev.2011.11.005; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Tiegs SD, 2013, ECOL INDIC, V32, P131, DOI 10.1016/j.ecolind.2013.03.013; TURNER RE, 1976, CONTRIB MAR SCI, V20, P47; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; USDA (U.S. Department of Agriculture), 2019, SOIL SURV; USDA (United States Department of Agriculture), 2019, OFF SOIL SER DESCR S; Wang CY, 2018, ENVIRON SCI POLLUT R, V25, P23261, DOI 10.1007/s11356-018-2357-8; Wang HQ, 2017, J COASTAL RES, V33, P507, DOI [10.2112/JCOASTRES-D-16-00014.1, 10.2112/jcoastres-d-16-00014.1]; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1	69	11	11	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226998	10.1371/journal.pone.0226998	http://dx.doi.org/10.1371/journal.pone.0226998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899783	Green Published, gold			2022-12-26	WOS:000534322000009
J	Holter, MM; Garibay, D; Lee, SA; Saikia, M; McGavigan, AK; Ngyuen, L; Moore, ES; Daugherity, E; Cohen, P; Kelly, K; Weiss, RS; Cummings, BP				Holter, Marlena M.; Garibay, Darline; Lee, Seon A.; Saikia, Mridusmita; McGavigan, Anne K.; Ngyuen, Lily; Moore, Elizabeth S.; Daugherity, Erin; Cohen, Paul; Kelly, Kathleen; Weiss, Robert S.; Cummings, Bethany P.			Hepatocyte p53 ablation induces metabolic dysregulation that is corrected by food restriction and vertical sleeve gastrectomy in mice	FASEB JOURNAL			English	Article						bariatric surgery; body weight; energy expenditure; p53	Y GASTRIC BYPASS; ENERGY-EXPENDITURE; MITOCHONDRIAL RESPIRATION; FATTY LIVER; EXPRESSION; SURGERY; GLUCOSE; IDENTIFICATION; INACTIVATION; DYSFUNCTION	P53 has been implicated in the pathogenesis of obesity and diabetes; however, the mechanisms and tissue sites of action are incompletely defined. Therefore, we investigated the role of hepatocyte p53 in metabolic homeostasis using a hepatocyte-specific p53 knockout mouse model. To gain further mechanistic insight, we studied mice under two complementary conditions of restricted weight gain: vertical sleeve gastrectomy (VSG) or food restriction. VSG or sham surgery was performed in high-fat diet-fed male hepatocyte-specific p53 wild-type and knockout littermates. Sham-operated mice were fed ad libitum or food restricted to match their body weight to VSG-operated mice. Hepatocyte-specific p53 ablation in sham-operated ad libitum-fed mice impaired glucose homeostasis, increased body weight, and decreased energy expenditure without changing food intake. The metabolic deficits induced by hepatocyte-specific p53 ablation were corrected, in part by food restriction, and completely by VSG. Unlike food restriction, VSG corrected the effect of hepatocyte p53 ablation to lower energy expenditure, resulting in a greater improvement in glucose homeostasis compared with food restricted mice. These data reveal an important new role for hepatocyte p53 in the regulation of energy expenditure and body weight and suggest that VSG can improve alterations in energetics associated with p53 dysregulation.	[Holter, Marlena M.; Garibay, Darline; Lee, Seon A.; Saikia, Mridusmita; McGavigan, Anne K.; Moore, Elizabeth S.; Daugherity, Erin; Kelly, Kathleen; Weiss, Robert S.; Cummings, Bethany P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Ngyuen, Lily; Cohen, Paul] Rockefeller Univ, Lab Mol Metab, 1230 York Ave, New York, NY 10021 USA	Cornell University; Rockefeller University	Cummings, BP (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	bpc68@cornell.edu		Lee, Seona/0000-0002-0124-6964; Nguyen, Lily/0000-0003-4425-2536	NIH [R21CA195002]; Cornell Comparative Cancer Biology Training Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Comparative Cancer Biology Training Program	NIH, Grant/Award Number: R21CA195002; Cornell Comparative Cancer Biology Training Program, Grant/Award Number: NA	Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Coen PM, 2015, DIABETES, V64, P3737, DOI 10.2337/db15-0809; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Faria SL, 2012, SURG OBES RELAT DIS, V8, P797, DOI 10.1016/j.soard.2012.06.008; Garibay D, 2016, ENDOCRINOLOGY, V157, P3405, DOI 10.1210/en.2016-1302; Hallenborg P, 2016, AM J PHYSIOL-ENDOC M, V310, pE116, DOI 10.1152/ajpendo.00119.2015; Hao Z, 2016, OBES SURG, V26, P2173, DOI 10.1007/s11695-016-2062-y; Homayounfar R, 2015, GEN COMP ENDOCR, V214, P134, DOI 10.1016/j.ygcen.2014.06.029; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li J, 2007, OBES SURG, V17, P800, DOI 10.1007/s11695-007-9146-7; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Marino S, 2000, GENE DEV, V14, P994; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Moulder DE, 2018, CANCERS, V10, DOI 10.3390/cancers10060189; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Nijhawan S, 2013, SURG ENDOSC, V27, P4569, DOI 10.1007/s00464-013-3125-y; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Porteiro B, 2018, MOL METAB, V8, P132, DOI 10.1016/j.molmet.2017.12.005; Prokesch A, 2017, FASEB J, V31, P732, DOI 10.1096/fj.201600845R; Quinones M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05711-6; Rubino F, 2010, NAT REV ENDOCRINOL, V6, P102, DOI 10.1038/nrendo.2009.268; Shin AC, 2013, OBES SURG, V23, P531, DOI 10.1007/s11695-012-0846-2; Vijgen GHEJ, 2013, SURG OBES RELAT DIS, V9, P936, DOI 10.1016/j.soard.2013.03.009; Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Yahagi N, 2004, J BIOL CHEM, V279, P20571, DOI 10.1074/jbc.M400884200; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang XM, 2016, PANCREAS, V45, P1010, DOI 10.1097/MPA.0000000000000637	46	4	4	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1846	1858		10.1096/fj.201902214R	http://dx.doi.org/10.1096/fj.201902214R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914635	Green Accepted			2022-12-26	WOS:000507308900122
J	Redick, SD; Leehy, L; Rittenhouse, AR; Blodgett, DM; Derr, AG; Kucukural, A; Garber, MG; Shultz, LD; Greiner, DL; Wang, JP; Harlan, DM; Bortell, R; Jurczyk, A				Redick, Sambra D.; Leehy, Linda; Rittenhouse, Ann R.; Blodgett, David M.; Derr, Alan G.; Kucukural, Alper; Garber, Manuel G.; Shultz, Leonard D.; Greiner, Dale L.; Wang, Jennifer P.; Harlan, David M.; Bortell, Rita; Jurczyk, Agata			Recovery of viable endocrine-specific cells and transcriptomes from human pancreatic islet-engrafted mice	FASEB JOURNAL			English	Article						graft recovery; insulin; L-type voltage-gated calcium channel; RNA-Seq; beta cell	GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; INSULIN-RELEASE; PROLIFERATION; GLUCOSE; ADULT; GENERATION; CHANNELS; MODEL	Human pancreatic islets engrafted into immunodeficient mice serve as an important model for in vivo human diabetes studies. Following engraftment, islet function can be monitored in vivo by measuring circulating glucose and human insulin; however, it will be important to recover viable cells for more complex graft analyses. Moreover, RNA analyses of dissected grafts have not distinguished which hormone-specific cell types contribute to gene expression. We developed a method for recovering live cells suitable for fluorescence-activated cell sorting from human islets engrafted in mice. Although yields of recovered islet cells were relatively low, the ratios of bulk-sorted beta, alpha, and delta cells and their respective hormone-specific RNA-Seq transcriptomes are comparable pretransplant and posttransplant, suggesting that the cellular characteristics of islet grafts posttransplant closely mirror the original donor islets. Single-cell RNA-Seq transcriptome analysis confirms the presence of appropriate beta, alpha, and delta cell subsets. In addition, ex vivo perifusion of recovered human islet grafts demonstrated glucose-stimulated insulin secretion. Viable cells suitable for patch-clamp analysis were recovered from transplanted human embryonic stem cell-derived beta cells. Together, our functional and hormone-specific transcriptome analyses document the broad applicability of this system for longitudinal examination of human islet cells undergoing developmental/metabolic/pharmacogenetic manipulation in vivo and may facilitate the discovery of treatments for diabetes.	[Redick, Sambra D.; Leehy, Linda; Derr, Alan G.; Greiner, Dale L.; Bortell, Rita; Jurczyk, Agata] Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2008, Worcester, MA 01605 USA; [Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Blodgett, David M.; Wang, Jennifer P.; Harlan, David M.] Univ Massachusetts, Sch Med, Dept Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Blodgett, David M.] Babson Coll, Div Math & Sci, Wellesley, MA USA; [Derr, Alan G.; Kucukural, Alper; Garber, Manuel G.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Babson College; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Jurczyk, A (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2008, Worcester, MA 01605 USA.	agata.jurczyk@umassmed.edu	Kucukural, Alper/T-3563-2018	Kucukural, Alper/0000-0001-9983-394X	HHS \ National Institutes of Health (NIH) [NIH R01 AI11692001A1]; HHS \ NIH \ Office of Extramural Research, National Institutes of Health (OER) [NIH R01 AI139095, UC4 DK104218]; NIDDK \ Integrated Islet Distribution Program (IIDP) [NIH 2UC4DK098085]; JDRF \ IIDP Islet Award Initiative	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS \ NIH \ Office of Extramural Research, National Institutes of Health (OER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK \ Integrated Islet Distribution Program (IIDP); JDRF \ IIDP Islet Award Initiative	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NIH R01 AI11692001A1; HHS vertical bar NIH vertical bar Office of Extramural Research, National Institutes of Health (OER), Grant/Award Number: NIH R01 AI139095 and UC4 DK104218; NIDDK vertical bar Integrated Islet Distribution Program (IIDP), Grant/Award Number: NIH 2UC4DK098085; JDRF vertical bar IIDP Islet Award Initiative	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brehm MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007757; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Carrano AC, 2017, MOL METAB, V6, P991, DOI 10.1016/j.molmet.2017.04.012; Dai CH, 2017, J CLIN INVEST, V127, P3835, DOI 10.1172/JCI91761; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Derr A, 2016, GENOME RES, V26, P1397, DOI 10.1101/gr.207902.116; diIorio P, 2011, PANCREAS, V40, P1147, DOI 10.1097/MPA.0b013e31821ffabe; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Gallagher GR, 2015, DIABETES, V64, P1358, DOI 10.2337/db14-1020; Greiner DL, 2011, ANN NY ACAD SCI, V1245, P55, DOI 10.1111/j.1749-6632.2011.06318.x; Jurczyk A, 2016, FASEB J, V30, P983, DOI 10.1096/fj.15-279810; Jurczyk A, 2013, DIABETES METAB SYNDR, V6, P493, DOI 10.2147/DMSO.S53154; Liu LW, 2003, NEUROPHARMACOLOGY, V45, P281, DOI 10.1016/S0028-3908(03)00153-9; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pearson T, 2008, DIABETOLOGIA, V51, P1449, DOI 10.1007/s00125-008-1057-1; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Russell MA, 2019, DIABETES, V68, P988, DOI 10.2337/db18-0686; Sasson A, 2016, DIABETES, V65, P3008, DOI 10.2337/db16-0365; Soumillon M., 2014, BIORXIV, DOI [10.1101/003236, DOI 10.1101/003236]; Veres A, 2019, NATURE, V569, P368, DOI 10.1038/s41586-019-1168-5; Yang CX, 2015, DIABET METAB SYND OB, V8, P387, DOI 10.2147/DMSO.S87253; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023	34	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1901	1911		10.1096/fj.201901022RR	http://dx.doi.org/10.1096/fj.201901022RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914605	Green Published, hybrid			2022-12-26	WOS:000507308900126
J	Shao, LY; Liu, Y; Wang, WB; Li, AX; Wan, P; Liu, WY; Shereen, MA; Liu, F; Zhang, W; Tan, QP; Wu, KL; Liu, YL; Wu, JG				Shao, Luyao; Liu, Yan; Wang, Wenbiao; Li, Aixin; Wan, Pin; Liu, Weiyong; Shereen, Muhammad Adnan; Liu, Fang; Zhang, Wen; Tan, Quiping; Wu, Kailang; Liu, Yingle; Wu, Jianguo			SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation	FASEB JOURNAL			English	Article						inflammasome; innate immune response; interleukin-1 beta; posttranslational modification; SUMO1-catalyzed SUMOylation	NALP3 INFLAMMASOME; CONJUGATION; RECEPTORS; CRYSTALS; PATHWAY; FAMILY; P53; ASC	The NLRP3 inflammasome regulates innate immune and inflammatory responses by promoting caspase1-dependent induction of pro-inflammatory cytokines. However, aberrant inflammasome activation causes diverse diseases, and thus inflammasome activity must be tightly controlled. Here, we reveal a molecular mechanism underlying the regulation of NLRP3 inflammasome. NLRP3 interacts with SUMO-conjugating enzyme (UBC9), which subsequently promotes small ubiquitin-like modifier 1 (SUMO1) to catalyze NLRP3 SUMOylation at residue Lys(204). SUMO1-catalyzed SUMOylation of NLRP3 facilitates ASC oligomerization, inflammasome activation, and interleukin-1 beta secretion. Moreover, this study also reveals that SUMO-specific protease 3 (SENP3) is required for the deSUMOylation of NLRP3. Interestingly, SENP3 deSUMOylates NLRP3 to attenuate ASC recruitment and speck formation, the NLRP3 inflammasome activation, as well as IL-1 beta cleavage and secretion. In conclusion, we reveal that SUMO1-catalyzed SUMOylation and SENP3-mediated deSUMOylation of NLRP3 orchestrate the inflammasome activation.	[Shao, Luyao; Liu, Yan; Wang, Wenbiao; Li, Aixin; Wan, Pin; Liu, Weiyong; Shereen, Muhammad Adnan; Liu, Fang; Wu, Kailang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou, Peoples R China; [Zhang, Wen; Tan, Quiping] Guangdong LongFan Biol Sci & Technol Co, Foshan, Peoples R China	Wuhan University; Jinan University	Wu, KL; Liu, YL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	wukailang@whu.edu.cn; mvlwu@whu.edu.cn; jwu@whu.edu.cn	Liu, Fang/HCH-6710-2022; Li, Aixin/AAO-7926-2020; Wu, Jian/AAU-5221-2020; wang, wenbiao/AAQ-9104-2021; Wu, Jian/AAU-5221-2020	Liu, Fang/0000-0003-0972-9968; Li, Aixin/0000-0002-3158-0170; Wu, Jian/0000-0001-9933-7364; Shereen, Dr. Muhammad Adnan/0000-0002-0914-0697; Shao, Luyao/0000-0001-8272-4325; Wu, Jian/0000-0002-3394-1507	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81730061]; National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China) [2017ZX10103005]; Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program) [2017ZT07Y580]	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China); Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program)	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81730061; National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China), Grant/Award Number: 2017ZX10103005; Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program), Grant/Award Number: 2017ZT07Y580	Aillet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051672; Barry R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05321-2; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Enserink JM, 2017, ADV EXP MED BIOL, V963, P89, DOI 10.1007/978-3-319-50044-7_5; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang CJ, 2015, DNA CELL BIOL, V34, P652, DOI 10.1089/dna.2015.2933; Humphries F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03669-z; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; Ivanschitz L, 2015, P NATL ACAD SCI USA, V112, P14278, DOI 10.1073/pnas.1507540112; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; Liu Q, 2009, J BIOL CHEM, V284, P13686, DOI 10.1074/jbc.M809275200; Liu YF, 2018, CURR MOL MED, V18, P523, DOI 10.2174/1566524019666190112142025; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Park S, 2017, P NATL ACAD SCI USA, V114, pE5335, DOI 10.1073/pnas.1703105114; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Stindt MH, 2011, CELL CYCLE, V10; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang M, 2016, PROTEIN CELL, V7, P63, DOI 10.1007/s13238-015-0216-7; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185	56	21	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1497	1515		10.1096/fj.201901653R	http://dx.doi.org/10.1096/fj.201901653R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914638				2022-12-26	WOS:000507308900099
J	Yu, L; Li, GX; Deng, J; Jiang, X; Xue, J; Zhu, YB; Huang, W; Tang, BS; Duan, RH				Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Tang, Beisha; Duan, Ranhui			The UFM1 cascade times mitosis entry associated with microcephaly	FASEB JOURNAL			English	Article						cell cycle; Drosophila; microcephaly; ufmylation	UBIQUITIN-LIKE MODIFICATIONS; RETICULUM STRESS-RESPONSE; BIALLELIC VARIANTS; PROTEIN; MECHANISMS; UFMYLATION; PATHWAY; CONJUGATION; ACTIVATION; REGULATOR	Posttranslational modifications enhance the functional diversity of the proteome by modifying the substrates. The UFM1 cascade is a novel ubiquitin-like modification system. The mutations in UFM1, its E1 (UBA5) and E2 (UFC1), have been identified in patients with microcephaly. However, its pathological mechanisms remain unclear. Herein, we observed the disruption of the UFM1 cascade in Drosophila neuroblasts (NBs) decreased the number of NBs, leading to a smaller brain size. The lack of ufmylation in NBs resulted in an increased mitotic index and an extended G2/M phase, indicating a defect in mitotic progression. In addition, live imaging of the embryos revealed an impaired E3 ligase (Ufl1) function resulted in premature entry into mitosis and failed cellularization. Even worse, the embryonic lethality occurred as early as within the first few mitotic cycles following the depletion of Ufm1. Knockdown of ufmylation in the fixed embryos exhibited severe phenotypes, including detached centrosomes, defective microtubules, and DNA bridge. Furthermore, we observed that the UFM1 cascade could alter the level of phosphorylation on tyrosine-15 of CDK1 (pY15-CDK1), which is a negative regulator of the G2 to M transition. These findings yield unambiguous evidence suggesting that the UFM1 cascade is a microcephaly-causing factor that regulates the progression of the cell cycle at mitosis phase entry.	[Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Tang, Beisha; Duan, Ranhui] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China; [Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Duan, Ranhui] Cent South Univ, Hunan Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Duan, Ranhui] Cent South Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Duan, RH (corresponding author), Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China.	duanranhui@sklmg.edu.cn			National Natural Science Foundation of China [81771385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81571253; The National Natural Science Foundation of China, Grant/Award Number: 81771385	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cai YF, 2016, EXP HEMATOL, V44, P442, DOI 10.1016/j.exphem.2016.03.007; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Eifler K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03486-4; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fang Z, 2019, DNA CELL BIOL, V38, P1030, DOI 10.1089/dna.2019.4861; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; FOE VE, 1983, J CELL SCI, V61, P31; Gannavaram S, 2012, MOL MICROBIOL, V86, P187, DOI 10.1111/j.1365-2958.2012.08183.x; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hamilton EMC, 2017, NEUROLOGY, V89, P1821, DOI 10.1212/WNL.0000000000004578; Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003; Hu XL, 2014, INT J MOL MED, V33, P1539, DOI 10.3892/ijmm.2014.1728; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Lim NR, 2017, STEM CELL REP, V9, P32, DOI 10.1016/j.stemcr.2017.05.015; Liu H, 2014, EXP MOL PATHOL, V97, P81, DOI 10.1016/j.yexmp.2014.05.010; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Miller C, 2017, AM J PHYSIOL-GASTR L, V312, pG314, DOI 10.1152/ajpgi.00176.2016; Morgan DO, 2007, NEW SCI, P88; Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015; Mukhopadhyay D, 2017, ADV EXP MED BIOL, V963, P171, DOI 10.1007/978-3-319-50044-7_10; Muona M, 2016, AM J HUM GENET, V99, P683, DOI 10.1016/j.ajhg.2016.06.020; Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135; Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097; Pirone L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40756; Pushpavalli SNCVL, 2014, FASEB J, V28, P655, DOI 10.1096/fj.13-231167; Qin B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09175-0; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Riparbelli MG, 2002, J CELL SCI, V115, P913; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858; Rump P, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0167-8; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Staller MV, 2013, GENETICS, V193, P51, DOI 10.1534/genetics.112.144915; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Stumpff J, 2004, CURR BIOL, V14, P2143, DOI 10.1016/j.cub.2004.11.050; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Wang ZF, 2017, MUTAT RES-FUND MOL M, V803, P56, DOI 10.1016/j.mrfmmm.2017.07.001; Wei Y, 2016, GENOM PROTEOM BIOINF, V14, P140, DOI 10.1016/j.gpb.2016.04.001; Wen DH, 2017, CELL REP, V21, P2147, DOI 10.1016/j.celrep.2017.10.085; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yoo HM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00036; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	70	4	4	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1319	1330		10.1096/fj.201901751R	http://dx.doi.org/10.1096/fj.201901751R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914610				2022-12-26	WOS:000507308900088
J	Zhang, MJ; Zhao, QC; Xia, MX; Chen, J; Chen, YT; Cao, X; Liu, Y; Yuan, ZQ; Wang, XY; Xu, Y				Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Yuan, Zeng-Qiang; Wang, Xiao-Ying; Xu, Yun			The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome	FASEB JOURNAL			English	Article						AIM2 inflammasome; HDAC3; microglia; STAT1; stroke	GENE-EXPRESSION PROGRAM; EXPERIMENTAL STROKE; NEGATIVE REGULATOR; CELL-DEATH; MEMORY; ACTIVATION; NLRP3; NRF2; PHOSPHORYLATION; ACETYLATION	Histone deacetylases 3 (HDAC3) modulates the acetylation state of histone and non-histone proteins and could be a powerful regulator of the inflammatory process in stroke. Inflammasome activation is a ubiquitous but poorly understood consequence of acute ischemic stroke. Here, we investigated the potential contributions of HDAC3 to inflammasome activation in primary cultured microglia and experimental stroke models. In this study, we documented that HDAC3 expression was increased in microglia of mouse experimental stroke model. Intraperitoneal injection of RGFP966 (a selective inhibitor of HDAC3) decreased infarct size and alleviated neurological deficits after the onset of middle cerebral artery occlusion (MCAO). In vitro data indicated that LPS stimulation evoked a time-dependent increase of HDAC3 and absent in melanoma 2 (AIM2) inflammasome in primary cultured microglia. Interestingly, AIM2 was subjected to spatiotemporal regulation by RGFP966. The ability of RGFP966 to inhibit the AIM2 inflammasome was confirmed in an experimental mouse model of stroke. As expected, AIM2 knockout mice also demonstrated significant resistance to ischemia injury compared with their wild-type littermates. RGFP966 failed to exhibit extra protective effects in AIM2-/- stroke mice. Furthermore, we found that RGFP966 enhanced STAT1 acetylation and subsequently attenuated STAT1 phosphorylation, which may at least partially contributed to the negative regulation of AIM2 by RGFP966. Together, we initially found that RGFP966 alleviated the inflammatory response and protected against ischemic stroke by regulating the AIM2 inflammasome.	[Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Xu, Yun] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing, Peoples R China; [Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Xu, Yun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Zhao, Qiu-Chen; Wang, Xiao-Ying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Yuan, Zeng-Qiang] Acad Mil Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Xu, Yun] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing, Peoples R China; [Xu, Yun] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Peoples R China	Nanjing University; Nanjing University; Harvard University; Massachusetts General Hospital; Academy of Military Medical Sciences - China; Nanjing University	Xu, Y (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com			 [81571135];  [JQX15003];  [ZDXKA2016020];  [BE2016610];  [2016YFC1300504];  [JQX16024];  [81630028];  [81971112]	; ; ; ; ; ; ; 	Meijuan Zhang, Grant/Award Number: 81571135; Meijuan Zhang, Grant/Award Number: JQX15003; Yun Xu, Grant/Award Number: ZDXKA2016020; Yun Xu, Grant/Award Number: BE2016610; Yun Xu, Grant/Award Number: 2016YFC1300504; Yanting Chen, Grant/Award Number: JQX16024; Yun Xu, Grant/Award Number: 81630028; Meijuan Zhang, Grant/Award Number: 81971112	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chen YT, 2012, CLIN EXP PHARMACOL P, V39, P751, DOI 10.1111/j.1440-1681.2012.05729.x; Choi HK, 2015, HUM MOL GENET, V24, P1127, DOI 10.1093/hmg/ddu526; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ganai SA, 2016, CURR NEUROPHARMACOL, V14, P55, DOI 10.2174/1570159X13666151021111609; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hennig P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020562; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu SQ, 2015, CELL REP, V13, P1922, DOI 10.1016/j.celrep.2015.10.040; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Komaroff AL, 2018, JAMA-J AM MED ASSOC, V319, P2381, DOI 10.1001/jama.2018.5240; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Leus NGJ, 2016, BIOCHEM PHARMACOL, V108, P58, DOI 10.1016/j.bcp.2016.03.010; Li DJ, 2016, FASEB J, V30, P3388, DOI 10.1096/fj.201600495R; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Martin BN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5977; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Rogge GA, 2013, J NEUROSCI, V33, P6623, DOI 10.1523/JNEUROSCI.4472-12.2013; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vecera J, 2018, J CELL PHYSIOL, V233, P530, DOI 10.1002/jcp.25914; Wang ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19626; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wu PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32405; Xia MX, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6237351; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XY, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00131; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang J, 2018, AM J PHYSIOL-ENDOC M, V315, pE150, DOI 10.1152/ajpendo.00465.2017; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zhao QC, 2019, J NEUROCHEM, V149, P298, DOI 10.1111/jnc.14619; Zhu XL, 2017, AGING CELL, V16, P1073, DOI 10.1111/acel.12642; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	49	33	35	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					648	662		10.1096/fj.201900394RRR	http://dx.doi.org/10.1096/fj.201900394RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914678	hybrid			2022-12-26	WOS:000507308900045
J	Zhang, T; Sui, DX; Zhang, C; Cole, L; Hu, J				Zhang, Tuo; Sui, Dexin; Zhang, Chi; Cole, Logan; Hu, Jian			Asymmetric functions of a binuclear metal center within the transport pathway of a human zinc transporter ZIP4	FASEB JOURNAL			English	Article						crystallography; crystal soaking; metal cluster; transport kinetics	BINDING; FAMILY; SELECTIVITY; AFFINITY; PROTEIN; ATPASE; SITES	Metal clusters are exploited by numerous metalloenzymes for catalysis, but it is not common to utilize a metal cluster for substrate transport across membrane. The recent crystal structure of a prototypic Zrt-/Irt-like protein (ZIP) metal transporter from Bordetella bronchiseptica (BbZIP) revealed an unprecedented binuclear metal center (BMC) within the transport pathway. Here, through a combination of bioinformatics, biochemical and structural approaches, we concluded that the two physically associated metal-binding sites in the BMC of human ZIP4 (hZIP4) zinc transporter exert different functions: one conserved transition metal-binding site acts as the transport site essential for activity, whereas the variable metal-binding site is required for hZIP4's optimal activity presumably by serving as a secondary transport site and modulating the properties of the primary transport site. Sequential soaking experiments on BbZIP crystals clarified the process of metal release from the BMC to the bulky solvent. This work provides important insights into the transport mechanism of the ZIPs broadly involved in transition metal homeostasis and signaling, and also a paradigm on a novel function of metal cluster in metalloproteins.	[Zhang, Tuo; Sui, Dexin; Zhang, Chi; Cole, Logan; Hu, Jian] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Zhang, Tuo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China	Michigan State University; Michigan State University; China Agricultural University	Hu, J (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hujian1@msu.edu	, jonah/AAH-2478-2020		NIH [GM115373, GM129004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: GM115373 and GM129004	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Anzilotti C, 2019, NAT IMMUNOL, V20, P350, DOI 10.1038/s41590-018-0295-8; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Faxen K, 2011, J BIOL CHEM, V286, P1609, DOI 10.1074/jbc.M110.176784; Gyimesi G, 2019, J BIOL CHEM, V294, P8046, DOI 10.1074/jbc.RA118.006113; INESI G, 1980, J BIOL CHEM, V255, P3025; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; Kato T, 2019, NAT PLANTS, V5, P308, DOI 10.1038/s41477-019-0367-2; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mattle D, 2015, EMBO REP, V16, P728, DOI 10.15252/embr.201439927; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Takagishi T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122708; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2000, IUBMB LIFE, V49, P249, DOI 10.1080/15216540050033087; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang TY, 2008, J AM CHEM SOC, V130, P3844, DOI 10.1021/ja076277h; Zhang T, 2019, BIOCHEM J, V476, P1791, DOI 10.1042/BCJ20190108; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	32	17	17	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					237	247		10.1096/fj.201902043R	http://dx.doi.org/10.1096/fj.201902043R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914589	Green Accepted			2022-12-26	WOS:000507308900018
J	van den Hoogen, P; de Jager, SCA; Mol, EA; Schoneveld, AS; Huibers, MMH; Vink, A; Doevendans, PA; Laman, JD; Sluijter, JPG				van den Hoogen, Patricia; de Jager, Saskia C. A.; Mol, Emma A.; Schoneveld, Arjan S.; Huibers, Manon M. H.; Vink, Aryan; Doevendans, Pieter A.; Laman, Jon D.; Sluijter, Joost P. G.			Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; IMMUNE-SYSTEM; STROMAL CELLS; INFLAMMATION; IMPROVE; DISEASE; FETAL; ANGIOGENESIS; REGENERATION	Upon myocardial damage, the release of cardiac proteins induces a strong antibody-mediated immune response, which can lead to adverse cardiac remodeling and eventually heart failure (HF). Stem cell therapy using mesenchymal stromal cells (MSCs) or cardiomyocyte progenitor cells (CPCs) previously showed beneficial effects on cardiac function despite low engraftment in the heart. Paracrine mediators are likely of great importance, where, for example, MSC-derived extracellular vesicles (EVs) also show immunosuppressive properties in vitro. However, the limited capacity of MSCs to differentiate into cardiac cells and the sufficient scaling of MSC-derived EVs remain a challenge to clinical translation. Therefore, we investigated the immunosuppressive actions of endogenous CPCs and CPC-derived EVs on antibody production in vitro, using both healthy controls and end-stage HF patients. Both MSCs and CPCs strongly inhibit lymphocyte proliferation and antibody production in vitro. Furthermore, CPC-derived EVs significantly lowered the levels of IgG1, IgG4, and IgM, especially when administered for longer duration. In line with previous findings, plasma cells of end-stage HF patients showed high production of IgG3, which can be inhibited by MSCs in vitro. MSCs and CPCs inhibit in vitro antibody production of both healthy and end stage HF-derived immune cells. CPC-derived paracrine factors, such as EVs, show similar effects, but do not provide the complete immunosuppressive capacity of CPCs. The strongest immunosuppressive effects were observed using MSCs, suggesting that MSCs might be the best candidates for therapeutic targeting of B-cell responses in HF.	[van den Hoogen, Patricia; de Jager, Saskia C. A.; Mol, Emma A.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, UMC Utrecht Regenerat Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands; [Mol, Emma A.] Leiden Univ, Dept Cell & Chem Biol, Lab Cardiovasc Cell Biol, Med Ctr, Leiden, Netherlands; [Schoneveld, Arjan S.] Univ Med Ctr Utrecht, ARCADIA, Lab Clin Chem & Haematol, Utrecht, Netherlands; [Huibers, Manon M. H.; Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Huibers, Manon M. H.] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands; [Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Doevendans, Pieter A.] Netherlands Heart Inst, Utrecht, Netherlands; [Doevendans, Pieter A.] Cent Mil Hosp, Utrecht, Netherlands; [Laman, Jon D.] Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst BSCS, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	de Jager, SCA (corresponding author), Univ Med Ctr Utrecht, UMC Utrecht Regenerat Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands.	s.c.a.dejager@umcutrecht.nl	de+Jager, Saskia/ABC-4264-2020; de+Jager, Saskia/AAE-1132-2022	Doevendans, Pieter/0000-0002-6257-7169; de Jager, Saskia/0000-0002-5233-0066	CVON2011-12 HUSTCare grant from the Netherlands CardioVascular Research Initiative (CVON): The Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Science; ZonMW Translational Adult Stem Cell grant [1161002016]; Horizon2020 ERC-2016-COG EVICARE [725229]	CVON2011-12 HUSTCare grant from the Netherlands CardioVascular Research Initiative (CVON): The Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Science; ZonMW Translational Adult Stem Cell grant; Horizon2020 ERC-2016-COG EVICARE	This work was supported by CVON2011-12 HUSTCare grant from the Netherlands CardioVascular Research Initiative (CVON): The Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development, the Royal Netherlands Academy of Science, the ZonMW Translational Adult Stem Cell grant 1161002016, and by Horizon2020 ERC-2016-COG EVICARE (725229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Anzai T, 2018, CIRC J, V82, P629, DOI 10.1253/circj.CJ-18-0063; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Banerjee MN, 2018, CIRC RES, V123, P266, DOI 10.1161/CIRCRESAHA.118.311217; Bao L, 2017, J CARD FAIL, V23, P403, DOI 10.1016/j.cardfail.2017.03.002; Beez CM, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0504-0; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Bolli R, 2018, CIRC RES, V122, P1703, DOI 10.1161/CIRCRESAHA.118.312978; Bollini S, 2013, J CLIN MED, V2, P302, DOI 10.3390/jcm2040302; Caforio ALP, 2005, LUPUS, V14, P652, DOI 10.1191/0961203305lu2193oa; Carreras-Planella L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01288; Cha JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19211-6; Charif N, 2017, BIO-MED MATER ENG, V28, pS57, DOI 10.3233/BME-171624; Chen WC, 2016, IMMUNOL RES, V64, P831, DOI 10.1007/s12026-016-8798-6; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Cordero-Reyes Andrea M, 2013, Methodist Debakey Cardiovasc J, V9, P15; Davies LC, 2017, STEM CELLS, V35, P766, DOI 10.1002/stem.2509; Dick SA, 2016, CIRC RES, V119, P159, DOI 10.1161/CIRCRESAHA.116.308030; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Efimenko AY, 2015, BIORESEARCH OPEN ACC, V4, P26, DOI 10.1089/biores.2014.0042; Eriksson U, 2005, INT J BIOCHEM CELL B, V37, P27, DOI 10.1016/j.biocel.2004.06.014; Frangogiannis NG, 2014, J CARDIOVASC PHARM, V63, P185, DOI 10.1097/FJC.0000000000000003; Franquesa M, 2015, STEM CELLS, V33, P880, DOI 10.1002/stem.1881; Franquesa M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00212; Hocine HR, 2019, STEM CELL TRANSL MED, V8, P911, DOI 10.1002/sctm.18-0256; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Keppner L, 2018, AM J PHYSIOL-HEART C, V315, pH1358, DOI 10.1152/ajpheart.00144.2018; Lai PL, 2019, BIOMARK RES, V7, DOI 10.1186/s40364-019-0156-0; Latet SC, 2015, INT J CARDIOL, V179, P240, DOI 10.1016/j.ijcard.2014.11.006; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le TYL, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.52; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Luk F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01042; Madonna R, 2016, EUR HEART J, V37, P1789, DOI 10.1093/eurheartj/ehw113; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Mol EA, 2017, NANOMED-NANOTECHNOL, V13, P2061, DOI 10.1016/j.nano.2017.03.011; Noort WA, 2010, PANMINERVA MED, V52, P27; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Nussinovitch U, 2013, CLIN REV ALLERG IMMU, V44, P75, DOI 10.1007/s12016-010-8228-9; O'Donohoe TJ, 2016, INT J CARDIOL, V209, P226, DOI 10.1016/j.ijcard.2016.02.035; Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001; Rasmusson I, 2007, SCAND J IMMUNOL, V65, P336, DOI 10.1111/j.1365-3083.2007.01905.x; Sattler S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0022-3; Sebastiao MJ, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1010-2; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Thygesen Kristian, 2019, [Российский кардиологический журнал, Rossiiskii kardiologicheskii zhurnal], V24, P107, DOI 10.15829/1560-4071-2019-3-107-138; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Torre-Amione G, 2005, AM J CARDIOL, V95, p3C, DOI 10.1016/j.amjcard.2005.03.006; van den Akker F, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00642; van den Akker F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/181020; van den Akker F, 2013, BBA-GEN SUBJECTS, V1830, P2449, DOI 10.1016/j.bbagen.2012.08.026; van den Akker F, 2017, EUR HEART J, V38, P184, DOI 10.1093/eurheartj/ehw056; van Vliet P, 2010, J CELL MOL MED, V14, P861, DOI 10.1111/j.1582-4934.2010.01053.x; Wei F, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0274-4; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Wilkins E., 2017, EUROPEAN CARDIOVASCU; Youker KA, 2014, EUR HEART J, V35, P1061, DOI 10.1093/eurheartj/eht506; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390	63	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227283	10.1371/journal.pone.0227283	http://dx.doi.org/10.1371/journal.pone.0227283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891633	Green Published, gold			2022-12-26	WOS:000515096600076
J	Geraerds, AJLM; Haagsma, JA; de Munter, L; Kruithof, N; de Jongh, M; Polinder, S				Geraerds, A. J. L. M.; Haagsma, Juanita A.; de Munter, L.; Kruithof, N.; de Jongh, M.; Polinder, Suzanne			Medical and productivity costs after trauma	PLOS ONE			English	Article							RISK-FACTORS; HEALTH-CARE; INJURY; MORTALITY; BURDEN	Background Well-advised priority setting in prevention and treatment of injuries relies on detailed insight into costs of injury. This study aimed to provide a detailed overview of medical and productivity costs due to injury up to two years post-injury and compare these costs across subgroups for injury severity and age. Methods A prospective longitudinal cohort study followed all adult (>= 18 years) injury patients admitted to a hospital in Noord-Brabant, the Netherlands. Patients filled out questionnaires 1 week, 1, 3, 6, 12 and 24 months after trauma, including items on health care consumption from the medical consumption questionnaire (iMCQ) and productivity loss from the productivity cost questionnaire (PCQ). Furthermore, injury severity was defined by Injury Severity Score (ISS). Data on diagnostics was retrieved from hospital registries. We calculated medical costs, consisting of in-hospital costs and post-hospital medical costs, and productivity costs due to injury up to two years post-injury. Results Approximately 50% (N = 4883) of registered patients provided informed consent, and 3785 filled out at least one questionnaire. In total, the average costs per patient were (sic)12,190. In-hospital costs, post-hospital medical costs and productivity costs contributed (sic)4810, (sic)5110 and (sic)5830, respectively. Total costs per patient increased with injury severity, from (sic)7030 in ISS1-3 to (sic)23,750 in ISS16+ and were lowest for age category 18-24y ((sic)7980), highest for age category 85 years and over ((sic)15,580), and fluctuated over age groups in between. Conclusion Both medical costs and productivity costs generally increased with injury severity. Furthermore, productivity costs were found to be a large component of total costs of injury in ISS1-8 and are therefore a potentially interesting area with regard to reducing costs.	[Geraerds, A. J. L. M.; Haagsma, Juanita A.; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [de Munter, L.; Kruithof, N.; de Jongh, M.] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Trauma TopCare, Tilburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Geraerds, AJLM (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.	a.geraerds@erasmusmc.nl			Netherlands Organisation for Health Research and Development (ZonMw) [80-84200-98-14225]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development (ZonMw) under grant number 80-84200-98-14225. (https://www.zonmw.nl/nl/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belmont PJ, 2014, ARCH ORTHOP TRAUM SU, V134, P597, DOI 10.1007/s00402-014-1959-y; Bouwmans C, 2013, HANDLEIDING IMTA MED; Bouwmans C, 2015, VALUE HEALTH, V18, P753, DOI 10.1016/j.jval.2015.05.009; CBS, WORK POP WORK TIM 20; CBS, 2017, HOOGST BEH OND 2017; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; Dias JJ, 2006, INJURY, V37, P1071, DOI 10.1016/j.injury.2006.07.023; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Elkerliek, STAND PRIJSL OV ZORG; Erasmus M.C., 2016, PASSANTENPRIJSLIJST; Gennarelli TA, 2008, ABBREVIATED INJURY S; Hakkaart-van Roijen L., 2015, KOSTENHANDLEIDING ME; HARLAN LC, 1990, AM J PUBLIC HEALTH, V80, P453, DOI 10.2105/AJPH.80.4.453; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Morrison A, 2000, EUR J PUBLIC HEALTH, V10, P201, DOI 10.1093/eurpub/10.3.201; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nederlandse Zorgautoriteit, 2014, TAR EERST 2014; Nederlandse Zorgautoriteit, BRCU 2015 BIJL 2 MED; Nederlandse Zorgautoriteit, NED ZORG ZORG; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2016, ACCIDENT ANAL PREV, V93, P92, DOI 10.1016/j.aap.2016.04.003; Rivas, BIOIMP 2019; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Upatising B, 2015, TELEMED E-HEALTH, V21, P3, DOI 10.1089/tmj.2014.0021; Velopulos CG, 2013, J SURG RES, V184, P444, DOI 10.1016/j.jss.2013.05.068; Zeelandcare, PASS PRIJSL DBC OVP	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227131	10.1371/journal.pone.0227131	http://dx.doi.org/10.1371/journal.pone.0227131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8JV	31887211	Green Published, gold			2022-12-26	WOS:000515092200080
J	Piers, TM; Cosker, K; Mallach, A; Johnson, GT; Guerreiro, R; Hardy, J; Pocock, JM				Piers, Thomas M.; Cosker, Katharina; Mallach, Anna; Johnson, Gabriel Thomas; Guerreiro, Rita; Hardy, John; Pocock, Jennifer M.			A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia	FASEB JOURNAL			English	Article						Alzheimer's disease; glycolysis; metabolism; microglia	PROLIFERATOR-ACTIVATED RECEPTOR; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PPAR-GAMMA; CELLS; EXPRESSION; PFKFB3; GLYCOLYSIS; METABOLISM; PROMOTES	Loss-of-function genetic variants of triggering receptor expressed on myeloid cells 2 (TREM2) are linked with an enhanced risk of developing dementias. Microglia, the resident immune cell of the brain, express TREM2, and microglial responses are implicated in dementia pathways. In a normal surveillance state, microglia use oxidative phosphorylation for their energy supply, but rely on the ability to undergo a metabolic switch to glycolysis to allow them to perform rapid plastic responses. We investigated the role of TREM2 on the microglial metabolic function in human patient iPSC-derived microglia expressing loss of function variants in TREM2. We show that these TREM2 variant iPSC-microglia, including the Alzheimer's disease R47H risk variant, exhibit significant metabolic deficits including a reduced mitochondrial respiratory capacity and an inability to perform a glycolytic immunometabolic switch. We determined that dysregulated PPAR gamma/p38MAPK signaling underlies the observed phenotypic deficits in TREM2 variants and that activation of these pathways can ameliorate the metabolic deficit in these cells and consequently rescue critical microglial cellular function such as beta-Amyloid phagocytosis. These findings have ramifications for microglial focussed-treatments in AD.	[Piers, Thomas M.; Cosker, Katharina; Mallach, Anna; Johnson, Gabriel Thomas; Pocock, Jennifer M.] UCL, Dept Neuroinflammat, Inst Neurol, Queen Sq,1 Wakefield St, London WC1N 1PJ, England; [Guerreiro, Rita] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA; [Hardy, John] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England	University of London; University College London; Van Andel Institute; University of London; University College London	Pocock, JM (corresponding author), UCL, Dept Neuroinflammat, Inst Neurol, Queen Sq,1 Wakefield St, London WC1N 1PJ, England.	j.pocock@ucl.ac.uk	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Mallach, Anna/0000-0001-7181-3429; Guerreiro, Rita/0000-0001-5879-3486	Innovative Medicines Initiative (IMI) [115976]; Eisai; RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M009513/1]; MRC [G0901254, MR/N026004/1, G0701075, MR/M02492X/1, UKDRI-1009] Funding Source: UKRI	Innovative Medicines Initiative (IMI); Eisai(Eisai Co Ltd); RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Innovative Medicines Initiative (IMI), Grant/Award Number: 115976; Eisai; RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/M009513/1	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; Bolanos Juan P, 2013, Biochem J, V452, pe7, DOI 10.1042/BJ20130560; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carpentier G., 2010, P IMAGEJ US DEV C, P238; Cheng J., 2016, D3HEATMAP INTERACTIV; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; Culmsee C, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00739; Finucane OM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40619-1; Machado MMF, 2019, PHARMACOL REP, V71, P556, DOI 10.1016/j.pharep.2018.11.005; Garcia-Reitboeck P, 2018, CELL REP, V24, P2300, DOI 10.1016/j.celrep.2018.07.094; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gu RN, 2017, BRAIN BEHAV IMMUN, V60, P206, DOI 10.1016/j.bbi.2016.10.018; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang H, 2016, J IMMUNOL, V197, P2880, DOI 10.4049/jimmunol.1600474; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan MA, 2019, CURR NEUROPHARMACOL, V17, P232, DOI 10.2174/1570159X16666180828100002; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Li L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07127-8; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nair S, 2019, GLIA, V67, P1047, DOI 10.1002/glia.23587; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3; Rodriguez-Garcia A, 2017, FEBS J, V284, P3437, DOI 10.1111/febs.14201; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sharma PK, 2010, CANCER LETT, V295, P154, DOI 10.1016/j.canlet.2010.02.021; Shen YG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00707-0; Shutt DC, 2010, CANCER BIOL THER, V9, P853, DOI 10.4161/cbt.9.11.11632; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Xiang XY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0280-6; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015	55	45	45	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2436	2450		10.1096/fj.201902447R	http://dx.doi.org/10.1096/fj.201902447R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907987	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000504095300001
J	Akara-amornthum, P; Lomphithak, T; Choksi, S; Tohtong, R; Jitkaew, S				Akara-amornthum, Perawatt; Lomphithak, Thanpisit; Choksi, Swati; Tohtong, Rutaiwan; Jitkaew, Siriporn			Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-alpha and chemotherapeutic gemcitabine-induced necroptosis	PLOS ONE			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; NF-KAPPA-B; PROGNOSTIC BIOMARKER; PROGRAMMED NECROSIS; APOPTOSIS PROTEINS; LEUKEMIA CELLS; CANCER-CELLS; DEATH; EXPRESSION	Cholangiocarcinoma (CCA), a malignant tumor originating in the biliary tract, is well known to be associated with adverse clinical outcomes and high mortality rates due to the lack of effective therapy. Evasion of apoptosis is considered a key contributor to therapeutic success and chemotherapy resistance in CCA, highlighting the need for novel therapeutic strategies. In this study, we demonstrated that the induction of necroptosis, a novel regulated form of necrosis, could potentially serve as a novel therapeutic approach for CCA patients. The RNA sequencing data in The Cancer Genome Atlas (TCGA) database were analyzed and revealed that both receptor-interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL), two essential mediators of necroptosis, were upregulated in CCA tissues when compared with the levels in normal bile ducts. We demonstrated in a panel of CCA cell lines that RIPK3 was differentially expressed in CCA cell lines, while MLKL was more highly expressed in CCA cell lines than in nontumor cholangiocytes. We therefore showed that treatment with both tumor necrosis factor-alpha (TNF-alpha) and Smac mimetic, an inhibitor of apoptosis protein (IAP) antagonist, induced RIPK1/RIPK3/MLKL-dependent necroptosis in CCA cells when caspases were blocked. The necroptotic induction in a panel of CCA cells was correlated with RIPK3 expression. Intriguingly, we demonstrated that Smac mimetic sensitized CCA cells to a low dose of standard chemotherapy, gemcitabine, and induced necroptosis in an RIPK1/RIPK3/MLKL-dependent manner upon caspase inhibition but not in nontumor cholangiocytes. We further demonstrated that Smac mimetic and gemcitabine synergistically induced an increase in TNF-alpha mRNA levels and that Smac mimetic reversed gemcitabine-induced cell cycle arrest, leading to cell killing. Collectively, our present study demonstrated that TNF-alpha and gemcitabine induced RIPK1/RIPK3/MLKL-dependent necroptosis upon IAP depletion and caspase inhibition; therefore, our findings have pivotal implications for designing a novel necroptosis-based therapeutic strategy for CCA patients.	[Akara-amornthum, Perawatt; Lomphithak, Thanpisit] Chulalongkorn Univ, Grad Program Clin Biochem & Mol Med, Dept Clin Chem, Fac Allied Hlth Sci, Bangkok, Thailand; [Choksi, Swati] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Convent Dr, Bethesda, MD 20892 USA; [Tohtong, Rutaiwan] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Jitkaew, Siriporn] Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Dept Clin Chem, Fac Allied Hlth Sci, Bangkok, Thailand	Chulalongkorn University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mahidol University; Chulalongkorn University	Jitkaew, S (corresponding author), Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Dept Clin Chem, Fac Allied Hlth Sci, Bangkok, Thailand.	Siriporn.ji@chula.ac.th		Jitkaew, Siriporn/0000-0002-7931-2319	National Research University Project, Office of Higher Education Commission [NRU59-030-HR]; Korea Foundation for Advanced Studies [009/2560]; Thailand Research Fund; Medical Research Council (UK); Newton Fund [DBG5980006, MR/N01247X/1]; Graduate School, Chulalongkorn University [GCUGE12-2]; Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125612059M]; MRC [MR/N01247X/1] Funding Source: UKRI	National Research University Project, Office of Higher Education Commission; Korea Foundation for Advanced Studies; Thailand Research Fund(Thailand Research Fund (TRF)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newton Fund; Graduate School, Chulalongkorn University(Chulalongkorn University); Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from National Research University Project, Office of Higher Education Commission [NRU59-030-HR] and Korea Foundation for Advanced Studies [009/2560] to SJ and the Thailand Research Fund and the Medical Research Council (UK), Newton Fund [DBG5980006] and [MR/N01247X/1] to RT. PA gratefully acknowledged the Scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd anniversary of his Majesty King Bhumibol Aduladej [GCUGE12-2] and the Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125612059M]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Brumatti G, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3099; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chou T-C, 2010, CANCER RES; Chromik J, 2014, CANCER LETT, V344, P101, DOI 10.1016/j.canlet.2013.10.018; Colbert LE, 2013, CANCER-AM CANCER SOC, V119, P3148, DOI 10.1002/cncr.28144; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Czaplinski S, 2015, ONCOTARGET, V6, P41522, DOI 10.18632/oncotarget.6308; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; DiPersio JF, 2015, CL LYMPH MYELOM LEUK, V15, P443, DOI 10.1016/j.clml.2015.02.020; Eckmann Karen R, 2011, Gastrointest Cancer Res, V4, P155; Feng X, 2015, NEOPLASMA, V62, P592, DOI 10.4149/neo_2015_071; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fingas CD, 2010, HEPATOLOGY, V52, P550, DOI 10.1002/hep.23729; Fulda S, 2015, CLIN CANCER RES, V21, P5030, DOI 10.1158/1078-0432.CCR-15-0365; Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Geserick P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.240; Greer RM, 2011, CANCER RES, V71, P7640, DOI 10.1158/0008-5472.CAN-10-3947; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Krysko O, 2017, IMMUNOL REV, V280, P207, DOI 10.1111/imr.12583; Lee EK, 2013, CANCER BIOL THER, V14, P812, DOI 10.4161/cbt.25326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Marin JJG, 2017, CURR DRUG TARGETS, V18, P889, DOI 10.2174/1389450116666150223121508; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Min DJ, 2016, ANTICANCER RES, V36, P2649; Mohamed MS, 2017, APOPTOSIS, V22, P1487, DOI 10.1007/s10495-017-1429-4; Montano R, 2017, ONCOTARGET, V8, P67754, DOI 10.18632/oncotarget.18834; Moriwaki K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.16; Nugues AL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.347; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rattanasinganchan P, 2006, WORLD J GASTROENTERO, V12, P6500, DOI 10.3748/wjg.v12.i40.6500; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Ruan JY, 2015, INT J CLIN EXP PATHO, V8, P15035; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; SIRISINHA S, 1991, ASIAN PAC J ALLERGY, V9, P153; Snyder AG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2004; Stadel D, 2011, NEOPLASIA, V13, P1162, DOI 10.1593/neo.11460; Steinhart L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.320; Stoll G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1299302; Su Z, 2016, CELL DEATH DIFFER, V23, P748, DOI 10.1038/cdd.2016.8; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Thibault B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35860-z; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Van Hoecke L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05979-8; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wagner L, 2013, ONCOGENE, V32, P988, DOI 10.1038/onc.2012.108; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wehrkamp CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090238; Xu BB, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.96; Yang H, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1149673; Yatim N, 2017, NAT REV IMMUNOL, V17, P262, DOI 10.1038/nri.2017.9; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	70	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227454	10.1371/journal.pone.0227454	http://dx.doi.org/10.1371/journal.pone.0227454			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914150	Green Published, gold			2022-12-26	WOS:000534337700045
J	Nadel, JA; Pawelko, SS; Copes-Finke, D; Neidhart, M; Howard, CD				Nadel, Jacob A.; Pawelko, Sean S.; Copes-Finke, Della; Neidhart, Maya; Howard, Christopher D.			Lesion of striatal patches disrupts habitual behaviors and increases behavioral variability	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINE SYSTEM; LONG-TERM DEPRESSION; BASAL GANGLIA; DORSOLATERAL STRIATUM; ORBITOFRONTAL CORTEX; DORSAL STRIATUM; SERIAL ORDER; ORGANIZATION; RAT; NEURONS	Habits are automated behaviors that are insensitive to changes in behavioral outcomes. Habitual responding is thought to be mediated by the striatum, with medial striatum guiding goal-directed action and lateral striatum promoting habits. However, interspersed throughout the striatum are neurochemically differing subcompartments known as patches, which are characterized by distinct molecular profiles relative to the surrounding matrix tissue. These structures have been thoroughly characterized neurochemically and anatomically, but little is known regarding their function. Patches have been shown to be selectively activated during inflexible motor stereotypies elicited by stimulants, suggesting that patches may subserve habitual behaviors. To explore this possibility, we utilized transgenic mice (Sepw1 NP67) preferentially expressing Cre recombinase in striatal patch neurons to target these neurons for ablation with a virus driving Cre-dependent expression of caspase 3. Mice were then trained to press a lever for sucrose rewards on a variable interval schedule to elicit habitual responding. Mice were not impaired on the acquisition of this task, but lesioning striatal patches disrupted behavioral stability across training, and lesioned mice utilized a more goal-directed behavioral strategy during training. Similarly, when mice were forced to omit responses to receive sucrose rewards, habitual responding was impaired in lesioned mice. To rule out effects of lesion on motor behaviors, mice were then tested for impairments in motor learning on a rotarod and locomotion in an open field. We found that patch lesions partially impaired initial performance on the rotarod without modifying locomotor behaviors in open field. This work indicates that patches promote behavioral stability and habitual responding, adding to a growing literature implicating striatal patches in stimulus-response behaviors.	[Nadel, Jacob A.; Pawelko, Sean S.; Copes-Finke, Della; Neidhart, Maya; Howard, Christopher D.] Oberlin Coll, Neurosci Dept, Oberlin, OH 44074 USA; [Nadel, Jacob A.] US Natl Inst Hlth, Lab Integrat Neurosci, NIAAA, Rockville, MD USA	Oberlin College; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Howard, CD (corresponding author), Oberlin Coll, Neurosci Dept, Oberlin, OH 44074 USA.	choward@oberlin.edu		Howard, Christopher/0000-0002-4838-6323; Copes-Finke, Della/0000-0002-0175-0992	Nu Rho Psi	Nu Rho Psi	This work was partially funded by a grant from Nu Rho Psi to JAN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; Atwood BK, 2014, TRENDS NEUROSCI, V37, P663, DOI 10.1016/j.tins.2014.07.010; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Bloem B, 2017, ELIFE, V6, DOI 10.7554/eLife.32353; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Canales JJ, 2005, NEUROBIOL LEARN MEM, V83, P93, DOI 10.1016/j.nlm.2004.10.006; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Compton DM, 2004, BEHAV PROCESS, V67, P335, DOI 10.1016/j.beproc.2004.06.002; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DAVIS J, 1971, J EXP ANAL BEHAV, V15, P237, DOI 10.1901/jeab.1971.15-237; Davis MI, 2018, PLOSE ONE, V13, DOI 10.1371/journal.pone.0191436; Delorme C, 2016, BRAIN, V139, P605, DOI 10.1093/brain/awv307; DESBAN M, 1993, NEUROSCIENCE, V57, P661, DOI 10.1016/0306-4522(93)90013-6; Dezfouli A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0482; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Faust T.W., 2017, INFLUENCE NEOSTRIATA; Friedman A, 2017, CELL, V171, P1191, DOI 10.1016/j.cell.2017.10.017; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Garcia-Calero E, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00046; Garr E, 2020, J EXP PSYCHOL-ANIM L, V46, P47, DOI 10.1037/xan0000229; Geddes CE, 2018, CELL, V174, P32, DOI 10.1016/j.cell.2018.06.012; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gillan CM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0475; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Gremel CM, 2016, NEURON, V90, P1312, DOI 10.1016/j.neuron.2016.04.043; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; Ikeda H, 2013, NEUROSCIENCE, V252, P60, DOI 10.1016/j.neuroscience.2013.07.066; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jenrette TA, 2019, NEUROSCIENCE, V415, P161, DOI 10.1016/j.neuroscience.2019.07.033; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; JOHNSTON JG, 1990, DEV BRAIN RES, V57, P93, DOI 10.1016/0165-3806(90)90189-6; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; KUHAR MJ, 1973, NATURE, V245, P447, DOI 10.1038/245447a0; Lawhorn C, 2009, NEUROSCIENCE, V163, P109, DOI 10.1016/j.neuroscience.2009.05.021; Li Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00393; Lingawi N.W., 2016, WILEY HDB COGNITIVE, P409, DOI [10.1002/9781118650813.ch16, DOI 10.1002/9781118650813.CH16]; Lopez-Huerta VG, 2016, BRAIN STRUCT FUNCT, V221, P1737, DOI 10.1007/s00429-015-1000-4; Malvaez M, 2018, BIOL PSYCHIAT, V84, P383, DOI 10.1016/j.biopsych.2018.01.025; Martin A, 2019, PREPRINT, DOI [10.1101/613596, DOI 10.1101/613596]; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McGregor MM, 2019, CELL REP, V29, P1419, DOI 10.1016/j.celrep.2019.09.076; McNamee D, 2015, J NEUROSCI, V35, P3764, DOI 10.1523/JNEUROSCI.4677-14.2015; Morigaki R, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00034; Murray RC, 2015, BRAIN RES, V1618, P286, DOI 10.1016/j.brainres.2015.06.012; Murray RC, 2014, BRAIN STRUCT FUNCT, V219, P1213, DOI 10.1007/s00429-013-0559-x; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; O'Hare JK, 2016, NEURON, V89, P472, DOI 10.1016/j.neuron.2015.12.032; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Okada K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4778; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Rossi Mark A, 2012, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0829s60; Sakamoto T, 2001, NEUROBIOL LEARN MEM, V76, P192, DOI 10.1006/nlme.2001.4006; Schoenbaum G, 2007, ANN NY ACAD SCI, V1121, P320, DOI 10.1196/annals.1401.001; Shivkumar S, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00045; Shumilov K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203135; Sjoerds Z, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00008; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Smith RJ, 2018, PROG NEURO-PSYCHOPH, V87, P11, DOI 10.1016/j.pnpbp.2017.09.003; Thrailkill EA, 2018, J EXP PSYCHOL-ANIM L, V44, P370, DOI 10.1037/xan0000188; Torregrossa MM, 2008, BIOL PSYCHIAT, V63, P253, DOI 10.1016/j.biopsych.2007.11.014; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; VANDENBERCKEN JHL, 1982, BEHAV BRAIN RES, V4, P319, DOI 10.1016/0166-4328(82)90058-4; Voon V, 2015, MOL PSYCHIATR, V20, P345, DOI 10.1038/mp.2014.44; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2010, J NEUROSCI, V30, P14719, DOI 10.1523/JNEUROSCI.3989-10.2010; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Yoshizawa T, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0367-17.2018; Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009	87	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0224715	10.1371/journal.pone.0224715	http://dx.doi.org/10.1371/journal.pone.0224715			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914121	gold, Green Published, Green Submitted			2022-12-26	WOS:000534337700008
J	Penazova, E; Dvorak, M; Ragasova, L; Kiss, T; Pecenka, J; Cechova, J; Eichmeier, A				Penazova, Eliska; Dvorak, Milon; Ragasova, Lucia; Kiss, Tomas; Pecenka, Jakub; Cechova, Jana; Eichmeier, Ales			Multiplex real-time PCR for the detection of Clavibacter michiganensis subsp. michiganensis, Pseudomonas syringae pv. tomato and pathogenic Xanthomonas species on tomato plants	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; BACTERIAL SPOT; GENE-CLUSTER; PEPPER; IDENTIFICATION; SEEDS; AMPLIFICATION; VESICATORIA; SURVIVAL; STRAINS	A multiplex real-time PCR method based on fluorescent TaqMan (R) probes was developed for the simultaneous detection of the tomato pathogenic bacteria Clavibacter michiganensis subsp. michiganensis, Pseudomonas syringae pv. tomato and bacterial spot-causing xanthomonads. The specificity of the multiplex assay was validated on 44 bacterial strains, including 32 target pathogen strains as well as closely related species and nontarget tomato pathogenic bacteria. The designed multiplex real-time PCR showed high sensitivity when positive amplification was observed for one pg of bacterial DNA in the cases of Clavibacter michiganensis subsp. michiganensis and Pseudomonas syringae pv. tomato bacteria and 100 pg for bacterial spot-causing xanthomonads. The reliability of the developed multiplex real-time PCR assay for in planta detection was verified by recognition of the target pathogens in 18 tomato plants artificially inoculated by each of the target bacteria and tomato samples from production greenhouses.	[Penazova, Eliska; Kiss, Tomas; Pecenka, Jakub; Cechova, Jana; Eichmeier, Ales] Mendel Univ Brno, Mendeleum Dept Genet, Fac Hort, Lednice, Czech Republic; [Dvorak, Milon] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno, Czech Republic; [Ragasova, Lucia] Mendel Univ Brno, Dept Vegetable Sci, Fac Hort, Lednice, Czech Republic	Mendel University in Brno; Mendel University in Brno; Mendel University in Brno	Penazova, E (corresponding author), Mendel Univ Brno, Mendeleum Dept Genet, Fac Hort, Lednice, Czech Republic.	eliska.penazova@mendelu.cz	Ragasová, Lucia/AAE-2671-2021; Eichmeier, Aleš/F-1209-2016; Hakalová, Eliška/AAE-7573-2021; Cechova, Jana/AAJ-8398-2020; Dvorak, Milon/B-2880-2014; Kiss, Tomáš/AAH-1767-2019; Pečenka, Jakub/AAE-7721-2021	Eichmeier, Aleš/0000-0001-7358-3903; Hakalová, Eliška/0000-0002-5433-8993; Cechova, Jana/0000-0003-3027-6916; Dvorak, Milon/0000-0002-4390-4718; Kiss, Tomáš/0000-0002-4344-4387; Pečenka, Jakub/0000-0001-6195-7592; Ragasova, Lucia/0000-0002-7515-4835	ERDF "Multidisciplinary research to increase application potential of nanomaterials in agricultural practice" [CZ.02.1.01/0.0/0.0/16_025/0007314];  [TJ01000274]	ERDF "Multidisciplinary research to increase application potential of nanomaterials in agricultural practice"; 	The work was supported from ERDF "Multidisciplinary research to increase application potential of nanomaterials in agricultural practice" (No. CZ.02.1.01/0.0/0.0/16_025/0007314). This research was also supported by the project no. TJ01000274. The real-time instrument was provided by Phytophthora Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Araujo ER, 2012, J APPL MICROBIOL, V113, P1479, DOI 10.1111/j.1365-2672.2012.05431.x; Bach HJ, 2003, J MICROBIOL METH, V52, P85, DOI 10.1016/S0167-7012(02)00152-5; BASHAN Y, 1982, PLANT SOIL, V68, P161, DOI 10.1007/BF02373702; BERESWILL S, 1994, APPL ENVIRON MICROB, V60, P2924, DOI 10.1128/AEM.60.8.2924-2930.1994; Blancard D., 2012, TOMATO DIS COLOUR HD; Burokiene D., 2006, Agronomy Research, V4, P151; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Carlton WM, 1998, PHYTOPATHOLOGY, V88, P525, DOI 10.1094/PHYTO.1998.88.6.525; Chalupowicz L, 2012, PHYTOPATHOLOGY, V102, P23, DOI 10.1094/PHYTO-05-11-0135; de Leon L, 2011, PLANT DIS, V95, P1328, DOI 10.1094/PDIS-02-11-0091; DREIER J, 1995, PHYTOPATHOLOGY, V85, P462, DOI 10.1094/Phyto-85-462; Dutta B, 2014, PHYTOPATHOLOGY, V104, P232, DOI 10.1094/PHYTO-05-13-0138-R; EPPO, 2018, EPPO A2 LIST PESTS R; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Fanelli V, 2007, PLANT PATHOL, V56, P683, DOI 10.1111/j.1365-3059.2007.01612.x; Fath-Allah MM, 2006, EGYPTIAN J EXPT BIOL, V2, P7; Ftayeh R, 2008, PLANT DIS, V92, P649, DOI 10.1094/PDIS-92-4-0649C; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Goode M. J., 1980, Plant Disease, V64, P831, DOI 10.1094/PD-64-831; Hadas R, 2005, PLANT PATHOL, V54, P643, DOI 10.1111/j.1365-3059.2005.01230.x; Hamza AA, 2010, PLANT DIS, V94, P993, DOI 10.1094/PDIS-94-8-0993; He LS, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01965-17; HUANG HC, 1995, MOL PLANT MICROBE IN, V8, P733, DOI 10.1094/MPMI-8-0733; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; JONES JB, 1986, PHYTOPATHOLOGY, V76, P430, DOI 10.1094/Phyto-76-430; Kleitman F, 2008, EUR J PLANT PATHOL, V121, P463, DOI 10.1007/s10658-007-9264-z; Koenraadt H, 2009, ACTA HORTIC, V808, P99, DOI 10.17660/ActaHortic.2009.808.13; Kokoskova B, 2010, FOLIA MICROBIOL, V55, P239, DOI 10.1007/s12223-010-0035-4; Kolomiets J. V., 2017, Annals of Agrarian Science, V15, P213, DOI 10.1016/j.aasci.2017.05.010; Kozik E. U., 2007, Phytopathologia Polonica, P17; LEITE RP, 1994, APPL ENVIRON MICROB, V60, P1068, DOI 10.1128/AEM.60.4.1068-1077.1994; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Luo LX, 2008, PLANT PATHOL, V57, P332, DOI 10.1111/j.1365-3059.2007.01736.x; MCCARTER SM, 1983, PHYTOPATHOLOGY, V73, P1393, DOI 10.1094/Phyto-73-1393; Medina-Mora CM, 2001, PLANT DIS, V85, P88, DOI 10.1094/PDIS.2001.85.1.88; Moretti C, 2009, LETT APPL MICROBIOL, V49, P466, DOI 10.1111/j.1472-765X.2009.02690.x; Oosterhof J, 2011, PHYTOPATHOLOGY, V101, pS133; Ozdemir Z, 2009, J PLANT PATHOL, V91, P495; Pastrik KH, 1999, J PHYTOPATHOL, V147, P687, DOI 10.1046/j.1439-0434.1999.00442.x; Potnis N, 2015, MOL PLANT PATHOL, V16, P907, DOI 10.1111/mpp.12244; Preston GM, 2000, MOL PLANT PATHOL, V1, P263, DOI 10.1046/j.1364-3703.2000.00036.x; Ritchie D.F., 2000, PLANT HLTH INSTR, DOI [10.1094/PHI-I-2000-1027-01, DOI 10.1094/PHI-I-2000-1027-01]; Schwartz Allison R, 2015, Front Microbiol, V6, P535, DOI 10.3389/fmicb.2015.00535; Strayer AL, 2016, PLANT DIS, V100, P1660, DOI 10.1094/PDIS-09-15-1085-RE; Timilsina S, 2015, APPL ENVIRON MICROB, V81, P1520, DOI 10.1128/AEM.03000-14; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Youngman EM, 2007, CURR BIOL, V17, pR136, DOI 10.1016/j.cub.2006.12.029; Zaccardelli M, 2005, EUR J PLANT PATHOL, V111, P85, DOI 10.1007/s10658-004-2734-7; Zaccardelli M, 2002, J PLANT PATHOL, V84, P200; Zhao WJ, 2007, J PLANT PATHOL, V89, P349; 2016, EPPO B, V46, P202, DOI DOI 10.1111/EPP.12302	54	3	3	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227559	10.1371/journal.pone.0227559	http://dx.doi.org/10.1371/journal.pone.0227559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910230	gold, Green Published			2022-12-26	WOS:000534333800050
J	Mashela, PW; Shokoohi, E; Pofu, KM				Mashela, Phatu W.; Shokoohi, Ebrahim; Pofu, Kgabo M.			Morphological adjustment in free-living Steinernema feltiae infective juveniles to increasing concentration of Nemafric-BL phytonematicide	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODES; PESTICIDES; VIRULENCE	Third-stage larvae (L3) of Steinernema feltiae exist as free-living infective juveniles (IJ), with suspended development activities. In contrast, parasitic stages (L1, L2, L4, adult) have mutualistic relations with Xenorhabdus species bacteria, along with unique morphological changes and development inside the cadaver of host insects and/or plant-parasitic nematodes. Commercial IJ strains are tolerant to cucurbitacin-containing phytonematicides, but we have scant information on how morphological adjustments in IJ are achieved. In this study, we investigated the nature of morphological adjustments in commercial S. feltiae IJ strains to Nemafric-BL phytonematicide, which contains cucurbitacin B as active ingredient. Post-72 h exposure to phytonematicide concentration, IJ specimens were fixed on mounting slides. Length (body, excretory pore to anterior end, pharynx, rectum, stoma, tail), diameter (head width, neck base, mid-body, anal body), cuticle thickness and De Man ratios were measured with a computer software programme attached to Omax light microscope. Morphometric data against increasing phytonematicide concentration exhibited either densitydependent quadratic, linear or neutral relations. Increase in body length at low phytonematicide concentration was accompanied by decrease in tail length and pharynx length during muscle contraction when IJ were still alive. After death at high phytonematicide concentration, the opposite morphometric effects ensued due to muscle relaxation. The observed changes in morphometric structures were explained on the basis of morphological adjustments that modulated volumes of pseudocoelom cavity in IJ. The modulation is intended to maintain hydrostatic pressure within permissible upper limits in order to avoid structural damage to internal organs embedded in the pseudocoelom fluids.	[Mashela, Phatu W.; Shokoohi, Ebrahim; Pofu, Kgabo M.] Univ Limpopo, Green Biotechnol Res Ctr Excellence, Sovenga, South Africa; [Pofu, Kgabo M.] Agr Res Council VOP, Pretoria, South Africa	University of Limpopo	Mashela, PW (corresponding author), Univ Limpopo, Green Biotechnol Res Ctr Excellence, Sovenga, South Africa.	phatu.mashela@ul.ac.za	Pofu, Kgabo/AAT-7433-2021	Mashela, Phatu/0000-0002-9759-2625	Flemish Interuniversity Council; Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centres; National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries	Flemish Interuniversity Council; Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centres; National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries	This work was supported by the Flemish Interuniversity Council, the Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centres, the National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries.	Basyoni Maha M.A., 2016, Journal of Parasitic Diseases, V40, P1130, DOI 10.1007/s12639-015-0707-8; Bird AF, 1991, STRUCTURE NEMATODES; Causton DR, 1977, CONT BIOL BIOL MATH; Chang DZ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007626; De Grisse AT, 1936, CONTRIBUTION MORPHOL; De Nardo EAB, 2003, BIOCONTROL SCI TECHN, V13, P441, DOI 10.1080/0958315031000124495; Dillman AR, 2012, CURR BIOL, V22, pR430, DOI 10.1016/j.cub.2012.03.047; Dube ZP, 2017, ACTA AGR SCAND B-S P, V67, P571, DOI 10.1080/09064710.2017.1318165; Dube ZP, 2019, P S NEMATOL SOC SN A, V22, P17; Ferreira T, 2014, AFR ENTOMOL, V22, P1, DOI 10.4001/003.022.0115; Gomez K.A., 1984, STAT PROCEDURES AGR; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Gutierrez C, 2008, BIOCONTROL SCI TECHN, V18, P101, DOI 10.1080/09583150701684267; HARRIS JE, 1957, J EXP BIOL, V34, P116; Higa T., 1994, BENEFICIAL EFFECTIVE; Hunt DJ, 2016, NEMATOLOGY MONOGRAPH; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Khan SA, 2016, PAK J ZOOL, V48, P763; Krishnayya PV, 2002, BIOCONTROL SCI TECHN, V12, P259, DOI 10.1080/09583150120124513; Lacey LA, 2012, J NEMATOL, V44, P218; Lewis EE, 2006, BIOL CONTROL, V38, P66, DOI 10.1016/j.biocontrol.2005.11.007; Liu De Li, 2003, Nonlinearity Biol Toxicol Med, V1, P37, DOI 10.1080/15401420390844456; Lu DH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006302; Madaure J. T., 2017, Research on Crops, V18, P739, DOI 10.5958/2348-7542.2017.00121.8; Madaure JT, 2018, TRANSYLV REV, V26, P8709; Mashela PW, 2017, NEMATOLOGY S AFRICA; Molina JP, 2007, J NEMATOL, V39, P338; Radova Stepanka, 2010, Plant Protection Science, V46, P83; Shokoohi E., 2019, PLANT NEMATOLOGY EMP, P272; Sumit Vashisth, 2013, Agricultural Reviews, V34, P163, DOI 10.5958/j.0976-0741.34.3.001; Tseke P. E., 2017, Research on Crops, V18, P289, DOI 10.5958/2348-7542.2017.00049.3; Wharton D. A, 1986, FUNCTIONAL BIOL NEMA	32	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227448	10.1371/journal.pone.0227448	http://dx.doi.org/10.1371/journal.pone.0227448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899763	gold, Green Published			2022-12-26	WOS:000534322000028
J	Morro, B; Doherty, MK; Balseiro, P; Handeland, SO; MacKenzie, S; Sveier, H; Albalat, A				Morro, Bernat; Doherty, Mary K.; Balseiro, Pablo; Handeland, Sigurd O.; MacKenzie, Simon; Sveier, Harald; Albalat, Amaya			Plasma proteome profiling of freshwater and seawater life stages of rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							SALMON SALMO-SALAR; DIFFERENTIAL GENE-EXPRESSION; PARR-SMOLT TRANSFORMATION; POOLING MESSENGER-RNA; K+-ATPASE ACTIVITY; APOLIPOPROTEIN B-100; JUVENILE RESIDENT; STEELHEAD TROUT; GROWTH-HORMONE; NA+/K+-ATPASE	The sea-run phenotype of rainbow trout (Oncorhynchus mykiss), like other anadromous salmonids, present a juvenile stage fully adapted to life in freshwater known as parr. Development in freshwater is followed by the smolt stage, where preadaptations needed for sea-water life are developed making fish ready to migrate to the ocean, after which event they become post-smolts. While these three life stages have been studied using a variety of approaches, proteomics has never been used for such purpose. The present study characterised the blood plasma proteome of parr, smolt and post-smolt rainbow trout using a gel electrophoresis liquid chromatography tandem mass spectrometry approach alone or in combination with low-abundant protein enrichment technology (combinatorial peptide ligand library). In total, 1,822 proteins were quantified, 17.95% of them being detected only in plasma post enrichment. Across all life stages, the most abundant proteins were ankyrin-2, DNA primase large subunit, actin, serum albumin, apolipoproteins, hemoglobin subunits, hemopexin-like proteins and complement C3. When comparing the different life stages, 17 proteins involved in mechanisms to cope with hyperosmotic stress and retinal changes, as well as the downregulation of nonessential processes in smolts, were significantly different between parr and smolt samples. On the other hand, 11 proteins related to increased growth in post-smolts, and also related to coping with hyperosmotic stress and to retinal changes, were significantly different between smolt and post-smolt samples. Overall, this study presents a series of proteins with the potential to complement current seawater-readiness assessment tests in rainbow trout, which can be measured non-lethally in an easily accessible biofluid. Furthermore, this study represents a first in-depth characterisation of the rainbow trout blood plasma proteome, having considered three life stages of the fish and used both fractionation alone or in combination with enrichment methods to increase protein detection.	[Morro, Bernat; MacKenzie, Simon; Albalat, Amaya] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Doherty, Mary K.] Univ Highlands & Isl, Inst Hlth Res & Innovat, Ctr Hlth Sci, Inverness, Scotland; [Balseiro, Pablo; Handeland, Sigurd O.; MacKenzie, Simon] Univ Bergen, NORCE AS, Bergen, Norway; [Sveier, Harald] Univ Bergen, Leroy Seafood Grp ASA, Bergen, Norway	University of Stirling; UHI Millennium Institute; Norwegian Research Centre (NORCE); University of Bergen; University of Bergen	Morro, B (corresponding author), Univ Stirling, Inst Aquaculture, Stirling, Scotland.	bernat.morro.cortes@stir.ac.uk	Balseiro, Pablo/I-7406-2013; Morro, Bernat/AAH-7529-2020; MacKenzie, Simon/Q-2362-2019	Morro, Bernat/0000-0002-6799-3882; MacKenzie, Simon/0000-0003-1845-6826; Albalat, Amaya/0000-0002-8606-2995; Balseiro, Pablo/0000-0002-9365-6775; Doherty, Mary/0000-0002-3480-4088	Regionale Foskningsfond Vestalandet project: Utvikling av en sesonguavhengig protokoll for intensiv produksjon av regnbueorret (O. mykiss) (Development of a season independent protocol for the intensive production of rainbow trout (O. mykiss)) (RFFVest pro [248020]; CtrlAQUA SFI, Centre for Closed-Containment Aquaculture programme (SFI project) [237856]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) [SASG9]; Scottish Funding Council [HR09011]; Japan Society for the Promotion of Science Bilateral Joint Research Project	Regionale Foskningsfond Vestalandet project: Utvikling av en sesonguavhengig protokoll for intensiv produksjon av regnbueorret (O. mykiss) (Development of a season independent protocol for the intensive production of rainbow trout (O. mykiss)) (RFFVest pro; CtrlAQUA SFI, Centre for Closed-Containment Aquaculture programme (SFI project); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Japan Society for the Promotion of Science Bilateral Joint Research Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Regionale Foskningsfond Vestalandet project: Utvikling av en sesonguavhengig protokoll for intensiv produksjon av regnbueorret (O. mykiss) (Development of a season independent protocol for the intensive production of rainbow trout (O. mykiss)) (RFFVest project 248020), the CtrlAQUA SFI, Centre for Closed-Containment Aquaculture programme (SFI project 237856), and by Japan Society for the Promotion of Science Bilateral Joint Research Project (Open Partnership with Norway). This work also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland; grant SASG9) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions.	Adkins JN, 2005, PROTEOMICS, V5, P3454, DOI 10.1002/pmic.200401333; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Baerwald MR, 2016, MOL ECOL, V25, P1785, DOI 10.1111/mec.13231; Bandow JE, 2010, PROTEOMICS, V10, P1416, DOI 10.1002/pmic.200900431; Barnea E, 2005, PROTEOMICS, V5, P3367, DOI 10.1002/pmic.200401221; Barton C, 2009, PROTEOMICS, V9, P3058, DOI 10.1002/pmic.200800737; Beckman BR, 2004, T AM FISH SOC, V133, P1057, DOI 10.1577/T03-098.1; Beckman BR, 2004, GEN COMP ENDOCR, V135, P334, DOI 10.1016/j.ygcen.2003.10.013; Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bjornsson BT, 2007, AQUACULTURE, V273, P384, DOI 10.1016/j.aquaculture.2007.10.020; Bjornsson BT, 2011, GEN COMP ENDOCR, V170, P290, DOI 10.1016/j.ygcen.2010.07.003; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; Coughlin DJ, 2001, J EXP ZOOL, V290, P115, DOI 10.1002/jez.1041; Cunha SR, 2009, J CELL MOL MED, V13, P4364, DOI 10.1111/j.1582-4934.2009.00943.x; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; Dann SG, 2003, COMP BIOCHEM PHYS B, V136, P849, DOI 10.1016/S1096-4959(03)00262-8; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; De Bock M, 2010, TALANTA, V82, P245, DOI 10.1016/j.talanta.2010.04.029; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Ebbesson LOE, 2007, AQUACULTURE, V273, P345, DOI 10.1016/j.aquaculture.2007.10.016; Ebbesson LOE, 2008, COMP BIOCHEM PHYS A, V151, P698, DOI 10.1016/j.cbpa.2008.08.017; Enerstvedt KS, 2018, MAR ENVIRON RES, V138, P46, DOI 10.1016/j.marenvres.2018.03.009; Epting D, 2007, GENE EXPR PATTERNS, V7, P389, DOI 10.1016/j.modgep.2006.11.010; EWING RD, 1994, AQUACULTURE, V121, P277, DOI 10.1016/0044-8486(94)90027-2; Fang YJ, 2010, TOXICOL LETT, V199, P69, DOI 10.1016/j.toxlet.2010.08.008; Fast MD, 2008, FISH SHELLFISH IMMUN, V24, P194, DOI 10.1016/j.fsi.2007.10.009; Fischer H, 2007, J APPL PHYSL; Fleming IA, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P264; FONTAINE M, 1950, CR SOC BIOL, V144, P953; FOOTE CJ, 1994, CAN J ZOOL, V72, P397, DOI 10.1139/z94-056; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Geyer PE, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20156297; Hale MC, 2016, COMP BIOCHEM PHYS D, V20, P136, DOI 10.1016/j.cbd.2016.07.006; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Handeland SO, 2013, J FISH BIOL, V83, P1197, DOI 10.1111/jfb.12215; Hecht BC, 2014, MAR BIOTECHNOL, V16, P638, DOI 10.1007/s10126-014-9579-7; Hecht BC, 2012, G3-GENES GENOM GENET, V2, P1113, DOI 10.1534/g3.112.003137; Hiramatsu N, 2006, MAR BIOL, V149, P35, DOI 10.1007/s00227-005-0214-z; Hoar W.S., 1988, P275; Horgan GW, 2007, J PROTEOME RES, V6, P2884, DOI 10.1021/pr070114a; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Jacobs JM, 2005, J PROTEOME RES, V4, P1073, DOI 10.1021/pr0500657; Johansson LH, 2016, FISH SHELLFISH IMMUN, V58, P33, DOI 10.1016/j.fsi.2016.09.026; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Kendall NW, 2015, CAN J FISH AQUAT SCI, V72, P319, DOI 10.1139/cjfas-2014-0192; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Kobayashi R, 1954, B FACULTY FISHERIES, V5, P223; Kreuter J, 2007, J CONTROL RELEASE, V118, P54, DOI 10.1016/j.jconrel.2006.12.012; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kultz D, 2015, PROTEOMICS, V15, P3980, DOI 10.1002/pmic.201500132; Kumar G, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800101; Li CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep24329; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li JY, 2015, J BIOL CHEM, V290, P10216, DOI 10.1074/jbc.M114.612572; Liumbruno G, 2010, J PROTEOMICS, V73, P483, DOI 10.1016/j.jprot.2009.06.010; MADSEN SS, 1989, J FISH BIOL, V34, P829, DOI 10.1111/j.1095-8649.1989.tb03367.x; Mancera Juan Miguel, 2007, P497; MARTINEZ I, 1993, COMP BIOCHEM PHYS B, V106, P1021, DOI 10.1016/0305-0491(93)90067-F; Martinez-Fernandez M, 2008, J PROTEOME RES, V7, P4926, DOI 10.1021/pr700863e; McCormick SD, 2009, J EXP BIOL, V212, P3994, DOI 10.1242/jeb.037275; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Medina-Gali R, 2019, FISH SHELLFISH IMMUN, V86, P892, DOI 10.1016/j.fsi.2018.12.035; Millar JS, 2005, ARTERIOSCL THROM VAS, V25, P560, DOI 10.1161/01.ATV.0000155323.18856.a2; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Morro B, 2019, AQUACULTURE, V507, P282, DOI 10.1016/j.aquaculture.2019.04.039; Murphy S, 2018, METHODS MOL BIOL, V1664, P109, DOI 10.1007/978-1-4939-7268-5_10; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Neubauer H, 2006, ELECTROPHORESIS, V27, P1840, DOI 10.1002/elps.200500739; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Norman JD, 2013, AM J PHYSL HEART CIR; Norman JD, 2014, J EXP BIOL, V217, P4029, DOI 10.1242/jeb.107441; Nynca J, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600460; Nynca J, 2015, REPROD FERT DEVELOP, V27, P504, DOI 10.1071/RD13224; Nynca J, 2014, PROTEOMICS, V14, P133, DOI 10.1002/pmic.201300267; O'Loughlin A, 2014, RES VET SCI, V97, P458, DOI 10.1016/j.rvsc.2014.06.003; Palermo FA, 2008, ARCH ENVIRON CON TOX, V55, P295, DOI 10.1007/s00244-007-9113-2; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paulo Joao A, 2013, Webmedcentral, V4; Pernemalm M, 2014, EXPERT REV PROTEOMIC, V11, P431, DOI 10.1586/14789450.2014.901157; PRUNET P, 1989, GEN COMP ENDOCR, V74, P355, DOI 10.1016/S0016-6480(89)80031-0; Quinn TP, 2016, CAN J FISH AQUAT SCI, V73, P1015, DOI 10.1139/cjfas-2015-0345; Quinn TP, 2011, T AM FISH SOC, V140, P45, DOI 10.1080/00028487.2010.550244; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Riley WD, 2014, J FISH BIOL, V85, P1042, DOI 10.1111/jfb.12457; Rousseau K, 2012, SALMONID SMOLTIFICAT, P167; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Segrest JP, 2001, J LIPID RES, V42, P1346; Selvaraju S, 2011, ELECTROPHORESIS, V32, P674, DOI 10.1002/elps.201000606; Shih JH, 2004, BIOINFORMATICS, V20, P3318, DOI 10.1093/bioinformatics/bth391; Shimomura T, 2012, GEN COMP ENDOCR, V178, P427, DOI 10.1016/j.ygcen.2012.06.011; Simpson KL, 2009, J CHROMATOGR B, V877, P1240, DOI 10.1016/j.jchromb.2008.11.023; Sullivan LS, 2017, INVEST OPHTH VIS SCI, V58, P2774, DOI 10.1167/iovs.16-21341; Sutherland BJG, 2014, MOL ECOL, V23, P1952, DOI 10.1111/mec.12713; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Tanaka Y, 2006, PROTEOMICS, V6, P4845, DOI 10.1002/pmic.200500774; Thorpe JE, 1998, AQUACULTURE, V168, P95, DOI 10.1016/S0044-8486(98)00342-1; Tilli TM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2946-1; Vu V.Q., 2011, GGBIPLOT GGPLOT2 BAS, P342; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wang XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34149-5; Watanabe K, 2018, CELL REP, V22, P2809, DOI 10.1016/j.celrep.2018.02.045; Weinkauf M, 2006, ELECTROPHORESIS, V27, P4555, DOI 10.1002/elps.200600207; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WINANS GA, 1987, AQUACULTURE, V66, P235, DOI 10.1016/0044-8486(87)90109-8; Yasunaga M, 2012, J MOL BIOL, V417, P336, DOI 10.1016/j.jmb.2012.01.041; ZAUGG WS, 1973, COMP BIOCHEM PHYSIOL, V45, P955, DOI 10.1016/0305-0491(73)90156-9; Zhang WY, 2007, BIOINFORMATICS, V23, P1217, DOI 10.1093/bioinformatics/btm081; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zolg W, 2006, MOL CELL PROTEOMICS, V5, P1720, DOI 10.1074/mcp.R600001-MCP200	120	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227003	10.1371/journal.pone.0227003	http://dx.doi.org/10.1371/journal.pone.0227003			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899766	Green Published, gold			2022-12-26	WOS:000534322000010
J	de Souza, FP; de Lima, ECS; Urrea-Rojas, AM; Suphoronski, SA; Facimoto, CT; Bezerra, JD; de Oliveira, TES; Pereira, UD; Di Santis, GW; de Oliveira, CAL; Lopera-Barrero, NM				de Souza, Felipe Pinheiro; Suzuki de Lima, Ed Christian; Urrea-Rojas, Angela Maria; Suphoronski, Suelen Aparecida; Facimoto, Cesar Toshio; Bezerra Junior, Jailton da Silva; Silva de Oliveira, Thalita Evani; Pereira, Ulisses de Padua; Di Santis, Giovana Wingeter; Lopes de Oliveira, Carlos Antonio; Lopera-Barrero, Nelson Mauricio			Effects of dietary supplementation with a microalga (Schizochytrium sp.) on the hemato-immunological, and intestinal histological parameters and gut microbiota of Nile tilapia in net cages	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; TROUT ONCORHYNCHUS-MYKISS; CETOBACTERIUM-SOMERAE; EMENDED DESCRIPTION; GROWTH-PERFORMANCE; IMMUNE-RESPONSES; SP NOV.; FISH; OILS; MORPHOLOGY	Nutritional improvements in intensive aquaculture production systems is necessary for the reduction of stress, maximum utilization of nutritional components, and expression of the genetic potential of fish. The objective of this study was to evaluate the hemato-immunological, and histological parameters and gut microbiota of Nile tilapia fed with the microalga Schizochytrium sp. Males of Nile tilapia were distributed among eight net cages (6 m(3)), and fed for 105 days with two diets: control (CON), without Schizochytrium sp., and supplemented (SUP), with 1.2% Schizochytrium sp. in the diet. The final weight, mortality, hemato-crit, total erythrocyte count (RBC), hemoglobin, hematimetric indices, white blood cell count (WBC), total protein, and serum lysozyme were measured. Alterations in intestinal morphology were evaluated. The gut microbiota was evaluated with next-generation sequencing. No significant differences (p>0.05) were found in the final weight and mortality between diets. Regarding the hematological parameters, a difference (p<0.05) was detected only in RBC, with there being lower values in the SUP, although this group also showed a tendency toward having an increased mean corpuscular hemoglobin level. There were no differences (p>0.05) in total protein and serum lysozyme concentrations or in WBCs between diets, except for lymphocytes, which presented lower values (p<0.05) in the SUP, suggesting immunomodulation by the polyunsaturated fatty acids present in the microalga. There was no difference (p>0.05) in the intestinal morphology between diets. Metagenomic data indicated greater richness (represented by the Chao index) and a higher abundance of the bacterial phylum Firmicutes in the gut microbiota of the tilapia fed with the SUP diet, demonstrating that the digestion and use of the components of the microalga could influence the microbial community. The results indicated that the microalga had modulatory effects on blood cells and the intestinal microbiota, without affecting the structure and integrity of the intestinal villi.	[de Souza, Felipe Pinheiro; Suzuki de Lima, Ed Christian; Urrea-Rojas, Angela Maria; Lopera-Barrero, Nelson Mauricio] Univ Estadual Londrina, Dept Anim Sci, Londrina, Parana, Brazil; [Suphoronski, Suelen Aparecida; Facimoto, Cesar Toshio; Silva de Oliveira, Thalita Evani; Pereira, Ulisses de Padua; Di Santis, Giovana Wingeter] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Bezerra Junior, Jailton da Silva; Lopes de Oliveira, Carlos Antonio] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Maringa	Lopera-Barrero, NM (corresponding author), Univ Estadual Londrina, Dept Anim Sci, Londrina, Parana, Brazil.	nmlopera@uel.br	APARECIDA SUPHORONSKI, SUELEN/AAY-7599-2021; de Oliveira, Thalita Evani Silva/R-3865-2018	de Oliveira, Thalita Evani Silva/0000-0001-6894-9253; Pinheiro de Souza, Felipe/0000-0003-3436-4147	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); onselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (Cnpq); Fundacao Araucaia	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); onselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (Cnpq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Araucaia	This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (Cnpq), and Fundacao Araucaia for their support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or pYreparation of the manuscript.	Adamante WB, 2008, ARQ BRAS MED VET ZOO, V60, P755, DOI 10.1590/S0102-09352008000300034; AHMED SA, 2009, ADV EXPT MED BIOL, P17, DOI DOI 10.1007/978-0-387-88483-7_3; Araujo DD, 2011, PESQUI AGROPECU BRAS, V46, P294, DOI 10.1590/S0100-204X2011000300010; Baldo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127462; BLAXHALL PC, 1973, J FISH BIOL, V5, P771, DOI 10.1111/j.1095-8649.1973.tb04510.x; Bledsoe JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166379; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bravo-Tello K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187696; Buck EL, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019404; Carda-Dieguez M, 2014, FEMS MICROBIOL ECOL, V87, P451, DOI 10.1111/1574-6941.12236; CHAMBERLAIN AHL, 1988, BIOSYSTEMS, V21, P341, DOI 10.1016/0303-2647(88)90031-7; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; DARLEY WM, 1973, ARCH MIKROBIOL, V90, P89, DOI 10.1007/BF00414512; Dawood MAO, 2017, AQUACULTURE, V470, P214, DOI 10.1016/j.aquaculture.2016.12.036; de Oliveira SN, 2019, REV BRAS ZOOTECN, V48, DOI 10.1590/rbz4820170179; Quezada-Rodriguez PD, 2017, J APPL PHYCOL, V29, P423, DOI 10.1007/s10811-016-0903-7; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; dos Santos SKA, 2015, CAD CIENCIAS AGRARIA, V7, P75; Eichmiller JJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0190-1; Ellis A.E., 1990, Fish Immunology Technical Communications, P101; Etyemez M, 2015, RES VET SCI, V100, P8, DOI 10.1016/j.rvsc.2015.03.026; Fan LM, 2017, AQUAC RES, V48, P459, DOI 10.1111/are.12894; FAO, 2018, STAT WORLD FISH AQ 2, V35; Finegold SM, 2003, SYST APPL MICROBIOL, V26, P177, DOI 10.1078/072320203322346010; Garcia F, 2012, ARQ BRAS MED VET ZOO, V64, P198, DOI 10.1590/S0102-09352012000100028; Gerritsen J, 2017, PEERJ, V5, DOI 10.7717/peerj.3698; Gerritsen J, 2014, INT J SYST EVOL MICR, V64, P1600, DOI 10.1099/ijs.0.059543-0; Gram L, 1999, APPL ENVIRON MICROB, V65, P969; Han SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488; IBGE, 2017, PESQ PEC MUN PPM; JOSEPH JD, 1992, J AOAC INT, V75, P488; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kubitza F., 2011, TILAPIA TECNOLOGIA P, P316; Kumala F. B., 2018, AACL Bioflux, V11, P1368; Levy-Pereira N, 2018, REV BRAS ZOOTECN, V47, DOI [10.1590/rbz472010006, 10.1590/rbz4720170006]; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813; Li MHH, 2009, AQUACULTURE, V292, P232, DOI 10.1016/j.aquaculture.2009.04.033; Lyons PP, 2017, AQUAC RES, V48, P2438, DOI 10.1111/are.13080; Marino F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00459; Martins ML, BIL I PESAC, V30, P71; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124042; Panigrahi A, 2004, VET IMMUNOL IMMUNOP, V102, P379, DOI 10.1016/j.vetimm.2004.08.006; R Core Team, 2021, R LANG ENV STAT; Ranzani-Paiva M. J. T., 2013, METODOS ANALISE HEMA; Reveco FE, 2014, AQUACULTURE, V420, P262, DOI 10.1016/j.aquaculture.2013.11.007; Sarker PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156684; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silva BC, 2009, PESQUI VET BRASIL, V29, P874, DOI 10.1590/S0100-736X2009001100002; Silva DJ, 2009, ANALISE ALIMENTOS ME; Standen BT, 2016, FISH SHELLFISH IMMUN, V49, P427, DOI 10.1016/j.fsi.2015.11.037; Standen BT, 2013, FISH SHELLFISH IMMUN, V35, P1097, DOI 10.1016/j.fsi.2013.07.018; Suphoronski SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42480-8; Tan CK, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.734; Tarnecki AM, 2017, J APPL MICROBIOL, V123, P2, DOI 10.1111/jam.13415; Tavares-Dias M, 2007, J APPL ICHTHYOL, V23, P709, DOI 10.1111/j.1439-0426.2007.00850.x; Telli GS, 2014, FISH SHELLFISH IMMUN, V39, P305, DOI 10.1016/j.fsi.2014.05.025; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Turco PHN, 2014, ECONOMICAS, V44, P5; Uran PA, 2008, AQUACULT NUTR, V14, P324, DOI 10.1111/j.1365-2095.2007.00534.x; Valladao GMR, 2017, AQUAC RES, V48, P5640, DOI 10.1111/are.13386; Visentainer JV, 2012, QUIM NOVA, V35, P274, DOI 10.1590/S0100-40422012000200008; Wan AHL, 2016, J APPL PHYCOL, V28, P3091, DOI 10.1007/s10811-016-0821-8; Wang YW, 2015, INT J SYST EVOL MICR, V65, P1193, DOI 10.1099/ijs.0.000079; Yeganeh S, 2018, J APPL PHYCOL, V18, P1; Zahran E, 2014, FISH SHELLFISH IMMUN, V38, P149, DOI 10.1016/j.fsi.2014.03.002; Zhang ML, 2016, AQUACULTURE, V454, P72, DOI 10.1016/j.aquaculture.2015.12.014; Zheng X, 2019, FISH SHELLFISH IMMUN, V89, P127, DOI 10.1016/j.fsi.2019.03.054	69	22	22	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226977	10.1371/journal.pone.0226977	http://dx.doi.org/10.1371/journal.pone.0226977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31896132	Green Published, gold			2022-12-26	WOS:000534267300012
J	Noguchi, G; Kawahara, T; Kobayashi, K; Tsutsumi, S; Ohtake, S; Osaka, K; Umemoto, S; Nakaigawa, N; Uemura, H; Kishida, T; Yao, M				Noguchi, Go; Kawahara, Takashi; Kobayashi, Kota; Tsutsumi, Sohgo; Ohtake, Shinji; Osaka, Kimito; Umemoto, Susumu; Nakaigawa, Noboru; Uemura, Hiroji; Kishida, Takeshi; Yao, Masahiro			A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; PROGNOSTIC-FACTOR; SKELETAL-MUSCLE; SARCOPENIA; PREDICTION; RESECTION; SURVIVAL; IMPACT; STAGE; RISK	Background Sarcopenia is defined as a low skeletal muscle volume. Recent studies have reported that sarcopenia is associated with a poor prognosis in various cancers. The purpose of this study is to evaluate the correlation between the psoas muscle volume and recurrence-free survival in patients with localized clear cell renal cell carcinoma (ccRCC). Methods A total of 316 male patients with localized ccRCC who underwent radical nephrectomy at Yokohama City University Hospital (Yokohama, JAPAN) and Kanagawa Cancer Center (Yokohama, JAPAN) between 2002 and 2018 were enrolled in this study. The psoas muscle index (PMI) was calculated by normalizing the psoas muscle area on the contralateral side of the tumor on axial CT, which was calculated at the level of L4 (mm(2)) divided by the square of the body height (m(2)). We divided patients into two groups based on the median PMI (409.64mm(2)/m(2)). Results The lower PMI group showed poorer recurrence-free survival (RFS) than the higher PMI group (p = 0.030). Regarding 5-year RFS, a lower PMI was a significant predictor of recurrence (p = 0.022, hazard ratio (HR): 2.306) and a multivariate analysis revealed that a lower PMI (< median, p = 0.035, HR: 2.167), tumor size > 4 cm (p = 0.044, HR: 2.341), and pathological stage > 2 (p< 0.001, HR: 3.660) were independent risk factors for poor RFS. Conclusions The presence of sarcopenia (lower PMI) was found to be associated with poor RFS in male ccRCC patients. The PMI might serve as a measure of patient frailty and might be useful for prognostic risk stratification in ccRCC.	[Noguchi, Go; Kobayashi, Kota; Tsutsumi, Sohgo; Osaka, Kimito; Umemoto, Susumu; Kishida, Takeshi] Kanagawa Canc Ctr, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Uemura, Hiroji] Yokohama City Univ, Med Ctr, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Uemura, Hiroji] Yokohama City Univ, Med Ctr, Dept Renal Transplantat, Yokohama, Kanagawa, Japan; [Ohtake, Shinji; Nakaigawa, Noboru; Yao, Masahiro] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan	Kanagawa Prefectural Cancer Center; Yokohama City University; Yokohama City University; Yokohama City University	Kawahara, T (corresponding author), Yokohama City Univ, Med Ctr, Dept Urol, Yokohama, Kanagawa, Japan.; Kawahara, T (corresponding author), Yokohama City Univ, Med Ctr, Dept Renal Transplantat, Yokohama, Kanagawa, Japan.	kawahara@yokohama-cu.ac.jp		Kawahara, Takashi/0000-0002-7049-3379				Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Lam JS, 2005, J UROLOGY, V174, P466, DOI 10.1097/01.ju.0000165572.38887.da; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.3.CO;2-H; Okumura S, 2015, SURGERY, V157, P1088, DOI 10.1016/j.surg.2015.02.002; Psutka SP, 2016, J UROLOGY, V195, P270, DOI 10.1016/j.juro.2015.08.072; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Saitoh-Maeda Y, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0279-2; Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	14	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226581	10.1371/journal.pone.0226581	http://dx.doi.org/10.1371/journal.pone.0226581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895931	Green Published, gold			2022-12-26	WOS:000534267300007
J	Bhedi, CD; Nasirova, S; Toksoz, D; Warburton, RR; Morine, KJ; Kapur, NK; Galper, JB; Preston, IR; Hill, NS; Fanburg, BL; Penumatsa, KC				Bhedi, Chinmayee D.; Nasirova, Sabina; Toksoz, Deniz; Warburton, Rod R.; Morine, Kevin J.; Kapur, Navin K.; Galper, Jonas B.; Preston, Ioana R.; Hill, Nicholas S.; Fanburg, Barry L.; Penumatsa, Krishna C.			Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling	FASEB JOURNAL			English	Article						glycolysis; hyperglycemia; PKM2; TG2; tissue fibrosis	PYRUVATE-KINASE M2; TISSUE TRANSGLUTAMINASE; HEART-FAILURE; PULMONARY-HYPERTENSION; FIBROBLAST ACTIVATION; GLUCOSE-METABOLISM; INHIBITION; CELLS; DYSFUNCTION; MECHANISMS	The pathophysiology of pulmonary hypertension (PH) and heart failure (HF) includes fibrogenic remodeling associated with the loss of pulmonary arterial (PA) and cardiac compliance. We and others have previously identified transglutaminase 2 (TG2) as a participant in adverse fibrogenic remodeling. However, little is known about the biologic mechanisms that regulate TG2 function. We examined physiological mouse models of experimental PH, HF, and type 1 diabetes that are associated with altered glucose metabolism/glycolysis and report here that TG2 expression and activity are elevated in pulmonary and cardiac tissues under all these conditions. We additionally used PA adventitial fibroblasts to test the hypothesis that TG2 is an intermediary between enhanced tissue glycolysis and fibrogenesis. Our in vitro results show that glycolytic enzymes and TG2 are upregulated in fibroblasts exposed to high glucose, which stimulates cellular glycolysis as measured by Seahorse analysis. We examined the relationship of TG2 to a terminal glycolytic enzyme, pyruvate kinase M2 (PKM2), and found that PKM2 regulates glucose-induced TG2 expression and activity as well as fibrogenesis. Our studies further show that TG2 inhibition blocks glucose-induced fibrogenesis and cell proliferation. Our findings support a novel role for glycolysis-mediated TG2 induction and tissue fibrosis associated with experimental PH, HF, and hyperglycemia.	[Bhedi, Chinmayee D.; Nasirova, Sabina; Toksoz, Deniz; Warburton, Rod R.; Preston, Ioana R.; Hill, Nicholas S.; Fanburg, Barry L.; Penumatsa, Krishna C.] Tufts Med Ctr, Dept Med, Div Pulm, Boston, MA 02111 USA; [Morine, Kevin J.; Kapur, Navin K.; Galper, Jonas B.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center	Penumatsa, KC (corresponding author), Tufts Med Ctr, Dept Med, Pulm Crit Care & Sleep Div, 800 Washington St,Box 257, Boston, MA 02111 USA.	kpenumatsa@tuftsmedicalcenter.org			Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension; American Heart Association [18CDA34140005]; National Institutes of Health [HL107713, HL074876]	Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by research funding from Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension (KCP), an American Heart Association Career Development Award 18CDA34140005 (KCP) and the National Institutes of Health HL107713 (BLF) and HL074876 (JBG)	Al-Naamani N, 2015, JACC-HEART FAIL, V3, P467, DOI 10.1016/j.jchf.2015.01.013; Altuntas S, 2015, ONCOTARGET, V6, P44941, DOI 10.18632/oncotarget.6759; Archer SL, 2013, PULM CIRC, V3, P144, DOI 10.4103/2045-8932.109960; Baandrup JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015859; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Cho SJ, 2017, AM J RESP CELL MOL, V56, P521, DOI 10.1165/rcmb.2016-0225OC; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; Dong GC, 2016, ONCOL LETT, V11, P1980, DOI 10.3892/ol.2016.4168; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Jeon HY, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116711; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Kumar S, 2014, INT J CANCER, V134, P2798, DOI 10.1002/ijc.28623; Lai YC, 2019, J PHYSIOL-LONDON, V597, P1143, DOI 10.1113/JP275858; Lee J, 2015, CLIN CANCER RES, V21, P4482, DOI 10.1158/1078-0432.CCR-15-0226; LEE SL, 1987, CIRC RES, V60, P653, DOI 10.1161/01.RES.60.5.653; Lee ZW, 2003, BIOCHEM BIOPH RES CO, V305, P633, DOI 10.1016/S0006-291X(03)00835-0; Liu CY, 2017, CANCER RES, V77, P4734, DOI 10.1158/0008-5472.CAN-16-3535; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Oh YJ, 2017, AMINO ACIDS, V49, P695, DOI 10.1007/s00726-016-2295-z; Oh Young S, 2018, Clin Hypertens, V24, P17, DOI 10.1186/s40885-018-0102-8; Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130; Penumatsa KC, 2014, AM J PHYSIOL-LUNG C, V306, pL309, DOI 10.1152/ajplung.00321.2013; Penumatsa KC, 2017, AM J PHYSIOL-LUNG C, V313, pL752, DOI 10.1152/ajplung.00170.2017; Penumatsa KC, 2014, AM J PHYSIOL-LUNG C, V307, pL576, DOI 10.1152/ajplung.00162.2014; Rain S, 2013, CIRCULATION, V128, P2016, DOI 10.1161/CIRCULATIONAHA.113.001873; Rossin F, 2015, CELL DEATH DIFFER, V22, P408, DOI 10.1038/cdd.2014.106; Sankaralingam S, 2015, PULM CIRC, V5, P15, DOI 10.1086/679608; Schafer M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0609-2; Shimoda L. A., 1985, J APPL PHYSIOL, V116, P867, DOI DOI 10.1152/JAPPLPHYSIOL.00643.2013.; Shinde AV, 2018, J MOL CELL CARDIOL, V117, P36, DOI 10.1016/j.yjmcc.2018.02.016; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thenappan T, 2018, AM J PHYSIOL-HEART C, V315, pH1322, DOI 10.1152/ajpheart.00136.2018; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang ZJ, 2017, J APPL PHYSIOL, V122, P253, DOI 10.1152/japplphysiol.00325.2016; Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0573-2; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Wei QQ, 2019, AM J PHYSIOL-RENAL, V316, pF1162, DOI 10.1152/ajprenal.00422.2018; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Xie N, 2015, AM J RESP CRIT CARE; Xiong PY, 2019, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00195; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Zhang H, 2017, CIRCULATION, V136, P2468, DOI 10.1161/CIRCULATIONAHA.117.028069; Zhang YL, 2014, DIABETES, V63, P2097, DOI 10.2337/db12-1459	62	12	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					930	944		10.1096/fj.201902155R	http://dx.doi.org/10.1096/fj.201902155R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914588	Green Accepted			2022-12-26	WOS:000507308900063
J	Canet, G; Pineau, F; Zussy, C; Hernandez, C; Hunt, H; Chevallier, N; Perrier, V; Torrent, J; Belanoff, JK; Meijer, OC; Desrumaux, C; Givalois, L				Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Hunt, Hazel; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Belanoff, Joseph K.; Meijer, Onno C.; Desrumaux, Catherine; Givalois, Laurent			Glucocorticoid receptors signaling impairment potentiates amyloid-beta oligomers-induced pathology in an acute model of Alzheimer's disease	FASEB JOURNAL			English	Article						Cdk5; GSK-3 beta; PDK1; ROCK; selective GR modulator	TAU PHOSPHORYLATION; RHO-KINASE; IN-VIVO; HIPPOCAMPAL-NEURONS; PREFRONTAL CORTEX; MOUSE MODEL; PROTEIN; INHIBITION; STRESS; ACTIVATION	Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis occurs early in Alzheimer's disease (AD), associated with elevated circulating glucocorticoids (GC) and glucocorticoid receptors (GR) signaling impairment. However, the precise role of GR in the pathophysiology of AD remains unclear. Using an acute model of AD induced by the intracerebroventricular injection of amyloid-beta oligomers (oA beta), we analyzed cellular and behavioral hallmarks of AD, GR signaling pathways, processing of amyloid precursor protein, and enzymes involved in Tau phosphorylation. We focused on the prefrontal cortex (PFC), particularly rich in GR, early altered in AD and involved in HPA axis control and cognitive functions. We found that oA beta impaired cognitive and emotional behaviors, increased plasma GC levels, synaptic deficits, apoptosis and neuroinflammatory processes. Moreover, oA beta potentiated the amyloidogenic pathway and enzymes involved both in Tau hyperphosphorylation and GR activation. Treatment with a selective GR modulator (sGRm) normalized plasma GC levels and all behavioral and biochemical parameters analyzed. GR seems to occupy a central position in the pathophysiology of AD. Deregulation of the HPA axis and a feed-forward effect on PFC GR sensitivity could participate in the etiology of AD, in perturbing A beta and Tau homeostasis. These results also reinforce the therapeutic potential of sGRm in AD.	[Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] INSERM, U1198, Mol Mech Neurodegenerat Dementia MMDN Lab, Team Environm Impact Alzheimers Dis & Related Dis, Pl E Bataillon, F-34095 Montpellier, France; [Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] Univ Montpellier, Montpellier, France; [Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] EPHE, Paris, France; [Hunt, Hazel; Belanoff, Joseph K.] Corcept Therapeut, Menlo Pk, CA USA; [Meijer, Onno C.] Leiden Univ, Div Endocrinol, Dept Med, Einthoven Lab,Med Ctr, Leiden, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Givalois, L (corresponding author), INSERM, U1198, Mol Mech Neurodegenerat Dementia MMDN Lab, Team Environm Impact Alzheimers Dis & Related Dis, Pl E Bataillon, F-34095 Montpellier, France.	laurent.givalois@umontpellier.fr	Perrier, Veronique/AAK-3594-2020; Desrumaux, Catherine/O-1925-2018	Givalois, Laurent/0000-0002-6698-5346; CANET, Geoffrey/0000-0001-7291-4512	Association France Alzheimer (French Alzheimer's Association) [1512]; Agence Nationale de la Recherche (ANR) [ANR-11-LABEX-0021-LipSTIC]; Corcept Therapeutics (Menlo Park, CA, USA); University of Montpellier, France; University of Montpellier, France, CBS2 PhD program	Association France Alzheimer (French Alzheimer's Association); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Corcept Therapeutics (Menlo Park, CA, USA); University of Montpellier, France; University of Montpellier, France, CBS2 PhD program	Association France Alzheimer (French Alzheimer's Association), Grant/Award Number: SM2016#1512 -LG; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-11-LABEX-0021-LipSTIC - CD; Corcept Therapeutics (Menlo Park, CA, USA), Grant/Award Number: Exceptional subvention - LG; University of Montpellier, France, Grant/Award Number: CBS2 PhD program - GC; University of Montpellier, France, Grant/Award Number: CBS2 PhD program - CH	Alleaume-Butaux A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005073; Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Baglietto-Vargas D, 2013, BIOL PSYCHIAT, V74, P357, DOI 10.1016/j.biopsych.2012.12.003; Beaudry JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091248; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Brureau A, 2013, NEUROBIOL AGING, V34, P1426, DOI 10.1016/j.neurobiolaging.2012.11.015; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Chen YM, 2014, J NEUROSCI, V34, P2464, DOI 10.1523/JNEUROSCI.0151-13.2014; Choi GE, 2017, J NEUROSCI, V37, P8459, DOI 10.1523/JNEUROSCI.0074-17.2017; Clark RD, 2008, BIOORG MED CHEM LETT, V18, P1312, DOI 10.1016/j.bmcl.2008.01.027; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Deng J, 2015, J NEUROCHEM, V135, P630, DOI 10.1111/jnc.13351; Dey A, 2017, NEUROBIOL AGING, V57, P75, DOI 10.1016/j.neurobiolaging.2017.05.010; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Castro-Alvarez JF, 2011, BEHAV NEUROSCI, V125, P465, DOI 10.1037/a0023167; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Garcia-Rojo G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00483; Gentry EG, 2016, J NEUROSCI, V36, P1316, DOI 10.1523/JNEUROSCI.2336-15.2016; Gray JD, 2017, NAT REV ENDOCRINOL, V13, P661, DOI 10.1038/nrendo.2017.97; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Groeneweg FL, 2012, MOL CELL ENDOCRINOL, V350, P299, DOI 10.1016/j.mce.2011.06.020; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020; Hartmann A, 1997, NEUROBIOL AGING, V18, P285, DOI 10.1016/S0197-4580(97)80309-0; Henderson BW, 2016, J NEUROCHEM, V138, P525, DOI 10.1111/jnc.13688; Herskowitz JH, 2013, J NEUROSCI, V33, P19086, DOI 10.1523/JNEUROSCI.2508-13.2013; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoogendijk WJG, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.07.017; Hu YB, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00253; Huang GX, 2017, CANCER LETT, V410, P1, DOI 10.1016/j.canlet.2017.09.005; Hunt HJ, 2015, BIOORG MED CHEM LETT, V25, P5720, DOI 10.1016/j.bmcl.2015.10.097; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; Jozic I, 2017, J INVEST DERMATOL, V137, P1144, DOI 10.1016/j.jid.2016.11.036; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Kurbatskaya K, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0299-2; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lahiri DK, 2004, ANN NY ACAD SCI, V1030, P282, DOI 10.1196/annals.1329.035; Lai AY, 2018, J NEUROCHEM, V144, P659, DOI 10.1111/jnc.14130; Lante F, 2015, NEUROPSYCHOPHARMACOL, V40, P1772, DOI 10.1038/npp.2015.25; LAPING NJ, 1994, ENDOCRINOLOGY, V135, P1928, DOI 10.1210/en.135.5.1928; Le Menuet D, 2014, STEROIDS, V91, P11, DOI 10.1016/j.steroids.2014.05.018; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesuis SL, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0101-2; Li XH, 2007, CHIN MED J, V120, P66974; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Liu D, 2014, CELL PHYSIOL BIOCHEM, V33, P1654, DOI 10.1159/000362948; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; LV Z, 2016, J DIABETES RES, V2016; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Meijer OC, 2018, ANN ENDOCRINOL-PARIS, V79, P107, DOI 10.1016/j.ando.2018.03.004; Meunier J, 2013, EUR J PHARMACOL, V698, P193, DOI 10.1016/j.ejphar.2012.10.033; Meyer M, 2018, NEUROSCIENCE, V384, P384, DOI 10.1016/j.neuroscience.2018.05.042; Naert G, 2015, EUR NEUROPSYCHOPHARM, V25, P2170, DOI 10.1016/j.euroneuro.2015.03.018; Notarianni E, 2013, CURR ALZHEIMER RES, V10, P714, DOI 10.2174/15672050113109990137; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pietri M, 2013, NAT MED, V19, P1124, DOI 10.1038/nm.3302; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pineau F, 2016, NEUROBIOL AGING, V45, P109, DOI 10.1016/j.neurobiolaging.2016.05.018; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Rothman SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.005; Rubenstein NM, 2007, BIOCHEM BIOPH RES CO, V354, P603, DOI 10.1016/j.bbrc.2007.01.024; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Scales TME, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-12; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Solomon MB, 2014, HORM BEHAV, V65, P363, DOI 10.1016/j.yhbeh.2014.02.002; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Sun LH, 2015, J NEUROCHEM, V134, P1139, DOI 10.1111/jnc.13212; Swanger S.A., 2015, CELLULAR LOGISTICS, V5, DOI 10.1080/21592799.2015.1133266; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Yamada K, 2000, PHARMACOL THERAPEUT, V88, P93, DOI 10.1016/S0163-7258(00)00081-4; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zussy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053117; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	95	11	12	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1150	1168		10.1096/fj.201900723RRR	http://dx.doi.org/10.1096/fj.201900723RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914623	Green Submitted			2022-12-26	WOS:000507308900078
J	Dickman, CTD; Russo, V; Thain, K; Pan, S; Beyer, ST; Walus, K; Getsios, S; Mohamed, T; Wadsworth, SJ				Dickman, Christopher T. D.; Russo, Valerio; Thain, Katherine; Pan, Sheng; Beyer, Simon T.; Walus, Konrad; Getsios, Spiro; Mohamed, Tamer; Wadsworth, Sam J.			Functional characterization of 3D contractile smooth muscle tissues generated using a unique microfluidic 3D bioprinting technology	FASEB JOURNAL			English	Article						3D bioprinting; airway; decellularized extracellular matrix; intestine; microfluidic; smooth muscle; tissue engineering; tissue remodeling	CUT LUNG SLICES; EXTRACELLULAR-MATRIX; AIRWAY-OBSTRUCTION; CELLS; BETA; HYPERRESPONSIVENESS; SALBUTAMOL; CONSTRUCTS; HISTAMINE; MICE	Conditions such as asthma and inflammatory bowel disease are characterized by aberrant smooth muscle contraction. It has proven difficult to develop human cell-based models that mimic acute muscle contraction in 2D in vitro cultures due to the nonphysiological chemical and mechanical properties of lab plastics that do not allow for muscle cell contraction. To enhance the relevance of in vitro models for human disease, we describe how functional 3D smooth muscle tissue that exhibits physiological and pharmacologically relevant acute contraction and relaxation responses can be reproducibly fabricated using a unique microfluidic 3D bioprinting technology. Primary human airway and intestinal smooth muscle cells were printed into rings of muscle tissue at high density and viability. Printed tissues contracted to physiological concentrations of histamine (0.01-100 mu M) and relaxed to salbutamol, a pharmacological compound used to relieve asthmatic exacerbations. The addition of TGF beta to airway muscle rings induced an increase in unstimulated muscle shortening and a decreased response to salbutamol, a phenomenon which also occurs in chronic lung diseases. Results indicate that the 3D bioprinted smooth muscle is a physiologically relevant in vitro model that can be utilized to study disease pathways and the effects of novel therapeutics on acute contraction and chronic tissue stenosis.	[Dickman, Christopher T. D.; Russo, Valerio; Thain, Katherine; Pan, Sheng; Beyer, Simon T.; Walus, Konrad; Getsios, Spiro; Mohamed, Tamer; Wadsworth, Sam J.] Aspect Biosyst Ltd, 1781 West 75th Ave, Vancouver, BC V6P 6P2, Canada; [Walus, Konrad] Univ British Columbia, Dept Elect & Comp Engn, Fac Engn, Vancouver, BC, Canada	University of British Columbia	Wadsworth, SJ (corresponding author), Aspect Biosyst Ltd, 1781 West 75th Ave, Vancouver, BC V6P 6P2, Canada.	info@aspectbiosystems.com			Industrial Research Assistance Program of the National Research Council Canada [891779]	Industrial Research Assistance Program of the National Research Council Canada	This work was supported by the Industrial Research Assistance Program of the National Research Council Canada (Grant #891779)	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Backman KS, 1997, CHEST, V112, P1234, DOI 10.1378/chest.112.5.1234; Biopta, 2018, ASS BRONCH TERT LOW; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BROWN RH, 1994, AM J RESP CRIT CARE, V150, P233, DOI 10.1164/ajrccm.150.1.8025755; Choi YJ, 2016, ADV HEALTHC MATER, V5, P2636, DOI 10.1002/adhm.201600483; Costantini M, 2017, BIOMATERIALS, V131, P98, DOI 10.1016/j.biomaterials.2017.03.026; Coutts A, 2001, AM J PHYSIOL-LUNG C, V280, pL999, DOI 10.1152/ajplung.2001.280.5.L999; Doeing DC, 2013, J APPL PHYSIOL, V114, P834, DOI 10.1152/japplphysiol.00950.2012; Fey SJ, 2012, TOXICOL SCI, V127, P403, DOI 10.1093/toxsci/kfs122; Finkbeiner SR, 2015, BIOL OPEN, V4, P1462, DOI 10.1242/bio.013235; Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ihida-Stansbury K, 2015, PULM CIRC, V5, P382, DOI 10.1086/681272; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kim JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29968-5; Kitamura N, 2008, INT ARCH ALLERGY IMM, V146, P36, DOI 10.1159/000126059; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; LEMOINE H, 1992, LUNG, V170, P163; Lin CC, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-187; LIPWORTH BJ, 1989, EUR J CLIN PHARMACOL, V37, P567; Maiullari F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31848-x; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Mitzner W, 2004, AM J RESP CRIT CARE, V169, P787, DOI 10.1164/rccm.200312-1636PP; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Nassimi Matthias, 2009, Inhal Toxicol, V21 Suppl 1, P104, DOI 10.1080/08958370903005769; Neuhaus V, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0158-5; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Rego SL, 2016, METHODS, V99, P128, DOI 10.1016/j.ymeth.2015.08.014; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Sakota Y, 2014, BIOL PHARM BULL, V37, P1014, DOI 10.1248/bpb.b13-00996; Schittny JC, 2000, AM J RESP CELL MOL, V23, P11, DOI 10.1165/ajrcmb.23.1.3926; Severi C, 2014, EUR J HISTOCHEM, V58, P307, DOI 10.4081/ejh.2014.2457; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Stock K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28951; SUTERA SP, 1993, ANNU REV FLUID MECH, V25, P1, DOI 10.1146/annurev.fl.25.010193.000245; VERMILLION DL, 1993, GASTROENTEROLOGY, V104, P1692, DOI 10.1016/0016-5085(93)90647-U; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; WIDDOP S, 1993, AM J RESP CELL MOL, V9, P541, DOI 10.1165/ajrcmb/9.5.541; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; WOOLCOCK AJ, 1984, AM REV RESPIR DIS, V130, P71; Wright DB, 2013, PULM PHARMACOL THER, V26, P42, DOI 10.1016/j.pupt.2012.08.005; YAN K, 1985, AM REV RESPIR DIS, V132, P25; Yipeng Jin, 2017, Front Physiol, V8, P534, DOI 10.3389/fphys.2017.00534; Young BM, 2017, ACS BIOMATER SCI ENG, V3, P3480, DOI 10.1021/acsbiomaterials.7b00384	52	15	18	14	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1652	1664		10.1096/fj.201901063RR	http://dx.doi.org/10.1096/fj.201901063RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914670				2022-12-26	WOS:000507308900109
J	Ranaweera, LT; Wijesundara, WWMUK; Jayarathne, HSM; Knowles, NJ; Wadsworth, J; Gray, A; Adikari, AMJB; Weebadde, CK; Sooriyapathirana, SDSS				Ranaweera, L. T.; Wijesundara, W. W. M. U. K.; Jayarathne, H. S. M.; Knowles, N. J.; Wadsworth, J.; Gray, A.; Adikari, A. M. J. B.; Weebadde, C. K.; Sooriyapathirana, S. D. S. S.			Transboundary movements of foot-and-mouth disease from India to Sri Lanka: A common pattern is shared by serotypes O and C	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; VIRUS; EAST; AFRICA; INFORMATION; DIVERSITY; SELECTION; SPREAD; MODEL; ASIA	Foot-and-mouth disease (FMD) affects the livestock industry in a transboundary manner. It is essential to understand the FMD phylodynamics to assist in the disease-eradication. FMD critically affects the Sri Lankan cattle industry causing substantial economic losses. Even though many studies have covered the serotyping and genotyping of FMD virus (FMDV) in Sri Lanka, there is a significant knowledge gap exists in understanding the FMDV phylodynamics in the country. In the present study, the VP1 genomic region of FMD viral isolates belonging to serotype C from Sri Lanka and other South Asian countries were sequenced. All the published VPI sequences of serotype C and most of the published VP1 sequences for lineage ME-SA/Ind-2001d of serotype 0 from Sri Lanka, India, and other South Asian countries were retrieved. The datasets of serotype C and serotype 0 were separately analyzed using Bayesian, maximum likelihood, and phylogenetic networking methods to infer the transboundary movements and evolutionary aspects of the FMDV incursions in Sri Lanka. A model-based approach was used to detect any possible recombination events of FMDV incursions. Our results revealed that the invasions of the topotype ASIA of serotype C and the lineage ME-SA/Ind-2001d have a similar pattern of transboundary movement and evolution. The haplotype networks and phylogenies developed in the present study confirmed that FMDV incursions in Sri Lanka mainly originate from the Indian subcontinent, remain quiet after migration, and then cause outbreaks in a subsequent year. Since there are no recombination events detected among the different viral strains across serotypes and topotypes, we can assume that the incursions tend to show the independent evolution compared to the ancestral viral populations. Thus, we highlight the need for thorough surveillance of cattle/ruminants and associated product-movement into Sri Lanka from other regions to prevent the transboundary movement of FMDV.	[Ranaweera, L. T.; Wijesundara, W. W. M. U. K.; Jayarathne, H. S. M.; Sooriyapathirana, S. D. S. S.] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Knowles, N. J.; Wadsworth, J.; Gray, A.] Pirbright Inst, Woking, Surrey, England; [Adikari, A. M. J. B.] Rajarata Univ Sri Lanka, Fac Agr, Dept Anim & Food Sci, Puliyankulama, Anuradhapura, Sri Lanka; [Weebadde, C. K.] Michigan State Univ, Coll Agr & Nat Resources, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Sooriyapathirana, S. D. S. S.] Univ Peradeniya, Postgrad Inst Sci, Peradeniya, Sri Lanka	University of Peradeniya; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Rajarata University of Sri Lanka; Michigan State University; University of Peradeniya	Sooriyapathirana, SDSS (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Sooriyapathirana, SDSS (corresponding author), Univ Peradeniya, Postgrad Inst Sci, Peradeniya, Sri Lanka.	sunethuop@gmail.com		Sooriyapathirana, Suneth/0000-0002-5592-1742	Department for Environment, Food and Rural Affairs of the UK [SE2943]; European Union (via a contract from EuFMD, Rome); Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/E/I/00007035, BB/E/I/00007036, BBS/E/I/00007037]; National research council, Sri Lanka (NRC) [NRC/TO/1410]; BBSRC [BBS/E/I/00007036, BBS/E/I/00007035, BBS/E/I/00007037] Funding Source: UKRI	Department for Environment, Food and Rural Affairs of the UK(Department for Environment, Food & Rural Affairs (DEFRA)); European Union (via a contract from EuFMD, Rome); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National research council, Sri Lanka (NRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NJK, JW and AG received funding from the Department for Environment, Food and Rural Affairs of the UK (Grant No. SE2943), with funding provided from the European Union (via a contract from EuFMD, Rome), and the funding of Biotechnology and Biological Sciences Research Council of the United Kingdom (projects BB/E/I/00007035, BB/E/I/00007036 and BBS/E/I/00007037). SDSSS received funding from National research council, Sri Lanka (NRC grant No: NRC/TO/1410)	Abdul-Hamid NF, 2011, INFECT GENET EVOL, V11, P320, DOI 10.1016/j.meegid.2010.11.003; Abeyratne SAE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194077; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P667, DOI 10.1109/TAC.1974.1100707; Bachanek-Bankowska K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32693-8; Balinda SN, 2010, INFECT GENET EVOL, V10, P1058, DOI 10.1016/j.meegid.2010.06.017; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BECK E, 1987, J VIROL, V61, P1621, DOI 10.1128/JVI.61.5.1621-1629.1987; Brito BP, 2017, TRANSBOUND EMERG DIS, V64, P316, DOI 10.1111/tbed.12373; Burnham K P, 2003, MODEL SELECT MULTIMO; Casey MB, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P21, DOI 10.1016/B978-0-12-405191-1.00002-8; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Chen JD, 2006, VIRUS GENES, V32, P139, DOI 10.1007/s11262-005-6869-1; Chhetri BK, 2010, TROP ANIM HEALTH PRO, V42, P1441, DOI 10.1007/s11250-010-9573-7; Clement M., 2002, P 16 INT PARALLEL DI, P7; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Donaldson AI, 1997, VET REC, V140, P407; Fernando W. W. H. S., 1980, Ceylon Veterinary Journal, V28, P51; FERNANDO W W H S, 1969, Ceylon Veterinary Journal, V17, P43; Forman S, 2009, REV SCI TECH OIE, V28, P883, DOI 10.20506/rst.28.3.1935; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; French N., 2014, CAMPYLOBACTER ECOLOG, P221; Gleeson LJ, 2002, REV SCI TECH OIE, V21, P465, DOI 10.20506/rst.21.3.1346; Gunarathne A, 2016, ASIAN AUSTRAL J ANIM, V29, P280, DOI 10.5713/ajas.15.0241; Gurumurthy CB, 2002, ARCH VIROL, V147, P85, DOI 10.1007/s705-002-8304-y; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibrahim MN, APPRAISAL SRI LANKA, V2; Jackson T, 1997, J VIROL, V71, P8357, DOI 10.1128/JVI.71.11.8357-8361.1997; James AD, 2002, REV SCI TECH OIE, V21, P637, DOI 10.20506/rst.21.3.1356; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; Kitching R.P., 1987, REV SCI TECH OIE, V6, P263, DOI DOI 10.20506/RST.6.1.291; Knowles NJ, 2016, REV SCI TECH OIE, V35, P741, DOI 10.20506/rst.35.3.2565; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lavine JS, 2008, TRENDS MICROBIOL, V16, P165, DOI 10.1016/j.tim.2008.01.007; Lin YL, 2010, VET MICROBIOL, V145, P34, DOI 10.1016/j.vetmic.2010.03.003; Loth L, 2011, TRANSBOUND EMERG DIS, V58, P240, DOI 10.1111/j.1865-1682.2011.01206.x; MARTINEZ MA, 1992, J VIROL, V66, P3557; Miller M.A., 2010, P GAT COMP ENV WORKS; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qian F, 2002, BIOCHEM BIOPH RES CO, V30, P715; Rambaut A., 2014, FIGTREE V1 4 3 SOFTW; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; SAIZ JC, 1993, J GEN VIROL, V74, P2281, DOI 10.1099/0022-1317-74-10-2281; Sakamoto K, 2002, REV SCI TECH OIE, V21, P459, DOI 10.20506/rst.21.3.1347; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subramaniam S, 2013, TRANSBOUND EMERG DIS, V60, P197, DOI 10.1111/j.1865-1682.2012.01332.x; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; Tekleghiorghis T, 2016, TRANSBOUND EMERG DIS, V63, P136, DOI 10.1111/tbed.12248; Tosh C, 2003, ARCH VIROL, V148, P853, DOI 10.1007/s00705-002-0968-2; Tosh C, 2002, ARCH VIROL, V147, P493, DOI 10.1007/s007050200002; Valarcher JF, 2005, VET REC, V157, P30, DOI 10.1136/vr.157.1.30; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; Vosloo W, 2004, SESS RES GROUP STAND; Wijewardana BD, 1983, REV SCI TECH OIE; Zhang Q, 2015, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2015.7309661	63	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227126	10.1371/journal.pone.0227126	http://dx.doi.org/10.1371/journal.pone.0227126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891636	Green Published, gold			2022-12-26	WOS:000515096600063
J	Zhang, QW; Zhao, YB; Zhang, WW; Sun, LJ; Su, RJ				Zhang, Qiuwen; Zhao, Yongbo; Zhang, Weiwei; Sun, Lijun; Su, Rijian			Efficient intra mode decision for low complexity HEVC screen content compression	PLOS ONE			English	Article							MOTION	High efficiency video coding screen content coding (HEVC-SCC) extension is the latest HEVC development to improve the compression performance of screen content (SC) video. Similar to HEVC, the intra mode selection in HEVC-SCC is performed all the coding unit (CU) partitions to find the least rate distortion (RD) cost. Furthermore, additional intra tools are introduced to improve HEVC-SCC coding efficiency. However, these new tools could cause high computation complexity which restricts HEVC-SCC from ongoing applications. To solve the problem, an efficient intra mode decision for HEVC-SCC that adaptively utilizes the texture complexity of SC treeblock is proposed. The texture complexity of a SC treeblock is first analyzed according to the variation degree of the luminance value. And then, two efficient approaches are proposed based on the constructed model, which are early CU depth level determination and adaptive intra mode selection. Experimental results demonstrate that the proposed method can save 48.5% encoder runtime while keeping nearly the same coding efficiency as the HEVC-SCC encoders.	[Zhang, Qiuwen; Zhao, Yongbo; Zhang, Weiwei; Su, Rijian] Zhengzhou Univ Light Ind, Coll Comp & Commun Engn, Zhengzhou, Henan, Peoples R China; [Sun, Lijun] Henan Univ Technol, Sch Elect Engn, Zhengzhou, Henan, Peoples R China	Zhengzhou University of Light Industry; Henan University of Technology	Zhang, QW; Su, RJ (corresponding author), Zhengzhou Univ Light Ind, Coll Comp & Commun Engn, Zhengzhou, Henan, Peoples R China.	zhangqwen@126.com; rijiansu@126.com			National Natural Science Foundation of China [61771432, 61302118, 61773018, 61702464, 61803346, U1604151]; Scientific Project of Henan [182102210156]; Innovation Talents of Henan [17HASTIT022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Project of Henan; Innovation Talents of Henan	This work was supported in part by the National Natural Science Foundation of China No.61771432, 61302118, 61773018, 61702464, 61803346 and U1604151, Scientific Project of Henan No. 182102210156, Innovation Talents of Henan No. 17HASTIT022.	Bjontegaard G., 2001, P 13 ITU T SG 16 Q6; Correa G, 2015, IEEE T CIRC SYST VID, V25, P660, DOI 10.1109/TCSVT.2014.2363753; Donghyun Lee, 2015, 2015 IEEE MTT-S International Microwave Symposium (IMS2015), P1, DOI 10.1109/MWSYM.2015.7166897; Duan F, 2021, IEEE T COGN DEV SYST, V13, P200, DOI 10.1109/TCDS.2018.2884942; Duanmu F, 2016, IEEE J EM SEL TOP C, V6, P517, DOI 10.1109/JETCAS.2016.2597698; Duanmu F, 2015, IEEE IMAGE PROC, P4972, DOI 10.1109/ICIP.2015.7351753; Joshi R., 2014, JOINT COLLABORATIVE; Kwon DK, 2014, IEEE INT SYMP CIRC S, P9, DOI 10.1109/ISCAS.2014.6865052; Lei JJ, 2017, IEEE T BROADCAST, V63, P48, DOI 10.1109/TBC.2016.2623241; Li B, 2015, IEEE DATA COMPR CONF, P243, DOI 10.1109/DCC.2015.17; Ma Z, 2014, IEEE T IMAGE PROCESS, V23, P4399, DOI 10.1109/TIP.2014.2346995; Pena G, 2020, ADV WOUND CARE, V9, P9, DOI 10.1089/wound.2019.0973; Sanchez V, 2015, 2015 IEEE GLOBAL CONFERENCE ON SIGNAL AND INFORMATION PROCESSING (GLOBALSIP), P1367, DOI 10.1109/GlobalSIP.2015.7418422; Shen LQ, 2014, IEEE T CIRC SYST VID, V24, P1709, DOI 10.1109/TCSVT.2014.2313892; Shen LQ, 2014, IEEE T IMAGE PROCESS, V23, P4232, DOI 10.1109/TIP.2014.2341927; Shen LQ, 2013, IEEE T MULTIMEDIA, V15, P465, DOI 10.1109/TMM.2012.2231060; Sole J., 2014, JOINT COLLABORATIVE; Sullivan GJ, 2013, IEEE J-STSP, V7, P1001, DOI 10.1109/JSTSP.2013.2283657; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Sun YC, 2015, IEEE IMAGE PROC, P2409, DOI 10.1109/ICIP.2015.7351234; Tsang SH, 2019, IEEE T MULTIMEDIA, V21, P269, DOI 10.1109/TMM.2018.2856078; Tsang SH, 2015, INT CONF ACOUST SPEE, P1409, DOI 10.1109/ICASSP.2015.7178202; Xiao W, 2018, IEEE T CIRC SYST VID, V28, P1169, DOI 10.1109/TCSVT.2016.2643701; Xiong J, 2014, IEEE T MULTIMEDIA, V16, P559, DOI 10.1109/TMM.2013.2291958; Xu JZ, 2016, IEEE T CIRC SYST VID, V26, P50, DOI 10.1109/TCSVT.2015.2478706; Xue Y, 2019, INT CONF ACOUST SPEE, P8543, DOI 10.1109/ICASSP.2019.8682707; Yang H, 2018, SIGNAL PROCESS-IMAGE, V62, P74, DOI 10.1016/j.image.2017.12.001; Yu H., 2015, JOINT COLLABORATIVE; Zhang H, 2016, INT CONF ACOUST SPEE, P1377, DOI 10.1109/ICASSP.2016.7471902; Zhang H, 2014, IEEE T CIRC SYST VID, V24, P660, DOI 10.1109/TCSVT.2013.2290578; Zhang L., 2014, JOINT COLLABORATIVE; Zhang MM, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P390, DOI 10.1109/VCIP.2014.7051588; Zhang QW, 2016, MULTIDIM SYST SIGN P, V27, P743, DOI 10.1007/s11045-014-0303-6; Zhang Y, 2015, IEEE T IMAGE PROCESS, V24, P2225, DOI 10.1109/TIP.2015.2417498; Zhu WJ, 2014, IEEE T MULTIMEDIA, V16, P1316, DOI 10.1109/TMM.2014.2315782	35	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226900	10.1371/journal.pone.0226900	http://dx.doi.org/10.1371/journal.pone.0226900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891600	Green Published, gold			2022-12-26	WOS:000515096600043
J	Zwaagstra, JC; Sulea, T; Baardsnes, J; Radinovic, S; Cepero-Donates, Y; Robert, A; O'Connor-McCourt, MD; Tikhomirov, IA; Jaramillo, ML				Zwaagstra, John C.; Sulea, Traian; Baardsnes, Jason; Radinovic, Stevo; Cepero-Donates, Yuneivy; Robert, Alma; O'Connor-McCourt, Maureen D.; Tikhomirov, Ilia A.; Jaramillo, Maria Luz			Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates	PLOS ONE			English	Article							TRASTUZUMAB EMTANSINE T-DM1; FACTOR RECEPTOR 2; BREAST-CANCER; PHASE-I; AFFINITY; TOXICITIES; CHALLENGES; PREDICTION; COMPLEXES; HERCEPTIN	An increasingly appreciated conundrum in the discovery of antibody drug conjugates (ADCs) is that an antibody that was selected primarily for strong binding to its cancer target may not serve as an optimal ADC. In this study, we performed mechanistic cell-based experiments to determine the correlation between antibody affinity, avidity, internalization and ADC efficacy. We used structure-guided design to assemble a panel of antibody mutants with predicted Her2 affinities ranging from higher to lower relative to the parent antibody, Herceptin. These antibodies were ranked for binding via SPR and via flow-cytometry on high-Her2 SKOV3 cells and low-Her2 MCF7 cells, the latter acting as a surrogate for low-Her2 normal cells. A subpanel of variants, representative of different Her2-binding affinities (2 strong, 2 moderate and 3 weak), were further screened via high-content imaging for internalization efficacies in high versus low-Her2 cells. Finally, these antibodies were evaluated in ADC cytotoxicity screening assays (using DM1 and MMAE secondary antibodies) and as antibody-drug conjugates (DM1 and PNU159682). Our results identified specific but weak Her2-binding variants as optimal candidates for developing DM1 and PNU ADCs since they exhibited high potencies (low to sub-nM) in high-Her2 SKOV3 cells and low toxicities in low-Her2 cells. The 2 strong-affinity variants were highly potent in SKOV3 cells but also showed significant toxicities in low-Her2 cells and therefore are predicted to be toxic in normal tissues. Our findings show that pharmacological profiling of an antibody library in multiple binding and functional assays allows for selection of optimal ADCs.	[Zwaagstra, John C.; Sulea, Traian; Baardsnes, Jason; Radinovic, Stevo; Cepero-Donates, Yuneivy; Robert, Alma; Jaramillo, Maria Luz] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada; [O'Connor-McCourt, Maureen D.; Tikhomirov, Ilia A.] Forbius, Montreal, PQ, Canada	National Research Council Canada	Zwaagstra, JC; Jaramillo, ML (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada.	john.zwaagstra@nrc-cnrc.gc.ca; maria.jaramillo@nrc-cnrc.gc.ca						Annunziata CM, 2013, INVEST NEW DRUG, V31, P77, DOI 10.1007/s10637-012-9801-2; Beck A, 2017, NAT REV DRUG DISCOV, V16, P315, DOI 10.1038/nrd.2016.268; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Chalouni C, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-017-0667-1; Charlton SJ, 2009, BRIT J PHARMACOL, V158, P165, DOI 10.1111/j.1476-5381.2009.00352.x; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; de Goeij BECG, 2015, MOL CANCER THER, V14, P1130, DOI 10.1158/1535-7163.MCT-14-0798; Donaghy H, 2016, MABS-AUSTIN, V8, P659, DOI 10.1080/19420862.2016.1156829; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Endo Yukinori, 2018, Oncotarget, V9, P37200, DOI 10.18632/oncotarget.26461; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harms BD, 2012, METHOD ENZYMOL, V502, P67, DOI 10.1016/B978-0-12-416039-2.00004-5; JUWEID M, 1992, CANCER RES, V52, P5144; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Litvak-Greenfeld D, 2012, ADV DRUG DELIVER REV, V64, P1782, DOI 10.1016/j.addr.2012.05.013; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; OConchuir S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0130433, DOI 10.1371/JOURNAL.PONE.0130433]; Peddi PF, 2014, THER ADV MED ONCOL, V6, P202, DOI 10.1177/1758834014539183; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Rudnick SI, 2009, CANCER BIOTHER RADIO, V24, P155, DOI 10.1089/cbr.2009.0627; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Slaga D, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat5775; Stagg NJ, 2016, REGUL TOXICOL PHARM, V82, P1, DOI 10.1016/j.yrtph.2016.10.012; Stefan N, 2017, MOL CANCER THER, V16, P879, DOI 10.1158/1535-7163.MCT-16-0688; Sulea T, 2016, J CHEM INF MODEL, V56, P1292, DOI 10.1021/acs.jcim.6b00043; Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Tolcher AW, 2016, ANN ONCOL, V27, P2168, DOI 10.1093/annonc/mdw424; Tsumura R, 2018, J CONTROL RELEASE, V284, P49, DOI 10.1016/j.jconrel.2018.06.016; Vivcharuk V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181490; Wolska-Washer A, 2019, DRUG SAF; Yan HH, 2016, MOL CANCER THER, V15, P480, DOI 10.1158/1535-7163.MCT-15-0580; Yan HJ, 2017, ONCOTARGET, V8, P102458, DOI 10.18632/oncotarget.22270; Zhao H, 2017, MOL CANCER THER, V16, P1877, DOI 10.1158/1535-7163.MCT-16-0710; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226593	10.1371/journal.pone.0226593	http://dx.doi.org/10.1371/journal.pone.0226593			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891584	gold, Green Published			2022-12-26	WOS:000515096600020
J	Jehle, J; Goerich, H; Bindila, L; Lutz, B; Nickenig, G; Tiyerili, V				Jehle, Julian; Goerich, Hanna; Bindila, Laura; Lutz, Beat; Nickenig, Georg; Tiyerili, Vedat			Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome	PLOS ONE			English	Article							INFLAMMATION; ACTIVATION; RECEPTOR; DISEASE; BINDS	Objectives The endocannabinoid system modulates coronary circulatory function and atherogenesis. The two major endocannabinoids (eCB), 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamide (AEA), are increased in venous blood from patients with coronary artery disease (CAD). However, given their short half-life and their autocrine/paracrine mechanism of action, eCB levels in venous blood samples might not reflect arterial or coronary eCB concentrations. The aim of this cross-sectional study was to identify the local concentration profile of eCB and to detect whether and how this concentration profile changes in CAD and NSTEMI versus patients without CAD. Methods and results 83 patients undergoing coronary angiography were included in this study. Patients were divided into three groups based on their definite diagnosis of a) no CAD, b) stable CAD, or c) non-ST-segment elevation myocardial infarction (NSTEMI). Blood was drawn from the arterial sheath and the aorta in all patients and additionally distal to the culprit coronary lesion in CAD- and NSTEMI patients. 2-AG levels varied significantly between patient groups and between the sites of blood extraction. The lowest levels were detected in patients without CAD; the highest 2-AG concentrations were detected in NSTEMI patients and in the coronary arteries. Peripheral 2-AG levels were significantly higher in NSTEMI patients (107.4 +/- 28.4 pmol/ml) than in CAD- (17.4 +/- 5.4 pmol/ml; p < 0.001), or no-CAD patients (23.9 +/- 7.1 pmol/ml; p < 0.001). Moreover, coronary 2-AG levels were significantly higher in NSTEMI patients than in CAD patients (369.3 +/- 57.2 pmol/ml vs. 240.1 +/- 25.3 pmol/ml; p = 0.024). Conclusions 2-AG showed significant variability in arterial blood samples drawn from distinct locations. Possibly, lesional macrophages synthesise 2-AG locally, which thereby contributes to endothelial dysfunction and local inflammation.	[Jehle, Julian; Goerich, Hanna; Nickenig, Georg; Tiyerili, Vedat] Univ Hosp Bonn, Dept Internal Med Cardiol 2, Pneumol, Angiol, Bonn, Germany; [Bindila, Laura; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany	University of Bonn; Johannes Gutenberg University of Mainz	Jehle, J (corresponding author), Univ Hosp Bonn, Dept Internal Med Cardiol 2, Pneumol, Angiol, Bonn, Germany.	julian.jehle@ukbonn.de	Tiyerili, Vedat/CAF-1914-2022; Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022		Bonfor program of the University of Bonn [O-109.0057]	Bonfor program of the University of Bonn	This work was supported by the Bonfor program of the University of Bonn, grant number O-109.0057 (https://www.medfak.uni-bonn.de/de/forschung/foerderung/interne-foerderung/bonfor) to JJ. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; Brantl SA, 2014, PLATELETS, V25, P151, DOI 10.3109/09537104.2013.803530; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Fanola CL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005637; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Huang SB, 2018, BRIT J PHARMACOL, V175, P1377, DOI 10.1111/bph.14155; Jehle J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197751; Jehle J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146267; Lenglet S, 2013, ARTERIOSCL THROM VAS, V33, P215, DOI 10.1161/ATVBAHA.112.300275; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Lomazzo E, 2015, NEUROPSYCHOPHARMACOL, V40, P488, DOI 10.1038/npp.2014.198; Maeda N, 2009, FUND CLIN PHARMACOL, V23, P351, DOI 10.1111/j.1472-8206.2009.00679.x; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Quercioli A, 2012, JACC-CARDIOVASC IMAG, V5, P805, DOI 10.1016/j.jcmg.2012.01.020; Quercioli A, 2011, EUR HEART J, V32, P1369, DOI 10.1093/eurheartj/ehr029; Randall MD, 2007, BRIT J PHARMACOL, V152, P671, DOI 10.1038/sj.bjp.0707420; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2018, N ENGL J MED; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sido JM, 2016, EUR J IMMUNOL, V46, P1472, DOI 10.1002/eji.201546181; Stanley CP, 2016, PHARMACOL RES, V113, P356, DOI 10.1016/j.phrs.2016.08.028; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Tamaki C, 2012, J PHARMACOL SCI, V118, P496, DOI 10.1254/jphs.11236FP; Wenzel D, 2013, P NATL ACAD SCI USA, V110, P18710, DOI 10.1073/pnas.1308130110	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227142	10.1371/journal.pone.0227142	http://dx.doi.org/10.1371/journal.pone.0227142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887202	gold, Green Published			2022-12-26	WOS:000515092200082
J	Read, J; Cable, S; Lofqvist, C; Iwarsson, S; Bartl, G; Schrag, A				Read, Joy; Cable, Sarah; Lofqvist, Charlotte; Iwarsson, Susanne; Bartl, Gergely; Schrag, Anette			Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: A qualitative study	PLOS ONE			English	Article							PALLIATIVE CARE; OF-LIFE; DISEASE PATIENT; DEMENTIA; RECOMMENDATIONS; PERSPECTIVES; MANAGEMENT; CAREGIVERS	Aim To explore experiences of health services and unmet care needs by people with late-stage Parkinsons in England. Method Ten participants, at Hoehn and Yahr stage 4 or 5, were interviewed using semi-structured open-ended questions. Data were analysed using qualitative thematic analysis. Findings Participants reported that whilst under the treatment of specialist hospitals, the majority of care provision had shifted into the community, often because hospital-based services were felt to be difficult to access and have limited benefit to them. When using health-care services, participants frequently experienced having to 'fit-in' to service structures that did not always accommodate their complex needs. Despite high levels of disability, participants expressed their desire to maintain their identity, normality of interests and activities in their lives, including remaining in their own homes. This was facilitated by bespoke care and equipment, and positive relationships with care providers. Knowledge on disease management was a key factor in their perceived ability to remain in control. Family caregivers had a central role in facilitating care at home. There was uncertainty about and little planning for the future, and moving to a residential nursing home was perceived an undesirable but potentially necessary option for future care. Conclusion Unmet care needs identified by people with late stage Parkinson's in England include greater flexibility of healthcare structures and bespoke service provision, to accommodate their individual complex needs. Support in their own homes and positive relationships with healthcare providers help People with Parkinson's (PwP) to maintain a degree of normality and identity, and provision of information help them maintain some control. There is a need for more informed discussions on future care planning for this specific population.	[Read, Joy; Cable, Sarah; Bartl, Gergely; Schrag, Anette] UCL, Dept Clin & Movement Neu Rosci, UCL Queen Sq Inst Neurol, London, England; [Lofqvist, Charlotte; Iwarsson, Susanne] Lund Univ, Dept Hlth Sci, Lund, Sweden	University of London; University College London; Lund University	Schrag, A (corresponding author), UCL, Dept Clin & Movement Neu Rosci, UCL Queen Sq Inst Neurol, London, England.	a.schrag@ucl.ac.uk	Schrag, Anette/AAA-9344-2020	Schrag, Anette/0000-0002-9872-6680; Read, Joy/0000-0002-3028-3975; Bartl, Gergely/0000-0002-5947-1304	European Commission [ES/L009250/1, HC-559-002]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; ESRC [ES/L009250/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The CLaSP study was funded by the European Commission (Joint Programme Neurodegenerative Disease Research "European research projects for the evaluation of health care policies, strategies and interventions for Neurodegenerative Diseases") through national funding bodies in participating countries (England: Economic and Social Research Council ES/L009250/1; Lund, Sweden: HC-559-002,). AS was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, QUALITATIVE INTERVIE; Archibald Neil, 2013, Handb Clin Neurol, V110, P435, DOI 10.1016/B978-0-444-52901-5.00037-X; Arntzen C, 2015, DISABIL REHABIL, V37, P1626, DOI 10.3109/09638288.2014.972590; Bakker M, 2015, AMYOTROPH LAT SCL FR, V16, P180, DOI 10.3109/21678421.2014.971811; Balzer-Geldsetzer M, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1184-3; BARTON G, 2012, MOVEMENT DISORD, V27, DOI DOI 10.1142/S0217751X12600020; Boersma I, 2014, NEUROLOGY, V83, P561, DOI 10.1212/WNL.0000000000000674; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chaudhuri KR, 2016, PARKINSONISM RELAT D, V33, pS2, DOI 10.1016/j.parkreldis.2016.11.018; Chen YY, 2020, J TELEMED TELECARE, V26, P3, DOI 10.1177/1357633X18792805; Davies N, 2017, PALLIATIVE MED, V31, P726, DOI 10.1177/0269216316673552; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dorsey ER, 2010, MOVEMENT DISORD, V25, P2128, DOI 10.1002/mds.23160; Droes RM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0472-x; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Ferreira JJ, 2013, EUR J NEUROL, V20, P5, DOI 10.1111/j.1468-1331.2012.03866.x; Findley Leslie J, 2011, J Med Econ, V14, P130, DOI 10.3111/13696998.2010.551164; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox S, 2017, PALLIATIVE MED, V31, P634, DOI 10.1177/0269216316669922; Gallagher DA, 2010, MOVEMENT DISORD, V25, P2493, DOI 10.1002/mds.23394; Giles S, 2009, PALLIATIVE MED, V23, P120, DOI 10.1177/0269216308100773; Haahr A, 2011, J ADV NURS, V67, P408, DOI 10.1111/j.1365-2648.2010.05459.x; Hasson F, 2010, PALLIATIVE MED, V24, P731, DOI 10.1177/0269216310371414; Hechtner MC, 2014, PARKINSONISM RELAT D, V20, P969, DOI 10.1016/j.parkreldis.2014.06.001; Higginson IJ, 2010, CANCER J, V16, P423, DOI 10.1097/PPO.0b013e3181f684e5; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lum HD, 2019, NEUROLOGY, V92, pE2571, DOI 10.1212/WNL.0000000000007552; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Mateus C., 2013, EUR NEUROL REV, V8, P6, DOI [DOI 10.17925/ENR.2013.08.016, 10.17925/ENR.2013.08.01.6, DOI 10.17925/ENR.2013.08.01.6]; Merritt RK, 2018, EUROPEAN J PERSON CT, V6, P447; National Institute for Health and Care Excellence (NICE), 2017, PARK DIS AD; Provinciali L, 2016, NEUROL SCI, V37, P1581, DOI 10.1007/s10072-016-2614-x; Schrag A, 2018, EUR J NEUROL, V25, P1410, DOI 10.1111/ene.13738; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schwab R.S., 1969, 3 S PARK DIS, P152; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Soundy Andrew, 2014, ScientificWorldJournal, V2014, P613592, DOI 10.1155/2014/613592; van der Eijk M, 2011, PARKINSONISM RELAT D, V17, P360, DOI 10.1016/j.parkreldis.2011.02.012; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; van Vliet LM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0583-6; World Health Organization (WHO), 2006, NEUR DIS PUBL HLTH C, P142	43	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226916	10.1371/journal.pone.0226916	http://dx.doi.org/10.1371/journal.pone.0226916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887175	Green Published, gold			2022-12-26	WOS:000515092200050
J	Xiao, K; Liu, CC; Qin, Q; Zhang, Y; Wang, XY; Zhang, J; Odle, J; Lin, X; Hu, CAA; Liu, YL				Xiao, Kan; Liu, Congcong; Qin, Qin; Zhang, Yang; Wang, Xiuying; Zhang, Jing; Odle, Jack; Lin, Xi; Hu, Chien-An Andy; Liu, Yulan			EPA and DHA attenuate deoxynivalenol-induced intestinal porcine epithelial cell injury and protect barrier function integrity by inhibiting necroptosis signaling pathway	FASEB JOURNAL			English	Article						barrier function; cell injury; deoxynivalenol; necroptosis signaling pathway; n-3 PUFA	POLYUNSATURATED FATTY-ACIDS; WEANED PIGS; HEALTH; DEATH; PHOSPHORYLATION; LOCALIZATION; DISRUPTION; MYCOTOXIN; NECROSIS; DISEASE	Deoxynivalenol (DON) is one of the most common mycotoxins that contaminates food or feed and cause intestinal damage. Long-chain n-3 polyunsaturated fatty acids (PUFA) such as EPA and DHA exert beneficial effects on intestinal integrity in animal models and clinical trials. Necroptosis signaling pathway plays a critical role in intestinal cell injury. This study tested the hypothesis that EPA and DHA could alleviate DON-induced injury to intestinal porcine epithelial cells through modulation of the necroptosis signaling pathway. Intestinal porcine epithelial cell 1 (IPEC-1) cells were cultured with or without EPA or DHA (6.25-25 mu g/mL) in the presence or absence of 0.5 mu g/mL DON for indicated time points. Cell viability, cell number, lactate dehydrogenase (LDH) activity, cell necrosis, transepithelial electrical resistance (TEER), fluorescein isothiocyanate-labeled dextran 4kDa (FD4) flux, tight junction protein distribution, and protein abundance of necroptosis related signals were determined. EPA and DHA promoted cell growth indicated by higher cell viability and cell number, and inhibited cell injury indicated by lower LDH activity in the media. EPA and DHA also improved intestinal barrier function, indicated by higher TEER and lower permeability of FD4 flux as well as increased proportions of tight junction proteins located in the plasma membrane. Moreover, EPA and DHA decreased cell necrosis demonstrated by live cell imaging and transmission electron microscopy. Finally, EPA and DHA downregulated protein expressions of necroptosis related signals including tumor necrosis factor receptor (TNFR1), receptor interacting protein kinase 1 (RIP1), RIP3, phosphorylated mixed lineage kinase-like protein (MLKL), phosphoglycerate mutase family 5 (PGAM5), dynamin-related protein 1 (Drp1), and high mobility group box-1 protein (HMGB1). EPA and DHA also inhibited protein expression of caspase-3 and caspase-8. These results suggest that EPA and DHA prevent DON-induced intestinal cell injury and enhance barrier function, which is associated with inhibition of the necroptosis signaling pathway.	[Xiao, Kan; Liu, Congcong; Qin, Qin; Zhang, Yang; Wang, Xiuying; Zhang, Jing; Hu, Chien-An Andy; Liu, Yulan] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Xuefunan Rd, Wuhan 430023, Hubei, Peoples R China; [Odle, Jack; Lin, Xi] North Carolina State Univ, Lab Dev Nutr, Dept Anim Sci, Raleigh, NC USA; [Hu, Chien-An Andy] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	Wuhan Polytechnic University; University of North Carolina; North Carolina State University; University of New Mexico	Liu, YL (corresponding author), Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Xuefunan Rd, Wuhan 430023, Hubei, Peoples R China.	yulanflower@126.com	lin, xi/GZL-4959-2022; Odle, Jack/K-9660-2017	Odle, Jack/0000-0003-4965-2096; Xi, Lin/0000-0003-3911-9677; Wang, Xiuying/0000-0001-6693-3813	National Natural Science Foundation of China (NSFC) [31772615]; Wuhan Science and Technology Burea [2018020401011304]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Burea	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31772615; the projects of Wuhan Science and Technology Burea, Grant/Award Number: 2018020401011304	Adameova A, 2016, HEART FAIL REV, V21, P213, DOI 10.1007/s10741-016-9537-8; Ajami M, 2013, FUND CLIN PHARMACOL, V27, P593, DOI 10.1111/j.1472-8206.2012.01066.x; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bodea GOD, 2009, ROM BIOTECH LETT, V14, P4349; Brahmbhatt V, 2013, J NUTR BIOCHEM, V24, P104, DOI 10.1016/j.jnutbio.2012.02.014; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427; Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Flock MR, 2013, NUTR REV, V71, P692, DOI 10.1111/nure.12071; Ghareeb K, 2015, J APPL TOXICOL, V35, P327, DOI 10.1002/jat.3083; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jacobi SK, 2012, ADV NUTR, V3, P687, DOI 10.3945/an.112.002683; Kearney CJ, 2017, MOL CELL, V65, P965, DOI 10.1016/j.molcel.2017.02.024; Kishida E, 2006, BBA-MOL CELL BIOL L, V1761, P454, DOI 10.1016/j.bbalip.2006.03.023; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Li QR, 2008, MOL IMMUNOL, V45, P1356, DOI 10.1016/j.molimm.2007.09.003; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Li XL, 2012, BBA-MOL BASIS DIS, V1822, P196, DOI 10.1016/j.bbadis.2011.09.019; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Magee P, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-24; Mayer E, 2017, MYCOTOXIN RES, V33, P297, DOI 10.1007/s12550-017-0289-7; Nossol C, 2018, TOXINS, V9, P10; Nunes T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/218493; Pacheco FJ, 2014, INFLAMM RES, V63, P859, DOI 10.1007/s00011-014-0760-2; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Pierron A, 2016, ANIM NUTR, V2, P63, DOI 10.1016/j.aninu.2016.03.001; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Ren Z, 2019, INT J MOL SCI, V20, P11; Shahidi F, 2018, ANNU REV FOOD SCI T, V9, P345, DOI 10.1146/annurev-food-111317-095850; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Whiting CV, 2005, INFLAMM BOWEL DIS, V11, P340, DOI 10.1097/01.MIB.0000164016.98913.7c; Willemsen LEM, 2008, EUR J NUTR, V47, P183, DOI 10.1007/s00394-008-0712-0; Xiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073571; Zhu HL, 2016, BRIT J NUTR, V115, P1947, DOI 10.1017/S0007114516001100	46	24	27	6	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2483	2496		10.1096/fj.201902298R	http://dx.doi.org/10.1096/fj.201902298R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909535				2022-12-26	WOS:000503397900001
J	Try, S; Tanaka, S; Tanaka, K; Sayama, T; Oeurng, C; Uk, S; Takara, K; Hu, M; Hans, D				Try, Sophal; Tanaka, Shigenobu; Tanaka, Kenji; Sayama, Takahiro; Oeurng, Chantha; Uk, Sovannara; Takara, Kaoru; Hu, Maochuan; Hans, Dawei			Comparison of gridded precipitation datasets for rainfall-runoff and inundation modeling in the Mekong River Basin	PLOS ONE			English	Article							HIGH-RESOLUTION SATELLITE; TONLE SAP LAKE; FLOOD; MANAGEMENT; PRODUCTS; TRMM; MAP	Precipitation, as a primary hydrological variable in the water cycle plays an important role in hydrological modeling. The reliability of hydrological modeling is highly related to the quality of precipitation data. Accurate long-term gauged precipitation in the Mekong River Basin, however, is limited. Therefore, the main objective of this study is to assess the performances of various gridded precipitation datasets in rainfall-runoff and flood-inundation modeling of the whole basin. Firstly, the performance of the Rainfall-Runoff-Inundation (RRI) model in this basin was evaluated using the gauged rainfall. The calibration (2000-2003) and validation (2004-2007) results indicated that the RRI model had acceptable performance in the Mekong River Basin. In addition, five gridded precipitation datasets including APHRODITE, GPCC, PERSIANN-CDR, GSMaP (RNL), and TRMM (3B42V7) from 2000 to 2007 were applied as the input to the calibrated model. The results of the simulated river discharge indicated that TRMM, GPCC, and APHRODITE performed better than other datasets. The statistical index of the annual maximum inundated area indicated similar conclusions. Thus, APHRODITE, TRMM, and GPCC precipitation datasets were considered suitable for rainfall-runoff and flood inundation modeling in the Mekong River Basin. This study provides useful guidance for the application of gridded precipitation in hydrological modeling in the Mekong River basin.	[Try, Sophal] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Try, Sophal; Oeurng, Chantha] Inst Technol Cambodia, Fac Hydrol & Water Resources Engn, Phnom Penh, Cambodia; [Tanaka, Shigenobu; Tanaka, Kenji; Sayama, Takahiro; Hu, Maochuan] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Uk, Sovannara] Tokyo Inst Technol, Dept Civil & Environm Engn, Tokyo, Japan; [Takara, Kaoru] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Kyoto, Japan; [Hans, Dawei] Univ Bristol, Dept Civil Engn, Bristol BS8 1TR, Avon, England	Kyoto University; Kyoto University; Tokyo Institute of Technology; Kyoto University; University of Bristol	Hu, M (corresponding author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan.	maachuanhu@gmail.com	Takara, Kaoru/AAR-5083-2020	Uk, Sovannara/0000-0003-1485-2952; Try, Sophal/0000-0003-4736-4568				Ashouri H, 2015, B AM METEOROL SOC, V96, P69, DOI 10.1175/BAMS-D-13-00068.1; Bhagabati SS, 2017, HYDROL RES LETT, V11, P155, DOI 10.3178/hrl.11.155; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Guo H, 2015, REMOTE SENS-BASEL, V7, P7181, DOI 10.3390/rs70607181; Habib E, 2010, REMOTE SENSING, V6, P6688; Hu MC, 2019, J CLEAN PROD, V222, P373, DOI 10.1016/j.jclepro.2019.03.044; Hu MC, 2017, HYDROLOG SCI J, V62, P1255, DOI 10.1080/02626667.2017.1319063; Hu M, 2017, J ENVIRON MANAGE, V193, P430, DOI 10.1016/j.jenvman.2017.02.020; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Kubota T, 2007, IEEE T GEOSCI REMOTE, V45, P2259, DOI 10.1109/TGRS.2007.895337; Kummu M, 2009, J ENVIRON MANAGE, V90, P1413, DOI 10.1016/j.jenvman.2008.08.007; Kuribayashi D, 2016, J DISASTER RES, V11, P1161, DOI 10.20965/jdr.2016.p1161; Lu XX, 2014, EARTH SURF PROC LAND, V39, P1855, DOI 10.1002/esp.3573; Luo X, 2019, CHINESE GEOGR SCI, V29, P13, DOI 10.1007/s11769-019-1014-6; MRC, 2011, PLANN ATL LOW MEK RI; MRC (Mekong River Commission), 2015, ANN MEK FLOOD REP 20, P1728; Oeurng C, 2019, WATER-SUI, V11, DOI 10.3390/w11030618; Okada T, 2011, NAT HAZARD EARTH SYS, V11, P3373, DOI 10.5194/nhess-11-3373-2011; Ono K, 2013, HYDROL RES LETT, V7, P66, DOI 10.3178/hrl.7.66; Perera EDP, 2017, HYDROLOGY-BASEL, V4, DOI 10.3390/hydrology4040055; Phoeurn C, 2018, ENG J-THAIL, V22, P229, DOI 10.4186/ej.2018.22.1.229; Sayama T, 2017, J FLOOD RISK MANAG, V10, P65, DOI 10.1111/jfr3.12147; Sayama T, 2015, NAT HAZARD EARTH SYS, V15, P1617, DOI 10.5194/nhess-15-1617-2015; Sayama T, 2012, HYDROLOG SCI J, V57, P298, DOI 10.1080/02626667.2011.644245; Shrestha BB, 2016, J FLOOD RISK MANAG, V9, P355, DOI 10.1111/jfr3.12174; Sokly S, 2018, SCI TOTAL ENVIRON, V631-632, P597, DOI 10.1016/j.scitotenv.2018.03.066; Tan ML, 2015, REMOTE SENS-BASEL, V7, P1504, DOI 10.3390/rs70201504; Tanaka T, 2018, WATER-SUI, V10, DOI 10.3390/w10091213; Try S., 2018, Journal of Korea Water Resources Association, V51, P565, DOI 10.3741/JKWRA.2018.51.7.565; Try S, 2019, QUATERN INT, V503, P79, DOI 10.1016/j.quaint.2018.06.026; Try S, 2018, J HYDROL ENG, V23, DOI 10.1061/(ASCE)HE.1943-5584.0001664; Uk Sovannara, 2018, Lakes & Reservoirs Research and Management, V23, P177, DOI 10.1111/lre.12222; Vu MT, 2012, HYDROL EARTH SYST SC, V16, P2801, DOI 10.5194/hess-16-2801-2012; Thom VT, 2017, J HYDROL HYDROMECH, V65, P18, DOI 10.1515/johh-2016-0047; Yamazaki D, 2017, GEOPHYS RES LETT, V44, P5844, DOI 10.1002/2017GL072874; Yasutomi N., 2011, GLOBAL ENV RES, V15, P165; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Ziese M., 2018, GPCC FULL DATA DAILY, DOI [10.5676/DWD_GPCC/FD_D_V2018_100, DOI 10.5676/DWD_GPCC/FD_D_V2018_100]	40	32	32	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226814	10.1371/journal.pone.0226814	http://dx.doi.org/10.1371/journal.pone.0226814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914161	gold, Green Published			2022-12-26	WOS:000534337700019
J	Makurumidze, R; Mutasa-Apollo, T; Decroo, T; Choto, RC; Takarinda, KC; Dzangare, J; Lynen, L; Van Damme, W; Hakim, J; Magure, T; Mugurungi, O; Rusakaniko, S				Makurumidze, Richard; Mutasa-Apollo, Tsitsi; Decroo, Tom; Choto, Regis C.; Takarinda, Kudakwashe C.; Dzangare, Janet; Lynen, Lutgarde; Van Damme, Wim; Hakim, James; Magure, Tapuwa; Mugurungi, Owen; Rusakaniko, Simbarashe			Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015	PLOS ONE			English	Article							ADVANCED HIV-INFECTION; FOLLOW-UP; SOUTH-AFRICA; OPEN-LABEL; ADULTS; ADOLESCENTS; MORTALITY; OUTCOMES; ADHERENCE; CHILDREN	Background The last evaluation to assess outcomes for patients receiving antiretroviral therapy (ART) through the Zimbabwe public sector was conducted in 2011, covering the 2007-2010 cohorts. The reported retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. We report findings of a follow-up evaluation for the 2012-2015 cohorts to assess the implementation and impact of recommendations from this prior evaluation. Methods A nationwide retrospective study was conducted in 2016. Multi-stage proportional sampling was used to select health facilities and study participants records. The data extracted from patient manual records included demographic, baseline clinical characteristics and patient outcomes (active on treatment, died, transferred out, stopped ART and lost to follow-up (LTFU)) at 6, 12, 24 and 36 months. The data were analysed using Stata/IC 14.2. Retention was estimated using survival analysis. The predictors associated with attrition were determined using a multivariate Cox regression model. Results A total of 3,810 participants were recruited in the study. The median age in years was 35 (IQR: 28-42). Overall, retention increased to 92.4% (p-value = 0.060), 86.5% (p-value< 0.001), 79.2% (p-value< 0.001) and 74.4% (p-value< 0.001) at 6, 12, 24 and 36 months respectively. LTFU accounted for 98% of attrition. Being an adolescent or a young adult (15-24 years) (vs adult;1.41; 95% CI:1.14-1.74), children (< 15years) (vs adults; aHR 0.64; 95% CI:0.46-0.91), receiving care at primary health care facility (vs central and provincial facility; aHR 1.23; 95% CI:1.01-1.49), having initiated ART between 2014-2015 (vs 2012-2013; aHR1.45; 95%CI:1.24-1.69), having WHO Stage IV (vs Stage I-III; aHR2.06; 95%CI:1.51-2.81) and impaired functional status (vs normal status; aHR1.25; 95%CI:1.041.49) predicted attrition. Conclusion The overall retention was higher in comparison to the previous 2007-2010 evaluation. Further studies to understand why attrition was found to be higher at primary health care facilities are warranted. Implementation of strategies for managing patients with advanced HIV disease, differentiated care for adolescents and young adults and tracking of LTFU clients should be prioritised to further improve retention.	[Makurumidze, Richard; Hakim, James; Rusakaniko, Simbarashe] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Makurumidze, Richard; Decroo, Tom; Lynen, Lutgarde; Van Damme, Wim] Inst Trop Med, Antwerp, Belgium; [Makurumidze, Richard; Van Damme, Wim] Free Univ Brussels VUB, Fac Med & Pharm, Gerontol, Brussels, Belgium; [Mutasa-Apollo, Tsitsi; Choto, Regis C.; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen] Minist Hlth & Child Care, AIDS & TB Unit, Harare, Zimbabwe; [Decroo, Tom] Res Fdn Flanders, Brussels, Belgium; [Takarinda, Kudakwashe C.] Int Union TB & Lung Dis, Paris, France; [Magure, Tapuwa] Natl AIDS Council, Harare, Zimbabwe	University of Zimbabwe; Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel	Makurumidze, R (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe.; Makurumidze, R (corresponding author), Inst Trop Med, Antwerp, Belgium.; Makurumidze, R (corresponding author), Free Univ Brussels VUB, Fac Med & Pharm, Gerontol, Brussels, Belgium.	rmakurumidze@ext.itg.be	Decroo, Tom/AAV-7208-2020; Lynen, Lutgarde/A-1212-2014; Van Damme, Wim/F-7404-2011; Lynen, Lutgarde/AAT-9180-2020	Decroo, Tom/0000-0002-1205-1484; Lynen, Lutgarde/0000-0001-7183-4895; Van Damme, Wim/0000-0002-6344-3007; Lynen, Lutgarde/0000-0001-7183-4895; Makurumidze, Richard/0000-0001-6490-1818	Global Fund for AIDS, Tuberculosis, and Malaria (GFATM); Institute of Tropical Medicine - Belgian Development Cooperation	Global Fund for AIDS, Tuberculosis, and Malaria (GFATM); Institute of Tropical Medicine - Belgian Development Cooperation	The study was supported with funding from the Global Fund for AIDS, Tuberculosis, and Malaria (GFATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Richard Makurumidze receives a PhD scholarship grant from the Institute of Tropical Medicine, funded by the Belgian Development Cooperation.	Abuogi LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156506; Alhaj M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25239; Altice F, 2019, PATIENT PREFER ADHER, V13, P475, DOI 10.2147/PPA.S192735; Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Auld AF, 2015, PEDIATR INFECT DIS J, V34, pE191, DOI 10.1097/INF.0000000000000741; Auld AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098183; Benzekri NA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3826-5; Bigna JJR, 2016, INFECT DIS POVERTY, P1; Brown LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210126; Bulsara SM, 2018, AIDS BEHAV, V22, P752, DOI 10.1007/s10461-016-1644-y; Busza J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18839; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coker M, 2015, CURR HIV RES, V13, P279, DOI 10.2174/1570162X13666150407143838; Cornell M, 2014, JAIDS-J ACQ IMM DEF, V67, pE67, DOI 10.1097/QAI.0000000000000269; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Ferrand RA, 2017, LANCET CHILD ADOLESC, V1, P175, DOI 10.1016/S2352-4642(17)30051-2; Ferrand RA, 2016, PUBLIC HEALTH ACTION, V6, P53, DOI 10.5588/pha.16.0035; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2015, AIDS, V29, P493, DOI 10.1097/QAD.0000000000000559; Gonese G, 2017, INT AIDS C 23 26 JUL; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; ICAP at Columbia University, 2016, ZIMB POP BAS HIV IMP; Janssen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140746; Jones MP, 1996, J AM STAT ASSOC, V91, P222, DOI 10.2307/2291399; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Matyanga CMJ, 2016, PUBLIC HEALTH ACTION, V6, P97, DOI 10.5588/pha.15.0077; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Ministry of Health and Child Care (MoHCC), 2016, TECHNICAL REPORT; Ministry of Health and Child Care (MoHCC), 2010, NAT CHILD SURV STRAT; Ministry of Health and Child Care (MoHCC), 2015, ZIMB ART ANN REP; Ministry of Health and Child Care(MoHCC), 2012, EV US POINT CAR CD4; Ministry of Health and Child Care (MoHCC), 2018, ZIMB ART ANN REP; Ministry of Health and Child Care Zimbabwe (MoHCC), 2015, OP SERV DEL MAN PREV; Murray KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184879; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; NAC, 2011, ZIMB NAT HIV AIDS ST; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Shamu T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186726; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Stafford KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218555; StataCorp, 2015, STAT STAT SOFTW REL; Takarinda KC, 2018, PUBLIC HEALTH ACTION, V8, P218, DOI 10.5588/pha.18.0051; Tiruneh YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156619; Tlhajoane M, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0358-1; Ugoji C, 2015, CURR HIV RES, V13, P300, DOI 10.2174/1570162X13999150317155348; UNAIDS, 2019, GLOBAL HIV AIDS STAT, DOI DOI 11/44679/INDEX.HTM; UNAIDS, 2019, UNAIDS DATA 2019; United States of America President's Emergency Plan for AIDS Relief (PEPFAR), 2019, LOSS FOLL TOOL TRACK; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; Willis N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6447-4; Woelk G, 2016, ENHANCING RETENTION; Zanoni BC, 2019, AIDS BEHAV, V23, P957, DOI 10.1007/s10461-018-2352-6; Zimbabwe National Statistics Agency (ZIMSTAT), 2012, ZIMB NAT CENS REP; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843	64	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0222309	10.1371/journal.pone.0222309	http://dx.doi.org/10.1371/journal.pone.0222309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910445	Green Published, gold, Green Submitted			2022-12-26	WOS:000534333800003
J	Robinson, JL; McBreairty, LE; Ryan, RA; Randunu, R; Walsh, CJ; Martin, GM; Brunton, JA; Bertolo, RF				Robinson, Jason L.; McBreairty, Laura E.; Ryan, Rebecca A.; Randunu, Raniru; Walsh, Carolyn J.; Martin, Gerard M.; Brunton, Janet A.; Bertolo, Robert F.			Effects of supplemental creatine and guanidinoacetic acid on spatial memory and the brain of weaned Yucatan miniature pigs	PLOS ONE			English	Article							PREFRONTAL CORTEX; PERFORMANCE; METABOLISM; BIOSYNTHESIS; ARGININE; CEREBELLUM; TRANSPORT; RESPONSES; WORKING; MUSCLE	The emergence of creatine as a potential cognitive enhancement supplement for humans prompted an investigation as to whether supplemental creatine could enhance spatial memory in young swine. We assessed memory performance and brain concentrations of creatine and its precursor guanidinoacetic acid (GAA) in 14-16-week-old male Yucatan miniature pigs supplemented for 2 weeks with either 200 mg/kg.d creatine (+Cr; n = 7) or equimolar GAA (157 mg/kg.d) (+GAA; n = 8) compared to controls (n = 14). Spatial memory tests had pigs explore distinct sets of objects for 5 min. Objects were spatially controlled, and we assessed exploration times of previously viewed objects relative to novel objects in familiar or novel locations. There was no effect of either supplementation on memory performance, but pigs successfully identified novel objects after 10 (p < 0.01) and 20 min (p < 0.01) retention intervals. Moreover, pigs recognized spatial transfers after 65 min (p < 0.05). Regression analyses identified associations between the ability to identify novel objects in memory tests and concentrations of creatine and GAA in cerebellum, and GAA in prefrontal cortex (p < 0.05). The concentration of creatine in brain regions was not influenced by creatine supplementation, but GAA supplementation increased GAA concentration in cerebellum (p < 0.05), and the prefrontal cortex of +GAA pigs had more creatine/g and less GAA/g compared to +Cr pigs (p < 0.05). Creatine kinase activity and maximal reaction velocity were also higher with GAA supplementation in prefrontal cortex (p < 0.05). In conclusion, there appears to be a relationship between memory performance and guanidino compounds in the cerebellum and prefrontal cortex, but the effects were unrelated to dietary supplementation. The cerebellum is identified as a target site for GAA accretion.	[Robinson, Jason L.; McBreairty, Laura E.; Ryan, Rebecca A.; Randunu, Raniru; Brunton, Janet A.; Bertolo, Robert F.] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada; [Walsh, Carolyn J.; Martin, Gerard M.] Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Bertolo, RF (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	rbertolo@mun.ca		Bertolo, Robert/0000-0001-5069-5785	Janeway Children's Hospital Foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-04109]; Research and Development Corporation of Newfoundland and Labrador; Canadian Institutes of Health Research	Janeway Children's Hospital Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research and Development Corporation of Newfoundland and Labrador; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Janeway Children's Hospital Foundation (awarded to RFB, LEM, JLR) (https://janewayfoundation.nf.ca/about-us/about-the-foundation/) and Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-04109) (RFB) (http://www.nserc-crsng.gc.ca/index_eng. asp). Fellowship funding was also provided by the Research and Development Corporation of Newfoundland and Labrador and the Canadian Institutes of Health Research (JLR) (http://www.cihr-irsc.gc.ca/e/193.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley Dean Philip John, 2017, Concussion, V2, pCNC34, DOI 10.2217/cnc-2016-0016; Almeida AS, 2017, NEUROCHEM RES, V42, P1787, DOI 10.1007/s11064-016-2150-3; Almeida LS, 2004, MOL GENET METAB, V82, P214, DOI 10.1016/j.ymgme.2004.05.001; Andreasen NC, 1999, HUM BRAIN MAPP, V8, P226, DOI 10.1002/(SICI)1097-0193(1999)8:4<226::AID-HBM6>3.3.CO;2-W; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Bender A, 2016, AMINO ACIDS, V48, P1929, DOI 10.1007/s00726-015-2165-0; Benton D, 2011, BRIT J NUTR, V105, P1100, DOI 10.1017/S0007114510004733; Bera S, 2008, FEBS J, V275, P5899, DOI 10.1111/j.1742-4658.2008.06718.x; Braissant O, 2010, NEUROBIOL DIS, V37, P423, DOI 10.1016/j.nbd.2009.10.022; Brosnan JT, 2009, J NUTR, V139, P1292, DOI 10.3945/jn.109.105411; Buchberger W, 2004, J SEP SCI, V27, P1309, DOI 10.1002/jssc.200401866; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Curt MJC, 2015, BIOCHIMIE, V119, P146, DOI 10.1016/j.biochi.2015.10.022; da Silva RP, 2009, AM J PHYSIOL-ENDOC M, V296, pE256, DOI 10.1152/ajpendo.90547.2008; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Dilger RN, 2013, POULTRY SCI, V92, P171, DOI 10.3382/ps.2012-02425; dos Santos FS, 2014, PHARM BIOL, V52, P1033, DOI 10.3109/13880209.2013.876654; Ettrup A, 2011, SYNAPSE, V65, P136, DOI 10.1002/syn.20827; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Gibbs Marie E, 2011, Neuron Glia Biol, V7, P177, DOI 10.1017/S1740925X12000117; Goldstein G, 2014, NEUROPSYCHOLOGY, V28, P496, DOI 10.1037/neu0000053; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Gustafsson M, 1999, APPL ANIM BEHAV SCI, V62, P305, DOI 10.1016/S0168-1591(98)00236-6; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Josselyn SA, 2012, LEARN MEMORY, V19, P423, DOI 10.1101/lm.021311.110; Knowlton BJ, 2016, BEHAV NEUROSCI, V130, P545, DOI 10.1037/bne0000174; Koga Y, 2005, NEUROSCIENCE, V132, P65, DOI 10.1016/j.neuroscience.2005.01.004; Kornum BR, 2007, BEHAV BRAIN RES, V181, P210, DOI 10.1016/j.bbr.2007.04.007; Kouwenberg AL, 2009, APPL ANIM BEHAV SCI, V117, P165, DOI 10.1016/j.applanim.2009.01.005; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Mak CSW, 2009, NEUROSCIENCE, V163, P571, DOI 10.1016/j.neuroscience.2009.06.065; McBreairty LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131563; McMorris T, 2006, PSYCHOPHARMACOLOGY, V185, P93, DOI 10.1007/s00213-005-0269-z; McMorris T, 2007, AGING NEUROPSYCHOL C, V14, P517, DOI 10.1080/13825580600788100; Michael Swindle M., 2008, SOURCEBOOK MODELS BI, P233, DOI DOI 10.1007/978-1-59745-285-4_26; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Neu A, 2002, NEUROBIOL DIS, V11, P298, DOI 10.1006/nbdi.2002.0547; Ostojic SM, 2017, NUTRITION, V33, P149, DOI 10.1016/j.nut.2016.06.001; Persky AM, 2003, CLIN PHARMACOKINET, V42, P557, DOI 10.2165/00003088-200342060-00005; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Rawson ES, 2008, PHYSIOL BEHAV, V95, P130, DOI 10.1016/j.physbeh.2008.05.009; Roelofs S, 2017, ANIM COGN, V20, P739, DOI 10.1007/s10071-017-1095-5; Snow WM, 2018, LEARN MEMORY, V25, P54, DOI 10.1101/lm.046284.117; Tachikawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032557; Tachikawa M, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-13; Uematsu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046970; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Zugno AI, 2008, METAB BRAIN DIS, V23, P189, DOI 10.1007/s11011-008-9085-6	53	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226806	10.1371/journal.pone.0226806	http://dx.doi.org/10.1371/journal.pone.0226806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4ZR	31905208	gold, Green Published, Green Accepted			2022-12-26	WOS:000534327700009
J	Locatelli, L; Cazzaniga, A; De Palma, C; Castiglioni, S; Maier, JAM				Locatelli, Laura; Cazzaniga, Alessandra; De Palma, Clara; Castiglioni, Sara; Maier, Jeanette A. M.			Mitophagy contributes to endothelial adaptation to simulated microgravity	FASEB JOURNAL			English	Article						cytoskeleton; HUVEC; mitochondria; RWV	CELL METABOLISM; AUTOPHAGY; STRESS; MITOCHONDRIA; CYTOSKELETON; PHOSPHORYLATION; GRAVITY; GROWTH	Exposure to real or simulated microgravity is sensed as a stress by mammalian cells, which activate a complex adaptive response. In human primary endothelial cells, we have recently shown the sequential intervention of various stress proteins which are crucial to prevent apoptosis and maintain cell function. We here demonstrate that mitophagy contributes to endothelial adaptation to gravitational unloading. After 4 and 10 d of exposure to simulated microgravity in the rotating wall vessel, the amount of BCL2 interacting protein 3, a marker of mitophagy, is increased and, in parallel, mitochondrial content, oxygen consumption, and maximal respiratory capacity are reduced, suggesting the acquisition of a thrifty phenotype to meet the novel metabolic challenges generated by gravitational unloading. Moreover, we suggest that microgravity induced-disorganization of the actin cytoskeleton triggers mitophagy, thus creating a connection between cytoskeletal dynamics and mitochondrial content upon gravitational unloading.	[Locatelli, Laura; Cazzaniga, Alessandra; Castiglioni, Sara; Maier, Jeanette A. M.] Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy; [De Palma, Clara] ASST Fatebenefratelli Sacco, Luigi Sacco Univ Hosp, Unit Clin Pharmacol, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Maier, JAM (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	jeanette.maier@unimi.it	LOCATELLI, LAURA/AAP-4110-2021; De Palma, Clara/M-9842-2019; castiglioni, sara/H-9289-2012	LOCATELLI, LAURA/0000-0002-4568-7825; De Palma, Clara/0000-0003-0365-7414; Cazzaniga, Alessandra/0000-0001-7153-2256; castiglioni, sara/0000-0002-8785-9891	Agenzia Spaziale Italiana (ASI)	Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	Agenzia Spaziale Italiana (ASI), Grant/Award Number: ENDOSTEO Project	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Caja S, 2017, REDOX BIOL, V12, P821, DOI 10.1016/j.redox.2017.04.021; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castiglioni S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16538; Cazzaniga A, 2019, FASEB J, V33, P5957, DOI 10.1096/fj.201801586RR; Cotrupi S, 2005, BBA-MOL CELL RES, V1746, P163, DOI 10.1016/j.bbamcr.2005.10.002; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Espinosa-Jeffrey A, 2016, J NEUROSCI RES, V94, P1434, DOI 10.1002/jnr.23958; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Feger BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34091; Garcia-Cardena G, 2006, Handb Exp Pharmacol, P79; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Indo HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep39015; Janmaleki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32418; Jeong AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32965-3; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Kapitonova MY, 2013, B EXP BIOL MED+, V154, P796, DOI 10.1007/s10517-013-2059-7; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512; Li CF, 2019, APOPTOSIS, V24, P812, DOI 10.1007/s10495-019-01560-w; Li CF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0185-2; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; Martinez EM, 2015, AM J PHYSIOL-REG I, V308, pR480, DOI 10.1152/ajpregu.00449.2014; Michaletti A., 2017, SCI REP, V7, P1; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Moore AS, 2018, CURR OPIN PHYSIOL, V3, P94, DOI 10.1016/j.cophys.2018.03.003; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rohlenova K, 2018, TRENDS CELL BIOL, V28, P224, DOI 10.1016/j.tcb.2017.10.010; Strzyz P, 2018, NAT REV MOL CELL BIO, V19, P212, DOI 10.1038/nrm.2018.16; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang YC, 2013, BIOCHEM CELL BIOL, V91, P309, DOI 10.1139/bcb-2013-0029; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243	48	21	21	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1833	1845		10.1096/fj.201901785RRR	http://dx.doi.org/10.1096/fj.201901785RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914607	Green Published			2022-12-26	WOS:000507308900121
J	Chen, LM; Wang, P; Bahal, R; Manautou, JE; Zhong, XB				Chen, Liming; Wang, Pei; Bahal, Raman; Manautou, Jose E.; Zhong, Xiao-bo			Ontogenic mRNA expression of RNA modification writers, erasers, and readers in mouse liver	PLOS ONE			English	Article							RIBOSOMAL-RNA; GENE-EXPRESSION; NUCLEAR-RNA; TISSUE DISTRIBUTION; HEPATIC ONTOGENY; METHYLATION; METHYLTRANSFERASE; PROTEIN; N-6-METHYLADENOSINE; PSEUDOURIDYLATION	RNA modifications are recently emerged epigenetic modifications. These diverse RNA modifications have been shown to regulate multiple biological processes, including development. RNA modifications are dynamically controlled by the "writers, erasers, and readers", where RNA modifying proteins are able to add, remove, and recognize specific chemical modification groups on RNAs. However, little is known about the ontogenic expression of these RNA modifying proteins in various organs, such as liver. In the present study, the hepatic mRNA expression of selected RNA modifying proteins involve in m(6)A, m(1)A, m(5)C, hm(5)C, m(7)G, and psi modifications was analyzed using the RNA-seq technique. Liver samples were collected from male C57BU6 mice at several ages from prenatal through neonatal, infant, child to young adult. Results showed that most of the RNA modifying proteins were highly expressed in prenatal mouse liver with a dramatic drop at birth. After birth, most of the RNA modifying proteins showed a downregulation trend during liver maturation. Moreover, the RNA modifying proteins that belong to the same enzyme family were expressed at different abundances at the same ages in mouse liver. In conclusion, this study unveils that the mRNA expression of RNA modifying proteins follows specific ontogenic expression patterns in mice liver during maturation. These data indicated that the changes in expression of RNA modifying proteins might have a potential role to regulate gene expression in liver through alteration of RNA modification status.	[Chen, Liming; Bahal, Raman; Manautou, Jose E.; Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Wang, Pei] Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou, Peoples R China	University of Connecticut; Zhengzhou University	Zhong, XB (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	xiaobo.zhong@uconn.edu	Chen, Liming/HHZ-1212-2022	Bahal, Raman/0000-0002-4514-8004; Zhong, Xiao-bo/0000-0002-6537-5415; Chen, Liming/0000-0001-5065-9557	National Institutes of Health [R01GM118367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [Grant R01GM118367] to XBZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Alexandrov A, 2005, RNA, V11, P821, DOI 10.1261/rna.2030705; AMOS H, 1958, BIOCHIM BIOPHYS ACTA, V29, P444, DOI 10.1016/0006-3002(58)90214-2; Anderson JT, 2005, TOP CURR GENET, V12, P121, DOI 10.1007/b106364; BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bokar JA, 1997, RNA, V3, P1233; Bourgeois G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133321; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Chen X, 2019, NAT CELL BIOL, V21, P978, DOI 10.1038/s41556-019-0361-y; Cheng JX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03513-4; Cheng ZY, 2018, J NUTR BIOCHEM, V54, P1, DOI 10.1016/j.jnutbio.2017.10.004; Dai XX, 2018, ANAL CHEM, V90, P6380, DOI 10.1021/acs.analchem.8b01703; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; DUNN DB, 1961, BIOCHIM BIOPHYS ACTA, V46, P198, DOI 10.1016/0006-3002(61)90668-0; Dupont C, 2009, SEMIN REPROD MED, V27, P351, DOI 10.1055/s-0029-1237423; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Flores JV, 2017, STEM CELL REP, V8, P112, DOI 10.1016/j.stemcr.2016.11.014; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gonatopoulos-Pournatzis T, 2014, BIOCHEM J, V457, P231, DOI 10.1042/BJ20131214; Gunewardena SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141220; Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885; Haag S, 2015, RNA, V21, P180, DOI 10.1261/rna.047910.114; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Incarnato D, 2017, TRENDS BIOTECHNOL, V35, P318, DOI 10.1016/j.tibtech.2016.11.002; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaffrey SR, 2014, NAT STRUCT MOL BIOL, V21, P945, DOI 10.1038/nsmb.2911; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jonkhout N, 2017, RNA, V23, P1754, DOI 10.1261/rna.063503.117; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Klungland A, 2014, CURR OPIN GENET DEV, V26, P47, DOI 10.1016/j.gde.2014.05.006; Kretschmer J, 2018, RNA, V24, P1339, DOI 10.1261/rna.064238.117; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Lambert MC, 2011, ENCY CHILD BEHAV DEV, P1037; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Lewis CJT, 2017, NAT REV MOL CELL BIO, V18, P202, DOI 10.1038/nrm.2016.163; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/NCHEMBIO.1836, 10.1038/nchembio.1836]; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Liu FG, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.045; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Lu H, 2013, DRUG METAB DISPOS, V41, P844, DOI 10.1124/dmd.112.050211; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Malbec L, 2019, CELL RES, V29, P927, DOI 10.1038/s41422-019-0230-z; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Molinie B, 2017, METHODS MOL BIOL, V1562, P45, DOI 10.1007/978-1-4939-6807-7_4; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Oerum S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010020; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Oliva R, 2006, NUCLEIC ACIDS RES, V34, P865, DOI 10.1093/nar/gkj491; Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Rodriguez-Antona C, 2001, ARCH BIOCHEM BIOPHYS, V393, P308, DOI 10.1006/abbi.2001.2499; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sadler NC, 2016, DRUG METAB DISPOS, V44, P984, DOI 10.1124/dmd.115.068593; Saletore Y, 2013, RNA BIOL, V10, P342, DOI 10.4161/rna.23812; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schosserer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7158; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Shaheen R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0779-x; Shakya K, 2012, EPIGENETICS-US, V7, P982, DOI 10.4161/epi.21493; Sharma S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30383-z; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Skvortsova K, 2018, NAT REV MOL CELL BIO, V19, P774, DOI 10.1038/s41580-018-0074-2; Soubry A, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700113; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; Tuorto F, 2015, EMBO J, V34, P2350, DOI 10.15252/embj.201591382; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Van Haute L, 2019, NUCLEIC ACIDS RES, V47, P8720, DOI 10.1093/nar/gkz559; Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+; Waku T, 2016, J CELL SCI, V129, P2382, DOI 10.1242/jcs.183723; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Wickramasinghe VO, 2015, NAT REV MOL CELL BIO, V16, P431, DOI 10.1038/nrm4010; Wojtas MN, 2017, MOL CELL, V68, P374, DOI 10.1016/j.molcel.2017.09.021; Wu R, 2019, CELL RES, V29, P23, DOI 10.1038/s41422-018-0113-8; WYATT GR, 1950, NATURE, V166, P237, DOI 10.1038/166237b0; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xuan JJ, 2018, NUCLEIC ACIDS RES, V46, pD327, DOI 10.1093/nar/gkx934; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Zhang LS, 2019, MOL CELL, V74, P1304, DOI 10.1016/j.molcel.2019.03.036; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	110	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227102	10.1371/journal.pone.0227102	http://dx.doi.org/10.1371/journal.pone.0227102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891622	Green Published, gold			2022-12-26	WOS:000515096600060
J	Hair, PS; Enos, AI; Krishna, NK; Cunnion, KM				Hair, Pamela S.; Enos, Adrianne, I; Krishna, Neel K.; Cunnion, Kenji M.			Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants	PLOS ONE			English	Article								Background A product of rational molecular design, PA-dPEG24 is the lead derivative of the PIC1 family of peptides with multiple functional abilities including classical complement pathway inhibition, myeloperoxidase inhibition, NET inhibition and antioxidant activity. PA-dPEG24 is composed of a sequence of 15 amino acid, IALILEPICCQERAA, and contains a monodisperse 24-mer PEGylated moiety at its C terminus to increase aqueous solubility. Here we explore a sarcosine substitution scan of the PA peptide to evaluate impacts on solubility in the absence of PEGylation and functional characteristics. Methods Sixteen sarcosine substitution variants were synthesized and evaluated for solubility in water. Aqueous soluble variants were then tested in standard complement, myeloperoxidase, NET formation and antioxidant capacity assays. Results Six sarcosine substitution variants were aqueous soluble without requiring PEGylation. Substitution with sarcosine of the isoleucine at position eight yielded a soluble peptide that surpassed the parent molecule for complement inhibition and myeloperoxidase inhibition. Substitution with sarcosine of the cysteine at position nine improved solubility, but did not otherwise change the functional characteristics compared with the parent compound. However, replacement of both vicinal cysteine residues at positions 9 and 10 with a single sarcosine residue reduced functional activity in most of the assays tested. Conclusions Several of the sarcosine PIC1 variant substitutions synthesized yielded improved solubility as well as a number of unanticipated structure-function findings that provide new insights. Several sarcosine substitution variants demonstrate increased potency over the parent peptide suggesting enhanced therapeutic potential for inflammatory disease processes involving complement, myeloperoxidase, NETs or oxidant stress.	[Hair, Pamela S.; Enos, Adrianne, I; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA 23507 USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.; Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.; Cunnion, KM (corresponding author), Childrens Specialty Grp, Norfolk, VA 23507 USA.; Cunnion, KM (corresponding author), Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA.	cunniokm@evms.edu		Cunnion, Kenji/0000-0001-8604-348X	NIH [R21 AI135222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R21 AI135222. The funder did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://grants.nih.gov/grants/funding/r21.htm	Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Carlin JB, 2001, J PAEDIATR CHILD H, V37, P72, DOI 10.1046/j.1440-1754.2001.00634.x; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; Frank MM, 2000, IMMUNOL RES, V22, P137, DOI 10.1385/IR:22:2-3:137; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Hair Pamela S, 2017, Int J Pept, V2017, P9454583, DOI 10.1155/2017/9454583; Hair PS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00558; Hair PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170203; Hair PS, 2017, INT J PEPTIDE RES TH; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Matsui SM, 2001, NOVART FDN SYMP, V238, P219; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Moretto A, 2006, BIOPOLYMERS, V84, P553, DOI 10.1002/bip.20560; Rivera MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193931; Sebire NJ, 2004, J CLIN PATHOL, V57, P1001, DOI 10.1136/jcp.2004.017178; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446	17	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226875	10.1371/journal.pone.0226875	http://dx.doi.org/10.1371/journal.pone.0226875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891617	gold, Green Published			2022-12-26	WOS:000515096600039
J	Hsu, CH; Chan, JK; Yin, CH; Lee, CC; Chern, CU; Liao, CI				Hsu, Chun-Hsiang; Chan, John K.; Yin, Chun-Hao; Lee, Ching-Chih; Chern, Chyi-Uei; Liao, Cheng-, I			Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States	PLOS ONE			English	Article							GUIDELINES; SPECIMENS; DIAGNOSIS; POLICIES	This study aimed to identify the trends in the incidence of thymic cancer, i.e., thymoma, thymic carcinoma, and thymic neuroendocrine tumor, in the United States. Data from the United States Cancer Statistics (USCS) database (2001-2015) and those from the Surveillance, Epidemiology, and End Results (SEER) database (SEER 9 [1973-2015], SEER 13 [1992-2015], and SEER 18 [2000-2015]) were used in this study. All incidences were per 100,000 population at risk. The trends in incidence were described as annual percent change (APC) using the Joinpoint regression program. Data from the USCS (2001-2015) database showed an increase in thymic cancer diagnosis with an APC of 4.89% from 2001 to 2006, which is mainly attributed to the significant increase in the incidence of thymoma and thymic carcinoma particularly in women. The incidence of thymic cancer did not increase from 2006 to 2015, which may be attributed to the increase in the diagnosis of thymic carcinoma from 2004 to 2015, with a concomitant decrease in thymoma from 2008 to 2015. Before declining, the age-specific incidence of thymic cancer peaked at ages 70-74 years, with a peak incidence at 1.06 per 100,000 population, and decreased in older age groups. The incidence of thymic cancer was higher in men than in women. Asian/Pacific Islanders had the highest incidence of thymoma, followed by black and then white people. The incidence of thymic carcinoma increased from 2004 to 2015, with a concomitant decrease in thymoma from 2008 to 2015. Asian/Pacific Islanders had the highest incidence of thymoma than other races.	[Hsu, Chun-Hsiang] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Kaohsiung, Taiwan; [Chan, John K.] Calif Pacific & Palo Alto Med Fdn Sutter Hlth, Div Gynecol Oncol, San Francisco, CA USA; [Yin, Chun-Hao; Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Chern, Chyi-Uei; Liao, Cheng-, I] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Liao, Cheng-, I] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Liao, CI (corresponding author), Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.; Liao, CI (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	justice.obgy@gmail.com						Ahmad U, 2015, J THORAC CARDIOV SUR, V149, P95, DOI 10.1016/j.jtcvs.2014.09.124; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1730, DOI 10.1097/JTO.0b013e31821ea567; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Gal AA, 2001, ANN THORAC SURG, V72, P1179, DOI 10.1016/S0003-4975(01)03032-6; Gaur P, 2010, ANN SURG, V251, P1117, DOI 10.1097/SLA.0b013e3181dd4ec4; Health Promotion Administration Ministry of Health and Wel- fare, 2016, CANC REGISTRY ANN RE; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; Kim HJ, 2001, STAT MED, V20, P655, DOI 10.1002/sim.811; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Marchevsky A, 2011, J THORAC ONCOL, V6, pS1724, DOI 10.1097/JTO.0b013e31821ea57c; Marx A, 2011, THORAC SURG CLIN, V21, P25, DOI 10.1016/j.thorsurg.2010.08.010; Masaoka A, 2010, J THORAC ONCOL, V5, pS304, DOI 10.1097/JTO.0b013e3181f20c05; National Cancer Institute, 2018, JOINP REGR PROGR VER; Oberg K, 2012, ANN ONCOL, V23, P120, DOI 10.1093/annonc/mds267; Rosai J., 1999, HISTOLOGICAL TYPING, V2nd; Siesling S, 2012, EUR J CANCER, V48, P949, DOI 10.1016/j.ejca.2012.02.047; Travis WD, 2004, PATHOLOGY GENETICS T, P190; Travis WD, WHO CLASSIFICATION T; Weissferdt A, 2014, APPL IMMUNOHISTO M M, V22, P479, DOI 10.1097/PAI.0b013e3182a53856; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006	22	30	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227197	10.1371/journal.pone.0227197	http://dx.doi.org/10.1371/journal.pone.0227197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891634	gold, Green Published			2022-12-26	WOS:000515096600066
J	Watanabe, F; Suzuki, K; Tamaki, S; Abe, I; Endo, Y; Takayama, Y; Ishikawa, H; Kakizawa, N; Saito, M; Futsuhara, K; Noda, H; Konishi, F; Rikiyama, T				Watanabe, Fumiaki; Suzuki, Koichi; Tamaki, Sawako; Abe, Iku; Endo, Yuhei; Takayama, Yuji; Ishikawa, Hideki; Kakizawa, Nao; Saito, Masaaki; Futsuhara, Kazushige; Noda, Hiroshi; Konishi, Fumio; Rikiyama, Toshiki			Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer	PLOS ONE			English	Article							CELL-FREE DNA; MUTATIONS; PLASMA; HETEROGENEITY; EVOLUTION; UTILITY; SERUM; BIOMARKER; CA19-9; MARKER	Background Liquid biopsies enable the detection of circulating tumor DNA (ctDNA). However, the clinical significance of KRAS-mutated ctDNA for pancreatic cancer has been inconsistent with respect to its prognostic and predictive potential. Methods and findings A total of 422 blood samples were collected from 78 patients undergoing treatments for localized and metastatic pancreatic ductal adenocarcinoma. KRAS mutation in tissues and KRASctDNA levels in plasma were determined by RASKET and droplet digital polymerase chain reaction. Longitudinal monitoring of KRAS ctDNA was performed to assess its significance for predicting recurrence and prognosis and for evaluating therapeutic responses to chemotherapy compared with carbohydrate antigen 19-9 (CA19-9). In 67 tumor tissues, discrepancies in point mutations of KRAS were rarely observed among individual patients, implying that one targeted point mutation of KRAS can be determined in tumor tissues prior to longitudinal blood monitoring. One-time blood assessment of KRAS-mutated ctDNA before surgery or chemotherapy was not clearly associated with recurrence and prognosis. Sequential blood monitoring was performed in 39 patients who underwent surgery for potentially resectable tumors. Increased CA19-9 levels were significantly associated with recurrence, but not prognosis (P<0.001, P= 1.0, respectively), whereas emergence of KRAS ctDNA was significantly associated with prognosis (P<0.001) regardless of recurrence. Furthermore, in 39 patients who did not undergo surgery, detection of KRASctDNA was a predictive factor for prognosis (P= 0.005). Multivariate analysis revealed that detection of KRASctDNA was the only independent prognostic factor regardless of tumor resection (hazard ratios = 54.5 for patients who underwent surgery and 10.1 for patients who did not undergo surgery; P<0.001 for both). Patients without emergence of KRAS ctDNA within 1 year after surgery showed significantly better prognosis irrespective of recurrence (P<0.001). No detection or disappearance of KRAS ctDNA within 6 months of treatment was significantly correlated with therapeutic responses to first-line chemotherapy (P<0.001). Changes in KRAS status provided critical information for the prediction of therapeutic responses. Conclusions Our study showed for the first time that detection of KRAS ctDNA levels within a short period enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.	[Watanabe, Fumiaki; Suzuki, Koichi; Tamaki, Sawako; Abe, Iku; Endo, Yuhei; Takayama, Yuji; Ishikawa, Hideki; Kakizawa, Nao; Saito, Masaaki; Futsuhara, Kazushige; Noda, Hiroshi; Rikiyama, Toshiki] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Omiya Ku, Amanuma Cho, Saitama, Japan; [Konishi, Fumio] Nerima Hikarigaoka Hosp, Nerima Ku, Tokyo, Japan	Jichi Medical University	Suzuki, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Surg, Omiya Ku, Amanuma Cho, Saitama, Japan.	ksuzubnhm@yahoo.co.jp		Suzuki, Koichi/0000-0002-3548-0628	Ministry of Education, Culture, Sports, Science and Technology [JP 16K10514]; JKA Foundation through its promotion funds from the Keirin Race [27-1-068 (2)]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JKA Foundation through its promotion funds from the Keirin Race	The present study was supported by Grant-in-Aid for Scientific Research (grant number JP 16K10514) from the Ministry of Education, Culture, Sports, Science and Technology and the JKA Foundation through its promotion funds from the Keirin Race (grant number 27-1-068 (2)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako S, 2017, PANCREATOLOGY, V17, P285, DOI 10.1016/j.pan.2016.12.011; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bernard V, 2019, GASTROENTEROLOGY, V156, P108, DOI 10.1053/j.gastro.2018.09.022; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bidard FC, 2014, INT J CANCER, V134, P1207, DOI 10.1002/ijc.28436; Castells A, 1999, J CLIN ONCOL, V17, P578, DOI 10.1200/JCO.1999.17.2.578; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Chen LY, 2018, GENE, V679, P328, DOI 10.1016/j.gene.2018.09.029; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2011, FUTURE ONCOL, V7, P1385, DOI [10.2217/fon.11.122, 10.2217/FON.11.122]; Del Re M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08297-z; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferrone CR, 2006, J CLIN ONCOL, V24, P2897, DOI 10.1200/JCO.2005.05.3934; Gall TMH, 2019, AM J PATHOL, V189, P71, DOI 10.1016/j.ajpath.2018.03.020; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hadano N, 2016, BRIT J CANCER, V115, P59, DOI 10.1038/bjc.2016.175; Hartwig W, 2013, ANN SURG ONCOL, V20, P2188, DOI 10.1245/s10434-012-2809-1; Hashimoto D, 2016, PANCREAS, V45, P1111, DOI 10.1097/MPA.0000000000000624; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hori M, 2015, JPN J CLIN ONCOL, V45, P884, DOI 10.1093/jjco/hyv088; Kamat AA, 2010, CANCER-AM CANCER SOC, V116, P1918, DOI 10.1002/cncr.24997; Kato S, 2015, BIOMARK MED, V9, P703, DOI [10.2217/BMM.15.38, 10.2217/bmm.15.38]; Kim K, 2014, ANN SURG TREAT RES, V86, P136, DOI 10.4174/astr.2014.86.3.136; Kinugasa H, 2015, CANCER-AM CANCER SOC, V121, P2271, DOI 10.1002/cncr.29364; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Kruger S, 2018, ANN ONCOL, V29, P2348, DOI 10.1093/annonc/mdy417; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Sausen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8686; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Takayama Y, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e15630; Tjensvoll K, 2016, MOL ONCOL, V10, P635, DOI 10.1016/j.molonc.2015.11.012; Watanabe M, 2015, CLIN CANCER RES, V21, P3552, DOI 10.1158/1078-0432.CCR-14-2151; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	43	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227366	10.1371/journal.pone.0227366	http://dx.doi.org/10.1371/journal.pone.0227366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891652	Green Published, gold			2022-12-26	WOS:000515096600079
J	Carolino, ROG; Barros, PT; Kalil, B; Anselmo-Franci, J				Carolino, Ruither O. G.; Barros, Paulo T.; Kalil, Bruna; Anselmo-Franci, Janete			Endocrine profile of the VCD-induced perimenopausal model rat	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; 5-DAY ESTROUS CYCLES; SPRAGUE-DAWLEY RATS; INDUCED MOUSE MODEL; AGE-RELATED-CHANGES; 4-VINYLCYCLOHEXENE DIEPOXIDE; LUTEINIZING-HORMONE; REPRODUCTIVE SENESCENCE; MENOPAUSAL STATUS; OVARIAN FAILURE	During the transition to menopause, women experience a variety of physical and psychological symptoms that are directly or indirectly linked to changes in hormone secretion. Establishing animal models with intact ovaries is essential for understanding these interactions and finding new therapeutic targets. In this study, we assessed the endocrine profile, as well as the estrous cycle, in the 4-vinylcyclohexene diepoxide (VCD)-induced follicular depletion rat model in 10-day intervals over 1 month to accurately establish the best period for studies of the transition period. Twenty-eight-day-old female rats were injected daily with VCD or oil s.c. for 15 days and euthanized in the diestrus phase approximately 70, 80, 90 and 100 days after the onset of treatment. The percentage of rats showing irregular cycles and the plasma level of FSH increased only in the 100-day VCD group. Plasma anti-Mullerian hormone (AMH) and progesterone were lower in all VCD groups compared to control groups, while estradiol remained unchanged or higher. As in control groups, dihydrotestosterone (DHT) progressively decreased in the 70-90-day VCD groups; however, it was followed by a sharp increase only in the 100-day VCD group. No changes were found in plasma corticosterone, prolactin, thyroid hormones or luteinizing hormone. Based on the estrous cycle and endocrine profile, we conclude that 1) the time window from 70 to 100 days is suitable to study a perimenopause-like state in this model, and 2) regular cycles with low progesterone and AMH and normal FSH can be used as markers of the early/mid-transition period, whereas irregular cycles associated with higher FSH and DHT can be used as markers of the late transition period to estropause.	[Carolino, Ruither O. G.; Anselmo-Franci, Janete] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Basic & Oral Biol, Ribeirao Preto, SP, Brazil; [Barros, Paulo T.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Kalil, Bruna] Univ Fed Alfenas, Inst Biomed Sci, Dept Physiol, Alfenas, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Alfenas	Anselmo-Franci, J (corresponding author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Basic & Oral Biol, Ribeirao Preto, SP, Brazil.	jaafranc@usp.br	Cutti, Bruna/AAO-5901-2020		Foundation for Research Support of the State of Sao Paulo -FAPESP; CAPES/PROEX (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior-Brazil) [001]; National Council of Scientific and Technological Development (CNPq)	Foundation for Research Support of the State of Sao Paulo -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PROEX (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior-Brazil); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from Foundation for Research Support of the State of Sao Paulo -FAPESP and by CAPES/PROEX (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior-Brazil; Finance Code 001). JAAF is supported by the National Council of Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1983, MATURITAS, V5, P31, DOI 10.1016/0378-5122(83)90019-1; Ala-Fossi SL, 1998, MATURITAS, V29, P239, DOI 10.1016/S0378-5122(98)00034-6; Appt SE, 2010, COMPARATIVE MED, V60, P380; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; BALLINGER CB, 1987, MATURITAS, V9, P235, DOI 10.1016/0378-5122(87)90006-5; Battiston FG, 2017, J STEROID BIOCHEM, V165, P170, DOI 10.1016/j.jsbmb.2016.06.001; Brooks HL, 2016, PHYSIOLOGY, V31, P250, DOI 10.1152/physiol.00057.2014; Burger HG, 2008, MENOPAUSE, V15, P603, DOI 10.1097/gme.0b013e318174ea4d; BURGER HG, 1995, J CLIN ENDOCR METAB, V80, P3537, DOI 10.1210/jc.80.12.3537; Burger HG, 1998, CLIN ENDOCRINOL, V48, P809; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Chakraborty TR, 2004, EXP BIOL MED, V229, P977, DOI 10.1177/153537020422901001; Crawford S, 2009, J CLIN ENDOCR METAB, V94, P2945, DOI 10.1210/jc.2009-0386; Cui LL, 2016, FERTIL STERIL, V105, P481, DOI 10.1016/j.fertnstert.2015.10.017; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; FAROOKHI R, 1980, ENDOCRINOLOGY, V106, P1216, DOI 10.1210/endo-106-4-1216; FINCH CE, 1984, ENDOCR REV, V5, P467, DOI 10.1210/edrv-5-4-467; Frye JB, 2012, COMPARATIVE MED, V62, P193; Gore AC, 2000, ENDOCRINE, V13, P315, DOI 10.1385/ENDO:13:3:315; Haim S, 2003, J ENDOCRINOL INVEST, V26, P1013, DOI 10.1007/BF03348201; Hale GE, 2009, BEST PRACT RES CL OB, V23, P7, DOI 10.1016/j.bpobgyn.2008.10.001; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; HUANG HH, 1978, ENDOCRINOLOGY, V103, P1855, DOI 10.1210/endo-103-5-1855; JUDD HL, 1994, EXP GERONTOL, V29, P285, DOI 10.1016/0531-5565(94)90008-6; Kalil B, 2013, STRESS, V16, P452, DOI 10.3109/10253890.2013.777832; KANEKO S, 1986, BIOL REPROD, V34, P488, DOI 10.1095/biolreprod34.3.488; Kao SW, 1999, REPROD TOXICOL, V13, P67, DOI 10.1016/S0890-6238(98)00061-6; Kappeler CJ, 2012, SYST BIOL REPROD MED, V58, P57, DOI 10.3109/19396368.2011.648820; Klein NA, 2004, J CLIN ENDOCR METAB, V89, P2977, DOI 10.1210/jc.2003-031515; Krassas GE, 2000, FERTIL STERIL, V74, P1063, DOI 10.1016/S0015-0282(00)01589-2; Landgren BM, 2004, J CLIN ENDOCR METAB, V89, P2763, DOI 10.1210/jc.2003-030824; LEE SJ, 1988, HUM REPROD, V3, P851, DOI 10.1093/oxfordjournals.humrep.a136796; LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780; LENTON EA, 1988, MATURITAS, V10, P35, DOI 10.1016/0378-5122(88)90129-6; Lo MJ, 2006, J CELL BIOCHEM, V97, P351, DOI 10.1002/jcb.20576; Lohff JC, 2005, COMPARATIVE MED, V55, P523; Lohff JC, 2006, MENOPAUSE, V13, P482, DOI 10.1097/01.gme.0000191883.59799.2e; Lovick TA, 2017, PSYCHONEUROENDOCRINO, V75, P83, DOI 10.1016/j.psyneuen.2016.10.024; Lukefahr AL, 2012, CALCIFIED TISSUE INT, V90, P239, DOI 10.1007/s00223-011-9565-2; MACNAUGHTON J, 1992, CLIN ENDOCRINOL, V36, P339, DOI 10.1111/j.1365-2265.1992.tb01457.x; Mayer LP, 2004, BIOL REPROD, V71, P130, DOI 10.1095/biolreprod.103.016113; Mayer LP, 2002, REPROD TOXICOL, V16, P775, DOI 10.1016/S0890-6238(02)00048-5; MEITES J, 1980, FED PROC, V39, P3168; MELDRUM DR, 1984, OBSTET GYNECOL, V64, P752; MOON YS, 1984, BIOCHEM BIOPH RES CO, V119, P694, DOI 10.1016/S0006-291X(84)80306-X; Muhammad FS, 2009, COMPARATIVE MED, V59, P46; NEQUIN LG, 1979, BIOL REPROD, V20, P659, DOI 10.1095/biolreprod20.3.659; Organisation for the Economic Co-operation and Development (OECD), READ REP VAG UNPUB 5; Overlie I, 1999, ACTA OBSTET GYN SCAN, V78, P642, DOI 10.1034/j.1600-0412.1999.780714.x; PELUSO JJ, 1978, J REPROD FERTIL, V54, P275, DOI 10.1530/jrf.0.0540275; Pestana-Oliveira N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0247-17.2017; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Prior Jerilynn C, 2011, Front Biosci (Schol Ed), V3, P474, DOI 10.2741/s166; Reinwald S, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/145170; Reis FMCV, 2014, PSYCHONEUROENDOCRINO, V49, P130, DOI 10.1016/j.psyneuen.2014.06.019; REYES FI, 1977, AM J OBSTET GYNECOL, V129, P557; Rivera Z, 2009, BIOL REPROD, V80, P328, DOI 10.1095/biolreprod.108.070359; Robertson DM, 2008, MENOPAUSE, V15, P1139, DOI 10.1097/gme.0b013e3181735687; ROJAS LV, 2008, ETHNIC DIS, V18; Sahambi SK, 2008, REPROD TOXICOL, V26, P116, DOI 10.1016/j.reprotox.2008.07.005; Santoro N, 1996, J CLIN ENDOCR METAB, V81, P1495, DOI 10.1210/jc.81.4.1495; Santoro N, 2011, OBSTET GYN CLIN N AM, V38, P455, DOI 10.1016/j.ogc.2011.05.004; SHERMAN BM, 1975, J CLIN INVEST, V55, P699, DOI 10.1172/JCI107979; SHIDELER SE, 1989, MATURITAS, V11, P331, DOI 10.1016/0378-5122(89)90029-7; Silva JF, 2018, BIOL REPROD, V99, P907, DOI 10.1093/biolre/ioy115; Sone K, 2007, EXP ANIM TOKYO, V56, P139, DOI 10.1538/expanim.56.139; Sowers M, 2003, CLIN ENDOCRINOL, V58, P340, DOI 10.1046/j.1365-2265.2003.01718.x; Tanner MJ, 2011, AUST NZ J OBSTET GYN, V51, P321, DOI 10.1111/j.1479-828X.2011.01321.x; Thompson KE, 2005, TOXICOL APPL PHARM, V203, P114, DOI 10.1016/j.taap.2004.07.010; Toffol E, 2014, MENOPAUSE, V21, P493, DOI 10.1097/GME.0b013e3182a6c8f3; Van Voorhis BJ, 2008, OBSTET GYNECOL, V112, P101, DOI 10.1097/AOG.0b013e31817d452b; *WHO SCI GROUP, 1996, RES MEN 1990S REP WH; WISE PM, 1984, ENDOCRINOLOGY, V115, P801, DOI 10.1210/endo-115-2-801; Woods NF, 2006, MENOPAUSE, V13, P212, DOI 10.1097/01.gme.0000198490.57242.2e; Yeh J, 2007, FERTIL STERIL, V87, P1227, DOI 10.1016/j.fertnstert.2006.11.011; ZUMOFF B, 1995, J CLIN ENDOCR METAB, V80, P1429, DOI 10.1210/jc.80.4.1429	77	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226874	10.1371/journal.pone.0226874	http://dx.doi.org/10.1371/journal.pone.0226874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887176	gold, Green Published			2022-12-26	WOS:000515092200046
J	Perin, B; Addetia, A; Qin, X				Perin, Benji; Addetia, Amin; Qin, Xuan			Transfer of skin microbiota between two dissimilar autologous microenvironments: A pilot study	PLOS ONE			English	Article							TRANSPLANTATION; INFECTION	Dysbiosis of skin microbiota is associated with several inflammatory skin conditions, including atopic dermatitis, acne, and hidradenitis suppurativa. There is a surge of interest by clinicians and the lay public to explore targeted bacteriotherapy to treat these dermatologic conditions. To date, skin microbiota transplantation studies have focused on moving single, enriched strains of bacteria to target sites rather than a whole community. In this prospective pilot study, we examined the feasibility of transferring unenriched skin microbiota communities between two anatomical sites of the same host. We enrolled four healthy volunteers (median age: 28 [range: 24, 36] years; 2 [50%] female) who underwent collection and transfer of skin microbiota from the forearm to the back unidirectionally. Using culture methods and 16S rRNA V1-V3 deep sequencing, we compared baseline and mixed ("transplant") communities, at T = 0 and T = 24 hours. Our ability to detect movement from one site to the other relied on the inherent diversity of the microenvironment of the antecubital fossa relative to the less diverse back. Comparing bacterial species present in the arm and mixed ("transplant") communities that were absent from the baseline back, we saw evidence of transfer of a partial DNA signature; our methods limit conclusions regarding the viability of transferred organisms. We conclude that unenriched transfer of whole cutaneous microbiota is challenging, but our simple technique, intended to move viable skin organisms from one site to another, is worthy of further investigation.	[Perin, Benji] Univ Washington, Div Dermatol & Dermatol Residency, Seattle, WA 98195 USA; [Addetia, Amin; Qin, Xuan] Seattle Childrens Hosp, Seattle, WA USA; [Qin, Xuan] Univ Washington, Dept Lab Med, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Addetia, Amin] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Perin, B (corresponding author), Univ Washington, Div Dermatol & Dermatol Residency, Seattle, WA 98195 USA.	bip2@uw.edu		Perin, Benji/0000-0002-9635-2531	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000423]; Seattle Children's CCTR Pediatric Pilot Fund Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Seattle Children's CCTR Pediatric Pilot Fund Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	BP received funding by The National Center for Advancing Translational Sciences of the National Institutes of Health (https://ncats.nih.gov, Award Number UL1TR000423), as awarded by the Seattle Children's CCTR Pediatric Pilot Fund Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'hoe K, 2018, ELIFE, V7, DOI 10.7554/eLife.37090; Dybboe R, 2017, BR J DERMATOL; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kronman MP, 2015, J PEDIATR GASTR NUTR, V60, P23, DOI 10.1097/MPG.0000000000000545; Lomholt HB, 2017, ANAEROBE, V47, P57, DOI 10.1016/j.anaerobe.2017.04.006; Louis P, 2017, ENV MICROBIOLOGY; Melter O, 2010, FOLIA MICROBIOL, V55, P548, DOI 10.1007/s12223-010-0089-3; Metcalf JL, 2017, TRENDS BIOTECHNOL, V35, P814, DOI 10.1016/j.tibtech.2017.03.006; Minot S.S., 2015, ONE CODEX SENSITIVE; Morris BEL, 2013, FEMS MICROBIOLOGY RE; Myles IA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120608; Myles IA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86955; Myles IA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0684-9; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Qamer S, 2003, J CLIN MICROBIOL, V41, P2644, DOI 10.1128/JCM.41.6.2644-2646.2003; Qin X, 2016, CRIT REV MICROBIOL, V42, P144, DOI 10.3109/1040841X.2014.907235; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Staley C, 2017, GUT MICROBES, V8, P276, DOI 10.1080/19490976.2017.1299310; van Hoek MJA, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0430-4; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; WYBER JA, 1994, LETT APPL MICROBIOL, V19, P312, DOI 10.1111/j.1472-765X.1994.tb00463.x; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	26	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226857	10.1371/journal.pone.0226857	http://dx.doi.org/10.1371/journal.pone.0226857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887174	Green Published, gold			2022-12-26	WOS:000515092200045
J	Delitsikou, V; Jarad, G; Rajaram, RD; Ino, F; Rutkowski, JM; Chen, CD; Santos, CXC; Scherer, PE; Abraham, CR; Shah, AM; Feraille, E; Miner, JH; de Seigneux, S				Delitsikou, Vasiliki; Jarad, George; Rajaram, Renuga Devi; Ino, Frederique; Rutkowski, Joseph M.; Chen, Ci-Di; Santos, Celio X. C.; Scherer, Philipp E.; Abraham, Carmela R.; Shah, Ajay M.; Feraille, Eric; Miner, Jeffrey H.; de Seigneux, Sophie			Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress	FASEB JOURNAL			English	Article						albuminuria; ATF3; CKD; ER stress; Klotho	CHRONIC KIDNEY-DISEASE; TRANSCRIPTS ENCODING MEMBRANE; GLOMERULAR-FILTRATION-RATE; ALPHA-KLOTHO; SECRETED KLOTHO; RENAL FIBROSIS; PROTEIN; GENE; PROGRESSION; PHOSPHATE	Proteinuria is associated with renal function decline and cardiovascular mortality. This association may be attributed in part to alterations of Klotho expression induced by albuminuria, yet the underlying mechanisms are unclear. The presence of albumin decreased Klotho expression in the POD-ATTAC mouse model of proteinuric kidney disease as well as in kidney epithelial cell lines. This downregulation was related to both decreased Klotho transcription and diminished protein half-life, whereas cleavage by ADAM proteases was not modified. The regulation was albumin specific since it was neither observed in the analbuminemic Col4 alpha 3(-/-) Alport mice nor induced by exposure of kidney epithelial cells to purified immunoglobulins. Albumin induced features of ER stress in renal tubular cells with ATF3/ATF4 activation. ATF3 and ATF4 induction downregulated Klotho through altered transcription mediated by their binding on the Klotho promoter. Inhibiting ER stress with 4-PBA decreased the effect of albumin on Klotho protein levels without altering mRNA levels, thus mainly abrogating the increased protein degradation. Taken together, albuminuria decreases Klotho expression through increased protein degradation and decreased transcription mediated by ER stress induction. This implies that modulating ER stress may improve proteinuria-induced alterations of Klotho expression, and hence renal and extrarenal complications associated with Klotho loss.	[Delitsikou, Vasiliki; Rajaram, Renuga Devi; Ino, Frederique; Feraille, Eric; de Seigneux, Sophie] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, CMU, Geneva, Switzerland; [Delitsikou, Vasiliki; Rajaram, Renuga Devi; Ino, Frederique; de Seigneux, Sophie] HUG, Dept Internal Med Specialties, Lab Nephrol, Rue Michel Servet 1, CH-1205 Geneva, Switzerland; [Jarad, George; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Med, Div Nephrol, St Louis, MO 63110 USA; [Rutkowski, Joseph M.; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX USA; [Rutkowski, Joseph M.] Texas A&M Coll Med, Dept Med Physiol, College Stn, TX USA; [Chen, Ci-Di; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Santos, Celio X. C.; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr Excellence, Sch Cardiovasc Med & Sci, London, England	University of Geneva; University of Geneva; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Boston University; University of London; King's College London	de Seigneux, S (corresponding author), HUG, Dept Internal Med Specialties, Lab Nephrol, Rue Michel Servet 1, CH-1205 Geneva, Switzerland.	Sophie.deSeigneux@hcuge.ch		Feraille, Eric/0000-0003-1656-8365; Shah, Ajay/0000-0002-6547-0631	Swiss National Science Foundation [PP00P3_157454]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: PP00P3_157454	Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Barker SL, 2015, NEPHROL DIAL TRANSPL, V30, P223, DOI 10.1093/ndt/gfu291; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Cheng YC, 2015, J BIOCHEM, V158, P101, DOI 10.1093/jb/mvv020; Choi YM, 2014, BIOCHEM BIOPH RES CO, V448, P182, DOI 10.1016/j.bbrc.2014.04.083; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; de Seigneux S, 2019, NEPHROL DIAL TRANSPL, pgfz083; de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104; Dizin E, 2013, AM J PHYSIOL-RENAL, V305, pF1053, DOI 10.1152/ajprenal.00006.2013; El Karoui K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10330; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fernandez-Fernandez B, 2018, NEPHROL DIAL TRANSPL, V33, P1712, DOI 10.1093/ndt/gfx376; GALASKE RG, 1979, KIDNEY INT, V16, P394, DOI 10.1038/ki.1979.142; Goncalves GL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36933-9; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Hage V, 2014, J RENAL NUTR, V24, P390, DOI 10.1053/j.jrn.2014.06.009; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hsu SC, 2014, INT J BIOCHEM CELL B, V53, P361, DOI 10.1016/j.biocel.2014.06.002; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2016, J AM SOC NEPHROL, V27, P79, DOI 10.1681/ASN.2014101030; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Hu Y, 2016, MOL MED REP, V14, P3229, DOI 10.3892/mmr.2016.5601; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Jarad G, 2016, AM J PHYSIOL-RENAL, V311, pF120, DOI 10.1152/ajprenal.00456.2015; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Kim H, 2019, NEPHROL DIAL TRANSPL, pgfy403; King GD, 2012, BIOCHEM J, V441, P453, DOI 10.1042/BJ20101909; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lee EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102984; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu QF, 2015, IRAN J KIDNEY DIS, V9, P291; Liu SH, 2016, ONCOTARGET, V7, P22116, DOI 10.18632/oncotarget.7904; Maltese G, 2017, DIABETOLOGIA, V60, P911, DOI 10.1007/s00125-017-4219-1; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mencke R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94375; Nie F, 2017, J DIABETES COMPLICAT, V31, P594, DOI 10.1016/j.jdiacomp.2016.11.008; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Qi W, 2011, METABOLISM, V60, P594, DOI 10.1016/j.metabol.2010.07.021; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ravikumar P, 2014, AM J PHYSIOL-LUNG C, V307, pL566, DOI 10.1152/ajplung.00306.2013; Remuzzi G, 2004, KIDNEY INT, V66, pS90, DOI 10.1111/j.1523-1755.2004.09221.x; Rutkowski JM, 2017, KIDNEY INT, V91, P324, DOI 10.1016/j.kint.2016.09.016; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saito K, 2003, FEBS LETT, V551, P58, DOI 10.1016/S0014-5793(03)00894-9; Santos CXC, 2016, EMBO J, V35, P319, DOI 10.15252/embj.201592394; Schuh CD, 2018, J AM SOC NEPHROL, V29, P2696, DOI 10.1681/ASN.2018050522; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Williams MJ, 2018, KIDNEY INT, V93, P147, DOI 10.1016/j.kint.2017.06.016; Wu XW, 2010, OMICS, V14, P61, DOI 10.1089/omi.2009.0073; Yoshida T, 2008, J AM SOC NEPHROL, V19, P217, DOI 10.1681/ASN.2005111155; Yum V, 2017, AM J PHYSIOL-RENAL, V312, pF230, DOI 10.1152/ajprenal.00119.2016; Zhang H, 2018, J MOL MED, V96, P53, DOI 10.1007/s00109-017-1601-x; Zhang SQ, 2013, KIDNEY INT, V84, P713, DOI 10.1038/ki.2013.194; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	72	12	14	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2087	2104		10.1096/fj.201900893R	http://dx.doi.org/10.1096/fj.201900893R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907991	Green Published, Bronze			2022-12-26	WOS:000504094300001
J	Ramachandran, A; Summerville, L; Learn, BA; DeBell, L; Bailey, S				Ramachandran, Anita; Summerville, Lesley; Learn, Brian A.; DeBell, Lily; Bailey, Scott			Processing and integration of functionally oriented prespacers in the Escherichia coli CRISPR system depends on bacterial host exonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; CRISPR-RNA (crRNA); DNA; deoxyribonuclease (DNase); integrase; 3'-5' exonuclease; bacterial immunity; DnaQ; prespacer processing; primed adaptation; protospacer adjacent motif (PAM)	SPACER ACQUISITION; MECHANISTIC BASIS; EPSILON-SUBUNIT; DNA; IMMUNITY; REPEATS; PAM; RESISTANCE; ESTABLISH; PROTEINS	CRISPR-Cas systems provide bacteria with adaptive immunity against viruses. During spacer adaptation, the Cas1-Cas2 complex selects fragments of foreign DNA, called prespacers, and integrates them into CRISPR arrays in an orientation that provides functional immunity. Cas4 is involved in both the trimming of prespacers and the cleavage of protospacer adjacent motif (PAM) in several type I CRISPR-Cas systems, but how the prespacers are processed in systems lacking Cas4, such as the type I-E and I-F systems, is not understood. In Escherichia coli, which has a type I-E system, Cas1-Cas2 preferentially selects prespacers with 3? overhangs via specific recognition of a PAM, but how these prespacers are integrated in a functional orientation in the absence of Cas4 is not known. Using a biochemical approach with purified proteins, as well as integration, prespacer protection, sequencing, and quantitative PCR assays, we show here that the bacterial 3??5? exonucleases DnaQ and ExoT can trim long 3? overhangs of prespacers and promote integration in the correct orientation. We found that trimming by these exonucleases results in an asymmetric intermediate, because Cas1-Cas2 protects the PAM sequence, which helps to define spacer orientation. Our findings implicate the E. coli host 3??5? exonucleases DnaQ and ExoT in spacer adaptation and reveal a mechanism by which spacer orientation is defined in E. coli.	[Ramachandran, Anita; Summerville, Lesley; Learn, Brian A.; DeBell, Lily; Bailey, Scott] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Bailey, Scott] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Bailey, S (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu		Bailey, Scott/0000-0003-1953-7089	National Institutes of Health [GM097330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM097330 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Hamdan S, 2000, J STRUCT BIOL, V131, P164, DOI 10.1006/jsbi.2000.4291; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hsiao YY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001803; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lee H, 2019, ELIFE, V8, DOI 10.7554/eLife.44248; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Shiimori M, 2017, NUCLEIC ACIDS RES, V45, P11281, DOI 10.1093/nar/gkx839; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shiriaeva AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12417-w; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	50	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3403	3414		10.1074/jbc.RA119.012196	http://dx.doi.org/10.1074/jbc.RA119.012196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31914418	Green Published, hybrid			2022-12-26	WOS:000527725300003
J	Govindappa, PK; Patil, M; Garikipati, VNS; Verma, SK; Saheera, S; Narasimhan, G; Zhu, WQ; Kishore, R; Zhang, JY; Krishnamurthy, P				Govindappa, Prem Kumar; Patil, Mallikarjun; Garikipati, Venkata Naga Srikanth; Verma, Suresh K.; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Kishore, Raj; Zhang, Jianyi; Krishnamurthy, Prasanna			Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart	FASEB JOURNAL			English	Article						cardiac fibrosis; cardiac inflammation; diabetes; exosome; HuR; intercellular signaling	BINDING PROTEIN HUR; MESSENGER-RNA; MACROPHAGES; CARDIOMYOCYTES; DYSFUNCTION; ACTIVATION; APOPTOSIS; MEDIATE; RATS	RNA-binding proteins like human antigen R (HuR) are key regulators in post-transcriptional control of gene expression in several pathophysiological conditions. Diabetes adversely affects monocyte/macrophage biology and function. It is not known whether diabetic milieu affects cellular/exosome-HuR and its implications on cardiac inflammation and fibrosis. Here, we evaluate in vitro and in vivo effects of diabetic milieu on macrophage cellular/exosome-HuR, alterations in intercellular cross talk with fibroblasts, and its impact on cardiac remodeling. Human failing hearts show higher HuR levels. Diabetic milieu activates HuR expression in cardiac- and cultured bone marrow-derived macrophages (BMMo) and stimulates HuR nuclear-to-cytoplasmic translocation and exosome transfer. Exosomes from macrophages exposed to diabetic milieu (high glucose or db/db mice) significantly increase inflammatory and profibrogenic responses in fibroblast (in vitro) and cardiac fibrosis in mice. Intriguingly, Exo-HuR deficiency (HuR knockdown in macrophage) abrogates the above effects. In diabetic mice, macrophage depletion followed by reconstitution with BMMo-derived HuR-deficient exosomes inhibits angiotensin II-induced cardiac fibrosis response and preserves left ventricle function as compared to control-exosome administration. To the best of our knowledge, this is the first study to demonstrate that diabetes activates BMMo HuR expression and its transfer into exosome. The data suggest that HuR might be targeted to alleviate macrophage dysfunction and pathological fibrosis in diabetes.	[Govindappa, Prem Kumar; Patil, Mallikarjun; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Zhang, Jianyi; Krishnamurthy, Prasanna] Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL USA; [Govindappa, Prem Kumar; Patil, Mallikarjun; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Zhang, Jianyi; Krishnamurthy, Prasanna] Univ Alabama Birmingham, Sch Engn, Dept Biomed Engn, Birmingham, AL USA; [Garikipati, Venkata Naga Srikanth; Kishore, Raj] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA USA; [Verma, Suresh K.] Univ Alabama Birmingham, Sch Med, Div Cardiovasc Dis, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham	Krishnamurthy, P (corresponding author), Univ Alabama Birmingham, Sch Med & Engn, Dept Biomed Engn, 1675 Univ Blvd,Volker Hall G094, Birmingham, AL 35294 USA.	prasanak@uab.edu	GOVINDAPPA, PREM KUMAR/AAY-2926-2021; Saheera, Sherin/AAL-4028-2020; Verma, Suresh/AAU-9979-2020	GOVINDAPPA, PREM KUMAR/0000-0001-8069-234X; Saheera, Sherin/0000-0002-1336-5872; Narasimhan, Gayathri/0000-0003-0495-5210; Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364	American Heart Association-American Stroke Association [0930219N] Funding Source: Medline; HHS | National Institutes of Health (NIH) [HL138023, HL126186, HL116729, HL134608] Funding Source: Medline; NHLBI NIH HHS [R01 HL142627, R56 HL142627, R01 HL116729, R01 HL138023, R01 HL126186, P01 HL134608] Funding Source: Medline; NIDDK NIH HHS [P30 DK079626] Funding Source: Medline	American Heart Association-American Stroke Association(American Heart Association); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babu SS, 2015, TRENDS CARDIOVAS MED, V25, P676, DOI 10.1016/j.tcm.2015.02.006; Chen B, 2016, CIRC RES, V119, P776, DOI 10.1161/CIRCRESAHA.116.309624; Chen JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42001; Diaz-Munoz MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01094; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Garcia-Martinez J, 2016, NUCLEIC ACIDS RES, V44, P3643, DOI 10.1093/nar/gkv1512; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Honold L, 2018, CIRC RES, V122, P113, DOI 10.1161/CIRCRESAHA.117.311071; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Janakiraman H, 2017, ONCOGENE, V36, P3137, DOI 10.1038/onc.2016.451; Jeyabal P, 2016, BIOCHEM BIOPH RES CO, V471, P423, DOI 10.1016/j.bbrc.2016.02.065; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kotta-Loizou I, 2016, NEOPLASIA, V18, P674, DOI 10.1016/j.neo.2016.09.002; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oh JG, 2018, CIRC RES, V123, P673, DOI 10.1161/CIRCRESAHA.118.312751; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Patel B, 2016, ONCOGENE, V35, P3027, DOI 10.1038/onc.2015.358; Roper NA, 2002, DIABETES CARE, V25, P43, DOI 10.2337/diacare.25.1.43; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Slone S, 2016, CELL SIGNAL, V28, P1735, DOI 10.1016/j.cellsig.2016.08.005; Szuszkiewicz-Garcia MM, 2014, ENDOCRIN METAB CLIN, V43, P25, DOI 10.1016/j.ecl.2013.09.001; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wigington CP, 2015, J BIOL CHEM, V290, P3468, DOI 10.1074/jbc.M114.631937	33	21	23	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2238	2251		10.1096/fj.201901995R	http://dx.doi.org/10.1096/fj.201901995R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907992	Green Accepted			2022-12-26	WOS:000514663600022
J	Yamazaki, H; Shirakawa, K; Matsumoto, T; Kazuma, Y; Matsui, H; Horisawa, Y; Stanford, E; Sarca, AD; Shirakawa, R; Shindo, K; Takaori-Kondo, A				Yamazaki, Hiroyuki; Shirakawa, Kotaro; Matsumoto, Tadahiko; Kazuma, Yasuhiro; Matsui, Hiroyuki; Horisawa, Yoshihito; Stanford, Emani; Sarca, Anamaria Daniela; Shirakawa, Ryutaro; Shindo, Keisuke; Takaori-Kondo, Akifumi			APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; LUNG-CANCER; ATM; REPLICATION; INHIBITION; ACTIVATION; GENOME; PHOSPHORYLATION; SIGNATURES; RESISTANT	Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) DNA cytosine deaminase 3B (A3B) is a DNA editing enzyme which induces genomic DNA mutations in multiple myeloma and in various other cancers. APOBEC family proteins are highly homologous so it is especially difficult to investigate the biology of specifically A3B in cancer cells. To easily and comprehensively investigate A3B function in myeloma cells, we used CRISPR/Cas9 to generate A3B reporter cells that contain 3xFLAG tag and IRES-EGFP sequences integrated at the end of the A3B gene. These reporter cells stably express 3xFLAG tagged A3B and the reporter EGFP and this expression is enhanced by known stimuli, such as PMA. Conversely, shRNA knockdown of A3B decreased EGFP fluorescence and 3xFLAG tagged A3B protein levels. We screened a series of anticancer treatments using these cell lines and identified that most conventional therapies, such as antimetabolites or radiation, exacerbated endogenous A3B expression, but recent molecular targeted therapeutics, including bortezomib, lenalidomide and elotuzumab, did not. Furthermore, chemical inhibition of ATM, ATR and DNA-PK suppressed EGFP expression upon treatment with antimetabolites. These results suggest that DNA damage triggers A3B expression through ATM, ATR and DNA-PK signaling.	[Yamazaki, Hiroyuki; Shirakawa, Kotaro; Matsumoto, Tadahiko; Kazuma, Yasuhiro; Matsui, Hiroyuki; Horisawa, Yoshihito; Stanford, Emani; Sarca, Anamaria Daniela; Shindo, Keisuke; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Shirakawa, Ryutaro] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Sendai, Miyagi, Japan	Kyoto University; Tohoku University	Takaori-Kondo, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan.	atakaori@kuhp.kyoto-u.ac.jp		Kazuma, Yasuhiro/0000-0002-1046-8286; Sarca, Anamaria/0000-0002-4468-7786; Yamazaki, Hiroyuki/0000-0002-7690-5522	JSPS KAKENHI [JP19H03502, 18H03992, JP19K07591]; Amedisys Home Health and Hospice Care (AMED) [JP19ck0106250, JP19cm0106501]; Ono Pharmaceutical Co.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Amedisys Home Health and Hospice Care (AMED); Ono Pharmaceutical Co.	This work was partly supported by JSPS KAKENHI Grant numbers JP19H03502, 18H03992 for A.T-K., JP19K07591 for K.S. and by Amedisys Home Health and Hospice Care (AMED) under Grant Number JP19ck0106250, JP19cm0106501 for A.T-K. Research funding from Ono Pharmaceutical Co. for A.T-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akre MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155391; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bhattacharya S, 2009, CELL SIGNAL, V21, P509, DOI 10.1016/j.cellsig.2008.12.003; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Blum R, 1999, J CELL SCI, V112, P537; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; BROWN R, 1993, INT J CANCER, V55, P678, DOI 10.1002/ijc.2910550428; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Cho YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161899; Choi S, 2011, DNA REPAIR, V10, P1000, DOI 10.1016/j.dnarep.2011.07.013; Chou WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44089; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Du Y, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0572-5; Eggenschwiler R, 2013, STEM CELL TRANSL MED, V2, P641, DOI 10.5966/sctm.2013-0017; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Fallone F, 2013, ONCOGENE, V32, P4387, DOI 10.1038/onc.2012.462; Gao JL, 2018, CANCER SCI, V109, P2375, DOI 10.1111/cas.13658; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Li H, 2005, MUTAT RES-GEN TOX EN, V588, P118, DOI 10.1016/j.mrgentox.2005.09.005; Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295; Li YQ, 2019, BIOENGINEERED, V10, P98, DOI 10.1080/21655979.2019.1607126; Li ZH, 2018, BIOTECHNOL LETT, V40, P1495, DOI 10.1007/s10529-018-2608-2; Maruyama W, 2016, BIOCHEM BIOPH RES CO, V478, P1466, DOI 10.1016/j.bbrc.2016.08.148; Maura F, 2018, LEUKEMIA, V32, P1043, DOI 10.1038/leu.2017.345; Mishra N, 2018, J CELL BIOCHEM, V119, P6695, DOI 10.1002/jcb.26855; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Ng JCF, 2019, NUCL ACIDS RES; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Sakasai R, 2010, DNA REPAIR, V9, P76, DOI 10.1016/j.dnarep.2009.10.008; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Sedletska Y, 2007, J MOL BIOL, V369, P27, DOI 10.1016/j.jmb.2007.02.048; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan LL, 2019, APPL BIOCHEM BIOTECH, V187, P1344, DOI 10.1007/s12010-018-2890-4; Shimizu A, 2018, BIOCHEM BIOPHYS REP, V16, P115, DOI 10.1016/j.bbrep.2018.10.010; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Veach RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204487; Vesela E, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010019; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Williams TM, 2013, INT J RADIAT ONCOL, V86, P969, DOI 10.1016/j.ijrobp.2013.04.028; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; Xiao X, 2017, NUCLEIC ACIDS RES, V45, P7494, DOI 10.1093/nar/gkx362; Yamazaki H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43575-y; Yan SM, 2016, J CANCER, V7, P618, DOI 10.7150/jca.14030; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x	69	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0223463	10.1371/journal.pone.0223463	http://dx.doi.org/10.1371/journal.pone.0223463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914134	Green Submitted, Green Published, gold			2022-12-26	WOS:000534337700005
J	Blagburn, JM				Blagburn, Jonathan M.			A new method of recording from the giant fiber of Drosophila melanogaster shows that the strength of its auditory inputs remains constant with age	PLOS ONE			English	Article							COURTSHIP SONG; ESCAPE; NEURONS; SYNAPSES; BEHAVIOR; PATHWAY; REPRESENTATIONS; ACETYLCHOLINE; TRANSDUCTION; MUTATIONS	There have been relatively few studies of how central synapses age in adult Drosophila melanogaster. In this study we investigate the aging of the synaptic inputs to the Giant Fiber (GF) from auditory Johnston's Organ neurons (JONs). In previously published experiments an indirect assay of this synaptic connection was used; here we describe a new, more direct assay, which allows reliable detection of the GF action potential in the neck connective, and long term recording of its responses to sound. Genetic poisoning using diphtheria toxin expressed in the GF with R68A06-GAL4 was used to confirm that this signal indeed arose from the GF and not from other descending neurons. As before, the sound-evoked action potentials (SEPs) in the antennal nerve were recorded via an electrode inserted at the base of the antenna. It was noted that an action potential in the GF elicited an antennal twitch, which in turn evoked a mechanosensory response from the JONs in the absence of sound. We then used these extracellular recording techniques in males and female of different ages to quantify the response of the JONs to a brief sound impulse, and also to measure the strength of the connection between the JONs and the GF. At no age was there any significant difference between males and females, for any of the parameters measured. The sensitivity of the JONs to a sound impulse approximately doubled between 1 d and 10 d after eclosion, which corresponds to the period when most mating is taking place. Subsequently JON sensitivity decreased with age, being approximately half as sensitive at 20 d and onethird as sensitive at 50 d, as compared to 10 d. However, the strength of the connection between the auditory input and the GF itself remained unchanged with age, although it did show some variability that could mask any small changes.	[Blagburn, Jonathan M.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Blagburn, JM (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	jonathan.blagburn@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	National Institutes of Health, National Institute of General Medical Sciences [SC3GM121190]; National Institute on Minority Health and Health Disparities [G12 MD007600]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	JMB is supported by National Institutes of Health, National Institute of General Medical Sciences grant SC3GM121190. The Institute Drosophila resource center is supported by National Institute on Minority Health and Health Disparities G12 MD007600 (Research Centers for Minority Institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript"	Ache JM, 2019, CURR BIOL, V29, P1073, DOI 10.1016/j.cub.2019.01.079; Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Allen MJ, 2010, COLD SPRING HARB PRO, V2010; Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Augustin H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001655; Azpurua J, 2018, AGING CELL, V17, DOI 10.1111/acel.12729; Azpurua J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00208; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; BARNES CA, 1994, TRENDS NEUROSCI, V17, P13, DOI 10.1016/0166-2236(94)90029-9; Bennet-Clark HC, 1967, NATURE, P669, DOI [10.1038/213669a0, DOI 10.1038/213669A0]; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Beramendi A, 2007, J COMP NEUROL, V501, P498, DOI 10.1002/cne.21253; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Boekhoff-Falk G, 2014, WIRES DEV BIOL, V3, P179, DOI 10.1002/wdev.128; Booth D, 2009, J NEUROSCI, V29, P7181, DOI 10.1523/JNEUROSCI.1374-09.2009; Card GM, 2012, CURR OPIN NEUROBIOL, V22, P180, DOI 10.1016/j.conb.2011.12.009; Deutsch D, 2019, CURR BIOL, V29, P3200, DOI 10.1016/j.cub.2019.08.008; Eberl Daniel F, 2011, Cold Spring Harb Protoc, V2011, pprot5576, DOI 10.1101/pdb.prot5576; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fotowat H, 2009, J NEUROPHYSIOL, V102, P875, DOI 10.1152/jn.00073.2009; Fricke C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0428; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Graham LC, 2019, CELL REP, V27, P1018, DOI 10.1016/j.celrep.2019.03.096; Gupta VK, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002563; Haddadi M, 2014, BEHAV BRAIN RES, V259, P60, DOI 10.1016/j.bbr.2013.10.036; Hammer O, 2001, ALEONTOLOGICAL STAT, V4; Hammond S, 2007, J COMP PHYSIOL A, V193, P471, DOI 10.1007/s00359-006-0203-9; Hobert O, 2019, CURR OPIN NEUROBIOL, V56, P97, DOI 10.1016/j.conb.2018.12.006; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ishikawa Y, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00046; Jezzini SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198710; Kadas D, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0181-19.2019; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; Kudumala SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183605; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; LEVINE J, 1973, J COMP PHYSIOL, V87, P213, DOI 10.1007/BF00696043; Leyva-Diaz E, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177378; Mahoney RE, 2014, J NEUROSCI, V34, P2111, DOI 10.1523/JNEUROSCI.3556-13.2014; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Mamiya A, 2011, J NEUROSCI, V31, P6900, DOI 10.1523/JNEUROSCI.0498-11.2011; Marie B, 2002, J NEUROSCI, V22, P832, DOI 10.1523/JNEUROSCI.22-03-00832.2002; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Masoudi N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004979; Miller PB, 2014, FLY, V8, P127, DOI 10.4161/19336934.2014.969144; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Mu LY, 2014, J EXP BIOL, V217, P2121, DOI 10.1242/jeb.099135; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; MURPHEY RK, 1983, J NEUROSCI, V3, P659; Orr BO, 2014, J NEUROSCI, V34, P5416, DOI 10.1523/JNEUROSCI.3183-13.2014; Patella P, 2018, CURR BIOL, V28, P1189, DOI 10.1016/j.cub.2018.02.074; Peters A, 2008, NEUROSCIENCE, V152, P970, DOI 10.1016/j.neuroscience.2007.07.014; Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003; Pezier A, 2014, J NEUROSCI, V34, P11691, DOI 10.1523/JNEUROSCI.1939-14.2014; Pezier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071419; Pezier AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152211; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Rozycka A, 2017, AGING CELL, V16, P634, DOI 10.1111/acel.12605; Ruhmann H, 2016, BEHAV ECOL NARNIA, V27; Ruhmann H, 2018, EXP GERONTOL, V103, P1, DOI 10.1016/j.exger.2017.12.013; Sivan-Loukianova E, 2005, J COMP NEUROL, V491, P46, DOI 10.1002/cne.20687; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; THOMAS JB, 1984, J NEUROSCI, V4, P530; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; TRIMARCHI JR, 1993, J EXP BIOL, V177, P149; von Reyn CR, 2017, NEURON, V94, P1190, DOI 10.1016/j.neuron.2017.05.036; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Von Schilcher F., 1976, Animal Behav, V24, P18, DOI 10.1016/S0003-3472(76)80095-4; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843	78	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0224057	10.1371/journal.pone.0224057	http://dx.doi.org/10.1371/journal.pone.0224057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910219	Green Published, gold, Green Submitted			2022-12-26	WOS:000534333800006
J	Nozato, Y; Takami, Y; Yamamoto, K; Nagasawa, M; Nozato, S; Imaizumi, Y; Takeshita, H; Wang, C; Ito, Y; Takeda, S; Takeya, Y; Sugimoto, K; Nakagami, H; Hanayama, R; Rakugi, H				Nozato, Yoichi; Takami, Yoichi; Yamamoto, Koichi; Nagasawa, Motonori; Nozato, Satoko; Imaizumi, Yuki; Takeshita, Hikari; Wang, Cheng; Ito, Yuki; Takeda, Shuko; Takeya, Yasushi; Sugimoto, Ken; Nakagami, Hironori; Hanayama, Rikinari; Rakugi, Hiromi			Novel properties of myoferlin in glucose metabolism via pathways involving modulation of adipose functions	FASEB JOURNAL			English	Article						adipocyte differentiation; insulin resistance; myoferlin; obesity	MUSCLE FIBER-TYPE; INSULIN SENSITIVITY; MYOBLAST FUSION; SKELETAL; OBESITY; DEFICIENCY; PROTEINS; IMPACT; INJURY; NFAT	While adipose tissue is required to maintain glucose metabolism, excessive calorie intake induces obesity via mechanisms including accelerated proliferation and differentiation of preadipocytes, leading to insulin resistance. Here, we investigated the role of myoferlin (MYOF), a ferlin family protein, in regulating glucose metabolism by mainly focusing on its unknown role in adipose tissue. Whereas young MYOF knockout (KO) mice on a normal diet showed aggravated glucose tolerance and insulin sensitivity, those on a high-fat diet (HFD) showed preserved glucose tolerance with an attenuated gain of body weight, reduced visceral fat deposits, and less severe fatty liver. The Adipose MYOF expression was reduced by aging but was restored by an HFD along with the retained expression of NFAT transcription factors. Loss-of-function of MYOF in preadipocytes suppressed proliferation and differentiation into mature adipocytes along with the decreased expression of genes involved in adipogenesis. The MYOF expression in preadipocytes was reduced with differentiation. Attenuated obesity in MYOF KO mice on an HFD was also accompanied with increased oxygen consumption by an unidentified mechanism and with reduced adipose inflammation due to less inflammatory macrophages. These insights suggest that the multifunctional roles of MYOF involve the regulation of preadipocyte function and affect glucose metabolism bidirectionally depending on consumed calories.	[Nozato, Yoichi; Takami, Yoichi; Yamamoto, Koichi; Nagasawa, Motonori; Nozato, Satoko; Imaizumi, Yuki; Takeshita, Hikari; Wang, Cheng; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ito, Yuki; Takeda, Shuko] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Nakagami, Hironori] Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, Suita, Osaka, Japan; [Hanayama, Rikinari] Kanazawa Univ, Grad Sch Med, Dept Immunol, Kanazawa, Ishikawa, Japan; [Hanayama, Rikinari] Kanazawa Univ, WPI Nano Life Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan	Osaka University; Osaka University; Osaka University; Kanazawa University; Kanazawa University	Takami, Y; Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takami@geriat.med.osaka-u.ac.jp; kyamamoto@geriat.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022; Hanayama, Rikinari/AAO-4959-2021; Takeshita, Hikari/L-9812-2014	Nakagami, Hironori/0000-0003-4494-3601; Hanayama, Rikinari/0000-0003-2102-3386; Takami, Yoichi/0000-0001-9018-6707; Yamamoto, Koichi/0000-0003-0107-9315	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18K08476]; Osaka Medical Research Foundation for Intractable Diseases	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Intractable Diseases	The Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 18K08476; The Osaka Medical Research Foundation for Intractable Diseases	Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Broekema MF, 2019, BBA-MOL CELL BIOL L, V1864, P715, DOI 10.1016/j.bbalip.2019.02.002; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Del Corno M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00265; Demonbreun AR, 2010, J CELL SCI, V123, P2413, DOI 10.1242/jcs.065375; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Haka AS, 2016, J LIPID RES, V57, P980, DOI 10.1194/jlr.M064089; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu L, 2018, J MOL ENDOCRINOL, V61, P79, DOI 10.1530/JME-18-0070; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137; Mikami Y, 2002, J NEUROSURG, V97, P142, DOI 10.3171/spi.2002.97.1.0142; Miyatake Y, 2018, J IMMUNOL, V201, P3051, DOI 10.4049/jimmunol.1800268; PLOUG T, 1987, AM J PHYSIOL, V253, pE12, DOI 10.1152/ajpendo.1987.253.1.E12; Posey AD, 2011, CURR TOP DEV BIOL, V96, P203, DOI 10.1016/B978-0-12-385940-2.00008-5; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YC, 2016, MOL CELL BIOCHEM, V412, P27, DOI 10.1007/s11010-015-2605-x; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	32	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2792	2811		10.1096/fj.201901539RR	http://dx.doi.org/10.1096/fj.201901539RR		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912559				2022-12-26	WOS:000506146900001
J	RingvoldID, H; Moum, T				Ringvold, Halldis; Moum, Truls			On the genus Crossaster (Echinodermata: Asteroidea) and its distribution	PLOS ONE			English	Article							FAROE-SHETLAND CHANNEL; MID-ATLANTIC RIDGE; DEEP-SEA AMPHIPODS; MOLECULAR PHYLOGENY; CONTINENTAL-SHELF; BENTHIC FAUNA; DIVERGENCE; DIVERSITY; MEGAFAUNA; ABUNDANCE	Several starfish (Echinodermata, Asteroidea) are keystone species of marine ecosystems, but some of the species are difficult to identify using morphological criteria only. The common sunstar, Crossaster papposus (Linnaeus, 1767), is a conspicuous species with a wide circumboreal distribution. In 1900, a closely similar species, C. squamatus (Doderlein, 1900) was described from the NE Atlantic Ocean, but subsequent authors have differed in their views on whether this is a valid taxon or rather an ecotype associated with temperature variations. We assessed the differentiating morphological characters of specimens from Norwegian and Greenland waters identified as C. papposus and C. squamatus and compared their distributions in the NE Atlantic as inferred from research cruises. The field data show that C. papposus is found mainly in temperate and shallow waters, whereas C. squamatus resides on the shelf-break in colder, mixed water masses. Intraspecific diversity and interspecific genetic differentiation of the two putative species, and their phylogenetic relationships to several Crossaster congeners worldwide, were explored using mitochondrial and nuclear DNA sequences. The molecular evidence suggests that C. papposus is the more diverse and geographically structured taxon, in line with its wide distribution. C. papposus and C. squamatus are closely related, yet clearly distinct taxa, while C. papposus and C. multispinus H.L. Clark, 1916, the latter from the South Pacific Ocean, are closely related, possibly sister taxa.	[Ringvold, Halldis] Sea Snack Norway, Bergen, Norway; [Moum, Truls] Nord Univ, Fac Biosci & Aquaculture, Genom Div, Bodo, Norway	Nord University	RingvoldID, H (corresponding author), Sea Snack Norway, Bergen, Norway.	halldisr@gmail.com		Moum, Truls/0000-0002-0651-6863; Ringvold, Halldis/0000-0001-5495-0122				Agassiz A., 1877, MEMOIRS MUSEUM COMP; Anisimova N.A., 1989, P281; Anisimova NA, 2003, SARSIA, V88, P113, DOI 10.1080/00364820310000102; Apellof A., 1912, INT C ZOOL GRAZ; Arndt A, 1996, MOL PHYLOGENET EVOL, V6, P425, DOI 10.1006/mpev.1996.0091; Bell FJ, 1892, CATALOGUE BRIT ECHIN; Birk MH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2743; BLAKE DB, 1993, PALAEONTOLOGY, V36, P147; Brandt JF, 1835, PRODROMUS DESCRIPTIO; Buhl-Mortensen L, 2015, NEW KNOWLEDGE MAREAN; Clark A.M., 1992, P1; Clark Ailsa M., 1996, Echinoderm Studies, V5, P183; Clark HL, 1923, AM NAT, V57, P229, DOI 10.1086/279917; Clark HL, 1916, ENDEAVOUR COASTS QUE; Copley JTP, 1996, OCEANOL ACTA, V19, P549; Danielssen DC, 1882, ANN MAG NAT HIST, V10, P436; Dauvin JC, 2012, DEEP-SEA RES PT I, V68, P12, DOI 10.1016/j.dsr.2012.04.013; de Clusius C, 1605, EXOTICORUM LIBRI DEC; Djakonov A. M., 1950, Tableaux Analytique de la Faune de l'URSS, V34, P1; Doderlein L., 1900, WISSENSCHAFTLICHE ME, V4, P195; Dons C., 1935, KGL NORSKE VIDENSK S, V8, P29; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Einarsson H., 1948, ZOOLOGY ICELAND, V4; Fisher W. K., 1913, Proceedings of the United States National Museum Smithsonian Institution Washington, V46; Fisher W. K., 1905, Bull U S Bureau Fisheries, Vxxiv, P291; Fisher WK, 1911, B US NATN MUS, P76; Fisher WK, 1940, ASTEROIDEA DISCOV RE, V20, P69; Fisher WK, 1906, P WASHINGTON ACAD SC, V8, P111; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; FRANCE SC, 1994, MAR BIOL, V118, P67, DOI 10.1007/BF00699220; FRANZ DR, 1981, BIOL BULL-US, V160, P394, DOI 10.2307/1540848; Gage J.D., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P263; GAGE JD, 1986, P ROY SOC EDINB B, V88, P159, DOI 10.1017/S026972700000453X; Gale KS, 2014, MAR ECOL, V36, P734; Gebruk AV, 2010, J MAR BIOL ASSOC UK, V90, P1, DOI 10.1017/S0025315409991111; Grainger EH, 1966, FISHERIES RES BOARD, P1; Grieg J. A., 1919, Annals & Magazine of Natural History, V3; Grieg JA, 1907, REPORT 2 NORWEGIAN A, V2, P1; Grieg JA, 1906, BERGENS MUS AARB, V13, P1; Gulliksen B, 1999, 19994 DN; Haedrich RL, 1984, P 5 INT ECH C GALW 2, P37, DOI DOI 10.1201/9781003079224-7; Hansson HG, 1999, EUROPEAN ECHINODERMA; Harvey R., 1988, Bulletin of the British Museum (Natural History) Zoology, V54, P153; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernroth B, 2011, AQUAT TOXICOL, V103, P222, DOI 10.1016/j.aquatox.2011.03.001; Hofsten N., 1915, KUNGLIGA SVENSKA VET, V54, P1; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Jamieson A, 2015, HADAL ZONE: LIFE IN THE DEEPEST OCEANS, P241; Jones DOB, 2007, DEEP-SEA RES PT I, V54, P1111, DOI 10.1016/j.dsr.2007.04.001; Jorgensen LL, 2015, ICES J MAR SCI, V72, P595, DOI 10.1093/icesjms/fsu106; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Koehler R., 1909, CAMP SCI MONACO, VXXXIV, P34; Korcheck K., 2015, THESIS FACULTY HUMBO; Kumar S, 2018, MOL BIOL EVOL, V35, P1, DOI 10.1093/molbev/msx313; Lawrence M, 2013, STARFISH BIOL ECOLOG; Layton KKS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166118; Lieberkind I., 1929, ZOOLOGY FAROES 1928, V3, P1; Loeza-Quintana T, 2018, J MOL EVOL, V86, P118, DOI 10.1007/s00239-018-9831-2; Mah C.L., 2019, CROSSASTER; Mah C, 2011, ZOOL J LINN SOC-LOND, V161, P769, DOI 10.1111/j.1096-3642.2010.00659.x; Mah Christopher L., 2009, P371; Mah CL, 1900, CROSSASTER SQUAMATUS; McKnight DG, 2006, MARINE FAUNA NZ ECHI; McKnight DG, 1973, NZOI RECORDS, V2, P1; Menge BA, 2013, STARFISH BIOL ECOLOG, P67; Mortensen T., 1927, HDB ECHINODERMS BRIT; Murray J, 1912, DEPTHS OCEAN; ostergren H., 1904, ZOOLOGISCHE ANZEIGER, V27, P614; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Petrov NB, 2016, BIOCHEMISTRY-MOSCOW+, V81, P972, DOI 10.1134/S0006297916090066; Ringvold H, 2016, DEEP-SEA RES PT I, V107, P22, DOI 10.1016/j.dsr.2015.09.004; Ringvold H, 2001, HYDROBIOLOGIA, V459, P57, DOI 10.1023/A:1012539821086; Ringvold H., 1996, THESIS; Ringvold H, 2015, MAR BIOL RES, V11, P62, DOI 10.1080/17451000.2014.889308; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; Scholz J, 2012, SPIXIANA, V35, P177; Schorygin A. A., 1928, Bericht des Wissenschaftlichen Meeresinstituts Moscow, V3, P1; Sladen WP, 1889, ZOOLOGY, V30, P51; Sladen WP, 1882, P ROY SOC EDINB, V11, P698; STEWART PL, 1985, ARCTIC, V38, P281; Turrell WR, 1999, DEEP-SEA RES PT I, V46, P1, DOI 10.1016/S0967-0637(98)00067-3; Verrill AE, 1914, HARRIMAN ALASKA SERI, V14, P1, DOI DOI 10.5962/BHL.TITLE.25926; Ward RD, 2008, MOL ECOL RESOUR, V8, P1202, DOI 10.1111/j.1755-0998.2008.02332.x; WILSON GDF, 1987, ANNU REV ECOL SYST, V18, P185, DOI 10.1146/annurev.es.18.110187.001153	88	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227223	10.1371/journal.pone.0227223	http://dx.doi.org/10.1371/journal.pone.0227223			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB5RZ	31910238	Green Published, gold			2022-12-26	WOS:000524694500001
J	Gresner, P; Jablonska, E; Gromadzinska, J				Gresner, Peter; Jablonska, Ewa; Gromadzinska, Jolanta			Rad51 paralogs and the risk of unselected breast cancer: A case-control study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; REPAIR GENE XRCC3; CELL-CYCLE PROGRESSION; HOMOLOGOUS RECOMBINATION; FANCONI-ANEMIA; THR241MET POLYMORPHISM; SUSCEPTIBILITY; ASSOCIATION; METAANALYSIS; PROTEIN	A case-control study was conducted in which we evaluated the association between genetic variability of DNA repair proteins belonging to the Rad51 family and breast cancer (BrC) risk. In the study, 132 female BrC cases and 189 healthy control females were genotyped for a total of 14 common single nucleotide polymorphisms (SNPs) within Rad51 and Xrcc3. Moreover, our previously reported Rad51C genetic data were involved to explore the nonlinear interactions among SNPs within the three genes and effect of such interactions on BrC risk. The rare rs5030789 genotype ((-4601) AA) in Rad51 was found to significantly decrease the BrC risk (OR = 0.5, 95% CI: 0.3-1.0, p < 0.05). An interaction between this SNP, rs2619679 and rs2928140 (both in Rad51), was found to result in a two three-locus genotypes (-4719)AA/(-4601) AA/(2972) CG and (-4719)AT/-(4601) GA/(2972) CC, both of which were found to increase the risk of BrC (OR = 8.4, 95% CI: 1.8-38.6, p < 0.0001), instead. Furthermore, rare Rad51 rs1801320 ((135) CC) and heterozygous Xrcc3 rs3212057 ((10343) GA) genotypes were found to respectively increase (OR = 10.6, 95% CI: 1.9-198, p < 0.02) and decrease (OR = 0.0, 95% CI: 0.0-NA, p< 0.05) the risk of BrC. Associations between these SNPs and BrC risk were further supported by outcomes of employed machine learning analyses. In Xrcc3, the (4541) A/(9685) A haplotype was found to be significantly associated with reduced BrC risk (OR = 0.5; 95% CI: 0.3-0.9; p < 0.05). Concluding, our study indicates a complex role of SNPs within Rad51 (especially rs5030789) and Xrcc3 in BrC, although their significance with respect to the disease needs to be further clarified.	[Gresner, Peter] Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland; [Jablonska, Ewa] Nofer Inst Occupat Med, Dept Mol Genet & Epigenet, Lodz, Poland; [Gromadzinska, Jolanta] Nofer Inst Occupat Med, Dept Biol & Environm Monitoring, Lodz, Poland	Nofer Institute of Occupational Medicine; Nofer Institute of Occupational Medicine; Nofer Institute of Occupational Medicine	Gresner, P (corresponding author), Nofer Inst Occupat Med, Dept Toxicol & Carcinogenesis, Lodz, Poland.	peter.gresner@imp.lodz.pl	Grešner, Peter/G-5905-2010; Jablonska, Ewa/F-6005-2010	Gresner, Peter/0000-0002-7008-396X; Jablonska, Ewa/0000-0002-3946-3964; Gromadzinska, Jolanta/0000-0001-6878-2297	Nofer Institute of Occupational Medicine funds [IMP 1.5/2009, IMP 1.5/2011]	Nofer Institute of Occupational Medicine funds	This study was supported by the Nofer Institute of Occupational Medicine funds No. IMP 1.5/2009 and IMP 1.5/2011.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; Al-Zoubi MS, 2016, BIOCHEM GENET, V54, P83, DOI 10.1007/s10528-015-9703-z; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chai F, 2015, MED SCI MONITOR, V21, P3231, DOI 10.12659/MSM.894033; Chang WS, 2015, ANTICANCER RES, V35, P4691; Chen HJ, 2015, ANTICANCER RES, V35, P3893; Clague J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025632; De Leeneer K, 2012, BREAST CANCER RES TR, V133, P393, DOI 10.1007/s10549-012-1998-4; Ding SL, 2009, CARCINOGENESIS, V30, P43, DOI 10.1093/carcin/bgn233; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gresner P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110696; Gresner P, 2012, GENE, V504, P166, DOI 10.1016/j.gene.2012.05.030; Hankin RKS, PACKAGE PERMUTATIONS; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; He XF, 2013, GENE, V523, P10, DOI 10.1016/j.gene.2013.03.071; He XF, 2012, MOL BIOL REP, V39, P5125, DOI 10.1007/s11033-011-1308-y; Ishwaran H, 2019, FAST UNIFIED RANDOM; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Kulakovskiy IV, 2015, P INT C BIOINF MOD M, V1, P102, DOI DOI 10.5220/0005189301020108; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kurumizaka H, 2003, NUCLEIC ACIDS RES, V31, P4041, DOI 10.1093/nar/gkg442; Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368; LEWONTIN RC, 1995, GENETICS, V140, P377; Li J, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0093-5; Liu JC, 2015, CHINESE J PHYSIOL, V58, P64, DOI 10.4077/CJP.2015.BAD279; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lu JC, 2007, CARCINOGENESIS, V28, P988, DOI 10.1093/carcin/bgl225; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Mao CF, 2014, ASIAN PAC J CANCER P, V15, P6613, DOI 10.7314/APJCP.2014.15.16.6613; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Michalska MM, 2015, PATHOL ONCOL RES, V21, P935, DOI 10.1007/s12253-015-9922-y; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nowacka-Zawisza M, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/828646; Pang ZY, 2011, BREAST CANCER RES TR, V129, P1019, DOI 10.1007/s10549-011-1574-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pomerleau CS, 2004, ADDICT BEHAV, V29, P1149, DOI 10.1016/j.addbeh.2004.03.008; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Rollinson S, 2007, LEUKEMIA RES, V31, P169, DOI 10.1016/j.leukres.2006.05.028; Romanowicz H, 2017, PATHOL ONCOL RES, V23, P117, DOI 10.1007/s12253-016-0110-5; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sassi A, 2013, PATHOL ONCOL RES, V19, P451, DOI 10.1007/s12253-013-9602-8; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sekhar D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11588; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smolarz B, 2015, CLIN EXP MED, V15, P151, DOI 10.1007/s10238-014-0284-7; Smolarz B, 2013, POL J PATHOL, V64, P39, DOI 10.5114/PJP.2013.34602; Somyajit K, 2012, J BIOL CHEM, V287, P3366, DOI 10.1074/jbc.M111.311241; Spitz MR, 2009, J NATL CANCER I, V101, P1731, DOI 10.1093/jnci/djp394; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Su CH, 2015, CANCER GENOM PROTEOM, V12, P359; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Tulbah S, 2016, ONCOTARGETS THER, V9, P269, DOI 10.2147/OTT.S93343; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Yoo S, 2004, CHROMOSOMA, V113, P92, DOI 10.1007/s00412-004-0300-x; Zhang BB, 2014, FAM CANCER, V13, P515, DOI 10.1007/s10689-014-9729-0; Zhao MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087259; Zheng YL, 2010, BREAST CANCER RES TR, V124, P857, DOI 10.1007/s10549-010-1095-5	69	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226976	10.1371/journal.pone.0226976	http://dx.doi.org/10.1371/journal.pone.0226976			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905201	Green Submitted, gold, Green Published			2022-12-26	WOS:000534327700012
J	Ali, SR; Malone, TJ; Zhang, YL; Prechova, M; Kaczmarek, LK				Ali, Syed Rydwan; Malone, Taylor Joseph; Zhang, Yalan; Prechova, Magdalena; Kaczmarek, Leonard Konrad			Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1)	FASEB JOURNAL			English	Article						dephosphorylation; epilepsy; intellectual disability; KCNT1; Phactr1; Slack channels	MENTAL-RETARDATION PROTEIN; MIGRATING PARTIAL SEIZURES; K+ CHANNELS; MUTATIONS; EPILEPSY; LEUKOENCEPHALOPATHY; MEMBRANE; CURRENTS; NEURONS; FAMILY	The Slack (KCNT1) gene encodes sodium-activated potassium channels that are abundantly expressed in the central nervous system. Human mutations alter the function of Slack channels, resulting in epilepsy and intellectual disability. Most of the disease-causing mutations are located in the extended cytoplasmic C-terminus of Slack channels and result in increased Slack current. Previous experiments have shown that the C-terminus of Slack channels binds a number of cytoplasmic signaling proteins. One of these is Phactr1, an actin-binding protein that recruits protein phosphatase 1 (PP1) to certain phosphoprotein substrates. Using co-immunoprecipitation, we found that Phactr1 is required to link the channels to actin. Using patch clamp recordings, we found that co-expression of Phactr1 with wild-type Slack channels reduces the current amplitude but has no effect on Slack channels in which a conserved PKC phosphorylation site (S407) that regulates the current amplitude has been mutated. Furthermore, a Phactr1 mutant that disrupts the binding of PP1 but not that of actin fails to alter Slack currents. Our data suggest that Phactr1 regulates the Slack by linking PP1 to the channel. Targeting Slack-Phactr1 interactions may therefore be helpful in developing the novel therapies for brain disorders associated with the malfunction of Slack channels.	[Ali, Syed Rydwan; Malone, Taylor Joseph; Zhang, Yalan; Kaczmarek, Leonard Konrad] Yale Sch Med, Dept Pharmacol, Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA; [Prechova, Magdalena] Francis Crick Inst, Signalling & Transcript Grp, London, England; [Prechova, Magdalena] Czech Acad Sci, Lab Integrat Biol, Inst Mol Genet, Prague, Czech Republic; [Kaczmarek, Leonard Konrad] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA	Yale University; Francis Crick Institute; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Yale University	Kaczmarek, LK (corresponding author), Yale Sch Med, Dept Pharmacol, Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	, WaNgtJ/AAR-7045-2020; Přechová, Magdalena/AAO-3848-2020	Přechová, Magdalena/0000-0002-4591-854X	NIH [R01DC001919, 1R01NS102239, GM007324]; FRAXA; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship [F32HD093292]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship	This work is supported by NIH R01DC001919 (LKK), NIH 1R01NS102239, FRAXA (LKK), Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship under Award Number F32HD093292 (SRA) and NIH Grant GM007324 (TJM)	Abekhoukh S, 2017, DIS MODEL MECH; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Arai-Ichinoi N, 2016, HUM GENET, V135, P89, DOI 10.1007/s00439-015-1617-7; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bausch AE, 2015, LEARN MEMORY, V22, P323, DOI 10.1101/lm.037820.114; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Evely KM, 2017, NEUROSCIENCE, V351, P65, DOI 10.1016/j.neuroscience.2017.03.035; Fleming MR, 2016, CELL REP, V16, P2281, DOI 10.1016/j.celrep.2016.07.024; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Hamada N, 2018, BRAIN, V141, P3098, DOI 10.1093/brain/awy246; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Huang Y, 2015, J INVERTEBR PATHOL, V127, P1, DOI 10.1016/j.jip.2015.01.007; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Ito H, 2018, NEUROSCI RES, V128, P50, DOI 10.1016/j.neures.2017.08.002; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Juang JMJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06733; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; Kaczmarek LK, 2014, NEUROSCI ABSTR, V126.08, P153; Kang S, 2014, J BIOL CHEM, V289, P11536, DOI 10.1074/jbc.M113.528497; Kelloniemi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130502; Kim GE, 2014, CELL REP, V9, P1661, DOI 10.1016/j.celrep.2014.11.015; Kim GE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00209; Kim JY, 2012, NEUROSCIENCE, V221, P37, DOI 10.1016/j.neuroscience.2012.06.059; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Lim CX, 2016, J MED GENET, V53, P217, DOI 10.1136/jmedgenet-2015-103508; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Ohba C, 2015, EPILEPSIA, V56, pE121, DOI 10.1111/epi.13072; Park HA, 2017, CELL DEATH DIFFER, V24, P1963, DOI 10.1038/cdd.2017.123; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Prechova M, 2018, SIGNALLING TRANSCRIP; Quraishi IH, 2019, J NEUROSCI, V39, P7438, DOI 10.1523/JNEUROSCI.1628-18.2019; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Vanderver A, 2014, PEDIATR NEUROL, V50, P112, DOI 10.1016/j.pediatrneurol.2013.06.024; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Zhang Y, 2017, J NEUROSCI, V37, P2258, DOI 10.1523/JNEUROSCI.3102-16.2017; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	48	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1591	1601		10.1096/fj.201902366R	http://dx.doi.org/10.1096/fj.201902366R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914597	Bronze, Green Accepted			2022-12-26	WOS:000507308900105
J	Liu, YY; Wang, CR; Li, JS; Li, TT; Zhang, Y; Liang, YX; Mei, YX				Liu, Yangyang; Wang, Chaorui; Li, Jinshan; Li, Tiantian; Zhang, Yong; Liang, Yunxiang; Mei, Yuxia			Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition	FASEB JOURNAL			English	Article						gut microbiota; insulin signaling; inflammation; Phellinus linteus polysaccharide; short-chain fatty acids	CHAIN FATTY-ACIDS; DIETARY FIBER; AGARICUS-BISPORUS; OBESITY; STREPTOZOTOCIN; METABOLISM; FERMENTATION; DYSFUNCTION; INDIVIDUALS; METAGENOME	The hypoglycemic effect of Phellinus linteus polysaccharide extract (PLPE) has been documented in several previous studies, but the functional interactions among PLPE, gut microbiota, and the hypoglycemic effect remain unclear. We examined the regulatory effect of PLPE on gut microbiota, and the molecular mechanism underlying improvement of insulin resistance, using a type 2 diabetic rat model. Here, 24 male Sprague-Dawley rats were randomly divided into four groups that were subjected to intervention of saline (normal and model control group), metformin (120 mg/kg.bw), and PLPE (600 mg/kg.bw) by oral administration. After 8 weeks of treatment, PLPE increased levels of short-chain fatty acids (SCFAs) by enhancing abundance of SCFA-producing bacteria. SCFAs maintained intestinal barrier function and reduced lipopolysaccharides content in blood, thereby helping to reduce systemic inflammation and reverse insulin resistance. Our findings suggest that PLPE (in which polysaccharides are the major component) has potential application as a prebiotic for regulating gut microbiota composition in diabetic patients.	[Liu, Yangyang; Wang, Chaorui; Li, Jinshan; Li, Tiantian; Zhang, Yong; Liang, Yunxiang; Mei, Yuxia] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Mei, Yuxia] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Huazhong Agricultural University; University of California System; University of California Davis	Mei, YX (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.	mei@mail.hzau.edu.cn	Li, Jinshan/AAQ-9461-2020	Li, Jinshan/0000-0003-3109-5092	State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University; Fundamental Research Funds for the Central Universities of China [2662019PY066, 2662016PY132]; China Scholarship Council [201706765055]	State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); China Scholarship Council(China Scholarship Council)	This study was supported by funds from the State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Fundamental Research Funds for the Central Universities of China (grant No. 2662019PY066, No. 2662016PY132), and a special grant from China Scholarship Council (No. 201706765055). The authors are grateful to Dr. S. Anderson for English editing of the manuscript.	Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Chen H, 2016, FITOTERAPIA, V113, P6, DOI 10.1016/j.fitote.2016.06.009; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; de Assis AM, 2009, EXP BIOL MED, V234, P1296, DOI 10.3181/0904-RM-126; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Ding QA, 2017, FOOD HYDROCOLLOID, V63, P646, DOI 10.1016/j.foodhyd.2016.10.018; Duan YH, 2019, FASEB J, V33, P10019, DOI 10.1096/fj.201900665RR; Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feng H, 2018, CARBOHYD POLYM, V200, P144, DOI 10.1016/j.carbpol.2018.07.086; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Hehemann JH, 2019, ISME J, V13, P1883, DOI 10.1038/s41396-019-0406-z; Hu T, 2018, CARBOHYD POLYM, V200, P487, DOI 10.1016/j.carbpol.2018.08.021; Hwang HJ, 2008, KOREAN J CHEM ENG, V25, P308, DOI 10.1007/s11814-008-0054-x; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jayachandran M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091934; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kieler IN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41195-0; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Liu YY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020296; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142; Martens EC, 2018, NAT REV MICROBIOL, V16, P457, DOI 10.1038/s41579-018-0036-x; Mei YX, 2015, CARBOHYD POLYM, V124, P90, DOI 10.1016/j.carbpol.2015.02.009; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Palacio J C, 1990, Nutr Clin Pract, V5, P99, DOI 10.1177/011542659000500399; Puddu Alessandra, 2014, Mediators Inflamm, V2014, P162021, DOI 10.1155/2014/162021; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040; Singh A, 2019, FASEB J, V33, P6748, DOI 10.1096/fj.201801627RRR; Solano-Aguilar GI, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111721; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Tian Y, 2018, J FUNCT FOODS, V45, P223, DOI 10.1016/j.jff.2018.04.008; Uyanoglu M, 2014, INT J FOOD SCI NUTR, V65, P482, DOI 10.3109/09637486.2013.869796; Vanegas SM, 2017, AM J CLIN NUTR, V105, P635, DOI 10.3945/ajcn.116.146928; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wan Y, 2019, GUT, V68, P1417, DOI 10.1136/gutjnl-2018-317609; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Yang WY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205784; You YM, 2015, FOOD FUNCT, V6, P3144, DOI 10.1039/c5fo00432b; Zhang BW, 2018, J FUNCT FOODS, V46, P256, DOI 10.1016/j.jff.2018.04.070; Zhao C, 2014, J FOOD SCI, V79, pH1002, DOI 10.1111/1750-3841.12464; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhou D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01751-y	55	34	37	3	70	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1065	1078		10.1096/fj.201901943RR	http://dx.doi.org/10.1096/fj.201901943RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914668				2022-12-26	WOS:000507308900072
J	Ricci, A; Galluzzi, L; Magnani, M; Menotta, M				Ricci, Anastasia; Galluzzi, Luca; Magnani, Mauro; Menotta, Michele			DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia	FASEB JOURNAL			English	Article						ataxia telangiectasia; DDIT4; dexamethasone; HDAC4	HISTONE DEACETYLASE 4; NEUROLOGICAL SYMPTOMS; LOADING CONTROL; ATM DEFICIENCY; CELL-GROWTH; DNA-DAMAGE; MTOR; DEXAMETHASONE; LC3; BETAMETHASONE	Ataxia telangiectasia (AT) is a rare, severe, and ineluctably progressive multisystemic neurodegenerative disease. Histone deacetylase 4 (HDAC4) nuclear accumulation has been related to neurodegeneration in AT. Since treatment with glucocorticoid analogues has been shown to improve the neurological symptoms that characterize this syndrome, the effects of dexamethasone on HDAC4 were investigated. In this paper, we describe a novel nonepigenetic function of HDAC4 induced by dexamethasone, through which it can directly modulate HIF-1a activity and promote the upregulation of the DDIT4 gene and protein expression. This new HDAC4 transcription regulation mechanism leads to a positive effect on autophagic flux, an AT-compromised biological pathway. This signaling was specifically induced by dexamethasone only in AT cell lines and can contribute in explaining the positive effects of dexamethasone observed in AT-treated patients.	[Ricci, Anastasia; Galluzzi, Luca; Magnani, Mauro; Menotta, Michele] Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, Italy	University of Urbino	Ricci, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, Italy.	anastasia.ricci@uniurb.it	Magnani, Mauro/A-1919-2008; Galluzzi, Luca/G-3969-2012	Galluzzi, Luca/0000-0002-1747-526X; Magnani, Mauro/0000-0001-6456-6626	EC | Horizon 2020 (EU Framework Programme for Research and Innovation) [667946]; FanoAteneo	EC | Horizon 2020 (EU Framework Programme for Research and Innovation); FanoAteneo	EC | Horizon 2020 (EU Framework Programme for Research and Innovation), Grant/Award Number: 667946; FanoAteneo	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Alexander A, 2010, AUTOPHAGY, V6, P672, DOI 10.4161/auto.6.5.12509; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Cirillo E, 2018, EUR J NEUROL, V25, P833, DOI 10.1111/ene.13606; D'Assante R, 2017, CLIN IMMUNOL, V175, P16, DOI 10.1016/j.clim.2016.11.015; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Du F, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0315-y; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Leuzzi V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000098; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Mani M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8394; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Menotta M, 2017, MOL CELL BIOCHEM, V12, P126, DOI DOI 10.1186/S13023-017-0669-2; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Menotta M, 2017, CELL BIOCHEM BIOPHYS, V75, P95, DOI 10.1007/s12013-016-0775-0; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Menotta M, 2010, BIOSENS BIOELECTRON, V25, P2490, DOI 10.1016/j.bios.2010.04.022; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molitoris JK, 2011, J BIOL CHEM, V286, P30181, DOI 10.1074/jbc.M111.245423; Napione L, 2012, BLOOD, V119, P5599, DOI 10.1182/blood-2011-11-390666; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Peng C, 2012, J BIOL CHEM, V287, P32861, DOI 10.1074/jbc.M112.384305; Polman JAE, 2012, ENDOCRINOLOGY, V153, P4317, DOI 10.1210/en.2012-1255; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Rybak JN, 2004, PROTEOMICS, V4, P2296, DOI 10.1002/pmic.200300780; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Tang YF, 2016, ONCOTARGET, V7, P15854, DOI 10.18632/oncotarget.7493; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Wolff NC, 2014, MOL CANCER RES, V12, P867, DOI 10.1158/1541-7786.MCR-13-0625; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126	87	6	6	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1802	1818		10.1096/fj.201902039R	http://dx.doi.org/10.1096/fj.201902039R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914654	hybrid, Green Published			2022-12-26	WOS:000507308900119
J	Wang, C; Feng, YP; Zhang, CY; Cheng, D; Wu, RY; Yang, YQ; Sargsyan, D; Kumar, D; Kong, AN				Wang, Chao; Feng, Yaping; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kumar, Dibyendu; Kong, Ah-Ng			PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer	FASEB JOURNAL			English	Article						CXCL1; DNA methylation; prostate cancer; PTEN; transcriptome	TUMOR-SUPPRESSOR; MICROSATELLITE INSTABILITY; EPIGENETIC REACTIVATION; PROMOTER METHYLATION; INFLAMMATION; CXCL1; GENE; INACTIVATION; EXPRESSION; BREAST	Phosphatase and tensin homolog located on chromosome 10 (PTEN) is a tumor suppressor gene and one of the most frequently mutated/deleted genes in human prostate cancer (PCa). However, how PTEN deletion would impact the epigenome and transcriptome alterations remain unknown. This hypothesis was tested in a prostate-specific PTEN-/- (KO) mouse prostatic adenocarcinoma model through DNA methyl-Seq and RNA-Seq analyses. Examination of cancer genomic datasets revealed that PTEN is expressed at lower levels in PTEN-deleted tumor samples than in normal solid tissue samples. Methylome and transcriptome profiling identified several inflammatory responses and immune response signaling pathways, including NF-kB signaling, IL-6 signaling, LPS/IL-1-mediated inhibition of RXR Function, PI3K in B lymphocytes, iCOS-iCOSL in T helper cells, and the role of NFAT in regulating the immune response, were affected by PTEN deletion. Importantly, a small subset of genes that showed DNA hypermethylation or hypomethylation was correlated with decreased or increased gene expression including CXCL1. quantitative polymerase chain reaction analyses of representative genes validated the RNA-Seq results. Histopathological examinations showed that the severity of prostatic intraepithelial neoplasia and inflammation development gradually increased as PTEN null mice aged. Collectively, these findings suggest that loss of PTEN drives global changes in DNA CpG methylation and transcriptomic gene expression and highly associated with several inflammatory and immune molecular pathways during PCa development. These biomarkers could be valuable molecular targets for cancer drug discovery and development against PCa.	[Wang, Chao; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kong, Ah-Ng] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ USA; [Wang, Chao; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kong, Ah-Ng] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Phytochem Epigenome Studies, Piscataway, NJ USA; [Feng, Yaping; Kumar, Dibyendu] Rutgers State Univ, Waksman Inst Microbiol, Genom Core Facil, Piscataway, NJ USA; [Cheng, David; Sargsyan, Davit] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kong, AN (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Phytochem Epigenome Studies, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	KongT@pharmacy.rutgers.edu	Sargsyan, Davit/AHB-2158-2022; Kong, Ah-Ng Tony/AAX-2828-2020	Sargsyan, Davit/0000-0003-1594-6715	HHS \ NIH \ National Center for Complementary and Integrative Health (NCCIH) [AT009152, R01AT007065]; HHS \ NIH \ National Cancer Institute (NCI) [CA200129]	HHS \ NIH \ National Center for Complementary and Integrative Health (NCCIH); HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Center for Complementary and Integrative Health (NCCIH), Grant/Award Number: AT009152 and R01AT007065; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA200129	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Birbach A, 2011, NEOPLASIA, V13, P692, DOI 10.1593/neo.11524; Boyanapalli SSS, 2016, PHARMACOL RES, V114, P175, DOI 10.1016/j.phrs.2016.10.021; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dluzniewski PJ, 2012, CANCER EPIDEM BIOMAR, V21, P1774, DOI 10.1158/1055-9965.EPI-12-0458; Dugue PA, 2018, PROSTATE, V78, P962, DOI 10.1002/pros.23654; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Garcia AJ, 2014, MOL CELL BIOL, V34, P2017, DOI 10.1128/MCB.00090-14; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Geybels MS, 2017, ONCOTARGET, V8, P84338, DOI 10.18632/oncotarget.20940; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Graca I, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0264-8; Guo Y, 2017, BIOCHEM PHARMACOL, V135, P22, DOI 10.1016/j.bcp.2017.02.021; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Huang FY, 2013, EUR J CANCER, V49, P2760, DOI 10.1016/j.ejca.2013.03.031; Huidobro C, 2012, EUR J CANCER, V48, P2270, DOI 10.1016/j.ejca.2011.12.019; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100; Khor TO, 2014, CANCER PREV RES, V7, P1186, DOI 10.1158/1940-6207.CAPR-14-0127; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maxwell PJ, 2013, EUR UROL, V64, P177, DOI 10.1016/j.eururo.2012.08.032; Miyake M, 2019, THERANOSTICS, V9, P853, DOI 10.7150/thno.29553; Miyake M, 2014, PATHOL RES PRACT, V210, P74, DOI 10.1016/j.prp.2013.08.013; Piras G, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-16; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez-Berriguete G, 2013, CYTOKINE, V64, P555, DOI 10.1016/j.cyto.2013.09.003; Roh MR, 2016, J INVEST DERMATOL, V136, P1002, DOI 10.1016/j.jid.2016.01.024; Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S; Song EY, 2010, CANCER RES, V70, P4394, DOI 10.1158/0008-5472.CAN-10-0427; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Su ZY, 2013, CHEM RES TOXICOL, V26, P477, DOI 10.1021/tx300524p; Tommasi S, 2005, CANCER RES, V65, P92; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Wang N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0876-3; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wu Y, 2016, EPIGENETICS-US, V11, P247, DOI 10.1080/15592294.2016.1148867; Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	57	13	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1304	1318		10.1096/fj.201901205RR	http://dx.doi.org/10.1096/fj.201901205RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914691	Green Accepted			2022-12-26	WOS:000507308900087
J	Cuello, C; Baldy, A; Brunaud, V; Joets, J; Delannoy, E; Jacquemot, MP; Botran, L; Griveau, Y; Guichard, C; Soubigou-Taconnat, L; Martin-Magniette, ML; Leroy, P; Mechin, V; Reymond, M; Coursol, S				Cuello, Clement; Baldy, Aurelie; Brunaud, Veronique; Joets, Johann; Delannoy, Etienne; Jacquemot, Marie-Pierre; Botran, Lucy; Griveau, Yves; Guichard, Cecile; Soubigou-Taconnat, Ludivine; Martin-Magniette, Marie-Laure; Leroy, Philippe; Mechin, Valerie; Reymond, Matthieu; Coursol, Sylvie			A systems biology approach uncovers a gene co-expression network associated with cell wall degradability in maize	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PLANT CYSTEINE OXIDASES; ALDO-KETO REDUCTASES; LOCI AFFECTING FIBER; GENOME-WIDE ANALYSIS; LIGNIN CONTENT; MOLECULAR-BASIS; QUALITY TRAITS; TOP-CROSS; PROTEIN	Understanding the mechanisms triggering variation of cell wall degradability is a prerequisite to improving the energy value of lignocellulosic biomass for animal feed or biorefinery. Here, we implemented a multiscale systems approach to shed light on the genetic basis of cell wall degradability in maize. We demonstrated that allele replacement in two pairs of near-isogenic lines at a region encompassing a major quantitative trait locus (QTL) for cell wall degradability led to phenotypic variation of a similar magnitude and sign to that expected from a QTL analysis of cell wall degradability in the F271 x F288 recombinant inbred line progeny. Using DNA sequences within the QTL interval of both F271 and F288 inbred lines and Illumina RNA sequencing datasets from internodes of the selected near-isogenic lines, we annotated the genes present in the QTL interval and provided evidence that allelic variation at the introgressed QTL region gives rise to coordinated changes in gene expression. The identification of a gene co-expression network associated with cell wall-related trait variation revealed that the favorable F288 alleles exploit biological processes related to oxidation-reduction, regulation of hydrogen peroxide metabolism, protein folding and hormone responses. Nested in modules of co-expressed genes, potential new cell-wall regulators were identified, including two transcription factors of the group VII ethylene response factor family, that could be exploited to fine-tune cell wall degradability. Overall, these findings provide new insights into the regulatory mechanisms by which a major locus influences cell wall degradability, paving the way for its map-based cloning in maize.	[Cuello, Clement; Baldy, Aurelie; Jacquemot, Marie-Pierre; Botran, Lucy; Griveau, Yves; Mechin, Valerie; Reymond, Matthieu; Coursol, Sylvie] Univ Paris Saclay, Inst Jean Pierre Bourgin, CNRS, AgroParisTech,INRA, Versailles, France; [Brunaud, Veronique; Delannoy, Etienne; Guichard, Cecile; Soubigou-Taconnat, Ludivine; Martin-Magniette, Marie-Laure] Univ Paris Saclay, Univ Evry, Univ Paris Sud, Inst Plant Sci Paris Saclay,CNRS,INRA, Gif Sur Yvette, France; [Brunaud, Veronique; Delannoy, Etienne; Guichard, Cecile; Soubigou-Taconnat, Ludivine; Martin-Magniette, Marie-Laure] Univ Paris Diderot, Sorbonne Paris Cite, Inst Plant Sci Paris Saclay, CNRS,INRA, Gif Sur Yvette, France; [Joets, Johann] Univ Paris Saclay, Genet Quantitat & Evolut Le Moulon, INRA, Univ Paris Sud,CNRS,AgroParisTech, Gif Sur Yvette, France; [Martin-Magniette, Marie-Laure] Univ Paris Saclay, INRA, AgroParisTech, UMR MIA Paris, Paris, France; [Leroy, Philippe] UCA, INRA, GDEC, Clermont Ferrand, France; [Cuello, Clement] INRA, ONF, UMR BioForA, Orleans, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Coursol, S (corresponding author), Univ Paris Saclay, Inst Jean Pierre Bourgin, CNRS, AgroParisTech,INRA, Versailles, France.	sylvie.coursol@inra.fr	Cuello, Clément/AAM-2724-2020; Delannoy, Etienne/ABF-2513-2021; Delannoy, Etienne/E-5077-2011; Martin-Magniette, Marie-Laure/AAP-1644-2020	Cuello, Clément/0000-0002-5901-9748; Delannoy, Etienne/0000-0002-0866-2063; Delannoy, Etienne/0000-0002-0866-2063; Martin-Magniette, Marie-Laure/0000-0003-4000-9600	ProMais (ZeaWall II project); French Government (LabEx Saclay Plant SciencesSPS) [ANR-10-LABX-0040-SPS, ANR-11-BTBR-0006, ANR-11-IDEX-0003-02]	ProMais (ZeaWall II project); French Government (LabEx Saclay Plant SciencesSPS)	This research was supported by grants from ProMais (ZeaWall II project to MR) and the French Government (LabEx Saclay Plant SciencesSPS, ref. ANR-10-LABX-0040-SPS to SC, and ANR-11-BTBR-0006 BIOMASS FOR THE FUTURE to SC), managed by the French National Research Agency under an Investment for the Future program (ref. ANR-11-IDEX-0003-02 to SC).	Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano N, 2010, DNA RES, V17, P271, DOI 10.1093/dnares/dsq017; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baldauf JA, 2018, CURR BIOL, V28, P431, DOI 10.1016/j.cub.2017.12.027; Barghetti A, 2017, GENE DEV, V31, P2282, DOI 10.1101/gad.301242.117; Barriere Y, 2008, PLANT SCI, V175, P585, DOI 10.1016/j.plantsci.2008.06.009; Barriere Y, 2004, MAYDICA, V49, P115; Barriere Y, 2010, CROP SCI, V50, P1761, DOI 10.2135/cropsci2009.11.0671; Barriere Y, 2017, MAYDICA, V62; Barriere Y, 2016, PLANT SCI, V242, P310, DOI 10.1016/j.plantsci.2015.08.007; Barriere Y, 2012, THEOR APPL GENET, V125, P531, DOI 10.1007/s00122-012-1851-5; Barriere Y, 2009, EUPHYTICA, V170, P183, DOI 10.1007/s10681-009-9923-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baute J, 2016, PLANT PHYSIOL, V170, P1848, DOI 10.1104/pp.15.01883; Bernard V, 2010, GENOME, V53, P739, DOI [10.1139/g10-042, 10.1139/G10-042]; Bohn M, THEORETICAL APPL GEN, V101, P907; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Cardinal AJ, 2003, THEOR APPL GENET, V106, P866, DOI 10.1007/s00122-002-1136-5; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Clasen SJ, 2017, ELIFE, V6, DOI 10.7554/eLife.28563; Courtial A, 2012, MAYDICA, V57, P56; Courtial A, 2014, BIOENERG RES, V7, P142, DOI 10.1007/s12155-013-9358-8; Courtial A, 2013, THEOR APPL GENET, V126, P1151, DOI 10.1007/s00122-013-2043-7; Darracq A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4490-7; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feltus FA, 2014, PLANT SCI, V223, P45, DOI 10.1016/j.plantsci.2014.03.003; Fontaine AS, 2003, MAYDICA, V48, P75; Fu YB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01182; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Giuntoli B, 2018, PLANT PHYSIOL, V176, P1143, DOI 10.1104/pp.17.01225; Gonzali S, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.151, 10.1038/nplants.2015.151]; Grabber JH, 2004, CR BIOL, V327, P455, DOI 10.1016/j.crvi.2004.02.009; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Jin ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep18936; Kim HJ, 2018, P NATL ACAD SCI USA, V115, pE4930, DOI 10.1073/pnas.1721523115; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krakowsky MD, 2003, MAYDICA, V48, P283; Kulich I, 2013, TRAFFIC, V14, P1155, DOI 10.1111/tra.12101; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leng PF, 2018, PLANT BREEDING, V137, P139, DOI 10.1111/pbr.12572; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01472; Li K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158906; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lubberstedt T, 1997, CROP SCI, V37, P1913, DOI 10.2135/cropsci1997.0011183X003700060041x; Marcon C, 2017, PLANT PHYSIOL, V173, P1247, DOI 10.1104/pp.16.01045; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Mechin V, 2001, CROP SCI, V41, P690, DOI 10.2135/cropsci2001.413690x; Mejia-Guerra MK, 2015, PLANT CELL, V27, P3309, DOI 10.1105/tpc.15.00630; Meng XZ, 2014, CURR OPIN BIOTECH, V27, P150, DOI 10.1016/j.copbio.2014.01.014; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Napoleao TA, 2017, PLANT SCI, V263, P46, DOI 10.1016/j.plantsci.2017.06.014; Paschold A, 2014, PLANT CELL, V26, P3939, DOI 10.1105/tpc.114.130948; Paschold A, 2012, GENOME RES, V22, P2445, DOI 10.1101/gr.138461.112; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Ralph J, 2004, CR BIOL, V327, P467, DOI 10.1016/j.crvi.2004.03.004; Riboulet C, 2008, MAYDICA, V53, P1; Riboulet C, 2009, CROP SCI, V49, P211, DOI 10.2135/cropsci2008.03.0130; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Roussel V, 2002, MAYDICA, V47, P9; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; Sengupta D, 2015, J PLANT PHYSIOL, V179, P40, DOI 10.1016/j.jplph.2015.03.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Suekawa M, 2016, J PLANT PHYSIOL, V200, P35, DOI 10.1016/j.jplph.2016.05.015; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Szalma SJ, 2007, THEOR APPL GENET, V114, P1211, DOI 10.1007/s00122-007-0512-6; Thieme CJ, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.25, 10.1038/nplants.2015.25]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas J, 2010, MOL BREEDING, V25, P105, DOI 10.1007/s11032-009-9311-x; Torres AF, 2015, BIOENERG RES, V8, P187, DOI 10.1007/s12155-014-9507-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Verger S, 2016, DEVELOPMENT, V143, P2536, DOI 10.1242/dev.132308; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Wang RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10269; Wang WW, 2012, GENET MOL RES, V11, P1690, DOI 10.4238/2012.June.25.2; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; Wen WW, 2016, PLANT PHYSIOL, V170, P136, DOI 10.1104/pp.15.01444; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Yao Y, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1329073; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin XY, 2004, TRENDS PLANT SCI, V9, P426, DOI 10.1016/j.tplants.2004.07.007; Yu YL, 2012, GENE, V498, P212, DOI 10.1016/j.gene.2012.01.094; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zhang XC, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.49, 10.1038/nplants.2015.49]; Zhao XB, 2012, BIOFUEL BIOPROD BIOR, V6, P465, DOI 10.1002/bbb.1331	104	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227011	10.1371/journal.pone.0227011	http://dx.doi.org/10.1371/journal.pone.0227011			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891625	gold, Green Submitted, Green Published			2022-12-26	WOS:000515096600051
J	Zschocke, J; Kluge, M; Pelikan, L; Graf, A; Glos, M; Muller, A; Mikolajczyk, R; Bartsch, RP; Penzel, T; Kantelhardt, JW				Zschocke, Johannes; Kluge, Maria; Pelikan, Luise; Graf, Antonia; Glos, Martin; Mueller, Alexander; Mikolajczyk, Rafael; Bartsch, Ronny P.; Penzel, Thomas; Kantelhardt, Jan W.			Detection and analysis of pulse waves during sleep via wrist-worn actigraphy	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; TIME; DYNAMICS	The high temporal and intensity resolution of modern accelerometers gives the opportunity of detecting even tiny body movements via motion-based sensors. In this paper, we demonstrate and evaluate an approach to identify pulse waves and heartbeats from acceleration data of the human wrist during sleep. Specifically, we have recorded simultaneously full night polysomnography and 3d wrist actigraphy data of 363 subjects during one night in a clinical sleep laboratory. The acceleration data was segmented and cleaned, excluding body movements and separating episodes with different sleep positions. Then, we applied a bandpass filter and a Hilbert transform to uncover the pulse wave signal, which worked well for an average duration of 1.7 h per subject. We found that 81 percent of the detected pulse wave intervals could be correctly associated with the R peak intervals from independently recorded ECGs and obtained a median Pearson cross-correlation of 0.94. While the low-frequency components of both signals were practically identical, the high-frequency component of the pulse wave interval time series was increased, indicating a respiratory modulation of pulse transit times, probably as an additional contribution to respiratory sinus arrhythmia. Our approach could be used to obtain long-term nocturnal heartbeat interval time series and pulse wave signals from wrist-worn accelerometers without the need of recording ECG or photoplethysmography. This is particularly useful for an ambulatory monitoring of high-risk cardiac patients as well as for assessing cardiac dynamics in large cohort studies solely with accelerometer devices that are already used for activity tracking and sleep pattern analysis.	[Zschocke, Johannes; Mikolajczyk, Rafael] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Fac Med, Halle, Germany; [Zschocke, Johannes; Kantelhardt, Jan W.] Martin Luther Univ Halle Wittenberg, Inst Phys, Halle, Germany; [Kluge, Maria; Pelikan, Luise; Graf, Antonia; Glos, Martin; Penzel, Thomas] Charite Univ Med Berlin, Interdisziplinares Schlafmed Zentrum, Berlin, Germany; [Mueller, Alexander] Tech Univ Munich, Klin & Poliklin Innere Med 1, Munich, Germany; [Bartsch, Ronny P.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Bar Ilan University	Kantelhardt, JW (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Phys, Halle, Germany.	jan.kantelhardt@physik.uni-halle.de	Penzel, Thomas/M-2344-2014; Bartsch, Ronny/E-7117-2012; Mikolajczyk, Rafael/ABB-5259-2021	Penzel, Thomas/0000-0002-4304-0112; Bartsch, Ronny/0000-0001-8336-5141; Kantelhardt, Jan W./0000-0002-9293-0293; Mikolajczyk, Rafael/0000-0003-1271-7204; Zschocke, Johannes/0000-0003-0113-4476	German Israel Foundation (GIF) [I-1298-415.13/2015, I-1372303.7/2016]; German National Cohort study - Federal Ministry of Education and Research (BMBF); Helmholtz Association; Minerva Short-Term Research Grant; German Research Foundation (DFG)	German Israel Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German National Cohort study - Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Minerva Short-Term Research Grant; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Israel Foundation (GIF, http://www.gif.org.il) grants I-1298-415.13/2015 (for JZ and JK) and I-1372303.7/2016 (for MG, RB, and TP) and the German National Cohort study (www.nako.de), funded by the Federal Ministry of Education and Research (BMBF) and the Helmholtz Association (for JZ, AM and RM). JZ acknowledges support from a Minerva Short-Term Research Grant. We acknowledge the financial support within the funding programme Open Access Publishing by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Berry RB., 2020, AASM MANUAL SCORING; Camm AJ, 1996, CIRCULATION, V93, P1043; Castiglioni Paolo, 2007, 2007 ANN INT C IEEE; Einbrodt P., 1860, SITZUNGSBERICHTE AKA, P361; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Gesche H, 2012, EUR J APPL PHYSIOL, V112, P309, DOI 10.1007/s00421-011-1983-3; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Gong S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4132; Haescher Marian, 2016, P 2016 CHI C HUM FAC, P2209, DOI DOI 10.1145/2851581.2892279; Haescher Marian, 2015, P 2 INT WORKSH SENS; Hamann C, 2009, CHAOS, V19, DOI 10.1063/1.3096415; Hernandez J, 2015, INT CONF PER COMP, P169, DOI 10.4108/icst.pervasivehealth.2015.259064; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2003, PROC SPIE, V5110, P235, DOI 10.1117/12.497057; Inan OT, 2015, IEEE J BIOMED HEALTH, V19, P1414, DOI 10.1109/JBHI.2014.2361732; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Ivanov PC, 1998, PHYSICA A, V249, P587, DOI 10.1016/S0378-4371(97)00522-0; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Karasik R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062902; Koenig SM, 2008, AGING MED, P77, DOI 10.1007/978-1-59745-233-5_5; KUPFER DJ, 1974, ARCH GEN PSYCHIAT, V30, P765; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nitzan M, 2002, PHYSIOL MEAS, V23, P85, DOI 10.1088/0967-3334/23/1/308; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Pandia K, 2012, PHYSIOL MEAS, V33, P1643, DOI 10.1088/0967-3334/33/10/1643; Penzel T, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00460; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; Schneider R, 2004, COMPUT CARDIOL, V31, P53, DOI 10.1109/CIC.2004.1442869; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Tadi MJ, 2016, PHYSIOL MEAS, V37, P1885, DOI 10.1088/0967-3334/37/11/1885; Tadi MJ, 2014, INT J BIOMED IMAGING, V2014, DOI 10.1155/2014/690124; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; van Hees VT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31266-z; Will C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29984-5; Wohlfahrt P, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/68002; ZANETTI JM, 1991, COMPUTER-BASED MEDICA SYSTEMS, P4, DOI 10.1109/CBMS.1991.128936; Zinkhan M, 2016, SLEEP MED CLIN, V11, P469, DOI 10.1016/j.jsmc.2016.08.006; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015	43	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226843	10.1371/journal.pone.0226843	http://dx.doi.org/10.1371/journal.pone.0226843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891612	gold, Green Published			2022-12-26	WOS:000515096600034
J	Rusmili, MRA; Othman, I; Abidin, SAZ; Yusof, FA; Ratanabanangkoon, K; Chanhome, L; Hodgson, WC; Chaisakul, J				Rusmili, Muhamad Rusdi Ahmad; Othman, Iekhsan; Abidin, Syafiq Asnawi Zainal; Yusof, Fathin Athirah; Ratanabanangkoon, Kavi; Chanhome, Lawan; Hodgson, Wayne C.; Chaisakul, Janeyuth			Variations in neurotoxicity and proteome profile of Malayan krait (Bungarus candidus) venoms	PLOS ONE			English	Article							TAIPAN OXYURANUS-SCUTELLATUS; IN-VITRO NEUROTOXICITY; PRESYNAPTIC NEUROTOXIN; FASCIATUS; ANTIVENOM; TOXINS; COBRA; INDIA; PHOSPHOLIPASES; NEUTRALIZATION	Malayan krait (Bungarus candidus) is a medically important snake species found in Southeast Asia. The neurotoxic effects of envenoming present as flaccid paralysis of skeletal muscles. It is unclear whether geographical variation in venom composition plays a significant role in the degree of clinical neurotoxicity. In this study, the effects of geographical variation on neurotoxicity and venom composition of B. candidus venoms from Indonesia, Malaysia and Thailand were examined. In the chick biventer cervicis nerve-muscle preparation, all venoms abolished indirect twitches and attenuated contractile responses to nicotinic receptor agonists, with venom from Indonesia displaying the most rapid neurotoxicity. A proteomic analysis indicated that three finger toxins (3FTx), phospholipase A(2) (PLA(2)) and Kunitz-type serine protease inhibitors were common toxin groups in the venoms. In addition, venom from Thailand contained L-amino acid oxidase (LAAO), cysteine rich secretory protein (CRISP), thrombin-like enzyme (TLE) and snake venom metalloproteinase (SVMP). Short-chain post-synaptic neurotoxins were not detected in any of the venoms. The largest quantity of long-chain post-synaptic neurotoxins and non-conventional toxins was found in the venom from Thailand. Analysis of PLA(2) activity did not show any correlation between the amount of PLA(2) and the degree of neurotoxicity of the venoms. Our study shows that variation in venom composition is not limited to the degree of neurotoxicity. This investigation provides additional insights into the geographical differences in venom composition and provides information that could be used to improve the management of Malayan krait envenoming in Southeast Asia.	[Rusmili, Muhamad Rusdi Ahmad] Int Islamic Univ Malaysia, Kulliyyah Pharm, Kuantan Campus, Kuantan, Pahang Darul Ma, Malaysia; [Othman, Iekhsan; Abidin, Syafiq Asnawi Zainal; Yusof, Fathin Athirah] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Bandar Sunway, Malaysia; [Ratanabanangkoon, Kavi] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Chanhome, Lawan] Thai Red Cross Soc, Queen Saovabha Mem Inst, Snake Farm, Bangkok, Thailand; [Hodgson, Wayne C.] Monash Univ, Biomed Discovery Inst, Dept Pharmacol, Monash Venom Grp, Clayton, Vic, Australia; [Chaisakul, Janeyuth] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand	International Islamic University Malaysia; Monash University; Monash University Sunway; Mahidol University; Thai Red Cross Society; Monash University; Phramongkutklao College of Medicine	Chaisakul, J (corresponding author), Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand.	janeyuth.cha@pcm.ac.th	Ahmad Rusmili, Muhamad Rusdi/GLN-6761-2022; Zainal Abidin, Syafiq Asnawi/M-8744-2016	Hodgson, Wayne/0000-0002-9919-0144; Zainal Abidin, Syafiq Asnawi/0000-0002-8249-7668; Ahmad Rusmili, Muhamad Rusdi/0000-0002-0327-060X	Office of Research Development, Phramongkutklao College of Medicine & Phramongkutklao Hospital; Thailand Research Fund [TRG6080009]; British Council [2017-18, PDG61W0015]; Research Incentive Grant Scheme of International Islamic University Malaysia [RIGS 17-007-0582]; Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant [1110343]	Office of Research Development, Phramongkutklao College of Medicine & Phramongkutklao Hospital; Thailand Research Fund(Thailand Research Fund (TRF)); British Council(The British Council in India); Research Incentive Grant Scheme of International Islamic University Malaysia; Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia)	We gratefully acknowledge the following funding: Office of Research Development, Phramongkutklao College of Medicine & Phramongkutklao Hospital (ORD, PCM & PMK, Bangkok, Thailand); Thailand Research Fund (TRG6080009); British Council and Newton Fund for Thailand-UK researcher Link award 2017-18 (PDG61W0015); Research Incentive Grant Scheme of International Islamic University Malaysia (Grant no.: RIGS 17-007-0582); Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant ID: 1110343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwinata R, 2015, ACTA MED INDONES, V47, P358; Barber CM, 2012, TOXICOL LETT, V210, P318, DOI 10.1016/j.toxlet.2012.02.001; Chaisakul J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007338; Chaisakul J, 2017, TOXINS, V9, DOI 10.3390/toxins9040122; Chaisakul J, 2013, BASIC CLIN PHARMACOL, V112, P325, DOI 10.1111/bcpt.12048; CHANG C C, 1985, Proceedings of the National Science Council Republic of China Part B Life Sciences, V9, P126; Chanhome L., 2009, Journal of Cell and Animal Biology, V3, P093; Chapeaurouge A, 2018, TOXINS, V10, DOI 10.3390/toxins10090373; Charoenpitakchai M, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0146-y; Chew KS, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-41; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Crachi MT, 1999, TOXICON, V37, P1721, DOI 10.1016/S0041-0101(99)00114-2; Fry BG, 2001, TOXICOL APPL PHARM, V175, P140, DOI 10.1006/taap.2001.9233; Karsani SA, 2009, BIOCHEM BIOPH RES CO, V389, P343, DOI 10.1016/j.bbrc.2009.08.145; Kessler P, 2017, J NEUROCHEM, V142, P7, DOI 10.1111/jnc.13975; Khow O, 2003, J BIOCHEM, V134, P799, DOI 10.1093/jb/mvg187; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Kuhn P, 2000, ACTA CRYSTALLOGR D, V56, P1401, DOI 10.1107/S0907444900011501; Kunalan S, 2018, TOXINS, V10, DOI 10.3390/toxins10110434; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laothong C, 2001, TOXICON, V39, P1353, DOI 10.1016/S0041-0101(01)00087-3; Leeprasert Wirat, 2007, Journal of the Medical Association of Thailand, V90, P1467; Leong PK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001672; Liu C, 1999, J MICROELECTROMECH S, V8, P135, DOI 10.1109/84.767109; Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Oh AMF, 2019, J PROTEOMICS, V193, P243, DOI 10.1016/j.jprot.2018.10.016; Oh AMF, 2017, J PROTEOMICS, V164, P1, DOI [10.1016/j.jprot.2017.04.018, 10.1016/j.jrot.2017.04.018]; Patra A, 2019, EXPERT REV PROTEOMIC, V16, P457, DOI 10.1080/14789450.2019.1609945; Prasarnpun S, 2005, BRAIN, V128, P2987, DOI 10.1093/brain/awh642; Rossetto O, 2006, J NEUROCHEM, V97, P1534, DOI 10.1111/j.1471-4159.2006.03965.x; Rouault M, 2006, BIOCHEMISTRY-US, V45, P5800, DOI 10.1021/bi060217r; Rusmili MRA, 2014, J PROTEOMICS, V110, P129, DOI 10.1016/j.jprot.2014.08.001; Rusmili MRA, 2014, BIOCHEM PHARMACOL, V91, P409, DOI 10.1016/j.bcp.2014.07.001; Rusmili MRA, 2014, TOXINS, V6, P1036, DOI 10.3390/toxins6031036; Rusmili MRA, 2014, BIOCHEM PHARMACOL, V88, P229, DOI 10.1016/j.bcp.2014.01.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shan LL, 2016, J PROTEOMICS, V138, P83, DOI 10.1016/j.jprot.2016.02.028; Skejic J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063988; SLOWINSKI JB, 1994, J HERPETOL, V28, P440, DOI 10.2307/1564956; Tan CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37299; Tan KY, 2016, COMP BIOCHEM PHYS C, V185, P77, DOI 10.1016/j.cbpc.2016.03.005; Tongpoo A, 2018, THER CLIN RISK MANAG, V14, P1711, DOI 10.2147/TCRM.S169581; Trinh KX, 2010, TOXICON, V56, P1070, DOI 10.1016/j.toxicon.2010.06.026; Tsai IH, 2007, FEBS J, V274, P512, DOI 10.1111/j.1742-4658.2006.05598.x; Utkin YN, 2019, BIOCHEM J, V476, P1285, DOI 10.1042/BCJ20180909; WARRELL DA, 1983, BRIT MED J, V286, P678, DOI 10.1136/bmj.286.6366.678; WHO, 2016, GUIDELINES MANAGEMEN, VVolume 2; WHO, 2010, GUID MAN SNAK BIT GU; Wickramaratna JC, 2003, TOXICOL SCI, V74, P352, DOI 10.1093/toxsci/kfg144; Winter KL, 2010, TOXICOL LETT, V192, P419, DOI 10.1016/j.toxlet.2009.11.019; Wong KY, 2018, J PROTEOMICS, V175, P156, DOI 10.1016/j.jprot.2017.12.012	55	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227122	10.1371/journal.pone.0227122	http://dx.doi.org/10.1371/journal.pone.0227122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887191	gold, Green Published, Green Accepted			2022-12-26	WOS:000515092200079
J	Trevarthen, AC; Kappel, S; Roberts, C; Finnegan, EM; Paul, ES; Planas-Sitja, I; Mendl, MT; Fureix, C				Trevarthen, Anna C.; Kappel, Sarah; Roberts, Claire; Finnegan, Emily M.; Paul, Elizabeth S.; Planas-Sitja, Isaac; Mendl, Michael T.; Fureix, Carole			Measuring affect-related cognitive bias: Do mice in opposite affective states react differently to negative and positive stimuli?	PLOS ONE			English	Article							INBRED MOUSE STRAINS; ATTENTIONAL BIAS; JUDGMENT BIAS; EXPLICIT MEMORY; ANIMAL BEHAVIOR; ENRICHED CAGES; ANXIETY; RESPONSES; EMOTION; STRESS	Affect-driven cognitive biases can be used as an indicator of affective (emotional) state. Since humans in negative affective states demonstrate greater responses to negatively-valenced stimuli, we investigated putative affect-related bias in mice by monitoring their response to unexpected, task-irrelevant stimuli of different valence. Thirty-one C57BLI6J and 31 DBA/2J females were individually trained to return to their home-cage in a runway. Mice then underwent an affective manipulation acutely inducing a negative (NegAff) or a comparatively less negative (CompLessNeg) affective state before immediately being tested in the runway with either an 'attractive' (familiar food) or 'threatening' (flashing light) stimulus. Mice were subsequently trained and tested again (same affective manipulation) with the alternative stimulus. As predicted, mice were slower to approach the light and spent more time with the food. DBA/2J mice were slower than C57BLJ6J overall. Contrary to predictions, NegAff mice tended to approach both stimuli more readily than CompLessNeg mice, especially the light, and even more so for DBA/2Js. Although the stimuli successfully differentiated the response of mice to unexpected, task-irrelevant stimuli, further refinement may be required to disentangle the effects of affect manipulation and arousal on the response to valenced stimuli. The results also highlight the significant importance of considering strain differences when developing cognitive tasks.	[Trevarthen, Anna C.; Roberts, Claire; Finnegan, Emily M.; Paul, Elizabeth S.; Mendl, Michael T.] Univ Bristol, Bristol Vet Sch, Bristol, Avon, England; [Kappel, Sarah; Fureix, Carole] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England; [Planas-Sitja, Isaac] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Tokyo, Japan	University of Bristol; University of Plymouth; Tokyo Metropolitan University	Mendl, MT (corresponding author), Univ Bristol, Bristol Vet Sch, Bristol, Avon, England.	mike.mendl@bristol.ac.uk	Kappel, Sarah/AAE-1095-2022; Mendl, Michael/D-7220-2016	Trevarthen, Anna/0000-0001-9575-7150; Mendl, Michael/0000-0002-5302-1871; Kappel, Sarah/0000-0002-8877-5462	BBSRC [BB/P019218/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by BBSRC (www.bbsrc.ukri.org) (Grant number: BB/P019218/1). The recipients for the grant were MM, CF, EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Atalayer D, 2010, PHYSIOL BEHAV, V99, P679, DOI 10.1016/j.physbeh.2010.02.001; Baciadonna L, 2015, ANIM WELFARE, V24, P81, DOI 10.7120/09627286.24.1.081; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Baron SP, 2001, BEHAV BRAIN RES, V118, P143, DOI 10.1016/S0166-4328(00)00322-3; Barry TJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00968; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125481; Bateson M, 2015, PEERJ, V3, DOI 10.7717/peerj.998; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Biss RK, 2011, EMOTION, V11, P1474, DOI 10.1037/a0023855; Blizard DA, 2006, COMPARATIVE MED, V56, P196; Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039; Boly M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00625; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Bradley BP, 1997, COGNITION EMOTION, V11, P25, DOI 10.1080/026999397380014; BRADLEY BP, 1994, BEHAV RES THER, V32, P65, DOI 10.1016/0005-7967(94)90085-X; Brilot BO, 2012, BIOL LETTERS, V8, P379, DOI 10.1098/rsbl.2011.1200; Brilot BO, 2009, ANIM BEHAV, V78, P801, DOI 10.1016/j.anbehav.2009.07.022; Brydges NM, 2017, J NEUROSCI METH, V286, P1, DOI 10.1016/j.jneumeth.2017.05.015; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Cabib S, NEUROBIOLOGY STEREOT, P227; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clarkson JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20716-3; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Crump A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8080136; Cussen VA, 2014, ANIM BEHAV, V89, P123, DOI 10.1016/j.anbehav.2013.12.022; d'Ettorre P, 2017, BEHAV PROCESS, V134, P63, DOI 10.1016/j.beproc.2016.09.008; Deakin A, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0779; Deakin A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158222; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1992, PERS INDIV DIFFER, V13, P793, DOI 10.1016/0191-8869(92)90052-Q; Ferguson M, 2008, EXP GERONTOL, V43, P757, DOI 10.1016/j.exger.2008.04.016; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Fureix C, 2016, BEHAV BRAIN RES, V305, P186, DOI 10.1016/j.bbr.2016.02.005; Gouveia K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44999; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Guillot PV, 1996, BEHAV BRAIN RES, V77, P211, DOI 10.1016/0166-4328(95)00163-8; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hintze S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23459-3; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Johnson M., 2012, MAT METHODS, V2, P213, DOI [10.13070/mm.en.2.113, DOI 10.13070/MM.EN.2.113]; Jones S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30571-x; Kloke V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105431; Kress L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193311; Kret ME, 2016, P NATL ACAD SCI USA, V113, P3761, DOI 10.1073/pnas.1522060113; Lapointe MLB, 2013, ANXIETY STRESS COPIN, V26, P293, DOI 10.1080/10615806.2012.687722; Lee C, 2018, APPL ANIM BEHAV SCI, V205, P210, DOI 10.1016/j.applanim.2017.11.003; Lee C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0977; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lewis SR, 2005, PHYSIOL BEHAV, V85, P546, DOI 10.1016/j.physbeh.2005.06.003; Li XJ, 2018, NEUROQUANTOLOGY, V16, P396, DOI 10.14704/nq.2018.16.5.1307; MACLEOD C, 1993, J ABNORM PSYCHOL, V102, P238, DOI 10.1037/0021-843X.102.2.238; MACLEOD C, 1995, BEHAV RES THER, V33, P1, DOI 10.1016/0005-7967(94)E0004-3; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x; Mendl M, 2011, CURR BIOL, V21, pR463, DOI 10.1016/j.cub.2011.05.028; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Mogg K, 2016, BEHAV RES THER, V87, P76, DOI 10.1016/j.brat.2016.08.001; Monk JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190404; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Novak J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130718; Parker RMA, 2014, BEHAV BRAIN RES, V274, P73, DOI 10.1016/j.bbr.2014.07.048; Paul E, 2016, ANIM SENTIENCE, V1, P16; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Sanger ME, 2011, APPL ANIM BEHAV SCI, V131, P94, DOI 10.1016/j.applanim.2011.02.001; Segerstrom SC, 2001, PERS SOC PSYCHOL B, V27, P1334, DOI 10.1177/01461672012710009; Solvi C, 2016, SCIENCE, V353, P1529, DOI 10.1126/science.aaf4454; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; van Rooijen R, 2017, PSYCHON B REV, V24, P1686, DOI 10.3758/s13423-016-1224-1; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Waddell J, 2004, BEHAV BRAIN RES, V154, P567, DOI 10.1016/j.bbr.2004.03.025; Walker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077541; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wilson DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207378; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a	89	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226438	10.1371/journal.pone.0226438	http://dx.doi.org/10.1371/journal.pone.0226438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887167	Green Published, gold			2022-12-26	WOS:000515092200017
J	Choi, EK; Aring, L; Das, NK; Solanki, S; Inohara, N; Iwase, S; Samuelson, LC; Shah, YM; Seo, YA				Choi, Eun-Kyung; Aring, Luisa; Das, Nupur K.; Solanki, Sumeet; Inohara, Naohiro; Iwase, Shigeki; Samuelson, Linda C.; Shah, Yatrik M.; Seo, Young Ah			Impact of dietary manganese on experimental colitis in mice	FASEB JOURNAL			English	Article						colitis; gut microbiota; inflammatory bowel disease; manganese; tight junction	INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE DNA-DAMAGE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; DEXTRAN SULFATE; GUT MICROBIOTA; NUTRITION; HOMEOSTASIS; BIOMARKER; ELEMENTS	Diet plays a significant role in the pathogenesis of inflammatory bowel disease (IBD). A recent epidemiological study has shown an inverse relationship between nutritional manganese (Mn) status and IBD patients. Mn is an essential micronutrient required for normal cell function and physiological processes. To date, the roles of Mn in intestinal homeostasis remain unknown and the contribution of Mn to IBD has yet to be explored. Here, we provide evidence that Mn is critical for the maintenance of the intestinal barrier and that Mn deficiency exacerbates dextran sulfate sodium (DSS)-induced colitis in mice. Specifically, when treated with DSS, Mn-deficient mice showed increased morbidity, weight loss, and colon injury, with a concomitant increase in inflammatory cytokine levels and oxidative and DNA damage. Even without DSS treatment, dietary Mn deficiency alone increased intestinal permeability by impairing intestinal tight junctions. In contrast, mice fed a Mn-supplemented diet showed slightly increased tolerance to DSS-induced experimental colitis, as judged by the colon length. Despite the well-appreciated roles of intestinal microbiota in driving inflammation in IBD, the gut microbiome composition was not altered by changes in dietary Mn. We conclude that Mn is necessary for proper maintenance of the intestinal barrier and provides protection against DSS-induced colon injury.	[Choi, Eun-Kyung; Aring, Luisa; Seo, Young Ah] Univ Michigan, Dept Nutr Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Das, Nupur K.; Solanki, Sumeet; Samuelson, Linda C.; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Inohara, Naohiro] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Iwase, Shigeki] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seo, YA (corresponding author), Univ Michigan, Dept Nutr Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	youngseo@umich.edu	Seo, Young Ah/AAT-5022-2020; Iwase, Shigeki/J-8294-2019; Das, Nupur/AAK-7877-2020	Seo, Young Ah/0000-0003-3884-0665; Iwase, Shigeki/0000-0003-2280-7422; Das, Nupur/0000-0002-5652-1134; Aring, Luisa/0000-0002-0437-4785	HHS \ National Institutes of Health (NIH) [R00 ES024340, R01 DK095201, R01 DK118023, R01 NS089896]; Crohn's and Colitis Foundation; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5P30DK034933]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R00 ES024340, R01 DK095201, R01 DK118023 and R01 NS089896; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation); HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 5P30DK034933	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Association CN, 2001, CHIN DIET REF INT; Barrett CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067845; Caruso R, 2019, CELL REP, V27, P3401, DOI 10.1016/j.celrep.2019.05.042; Cho JM, 2018, BIOL TRACE ELEM RES, V185, P20, DOI 10.1007/s12011-017-1225-6; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Colombel JF, 2017, GASTROENTEROLOGY, V152, P309, DOI 10.1053/j.gastro.2016.12.004; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Egan SK, 2002, FOOD ADDIT CONTAM A, V19, P103, DOI 10.1080/02652030110071354; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Finley JW, 2003, J NUTR, V133, P2849, DOI 10.1093/jn/133.9.2849; Freeland-Graves JH, 2016, J TRACE ELEM MED BIO, V38, P24, DOI 10.1016/j.jtemb.2016.05.004; Gilca-Blanariu GE, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1813047; HALLFRISCH J, 1987, J NUTR, V117, P48, DOI 10.1093/jn/117.1.48; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jiang J, 2015, J FOOD COMPOS ANAL, V39, P1, DOI 10.1016/j.jfca.2014.10.012; Kang M, 2014, EUR J CLIN NUTR, V68, P804, DOI 10.1038/ejcn.2014.77; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Khalili H, 2018, NAT REV GASTRO HEPAT, V15, P525, DOI 10.1038/s41575-018-0022-9; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kim Eun-Young, 2008, Nutr Res Pract, V2, P22, DOI 10.4162/nrp.2008.2.1.22; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Kudva AK, 2015, AM J PHYSIOL-GASTR L, V309, pG71, DOI 10.1152/ajpgi.00379.2014; Lechuga S, 2017, BBA-MOL CELL RES, V1864, P1183, DOI 10.1016/j.bbamcr.2017.03.007; Lomer MCE, 2019, ANN NUTR METAB, V74, P18, DOI 10.1159/000495214; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Penagini F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060334; Rapozo DCM, 2017, WORLD J GASTROENTERO, V23, P2124, DOI 10.3748/wjg.v23.i12.2124; Reddavide Rosa, 2018, Acta Biomed, V89, P60, DOI 10.23750/abm.v89i9-S.7952; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Stein J, 2013, ANN GASTROENTEROL, V26, P104; Suwendi E, 2012, BIOMED RES-TOKYO, V33, P329, DOI 10.2220/biomedres.33.329; Trivedi PP, 2013, CHEM-BIOL INTERACT, V201, P19, DOI 10.1016/j.cbi.2012.12.004; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; van't Erve TJ, 2016, FREE RADICAL BIO MED, V95, P65, DOI 10.1016/j.freeradbiomed.2016.03.001; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yahia D, 2016, ENVIRON TOXICOL, V31, P192, DOI 10.1002/tox.22034; Zanello G, 2014, NESTLE NUTR WORKS SE, V79, P41, DOI 10.1159/000360676; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	52	20	20	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2929	2943		10.1096/fj.201902396R	http://dx.doi.org/10.1096/fj.201902396R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908045	Green Accepted, Green Published, Bronze			2022-12-26	WOS:000504854200001
J	Machado, MG; Tavares, LP; Souza, GVS; Queiroz, CM; Ascencao, FR; Lopes, ME; Garcia, CC; Menezes, GB; Perretti, M; Russo, RC; Teixeira, MM; Sousa, LP				Machado, Marina Gomes; Tavares, Luciana Padua; Souza, Geovanna V. Santos; Queiroz-Junior, Celso M.; Ascencao, Fernando Roque; Lopes, Mateus Eustaquio; Garcia, Cristiana Couto; Menezes, Gustavo Batista; Perretti, Mauro; Russo, Remo Castro; Teixeira, Mauro Martins; Sousa, Lirlandia Pires			The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia	FASEB JOURNAL			English	Article						inflammation; pro-resolving mediator; resolution; Streptococcus pneumoniae	ANTIINFLAMMATORY DRUGS; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; RESOLUTION; INFECTION; DEXAMETHASONE; MACROPHAGES; MODULATION; MECHANISMS; MEDIATORS	Streptococcus pneumoniae is a major cause of community-acquired pneumonia leading to high mortality rates. Inflammation triggered by pneumococcal infection is necessary for bacterial clearance but must be spatially and temporally regulated to prevent further tissue damage and bacterial dissemination. Annexin A1 (AnxA1) mainly acts through Formyl Peptide Receptor 2 (FPR2) inducing the resolution of inflammation. Here, we have evaluated the role of AnxA1 and FPR2 during pneumococcal pneumonia in mice. For that, AnxA1, Fpr2/3 knockout (KO) mice and wild-type (WT) controls were infected intranasally with S pneumoniae. AnxA1 and Fpr2/3 KO mice were highly susceptible to infection, displaying uncontrolled inflammation, increased bacterial dissemination, and pulmonary dysfunction compared to WT animals. Mechanistically, the absence of AnxA1 resulted in the loss of lung barrier integrity and increased neutrophil activation upon S pneumoniae stimulation. Importantly, treatment of WT or AnxA1 KO-infected mice with Ac2-26 decreased inflammation, lung damage, and bacterial burden in the airways by increasing macrophage phagocytosis. Conversely, Ac2-26 peptide was ineffective to afford protection in Fpr2/3 KO mice during infection. Altogether, these findings show that AnxA1, via FPR2, controls inflammation and bacterial dissemination during pneumococcal pneumonia by promoting host defenses, suggesting AnxA1-based peptides as a novel therapeutic strategy to control pneumococcal pneumonia.	[Machado, Marina Gomes; Souza, Geovanna V. Santos; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Lab Sinalizacao Inflamacao, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Machado, Marina Gomes; Tavares, Luciana Padua; Souza, Geovanna V. Santos; Ascencao, Fernando Roque; Teixeira, Mauro Martins; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Queiroz-Junior, Celso M.; Lopes, Mateus Eustaquio; Menezes, Gustavo Batista] Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil; [Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Russo, Remo Castro] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Lab Imunol & Mecan Pulm, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; University of London; Queen Mary University London; Universidade Federal de Minas Gerais	Sousa, LP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Lab Sinalizacao Inflamacao, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Teixeira, MM (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	mmtex.ufmg@gmail.com; lipsousa72@gmail.com	Garcia, Cristiana Couto/AAE-4290-2022; Menezes, Gustavo B/B-3350-2013; Teixeira, Mauro M/A-4587-2008; Russo, Remo Castro/O-8980-2019; Eustaquio de Moura Lopes, Mateus/T-3145-2017	Garcia, Cristiana Couto/0000-0002-4400-9141; Teixeira, Mauro M/0000-0002-6944-3008; Russo, Remo Castro/0000-0002-1715-3834; Padua Tavares, Luciana/0000-0002-5319-0210; Gomes Machado, Marina/0000-0002-8996-613X; Eustaquio de Moura Lopes, Mateus/0000-0001-8730-7336	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-03221-18]; Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii) [465425/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [465425, 2014-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant/Award Number: APQ-03221-18; Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii), Grant/Award Number: 465425/2014-3; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award Number: 465425 and 2014-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Choi EH, 2016, CLIN VACCINE IMMUNOL, V23, P162, DOI 10.1128/CVI.00591-15; Cooray Sadani N, 2013, Proc Natl Acad Sci U S A, V110, P18232, DOI 10.1073/pnas.1308253110; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Dalli J, 2017, MOL ASPECTS MED, V58, P12, DOI 10.1016/j.mam.2017.03.007; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Dockrell DH, 2012, CHEST, V142, P482, DOI 10.1378/chest.12-0210; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fica A, 2014, BRAZ J INFECT DIS, V18, P115, DOI 10.1016/j.bjid.2013.06.001; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Galvao I, 2017, EUR J IMMUNOL, V47, P585, DOI 10.1002/eji.201646551; Garcia CC, 2010, DISCOV MED, V10, P479; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Leoni G, 2016, BIOL CHEM, V397, P971, DOI 10.1515/hsz-2016-0180; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; Liao WI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081771; Light R B, 1999, Semin Respir Infect, V14, P218; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Meduri GU, 2002, CRIT CARE, V6, P24, DOI 10.1186/cc1450; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Patel DM, 2011, J CELL SCI, V124, P578, DOI 10.1242/jcs.076208; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2004, BIOCHEM SOC T, V32, P507, DOI 10.1042/BST0320507; Scalerandi MV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01980; Schloer S, 2019, FASEB J, V33, P12188, DOI 10.1096/fj.201901265R; Senthilkumaran C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-24; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Steel HC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/490346; Sugimoto MA, 2019, TRENDS IMMUNOL, V40, P212, DOI 10.1016/j.it.2019.01.007; Tavares LP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01799; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Vanessa KHQ, 2015, IMMUNOBIOLOGY, V220, P614, DOI 10.1016/j.imbio.2014.12.001; Wang H, 2017, CLIN SCI, V131, P2347, DOI 10.1042/CS20171006; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	57	39	41	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2749	2764		10.1096/fj.201902172R	http://dx.doi.org/10.1096/fj.201902172R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908042	Bronze			2022-12-26	WOS:000504667700001
J	Tang, JQ; Goldschmeding, R; Samarakoon, R; Higgins, PJ				Tang, Jiaqi; Goldschmeding, Roel; Samarakoon, Rohan; Higgins, Paul J.			Protein phosphatase Mg2+/Mn2+ dependent-1A and PTEN deregulation in renal fibrosis: Novel mechanisms and co-dependency of expression	FASEB JOURNAL			English	Article						CCN2; CTGF; CKD; epithelial dysfunction; PAI-1; TGF-beta 1	CHRONIC KIDNEY-DISEASE; ARISTOLOCHIC ACID NEPHROPATHY; TGF-BETA; MOUSE FIBROBLASTS; DOWN-REGULATION; TARGETING PTEN; TGF-BETA-1; GENES; DEGRADATION; ACTIVATION	PPM1A and PTEN emerged as novel suppressors of chronic kidney disease (CKD). Since loss of PPM1A and PTEN in the tubulointerstitium promotes fibrogenesis, defining molecular events underlying PPM1A/PTEN deregulation is necessary to develop expression rescue as novel therapeutic strategies. Here we identify TGF-beta 1 as a principle repressor of PPM1A, as conditional renal tubular-specific induction of TGF-beta 1 in mice dramatically downregulates kidney PPM1A expression. TGF-beta 1 similarly attenuates PPM1A and PTEN expression in human renal epithelial cells and fibroblasts, via a protein degradation mechanism by promoting their ubiquitination. A proteasome inhibitor MG132 rescues PPM1A and PTEN expression, even in the presence of TGF-beta 1, along with decreased fibrogenesis. Restoration of PPM1A or PTEN similarly limits SMAD3 phosphorylation and the activation of TGF-beta 1-induced fibrotic genes. Concurrent loss of PPM1A and PTEN levels in aristolochic acid nephropathy further suggests crosstalk between these repressors. PPM1A silencing in renal fibroblasts, moreover, results in PTEN loss, while PTEN stable depletion decreases PPM1A expression with acquisition of a fibroproliferative phenotype in each case. Transient PPM1A expression, conversely, elevates cellular PTEN levels while lentiviral PTEN introduction increases PPM1A expression. PPM1A and PTEN, therefore, co-regulate each other's relative abundance, identifying a previously unknown pathological link between TGF-beta 1 repressors, contributing to CKD.	[Tang, Jiaqi; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Ctr, Dept Regenerat & Canc Cell Biol, Albany, NY USA; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Utrecht University; Utrecht University Medical Center	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave, Albany, NY 12208 USA.	samarar@amc.edu; higginp@amc.edu		Tang, Jiaqi/0000-0002-3544-3456	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM057242]; A Capital Region Medical Institute Grant; Graver Family Endowment; Friedman Family Fund; Butler Family Foundation; Roach Family Foundation	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); A Capital Region Medical Institute Grant; Graver Family Endowment; Friedman Family Fund; Butler Family Foundation; Roach Family Foundation	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM057242; A Capital Region Medical Institute Grant; The Graver Family Endowment; The Friedman Family Fund; The Butler Family Foundation; The Roach Family Foundation	Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bera A, 2017, AM J PHYSIOL-CELL PH, V313, pC430, DOI 10.1152/ajpcell.00081.2017; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JK, 2015, J CLIN INVEST, V125, P2429, DOI 10.1172/JCI78945; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Higgins DF, 2017, BBA-MOL BASIS DIS, V1863, P3095, DOI 10.1016/j.bbadis.2017.09.011; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lan RP, 2012, AM J PHYSIOL-RENAL, V302, pF1210, DOI 10.1152/ajprenal.00660.2011; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu SX, 2013, ARTHRITIS RHEUM-US, V65, P2940, DOI 10.1002/art.38121; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Macconi D, 2014, KIDNEY INT SUPPL, V4, P58, DOI 10.1038/kisup.2014.11; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Parapuram SK, 2011, J INVEST DERMATOL, V131, P1996, DOI 10.1038/jid.2011.156; Patel S, 2019, FASEB J, V33, P9797, DOI 10.1096/fj.201802489RR; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Tang JQ, 2018, CANCERS, V10, DOI 10.3390/cancers10060159; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zeniya M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13486-x; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhou Y, 2013, AM J PATHOL, V183, P1183, DOI 10.1016/j.ajpath.2013.06.032	44	8	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2641	2656		10.1096/fj.201902015RR	http://dx.doi.org/10.1096/fj.201902015RR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909517				2022-12-26	WOS:000504067500001
J	Tao, LC; Huang, XL; Xu, M; Yang, L; Hua, F				Tao, Lichan; Huang, Xiaoli; Xu, Min; Yang, Ling; Hua, Fei			MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis	FASEB JOURNAL			English	Article						cardiac function; hyperglycemia; miR-144; mitochondrial biogenesis	DIABETIC CARDIOMYOPATHY; ENDOTHELIAL-CELLS; TRANSCRIPTIONAL CONTROL; OXIDATIVE STRESS; GLUCOSE-UPTAKE; ACTIVATION; MITOPHAGY; RAC1; ANGIOGENESIS; DYSFUNCTION	Several lines of evidence have revealed the potential of microRNAs (miRNAs, miRs) as biomarkers for detecting diabetic cardiomyopathy, although their functions in hyperglycemic cardiac dysfunction are still lacking. In this study, mitochondrial biogenesis was markedly impaired induced by high glucose (HG), as evidenced by dysregulated mitochondrial structure, reduced mitochondrial DNA contents, and biogenesis-related mRNA levels, accompanied by increased cell apoptosis. MiR-144 was identified to be decreased in HG-induced cardiomyocytes and in streptozotocin (STZ)-challenged heart samples. Forced miR-144 expression enhanced mitochondrial biogenesis and suppressed cell apoptosis, while miR-144 inhibition exhibited the opposite results. Rac-1 was identified as a target gene of miR-144. Decreased Rac-1 levels activated AMPK phosphorylation and PGC-1 alpha deacetylation, leading to increased mitochondrial biogenesis and reduced cell apoptosis. Importantly, the systemic neutralization of miR-144 attenuated mitochondrial disorder and ventricular dysfunction following STZ treatment. Additionally, plasma miR-144 decreased markedly in diabetic patients with cardiac dysfunction. The receiver-operator characteristic curve showed that plasma miR-144 could specifically predict diabetic patients developing cardiac dysfunction. In conclusion, this study provides strong evidence suggesting that miR-144 protects heart from hyperglycemia-induced injury by improving mitochondrial biogenesis and decreasing cell apoptosis via targeting Rac-1. Forced miR-144 expression might, thus, be a protective strategy for treating hyperglycemia-induced cardiac dysfunction.	[Tao, Lichan; Yang, Ling] Soochow Univ, Affiliated Hosp 3, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Huang, Xiaoli; Hua, Fei] Soochow Univ, Affiliated Hosp 3, Dept Endocrinol, Changzhou 213003, Jiangsu, Peoples R China; [Xu, Min] Soochow Univ, Affiliated Hosp 3, Dept Echocardiog, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Hua, F (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Endocrinol, Changzhou 213003, Jiangsu, Peoples R China.	huafei1970@suda.edu.cn	TAO, Li/HIR-4254-2022; min, xu/AGJ-0451-2022	min, xu/0000-0002-0576-497X				Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Battiprolu Pavan K, 2010, Drug Discov Today Dis Mech, V7, pe135; Battiprolu PK, 2013, LIFE SCI, V92, P609, DOI 10.1016/j.lfs.2012.10.011; Battogtokh G, 2018, ACTA PHARM SIN B, V8, P862, DOI 10.1016/j.apsb.2018.05.006; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Dai BB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0767-z; Dingreville F, 2019, DIABETES, V68, P1778, DOI 10.2337/db18-1112; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Feng B, 2017, J MOL CELL CARDIOL, V105, P70, DOI 10.1016/j.yjmcc.2017.03.002; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jang WB, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4528184; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Liang C, 2019, LIFE SCI, V224, P12, DOI 10.1016/j.lfs.2019.02.059; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; Liu YQ, 2016, MOL PHARMACOL, V89, P313, DOI 10.1124/mol.115.102004; Lynn EG, 2010, J MOL CELL CARDIOL, V49, P693, DOI 10.1016/j.yjmcc.2010.06.008; Ma S, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4602715; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nandi SS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01275; Nandi SS, 2018, ADV EXP MED BIOL, V1056, P47, DOI 10.1007/978-3-319-74470-4_4; Ni R, 2016, DIABETES, V65, P255, DOI 10.2337/db15-0963; Oclon E, 2016, J ENDOCRINOL, V229, P259, DOI 10.1530/JOE-15-0495; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Palomer X, 2018, TRENDS PHARMACOL SCI, V39, P452, DOI 10.1016/j.tips.2018.02.010; Piccoli MT, 2015, J MOL CELL CARDIOL, V89, P59, DOI 10.1016/j.yjmcc.2015.02.002; Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820; Rabinovich-Nikitin I, 2019, CIRC RES, V124, P1288, DOI 10.1161/CIRCRESAHA.119.314967; Raut SK, 2016, MOL CELL BIOCHEM, V417, P191, DOI 10.1007/s11010-016-2729-7; Rawal S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0814-4; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Riehle C, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-018-0711-0; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Schiattarella GG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007322; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Singh GB, 2017, MOL CELL BIOCHEM, V424, P1, DOI 10.1007/s11010-016-2838-3; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; Tao LC, 2019, MOL CELL ENDOCRINOL, V481, P95, DOI 10.1016/j.mce.2018.11.015; Tao LC, 2018, METHODS MOL BIOL, V1733, P203, DOI 10.1007/978-1-4939-7601-0_17; Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607; van der Pluijm I, 2018, CARDIOVASC RES, V114, P1776, DOI 10.1093/cvr/cvy150; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang XH, 2016, DIABETES, V65, P3111, DOI 10.2337/db15-1563; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wang YH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.193; Wu SN, 2019, CIRCULATION, V139, P1913, DOI 10.1161/CIRCULATIONAHA.118.033552; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Yao GH, 2016, EUR HEART J-CARD IMG, V17, P512, DOI 10.1093/ehjci/jev330; Yin ZW, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0811-7; Yu ML, 2015, CARDIOVASC PATHOL, V24, P375, DOI 10.1016/j.carpath.2015.06.003; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135	67	18	19	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2173	2197		10.1096/fj.201901838R	http://dx.doi.org/10.1096/fj.201901838R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907983	hybrid			2022-12-26	WOS:000514663600018
J	Manierre, M; Jansen, E; Boolani, A				Manierre, Matthew; Jansen, Erica; Boolani, Ali			Sleep quality and sex modify the relationships between trait energy and fatigue on state energy and fatigue	PLOS ONE			English	Article							EMOTION-REGULATION; EXERCISE	The objective of this study was to identify the associations between trait energy and fatigue with state energy fatigue, as well as exploring if these relationships interacted with sex and/or sleep quality. The study population included a convenience sample of adults and college students (n ranges from 687 to 694). Key measures were state and trait mental and physical energy and fatigue scales, PSQI (a measure of sleep quality), and sex. Multiple regression models included age, polyphenol consumption, POMS scores, physical activity, mental load, and caffeine consumption as covariates. Analyses yielded a strong (r = .65) positive association between each trait and state variable. Overall, several statistically significant interactions were identified. First, the relationship between state and trait physical fatigue was particularly strong for women with high trait scores. There were also interactions with sleep quality. In the case of physical fatigue, poor sleep quality magnified the association between physical fatigue trait and state among those with low trait physical fatigue, while sleep quality did not make a difference for those with high trait physical fatigue. Conversely, in the case of physical energy and mental fatigue, good sleep quality was associated with both higher "highs" and lower "lows" of their respective traits; both interactions were present only among males. Our analyses suggest that sleep quality and sex could influence the effects of trait physical and mental energy and fatigue on state. Findings were more complex than initially assumed, suggesting that the interrelationship between trait and state may be modified by how males and females react and adapt to their trait.	[Manierre, Matthew] Clarkson Univ, Dept Humanities & Social Sci, Potsdam, NY 13699 USA; [Jansen, Erica] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA; [Jansen, Erica] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Boolani, Ali] Clarkson Univ, Dept Phys Therapy, Potsdam, NY USA; [Boolani, Ali] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA	Clarkson University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clarkson University; Clarkson University	Manierre, M (corresponding author), Clarkson Univ, Dept Humanities & Social Sci, Potsdam, NY 13699 USA.	Mmanierr@clarkson.edu	Boolani, Ali/AHC-2152-2022	Boolani, Ali/0000-0002-2261-4498; Manierre, Matt/0000-0002-7422-8775	Isagenix International, LLC	Isagenix International, LLC	The original data collection for this study was funded via a grant from, Isagenix International, LLC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. AB received salary and financial support for data collection and writing for the original (unrelated) research project, which did not use this dataset.	Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Bakker RJ, 2009, PEDIATRICS, V124, pE89, DOI 10.1542/peds.2008-1260; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bird CE, 2008, GENDER AND HEALTH: THE EFFECTS OF CONSTRAINED CHOICES AND SOCIAL POLICIES, P1, DOI 10.1017/CBO9780511807305; Boolani A, FATIGUE BIOMED HLTH; Boolani A., 2017, BMC NUTR, V3, P8, DOI [10.1186/s40795-016-0117-z, DOI 10.1186/S40795-016-0117-Z]; Boolani A, 2019, J GERIATR PHYS THER, V2001; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Chiappelli J, 2013, SCHIZOPHR B, V40, P132, DOI DOI 10.1093/SCHBUL/; Cole DA, 2006, J ABNORM PSYCHOL, V115, P40, DOI 10.1037/0021-843X.115.1.40; Courtenay W., 2011, DYING BE MEN PSYCHOS; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; Dishman RK, 2010, PSYCHOPHYSIOLOGY, V47, P1066, DOI 10.1111/j.1469-8986.2010.01014.x; Dupree EJ, 2019, ADV EXP MED BIOL, V1140, P601, DOI 10.1007/978-3-030-15950-4_36; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fukuda S, 2010, BEHAV MED, V36, P53, DOI 10.1080/08964281003774919; Gomez-Pinilla F, 2012, NUTR NEUROSCI, V15, P127, DOI 10.1179/1476830511Y.0000000035; Hayes A., 2017, INTRO MEDIATION MODE; Hunter SK, 2009, EXERC SPORT SCI REV, V37, P113, DOI 10.1097/JES.0b013e3181aa63e2; Loy BD, 2018, MED HYPOTHESES, V113, P46, DOI 10.1016/j.mehy.2018.02.014; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Mataran-Penarrocha GA, 2011, EVID BASED COMPLEMEN, V2011; Mauss IB, 2013, COGNITION EMOTION, V27, P567, DOI 10.1080/02699931.2012.727783; Miaskowski Christine, 2004, J Natl Cancer Inst Monogr, P139; Nozaki S, 2009, NUTRITION, V25, P51, DOI 10.1016/j.nut.2008.07.010; O'Connor PJ, 2004, J PSYCHOSOM RES, V57, P435, DOI 10.1016/j.jpsychores.2003.12.006; O'Connor PJ., 2006, MENTAL PHYS STATE TR; Palmer CA, 2017, SLEEP MED REV, V31, P6, DOI 10.1016/j.smrv.2015.12.006; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Puetz TW, 2006, PSYCHOL BULL, V132, P866, DOI 10.1037/0033-2909.132.6.866; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Read JG, 2010, ANNU REV SOCIOL, V36, P371, DOI 10.1146/annurev.soc.012809.102535; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Rothman KJ, 1990, EPIDEMIOLOGY, V43-6; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; Spielberger C. D., 1983, MIND GARDEN; Spielberger CD, 1994, STATE TRAIT ANXIETY; Spielberger CD, 2017, REV INTERAM PSICOL J, V5; Steyer R, 2015, ANNU REV CLIN PSYCHO, V11, P71, DOI 10.1146/annurev-clinpsy-032813-153719; Tang WR, 2010, J CLIN NURS, V19, P69, DOI 10.1111/j.1365-2702.2009.02959.x; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Van Dongen HPA, 2009, IND HEALTH, V47, P518, DOI 10.2486/indhealth.47.518; Watson D., 2000, MOOD TEMPERAMENT	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227511	10.1371/journal.pone.0227511	http://dx.doi.org/10.1371/journal.pone.0227511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914459	Green Published, gold			2022-12-26	WOS:000534337700047
J	Simone, LRL; Cavallari, DC				Simone, Luiz Ricardo L.; Cavallari, Daniel C.			A new species of Macrocypraea (Gastropoda, Cypraeidae) from Trindade Island, Brazil, including phenotypic differentiation from remaining congeneric species	PLOS ONE			English	Article								Macrocypraea mammoth is a new species from Trindade, a remote oceanic island located 1160 km off Espi ' rito Santo, Brazil. This isolated species is described in a detailed morphological scenario that includes all Recent congeneric species. The detailed anatomy of two Recent species, M. zebra and M. cervinetta, were described in a previous paper. The remaining one, M. cervus, is included herein. Brief taxonomical comments on all these species is also included. The new species can be distinguished from other Western Atlantic species by its larger size, proportionally heavier and more solid shell, more rounded and wider outline, longer posterior tapered ending and slightly inflated base; anatomically it has some exclusivities, such as the mantle papillae mostly bearing 3-5 distal aligned projections, osphradium with a shorter branch, modifications in some odontophore muscles, penis with a clear glandular region, and a sac-like bursa copulatrix with a long duct. Based on the comparative analysis, the genus Macrocypraea can be defined by the wide distance between the osphradium and gill; a twofold buccal muscle (mc); a radular ventral tensor muscle (pair m11) surrounding radular sac; and a bursa copulatrix located at middle level of the pallial oviduct.	[Simone, Luiz Ricardo L.] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Cavallari, Daniel C.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Simone, LRL (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	Irsimone@usp.br	Cavallari, Daniel C/C-6380-2014	Cavallari, Daniel C/0000-0003-3104-6434	CNPq [403940/2012-5]; FAPESP [2016/50373-6]; Centro para Documentacao da Biodiversidade (Center for Biodiversity Documentation), Department of Biology, FFCLRP, Brazil; Funding Authority for Studies and Projects (FINEP) [01/2013]; Ministry of Science, Technology, Innovations and Communication; Brazilian Federal Government	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro para Documentacao da Biodiversidade (Center for Biodiversity Documentation), Department of Biology, FFCLRP, Brazil; Funding Authority for Studies and Projects (FINEP); Ministry of Science, Technology, Innovations and Communication; Brazilian Federal Government	This work was supported by CNPq 403940/2012-5 and FAPESP 2016/50373-6 as part of the ProTrindade Project and the Centro para Documentacao da Biodiversidade (Center for Biodiversity Documentation), Department of Biology, FFCLRP, Brazil. This article constitutes part of the project 'Core-facility for the conservation of scientific documentation: biological collections and high technology research in comparative morphology' (CT-INFRA 01/2013), financed by the Funding Authority for Studies and Projects (FINEP), Ministry of Science, Technology, Innovations and Communication, Brazilian Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGESS CM, 1985, COWRIES WORLD; Couto DR, 2012, AM MALACOL BULL, V30, P103; CROVO M E, 1971, Veliger, V13, P292; Fernandes MR, 2013, NAUTILUS, V127, P1; Guevara-Fletcher Carlos E., 2011, Journal of Marine Biology, V2011, P1; Landa-Jaime V, 2013, REV MEX BIODIVERS, V84, P1121, DOI 10.7550/rmb.32994; LEAL J.H., 1991, MARINE PROSOBRANCH G; Linnaeus C, 1771, MANTISSA PLANTARUM, P543; Lorenz F, 2017, BIOL SYSTEMATICS, V1; Meyer CP, 2004, MALACOLOGIA, V46, P127; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Petuch E.J, 2011, COMPENDIUM FLORIDA F, V1; PETUCH EJ, 1990, NAUTILUS, V104, P96; Petuch EJ, 2018, JEWELS EVERGLADES FO; RIGHI GILBERTO, 1966, MALACOLOGIA, V4-(2), P269; Rios E.C., 1989, Comunicaciones de la Sociedad Malacologica del Uruguay, V7, P57; Rios E.C., 2009, COMPENDIUM BRAZILIAN; Rosenberg G, 2011, MALACOLOG VERSION 4; Rosenberg Gary, 2009, P579; Salvador RB, 2013, J NAT HIST, V47, P949, DOI 10.1080/00222933.2012.759290; Schilder F. A., 1968, Veliger, V10, P264; SCHILDER F. A., 1930, PROC MALAC SOC LONDON, V19, P49; SCHILDER FRANZ ALFRED, 1966, VELIGER, V9, P91; Schobbenhaus C, 2002, SITIOS GEOLOGICOS PA, V1st, P369; Simone LRL., 2004, MORPHOLOGY PHYLOGENY; Simone Luiz Ricardo L., 2011, Arquivos de Zoologia (Sao Paulo), V42, P161; SOLEM A., 1979, SPIRA, V1072; Torreblanca-Ramirez C, 2017, REV BIOL MAR OCEANOG, V52, P81; Torreblanca-Ramirez C, 2014, REV BIOL MAR OCEANOG, V49, P547, DOI 10.4067/S0718-19572014000300011; Torreblanca-Ramirez C, 2012, REV BIOL MAR OCEANOG, V47, P283, DOI 10.4067/S0718-19572012000200010	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0225963	10.1371/journal.pone.0225963	http://dx.doi.org/10.1371/journal.pone.0225963			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914132	gold, Green Published			2022-12-26	WOS:000534337700011
J	Lin, SC; Carey, BD; Callahan, V; Lee, JH; Bracci, N; Patnaik, A; Smith, AK; Narayanan, A; Lepene, B; Kehn-Hall, K				Lin, Shih-Chao; Carey, Brian D.; Callahan, Victoria; Lee, Ji-Hyun; Bracci, Nicole; Patnaik, Anurag; Smith, Amy K.; Narayanan, Aarthi; Lepene, Benjamin; Kehn-Hall, Kylene			Use of Nanotrap particles for the capture and enrichment of Zika, chikungunya and dengue viruses in urine	PLOS ONE			English	Article							HYDROGEL PARTICLES; PCR	Nanotrap (R) (NT) particles are hydrogel microspheres developed for target analyte separation and discovery applications. NT particles consist of cross-linked N-isopropylacrylamide (NIPAm) copolymers that are functionalized with a variety of chemical affinity baits to enable broad-spectrum collection and retention of target proteins, nucleic acids, and pathogens. NT particles have been previously shown to capture and enrich arboviruses including Rift Valley fever and Venezuelan equine encephalitis viruses. Yet, there is still a need to enhance the detection ability for other re-emerging viruses such as Zika (ZIKV), chikungunya (CHIKV), and dengue (DENV) viruses. In this study, we exploited NT particles with different affinity baits, including cibacron blue, acrylic acid, and reactive red 120, to evaluate their capturing and enrichment capability for ZIKV, DENV and CHIKV in human fluids. Our results demonstrate that CN1030, a NT particle conjugated with reactive red 120, can recover between 8-16-fold greater genomic copies of ZIKV, CHIKV and DENV in virus spiked urine samples via RT-qPCR, superior to the other chemical baits. Also, we observed that CN1030 simultaneously enriched ZIKV, CHIKV and DENV in co-infection-based settings and could stabilize ZIKV, but not CHIKV infectivity in saliva spiked samples. CN1030 enriched viral detection at various viral concentrations, with significant enhancement observed at viral titers as low as 100 PFU/mL for ZIKV and 10 PFU/mL for CHIKV. The detection of ZIKV was further enhanced with NT particles by processing of larger volume urine samples. Furthermore, we developed a magnetic NT particle, CN3080, based on the same backbone of CN1030, and demonstrated that CN3080 could also capture and enrich ZIKV and CHIKV in a dose-dependent manner. Finally, in silico docking predictions support that the affinity between reactive red 120 and ZIKV or CHIKV envelope proteins appeared to be greater than acrylic acid. Overall, our data show that NT particles along with reactive red 120 can be utilized as a pre-processing technology for enhancement of detecting febrile-illness causing viruses.	[Lin, Shih-Chao; Carey, Brian D.; Callahan, Victoria; Lee, Ji-Hyun; Bracci, Nicole; Narayanan, Aarthi; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Patnaik, Anurag; Lepene, Benjamin] Ceres Nanosci Inc, Manassas, VA USA; [Smith, Amy K.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Smith, Amy K.] George Mason Univ, Computat Mat Sci Ctr, Manassas, VA USA	George Mason University; George Mason University; George Mason University	Kehn-Hall, K (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.	kkehnhal@gmu.edu	Carey, Brian/AAT-6657-2021; Lin, Shih-Chao/AAG-9173-2020	Carey, Brian/0000-0002-5493-3880; Lin, Shih-Chao/0000-0003-2942-5937; Kehn-Hall, Kylene/0000-0001-8036-7213; Bracci, Nicole/0000-0002-7298-4796	Defense Advanced Research Projects Agency [W911NF-16-C-0060]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Support for this work was provided by the Defense Advanced Research Projects Agency: Contract No. W911NF-16-C-0060. DARPA does not have any role in the design of the study and collection, analysis, and interpretation of data and nor in writing the manuscript. Authors AP and BL are employed by the company Ceres Nanosciences, Inc. Ceres Nanosciences provided support in the form of salaries for authors AP and BL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2; Kanbara A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-39; Khurshid Z, 2019, J INFECT PUBLIC HEAL, V12, P601, DOI 10.1016/j.jiph.2019.05.004; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lin SC, 2019, INT J ANTIMICROB AG, V54, P80, DOI 10.1016/j.ijantimicag.2019.03.017; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Musso D, 2016, VIROL J, V13; Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; PAIXAO ES, 2018, BMJ GLOB HEALTH, V3, DOI DOI 10.1136/BMJGH-2017-000530.; Patanarut A, 2010, COLLOID SURFACE A, V362, P8, DOI 10.1016/j.colsurfa.2010.03.023; Paul J, 2013, CHEMOSPHERE, V90, P1348, DOI 10.1016/j.chemosphere.2012.07.049; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prevention CfDCa, 2018, ZIK VIR TEST GUID SY; Prevention CfDCa, 2017, EST POT RANG AED AEG; Rahman N, 2018, ENVIRON SCI POLLUT R, V25, P26114, DOI 10.1007/s11356-018-2566-1; Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496; SALAM N, 2018, BMC PUBLIC HEALTH, V18, pNIL1, DOI DOI 10.1186/s12889-018-5626-z; Shafagati N, 2016, VIRULENCE, V7, P756, DOI 10.1080/21505594.2016.1185585; Shafagati N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128215; Shafagati N, 2014, PATHOG DIS, V71, P162, DOI 10.1111/2049-632X.12136; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970; Suwanmanee S, 2018, ACTA TROP, V188, P244, DOI 10.1016/j.actatropica.2018.09.012; Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007	38	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227058	10.1371/journal.pone.0227058	http://dx.doi.org/10.1371/journal.pone.0227058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910225	gold, Green Published			2022-12-26	WOS:000534333800025
J	Lusambili, AM; Naanyu, V; Wade, TJ; Mossman, L; Mantel, M; Pell, R; Ngetich, A; Mulama, K; Nyaga, L; Obure, J; Temmerman, M				Lusambili, Adelaide M.; Naanyu, Violet; Wade, Terrance J.; Mossman, Lindsay; Mantel, Michaela; Pell, Rachel; Ngetich, Angela; Mulama, Kennedy; Nyaga, Lucy; Obure, Jerim; Temmerman, Marleen			Deliver on Your Own: Disrespectful Maternity Care in rural Kenya	PLOS ONE			English	Article								Background Under the Free Maternity Policy (FMP), Kenya has witnessed an increase in health facility deliveries rather than home deliveries with Traditional Birth Attendants (TBA) resulting in improved maternal and neonatal outcomes. Despite these gains, maternal and infant mortality and morbidity rates in Kenya remain unacceptably high indicating that more needs to be done. Aim Using data from the Access to Quality Care through Extending and Strengthening Health Systems (AQCESS) project's qualitative gender assessment, this paper examines women's experience of disrespectful care during pregnancy, labour, and delivery. The goal is to promote an improved understanding of the actual care conditions to inform the development of interventions that can lift the standard of care, increase maternity facility use, and improve health outcomes for both women and newborns. Methodology We conducted sixteen focus group discussions (FGDs), two each for adolescent females, adult females, adult males, and community health committee members. As well, twenty-four key Informants interviews (KII) were also conducted including religious leaders, and persons from local government representatives, Ministry of Health (MOH), and local women's organizations. Data were captured through audio recordings and reflective field notes. Research site Kisii and Kilifi Counties in Kenya. Findings Findings show nursing and medical care during labour and delivery were at times disrespectful, humiliating, uncompassionate, neglectful, or abusive. In both counties, male health workers were preferred by women giving birth, as they were perceived as more friendly and sensitive. Adolescent females were more likely to report abuse during maternity care while women with disabled children reported being stigmatized. Structural barriers related to transportation and available resources at facilities associated with disrespectful care were identified. Conclusions A focus on quality and compassionate care as well as more facility resources will lead to increased, successful, and sustainable use of facility care. Interpreting these results within a systems perspective, Kenya needs to implement, enforce, and monitor quality of care guidelines for pregnancy and delivery including respectful maternity care of pregnant women. To ensure these procedures are enforced, measurable benchmarks for maternity care need to be established, and hospitals need to be regularly monitored to ensure these benchmarks are achieved.	[Lusambili, Adelaide M.; Naanyu, Violet; Mantel, Michaela; Nyaga, Lucy; Obure, Jerim; Temmerman, Marleen] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Nairobi, East Africa, Kenya; [Wade, Terrance J.] Brock Univ, Dept Hlth Sci, St Catharines, ON, Canada; [Mossman, Lindsay; Pell, Rachel] Aga Khan Fdn, Ottawa, ON, Canada; [Ngetich, Angela; Mulama, Kennedy] Aga Khan Fdn, Nairobi, Kenya	Aga Khan University; Brock University	Lusambili, AM (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Nairobi, East Africa, Kenya.	adelaide.lusambili@aku.edu		Lusambili, Adelaide/0000-0001-8174-7963	Aga Khan Foundation Canada; Government of Canada	Aga Khan Foundation Canada; Government of Canada(CGIAR)	FUNDING This research has been supported by Aga Khan Foundation Canada and the Government of Canada	Abuya T, 2015, PLOS ONE; Aga Khan University, 2014, INT PRIM HLTH CAR IP; Banda PC, 2017, WOMEN RISK GENDER IN; Bohren MA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0265-2; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Gebremichael MW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2026-4; Gichuhi E, 2019, IMEDPUB J EFFICACY F, P4; Gitobu CM, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1708-2; Kenya National Bureau of statistics, 2010, POP HOUS CENS HIGHL; Kisii county, 2013, COUNTY INTEGRATED DE; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; Mmari K, 2017, J ADOLESCENT HLTH; Mohale H, 2017, WOMEN BIRTH; Moindi RO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2780-z; Namasivayam A, 2012, INT J WOMENS HLTH; Odallo B, 2018, REPROD HLTH MATTERS; Okafor II, 2015, DISRESPECT ABUSE FAC; Oyerinde K, 2014, J COMMUNITY MED HLTH; Population Council, 2014, SERV INT; Singh K, 2012, AFRICAN J REPROD HLT; The White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; Tunc O, 2015, BJOG; World Health Organization, 2015, WHO STAT PREV EL DIS; 2017, WHO TECH REP SER, V1004, P1	24	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0214836	10.1371/journal.pone.0214836	http://dx.doi.org/10.1371/journal.pone.0214836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910210	Green Published, Green Submitted, gold			2022-12-26	WOS:000534333800001
J	Metzger, JM; Matsoff, HN; Zinnen, AD; Fleddermann, RA; Bondarenko, V; Simmons, HA; Mejia, A; Moore, CF; Emborg, ME				Metzger, Jeanette M.; Matsoff, Helen N.; Zinnen, Alexandra D.; Fleddermann, Rachel A.; Bondarenko, Viktoriya; Simmons, Heather A.; Mejia, Andres; Moore, Colleen F.; Emborg, Marina E.			Post mortem evaluation of inflammation, oxidative stress, and PPAR gamma activation in a nonhuman primate model of cardiac sympathetic neurodegeneration	PLOS ONE			English	Article							PARKINSON DISEASE; ORTHOSTATIC HYPOTENSION; MYOCARDIAL SCINTIGRAPHY; INSULIN-RESISTANCE; MIBG SCINTIGRAPHY; CD36 EXPRESSION; ADRENAL-MEDULLA; ADIPOSE-TISSUE; PIOGLITAZONE; DENERVATION	Cardiac dysautonomia is a common nonmotor symptom of Parkinson's disease (PD) associated with loss of sympathetic innervation to the heart and decreased plasma catechol-amines. Disease-modifying strategies for PD cardiac neurodegeneration are not available, and biomarkers of target engagement are lacking. Systemic administration of the catechol-aminergic neurotoxin 6-hydroxydopamine (6-OHDA) recapitulates PD cardiac dysautonomia pathology. We recently used positron emission tomography (PET) to visualize and quantify cardiac sympathetic innervation, oxidative stress, and inflammation in adult male rhesus macaques (Macaca mulatta; n = 10) challenged with 6-OHDA (50mg/kg; i.v.). Twenty-four hours post-intoxication, the animals were blindly and randomly assigned to receive daily doses of the peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist pioglitazone (n = 5; 5mg/kg p.o.) or placebo (n = 5). Quantification of PET radioligand uptake showed increased oxidative stress and inflammation one week after 6-OHDA which resolved to baseline levels by twelve weeks, at which time pioglitazone-treated animals showed regionally preserved sympathetic innervation. Here we report post mortem characterization of heart and adrenal tissue in these animals compared to age and sex matched normal controls (n = 5). In the heart, 6-OHDA-treated animals showed a significant loss of sympathetic nerve fibers density (tyrosine hydroxylase (TH)-positive fibers). The anatomical distribution of markers of sympathetic innervation (TH) and inflammation (HLA-DR) significantly correlated with respective in vivo PET findings across left ventricle levels and regions. No changes were found in alpha-synuclein immunoreactivity. Additionally, CD36 protein expression was increased at the cardiomyocyte intercalated discs following PPAR gamma-activation compared to placebo and control groups. Systemic 6-OHDA decreased adrenal medulla expression of catecholamine producing enzymes (TH and aromatic L-amino acid decarboxylase) and circulating levels of norepinephrine, which were attenuated by PPAR gamma-activation. Overall, these results validate in vivo PET findings of cardiac sympathetic innervation, oxidative stress, and inflammation and illustrate cardiomyocyte CD36 upregulation as a marker of PPAR gamma target engagement.	[Metzger, Jeanette M.; Matsoff, Helen N.; Zinnen, Alexandra D.; Fleddermann, Rachel A.; Bondarenko, Viktoriya; Simmons, Heather A.; Mejia, Andres; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Metzger, Jeanette M.; Emborg, Marina E.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI 53706 USA; [Moore, Colleen F.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Fleddermann, Rachel A.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of New Mexico	Emborg, ME (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.; Emborg, ME (corresponding author), Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI 53706 USA.; Emborg, ME (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.	emborg@primate.wisc.edu		Zinnen, Alexandra/0000-0001-7130-9417	NIH [P51OD011106, R21NS084158]; NIH Kirschstein-NRSA [F31HL136047]; Welton L&S Honors Sophomore Scholarship; Trewartha Undergraduate Honors Research Grant [PFAPDA-SFW-1854]; University of Wisconsin-Madison Office of Vice Chancellor for Research and Graduate Education; Cellular and Molecular Pathology Graduate Program; Department of Medical Physics	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Kirschstein-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welton L&S Honors Sophomore Scholarship; Trewartha Undergraduate Honors Research Grant; University of Wisconsin-Madison Office of Vice Chancellor for Research and Graduate Education; Cellular and Molecular Pathology Graduate Program; Department of Medical Physics	This study was supported by NIH P51OD011106 (nih.gov), NIH R21NS084158 [MEE] (nih.gov), NIH Kirschstein-NRSA F31HL136047 [JMM] (nih.gov), Welton L&S Honors Sophomore Scholarship [RAF] (honors.ls. wisc.edu), Trewartha Undergraduate Honors Research Grant [R.A.F] (honors.ls.wisc.edu), PFAPDA-SFW-1854 [HNM] (apdaparkinson.org), and the University of Wisconsin-Madison Office of Vice Chancellor for Research and Graduate Education (research.wisc.edu), Cellular and Molecular Pathology Graduate Program (cmp.wisc.edu), and Department of Medical Physics (medphysics.wisc. edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028981; Ahn HY, 2018, PPAR RES, V2018, DOI 10.1155/2018/9568269; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Amino T, 2005, BRAIN PATHOL, V15, P29, DOI 10.1111/j.1750-3639.2005.tb00097.x; Asghar O, 2017, NUCL MED COMMUN, V38, P44, DOI 10.1097/MNM.0000000000000608; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Barbieri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035999; Bird JLE, 2010, ATHEROSCLEROSIS, V210, P388, DOI 10.1016/j.atherosclerosis.2009.11.047; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962; Brauer R, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001854; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Courbon F, 2003, MOVEMENT DISORD, V18, P890, DOI 10.1002/mds.10461; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Eto M, 2008, J PERIPHER NERV SYST, V13, P242, DOI 10.1111/j.1529-8027.2008.00183.x; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Garcia-Ruiz I, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-88; Glatz JFC, 2017, BIOCHIMIE, V136, P21, DOI 10.1016/j.biochi.2016.12.007; Goldstein DS, 2018, PARKINSONISM RELAT D, V52, P90, DOI 10.1016/j.parkreldis.2017.10.003; Goldstein DS, 2002, NEUROLOGY, V58, P1247, DOI 10.1212/WNL.58.8.1247; Goldstein DS, 2003, LANCET NEUROL, V2, P669, DOI 10.1016/S1474-4422(03)00555-6; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Hammarstedt A, 2008, J INTERN MED, V263, P440, DOI 10.1111/j.1365-2796.2007.01914.x; Hamza AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28029-1; Hirakata M, 2004, BIOCHEM BIOPH RES CO, V323, P782, DOI 10.1016/j.bbrc.2004.08.151; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Jain S, 2012, NEUROBIOL DIS, V46, P572, DOI 10.1016/j.nbd.2011.10.025; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; Joers V, 2014, AM J NUCL MED MOLEC, V4, P125; Joers V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035371; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kashihara K, 2010, PARKINSONISM RELAT D, V16, P252, DOI 10.1016/j.parkreldis.2009.12.010; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Li ST, 2002, ANN NEUROL, V52, P220, DOI 10.1002/ana.10236; Mannelli M, 2010, NEUROENDOCRINOLOGY, V92, P23, DOI 10.1159/000314312; Metzger JM, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0057-1; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Morais AD, 2007, INT J MOL MED, V19, P105; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Munch G, 2000, CIRCULATION, V101, P516, DOI 10.1161/01.CIR.101.5.516; Nagayama H, 2005, J NEUROL NEUROSUR PS, V76, P249, DOI 10.1136/jnnp.2004.037028; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakamura T, 2014, PARKINSONISM RELAT D, V20, P409, DOI 10.1016/j.parkreldis.2014.01.003; Nakamura T, 2011, MOVEMENT DISORD, V26, P1869, DOI 10.1002/mds.23744; Nakamura T, 2010, MOVEMENT DISORD, V25, P1183, DOI 10.1002/mds.23127; Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Pagel-Langenickel I, 2008, J BIOL CHEM, V283, P22464, DOI 10.1074/jbc.M800842200; Pan ZQ, 2014, MOL CELL ENDOCRINOL, V394, P119, DOI 10.1016/j.mce.2014.07.007; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peng J, 2014, PPAR RES, V2014, DOI 10.1155/2014/538183; Pisanu A, 2014, NEUROBIOL DIS, V71, P280, DOI 10.1016/j.nbd.2014.08.011; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Pysz MA, 2010, CLIN RADIOL, V65, P500, DOI 10.1016/j.crad.2010.03.011; Qi NN, 2002, J BIOL CHEM, V277, P48501, DOI 10.1074/jbc.M206655200; Rasouli N, 2009, ARTERIOSCL THROM VAS, V29, P1328, DOI 10.1161/ATVBAHA.109.186957; Rocha NP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/628192; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; SENARD JM, 1993, CLIN NEUROPHARMACOL, V16, P70, DOI 10.1097/00002826-199302000-00008; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simmons HA, 2016, VET PATHOL, V53, P399, DOI 10.1177/0300985815620628; Simon DK, 2015, J PARKINSON DIS, V5, P731, DOI 10.3233/JPD-150666; Simuni T, 2015, LANCET NEUROL, V14, P795, DOI 10.1016/S1474-4422(15)00144-1; Stoddard S L, 1994, Rev Neurosci, V5, P293; STODDARD SL, 1989, EXP NEUROL, V104, P22, DOI 10.1016/0014-4886(89)90004-6; STODDARD SL, 1994, MICROSC RES TECHNIQ, V29, P151, DOI 10.1002/jemt.1070290212; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Tai YC, 2005, J NUCL MED, V46, P455; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Umbarawan Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30616-1; Uruno A, 2011, J MOL ENDOCRINOL, V46, P37, DOI 10.1677/JME-10-0088; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Velseboer DC, 2011, PARKINSONISM RELAT D, V17, P724, DOI 10.1016/j.parkreldis.2011.04.016; Wierzbicki M, 2009, J PHYSIOL PHARMACOL, V60, P99; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wong KK, 2017, J NUCL MED, V58, P326, DOI 10.2967/jnumed.116.176891; Wong KK, 2012, RADIOLOGY, V265, P240, DOI 10.1148/radiol.12112723; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yang KJ, 2010, LIFE SCI, V87, P405, DOI 10.1016/j.lfs.2010.08.002; Yu M, 2016, J BIOL CHEM, V291, P16977, DOI 10.1074/jbc.M116.740092	91	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226999	10.1371/journal.pone.0226999	http://dx.doi.org/10.1371/journal.pone.0226999			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910209	Green Published, gold			2022-12-26	WOS:000534333800023
J	Hu, JC; Tan, L; Huang, G; Yu, WJ				Hu, Jingchu; Tan, Ling; Huang, Gang; Yu, Wenjun			Disparity in depressive symptoms between heterosexual and sexual minority men in China: The role of social support	PLOS ONE			English	Article							SELF-ESTEEM; MULTIDIMENSIONAL SCALE; SUICIDAL IDEATION; BISEXUAL YOUTH; HEALTH; GAY; RISK; ADOLESCENTS; ORIENTATION; STRESS	Accumulating evidence suggests that sexual minorities experience elevated levels of depressive symptoms compared to heterosexuals in Western countries. Still, little is known about whether there is any difference in depressive symptoms between sexual minority men and heterosexual men in China. This study investigated the differences in depressive symptoms and social support between 302 Chinese sexual minority men and 249 heterosexual men. The association between depressive symptoms, social support and sexual orientation was also explored. Our results indicated that Chinese sexual minority men have more depressive symptoms and perceived lower social support than heterosexual men. Overall, sexual orientation and social support both predicted depressive symptoms. Different from previous Western studies, in our results, social support fully mediates but does not moderate the relationship between sexual orientation and depressive symptoms in Chinese men. The current findings suggest that social support has a significant impact on depressive symptoms among Chinese sexual minority men, highlighting the unique role of social support in understanding depressive symptoms among Chinese sexual minority men. Providing more social support, as well as promoting accepting and positive environments, may lead to better adjustment in this population in China.	[Hu, Jingchu] Shenzhen Kangning Hosp, Dept Anxiety Disorders, Shenzhen, Guangdong, Peoples R China; [Tan, Ling] Guangdong Univ Technol, Sch Management, Guangzhou, Guangdong, Peoples R China; [Huang, Gang] Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China; [Huang, Gang] Shenzhen Univ, Normal Coll, Shenzhen, Guangdong, Peoples R China; [Yu, Wenjun] Jinggangshan Univ, Coll Educ, Jian, Jiangxi, Peoples R China	Guangdong University of Technology; Shenzhen University; Jinggangshan University	Tan, L (corresponding author), Guangdong Univ Technol, Sch Management, Guangzhou, Guangdong, Peoples R China.; Yu, WJ (corresponding author), Jinggangshan Univ, Coll Educ, Jian, Jiangxi, Peoples R China.	tanling@m.scnu.edu.cn; 2014010149@m.scnu.edu.cn			PhD Research Startup Foundation of Guangdong Natural Science Foundation [2018A030310661]; China Postdoctoral Science Foundation [2018M640791, 2019T120738]; National Natural Science Foundation of China [71802203]; Fundamental Research Funds for the Central Universities [18wkpy16]	PhD Research Startup Foundation of Guangdong Natural Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the PhD Research Startup Foundation of Guangdong Natural Science Foundation (Grant No. 2018A030310661) and China Postdoctoral Science Foundation (Grant No. 2018M640791 & 2019T120738) to J.H.; and the grant funded by National Natural Science Foundation of China (Grant No. 71802203) and Fundamental Research Funds for the Central Universities (Grant No. 18wkpy16) to L.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baams L, 2015, DEV PSYCHOL, V51, P688, DOI 10.1037/a0038994; Balsam KF, 2005, J ABNORM PSYCHOL, V114, P471, DOI 10.1037/0021-843X.114.3.471; Bishop GD, 2005, AM HEART J, V150, P602, DOI 10.1016/j.ahj.2004.10.015; [陈祉妍 CHEN Zhi-yan], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P443; Chou KL, 2000, PERS INDIV DIFFER, V28, P299, DOI 10.1016/S0191-8869(99)00098-7; Chow PKY, 2010, J COUNS PSYCHOL, V57, P92, DOI 10.1037/a0017930; DAHLEM NW, 1991, J CLIN PSYCHOL, V47, P756, DOI 10.1002/1097-4679(199111)47:6<756::AID-JCLP2270470605>3.0.CO;2-L; de Man AF, 2002, CAN J BEHAV SCI, V34, P235, DOI 10.1037/h0087176; Doty ND, 2010, J YOUTH ADOLESCENCE, V39, P1134, DOI 10.1007/s10964-010-9566-x; Fang J., 2008, CHINESE MENTAL HLTH, V3, P184; Galliher RV, 2004, J YOUTH ADOLESCENCE, V33, P235, DOI 10.1023/B:JOYO.0000025322.11510.9d; Gao S. Y., 2008, CHINA J HLTH PSYCHOL, V16, P461; Hu JC, 2016, J HOMOSEXUAL, V63, P72, DOI 10.1080/00918369.2015.1078651; Huang JQJ, 1996, CHIN MENT HLTH J, V10, P160; Huang QBWX., 2015, CHIN J HLTH PSYCHOL, V23, P1036, DOI DOI 10.13342/J.CNKI.CJHP.2015.07.023; la Roi C, 2016, J YOUTH ADOLESCENCE, V45, P440, DOI 10.1007/s10964-015-0403-0; Lam TH, 2004, ARCH SEX BEHAV, V33, P487, DOI 10.1023/B:ASEB.0000037429.79394.c6; Lehavot K, 2011, J CONSULT CLIN PSYCH, V79, P159, DOI 10.1037/a0022839; Lewis NM, 2009, HEALTH PLACE, V15, P1029, DOI 10.1016/j.healthplace.2009.05.003; Li C, 2014, ASIA-PAC PSYCHIAT, V6, P161, DOI 10.1111/appy.12084; Liu W. N., 2010, CHINA J HLTH PSYCHOL, V18, P1494; Liu XJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061065; Lock J, 1999, J AM ACAD CHILD PSY, V38, P297, DOI 10.1097/00004583-199903000-00017; Marshal MP, 2013, J YOUTH ADOLESCENCE, V42, P1243, DOI 10.1007/s10964-013-9970-0; Marshal MP, 2011, J ADOLESCENT HEALTH, V49, P115, DOI 10.1016/j.jadohealth.2011.02.005; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Parra LA, 2018, J SOC PERS RELAT, V35, P854, DOI 10.1177/0265407517699713; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Prestage G, 2018, INT J DRUG POLICY, V55, P169, DOI 10.1016/j.drugpo.2018.01.020; Puckett JA, 2015, LGBT HEALTH, V2, P265, DOI 10.1089/lgbt.2013.0024; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Russell ST, 2001, AM J PUBLIC HEALTH, V91, P1276, DOI 10.2105/AJPH.91.8.1276; Safren SA, 1999, J CONSULT CLIN PSYCH, V67, P859, DOI 10.1037/0022-006X.67.6.859; Secor AM, 2015, AIDS, V29, pS251, DOI 10.1097/QAD.0000000000000846; Shilo G, 2011, FAM RELAT, V60, P318, DOI 10.1111/j.1741-3729.2011.00648.x; Tan L, 2018, CHILD YOUTH CARE FOR, V47, P219, DOI 10.1007/s10566-017-9427-9; Tang XL, 1995, CHIN MENT HLTH J, V1, P19; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Teasdale B, 2010, J HOMOSEXUAL, V57, P287, DOI 10.1080/00918360903489127; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; van Beusekom G, 2016, J SEX RES, V53, P98, DOI 10.1080/00224499.2014.993462; VINCKE J, 1994, HUM RELAT, V47, P1049, DOI 10.1177/001872679404700902; Watson RJ, 2019, YOUTH SOC, V51, P30, DOI 10.1177/0044118X16660110; Wight RG, 2015, SOC SCI MED, V147, P200, DOI 10.1016/j.socscimed.2015.10.066; Williams T, 2005, J YOUTH ADOLESCENCE, V34, P471, DOI 10.1007/s10964-005-7264-x; Wills TA., 1991, PROSOCIAL BEHAV, P265; Wong CF, 2014, PREV SCI, V15, P44, DOI 10.1007/s11121-012-0348-4; Wu Jin, 2003, MENTAL HLTH PROFESSI, P117, DOI DOI 10.1300/J236v07n01_08; Zhang HP, 2017, J HOMOSEXUAL, V64, P382, DOI 10.1080/00918369.2016.1190221	50	7	7	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226178	10.1371/journal.pone.0226178	http://dx.doi.org/10.1371/journal.pone.0226178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4ZR	31905216	Green Published, gold			2022-12-26	WOS:000534327700004
J	Kitamura, N; Shindo, M; Ohtsuka, J; Nakamura, A; Tanokura, M; Hiroi, T; Kaminuma, O				Kitamura, Noriko; Shindo, Mayumi; Ohtsuka, Jun; Nakamura, Akira; Tanokura, Masaru; Hiroi, Takachika; Kaminuma, Osamu			Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells	FASEB JOURNAL			English	Article						calcineurin-binding region; cytokine; immunosuppressant; nuclear translocation	CYCLOSPORINE-A; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NFAT; PEPTIDE; GROWTH; INHIBITION; MECHANISMS; DEFICIENT; RESPONSES	Nuclear factor of activated T cells (NFAT) leads to the transcription of diverse inducible genes involved in many biological processes; therefore, aberrant NFAT expression is responsible for the development and exacerbation of various disorders. Since five isoforms of NFAT (NFATc1-c4, NFAT5) exhibit distinct and overlapping functions, selective control of a part, but not all, of NFAT family members is desirable. By comparing the binding activity of each NFATc1-c4 with its regulatory enzyme, calcineurin (CN), using a quantitative immunoprecipitation assay, we found a new CN-binding region (CNBR) selectively functioning in NFATc1 and NFATc4. This region, termed CNBR3, is located between two preexisting CNBR1 and CNBR2, within the Ca2+ regulatory domain. The nuclear translocation of NFATc1 but not NFATc2 in T cells was suppressed by ectopic expression of CNBR3 and, accordingly, NFATc1-dependent cytokine expression was downregulated. Through competition assays using NFATc1-derived partial peptides and mass spectrometry with photoaffinity technology, we identified 18 amino acids in NFATc1 (Arg(258) to Pro(275)) and 13 amino acids in CN catalytic subunit (CNA) (Asn(77) to Gly(89)) responsible for CNA/CNBR3 binding in which Cys(263) and Asp(82), respectively, played crucial roles. The possible selective regulation of NFAT-mediated biological processes by targeting this new CN/NFAT-binding region is suggested.	[Kitamura, Noriko; Hiroi, Takachika; Kaminuma, Osamu] Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Tokyo, Japan; [Shindo, Mayumi] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Japan; [Ohtsuka, Jun; Nakamura, Akira; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakamura, Akira] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo, Japan; [Kaminuma, Osamu] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Gakushuin University; Hiroshima University	Kaminuma, O (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	okami@hiroshima-u.ac.jp	; Nakamura, Akira/C-1658-2016	Tanokura, Masaru/0000-0001-5072-2480; Nakamura, Akira/0000-0001-7733-4007	MEXT | Japan Society for the Promotion of Science (JSPS) [24590107, 21590086]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 24590107 and 21590086	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen Zhao-Li, 2011, Chin J Cancer, V30, P62; Choi JM, 2012, IMMUNOL LETT, V143, P170, DOI 10.1016/j.imlet.2012.01.016; Erb KJ, 2003, INFECT IMMUN, V71, P6641, DOI 10.1128/IAI.71.11.6641-6647.2003; Fougere M, 2010, ONCOGENE, V29, P2292, DOI 10.1038/onc.2009.499; Gal M, 2014, STRUCTURE, V22, P1016, DOI 10.1016/j.str.2014.05.006; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Im SH, 2004, MOL CELLS, V18, P1; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kaminuma O, 2018, J IMMUNOL, V200, P92, DOI 10.4049/jimmunol.1602113; Kaminuma O, 2012, INT ARCH ALLERGY IMM, V158, P30, DOI 10.1159/000337757; Koch S, 2015, CLIN EXP ALLERGY, V45, P1356, DOI 10.1111/cea.12493; Kwon HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19453; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; LUNN CA, 1984, J BIOL CHEM, V259, P469; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Quang CT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.14; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Rojanathammanee L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0255-2; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Tripathi MK, 2014, CANCER RES, V74, P6947, DOI 10.1158/0008-5472.CAN-14-1592; Vihma H, 2016, J NEUROCHEM, V137, P394, DOI 10.1111/jnc.13568; Woo M, 1997, BONE MARROW TRANSPL, V20, P1095, DOI 10.1038/sj.bmt.1701027; Yu HX, 2012, CIRC RES, V110, P200, DOI 10.1161/CIRCRESAHA.111.240895; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang L, 2013, BRIT J PHARMACOL, V170, P426, DOI 10.1111/bph.12292	42	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3197	3208		10.1096/fj.201902229	http://dx.doi.org/10.1096/fj.201902229		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909857	Bronze			2022-12-26	WOS:000505940000001
J	Wang, JX; Liang, J; Cheng, JY; Guo, YM; Zeng, L				Wang, Jiaxi; Liang, Jun; Cheng, Jingye; Guo, Yumeng; Zeng, Li			Deep learning based image reconstruction algorithm for limited-angle translational computed tomography	PLOS ONE			English	Article							CT RECONSTRUCTION; IMPLEMENTATION; ART	As a low-end computed tomography (CT) system, translational CT (TCT) is in urgent demand in developing countries. Under some circumstances, in order to reduce the scan time, decrease the X-ray radiation or scan long objects, furthermore, to avoid the inconsistency of the detector for the large angle scanning, we use the limited-angle TCT scanning mode to scan an object within a limited angular range. However, this scanning mode introduces some additional noise and limited-angle artifacts that seriously degrade the imaging quality and affect the diagnosis accuracy. To reconstruct a high-quality image for the limited-angle TCT scanning mode, we develop a limited-angle TCT image reconstruction algorithm based on a U-net convolutional neural network (CNN). First, we use the SART method to the limited-angle TCT projection data, then we import the image reconstructed by SART method to a well-trained CNN which can suppress the artifacts and preserve the structures to obtain a better reconstructed image. Some simulation experiments are implemented to demonstrate the performance of the developed algorithm for the limited-angle TCT scanning mode. Compared with some state-of-the-art methods, the developed algorithm can effectively suppress the noise and the limited-angle artifacts while preserving the image structures.	[Wang, Jiaxi; Zeng, Li] Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Chongqing, Peoples R China; [Wang, Jiaxi; Zeng, Li] Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China; [Liang, Jun] Civil Aviat Flight Univ China, Coll Comp Sci, Guanghan, Sichuan, Peoples R China; [Cheng, Jingye; Zeng, Li] Chongqing Univ, Coll Math & Stat, Chongqing, Peoples R China; [Guo, Yumeng] Chongqing Technol & Business Univ, Coll Math & Stat, Chongqing, Peoples R China	Chongqing University; Chongqing University; Civil Aviation Flight University of China; Chongqing University; Chongqing Technology & Business University	Zeng, L (corresponding author), Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Chongqing, Peoples R China.; Zeng, L (corresponding author), Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China.; Zeng, L (corresponding author), Chongqing Univ, Coll Math & Stat, Chongqing, Peoples R China.	drlizeng@cqu.edu.cn			National Natural Science Foundation of China [61771003, 61701174]; National Instrumentation Program of China [2013YQ030629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Program of China	This work was supported in part by the National Natural Science Foundation of China under Grant 61771003 and 61701174, in part by National Instrumentation Program of China under Grant 2013YQ030629.; This work is supported in part by the National Natural Science Foundation of China under Grant 61771003 and 61701174, in part by National Instrumentation Program of China under Grant 2013YQ030629.	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Boublil D, 2015, IEEE T MED IMAGING, V34, P1474, DOI 10.1109/TMI.2015.2401131; Chen H, 2017, BIOMED OPT EXPRESS, V8, P679, DOI 10.1364/BOE.8.000679; Chen ZQ, 2013, PHYS MED BIOL, V58, P2119, DOI 10.1088/0031-9155/58/7/2119; Chun SY, 2014, IEEE T MED IMAGING, V33, P1960, DOI 10.1109/TMI.2014.2328660; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Fuchs VR, 2001, HEALTH AFFAIR, V20, P30, DOI 10.1377/hlthaff.20.5.30; Gao HW, 2007, OPT ENG, V46, DOI 10.1117/1.2739624; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Jin KH, 2017, IEEE T IMAGE PROCESS, V26, P4509, DOI 10.1109/TIP.2017.2713099; Jin X, 2010, IEEE NUCL SCI CONF R, P2232, DOI 10.1109/NSSMIC.2010.5874180; Kim J., 2016, ACCURATE IMAGE SUPER, P1646, DOI [DOI 10.1109/CVPR.2016.182, 10.1109/CVPR.2016.182]; Kong HH, 2015, J X-RAY SCI TECHNOL, V23, P213, DOI 10.3233/XST-150482; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lauzier PT, 2012, MED PHYS, V39, P66, DOI 10.1118/1.3666946; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu FL, 2014, J X-RAY SCI TECHNOL, V22, P673, DOI 10.3233/XST-140453; Liu Y, 2012, PHYS MED BIOL, V57, P7923, DOI 10.1088/0031-9155/57/23/7923; McGaffin MG, 2015, IEEE TRANS COMPUT IM, V1, P186, DOI 10.1109/TCI.2015.2479555; Natterer F., 2001, CLASSICS APPL MATH, V32, DOI [10.1137/1.9780898719284, DOI 10.1137/1.9780898719284]; Pelt DM, 2013, IEEE T IMAGE PROCESS, V22, P5238, DOI 10.1109/TIP.2013.2283142; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Seger MM, 2003, COMPUT ELECTRON AGR, V41, P45, DOI 10.1016/S0168-1699(03)00041-3; Vedaldi A, 2012, P 23 ACM INT C MULT, P689; Wang CX, 2017, INVERSE PROBL IMAG, V11, P917, DOI 10.3934/ipi.2017043; Wang CX, 2016, INVERSE PROBL IMAG, V10, P829, DOI 10.3934/ipi.2016023; Wang G, 2018, IEEE T MED IMAGING, P99; Wang G, 2016, IEEE ACCESS, V4, P8914, DOI 10.1109/ACCESS.2016.2624938; Wang T, 2017, IEEE T NUCL SCI, V64, P2742, DOI 10.1109/TNS.2017.2750199; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu WW, 2018, APPL MATH MODEL, V63, P538, DOI 10.1016/j.apm.2018.07.006; Wu WW, 2016, ACTA OPT SINICA, DOI [10.3788/AOS201636.0911009, DOI 10.3788/AOS201636.0911009]; Yang Q, 2019, IEEE T SMART GRID, V10, P4457, DOI 10.1109/TSG.2018.2860783; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu W, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4981132	37	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226963	10.1371/journal.pone.0226963	http://dx.doi.org/10.1371/journal.pone.0226963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4PC	31905225	Green Published, gold			2022-12-26	WOS:000534300000001
J	Dunstan, RH; Macdonald, MM; Thorn, B; Wood, D; Roberts, TK				Dunstan, R. Hugh; Macdonald, Margaret M.; Thorn, Brittany; Wood, David; Roberts, Timothy K.			Modelling of amino acid turnover in the horse during training and racing: A basis for developing a novel supplementation strategy	PLOS ONE			English	Article							PROTEIN-TURNOVER; METABOLISM; HISTIDINE; SERINE; REQUIREMENTS; NUTRITION; CARNOSINE; ORNITHINE; ACTIN; RATS	Horses in heavy training in preparation for racing and competition have increased metabolic demands to support the more intensive levels of exercise and recovery. However, little is known at the metabolic level about amino acid turnover and the specific alterations of demand caused by high intensity exercise. During exercise, certain amino acids are required in greater quantities due to disproportionate losses via excretory systems and usage in biosynthetic pathways. This investigation has built a theoretical computer model in an attempt to bring together the published rates of protein intake and utilisation to try to understand how some amino acids might be in higher demand than others. The model indicated that after evaluation of the daily amino acid turnover, glutamine/glutamic acid (Glx), serine and ornithine were in negative nitrogen balance which identified these amino acids as critical limiting factors for anabolism. Adjustment of the modelling conditions to cater for high intensity training indicated that an additional demand was placed on eight amino acids, including GLx, valine, lysine, histidine and phenylalanine which could thus become limiting under these conditions. The modelling results indicated that an amino acid supplement with the correct amino acids to match demand could theoretically be beneficial to a 500Kg horse in quantities of 20-80g/day. These results open new avenues of research for specifically tailoring amino acid supplementation to meet demands for sports horses in heavy training and improving general well-being, especially in hotter climates.	[Dunstan, R. Hugh; Macdonald, Margaret M.; Thorn, Brittany; Roberts, Timothy K.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Wood, David] Horsepower Pty Ltd, Windsor, NSW, Australia	University of Newcastle	Dunstan, RH (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia.	hugh.dunstan@newcastle.edu.au			Gideon Lang Research Foundation; Horsepower Pty Ltd.	Gideon Lang Research Foundation; Horsepower Pty Ltd.	The work was supported by the Gideon Lang Research Foundation. Dr David Wood works as a veterinarian consultant to Horsepower Pty Ltd to provide independent advice. Horsepower Pty Ltd provided support in the form of salary for author DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Dr David Wood works as a veterinarian consultant to Horsepower to provide independent advice. Dr Wood assisted us in the final stages of preparation of the manuscript and provided valuable insight for checking the protein model and clinical interpretation of the data.474 The university authors have not been paid as consultants and have not received any direct grant funding from Horsepower Pty Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The work was supported by the Gideon Lang Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gaby AMA, 1998, NAHRUNG, V42, P290, DOI [10.1002/(SICI)1521-3803(199810)42:05<290::AID-FOOD290>3.0.CO;2-Y, 10.1002/(SICI)1521-3803(199810)42:05&lt;290::AID-FOOD290&gt;3.0.CO;2-Y]; Babinec J., 2001, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P235; Bauchart C, 2007, J NUTR, V137, P589, DOI 10.1093/jn/137.3.589; BEELEY JG, 1986, BIOCHEM J, V235, P645, DOI 10.1042/bj2350645; Boldt J, 2010, BRIT J ANAESTH, V104, P276, DOI 10.1093/bja/aep393; BRIGGS S, 1976, BIOCHEM J, V160, P205, DOI 10.1042/bj1600205; BROUNS F, 1987, INT J SPORTS MED, V8, P175, DOI 10.1055/s-2008-1025653; Burton D.A, 2004, BJA ED, V4; BUTTERFIELD GE, 1987, MED SCI SPORT EXER, V19, pS157; CARSTEN ME, 1963, BIOCHEMISTRY-US, V2, P32, DOI 10.1021/bi00901a007; CHEN CH, 1970, CAN J PLANT SCI, V50, P9, DOI 10.4141/cjps70-002; CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200; CLEMENS RA, 1984, J NUTR, V114, P2138, DOI 10.1093/jn/114.11.2138; Cooperman JM, 2002, EXP BIOL MED, V227, P998, DOI 10.1177/153537020222701107; Darling PB, 1999, AM J CLIN NUTR, V69, P105; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; de Paz-Lugo P, 2018, AMINO ACIDS, V50, P1357, DOI 10.1007/s00726-018-2611-x; Dunstan RH, 2019, AMINO ACIDS, V51, P945, DOI 10.1007/s00726-019-02734-1; Dunstan RH, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0240-y; Dunstan RH, 2015, COMP EXERC PHYSIOL, V11, P201, DOI 10.3920/CEP150027; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; Evans DL, 2007, EQUINE VET J, V39, P373, DOI 10.2746/042516407X206418; FOLKES BF, 1956, BIOCHEM J, V62, P4, DOI 10.1042/bj0620004; FREEMAN DW, 1988, J ANIM SCI, V66, P407; Geor R, 2013, EQUINE CLIN APPL NUT, P696; Graham-Thiers PM, 2005, J ANIM SCI, V83, P2783; Gunn H. M., 1987, EQUINE EXERCISE PHYS, V2, P253; Hodgson D.R, 2014, PRINCIPLES PRACTICE, P408, DOI [10.1016/C2009-0-46058-6, DOI 10.1016/C2009-0-46058-6]; Imayama I, 2013, J PHYS ACT HEALTH, V10, P676, DOI 10.1123/jpah.10.5.676; JACKSON AA, 1991, EUR J CLIN NUTR, V45, P59; Knottenbelt D.C, 2015, SAUNDERS EQUINE FORM, P1, DOI [10.1016/B978-0-7020-5109-8.00001-8, DOI 10.1016/B978-0-7020-5109-8.00001-8]; Knowles AM, 2015, AGE, V37, DOI 10.1007/s11357-015-9763-3; KOPPLE JD, 1975, J CLIN INVEST, V55, P881, DOI 10.1172/JCI108016; Lawrence Laurie, 2008, R. Bras. Zootec., V37, P206; MANOHAR M, 1987, RESP PHYSIOL, V68, P77, DOI 10.1016/0034-5687(87)90078-8; Martin-Rosset W, 2008, NUTR EXERCISING HORS, P183, DOI DOI 10.3920/978-90-8686-644-1; MARTINROSSET W, 1994, LIVEST PROD SCI, V40, P37, DOI 10.1016/0301-6226(94)90264-X; MCCOY TA, 1956, CANCER RES, V16, P979; McGowan C.M., 2014, ATHLETIC HORSE PRINC, P56, DOI [10.1016/B978-0-7216-0075-8.00014-9, DOI 10.1016/B978-0-7216-0075-8.00014-9]; Melendez-Hevia E, 2009, J BIOSCIENCES, V34, P853, DOI 10.1007/s12038-009-0100-9; Millward D.J, 1983, C INRA FRANCE, V1, P69; Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250; NRC, 2007, NUTR REQ HORS, P360, DOI [10.17226/11653pp, DOI 10.17226/11653PP]; Pokrovskiy MV, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/515047; Poole D. C., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P699, DOI 10.1016/B978-0-7020-2671-3.50036-2; Poortmans JR, 2012, BRAZ J MED BIOL RES, V45, P875, DOI 10.1590/S0100-879X2012007500096; Pratt-Phillips SE, 2014, THE ATHLETIC HORSE, P34, DOI [10.1016/b978-0-7216-0075-8.00013-7, DOI 10.1016/B978-0-7216-0075-8.00013-7]; Rasmussen BB, 2000, J APPL PHYSIOL, V88, P386, DOI 10.1152/jappl.2000.88.2.386; RASZKOWSKI RR, 1977, CIRC RES, V40, P191, DOI 10.1161/01.RES.40.2.191; Reeds P.J, 1981, NITROGEN METABOLISM, P391; Rezaei R, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-7; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; ROBBINS GS, 1971, J AGR FOOD CHEM, V19, P536, DOI 10.1021/jf60175a016; Rodwell V. W., 2000, HARPERS BIOCH; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; SPAHR PF, 1964, J BIOL CHEM, V239, P850; Stein W.H., 1958, P NATL ACAD SCI US N; STEIN WH, 1957, BIOCHIM BIOPHYS ACTA, V24, P640, DOI 10.1016/0006-3002(57)90261-5; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Sugino T, 2008, NUTR RES, V28, P738, DOI 10.1016/j.nutres.2008.08.008; TAMAKI N, 1984, J NUTR SCI VITAMINOL, V30, P541, DOI 10.3177/jnsv.30.541; Tessari P., 2006, CACHEXIA WASTING MOD, P73, DOI DOI 10.1007/978-88-470-0552-5_8; Tokita N, 2006, ASIAN AUSTRAL J ANIM, V19, P651, DOI 10.5713/ajas.2006.651; van Wijck K, 2013, AM J PHYSIOL-REG I, V304, pR356, DOI 10.1152/ajpregu.00294.2012; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; WATERLOW JC, 1981, BRIT MED BULL, V37, P5, DOI 10.1093/oxfordjournals.bmb.a071676; Wickens C.L, 2003, P 18 EQ NUTR PHYS SO, P129; Williams BD, 1996, AM J PHYSIOL-ENDOC M, V270, pE85, DOI 10.1152/ajpendo.1996.270.1.E85; Winkel C, 1977, THESIS; Wu G. Y., 2010, Journal of Animal Science and Biotechnology, V1, P118; Wu GY, 2010, ADV NUTR, V1, P31, DOI 10.3945/an.110.1008	72	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226988	10.1371/journal.pone.0226988	http://dx.doi.org/10.1371/journal.pone.0226988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899789	Green Submitted, gold, Green Published			2022-12-26	WOS:000534322000008
J	Huang, Y; Li, D; Zhang, PF; Liu, M; Liang, X; Yang, X; Jiang, L; Zhang, LF; Zhou, WL; Su, JH; Gong, YL; Gou, HF; Wei, YQ; Wang, W				Huang, Yong; Li, Dan; Zhang, Peng-Fei; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Gong, You-Ling; Gou, Hong-Feng; Wei, Yu-Quan; Wang, Wei			IL-18R-dependent and independent pathways account for IL-18-enhanced antitumor ability of CAR-T cells	FASEB JOURNAL			English	Article						CAR-T; IL-18; IL-18 receptor; cancer immunotherapy	ADOPTIVE TRANSFER; IFN-GAMMA; MEMORY; CD8(+); LYMPHOCYTES; PROMOTES; CANCER; IL-12; IMMUNOTHERAPY; ACTIVATION	Interleukin-18 (IL-18) has been demonstrated to augment the antitumor capacity of chimeric antigen receptor-T cells (CAR-T) but the underlying mechanisms are largely unknown. Here we explored the effects and mechanisms of exogenous IL-18 on the antitumor response of CAR-T cells. IL-18 boosted the cytotoxicity of human epidermal growth factor receptor-2 (HER2)-specific CAR-T cells ex vivo and enhanced the antitumor efficacy of the CAR-T cells in immunodeficient mice, moreover, IL-18 improved the antitumor capacity of OVA-specific T cells in immunocompetent mice, indicating the universal enhancing function of IL-18 for adoptive cell therapy. To address the roles of IL-18 receptor (IL-18R) in the enhancing function, we evaluated the effects of IL-18R knockout (IL-18R(-/-)) condition in immunocompetent host and CAR-T cells on the IL-18-enhanced antitumor activities. Interestingly, IL-18 persisted to improve the antitumor ability of IL-18R intact CAR-T cells in IL-18R(-/-) mice. For IL-18R(-/-) CAR-T cells, however, IL-18 still holds the enhancing ability to boost the antitumor efficacy in IL-18R(-/-) mice, albeit the ex vivo tumor-killing ability was lower than that of IL-18R intact CAR-T cells, indicating that IL-18R-independent pathway is involved in the enhancement. Furthermore, tagged IL-18 binded to the membrane of IL-18R(-/-) splenic and lymph node cells and IL-18R intact and IL-18R(-/-) CAR-T cells showed distinct transcriptomic profiles when stimulated by IL-18. These data demonstrate that IL-18R-independent pathways contribute to functions of IL-18.	[Huang, Yong; Li, Dan; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Wei, Yu-Quan; Wang, Wei] Sichuan Univ, West China Hosp, Dept Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Huang, Yong; Li, Dan; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Wei, Yu-Quan; Wang, Wei] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Huang, Yong; Li, Dan; Zhang, Peng-Fei; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Gou, Hong-Feng; Wei, Yu-Quan; Wang, Wei] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Zhang, Peng-Fei; Liang, Xiao; Gou, Hong-Feng; Wei, Yu-Quan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Med Oncol,Canc Ctr, Chengdu, Peoples R China; [Gong, You-Ling; Wei, Yu-Quan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol,Canc Ctr, Chengdu, Peoples R China; [Zhang, Li-Feng] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wang, W (corresponding author), Sichuan Univ, West China Hosp, Dept Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Wang, W (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.; Wang, W (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.	weiwang@scu.edu.cn		liang, xiao/0000-0003-0330-7027	National Key Research and Development [2016YFC1303403]; National Natural and Scientific Foundation of China [81572981/H1611, 81672397/H1617]; National High-tech RD [2014AA020704]; Science and Technology Major Project in Sichuan Province of China [2017SZDZX0012]	National Key Research and Development; National Natural and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD; Science and Technology Major Project in Sichuan Province of China	National Key Research and Development, Grant/Award Number: 2016YFC1303403; National Natural and Scientific Foundation of China, Grant/Award Number: 81572981/H1611 and 81672397/H1617; National High-tech R&D, Grant/Award Number: 2014AA020704; Science and Technology Major Project in Sichuan Province of China, Grant/Award Number: 2017SZDZX0012	Abken H, 2017, HUM GENE THER, V28, P1047, DOI 10.1089/hum.2017.115; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Avanzi MP, 2018, CELL REP, V23, P2130, DOI 10.1016/j.celrep.2018.04.051; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cerignoli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193498; Chen N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1273302; Chinnasamy D, 2012, CLIN CANCER RES, V18, P1672, DOI 10.1158/1078-0432.CCR-11-3050; Chmielewski M, 2017, CELL REP, V21, P3205, DOI 10.1016/j.celrep.2017.11.063; Chmielewski M, 2011, CANCER RES, V71, P5697, DOI 10.1158/0008-5472.CAN-11-0103; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Fan HT, 2002, CYTOKINE, V19, P126, DOI 10.1006/cyto.2002.1958; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hashimoto W, 1999, J IMMUNOL, V163, P583; Hege KM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0222-9; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Hu BL, 2017, CELL REP, V20, P3025, DOI 10.1016/j.celrep.2017.09.002; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; Kaartinen T, 2017, CYTOTHERAPY, V19, P689, DOI 10.1016/j.jcyt.2017.03.067; Kerkar SP, 2011, J IMMUNOTHER, V34, P343, DOI 10.1097/CJI.0b013e3182187600; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Li J, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0568-6; Micallef MJ, 1997, CANCER RES, V57, P4557; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osaki T, 1998, J IMMUNOL, V160, P1742; Palma G, 2013, BBA-REV CANCER, V1836, P296, DOI 10.1016/j.bbcan.2013.09.001; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Perna SK, 2014, CLIN CANCER RES, V20, P131, DOI 10.1158/1078-0432.CCR-13-1016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Shum T, 2017, CANCER DISCOV, V7, P1238, DOI 10.1158/2159-8290.CD-17-0538; Slovin SF, 2013, J CLIN ONCOL S, V31; Tanyi JL, 2017, J IMMUNOTHER, V40, P104, DOI 10.1097/CJI.0000000000000160; Tanyi JL, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT105; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Wang RF, 2017, CELL RES, V27, P11, DOI 10.1038/cr.2016.155; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7; Yang YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1209	49	7	8	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1768	1782		10.1096/fj.201901809R	http://dx.doi.org/10.1096/fj.201901809R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914650	Bronze			2022-12-26	WOS:000507308900117
J	Nagao, T; Shintani, Y; Hayashi, T; Kioka, H; Kato, H; Nishida, Y; Yamazaki, S; Tsukamoto, O; Yashirogi, S; Yazawa, I; Asano, Y; Shinzawa-Itoh, K; Imamura, H; Suzuki, T; Suzuki, T; Goto, Y; Takashima, S				Nagao, Takemasa; Shintani, Yasunori; Hayashi, Takaharu; Kioka, Hidetaka; Kato, Hisakazu; Nishida, Yuya; Yamazaki, Satoru; Tsukamoto, Osamu; Yashirogi, Shohei; Yazawa, Issei; Asano, Yoshihiro; Shinzawa-Itoh, Kyoko; Imamura, Hiromi; Suzuki, Takeo; Suzuki, Tsutomu; Goto, Yu-ichi; Takashima, Seiji			Higd1a improves respiratory function in the models of mitochondrial disorder	FASEB JOURNAL			English	Article						cytochrome c oxidase; hypoxia; mitochondria; respiratory chain	POSITIVE REGULATOR; ATP LEVELS; CELLS; DYSFUNCTION; EXPRESSION; MUTATION; DISEASES; OXIDASE; PROTEIN; MICE	The respiratory chain (RC) transports electrons to form a proton motive force that is required for ATP synthesis in the mitochondria. RC disorders cause mitochondrial diseases that have few effective treatments; therefore, novel therapeutic strategies are critically needed. We previously identified Higd1a as a positive regulator of cytochrome c oxidase (CcO) in the RC. Here, we test that Higd1a has a beneficial effect by increasing CcO activity in the models of mitochondrial dysfunction. We first demonstrated the tissue-protective effects of Higd1a via in situ measurement of mitochondrial ATP concentrations ([ATP](mito)) in a zebrafish hypoxia model. Heart-specific Higd1a overexpression mitigated the decline in [ATP](mito) under hypoxia and preserved cardiac function in zebrafish. Based on the in vivo results, we examined the effects of exogenous HIGD1A on three cellular models of mitochondrial disease; notably, HIGD1A improved respiratory function that was coupled with increased ATP synthesis and demonstrated cellular protection in all three models. Finally, enzyme kinetic analysis revealed that Higd1a significantly increased the maximal velocity of the reaction between CcO and cytochrome c without changing the affinity between them, indicating that Higd1a is a positive modulator of CcO. These results corroborate that Higd1a, or its mimic, provides therapeutic options for the treatment of mitochondrial diseases.	[Nagao, Takemasa; Shintani, Yasunori; Kato, Hisakazu; Nishida, Yuya; Tsukamoto, Osamu; Yashirogi, Shohei; Yazawa, Issei; Takashima, Seiji] Osaka Univ, Grad Sch Frontier Biol Sci, Dept Med Biochem, Suita, Osaka 5650871, Japan; [Hayashi, Takaharu; Kioka, Hidetaka; Asano, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nishida, Yuya; Takashima, Seiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; [Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Suita, Osaka, Japan; [Shinzawa-Itoh, Kyoko] Univ Hyogo, Dept Life Sci, Kobe, Hyogo, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Goto, Yu-ichi] Natl Ctr Hosp Neurol & Psychiat NCNP, Dept Child Neurol, Kodaira, Tokyo, Japan; [Shintani, Yasunori; Nishida, Yuya; Yamazaki, Satoru; Yazawa, Issei] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Suita, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); National Cerebral & Cardiovascular Center - Japan; University of Hyogo; Kyoto University; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Shintani, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biol Sci, Dept Med Biochem, Suita, Osaka 5650871, Japan.	yshintani@medbio.med.osaka-u.ac.jp	; Suzuki, Tsutomu/J-1776-2015	Tsukamoto, Osamu/0000-0002-9504-8001; nishida, yuya/0000-0002-1994-0807; Shintani, Yasunori/0000-0001-9579-0727; Suzuki, Tsutomu/0000-0002-9731-1731; Kato, Hisakazu/0000-0003-4619-3680	Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Takeda Science Foundation; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Japan Foundation of Applied Enzymology; Japan Medical Association; Uehara Memorial Foundation; Mochida Memorial Foundation; Osaka Medical Research Foundation for intractable diseases; Ichiro Kanehara Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Japan Medical Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Osaka Medical Research Foundation for intractable diseases; Ichiro Kanehara Foundation	This research was supported by the Japan Society for the Promotion of Science (JSPS), grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan, and grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This research was also supported by grants from Takeda Science Foundation, Japan Heart Foundation, Japan Cardiovascular Research Foundation, Japan Intractable Diseases Research Foundation, Japan Foundation of Applied Enzymology, Japan Medical Association, Uehara Memorial Foundation, Mochida Memorial Foundation, Osaka Medical Research Foundation for intractable diseases, and Ichiro Kanehara Foundation. We appreciated Drs. Tomitake Tsukihara and Shinya Yoshikawa for insightful discussions and continuing support. We thank S. Gion, E. Takada, K. Shingu, M. Kishimoto, M. Nishizawa, and Y Ishizuka for technical assistance; Y. Okada for secretarial support; and all Takashima Labo members for discussion.	Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; An HJ, 2013, P NATL ACAD SCI USA, V110, P13014, DOI 10.1073/pnas.1307170110; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Denko N, 2000, CLIN CANCER RES, V6, P480; Ferrari M, 2017, P NATL ACAD SCI USA, V241, P201621511; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guo, 2015, NONLINEAR DYNAM, V2015, P1; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kioka H, 2020, FASEB J, V34, P2041, DOI 10.1096/fj.201901686R; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Pfeffer G, 2012, COCHRANE DB SYST REV, V45, P1193; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	31	8	8	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1859	1871		10.1096/fj.201800389R	http://dx.doi.org/10.1096/fj.201800389R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914602				2022-12-26	WOS:000507308900123
J	Lee, DM; Sevits, KJ; Battson, ML; Wei, YR; Cox-York, KA; Gentile, CL				Lee, Dustin M.; Sevits, Kyle J.; Battson, Micah L.; Wei, Yuren; Cox-York, Kimberly A.; Gentile, Christopher L.			Monounsaturated fatty acids protect against palmitate-induced lipoapoptosis in human umbilical vein endothelial cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CORONARY-HEART-DISEASE; PALMITOLEIC ACID; INSULIN-RESISTANCE; INDUCED APOPTOSIS; PHOSPHATASE 2A; SERUM-LIPIDS; BETA-CELLS; ACTIVATION; DYSFUNCTION	Diets high in saturated fatty acids are linked to increased cardiovascular disease risk, whereas monounsaturated fatty acids have been associated with improved cardiovascular outcomes. Accordingly, cell culture studies have demonstrated that saturated fatty acids, particularly long chain saturated fatty acids such as palmitate, induce dysfunction and cell death in a variety of cell types, and monounsaturated fatty acids may confer protection against palmitate-mediated damage. The aim of the present study was to examine whether monounsaturated fatty acids could protect against palmitate-mediated cell death in endothelial cells, to determine if AMPK inactivation and activation (via compound C and AICAR, respectively) underlies both palmitate-induced damage and monounsaturated fatty acid mediated protection, and to explore the role of ER stress in this context. Human umbilical vein endothelial cells were examined for cell viability and apoptosis following treatment for 24 hours with palmitate (0.25 and 0.5mM) alone or in combination with the monounsaturated fatty acids oleate or palmitoleate (0.25 and 0.5mM), AICAR, compound C, 4 mu 8C, or TUDCA. Compared to control cells, palmitate significantly decreased cell viability and increased apoptosis in a dose-dependent manner. The monounsaturated fatty acids oleate and palmitoleate completely prevented the cytotoxic effects of palmitate. Although palmitate induced markers of ER stress, chemical inhibition of ER stress did not prevent palmitate-induced lipoapoptosis. Conversely, the AMPK activator AICAR (0.1 and 0.5mM) conferred protection from palmitate mediated-alterations in viability, apoptosis and ER stress, whereas the AMPK inhibitor compound C (20 and 40 mu M) significantly exacerbated palmitate-mediated damage. Lastly, co-incubation with palmitate, monounsaturated fatty acids, and compound C significantly mitigated the protective effects of both oleate and palmitoleate. In conclusion, monounsaturated fatty acids confer protection against the cytotoxic effects of palmitate in vascular endothelial cells; and palmitate-mediated damage, as well as monounsaturated-mediated protection, are due in part to inactivation and activation, respectively, of the metabolic regulator AMPK. These results may have implications for understanding the deleterious effects of high saturated fat diets on cardiovascular dysfunction and disease risk.	[Lee, Dustin M.; Sevits, Kyle J.; Battson, Micah L.; Wei, Yuren; Cox-York, Kimberly A.; Gentile, Christopher L.] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA	Colorado State University	Gentile, CL (corresponding author), Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA.	Christopher.gentile@colostate.edu			Boettcher Foundation Webb-Waring Biomedical Research Grant	Boettcher Foundation Webb-Waring Biomedical Research Grant	This study was funded by the Boettcher Foundation Webb-Waring Biomedical Research Grant. CLG was funded for a portion of his salary during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Artwohl M, 2008, J LIPID RES, V49, P2627, DOI 10.1194/jlr.M800393-JLR200; Bairwa SC, 2016, BBA-MOL BASIS DIS, V1862, P2199, DOI 10.1016/j.bbadis.2016.07.001; Battson ML, 2017, AM J PHYSIOL-HEART C, V312, pH355, DOI 10.1152/ajpheart.00437.2016; Battson ML, 2017, J VASC RES, V54, P280, DOI 10.1159/000479967; Bernstein AM, 2014, J CLIN LIPIDOL, V8, P612, DOI 10.1016/j.jacl.2014.08.001; Bharath LP, 2015, DIABETES, V64, P3914, DOI 10.2337/db15-0244; Cimen I, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9087; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Frigolet ME, 2017, ADV NUTR, V8, p173S, DOI 10.3945/an.115.011130; Vazquez-Jimenez JG, 2016, CELL SIGNAL, V28, P53, DOI 10.1016/j.cellsig.2015.10.001; Harvey KA, 2010, J LIPID RES, V51, P3470, DOI 10.1194/jlr.M010371; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Jung IR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13365-5; Kabagambe EK, 2003, EUR J CLIN NUTR, V57, P1447, DOI 10.1038/sj.ejcn.1601709; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010; Li Y, 2015, PHARMACOL RES, V99, P101, DOI 10.1016/j.phrs.2015.05.012; Liu TY, 2016, DIABETES, V65, P3262, DOI 10.2337/db16-0356; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Martinez-Gonzalez MA, 2019, CIRC RES, V124, P779, DOI 10.1161/CIRCRESAHA.118.313348; Mathew M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-9; Mayneris-Perxachs J, 2014, CLIN NUTR, V33, P90, DOI 10.1016/j.clnu.2013.03.001; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Praagman J, 2016, ARTERIOSCL THROM VAS, V36, P2011, DOI 10.1161/ATVBAHA.116.307578; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Sarabi M, 2001, ATHEROSCLEROSIS, V156, P349, DOI 10.1016/S0021-9150(00)00658-4; Sargsyan E, 2016, BBA-MOL CELL BIOL L, V1861, P1151, DOI 10.1016/j.bbalip.2016.06.012; Schwingshackl L, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-154; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Sun Y, 2008, ACTA PHARMACOL SIN, V29, P443, DOI 10.1111/j.1745-7254.2008.00717.x; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Tummala PE, 1999, CIRCULATION, V100, P1223, DOI 10.1161/01.CIR.100.11.1223; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Wang D, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/514206; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Winn RK, 2005, J THROMB HAEMOST, V3, P1815, DOI 10.1111/j.1538-7836.2005.01378.x; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang WM, 2014, BIOCHEM BIOPH RES CO, V452, P715, DOI 10.1016/j.bbrc.2014.08.145; Ye J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005875	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226940	10.1371/journal.pone.0226940	http://dx.doi.org/10.1371/journal.pone.0226940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891641	Green Published, gold			2022-12-26	WOS:000515096600046
J	Chun, LY; Dolle-Molle, L; Bethel, C; Dimitroyannis, RC; Williams, BL; Schechet, SA; Hariprasad, SM; Missiakas, D; Schneewind, O; Beavis, KG; Skondra, D				Chun, Lindsay Y.; Dolle-Molle, Laura; Bethel, Cindy; Dimitroyannis, Rose C.; Williams, Blake L.; Schechet, Sidney A.; Hariprasad, Seenu M.; Missiakas, Dominique; Schneewind, Olaf; Beavis, Kathleen G.; Skondra, Dimitra			Rapid pathogen identification and antimicrobial susceptibility testing in in vitro endophthalmitis with matrix assisted laser desorption-ionization Time-of-Flight Mass Spectrometry and VITEK 2 without prior culture	PLOS ONE			English	Article							INTRAVITREAL INJECTION; RETINAL-DETACHMENT; BACTERIAL; DIAGNOSIS	Purpose Prompt clinical diagnosis and initiation of treatment are critical in the management of infectious endophthalmitis. Current methods used to identify causative agents of infectious endophthalmitis are mostly inefficient, owing to suboptimal sensitivity, length, and cost. Matrix Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) can be used to rapidly identity pathogens without a need for culture. Similarly, automated antimicrobial susceptibility test systems (AST, VITEK 2) provide accurate antimicrobial susceptibility profiles. In this proof-of-concept study, we apply these technologies for the direct identification and characterization of pathogens in vitreous samples, without culture, as an in vitro model of infectious endophthalmitis. Methods Vitreous humor aspirated from freshly enucleated porcine eyes was inoculated with different inocula of Staphylococcus aureus (S. aureus) and incubated at 37 degrees C. Vitreous endophthalmitis samples were centrifuged and pellets were directly analyzed with MALDI-TOF MS and VITEK 2 without prior culture. S. aureus colonies that were conventionally grown on culture medium were used as control samples. Time-to-identification, minimum concentration of bacteria required for identification, and accuracy of results compared to standard methods were determined. Results MALDI-TOF MS achieved accurate pathogen identification from direct analysis of intraocular samples with confidence values of up to 99.9%. Time from sample processing to pathogen identification was <30 minutes. The minimum number of bacteria needed for positive identification was 7.889x10(6) colony forming units (cfu/mu l). Direct analysis of intraocular samples with VITEK 2 gave AST profiles that were up to 94.4% identical to the positive control S. aureus analyzed per standard protocol. Conclusion Our findings demonstrate that the direct analysis of vitreous samples with MALDI-TOF MS and VITEK 2 without prior culture could serve as new, improved methods for rapid, accurate pathogen identification and targeted treatment design in infectious endophthalmitis. In vivo models and standardized comparisons against other microbiological methods are needed to determine the value of direct analysis of intraocular samples from infectious endophthalmitis with MALDI-TOF MS and VITEK 2.	[Chun, Lindsay Y.; Dimitroyannis, Rose C.; Williams, Blake L.; Schechet, Sidney A.; Hariprasad, Seenu M.; Skondra, Dimitra] Univ Chicago Hosp & Hlth Syst, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA; [Dolle-Molle, Laura; Bethel, Cindy; Beavis, Kathleen G.] Univ Chicago Hosp & Hlth Syst, Clin Microbiol Lab, Chicago, IL USA; [Missiakas, Dominique; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Beavis, Kathleen G.] Univ Chicago Hosp & Hlth Syst, Dept Pathol, Chicago, IL USA	University of Chicago; University of Illinois System; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; University of Illinois System	Skondra, D (corresponding author), Univ Chicago Hosp & Hlth Syst, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA.	dskondra@bsd.uchicago.edu		Chun, Lindsay/0000-0001-7454-4199; Schechet, Sidney/0000-0001-8996-3855	Illinois Society for the Prevention of Blindness; University of Chicago Pritzker School of Medicine Calvin Fentress Scholarship	Illinois Society for the Prevention of Blindness; University of Chicago Pritzker School of Medicine Calvin Fentress Scholarship	LC, No grant number, Illinois Society for the Prevention of Blindness, http://www.eyehealthillinois.org/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LC, No grant number, University of Chicago Pritzker School of Medicine Calvin Fentress Scholarship, https://pritzker.uchicago.edu/scholarlyopportunities, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeletti S, 2017, J MICROBIOL METH, V138, P20, DOI 10.1016/j.mimet.2016.09.003; Astley RA, 2016, PROG RETIN EYE RES, V54, P30, DOI 10.1016/j.preteyeres.2016.04.007; Bitew A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2743-8; Bobenchik AM, 2014, J CLIN MICROBIOL, V52, P392, DOI 10.1128/JCM.02432-13; Chun L.Y., 2019, J VITR DIS, V3, P255, DOI [10.1177/2474126419847635, DOI 10.1177/2474126419847635]; Dave VP, 2017, OSLI RETINA, V48, P546, DOI 10.3928/23258160-20170630-05; Doft BM, 2000, ARCH OPHTHALMOL-CHIC, V118, P1661, DOI 10.1001/archopht.118.12.1661; Dossarps D, 2015, AM J OPHTHALMOL, V160, P17, DOI 10.1016/j.ajo.2015.04.013; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Durand ML, 2017, CLIN MICROBIOL REV, V30, P597, DOI 10.1128/CMR.00113-16; Guo L, 2014, J THORAC DIS, V6, P534, DOI 10.3978/j.issn.2072-1439.2014.02.18; Han DP, 1996, AM J OPHTHALMOL, V122, P830; Inigo M, 2016, J CLIN MICROBIOL, V54, P988, DOI 10.1128/JCM.02832-15; Jones DB, 2010, ARCH OPHTHALMOL-CHIC, V128, P789, DOI 10.1001/archophthalmol.2010.105; Levesque S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144878; Ling TKW, 2003, J CLIN MICROBIOL, V41, P4705, DOI 10.1128/JCM.41.10.4705-4707.2003; Ma WJ, 2011, INT J OPHTHALMOL-CHI, V4, P100, DOI 10.3980/j.issn.2222-3959.2011.01.23; Mailhac A, 2017, J PROTEOMICS, V152, P150, DOI 10.1016/j.jprot.2016.10.017; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Martin DF, 2018, AM J OPHTHALMOL, V191, pXLI, DOI 10.1016/j.ajo.2017.12.019; Peyman GA, 2009, RETINA-J RET VIT DIS, V29, P875, DOI 10.1097/IAE.0b013e3181a94f01; Piczenik Y, 1997, ACTA OPHTHALMOL SCAN, V75, P466; Relhan N, 2018, AM J OPHTHALMOL, V187, pXX, DOI 10.1016/j.ajo.2017.11.021; Relhan N, 2016, BRIT J OPHTHALMOL, V100, P446, DOI 10.1136/bjophthalmol-2015-307722; Segawa S, 2014, CLIN CHIM ACTA, V435, P59, DOI 10.1016/j.cca.2014.04.024; Shah CP, 2011, OPHTHALMOLOGY, V118, P2028, DOI 10.1016/j.ophtha.2011.02.034; Sharma S, 1996, RETINA-J RET VIT DIS, V16, P525, DOI 10.1097/00006982-199616060-00010; Sheu Shwu Jiuan, 2017, Korean J Ophthalmol, V31, P283, DOI 10.3341/kjo.2017.0036; Shivaramaiah Hegde Sharat, 2018, Am J Ophthalmol Case Rep, V10, P211, DOI 10.1016/j.ajoc.2018.02.030; de Liano CSG, 2017, EYE VISION, V4, DOI 10.1186/s40662-017-0083-9; Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613; Tanaka T, 2017, DIAGN MICR INFEC DIS, V88, P222, DOI 10.1016/j.diagmicrobio.2017.04.008; Vaziri K, 2015, CLIN OPHTHALMOL, V9, P317, DOI 10.2147/OPTH.S75286	33	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227071	10.1371/journal.pone.0227071	http://dx.doi.org/10.1371/journal.pone.0227071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887220	Green Published, gold			2022-12-26	WOS:000515092200069
J	Sebak, M; Saafan, AE; AbdelGhani, S; Bakeer, W; El-Gendy, AO; Espriu, LC; Duncan, K; Edrada-Ebel, R				Sebak, Mohamed; Saafan, Amal E.; AbdelGhani, Sameh; Bakeer, Walid; El-Gendy, Ahmed O.; Espriu, Laia Castano; Duncan, Katherine; Edrada-Ebel, Ruangelie			Bioassay- and metabolomics-guided screening of bioactive soil actinomycetes from the ancient city of Ihnasia, Egypt	PLOS ONE			English	Article							NATURAL-PRODUCTS; ENDOPHYTIC FUNGUS; DEREPLICATION STRATEGIES; MASS-SPECTROMETRY; DRUG DISCOVERY; STREPTOMYCES; IDENTIFICATION; ANTIBIOTICS; METABOLITES; DERIVATIVES	Literature surveys, taxonomical differences, and bioassay results have been utilized in the discovery of new natural products to aid in Actinomycetes isolate-selection. However, no or less investigation have been done on establishing the differences in metabolomic profiles of the isolated microorganisms. The study aims to utilise bioassay- and metabolomics-guided tools that included dereplication study and multivariate analysis of the NMR and mass spectral data of microbial extracts to assist the selection of isolates for scaling-up the production of antimicrobial natural products. A total of 58 actinomycetes were isolated from different soil samples collected from Ihnasia City, Egypt and screened for their antimicrobial activities against indicator strains that included Bacillus subtilis, Escherichia coli, methicillin-resistant Staphylococcus aureus and Candida albicans. A number of 25 isolates were found to be active against B. subtilis and/or to at least one of the tested indicator strains. Principal component analyses showed chemical uniqueness for four outlying bioactive actinomycetes extracts. In addition, Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) and dereplication study led us to further select two outlying anti-MRSA active isolates MS.REE.13 and 22 for scale-up work. MS.REE.13 and 22 exhibited zones of inhibition at 19 and 13 mm against MRSA, respectively. A metabolomics-guided approach provided the steer to target the bioactive metabolites (P<0.01) present in a crude extract or fraction even at nanogram levels but it was a challenge that such low-yielding bioactive natural products would be feasible to isolate. Validated to occur only on the active side of OPLS-DA loadings plot, the isolated compounds exhibited medium to weak antibiotic activity with MIC values between 250 and 800 mu M. Two new compounds, P_24306 (C10H13N2) and N_12799 (C18H32O3) with MICs of 795 and 432 mu M, were afforded from the scale-up of MS.REE. 13 and 22, respectively.	[Sebak, Mohamed; Espriu, Laia Castano; Duncan, Katherine; Edrada-Ebel, Ruangelie] Univ Strathclyde, Fac Sci, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Sebak, Mohamed; Saafan, Amal E.] Menoufia Univ, Fac Pharm, Dept Pharmaceut Microbiol, Menoufia, Egypt; [Saafan, Amal E.; AbdelGhani, Sameh; Bakeer, Walid; El-Gendy, Ahmed O.] Beni Suef Univ, Fac Pharm, Microbiol & Immunol Dept, Bani Suwayf, Egypt	University of Strathclyde; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Beni Suef University	Sebak, M; Edrada-Ebel, R (corresponding author), Univ Strathclyde, Fac Sci, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.; Sebak, M (corresponding author), Menoufia Univ, Fac Pharm, Dept Pharmaceut Microbiol, Menoufia, Egypt.	mohamed.sebak@pharm.bsu.edu.eg; ruangelie.edrada-ebel@strath.ac.uk	El-Gendy, Ahmed O./K-1500-2017; Sebak, Mohamed/AAC-3408-2020; Edrada-Ebel, RuAngelie/G-6127-2015; Saafan, Amal/GRJ-5520-2022; Duncan, Katherine R./M-9460-2016	El-Gendy, Ahmed O./0000-0002-0980-5185; Sebak, Mohamed/0000-0002-9229-2965; Edrada-Ebel, RuAngelie/0000-0003-2420-1117; Duncan, Katherine R./0000-0002-3670-4849; Castano-Espriu, Laia/0000-0002-8222-1629	Missions Sector, Ministry of Higher Education of Egypt	Missions Sector, Ministry of Higher Education of Egypt	MS was financially sponsored by the Missions Sector, Ministry of Higher Education of Egypt, https://www.mohe-casm.edu.eg/index.jsp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The fund was only covering MS's living expenses and research fees during two years of study at Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde from 10th of October 2016 to 8th of October 2018. Funder does not cover any publication fees.	Abdel-Aziz M. S., 2019, Comunicata Scientiae, V10, P218; Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Abidin ZAZ, 2016, FRONT LIFE SCI, V9, P24, DOI 10.1080/21553769.2015.1051244; Aghamirian Mohammad Reza, 2009, Open Microbiol J, V3, P53, DOI 10.2174/1874285800903010053; Ahmad MS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00438; AKos, 2014, AKOS024357626 AK CON; Amin D.H., 2017, INT J CURR MICROBIOL, V6, P82524, DOI [10.20546/ijcmas.2017.608.300, DOI 10.20546/IJCMAS.2017.608.300]; Arakawa K, 2006, ANTIMICROB AGENTS CH, V50, P1946, DOI 10.1128/AAC.00016-06; Awad M. H., 2009, World Applied Sciences Journal, V7, P637; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bizuye A, 2013, ASIAN PAC J TROP DIS, V3, P375, DOI DOI 10.1016/S2222-1808(13)60087-0; Bobzin SC, 2000, J IND MICROBIOL BIOT, V25, P342, DOI 10.1038/sj.jim.7000057; Boroujerdi AFB, 2009, ENVIRON SCI TECHNOL, V43, P7658, DOI 10.1021/es901675w; Chagas-Paula DA, 2015, METABOLITES, V5, P404, DOI 10.3390/metabo5030404; Chagas-Paula DA, 2015, PLANTA MED, V81, P450, DOI 10.1055/s-0034-1396206; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chavan D. V., 2013, INT J PHARM SCI RES, V4, P1730, DOI DOI 10.13040/IJPSR.0975-8232.4(5).1730-42; CHEN CL, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/JOUMAL.PONE.0138528; Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16; Dumas A, 2011, 8 SUBSTITUTED 2 DEOX; El-Shatoury S., 2009, EGYPT J NAT TOXINS, V6, P1; Elbendary AA, 2018, SAUDI J BIOL SCI, V25, P44, DOI 10.1016/j.sjbs.2017.05.003; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; Fu P, 2011, J NAT PROD, V74, P2219, DOI 10.1021/np200597m; Garg G., 2014, DESIGN SYNTHESIS BIO; GAVIN JJ, 1957, APPL MICROBIOL, V5, P25, DOI 10.1128/AEM.5.1.25-33.1957; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Guo JP, 2011, J NAT PROD, V74, P2278, DOI 10.1021/np200365z; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; HARADA S, 1975, CHEM PHARM BULL, V23, P2201; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Hozzein WN, 2007, INT J SYST EVOL MICR, V57, P2009, DOI 10.1099/ijs.0.65037-0; Hozzein WN, 2011, AFR J BIOTECHNOL, V10, P2295; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Jonsbu E, 2002, J BIOTECHNOL, V95, P133, DOI 10.1016/S0168-1656(02)00003-2; Kamal N, 2017, PLANTA MED, V83, P565, DOI 10.1055/s-0042-118601; Khalifa ME, 2018, MOLECULES, V23, DOI 10.3390/molecules23123285; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lavanya A, 2017, J SAUDI CHEM SOC, V21, P277, DOI 10.1016/j.jscs.2015.06.008; Li JL, 2015, FITOTERAPIA, V102, P203, DOI 10.1016/j.fitote.2015.01.014; LUMB M, 1965, NATURE, V206, P263, DOI 10.1038/206263a0; Macintyre L, 2014, MAR DRUGS, V12, P3416, DOI 10.3390/md12063416; MAEHR H, 1987, J ANTIBIOT, V40, P1455, DOI 10.7164/antibiotics.40.1455; Masand M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00687; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nisic F, 2010, STEREOSELECTIVE SYNT; OMURA S, 1969, J ANTIBIOT, V22, P629, DOI 10.7164/antibiotics.22.629; Padmavathi V, 2005, ARKIVOC, P1, DOI 10.3998/ark.5550190.0006.e01; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Rabah F. L., 2007, Biotechnology, V6, P489; Raheem DJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38940-w; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Reddy N.G., 2011, ASIAN J BIO SCI, V4, P1, DOI DOI 10.3923/AJBS.2011.1.14; Ritacco FV, 2003, J IND MICROBIOL BIOT, V30, P472, DOI 10.1007/s10295-003-0038-0; Robinette SL, 2012, ACCOUNTS CHEM RES, V45, P288, DOI 10.1021/ar2001606; ROMANKOV.AG, 1971, ANTIBIOT MED BIOTEK, V16, P579; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savic S, 2008, BRIT J CANCER, V98, P154, DOI 10.1038/sj.bjc.6604142; Selvameenal L, 2009, INDIAN J PHARM SCI, V71, P499, DOI 10.4103/0250-474X.58174; SHEU CW, 1975, ANTIMICROB AGENTS CH, V7, P349, DOI 10.1128/AAC.7.3.349; Soldatenkov AT, 2003, PHARM CHEM J, V37, P16; Song J, 2004, INT J SYST EVOL MICR, V54, P203, DOI 10.1099/ijs.0.02624-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LTH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01316; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Tawfike AF, 2019, J CHROMATOGR B, V1106, P71, DOI 10.1016/j.jchromb.2018.12.032; Tawfike AF, 2018, PLANTA MED, V84, P182, DOI 10.1055/s-0043-118807; Tawfike AF, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700040; Tawfike AF, 2013, METHODS MOL BIOL, V1055, P227, DOI 10.1007/978-1-62703-577-4_17; Thakur D, 2007, J MYCOL MED, V17, P242, DOI 10.1016/j.mycmed.2007.08.001; Ugale V, 2017, ARAB J CHEM, V10, pS389, DOI 10.1016/j.arabjc.2012.09.011; Undabarrena A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01135; van der Werf MJ, 2005, J IND MICROBIOL BIOT, V32, P234, DOI 10.1007/s10295-005-0231-4; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Waters AL, 2010, CURR OPIN BIOTECH, V21, P780, DOI 10.1016/j.copbio.2010.09.013; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1815; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; Zheng K, 2017, J AM CHEM SOC, V139, P12939, DOI 10.1021/jacs.7b08500; Zhu QH, 2012, ANTIMICROB AGENTS CH, V56, P110, DOI 10.1128/AAC.05278-11	88	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226959	10.1371/journal.pone.0226959	http://dx.doi.org/10.1371/journal.pone.0226959			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887193	gold, Green Published, Green Accepted			2022-12-26	WOS:000515092200054
J	Williams, HE; Chapman, CS; Pilarski, PM; Vette, AH; Hebert, JS				Williams, Heather E.; Chapman, Craig S.; Pilarski, Patrick M.; Vette, Albert H.; Hebert, Jacqueline S.			Gaze and Movement Assessment (GaMA): Inter-site validation of a visuomotor upper limb functional protocol	PLOS ONE			English	Article							CHILDREN; RELIABILITY; KINEMATICS; MOTION	Background Successful hand-object interactions require precise hand-eye coordination with continual movement adjustments. Quantitative measurement of this visuomotor behaviour could provide valuable insight into upper limb impairments. The Gaze and Movement Assessment (GaMA) was developed to provide protocols for simultaneous motion capture and eye tracking during the administration of two functional tasks, along with data analysis methods to generate standard measures of visuomotor behaviour. The objective of this study was to investigate the reproducibility of the GaMA protocol across two independent groups of non disabled participants, with different raters using different motion capture and eye tracking technology. Methods Twenty non-disabled adults performed the Pasta Box Task and the Cup Transfer Task. Upper body and eye movements were recorded using motion capture and eye tracking, respectively. Measures of hand movement, angular joint kinematics, and eye gaze were compared to those from a different sample of twenty non-disabled adults who had previously performed the same protocol with different technology, rater and site. Results Participants took longer to perform the tasks versus those from the earlier study, although the relative time of each movement phase was similar. Measures that were dissimilar between the groups included hand distances travelled, hand trajectories, number of movement units, eye latencies, and peak angular velocities. Similarities included all hand velocity and grip aperture measures, eye fixations, and most peak joint angle and range of motion measures. Discussion The reproducibility of GaMA was confirmed by this study, despite a few differences introduced by learning effects, task demonstration variation, and limitations of the kinematic model. GaMA accurately quantifies the typical behaviours of a non-disabled population, producing precise quantitative measures of hand function, trunk and angular joint kinematics, and associated visuomotor behaviour. This work advances the consideration for use of GaMA in populations with upper limb sensorimotor impairment.	[Williams, Heather E.; Vette, Albert H.] Univ Alberta, Fac Engn, Dept Mech Engn, Edmonton, AB, Canada; [Chapman, Craig S.] Univ Alberta, Fac Kinesiol Sport & Recreat, Edmonton, AB, Canada; [Pilarski, Patrick M.; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Vette, Albert H.; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada; [Vette, Albert H.; Hebert, Jacqueline S.] Glenrose Rehabil Hosp, Alberta Hlth Serv, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS)	Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.; Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada.; Hebert, JS (corresponding author), Glenrose Rehabil Hosp, Alberta Hlth Serv, Edmonton, AB, Canada.	jhebert@ualberta.ca	Hebert, Jacqueline/E-1881-2016	Hebert, Jacqueline/0000-0003-0788-0568	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA Contracts Management Office [N6600115-C-4015]; National Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates Graduate Student Scholarship	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA Contracts Management Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Graduate Student Scholarship	This work was sponsored by the Defense Advanced Research Projects Agency (DARPA) BTO under the auspices of Dr. Doug Weber and Dr. Al Emondi through the DARPA Contracts Management Office Grant/Contract No. N6600115-C-4015. HW was additionally supported through the National Sciences and Engineering Research Council of Canada (NSERC) and Alberta Innovates Graduate Student Scholarship.	Cacho EWA, 2011, INT J REHABIL RES, V34, P65, DOI 10.1097/MRR.0b013e32833d6cf3; Boser QA, 2018, J BIOMECH, V72, P228, DOI 10.1016/j.jbiomech.2018.02.028; Chang JJ, 2005, CLIN BIOMECH, V20, P381, DOI 10.1016/j.clinbiomech.2004.11.015; Cognolato M, 2018, J REHABIL ASSIST TER, V5, DOI 10.1177/2055668318773991; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lang CE, 2005, EXP BRAIN RES, V166, P126, DOI 10.1007/s00221-005-2350-6; Lavoie EB, 2018, J VISION, V18, DOI 10.1167/18.6.18; Lobo-Prat J, 2014, COMPUT METHOD BIOMEC, V17, P1144, DOI 10.1080/10255842.2012.738199; Mateo S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-9; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Pinzone O, 2014, GAIT POSTURE, V40, P286, DOI 10.1016/j.gaitpost.2014.03.185; Reid S, 2010, GAIT POSTURE, V32, P10, DOI 10.1016/j.gaitpost.2010.02.015; Ronnqvist L, 2007, CLIN BIOMECH, V22, P165, DOI 10.1016/j.clinbiomech.2006.09.004; Schaefer SY, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.024745; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Shmuelof L, 2012, J NEUROPHYSIOL, V108, P578, DOI 10.1152/jn.00856.2011; Shumway-Cook A., 2012, MOTOR CONTROL TRANSL, V6th; Slezak P, 2011, PHYSIOL RES, V60, P203; Stokes E, 2011, REHABILITATION OUTCO; Valevicius AM, 2019, GAIT POSTURE, V69, P176, DOI 10.1016/j.gaitpost.2019.01.037; Valevicius AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199549; Valevicius AM, 2018, J ELECTROMYOGR KINES, V40, P1, DOI 10.1016/j.jelekin.2018.02.011; Vanezis A, 2015, GAIT POSTURE, V41, P431, DOI 10.1016/j.gaitpost.2014.11.007; Velstra IM, 2011, PM&R, V3, P846, DOI 10.1016/j.pmrj.2011.03.014; WILLIAMS JG, 1989, PERCEPT MOTOR SKILL, V68, P891, DOI 10.2466/pms.1989.68.3.891; Yang NF, 2002, J BIOMECH, V35, P739, DOI 10.1016/S0021-9290(02)00018-0	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0219333	10.1371/journal.pone.0219333	http://dx.doi.org/10.1371/journal.pone.0219333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887218	Green Submitted, gold, Green Published			2022-12-26	WOS:000515092200005
J	Talamonti, E; Sasso, V; To, H; Haslam, RP; Napier, JA; Ulfhake, B; Pernold, K; Asadi, A; Hessa, T; Jacobsson, A; Chiurchiu, V; Viscomi, MT				Talamonti, Emanuela; Sasso, Valeria; To, Hoi; Haslam, Richard P.; Napier, Johnathan A.; Ulfhake, Brun; Pernold, Karin; Asadi, Abolfazl; Hessa, Tara; Jacobsson, Anders; Chiurchiu, Valerio; Viscomi, Maria Teresa			Impairment of DHA synthesis alters the expression of neuronal plasticity markers and the brain inflammatory status in mice	FASEB JOURNAL			English	Article						anti-inflammatory molecules; brain plasticity; microglia; omega-3; PUFA	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; SYSTEMIC DHA; DEFICIENCY; MOUSE; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; DEPRIVATION; MICROGLIA; BEHAVIOR	Docosahexaenoic acid (DHA) is a omega-3 fatty acid typically obtained from the diet or endogenously synthesized through the action of elongases (ELOVLs) and desaturases. DHA is a key central nervous system constituent and the precursor of several molecules that regulate the resolution of inflammation. In the present study, we questioned whether the impaired synthesis of DHA affected neural plasticity and inflammatory status in the adult brain. To address this question, we investigated neural and inflammatory markers from mice deficient for ELOVL2 (Elovl2(-/-)), the key enzyme in DHA synthesis. From our findings, Elovl2(-/-) mice showed an altered expression of markers involved in synaptic plasticity, learning, and memory formation such as Egr-1, Arc1, and BDNF specifically in the cerebral cortex, impacting behavioral functions only marginally. In parallel, we also found that DHA-deficient mice were characterized by an increased expression of pro-inflammatory molecules, namely TNF, IL-1 beta, iNOS, caspase-1 as well as the activation and morphologic changes of microglia in the absence of any brain injury or disease. Reintroducing DHA in the diet of Elovl2(-/-) mice reversed such alterations in brain plasticity and inflammation. Hence, impairment of systemic DHA synthesis can modify the brain inflammatory and neural plasticity status, supporting the view that DHA is an essential fatty acid with an important role in keeping inflammation within its physiologic boundary and in shaping neuronal functions in the central nervous system.	[Talamonti, Emanuela; To, Hoi; Hessa, Tara] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Talamonti, Emanuela; Asadi, Abolfazl; Jacobsson, Anders] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Sasso, Valeria] IRCCS Santa Lucia Fdn, Lab Expt Neurorehabil, Rome, Italy; [Haslam, Richard P.; Napier, Johnathan A.] Rothamsted Res, Dept Plant Sci, Harpenden, Herts, England; [Ulfhake, Brun; Pernold, Karin] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Chiurchiu, Valerio] Campus Biomed Univ Rome, Dept Med, Rome, Italy; [Chiurchiu, Valerio] IRCCS Santa Lucia Fdn, Lab Resolut Neuroinflammat, Rome, Italy; [Viscomi, Maria Teresa] Univ Cattolica S Cuore, Ist Istol & Embriol, Rome, Italy	Stockholm University; Stockholm University; IRCCS Santa Lucia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Karolinska Institutet; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Talamonti, E (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.; Chiurchiu, V (corresponding author), Univ Campus Biomed, Dept Med, Via Alvaro del Portillo 21, I-00123 Rome, Italy.; Viscomi, MT (corresponding author), Univ Cattolica Sacro Cuore, Ist Istol & Embriol, Largo Francesco Vito 1, I-00168 Rome, Italy.	emanuela.talamonti@su.se; v.chiurchiu@unicampus.it; mariateresa.viscomi@unicatt.it	Viscomi, Maria Teresa/AAL-6625-2021; Viscomi, Maria Teresa/AAB-9412-2022; Chiurchiu, Valerio/G-6227-2011	Viscomi, Maria Teresa/0000-0002-9096-4967; Haslam, Richard/0000-0001-6226-5643; Napier, Johnathan/0000-0003-3580-3607; Chiurchiu, Valerio/0000-0002-0316-7311	BBSRC [BBS/E/C/000I0420] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/000I0420] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Belkind-Gerson J, 2008, J PEDIATR GASTR NUTR, V47, pS7, DOI 10.1097/MPG.0b013e3181818e3f; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bisicchia E, 2018, MOL NEUROBIOL, V55, P6894, DOI 10.1007/s12035-018-0889-z; Brand A, 2008, J NEUROCHEM, V105, P1325, DOI 10.1111/j.1471-4159.2008.05234.x; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Ciappolino V, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040769; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; CRAWFORD MA, 1976, COMP BIOCHEM PHYS B, V54, P395, DOI 10.1016/0305-0491(76)90264-9; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Echeverria F, 2017, PROSTAG LEUKOTR ESS, V124, P1, DOI 10.1016/j.plefa.2017.08.001; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fahlstrom A, 2012, AGE, V34, P1435, DOI 10.1007/s11357-011-9320-7; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Ji AL, 2012, NEUROTOXICOLOGY, V33, P780, DOI 10.1016/j.neuro.2012.02.018; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kim HY, 2014, MIL MED, V179, P106, DOI 10.7205/MILMED-D-14-00162; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Krashia P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11928-w; Labrousse VF, 2018, BRAIN BEHAV IMMUN, V73, P427, DOI 10.1016/j.bbi.2018.06.004; Labrousse VF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036861; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Leuti A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8107265; Levin SG, 2017, BIOCHEMISTRY-MOSCOW+, V82, P264, DOI 10.1134/S000629791703004X; Lo Iacono L, 2018, BIOL PSYCHIAT, V84, P905, DOI 10.1016/j.biopsych.2018.05.022; Lorente-Cebrian S, 2015, J PHYSIOL BIOCHEM, V71, P341, DOI 10.1007/s13105-015-0395-y; Luchtman DW, 2013, NEUROPHARMACOLOGY, V64, P550, DOI 10.1016/j.neuropharm.2012.07.019; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Mamik MK, 2017, BRAIN, V140, P2273, DOI 10.1093/brain/awx133; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Moranis A, 2012, BRAIN BEHAV IMMUN, V26, P721, DOI 10.1016/j.bbi.2011.11.001; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Oster T, 2010, BBA-MOL CELL BIOL L, V1801, P791, DOI 10.1016/j.bbalip.2010.02.011; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pauter AM, 2017, J LIPID RES, V58, P111, DOI 10.1194/jlr.M070862; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Sheets KG, 2013, MOL VIS, V19, P1747; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Solas M, 2017, CURR OPIN PHARMACOL, V37, P87, DOI 10.1016/j.coph.2017.10.005; Talamonti E, 2017, CELL MOL LIFE SCI, V74, P2815, DOI 10.1007/s00018-017-2498-9; Tamminga CA, 2007, AM J PSYCHIAT, V164, P1790, DOI 10.1176/appi.ajp.2007.07101634; Tanaka K, 2012, BIOMOL THER, V20, P152, DOI 10.4062/biomolther.2012.20.2.152; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Viscomi MT, 2008, NEUROSCIENCE, V154, P1267, DOI 10.1016/j.neuroscience.2008.04.024; Wohleb ES, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00544; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhang YP, 2018, J NEUROL NEUROSUR PS, V89, P382, DOI 10.1136/jnnp-2017-316176	68	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2024	2040		10.1096/fj.201901890RR	http://dx.doi.org/10.1096/fj.201901890RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909582	Green Published, hybrid			2022-12-26	WOS:000514663600009
J	Walter, LM; Franz, P; Lindner, R; Tsiavaliaris, G; Hensel, N; Claus, P				Walter, Lisa Marie; Franz, Peter; Lindner, Robert; Tsiavaliaris, Georgios; Hensel, Niko; Claus, Peter			Profilin2a-phosphorylation as a regulatory mechanism for actin dynamics	FASEB JOURNAL			English	Article						actin binding; actin polymerization; phosphatidylinositol; poly-L-proline; protein phosphorylation	L-PROLINE-BINDING; PROFILIN II; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRUCTURAL-ANALYSIS; PROTEIN SMN; IN-VITRO; PHOSPHORYLATION; SITE; OLIGOMERIZATION; POLYMERIZATION	Profilin is a major regulator of actin dynamics in multiple specific processes localized in different cellular compartments. This specificity is not only meditated by its binding to actin but also its interaction with phospholipids such as phosphatidylinositol (4,5)-bisphosphate (PIP2) at the membrane and a plethora of proteins containing poly-L-proline (PLP) stretches. These interactions are fine-tuned by posttranslational modifications such as phosphorylation. Several phospho-sites have already been identified for profilin1, the ubiquitously expressed isoform. However, little is known about the phosphorylation of profilin2a. Profilin2a is a neuronal isoform important for synapse function. Here, we identified several putative profilin2a phospho-sites in silico and tested recombinant phospho-mimetics with regard to their actin-, PLP-, and PIP2-binding properties. Moreover, we assessed their impact on actin dynamics employing a pyrene-actin polymerization assay. Results indicate that distinct phospho-sites modulate specific profilin2a functions. We could identify a molecular switch site at serine residue 71 which completely abrogated actin binding-as well as other sites important for fine-tuning of different functions, for example, tyrosine 29 for PLP binding. Our findings suggest that differential profilin2a phosphorylation is a sensitive mechanism for regulating its neuronal functions. Moreover, the dysregulation of profilin2a phosphorylation may contribute to neurodegeneration.	[Walter, Lisa Marie; Lindner, Robert; Hensel, Niko; Claus, Peter] Inst Neuroanat, Hannover Med Sch, Cell Biol, Hannover, Germany; [Walter, Lisa Marie; Hensel, Niko; Claus, Peter] Ctr Syst Neuroscience, Hannover, Germany; [Franz, Peter; Tsiavaliaris, Georgios] Inst Cellular BioPhys, Hannover Med Sch, Hannover, Germany; Inst Neuroanat, Hannover Med Sch, Peter Claus, Cell Biol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Claus, P (corresponding author), Inst Neuroanat, Hannover Med Sch, Cell Biol, Hannover, Germany.	claus.peter@mh-hannover.de	Lindner, Robert/AAO-9538-2020; Claus, Peter/A-7978-2008	Lindner, Robert/0000-0002-6421-5778; Claus, Peter/0000-0003-3824-9445; Franz, Peter/0000-0001-9770-743X				ARCHER SJ, 1994, FEBS LETT, V337, P145, DOI 10.1016/0014-5793(94)80262-9; BJORKEGREN C, 1993, FEBS LETT, V333, P123, DOI 10.1016/0014-5793(93)80388-B; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; CARLSSON L, 1976, J MOL BIOL, V105, P353, DOI 10.1016/0022-2836(76)90098-X; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; D'Ambrosi N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00279; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Fil D, 2017, HUM MOL GENET, V26, P686, DOI 10.1093/hmg/ddw429; Freischmidt A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0214-y; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Gibbon BC, 1997, BIOCHEM J, V327, P909; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; Hensel N, 2018, NEUROSCIENTIST, V24, P54, DOI 10.1177/1073858417705059; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Jonckheere V, 1999, FEBS LETT, V447, P257, DOI 10.1016/S0014-5793(99)00293-8; Kaiser DA, 1999, J CELL SCI, V112, P3779; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kiaei M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31199-7; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; Krishnan Kannan, 2009, Biophys Rev, V1, P71, DOI 10.1007/s12551-009-0010-y; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Michaelsen-Preusse K, 2016, P NATL ACAD SCI USA, V113, P3365, DOI 10.1073/pnas.1516697113; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; Mittermann I, 1998, SEX PLANT REPROD, V11, P183, DOI 10.1007/s004970050140; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Nyman T, 2002, J BIOL CHEM, V277, P15828, DOI 10.1074/jbc.M112195200; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; POLLARD TD, 1981, J CELL BIOL, V88, P654, DOI 10.1083/jcb.88.3.654; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; Topf A, 2017, BIOTECHNIQUES, V63, P187, DOI 10.2144/000114599; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113	62	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2147	2160		10.1096/fj.201901883R	http://dx.doi.org/10.1096/fj.201901883R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908005	hybrid			2022-12-26	WOS:000514663600016
J	Jeon, N; Bortolato, M				Jeon, Nakyung; Bortolato, Marco			What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; OPEN-LABEL; DOPAMINE AGONISTS; ANTIPSYCHOTICS; EFFICACY; SCHIZOPHRENIA; ESCITALOPRAM; PRAMIPEXOLE; DYSKINESIA	Introduction Parkinson's disease (PD) patients treated with pramipexole (PPX) and ropinirole (ROP) exhibit a higher risk of developing impulse control disorders (ICDs), including gambling disorder, compulsive shopping, and hypersexuality. The management of ICDs in PD is challenging, due to the limited availability of effective therapeutic alternatives or counteractive strategies. Here, we used a pharmacoepidemiological approach to verify whether the risk for PPX/ROP-associated ICDs in PD patients was reduced by drugs that have been posited to exert therapeutic effects on idiopathic ICDs-including atypical antipsychotics (AAs), selective serotonin reuptake inhibitors (SSRIs), and glutamatergic modulators (GMs). Methods To quantify the strength of the associations between PPX/ROP and other medications with respect to ICD risk, odds ratios (ORs) were calculated by multivariable logistic regression, adjusting for age, gender, marital status race, psychiatric comorbidities, and use of cabergoline and levodopa. Results A total of 935 patients were included in the analysis. Use of GMs, SSRIs, and AAs was not associated with a decreased ICD risk in PD patients treated with PPX/ROP; conversely, ICD risk was significantly increased in patients treated with either GMs (Adjusted Odds Ratio, ORa: 14.00 [3.58-54.44]) or SSRIs (ORa: 3.67 [1.07-12.59]). Results were inconclusive for AAs, as available data were insufficient to compute a reliable ORa. Conclusions These results suggest that some of the key pharmacological strategies used to treat idiopathic ICD may not be effective for ICDs associated with PPX and ROP in PD patients. Future studies with larger cohorts are needed to confirm, validate, and extend these findings.	[Jeon, Nakyung] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea; [Bortolato, Marco] Univ Utah, Dept Pharmacol & Toxicol, Coll Pharm, 112 Skaggs Hall, Salt Lake City, UT 84112 USA	Chonnam National University; Utah System of Higher Education; University of Utah	Jeon, N (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea.; Bortolato, M (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, Coll Pharm, 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	nakyung.jeon@jnu.ac.kr; marco.bortolato@utah.edu						Aguirre C, 2016, BASIC CLIN PHARMACOL, V119, P40; Bidzan L, 2012, MED SCI MONITOR, V18, pCR182, DOI 10.12659/MSM.882523; Biundo R, 2017, MOVEMENT DISORD, V32, P1557, DOI 10.1002/mds.27181; Burstein ES, 2005, J PHARMACOL EXP THER, V315, P1278, DOI 10.1124/jpet.105.092155; Coccaro EF, 2009, J CLIN PSYCHIAT, V70, P653, DOI 10.4088/JCP.08m04150; Coskun F, 2018, CLIN NEUROPHARMACOL, V41, P82, DOI 10.1097/WNF.0000000000000276; Dell'Osso B, 2008, J CLIN PSYCHIAT, V69, P452, DOI 10.4088/JCP.v69n0316; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Fernandez HH, 2003, DRUG SAFETY, V26, P643, DOI 10.2165/00002018-200326090-00004; Fong T, 2008, PHARMACOL BIOCHEM BE, V89, P298, DOI 10.1016/j.pbb.2007.12.025; Friedman JH, 2003, PSYCHONEUROENDOCRINO, V28, P39, DOI 10.1016/S0306-4530(02)00111-7; Grall-Bronnec M, 2018, DRUG SAFETY, V41, P19, DOI 10.1007/s40264-017-0590-6; Grant JE, 2006, AM J PSYCHIAT, V163, P303, DOI 10.1176/appi.ajp.163.2.303; Grant JE, 2007, BIOL PSYCHIAT, V62, P652, DOI 10.1016/j.biopsych.2006.11.021; Grant JE, 2006, INT CLIN PSYCHOPHARM, V21, P203, DOI 10.1097/00004850-200607000-00002; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Hoptman MJ, 2015, CNS SPECTRUMS, V20, P280, DOI 10.1017/S1092852915000206; Kim SW, 2002, J CLIN PSYCHIAT, V63, P501, DOI 10.4088/JCP.v63n0606; Korczyn AD, 1998, MOVEMENT DISORD, V13, P46, DOI 10.1002/mds.870130112; Lejoyeux M, 2002, J NERV MENT DIS, V190, P310, DOI 10.1097/00005053-200205000-00007; LEYSEN JE, 1994, J CLIN PSYCHIAT, V55, P5; Marques A, 2018, J NEURAL TRANSM, V125, P1299, DOI 10.1007/s00702-018-1870-8; McElroy SL, 1996, COMPR PSYCHIAT, V37, P229, DOI 10.1016/S0010-440X(96)90001-2; Mizrahi R, 2011, SCHIZOPHR RES, V131, P63, DOI 10.1016/j.schres.2011.05.005; Molde H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00330; Molho E S, 2001, Curr Neurol Neurosci Rep, V1, P320, DOI 10.1007/s11910-001-0085-8; Moore TJ, 2014, JAMA INTERN MED, V174, P1930, DOI 10.1001/jamainternmed.2014.5262; Nirenberg MJ, 2013, DRUG AGING, V30, P587, DOI 10.1007/s40266-013-0090-z; Pallanti S, 2002, J CLIN PSYCHIAT, V63, P559, DOI 10.4088/JCP.v63n0704; Papay K, 2014, NEUROLOGY, V83, P826, DOI 10.1212/WNL.0000000000000729; Pes R, 2017, NEUROPHARMACOLOGY, V114, P77, DOI 10.1016/j.neuropharm.2016.11.014; Pettorruso M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/109786; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schreiber L., 2011, FRONT PSYCHIATRY, V2, P1, DOI [10.3389/fpsyt.2011.00001, DOI 10.3389/FPSYT.2011.00001]; Seeman P, 2015, SYNAPSE, V69, P183, DOI 10.1002/syn.21805; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Thomas A, 2004, J NEUROL NEUROSUR PS, V75, P141; Thomas A, 2010, ANN NEUROL, V68, P400, DOI 10.1002/ana.22029; Van den Eynde F, 2008, J CLIN PSYCHOPHARM, V28, P147, DOI 10.1097/JCP.0b013e318166c4bf; Vilas Dolores, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS80, DOI 10.1016/S1353-8020(11)70026-8; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Walsh R A, 2012, Mov Disord, V27, P326, DOI 10.1002/mds.23964; Weddle KE, 2011, PHARMACOEPIDEM DR S, V20, pS196; Weintraub D, 2014, J NEUROPSYCHIATRY CL, V18, P377; Weintraub D, 2010, ANN NEUROL, V68, P963, DOI 10.1002/ana.22164; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Weiss Howard D, 2012, Neurol Clin Pract, V2, P267; Zimmerman M, 2002, J CLIN PSYCHIAT, V63, P44	48	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227128	10.1371/journal.pone.0227128	http://dx.doi.org/10.1371/journal.pone.0227128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5BZ	31910240	Green Published, gold			2022-12-26	WOS:000534333800028
J	Carmicheal, J; Atri, P; Sharma, S; Kumar, S; Venkata, RC; Kulkarni, P; Salgia, R; Ghersi, D; Kaur, S; Batra, SK				Carmicheal, Joseph; Atri, Pranita; Sharma, Sunandini; Kumar, Sushil; Chirravuri Venkata, Ramakanth; Kulkarni, Prakash; Salgia, Ravi; Ghersi, Dario; Kaur, Sukhwinder; Batra, Surinder K.			Presence and structure-activity relationship of intrinsically disordered regions across mucins	FASEB JOURNAL			English	Article						intrinsically disordered protein; glycoprotein; protein-protein interaction; protein structure	MOLECULAR RECOGNITION FEATURES; PROTEIN-PROTEIN INTERACTION; PANCREATIC-CANCER; GENE ONTOLOGY; WEB SERVER; SEA DOMAIN; CELL; SEQUENCE; GLYCOSYLATION; PROMISCUITY	Many members of the mucin family are evolutionarily conserved and are often aberrantly expressed and glycosylated in various benign and malignant pathologies leading to tumor invasion, metastasis, and immune evasion. The large size and extensive glycosylation present challenges to study the mucin structure using traditional methods, including crystallography. We offer the hypothesis that the functional versatility of mucins may be attributed to the presence of intrinsically disordered regions (IDRs) that provide dynamism and flexibility and that the IDRs offer potential therapeutic targets. Herein, we examined the links between the mucin structure and function based on IDRs, posttranslational modifications (PTMs), and potential impact on their interactome. Using sequence-based bioinformatics tools, we observed that mucins are predicted to be moderately (20%-40%) to highly (>40%) disordered and many conserved mucin domains could be disordered. Phosphorylation sites overlap with IDRs throughout the mucin sequences. Additionally, the majority of predicted O- and N- glycosylation sites in the tandem repeat regions occur within IDRs and these IDRs contain a large number of functional motifs, that is, molecular recognition features (MoRFs), which directly influence protein-protein interactions (PPIs). This investigation provides a novel perspective and offers an insight into the complexity and dynamic nature of mucins.	[Carmicheal, Joseph; Atri, Pranita; Sharma, Sunandini; Kumar, Sushil; Chirravuri Venkata, Ramakanth; Kaur, Sukhwinder; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Kumar, Sushil; Kaur, Sukhwinder; Batra, Surinder K.] Univ Nebraska Med Ctr, Buffett Canc Ctr, Omaha, NE USA; [Kulkarni, Prakash; Salgia, Ravi] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Ghersi, Dario] Univ Nebraska Omaha, Sch Interdisciplinary Informat, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; City of Hope; University of Nebraska System; University of Nebraska Omaha	Ghersi, D (corresponding author), Univ Nebraska Omaha, Sch Interdisciplinary Informat, Omaha, NE 68182 USA.; Kaur, S; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	dghersi@unomaha.edu; skaur@unmc.edu; sbatra@unmc.edu			National Institutes of Health [R01 CA183459, RO1 CA195586, RO1 CA210637, UO1 CA200466, UO1 CA210240, P01 CA217798, R44CA224619]; Nebraska Department of Health and Human Services [LB595]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services	National Institutes of Health, Grant/Award Number: R01 CA183459, RO1 CA195586, RO1 CA210637, UO1 CA200466, UO1 CA210240, P01 CA217798, R44CA224619 and UO1 CA210240; Nebraska Department of Health and Human Services, Grant/Award Number: LB595	Aithal A, 2018, EXPERT OPIN THER TAR, V22, P675, DOI 10.1080/14728222.2018.1498845; Ambadipudi S, 2016, EXPERT OPIN DRUG DIS, V11, P65, DOI 10.1517/17460441.2016.1107041; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Astro V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3312; Baert T, 2018, GYNECOL ONCOL, V150, P31, DOI 10.1016/j.ygyno.2018.05.004; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Basile W, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007186; Bauer AK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120941; Boomsma W, 2016, PEERJ, V4, DOI 10.7717/peerj.1725; Boze H, 2010, BIOPHYS J, V99, P656, DOI 10.1016/j.bpj.2010.04.050; Burgi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158594; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Charon J, 2018, MOL BIOL EVOL, V35, P38, DOI 10.1093/molbev/msx249; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chuang GY, 2012, BIOINFORMATICS, V28, P2249, DOI 10.1093/bioinformatics/bts426; Das S, 2015, ONCOTARGET, V6, P5772, DOI 10.18632/oncotarget.3308; Dong GQ, 2017, J MED CHEM, V60, P7965, DOI 10.1021/acs.jmedchem.7b00467; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Goyal S, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S8; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Guharoy M, 2013, CYTOSKELETON, V70, P550, DOI 10.1002/cm.21118; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hale ML, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2960-9; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hoshi H, 2013, INT J ONCOL, V42, P887, DOI 10.3892/ijo.2013.1760; Hu G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122761; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kaur S, 2017, AM J GASTROENTEROL, V112, P172, DOI 10.1038/ajg.2016.482; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kjaergaard M, 2017, CELL MOL LIFE SCI, V74, P3205, DOI 10.1007/s00018-017-2562-5; Krishn SR, 2016, CANCER LETT, V374, P304, DOI 10.1016/j.canlet.2016.02.016; Kurotani A, 2015, INT J MOL SCI, V16, P19812, DOI 10.3390/ijms160819812; Lakshmanan I, 2017, CLIN CANCER RES, V23, P3906, DOI 10.1158/1078-0432.CCR-16-2530; Lakshmanan I, 2015, ONCOTARGET, V6, P21085, DOI 10.18632/oncotarget.3912; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Larion M., 2015, INTRINSICALLY DISORD, V3, P1; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Lo PW, 2018, P NATL ACAD SCI USA, V115, P7302, DOI 10.1073/pnas.1801850115; Machkalyan G, 2016, CELL SIGNAL, V28, P401, DOI 10.1016/j.cellsig.2016.02.002; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; Malaney P, 2015, METHODS, V77-78, P69, DOI 10.1016/j.ymeth.2014.10.005; Malhis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141603; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marcotte EM, 2009, CELL, V138, P16, DOI 10.1016/j.cell.2009.06.024; Merino F, 2017, ANGEW CHEM INT EDIT, V56, P2846, DOI 10.1002/anie.201608432; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Mitrea DM, 2012, BIOL CHEM, V393, P259, DOI 10.1515/hsz-2011-0254; Muniyan Sakthivel, 2016, Genes Cancer, V7, P110, DOI 10.18632/genesandcancer.104; Neira JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39732; Niv Y, 2019, J CLIN GASTROENTEROL, V53, P434, DOI 10.1097/MCG.0000000000001050; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Pai P, 2016, CARCINOGENESIS, V37, P223, DOI 10.1093/carcin/bgw005; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pelaseyed T, 2013, FEBS J, V280, P1491, DOI 10.1111/febs.12144; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pryor EE, 2014, BIOPHYS J, V106, P1638, DOI 10.1016/j.bpj.2014.02.025; Quin RJ, 2000, INT J CANCER, V87, P499, DOI 10.1002/1097-0215(20000815)87:4<499::AID-IJC6>3.0.CO;2-9; Raina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135156; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Ridley C, 2018, BIOCHEM SOC T, V46, P1099, DOI 10.1042/BST20170402; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Salgia R, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060156; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shammas SL, 2017, CURR OPIN STRUC BIOL, V42, P155, DOI 10.1016/j.sbi.2017.02.003; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Silverman HS, 2001, GLYCOBIOLOGY, V11, P459, DOI 10.1093/glycob/11.6.459; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tamarozzi ER, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010198; Tarakhovsky A, 2018, J EXP MED, V215, P1777, DOI 10.1084/jem.20180099; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsafou K, 2018, J MOL BIOL, V430, P2321, DOI 10.1016/j.jmb.2018.04.008; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111874; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Putten JPM, 2017, J INNATE IMMUN, V9, P281, DOI 10.1159/000453594; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Verkhivker GM, 2018, METHODS MOL BIOL, V1709, P253, DOI 10.1007/978-1-4939-7477-1_19; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wang RY, 2013, GASTROENTEROLOGY, V145, P1436, DOI 10.1053/j.gastro.2013.08.009; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wojcik S, 2018, METHOD ENZYMOL, V611, P703, DOI 10.1016/bs.mie.2018.09.036; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, MOL BIOSYST, V8, P134, DOI 10.1039/c1mb05163f; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yadav LR, 2015, J BIOMOL STRUCT DYN, V33, P2469, DOI 10.1080/07391102.2014.1000973; Yamashita MSD, 2018, CELL TISSUE RES, V374, P455, DOI 10.1007/s00441-018-2916-9; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22298; Zhou JH, 2018, J MOL BIOL, V430, P2342, DOI 10.1016/j.jmb.2018.03.028	116	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1939	1957		10.1096/fj.201901898RR	http://dx.doi.org/10.1096/fj.201901898RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908009	Green Accepted, Bronze			2022-12-26	WOS:000505692800001
J	Shi, MJ; Maique, J; Shaffer, J; Davidson, T; Sebti, S; Fernandez, AF; Zou, ZJ; Yan, S; Levine, B; Moe, OW; Hu, MC				Shi, Mingjun; Maique, Jenny; Shaffer, Joy; Davidson, Taylor; Sebti, Salwa; Fernandez, Alvaro F.; Zou, Zhongju; Yan, Shirley; Levine, Beth; Moe, Orson W.; Hu, Ming Chang			The tripartite interaction of phosphate, autophagy, and alpha Klotho in health maintenance	FASEB JOURNAL			English	Article						aging; autophagy; BCL2; beclin 1; fertility; longevity; NaPi cotransporter; phosphorus; phosphotoxicity; alpha Klotho	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; VASCULAR CALCIFICATION; DIETARY PHOSPHORUS; GENETIC-EVIDENCE; MICE; PROGRESSION; DEFICIENCY; MECHANISMS; INHIBITION	Aging-related organ degeneration is driven by multiple factors including the cell maintenance mechanisms of autophagy, the cytoprotective protein alpha Klotho, and the lesser known effects of excess phosphate (Pi), or phosphotoxicity. To examine the interplay between Pi, autophagy, and alpha Klotho, we used the BK/BK mouse (homozygous for mutant Becn1(F121A)) with increased autophagic flux, and alpha Klotho-hypomorphic mouse (kl/kl) with impaired urinary Pi excretion, low autophagy, and premature organ dysfunction. BK/BK mice live longer than WT littermates, and have heightened phosphaturia from downregulation of two key NaPi cotransporters in the kidney. The multi-organ failure in kl/kl mice was rescued in the double-mutant BK/BK;kl/kl mice exhibiting lower plasma Pi, improved weight gain, restored plasma and renal alpha Klotho levels, decreased pathology of multiple organs, and improved fertility compared to kl/kl mice. The beneficial effects of heightened autophagy from Becn1(F121A) was abolished by chronic high-Pi diet which also shortened life span in the BK/BK;kl/kl mice. Pi promoted beclin 1 binding to its negative regulator BCL2, which impairs autophagy flux. Pi downregulated alpha Klotho, which also independently impaired autophagy. In conclusion, Pi, alpha Klotho, and autophagy interact intricately to affect each other. Both autophagy and alpha Klotho antagonizes phosphotoxicity. In concert, this tripartite system jointly determines longevity and life span.	[Shi, Mingjun; Maique, Jenny; Shaffer, Joy; Moe, Orson W.; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Davidson, Taylor; Sebti, Salwa; Fernandez, Alvaro F.; Levine, Beth; Moe, Orson W.; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sebti, Salwa; Fernandez, Alvaro F.; Zou, Zhongju; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Zou, Zhongju; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yan, Shirley] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Moe, Orson W.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Moe, OW; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	orson.moe@utsouthwestern.edu; ming-chang.hu@utsouthwestern.edu	Fernández, Álvaro F./A-7375-2019; Sebti, Salwa/AAB-3188-2020	Fernández, Álvaro F./0000-0002-7704-4285; Sebti, Salwa/0000-0003-4327-1129	NIH [R01-CA109618, R01-DK091392, R01-DK092461]; UT Southwestern Medical Center O'Brien Kidney Research Center [P30DK07938, U19AI199725]; Fondation Leducq [15CBD04]; Simmons Family Foundation; Pak Center Innovative Research; Pak-Seldin Center for Metabolic Research; Endowed Professors Collaborative Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern Medical Center O'Brien Kidney Research Center; Fondation Leducq(Leducq Foundation); Simmons Family Foundation; Pak Center Innovative Research; Pak-Seldin Center for Metabolic Research; Endowed Professors Collaborative Research	NIH, Grant/Award Number: R01-CA109618 (BL), R01-, DK091392 and R01-DK092461; UT Southwestern Medical Center O'Brien Kidney Research Center, Grant/Award Number: P30DK07938 and U19AI199725; Fondation Leducq, Grant/Award Number: 15CBD04; Simmons Family Foundation; Pak Center Innovative Research; Endowed Professors Collaborative Research; Pak-Seldin Center for Metabolic Research	AlGhatrif M, 2017, MED CLIN N AM, V101, P81, DOI 10.1016/j.mcna.2016.08.006; Barker SL, 2015, NEPHROL DIAL TRANSPL, V30, P223, DOI 10.1093/ndt/gfu291; Bian A, 2014, J ENDOCRINOL INVEST, V37, P1121, DOI 10.1007/s40618-014-0158-6; Bian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181848; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Cherqui S, 2017, NAT REV NEPHROL, V13, P115, DOI 10.1038/nrneph.2016.182; Crawford NM, 2015, OBSTET GYN CLIN N AM, V42, P15, DOI 10.1016/j.ogc.2014.09.005; Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Garcia-Sanz P, 2018, AUTOPHAGY, V14, P717, DOI 10.1080/15548627.2018.1427396; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grieco G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32389-z; Haller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039229; Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hoorn EJ, 2017, KIDNEY INT, V91, P1003, DOI 10.1016/j.kint.2017.01.033; Hsu YJ, 2015, J VASC SURG, V62, P210, DOI 10.1016/j.jvs.2014.02.040; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Hu MC, 2019, PFLUG ARCH EUR J PHY, V471, P99, DOI 10.1007/s00424-018-2238-5; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2016, J AM SOC NEPHROL, V27, P79, DOI 10.1681/ASN.2014101030; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2014, CURR OPIN NEPHROL HY, V23, P331, DOI 10.1097/01.mnh.0000447024.97464.a3; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Kawai M, 2016, J AM SOC NEPHROL, V27, P2810, DOI 10.1681/ASN.2015040446; Kempe DS, 2010, NEPHROL DIAL TRANSPL, V25, P2938, DOI 10.1093/ndt/gfq172; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Khositseth S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18311; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lanning NJ, 2018, AM J PHYSIOL-RENAL, V315, pF1465, DOI 10.1152/ajprenal.00009.2018; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Lu X, 2017, KIDNEY DIS-BASEL, V3, P15, DOI 10.1159/000452880; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Neyra JA, 2017, BONE, V100, P41, DOI 10.1016/j.bone.2017.01.017; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z; Peraro L, 2017, J AM CHEM SOC, V139, P7792, DOI 10.1021/jacs.7b01698; Pletcher SD, 2002, CURR BIOL, V12, pR328, DOI 10.1016/S0960-9822(02)00832-1; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ritter CS, 2016, CLIN J AM SOC NEPHRO, V11, P1088, DOI 10.2215/CJN.11901115; Rocchi A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006962; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Scanni R, 2014, J AM SOC NEPHROL, V25, P2730, DOI 10.1681/ASN.2013101076; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Schwarz C, 2001, NEPHROL DIAL TRANSPL, V16, P378, DOI 10.1093/ndt/16.2.378; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Shanahan CM, 2013, KIDNEY INT, V83, P984, DOI 10.1038/ki.2013.75; Shi M, 2017, AM J PHYSIOL-RENAL, V314, pF501; Shi MJ, 2018, LAB INVEST, V98, P1105, DOI 10.1038/s41374-018-0063-2; Shi MJ, 2016, J AM SOC NEPHROL, V27, P2331, DOI 10.1681/ASN.2015060613; Shiraki-Iida T, 2000, J GENE MED, V2, P233, DOI 10.1002/1521-2254(200007/08)2:4<233::AID-JGM110>3.0.CO;2-5; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vega-Rubin-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115; Wagner CA, 2019, PEDIATR NEPHROL, V34, P549, DOI 10.1007/s00467-017-3873-3; Watanabe R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07341-2; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18427-2; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XL, 2016, AUTOPHAGY, V12, P1954, DOI 10.1080/15548627.2016.1212787; Zhang YY, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0836-2	87	11	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3129	3150		10.1096/fj.201902127R	http://dx.doi.org/10.1096/fj.201902127R		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908069	Bronze, Green Accepted			2022-12-26	WOS:000505692500001
J	Bierschenk, B; Tagele, MT; Ali, B; Ashrafuzzaman, M; Wu, LB; Becker, M; Frei, M				Bierschenk, Birgit; Tagele, Melle Tilahun; Ali, Basharat; Ashrafuzzaman, M. d.; Wu, Lin-Bo; Becker, Matthias; Frei, Michael			Evaluation of rice wild relatives as a source of traits for adaptation to iron toxicity and enhanced grain quality	PLOS ONE			English	Article							SATIVA F SPONTANEA; ORYZA-SATIVA; CULTIVATED RICE; TOLERANCE; MECHANISMS; RESISTANCE; PHYTATE; STRESS; LOCI; DOMESTICATION	Rice wild relatives (RWR) constitute an extended gene pool that can be tapped for the breeding of novel rice varieties adapted to abiotic stresses such as iron (Fe) toxicity. Therefore, we screened 75 Oryza genotypes including 16 domesticated O. sativa genotypes, one O. glaberrima, and 58 RWR representing 21 species, for tolerance to Fe toxicity. Plants were grown in a semi-artificial greenhouse setup, in which they were exposed either to control conditions, an Fe shock during the vegetative growth stage (acute treatment), or to a continuous moderately high Fe level (chronic treatment). In both stress treatments, foliar Fe concentrations were characteristic of Fe toxicity, and plants developed foliar stress symptoms, which were more pronounced in the chronic Fe stress especially toward the end of the growing season. Among the genotypes that produced seeds, only the chronic stress treatment significantly reduced yields due to increases in spikelet sterility. Moreover, a moderate but non-significant increase in grain Fe concentrations, and a significant increase in grain Zn concentrations were seen in chronic stress. Both domesticated rice and RWR exhibited substantial genotypic variation in their responses to Fe toxicity. Although no RWR strikingly outperformed domesticated rice in Fe toxic conditions, some genotypes scored highly in individual traits. Two O. meridionalis accessions were best in avoiding foliar symptom formation in acute Fe stress, while an O. rufipogon accession produced the highest grain yields in both chronic and acute Fe stress. In conclusion, this study provides the basis for using interspecific crosses for adapting rice to Fe toxicity.	[Bierschenk, Birgit; Tagele, Melle Tilahun; Ali, Basharat; Ashrafuzzaman, M. d.; Wu, Lin-Bo; Becker, Matthias; Frei, Michael] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Ali, Basharat] Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan; [Ashrafuzzaman, M. d.] Shahjalal Univ Sci & Technol, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh	University of Bonn; University of Agriculture Faisalabad; Shahjalal University of Science & Technology (SUST)	Frei, M (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.	mfrei@uni-bonn.de	, Ashrafuzzaman/P-6485-2016; Frei, Michael/K-5511-2013; Wu, Linbo/AAW-6176-2021	, Ashrafuzzaman/0000-0001-8564-7943; Frei, Michael/0000-0002-2474-6558; Ali, Basharat/0000-0002-5965-7352; Wu, Linbo/0000-0001-5286-1994	foundation fiat panis	foundation fiat panis	This study was financially supported by the foundation fiat panis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arbelaez JD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0276-7; Audebert A, 2009, J AGRON CROP SCI, V195, P66, DOI 10.1111/j.1439-037X.2008.00339.x; Becana M, 1998, PLANT SOIL, V201, P137, DOI 10.1023/A:1004375732137; Becker M, 2005, J PLANT NUTR SOIL SC, V168, P558, DOI 10.1002/jpln.200520504; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; Cogle AL, 2011, SOIL RES, V49, P87, DOI 10.1071/SR10069; Dobermann A., 2000, RICE NUTR DISORDERS; Dufey I, 2012, CROP SCI, V52, P539, DOI 10.2135/cropsci2009.09.0544; Dufey I, 2015, EUPHYTICA, V203, P59, DOI 10.1007/s10681-014-1255-5; Engel K, 2012, J PLANT NUTR SOIL SC, V175, P871, DOI 10.1002/jpln.201100421; Frei M, 2016, PLANT SOIL, V408, P149, DOI 10.1007/s11104-016-2918-x; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GRiSP (Global Rice Science Partnership), 2013, RICE ALMANAC; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hilbert L, 2017, NAT ECOL EVOL, V1, P1693, DOI 10.1038/s41559-017-0322-4; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ishimaru T, 2010, ANN BOT-LONDON, V106, P515, DOI 10.1093/aob/mcq124; Jena KK, 2010, BREEDING SCI, V60, P518, DOI 10.1270/jsbbs.60.518; Li BH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11892-5; Mammadov J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00886; Mao DH, 2015, THEOR APPL GENET, V128, P1359, DOI 10.1007/s00122-015-2511-3; Matthus E, 2015, THEOR APPL GENET, V128, P2085, DOI 10.1007/s00122-015-2569-y; Menguer PK, 2017, GENET MOL BIOL, V40, P238, DOI [10.1590/1678-4685-gmb-2016-0093, 10.1590/1678-4685-GMB-2016-0093]; Narain A, 2016, EUPHYTICA, V209, P603, DOI 10.1007/s10681-016-1633-2; Nguyen BD, 2003, THEOR APPL GENET, V106, P583, DOI 10.1007/s00122-002-1072-4; Olsen LI, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.36, 10.1038/nplants.2016.36]; Poschenrieder C, 2013, PLANT SCI, V212, P15, DOI 10.1016/j.plantsci.2013.07.012; Prathepha P, 2011, AUST J CROP SCI, V5, P49; Quinet M, 2012, PLANT CELL ENVIRON, V35, P1837, DOI 10.1111/j.1365-3040.2012.02521.x; Raboy V, 2002, J NUTR, V132, p503S, DOI 10.1093/jn/132.3.503S; Ricachenevsky FK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00974; Sahrawat KL, 2004, J PLANT NUTR, V27, P1471, DOI [10.1081/PLN-200025869, 10.1081/pln-200025869]; Sandstead HH, 2013, ADV NUTR, V4, P76, DOI 10.3945/an.112.003186; Sikirou M, 2016, PLANT PROD SCI, V19, P489, DOI 10.1080/1343943X.2016.1186496; Stein JC, 2018, NAT GENET, V50, P285, DOI 10.1038/s41588-018-0040-0; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Hoang TML, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6040054; Trijatmiko KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19792; Tu J, 1998, THEOR APPL GENET, V97, P31, DOI 10.1007/s001220050863; VAINTRAUB IA, 1988, ANAL BIOCHEM, V175, P227, DOI 10.1016/0003-2697(88)90382-X; Vaughan D.A., 1994, GENETIC HDB; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang YX, 2011, AGR ECOSYST ENVIRON, V141, P271, DOI 10.1016/j.agee.2011.03.017; Wu LB, 2017, PLANT CELL ENVIRON, V40, P570, DOI 10.1111/pce.12733; Wu LB, 2014, RICE, V7, DOI 10.1186/s12284-014-0008-3	50	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0223086	10.1371/journal.pone.0223086	http://dx.doi.org/10.1371/journal.pone.0223086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899771	Green Submitted, Green Published, gold			2022-12-26	WOS:000534322000003
J	Buscetta, M; Di Vincenzo, S; Miele, M; Badami, E; Pace, E; Cipollina, C				Buscetta, Marco; Di Vincenzo, Serena; Miele, Monica; Badami, Ester; Pace, Elisabetta; Cipollina, Chiara			Cigarette smoke inhibits the NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human macrophages	FASEB JOURNAL			English	Article						caspase-8; inflammation; IL-1 beta; IL-18; metabolism; smoking	NF-KAPPA-B; AEROBIC GLYCOLYSIS; IL-1-BETA; CELLS; DYSFUNCTION; DOWNSTREAM; RELEASE; PROTEIN	The NLRP3 inflammasome is formed by the sensor NLRP3, the adaptor ASC, and pro-caspase-1. Assembly and activation of the inflammasome trigger caspase-1-dependent cleavage of pro-IL-1 beta and pro-IL-18 into their secreted forms. Cigarette smoke is a risk factor for chronic inflammatory diseases and is associated with macrophage dysfunction. The impact of cigarette smoke on NLRP3-dependent responses in macrophages is largely unknown. Herein, we investigated the effects of cigarette smoke extract (CSE) on the NLRP3 inflammasome in human monocyte-derived macrophages (MDMs) and THP-1 cells stimulated with lipopolysaccharide (LPS) and LPS plus the NLRP3 inflammasome activator ATP. We found that CSE inhibited the release of IL-1 beta and IL-18 as well as the expression of NLRP3 acting mainly at the transcriptional level. Interestingly, we found that CSE increased the caspase-1 activity via an NLRP3-independent and TLR4-TRIF-caspase-8-dependent pathway. Activation of caspase-1 by CSE led to a reduction of the basal glycolytic flux and impaired glycolytic burst in response to LPS. Overall, our findings unveil novel pathways leading to immune-metabolic alterations in human macrophages exposed to cigarette smoke. These mechanisms may contribute to macrophage dysfunction and increased risk of infection in smokers.	[Buscetta, Marco; Miele, Monica; Badami, Ester; Cipollina, Chiara] Fdn Ri MED, Palermo, Italy; [Di Vincenzo, Serena; Pace, Elisabetta; Cipollina, Chiara] CNR, Ist Ric Innovaz Biomed, Via Ugo La Malfa 153, I-90146 Palermo, Italy; [Miele, Monica; Badami, Ester] Ist Mediterraneo Trapianti & Terapie Ad Alta Spec, Dept Lab Med & Adv Biotechnol, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Ricerca l'Innovazione Biomedica (IRIB-CNR); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Cipollina, C (corresponding author), CNR, Ist Ric Innovaz Biomed, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	ccipollina@fondazionerimed.com	Di Vincenzo, Serena/K-3330-2018; Pace, Elisabetta/AAL-2537-2020; Di Vincenzo, Serena/Q-7852-2019	Di Vincenzo, Serena/0000-0003-1695-9307; Pace, Elisabetta/0000-0003-1141-9010; Buscetta, Marco/0000-0001-8313-2647; Badami, Ester/0000-0002-0154-6270; Miele, Monica/0000-0002-1606-651X	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST [CUP G77B17000110001]; Fondazione Ri.MED	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST; Fondazione Ri.MED	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST, Grant/Award Number: CUP G77B17000110001; Fondazione Ri.MED	Aghapour M, 2018, AM J RESP CELL MOL, V58, P157, DOI 10.1165/rcmb.2017-0200TR; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Chen L, 2016, AM J RESP CELL MOL, V55, P815, DOI 10.1165/rcmb.2016-0051OC; Cipollina C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37625; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Faner R, 2016, ERJ OPEN RES, V2; Ferraro M, 2019, EXP GERONTOL, V118, P78, DOI 10.1016/j.exger.2019.01.016; Finucane OM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40619-1; Gaidt MM, 2017, CURR OPIN IMMUNOL, V44, P7, DOI 10.1016/j.coi.2016.10.007; Gleeson LE, 2018, AM J RESP CELL MOL, V59, P572, DOI 10.1165/rcmb.2018-0162OC; Gleeson LE, 2016, J IMMUNOL, V196, P2444, DOI 10.4049/jimmunol.1501612; Han S, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0485-6; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hiemstra Pieter S, 2013, Ann Am Thorac Soc, V10 Suppl, pS180, DOI 10.1513/AnnalsATS.201305-123AW; Jaccard G, 2019, TOXICOL REP, V6, P222, DOI 10.1016/j.toxrep.2019.02.009; Kang MJ, 2015, J CLIN INVEST, V125, P2458, DOI 10.1172/JCI71747; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim YH, 2018, ENV HLTH TOXICOL, V33, pe2018010; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Metcalfe HJ, 2014, CLIN EXP IMMUNOL, V176, P461, DOI 10.1111/cei.12289; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pinkerton JW, 2017, MOL IMMUNOL, V86, P44, DOI 10.1016/j.molimm.2017.01.014; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; Tsai M, 2018, AM J RESP CRIT CARE, V197; Wang HY, 2018, INFLAMMATION, V41, P1321, DOI 10.1007/s10753-018-0780-0; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Yang DQ, 2016, FEBS LETT, V590, P3179, DOI 10.1002/1873-3468.12360; Yang WL, 2015, INT J CLIN EXP PATHO, V8, P13209; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yi G, 2018, INFLAMM RES, V67, P539, DOI 10.1007/s00011-018-1145-8; Zhu QF, 2017, J IMMUNOL, V198, P4210, DOI 10.4049/jimmunol.1700352	50	29	29	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1819	1832		10.1096/fj.201901239R	http://dx.doi.org/10.1096/fj.201901239R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914643	Green Published, hybrid			2022-12-26	WOS:000507308900120
J	Chakraborty, D; Strayve, DG; Makia, MS; Conley, SM; Kakahel, M; Al-Ubaidi, MR; Naash, MI				Chakraborty, Dibyendu; Strayve, Daniel G.; Makia, Mustafa S.; Conley, Shannon M.; Kakahel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Novel molecular mechanisms for Prph2-associated pattern dystrophy	FASEB JOURNAL			English	Article						butterfly pattern dystrophy; C213Y knockin; disulfide linkages; extracellular loop; retinitis pigmentosa; retinal degeneration slow (RDS); tetraspanin	ACID-RICH PROTEINS; OF-FUNCTION PHENOTYPE; PERIPHERIN RDS GENE; RETINITIS-PIGMENTOSA; OUTER SEGMENTS; MEMBRANE-PROTEINS; TRANSGENIC MICE; R172W MUTATION; MOUSE MODEL; ROD	Mutations in peripherin 2 (PRPH2) have been associated with retinitis pigmentosa (RP) and macular/pattern dystrophies, but the origin of this phenotypic variability is unclear. The majority of Prph2 mutations are located in the large intradiscal loop (D2), a region that contains seven cysteines involved in intra- and intermolecular disulfide bonding and protein folding. A mutation at cysteine 213, which is engaged in an intramolecular disulfide bond, leads to butterfly-shaped pattern dystrophy in humans, in sharp contrast to mutations in the adjacent cysteine at position 214 which result in RP. To help understand this unexpected phenotypic variability, we generated a knockin mouse line carrying the C213Y disease mutation. The mutant Prph2 protein lost the ability to oligomerize with rod outer segment membrane protein 1 (Rom1), but retained the ability to form homotetramers. C213Y heterozygotes had significantly decreased overall Prph2 levels as well as decreased rod and cone function. Critically, supplementation with extra wild-type Prph2 protein elicited improvements in Prph2 protein levels and rod outer segment structure, but not functional rescue in rods or cones. These findings suggest that not all interruptions of D2 loop intramolecular disulfide bonding lead to haploinsufficiency-related RP, but rather that more subtle changes can lead to mutant proteins stable enough to exert gain-of-function defects in rods and cones. This outcome highlights the difficulty in targeting Prph2-associated gain-of-function disease and suggests that elimination of the mutant protein will be a pre-requisite for any curative therapeutic strategy.	[Chakraborty, Dibyendu; Strayve, Daniel G.; Makia, Mustafa S.; Kakahel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd SERC 2009, Houston, TX 77204 USA; [Chakraborty, Dibyendu; Conley, Shannon M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Chakraborty, Dibyendu] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	University of Houston System; University of Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd SERC 2009, Houston, TX 77204 USA.	malubaid@Central.UH.EDU; mnaash@central.uh.edu		kakakhel, mashal/0000-0001-9516-8161	NEI/NIH [EY010609]	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NEI/NIH, Grant/Award Number: EY010609	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Becirovic E, 2014, HUM MOL GENET, V23, P5989, DOI 10.1093/hmg/ddu323; Bhattacharya S, 2017, INVEST OPHTH VIS SCI, V58, P2366, DOI 10.1167/iovs.16-21162; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; Chakraborty D, 2013, FEBS J, V280, P127, DOI 10.1111/febs.12055; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; Conley SM, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017376; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Conley SM, 2012, CELL MOL LIFE SCI, V69, P1035, DOI 10.1007/s00018-011-0736-0; Ding XQ, 2005, BIOCHEMISTRY-US, V44, P4897, DOI 10.1021/bi048414i; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fossarello M, 1996, ARCH OPHTHALMOL-CHIC, V114, P448, DOI 10.1001/archopht.1996.01100130444016; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P1115, DOI 10.1136/bjo.2004.062695; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Katagiri S, 2018, OPHTHALMIC GENET, V39, P357, DOI 10.1080/13816810.2018.1459737; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; Kedzierski W, 1999, J BIOL CHEM, V274, P29181, DOI 10.1074/jbc.274.41.29181; Koirala A, 2013, HUM MOL GENET, V22, P1632, DOI 10.1093/hmg/ddt013; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Manes G, 2015, AM J OPHTHALMOL, V159, P302, DOI 10.1016/j.ajo.2014.10.033; Nguyen ONP, 2016, HUM MOL GENET, V25, P2367, DOI 10.1093/hmg/ddw103; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; SAGA M, 1993, HUM GENET, V92, P519, DOI 10.1007/BF00216463; Salinas RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054292; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shankar SP, 2016, INVEST OPHTH VIS SCI, V57, P349, DOI 10.1167/iovs.15-16965; Souied EH, 1998, EUR J OPHTHALMOL, V8, P98, DOI 10.1177/112067219800800208; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Vaclavik V, 2012, RETINA-J RET VIT DIS, V32, P1942, DOI 10.1097/IAE.0b013e31824b32e4; Villaverde Cristina, 2007, Hum Genet, V122, P555; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; Zhang K, 2002, ARCH OPHTHALMOL-CHIC, V120, P485; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zulliger R, 2018, HUM MOL GENET, V27, P3507, DOI 10.1093/hmg/ddy240	62	13	13	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1211	1230		10.1096/fj.201901888R	http://dx.doi.org/10.1096/fj.201901888R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914632	Green Accepted			2022-12-26	WOS:000507308900082
J	Liu, ZQ; Shan, HH; Chen, SY; Chen, M; Song, YN; Lai, LX; Li, ZJ				Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Song, Yuning; Lai, Liangxue; Li, Zhanjun			Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits	FASEB JOURNAL			English	Article						base editor; CRISPR; Cas9; NG PAMs; rabbit	GENOMIC DNA; HAIR; MUTATION; FGF5; IDENTIFICATION; DELETION; LONG	Base editors, composed of a cytidine deaminase or an evolved adenine deaminase fused to Cas9 nickase, enable efficient C-to-T or A-to-G conversion in various organisms. However, the NGG protospacer adjacent motif (PAM) requirement of Streptococcus pyogenes Cas9 (SpCas9) substantially limits the target sites suitable for base editing. Quite recently, a new engineered SpCas9-NG variant, which can recognize minimal NG PAMs more efficiently than the present xCas9 variant. Here, we investigated the efficiency and PAM compatibility of SpCas9-NG-assisted cytidine base editors (CBEs) and adenine base editors (ABEs) in rabbits. In this study, we showed that NG-BE4max and NG-ABEmax systems can achieve a targeted mutation efficiency of 75%-100% and 80%-100% with excellent PAM compatibility of NGN PAMs in rabbit embryos, respectively. In addition, both base editors were successfully applied to create new rabbit models with precise point mutations, demonstrating their high efficiency and expanded genome-targeting scope in rabbits. Meanwhile, NG-ABEmax can be used to precisely mimic human Hoxc13 p.Q271R missense mutation in Founder (F0) rabbits, which is arduous for conventional ABEs to achieve due to a NGA PAM requirement. Collectively, NG-BE4max and NG-ABEmax systems provide promising tools to perform efficient base editing with expanded targeting scope in rabbits and enhances its capacity to model human diseases.	[Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Song, Yuning; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun 130062, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol,Guangzhou Inst Biomed, Guangzhou, Peoples R China; [Lai, Liangxue] GRMH GDL, Guangzhou, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences	Lai, LX; Li, ZJ (corresponding author), Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun 130062, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn		li, zhanjun/0000-0001-6914-8589; Liu, Zhiquan/0000-0001-5433-5656	National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104004]	National Key Research and Development Program of China Stem Cell and Translational Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	This study was financially supported by the National Key Research and Development Program of China Stem Cell and Translational Research (2017YFA0105101). The Program for Changjiang Scholars and Innovative Research Team in University (No.IRT_16R32). The Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030501, XDA16030503), Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104004).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Chatterjee P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau0766; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Edraki A, 2019, MOL CELL, V73, P714, DOI 10.1016/j.molcel.2018.12.003; Endo M, 2019, NAT PLANTS, V5, P14, DOI 10.1038/s41477-018-0321-8; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Grunewald J, 2019, NATURE, V569, P433, DOI 10.1038/s41586-019-1161-z; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hua K, 2019, MOL PLANT, V12, P1003, DOI 10.1016/j.molp.2019.03.009; Huang TP, 2019, NAT BIOTECHNOL, V37, P626, DOI 10.1038/s41587-019-0134-y; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Ki CS, 2002, J HUM GENET, V47, P225, DOI 10.1007/s100380200029; Kim D, 2019, NAT BIOTECHNOL, V37, P430, DOI 10.1038/s41587-019-0050-1; Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kostrzewa M, 1996, HUM GENET, V98, P48, DOI 10.1007/s004390050157; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Li XX, 2017, PEDIATR DERMATOL, V34, P172, DOI 10.1111/pde.13074; Liu XY, 2019, MOL THER-NUCL ACIDS, V17, P626, DOI 10.1016/j.omtn.2019.06.024; Liu ZQ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0099-5; Liu ZQ, 2019, CELL MOL LIFE SCI, V76, P4155, DOI 10.1007/s00018-019-03110-8; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Ren B, 2019, MOL PLANT, V12, P1015, DOI 10.1016/j.molp.2019.03.010; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Thuronyi BW, 2019, NAT BIOTECHNOL, V37, P1070, DOI 10.1038/s41587-019-0193-0; Villiger L, 2018, NAT MED, V24, P1519, DOI 10.1038/s41591-018-0209-1; Wang JJ, 2019, PLANT BIOTECHNOL J, V17, P709, DOI 10.1111/pbi.13053; Wang X, 2018, NAT BIOTECHNOL, V36, P946, DOI 10.1038/nbt.4198; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Yoshizawa Y, 2015, MAMM GENOME, V26, P630, DOI 10.1007/s00335-015-9608-5; Zhong ZH, 2019, MOL PLANT, V12, P1027, DOI 10.1016/j.molp.2019.03.011; Zhou CY, 2019, NATURE, V571, P275, DOI 10.1038/s41586-019-1314-0; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	43	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					588	596		10.1096/fj.201901587R	http://dx.doi.org/10.1096/fj.201901587R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914687	Bronze			2022-12-26	WOS:000507308900040
J	Konieczny, P; Artero, R				Konieczny, Piotr; Artero, Ruben			Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA	FASEB JOURNAL			English	Article						drug repurposing; SMA; SMN2; splicing	SPINAL MUSCULAR-ATROPHY; EXONIC SPLICING ENHANCER; KAPPA-OPIOID-RECEPTOR; PRE-MESSENGER-RNA; SINGLE NUCLEOTIDE; POTENTIAL THERAPY; VALPROIC ACID; SMN2 GENE; PROTEIN; SURVIVAL	Spinal muscular atrophy is a rare and fatal neuromuscular disorder caused by the loss of alpha motor neurons. The affected individuals have mutated the ubiquitously expressed SMN1 gene resulting in the loss or reduction in the survival motor neuron (SMN) protein levels. However, an almost identical paralog exists in humans: SMN2. Pharmacological activation of SMN2 exon 7 inclusion by small molecules or modified antisense oligonucleotides is a valid approach to treat SMA. Here we describe an in vivo SMN2 minigene reporter system in Drosophila motor neurons that serves as a cost-effective, feasible, and stringent primary screening model for identifying chemicals capable of crossing the conserved Drosophila blood-brain barrier and modulating exon 7 inclusion. The model was used for the screening of 1100 drugs from the Prestwick Chemical Library, resulting in 2.45% hit rate. The most promising candidate drugs were validated in patient-derived fibroblasts where they proved to increase SMN protein levels. Among them, moxifloxacin modulated SMN2 splicing by promoting exon 7 inclusion. The recovery of SMN protein levels was confirmed by increased colocalization of nuclear gems with Cajal Bodies. Thus, a Drosophila-based drug screen allowed the discovery of an FDA-approved small molecule with the potential to become a novel therapy for SMA.	[Konieczny, Piotr; Artero, Ruben] Univ Valencia, Interdisciplinary Res Struct Biotechnol & Biomed, Valencia, Spain; [Konieczny, Piotr; Artero, Ruben] Incliva Hlth Res Inst, Translat Genom Grp, Valencia, Spain; [Konieczny, Piotr; Artero, Ruben] Incliva CIPF Joint Unit, Valencia, Spain	University of Valencia	Artero, R (corresponding author), Univ Valencia, ERI Biotecmed, C Doctor Moliner 50, E-46100 Burjassot, Spain.	ruben.artero@uv.es	Artero, Ruben/K-6815-2014	Artero, Ruben/0000-0003-1596-047X; Konieczny, Piotr/0000-0003-2644-5502	SMA Europe, FundAME [19243]; AFM-Telethon [22346]	SMA Europe, FundAME; AFM-Telethon(Association Francaise contre les Myopathies)	SMA Europe, FundAME, Grant/Award Number: 19243; AFM-Telethon, Grant/Award Number: 22346	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bowerman M, 2009, MOL CELL NEUROSCI, V42, P66, DOI 10.1016/j.mcn.2009.05.009; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Clermont O, 1995, LANCET, V346, P1712, DOI 10.1016/S0140-6736(95)92881-2; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Dimitriadi M, 2013, J NEUROSCI, V33, P6557, DOI 10.1523/JNEUROSCI.1536-12.2013; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Fabian I, 2006, BRIT J CANCER, V95, P1038, DOI 10.1038/sj.bjc.6603355; Farrelly-Rosch A, 2017, NEUROCHEM INT, V108, P213, DOI 10.1016/j.neuint.2017.02.016; Fayzullina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093329; Garcia-Lopez A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04110-1; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hindle SJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00414; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lemos JC, 2011, METHODS MOL BIOL, V717, P197, DOI 10.1007/978-1-61779-024-9_11; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Martinez-Hernandez R, 2014, J NEUROPATH EXP NEUR, V73, P559, DOI 10.1097/NEN.0000000000000078; Mascarenhas JB, 2018, AM J RESP CELL MOL, V58, P604, DOI 10.1165/rcmb.2017-0141OC; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Pinard E, 2017, J MED CHEM, V60, P4444, DOI 10.1021/acs.jmedchem.7b00406; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reuveni D, 2010, INT J ONCOL, V37, P463, DOI 10.3892/ijo_00000695; Salemi S, 2005, BIOCHEM BIOPH RES CO, V338, P1012, DOI 10.1016/j.bbrc.2005.10.072; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2015, ANN NY ACAD SCI, V1341, P176, DOI 10.1111/nyas.12727; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh RN, 2018, ADV NEUROBIOL, V20, P31, DOI 10.1007/978-3-319-89689-2_2; Solier S, 2004, MOL CANCER RES, V2, P53; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wang JX, 2018, P NATL ACAD SCI USA, V115, pE4604, DOI 10.1073/pnas.1800260115; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	61	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3021	3036		10.1096/fj.201802554RRR	http://dx.doi.org/10.1096/fj.201802554RRR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909520				2022-12-26	WOS:000505012200001
J	Heil, SG; Herzog, EM; Griffioen, PH; van Zelst, B; Willemsen, SP; de Rijke, YB; Steegers-Theunissen, RPM; Steegers, EAP				Heil, Sandra G.; Herzog, Emilie M.; Griffioen, Pieter H.; van Zelst, Bertrand; Willemsen, Sten P.; de Rijke, Yolanda B.; Steegers-Theunissen, Regine P. M.; Steegers, Eric A. P.			Lower S-adenosylmethionine levels and DNA hypomethylation of placental growth factor (PlGF) in placental tissue of early-onset preeclampsia-complicated pregnancies	PLOS ONE			English	Article							TYROSINE KINASE-1; METHYLATION; HOMOCYSTEINE; RISK; DETERMINANTS; HYPERTENSION; BLOOD	Introduction The pathophysiology of preeclampsia is largely unknown. Serum placental induced growth factor (PlGF) levels are decreased during second trimester pregnancy. Aberrant DNA methylation is suggested to be involved in the etiology of preeclampsia (PE). We hypothesize that DNA methylation is altered in PE placentas determined the methylation index by measuring placental S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) levels. In addition, we assessed global DNA methylation status by long-interspersed nuclear element-1 (LINE-1) and DNA methylation status of the PlGF gene. Methods Placental tissue of 11 early onset PE (EOPE), 11 late onset PE (LOPE) and 60 controls consisting of 25 uncomplicated controls 20 fetal growth restriction (FGR) and 15 preterm births (PTB) controls was collected from a nested case-control study of The Rotterdam Periconceptional Cohort. RNA and DNA was isolated from placental tissue and DNA was treated with sodium bisulfite. SAM and SAH levels were measured by LC-ESI-MS/MS. Methylation of LINE-1 and PlGF genes was analyzed by Sequenom Epityper and. mRNA expression of PlGF was assessed with qPCR. Differences were assessed by analysis of covariance (ANCOVA) corrected for gestational age and birth weight. Results Placental SAM levels were significantly lower in placental tissue of EOPE pregnancies compared to PTB controls (mean difference -240 +/- 71.4 nmol/g protein, P = 0.01). PlGF DNA methylation was decreased in placental tissue of EOPE cases versus LOPE (mean difference -17.4 +/- 5.1%, P = 0.01), uncomplicated controls (mean difference -23.4 +/- 5.4%%, P <0.001), FGR controls (mean difference -17.9 +/- 4.6%, P = 0.002) and PTB controls (mean difference -11.3 +/- 3.8% P = 0.04). No significant differences were observed in SAH, SAM:SAH ratio, LINE-1 DNA methylation and PlGF mRNA expression between groups. Discussion The hypomethylation state of the placenta in EOPE, which is reflected by lower SAM and PlGF DNA hypomethylation underlines the possible role of placental DNA hypomethylation in the pathophysiology of EOPE, which needs further investigation.	[Heil, Sandra G.; Griffioen, Pieter H.; van Zelst, Bertrand; de Rijke, Yolanda B.] Erasmus MC, Dept Clin Chem, Univ Med Ctr, Rotterdam, Netherlands; [Herzog, Emilie M.; Willemsen, Sten P.; Steegers-Theunissen, Regine P. M.; Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Univ Med Ctr, Rotterdam, Netherlands; [Willemsen, Sten P.] Erasmus MC, Univ Med Ctr, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Heil, SG (corresponding author), Erasmus MC, Dept Clin Chem, Univ Med Ctr, Rotterdam, Netherlands.	s.heil@erasmusmc.nl	de Rijke, Yolanda/AAQ-5497-2020; Heil, Sandra/AAM-8104-2020		Erasmus MC; MRC [MR/S03658X/1] Funding Source: UKRI	Erasmus MC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work recieved funding by Erasmus MC to SH and ES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100148; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Bouwland-Both MI, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.009; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chuah TT, 2019, J PERINAT MED, V47, P35, DOI 10.1515/jpm-2017-0288; Coolman M, 2012, OBSTET GYNECOL, V119, P1190, DOI 10.1097/AOG.0b013e318256187f; Martin EMD, 2015, HAEMATOLOGICA, V100, P177; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Herzog EM, 2017, PLACENTA, V58, P122, DOI 10.1016/j.placenta.2017.08.070; Herzog EM, 2016, J REPROD IMMUNOL, V116, P81, DOI 10.1016/j.jri.2016.05.002; Hoeller A, 2017, HYPERTENS PREGNANCY, V36, P151, DOI 10.1080/10641955.2016.1273363; Hogg K, 2013, EARLY ONSET PREECLAM; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Liu H, 2014, PLACENTA, V35, P981, DOI 10.1016/j.placenta.2014.09.016; Mandaviya PR, 2014, MOL GENET METAB, V113, P243, DOI 10.1016/j.ymgme.2014.10.006; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nomura R, 2010, IEEE INT SYMP INFO, P131, DOI 10.1109/ISIT.2010.5513268; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Steegers-Theunissen RPM, 2016, INT J EPIDEMIOL, V45, P374, DOI 10.1093/ije/dyv147; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; van Mil NH, 2014, REPRODUCTION, V148, P581, DOI 10.1530/REP-14-0260; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Wilson SL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0257-z; Yan YH, 2013, EUR REV MED PHARMACO, V17, P3083; Zhu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134119; Zusterzeel PLM, 2000, HYPERTENS PREGNANCY, V19, P299, DOI 10.1081/PRG-100101991	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226969	10.1371/journal.pone.0226969	http://dx.doi.org/10.1371/journal.pone.0226969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887212	Green Published, gold			2022-12-26	WOS:000515092200057
J	Zhang, HW; Wang, RF; Wang, HL; Liu, B; Xu, MP; Guan, YA; Yang, YB; Qin, L; Chen, EY; Li, FF; Huang, RD; Zhou, YF				Zhang, Huawen; Wang, Runfeng; Wang, Hailian; Liu, Bin; Xu, Mengping; Guan, Yan'an; Yang, Yanbing; Qin, Ling; Chen, Erying; Li, Feifei; Huang, Ruidong; Zhou, Yufei			Heterogeneous root zone salinity mitigates salt injury to Sorghum bicolor (L.) Moench in a split-root system	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DROUGHT STRESS; AUXIN BIOSYNTHESIS; HYDROGEN-PEROXIDE; PLANT-RESPONSES; WATER RELATIONS; SALICYLIC-ACID; TOLERANCE; EXPRESSION; GENES	The heterogeneous distribution of soil salinity across the rhizosphere can moderate salt injury and improve sorghum growth. However, the essential molecular mechanisms used by sorghum to adapt to such environmental conditions remain uncharacterized. The present study evaluated physiological parameters such as the photosynthetic rate, antioxidative enzyme activities, leaf Na+ and K+ contents, and osmolyte contents and investigated gene expression patterns via RNA sequencing (RNA-seq) analysis under various conditions of nonuniformly distributed salt. Totals of 5691 and 2047 differentially expressed genes (DEGs) in the leaves and roots, respectively, were identified by RNA-seq under nonuniform (NaCl-free and 200 mmol.L-1 NaCl) and uniform (100 mmol.L-1 and 100 mmol.L-1 NaCl) salinity conditions. The expression of genes related to photosynthesis, Na+ compartmentalization, phytohormone metabolism, antioxidative enzymes, and transcription factors (TFs) was enhanced in leaves under nonuniform salinity stress compared with uniform salinity stress. Similarly, the expression of the majority of aquaporins and essential mineral transporters was upregulated in the NaCl-free root side in the nonuniform salinity treatment, whereas abscisic acid (ABA)-related and salt stress-responsive TF transcripts were more abundant in the high-saline root side in the nonuniform salinity treatment. In contrast, the expression of the DEGs identified in the nonuniform salinity treatment remained virtually unaffected and was even downregulated in the uniform salinity treatment. The transcriptome findings might be supportive of the increased photosynthetic rate, reduced Na+ levels, increased antioxidative capability in the leaves and, consequently, the growth recovery of sorghum under nonuniform salinity stress as well as the inhibited sorghum growth under uniform salinity conditions. The increased expression of salt resistance genes activated in response to the nonuniform salinity distribution implied that the cross-talk between the nonsaline and high-saline sides of the roots exposed to nonuniform salt stress is potentially regulated.	[Zhang, Huawen; Huang, Ruidong; Zhou, Yufei] Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China; [Zhang, Huawen; Wang, Runfeng; Wang, Hailian; Liu, Bin; Xu, Mengping; Guan, Yan'an; Yang, Yanbing; Qin, Ling; Chen, Erying; Li, Feifei] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China; [Zhang, Huawen; Wang, Runfeng; Wang, Hailian; Liu, Bin; Xu, Mengping; Guan, Yan'an; Yang, Yanbing; Qin, Ling; Chen, Erying; Li, Feifei] Shandong Engn Lab Featured Crops, Jinan, Shandong, Peoples R China	Shenyang Agricultural University; Shandong Academy of Agricultural Sciences	Zhou, YF (corresponding author), Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China.	zhouyufei2002@aliun.com			Earmarked Fund for China Agriculture Research System from the Ministry of Agriculture and Rural Affairs, China [CARS-06-13.5-B23]; Agricultural Scientific and Technological Innovation Project - Shandong Academy of Agricultural Sciences [CXGC2018D02]; Shandong Academy of Agricultural Sciences (Agricultural Scientific and Technological Innovation Project) [CXGC2018D02]; Earmarked Fund for China Agriculture Research System [CARS-06-13.5-B23]	Earmarked Fund for China Agriculture Research System from the Ministry of Agriculture and Rural Affairs, China; Agricultural Scientific and Technological Innovation Project - Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences (Agricultural Scientific and Technological Innovation Project); Earmarked Fund for China Agriculture Research System	H. Z. received the award of the Earmarked Fund for China Agriculture Research System (CARS-06-13.5-B23) from the Ministry of Agriculture and Rural Affairs, China, and the grant from the Agricultural Scientific and Technological Innovation Project (CXGC2018D02), initiated by Shandong Academy of Agricultural Sciences. The funders did not have any role in the research work.; We appreciated the help of Dr. Zhen Qin and Dr. Ling'an Kong who advised designing the research and preparing the writing of the manuscript. Also, we gratefully acknowledged financial support from Shandong Academy of Agricultural Sciences (Agricultural Scientific and Technological Innovation Project, CXGC2018D02) and (Earmarked Fund for China Agriculture Research System, CARS-06-13.5-B23).	Abid MA, 2018, J PLANT GROWTH REGUL, V37, P668, DOI 10.1007/s00344-017-9744-0; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Afzal Z, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010009; Ali A, 2017, J PLANT BIOL, V60, P431, DOI 10.1007/s12374-017-0133-9; Anjula Chaudhary, 2015, Plant Archives, V15, P7; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Bagheri M, 2019, SCI HORTIC-AMSTERDAM, V243, P207, DOI 10.1016/j.scienta.2018.08.026; Amorim LLB, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0354-z; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bazihizina N, 2012, J EXP BOT, V63, P6347, DOI 10.1093/jxb/ers302; Bazihizina N, 2012, PLANT SOIL, V354, P1, DOI 10.1007/s11104-012-1193-8; Bernal A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010294; Boro P, 2018, NUCLEUS CALCUTTA, V61, P241, DOI 10.1007/s13237-018-0256-5; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Chen HY, 2018, PLANT CELL ENVIRON, V41, P50, DOI 10.1111/pce.12925; Chen S, 2019, SCI HORTIC-AMSTERDAM, V249, P120, DOI 10.1016/j.scienta.2019.01.049; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Dong HZ, 2010, EUR J AGRON, V33, P285, DOI 10.1016/j.eja.2010.08.002; Feng XH, 2017, SCI HORTIC-AMSTERDAM, V226, P24, DOI 10.1016/j.scienta.2017.08.011; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Ghassmi-Golezani K, 2018, ECOTOX ENVIRON SAFE, V166, P18, DOI 10.1016/j.ecoenv.2018.09.059; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Haddadi P, 2016, MOL PLANT PATHOL, V17, P1196, DOI 10.1111/mpp.12356; Hu YR, 2017, J EXP BOT, V68, P1361, DOI 10.1093/jxb/erx004; Huang LL, 2018, PLANT PHYSIOL BIOCH, V127, P185, DOI 10.1016/j.plaphy.2018.03.031; Ibrahim W, 2019, PHYSIOL PLANTARUM, V165, P343, DOI 10.1111/ppl.12862; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Jin HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150504; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Khan SA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061634; KLAPHECK S, 1990, PLANT CELL PHYSIOL, V31, P1005; Kollath-Leiss K, 2014, EUKARYOT CELL, V13, P1051, DOI 10.1128/EC.00061-14; Kong XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03302-x; Kong XQ, 2016, J EXP BOT, V67, P2247, DOI 10.1093/jxb/erw026; Kong XQ, 2012, J EXP BOT, V63, P2105, DOI 10.1093/jxb/err420; Kriechbaumer V, 2006, PLANT BIOLOGY, V8, P334, DOI 10.1055/s-2006-923883; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lin J, 2018, PHOTOSYNTHETICA, V56, P998, DOI 10.1007/s11099-018-0824-6; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu XM, 2015, INT J MOL SCI, V16, P5975, DOI 10.3390/ijms16035975; Liu ZQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00780; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu SP, 2013, PLANT BIOTECHNOL J, V11, P380, DOI 10.1111/pbi.12028; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Munns R, 2003, AUST J AGR RES, V54, P627, DOI 10.1071/AR03027; Varela ALN, 2019, J PROTEOMICS, V194, P200, DOI 10.1016/j.jprot.2018.11.015; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Per TS, 2017, PLANT PHYSIOL BIOCH, V115, P126, DOI 10.1016/j.plaphy.2017.03.018; Ryu H, 2015, J PLANT BIOL, V58, P147, DOI 10.1007/s12374-015-0103-z; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Secchi F, 2007, ANN APPL BIOL, V150, P163, DOI 10.1111/j.1744-7348.2007.00118.x; Seo M, 1998, PLANT PHYSIOL, V116, P687, DOI 10.1104/pp.116.2.687; Sergiev I, 2019, SCI HORTIC-AMSTERDAM, V248, P200, DOI 10.1016/j.scienta.2019.01.015; Singh M, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2345-x; Sobajima H, 2007, BIOSCI BIOTECH BIOCH, V71, P3110, DOI 10.1271/bbb.70532; Sun JJ, 2016, PLANT SOIL, V408, P211, DOI 10.1007/s11104-016-2922-1; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang JP, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01381; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Xing Y, 2015, J EXP BOT, V66, P5971, DOI 10.1093/jxb/erv305; Xiong M, 2018, SCI HORTIC-AMSTERDAM, V237, P277, DOI 10.1016/j.scienta.2018.04.023; Xiong X, 2018, PLANT PHYSIOL BIOCH, V132, P434, DOI 10.1016/j.plaphy.2018.09.028; Yang H, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00160; Yin HS, 2019, ACAD PEDIATR, V19, P1, DOI 10.1016/j.acap.2018.07.012; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-898; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhang SC, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1416-0; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	77	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227020	10.1371/journal.pone.0227020	http://dx.doi.org/10.1371/journal.pone.0227020			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887166	Green Published, gold			2022-12-26	WOS:000515092200063
J	Wu, HT; Chen, SC; Fan, KC; Kuo, CH; Lin, SY; Wang, SH; Chang, CJ; Li, HY				Wu, Hung-Tsung; Chen, Szu-Chi; Fan, Kang-Chih; Kuo, Chun-Heng; Lin, Shin-Yu; Wang, Shu-Huei; Chang, Chih-Jen; Li, Hung-Yuan			Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity	FASEB JOURNAL			English	Article						adipogenesis; adipokine; fibrinogen-like protein-1; hepassocin; obesity	ALL-CAUSE MORTALITY; BODY-MASS INDEX; HUMAN HEPASSOCIN; INSULIN; PROLIFERATION; OVERWEIGHT; EXPRESSION; DELTA	Fibrinogen-like-protein 1 (FGL1) is a novel hepatokine that plays an important role in hepatic steatosis and insulin resistance. Although FGL1 expression can be detected in adipose tissues, the functions of FGL1 in adipose tissues are still unknown. In this study, 356 participants with (body mass index (BMI) >= 25 kg/m(2); n = 134) or without obesity (BMI <25 kg/m(2); n = 222) were recruited, and we found that the plasma FGL1 concentrations were significantly higher in obese group than those of in the normal weight group, and were positively correlated with age, BMI, waist circumference, fat content, plasma glucose at 2 hours during an oral glucose tolerance test, and the insulin sensitivity index. In univariate analyses, BMI, waist circumference, total fat, visceral fat, and subcutaneous fat areas were positively correlated with FGL1 levels. After adjusting for age and gender, obesity indices, including the BMI and different fat areas, remained significantly associated with FGL1 levels. In order to investigate the causal relationship between FGL1 and obesity, animal and cell models were used. Overexpression of FGL1 in epididymal adipose tissue by lentiviral vector encoding FGL1 increased the fat pad size, whereas FGL1-knockdown by lentiviral vector encoding short-hairpin RNA targeted to FGL1 decreased high-fat diet-induced adiposity. In addition, 3T3-L1 adipocytes were used to clarify the possible mechanism of FGL1-induced adipogenesis. FGL1 induced adipogenesis through an ERK1/2-C/EBP beta-dependent pathway in 3T3-L1 adipocytes. These findings highlight the pathophysiological role of FGL1 in obesity, and FGL1 might be a novel therapeutic target to combat obesity.	[Wu, Hung-Tsung] Taipei Med Univ, Grad Inst Metab & Obes Sci, Taipei, Taiwan; [Chen, Szu-Chi] Cardinal Tien Hosp, Div Endocrinol, Dept Internal Med, Xindian, Taiwan; [Fan, Kang-Chih] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Kuo, Chun-Heng] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Lin, Shin-Yu] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan.	larsli@ntuh.gov.tw	Fan, Kang-Chih/AAH-1425-2021; Kuo, Chun-Heng/AGT-3969-2022	LIN, SHIN-YU/0000-0002-0753-2793; WANG, SHU-HUEI/0000-0002-9208-3135; Li, Hung-Yuan/0000-0001-9644-2855; FAN, KANG-CHIH/0000-0002-6993-4528	Ministry of Science and Technology, Taiwan (MOST) [MOST107-2314-B-038 -112, 107-2314-B-002-178-MY3, 104-2314-B-006 -029-MY2]; National Cheng Kung University Hospital (NCKU) [NCKUH-10804038]; Ministry of Science and Technology; National Cheng Kung University Hospital	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital (NCKU); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST107-2314-B-038 -112, 107-2314-B-002-178-MY3 and 104-2314-B-006 -029-MY2; National Cheng Kung University Hospital (NCKU), Grant/Award Number: NCKUH-10804038; Ministry of Science and Technology; National Cheng Kung University Hospital	Abdelmoemen G, 2019, ENDOCR METAB IMMUNE, V19, P185, DOI 10.2174/1871530318666180716100543; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Balkow Aileen, 2016, J Biol Methods, V3, pe48, DOI 10.14440/jbm.2016.123; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Chen MX, 2017, OBES RES CLIN PRACT, V11, P227, DOI 10.1016/j.orcp.2016.07.004; Choi HY, 2013, DIABETES METAB J, V37, P63, DOI 10.4093/dmj.2013.37.1.63; Demchev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058084; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gao M, 2015, BIOCHEM BIOPH RES CO, V463, P466, DOI 10.1016/j.bbrc.2015.05.121; Gao M, 2014, CELL SIGNAL, V26, P2161, DOI 10.1016/j.cellsig.2014.04.013; Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hishida T, 2009, BIOCHIMIE, V91, P654, DOI 10.1016/j.biochi.2009.02.002; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Hung CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112355; Iroz A, 2015, DIABETOLOGIA, V58, P1699, DOI 10.1007/s00125-015-3634-4; Jung TW, 2018, MOL CELL ENDOCRINOL, V470, P26, DOI 10.1016/j.mce.2017.10.014; Kuo C-H, 2005, INT J OBESITY, V2019, P512; Li CY, 2010, GUT, V59, P817, DOI 10.1136/gut.2008.171124; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Oh KJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010008; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ou HY, 2017, J CLIN ENDOCR METAB, V102, P2407, DOI 10.1210/jc.2016-3287; Rosen ED, 2000, GENE DEV, V14, P1293; Thakkinstian A, 2014, CLIN ENDOCRINOL, V81, P197, DOI 10.1111/cen.12303; TREPANOWSKI JF, 2015, INT J OBESITY, V39, P734, DOI DOI 10.1038/IJO.2014.203; Wu HT, 2016, DIABETOLOGIA, V59, P1732, DOI 10.1007/s00125-016-3991-7; Wu HT, 2013, J HEPATOL, V59, P1065, DOI 10.1016/j.jhep.2013.06.004; Zheng Y, 2017, JAMA-J AM MED ASSOC, V318, P255, DOI 10.1001/jama.2017.7092	32	19	19	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2958	2967		10.1096/fj.201901925R	http://dx.doi.org/10.1096/fj.201901925R		DEC 2019	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908014	Bronze			2022-12-26	WOS:000504676600001
J	Li, L; Tian, FY; Yuan, Y; Zhang, T; Yang, WB; Kong, R; Wang, G; Chen, H; Chen, HZ; Hu, JS; Zhang, GQ; Zhao, ZJ; Wang, XL; Li, GQ; Sun, B				Li, Le; Tian, Feng-Yu; Yuan, Yue; Zhang, Tao; Yang, Wen-Bo; Kong, Rui; Wang, Gang; Chen, Hua; Chen, Hong-Ze; Hu, Ji-Sheng; Zhang, Guang-Quan; Zhao, Zhong-Jie; Wang, Xin-Long; Li, Guan-Qun; Sun, Bei			HYAL-1-induced autophagy facilitates pancreatic fistula for patients who underwent pancreaticoduodenectomy	FASEB JOURNAL			English	Article						autophagy; fibrosis; HYAL-1; pancreaticoduodenectomy; pancreatic fistula	ACTIVATED PROTEIN-KINASE; HYALURONIDASE 1; CANCER; STAT3; AMPK; METABOLISM; PREDICTION; HYAL-1; CELLS; PHOSPHORYLATION	The main mechanism of hyaluronidase 1(HYAL-1) in the development of postoperative pancreatic fistula (POPF) after pancreatoduodenectomy (PD) was unknown. In this study, a comprehensive inventory of pre-, intra-, and postoperative clinical and biological data of two cohorts (62 pancreatic cancer [PCa] and 111 pancreatic ductal adenocarcinoma [PDAC]) which could induce POPF were retrospectively analyzed. Then, a total of 7644 genes correlated with HYAL-1 was predicted in PDAC tissues and the enriched pathway, kinase targets and biological process of those correlated genes were evaluated. Finally, a mouse pancreatic fistula (PF) model was first built and in vitro studies were performed to investigate the effects of HYAL-1 on PF progression. Our data indicated that preoperative serum HYAL-1 level, pancreatic fibrosis score, and pancreatic duct size were valuable factors for detecting POPF of Grade B and C. The serum HYAL-1 level of 2.07 mg/ml and pancreatic fibrosis score of 2.5 were proposed as the cutoff values for indicating POPF. The bioinformatic analysis and in vitro and in vivo studies demonstrated that HYAL-1 facilitates pancreatic acinar cell autophagy via the dephosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK) and signal transducers and activators of transcription 3 (STAT3) signaling pathways, which exacerbate pancreatic secretion and inflammation. In summary, the preoperative serum HYAL-1 was a significant predictor for POPF in patients who underwent PD. Tumor-induced HYAL-1 is one of core risk in accelerating PF and then promoting pancreatic secretion and acute inflammation response through the AMPK and STAT3-induced autophagy.	[Li, Le; Tian, Feng-Yu; Zhang, Tao; Yang, Wen-Bo; Kong, Rui; Wang, Gang; Chen, Hua; Chen, Hong-Ze; Hu, Ji-Sheng; Zhang, Guang-Quan; Zhao, Zhong-Jie; Wang, Xin-Long; Li, Guan-Qun; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Heilongjiang, Peoples R China; [Yuan, Yue] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Kong, Rui; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Minist Educ, Key Lab Hepatosplen Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Sun, B (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Key Lab Hepatosplen Surg,Minist Educ, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China.	sunbei70@tom.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81800572, 81670583, 81871974, 81770639]; China Postdoctoral Science Foundation [2017M621300, 2018T110316]; Heilongjiang Providence Postdoctoral Science Foundation [LBH-Z17179, LBH-TZ17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Providence Postdoctoral Science Foundation	This work was supported by The National Natural Science Foundation of China (81800572, 81670583, 81871974, 81770639). The China Postdoctoral Science Foundation (2017M621300, 2018T110316) and The Heilongjiang Providence Postdoctoral Science Foundation (LBH-Z17179, LBH-TZ17).	Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Biczo G, 2018, GASTROENTEROLOGY, V154, P689, DOI 10.1053/j.gastro.2017.10.012; Deng Y, 2018, J GASTROINTEST SURG, V22, P438, DOI 10.1007/s11605-017-3660-2; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Dogne S, 2016, DIABETES, V65, P2742, DOI 10.2337/db15-1662; Dumaresq-Doiron K, 2012, J CELL PHYSIOL, V227, P1911, DOI 10.1002/jcp.22919; Gayral F, 2009, ANN SURG, V250, P872, DOI 10.1097/SLA.0b013e3181b2489f; Gilardini Montani MS, 2019, AUTOPHAGY, V15, P652, DOI 10.1080/15548627.2018.1536530; Goyert N, 2017, ANN SURG, V265, P2, DOI 10.1097/SLA.0000000000001889; Guo XJ, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0534-4; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hogg ME, 2016, ANN SURG, V264, P482, DOI 10.1097/SLA.0000000000001862; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Hu JS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0839-8; Hu W, 2018, PROG LIPID RES, V70, P17, DOI 10.1016/j.plipres.2018.04.002; Inata Y, 2018, FASEB J, V32, P728, DOI 10.1096/fj.201700576R; Ji L, 2016, J CELL MOL MED, V20, P2349, DOI 10.1111/jcmm.12928; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kang JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177052; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kiyochi H, 2015, WORLD J SURG, V39, P2967, DOI 10.1007/s00268-015-3211-5; Kosaka H, 2014, J HEPATO-BIL-PAN SCI, V21, P128, DOI 10.1002/jhbp.11; Kosztelnik M, 2019, FASEB J, V33, P2372, DOI 10.1096/fj.201800565RR; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Li L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0980-4; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Lokeshwar VB, 2008, J BIOL CHEM, V283, P29215, DOI 10.1074/jbc.M801101200; Ma LW, 2017, ANN SURG, V265, P11, DOI 10.1097/SLA.0000000000001892; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Maggino L, 2019, ANN SURG, V269, P1146, DOI 10.1097/SLA.0000000000002673; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Mazzaferro V, 2019, ANN SURG, V270, P791, DOI 10.1097/SLA.0000000000003514; McMillan MT, 2017, JAMA SURG, V152, P327, DOI 10.1001/jamasurg.2016.4755; Neoptolemos JP, 2018, NAT REV GASTRO HEPAT, V15, P332, DOI 10.1038/s41575-018-0005-x; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Ohgi K, 2020, HPB, V22, P67, DOI 10.1016/j.hpb.2019.05.008; Partelli S, 2017, HPB, V19, P580, DOI 10.1016/j.hpb.2017.03.001; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Poves I, 2018, ANN SURG, V268, P731, DOI 10.1097/SLA.0000000000002893; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Qi YL, 2014, CANCER RES, V74, P3740, DOI 10.1158/0008-5472.CAN-13-3182; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Smits FJ, 2017, JAMA SURG, V152, P540, DOI 10.1001/jamasurg.2016.5708; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Sugimoto M, 2017, J GASTROINTEST SURG, V21, P846, DOI 10.1007/s11605-017-3356-7; Sun LH, 2017, AUTOPHAGY, V13, P703, DOI 10.1080/15548627.2017.1280217; Tanaka T, 2013, J GASTROENTEROL, V48, P1081, DOI 10.1007/s00535-012-0706-9; Van Buren G, 2014, ANN SURG, V259, P605, DOI 10.1097/SLA.0000000000000460; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Witzel I, 2017, BREAST CANCER RES TR, V162, P427, DOI 10.1007/s10549-017-4135-6; Yamashita S, 2018, ANN SURG, V267, P989; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; You LK, 2015, AUTOPHAGY, V11, P729, DOI 10.1080/15548627.2015.1017192; Zhao YX, 2015, ACTA OCEANOL SIN, V34, P1, DOI 10.1007/s13131-015-0736-2	57	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2524	2540		10.1096/fj.201901583R	http://dx.doi.org/10.1096/fj.201901583R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908026				2022-12-26	WOS:000503399000001
J	Sun, M; Luong, G; Plastikwala, F; Sun, Y				Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue			Control of Rab7a activity and localization through endosomal type Igamma PIP 5-kinase is required for endosome maturation and lysosome function	FASEB JOURNAL			English	Article						autophagy; endosome maturation; lysosome; PIPKI gamma i5; Rab7a	PHOSPHATIDYLINOSITOL-PHOSPHATE KINASE; COMPLEX; AUTOPHAGY; PROTEINS; CELLS; PROGRESSION; TRAFFICKING; ASSOCIATION; RECEPTORS; TRANSPORT	The small GTPase Ras-related protein Rab-7a (Rab7a) serves as a key organizer of the endosomal-lysosomal system. However, molecular mechanisms controlling Rab7a activation levels and subcellular translocation are still poorly defined. Here, we demonstrate that type Igamma phosphatidylinositol phosphate 5-kinase i5 (PIPKI gamma i5), an endosome-localized enzyme that produces phosphatidylinositol 4,5-bisphosphate, directly interacts with Rab7a and plays critical roles in the control of the endosomal-lysosomal system. The loss of PIPKI gamma i5 blocks Rab7a recruitment to early endosomes, which prevents the maturation of early to late endosomes. PIPKI gamma i5 loss disturbs retromer complex connection with Rab7a, which blocks the retrograde sorting of Cation-independent Mannose 6-Phosphate Receptor from late endosomes. This leads to the decreased sorting of hydrolases to lysosomes and reduces the autophagic degradation. By modulating the retromer-Rab7a connection, PIPKI gamma i5 is also required for the recruitment of the GTPase-activating protein TBC1 domain family member 5 to late endosomes, which controls the conversion of Rab7a from the active state to the inactive state. Thus, PIPKI gamma i5 is critical for the modulation of Rab7a activity, localization, and function in the endosomal-lysosomal system.	[Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue] Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA; [Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Sun, Y (corresponding author), Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA.; Sun, Y (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA.	ysun4@vcu.edu			HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR) [R03DE025893]; American Cancer Society (ACS) [RSG-17-064-01-TBE]	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR); American Cancer Society (ACS)(American Cancer Society)	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R03DE025893; American Cancer Society (ACS), Grant/Award Number: RSG-17-064-01-TBE	Baba T, 2019, EMBO J, V38, DOI 10.15252/embj.2018100312; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Choy CH, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213587; Cullen PJ, 2018, NAT REV MOL CELL BIO, V19, P679, DOI 10.1038/s41580-018-0053-7; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Durchfort N, 2012, TRAFFIC, V13, P108, DOI 10.1111/j.1600-0854.2011.01300.x; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldenring JR, 2015, CURR OPIN CELL BIOL, V35, P117, DOI 10.1016/j.ceb.2015.04.018; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hasanagic M, 2015, INT REV CEL MOL BIO, V320, P75, DOI 10.1016/bs.ircmb.2015.07.008; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jacobi AM, 2017, METHODS, V121, P16, DOI 10.1016/j.ymeth.2017.03.021; Jia D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13305; Jimenez-Orgaz A, 2018, EMBO J, V37, P235, DOI 10.15252/embj.201797128; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Kvainickas A, 2017, J CELL BIOL, V216, P3677, DOI 10.1083/jcb.201702137; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Langemeyer L, 2018, TRENDS CELL BIOL, V28, P957, DOI 10.1016/j.tcb.2018.06.007; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu K, 2017, J CELL BIOL, V216, P3307, DOI 10.1083/jcb.201705151; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Luzio JP, 2000, J CELL SCI, V113, P1515; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; McNally KE, 2018, TRENDS CELL BIOL, V28, P807, DOI 10.1016/j.tcb.2018.06.005; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Podinovskaia M, 2018, PROG MOL SUBCELL BIO, V57, P1, DOI 10.1007/978-3-319-96704-2_1; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sleat DE, 2005, PROTEOMICS, V5, P1520, DOI 10.1002/pmic.200401054; Soori M, 2016, J PHARMACOL EXP THER, V356, P375, DOI 10.1124/jpet.115.229229; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun Jim, 2009, V531, P57, DOI 10.1007/978-1-59745-396-7_5; Sun M, 2016, J BIOL CHEM, V291, P21461, DOI 10.1074/jbc.M116.736041; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Tan XJ, 2016, P NATL ACAD SCI USA, V113, P10896, DOI 10.1073/pnas.1523145113; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Xiong XH, 2012, MOL BIOL CELL, V23, P87, DOI 10.1091/mbc.E11-05-0449; Yang MJ, 2004, BIOCHEM BIOPH RES CO, V318, P792, DOI 10.1016/j.bbrc.2004.04.115; Zhan LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.330	69	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2730	2748		10.1096/fj.201901830R	http://dx.doi.org/10.1096/fj.201901830R		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908013	Green Accepted			2022-12-26	WOS:000503397700001
J	Luca, VC; Miao, Y; Li, XN; Hollander, MJ; Kuo, CJ; Garcia, KC				Luca, Vincent C.; Miao, Yi; Li, Xingnan; Hollander, Michael J.; Kuo, Calvin J.; Garcia, K. Christopher			Surrogate R-spondins for tissue-specific potentiation of Wnt Signaling	PLOS ONE			English	Article							WNT/BETA-CATENIN; HUMAN-ANTIBODIES; STRUCTURAL BASIS; CANONICAL WNT; STEM-CELLS; LGR5; INTERLEUKIN-2; RECEPTORS; RECOGNITION; ENDOCYTOSIS	Secreted R-spondin1-4 proteins (RSPO1-4) orchestrate stem cell renewal and tissue homeostasis by potentiating Wnt/beta-catenin signaling. RSPOs induce the turnover of negative Wnt regulators RNF43 and ZNRF3 through a process that requires RSPO interactions with Leucine-rich repeat-containing G-protein coupled receptors (LGRs), or through an LGR-independent mechanism that is enhanced by RSPO binding to heparin sulfate proteoglycans (HSPGs). Here, we describe the engineering of `surrogate RSPOs' that function independently of LGRs to potentiate Wnt signaling on cell types expressing a target surface marker. These bispecific proteins were generated by fusing an RNF43-or ZNRF3-specific single chain antibody variable fragment (scFv) to the immune cytokine IL-2. Surrogate RSPOs mimic the function of natural RSPOs by crosslinking the extracellular domain (ECD) of RNF43 or ZNRF3 to the ECD of the IL-2 receptor CD25, which sequesters the complex and results in highly selective amplification of Wnt signaling on CD25+ cells. Furthermore, surrogate RSPOs were able substitute for wild type RSPO in a colon organoid growth assay when intestinal stem cells were transduced to express CD25. Our results provide proof-ofconcept for a technology that may be adapted for use on a broad range of cell-or tissuetypes and will open new avenues for the development of Wnt-based therapeutics for regenerative medicine.	[Luca, Vincent C.; Miao, Yi; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Luca, Vincent C.; Miao, Yi; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Li, Xingnan; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Hollander, Michael J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luca, Vincent C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; H Lee Moffitt Cancer Center & Research Institute	Luca, VC; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Luca, VC; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Luca, VC (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA.	vince.luca@moffitt.org; kcgarcia@stanford.edu		Kuo, Calvin/0000-0002-7427-5985; Hollander, Michael/0000-0002-3108-2788	Ludwig Cancer Foundation; Howard Hughes Medical Institute; NIH [R01-DK115728, DK085527]	Ludwig Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a gift from the Mathers Fund (mathersfoundation.org)(KCG); the Ludwig Cancer Foundation (ludwigcancerresearch.org) (KCG); the Howard Hughes Medical Institute (hhmi.org) (KCG); NIH R01-DK115728 (nih.gov) (KCG and CJK); and NIH DK085527 (nih.gov) (CJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Janda CY, 2017, NATURE, V545, P234, DOI 10.1038/nature22306; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Park S, 2018, J BIOL CHEM, V293, P9759, DOI 10.1074/jbc.RA118.002743; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	29	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226928	10.1371/journal.pone.0226928	http://dx.doi.org/10.1371/journal.pone.0226928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914456	Green Published, Green Submitted, gold			2022-12-26	WOS:000534337700020
J	Zhang, AZ; Negoescu, D; Munoz-Zanzi, C				Zhang, Anthony Zhenhuan; Negoescu, Diana; Munoz-Zanzi, Claudia			When and what to test for: A cost-effectiveness analysis of febrile illness test-and-treat strategies in the era of responsible antibiotic use	PLOS ONE			English	Article							LEPTOSPIROSIS; DIAGNOSIS; RESISTANCE; BURDEN	Background Febrile illness caused by viral and bacterial diseases (e.g., dengue and leptospirosis) often have similar symptoms and are difficult to differentiate without diagnostic tests. If not treated appropriately, patients may experience serious complications. The question of what diagnostic tests to make available to providers in order to inform antibiotic therapy remains an open problem for health services facing limited resources. Methods and findings We formulated the problem of minimizing the weighted average of antibiotic underuse and overuse to inform the optimal diagnostic test and antibiotic treatment options for given occurrence probabilities of several bacterial and viral infections. We modeled the weight of antibiotic overuse as a monetary penalty per unnecessarily administered course, which we varied in both the base case and sensitivity analysis. Detailed Markov cohort models of febrile illness progression were used to estimate the weight of antibiotic underuse. The model accounted for multiple infections simultaneously and incorporated test, treatment, and other direct and indirect costs, as well as the effect of delays in seeking care and test turnaround times. We used the Markov models to numerically estimate disability-adjusted life years (DALYs), pre-penalty costs, and likelihood of antibiotics overuse per patient for fifteen different strategies in two example settings in Thailand, one with a higher probability of bacterial infections (Northern Thailand, Scenario A) and one with a higher probability of viral infections (Bangkok, Scenario B). We found that empirical antibiotic treatment to all patients always incurs the lowest pre-penalty cost (Scenario A: $47.5/patient, $100.6/patient, $149.5/patient for patients seeking care on day one, day four, and day ten respectively; Scenario B: $94.1/patient, $108.7/patient, $122.1/patient on day one, day four, and day ten respectively), and the lowest DALYs, (Scenario A: 0.2 DALYs/patient, 0.9 DALYs/patient, 1.7 DALYs/patient on day one, day four, and day ten, respectively; Scenario B: 0.5 DALYs/patient, 0.7 DALYs/patient, 0.9 DALYs/patient on day one, day four, and day ten, respectively). However, such strategy resulted in the highest proportion of antibiotic overuse per patient (Scenario A: 38.1%, 19.3%, 7.5% on day one, day four, and day ten, respectively; Scenario B: 82.9%, 42.1%, 16.3% on day one, day four, and day ten, respectively). Consequently, empirical antibiotic treatment became suboptimal with antibiotic overuse penalties above $12,800/course, $18,400/course, $23,900/course for patients presenting on day one, day four, and day ten in Scenario A and above $1,100/course, $1,500/course, $1,600/course for patients presenting on day one, day four, and day ten in Scenario B. Conclusions Empirical antibiotic treatment to all patients provided the best outcomes if antibiotic overuse was not the primary concern or if presenting with viral disease (such as dengue) was unlikely. Empirical antibiotic treatment to severe patients only was in most cases not beneficial. Otherwise, strategies involving diagnostic tests became optimal. In particular, our results indicated that single test strategies (bacterial RDT or viral PCR) were optimal in regions with a greater probability of presenting with viral infection. PCR-led strategies (e.g., parallel bacterial PCR, or multiplex PCR) are robust under parameter uncertainty (e.g., with uncertain disease occurrence probabilities).	[Zhang, Anthony Zhenhuan; Negoescu, Diana] Univ Minnesota, Coll Sci & Engn Ind & Syst Engn, Minneapolis, MN 55455 USA; [Munoz-Zanzi, Claudia] Univ Minnesota, Div Environm Hlth Sci, Sch Publ Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, AZ (corresponding author), Univ Minnesota, Coll Sci & Engn Ind & Syst Engn, Minneapolis, MN 55455 USA.; Munoz-Zanzi, C (corresponding author), Univ Minnesota, Div Environm Hlth Sci, Sch Publ Hlth, Minneapolis, MN 55455 USA.	zhan4490@umn.edu; munozzan@umn.edu		Munoz-Zanzi, Claudia/0000-0001-9317-7152				Ahmed NH, 2014, J VECTOR DIS, V51, P194; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W; Centers for Disease Control and Prevention, 2019, ANT RES GLOB THREAT; Christou L, 2011, CLIN MICROBIOL INFEC, V17, P326, DOI 10.1111/j.1469-0691.2010.03441.x; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Crump J, 2017, FEBRILE ILLNESS ADOL, V4; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; Dupouey J, 2014, COMP IMMUNOL MICROB, V37, P77, DOI 10.1016/j.cimid.2013.12.002; Durski KN, 2014, INT J ENV RES PUB HE, V11, P6000, DOI 10.3390/ijerph110606000; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1019-1; Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290; Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003575; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Lubell Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152420; Luvira V, 2019, AM J TROP MED HYG, V100, P622, DOI 10.4269/ajtmh.18-0407; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Riediger IN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005940; Robinson ML, 2017, AM J TROP MED HYG, V96, P1285, DOI 10.4269/ajtmh.16-0667; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Shallcross LJ, 2014, BRIT J GEN PRACT, V64, P604, DOI 10.3399/bjgp14X682561; Silpasakorn Saowaluk, 2012, J Med Assoc Thai, V95 Suppl 2, pS18; Suputtamongkol Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000610; Suttinont C, 2006, ANN TROP MED PARASIT, V100, P363, DOI 10.1179/136485906X112158; Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122; Ventola C Lee, 2015, P T, V40, P277; Waggoner JJ, 2014, J CLIN MICROBIOL, V52, P2011, DOI 10.1128/JCM.00341-14; Wangrangsimakul T, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006477; World Health Organization, 2014, DENG SEV DENG WORLD; World Health Organization, DRUG RES 2019; Worldbank, 2019, THAIL GDP PER CAP 20	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227409	10.1371/journal.pone.0227409	http://dx.doi.org/10.1371/journal.pone.0227409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914143	Green Published, gold			2022-12-26	WOS:000534337700039
J	Arauco-Shapiro, G; Schumacher, KI; Boersma, D; Bouzat, JL				Arauco-Shapiro, Gabriella; Schumacher, Katelyn I.; Boersma, Dee; Bouzat, Juan L.			The role of demographic history and selection in shaping genetic diversity of the Galapagos penguin (Spheniscus mendiculus)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II LOCI; INBREEDING DEPRESSION; BALANCING SELECTION; POPULATION-SIZE; MHC DIVERSITY; MAGELLANIC PENGUIN; EL-NINO; NUCLEOTIDE SUBSTITUTION; CONSERVATION GENETICS	Although many studies have documented the effects of demographic bottlenecks on the genetic diversity of natural populations, there is conflicting evidence of the roles that genetic drift and selection may play in driving changes in genetic variation at adaptive loci. We analyzed genetic variation at microsatellite and mitochondrial loci in conjunction with an adaptive MHC class II locus in the Galapagos penguin (Spheniscus mendiculus), a species that has undergone serial demographic bottlenecks associated with El Nino events through its evolutionary history. We compared levels of variation in the Galapagos penguin to those of its congener, the Magellanic penguin (Spheniscus magellanicus), which has consistently maintained a large population size and thus was used as a non-bottlenecked control. The comparison of neutral and adaptive markers in these two demographically distinct species allowed assessment of the potential role of balancing selection in maintaining levels of MHC variation during bottleneck events. Our analysis suggests that the lack of genetic diversity at both neutral and adaptive loci in the Galapagos penguin likely resulted from its restricted range, relatively low abundance, and history of demographic bottlenecks. The Galapagos penguin revealed two MHC alleles, one mitochondrial haplotype, and six alleles across five microsatellite loci, which represents only a small fraction of the diversity detected in Magellanic penguins. Despite the decreased genetic diversity in the Galapagos penguin, results revealed signals of balancing selection at the MHC, which suggest that selection can mitigate some of the effects of genetic drift during bottleneck events. Although Galapagos penguin populations have persisted for a long time, increased frequency of El Nino events due to global climate change, as well as the low diversity exhibited at immunological loci, may put this species at further risk of extinction.	[Arauco-Shapiro, Gabriella; Schumacher, Katelyn I.; Bouzat, Juan L.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Boersma, Dee] Univ Washington, Ctr Ecosyst Sentinels, Seattle, WA 98195 USA; [Boersma, Dee] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Arauco-Shapiro, Gabriella] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University System of Ohio; Bowling Green State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania	Bouzat, JL (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	jbouzat@bgsu.edu			Bowling Green State University	Bowling Green State University	This study was performed with funds from Bowling Green State University assigned to JLB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCOLLA RS, 1995, IMMUNOL TODAY, V16, P8, DOI 10.1016/0167-5699(95)80063-8; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Akst EP, 2002, CONSERV GENET, V3, P375, DOI 10.1023/A:1020555303124; Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Babik W, 2008, MOL ECOL, V17, P2339, DOI 10.1111/j.1365-294X.2008.03757.x; Boersma PD, 2017, WILSON J ORNITHOL, V129, P186, DOI 10.1676/1559-4491-129.1.186; Boersma PD, 1998, CONDOR, V100, P245, DOI 10.2307/1370265; Boersma PD, 1976, LIVING BIRD, V15, P43; Bollmer JL, 2007, IMMUNOGENETICS, V59, P593, DOI 10.1007/s00251-007-0221-y; Bollmer JL, 2010, J HERED, V101, P448, DOI 10.1093/jhered/esq018; Bos DH, 2008, EVOLUTION, V62, P1458, DOI 10.1111/j.1558-5646.2008.00364.x; Bouzat JL, 1998, AM NAT, V152, P1, DOI 10.1086/286145; Bouzat JL, 2013, 8 INT PENG C SEP 2 6; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Bouzat JL, 2009, AUK, V126, P326, DOI 10.1525/auk.2009.07122; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Davies CJ, 1997, ANIM GENET, V28, P159, DOI 10.1111/j.1365-2052.1997.00106.x; Boersma PD, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P233; DEEBOERSMA P, 1978, SCIENCE, V200, P1481, DOI 10.1126/science.200.4349.1481; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Doherty P C, 1975, Nature, V256, P50; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Ejsmond MJ, 2011, CONSERV GENET, V12, P129, DOI 10.1007/s10592-009-9998-6; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FRANK R, 2002, SPRING LAB MAN, P1; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R, 2001, CONSERV GENET, V2, P279, DOI 10.1023/A:1012299230482; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Frere E., 1998, ATLAS DISTRIBUCION R, P153; Gandini P., 1996, Bird Conservation International, V6, P307; Garrigan D, 2003, EVOLUTION, V57, P1707; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; HEDRICK PW, 1983, GENETICS, V104, P449; Hedrick PW, 2002, MOL ECOL, V11, P1905, DOI 10.1046/j.1365-294X.2002.01579.x; Hedrick PW, 2000, EVOLUTION, V54, P2145; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; Hedrick PW, 2001, MOL ECOL, V10, P851, DOI 10.1046/j.1365-294X.2001.01243.x; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Vargas FH, 2007, BIOL CONSERV, V137, P138, DOI 10.1016/j.biocon.2007.02.005; HILL AVS, 1991, MOL EVOLUTION MAJOR, P403, DOI DOI 10.1007/978-3-642-84622-9_33; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennedy LJ, 1999, TISSUE ANTIGENS, V54, P312, DOI 10.1034/j.1399-0039.1999.540319.x; Kikkawa EF, 2005, IMMUNOGENETICS, V57, P99, DOI 10.1007/s00251-005-0774-6; Kikkawa EF, 2009, IMMUNOGENETICS, V61, P341, DOI 10.1007/s00251-009-0363-1; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kimura M., 1983, NEUTRAL THEORY MOL E; Knafler GJ, 2012, J HERED, V103, P759, DOI 10.1093/jhered/ess054; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Levin II, 2009, BIOL CONSERV, V142, P3191, DOI 10.1016/j.biocon.2009.06.017; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Marsh S. G. E., 2001, Tissue Antigens, V57, P236; MARUYAMA T, 1985, GENETICS, V111, P675; MARUYAMA T, 1981, GENETICS, V98, P441; Dantas GPM, 2018, J ORNITHOL, V159, P643, DOI 10.1007/s10336-018-1538-z; Miller HC, 2008, ANIM CONSERV, V11, P206, DOI 10.1111/j.1469-1795.2008.00168.x; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Mona S, 2008, MOL ECOL, V17, P4053, DOI 10.1111/j.1365-294X.2008.03892.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nims BD, 2008, CONSERV GENET, V9, P1413, DOI 10.1007/s10592-007-9465-1; O'Brien SJ, 2017, J HERED, V108, P671, DOI 10.1093/jhered/esx047; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O; Pozzi LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119002; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Radwan J, 2003, HEREDITY, V90, P371, DOI 10.1038/sj.hdy.6800254; Radwan J, 2007, MOL ECOL, V16, P531, DOI 10.1111/j.1365-294X.2006.03179.x; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rebstock GA, 2016, POPUL ECOL, V58, P105, DOI 10.1007/s10144-015-0523-0; Reed DH, 2010, ANIM CONSERV, V13, P448, DOI 10.1111/j.1469-1795.2010.00353.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; Schuster AC, 2016, IMMUNOGENETICS, V68, P429, DOI 10.1007/s00251-016-0916-z; Seddon JM, 1999, MOL ECOL, V8, P2071, DOI 10.1046/j.1365-294x.1999.00822.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SIMONSEN KL, 1995, GENETICS, V141, P413; SLADE RW, 1992, P ROY SOC B-BIOL SCI, V249, P163, DOI 10.1098/rspb.1992.0099; SLADE RW, 1992, GENETICS, V132, P861; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; SLATKIN M, 1995, GENETICS, V139, P457; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stokes DL, 2014, BIOL CONSERV, V170, P151, DOI 10.1016/j.biocon.2013.12.024; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Swindell WR, 2006, EVOLUTION, V60, P762, DOI 10.1111/j.0014-3820.2006.tb01154.x; TAJIMA F, 1989, GENETICS, V123, P585; VALLE CA, 1987, CONDOR, V89, P276, DOI 10.2307/1368480; Valle CA, 1986, NOTICIAS GALAPAGOS, V43, P16; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Vargas H, 2005, IBIS, V147, P367, DOI 10.1111/j.1474-919x.2005.00412.x; VRIJENHOEK RC, 1994, EXS, V68, P37; WATTERSON GA, 1978, GENETICS, V88, P405; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhai T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05640-2	117	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226439	10.1371/journal.pone.0226439	http://dx.doi.org/10.1371/journal.pone.0226439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910443	Green Published, gold			2022-12-26	WOS:000534333800011
J	Liang, S; Fuchs, S; Mymrikov, EV; Stulz, A; Kaiser, M; Heerklotz, H; Hunte, C				Liang, Shuo; Fuchs, Simon; Mymrikov, Evgeny V.; Stulz, Anja; Kaiser, Michael; Heerklotz, Heiko; Hunte, Carola			Calcium affects CHP1 and CHP2 conformation and their interaction with sodium/proton exchanger 1	FASEB JOURNAL			English	Article						calcineurin B homologous proteins; Ca2+ signaling; EF-hand Ca2+-binding proteins; NHE1; protein-protein interaction	CALCINEURIN HOMOLOGOUS PROTEIN; CA2+-BINDING PROTEIN; NA+/H+ EXCHANGER; CYTOPLASMIC REGION; ESSENTIAL COFACTOR; BINDING; MEMBRANE; P22; ORGANIZATION; CALMODULIN	Calcineurin B homologous proteins (CHPs) belong to the EF-hand Ca2+-binding protein (EFCaBP) family. They have multiple important functions including the regulation of the Na+/H+ exchanger 1 (NHE1). The human isoforms CHP1 and CHP2 share high sequence similarity, but have distinct expression profiles with CHP2 levels for instance increased in malignant cells. These CHPs bind Ca2+ with high affinity. Biochemical data indicated that Ca2+ can regulate their functions. Experimental evidence for Ca2+-modulated structural changes was lacking. With a newly established fluorescent probe hydrophobicity (FPH) assay, we detected Ca2+-induced conformational changes in both CHPs. These changes are in line with an opening of their hydrophobic pocket that binds the CHP-binding region (CBD) of NHE1. Whereas the pocket is closed in the absence of Ca2+ in CHP2, it is still accessible for the dye in CHP1. Both CHPs interacted with CBD in the presence and absence of Ca2+. Isothermal titration calorimetry (ITC) analysis revealed high binding affinity for both CHPs to CBD with equilibrium dissociation constants (K(D)s) in the nanomolar range. The K-D for CHP1:CBD was not affected by Ca2+, whereas Ca2+-depletion increased the K-D 7-fold for CHP2:CBD showing a decreased affinity. The data indicate an isoform specific regulatory interaction of CHP1 and CHP2 with NHE1.	[Liang, Shuo; Fuchs, Simon; Mymrikov, Evgeny V.; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Fac Med, Freiburg, Germany; [Liang, Shuo; Fuchs, Simon] Univ Freiburg, Fac Biol, Freiburg, Germany; [Mymrikov, Evgeny V.; Heerklotz, Heiko; Hunte, Carola] Univ Freiburg, CIBSS, Freiburg, Germany; [Stulz, Anja; Kaiser, Michael; Heerklotz, Heiko] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Freiburg, Germany; [Heerklotz, Heiko] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Heerklotz, Heiko; Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Toronto; University of Freiburg	Hunte, C (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, ZBMZ,CIBSS, Stefan Meier Str 17, D-79104 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de		Heerklotz, Heiko/0000-0003-4615-7022; Hunte, Carola/0000-0002-0826-3986; Mymrikov, Evgeny/0000-0003-4817-6278	Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Initiative [SFB 746, 403222702/SFB 1381, 278002225/RTG 2202, BIOSS - EXC294]; Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Strategy [CIBSS - EXC-2189, 390939984]	Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Initiative(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Strategy(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB 746, Project-ID 403222702/SFB 1381, Project-ID 278002225/RTG 2202, under Germanys Excellence Initiative, BIOSS - EXC294 and under Germanys Excellence Strategy,CIBSS - EXC-2189 - Project-ID 390939984	Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Battey N H, 1992, Methods Mol Biol, V11, P73, DOI 10.1385/0-89603-213-2:73; Ben Ammar Y, 2005, ACTA CRYSTALLOGR F, V61, P956, DOI [10.1107/S1744309105030836, 10.1107/s1744309105030836]; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cornish-Bowden A, 2002, J BIOSCIENCES, V27, P121, DOI 10.1007/BF02703768; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Elbers D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00355; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Fuchs S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33096-5; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; GILL SJ, 1976, P NATL ACAD SCI USA, V73, P2955, DOI 10.1073/pnas.73.9.2955; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Guissart C, 2015, HUM MOL GENET, V24, P463, DOI 10.1093/hmg/ddu461; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Iwama K, 2018, J HUM GENET, V63, P1049, DOI 10.1038/s10038-018-0488-x; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kroeger T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177024; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Li GD, 2008, J BIOL CHEM, V283, P32660, DOI 10.1074/jbc.M806684200; Li QH, 2011, GENES CELLS, V16, P416, DOI 10.1111/j.1365-2443.2011.01497.x; Liu Y, 2013, J NEUROSCI, V33, P12656, DOI 10.1523/JNEUROSCI.0406-13.2013; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mendoza-Ferreira N, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000209; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; ROCHETTEEGLY C, 1984, ELECTROPHORESIS, V5, P285, DOI 10.1002/elps.1150050508; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017	46	1	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3253	3266		10.1096/fj.201902093R	http://dx.doi.org/10.1096/fj.201902093R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912575	hybrid			2022-12-26	WOS:000506147000001
J	Qin, JL; Doyle, MT; Tran, ENH; Morona, R				Qin, Jilong; Doyle, Matthew Thomas; Tran, Elizabeth Ngoc Hoa; Morona, Renato			The virulence domain of Shigella IcsA contains a subregion with specific host cell adhesion function	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; N-WASP; FLEXNERI; SECRETION; MECHANISM; REVEALS	Shigella species cause bacillary dysentery, especially among young individuals. Shigellae target the human colon for invasion; however, the initial adhesion mechanism is poorly understood. The Shigella surface protein IcsA, in addition to its role in actin-based motility, acts as a host cell adhesin through unknown mechanism(s). Here we confirmed the role of IcsA in cell adhesion and defined the region required for IcsA adhesin activity. Purified IcsA passenger domain was able block S. flexneri adherence and was also used as a molecular probe that recognised multiple components from host cells. The region within IcsA's functional passenger domain (aa 138-148) was identified by mutagenesis. Upon the deletion of this region, the purified IcsA(Delta 138-148) was found to no longer block S. flexneri adherence and had reduced ability to interact with host molecules. Furthermore, S. flexneri expressing IcsA(Delta 138-148) was found to be significantly defective in both cell adherence and invasion. Taken together, our data identify an adherence region within the IcsA functional domain and provides useful information for designing therapeutics for Shigella infection.	[Qin, Jilong; Doyle, Matthew Thomas; Tran, Elizabeth Ngoc Hoa; Morona, Renato] Univ Adelaide, Sch Biol Sci, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Doyle, Matthew Thomas] NIH, Bldg 10, Bethesda, MD 20892 USA	University of Adelaide; National Institutes of Health (NIH) - USA	Morona, R (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Doyle, Matthew Thomas/K-2609-2015; Qin, Jilong/L-5800-2016	Doyle, Matthew Thomas/0000-0002-1876-1209; Tran, Elizabeth Ngoc Hoa/0000-0003-1644-2287; Qin, Jilong/0000-0002-5867-6332	University of Adelaide	University of Adelaide	Jilong Qin received a Faculty of Science Postgraduate Scholarship from the University of Adelaide. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerighi F, 2016, J INFECT DIS, V213, P516, DOI 10.1093/infdis/jiv461; ANAND BS, 1986, GASTROENTEROLOGY, V90, P654, DOI 10.1016/0016-5085(86)91120-0; Arena ET, 2015, P NATL ACAD SCI USA, V112, pE3282, DOI 10.1073/pnas.1509091112; Brotcke Zumsteg Anna, 2014, Cell Host Microbe, V15, P435, DOI 10.1016/j.chom.2014.03.001; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doyle MT, 2015, MICROBIOL-SGM, V161, P2087, DOI 10.1099/mic.0.000165; Doyle MT, 2015, MOL MICROBIOL, V97, P315, DOI 10.1111/mmi.13027; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; GOLDBERG MB, 1993, INFECT AGENT DIS, V2, P210; GOOD RC, 1969, J BACTERIOL, V97, P1048, DOI 10.1128/JB.97.3.1048-1055.1969; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Koseoglu VK, 2019, MBIO, V10, DOI 10.1128/mBio.01520-19; Koseoglu VK, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00861-18; Kotloff KL, 2018, LANCET, V391, P801, DOI 10.1016/S0140-6736(17)33296-8; Kozyreva VK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00344-16; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; Laarmann S, 2003, MICROBIOL-SGM, V149, P1871, DOI 10.1099/mic.0.26264-0; Leupold S, 2017, J STRUCT BIOL, V198, P19, DOI 10.1016/j.jsb.2017.03.003; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Magdalena J, 2002, CELL MOTIL CYTOSKEL, V51, P187, DOI 10.1002/cm.10024; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; May KL, 2012, MICROBIOL-SGM, V158, P1874, DOI 10.1099/mic.0.056465-0; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Perez-Zsolt D, 2019, NAT MICROBIOL, V4, P1558, DOI 10.1038/s41564-019-0453-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POPE LM, 1995, INFECT IMMUN, V63, P3642, DOI 10.1128/IAI.63.9.3642-3648.1995; Ranganathan S, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00740-18; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; SPEELMAN P, 1984, J INFECT DIS, V150, P899, DOI 10.1093/infdis/150.6.899; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 1998, JPN J MED SCI BIOL, V51, pS63, DOI 10.7883/yoken1952.51.Supplement1_S63; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Teh MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055152; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Zhao WD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04637-3	45	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227425	10.1371/journal.pone.0227425	http://dx.doi.org/10.1371/journal.pone.0227425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910229	Green Published, gold			2022-12-26	WOS:000534333800051
J	van Batenburg, AA; Kazemier, KM; van Oosterhout, MFM; van der Vis, JJ; van Es, HW; Grutters, JC; Goldschmeding, R; van Moorsel, CHM				van Batenburg, Aernoud A.; Kazemier, Karin M.; van Oosterhout, Matthijs F. M.; van der Vis, Joanne J.; van Es, Hendrik W.; Grutters, Jan C.; Goldschmeding, Roel; van Moorsel, Coline H. M.			From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis	PLOS ONE			English	Article							GENETIC-VARIATION; RISK-FACTOR; MUTATIONS; SENESCENCE; TISSUES; GUIDELINES	Rationale A subset of patients with idiopathic pulmonary fibrosis (IPF) contains short leukocyte telomeres or telomere related mutations. We previously showed that alveolar type 2 cells have short telomeres in fibrotic lesions. Our objectives were to better understand how telomere shortening associates with fibrosis in IPF lung and identify a subset of patients with telomere-related disease. Methods Average telomere length was determined in multiple organs, basal and apical lung, and diagnostic and end-stage fibrotic lung biopsies. Alveolar type 2 cells telomere length was determined in different areas of IPF lungs. Results In IPF but not in controls, telomere length in lung was shorter than in other organs, providing rationale to focus on telomere length in lung. Telomere length did not correlate with age and no difference in telomere length was found between diagnostic and explant lung or between basal and apical lung, irrespective of the presence of a radiological apicobasal gradient or fibrosis. Fifteen out of 28 IPF patients had average lung telomere length in the range of patients with a telomerase (TERT) mutation, and formed the IPFshort group. Only in this IPFshort and TERT group telomeres of alveolar type 2 cells were extremely short in fibrotic areas. Additionally, whole exome sequencing of IPF patients revealed two genetic variations in RTEL1 and one in PARN in the IPFshort group. Conclusions Average lung tissue telomere shortening does not associated with fibrotic patterns in IPF, however, approximately half of IPF patients show excessive lung telomere shortening that is associated with pulmonary fibrosis driven by telomere attrition.	[van Batenburg, Aernoud A.; van der Vis, Joanne J.; Grutters, Jan C.; van Moorsel, Coline H. M.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands; [Kazemier, Karin M.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Kazemier, Karin M.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [van Oosterhout, Matthijs F. M.] St Antonius Hosp, St Antonius ILD Ctr, Dept Pathol, Pathol DNA, Nieuwegein, Netherlands; [van der Vis, Joanne J.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Clin Chem, Nieuwegein, Netherlands; [van Es, Hendrik W.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Radiol, Nieuwegein, Netherlands; [Grutters, Jan C.; van Moorsel, Coline H. M.] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Moorsel, CHM (corresponding author), St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands.; van Moorsel, CHM (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands.	c.van.moorsel@antoniusziekenhuis.nl			ZonMW-TopZorg St Antonius Science Corner grant [842002003]; St Antonius Research fund	ZonMW-TopZorg St Antonius Science Corner grant; St Antonius Research fund	This research was enabled by ZonMW-TopZorg St Antonius Science Corner grant (grant number 842002003; www.zonmw.nl; JCG CHMvM JJvdV AAvB) and St Antonius Research fund (CHMvM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2018, P NATL ACAD SCI USA, V115, pE2358, DOI 10.1073/pnas.1720427115; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Alder JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001352; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Borie R, 2016, EUR RESPIR J, V48, P1721, DOI 10.1183/13993003.02115-2015; Carulli L, 2015, WORLD J GASTROENTERO, V21, P379, DOI 10.3748/wjg.v21.i2.379; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cha SI, 2010, AM J RESP CELL MOL, V42, P140, DOI 10.1165/rcmb.2008-0419OC; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Citrin DE, 2013, JNCI-J NATL CANCER I, V105, P1474, DOI 10.1093/jnci/djt212; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; Everaerts S, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0794-z; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Granick Mark, 2011, Eplasty, V11, pe15; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hoffman TW, 2018, CURR OPIN PULM MED, V24, P269, DOI 10.1097/MCP.0000000000000475; Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016; Martinez Fernando J, 2006, Proc Am Thorac Soc, V3, P315, DOI 10.1513/pats.200602-022TK; Naikawadi RP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86704; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Petrovski S, 2017, AM J RESP CRIT CARE, V196, P82, DOI [10.1164/rccm.201610-2088OC, 10.1164/rccm.201610-2088oc]; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Snetselaar R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189467; Snetselaar R, 2015, CHEST, V148, P1011, DOI 10.1378/chest.14-3078; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; van Batenburg AA, 2018, J HISTOCHEM CYTOCHEM; Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027	40	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226785	10.1371/journal.pone.0226785	http://dx.doi.org/10.1371/journal.pone.0226785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910222	gold, Green Published			2022-12-26	WOS:000534333800016
J	Kim, GD; Ng, HP; Chan, ER; Mahabeleshwar, GH				Kim, Gun-Dong; Ng, Hang Pong; Chan, E. Ricky; Mahabeleshwar, Ganapati H.			Kruppel-like factor 6 promotes macrophage inflammatory and hypoxia response	FASEB JOURNAL			English	Article						glycolysis; inflammation; KLF6; macrophage; metabolism	TRANSCRIPTIONAL REGULATION; CANDIDA-ALBICANS; LIPOPOLYSACCHARIDE; RECOGNITION; HIF-1-ALPHA; LEUKOCYTES	Macrophages are the professional phagocytes that protect the host from infection or injury. Tissue microenvironment at the site of injury and inflammation is characterized by low oxygen concentration and poor supply of nutrients. The responding macrophages have to advance against oxygen and nutrient gradients to reach the site of inflammation to perform host protection, and tissue repair functions. Thus, evolution has fashioned macrophages to orchestrate a coordinated inflammatory and hypoxic gene program to mount an effective immune response. Here, we discovered that Kruppel-like factor 6 (KLF6) governs macrophage functions by promoting inflammatory and hypoxic response gene programming. Our in vivo studies revealed that myeloid-KLF6-deficient mice were highly resistant to endotoxin-induced systemic inflammatory response syndrome symptomatology and mortality. Using complementary gain- and loss-of-function studies, we observed that KLF6 overexpression elevate and KLF6 deficiency attenuate inducible HIF1 alpha expression in macrophages. Our integrated transcriptomics and gene set enrichment analysis studies uncovered that KLF6 deficiency attenuates broad inflammatory and glycolytic gene expression in macrophages. More importantly, overexpression of oxygen stable HIF1 alpha reversed attenuated proinflammatory and glycolytic gene expression in KLF6-deficient macrophages. Collectively, our studies uncovered that KLF6 govern inflammatory and hypoxic response by regulating HIF1 alpha expression in macrophage.	[Kim, Gun-Dong; Ng, Hang Pong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Sch Med, Cleveland Inst Computat Biol, Cleveland, OH USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu		Chan, Ernest/0000-0001-9277-5329	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL141423, HL126626]; Crohn's and Colitis Foundation of America (CCFA) [421904]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Crohn's and Colitis Foundation of America (CCFA)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126626; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL141423; Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904	Backer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190074; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bartels K, 2013, P NATL ACAD SCI USA, V110, P18351, DOI 10.1073/pnas.1318345110; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Das A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00022; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7; Kim GD, 2019, FASEB J, V33, P10902, DOI 10.1096/fj.201900867RR; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Levene PA, 1912, J BIOL CHEM, V11, P361; Levene PA, 1912, J BIOL CHEM, V12, P265; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syafruddin SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09116-x; Takikawa A, 2016, DIABETES, V65, P3649, DOI 10.2337/db16-0012; Weber U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096933; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zheng NX, 2015, VIRULENCE, V6, P347, DOI 10.1080/21505594.2015.1014270	33	15	17	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3209	3223		10.1096/fj.201902221R	http://dx.doi.org/10.1096/fj.201902221R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908054	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000505939400001
J	Northeast, RC; Chrobok, L; Hughes, ATL; Petit, C; Piggins, HD				Northeast, Rebecca C.; Chrobok, Lukasz; Hughes, Alun T. L.; Petit, Cheryl; Piggins, Hugh D.			Keeping time in the lamina terminalis: Novel oscillator properties of forebrain sensory circumventricular organs	FASEB JOURNAL			English	Article						circadian; circumventricular organ; fluid balance; OVLT; SFO; suprachiasmatic	SUBFORNICAL ORGAN; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; SODIUM APPETITE; MOUSE; CLOCK; BRAIN; EXPRESSION; BEHAVIOR; THIRST	Drinking behavior and osmotic regulatory mechanisms exhibit clear daily variation which is necessary for achieving the homeostatic osmolality. In mammals, the master clock in the brain's suprachiasmatic nuclei has long been held as the main driver of circadian (24 h) rhythms in physiology and behavior. However, rhythmic clock gene expression in other brain sites raises the possibility of local circadian control of neural activity and function. The subfornical organ (SFO) and the organum vasculosum laminae terminalis (OVLT) are two sensory circumventricular organs (sCVOs) that play key roles in the central control of thirst and water homeostasis, but the extent to which they are subject to intrinsic circadian control remains undefined. Using a combination of ex vivo bioluminescence and in vivo gene expression, we report for the first time that the SFO contains an unexpectedly robust autonomous clock with unusual spatiotemporal characteristics in core and noncore clock gene expression. Furthermore, putative single-cell oscillators in the SFO and OVLT are strongly rhythmic and require action potential-dependent communication to maintain synchrony. Our results reveal that these thirst-controlling sCVOs possess intrinsic circadian timekeeping properties and raise the possibility that these contribute to daily regulation of drinking behavior.	[Northeast, Rebecca C.; Chrobok, Lukasz; Hughes, Alun T. L.; Petit, Cheryl; Piggins, Hugh D.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Piggins, Hugh D.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Chrobok, Lukasz] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland; [Hughes, Alun T. L.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England	University of Manchester; University of Bristol; Jagiellonian University; Liverpool John Moores University	Piggins, HD (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	hugh.piggins@bristol.ac.uk	Hughes, Alun/HCI-2220-2022	Hughes, Alun/0000-0001-7460-3216	Biotechnology and Biological Sciences Research Council [BB/M02329X, BB/090223]; Medical Research Council; University of Manchester; BBSRC [BB/R019223/1, BB/M02329X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/M02329X and BB/090223; Medical Research Council; University of Manchester	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Brancaccio M, 2019, SCIENCE, V363, P187, DOI 10.1126/science.aat4104; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Cottrell GT, 2004, J NEUROSCI, V24, P2375, DOI 10.1523/JNEUROSCI.5187-03.2004; Ferguson AV, 2013, NEUROBIOLOGY BODY FL, P1; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gizowski C, 2016, NATURE, V537, P685, DOI 10.1038/nature19756; Gizowski C, 2018, NAT REV NEPHROL, V14, P11, DOI 10.1038/nrneph.2017.149; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Landgraf D, 2016, EUR J NEUROSCI, V43, P1309, DOI 10.1111/ejn.13085; Langlet F, 2013, J COMP NEUROL, V521, P3389, DOI 10.1002/cne.23355; Lima HRC, 2004, AN ACAD BRAS CIENC, V76, P85, DOI 10.1590/S0001-37652004000100008; Lucas RJ, 2012, PROG BRAIN RES, V199, P1, DOI 10.1016/B978-0-444-59427-3.00001-0; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Miller JEK, 2014, J NEUROSCI, V34, P6040, DOI 10.1523/JNEUROSCI.4713-13.2014; MISELIS RR, 1981, BRAIN RES, V230, P1, DOI 10.1016/0006-8993(81)90388-7; MISELIS RR, 1979, SCIENCE, V205, P1022, DOI 10.1126/science.472723; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Myung J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03507-2; Nishinaga H, 2009, BIOMED RES-TOKYO, V30, P87, DOI 10.2220/biomedres.30.87; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Paul JR, 2019, EUR J NEUROSCI; Pavlovski I, 2018, NEUROSCIENCE, V393, P175, DOI 10.1016/j.neuroscience.2018.10.009; Pocsai K, 2015, J HISTOCHEM CYTOCHEM, V63, P367, DOI 10.1369/0022155415575027; RAMSAY DJ, 1983, PROG BRAIN RES, V60, P91; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riddle M, 2017, EUR J NEUROSCI, V45, P1357, DOI 10.1111/ejn.13441; ROUAHROSILIO M, 1994, PHYSIOL BEHAV, V55, P811, DOI 10.1016/0031-9384(94)90064-7; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P5025, DOI 10.1113/jphysiol.2014.280065; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P587, DOI 10.1113/jphysiol.2013.263319; Shan ZL, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4641; Smith PM, 1997, NEUROENDOCRINOLOGY, V66, P130, DOI 10.1159/000127230; SPITERI NJ, 1982, PHYSIOL BEHAV, V28, P139, DOI 10.1016/0031-9384(82)90115-9; Sujino M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19224-1; SWANSON LW, 1986, BRAIN RES, V379, P399, DOI 10.1016/0006-8993(86)90799-7; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tao WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15212; Timothy JWS, 2018, BIOL PSYCHIAT, V84, P827, DOI 10.1016/j.biopsych.2017.04.018; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Washburn DLS, 1999, NEUROSCIENCE, V93, P349, DOI 10.1016/S0306-4522(99)00125-6; Webb AB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002787; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Wegner S, 2017, J NEUROSCI, V37, P7824, DOI 10.1523/JNEUROSCI.0691-17.2017; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zimmerman CA, 2017, NAT REV NEUROSCI, V18, P459, DOI 10.1038/nrn.2017.71; Zimmerman CA, 2016, NATURE, V537, P680, DOI 10.1038/nature18950	62	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					974	987		10.1096/fj.201901111R	http://dx.doi.org/10.1096/fj.201901111R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914667	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000507308900066
J	Rapa, SF; Waltenberger, B; Di Paola, R; Adesso, S; Siracusa, R; Peritore, AF; D'Amico, R; Autore, G; Cuzzocrea, S; Stuppner, H; Marzocco, S				Rapa, Shara F.; Waltenberger, Birgit; Di Paola, Rosanna; Adesso, Simona; Siracusa, Rosalba; Peritore, Alessio F.; D'Amico, Ramona; Autore, Giuseppina; Cuzzocrea, Salvatore; Stuppner, Hermann; Marzocco, Stefania			Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo	FASEB JOURNAL			English	Article						plumericin; intestinal epithelial cells; DNBS-induced colitis; inflammation; oxidative stress	BOWEL-DISEASE; EPITHELIAL-CELLS; PATHOGENESIS; ACTIVATION; MANAGEMENT; FUMARATE; THERAPY; COLITIS; SULFATE	Inflammatory bowel diseases (IBDs) are characterized by an inflammatory and oxidative stress condition in the intestinal tissue. In this study, we evaluated the effect of plumericin, one of the main bioactive components of Himatanthus sucuuba (Woodson) bark, on intestinal inflammation and oxidative stress, both in vitro and in vivo. The effect of plumericin (0.5-2 mu M) in vitro was evaluated in rat intestinal epithelial cells (IEC-6) treated with lipopolysaccharides from E. coli (10 mu g/mL) plus interferon-gamma (10 U/mL). Moreover, a 2,4,6-dinitrobenzene sulfonic acid (DNBS)-induced colitis model was used to evaluate the anti-inflammatory and antioxidant activity of plumericin (3 mg/kg) in vivo. The results showed that plumericin significantly reduces intestinal inflammatory factors such as tumor necrosis factor-alpha, cyclooxygenase-2 and inducible nitric oxide synthase expression, and nitrotyrosine formation. Plumericin also inhibited nuclear factor-kappa B translocation, reactive oxygen species (ROS) release, and inflammasome activation. Moreover, plumericin activated the nuclear factor erythroid-derived 2 pathway in IEC-6. Using the DNBS-induced colitis model, a significant reduction in the weight loss and in the development of the macroscopic and histologic signs of colon injury, together with a reduced inflammatory and oxidative stress state, were observed in plumericin-treated mice. These results indicate that plumericin exerts a strong anti-inflammatory and antioxidant activity. Thus, it might be a candidate for the development of a new pharmacologic approach for IBDs treatment.	[Rapa, Shara F.; Adesso, Simona; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, Salerno, Italy; [Waltenberger, Birgit; Stuppner, Hermann] Univ Innsbruck, Inst Pharm Pharmacognosy, Innsbruck, Austria; [Waltenberger, Birgit; Stuppner, Hermann] Univ Innsbruck, CMBI, Innsbruck, Austria; [Di Paola, Rosanna; Siracusa, Rosalba; Peritore, Alessio F.; D'Amico, Ramona; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	University of Salerno; University of Innsbruck; University of Innsbruck; University of Messina	Marzocco, S (corresponding author), Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, Salerno, Italy.	smarzocco@unisa.it	Marzocco, Stefania/AAI-1493-2020; Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; D'Amico, Ramona/AAC-9061-2019; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; peritore, alessio filippo/0000-0001-8545-990X; D'Amico, Ramona/0000-0003-0389-3871; di paola, rosanna/0000-0001-6725-8581	University of Salerno [FARB 2018-ORSA180779]	University of Salerno	University of Salerno, Grant/Award Number: FARB 2018-ORSA180779	Adesso S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092280; Adesso S, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100365; Adesso S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030800; Adesso S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121343; Adesso S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00370; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Amaral A. C. F., 2007, Pharmacognosy Reviews, V1, P305; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Basilicata MG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071955; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Bryant RV, 2015, SCAND J GASTROENTERO, V50, P90, DOI 10.3109/00365521.2014.968864; Burge K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081912; Casili G, 2016, J CROHNS COLITIS, V10, P472, DOI 10.1093/ecco-jcc/jjv231; Chudy-Onwugaje KO, 2019, INFLAMM BOWEL DIS, V25, P820, DOI 10.1093/ibd/izy327; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; da Silva VC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124016; Fakhrudin N, 2014, BRIT J PHARMACOL, V171, P1676, DOI 10.1111/bph.12558; Farzaei MH, 2015, CURR PHARM BIOTECHNO, V16, P196, DOI 10.2174/1389201016666150118131704; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Guan G., 2018, BIOMED RES INT, V2018, P1; Han KH, 2017, GUT LIVER, V11, P655, DOI 10.5009/gnl16496; He Y, 2015, MOLECULES, V20, P9183, DOI 10.3390/molecules20059183; Heiss EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20771; Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Khan SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39501; Kuigoua GM, 2010, PLANTA MED, V76, P620, DOI 10.1055/s-0029-1240611; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Li L, 2018, BIOMED PHARMACOTHER, V104, P622, DOI 10.1016/j.biopha.2018.05.072; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Marzocco S., 2017, DORONICUM AUSTRIACUM, V22, P1003; McDaniel DK, 2016, INFLAMM BOWEL DIS, V22, P2265, DOI 10.1097/MIB.0000000000000858; Moldoveanu AC, 2015, ROM J INTERN MED, V53, P118, DOI 10.1515/rjim-2015-0016; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pepe G, 2016, J FUNCT FOODS, V26, P494, DOI 10.1016/j.jff.2016.08.021; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Ranneh Y, 2017, APPL BIOL CHEM, V60, P327, DOI 10.1007/s13765-017-0285-9; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; RIEDER F, 2015, AM J PHYSIOL-GASTR L, V303, pG786; Seidel P, 2009, AM J PHYSIOL-LUNG C, V297, pL326, DOI 10.1152/ajplung.90624.2008; Sharma Umakant, 2011, Indian J Med Res, V134, P709, DOI 10.4103/0971-5916.91005; Singh D, 2011, NAT PROD COMMUN, V6, P1567; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Waltenberger B, 2011, ACTA CRYSTALLOGR C, V67, pO409, DOI 10.1107/S0108270111035761; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698; Zhang J, 2015, BIOORG MED CHEM LETT, V25, P3661, DOI 10.1016/j.bmcl.2015.06.046	52	17	17	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1576	1590		10.1096/fj.201902040R	http://dx.doi.org/10.1096/fj.201902040R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914614	Bronze			2022-12-26	WOS:000507308900104
J	Roberston, MJ; Raghunathan, S; Potaman, VN; Zhang, F; Stewart, MD; McConnell, BK; Schwartz, RJ				Roberston, Matthew J.; Raghunathan, Suchi; Potaman, Vladimir N.; Zhang, Fan; Stewart, M. David; McConnell, Bradley K.; Schwartz, Robert J.			CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression	FASEB JOURNAL			English	Article						gene regulation; insulin-like growth factor 1; muscle atrophy	GROWTH-FACTOR; SATELLITE CELLS; ATROPHY; HYPERTROPHY; APOPTOSIS; PROGRAM	Muscle wasting, or muscle atrophy, can occur with age, injury, and disease; it affects the quality of life and complicates treatment. Insulin-like growth factor 1 (IGF1) is a key positive regulator of muscle mass. The IGF1/Igf1 gene encodes multiple protein isoforms that differ in tissue expression, potency, and function, particularly in cellular proliferation and differentiation, as well as in systemic versus localized signaling. Genome engineering is a novel strategy for increasing gene expression and has the potential to recapitulate the diverse biology seen in IGF1 signaling through the overexpression of multiple IGF1 isoforms. Using a CRISPR-Cas9 gene activation approach, we showed that the expression of multiple IGF1 or Igf1 mRNA variants can be increased in human and mouse skeletal muscle myoblast cell lines using a single-guide RNA (sgRNA). We found increased IGF1 protein levels in the cell culture media and increased cellular phosphorylation of AKT1, the main effector of IGF1 signaling. We also showed that the expression of Class 1 or Class 2 mRNA variants can be selectively increased by changing the sgRNA target location. The expression of multiple IGF1 or Igf1 mRNA transcript variants in human and mouse skeletal muscle myoblasts promoted myotube differentiation and prevented dexamethasone-induced atrophy in myotubes in vitro. Our findings suggest that this novel approach for enhancing IGF1 signaling has potential therapeutic applications for treating skeletal muscle atrophy.	[Roberston, Matthew J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Adv Technol Core, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Roberston, Matthew J.; Potaman, Vladimir N.; Schwartz, Robert J.] Texas Heart Inst, Stem Cell Lab, Houston, TX 77025 USA; [Raghunathan, Suchi; Zhang, Fan; McConnell, Bradley K.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth 2 H2 Bldg,Room 5024, Houston, TX 77204 USA; [Stewart, M. David; Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Coll Nat Sci & Math, 3455 Cullen Blvd,Room 4004, Houston, TX 77204 USA	Baylor College of Medicine; Texas Heart Institute; University of Houston System; University of Houston; University of Houston System; University of Houston	McConnell, BK (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth 2 H2 Bldg,Room 5024, Houston, TX 77204 USA.; Schwartz, RJ (corresponding author), Univ Houston, Dept Biol & Biochem, Coll Nat Sci & Math, 3455 Cullen Blvd,Room 4004, Houston, TX 77204 USA.	bkmcconn@central.uh.edu; rjschwartz@uh.edu			Center for the Advancement of Science in Space; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) [R15 HL141963, R15 HL124458]; American Heart Association (AHA) [18AIREA 33960175]; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	Center for the Advancement of Science in Space; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	The research reported in this manuscript was supported in part by a grant from the Center for the Advancement of Science in Space (R.J.S). Research was also supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) under Award Number R15 HL141963 to (B.K.M.), R15 HL124458 to (B.K.M.), American Heart Association (AHA) under Award Number 18AIREA 33960175 (B.K.M.), and a grant from Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (B.K.M.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Bioinformatics B, 2011, FASTQC QUALITY CONTR; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Cen YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154941; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Chakravarthy MV, 2001, MECH AGEING DEV, V122, P1303, DOI 10.1016/S0047-6374(01)00263-9; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Demonbreun AR, 2017, CURR OPIN PHARMACOL, V34, P7, DOI 10.1016/j.coph.2017.03.008; Dobrucki LW, 2010, J MOL CELL CARDIOL, V48, P1071, DOI 10.1016/j.yjmcc.2009.10.008; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Gallego-Colon E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/484357; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Holmes B, 2012, CELL SIGNAL, V24, P309, DOI 10.1016/j.cellsig.2011.09.015; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee WS, 2018, BBA-MOL BASIS DIS, V1864, P1931, DOI 10.1016/j.bbadis.2017.08.029; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lok C, 2015, NATURE, V528, P182, DOI 10.1038/528182a; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Oberbauer A., 2013, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FENDO.2013.0003923533068; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Philippou A, 2014, GROWTH HORM IGF RES, V24, P157, DOI 10.1016/j.ghir.2014.06.003; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; Rae FK, 2012, GROWTH HORM IGF RES, V22, P6, DOI 10.1016/j.ghir.2011.11.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607	41	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					555	570		10.1096/fj.201901107RR	http://dx.doi.org/10.1096/fj.201901107RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914652	Green Accepted			2022-12-26	WOS:000507308900038
J	Roberts, MWG; Sui, GP; Wu, R; Rong, WF; Wildman, S; Montgomery, B; Ali, A; Langley, S; Ruggieri, MR; Wu, CH				Roberts, Max W. G.; Sui, Guiping; Wu, Rui; Rong, Weifang; Wildman, Scott; Montgomery, Bruce; Ali, Ahmed; Langley, Steve; Ruggieri, Michael R., Sr.; Wu, Changhao			TRPV4 receptor as a functional sensory molecule in bladder urothelium: Stretch-independent, tissue-specific actions and pathological implications	FASEB JOURNAL			English	Article						aging; ATP release; overactive bladders; TRPV4 receptor; urothelium	CATION CHANNEL TRPV4; INTRACELLULAR CA2+ REGULATION; HEAT-EVOKED ACTIVATION; URINARY-BLADDER; ATP RELEASE; VANILLOID RECEPTOR; POTENTIAL VANILLOID-4; AFFERENT-FIBERS; EXPRESSION; CELLS	The newly recognized sensory role of bladder urothelium has generated intense interest in identifying its novel sensory molecules. Sensory receptor TRPV4 may serve such function. However, specific and physiologically relevant tissue actions of TRPV4, stretch-independent responses, and underlying mechanisms are unknown and its role in human conditions has not been examined. Here we showed TRPV4 expression in guinea-pig urothelium, suburothelium, and bladder smooth muscle, with urothelial predominance. Selective TRPV4 activation without stretch evoked significant ATP release-key urothelial sensory process, from live mucosa tissue, full-thickness bladder but not smooth muscle, and sustained muscle contractions. ATP release was mediated by Ca2+-dependent, pannexin/connexin-conductive pathway involving protein tyrosine kinase, but independent from vesicular transport and chloride channels. TRPV4 activation generated greater Ca2+ rise than purinergic activation in urothelial cells. There was intrinsic TRPV4 activity without exogeneous stimulus, causing ATP release. TRPV4 contributed to 50% stretch-induced ATP release. TRPV4 activation also triggered superoxide release. TRPV4 expression was increased with aging. Human bladder mucosa presented similarities to guinea pigs. Overactive bladders exhibited greater TRPV4-induced ATP release with age dependence. These data provide the first evidence in humans for the key functional role of TRPV4 in urothelium with specific mechanisms and identify TRPV4 up-regulation in aging and overactive bladders.	[Roberts, Max W. G.; Wu, Changhao] Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, Surrey, England; [Sui, Guiping] Guys & St Thomas Hosp NHS Trust, London, England; [Wu, Rui] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Rong, Weifang] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai, Peoples R China; [Wildman, Scott] Univ Kent, Sch Pharm, Chatham, Kent, England; [Montgomery, Bruce; Ali, Ahmed] Frimley Hlth NHS Trust, Frimley, England; [Langley, Steve] Royal Surrey Cty NHS Trust, Guildford, Surrey, England; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	University of Surrey; University of Warwick; Shanghai Jiao Tong University; University of Kent; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wu, CH (corresponding author), Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, Surrey, England.	c.wu@surrey.ac.uk		Rong, Weifang/0000-0003-4934-5715	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P004695/1]; HHS | NIH | National Institute on Aging (NIA) [1R01AG04932101A1]; Age UK Henry -Smith Charity [RiA 373]; BBSRC [BB/P004695/1] Funding Source: UKRI	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Age UK Henry -Smith Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/P004695/1; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: 1R01AG04932101A1; Age UK Henry -Smith Charity, Grant/Award Number: RiA 373	Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alexander R, 2013, BRIT J PHARMACOL, V168, P761, DOI 10.1111/j.1476-5381.2012.02186.x; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Beckel JM, 2006, AM J PHYSIOL-RENAL, V290, pF103, DOI 10.1152/ajprenal.00098.2005; Beckel JM, 2015, J PHYSIOL-LONDON, V593, P1857, DOI 10.1113/jphysiol.2014.283119; Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195; Birder LA, 2004, AM J PHYSIOL-RENAL, V287, pF1084, DOI 10.1152/ajprenal.00118.2004; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Birder LA, 2006, VASC PHARMACOL, V45, P221, DOI 10.1016/j.vph.2005.08.027; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Chien CT, 2003, AM J PHYSIOL-RENAL, V284, pF840, DOI 10.1152/ajprenal.00187.2002; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Chopra B, 2008, AM J PHYSIOL-RENAL, V294, pF821, DOI 10.1152/ajprenal.00321.2006; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Contreras-Sanz A, 2016, AM J PHYSIOL-RENAL, V311, pF805, DOI 10.1152/ajprenal.00339.2015; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; Deruyver Y, 2018, EUR UROL, V74, P336, DOI 10.1016/j.eururo.2018.05.020; Du SQ, 2007, UROLOGY, V69, P590, DOI 10.1016/j.urology.2007.01.039; Everaerts W, 2009, NEUROUROL URODYNAM, V28, P701; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fini M, 2008, BIOMED PHARMACOTHER, V62, P709, DOI 10.1016/j.biopha.2007.03.001; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gomez-Pinilla PJ, 2007, J UROLOGY, V177, P1558, DOI 10.1016/j.juro.2006.11.071; Guler AD, 2002, J NEUROSCI, V22, P6408; HABLER HJ, 1990, J PHYSIOL-LONDON, V425, P545; HORSFALL DJ, 1994, LAB INVEST, V70, P753; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Isogai A, 2016, PFLUG ARCH EUR J PHY, V468, P1573, DOI 10.1007/s00424-016-1863-0; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Jones SA, 2004, J PHYSIOL-LONDON, V560, P429, DOI 10.1113/jphysiol.2004.072108; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; KARIM OMA, 1992, J CELL BIOCHEM, V48, P373, DOI 10.1002/jcb.240480406; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Kumar V, 2007, J UROLOGY, V178, P1533, DOI 10.1016/j.juro.2007.05.116; Lee H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12561-7; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Malecot CO, 1998, BRIT J PHARMACOL, V124, P465, DOI 10.1038/sj.bjp.0701854; Masuda H, 2008, BJU INT, V101, P775, DOI 10.1111/j.1464-410X.2007.07310.x; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Pierre MS, 2009, EXP BRAIN RES, V196, P31, DOI 10.1007/s00221-009-1808-3; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rong W, 2002, J PHYSIOL-LONDON, V541, P591, DOI 10.1113/jphysiol.2001.013469; Schwartzberg PL, 1998, ONCOGENE, V17, P1463, DOI 10.1038/sj.onc.1202176; Shen CH, 2014, BIOMARK GENOM MED, V6, P37, DOI 10.1016/j.bgm.2014.01.004; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Sui GP, 2014, AM J PHYSIOL-RENAL, V306, pF286, DOI 10.1152/ajprenal.00291.2013; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Takaoka E, 2018, NEUROUROL URODYNAM, V37, P2527, DOI 10.1002/nau.23790; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu C, 1998, J PHYSIOL-LONDON, V508, P131, DOI 10.1111/j.1469-7793.1998.131br.x; Wu C, 2011, CELL CALCIUM, V49, P395, DOI 10.1016/j.ceca.2011.03.008; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yamada T, 2009, J HISTOCHEM CYTOCHEM, V57, P277, DOI 10.1369/jhc.2008.951962; Young JS, 2013, BJU INT, V111, P355, DOI 10.1111/j.1464-410X.2012.11300.x; Yu WQ, 2006, AM J PHYSIOL-CELL PH, V291, pC254, DOI 10.1152/ajpcell.00025.2006	80	18	18	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					263	286		10.1096/fj.201900961RR	http://dx.doi.org/10.1096/fj.201900961RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914645	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000507308900020
J	Taniguchi, K; Kawai, T; Kitawaki, J; Tomikawa, J; Nakabayashi, K; Okamura, K; Sago, H; Hata, K				Taniguchi, Kosuke; Kawai, Tomoko; Kitawaki, Jo; Tomikawa, Junko; Nakabayashi, Kazuhiko; Okamura, Kohji; Sago, Haruhiko; Hata, Kenichiro			Epitranscriptomic profiling in human placenta: N6-methyladenosine modification at the 5 '-untranslated region is related to fetal growth and preeclampsia	FASEB JOURNAL			English	Article						6-methyladenosine; epitranscriptome; fetal growth; preeclampsia; post-transcriptional regulation	MESSENGER-RNA METHYLATION; M(6)A RNA; GENE-EXPRESSION; CELL; MOUSE; RESTRICTION; REVEALS; N-6-METHYLADENOSINE; METABOLISM; BINDING	Intracellular mRNA levels are not always proportional to their respective protein levels, especially in the placenta. This discrepancy may be attributed to various factors including post-transcriptional regulation, such as mRNA methylation (N6-methyladenosine: m(6)A). Here, we conducted a comprehensive m(6)A analysis of human placental tissue from neonates with various birth weights to clarify the involvement of m(6)A in placental biology. The augmented m(6)A levels at the 5'-untranslated region (UTR) in mRNAs of small-for-date placenta samples were dominant compared to reduction of m(6)A levels, whereas a decrease in m(6)A in the vicinity of stop codons was common in heavy-for-date placenta samples. Notably, most of these genes showed similar expression levels between the different birth weight categories. In particular, preeclampsia placenta samples showed consistently upregulated SMPD1 protein levels and increased m(6)A at 5'-UTR but did not show increased mRNA levels. Mutagenesis of adenosines at 5'-UTR of SMPD1 mRNAs actually decreased protein levels in luciferase assay. Collectively, our findings suggest that m(6)A both at the 5'-UTR and in the vicinity of stop codon in placental mRNA may play important roles in fetal growth and disease.	[Taniguchi, Kosuke; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan; [Taniguchi, Kosuke; Kawai, Tomoko; Tomikawa, Junko; Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan	Kyoto Prefectural University of Medicine; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Kawai, T; Hata, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kawai-tm@ncchd.go.jp; hata-k@ncchd.go.jp		Tomikawa, Junko/0000-0002-6149-1400; Kawai, Tomoko/0000-0001-8137-0334	AMED [17gk0110013h0002, 17gk0110018s0602]; KAKENHI [26560076, 16K00898, 18K15737]; NCCHD of Japan [26-47, 26-13]	AMED; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NCCHD of Japan	AMED, Grant/Award Number: 17gk0110013h0002 and 17gk0110018s0602; KAKENHI, Grant/Award Number: 26560076, 16K00898 and 18K15737; NCCHD of Japan, Grant/Award Number: 26-47 and 26-13	Barton SJ, 2016, PLACENTA, V38, P100, DOI 10.1016/j.placenta.2015.12.015; Bassols J, 2010, INT J OBESITY, V34, P1365, DOI 10.1038/ijo.2010.62; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Bokar JA, 1997, RNA, V3, P1233; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CUI X, 2016, BIOMED RES INT, V2016; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dobierzewska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175118; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Ewing AC, 2017, MATERN CHILD HLTH J, V21, P786, DOI 10.1007/s10995-016-2165-z; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fry NJ, 2017, RNA, V23, P1444, DOI 10.1261/rna.061044.117; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levin HI, 2017, PLACENTA, V55, P5, DOI 10.1016/j.placenta.2017.04.014; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CH, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1435-z; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motomura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177994; Muy-Rivera M, 2004, AM J HYPERTENS, V17, P334, DOI 10.1016/j.amjhyper.2003.12.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Sabri A, 2014, FETAL DIAGN THER, V36, P173, DOI 10.1159/000360535; Schneider D, 2015, PLACENTA, V36, P552, DOI 10.1016/j.placenta.2015.02.003; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Sober S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13336; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Tian FJ, 2016, J PATHOL, V239, P36, DOI 10.1002/path.4694; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsang JCH, 2017, P NATL ACAD SCI USA, V114, pE7786, DOI 10.1073/pnas.1710470114; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	63	9	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					494	512		10.1096/fj.201900619RR	http://dx.doi.org/10.1096/fj.201900619RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914637	Green Published, hybrid			2022-12-26	WOS:000507308900034
J	Batsos, G; Christodoulou, E; Vartholomatos, G; Galanis, P; Stefaniotou, M				Batsos, Georgios; Christodoulou, Eleni; Vartholomatos, Georgios; Galanis, Petros; Stefaniotou, Maria			Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; CLASSIFICATION; INFLAMMATION; NGAL; PATHOGENESIS; ASSOCIATION; BIOMARKER; MEDIATOR; RISK; MICE	Purpose To measure vitreous levels of Lipocalin2 (LCN2) in patients with rhegmatogenous retinal detachment (RRD) and investigate potential association with presence of proliferative vitreoretinopathy (PVR). Materials and methods Collection of undiluted vitreous samples from 24 patients suffering from RRD and 10 control patients undergoing vitrectomy for: vitreomacular traction (VMT) (n = 2), idiopathic epiretinal membrane (iERM) (n = 6) and full thickness macular hole (FTMH) (n = 2). Quantitative analysis of LCN2 has been made with flow cytometry. Lens status, duration of symptoms, quadrants of detachment, as well as level of PVR, were assessed. Statistical analysis included Mann-Whitney test, Kruskal-Wallis test, t-test, Spearman's correlation coefficient and Fisher's exact test. Results Median LCN2 was significantly higher in the RRD group as compared to control (p<0.001). Within the RRD group there was a positive correlation between LCN2 and PVR grade (r(s) = 0.94, p<0.001). Median LCN2 was 35,759 pg/ml (IR = 55,347) in grade C PVR, 9,387 pg/ml (IR = 3721) in grade B, 4,917 pg/ml (IR = non computable) in grade A and 3,921 pg/ml (2132) in the no PVR group. Median LCN2 was also significantly higher in pseudophakic patients as compared to phakic patients (p = 0.007). LCN2 also correlates with the extend of detachment (<= 2 vs >2 quadrants, p<0.001) as well as with duration of symptoms (r(s) = 0.87, p<0.001). After multivariate linear regression analysis, only PVR was independently related with LCN2 concentration. In particular, increased PVR grading was associated with increased LCN2 concentration (coefficient b = 2.97, 95% confidence interval = 1.89 to 4.67, p<0.001). Conclusion A positive correlation between vitreous levels of LCN2 and PVR grading reveals a potential role in the pathogenesis and progression of PVR. Further studies could elucidate if LCN2 could be a therapeutic target.	[Batsos, Georgios; Christodoulou, Eleni; Stefaniotou, Maria] Univ Hosp Ioannina, Ophthalmol Dept, Ioannina, Greece; [Vartholomatos, Georgios] Univ Hosp Ioannina, Haematol Lab, Unit Mol Biol, Ioannina, Greece; [Galanis, Petros] Natl & Kapodistrian Univ Athens, Ctr Hlth Serv Management & Evaluat, Athens, Greece	University Hospital Ioannina; University Hospital Ioannina; National & Kapodistrian University of Athens	Batsos, G (corresponding author), Univ Hosp Ioannina, Ophthalmol Dept, Ioannina, Greece.	batsosgeorge@gmail.com	Galanis, Petros/AAG-3888-2021; BATSOS, GEORGIOS/AAB-6970-2021	Galanis, Petros/0000-0002-1308-5782; Batsos, Georgios/0000-0001-6660-3443				Abella V, 2015, BIOMARKERS, V20, P565, DOI 10.3109/1354750X.2015.1123354; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Brunner HI, 2012, ARTHRITIS RHEUM-US, V64, P2687, DOI 10.1002/art.34426; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Charteris DG, 2007, GRAEF ARCH CLIN EXP, V245, P93, DOI 10.1007/s00417-006-0323-5; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Eastlake K, 2016, GLIA, V64, P495, DOI 10.1002/glia.22942; Eastlake K, 2018, EXP EYE RES, V177, P197, DOI 10.1016/j.exer.2018.08.016; Enders P, 2017, RETINA-J RET VIT DIS, V37, P930, DOI 10.1097/IAE.0000000000001302; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hofmaier F, 2011, INVEST OPHTH VIS SCI, V52, P2314, DOI 10.1167/iovs.10-6475; Jang Y, 2012, CLIN EXP PHARMACOL P, V39, P194, DOI 10.1111/j.1440-1681.2011.05557.x; Khan MA, 2015, RETINA-J RET VIT DIS, V35, P165, DOI 10.1097/IAE.0000000000000447; Koban Y, 2018, INT OPHTHALMOLOGY; Kobayashi T, 2014, AM J PHYSIOL-LUNG C, V306, pL1006, DOI 10.1152/ajplung.00015.2014; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; LAQUA H, 1975, AM J OPHTHALMOL, V80, P602, DOI 10.1016/0002-9394(75)90390-6; LEAN JS, 1989, OPHTHALMOLOGY, V96, P765; LEAVER PK, 1995, BRIT J OPHTHALMOL, V79, P871, DOI 10.1136/bjo.79.10.871; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lindberg S, 2014, ARTERIOSCL THROM VAS, V34, P2135, DOI 10.1161/ATVBAHA.114.303950; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; MEAEDoO, 2018, QUALITY OUTCOMES; Mohamed YH, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/2193518; Moysidis SN, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/815937; Parmar T, 2018, J IMMUNOL, V200, P3128, DOI 10.4049/jimmunol.1701573; Parmar T, 2016, INVEST OPHTH VIS SCI, V57, P3257, DOI 10.1167/iovs.15-18993; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Ricker LJAG, 2012, AM J OPHTHALMOL, V154, P347, DOI 10.1016/j.ajo.2012.02.004; Rouberol F, 2014, J FR OPHTALMOL, V37, P557, DOI 10.1016/j.jfo.2014.04.001; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Salom D, 2010, MOL VIS, V16, P1448; Schaal S, 2011, RETINA-J RET VIT DIS, V31, P1500, DOI 10.1097/IAE.0b013e31820d3f55; Symeonidis C, 2011, ACTA OPHTHALMOL, V89, P339, DOI 10.1111/j.1755-3768.2009.01701.x; Tassoni A, 2015, STEM CELLS, V33, P3006, DOI 10.1002/stem.2095; The Royal College of Ophthalmologists, 2017, NAT EL RET DET SURG; Tosi GM, 2014, J CELL PHYSIOL, V229, P1577, DOI 10.1002/jcp.24606; Valapala M, 2014, AGING CELL, V13, P1091, DOI 10.1111/acel.12274; Wang Fang, 2010, Zhonghua Yan Ke Za Zhi, V46, P609; Wilson R, 2008, ARTHRITIS RHEUM, V58, P3120, DOI 10.1002/art.23789; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zandi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214674; Zeng Jun, 2003, Yan Ke Xue Bao, V19, P130; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	50	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227266	10.1371/journal.pone.0227266	http://dx.doi.org/10.1371/journal.pone.0227266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891637	Green Published, gold			2022-12-26	WOS:000515096600073
J	Fan, ZL; Wu, B; Wu, GY; Yao, J; Li, X; Hu, KH; Zhou, ZH; Sui, JF				Fan, Zheng-li; Wu, Bing; Wu, Guang-yan; Yao, Juan; Li, Xuan; Hu, Ke-hui; Zhou, Zhen-hua; Sui, Jian-feng			Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; PREFRONTAL CORTEX; DEFICITS; PHENCYCLIDINE; ABNORMALITIES; DISRUPTION; ACTIVATION; MECHANISMS; PSYCHOSIS; CIRCUITS	Schizophrenia (SZ) is a serious and incurable mental disorder characterized by clinical manifestations of positive and negative symptoms and cognitive dysfunction. High-frequency deep brain stimulation (DBS) of the ventral hippocampus (VHP) has been recently applied as a therapeutic approach for SZ in both experimental and clinical studies. However, little is known about the precise mechanism of VHP-DBS treatment for SZ and the role of hippocampal cell activation in the pathogenesis of SZ. With optogenetic technology in this study, we tried to inhibit neuronal activity in the VHP which has dense projections to the prefrontal cortex, before measuring long stumulus-induced delay eyeblink conditioning (long-dEBC) in a rodent model of SZ. Rats were administrated with phencyclidine (PCP, 3 mg/kg, 1/d, ip) for successive 7 days before optogenetic intervention. The current data show that PCP administration causes significant impairment in the acquisition and timing of long-dEBC; the inhibition of bilateral VHP neurons alleviates the decreased acquisition and impaired timing of longd-dEBC in PCP-administered rats. The results provide direct evidence at the cellular level that the inhibition of VHP neuronal cells may be a prominent effect of hippocampal DBS intervention, and increased activity in the hippocampal network play a pivotal role in SZ.	[Fan, Zheng-li; Wu, Bing; Wu, Guang-yan; Yao, Juan; Li, Xuan; Sui, Jian-feng] Army Med Univ, Coll Basic Med Sci, Dept Physiol, Chongqing, Peoples R China; [Fan, Zheng-li; Wu, Bing; Wu, Guang-yan; Yao, Juan; Li, Xuan; Sui, Jian-feng] Army Med Univ, Coll Basic Med Sci, Expt Ctr Basic Med, Chongqing, Peoples R China; [Hu, Ke-hui] Suining Cent Hosp, Dept Rehabil, Suining, Peoples R China; [Zhou, Zhen-hua] Army Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Sui, JF (corresponding author), Army Med Univ, Coll Basic Med Sci, Dept Physiol, Chongqing, Peoples R China.; Sui, JF (corresponding author), Army Med Univ, Coll Basic Med Sci, Expt Ctr Basic Med, Chongqing, Peoples R China.; Zhou, ZH (corresponding author), Army Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	exploiter001@126.com; jfsui2003@163.com	Zhou, Zhenhua/AID-6326-2022		National Natural Science Foundation of China [81771213]; Natural Science Foundation of Chongqing [cstc2019jcyj-msxmx0269]; Chongqing Medical Research Foundation of Science of Health [2019MSXM015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Chongqing Medical Research Foundation of Science of Health	This work was mainly supported by the National Natural Science Foundation of China (No. 81771213 to J.F. Sui); Natural Science Foundation of Chongqing (No. cstc2019jcyj-msxmx0269 to J. Yao); Chongqing Medical Research Foundation of Science of Health (No. 2019MSXM015 to S.L. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabid AL, 2002, MOVEMENT DISORD, V17, pS73, DOI 10.1002/mds.10145; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bikovsky L, 2016, EXP NEUROL, V283, P142, DOI 10.1016/j.expneurol.2016.06.012; Bolton MM, 2012, BEHAV BRAIN RES, V233, P35, DOI 10.1016/j.bbr.2012.04.049; Breit S, 2004, CELL TISSUE RES, V318, P275, DOI 10.1007/s00441-004-0936-0; Corripio I, 2016, BIOL PSYCHIAT, V80, pE69, DOI 10.1016/j.biopsych.2016.03.1049; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ewing SG, 2013, MED HYPOTHESES, V80, P827, DOI 10.1016/j.mehy.2013.03.026; Ewing SG, 2013, SCHIZOPHR RES, V143, P377, DOI 10.1016/j.schres.2012.11.023; Firth J, 2017, SCHIZOPHRENIA BULL, V43, P546, DOI 10.1093/schbul/sbw115; Forsyth JK, 2012, SCHIZOPHRENIA BULL, V38, P751, DOI 10.1093/schbul/sbq148; Gee S, 2012, J NEUROSCI, V32, P4959, DOI 10.1523/JNEUROSCI.5835-11.2012; Graat I, 2017, INT REV PSYCHIATR, V29, P178, DOI 10.1080/09540261.2017.1282439; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Harvey PD, 2009, NEUROPSYCHOL REV, V19, P324, DOI 10.1007/s11065-009-9103-4; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Jessen F, 2003, AM J PSYCHIAT, V160, P1305, DOI 10.1176/appi.ajp.160.7.1305; Jodo E, 2003, BRAIN RES, V962, P226, DOI 10.1016/S0006-8993(02)03967-7; Jodo E, 2013, J PHYSIOL-PARIS, V107, P434, DOI 10.1016/j.jphysparis.2013.06.002; Kalmbach BE, 2010, J NEUROPHYSIOL, V104, P627, DOI 10.1152/jn.00169.2010; Kent JS, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00146; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lakhan Shaheen E, 2010, BMC Res Notes, V3, P60, DOI 10.1186/1756-0500-3-60; Llado-Pelfort L, 2016, EUR NEUROPSYCHOPHARM, V26, P614, DOI 10.1016/j.euroneuro.2015.11.015; Ma JY, 2014, BEHAV BRAIN RES, V266, P174, DOI 10.1016/j.bbr.2014.03.010; Marenco S, 2003, BIOL PSYCHIAT, V53, P390, DOI 10.1016/S0006-3223(02)01506-8; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; Peled A, 2011, MED HYPOTHESES, V76, P914, DOI 10.1016/j.mehy.2011.03.009; Perez SM, 2013, INT J NEUROPSYCHOPH, V16, P1331, DOI 10.1017/S1461145712001344; Poortvliet PC, 2015, INTERN MED J, V45, P134, DOI 10.1111/imj.12656; Reeb-Sutherland BC, 2015, J AUTISM DEV DISORD, V45, P376, DOI 10.1007/s10803-013-1905-9; Sears LL, 2000, BIOL PSYCHIAT, V48, P204, DOI 10.1016/S0006-3223(00)00247-X; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; Takahata R, 2003, NEUROPSYCHOPHARMACOL, V28, P1117, DOI 10.1038/sj.npp.1300127; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tracy JA, 2001, NEUROBIOL LEARN MEM, V76, P253, DOI 10.1006/nlme.2001.4024; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Wu B, 2017, BEHAV BRAIN RES, V331, P169, DOI 10.1016/j.bbr.2017.05.035; Wu GY, 2018, CEREB CORTEX, V28, P3753, DOI 10.1093/cercor/bhx238; Wu GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071249	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227200	10.1371/journal.pone.0227200	http://dx.doi.org/10.1371/journal.pone.0227200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8LM	31891640	gold, Green Published			2022-12-26	WOS:000515096600067
J	Toldi, D; Gyugos, M; Darko, E; Szalai, G; Gulyas, Z; Gierczik, K; Szekely, A; Boldizsar, A; Galiba, G; Muller, M; Simon-Sarkadi, L; Kocsy, G				Toldi, David; Gyugos, Monika; Darko, Eva; Szalai, Gabriella; Gulyas, Zsolt; Gierczik, Krisztian; Szekely, Andras; Boldizsar, Akos; Galiba, Gabor; Mueller, Maria; Simon-Sarkadi, Livia; Kocsy, Gabor			Light intensity and spectrum affect metabolism of glutathione and amino acids at transcriptional level	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PLANT-GROWTH; REDOX REGULATION; BLUE-LIGHT; STRESS; BIOSYNTHESIS; ACCUMULATION; DISULFIDE; GLUTAMATE; PROLINE	The effects of various light intensities and spectral compositions on glutathione and amino acid metabolism were compared in wheat. Increase of light intensity (low normal high) was accompanied by a simultaneous increase in the shoot fresh weight, photosynthetic activity and glutathione content. These parameters were also affected by the modification of the ratios of blue, red and far-red components (referred to as blue, pink and far-red lights) compared to normal white light. The photosynthetic activity and the glutathione content decreased to 50% and the percentage of glutathione disulfide (characterising the redox state of the tissues) in the total glutathione pool doubled in far-red light. The alterations in the level and redox state of the antioxidant glutathione resulted from the effect of light on its synthesis as it could be concluded from the changes in the transcription of the related genes. Modification of the light conditions also greatly affected both the amount and the ratio of free amino acids. The total free amino acid content was greatly induced by the increase of light intensity and was greatly reduced in pink light compared to the normal intensity white light. The concentrations of most amino acids were similarly affected by the light conditions as described for the total free amino acid content but Pro, Met, Thr, ornithine and cystathionine showed unique response to light. As observed for the amino acid levels, the expression of several genes involved in their metabolism also enhanced due to increased light intensity. Interestingly, the modification of the spectrum greatly inhibited the expression of most of these genes. Correlation analysis of the investigated parameters indicates that changes in the light conditions may affect growth through the adjustment of photosynthesis and the glutathione-dependent redox state of the tissues. This process modifies the metabolism of glutathione and amino acids at transcriptional level.	[Toldi, David; Simon-Sarkadi, Livia] Szent Istvan Univ, Dept Food Chem & Nutr, Budapest, Hungary; [Toldi, David; Simon-Sarkadi, Livia] Szent Istvan Univ, Doctoral Sch Food Sci, Budapest, Hungary; [Gyugos, Monika; Darko, Eva; Szalai, Gabriella; Gulyas, Zsolt; Gierczik, Krisztian; Szekely, Andras; Boldizsar, Akos; Galiba, Gabor; Kocsy, Gabor] Ctr Agr Res, Agr Inst, Martonvaser, Hungary; [Gierczik, Krisztian; Galiba, Gabor] Univ Pannonia, Georgikon Fac, Festet Doctoral Sch, Keszthely, Hungary; [Mueller, Maria] Karl Franzens Univ Graz, Inst Biol, Dept Plant Sci, Graz, Austria	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Pannonia; University of Graz	Simon-Sarkadi, L (corresponding author), Szent Istvan Univ, Dept Food Chem & Nutr, Budapest, Hungary.; Simon-Sarkadi, L (corresponding author), Szent Istvan Univ, Doctoral Sch Food Sci, Budapest, Hungary.	sarkadi@mail.bme.hu	Darkó, Éva/AAR-8167-2021	Szekely, Andras/0000-0001-8768-4836	National Research, Development and Innovation Office [ANN 117949, TeT_15-1-2016-0048]; National Research, Development and Innovation Office (TEthe Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary)) [T_15-IN-1-2016-0028]; European Social Fund [EFOP-3.6.3-VEKOP-16-2017-00005, EFOP-3.6.3-VEKOP-16-2017-00008]; Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary); European Union	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); National Research, Development and Innovation Office (TEthe Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary)); European Social Fund(European Social Fund (ESF)); Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary); European Union(European Commission)	This research was supported by the National Research, Development and Innovation Office (grants ANN 117949, TeT_15-1-2016-0048 and TEthe Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary). T_15-IN-1-2016-0028), by the European Union and co-financed by the European Social Fund (grant agreements no. EFOP-3.6.3-VEKOP-16-2017-00005 and EFOP-3.6.3-VEKOP-16-2017-00008). D. Toldi earned a PhD scholarship from the Doctoral School for Food Sciences, Szent Istvan University (Budapest, Hungary).	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Bartoli CG, 2009, FEBS LETT, V583, P118, DOI 10.1016/j.febslet.2008.11.034; Biswal B, 2011, CURR SCI INDIA, V101, P47; Boldizsar A, 2016, J PLANT PHYSIOL, V202, P21, DOI 10.1016/j.jplph.2016.07.005; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Considine MJ, 2014, ANTIOXID REDOX SIGN, V21, P1305, DOI 10.1089/ars.2013.5665; Cook C. R., 2008, AFRICAN STUDIES Q, V10, P1; Davis MC, 2013, PLANT CELL ENVIRON, V36, P1391, DOI 10.1111/pce.12071; Dhakal R, 2014, HORTIC ENVIRON BIOTE, V55, P36, DOI 10.1007/s13580-014-0125-3; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Galle A, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01944; Geigenberger P, 2014, ANTIOXID REDOX SIGN, V21, P1389, DOI 10.1089/ars.2014.6018; Gruszecki WI, 1997, J PHOTOCH PHOTOBIO B, V39, P265, DOI 10.1016/S1011-1344(97)00014-6; Gulyas Z, 2017, PHYSIOL PLANTARUM, V159, P264, DOI 10.1111/ppl.12510; Heyneke E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-104; Kianianmomeni A, 2014, TRENDS PLANT SCI, V19, P488, DOI 10.1016/j.tplants.2014.05.004; Kim KangMin, 2013, Journal of Plant Pathology and Microbiology, V4, P203; Kocsy G, 2000, PLANTA, V210, P295, DOI 10.1007/PL00008137; Kocsy G, 2013, PLANT SCI, V211, P77, DOI 10.1016/j.plantsci.2013.07.004; Koga R., 2013, Agricultural Sciences, V4, P185, DOI 10.4236/as.2013.44027; Kolbe A, 2006, PLANT PHYSIOL, V141, P412, DOI 10.1104/pp.106.081208; Kranner I, 1996, PHYTOCHEM ANALYSIS, V7, P24, DOI 10.1002/(SICI)1099-1565(199601)7:1<24::AID-PCA277>3.0.CO;2-2; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lund JB, 2007, HORTSCIENCE, V42, P1609, DOI 10.21273/HORTSCI.42.7.1609; Manivannan A, 2015, HORTIC ENVIRON BIOTE, V56, P105, DOI 10.1007/s13580-015-0114-1; Mazzella MA, 2008, J EXP BOT, V59, P2469, DOI 10.1093/jxb/ern113; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Monostori I, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00605; Noctor G, 1998, PLANT PHYSIOL, V118, P471, DOI 10.1104/pp.118.2.471; OuYang FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127896; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Qaderi MM, 2015, BOTANY, V93, P475, DOI 10.1139/cjb-2014-0194; Ramesh SA, 2017, CELL MOL LIFE SCI, V74, P1577, DOI 10.1007/s00018-016-2415-7; Roach T, 2018, FREE RADICAL BIO MED, V122, P65, DOI 10.1016/j.freeradbiomed.2018.03.030; Ros R, 2014, TRENDS PLANT SCI, V19, P564, DOI 10.1016/j.tplants.2014.06.003; SNYDER RG, 1961, J MOL SPECTROSC, V7, P116, DOI 10.1016/0022-2852(61)90347-2; Suzuki A, 2001, PHYSIOL PLANTARUM, V112, P524, DOI 10.1034/j.1399-3054.2001.1120409.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takahashi T, 2010, ANN BOT-LONDON, V105, P1, DOI 10.1093/aob/mcp259; Taulavuori K, 2005, SILVA FENN, V39, P131, DOI 10.14214/sf.401; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Pham VN, 2018, PLANT PHYSIOL, V176, P1025, DOI 10.1104/pp.17.01384; Wildi B, 1996, PLANT CELL ENVIRON, V19, P138, DOI 10.1111/j.1365-3040.1996.tb00235.x; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; Yang DY, 2016, P NATL ACAD SCI USA, V113, P7667, DOI 10.1073/pnas.1601309113; Yao XY, 2017, J INTEGR AGR, V16, P97, DOI [10.1016/S2095-3119(16)61393-X, 10.1016/s2095-3119(16)61393-x]	48	25	25	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0227271	10.1371/journal.pone.0227271	http://dx.doi.org/10.1371/journal.pone.0227271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891631	Green Published, gold			2022-12-26	WOS:000515096600074
J	Pang, KL; Guo, SY; Chen, IA; Burgaud, G; Luo, ZH; Dahms, HU; Hwang, JS; Lin, YL; Huang, JS; Ho, TW; Tsang, LM; Chiang, MWL; Cha, HJ				Pang, Ka-Lai; Guo, Sheng-Yu; Chen, I-An; Burgaud, Gaetan; Luo, Zhu-Hua; Dahms, Hans U.; Hwang, Jiang-Shiou; Lin, Yi-Li; Huang, Jian-Shun; Ho, Tsz-Wai; Tsang, Ling-Ming; Chiang, Michael Wai-Lun; Cha, Hyo-Jung			Insights into fungal diversity of a shallow-water hydrothermal vent field at Kueishan Island, Taiwan by culture-based and metabarcoding analyses	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; ASPERGILLUS-SYDOWII; HORTAEA-WERNECKII; SPECIES RICHNESS; MARINE; SEDIMENTS; SAMPLES; EUKARYOTES; INFECTION; PATHOGEN	This paper reports the diversity of fungi associated with substrates collected at a shallow hydrothermal vent field at Kueishan Island, Taiwan, using both culture-based and metabarcoding methods. Culture of fungi from yellow sediment (with visible sulfur granules), black sediment (no visible sulfur granules), the vent crab Xenograpsus testudinatus, seawater and, animal egg samples resulted in a total of 94 isolates. Species identification based on the internal transcribed spacer regions of the rDNA revealed that the yellow sediment samples had the highest species richness with 25 species, followed by the black sediment (23) and the crab (13). The Ascomycota was dominant over the Basidiomycota; the dominant orders were Agaricales, Capnodiales, Eurotiales, Hypocreales, Pleosporales, Polyporales and Xylariales. Hortaea werneckii was the only common fungus isolated from the crab, seawater, yellow and black sediment samples. The metabarcoding analysis amplifying a small fragment of the rDNA (from 18S to 5.8S) recovered 7-27 species from the black sediment and 12-27 species from the yellow sediment samples and all species belonged to the Ascomycota and the Basidiomycota. In the yellow sediments, the dominant order was Pleosporales and this order was also dominant in the black sediment together with Sporidiobolales. Based on the results from both methods, 54 and 49 species were found in the black and yellow sediments, respectively. Overall, a higher proportion of Ascomycota (similar to 70%) over Basidiomycota was recovered in the yellow sediment and the two phyla were equally abundant in the black sediment. The top five dominant fungal orders in descending order based on species richness were Pleosporales>Eurotiales>Polyporales>Hypocreales>Capnodiales in the black sediment samples, and Polyporales>Pleosporales>Eurotiales>Capnodiales>Hypocreales in the yellow sediment samples. This study is the first to observe a high diversity of fungi associated with various substrates at a marine shallow water hydrothermal vent ecosystem. While some fungi found in this study were terrestrial species and their airborne spores might have been deposited into the marine sediment, several pathogenic fungi of animals, including Acremonium spp., Aspergillus spp., Fusarium spp., Malassezia spp., Hortaea werneckii, Parengyodontium album, and Westerdykella dispersa, were recovered suggesting that these fungi may be able to cause diseases of marine animals.	[Pang, Ka-Lai; Guo, Sheng-Yu; Chen, I-An; Hwang, Jiang-Shiou; Lin, Yi-Li; Huang, Jian-Shun; Cha, Hyo-Jung] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Pang, Ka-Lai; Guo, Sheng-Yu; Chen, I-An; Hwang, Jiang-Shiou; Lin, Yi-Li; Huang, Jian-Shun; Cha, Hyo-Jung] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Burgaud, Gaetan] Univ Brest, Lab Univ Biodiversite & Ecol Microbienne, Plouzane, France; [Luo, Zhu-Hua] Minist Nat Resources, Key Lab Marine Biogenet Resources, Inst Oceanog 3, Xiamen, Peoples R China; [Dahms, Hans U.] Kaohsiung Med Univ, Coll Life Sci, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Ho, Tsz-Wai] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; [Tsang, Ling-Ming] Chinese Univ Hong Kong, Sch Biol Sci, Kowloon Tong, Hong Kong, Peoples R China; [Chiang, Michael Wai-Lun] City Univ Hong Kong, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China	National Taiwan Ocean University; National Taiwan Ocean University; Universite de Bretagne Occidentale; Ministry of Natural Resources of the People's Republic of China; Kaohsiung Medical University; University of Western Australia; Chinese University of Hong Kong; City University of Hong Kong	Pang, KL (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Pang, KL (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	klpang@ntou.edu.tw	Pang, Ka-Lai/ABF-8500-2020; Guo, Sheng-Yu/AAZ-2685-2021	Pang, Ka-Lai/0000-0003-4403-925X; Chiang, Michael W. L./0000-0001-7661-5560	Ministry of Science of Technology, Taiwan [MOST105-2621-M-019-002-, MOST1062621-M-019-002-]	Ministry of Science of Technology, Taiwan	Ka-Lai Pang thanks the Ministry of Science of Technology, Taiwan for financial support (MOST105-2621-M-019-002-, MOST1062621-M-019-002-).	Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; [Anonymous], 2019, R LANG ENV STAT COMP; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Bonifaz A, 2008, STUD MYCOL, P77, DOI 10.3114/sim.2008.61.07; Burgaud G, 2016, INT J SYST EVOL MICR, V66, P3600, DOI 10.1099/ijsem.0.001239; Burgaud G, 2013, AQUAT MICROB ECOL, V70, P45, DOI 10.3354/ame01638; Burgaud G, 2011, ANTON LEEUW INT J G, V100, P75, DOI 10.1007/s10482-011-9566-1; Burgaud G, 2010, FEMS MICROBIOL ECOL, V73, P121, DOI 10.1111/j.1574-6941.2010.00881.x; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chi WC, 2019, PEERJ, V7, DOI 10.7717/peerj.7293; Ciobanu MC, 2014, ISME J, V8, P2352, DOI 10.1038/ismej.2014.110; Comeau AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30120; Connell L, 2009, GEOMICROBIOL J, V26, P597, DOI 10.1080/01490450903316174; de Errasti A, 2014, FLORA, V209, P704, DOI 10.1016/j.flora.2014.07.006; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb VP, 2016, ISME J, V10, P2643, DOI 10.1038/ismej.2016.58; Edgcomb VP, 2011, ENVIRON MICROBIOL, V13, P172, DOI 10.1111/j.1462-2920.2010.02318.x; Ein-Gil N, 2009, ISME J, V3, P752, DOI 10.1038/ismej.2009.18; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Frohlich-Nowoisky J, 2012, BIOGEOSCIENCES, V9, P1125, DOI 10.5194/bg-9-1125-2012; Gaboyer F, 2019, ADV ASTROBIOL BIOGEO, P87, DOI 10.1007/978-3-319-96175-0_4; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gunde-Cimerman Nina, 2006, Reviews in Environmental Science and Bio/Technology, V5, P323, DOI 10.1007/s11157-006-9105-0; Herring P, 2001, BIOL DEEP OCEAN; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Cabanes FJ, 2012, MED MYCOL, V50, P852, DOI 10.3109/13693786.2012.679628; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jiang W, 2014, CURR ORG CHEM, V18, P925, DOI 10.2174/138527281807140515155705; Jones EBG, 2009, FUNGAL DIVERS, V35, P1; Jones EBG, 2008, BR MYCOL SY, V28, P301; Jones EBG, 2019, FUNGAL DIVERS, V96, P347, DOI 10.1007/s13225-019-00426-5; Jones EBG, 2015, FUNGAL DIVERS, V73, P1, DOI 10.1007/s13225-015-0339-4; Ka S, 2011, ZOOL STUD, V50, P155; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kassambara A, 2017, FACTOEXTRA EXTRACT V, V5, P1; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Liu CH, 2017, ENVIRON MICROBIOL, V19, P803, DOI 10.1111/1462-2920.13653; Marchetta A, 2018, LIFE-BASEL, V8, DOI 10.3390/life8030031; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Mohamed DJ, 2011, ISME J, V5, P379, DOI 10.1038/ismej.2010.137; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Pang KL, 2017, BOT MAR, V60, P361, DOI 10.1515/bot-2017-0048; Redou V, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00467-16; Redou V, 2015, APPL ENVIRON MICROB, V81, P3571, DOI 10.1128/AEM.04064-14; Redou V, 2014, FEMS MICROBIOL ECOL, V90, P908, DOI 10.1111/1574-6941.12447; Reeb D., 2010, Mycology - An International Journal on Fungal Biology, V1, P155, DOI 10.1080/21501203.2010.492531; Sakayaroj J, 2012, MAR FRESHW BOTANY, P291; Spiers AG, 1997, NEW ZEAL J CROP HORT, V25, P19, DOI 10.1080/01140671.1997.9513983; Sue PK, 2014, J CLIN MICROBIOL, V52, P4407, DOI 10.1128/JCM.02012-14; Suetrong S, 2010, STUD MYCOL, V64, P155; Takishita K, 2006, EXTREMOPHILES, V10, P165, DOI 10.1007/s00792-005-0495-7; Takishita K, 2007, EXTREMOPHILES, V11, P563, DOI 10.1007/s00792-007-0068-z; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tsang CC, 2016, MED MYCOL, V54, P699, DOI 10.1093/mmy/myw025; von Cosel R, 2008, RAFFLES B ZOOL, P105; Wang L, 2017, MICROB ECOL, V73, P571, DOI 10.1007/s00248-016-0898-2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Xu W, 2017, DEEP-SEA RES PT I, V123, P48, DOI 10.1016/j.dsr.2017.03.004; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469	67	17	17	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0226616	10.1371/journal.pone.0226616	http://dx.doi.org/10.1371/journal.pone.0226616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887170	Green Published, gold			2022-12-26	WOS:000515092200023
J	Liu, B; Wu, XZ; Zeng, RH; Yin, YH; Guo, TT; Xu, YN; Zhang, YZ; Leng, J; Ge, JH; Yu, G; Guo, JW; Zhou, YB				Liu, Bin; Wu, Xiangzhong; Zeng, Ruhui; Yin, Yehu; Guo, Tingting; Xu, Yineng; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Guo, Jinwei; Zhou, Yingbi			Prostaglandin E-2 sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature	FASEB JOURNAL			English	Article						EP3; gene deficiency; PGE(2); renal vasoconstriction; TP	CYCLOOXYGENASE-1-MEDIATED PROSTACYCLIN SYNTHESIS; ENDOTHELIUM-DEPENDENT CONTRACTION; VASOCONSTRICTOR ACTIVITY; EP4 RECEPTORS; ARTERIES; AORTA	Although recognized to have an in vivo vasodepressor effect blunted by the vasoconstrictor effect of E-prostanoid receptor-3 (EP3), prostaglandin E-2 (PGE(2)) evokes contractions of many vascular beds that are sensitive to antagonizing the thromboxane prostanoid receptor (TP). This study aimed to determine the direct effect of PGE(2) on renal arteries and/or the whole renal vasculature and how each of these two receptors is involved in the responses. Experiments were performed on isolated vessels and perfused kidneys of wild-type mice and/or mice with deficiency in TP (TP-/-), EP3 (EP3(-/-)), or both TP and EP3 (TP-/-/EP3(-/-)). Here we show that PGE(2) (0.001-30 mu M) evoked not only contraction of main renal arteries, but also a decrease of flow in perfused kidneys. EP3(-/-) diminished the response to 0.001-0.3 mu M PGE(2), while TP-/- reduced that to the prostanoid of higher concentrations. In TP-/-/EP3(-/-) vessels and perfused kidneys, PGE(2) did not evoke contraction but instead resulted in vasodilator responses. These results demonstrate that PGE(2) functions as an overall direct vasoconstrictor of the mouse renal vasculature with an effect reflecting the vasoconstrictor activities outweighing that of dilation. Also, our results suggest that EP3 dominates the vasoconstrictor effect of PGE(2) of low concentrations (<= 0.001-0.3 mu M), but its effect is further added by that of TP, which has a higher efficacy, although activated by higher concentrations (from 0.01 mu M) of the same prostanoid PGE(2).	[Liu, Bin; Wu, Xiangzhong; Zeng, Ruhui; Yin, Yehu; Guo, Tingting; Xu, Yineng; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Guo, Jinwei; Zhou, Yingbi] Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou, Peoples R China; [Zeng, Ruhui] Shantou Univ, Dept Gynaecol & Obstet, Affiliated Hosp 1, Med Coll, Shantou, Peoples R China	Shantou University; Shantou University	Zhou, YB (corresponding author), Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation of China (NSFC) [31771272, 81970433, 81770678]; Major Research Program for Universities of Guangdong province [2017KZDXM037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Research Program for Universities of Guangdong province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771272, 81970433 and 81770678; the Major Research Program for Universities of Guangdong province, Grant/Award Number: 2017KZDXM037	ARMSTRONG JM, 1976, EUR J PHARMACOL, V39, P251, DOI 10.1016/0014-2999(76)90133-3; Audoly LP, 2001, AM J PHYSIOL-HEART C, V280, pH327, DOI 10.1152/ajpheart.2001.280.1.H327; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924, DOI 10.1152/ajpheart.1999.277.3.H924; BAER PG, 1973, KIDNEY INT, V4, P12, DOI 10.1038/ki.1973.75; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; DUNN MJ, 1985, ADV PROSTAG THROMB L, V13, P179; Eskildsen MP, 2014, HYPERTENSION, V64, P551, DOI 10.1161/HYPERTENSIONAHA.113.03051; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Hockel G M, 1980, Adv Prostaglandin Thromboxane Res, V7, P1061; HOCKEL GM, 1980, HYPERTENSION, V2, P529, DOI 10.1161/01.HYP.2.4.529; Hristovska AM, 2007, HYPERTENSION, V50, P525, DOI 10.1161/HYPERTENSIONAHA.107.088948; Hu CJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01247; INSCHO EW, 1990, AM J PHYSIOL, V259, pF157, DOI 10.1152/ajprenal.1990.259.1.F157; Ishida K, 2012, PFLUG ARCH EUR J PHY, V463, P593, DOI 10.1007/s00424-012-1088-9; Jin J, 2017, LIFE SCI, V174, P68, DOI 10.1016/j.lfs.2017.03.001; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; Kida T, 2014, HEART VESSELS, V29, P390, DOI 10.1007/s00380-013-0374-6; Li SS, 2016, CLIN EXP PHARMACOL P, V43, P67, DOI 10.1111/1440-1681.12501; Li Z, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.17; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Longrois D, 2012, EUR J PHARMACOL, V681, P55, DOI 10.1016/j.ejphar.2012.01.041; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; MARTINEAU A, 1984, HYPERTENSION, V6, pI161, DOI 10.1161/01.HYP.6.2_Pt_2.I161; MCGIFF JC, 1976, FED PROC, V35, P2382; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nasjletti A, 1998, HYPERTENSION, V31, P194, DOI 10.1161/01.HYP.31.1.194; Purdy KE, 2000, AM J PHYSIOL-RENAL, V279, pF755, DOI 10.1152/ajprenal.2000.279.4.F755; Rifkind JM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00492; Schweda F, 2004, AM J PHYSIOL-RENAL, V287, pF427, DOI 10.1152/ajprenal.00072.2004; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; TAN SY, 1978, PROSTAG OTH LIPID M, V15, P139, DOI 10.1016/S0090-6980(78)80012-4; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Thibodeau JF, 2016, ANTIOXID REDOX SIGN, V25, P642, DOI 10.1089/ars.2015.6592; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; WATABE A, 1993, J BIOL CHEM, V268, P20175; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014	44	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2568	2578		10.1096/fj.201901611R	http://dx.doi.org/10.1096/fj.201901611R		DEC 2019	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908041	Bronze			2022-12-26	WOS:000503400200001
J	McDonald, IM; Grant, GD; East, MP; Gilbert, TSK; Wilkerson, EM; Goldfarb, D; Beri, J; Herring, LE; Vaziri, C; Cook, JG; Emanuele, MJ; Graves, LM				McDonald, Ian M.; Grant, Gavin D.; East, Michael P.; Gilbert, Thomas S. K.; Wilkerson, Emily M.; Goldfarb, Dennis; Beri, Joshua; Herring, Laura E.; Vaziri, Cyrus; Cook, Jeanette Gowen; Emanuele, Michael J.; Graves, Lee M.			Mass spectrometry?based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); cell cycle; protein kinase; inhibitor; cell proliferation; G2; M checkpoint; kinome profiling; maternal embryonic leucine zipper kinase (MELK); mitotic delay; multiplexed kinase inhibitor beads; mass spectrometry (MIB; MS); inhibitor selectivity; NVS-MELK8a; AMPK family	LEUCINE-ZIPPER KINASE; THERAPEUTIC TARGET; BREAST-CANCER; CYCLE; PHOSPHORYLATION; PROLIFERATION; KINOME; GROWTH; CHECKPOINT; DISCOVERY	The maternal embryonic leucine zipper kinase (MELK) has been implicated in the regulation of cancer cell proliferation. RNAi-mediated MELK depletion impairs growth and causes G(2)/M arrest in numerous cancers, but the mechanisms underlying these effects are poorly understood. Furthermore, the MELK inhibitor OTSSP167 has recently been shown to have poor selectivity for MELK, complicating the use of this inhibitor as a tool compound to investigate MELK function. Here, using a cell-based proteomics technique called multiplexed kinase inhibitor beads/mass spectrometry (MIB/MS), we profiled the selectivity of two additional MELK inhibitors, NVS-MELK8a (8a) and HTH-01-091. Our results revealed that 8a is a highly selective MELK inhibitor, which we further used for functional studies. Resazurin and crystal violet assays indicated that 8a decreases triple-negative breast cancer cell viability, and immunoblotting revealed that impaired growth is due to perturbation of cell cycle progression rather than induction of apoptosis. Using double-thymidine synchronization and immunoblotting, we observed that MELK inhibition delays mitotic entry, which was associated with delayed activation of Aurora A, Aurora B, and cyclin-dependent kinase 1 (CDK1). Following this delay, cells entered and completed mitosis. Using live-cell microscopy of cells harboring fluorescent proliferating cell nuclear antigen, we confirmed that 8a significantly and dose-dependently lengthens G(2) phase. Collectively, our results provide a rationale for using 8a as a tool compound for functional studies of MELK and indicate that MELK inhibition delays mitotic entry, likely via transient G(2)/M checkpoint activation.	[McDonald, Ian M.; East, Michael P.; Gilbert, Thomas S. K.; Wilkerson, Emily M.; Beri, Joshua; Herring, Laura E.; Emanuele, Michael J.; Graves, Lee M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Grant, Gavin D.; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Vaziri, Cyrus] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [McDonald, Ian M.; Grant, Gavin D.; East, Michael P.; Vaziri, Cyrus; Cook, Jeanette Gowen; Emanuele, Michael J.; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gilbert, Thomas S. K.; Wilkerson, Emily M.; Beri, Joshua; Herring, Laura E.; Graves, Lee M.] Univ N Carolina, UNC Michael Hooker Prote Core Facil, Chapel Hill, NC 27599 USA; [Goldfarb, Dennis] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Goldfarb, Dennis] Washington Univ, Sch Med, Inst Informat, St Louis, MO 63110 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL)	Graves, LM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Grant, Gavin/0000-0002-8958-2056; Gilbert, Thomas/0000-0002-6833-6788; Goldfarb, Dennis/0000-0002-1584-5423	National Institutes of Health [R01 CA199064, GM083024, GM102413, T32 CA009156]; UNC Dissertation Completion Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Dissertation Completion Fellowship	This work was supported by National Institutes of Health Grants R01 CA199064 (to L. M. G.), GM083024 and GM102413 (to J. G. C.), and T32 CA009156 (to G. D. G.). This work was also supported in part by a UNC Dissertation Completion Fellowship (to I. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642; Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Boutard N, 2019, BIOORG MED CHEM LETT, V29, P607, DOI 10.1016/j.bmcl.2018.12.051; Chartrain I, 2013, BIOL OPEN, V2, P1037, DOI 10.1242/bio.20136080; Chlenski A, 2019, MOL CANCER THER, V18, P507, DOI 10.1158/1535-7163.MCT-18-0819; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Chung SY, 2012, ONCOTARGET, V3, P1629; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Currie CE, 2018, CURR BIOL, V28, pR929, DOI 10.1016/j.cub.2018.07.040; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Edupuganti R, 2017, BIOORGAN MED CHEM, V25, P2609, DOI 10.1016/j.bmc.2017.03.018; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Giuliano CJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32838; Grant GD, 2018, CELL CYCLE, V17, P2496, DOI 10.1080/15384101.2018.1547001; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Graves PR, 2019, ACS CHEM BIOL, V14, P1020, DOI 10.1021/acschembio.9b00222; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Guan S, 2018, ONCOTARGET, V9, P2591, DOI 10.18632/oncotarget.23515; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Janostiak R, 2017, CELL REP, V21, P2829, DOI 10.1016/j.celrep.2017.11.033; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Krulikas LJ, 2018, SLAS DISCOV, V23, P850, DOI 10.1177/2472555218773045; Le Page Y, 2011, J CELL SCI, V124, P958, DOI 10.1242/jcs.069567; Li S, 2016, ONCOTARGET, V7, P6266, DOI 10.18632/oncotarget.6673; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meraldi P, 2019, EMBO J, V38, DOI 10.15252/embj.2019101912; Minata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092546; Mirey G, 2005, CELL CYCLE, V4, P806, DOI 10.4161/cc.4.6.1716; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Offenburger SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04375-4; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Pitner MK, 2017, EXPERT OPIN THER TAR, V21, P849, DOI 10.1080/14728222.2017.1363183; Raaijmakers JA, 2018, CELL REP, V22, P1424, DOI 10.1016/j.celrep.2018.01.034; Rodriguez-Rodriguez JA, 2018, CURR BIOL, V28, P3422, DOI 10.1016/j.cub.2018.10.006; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Toure BB, 2016, J MED CHEM, V59, P4711, DOI 10.1021/acs.jmedchem.6b00052; Wang YB, 2018, ISCIENCE, V9, P149, DOI 10.1016/j.isci.2018.10.015; Wang YB, 2016, P NATL ACAD SCI USA, V113, P9810, DOI 10.1073/pnas.1606862113; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Xia HP, 2016, CANCER LETT, V383, P85, DOI 10.1016/j.canlet.2016.09.017; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zhang G, 2019, EMBO J, V38, DOI 10.15252/embj.2018100977; Zhang Y, 2018, ONCOGENE, V37, P5520, DOI 10.1038/s41388-018-0333-x	69	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2359	2374		10.1074/jbc.RA119.011083	http://dx.doi.org/10.1074/jbc.RA119.011083			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31896573	Green Published, hybrid			2022-12-26	WOS:000517330200018
J	Erickson, SL; Alston, L; Nieves, K; Chang, TKH; Mani, S; Flannigan, KL; Hirota, SA				Erickson, Sarah L.; Alston, Laurie; Nieves, Kristoff; Chang, Thomas K. H.; Mani, Sridhar; Flannigan, Kyle L.; Hirota, Simon A.			The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins	FASEB JOURNAL			English	Article						Clostridioides difficile; eosinophils; neutrophils; Nr1i2; pregnane X receptor; toxin	NF-KAPPA-B; NEUTROPHIL RECRUITMENT; INTESTINAL INFLAMMATION; COLONIC INFLAMMATION; BARRIER FUNCTION; INFECTION; ACTIVATION; EOSINOPHILS; EXPRESSION; CELLS	Clostridioides difficile (formerly Clostridium difficile; C difficile), the leading cause of nosocomial antibiotic-associated colitis and diarrhea in the industrialized world, triggers colonic disease through the release two toxins, toxin A (TcdA) and toxin B (TcdB), glucosyltransferases that modulate monomeric G-protein function and alter cytoskeletal function. The initial degree of the host immune response to C difficile and its pathogenic toxins is a common indicator of disease severity and infection recurrence. Thus, targeting the intestinal inflammatory response during infection could significantly decrease disease morbidity and mortality. In the current study, we sought to interrogate the influence of the pregnane X receptor (PXR), a modulator of xenobiotic and detoxification responses, which can sense and respond to microbial metabolites and modulates inflammatory activity, during exposure to TcdA and TcdB. Following intrarectal exposure to TcdA/B, PXR-deficient mice (Nr1i2(-/-)) exhibited reduced survival, an effect that was associated with increased levels of innate immune cell influx. This exacerbated response was associated with a twofold increase in the expression of Tlr4. Furthermore, while broad-spectrum antibiotic treatment (to deplete the intestinal microbiota) did not alter the responses in Nr1i2(-/-) mice, blocking TLR4 signaling significantly reduced TcdA/B-induced disease severity and immune responses in these mice. Lastly, to assess the therapeutic potential of targeting the PXR, we activated the PXR with pregnenolone 16 alpha-carbonitrile (PCN) in wild-type mice, which greatly reduced the severity of TcdA/B-induced damage and intestinal inflammation. Taken together, these data suggest that the PXR plays a role in the host's response to TcdA/B and may provide a novel target to dampen the inflammatory tissue damage in C difficile infections.	[Erickson, Sarah L.; Alston, Laurie; Nieves, Kristoff; Flannigan, Kyle L.; Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Chang, Thomas K. H.] Univ British Columbia, Fac Pharmaceut Sciences, Vancouver, BC, Canada; [Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Hirota, Simon A.] Univ Calgary, Dept MicroBiol, Immunol, Infect Dis, Calgary, AB, Canada; Univ Calgary, Calgary, AB T2N 4N1, Canada	University of Calgary; University of British Columbia; Yeshiva University; Albert Einstein College of Medicine; University of Calgary; University of Calgary	Flannigan, KL; Hirota, SA (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Hirota, SA (corresponding author), Univ Calgary, Dept MicroBiol, Immunol, Infect Dis, Calgary, AB, Canada.	kyle.flannigan1@ucalgary.ca; shirota@ucalgary.ca		, Thomas/0000-0003-2167-5165	NCI NIH HHS [R01 CA222469] Funding Source: Medline; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [CA161879, CA222469] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)		Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Buonomo EL, 2016, CELL REP, V16, P432, DOI 10.1016/j.celrep.2016.06.007; Castagliuolo I, 1998, J IMMUNOL, V160, P6039; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Darkoh C, 2014, CLIN VACCINE IMMUNOL, V21, P509, DOI 10.1128/CVI.00770-13; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dheer R, 2016, INFECT IMMUN, V84, P798, DOI 10.1128/IAI.01374-15; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Esposito G, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00120; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Flannigan KL, 2017, MUCOSAL IMMUNOL, V10, P673, DOI 10.1038/mi.2016.80; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Garg A, 2016, J PHARMACOL EXP THER, V359, P91, DOI 10.1124/jpet.116.234096; Gerding DN, 2015, INFECT DIS CLIN N AM, V29, P37, DOI 10.1016/j.idc.2014.11.004; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Huang KZ, 2018, PEDIATR RES, V83, P1031, DOI 10.1038/pr.2018.14; Hudson GM, 2017, BRIT J PHARMACOL, V174, P1857, DOI 10.1111/bph.13787; Hung YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069577; Hunt JJ, 2013, MICROBIOL MOL BIOL R, V77, P567, DOI 10.1128/MMBR.00017-13; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jefferson KK, 1999, J IMMUNOL, V163, P5183; Jose S, 2016, ANAEROBE, V41, P85, DOI 10.1016/j.anaerobe.2016.04.001; KELLY CP, 1994, J CLIN INVEST, V93, P1257, DOI 10.1172/JCI117080; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Kim J, 2017, ANN LAB MED, V37, P53, DOI 10.3343/alm.2017.37.1.53; Lamas B, 2018, MUCOSAL IMMUNOL, V11, P1024, DOI 10.1038/s41385-018-0019-2; Lee JY, 2007, J MOL MED-JMM, V85, P1393, DOI 10.1007/s00109-007-0237-7; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LYERLY DM, 1982, INFECT IMMUN, V35, P1147, DOI 10.1128/IAI.35.3.1147-1150.1982; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McDermott AJ, 2017, IMMUNOLOGY, V150, P468, DOI 10.1111/imm.12700; Miller KA, 2019, P NATL ACAD SCI USA, V116, P5955, DOI 10.1073/pnas.1814047116; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Pawlowski SW, 2010, J INFECT DIS, V202, P1708, DOI 10.1086/657086; Peretz A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1618-8; Qiu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31936; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ranhotra H.S, 2016, NUCL RECEPTOR RES, V3; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Terc J, 2014, EUR J PHARM SCI, V55, P12, DOI 10.1016/j.ejps.2014.01.007; van Beurden YH, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.07.025; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	63	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2198	2212		10.1096/fj.201902083RR	http://dx.doi.org/10.1096/fj.201902083RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907988	Green Published, hybrid			2022-12-26	WOS:000514663600019
J	Louis, M; Treger, K; Ashby, T; Smotherman, C; Gautum, S; Seeram, V; Cury, J; Jones, L				Louis, Mariam; Treger, Kasey; Ashby, Tracy; Smotherman, Carmen; Gautum, Shiva; Seeram, Vandana; Cury, James; Jones, Lisa			Patient-related factors may influence nursing perception of sleep in the Intensive Care Unit	PLOS ONE			English	Article							NURSES	Objective There exist conflicting data regarding the accuracy of ICU nurses accurately assessing patient sleep using validated questionnaires. Using the Richards-Campbell Sleep Questionnaire (RSQ), we hypothesize that patient factors might influence nursing perception of their sleep. Methods Patients in the ICU who met the inclusion criteria were asked to complete the sleep questionnaire, as were their nurses and intraclass correlation analysis was done. Results 38 paired patient-nurse surveys were included for analysis. The mean difference in total average score of the RSQ was not significantly different between patients and nurses. There was fair intraclass correlation by patient age, black race, and admission for respiratory illnesses. A good intraclass correlation existed for non-blacks and admission for nonrespiratory reasons. Most striking was the intraclass correlation by sex, with poor intraclass correlation for women compared to an excellent correlation for men. Conclusion The results of our study confirm that patients in our ICU have poor sleep with a fair intraclass correlation. When examined by patient related factor, the greatest divergence between patient and nursing perception of sleep in the ICU using the RCSQ was patient female sex. More research is needed in this area to better understand the divergence and improve sleep in the ICU.	[Louis, Mariam; Treger, Kasey; Ashby, Tracy; Smotherman, Carmen; Gautum, Shiva; Seeram, Vandana; Cury, James; Jones, Lisa] Univ Florida, UF Hlth Clin Ctr, Jacksonville, FL 32209 USA	State University System of Florida; University of Florida	Louis, M (corresponding author), Univ Florida, UF Hlth Clin Ctr, Jacksonville, FL 32209 USA.	Mariam.louis@jax.ufl.edu						Aitken LM, 2017, AUST CRIT CARE, V30, P59, DOI 10.1016/j.aucc.2016.04.001; Boyko Y, 2017, J CRIT CARE, V37, P99, DOI 10.1016/j.jcrc.2016.09.005; Campbell C, 1986, THESIS; Elliott R, 2013, CRIT CARE, V17, DOI 10.1186/cc12565; Freedman NS, 1999, AM J RESP CRIT CARE, V159, P1155, DOI 10.1164/ajrccm.159.4.9806141; Friese RS, 2008, CRIT CARE MED, V36, P697, DOI 10.1097/CCM.0B013E3181643F29; Frisk Ulla, 2003, Intensive Crit Care Nurs, V19, P342; Goel N, 2005, CHRONOBIOL INT, V22; Kamdar BB, 2012, J INTENSIVE CARE MED, V27; Kamdar BB, 2012, AM J CRIT CARE, V21, P261, DOI 10.4037/ajcc2012111; Mong JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0110; Nesbitt L, 2014, INTENS CRIT CARE NUR, V30, P231, DOI 10.1016/j.iccn.2013.12.005; Nicolas Ana, 2008, Nurs Crit Care, V13, P25, DOI 10.1111/j.1478-5153.2007.00255.x; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; Pulak LM, 2016, J INTENSIVE CARE MED, V31, P14, DOI 10.1177/0885066614538749; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Richards K C, 2000, J Nurs Meas, V8, P131; Ritmala-Castren M, 2017, NURS CRIT CARE, V22, P238, DOI 10.1111/nicc.12102; Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226323	10.1371/journal.pone.0226323	http://dx.doi.org/10.1371/journal.pone.0226323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905204	Green Published, gold			2022-12-26	WOS:000534327700006
J	Tanaka, N; Takahara, A; Hagio, T; Nishiko, R; Kanayama, J; Gotoh, O; Mori, S				Tanaka, Norio; Takahara, Akihisa; Hagio, Taichi; Nishiko, Rika; Kanayama, Junko; Gotoh, Osamu; Mori, Seiichi			Sequencing artifacts derived from a library preparation method using enzymatic fragmentation	PLOS ONE			English	Article							MUTATIONAL PROCESSES; SIGNATURES; DISCOVERY; CANCER; BIAS	DNA fragmentation is a fundamental step during library preparation in hybridization capture-based, short-read sequencing. Ultra-sonication has been used thus far to prepare DNA of an appropriate size, but this method is associated with a considerable loss of DNA sample. More recently, studies have employed library preparation methods that rely on enzymatic fragmentation with DNA endonucleases to minimize DNA loss, particularly in nano-quantity samples. Yet, despite their wide use, the effect of enzymatic fragmentation on the resultant sequences has not been carefully assessed. Here, we used pairwise comparisons of somatic variants of the same tumor DNA samples prepared using ultrasonic and enzymatic fragmentation methods. Our analysis revealed a substantially larger number of recurrent artifactual SNVs/indels in endonuclease-treated libraries as compared with those created through ultrasonication. These artifacts were marked by palindromic structure in the genomic context, positional bias in sequenced reads, and multi-nucleotide substitutions. Taking advantage of these distinctive features, we developed a filtering algorithm to distinguish genuine somatic mutations from artifactual noise with high specificity and sensitivity. Noise cancelling recovered the composition of the mutational signatures in the tumor samples. Thus, we provide an informatics algorithm as a solution to the sequencing errors produced as a consequence of endonuclease-mediated fragmentation, highlighted for the first time in this study.	[Tanaka, Norio; Takahara, Akihisa; Hagio, Taichi; Nishiko, Rika; Kanayama, Junko; Gotoh, Osamu; Mori, Seiichi] Japanese Fdn Canc Res, Project Dev Innovat Res Canc Therapeut, Canc Precis Med Ctr, Koto Ku, Tokyo, Japan; [Takahara, Akihisa; Hagio, Taichi] Data4Cs Co Ltd, Minato Ku, Tokyo, Japan	Japanese Foundation for Cancer Research	Mori, S (corresponding author), Japanese Fdn Canc Res, Project Dev Innovat Res Canc Therapeut, Canc Precis Med Ctr, Koto Ku, Tokyo, Japan.	seiichi.mori@jfcr.or.jp		Tanaka, Norio/0000-0003-2724-8009	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP15K06861, JP17K18337, JP18K07338]; JSPS KAKENHI [JP15K06861, JP17K18337, JP18K07338]; Data4C's co. ltd.	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Data4C's co. ltd.	MEXT vertical bar Japan Society for the Promotion of Science (JSPS) - JP15K06861 [S. M.]; MEXT vertical bar Japan Society for the Promotion of Science (JSPS) - JP17K18337 [O. G.]; MEXT vertical bar Japan Society for the Promotion of Science (JSPS) - JP18K07338 [S. M.]. This work was supported by JSPS KAKENHI Grant Numbers JP17K18337, JP15K06861, and JP18K07338. Data4C's co. ltd. was neither funding nor funded by any governmental research funding agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Whereas Data4C's co. ltd. provided support in the form of salaries for authors A.T. and T.H., Japanese Foundation for Cancer Research paid to Data4C's co. ltd. as a business consignment for their assisting analytic parts of this work.	Abnizova I., 2017, J PROTEOM BIOINFORM, V10, DOI [10.4172/jpb.1000420, DOI 10.4172/JPB.1000420]; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Chen GL, 2014, MOL DIAGN THER, V18, P587, DOI 10.1007/s40291-014-0115-2; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/NEMTH.2762, 10.1038/nmeth.2762]; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma XT, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1659-6; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Roberts R, 1993, NUCLEASES, P35; Taber KAJ, 2014, JAMA INTERN MED, V174, P275, DOI 10.1001/jamainternmed.2013.12048; Tate JG, 2010, NUCLEIC ACIDS RES, V38, P164; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227427	10.1371/journal.pone.0227427	http://dx.doi.org/10.1371/journal.pone.0227427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899787	gold, Green Published			2022-12-26	WOS:000534322000027
J	Xu, PL; Tang, GY; Cui, WP; Chen, GX; Ma, CL; Zhu, JQ; Li, PX; Shan, L; Liu, ZJ; Wan, SB				Xu, Pingli; Tang, Guiying; Cui, Weipei; Chen, Guangxia; Ma, Chang-Le; Zhu, Jieqiong; Li, Pengxiang; Shan, Lei; Liu, Zhanji; Wan, Shubo			Transcriptional Differences in Peanut (Arachis hypogaea L.) Seeds at the Freshly Harvested, After-ripening and Newly Germinated Seed Stages: Insights into the Regulatory Networks of Seed Dormancy Release and Germination	PLOS ONE			English	Article							ABSCISIC-ACID; GENE-EXPRESSION; NEGATIVE REGULATOR; PROTEIN OXIDATION; RNA-SEQ; REVEALS; ABA; BRASSINOSTEROIDS; MECHANISM; ROLES	Seed dormancy and germination are the two important traits related to plant survival, reproduction and crop yield. To understand the regulatory mechanisms of these traits, it is crucial to clarify which genes or pathways participate in the regulation of these processes. However, little information is available on seed dormancy and germination in peanut. In this study, seeds of the variety Luhua No.14, which undergoes nondeep dormancy, were selected, and their transcriptional changes at three different developmental stages, the freshly harvested seed (FS), the after-ripening seed (DS) and the newly germinated seed (GS) stages, were investigated by comparative transcriptomic analysis. The results showed that genes with increased transcription in the DS vs FS comparison were overrepresented for oxidative phosphorylation, the glycolysis pathway and the tricarboxylic acid (TCA) cycle, suggesting that after a period of dry storage, the intermediates stored in the dry seeds were rapidly mobilized by glycolysis, the TCA cycle, the glyoxylate cycle, etc.; the electron transport chain accompanied by respiration was reactivated to provide ATP for the mobilization of other reserves and for seed germination. In the GS vs DS pairwise comparison, dozens of the upregulated genes were related to plant hormone biosynthesis and signal transduction, including the majority of components involved in the auxin signal pathway, brassinosteroid biosynthesis and signal transduction as well as some GA and ABA signal transduction genes. During seed germination, the expression of some EXPANSIN and XYLOGLUCAN ENDOTRANSGLYCOSYLASE genes was also significantly enhanced. To investigate the effects of different hormones during seed germination, the contents and differential distribution of ABA, GAs, BRs and IAA in the cotyledons, hypocotyls and radicles, and plumules of three seed sections at different developmental stages were also investigated. Combined with previous data in other species, it was suggested that the coordination of multiple hormone signal transduction nets plays a key role in radicle protrusion and seed germination.	[Xu, Pingli; Tang, Guiying; Cui, Weipei; Zhu, Jieqiong; Li, Pengxiang; Shan, Lei; Wan, Shubo] Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China; [Cui, Weipei; Ma, Chang-Le; Zhu, Jieqiong; Li, Pengxiang; Shan, Lei; Wan, Shubo] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China; [Chen, Guangxia] Shandong Acad Grape, Jinan, Shandong, Peoples R China; [Liu, Zhanji] Shandong Acad Agr Sci, Shandong Cotton Res Ctr, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences	Shan, L; Wan, SB (corresponding author), Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China.; Shan, L; Wan, SB (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.; Liu, ZJ (corresponding author), Shandong Acad Agr Sci, Shandong Cotton Res Ctr, Jinan, Shandong, Peoples R China.	shlei1025@sina.com; scrcliuzhanji@sina.com; wansb@saas.ac.cn			Agricultural Scientific and Technological Innovation project of Shandong Academy of Agricultural Sciences; National Natural Science Foundation of China [31470349, 31171621]	Agricultural Scientific and Technological Innovation project of Shandong Academy of Agricultural Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agricultural Scientific and Technological Innovation project of Shandong Academy of Agricultural Sciences, and the National Natural Science Foundation of China (31470349 and 31171621).	Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Bellieny-Rabelo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep36009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchanan BB, 2000, BIOCH MOL BIOL PLANT, P679; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DC, 2016, PLANT PHYSIOL, V172, P2347, DOI 10.1104/pp.16.00384; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen F, 2002, J EXP BOT, V53, P215, DOI 10.1093/jexbot/53.367.215; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; [陈高 Chen Gao], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P214; Chen YT, 2013, PLANT J, V75, P965, DOI 10.1111/tpj.12259; Chitnis VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087543; Dekkers BJW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01323; Dekkers BJW, 2013, PLANT PHYSIOL, V163, P205, DOI 10.1104/pp.113.223511; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hu YR, 2014, PLANT CELL, V26, P4394, DOI 10.1105/tpc.114.130849; Issa F, 2010, AFR J BIOTECHNOL, V9, P1905; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Leubner-Metzger G, 2001, PLANTA, V213, P758, DOI 10.1007/s004250100542; Liu Y, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0638-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Luo CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10041; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; Meimoun P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086442; Muller K, 2006, PLANT CELL PHYSIOL, V47, P864, DOI 10.1093/pcp/pcj059; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nelson SK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02158; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ni DA, 2001, CELL RES, V11, P273, DOI 10.1038/sj.cr.7290096; Nie SM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01386; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh E, 2014, ELIFE, V3, DOI 10.7554/eLife.03031; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rigas S, 2013, NEW PHYTOL, V197, P1130, DOI 10.1111/nph.12092; Shu K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003577; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Walcher CL, 2012, PLANT PHYSIOL, V158, P273, DOI 10.1104/pp.111.187559; Wang YJ, 2014, MOL GENET GENOMICS, V289, P1, DOI 10.1007/s00438-013-0797-x; Wei T, 2015, BIOCHEM BIOPH RES CO, V464, P176, DOI 10.1016/j.bbrc.2015.06.110; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	64	5	7	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0219413	10.1371/journal.pone.0219413	http://dx.doi.org/10.1371/journal.pone.0219413			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899920	gold, Green Published			2022-12-26	WOS:000534322000002
J	Birkner, B; Rech, J; Stargardt, T				Birkner, Benjamin; Rech, Juergen; Stargardt, Tom			Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis	PLOS ONE			English	Article							ADALIMUMAB PLUS METHOTREXATE; DOUBLE-BLIND; ECONOMIC-EVALUATION; EULAR RECOMMENDATIONS; CONTINGENT VALUATION; PARALLEL-GROUP; PHASE-III; ETANERCEPT; REMISSION; SAFETY	Objective Recent guideline updates have suggested de-escalating DMARDs when patients with rheumatoid arthritis achieve remission or low disease activity. We aim to evaluate whether it is cost-effective to de-escalate the biological form of DMARDs (bDMARDs). Methods Using a Markov model, we performed a cost-utility analysis for RA patients on bDMARD treatment. We compared continuing treatment (standard care) to a tapering approach (i.e., an immediate 50% dose reduction), withdrawal (i.e., an immediate 100% dose reduction) and tapering followed by withdrawal of bDMARDs. The parametrization is based on a comprehensive literature review. Results were computed for 30 years with a cycle length of three months. We applied the payer's perspective for Germany and conducted deterministic and probabilistic sensitivity analyses. Results Tapering or withdrawing bDMARD treatment resulted in ICERs of (sic)526,254 (incr. costs -78,845, incr. QALYs -0.1498) or (sic)216,879 (incr. costs -(sic)121,691, incr. QALYs -0.5611) compared to standard care. Tapering followed by withdrawal resulted in a loss of 0.4354 QALYs and savings of (sic)107,969 per patient, with an ICER of (sic)247,987. Deterministic sensitivity analysis revealed that our results remained largely unaffected by parameter changes. Probabilistic sensitivity analysis suggests that tapering, withdrawal and tapering followed by withdrawal were dominant in 39.8%, 28.2% and 29.0% of 10,000 iterations. Conclusion Our findings suggest that de-escalating bDMARDs in patients with RA may result in high cost savings but also a decrease in quality of life compared to standard care. If decision makers choose to implement de-escalation in daily practice, our results suggest the tapering approach.	[Birkner, Benjamin; Stargardt, Tom] Univ Hamburg, HCHE, Hamburg, Germany; [Rech, Juergen] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med, Erlangen, Germany; Univ Klinikum Erlangen, Rheumatol & Immunol, Erlangen, Germany	University of Hamburg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Birkner, B (corresponding author), Univ Hamburg, HCHE, Hamburg, Germany.	benjamin.birkner@uni-hamburg.de		Birkner, Benjamin/0000-0002-4452-4733				Ahlert M, 2016, SOC SCI MED, V150, P40, DOI 10.1016/j.socscimed.2015.11.055; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Albrecht K, 2017, Z RHEUMATOL, V76, P50, DOI 10.1007/s00393-016-0156-5; Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; [Anonymous], 2016, HERC DATABASE MAPPIN; Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Boger RH, 2016, ARZNEIVERORDNUNGS RE, P369, DOI [10.1007/978-3-662-50351-5_19, DOI 10.1007/978-3-662-50351-5_19]; Briggs A., 2011, DECISION MODELLING H; Carthy T, 1998, J RISK UNCERTAINTY, V17, P187, DOI 10.1023/A:1007782800868; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2014, NEW ENGL J MED, V371, P1781, DOI 10.1056/NEJMoa1316133; Fautrel B, 2016, JOINT BONE SPINE, V83, P53, DOI 10.1016/j.jbspin.2015.02.023; Fiehn C, 2018, Z RHEUMATOL, V77, pS35, DOI 10.1007/s00393-018-0481-y; Filipovic-Pierucci A, 2017, ARXIV170203252TAT; Haschka J, 2016, ANN RHEUM DIS, V75, P45, DOI 10.1136/annrheumdis-2014-206439; Hense S, 2016, Z RHEUMATOL, V75, P819, DOI 10.1007/s00393-016-0088-0; Horslev-Petersen K, 2014, ANN RHEUM DIS, V73, P654, DOI 10.1136/annrheumdis-2012-202735; Huscher D, 2015, ANN RHEUM DIS, V74, P738, DOI 10.1136/annrheumdis-2013-204311; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jonsson B, 2008, EUR J HEALTH ECON, V8, pS61, DOI 10.1007/s10198-007-0089-7; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Keystone EC, 2016, RHEUMATOLOGY, V55, P327, DOI 10.1093/rheumatology/kev338; Kim HY, 2012, INT J RHEUM DIS, V15, P188, DOI 10.1111/j.1756-185X.2011.01680.x; Kobelt G, 2014, VALUE HEALTH, V17, P537, DOI 10.1016/j.jval.2014.04.005; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kuijper TM, 2015, J RHEUMATOL, V42, P2012, DOI 10.3899/jrheum.141520; Lau CS, 2015, INT J RHEUM DIS, V18, P685, DOI 10.1111/1756-185X.12754; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; Lundkvist J, 2008, EUR J HEALTH ECON, V8, pS49, DOI 10.1007/s10198-007-0088-8; Machado DA, 2014, JCR-J CLIN RHEUMATOL, V20, P25, DOI 10.1097/RHU.0000000000000055; Markusse IM, 2014, CLIN RHEUMATOL, V33, P1155, DOI 10.1007/s10067-014-2500-y; Nam JL, 2014, ANN RHEUM DIS, V73, P1027, DOI 10.1136/annrheumdis-2013-204882; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Neubauer S, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0032-4; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; Rubbert-Roth A, 2010, RHEUMATOLOGY, V49, P1683, DOI 10.1093/rheumatology/keq116; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; Tanaka Y, 2015, ANN RHEUM DIS, V74, P389, DOI 10.1136/annrheumdis-2013-204016; Tran-Duy A, 2018, ARTHRITIS RHEUMATOL, V70, P1557, DOI 10.1002/art.40546; VANHERWAARDEN N, 2015, BMJ-BRIT MED J, V350, P1389, DOI DOI 10.1136/BMJ.H1389; Vanier A, 2017, VALUE HEALTH, V20, P577, DOI 10.1016/j.jval.2017.01.005; Welsing PMJ, 2006, PHARMACOECONOMICS, V24, P1011, DOI 10.2165/00019053-200624100-00008; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090	55	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226754	10.1371/journal.pone.0226754	http://dx.doi.org/10.1371/journal.pone.0226754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895926	Green Published, gold			2022-12-26	WOS:000534267300009
J	Hatta, D; Shirotani, K; Hori, Y; Kurotaki, N; Iwata, N				Hatta, Daisuke; Shirotani, Keiro; Hori, Yuma; Kurotaki, Naohiro; Iwata, Nobuhisa			Activity-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons	FASEB JOURNAL			English	Article						calcium signaling; glutamate; neuronal excitation; NMDA receptor; proteolysis	PAROXYSMAL KINESIGENIC DYSKINESIA; MUTATIONS; DYSFUNCTION; CHANNELS	Mutations of PRRT2 (proline-rich transmembrane protein 2) cause several neurological disorders, represented by paroxysmal kinesigenic dyskinesia (PKD), which is characterized by attacks of involuntary movements triggered by sudden voluntary movements. PRRT2 is reported to suppress neuronal excitation, but it is unclear how the function of PRRT2 is modulated during neuronal excitation. We found that PRRT2 is processed to a 12 kDa carboxy-terminal fragment (12K-CTF) by calpain, a calcium-activated cysteine protease, in a neuronal activity-dependent manner, predominantly via NMDA receptors or voltage-gated calcium channels. Furthermore, we clarified that 12K-CTF is generated by sequential cleavages at Q220 and S244. The amino-terminal fragment (NTF) of PRRT2, which corresponds to PKD-related truncated mutants, is not detected, probably due to rapid cleavage at multiple positions. Given that 12K-CTF lacks most of the proline-rich domain, this cleavage might be involved in the activity-dependent enhancement of neuronal excitation perhaps through transient retraction of PRRT2's function. Therefore, PRRT2 might serve as a buffer for neuronal excitation, and lack of this function in PKD patients might cause neuronal hyperexcitability in their motor circuits.	[Hatta, Daisuke; Shirotani, Keiro; Hori, Yuma; Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, 1-14 Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan; [Kurotaki, Naohiro] Kagawa Univ, Grad Sch Med, Dept Clin Psychiat, Takamatsu, Kagawa, Japan	Nagasaki University; Kagawa University	Iwata, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, 1-14 Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan.	iwata-n@nagasaki-u.ac.jp			Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED) [JP16ek0109119h]; Japan Society for the Promotion of Science (JSPS) [18H02720]	Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP16ek0109119h; Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18H02720	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Atlas D, 2014, TRENDS BIOCHEM SCI, V39, P45, DOI 10.1016/j.tibs.2013.12.005; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Choi SM, 2016, J MOV DISORD, V9, P80, DOI 10.14802/jmd.16004; Coleman J, 2018, CELL REP, V22, P820, DOI 10.1016/j.celrep.2017.12.056; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; duVerle David, 2010, V22, P202; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Ebrahimi-Fakhari D, 2015, BRAIN, V138, P3476, DOI 10.1093/brain/awv317; EDMUNDS T, 1991, BIOCHIM BIOPHYS ACTA, V1077, P197, DOI 10.1016/0167-4838(91)90059-9; Fairless R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058260; Friedman LK, 2003, NEUROCHEM INT, V43, P179, DOI 10.1016/S0197-0186(03)00005-6; Fruscione F, 2018, BRAIN, V141, P1000, DOI 10.1093/brain/awy051; Gardiner AR, 2015, BRAIN, V138, P3567, DOI 10.1093/brain/awv310; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Itoh M, 2006, BIOTECHNIQUES, V41, P44, DOI 10.2144/000112209; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Ji ZS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-146; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kita M, 2017, MOV DISORD CLIN PRAC, V4, P625, DOI 10.1002/mdc3.12500; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li M, 2015, INT J MOL SCI, V16, P9134, DOI 10.3390/ijms16059134; Liu YT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00831; Liu YT, 2016, ONCOTARGET, V7, P39184, DOI 10.18632/oncotarget.9258; Ma HY, 2018, EPILEPSIA, V59, P1621, DOI 10.1111/epi.14511; Marini C, 2012, NEUROLOGY, V79, P2109, DOI 10.1212/WNL.0b013e3182752ca2; Michetti C, 2017, NEUROBIOL DIS, V99, P66, DOI 10.1016/j.nbd.2016.12.018; Mo J, 2019, NEUROBIOL DIS, V121, P274, DOI 10.1016/j.nbd.2018.10.011; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Ono S, 2012, J HUM GENET, V57, P338, DOI 10.1038/jhg.2012.23; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Otsuki T, 2005, DNA RES, V12, P117, DOI 10.1093/dnares/12.2.117; Rossi P, 2016, J BIOL CHEM, V291, P6111, DOI 10.1074/jbc.M115.683888; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shinkai-Ouchi F, 2016, MOL CELL PROTEOMICS, V15, P1262, DOI 10.1074/mcp.M115.053413; Tan GH, 2018, CELL RES, V28, P90, DOI 10.1038/cr.2017.128; Valente P, 2018, CEREB CORTEX, P1; Valente P, 2016, CELL REP, V15, P117, DOI 10.1016/j.celrep.2016.03.005; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Wu L, 2014, PARKINSONISM RELAT D, V20, P1399, DOI 10.1016/j.parkreldis.2014.10.012; Yan M, 2016, MOL MED REP, V13, P2499, DOI 10.3892/mmr.2016.4819	50	2	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					180	191		10.1096/fj.201902148R	http://dx.doi.org/10.1096/fj.201902148R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914621	Green Submitted, Bronze			2022-12-26	WOS:000507308900014
J	Leite, DM; Baskovic, BZ; Civita, P; Neto, C; Gumbleton, M; Pilkington, GJ				Leite, Diana M.; Zvar Baskovic, Barbara; Civita, Prospero; Neto, Catia; Gumbleton, Mark; Pilkington, Geoffrey J.			A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics	FASEB JOURNAL			English	Article						3D co-culture; drug resistance; human serum; hyaluronic acid hydrogel	CANCER-CELLS; GLIOMA; PROLIFERATION; MATRIX; HYALURONAN; TEMOZOLOMIDE; EXPRESSION; PHENOTYPE; CULTURE; TARGET	Despite the importance of the tumor microenvironment in regulating tumor progression, few in vitro models have been developed to understand the effects of non-neoplastic cells and extracellular matrix (ECM) on drug resistance in glioblastoma (GBM) cells. Using CellTrace-labeled human GBM and microglial (MG) cells, we established a 2D co-culture including various ratios of the two cell types. Viability, proliferation, migration, and drug response assays were carried out to assess the role of MG. A 3D model was then established using a hyaluronic acid-gelatin hydrogel to culture a mixture of GBM and MG and evaluate drug resistance. A contact co-culture of fluorescently labeled GBM and MG demonstrated that MG cells modestly promoted tumor cell proliferation (17%-30% increase) and greater migration of GBM cells (>1.5-fold increase). Notably, the presence of MG elicited drug resistance even when in a low ratio (10%-20%) relative to co-cultured tumor cells. The protective effect of MG on GBM was greater in the 3D model (>100% survival of GBM when challenged with cytotoxics). This new 3D human model demonstrated the influence of non-neoplastic cells and matrix on chemoresistance of GBM cells to three agents with different mechanisms of action suggesting that such sophisticated in vitro approaches may facilitate improved preclinical testing.	[Leite, Diana M.; Civita, Prospero; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Brain Tumour Res Ctr, IBBS, White Swan Rd, Portsmouth PO1 2DT, Hants, England; [Zvar Baskovic, Barbara] Univ Ljubljana, Biotehn Fak, Ljubljana, Slovenia; [Civita, Prospero] Fdn Pisana Sci ONLUS, Genom Sect, Pisa, Italy; [Neto, Catia; Gumbleton, Mark] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales; [Leite, Diana M.] UCL, Dept Chem, London, England	University of Portsmouth; University of Ljubljana; Cardiff University; University of London; University College London	Pilkington, GJ (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Brain Tumour Res Ctr, IBBS, White Swan Rd, Portsmouth PO1 2DT, Hants, England.	geoff.pilkington@port.ac.uk	Civita, Prospero/AAU-6170-2020; Neto, Catia/CAH-0167-2022; Leite, Diana Moreira/Z-1844-2018; Gumbleton, Mark/J-3861-2014	Neto, Catia/0000-0002-4693-3960; Leite, Diana Moreira/0000-0002-6017-6433; Civita, Prospero/0000-0002-8313-1094; Gumbleton, Mark/0000-0002-7386-311X	Jake McCarthy Foundation; Brain Tumour Research	Jake McCarthy Foundation; Brain Tumour Research	Jake McCarthy Foundation, Grant/Award Number: N/A; Brain Tumour Research, Grant/Award Number: N/A	An Q, 2014, NEURO-ONCOLOGY, V16, P265, DOI 10.1093/neuonc/not202; Beaney RP, 2005, J CLIN ONCOL, V23, p122S; Begum J, 2013, CYTOM PART A, V83, P1085, DOI 10.1002/cyto.a.22403; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Bolteus A J, 2001, Curr Neurol Neurosci Rep, V1, P225, DOI 10.1007/s11910-001-0022-x; Boyle FM, 2004, NEURO-ONCOLOGY, V6, P300, DOI 10.1215/S1152851703000516; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen W, 2015, MED ONCOL, V32, P1; da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025; Daley E, 2005, BIOCHEM BIOPH RES CO, V328, P623, DOI 10.1016/j.bbrc.2005.01.028; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; EMERMAN JT, 1987, IN VITRO CELL DEV B, V23, P134, DOI 10.1007/BF02623594; Gomez-Roman N, 2017, NEURO-ONCOLOGY, V19, P229, DOI 10.1093/neuonc/now164; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Herrera-Perez RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194183; Higgins SC, 2016, NEURO-ONCOLOGY, V18, P54; Hill R, 2016, RESIST TARGET ANTI-C, V11, P107, DOI 10.1007/978-3-319-46505-0_6; Howarth A, 2019, BRAIN PATHOL, P1; Ivanov DP, 2015, J BIOTECHNOL, V205, P3, DOI 10.1016/j.jbiotec.2015.01.002; Jadin L, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.07; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jassam SA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071474; Jassam SA, 2016, NEURO-ONCOLOGY, V18, P679, DOI 10.1093/neuonc/nov248; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Leiss L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3109-8; Lisi L, 2014, ASN NEURO, V6, DOI 10.1042/AN20130045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; Maherally Z, 2018, FASEB J, V32, P168, DOI 10.1096/fj.201700162R; Meredith EJ, 2005, FASEB J, V19, P1187, DOI 10.1096/fj.04-3477fje; Murray SA, 2010, SIGNIFICANCE SERUM S; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Papapetrou EP, 2016, NAT MED, V22, P1392, DOI 10.1038/nm.4238; Parker K., 2006, RADIOL ONCOL, V40, P87; Pedron S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700529; Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024; Pilkington G.J., 2006, RADIOL ONCOL, V40, P73; Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006; PLOWMAN J, 1994, CANCER RES, V54, P3793; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rolon-Reyes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131059; Shchors K, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.012; Smith RC, 2019, CELL STEM CELL, V24, P12, DOI 10.1016/j.stem.2018.11.012; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Xiao WK, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2016-0094; Yang N, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0278-y; Yoo KC, 2018, ONCOGENE, V37, P3317, DOI 10.1038/s41388-018-0199-y; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zhu W, 2016, CARCINOGENESIS, V37, P839, DOI 10.1093/carcin/bgw068	60	30	30	7	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1710	1727		10.1096/fj.201901858RR	http://dx.doi.org/10.1096/fj.201901858RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914660	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000507308900113
J	Ma, ZY; Guo, XJ; Liu, JP				Ma, Zongyuan; Guo, Xiaojiao; Liu, Jipeng			Translocator protein mediates olfactory repulsion	FASEB JOURNAL			English	Article						attraction; GPCR; migratory locusts; olfaction; tyramine receptor	18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTOR; COUPLED RECEPTOR; BINDING; LOCALIZATION; EXPRESSION; ALZHEIMERS; LOCUST; ACTIVATION; LIGANDS	Translocator protein (TSPO, 18kDa), which was previously known as a peripheral-type benzodiazepine receptor, is associated with psychiatric disorders and acts as a neuroimaging biomarker. However, its function and mechanism in modulating behaviors are less well-known. Herein, we found that TSPO in migratory locusts shows conserved protein traits and is expressed at high levels in the brains. The expression levels of tspo mRNA and protein were higher in brains of solitary locusts than those in gregarious locusts, whereas the mRNA and protein expression levels remained stable during crowding and isolation, suggesting that the expression level of TSPO is potentially associated with behavioral phenotype of solitary locusts. Moreover, tspo RNAi knockdown in the brains of solitary locusts decreased their olfactory repulsion. After RNAi knockdown of tyramine receptor (TyR) in the brains of solitary locusts, RNA-seq analysis identified that a functional class of receptors, which included tspo, was downregulated significantly. Moreover, tspo mRNA and protein expression levels were downregulated and upregulated after TyR RNAi knockdown and activation, respectively. tspo RNAi knockdown in the brains of solitary locusts induced the attractive response and inhibited the function of tyramine (TA)-TyR in inducing olfactory repulsion. In gregarious locusts, tspo RNAi knockdown inhibited the function of TA-TyR inducing olfactory repulsion. This study confirms that TSPO acts as a crucial effector protein in TA-TyR signaling to modulate olfactory repulsion. Furthermore, this study provides a novel mechanism by which TSPO functionally connects a G-protein-coupled receptor and a mitochondria membrane protein in modulating olfactory repulsion.	[Ma, Zongyuan; Guo, Xiaojiao; Liu, Jipeng] Chinese Acad Sci, Beijing Inst Life Sci, Beichen West Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences	Ma, ZY (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Beichen West Rd, Beijing 100101, Peoples R China.	mazy@biols.ac.cn			National nature science foundation of China [31772537,31472040,31522054]; Strategic priority Research Program of the Chinese Academy of Sciences [XDB11010700]	National nature science foundation of China(National Natural Science Foundation of China (NSFC)); Strategic priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	National nature science foundation of China, Grant/Award Number: 31772537,31472040,31522054; Strategic priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB11010700	ANHOLT RRH, 1984, J NEUROSCI, V4, P593; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Batoko H, 2015, TRENDS BIOCHEM SCI, V40, P497, DOI 10.1016/j.tibs.2015.07.001; Betlazar C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092707; BOLGER GT, 1984, EUR J PHARMACOL, V105, P143, DOI 10.1016/0014-2999(84)90658-7; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chelli B, 2008, EUR NEUROPSYCHOPHARM, V18, P249, DOI 10.1016/j.euroneuro.2007.10.003; Collett D, 2002, MODELING BINARY DATA; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; de Lima CB, 2012, BIOCHEM BIOPH RES CO, V417, P918, DOI 10.1016/j.bbrc.2011.12.078; Diotel N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00084; GARNIER M, 1993, ENDOCRINOLOGY, V132, P444, DOI 10.1210/en.132.1.444; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GAVISH M, 1992, J NEUROCHEM, V58, P1589, DOI 10.1111/j.1471-4159.1992.tb10030.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Guo XJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03437-z; Hernstadt H, 2009, BRAIN RES, V1286, P42, DOI 10.1016/j.brainres.2009.06.043; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Kupa LDK, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00766; Kim K, 2018, GENOMICS, V110, P43, DOI 10.1016/j.ygeno.2017.08.004; Li DM, 2016, PSYCHIAT RES, V245, P141, DOI 10.1016/j.psychres.2016.02.068; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Li HD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0921-7; Ma Z, 2016, TRACE AMINES AND NEUROLOGICAL DISORDERS: POTENTIAL MECHANISMS AND RISK FACTORS, P221; Ma ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08036; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Mirzaei N, 2016, GLIA, V64, P993, DOI 10.1002/glia.22978; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Qiu ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37345; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Simoes PMV, 2012, J EXP BIOL, V215, P1711, DOI 10.1242/jeb.068106; Sokal RR, 1998, BIOMETRY PRINCIPLES; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang XH, 2014, ANNU REV ENTOMOL, V59, P225, DOI 10.1146/annurev-ento-011613-162019; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; Xu L, 2017, INSECT MOL BIOL, V26, P1, DOI 10.1111/imb.12266; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021	47	2	2	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					513	524		10.1096/fj.201900528RR	http://dx.doi.org/10.1096/fj.201900528RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914587	Bronze			2022-12-26	WOS:000507308900035
J	Molla, G; Chaves-Sanjuan, A; Savinelli, A; Nardini, M; Pollegioni, L				Molla, Gianluca; Chaves-Sanjuan, Antonio; Savinelli, Antonio; Nardini, Marco; Pollegioni, Loredano			Structure and kinetic properties of human d-aspartate oxidase, the enzyme-controlling d-aspartate levels in brain	FASEB JOURNAL			English	Article						d-aspartate; d-aspartate oxidase; flavoprotein; NMDA receptor; structure-function relationships	AMINO-ACID OXIDASE; RHODOTORULA-GRACILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SERINE RACEMASE; BEEF KIDNEY; RAT; MECHANISM; SUBSTRATE; MODEL	d-Amino acids are the "wrong" enantiomers of amino acids as they are not used in proteins synthesis but evolved in selected functions. On this side, d-aspartate (d-Asp) plays several significant roles in mammals, especially as an agonist of N-methyl-d-aspartate receptors (NMDAR), and is involved in relevant diseases, such as schizophrenia and Alzheimer's disease. In vivo modulation of d-Asp levels represents an intriguing task to cope with such pathological states. As little is known about d-Asp synthesis, the only option for modulating the levels is via degradation, which is due to the flavoenzyme d-aspartate oxidase (DASPO). Here we present the first three-dimensional structure of a DASPO enzyme (from human) which belongs to the d-amino acid oxidase family. Notably, human DASPO differs from human d-amino acid oxidase (attributed to d-serine degradation, the main coagonist of NMDAR) showing peculiar structural features (a specific active site charge distribution), oligomeric state and kinetic mechanism, and a higher FAD affinity and activity. These results provide useful insights into the structure-function relationships of human DASPO: modulating its activity represents now a feasible novel therapeutic target.	[Molla, Gianluca; Savinelli, Antonio; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy; [Chaves-Sanjuan, Antonio; Nardini, Marco] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Insubria; University of Milan	Pollegioni, L (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.; Nardini, M (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	marco.nardini@unimi.it; loredano.pollegioni@uninsubria.it	Chaves-Sanjuan, Antonio/GLR-8353-2022; Chaves-Sanjuan, Antonio/AAA-7172-2019	Chaves-Sanjuan, Antonio/0000-0003-3287-9024; Chaves-Sanjuan, Antonio/0000-0003-3287-9024; POLLEGIONI, LOREDANO/0000-0003-1733-7243				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aliashkevich A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00683; Caldinelli L, 2010, PROTEIN SCI, V19, P1500, DOI 10.1002/pro.429; Caldinelli L, 2009, PROTEIN SCI, V18, P801, DOI 10.1002/pro.86; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cristino L, 2015, NEUROBIOL AGING, V36, P1890, DOI 10.1016/j.neurobiolaging.2015.02.003; D'Aniello A, 2017, NEUROSCI LETT, V651, P151, DOI 10.1016/j.neulet.2017.04.041; D'Aniello S, 2011, FASEB J, V25, P1014, DOI 10.1096/fj.10-168492; DALZIEL K, 1969, BIOCHEM J, V114, P547, DOI 10.1042/bj1140547; de Rosa V, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809278; DECKER LE, 1954, J NUTR, V53, P303; Di Fiore MM, 2014, AMINO ACIDS, V46, P1805, DOI 10.1007/s00726-014-1759-2; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errico F, 2008, MOL CELL NEUROSCI, V37, P236, DOI 10.1016/j.mcn.2007.09.012; Errico F, 2013, J PSYCHIATR RES, V47, P1432, DOI 10.1016/j.jpsychires.2013.06.013; Errico F, 2012, AMINO ACIDS, V43, P1861, DOI 10.1007/s00726-012-1356-1; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Errico F, 2009, REV NEUROSCIENCE, V20, P429; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frattini LF, 2011, FEBS J, V278, P4362, DOI 10.1111/j.1742-4658.2011.08354.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Guercio GD, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00014; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HASHIMOTO A, 1993, J NEUROCHEM, V61, P348, DOI 10.1111/j.1471-4159.1993.tb03575.x; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2016, J BIOCHEM, V160, P345, DOI 10.1093/jb/mvw043; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katane M, 2008, AMINO ACIDS, V35, P75, DOI 10.1007/s00726-007-0627-8; Katane M, 2018, BBA-PROTEINS PROTEOM, V1866, P806, DOI 10.1016/j.bbapap.2017.12.009; Katane M, 2017, BBA-PROTEINS PROTEOM, V1865, P1129, DOI 10.1016/j.bbapap.2017.06.010; Katane M, 2015, J MED CHEM, V58, P7328, DOI 10.1021/acs.jmedchem.5b00871; Katane M, 2015, BIOL PHARM BULL, V38, P298, DOI 10.1248/bpb.b14-00690; Katane M, 2010, CHEM BIODIVERS, V7, P1435, DOI 10.1002/cbdv.200900250; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Molinaro G, 2010, NEUROSCI LETT, V478, P128, DOI 10.1016/j.neulet.2010.04.077; Molla G, 2006, FEBS LETT, V580, P2358, DOI 10.1016/j.febslet.2006.03.045; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; NEGRI A, 1987, J BIOL CHEM, V262, P10026; NEGRI A, 1988, J BIOL CHEM, V263, P13557; Ota N, 2012, AMINO ACIDS, V43, P1873, DOI 10.1007/s00726-012-1364-1; Palazzo E, 2016, AMINO ACIDS, V48, P1553, DOI 10.1007/s00726-016-2205-4; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pollegioni L, 1997, J BIOTECHNOL, V58, P115, DOI 10.1016/S0168-1656(97)00142-9; Pollegioni L, 2002, J MOL BIOL, V324, P535, DOI 10.1016/S0022-2836(02)01062-8; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; Pollegioni L, 2010, CELL MOL LIFE SCI, V67, P2387, DOI 10.1007/s00018-010-0307-9; Sacchi S, 2016, CELL MOL LIFE SCI, V73, P2029, DOI 10.1007/s00018-016-2165-6; Sacchi S, 2013, CURR PHARM DESIGN, V19, P2499, DOI 10.2174/1381612811319140002; Sacchi S, 2011, MOL CELL NEUROSCI, V48, P20, DOI 10.1016/j.mcn.2011.06.001; Sasabe J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00933; Schell MJ, 1997, P NATL ACAD SCI USA, V94, P2013, DOI 10.1073/pnas.94.5.2013; Senda M, 2012, ACTA CRYSTALLOGR F, V68, P644, DOI 10.1107/S1744309112013243; Setoyama C, 1997, J BIOCHEM-TOKYO, V121, P798; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Takahashi S, 2004, J BIOCHEM, V135, P533, DOI 10.1093/jb/mvh068; Tickle IJ, 2018, 2010 STARANISO; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; VANVELDHOVEN PP, 1991, BIOCHIM BIOPHYS ACTA, V1073, P203, DOI 10.1016/0304-4165(91)90203-S; Weil ZM, 2006, BEHAV BRAIN RES, V171, P295, DOI 10.1016/j.bbr.2006.04.008; Wolosker H, 2000, NEUROSCIENCE, V100, P183, DOI 10.1016/S0306-4522(00)00321-3; Wolosker H, 2011, BBA-PROTEINS PROTEOM, V1814, P1558, DOI 10.1016/j.bbapap.2011.01.001; Zaar K, 2002, J COMP NEUROL, V450, P272, DOI 10.1002/cne.10320	69	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1182	1197		10.1096/fj.201901703R	http://dx.doi.org/10.1096/fj.201901703R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914658	Green Submitted			2022-12-26	WOS:000507308900080
J	Selvan, R; Parthasarathi, P; Iyengar, SS; Ananthamurthy, S; Bhattacharya, S				Selvan, Rekha; Parthasarathi, Praveen; Iyengar, Shruthi S.; Ananthamurthy, Sharath; Bhattacharya, Sarbari			Estimation of membrane bending modulus of stiffness tuned human red blood cells from micropore filtration studies	PLOS ONE			English	Article							ERYTHROCYTE DEFORMABILITY; MECHANICAL-PROPERTIES; AGGREGATION; FLUCTUATIONS; DEFORMATION; VELOCITY; FLOW; VISCOSITY; DYNAMICS; ALBUMIN	Human red blood cells (RBCs) need to deform in order to pass through capillaries in human vasculature with diameter smaller than that of the RBC. An altered RBC cell membrane stiffness (CMS), thereby, is likely to have consequences on their flow rate. RBC CMS is known to be affected by several commonly encountered disease conditions. This study was carried out to investigate whether an increase in RBC CMS, to the extent seen in such commonly encountered medical conditions, affects the RBC flow rate through channels with diameters comparable to that of the RBC. To do this, we use RBCs extracted from a healthy individual with no known medical conditions and treated with various concentrations of Bovine Serum Albumin (BSA). We study their flow through polycarbonate membranes with pores of diameter 5 mu m and 8 mu m which are smaller than and comparable to the RBC diameter respectively. The studies are carried out at constant hematocrit and volumetric flow rate. We find that when the diameter of the capillary is smaller than that of the RBC, the flow rate of the RBCs is lowered as the concentration of BSA is increased while the reverse is true when the diameter is comparable to that of the RBC. We confirm that this is a consequence of altered CMS of the RBCs from their reorientation dynamics in an Optical Tweezer. We find that a treatment with 0.50mg/ml BSA mimics the situation for RBCs extracted from a healthy individual while concentrations higher than 0.50mg/ml elevate the RBC CMS across a range expected for individuals with a condition of hyperglycemia. Using a simple theoretical model of the RBC deformation process at the entry of a narrow channel, we extract the RBC membrane bending modulus from their flow rate.	[Selvan, Rekha; Iyengar, Shruthi S.; Ananthamurthy, Sharath; Bhattacharya, Sarbari] Bangalore Univ, Dept Phys, Bangalore, Karnataka, India; [Parthasarathi, Praveen] Raman Res Inst, Soft Condensed Matter Grp, Bangalore, Karnataka, India; [Ananthamurthy, Sharath] Univ Hyderabad, Sch Phys, Hyderabad, Telangana, India	Bangalore University; Department of Science & Technology (India); Raman Research Institute (RRI); University of Hyderabad	Bhattacharya, S (corresponding author), Bangalore Univ, Dept Phys, Bangalore, Karnataka, India.	sarbari.bhattacharya@bub.ernet.in		Parthasarathi, Praveen/0000-0003-0734-2778; Bhattacharya, Sarbari/0000-0002-9939-3419	University Grants Commission, India Department of Science and Technology, India	University Grants Commission, India Department of Science and Technology, India	University Grants Commission, India Department of Science and Technology, India.; RS, SSI and PP acknowledge support received via fellowships under the UGC-NET, DST-PURSE and UGC-CPEPA programs respectively. Equipment for the red blood cell reorientation experiment was set up using funds from DST under "Nano mission". The authors wish to acknowledge the UGC-CPEPA and DST-PURSE programs for providing funds for procuring chemicals and consumables. The authors are grateful to Pramod Pullarkat, Professor, Soft Condensed Matter group, Raman Research Institute, Bangalore, for the use of his syringe pump. The authors acknowledge the assistance provided by Chennakeshava, Assistant Lab Technician, Primary Health Centre, Bangalore University, in the preparation of blood samples.	Agrawal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep15873; Alster Y, 1998, ARCH OPHTHALMOL-CHIC, V116, P1321, DOI 10.1001/archopht.116.10.1321; Babu N, 2004, CLIN HEMORHEOL MICRO, V31, P273; Barnes T., 2013, OPTICS PHOTONICS J, V3, P211, DOI DOI 10.4236/0PJ.2013; Braunmuller S, 2012, SOFT MATTER, V8, P11240, DOI 10.1039/c2sm26513c; Brown CD, 2005, KIDNEY INT, V67, P295, DOI 10.1111/j.1523-1755.2005.00082.x; CHEN TC, 1970, APPL SCI RES, V22, P403, DOI 10.1007/BF00400546; CHIEN S, 1978, BIOPHYS J, V24, P463, DOI 10.1016/S0006-3495(78)85395-8; Dobbe JGG, 2002, BLOOD CELL MOL DIS, V28, P373, DOI 10.1006/bcmd.2002.0528; Dulinska Molak I, 2006, J BIOCHEM BIOPH METH, V66, P1, DOI 10.1016/j.jbbm.2005.11.003; EVANS EA, 1983, BIOPHYS J, V43, P27, DOI 10.1016/S0006-3495(83)84319-7; Evans J, 2008, BIOPHYS J, V94, P4134, DOI 10.1529/biophysj.107.117952; Fedosov DA, 2014, SOFT MATTER, V10, P4258, DOI 10.1039/c4sm00248b; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Henon S, 1999, BIOPHYS J, V76, P1145, DOI 10.1016/S0006-3495(99)77279-6; JAY AWL, 1975, BIOPHYS J, V15, P205, DOI 10.1016/S0006-3495(75)85812-7; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Jeong JH, 2006, MICROVASC RES, V71, P212, DOI 10.1016/j.mvr.2006.02.006; Kim J, 2015, J CELL BIOTECHNOL, V1, P63, DOI [10.3233/JCB-15007, DOI 10.3233/JCB-15007]; Kirkpatrick UJ, 1998, BRIT J HAEMATOL, V101, P364; Maciaszek JL, 2011, J BIOMECH, V44, P657, DOI 10.1016/j.jbiomech.2010.11.008; MOIA M, 1985, RES CLIN LAB, V15, P127; Moon JS, 2016, DIABETES METAB, V42, P448, DOI 10.1016/j.diabet.2016.04.008; Munoz S, 2014, BBA-BIOMEMBRANES, V1838, P950, DOI 10.1016/j.bbamem.2013.10.020; Omori T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056321; Parthasarathi P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.025001; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Shin S, 2007, INDIAN J EXP BIOL, V45, P121; SINGH M, 1995, CLIN HEMORHEOL, V15, P273; Starosta W., 2017, APPL IONIZING RAD MA, V2; Stucker M, 1996, MICROVASC RES, V52, P188, DOI 10.1006/mvre.1996.0054; Tan CY, 2015, J CHEM ENG DATA, V60, P2827, DOI 10.1021/acs.jced.5b00018; TANFORD C, 1956, J PHYS CHEM-US, V60, P225, DOI 10.1021/j150536a020; Tomaiuolo G, 2009, SOFT MATTER, V5, P3736, DOI 10.1039/b904584h; Tsukada K, 2001, MICROVASC RES, V61, P231, DOI 10.1006/mvre.2001.2307; WILLIAMS AR, 1973, BIOCHIM BIOPHYS ACTA, V307, P58, DOI 10.1016/0005-2736(73)90024-2; XIA Y, 1992, AICHE J, V38, P1408, DOI 10.1002/aic.690380912; YANG T, 2016, MICROMACHINES, V7, DOI DOI 10.3390/MI7050090; Yawata Y, 2003, CELL MEMBRANE RED BL; Yoon YZ, 2011, SOFT MATTER, V7, P2042, DOI 10.1039/c0sm01117g; Zhang JF, 2009, MICROVASC RES, V77, P265, DOI 10.1016/j.mvr.2009.01.010; Zhang W, 2017, J NANOSCI NANOTECHNO, V17, P251, DOI 10.1166/jnn.2017.12593; Zheng Y, 2013, LAB CHIP, V13, P3275, DOI 10.1039/c3lc50427a	45	4	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226640	10.1371/journal.pone.0226640	http://dx.doi.org/10.1371/journal.pone.0226640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891585	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000515096600021
J	Bull, T; Corley, A; Lye, I; Spooner, AJ; Fraser, JF				Bull, Taressa; Corley, Amanda; Lye, India; Spooner, Amy J.; Fraser, John F.			Cannula and circuit management in peripheral extracorporeal membrane oxygenation: An international survey of 45 countries	PLOS ONE			English	Article							CATHETER-RELATED INFECTIONS; CARE-ASSOCIATED INFECTIONS; NOSOCOMIAL INFECTIONS; LIFE-SUPPORT; ADULT PATIENTS; RISK-FACTORS; SECUREMENT; HOSPITALS	Effective and safe practices during extracorporeal membrane oxygenation (ECMO) including infection precautions and securement of lines (cannulas and circuits) are critical to prevent life-threatening patient complications, yet little is known about the practices of bedside clinicians and data to support best practice is lacking. Therefore, the aim of this study was to identify and describe common line-related practices for patients supported by peripheral ECMO worldwide and to highlight any gaps for further investigation. An electronic survey was conducted to examine common line practices for patients managed on peripheral ECMO. Responses were obtained from 45 countries with the majority from the United States (n = 181) and United Kingdom (n = 32). Standardised infection precautions including hand hygiene, maximal barrier precautions and skin antisepsis were commonplace for cannulation. The most common antisepsis strategies included alcohol-based chlorhexidine gluconate (CHG) for cannula insertion (53%) and maintenance (54%), isopropyl alcohol on circuit access ports (39%), and CHG-impregnated dressings to cover insertion sites (36%). Adverse patient events due to line malposition or dislodgement were reported by 34% of respondents with most attributable to ineffective securement. Centres 'always' suturing peripheral cannula sites were more likely to experience a cannula adverse event than centres that 'never' sutured (35% [95% CI 30, 41] vs 0% [95% CI 0, 28]; Chi-square 4.40; p = 0.04) but this did not meet the a priori significance level of <0.01. An evidence-based guideline would be beneficial to improve ECMO line management according to 78% of respondents. Evidence gaps were identified for antiseptic agents, dressing products and regimens, securement methods, and needleless valves. Future research addressing these areas may provide opportunities for consensus guideline development and practice improvement.	[Bull, Taressa; Corley, Amanda; Lye, India; Spooner, Amy J.; Fraser, John F.] Prince Charles Hosp, Crit Care Res Grp, Chermside, Qld, Australia; [Bull, Taressa; Corley, Amanda; Lye, India; Spooner, Amy J.; Fraser, John F.] Univ Queensland, Chermside, Qld, Australia; [Fraser, John F.] Prince Charles Hosp, Adult Intens Care Serv, Chermside, Qld, Australia	Prince Charles Hospital; University of Queensland; Prince Charles Hospital	Bull, T (corresponding author), Prince Charles Hosp, Crit Care Res Grp, Chermside, Qld, Australia.; Bull, T (corresponding author), Univ Queensland, Chermside, Qld, Australia.	Taressa.Bull@health.qld.gov.au		Spooner, Amy/0000-0002-1830-1851; Fraser, John/0000-0002-7012-2519; Corley, Amanda/0000-0002-4250-4077	Prince Charles Hospital Foundation [NI2015-124]	Prince Charles Hospital Foundation	The study was supported by a competitive grant (AC; grant number NI2015-124) from The Prince Charles Hospital Foundation (www.tpchfoundation.org.au) who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study had no manufacturer funding or involvement.	Allou N, 2019, ASAIO J, V65, P180, DOI 10.1097/MAT.0000000000000771; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Belohlavek J, 2011, J CARDIOVASC SURG, V52, P445; Biffi S, 2017, INT J ANTIMICROB AG, V50, P9, DOI 10.1016/j.ijantimicag.2017.02.025; Bizzarro MJ, 2011, PEDIATR CRIT CARE ME, V12, P277, DOI 10.1097/PCC.0b013e3181e28894; Burket JS, 1999, CLIN INFECT DIS, V28, P828, DOI 10.1086/515200; Butt W, 2013, PEDIATR CRIT CARE ME, V14, pS13, DOI 10.1097/PCC.0b013e318292ddc8; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Combes A, 2017, INTENS CARE MED, V43, P1306, DOI 10.1007/s00134-017-4803-3; Conrad SA, 2015, CRIT CARE MED, V43, P1010, DOI 10.1097/CCM.0000000000000883; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Douglass BH, 1996, ARTIF ORGANS, V20, P202, DOI 10.1111/j.1525-1594.1996.tb04428.x; Extracorporeal Life Support Organization, 2017, ELSO GUID CARD EXTR; Extracorporeal Life Support Organization Infectious Disease Task Force, 2012, INF CONTR EXTR LIF S; Glater-Welt LB, 2016, J INTENSIVE CARE MED, V31, P654, DOI 10.1177/0885066615571540; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hahne K, 2015, J HOSP INFECT, V91, P372, DOI 10.1016/j.jhin.2015.08.022; Hsu MS, 2009, J HOSP INFECT, V73, P210, DOI 10.1016/j.jhin.2009.07.016; Infusion Nurses Society (INS), 2021, J INFUS NURS S1, V44, pS1, DOI [DOI 10.1097/NAN.0000000000000396, 10.1097/NAN.0000000000000396, DOI 10.1097/NHH.0000000000000481]; Inwood Sheila, 2014, Br J Nurs, V23, pS26; Jenks M, 2016, APPL HEALTH ECON HEA, V14, P135, DOI 10.1007/s40258-015-0202-5; Kao LS, 2011, ASAIO J, V57, P231, DOI 10.1097/MAT.0b013e31820d19ab; Klein D., 2019, STAT SOFTWARE COMPON; Lai NM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010140.pub2; Lindskov C, 2013, ACTA ANAESTH SCAND, V57, P303, DOI 10.1111/aas.12050; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Messika J, 2018, CRIT CARE MED, V46, pE171, DOI 10.1097/CCM.0000000000002790; MEYER DM, 1995, ANN THORAC SURG, V59, P975, DOI 10.1016/0003-4975(95)00044-L; Montgomery VL, 2000, CRIT CARE MED, V28, P526, DOI 10.1097/00003246-200002000-00040; Moureau NL, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/796762; Na SJ, 2018, INFECT CONT HOSP EP, V39, P871, DOI 10.1017/ice.2018.90; Niles S. C., 1992, J EXTRA CORPOREAL TE, V24, P69; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Schwebel C, 2012, CRIT CARE MED, V40, P11, DOI 10.1097/CCM.0b013e31822f0604; Sun HY, 2010, J THORAC CARDIOV SUR, V140, P1125, DOI 10.1016/j.jtcvs.2010.07.017; Thomas G, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0335-9; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Ullman AJ, 2016, INT J NURS STUD, V59, P177, DOI 10.1016/j.ijnurstu.2016.04.003; Yokoe DS, 2014, AM J INFECT CONTROL, V42, P820, DOI 10.1016/j.ajic.2014.07.002	40	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227248	10.1371/journal.pone.0227248	http://dx.doi.org/10.1371/journal.pone.0227248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887197	Green Published, Green Submitted, gold			2022-12-26	WOS:000515092200088
J	Soroush, F; Tang, Y; Mustafa, O; Sun, S; Yang, QL; Kilpatrick, LE; Kiani, MF				Soroush, Fariborz; Tang, Yuan; Mustafa, Omar; Sun, Shuang; Yang, Qingliang; Kilpatrick, Laurie E.; Kiani, Mohammad F.			Neutrophil-endothelial interactions of murine cells is not a good predictor of their interactions in human cells	FASEB JOURNAL			English	Article						biomimetic; endothelial cells; inflammation; microfluidics; mouse model	PROTEIN-KINASE-C; IN-VITRO; DELTA-PKC; ADHESION MOLECULES; MICROFLUIDIC ASSAY; ICAM-1 EXPRESSION; SEVERE SEPSIS; SEPTIC SHOCK; LUNG INJURY; MOUSE	All drugs recently developed in rodent models to treat inflammatory disease have failed in clinical trials. We therefore used our novel biomimetic microfluidic assay (bMFA) to determine whether the response of murine cells to inflammatory activation or anti-inflammatory treatment is predictive of the response in human cells. Under physiologically relevant flow conditions, permeability and transendothelial electrical resistance (TEER) of human or mouse lung microvascular endothelial cells (HLMVEC or MLMVEC), and neutrophil-endothelial cell interaction was measured. The differential impact of a protein kinase C-delta TAT peptide inhibitor (PKC delta-i) was also quantified. Permeability of HLMVEC and MLMVEC was similar under control conditions but tumor necrosis factor alpha (TNF-alpha) and PKC delta-i had a significantly higher impact on permeability of HLMVEC. TEER across HLMVEC was significantly higher than MLMVEC, but PKC delta-i returned TEER to background levels only in human cells. The kinetics of N-formylmethionyl-leucyl-phenylalanine (fMLP)-mediated neutrophil migration was significantly different between the two species and PKC delta-i was significantly more effective in attenuating human neutrophil migration. However, human and mouse neutrophil adhesion patterns to microvascular endothelium were not significantly different. Surprisingly, while intercellular adhesion molecule 1 (ICAM-1) was significantly upregulated on activated HLMVEC, it was not significantly upregulated on activated MLMVEC. Responses to activation and anti-inflammatory treatment in mice may not always be predictive of their response in humans.	[Soroush, Fariborz; Yang, Qingliang; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA; [Tang, Yuan] Univ Toledo, Coll Engn, Dept Bioengn, 2801 W Bancroft St, Toledo, OH 43606 USA; [Mustafa, Omar] Temple Univ, Dept Bioengn, Coll Engn, Philadelphia, PA 19122 USA; [Sun, Shuang; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Clin & Translat Lung Res, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kiani, Mohammad F.] Temple Univ, Dept Radiat Oncol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kiani, MF (corresponding author), Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA.	mkiani@temple.edu	Yang, Qingliang/GRY-1981-2022; Tang, Yuan/ABG-7928-2020	Tang, Yuan/0000-0003-0450-3222; Yang, Qingliang/0000-0002-4094-9662	American Heart Association [16PRE29860006, 16GRNT29980001]; National Institutes of Health [GM114359, GM134701, HL111552]; Defense Threat Reduction Agency [HDTRA11910012]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	American Heart Association, Grant/Award Number: 16PRE29860006 and 16GRNT29980001; National Institutes of Health, Grant/Award Number: GM114359, GM134701 and HL111552; Defense Threat Reduction Agency, Grant/Award Number: HDTRA11910012	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bailey KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08417-9; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; BURNS AR, 1994, J IMMUNOL, V153, P3189; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Drake AC, 2013, CELL MOL IMMUNOL, V10, P284, DOI 10.1038/cmi.2013.21; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Ghosh Subrata, 2010, Therap Adv Gastroenterol, V3, P239, DOI 10.1177/1756283X10373176; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Guo RF, 2006, J IMMUNOL, V177, P1306, DOI 10.4049/jimmunol.177.2.1306; Hagai T, 2018, NATURE, V563, P197, DOI 10.1038/s41586-018-0657-2; Hattori Y, 2017, PHARMACOL THERAPEUT, V177, P56, DOI 10.1016/j.pharmthera.2017.02.040; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jugg BJA, 2011, PHILOS T R SOC B, V366, P306, DOI 10.1098/rstb.2010.0235; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kiani MF, 2002, PHARM RES-DORDR, V19, P1317, DOI 10.1023/A:1020350708672; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lamberti G, 2015, MICROVASC RES, V99, P19, DOI 10.1016/j.mvr.2015.02.004; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Lamberti G, 2013, MICROVASC RES, V89, P107, DOI 10.1016/j.mvr.2013.03.007; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Ley K, 2006, Handb Exp Pharmacol, P97; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liverani E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195379; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Perlman H, 2013, AM J RESP CRIT CARE, V187, P898, DOI 10.1164/rccm.201303-0489ED; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Prabhakarpandian B, 2008, BIOMED MICRODEVICES, V10, P585, DOI 10.1007/s10544-008-9170-y; Prabhakarpandian B, 2011, MICROVASC RES, V82, P210, DOI 10.1016/j.mvr.2011.06.013; Prabhakarpandian B, 2011, MICROCIRCULATION, V18, P380, DOI 10.1111/j.1549-8719.2011.00099.x; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rosano JM, 2009, BIOMED MICRODEVICES, V11, P1051, DOI 10.1007/s10544-009-9322-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soroush F, 2016, J LEUKOCYTE BIOL, V100, P1027, DOI 10.1189/jlb.3MA0216-087R; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356; Tang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09815-9; Vogel SM, 2012, COMPR PHYSIOL, V2, P449, DOI 10.1002/cphy.c100006; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	71	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2691	2702		10.1096/fj.201900048R	http://dx.doi.org/10.1096/fj.201900048R		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908006	Bronze, Green Accepted			2022-12-26	WOS:000504095400001
J	Dai, SB; Horton, JR; Wilkinson, AW; Gozani, O; Zhang, X; Cheng, XD				Dai, Shaobo; Horton, John R.; Wilkinson, Alex W.; Gozani, Or; Zhang, Xing; Cheng, Xiaodong			An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S-adenosylmethionine (SAM); protein methylation; structural biology; enzyme catalysis; enzyme kinetics; histidine; glutamine methylation; histidine methylation; lysine methylation	SUBSTRATE-SPECIFICITY; HEMK2 PROTEIN; DOMAIN; CHROMATIN; IDENTIFICATION; EXPRESSION; DIM-5	Most characterized SET domain (SETD) proteins are protein lysine methyltransferases, but SETD3 was recently demonstrated to be a protein (i.e. actin) histidine-N-3 methyltransferase. Human SETD3 shares a high structural homology with two known protein lysine methyltransferases?human SETD6 and the plant LSMT?but differs in the residues constituting the active site. In the SETD3 active site, Asn(255) engages in a unique hydrogen-bonding interaction with the target histidine of actin that likely contributes to its >1300-fold greater catalytic efficiency (k(cat)/K-m) on histidine than on lysine. Here, we engineered active-site variants to switch the SETD3 target specificity from histidine to lysine. Substitution of Asn(255) with phenylalanine (N255F), together with substitution of Trp(273) with alanine (W273A), generated an active site mimicking that of known lysine methyltransferases. The doubly substituted SETD3 variant exhibited a 13-fold preference for lysine over histidine. We show, by means of X-ray crystallography, that the two target nitrogen atoms?the N-3 atom of histidine and the terminal ?-amino nitrogen of lysine?occupy the same position and point toward and are within a short distance of the incoming methyl group of SAM for a direct methyl transfer during catalysis. In contrast, SETD3 and its Asn(255) substituted derivatives did not methylate glutamine (another potentially methylated amino acid). However, the glutamine-containing peptide competed with the substrate peptide, and glutamine bound in the active site, but too far away from SAM to be methylated. Our results provide insight into the structural parameters defining the target amino acid specificity of SET enzymes.	[Dai, Shaobo; Horton, John R.; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Texas System; UTMD Anderson Cancer Center; Stanford University	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	xzhang21@mdanderson.org; xcheng5@mdanderson.org	Horton, John R/ABB-4770-2020	Dai, Shaobo/0000-0002-1629-4483; Cheng, Xiaodong/0000-0002-6967-6362; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [GM114306, GM133051]; Cancer Prevention and Research Institute of Texas Grant [RR160029]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant	This work was supported by National Institutes of Health Grants GM114306 (to X. C.) and GM133051 (to O. G.) and Cancer Prevention and Research Institute of Texas Grant RR160029 (to X. C.). X. C. is a CPRIT Scholar in Cancer Research. O. G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Coward J. K., 1977, BIOCH ADENOSYLMETHIO, P127; Dai SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11554-6; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Diep J, 2019, NAT MICROBIOL, V4, P2523, DOI 10.1038/s41564-019-0551-1; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Guo Q, 2019, ELIFE, V8, DOI 10.7554/eLife.43676; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; Kudithipudi S, 2012, BIOCHIMIE, V94, P2212, DOI 10.1016/j.biochi.2012.04.024; Kusevic D, 2016, J BIOL CHEM, V291, P6124, DOI 10.1074/jbc.M115.711952; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; Levy D, 2019, CELL MOL LIFE SCI, V76, P2873, DOI 10.1007/s00018-019-03142-0; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger E, 2019, NAT STRUCT MOL BIOL, V26, P361, DOI 10.1038/s41594-019-0219-9; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shechter D, 2019, CELL MOL LIFE SCI, V76, P2871, DOI 10.1007/s00018-019-03141-1; Tolsma TO, 2019, ESSAYS BIOCHEM, V63, P89, DOI 10.1042/EBC20180067; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Wood K, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010011; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0119-5; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936	39	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2582	2589		10.1074/jbc.RA119.012319	http://dx.doi.org/10.1074/jbc.RA119.012319			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31911441	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000519969100005
J	Porter, JJ; Jang, HS; Haque, MM; Stuehr, DJ; Mehl, RA				Porter, Joseph J.; Jang, Hyo Sang; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.; Mehl, Ryan A.			Tyrosine nitration on calmodulin enhances calcium-dependent association and activation of nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; reactive nitrogen species (RNS); calmodulin (CaM); nitric-oxide synthase; post-translational modification (PTM); calcium regulation; endothelial nitric-oxide synthase (eNOS); nitroTyrosine; ox-PTM; tyrosine nitration	STRUCTURAL BASIS; PHOSPHORYLATION; BINDING; PEPTIDES; DYNAMICS; ENOS	Production of reactive oxygen species caused by dysregulated endothelial nitric-oxide synthase (eNOS) activity is linked to vascular dysfunction. eNOS is a major target protein of the primary calcium-sensing protein calmodulin. Calmodulin is often modified by the main biomarker of nitroxidative stress, 3-nitrotyrosine (nitroTyr). Despite nitroTyr being an abundant post-translational modification on calmodulin, the mechanistic role of this modification in altering calmodulin function and eNOS activation has not been investigated. Here, using genetic code expansion to site-specifically nitrate calmodulin at its two tyrosine residues, we assessed the effects of these alterations on calcium binding by calmodulin and on binding and activation of eNOS. We found that nitroTyr?calmodulin retains affinity for eNOS under resting physiological calcium concentrations. Results from in vitro eNOS assays with calmodulin nitrated at Tyr-99 revealed that this nitration reduces nitric-oxide production and increases eNOS decoupling compared with WT calmodulin. In contrast, calmodulin nitrated at Tyr-138 produced more nitric oxide and did so more efficiently than WT calmodulin. These results indicate that the nitroTyr post-translational modification, like tyrosine phosphorylation, can impact calmodulin sensitivity for calcium and reveal Tyr site-specific gain or loss of functions for calmodulin-induced eNOS activation.	[Porter, Joseph J.; Jang, Hyo Sang; Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA; [Haque, Mohammad Mahfuzul] Jamia Millia Islamia, Dept Biotechnol, Maulana Mohammad Ali Jauhar Marg, New Delhi 110025, India	Oregon State University; Cleveland Clinic Foundation; Jamia Millia Islamia	Mehl, RA (corresponding author), Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg,2750 SW Campus Way, Corvallis, OR 97331 USA.	Ryan.Mehl@oregonstate.edu		Jang, Hyo Sang/0000-0003-0460-9924; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [RGM114653A]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RGM114653A (to R. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Boo YC, 2007, NITRIC OXIDE-BIOL CH, V16, P306, DOI 10.1016/j.niox.2006.09.004; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379; Haque MM, 2016, J BIOL CHEM, V291, P23047, DOI 10.1074/jbc.M116.737361; JOYAL JL, 1994, J BIOL CHEM, V269, P30039; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Mukherjea P, 1996, PROTEIN SCI, V5, P468; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Piazza M, 2014, BIOCHEMISTRY-US, V53, P1241, DOI 10.1021/bi401466s; Piazza M, 2012, BIOCHEMISTRY-US, V51, P3651, DOI 10.1021/bi300327z; Porter JJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7607463; Radi R, 2018, P NATL ACAD SCI USA, V115, P5839, DOI 10.1073/pnas.1804932115; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rhoads TW, 2013, J AM SOC MASS SPECTR, V24, P115, DOI 10.1007/s13361-012-0500-1; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Smallwood HS, 2007, BIOCHEMISTRY-US, V46, P10498, DOI 10.1021/bi7009713; Smallwood HS, 2003, CHEM RES TOXICOL, V16, P95, DOI 10.1021/tx025566a; Spratt DE, 2008, BIOCHEMISTRY-US, V47, P12006, DOI 10.1021/bi801418s; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Villalobo A, 2018, BIOCHEM J, V475, P4011, DOI 10.1042/BCJ20180755; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009	35	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2203	2211		10.1074/jbc.RA119.010999	http://dx.doi.org/10.1074/jbc.RA119.010999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31914408	Green Published, hybrid			2022-12-26	WOS:000517330200005
J	Haileselassie, M; Redae, G; Berhe, G; Henry, CJ; Nickerson, MT; Tyler, B; Mulugeta, A				Haileselassie, Mekonnen; Redae, Getachew; Berhe, Gebretsadik; Henry, Carol J.; Nickerson, Michael T.; Tyler, Bob; Mulugeta, Afework			Why are animal source foods rarely consumed by 6-23 months old children in rural communities of Northern Ethiopia? A qualitative study	PLOS ONE			English	Article							KENYAN SCHOOL-CHILDREN; PLASMA VITAMIN-B-12; YOUNG-CHILDREN; NUTRITION; LIVESTOCK; CONSUMPTION; KNOWLEDGE; IMPACT; GROWTH; MILK	Background Animal source foods provide high-quality protein and essential micronutrients within the human diet and are of particular significance for the health and development of children. Despite the availability of domestic livestock in rural households of Ethiopia, the diets of children are often monotonous and mainly cereal-based with low energy and nutrient density. Objective Explore barriers and facilitators for the consumption of animal source foods among 6-23 months old children from the rural communities of Northern Ethiopia. Methods A community-based exploratory qualitative study design was conducted in July through September 2018. A total of eight focus group discussions (56 individuals) and twenty-four qualitative interviews were conducted with mothers who are lactating, fathers, health extension workers, nutrition, and agriculture experts. Purposive sampling technique was used to include study participants based on their potential relevance in delivering a wealth of information. Thematic analysis strategies, a method for identifying, analyzing, and reporting themes within data, were used to code and grouped into related families and synthesize the qualitative data. Results Consumption of animal source foods among 6-23 months old children was very low and the home-reared livestock and their products were mainly used for market purposes. Animal products are consumed during special societal occasions since they are considered as luxury food rather than an essential part of daily children's diet. Lack of nutrition knowledge, high cost of animal source foods, mothers' workload to herd livestock, low household income, low milk production, the poor linkage between health and agriculture sectors, and social norms and beliefs were identified as common barriers. While the presence of nutrition experts, cooking demonstrations, in-kind credit programs, livestock ownership, and government-led stunting reduction programs were the facilitators for the consumption of animal source foods in the study communities. Conclusions Reduced consumption of animal source foods inadvertently impacted dietary diversity of 6-23 months old children from the study communities. Thus, strengthening social and behavior change communication to promote the consumption of animal source foods, creating opportunities for women to own small livestock for household consumption and provide nutrition education on dietary restriction of animal source foods during religious periods among 6-23 months old children in the rural communities of Northern Ethiopia are recommended.	[Haileselassie, Mekonnen; Redae, Getachew; Berhe, Gebretsadik; Mulugeta, Afework] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Haileselassie, Mekonnen] Bur Sci & Technol, Tigray Natl Reg State, Mekelle, Tigray, Ethiopia; [Henry, Carol J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Nickerson, Michael T.; Tyler, Bob] Univ Saskatchewan, Dept Food & Bioprod Sci, Saskatoon, SK, Canada	Mekelle University; University of Saskatchewan; University of Saskatchewan	Haileselassie, M (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	mekonnen210@yahoo.com		Mulugeta, Afework/0000-0003-0707-4363	Global Institute for Food Security (Saskatoon, SK, Canada)	Global Institute for Food Security (Saskatoon, SK, Canada)	The authors would like to thank the Global Institute for Food Security (Saskatoon, SK, Canada) for its support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Z, 2016, FOOD NUTR BULL, V37, P353, DOI 10.1177/0379572116651209; Abraha A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218101; Alive & Thrive, 2012, ETHIOPIA INFANT YOUN; Alive & Thrive, 2010, IYCF PRACTICES BELIE; Andualem Tonamo, 2016, International Journal of Livestock Production, V7, P5, DOI 10.5897/IJLP2015.0276; Ayele Z, 2003, J NUTR, V133, p3981S, DOI 10.1093/jn/133.11.3981S; Azzarri C, 2015, J DEV STUD, V51, P1034, DOI 10.1080/00220388.2015.1018905; Bazzano AN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208408; Benson T, 2007, FOOD NUTR BULL, V28, pS323, DOI 10.1177/15648265070282S211; Berhane HY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091142; Beruk B, 2018, INT J ENV RES PUB HE, V15, DOI [10.3390/ijerph15081767, DOI 10.3390/IJERPH15081767]; Betru S, 2009, LIVESTOCK RES RURAL, V21; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Central Statistical Agency (CSA) Federal Democratic Republic of Ethiopia Agricultural Sample Survey, 2016, FED DEM REP ETH AGR, VII; Chingala G, 2017, CLIMATIC CHANGE, V142, P129, DOI 10.1007/s10584-017-1924-1; Christiaensen L, 2004, ECON DEV CULT CHANGE, V52, P287, DOI 10.1086/380822; Christian AK, 2016, BRIT J NUTR, V115, P351, DOI 10.1017/S0007114515004468; Colecraft E, 2006, ECOL FOOD NUTR, V45, P351, DOI 10.1080/03670240600985464; Cornelsen L, 2016, BMC NUTR, V1, P1, DOI [10.1186/s40795-016-0109-z, DOI 10.1186/S40795-016-0109-Z]; Creed-Kanashiro H, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12600; Dumas SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191339; EDHS Central Statistics Agency, 2019, MIN DEM HLTH SURV AD; EDHS Central Statistics Agency, 2016, ETH DEM HLTH SURV; Eshetie T., 2018, J NUTR HLTH FOOD ENG, V8, P228, DOI [10.15406/jnhfe.2018.08.00274, DOI 10.15406/JNHFE.2018.08.00274]; Ethiopian Public Health Institute, 2013, ETH NAT FOOD CONS SU; Fantu B, 2017, 108 ETH DEV RES I; FMOH, 2011, ED SECT DEV PROGR I; Getachew A, 2018, 113 ETH; Ghosh S, 2014, ANN NY ACAD SCI, V1331, P76, DOI 10.1111/nyas.12596; Girmay A, 2017, BMC NUTR, V3; Gittelsohn J, 2003, J NUTR, V133, p4036S, DOI 10.1093/jn/133.11.4036S; Grillenberger M, 2006, BRIT J NUTR, V95, P379, DOI 10.1079/BJN20051641; Guest G., 2012, APPL THEMATIC ANAL, P320; Heinbuch U., 1994, IDAFWP58; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Iannotti LL, 2012, J NUTR, V142, P1568, DOI 10.3945/jn.111.157321; Kabir A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172119; Kibrom T., 2012, 38 ETH STRAT SUPP PR; Kim SS, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12695; Krebs NF, 2006, J PEDIATR GASTR NUTR, V42, P207; Kumera G, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0248-0; Liamputtong D. E, 2005, QUALITATIVE RES METH, DOI [10.1016/j.ymeth.2005.03.001, DOI 10.1016/J.YMETH.2005.03.001]; Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547; McLean ED, 2007, J NUTR, V137, P676, DOI 10.1093/jn/137.3.676; Mekasha A, 2014, AGR ECOSYST ENVIRON, V188, P150, DOI 10.1016/j.agee.2014.02.022; Mekonnen N, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0233-z; Ministry of Health (MOH), 2016, PROGR IMPL MAN NAT N; Ministry of Health (MOH), 2016, SEQ DECL GOV ETH COM; Mukta U.S, 2015, OPEN ACCESS LIB J, V2, pe1452, DOI [10.4236/oalib, DOI 10.4236/OALIB]; Mulugeta A., 2013, WORLD J AGR SCI, V1, P8; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; Nisbett N, 2017, GLOB FOOD SECUR-AGR, V13, P74, DOI 10.1016/j.gfs.2017.01.006; Njuki J.M., 2015, EUR J DEV RES, V2, P1; Nyantakyi-Frimpong H, 2018, SOC SCI MED, V212, P191, DOI 10.1016/j.socscimed.2018.07.028; Pachon H, 2007, FOOD NUTR BULL, V28, P215, DOI 10.1177/156482650702800211; Potts KS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020354; Radhika R, 2014, DIAM RELAT MATER, V48, P6, DOI 10.1016/j.diamond.2014.06.005; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Sanghvi T, 2013, FOOD NUTR BULL, V34, pS156, DOI 10.1177/15648265130343S203; Saunders M., 2012, DOING RES BUSINESS M, V6; Siekmann JH, 2003, J NUTR, V133, p3972S, DOI 10.1093/jn/133.11.3972S; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; SPRING, 2007, REV APPROACHES EXPER; SPRING, 2016, NIG COMPL FEED FOOD; Temesgen M., 2013, SCI REP, V2, P1, DOI DOI 10.4172/SCIENTIFICREP0RTS.621; Wong LP, 2008, SINGAP MED J, V49, P256; Wu YP, 2016, J PEDIATR PSYCHOL, V41, P493, DOI 10.1093/jpepsy/jsw032	70	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0225707	10.1371/journal.pone.0225707	http://dx.doi.org/10.1371/journal.pone.0225707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914130	Green Submitted, Green Published, gold			2022-12-26	WOS:000534337700010
J	Chu, CH; Chen, JS; Chuang, PC; Su, CH; Chan, YL; Yang, YJ; Chiang, YT; Su, YY; Gean, PW; Sun, HS				Chu, Chun-Hsien; Chen, Jia-Shing; Chuang, Pei-Chin; Su, Chia-Hao; Chan, Ya-Ling; Yang, Ying-Ju; Chiang, Yu-Ting; Su, Yu-Ya; Gean, Po-Wu; Sun, H. Sunny			TIAM2S as a novel regulator for serotonin level enhances brain plasticity and locomotion behavior	FASEB JOURNAL			English	Article						guanine nucleotide exchange factor (GEF); hyperlocomotion; neuroplasticity; serotonergic fiber; serotonin (5-HT); TIAM2	HYPERACTIVITY DISORDER ADHD; CELL LYMPHOMA INVASION; METASTASIS 2 TIAM2; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; 5-HT7 RECEPTORS; RAC1; PROTEIN; GENE; OVEREXPRESSION	TIAM2S, the short form of human T-cell lymphoma invasion and metastasis 2, can have oncogenic effects when aberrantly expressed in the liver or lungs. However, it is also abundant in healthy, non-neoplastic brain tissue, in which its primary function is still unknown. Here, we examined the neurobiological and behavioral significance of human TIAM2S using the human brain protein panels, a human NT2/D1-derived neuronal cell line model (NT2/N), and transgenic mice that overexpress human TIAM2S (TIAM2S-TG). Our data reveal that TIAM2S exists primarily in neurons of the restricted brain areas around the limbic system and in well-differentiated NT2/N cells. Functional studies revealed that TIAM2S has no guanine nucleotide exchange factor (GEF) activity and is mainly located in the nucleus. Furthermore, whole-transcriptome and enrichment analysis with total RNA sequencing revealed that TIAM2S-knockdown (TIAM2S-KD) was strongly associated with the cellular processes of the brain structural development and differentiation, serotonin-related signaling, and the diseases markers representing neurobehavioral developmental disorders. Moreover, TIAM2S-KD cells display decreased neurite outgrowth and reduced serotonin levels. Moreover, TIAM2S overexpressing TG mice show increased number and length of serotonergic fibers at early postnatal stage, results in higher serotonin levels at both the serum and brain regions, and higher neuroplasticity and hyperlocomotion in latter adulthood. Taken together, our results illustrate the non-oncogenic functions of human TIAM2S and demonstrate that TIAM2S is a novel regulator of serotonin level, brain neuroplasticity, and locomotion behavior.	[Chu, Chun-Hsien; Yang, Ying-Ju; Chiang, Yu-Ting; Su, Yu-Ya; Sun, H. Sunny] Natl Cheng Kung Univ, Inst Mol Med, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan; [Chen, Jia-Shing; Gean, Po-Wu; Sun, H. Sunny] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Chuang, Pei-Chin] Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chuang, Pei-Chin] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Su, Chia-Hao] Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Chan, Ya-Ling; Gean, Po-Wu] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Coll Biosci & Biotechnol, Tainan, Taiwan; [Gean, Po-Wu] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Sun, HS (corresponding author), Natl Cheng Kung Univ, Inst Mol Med, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.	hssun@mail.ncku.edu.tw		Chan, Ya-Ling/0000-0002-9721-6718; Chen, Jia-Shing/0000-0002-5256-2123; Sun, Sunny/0000-0002-3661-4448	Ministry of Science and Technology, Taiwan (MOST) [MOST 104-2811-B-006-004, MOST 1042811-B-006-065, MOST 105-2320-B-006056-MY2, MOST 105-2320-B-006046-MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 104-2811-B-006-004, MOST 1042811-B-006-065, MOST 105-2320-B-006056-MY2 and MOST 105-2320-B-006046-MY3	Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Barreiro-Iglesias A, 2015, CELL REP, V13, P924, DOI 10.1016/j.celrep.2015.09.050; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Cabaj AM, 2017, J PHYSIOL-LONDON, V595, P301, DOI 10.1113/JP272271; Caubit X, 2016, NAT GENET, V48, P1359, DOI 10.1038/ng.3681; Chahdi A, 2013, J BIOL CHEM, V288, P34019, DOI 10.1074/jbc.M113.480103; Chen JS, 2012, INT J CANCER, V130, P1302, DOI 10.1002/ijc.26117; Chiu CY, 1999, GENOMICS, V61, P66, DOI 10.1006/geno.1999.5936; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; Chu CH, 2016, BRAIN BEHAV IMMUN, V55, P260, DOI 10.1016/j.bbi.2016.04.015; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Dayer A, 2014, DIALOGUES CLIN NEURO, V16, P29; Ding Y, 2014, ONCOL REP, V32, P607, DOI 10.3892/or.2014.3241; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Gabriel JP, 2009, J NEUROSCI, V29, P10387, DOI 10.1523/JNEUROSCI.1978-09.2009; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang J, 2013, INT J CANCER, V132, P90, DOI 10.1002/ijc.27627; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Ito H, 2003, J NEUROSCI RES, V71, P648, DOI 10.1002/jnr.10532; Jin H, 2011, HUM PATHOL, V42, P541, DOI 10.1016/j.humpath.2010.08.013; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kent L, 2002, MOL PSYCHIATR, V7, P908, DOI 10.1038/sj.mp.4001100; Kiser D, 2012, NEUROSCI BIOBEHAV R, V36, P786, DOI 10.1016/j.neubiorev.2011.12.009; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Levitan RD, 2002, J AFFECT DISORDERS, V71, P229, DOI 10.1016/S0165-0327(01)00372-X; Li J, 2012, ONCOL REP, V27, P1835, DOI 10.3892/or.2012.1744; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Lin YMJ, 2007, ARCH GEN PSYCHIAT, V64, P1015, DOI 10.1001/archpsyc.64.9.1015; Lo SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18335; Maddaloni G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00202; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V75, P381, DOI 10.1016/S0091-3057(03)00107-2; Narboux-Neme N, 2013, ACS CHEM NEUROSCI, V4, P171, DOI 10.1021/cn300165x; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Quist JF, 2000, MOL PSYCHIATR, V5, P537, DOI 10.1038/sj.mp.4000779; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rojas PS, 2014, J NEUROSCI RES, V92, P1000, DOI 10.1002/jnr.23390; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Serre A, 2012, STEM CELLS DEV, V21, P539, DOI 10.1089/scd.2011.0079; Slawinska U, 2014, ACTA NEUROBIOL EXP, V74, P172; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Su CH, 2016, THERANOSTICS, V6, P837, DOI 10.7150/thno.14837; Subramanian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070422; Tang LTH, 2019, ELIFE, V8, DOI 10.7554/eLife.38949; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas J, 2015, PHARM BIOL, V53, P1539, DOI 10.3109/13880209.2014.991837; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai CY, 2013, NEUROIMAGE, V82, P190, DOI 10.1016/j.neuroimage.2013.05.124; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang S, 2015, ONCOL REP, V33, P1807, DOI 10.3892/or.2015.3785; Wong RWJ, 2017, BLOOD, V130, P2326, DOI 10.1182/blood-2017-06-792184; Wu JB, 2015, NEUROPHARMACOLOGY, V97, P220, DOI 10.1016/j.neuropharm.2015.04.035; Yokoi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024539; Yoo S, 2012, MOL CELLS, V34, P103, DOI 10.1007/s10059-012-0119-x; Zhao ZY, 2013, ASIAN PAC J CANCER P, V14, P6305, DOI 10.7314/APJCP.2013.14.11.6305; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	70	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3267	3288		10.1096/fj.201901323R	http://dx.doi.org/10.1096/fj.201901323R		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908036				2022-12-26	WOS:000505951500001
J	Ahmetaj-Shala, B; Kawai, R; Marei, I; Nikolakopoulou, Z; Shih, CC; Konain, B; Reed, DM; Mongey, R; Kirkby, NS; Mitchell, JA				Ahmetaj-Shala, Blerina; Kawai, Ryota; Marei, Isra; Nikolakopoulou, Zacharoula; Shih, Chih-Chin; Konain, Bhatti; Reed, Daniel M.; Mongey, Roisin; Kirkby, Nicholas S.; Mitchell, Jane A.			A bioassay system of autologous human endothelial, smooth muscle cells, and leukocytes for use in drug discovery, phenotyping, and tissue engineering	FASEB JOURNAL			English	Article						blood vessel; cytokine response; stem cells	PERIPHERAL-BLOOD; PROGENITOR CELLS; DIABETES-MELLITUS; CYTOKINE STORM; KAPPA-B; OUTGROWTH; TARGET; INTERFERON; RELEASE; DISEASE	Blood vessels are comprised of endothelial and smooth muscle cells. Obtaining both types of cells from vessels of living donors is not possible without invasive surgery. To address this, we have devised a strategy whereby human endothelial and smooth muscle cells derived from blood progenitors from the same donor could be cultured with autologous leukocytes to generate a same donor "vessel in a dish" bioassay. Autologous sets of blood outgrowth endothelial cells (BOECs), smooth muscle cells (BO-SMCs), and leukocytes were obtained from four donors. Cells were treated in monoculture and cumulative coculture conditions. The endothelial specific mediator endothelin-1 along with interleukin (IL)-6, IL-8, tumor necrosis factor alpha, and interferon gamma-induced protein 10 were measured under control culture conditions and after stimulation with cytokines. Cocultures remained viable throughout. The profile of individual mediators released from cells was consistent with what we know of endothelial and smooth muscle cells cultured from blood vessels. For the first time, we report a proof of concept study where autologous blood outgrowth "vascular" cells and leukocytes were studied alone and in coculture. This novel bioassay has usefulness in vascular biology research, patient phenotyping, drug testing, and tissue engineering.	[Ahmetaj-Shala, Blerina; Kawai, Ryota; Marei, Isra; Nikolakopoulou, Zacharoula; Konain, Bhatti; Reed, Daniel M.; Mongey, Roisin; Kirkby, Nicholas S.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, Cardiothorac Pharmacol, Dovehouse St, London SW3 6LY, England; [Kawai, Ryota] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Tokyo, Japan; [Marei, Isra] Qatar Fdn, Div Res & Dev, Doha, Qatar; [Nikolakopoulou, Zacharoula] Imperial Coll London, Ctr Haematol, Fac Med, London, England; [Shih, Chih-Chin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan	Imperial College London; Daiichi Sankyo Company Limited; Qatar Foundation (QF); Imperial College London; National Defense Medical Center	Ahmetaj-Shala, B; Mitchell, JA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Cardiothorac Pharmacol, Dovehouse St, London SW3 6LY, England.	b.ahmetaj@imperial.ac.uk; j.a.mitchell@ic.ac.uk	Marei, Isra/AAG-2598-2021; marei, Isra/GPW-6811-2022	Kirkby, Nicholas/0000-0003-3509-8549	British Heart Foundation Project Grant [PG/16/83/32467]; British Heart Foundation [FS/16/1/31699]; Daiichi-Sankyo Co.Ltd; Qatar Foundation	British Heart Foundation Project Grant(British Heart Foundation); British Heart Foundation(British Heart Foundation); Daiichi-Sankyo Co.Ltd(Daiichi Sankyo Company Limited); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	British Heart Foundation Project Grant, Grant/Award Number: PG/16/83/32467; British Heart Foundation Intermediate Fellow, Grant/Award Number: FS/16/1/31699; Daiichi-Sankyo Co.Ltd; Qatar Foundation Research Fellow	Badiger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046779; Boersema M, 2015, IMMUNOBIOLOGY, V220, P673, DOI 10.1016/j.imbio.2014.11.011; Brisset AC, 2007, CIRC RES, V100, P1055, DOI 10.1161/01.RES.0000262654.84810.6c; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; George PM, 2014, CIRC RES, V114, P677, DOI 10.1161/CIRCRESAHA.114.302221; Joo HJ, 2014, BIOCHEM BIOPH RES CO, V449, P405, DOI 10.1016/j.bbrc.2014.05.061; Kang HS, 2014, J NEUROSURG, V120, P415, DOI 10.3171/2013.9.JNS131000; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Kolster M, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417698852; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Medina RJ, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/346735; Merkulova-Rainon T, 2012, CARDIOVASC RES, V95, P205, DOI 10.1093/cvr/cvs097; Metharom P, 2008, ATHEROSCLEROSIS, V198, P29, DOI 10.1016/j.atherosclerosis.2007.09.020; Mitchell JA, 2019, BRIT J PHARMACOL, V176, P1038, DOI 10.1111/bph.14167; Phi JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169714; Reed DM, 2015, FASEB J, V29, P2595, DOI 10.1096/fj.14-268144; Reed DM, 2014, BIOCHEM BIOPH RES CO, V455, P172, DOI 10.1016/j.bbrc.2014.10.140; Reed DM, 2013, BRIT J CLIN PHARMACO, V75, P897, DOI 10.1111/j.1365-2125.2012.04361.x; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Stanford SJ, 2000, ARTERIOSCL THROM VAS, V20, P677, DOI 10.1161/01.ATV.20.3.677; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Subramanian M, 2014, SEMIN IMMUNOPATHOL, V36, P93, DOI 10.1007/s00281-013-0400-x; Sugiyama S, 2006, ATHEROSCLEROSIS, V187, P351, DOI 10.1016/j.atherosclerosis.2005.09.014; van Ark J, 2012, DIABETOLOGIA, V55, P2501, DOI 10.1007/s00125-012-2590-5; Wang CH, 2012, ARTERIOSCL THROM VAS, V32, P1875, DOI 10.1161/ATVBAHA.112.245852; WARNER SJC, 1989, J IMMUNOL, V142, P100; Woods M, 1998, J CARDIOVASC PHARM, V31, pS348, DOI 10.1097/00005344-199800001-00097; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Xie SZ, 2008, J ZHEJIANG UNIV-SC B, V9, P923, DOI 10.1631/jzus.B0820257; Yang Z, 2008, J VASC SURG, V47, P432, DOI 10.1016/j.jvs.2007.10.039; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692	37	3	3	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1745	1754		10.1096/fj.201901379RR	http://dx.doi.org/10.1096/fj.201901379RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914612	Green Published, hybrid			2022-12-26	WOS:000507308900115
J	Chu, AN; Wang, D; Guo, QQ; Lv, Z; Yuan, Y; Gong, YH				Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua			Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis	FASEB JOURNAL			English	Article						23SrRNA; antibiotic resistance; gyrA; rdxA; H; pylori	23S RIBOSOMAL-RNA; HELICOBACTER-PYLORI; CLARITHROMYCIN RESISTANCE; METRONIDAZOLE RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; CONFERRING RESISTANCE; T2182C MUTATION; GYRA; FLUOROQUINOLONE; THERAPY	To explore the mutation characteristics of H. pylori resistance-related genes to antibiotics of clarithromycin (CAM), levofloxacin (LVX) and metronidazole, 23SrRNA, gyrA, gyrB, rdxA, and frxA genes were amplified and sequenced, respectively. Molecular docking study was performed to explore molecular interactions between chemotherapeutic agents and target proteins. In the CAM-resistant strains, the mutation rate in site A2143G was 74.2% (n = 23). The interactions in sites of G1949A, C1953T, and G2211T with CAM were weaker after mutation. In the LVX-resistant strains, the mutation rates in 87 (N to K/I) and 91 (D to N/Y/G) of gyrA were 28.6% (n = 16) and 12.5% (n = 7), respectively. We could infer by docking studies that N87 K/I, D91Y/G/N, D99N, and D143E mutations in GyrA protein all had weakened interaction with LVX. The mutation types of RdxA protein consisted of protein truncation caused by premature stop codons (n = 26, 33.3%), frameshift mutations (n = 8, 10.3%), FMN-binding sites (n = 16, 20.5%), and the others (n = 11, 14.1%). Docking analysis showed that some mutations in those four types of RdxA protein could reduce interaction with MNZ, and play a significant role in antibiotic resistance. What's more, we performed natural transformation with some of these mutated DNA fragments to see if they really impact susceptibility to antibiotics. Our study suggested that in addition to the reported mutation sites, H. pylori antibiotic resistance in this region may also be associated with changes in some new sites. Our study provides novel ideas and methods for the identification of H. pylori resistance-related mutations, and also clues and basis for further investigation on specific molecular mechanism.	[Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China; [Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Dept Educ, Key Lab Canc Etiol & Prevent Liaoning, Shenyang, Peoples R China; [Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Key Lab GI Canc Etiol & Prevent Liaoning Prov, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Yuan, Y; Gong, YH (corresponding author), China Med Univ, Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China.	yuanyuan@cmu.edu.cn; yhgong@cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key R&D Program of China [2017YFC0907402]; National Natural Science Foundation [81970501]	National Key R&D Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2017YFC0907402; National Natural Science Foundation, Grant/Award Number: 81970501	Burucoa C, 2005, ANTIMICROB AGENTS CH, V49, P868, DOI 10.1128/AAC.49.2.868-870.2005; Chung JW, 2012, J GASTROEN HEPATOL, V27, P493, DOI 10.1111/j.1440-1746.2011.06874.x; De Palma GZ, 2017, MICROB DRUG RESIST, V23, P351, DOI 10.1089/mdr.2015.0361; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Ge Z, 1997, Methods Mol Med, V8, P145, DOI 10.1385/0-89603-381-3:145; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Gong YH, 2005, WORLD J GASTROENTERO, V11, P3523, DOI 10.3748/wjg.v11.i23.3523; Gong YH, 2018, CRIT REV MICROBIOL, V44, P371, DOI 10.1080/1040841X.2017.1418285; Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Kaneko F, 2004, ALIMENT PHARM THER, V20, P62, DOI 10.1111/j.1365-2036.2004.01993.x; Khan R, 2004, ANTIMICROB AGENTS CH, V48, P3567, DOI 10.1128/AAC.48.9.3567-3569.2004; Khashei R, 2016, APMIS, V124, P787, DOI 10.1111/apm.12567; Klesiewicz K, 2014, ACTA BIOCHIM POL, V61, P311; Kwon DH, 2000, J ANTIMICROB CHEMOTH, V46, P793, DOI 10.1093/jac/46.5.793; Lee JW, 2011, HELICOBACTER, V16, P301, DOI 10.1111/j.1523-5378.2011.00840.x; Matsuzaki J, 2012, ANTIMICROB AGENTS CH, V56, P1643, DOI 10.1128/AAC.05941-11; Matsuzaki J, 2010, J GASTROEN HEPATOL, V25, pS7, DOI 10.1111/j.1440-1746.2010.06245.x; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Miftahussurur M, 2017, AM J TROP MED HYG, V96, P1050, DOI 10.4269/ajtmh.16-0729; Miftahussurur M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166199; Mori H, 2018, UNITED EUR GASTROENT, V6, P391, DOI 10.1177/2050640617737215; Mori H, 2017, UNITED EUR GASTROENT, V5, P796, DOI 10.1177/2050640616688995; Mori H, 2016, HELICOBACTER, V21, P286, DOI 10.1111/hel.12286; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Nishizawa T, 2007, J CLIN MICROBIOL, V45, P303, DOI 10.1128/JCM.01997-06; Osaki T, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12396; Pagadala Nataraj S, 2017, Biophys Rev, V9, P91, DOI 10.1007/s12551-016-0247-1; Acosta CP, 2017, BIOMEDICA, V37, P191, DOI 10.7705/biomedica.v37i2.3007; Rasheed F, 2014, HELICOBACTER, V19, P387, DOI 10.1111/hel.12142; Sanches BS, 2016, WORLD J GASTROENTERO, V22, P7587, DOI 10.3748/wjg.v22.i33.7587; Seck A, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-3; Secka O, 2013, ANTIMICROB AGENTS CH, V57, P1231, DOI 10.1128/AAC.00517-12; Sohretoglu D, 2018, INT J BIOL MACROMOL, V108, P81, DOI 10.1016/j.ijbiomac.2017.11.151; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Suzuki H, 2009, ANTIMICROB AGENTS CH, V53, P1720, DOI 10.1128/AAC.00049-09; Suzuki RB, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-164; Take S, 2015, J GASTROENTEROL, V50, P638, DOI 10.1007/s00535-014-1004-5; Teh X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101481; Thung I, 2016, ALIMENT PHARM THER, V43, P514, DOI 10.1111/apt.13497; Binh TT, 2015, ANTIMICROB AGENTS CH, V59, P2343, DOI 10.1128/AAC.04852-14; Binh TT, 2014, J ANTIMICROB CHEMOTH, V69, P1796, DOI 10.1093/jac/dku050; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; Tu IF, 2014, HELICOBACTER, V19, P356, DOI 10.1111/hel.12140; Wang D, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1517-4; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; Zhao LJ, 2014, WORLD J GASTROENTERO, V20, P4761, DOI 10.3748/wjg.v20.i16.4761	48	7	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					610	618		10.1096/fj.201900774R	http://dx.doi.org/10.1096/fj.201900774R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914672	Bronze			2022-12-26	WOS:000507308900042
J	Neal, ML; Fleming, SM; Budge, KM; Boyle, AM; Kim, C; Alam, G; Beier, EE; Wu, LJ; Richardson, JR				Neal, Matthew L.; Fleming, Sheila M.; Budge, Kevin M.; Boyle, Alexa M.; Kim, Chunki; Alam, Gelareh; Beier, Eric E.; Wu, Long-Jun; Richardson, Jason R.			Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration	FASEB JOURNAL			English	Article						microglia; neuroprotection; Parkinson's disease; proliferation	COLONY-STIMULATING FACTOR; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; GENE-EXPRESSION; RECEPTOR; PROGRESSION; NEURON; CELLS; CSF-1; MICE	Increased pro-inflammatory cytokine levels and proliferation of activated microglia have been found in Parkinson's disease (PD) patients and animal models of PD, suggesting that targeting of the microglial inflammatory response may result in neuroprotection in PD. Microglial proliferation is regulated by many factors, but colony stimulating factor-1 receptor (CSF1R) has emerged as a primary factor. Using data mining techniques on existing microarray data, we found that mRNA expression of the CSF1R ligand, CSF-1, is increased in the brain of PD patients compared to controls. In two different neurotoxic mouse models of PD, acute MPTP and sub-chronic LPS treatment, mRNA and protein levels of CSF1R and CSF-1 were significantly increased. Treatment with the CSF1R inhibitor GW2580 significantly attenuated MPTP-induced CSF1R activation and Iba1-positive cell proliferation, without a reduction of the basal Iba1-positive population in the substantia nigra. GW2580 treatment also significantly decreased mRNA levels of pro-inflammatory factors, without alteration of anti-inflammatory mediators, and significantly attenuated the MPTP-induced loss of dopamine neurons and motor behavioral deficits. Importantly, these effects were observed in the absence of overt microglial depletion, suggesting that targeting CSF1R signaling may be a viable neuroprotective strategy in PD that disrupts pro-inflammatory signaling, but maintains the beneficial effects of microglia.	[Neal, Matthew L.; Kim, Chunki; Richardson, Jason R.] Florida Int Univ, Robert Stempel Sch Publ Hlth & Social Work, Dept Environm Hlth, 11200 SW 8th St AHC5-515, Miami, FL 33199 USA; [Neal, Matthew L.; Fleming, Sheila M.; Boyle, Alexa M.; Alam, Gelareh; Richardson, Jason R.] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH USA; [Neal, Matthew L.; Fleming, Sheila M.; Boyle, Alexa M.; Alam, Gelareh; Richardson, Jason R.] Northeast Ohio Med Univ, Ctr Neurodegenerat Dis & Aging, Rootstown, OH USA; [Budge, Kevin M.; Boyle, Alexa M.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA; [Beier, Eric E.; Richardson, Jason R.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Wu, Long-Jun] Mayo Clin, Dept Neurol, Rochester, MN USA	State University System of Florida; Florida International University; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Rutgers State University New Brunswick; Mayo Clinic	Richardson, JR (corresponding author), Florida Int Univ, Robert Stempel Sch Publ Hlth & Social Work, Dept Environm Hlth, 11200 SW 8th St AHC5-515, Miami, FL 33199 USA.	jarichar@fiu.edu	Wu, Long-Jun/AAK-7113-2020; Richardson, Jason/AAG-5281-2019	Wu, Long-Jun/0000-0001-8019-3380; Richardson, Jason/0000-0001-6521-610X; Kim, Chunki/0000-0003-2410-9118	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [R01ES021800]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS088627]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: R01ES021800; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS088627	Alam G, 2017, NEUROTOXICOLOGY, V60, P99, DOI 10.1016/j.neuro.2017.03.008; Beier EE, 2017, NEUROBIOL DIS, V108, P115, DOI 10.1016/j.nbd.2017.08.009; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Conway JG, 2008, J PHARMACOL EXP THER, V326, P41, DOI 10.1124/jpet.107.129429; Dammeijer F, 2017, CANCER IMMUNOL RES, V5, P535, DOI 10.1158/2326-6066.CIR-16-0309; De I, 2014, GLIA, V62, P1955, DOI 10.1002/glia.22717; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmore MRP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122912; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Eyo UB, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/456857; Fleming SM, 2018, NEUROTOXICOLOGY, V64, P256, DOI 10.1016/j.neuro.2017.06.005; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fornai F, 1997, J PHARMACOL EXP THER, V283, P100; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; FREI K, 1992, J NEUROIMMUNOL, V40, P189, DOI 10.1016/0165-5728(92)90133-6; Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Garcia S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0973-6; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Klinkert K, 2017, EUR SURG RES, V58, P109, DOI 10.1159/000451078; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kondo Y, 2009, J NEUROSCI RES, V87, P2686, DOI 10.1002/jnr.22096; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Leblond AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137515; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Martinez-Muriana A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25663; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Moreno M, 2014, J NEUROSCI, V34, P8175, DOI 10.1523/JNEUROSCI.1137-14.2014; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Neal ML, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1100-1; Noelker C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01393; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Parillaud VR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0830-9; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Smith CC, 2015, CANCER DISCOV, V5, P668, DOI 10.1158/2159-8290.CD-15-0060; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Wake H, 2011, NEURON GLIA BIOL, V7, P47, DOI 10.1017/S1740925X12000063; Walker DG, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00244; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Whitton PS, 2010, CURR OPIN INVEST DR, V11, P788; Yang XX, 2018, FASEB J, V32, P3336, DOI 10.1096/fj.201700833RR; Zhang QS, 2017, TOXICOL LETT, V265, P30, DOI 10.1016/j.toxlet.2016.11.002; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	61	37	37	4	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1679	1694		10.1096/fj.201900567RR	http://dx.doi.org/10.1096/fj.201900567RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914683	Green Accepted			2022-12-26	WOS:000507308900111
J	Wu, YC; Gong, YH; Luan, YX; Li, Y; Liu, JX; Yue, ZT; Yuan, BY; Sun, JX; Xie, CX; Li, LJ; Zhen, JL; Jin, XX; Zheng, Y; Wang, XM; Xie, LW; Wang, W				Wu, Yancheng; Gong, Yuhong; Luan, Yongxin; Li, Yang; Liu, Juxiong; Yue, Zitong; Yuan, Boyu; Sun, Jingxuan; Xie, Changxin; Li, Lijuan; Zhen, Junli; Jin, Xinxin; Zheng, Yan; Wang, Xiaomin; Xie, Liwei; Wang, Wei			BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						5XFAD mice; Alzheimer's disease; BHBA; inflammation; microglia; beta-amyloid	AMYLOID PRECURSOR PROTEIN; BETA-HYDROXYBUTYRATE; KETOGENIC DIET; KETONE ESTER; MICROGLIA; EXPRESSION; ENERGY; INFLAMMASOME; IMPAIRMENT; METABOLISM	Accumulation of amyloid beta (A beta) peptide, inflammation, and oxidative stress contribute to Alzheimer's disease (AD) and trigger complex pathogenesis. The ketone body beta-hydroxybutyrate (BHBA) is an endogenous metabolic intermediate that protects against stroke and neurodegenerative diseases, but the underlying mechanisms are unclear. The present study aims to elucidate the protective effects of BHBA in the early stage of AD model and investigate the underlying molecular mechanisms. Three-and-half-month-old double-transgenic mice (5XFAD) overexpressing beta-amyloid precursor protein (APP) and presenilin-1 (PS1) were used as the AD model. The 5XFAD mice received 1.5 mmol/kg/d BHBA subcutaneously for 28 days. Morris water maze test, nest construction, and passive avoidance experiments were performed to assess the therapeutic effects on AD prevention in vivo, and brain pathology of 5XFAD mice including amyloid plaque deposition and microglia activation were assessed. Gene expression profiles in the cortexes of 5XFAD- and BHBA-treated 5XFAD mice were performed with high-throughput sequencing and bioinformatic analysis. Mouse HT22 cells were treated with 2 mM BHBA to explore its in vitro protective effects of BHBA on hippocampal neurons against A beta oligomer toxicity, ATP production, ROS generation, and mitochondrial aerobic respiratory function. APP, BACE1, and neprilysin (NEP) expression levels were evaluated in HT22 cells following treatment with BHBA by measuring the presence or absence of G protein-coupled receptor 109A (GPR109A). BHBA improved cognitive function of 5XFAD mice in Morris water maze test, nesting construction and passive avoidance experiments, and attenuated A beta accumulation and microglia overactivation in the brain. BHBA also enhanced mitochondrial respiratory function of hippocampal neurons and protected it from A beta toxicity. The enzymes, APP and NEP were regulated by BHBA via G-protein-coupled receptor 109A (GPR109A). Furthermore, RNA sequencing revealed that BHBA-regulated genes mainly annotated in aging, immune system, nervous system, and neurodegenerative diseases. Our data suggested that BHBA confers protection against the AD-like pathological events in the AD mouse model by targeting multiple aspects of AD and it may become a promising candidate for the prevention and treatment of AD.	[Wu, Yancheng; Wang, Wei] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou 510225, Peoples R China; [Wu, Yancheng; Gong, Yuhong; Liu, Juxiong; Yuan, Boyu; Sun, Jingxuan; Xie, Changxin; Jin, Xinxin; Wang, Wei] Jilin Univ, Coll Vet Med, Changchun, Peoples R China; [Luan, Yongxin] First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China; [Li, Yang; Li, Lijuan; Zhen, Junli; Zheng, Yan; Wang, Xiaomin; Wang, Wei] Capital Med Univ, Minist Educ, Dept Neurobiol, Key Lab Neurodegenerat Disorders, Beijing 100069, Peoples R China; [Yue, Zitong] Changchun Jida Middle Sch Expt Sch, Changchun, Peoples R China; [Li, Lijuan] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Xie, Liwei] Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Peoples R China	Zhongkai University of Agriculture & Engineering; Jilin University; Jilin University; Capital Medical University; Hebei Medical University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wang, W (corresponding author), Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou 510225, Peoples R China.; Zheng, Y; Wang, XM (corresponding author), Capital Med Univ, Minist Educ, Dept Neurobiol, Key Lab Neurodegenerat Disorders, Beijing 100069, Peoples R China.; Xie, LW (corresponding author), Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Peoples R China.	zhengyan@ccmu.edu.cn; xmwang@ccmu.edu.cn; xielw@gdim.cn; wang_wei99@jlu.edu.cn	jin, xin/GQZ-5811-2022; Yuan, Boyu/HCI-9190-2022	Sun, Jingxuan/0000-0002-2502-6157; yuan, yuan bo yu/0000-0003-3150-5346	National Natural Science Foundation of China [31572479, 31872442]; Program for JLU Science and Technology Innovative Research Team [2017TD-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for JLU Science and Technology Innovative Research Team	This work was funded by the National Natural Science Foundation of China (31572479, 31872442) and Program for JLU Science and Technology Innovative Research Team (2017TD-30)	Ambrosi G, 2014, BBA-MOL BASIS DIS, V1842, P1385, DOI 10.1016/j.bbadis.2014.05.008; Aso E, 2013, CURR ALZHEIMER RES, V10, P290, DOI 10.2174/15672050112099990128; Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Boza-Serrano A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19699-y; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brownlow ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075713; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Cross Helen, 2015, BMJ Clin Evid, V2015; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Feng WQ, 2018, CELL PHYSIOL BIOCHEM, V47, P1617, DOI 10.1159/000490981; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Fu SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/983401; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kadakkuzha BM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00063; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kossoff EH, 2009, NEUROTHERAPEUTICS, V6, P406, DOI 10.1016/j.nurt.2009.01.005; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024620; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Mamelak M, 2017, NEUROSCI BIOBEHAV R, V75, P297, DOI 10.1016/j.neubiorev.2017.02.001; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nakamura K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020206; Nei M, 2014, SEIZURE-EUR J EPILEP, V23, P439, DOI 10.1016/j.seizure.2014.02.015; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ringheim GE, 1998, MOL BRAIN RES, V55, P35, DOI 10.1016/S0169-328X(97)00356-2; Rothman SM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1265-7; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2014, DIS MODEL MECH, V7, P1385, DOI 10.1242/dmm.018218; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yamanashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08055-1; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yin JX, 2016, NEUROBIOL AGING, V39, P25, DOI 10.1016/j.neurobiolaging.2015.11.018; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	63	29	31	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1412	1429		10.1096/fj.201901984R	http://dx.doi.org/10.1096/fj.201901984R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914599	hybrid			2022-12-26	WOS:000507308900094
J	Gupta, SK; Crants, J				Gupta, Sanjay K.; Crants, James			Identification and impact of stable prognostic biochemical markers for cold-induced sweetening resistance on selection efficiency in potato (Solanum tuberosum L.) breeding programs	PLOS ONE			English	Article							UDP-GLUCOSE PYROPHOSPHORYLASE; ACID INVERTASE ACTIVITY; TO-SUCROSE RATIO; POSTTRANSLATIONAL REGULATION; RUSSET BURBANK; SUGAR CONTENT; LATE BLIGHT; ACCUMULATION; INHIBITOR; STORAGE	Biochemical markers for cold-induced sweetening (CIS) resistance were tested for their stability over years and their use in selection of parents for crossing to achieve high selection efficiency in potato breeding programs. Two regulatory enzymes directly associated with reducing sugar (RS) accumulation during potato tubers cold storage were tested as a predictor for CIS resistance. These enzymes were studied in 33 potato clones from various breeding programs over four years. Clones with the presence of A-II isozymes of UDP-glucose pyrophosphorylase (UGPase) and low activity of vacuolar acid invertase (VAclnv) enzyme had increased resistance to cold induced sweetening (CIS). Depending on the levels of these enzymes, clones were divided into class A, class B and class C. Clones categorized as class A had average RS of 0.73 mg per g FW after six months at 5.5 degrees C storage. Class B and C had average RS of 1.15 and 3.80 mg per g FW respectively. The enzyme activity was closely associated with RS accumulation over long-term cold storage. The biochemical markers were found to be stable over the years. Repeated-measure analysis showed 75% chance of maintaining class from one year to the next and a 25% chance of switching, No clone switched between class A and class C, even across all four years. Application of these biochemical markers can identify clones with CIS resistance early in the selection process. Biochemical markers were used to select parents for crossing and six families were established. Results showed that with both parents from class A, 95% of their offspring had desirable glucose levels and chip color, which dropped to 52% when one parent was from class A and other from class B. These results suggest that two regulatory enzymes, i.e., UGPase and VAclnv, can be used as stable prognostic biochemical markers for CIS resistance for precise parent selection resulting in progenies with significantly higher percentage of clones with acceptable processing quality.	[Gupta, Sanjay K.; Crants, James] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Gupta, SK (corresponding author), Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA.	gupta020@umn.edu	Gupta, Sanjay/AAK-6402-2020		Cavendish Farms/Northern Plains Potato Growers Association; Minnesota Area II Potato Research and Promotion Council	Cavendish Farms/Northern Plains Potato Growers Association; Minnesota Area II Potato Research and Promotion Council	I (Sanjay K Gupta) received financial support from Cavendish Farms/Northern Plains Potato Growers Association and Minnesota Area II Potato Research and Promotion Council. The funders had no role in study design, data collection dna analysis, decision to publish, or preparation of the manuscript.	Bhaskar PB, 2010, PLANT PHYSIOL, V154, P939, DOI 10.1104/pp.110.162545; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw J. E., 1994, P467; Chen S, 2008, PLANT CELL ENVIRON, V31, P165, DOI 10.1111/j.1365-3040.2007.01747.x; Ciereszko I, 2001, BIOCHEM J, V354, P67, DOI 10.1042/0264-6021:3540067; Clasen BM, 2015, PLANT BIOTECHNOL J, P1, DOI [10.1111/pbi.12323, DOI 10.1111/PBI.12323]; COLEMAN WK, 1993, AM POTATO J, V70, P909, DOI 10.1007/BF02851476; Dale M. F. B., 1994, P285; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Gupta SK, 2008, J PLANT PHYSIOL, V165, P679, DOI 10.1016/j.jplph.2007.09.001; Gupta SK, 2017, AM J POTATO RES, V94, P297, DOI 10.1007/s12230-017-9565-5; Gupta SK, 2003, J PLANT PHYSIOL, V160, P589, DOI 10.1078/0176-1617-01045; Kingston-Smith AH, 1999, J EXP BOT, V50, P735, DOI 10.1093/jexbot/50.335.735; Knowles NR, 2009, POSTHARVEST BIOL TEC, V52, P49, DOI 10.1016/j.postharvbio.2008.08.015; Koh EJ, 2008, MOL CELLS, V26, P236; Kyriacou MC, 2009, J FOOD AGRIC ENVIRON, V7, P31; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2013, PLANT PHYSIOL BIOCH, V73, P237, DOI 10.1016/j.plaphy.2013.09.012; LINDSAY H, 1973, Potato Research, V16, P176, DOI 10.1007/BF02356048; Liu X, 2017, PLANT PHYSIOL BIOCH, V111, P77, DOI 10.1016/j.plaphy.2016.11.021; Liu X, 2013, POSTHARVEST BIOL TEC, V86, P265, DOI 10.1016/j.postharvbio.2013.07.001; Liu X, 2011, MOL GENET GENOMICS, V286, P109, DOI 10.1007/s00438-011-0632-1; Massa AN, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0672-1; Matsuura-Endo C, 2004, J PLANT RES, V117, P131, DOI 10.1007/s10265-003-0137-z; Mckenzie MJ, 2013, PLANT CELL ENVIRON, V36, P176, DOI 10.1111/j.1365-3040.2012.02565.x; McKenzie MJ, 2005, AM J POTATO RES, V82, P231, DOI 10.1007/BF02853589; Milczarek D, 2011, AM J POTATO RES, V88, P245, DOI 10.1007/s12230-011-9189-0; Oberhagemann P, 1999, MOL BREEDING, V5, P399, DOI 10.1023/A:1009623212180; Orawetz T, 2016, PLANT PHYSIOL BIOCH, V100, P141, DOI 10.1016/j.plaphy.2016.01.013; Ou YB, 2013, POTATO RES, V56, P157, DOI 10.1007/s11540-013-9237-x; PRESSEY R, 1969, AM POTATO J, V46, P291, DOI 10.1007/BF02877144; PRESSEY R, 1966, PLANT PHYSIOL, V41, P1657, DOI 10.1104/pp.41.10.1657; PRITCHARD MK, 1994, AM POTATO J, V71, P59, DOI 10.1007/BF02848745; RICHARDSON DL, 1990, J EXP BOT, V41, P95, DOI 10.1093/jxb/41.1.95; SASAKI T, 1971, PHYTOCHEMISTRY, V10, P2047, DOI 10.1016/S0031-9422(00)97195-4; Schreiber L, 2014, G3-GENES GENOM GENET, V4, P1797, DOI 10.1534/g3.114.012377; Sin'kevich MS, 2008, RUSS J PLANT PHYSL+, V55, P449, DOI 10.1134/S1021443708040031; Slater AT, 2016, ACTA HORTIC, V1127, P237, DOI 10.17660/ActaHortic.2016.1127.37; Slater AT, 2014, THEOR APPL GENET, V127, P809, DOI 10.1007/s00122-013-2258-7; Slater AT, 2013, MOL BREEDING, V32, P299, DOI 10.1007/s11032-013-9871-7; Sowokinos JR, 2018, AM J POTATO RES, V95, P487, DOI 10.1007/s12230-018-9653-1; Sowokinos JR, 2004, J PLANT PHYSIOL, V161, P947, DOI 10.1016/j.jplph.2004.04.006; SOWOKINOS JR, 1993, PLANT PHYSIOL, V101, P1073, DOI 10.1104/pp.101.3.1073; Sowokinos JR, 2000, AM J POTATO RES, V77, P47, DOI 10.1007/BF02853661; Sowokinos JR, 2001, AM J POTATO RES, V78, P221, DOI 10.1007/BF02883548; Sowokinos JR, 2001, AM J POTATO RES, V78, P57, DOI 10.1007/BF02874825; Sowokinos JR, 1995, PLANT PHYSIOL, V78, P489, DOI [10.1104/pp.110.162545, DOI 10.1104/PP.110.162545]; THILL CA, 1995, EUPHYTICA, V84, P73, DOI 10.1007/BF01677559; Wu L, 2011, CROP SCI, V51, P981, DOI 10.2135/cropsci2010.08.0473; Xu Changai, 2009, Potato Journal (Shimla), V36, P35; Xu X, 2017, CARBOHYD POLYM, V157, P1628, DOI 10.1016/j.carbpol.2016.11.043; Zhang HL, 2013, FEBS LETT, V587, P749, DOI 10.1016/j.febslet.2013.01.066; Zhu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093381; Zrenner R, 1996, PLANTA, V198, P246, DOI 10.1007/BF00206250	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0225411	10.1371/journal.pone.0225411	http://dx.doi.org/10.1371/journal.pone.0225411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891570	gold, Green Published			2022-12-26	WOS:000515096600005
J	Somogyi, M; Szimler, T; Baksa, A; Vegh, BM; Bakos, T; Parej, K; Adam, C; Zsigmond, A; Megyeri, M; Flachner, B; Sajo, R; Graczer, E; Zavodszky, P; Hajdu, I; Beinrohr, L				Somogyi, Mark; Szimler, Tamas; Baksa, Attila; Vegh, Barbara M.; Bakos, Tamas; Parej, Katalin; Adam, Csaba; Zsigmond, Aron; Megyeri, Marton; Flachner, Beata; Sajo, Rachel; Graczer, Eva; Zavodszky, Peter; Hajdu, Istvan; Beinrohr, Laszlo			A versatile modular vector set for optimizing protein expression among bacterial, yeast, insect and mammalian hosts	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; KINASES	We have developed a unified, versatile vector set for expression of recombinant proteins, fit for use in any bacterial, yeast, insect or mammalian cell host. The advantage of this system is its versatility at the vector level, achieved by the introduction of a novel expression cassette. This cassette contains a unified multi-cloning site, affinity tags, protease cleavable linkers, an optional secretion signal, and common restriction endonuclease sites at key positions. This way, genes of interest and all elements of the cassette can be switched freely among the vectors, using restriction digestion and ligation without the need of polymerase chain reaction (PCR). This vector set allows rapid protein expression screening of various hosts and affinity tags. The reason behind this approach was that it is difficult to predict which expression host and which affinity tag will lead to functional expression. The new system is based on four optimized and frequently used expression systems (Escherichia coli pET, the yeast Pichia pastoris, pVL and pIEx for Spodoptera frugiperda insect cells and pLEXm based mammalian systems), which were modified as described above. The resulting vector set was named pONE series. We have successfully applied the pONE vector set for expression of the following human proteins: the tumour suppressor RASSF1A and the protein kinases Aurora A and LIMK1. Finally, we used it to express the large multidomain protein, Rho-associated protein kinase 2 (ROCK2, 164 kDa) and demonstrated that the yeast Pichia pastoris reproducibly expresses the large ROCK2 kinase with identical activity to the insect cell produced counterpart. To our knowledge this is among the largest proteins ever expressed in yeast. This demonstrates that the cost-effective yeast system can match and replace the industry-standard insect cell expression system even for large and complex mammalian proteins. These experiments demonstrate the applicability of our pONE vector set.	[Somogyi, Mark; Szimler, Tamas; Baksa, Attila; Vegh, Barbara M.; Bakos, Tamas; Parej, Katalin; Adam, Csaba; Zsigmond, Aron; Megyeri, Marton; Flachner, Beata; Sajo, Rachel; Graczer, Eva; Zavodszky, Peter; Hajdu, Istvan; Beinrohr, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hajdu, I; Beinrohr, L (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	hajdu.istvan@ttk.mta.hu; laszlo@beinrohr.com		Parej, Katalin/0000-0002-2567-6061	National Research, Development and Innovation Office (NKFIH) [K108642]	National Research, Development and Innovation Office (NKFIH)	Present work was supported by grant K108642 provided by National Research, Development and Innovation Office (NKFIH) awarded to P.Z. (https://nkfih.gov.hu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Amin Karishma S, 2012, J Carcinog, V11, P3, DOI 10.4103/1477-3163.93000; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Balogh A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01240; Bokhove M, 2016, J STRUCT BIOL, V194, P1, DOI 10.1016/j.jsb.2016.01.016; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Chen B.-Y., 2002, PCR CLONING PROTOCOL; Dalken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014404; Deng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142558; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Fang F, 2011, YEAST, V28, P123, DOI 10.1002/yea.1824; Goulas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112643; Green MR, 2012, MOL CLONING LAB MANU, V1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herskowitz JH, 2013, J NEUROSCI, V33, P19086, DOI 10.1523/JNEUROSCI.2508-13.2013; Hirz M, 2013, APPL MICROBIOL BIOT, V97, P9465, DOI 10.1007/s00253-013-5156-7; Invitrogen, 2014, PICH EXPR KIT MAN; Invitrogen, GUID BAC EXPR VECT S; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Koch JC, 2018, PHARMACOL THERAPEUT, V189, P1, DOI 10.1016/j.pharmthera.2018.03.008; Laitinen OH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni042; Loomis Kathryn H., 2005, Journal of Structural and Functional Genomics, V6, P189, DOI 10.1007/s10969-005-5241-y; Lyska D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053787; Martin CD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-46; Mirmazloum I, 2019, INT J BIOL MACROMOL, V136, P847, DOI 10.1016/j.ijbiomac.2019.06.086; Novagen, 2009, INS GENEJUICE TRANSF; NovaGen, 2006, PET SYST MAN; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pustelny K, 2014, J BIOL CHEM, V289, P15544, DOI 10.1074/jbc.M113.507616; Reeves A., 2017, IN VITRO MUTAGENESIS; Reuten R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152386; Rodems SM, 2002, ASSAY DRUG DEV TECHN, V1, P9, DOI 10.1089/154065802761001266; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-12; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Sinah N, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-54; Szimler T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41972-x; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399; Zitzmann J., 2017, NEW INSIGHTS CELL CU, P43	41	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227110	10.1371/journal.pone.0227110	http://dx.doi.org/10.1371/journal.pone.0227110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887188	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000515092200075
J	Njavro, JR; Klotz, J; Dislich, B; Wanngren, J; Shmueli, MD; Herber, J; Kuhn, PH; Kumar, R; Koeglsperger, T; Conrad, M; Wurst, W; Feederle, R; Vlachos, A; Michalakis, S; Jedlicka, P; Muller, SA; Lichtenthaler, SF				Rudan Njavro, Jasenka; Klotz, Jakob; Dislich, Bastian; Wanngren, Johanna; Shmueli, Merav D.; Herber, Julia; Kuhn, Peer-Hendrik; Kumar, Rohit; Koeglsperger, Thomas; Conrad, Marcus; Wurst, Wolfgang; Feederle, Regina; Vlachos, Andreas; Michalakis, Stylianos; Jedlicka, Peter; Mueller, Stephan A.; Lichtenthaler, Stefan F.			Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1	FASEB JOURNAL			English	Article						gamma-secretase; inhibitory synapse; retina; secretase; SILAC	AMYLOID PRECURSOR PROTEIN; HUMAN INSULIN-RECEPTOR; GATED SODIUM-CHANNELS; CLEAVING ENZYME BACE1; BETA-SECRETASE; MEMORY DEFICITS; GAMMA-SECRETASE; RANDOMIZED-TRIAL; KNOCKOUT MICE; MIGRATION	The protease beta-site APP cleaving enzyme 1 (BACE1) has fundamental functions in the nervous system. Its inhibition is a major therapeutic approach in Alzheimer's disease, because BACE1 cleaves the amyloid precursor protein (APP), thereby catalyzing the first step in the generation of the pathogenic amyloid beta (A beta) peptide. Yet, BACE1 cleaves numerous additional membrane proteins besides APP. Most of these substrates have been identified in vitro, but only few were further validated or characterized in vivo. To identify BACE1 substrates with in vivo relevance, we used isotope label-based quantitative proteomics of wild type and BACE1-deficient (BACE1 KO) mouse brains. This approach identified known BACE1 substrates, including Close homolog of L1 and contactin-2, which were found to be enriched in the membrane fraction of BACE1 KO brains. VWFA and cache domain-containing protein 1 (CACHD)1 and MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (MDGA1), which have functions in synaptic transmission, were identified and validated as new BACE1 substrates in vivo by immunoblots using primary neurons and mouse brains. Inhibition or deletion of BACE1 from primary neurons resulted in a pronounced inhibition of substrate cleavage and a concomitant increase in full-length protein levels of CACHD1 and MDGA1. The BACE1 cleavage site in both proteins was determined to be located within the juxtamembrane domain. In summary, this study identifies and validates CACHD1 and MDGA1 as novel in vivo substrates for BACE1, suggesting that cleavage of both proteins may contribute to the numerous functions of BACE1 in the nervous system.	[Rudan Njavro, Jasenka; Klotz, Jakob; Dislich, Bastian; Shmueli, Merav D.; Herber, Julia; Kumar, Rohit; Koeglsperger, Thomas; Mueller, Stephan A.; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Rudan Njavro, Jasenka; Klotz, Jakob; Shmueli, Merav D.; Herber, Julia; Mueller, Stephan A.; Lichtenthaler, Stefan F.] Tech Univ Munich, Sch Med, Neuroprote, Klinikum Rechts Isar, Munich, Germany; [Dislich, Bastian] Univ Bern, Inst Pathol, Bern, Switzerland; [Wanngren, Johanna] Karolinska Inst, Div Neurogeriatr, Dept NVS, Ctr Alzheimer Res, Stockholm, Sweden; [Shmueli, Merav D.] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Kuhn, Peer-Hendrik] Tech Univ Munich, Inst Pathol, Munich, Germany; [Kumar, Rohit] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Munich, Germany; [Kumar, Rohit; Koeglsperger, Thomas] Ludwig Maximilian Univ Munich, Dept Neurol, Munich, Germany; [Conrad, Marcus; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Genome Engn, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Sch Life Sci Weihenstephan, Dev Genet, Freising Weihenstephan, Germany; [Wurst, Wolfgang; Feederle, Regina; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Feederle, Regina] Helmholtz Zentrum Munchen, Inst Diabet & Obes, German Res Ctr Environm Hlth, Monoclonal Antibody Core Facil, Neuherberg, Germany; [Feederle, Regina] German Ctr Neurodegenerat Dis DZNE, Core Facil Monoclonal Antibodies, Munich, Germany; [Vlachos, Andreas] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Fac Med, Freiburg, Germany; [Vlachos, Andreas] Univ Freiburg, Ctr Basics Neuromodulat NeuroModulBasics, Fac Med, Freiburg, Germany; [Michalakis, Stylianos] Ludwig Maximilian Univ Munich, Dept Ophthalmol, Munich, Germany; [Jedlicka, Peter] Justus Liebig Univ, ICAR3R Interdisciplinary Ctr 3Rs Anim Res, Fac Med, Giessen, Germany; [Jedlicka, Peter] Goethe Univ, Inst Clin Neuroanat, Neurosci Ctr, Frankfurt, Germany; [Jedlicka, Peter] Frankfurt Inst Adv Studies, Frankfurt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Bern; Karolinska Institutet; Weizmann Institute of Science; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Freiburg; University of Freiburg; University of Munich; Justus Liebig University Giessen; Goethe University Frankfurt	Lichtenthaler, SF (corresponding author), German Ctr Neurodegenerat Dis DZNE, Munich, Germany.	Stefan.Lichtenthaler@dzne.de	Kumar, Rohit/GYV-2433-2022; Shmueli, Merav/HDM-9859-2022; Jedlicka, Peter/AAW-4207-2020; Michalakis, Stylianos/M-4677-2019; Lichtenthaler, Stefan/B-6587-2016; Conrad, Marcus/E-8792-2015	Kumar, Rohit/0000-0001-9490-2387; Shmueli, Merav/0000-0002-9196-7633; Jedlicka, Peter/0000-0001-6571-5742; Michalakis, Stylianos/0000-0001-5092-9238; Lichtenthaler, Stefan/0000-0003-2211-2575; Feederle, Regina/0000-0002-3981-367X; Conrad, Marcus/0000-0003-1140-5612; Wurst, Wolfgang/0000-0003-4422-7410	Deutsche Forschungsgemeinschaft (DFG) [EXC 2145 SyNergy, 390857198, JE 528/6-1, FOR 2290]; BMBF Bundesministerium fur Bildung und Forschung [CLINSPECT-M]; Swedish Society of Medical Research [123]; Alzheimer Forschung Initiative (AFI) [15038]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Swedish Society of Medical Research; Alzheimer Forschung Initiative (AFI)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC 2145 SyNergy, project ID 390857198, JE 528/6-1 and FOR 2290; BMBF Bundesministerium fur Bildung und Forschung, Grant/Award Number: CLINSPECT-M; Swedish Society of Medical Research, Grant/Award Number: 123; Alzheimer Forschung Initiative (AFI), Grant/Award Number: 15038	Barao S, 2016, TRENDS NEUROSCI, V39, P158, DOI 10.1016/j.tins.2016.01.003; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; Colombo A, 2018, EMBO J, V37, DOI 10.15252/embj.201797390; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Connor SA, 2019, CURR OPIN NEUROBIOL, V57, P71, DOI 10.1016/j.conb.2019.01.002; Connor SA, 2017, CELL REP, V21, P3637, DOI 10.1016/j.celrep.2017.11.109; Cottrell GS, 2018, J NEUROSCI, V38, P9186, DOI 10.1523/JNEUROSCI.3572-15.2018; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dahimene S, 2018, CELL REP, V25, P1610, DOI 10.1016/j.celrep.2018.10.033; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dislich B, 2015, MOL CELL PROTEOMICS, V14, P2550, DOI 10.1074/mcp.M114.041533; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Gangwar SP, 2017, NEURON, V94, P1132, DOI 10.1016/j.neuron.2017.06.009; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Henley D, 2019, NEW ENGL J MED, V380, P1483, DOI 10.1056/NEJMc1813435; Herber J, 2018, MOL CELL PROTEOMICS, V17, P1487, DOI 10.1074/mcp.RA118.000608; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Hogl S, 2013, PROTEOMICS, V13, P1519, DOI 10.1002/pmic.201200582; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Ishikawa T, 2011, DEV DYNAM, V240, P96, DOI 10.1002/dvdy.22496; JAY SD, 1991, J BIOL CHEM, V266, P3287; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim JA, 2017, NEURON, V94, P1121, DOI 10.1016/j.neuron.2017.05.034; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lemberg MK, 2013, TRENDS CELL BIOL, V23, P210, DOI 10.1016/j.tcb.2013.01.002; Li JY, 2011, SCHIZOPHR RES, V125, P194, DOI 10.1016/j.schres.2010.11.002; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0080949, 10.1371/journal.pone.0103352, 10.1371/journal.pone.0109166]; May PC, 2015, J NEUROSCI, V35, P1199, DOI 10.1523/JNEUROSCI.4129-14.2015; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Nguyen QA, 2016, ELIFE, V5, DOI 10.7554/eLife.19236; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Oikawa N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030209; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vassar R, 2019, JPAD-J PREV ALZHEIM, V6, P78, DOI 10.14283/jpad.2019.3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vlachos A, 2013, P NATL ACAD SCI USA, V110, P8242, DOI 10.1073/pnas.1213677110; Vnencak M, 2019, BRAIN STRUCT FUNCT, V224, P1279, DOI 10.1007/s00429-019-01836-6; Volloch Vladimir, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020045; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voytyuk I, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800026; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhu KC, 2018, BIOL PSYCHIAT, V83, P428, DOI 10.1016/j.biopsych.2016.12.023; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	92	14	14	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2465	2482		10.1096/fj.201902347R	http://dx.doi.org/10.1096/fj.201902347R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908000	Green Published, hybrid			2022-12-26	WOS:000504676900001
J	O'Keefe, RA; Bhola, NE; Lee, DS; Johnson, DE; Grandis, JR				O'Keefe, Rachel A.; Bhola, Neil E.; Lee, David S.; Johnson, Daniel E.; Grandis, Jennifer R.			Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PLUS CETUXIMAB; HEAD; CANCER; MUTATIONS; STAT3; INHIBITION; CHEMOTHERAPY; RECURRENCE; ACTIVATION	The epidermal growth factor receptor inhibitor cetuximab is the only oncogene-targeted agent that has been FDA approved for the treatment of head and neck squamous cell carcinoma (HNSCC). Currently, there are no biomarkers used in the clinic to predict which HNSCC tumors will respond to cetuximab, and even in tumors that regress with treatment, acquired resistance occurs in the majority of cases. Though a number of mechanisms of acquired resistance to cetuximab have been identified in preclinical studies, no therapies targeting these resistance pathways have yet been effectively translated into the clinic. To address this unmet need, we examined the role of the cytokine interleukin 6 (IL-6) in acquired cetuximab resistance in preclinical models of HNSCC. We found that IL-6 secretion was increased in PE/CA-PJ49 cells that had acquired resistance to cetuximab compared to the parental cells from which they were derived. However, addition of exogenous IL-6 to parental cells did not promote cetuximab resistance, and inhibition of the IL-6 pathway did not restore cetuximab sensitivity in the cetuximab-resistant cells. Further examination of the IL-6 pathway revealed that expression of IL6R, which encodes a component of the IL-6 receptor, was decreased in cetuximab-resistant cells compared to parental cells, and that treatment of the cetuximab-resistant cells with exogenous IL-6 did not induce phosphorylation of signal transducer and activator of transcription 3, suggesting that the IL-6 pathway was functionally impaired in the cetuximab-resistant cells. These findings demonstrate that, even if IL-6 is increased in the context of cetuximab resistance, it is not necessarily required for maintenance of the resistant phenotype, and that targeting the IL-6 pathway may not restore sensitivity to cetuximab in cetuximab-refractory HNSCC.	[O'Keefe, Rachel A.; Bhola, Neil E.; Lee, David S.; Johnson, Daniel E.; Grandis, Jennifer R.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grandis, JR (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	jennifer.grandis@ucsf.edu		Lee, David/0000-0001-7286-325X	National Institutes of Health [R35 CA231998, R01 DE024728, F31 DE026951]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R35 CA231998 (JRG), R01 DE024728 (DEJ), and F31 DE026951 (RAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci AB, 2018, BIODRUGS, V32, P531, DOI 10.1007/s40259-018-0320-3; Beck TN, 2016, MOL CANCER THER, V15, P2486, DOI 10.1158/1535-7163.MCT-16-0243; Behren A, 2010, INT J ONCOL, V36, P849, DOI 10.3892/ijo_00000562; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Boeckx C, 2014, CANCER LETT, V354, P365, DOI 10.1016/j.canlet.2014.08.039; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Braig F, 2015, ONCOTARGET, V7; Bui N, 2018, MOL CANCER THER, V17, P1585, DOI 10.1158/1535-7163.MCT-17-0937; Cassell A, 2012, NEOPLASIA, V14, P1005, DOI 10.1593/neo.121212; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Cerami E., 2012, CBIO CANC GENOMICS P; Chen CC, 2010, INT J RADIAT ONCOL, V76, P1214, DOI 10.1016/j.ijrobp.2009.09.059; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; De S, 2018, CANCER RES, V78, P2396, DOI 10.1158/0008-5472.CAN-17-1920; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Fisher DT, 2014, SEMIN IMMUNOL, V26, P38, DOI 10.1016/j.smim.2014.01.008; Fletcher EVM, 2013, MOL CANCER RES, V11, P1574, DOI 10.1158/1541-7786.MCR-13-0187; Gao J, 2016, ONCOL REP, V35, P3265, DOI 10.3892/or.2016.4765; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Hsu HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/oncotarget.8076; Johnston PA, 2015, ASSAY DRUG DEV TECHN, V13, P356, DOI 10.1089/adt.2015.663; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Kennedy J, 2019, GENET MED, V21, P850, DOI 10.1038/s41436-018-0259-2; Kim HS, 2017, ONCOTARGET, V8, P100339, DOI 10.18632/oncotarget.22225; Kline CN, 2017, NEURO-ONCOLOGY, V19, P699, DOI 10.1093/neuonc/now254; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leonard B, 2018, CANCER RES, V78, P4331, DOI 10.1158/0008-5472.CAN-18-0459; Li H, 2014, MOL CANCER RES, V12, P571, DOI 10.1158/1541-7786.MCR-13-0396; Licitra L, 2011, ANN ONCOL, V22, P1078, DOI 10.1093/annonc/mdq588; Licitra L, 2013, EUR J CANCER, V49, P1161, DOI 10.1016/j.ejca.2012.11.018; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Luedke E, 2012, SURGERY, V152, P431, DOI 10.1016/j.surg.2012.05.035; Lv DG, 2017, CANCER RES, V77, P6190, DOI 10.1158/0008-5472.CAN-17-1388; Mehra Ranee, 2008, Clin Adv Hematol Oncol, V6, P742; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Pan C, 2019, CANC HEAD NECK, V4, P1; Pollock NI, 2015, CLIN CANCER RES, V21, P526, DOI 10.1158/1078-0432.CCR-14-1432; Rampias T, 2014, CLIN CANCER RES, V20, P2933, DOI 10.1158/1078-0432.CCR-13-2721; Rebucci M, 2011, INT J ONCOL, V38, P189, DOI 10.3892/ijo_00000838; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Sriuranpong V, 2003, CANCER RES, V63, P2948; Stabile LP, 2017, ORAL ONCOL, V69, P38, DOI 10.1016/j.oraloncology.2017.03.011; Stanam A, 2015, MOL ONCOL; Stein-O'Brien G, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0545-2; Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022; Verboogen DRJ, 2019, J MOL CELL BIOL, V11, P144, DOI 10.1093/jmcb/mjy038; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang Z., 2014, JNCI-J NATL CANCER I, V106, P1; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	53	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227261	10.1371/journal.pone.0227261	http://dx.doi.org/10.1371/journal.pone.0227261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914141	gold, Green Published, Green Submitted			2022-12-26	WOS:000534337700034
J	Jesumani, V; Du, H; Pei, PB; Aslam, M; Huang, N				Jesumani, Valentina; Du, Hong; Pei, Pengbing; Aslam, Muhammad; Huang, Nan			Comparative study on skin protection activity of polyphenol-rich extract and polysaccharide-rich extract from Sargassum vachellianum	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BROWN SEAWEED; TYROSINASE ACTIVITY; CAPACITY	Seaweed polyphenols and polysaccharide plays a broad range of biological activity. The objective of the present study was to study and compare the skin protection activity of fucoidan rich polysaccharide extract (SPS) and polyphenol-rich extract (SPP) from the seaweed Sargassum vachellianum. The skin protection activity was analyzed based on their ability to scavenge free radicals such as hydrogen peroxide and hydroxyl radicals, UV absorption potential, tyrosinase inhibition, moisture preservation, and antibacterial activity. From the results, both SPP and SPS protects the skin from UV damage. SPP showed good free radical scavenging ability, antimicrobial activity against E.coli and S. aureus and effectively absorbed the UVB and UVA rays whereas SPS hardly absorbs the UVA and UVB rays and showed weak free radical scavenging ability and no antimicrobial activity. SPS showed considerable inhibition on tyrosinase (51.21%) and had better moisture absorption (52.1%) and retention (63.24%) abilities than SPP. The results specified that both SPS and SPP have balancing potential on skin protection and suitable combinations of both could act as an active ingredient in cosmetics.	[Jesumani, Valentina; Du, Hong; Pei, Pengbing; Aslam, Muhammad; Huang, Nan] Shantou Univ, Coll Sci, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Guangdong, Peoples R China; [Aslam, Muhammad] Lasbela Univ, Fac Marine Sci, Uthal, Pakistan	Shantou University	Du, H (corresponding author), Shantou Univ, Coll Sci, Guangdong Prov Key Lab Marine Biotechnol, Shantou, Guangdong, Peoples R China.	hdu@stu.edu.cn			Guangdong university innovation team project [130-18219422]; National Natural Science Foundation of China [41976125]	Guangdong university innovation team project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Guangdong university innovation team project (130-18219422) and National Natural Science Foundation of China (41976125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboofetileh M, 2019, INT J BIOL MACROMOL, V124, P131, DOI 10.1016/j.ijbiomac.2018.11.201; Anand J, 2018, INT J BIOL MACROMOL, V111, P1238, DOI 10.1016/j.ijbiomac.2018.01.057; Berthon JY, 2017, FREE RADICAL RES, V51, P555, DOI 10.1080/10715762.2017.1355550; Chan YY, 2011, J ETHNOPHARMACOL, V137, P1183, DOI 10.1016/j.jep.2011.07.050; Chandini SK, 2008, FOOD CHEM, V107, P707, DOI 10.1016/j.foodchem.2007.08.081; Chao WW, 2017, PHYTOMEDICINE, V34, P191, DOI 10.1016/j.phymed.2017.08.024; Charoensiddhi S, 2017, J APPL PHYCOL, V29, P2407, DOI 10.1007/s10811-017-1146-y; Chen BJ, 2016, INT J BIOL MACROMOL, V92, P715, DOI 10.1016/j.ijbiomac.2016.07.082; Cheong KL, 2016, J FUNCT FOODS, V25, P174, DOI 10.1016/j.jff.2016.06.002; Barros-Gomes JAC, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9354296; de Morais DV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207510; DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ebrahimzadeh MA, 2014, IRAN J PHARM RES, V13, P1041; Fernando IPS, 2016, J MED FOOD, V19, P615, DOI 10.1089/jmf.2016.3706; Fernando IS, 2018, J APPL PHYCOL, P1; Fitton J., 2015, COSMETICS-BASEL, V2, P66, DOI DOI 10.3390/COSMETICS2020066; Ganesan P, 2008, BIORESOURCE TECHNOL, V99, P2717, DOI 10.1016/j.biortech.2007.07.005; Imjongjairak S, 2016, BIOSCI BIOTECH BIOCH, V80, P524, DOI 10.1080/09168451.2015.1101334; Kurup G.M., 2016, J PHARM REP, V1, P2; Lim SN, 2002, J AGR FOOD CHEM, V50, P3862, DOI 10.1021/jf020096b; Lu XN, 2011, FOOD CHEM, V129, P637, DOI 10.1016/j.foodchem.2011.04.105; Luo HY, 2010, J MED PLANTS RES, V4, P2557; Matanjun P, 2008, J APPL PHYCOL, V20, P367, DOI 10.1007/s10811-007-9264-6; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Ndlovu G, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-304; Parvez S, 2006, PHYTOTHER RES, V20, P921, DOI 10.1002/ptr.1954; Petkovsek Z, 2010, J CLIN MICROBIOL, V48, P3462, DOI 10.1128/JCM.01266-10; PILAWA B, 2007, POL J MED PHYS ENG, V10, P35; Rajauria G, 2013, J FOOD BIOCHEM, V37, P322, DOI 10.1111/j.1745-4514.2012.00663.x; Ray A, 2013, IND CROP PROD, V49, P712, DOI 10.1016/j.indcrop.2013.06.008; Roy Amit, 2013, Pharmacogn Rev, V7, P97, DOI 10.4103/0973-7847.120507; RUCH RJ, 1989, CARCINOGENESIS, V10, P1003, DOI 10.1093/carcin/10.6.1003; Saravana PS, 2016, CARBOHYD POLYM, V153, P518, DOI 10.1016/j.carbpol.2016.08.014; Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001; Shao P, 2015, INT J BIOL MACROMOL, V72, P924, DOI 10.1016/j.ijbiomac.2014.09.048; Sinanoglou VJ, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100139; Melo KRT, 2013, MOLECULES, V18, P14543, DOI 10.3390/molecules181214543; Ueda JI, 1996, ARCH BIOCHEM BIOPHYS, V333, P377, DOI 10.1006/abbi.1996.0404; Vasconcelos JB, 2019, J APPL PHYCOL, V31, P835, DOI 10.1007/s10811-018-1556-5; Wang HMD, 2015, BIORESOURCE TECHNOL, V184, P355, DOI 10.1016/j.biortech.2014.12.001; Wang J, 2013, INT J BIOL MACROMOL, V57, P26, DOI 10.1016/j.ijbiomac.2013.03.001; Wang J, 2018, WORLD ENVIRONMENTAL AND WATER RESOURCES CONGRESS 2018: HYDRAULICS AND WATERWAYS, WATER DISTRIBUTION SYSTEMS ANALYSIS, AND SMART WATER, P1; Wei XL, 2009, J AGR FOOD CHEM, V57, P7757, DOI 10.1021/jf901340f; Yanhua Wang, 2014, Open Biomed Eng J, V8, P153, DOI 10.2174/1874120701408010153; Zahra R, 2007, AFR J BIOTECHNOL, V6, P2740; Zhang ZS, 2012, CARBOHYD POLYM, V87, P2332, DOI 10.1016/j.carbpol.2011.10.067	47	33	34	10	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227308	10.1371/journal.pone.0227308	http://dx.doi.org/10.1371/journal.pone.0227308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910239	Green Published, gold			2022-12-26	WOS:000534333800040
J	Lei, MM; Farman, GP; Mayfield, RM; Strom, J; Chu, MS; Pappas, CT; Gregorio, CC				Lei Mi-Mi; Farman, Gerrie P.; Mayfield, Rachel M.; Strom, Joshua; Chu, Miensheng; Pappas, Christopher T.; Gregorio, Carol C.			In vivo elongation of thin filaments results in heart failure	PLOS ONE			English	Article							DISTRIBUTED DECONVOLUTION ANALYSIS; DILATED CARDIOMYOPATHY; NEMALINE MYOPATHY; ATPASE ACTIVITY; ACTIN-FILAMENT; POINTED END; GENE; MUSCLE; LENGTH; MICE	A novel cardiac-specific transgenic mouse model was generated to identify the physiological consequences of elongated thin filaments during post-natal development in the heart. Remarkably, increasing the expression levels in vivo of just one sarcomeric protein, Lmod2, results in similar to 10% longer thin filaments (up to 26% longer in some individual sarcomeres) that produce up to 50% less contractile force. Increasing the levels of Lmod2 in vivo (Lmod2-TG) also allows us to probe the contribution of Lmod2 in the progression of cardiac myopathy because Lmod2-TG mice present with a unique cardiomyopathy involving enlarged atrial and ventricular lumens, increased heart mass, disorganized myofibrils and eventually, heart failure. Turning off of Lmod2 transgene expression at postnatal day 3 successfully prevents thin filament elongation, as well as gross morphological and functional disease progression. We show here that Lmod2 has an essential role in regulating cardiac contractile force and function.	[Lei Mi-Mi; Farman, Gerrie P.; Mayfield, Rachel M.; Strom, Joshua; Chu, Miensheng; Pappas, Christopher T.; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Lei Mi-Mi; Farman, Gerrie P.; Mayfield, Rachel M.; Strom, Joshua; Chu, Miensheng; Pappas, Christopher T.; Gregorio, Carol C.] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ USA	University of Arizona; University of Arizona	Gregorio, CC (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	gregorio@email.arizona.edu		Strom, Joshua/0000-0003-1236-1877	American Heart Association [16POST31350016]; Sarver Heart Center Novel Research Project Award in the Area of Cardiovascular Disease and Medicine; National Institutes of Health [R01HL123078, R01GM120137]	American Heart Association(American Heart Association); Sarver Heart Center Novel Research Project Award in the Area of Cardiovascular Disease and Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Heart Association Postdoctoral Fellowship Award #16POST31350016, and a Sarver Heart Center Novel Research Project Award (Frank and Alex Frazer, and Mark Schiffman) in the Area of Cardiovascular Disease and Medicine to L.M.M., and National Institutes of Health #R01HL123078 and #R01GM120137, as well as funding from Linda and Jim Lee to C.C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens-Nicklas RC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2066; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; Arslan B, 2018, ARCH BIOCHEM BIOPHYS, V638, P18, DOI 10.1016/j.abb.2017.12.005; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Cenik BK, 2015, J CLIN INVEST, V125, P1569, DOI 10.1172/JCI80115; Chen XR, 2015, P NATL ACAD SCI USA, V112, P12687, DOI 10.1073/pnas.1512464112; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; de Winter JM, 2016, ANN NEUROL, V79, P959, DOI 10.1002/ana.24654; Editorial, 2016, NAT CLIM CHANGE, V6, P1, DOI [10.1038/nclimate2911, DOI 10.1038/s41598-016-0001-8]; Farman GP, 2006, AM J PHYSIOL-HEART C, V291, pH1847, DOI 10.1152/ajpheart.01237.2005; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; FORBES MS, 1985, TISSUE CELL, V17, P605, DOI 10.1016/0040-8166(85)90001-1; Fowler VM, 2017, BIOPHYS J, V112, P1742, DOI 10.1016/j.bpj.2017.03.034; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Gokhin DS, 2017, J MICROSC-OXFORD, V265, P11, DOI 10.1111/jmi.12456; Gokhin DS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00375; GRANZIER HLM, 1991, AM J PHYSIOL, V260, pC1060, DOI 10.1152/ajpcell.1991.260.5.C1060; Henderson CA, 2017, COMPR PHYSIOL, V7, P891, DOI 10.1002/cphy.c160033; KENTISH JC, 1994, J PHYSIOL-LONDON, V475, P175, DOI 10.1113/jphysiol.1994.sp020059; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Konhilas JP, 2002, PFLUG ARCH EUR J PHY, V445, P305, DOI 10.1007/s00424-002-0902-1; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lehtonen LA, 2004, CLIN PHARMACOKINET, V43, P187, DOI 10.2165/00003088-200443030-00003; Littlefield R, 2002, BIOPHYS J, V82, P2548, DOI 10.1016/S0006-3495(02)75598-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Nworu CU, 2014, J CELL SCI, pjcs152702; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pappas CT, 2018, J MOL CELL CARDIOL, V122, P88, DOI 10.1016/j.yjmcc.2018.08.009; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; PINSKY WW, 1979, AM J PHYSIOL, V237, pH575, DOI 10.1152/ajpheart.1979.237.5.H575; Sanger JW, 2016, HDB EXPT PHARM, P39; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; The I, 2015, NAT COMMUN, V6, P1, DOI DOI 10.1038/NCOMMS7971; Tian L, 2015, DIS MODEL MECH, V8, P635, DOI 10.1242/dmm.019430; Tsukada T, 2010, J CELL SCI, V123, P3136, DOI 10.1242/jcs.071837; Vite A, 2014, CELL COMMUN ADHES, V21, P169, DOI 10.3109/15419061.2014.908853; Walker JM, 2010, METHOD MOL BIOL, V633; Yuen M, 2015, J CLIN INVEST, V125, P456, DOI 10.1172/JCI80057; Zhang JCL, 1999, J MOL CELL CARDIOL, V31, P721, DOI 10.1006/jmcc.1998.0905	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0226138	10.1371/journal.pone.0226138	http://dx.doi.org/10.1371/journal.pone.0226138			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KD9MM	31899774	Green Published, gold			2022-12-26	WOS:000508185500001
J	Promchan, K; Natarajan, V				Promchan, Kanyarat; Natarajan, Ven			Leucine zipper transcription factor-like 1 binds adaptor protein complex-1 and 2 and participates in trafficking of transferrin receptor	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; NUCLEOTIDE EXCHANGE FACTOR; TRANS-GOLGI NETWORK; ENDOCYTIC TRAFFICKING; CLATHRIN; AP-1; MEMBRANE; APPENDAGE; CARGO; IDENTIFICATION	LZTFL1 participates in immune synapse formation, ciliogenesis, and the localization of ciliary proteins, and knockout of LZTFL1 induces abnormal distribution of heterotetrameric adaptor protein complex-1 (AP-1) in the Lztfl1-knockout mouse photoreceptor cells, suggesting that LZTFL1 is involved in intracellular transport. Here, we demonstrate that in vitro LZTFL1 directly binds to AP-1 and AP-2 and coimmunoprecipitates AP-1 and AP-2 from cell lysates. DxxFxxLxxxR motif of LZTFL1 is essential for these bindings, suggesting LZTFL1 has roles in AP-1 and AP-2-mediated protein trafficking. Since AP-1 and AP-2 are known to be involved in transferrin receptor 1 (TfR1) trafficking, the effect of LZTFL1 on TfR1 recycling was analyzed. TfR1, AP-1 and LZTFL1 from cell lysates could be coimmunoprecipitated. However, pull-down results indicate there is no direct interaction between TfR1 and LZTFL1, suggesting that LZTFL1 interaction with TfR1 is indirect through AP-1. We report the colocalization of LZTFL1 and AP-1, AP-1 and TfR1 as well as LZTFL1 and TfR1 in the perinuclear region (PNR) and the cytoplasm, suggesting a potential complex between LZTFL1, AP-1 and TfR1. The results from the disruption of adaptin recruitment with brefeldin A treatment suggested ADP-ribosylation factor-dependent localization of LZFL1 and AP-1 in the PNR. Knockdown of AP-1 reduces the level of LZTFL1 in the PNR, suggesting that AP-1 plays a role in LZTFL1 trafficking. Knockout of LZTFL1 reduces the cell surface level and the rate of internalization of TfR1, leading to a decrease of transferrin uptake, efflux, and internalization. However, knockout of LZTFL1 did not affect the cell surface levels of epidermal growth factor receptor and cation-independent mannose 6-phosphate receptor, indicating that LZTFL1 specifically regulates the cell surface level of TfR1. These data support a novel role of LZTFL1 in regulating the cell surface TfR1 level by interacting with AP-1 and AP-2.	[Promchan, Kanyarat; Natarajan, Ven] Leidos Biomed Res Inc, Lab Mol Cell Biol, Frederick Natl Lab Canc Res, Frederick, MD 21704 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Natarajan, V (corresponding author), Leidos Biomed Res Inc, Lab Mol Cell Biol, Frederick Natl Lab Canc Res, Frederick, MD 21704 USA.	vnatarajan@mail.nih.gov		/0000-0002-2536-5351	National Institute of Allergy and Infectious Disease; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institute of Allergy and Infectious Disease. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.; We thank Dr. Hong Jiang for plasmids, Heather Marshall for LZTFL1-knockout HeLa cell lines, and Dr. Stephen Lockett and Kim Peifley (Optical Microscopy and Analysis Laboratory, Frederick National Laboratory and Leidos Biomedical Research, Inc.) for confocal microscopy. HeLa cells were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HeLa CD4+ Cells from Dr. Richard Axel. This research was supported by the National Institute of Allergy and Infectious Disease. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Arias DAA, 2010, P NATL ACAD SCI USA, V107, P2556, DOI 10.1073/pnas.0913671107; Bay AEP, 2014, J CELL SCI, V127, P4457, DOI 10.1242/jcs.153437; Bay AEP, 2013, EMBO J, V32, P2125, DOI 10.1038/emboj.2013.130; Beattie EC, 2000, J NEUROSCI, V20, P7325; Beydoun R, 2017, J BIOL CHEM, V292, P4293, DOI 10.1074/jbc.M116.769240; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Cao H, 2016, J BIOL CHEM, V291, P16424, DOI 10.1074/jbc.M116.724997; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Caster AH, 2013, J BIOL CHEM, V288, P14788, DOI 10.1074/jbc.M113.453621; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cotton CU, 2013, TRAFFIC, V14, P337, DOI 10.1111/tra.12032; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Dellibovi-Ragheb T, 2016, EMBO J, V35, P1724, DOI 10.15252/embj.201695080; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Ghosh A, 2012, MANAGING RISKS IN COMMERCIAL AND RETAIL BANKING, P225; Graham RM, 2008, J HEPATOL, V48, P327, DOI 10.1016/j.jhep.2007.10.009; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Harbury PAB, 1998, STRUCT FOLD DES, V6, P1487, DOI 10.1016/S0969-2126(98)00147-6; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; Ishaq M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-41; Jian JL, 2011, J BIOL CHEM, V286, P35708, DOI 10.1074/jbc.M111.271585; Jiang H, 2016, J IMMUNOL, V196, P1081, DOI 10.4049/jimmunol.1500719; Jiang JS, 2016, J GENET GENOMICS, V43, P381, DOI 10.1016/j.jgg.2015.11.006; Jongsma MLM, 2016, CELL, V166, P152, DOI 10.1016/j.cell.2016.05.078; Kang RS, 2011, J CELL BIOL, V193, P51, DOI 10.1083/jcb.201012121; Kaplan OI, 2010, J CELL SCI, V123, P3966, DOI 10.1242/jcs.073908; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; LeBorgne R, 1997, J CELL BIOL, V137, P335; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lou XC, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160004; Lundmark R, 2002, BIOCHEM J, V362, P597, DOI 10.1042/0264-6021:3620597; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mi LX, 2011, CHEM RES TOXICOL, V24, P1735, DOI 10.1021/tx2002806; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nakatsu F, 2014, MEMBRANES, V4, P747, DOI 10.3390/membranes4040747; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Robb AD, 2004, AM J PHYSIOL-CELL PH, V287, pC1769, DOI 10.1152/ajpcell.00337.2004; Schaefer E, 2014, CLIN GENET, V85, P476, DOI 10.1111/cge.12198; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Simonetti B, 2019, CURR OPIN CELL BIOL, V56, P22, DOI 10.1016/j.ceb.2018.08.006; Sorkina T, 1999, J CELL SCI, V112, P317; Stahlschmidt W, 2014, J BIOL CHEM, V289, P4906, DOI 10.1074/jbc.M113.535211; Starks RD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005311; STROUS GJ, 1991, BIOL CELL, V71, P25, DOI 10.1016/0248-4900(91)90048-R; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wang LB, 2014, J CANCER RES CLIN, V140, P1997, DOI 10.1007/s00432-014-1753-9; Webster J, 2012, METHODS MOL BIOL, V800, P227, DOI 10.1007/978-1-61779-349-3_15; Wei Q, 2018, J MOL CELL BIOL, V10, P402, DOI 10.1093/jmcb/mjy022; Wei Q, 2010, CANCER RES, V70, P2942, DOI 10.1158/0008-5472.CAN-09-3826; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Wymant JM, 2016, J CANCER, V7, P2388, DOI 10.7150/jca.15055; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514	68	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226298	10.1371/journal.pone.0226298	http://dx.doi.org/10.1371/journal.pone.0226298			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895934	Green Published, gold			2022-12-26	WOS:000534267300004
J	Bhattachan, P; Rae, J; Yu, HY; Jung, W; Wei, JK; Parton, RG; Dong, B				Bhattachan, Punit; Rae, James; Yu, Haiyan; Jung, WooRam; Wei, Jiankai; Parton, Robert G.; Dong, Bo			Ascidian caveolin induces membrane curvature and protects tissue integrity and morphology during embryogenesis	FASEB JOURNAL			English	Article						caveolin; Ciona spp; null; lumen formation; membrane curvature; morphogenesis	CIONA-INTESTINALIS; LUMEN EXPANSION; SHOW EVIDENCE; CELL BIOLOGY; MICE SHOW; NULL MICE; NOTOCHORD; PROTEINS; MUSCLE; INVASION	Cell morphology and tissue integrity are essential for embryogenesis. Caveolins are membrane proteins that induce the formation of surface pits called caveolae that serve as membrane reservoirs for cell and tissue protection during development. In vertebrates, caveolin 1 (Cav1) and caveolin 3 (Cav3) are required for caveola formation. However, the formation of caveola and the function of caveolins in invertebrates are largely unknown. In this study, three caveolins, Cav-a, Cav-b, and CavY, are identified in the genome of the invertebrate chordate Ciona spp. Based on phylogenetic analysis, Cav-a is found to be closely related to the vertebrate Cav1 and Cav3. In situ hybridization shows that Cav-a is expressed in Ciona embryonic notochord and muscle. Cell-free experiments, model cell culture systems, and in vivo experiments demonstrate that Ciona Cav-a has the ability to induce membrane curvature at the plasma membrane. Knockdown of Cav-a in Ciona embryos causes loss of invaginations in the plasma membrane and results in the failure of notochord elongation and lumenogenesis. Expression of a dominant-negative Cav-a point mutation causes cells to change shape and become displaced from the muscle and notochord to disrupt tissue integrity. Furthermore, we demonstrate that Cav-a vesicles show polarized trafficking and localize at the luminal membrane during notochord lumenogenesis. Taken together, these results show that the invertebrate chordate caveolin from Ciona plays crucial roles in tissue integrity and morphology by inducing membrane curvature and intracellular vesicle trafficking during embryogenesis.	[Bhattachan, Punit; Yu, Haiyan; Wei, Jiankai; Dong, Bo] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Bhattachan, Punit; Yu, Haiyan; Wei, Jiankai; Dong, Bo] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China; [Bhattachan, Punit; Wei, Jiankai; Dong, Bo] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China; [Rae, James; Jung, WooRam; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Jung, WooRam] NCI, Ctr Canc Res, Frederick, MD 21701 USA	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Ocean University of China; University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dong, B (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.parton@imb.uq.edu.au; bodong@ouc.edu.cn	Jung, Wooram/D-3874-2017	Jung, Wooram/0000-0001-5748-5473; Dong, Bo/0000-0003-1616-5363	National Natural Science Foundation of China (NSFC) [31572352, 31771649]; Australian National health and Medical Research Council [APP569452, APP1150083]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Australian National health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31572352 and 31771649; Australian National health and Medical Research Council, Grant/Award Number: APP569452 and APP1150083	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Christiaen L., 2009, COLD SPRING HARB PRO, V2009, DOI 10.1101/pdb.prot5344; Corbo JC, 1997, DEVELOPMENT, V124, P589; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deng W, 2013, P NATL ACAD SCI USA, V110, P14972, DOI 10.1073/pnas.1220884110; Denker E, 2015, DEVELOPMENT, V142, P1639, DOI 10.1242/dev.117150; Di Gregorio A, 2002, DEV BIOL, V244, P385, DOI 10.1006/dbio.2002.0582; Dong B, 2009, DEV BIOL, V330, P237, DOI 10.1016/j.ydbio.2009.03.015; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Garcia J, 2017, CURR BIOL, V27, P1982, DOI 10.1016/j.cub.2017.05.035; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayashi K, 2001, CANCER RES, V61, P2361; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jung W, 2018, J CELL BIOL, V217, P2141, DOI 10.1083/jcb.201707004; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Lim YW, 2017, CURR BIOL, V27, P1968, DOI 10.1016/j.cub.2017.05.067; Ludwig A, 2016, J CELL SCI, V129, P3077, DOI 10.1242/jcs.191262; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Mizotani Y, 2018, P NATL ACAD SCI USA, V115, pE8873, DOI 10.1073/pnas.1808756115; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Rieth MD, 2012, BIOCHEMISTRY-US, V51, P3911, DOI 10.1021/bi3001853; Roitenberg N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745673; Shatz M, 2010, EXP CELL RES, V316, P1748, DOI 10.1016/j.yexcr.2010.02.006; Shi DB, 2016, MECH DEVELOP, V141, P78, DOI 10.1016/j.mod.2016.05.002; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sohn J, 2016, BIRTH DEFECTS RES C, V108, P45, DOI 10.1002/bdrc.21121; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoeber M, 2016, P NATL ACAD SCI USA, V113, pE8069, DOI 10.1073/pnas.1616838113; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; WADA S, 1995, MECH DEVELOP, V51, P115, DOI 10.1016/0925-4773(95)00359-9; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	54	12	12	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1345	1361		10.1096/fj.201901281R	http://dx.doi.org/10.1096/fj.201901281R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914618	Green Published, hybrid			2022-12-26	WOS:000507308900090
J	Larpin, Y; Besancon, H; Iacovache, MI; Babiychuk, VS; Babiychuk, EB; Zuber, B; Draeger, A; Koffel, R				Larpin, Yu; Besancon, Herve; Iacovache, Mircea-Ioan; Babiychuk, Victoriia S.; Babiychuk, Eduard B.; Zuber, Benoit; Draeger, Annette; Koffel, Rene			Bacterial pore-forming toxin pneumolysin: Cell membrane structure and microvesicle shedding capacity determines differential survival of cell types	FASEB JOURNAL			English	Article						bacterial pore-forming toxins; host-defense; lymphoid immune cells; myeloid immune cells; plasma membrane repair	REPAIR; CHOLESTEROL; PROTEIN; BINDING; RAFTS	Bacterial infectious diseases can lead to death or to serious illnesses. These outcomes are partly the consequence of pore-forming toxins, which are secreted by the pathogenic bacteria (eg, pneumolysin of Streptococcus pneumoniae). Pneumolysin binds to cholesterol within the plasma membrane of host cells and assembles to form trans-membrane pores, which can lead to Ca2+ influx and cell death. Membrane repair mechanisms exist that limit the extent of damage. Immune cells which are essential to fight bacterial infections critically rely on survival mechanisms after detrimental pneumolysin attacks. This study investigated the susceptibility of different immune cell types to pneumolysin. As a model system, we used the lymphoid T-cell line Jurkat, and myeloid cell lines U937 and THP-1. We show that Jurkat T cells are highly susceptible to pneumolysin attack. In contrast, myeloid THP-1 and U937 cells are less susceptible to pneumolysin. In line with these findings, human primary T cells are shown to be more susceptible to pneumolysin attack than monocytes. Differences in susceptibility to pneumolysin are due to (I) preferential binding of pneumolysin to Jurkat T cells and (II) cell type specific plasma membrane repair capacity. Myeloid cell survival is mostly dependent on Ca2+ induced expelling of damaged plasma membrane areas as microvesicles. Thus, in myeloid cells, first-line defense cells in bacterial infections, a potent cellular repair machinery ensures cell survival after pneumolysin attack. In lymphoid cells, which are important at later stages of infections, less efficient repair mechanisms and enhanced toxin binding renders the cells more sensitive to pneumolysin.	[Larpin, Yu; Besancon, Herve; Babiychuk, Victoriia S.; Babiychuk, Eduard B.; Draeger, Annette; Koffel, Rene] Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland; [Iacovache, Mircea-Ioan; Zuber, Benoit] Univ Bern, Inst Anat, Lab Expt Morphol, Bern, Switzerland	University of Bern; University of Bern	Koffel, R (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland.	rene.koeffel@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021; Köffel, René/ABI-2028-2020	Köffel, René/0000-0001-9477-4282; Zuber, Benoit/0000-0001-7725-5579; iacovache, ioan/0000-0001-8470-5056; Besancon, Herve/0000-0002-1426-1901; Larpin, Yu/0000-0002-4313-5509; Babiychuk, Eduard/0000-0003-1786-0085	Gebert-Ruf Foundation [GRS-073/14]	Gebert-Ruf Foundation	Gebert-Ruf Foundation, Grant/Award Number: GRS-073/14	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Baumgartner U, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0781-5; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drucker P, 2018, BBA-MOL CELL BIOL L, V1863, P795, DOI 10.1016/j.bbalip.2018.04.010; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Etxaniz A, 2018, TOXINS, V10, DOI 10.3390/toxins10060234; Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037; Iacovache I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12062; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Koffel R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01688; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Maekawa M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030504; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; MORGAN BP, 1987, J IMMUNOL, V138, P246; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Romero M, 2017, CELL DEATH DIFFER, V24, P798, DOI 10.1038/cdd.2017.11; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SKOAAJ M, 2014, PLOS ONE, V0009; Tan JMJ, 2018, NAT MICROBIOL, V3, P1472, DOI 10.1038/s41564-018-0293-5; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wolfmeier H, 2016, BBA-GEN SUBJECTS, V1860, P2498, DOI 10.1016/j.bbagen.2016.07.022; Wolfmeier H, 2015, BBA-MOL CELL RES, V1853, P2045, DOI 10.1016/j.bbamcr.2014.09.005; Yoo IH, 2010, FEMS IMMUNOL MED MIC, V60, P28, DOI 10.1111/j.1574-695X.2010.00699.x	31	17	17	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1665	1678		10.1096/fj.201901737RR	http://dx.doi.org/10.1096/fj.201901737RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914676				2022-12-26	WOS:000507308900110
J	San Segundo, PM; Terni, B; Burgueno, J; Monroy, X; Dordal, A; Merlos, M; Llobet, A				Martinez San Segundo, Pablo; Terni, Beatrice; Burgueno, Javier; Monroy, Xavier; Dordal, Albert; Merlos, Manuel; Llobet, Artur			Outside-in regulation of the readily releasable pool of synaptic vesicles by alpha 2 delta-1	FASEB JOURNAL			English	Article						i +/- 2i '-1; gabapentinoids; neurotransmission; presynaptic terminal; readily releasable pool; synaptic vesicle	RAT SYMPATHETIC NEURONS; CALCIUM-CHANNELS; FAST EXOCYTOSIS; CA2+ CHANNELS; UP-REGULATION; GABAPENTIN; EXPRESSION; SUBUNIT; BINDING; TRANSMISSION	The readily releasable pool (RRP) of synaptic vesicles is a key determinant of phasic neurotransmission. Although the size of the RRP is tightly regulated by intracellular factors, there is little evidence for its modification by extracellular signals. By studying the homogeneous population of synapses present in autaptic microcultures, we show that pregabalin, a prototypical gabapentinoid, decreases the effective RRP size. Simultaneous imaging of presynaptic calcium influx and recording of postsynaptic responses shows that the effect is not related to a reduction of calcium entry. The main cause is the impairment of the functional coupling among N-type calcium channels and the RRP, resembling an increase of intracellular mobile calcium buffers. The ectodomain of neurexin-1 alpha shows a similar action to pregabalin, acting as an endogenous ligand of alpha 2 delta-1 that reduces the RRP size without affecting presynaptic calcium influx. The regulatory actions described for pregabalin and the ectodomain of neurexin-1 alpha are mutually exclusive. The overexpression of alpha 2 delta-1 enhances the effect of pregabalin and the ectodomain of neurexin-1 alpha on neurotransmission by decreasing their effective concentration. In contrast, knockdown of alpha 2 delta-1 causes a profound inhibition of synaptic transmission. These observations prompt to consider alpha 2 delta-1 as an outside-in signaling platform that binds exogenous and endogenous cues for regulating the coupling of voltage-gated calcium channels to synaptic vesicles.	[Martinez San Segundo, Pablo; Terni, Beatrice; Llobet, Artur] Bellvitge Biomed Res Inst IDIBELL, Lab Neurobiol, Barcelona, Spain; [Martinez San Segundo, Pablo; Terni, Beatrice; Llobet, Artur] Univ Barcelona, Inst Neurosci, Sch Med, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Burgueno, Javier; Monroy, Xavier; Dordal, Albert; Merlos, Manuel] ESTEVE, Dept Pharmacol Drug Discovery & Preclin Dev, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Esteve	Llobet, A (corresponding author), Univ Barcelona, Sch Med, Lab Neurobiol, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08907, Spain.	allobet@ub.edu	Llobet, Artur/D-4339-2014; Merlos, Manuel/AAC-3064-2021	Llobet, Artur/0000-0001-5797-6782; Merlos, Manuel/0000-0002-8423-3033; Martinez San Segundo, Pablo/0000-0001-8719-5186	Spanish government (MICINN) [RTI2018-096948-B-100]; European Regional Development Fund (ERDF)	Spanish government (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (ERDF)(European Commission)	Spanish government (MICINN), Grant/Award Number: RTI2018-096948-B-100; European Regional Development Fund (ERDF)	Albrecht D, 2012, MOL CELL NEUROSCI, V49, P364, DOI 10.1016/j.mcn.2012.01.005; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Biederer T, 2017, NEURON, V96, P680, DOI 10.1016/j.neuron.2017.10.006; Brockhaus J, 2018, J NEUROSCI, V38, P8277, DOI 10.1523/JNEUROSCI.0511-18.2018; Brown JP, 1998, ANAL BIOCHEM, V255, P236, DOI 10.1006/abio.1997.2447; Brown JT, 2005, SYNAPSE, V55, P262, DOI 10.1002/syn.20115; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Chai ZY, 2017, NEURON, V96, P1317, DOI 10.1016/j.neuron.2017.10.028; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; CURRIE PJ, 1995, LIFE SCI, V57, P1911, DOI 10.1016/0024-3205(95)02178-L; de Arce KP, 2015, NEURON, V88, P1165, DOI 10.1016/j.neuron.2015.11.011; de Jong APH, 2016, P NATL ACAD SCI USA, V113, P5095, DOI 10.1073/pnas.1522927113; Delvendahl I, 2015, P NATL ACAD SCI USA, V112, pE3075, DOI 10.1073/pnas.1508419112; Di Guilmi MN, 2011, J PHARMACOL EXP THER, V336, P973, DOI 10.1124/jpet.110.172171; Dolphin AC, 2018, F1000RES, V7; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Fell B, 2016, J NEUROSCI, V36, P11024, DOI 10.1523/JNEUROSCI.3468-14.2016; Feng MHR, 2001, EUR J DRUG METAB PH, V26, P123, DOI 10.1007/BF03190385; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; Glebov OO, 2017, CELL REP, V18, P2715, DOI 10.1016/j.celrep.2017.02.064; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Hernandez-Vivanco A, 2012, J PHARMACOL EXP THER, V342, P263, DOI 10.1124/jpet.111.190652; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Kaeser PS, 2017, CURR OPIN NEUROBIOL, V43, P63, DOI 10.1016/j.conb.2016.12.012; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Lopez-Murcia FJ, 2015, P NATL ACAD SCI USA, V112, P13366, DOI 10.1073/pnas.1512202112; Lopez-Murcia FJ, 2014, J NEUROSCI, V34, P8618, DOI 10.1523/JNEUROSCI.5081-13.2014; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Micheva KD, 2006, MOL PHARMACOL, V70, P467, DOI 10.1124/mol.106.023309; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nieto-Rostro M, 2018, P NATL ACAD SCI USA, V115, pE12043, DOI 10.1073/pnas.1811212115; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Perez-Gonzalez AP, 2008, J PHYSIOL-LONDON, V586, P4675, DOI 10.1113/jphysiol.2008.160044; Quinn DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42920; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Schreiner D, 2015, ELIFE, V4, DOI 10.7554/eLife.07794; Scott MB, 2017, CHANNELS, V11, P555, DOI 10.1080/19336950.2017.1356954; Smillie KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3394; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; SUMANCHAUHAN N, 1993, EUR J PHARM-MOLEC PH, V244, P293, DOI 10.1016/0922-4106(93)90155-3; Thanawala MS, 2016, J NEUROSCI METH, V264, P136, DOI 10.1016/j.jneumeth.2016.02.021; THURLOW RJ, 1993, EUR J PHARM-MOLEC PH, V247, P341, DOI 10.1016/0922-4106(93)90204-M; Tong XJ, 2017, NEURON, V95, P326, DOI 10.1016/j.neuron.2017.06.018; Wang TT, 2016, CELL REP, V16, P2875, DOI 10.1016/j.celrep.2016.08.030; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wu MM, 2009, J PHYSIOL-LONDON, V587, P5377, DOI 10.1113/jphysiol.2009.176065; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	3	3	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1362	1377		10.1096/fj.201901551R	http://dx.doi.org/10.1096/fj.201901551R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914622				2022-12-26	WOS:000507308900091
J	Shi, YH; Wang, HA; Zheng, MJ; Xu, W; Yang, Y; Shi, FS				Shi, Yuhua; Wang, Huanan; Zheng, Mengjie; Xu, Wei; Yang, Yang; Shi, Fushan			Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly	FASEB JOURNAL			English	Article						anti-inflammation; ginsenoside Rg3; inflammasome; NLRP3 inflammasome	NALP3 INFLAMMASOME; IL-1-BETA; INNATE; MECHANISM; IMMUNITY; RECEPTOR; CELLS; NEK7	Ginsenoside Rg3 is one of the main constituents of Panax ginseng. Compelling evidence has demonstrated that ginsenoside Rg3 is capable of inhibiting inflammation. However, the mechanism mediating its anti-inflammatory effects remain unclear. Here we show that ginsenoside Rg3 blocks IL-1 beta secretion and caspase-1 activation through inhibiting LPS priming and the NLRP3 inflammasome activation in human and mouse macrophages. Rg3 specifically inhibits activation of NLRP3 but not the NLRC4 or AIM2 inflammasomes. In addition, Rg3 has no effect on upstream regulation of NLRP3 inflammasome, such as K+ efflux, ROS production, or mitochondrial membrane potential. Mechanistically, Rg3 abrogates NEK7-NLRP3 interaction, and subsequently inhibits NLRP3-ASC interaction, ASC oligomerization, and speckle formation. More importantly, Rg3 can reduce IL-1 beta secretion induced by LPS in mice and protect mice from lethal endotoxic shock. Thus, our findings reveal an anti-inflammatory mechanism for Rg3 and suggest its potential use in NLRP3-driven diseases.	[Shi, Yuhua; Wang, Huanan; Zheng, Mengjie; Xu, Wei; Shi, Fushan] Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Yang] Zhejiang A&F Univ, Zhejiang Prov Engn Lab Anim Hlth Inspect & Intern, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Coll Anim Sci & Technol, Hangzhou 311300, Zhejiang, Peoples R China; [Shi, Fushan] Zhejiang Univ, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University; Zhejiang University	Shi, FS (corresponding author), Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China.; Yang, Y (corresponding author), Zhejiang A&F Univ, Zhejiang Prov Engn Lab Anim Hlth Inspect & Intern, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Coll Anim Sci & Technol, Hangzhou 311300, Zhejiang, Peoples R China.	yyang@zafu.edu.cn; sfs@zju.edu.cn	Xu, Wei/AED-3066-2022; yanyan, zheng/ABF-1123-2020	Xu, Wei/0000-0002-1287-4552; 	Zhejiang Provincial Natural Science Foundation [LY18C180001, LQ15C180002]; National Natural Science Foundation of China [31502034]; Fundamental Research Funds for the Central Universities [2018QNA6032]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Zhejiang Provincial Natural Science Foundation, Grant/Award Number: LY18C180001 and LQ15C180002; National Natural Science Foundation of China, Grant/Award Number: 31502034; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2018QNA6032	Chen J, 2019, LIFE SCI, V216, P1, DOI 10.1016/j.lfs.2018.11.022; Cheng ZQ, 2016, INT IMMUNOPHARMACOL, V34, P53, DOI 10.1016/j.intimp.2016.02.011; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Huang Y, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708689; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Kim J, 2014, IMMUNOL LETT, V158, P143, DOI 10.1016/j.imlet.2013.12.017; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; Min JK, 2006, BIOCHEM BIOPH RES CO, V349, P987, DOI 10.1016/j.bbrc.2006.08.129; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Sun MY, 2017, INT J MOL MED, V39, P507, DOI 10.3892/ijmm.2017.2857; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Wang JJ, 2018, CANCER LETT, V415, P73, DOI 10.1016/j.canlet.2017.11.037; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Wang WB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006123; Wang XJ, 2019, EUR J PHARMACOL, V850, P141, DOI 10.1016/j.ejphar.2019.02.023; Wei XJ, 2012, FITOTERAPIA, V83, P636, DOI 10.1016/j.fitote.2012.01.006; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yoon SJ, 2015, BIOCHEM BIOPH RES CO, V463, P1184, DOI 10.1016/j.bbrc.2015.06.080; Zheng X, 2017, BIOMED PHARMACOTHER, V85, P620, DOI 10.1016/j.biopha.2016.11.072; Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347	43	30	30	7	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					208	221		10.1096/fj.201901537R	http://dx.doi.org/10.1096/fj.201901537R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914640				2022-12-26	WOS:000507308900016
J	Zhang, HX; Zhang, H; Wang, CJ; Wang, YH; Zou, RY; Shi, CX; Guan, BC; Gamper, N; Xu, YF				Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Wang, Yuhong; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Gamper, Nikita; Xu, Yanfang			Auxiliary subunits control biophysical properties and response to compound NS5806 of the Kv4 potassium channel complex	FASEB JOURNAL			English	Article						cardiomyocyte; dipeptidyl peptidase-like protein; K+ channel-interacting protein; transient outward K+ current	OUTWARD K+ CURRENT; PROTEIN DPPX; I-TO; ACTIVATOR; MODULATION; EXPRESSION; CURRENTS; REPOLARIZATION; MECHANISMS; INSIGHTS	Kv4 pore-forming subunits co-assemble with beta-subunits including KChIP2 and DPP6 and the resultant complexes conduct cardiac transient outward K+ current (I-to). Compound NS5806 has been shown to potentate I-to in canine cardiomyocytes; however, its effects on I-to in other species yet to be determined. We found that NS5806 inhibited native I-to in a concentration-dependent manner (0.1 similar to 30 mu M) in both mouse ventricular cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), but potentiated I-to in the canine cardiomyocytes. In HEK293 cells co-transfected with cloned Kv4.3 (or Kv4.2) and beta-subunit KChIP2, NS5806 significantly increased the peak current amplitude and slowed the inactivation. In contrast, NS5806 suppressed the current and accelerated inactivation of the channels when cells were co-transfected with Kv4.3 (or Kv4.2), KChIP2 and another beta-subunit, DPP6-L (long isoform). Western blot analysis showed that DPP6-L was dominantly expressed in both mouse ventricular myocardium and hiPSC-CMs, while it was almost undetectable in canine ventricular myocardium. In addition, low level of DPP6-S expression was found in canine heart, whereas levels of KChIP2 expression were comparable among all three species. siRNA knockdown of DPP6 antagonized the I-to inhibition by NS5806 in hiPSC-CMs. Molecular docking simulation suggested that DPP6-L may associate with KChIP2 subunits. Mutations of putative KChIP2-interacting residues of DPP6-L reversed the inhibitory effect of NS5806 into potentiation of the current. We conclude that a pharmacological modulator can elicit opposite regulatory effects on Kv4 channel complex among different species, depending on the presence of distinct beta-subunits. These findings provide novel insight into the molecular design and regulation of cardiac I-to. Since I-to is a potential therapeutic target for treatment of multiple cardiovascular diseases, our data will facilitate the development of new therapeutic I-to modulators.	[Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Gamper, Nikita; Xu, Yanfang] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Xu, Yanfang] Minist Educ, Key Lab New Drug Pharmacol & Toxicol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Xu, Yanfang] Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Yuhong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Masteria Med, Beijing, Peoples R China; [Gamper, Nikita] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England	Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Leeds	Gamper, N; Xu, YF (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China.; Gamper, N (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	n.gamper@leeds.ac.uk; yanfangxu@hebmu.edu.cn	Wang, Yu/GZL-9655-2022	Gamper, Nikita/0000-0001-5806-0207	National Natural Science Foundation of China (NSFC) [31771259]; Science and Technology Foundation of Hebei Province [17274803D]; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R003068/1, BB/R02104X/1]; BBSRC [BB/R003068/1, BB/R02104X/1] Funding Source: UKRI; MRC [G0700966] Funding Source: UKRI	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Hebei Province; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771259; Science and Technology Foundation of Hebei Province, Grant/Award Number: 17274803D; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/R003068/1 and BB/R02104X/1	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Calloe K, 2011, J CARDIOVASC ELECTR, V22, P1057, DOI 10.1111/j.1540-8167.2011.02053.x; Calloe K, 2010, J MOL CELL CARDIOL, V48, P191, DOI 10.1016/j.yjmcc.2009.07.017; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Cheng HW, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13172; Cheng Hsien C., 2006, Journal of Pharmacological and Toxicological Methods, V54, P278, DOI 10.1016/j.vascn.2006.01.002; Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Cordeiro JM, 2013, J MOL CELL CARDIOL, V60, P36, DOI 10.1016/j.yjmcc.2013.03.014; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Gonzalez WG, 2014, J BIOL CHEM, V289, P32201, DOI 10.1074/jbc.M114.577528; Kassiri Z, 2002, J MOL MED, V80, P351, DOI 10.1007/s00109-002-0325-7; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; Lei M, 2018, CIRCULATION, V138, P1879, DOI 10.1161/CIRCULATIONAHA.118.035455; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133274; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nerbonne Jeanne M, 2016, Card Electrophysiol Clin, V8, P257, DOI 10.1016/j.ccep.2016.01.001; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Radicke S, 2009, N-S ARCH PHARMACOL, V379, P617, DOI 10.1007/s00210-008-0389-1; Shi C, 2013, ACTA PHYSIOL, V208, P95, DOI 10.1111/apha.12071; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu YF, 2005, J PHYSIOL-LONDON, V562, P745, DOI 10.1113/jphysiol.2004.076216; Yang KC, 2016, TRENDS CARDIOVAS MED, V26, P209, DOI 10.1016/j.tcm.2015.07.002	35	4	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					807	821		10.1096/fj.201902010RR	http://dx.doi.org/10.1096/fj.201902010RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914636	Green Published, hybrid			2022-12-26	WOS:000507308900055
J	Zhang, WD; Sakoda, H; Nakazato, M				Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Masamitsu			Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic beta-cells	FASEB JOURNAL			English	Article						beta-cell; diabetes; insulin secretion; mitochondria; NMU	OXIDATIVE STRESS; ER-STRESS; EXPRESSION; PEPTIDE; ENERGY; GENERATION; RESISTANCE; CAPACITY; ROLES	Neuromedin U (NMU), a highly conserved peptide in mammals, is involved in a wide variety of physiological processes. NMU, which is synthesized in beta-cells and co-localizes with insulin, directly acts on beta-cells via NMU receptor 1 (NMUR1) to suppress glucose-stimulated insulin secretion (GSIS). The mechanism underlying this insulinostatic effect has yet to be elucidated. We observed that NMU caused mitochondrial dysfunction by impairing mitochondrial biogenesis, respiration, and mitochondrial Ca2+ uptake in beta-cell-derived MIN6-K8 cells. NMU administration induced the endoplasmic reticulum (ER) stress, as reflected by the activation of ER stress signaling pathways involving ATF6, XBP-1s, and PERK-ATF4-CHOP. Nmu knockdown in MIN6-K8 cells increased the number of insulin granules and improved mitochondrial biogenesis and function. NMU was upregulated in both the islets of db/db mice and palmitate-treated MIN6-K8 cells. Our results highlight the crucial role of NMU in the maintenance of beta-cell function and glucose metabolism through regulation of mitochondria dysfunction and ER stress. In pathological stages that develop into diabetes, upregulation of NMU could suppress the insulin secretion by inducing mitochondrial dysfunction and ER stress, which may contribute to subsequent beta-cell dysfunction.	[Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Masamitsu] Univ Miyazaki, Div Neurol Respirol Endocrinol & Metab, Dept Internal Med, Fac Med, Kihara 5200, Miyazaki 8891692, Japan; [Nakazato, Masamitsu] Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Miyazaki	Nakazato, M (corresponding author), Univ Miyazaki, Div Neurol Respirol Endocrinol & Metab, Dept Internal Med, Fac Med, Kihara 5200, Miyazaki 8891692, Japan.	nakazato@med.miyazaki-u.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP19gm0610016]; MEXT | Japan Society for the Promotion of Science (JSPS) [16H05333]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm0610016; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16H05333	Al-Amily IM, 2019, PFLUG ARCH EUR J PHY, V471, P633, DOI 10.1007/s00424-019-02262-7; Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Atanes P, 2018, CELL MOL LIFE SCI, V75, P3039, DOI 10.1007/s00018-018-2778-z; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kaczmarek P, 2006, INT J MOL MED, V18, P951; Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004; Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; Kuhre RE, 2019, CELL METAB, V29, P719, DOI 10.1016/j.cmet.2018.10.008; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Mitchell JD, 2009, CARDIOVASC RES, V81, P353, DOI 10.1093/cvr/cvn302; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; Moin ASM, 2012, BIOCHEM BIOPH RES CO, V428, P512, DOI 10.1016/j.bbrc.2012.10.073; Mukhuty A, 2017, BIOCHEM BIOPH RES CO, V491, P1118, DOI 10.1016/j.bbrc.2017.08.022; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Newsholme P, 2012, J ENDOCRINOL, V214, P11, DOI 10.1530/JOE-12-0072; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Przygodzka P, 2016, BBA-GEN SUBJECTS, V1860, P2445, DOI 10.1016/j.bbagen.2016.07.012; Rieusset J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0416-1; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; Silvander JSG, 2017, FASEB J, V31, P4578, DOI 10.1096/fj.201700095R; Silzer TK, 2018, MITOCHONDRION, V43, P16, DOI 10.1016/j.mito.2018.04.004; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vernochet C, 2014, FASEB J, V28, P4408, DOI 10.1096/fj.14-253971; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wang J, 2016, CELL SIGNAL, V28, P1099, DOI 10.1016/j.cellsig.2016.05.007; Zhang EM, 2019, CELL METAB, V29, P64, DOI 10.1016/j.cmet.2018.09.008; Zhang WD, 2017, BIOCHEM BIOPH RES CO, V493, P677, DOI 10.1016/j.bbrc.2017.08.132	50	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					133	147		10.1096/fj.201901743R	http://dx.doi.org/10.1096/fj.201901743R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914613	Bronze			2022-12-26	WOS:000507308900011
J	Chehayeb, RJ; Stiegler, AL; Boggon, TJ				Chehayeb, Rachel Jaber; Stiegler, Amy L.; Boggon, Titus J.			Crystal structures of p120RasGAP N-terminal SH2 domain in its apo form and in complex with a p190RhoGAP phosphotyrosine peptide	PLOS ONE			English	Article							SRC HOMOLOGY-2 DOMAIN; C-SRC; ACTIVATING PROTEIN; MOLECULAR-CLONING; REGULATES CELL; RHO; P190; RAS; GTPASE; GAP	The Rho and Ras pathways play vital roles in cell growth, division and motility. Cross-talk between the pathways amplifies their roles in cell proliferation and motility and its dysregulation is involved in disease pathogenesis. One important interaction for cross-talk occurs between p120RasGAP (RASA1), a GTPase activating protein (GAP) for Ras, and p190RhoGAP (p190RhoGAP-A, ARHGAP35), a GAP for Rho. The binding of these proteins is primarily mediated by two SH2 domains within p120RasGAP engaging phosphorylated tyrosines of p190RhoGAP, of which the best studied is pTyr-1105. To better understand the interaction between p120RasGAP and p190RhoGAP, we determined the 1.75 angstrom X-ray crystal structure of the N-terminal SH2 domain of p120RasGAP in the unliganded form, and its 1.6 angstrom co-crystal structure in complex with a synthesized phosphotyrosine peptide, EEENI(p-Tyr)SVPHDST, corresponding to residues 1100-1112 of p190RhoGAP. We find that the N-terminal SH2 domain of p120RhoGAP has the characteristic SH2 fold encompassing a central beta-sheet flanked by two alpha-helices, and that peptide binding stabilizes specific conformations of the beta E-beta F loop and arginine residues R212 and R231. Site-directed mutagenesis and native gel shifts confirm phosphotyrosine binding through the conserved FLVR motif arginine residue R207, and isothermal titration calorimetry finds a dissociation constant of 0.3 +/- 0.1 mu M between the phosphopeptide and SH2 domain. These results demonstrate that the major interaction between two important GAP proteins, p120RasGAP and p190RhoGAP, is mediated by a canonical SH2-pTyr interaction.	[Chehayeb, Rachel Jaber] Yale Coll, New Haven, CT USA; [Chehayeb, Rachel Jaber; Boggon, Titus J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Stiegler, Amy L.; Boggon, Titus J.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Boggon, Titus J.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA.	titus.boggon@yale.edu		Jaber Chehayeb, Rachel/0000-0002-2117-7433	National Institutes of Health [R01GM037355, S10OD018007, P41GM103403]; DOE Office of Science [DE-AC0206CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grants R01GM037355 and S10OD018007 to TJB funded this research. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health grant P41GM103403. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC0206CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; Antoine-Bertrand J, 2016, J BIOL CHEM, V291, P4589, DOI 10.1074/jbc.M115.674846; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Berndt SI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7889; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; BRYANT SS, 1995, J BIOL CHEM, V270, P17947, DOI 10.1074/jbc.270.30.17947; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Chan PC, 2012, CANCER RES, V72, P2405, DOI 10.1158/0008-5472.CAN-11-3078; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang Y, 2015, ONCOTARGET, V6, P13164, DOI 10.18632/oncotarget.3754; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskell MD, 2001, J CELL SCI, V114, P1699; Heraud C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040351; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; HIDAKA M, 1991, BIOCHEM BIOPH RES CO, V180, P1490, DOI 10.1016/S0006-291X(05)81364-6; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulkarni S, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P457; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; LECLERC S, 1991, J BIOL CHEM, V266, P17333; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; MCCORMICK F, 1988, COLD SPRING HARB SYM, V53, P849, DOI 10.1101/SQB.1988.053.01.097; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKercher MA, 2017, BIOCHEMISTRY-US, V56, P2225, DOI 10.1021/acs.biochem.7b00023; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Revencu N, 2013, HUM MUTAT, V34, P1632, DOI 10.1002/humu.22431; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Stiegler AL, 2018, BIOCHEM SOC T, V46, P1713, DOI 10.1042/BST20180481; Stiegler AL, 2018, STRUCTURE, V26, P1451, DOI 10.1016/j.str.2018.07.015; Stiegler AL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00483-x; Su L, 2009, EXP CELL RES, V315, P1347, DOI 10.1016/j.yexcr.2009.02.014; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Waksman Gabriel, 2004, Cell, VS116, pS45, DOI 10.1016/S0092-8674(04)00043-1; Wang DZM, 1997, CANCER RES, V57, P2478; Wang J, 2014, ONCOGENE, V33, P1181, DOI 10.1038/onc.2013.42; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	69	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226113	10.1371/journal.pone.0226113	http://dx.doi.org/10.1371/journal.pone.0226113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891593	Green Published, gold, Green Submitted			2022-12-26	WOS:000515096600010
J	Kvaavik, C; Oskarsson, GJ; Danielsdottir, AK; Marteinsdottir, G				Kvaavik, Cecilia; Oskarsson, Gudmundur J.; Danielsdottir, Anna Kristin; Marteinsdottir, Gudrun			Diet and feeding strategy of Northeast Atlantic mackerel (Scombrus scomber) in Icelandic waters	PLOS ONE			English	Article							LONG-TERM CHANGES; NORWEGIAN SEA; STOMACH CONTENTS; ZOOPLANKTON COMMUNITIES; CALANUS-FINMARCHICUS; CLUPEA-HARENGUS; NORDIC SEAS; ABUNDANCE; VARIABILITY; MIGRATION	Predator-prey relations, as well as the trophic ecology of highly migratory marine species, is important to understand their impact on the ecosystem. Conventional methods were used to study the diet composition and feeding strategy of the Northeast Atlantic mackerel (Scombrus scomber), during their summer feeding migration to Icelandic waters in 2009-2014. In addition, generalised additive modelling (GAM) was used to determine which biological and environmental factors contribute to the variation of their stomach weight in the years 2011-2014. From the dietary analysis, we found that calanoid copepods (especially Calanus finmarchicus) were the most important contributor to the overall diet of mackerel in the years studied. Although in some years and areas, they also preyed heavily on larger prey items such as euphausiids, amphipods and megalopa larvae of crab and shrimp. The GAM showed that temperature and the time the day of sampling were significant explanatory variables for the stomach weight, while zooplankton biomass did not seem to have much influence. The Northeast Atlantic mackerel are ferocious feeders upon copepods, as well as exhibiting an overall opportunistic feeding strategy. During their feeding migration in Icelandic waters, they were found to feed on the most dominant species available to them.	[Kvaavik, Cecilia; Oskarsson, Gudmundur J.] Marine & Freshwater Res Inst, Pelag Div, Reykjavik, Iceland; [Kvaavik, Cecilia; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Kvaavik, Cecilia; Danielsdottir, Anna Kristin] Matis, Reykjavik, Iceland	Marine & Freshwater Research Institute (MFRI); University of Iceland	Kvaavik, C (corresponding author), Marine & Freshwater Res Inst, Pelag Div, Reykjavik, Iceland.; Kvaavik, C (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.; Kvaavik, C (corresponding author), Matis, Reykjavik, Iceland.	cecilia.kvaavik@hafogvatn.is		Danielsdottir, Anna Kristin/0000-0002-9555-1731; Kvaavik, Cecilia/0000-0002-2376-974X; Marteinsdottir, Gudrun/0000-0001-6939-2434	Icelandic Centre for Research [163371-051]; Marine and Freshwater Institute of Iceland; Matis as a part of a PhD project on the ecosystem impact of mackerel in Icelandic waters	Icelandic Centre for Research; Marine and Freshwater Institute of Iceland; Matis as a part of a PhD project on the ecosystem impact of mackerel in Icelandic waters	This research was funded by the Icelandic Centre for Research (grant number: 163371-051), the Marine and Freshwater Institute of Iceland and Matis as a part of a PhD project on the ecosystem impact of mackerel in Icelandic waters.	Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2004, MODEL SELECTION MULT; [Anonymous], 2018, MULTIMODEL INFERENCE; Astthorsson OS, 2007, DEEP-SEA RES PT II, V54, P2456, DOI 10.1016/j.dsr2.2007.07.030; ASTTHORSSON OS, 1995, ICES J MAR SCI, V52, P657, DOI 10.1016/1054-3139(95)80079-4; ASTTHORSSON OS, 1992, SARSIA, V77, P225, DOI 10.1080/00364827.1992.10413508; Astthorsson OS, 2012, ICES J MARINE SCI J; Bachiller E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190345; Bachiller E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149238; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Beare DJ, 2000, ICES J MAR SCI, V57, P1545, DOI 10.1006/jmsc.2000.0973; Berge J, 2015, ARCTIC, V68, P54, DOI 10.14430/arctic4455; BRINTON E, 1967, LIMNOL OCEANOGR, V12, P451, DOI 10.4319/lo.1967.12.3.0451; Broms C, 2012, MAR BIOL RES, V8, P461, DOI 10.1080/17451000.2011.640689; Brown SC, 2012, ENVIRON BIOL FISH, V95, P3, DOI 10.1007/s10641-011-9959-z; Chipps Steven R., 2007, P473; Clarke KR, 1994, CHANGE MARINE COMMUN, V2, DOI 10.7863/jum.2011.30.10.1415; Dahl K, 1986, STOMACH CONTENTS MAC; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; Debes H, 2012, ICES CM, V1000, P07; Eiriksson H, 2018, HAF OG VATNARANNSOKN; Engelhard GH, 2014, ICES J MARINE SCI; Frederiksen M, 2013, GLOBAL CHANGE BIOL, V19, P364, DOI 10.1111/gcb.12072; GIBSON RN, 1992, J FISH BIOL, V40, P577, DOI 10.1111/j.1095-8649.1992.tb02607.x; Gislason A, 2004, SARSIA, V89, P467, DOI 10.1080/00364820410009256; Gislason A, 2005, MAR ECOL PROG SER, V286, P177, DOI 10.3354/meps286177; Gislason A, 2002, SARSIA, V87, P236, DOI 10.1080/00364820260294860; Gislason A, 2012, ICES J MAR SCI, V69, P1263, DOI 10.1093/icesjms/fss070; Gislason A, 2009, J PLANKTON RES, V31, P541, DOI 10.1093/plankt/fbp007; Godo OR, 2004, ICES J MAR SCI, V61, P1093, DOI 10.1016/j.icesjms.2004.06.009; Guillemette M, 2018, MAR ECOL PROG SER, V587, P235, DOI 10.3354/meps12442; Gunnarsson B, 2019, HAF OG VATNARANNSOKN; HALL SJ, 1995, J ANIM ECOL, V64, P39, DOI 10.2307/5826; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanna E, 2006, J CLIMATE, V19, P5652, DOI 10.1175/JCLI3933.1; Harms-Tuohy CA, 2016, MAR ECOL PROG SER, V558, P181, DOI 10.3354/meps11738; Hastie T, 1990, MONOGRAPHS STAT APPL, P1; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; ICES, 2019, ICES SCI REPORTS, DOI [10.17895/ices.pub.5574, DOI 10.17895/ICES.PUB.5574]; ICES, 2018, ICES WGINOR REP 2018; ICES, 2018, CRUIS REP INT EC SUM, P39; Jansen T, 2019, FISH RES, V214, P25, DOI 10.1016/j.fishres.2019.01.020; Jansen T, 2014, ICES J MAR SCI, V71, P299, DOI 10.1093/icesjms/fst148; Jonsdottir IG, 2012, MAR ECOL PROG SER, V469, P223, DOI 10.3354/meps09977; JONSSON S, 1992, ICES MAR SC, V195, P62; Jonsson S, 2005, DEV QUATER SCI, V5, P79; LAMBERT TC, 1985, CAN J ZOOL, V63, P817, DOI 10.1139/z85-120; Langoy H, 2012, MAR BIOL RES, V8, P442, DOI 10.1080/17451000.2011.642803; Macy WK, 1998, MAR ECOL PROG SER, V172, P89, DOI 10.3354/meps172089; Madgett AS, 2019, ESTUAR COAST SHELF S, V227, DOI 10.1016/j.ecss.2019.106327; McClain-Counts JP, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12449; Mehl S, 1983, DIET CONSUMPTION MAC; Navarro J, 2013, ENVIRON BIOL FISH, P1; Nikolioudakis N, 2018, ICES J MAR SCI, DOI [10.1093/icesjms/fsx225, DOI 10.1093/ICESJMS/FSX225]; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Nilssen KT, 2019, MAR BIOL RES, V15, P137, DOI 10.1080/17451000.2019.1605182; Nottestad L., 2006, FEEDING ECOLOGY ATLA; Nottestad L, 2014, MARINE ECOLOGY PROGR, DOI [10.3354/9123410820, DOI 10.3354/MEPS10820]; Nottestad L, 2016, ICES J MAR SCI, V73, P1127, DOI 10.1093/icesjms/fsv239; Nottestad L, 2016, ICES J MAR SCI, V73, P359, DOI 10.1093/icesjms/fsv218; Olafsdottir AH, 2015, ICES J MAR SCI; Olafsdottir AH, 2019, DEEP-SEA RES PT II, V159, P152, DOI 10.1016/j.dsr2.2018.05.023; Oskarsson GJ, 2016, MAR BIOL RES, V12, P16, DOI 10.1080/17451000.2015.1073327; PEPIN P, 1987, CAN J FISH AQUAT SCI, V44, P2012, DOI 10.1139/f87-247; PEPIN P, 1988, CAN J FISH AQUAT SCI, V45, P879, DOI 10.1139/f88-106; Plourde S, 2014, 2014092 DFO SCI ADV; Prokopchuk I, 2006, ICES J MAR SCI, V63, P117, DOI 10.1016/j.icesjms.2005.08.005; Sakamoto T, 1982, STUDIES FISHERY BIOL, P111; Santic M, 2012, J FISH BIOL, V81, P1070, DOI 10.1111/j.1095-8649.2012.03382.x; Silva T, 2016, MAR BIOL RES, V12, P864, DOI 10.1080/17451000.2016.1210808; Simenstad C, 2013, CONT STUDIES FISH FE; Skaret G, 2015, ICES J MARINE SCI; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Stefanson U., 1962, N ICELANDIC WATERS; Stige LC, 2018, ECOLOGY, V99, P632, DOI 10.1002/ecy.2126; Strom JF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44041-5; Temming A, 2002, J FISH BIOL, V61, P50, DOI [10.1006/jfbi.2002.2006, 10.1111/j.1095-8649.2002.tb01736.x]; Utne KR, 2012, MAR BIOL RES, V8, P548, DOI 10.1080/17451000.2011.639781; Valdimarsson H, 1999, RIT FISKIDEILDAR, V16, P23; Valdimarsson H, 2012, ICES J MAR SCI, V69, P816, DOI 10.1093/icesjms/fss027; Vigfusdottir F, 2013, BIRD STUDY, V60, P289, DOI 10.1080/00063657.2013.811214; Vikingsson GA, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00006; Weidner T, 2017, J APPL ICHTHYOL, DOI [10.1111/jai.13371, DOI 10.1111/JAI.13371]; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Young T, 2018, ICES J MAR SCI, V75, P1583, DOI 10.1093/icesjms/fsy025	87	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0225552	10.1371/journal.pone.0225552	http://dx.doi.org/10.1371/journal.pone.0225552			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887738	Green Published, gold			2022-12-26	WOS:000515092200008
J	Khan, N; Kim, SK; Gagneux, P; Dugan, LL; Varki, A				Khan, Naazneen; Kim, Stuart K.; Gagneux, Pascal; Dugan, Laura L.; Varki, Ajit			Maximum reproductive lifespan correlates with CD33rSIGLEC gene number: Implications for NADPH oxidase-derived reactive oxygen species in aging	FASEB JOURNAL			English	Article						CD33rSIGLEC; NADPH-oxidase; prolonged post-reproductive lifespan; reactive oxygen species	EVOLUTION; MECHANISMS; SIGLEC-9; MITOCHONDRIA; NEUTROPHILS; ACTIVATION; LONGEVITY; RECEPTOR; DEATH; MENOPAUSE	Humans and orcas are among the very rare species that have a prolonged post-reproductive lifespan (PRLS), during which the aging process continues. Reactive oxygen species (ROS) derived from mitochondria and from the NADPH oxidase (NOX) enzymes of innate immune cells are known to contribute to aging, with the former thought to be dominant. CD33-related-Siglecs are immune receptors that recognize self-associated-molecular-patterns and modulate NOX-derived-ROS. We herewith demonstrate a strong correlation of lifespan with CD33rSIGLEC gene number in 26 species, independent of body weight or phylogeny. The correlation is stronger when considering total CD33rSIGLEC gene number rather than those encoding inhibitory and activating subsets, suggesting that lifetime balancing of ROS is important. Combining independent lines of evidence including the short half-life and spontaneous activation of neutrophils, we calculate that even without inter-current inflammation, a major source of lifetime ROS exposure may actually be neutrophil NOX-derived. However, genomes of human supercentenarians (>110 years) do not harbor a significantly higher number of functional CD33rSIGLEC genes. Instead, lifespan correlation with CD33rSIGLEC gene number was markedly strengthened by excluding the post-reproductive lifespan of humans and orcas (R-2 = 0.83; P < .0001). Thus, CD33rSIGLEC modulation of ROS likely contributes to maximum reproductive lifespan, but other unknown mechanisms could be important to PRLS.	[Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Anthropol, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA; [Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Med Ctr, Stanford, CA 94305 USA; [Dugan, Laura L.] Vanderbilt Univ, Med Ctr, Med Geriatr, Nashville, TN USA; [Dugan, Laura L.] VA Tennessee Valley Geriatr Res Educ & Clin Ctr G, Nashville, TN USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA.; Varki, A (corresponding author), UCSD Sch Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	KHAN, NAAZNEEN/J-8868-2019	KHAN, NAAZNEEN/0000-0002-4386-1703	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R01GM32373]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01GM32373	Adams OJ, 2018, GLYCOBIOLOGY, V28, P640, DOI 10.1093/glycob/cwx108; Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110; Ali SS, 2011, BRAIN RES, V1368, P65, DOI 10.1016/j.brainres.2010.11.009; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Angata T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02885; AUSTAD SN, 1994, EXP GERONTOL, V29, P255, DOI 10.1016/0531-5565(94)90005-1; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bochner BS, 2015, J ALLERGY CLIN IMMUN, V135, P598, DOI 10.1016/j.jaci.2014.11.031; Bornhofft KF, 2018, DEV COMP IMMUNOL, V86, P219, DOI 10.1016/j.dci.2018.05.008; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Cachat J, 2015, CLIN SCI, V128, P635, DOI 10.1042/CS20140635; Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Croft DP, 2017, CURR BIOL, V27, P298, DOI 10.1016/j.cub.2016.12.015; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; Dugan Laura L, 2005, Sci Aging Knowledge Environ, V2005, ppe20, DOI 10.1126/sageke.2005.26.pe20; Ellis S, 2018, ECOL EVOL, V8, P2482, DOI 10.1002/ece3.3856; Favier B, 2016, IMMUNOL REV, V273, P140, DOI 10.1111/imr.12457; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2010, AGING CELL, V9, P519, DOI 10.1111/j.1474-9726.2010.00578.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hawkes K, 2013, EVOL ANTHROPOL, V22, P294, DOI 10.1002/evan.21382; Hawkes K, 2009, AM J PHYS ANTHROPOL, V140, P173, DOI 10.1002/ajpa.21061; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Jha JC, 2017, CLIN SCI, V131, P981, DOI 10.1042/CS20160846; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Karlstetter M, 2017, EMBO MOL MED, V9, P154, DOI 10.15252/emmm.201606627; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Khan SS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1617; Lahdenpera M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27213; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Lahoz-Beneytez J, 2016, BLOOD, V127, P3431, DOI 10.1182/blood-2016-03-700336; Lizcano A, 2017, BLOOD, V129, P3100, DOI 10.1182/blood-2016-11-751636; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McMillan SJ, 2014, J BIOL CHEM, V289, P20370, DOI 10.1074/jbc.M114.574624; Mitra N, 2011, J BIOL CHEM, V286, P23003, DOI 10.1074/jbc.M111.244152; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Newburger PE, 2013, SEMIN HEMATOL, V50, P198, DOI 10.1053/j.seminhematol.2013.06.010; Nutku-Bilir E, 2008, AM J RESP CELL MOL, V38, P121, DOI 10.1165/rcmb.2007-0154OC; Partridge L, 2014, TRENDS ENDOCRIN MET, V25, P555, DOI 10.1016/j.tem.2014.08.003; Patras KA, 2017, IMMUNOL CELL BIOL, V95, P960, DOI 10.1038/icb.2017.63; Photopoulou T, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0208-y; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157; Satoh A, 2017, NAT REV NEUROSCI, V18, P362, DOI 10.1038/nrn.2017.42; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwarz F, 2016, P NATL ACAD SCI USA, V113, P74, DOI 10.1073/pnas.1517951112; Schwarz F, 2015, ELIFE, V4, DOI 10.7554/eLife.06184; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Varki A, 2017, ESSENTIALS GLYCOBIOL, P450; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; White L, 2017, HEMATOL ONCOL CLIN N, V31, P981, DOI 10.1016/j.hoc.2017.08.004; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yamanaka M, 2009, GLYCOBIOLOGY, V19, P841, DOI 10.1093/glycob/cwp052; Yang Q, 2018, FREE RADICAL BIO MED, V124, P466, DOI 10.1016/j.freeradbiomed.2018.06.042; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	89	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1928	1938		10.1096/fj.201902116R	http://dx.doi.org/10.1096/fj.201902116R		DEC 2019	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907986	Bronze, Green Accepted			2022-12-26	WOS:000504269100001
J	Tang, HY; Mao, JW; Ye, XJ; Zhang, FR; Kerr, WG; Zheng, T; Zhu, Z				Tang, Haiying; Mao, Jingwei; Ye, Xujun; Zhang, Fengrui; Kerr, William G.; Zheng, Tao; Zhu, Zhou			SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis	FASEB JOURNAL			English	Article						endothelial-mesenchymal transition; lung fibrosis; miR-155; phosphatase SHIP-1	MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS; MICRORNAS; MYOFIBROBLASTS; PATHOGENESIS; INFLAMMATION; DEFICIENCY; PATHOLOGY; DISEASE; LEADS	Src Homology 2-containing Inositol Phosphatase-1 (SHIP-1) is a target of miR-155, a pro-inflammatory factor. Deletion of the SHIP-1 gene in mice caused spontaneous lung inflammation and fibrosis. However, the role and function of endothelial miR-155 and SHIP-1 in lung fibrosis remain unknown. Using whole-body miR-155 knockout mice and endothelial cell-specific conditional miR-155 (VEC-Cre-miR-155 or VEC-miR-155) or SHIP-1 (VEC-SHIP-1) knockout mice, we assessed endothelial-mesenchymal transition (EndoMT) and fibrotic responses in bleomycin (BLM) induced lung fibrosis models. Primary mouse lung endothelial cells (MLEC) and human umbilical vein endothelial cells (HUVEC) with SHIP-1 knockdown were analyzed in TGF-beta 1 or BLM, respectively, induced fibrotic responses. Fibrosis and EndoMT were significantly reduced in miR-155KO mice and changes in EndoMT markers in MLEC after TGF-beta 1 stimulation confirmed the in vivo findings. Furthermore, lung fibrosis and EndoMT responses were reduced in VEC-miR-155 mice but significantly enhanced in VEC-SHIP-1 mice after BLM challenge. SHIP-1 knockdown in HUVEC cells resulted in enhanced EndoMT induced by BLM. Meanwhile, these changes involved the PI3K/AKT, JAK/STAT3, and SMAD/STAT signaling pathways. These studies demonstrate that endothelial miR-155 plays an important role in fibrotic responses in the lung through EndoMT. Endothelial SHIP-1 is essential in controlling fibrotic responses and SHIP-1 is a target of miR-155. Endothelial cells are an integral part in lung fibrosis.	[Tang, Haiying; Mao, Jingwei; Ye, Xujun; Zhang, Fengrui; Zheng, Tao; Zhu, Zhou] Yale Univ Sch Med, Sect Allergy, Clin Immunol, New Haven, CT USA; [Tang, Haiying] Dalian Med Univ, Affiliated Hosp 1, Dept Pulm, Crit Care Med, Dalian, Peoples R China; [Mao, Jingwei] Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Peoples R China; [Kerr, William G.] SUNY Upstate Med Univ, Dept MicroBiol, Immunol, Syracuse, NY USA; [Zheng, Tao; Zhu, Zhou] Brown Univ Warren Alpert Med Sch, Dept Mol MicroBiol, Immunol, Providence, RI USA; Brown Univ Warren Alpert Med Sch, Dept Mol MicroBiol & Immunol, Providence, RI USA	Yale University; Dalian Medical University; Dalian Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Zhu, Z (corresponding author), Yale Univ Sch Med, Sect Allergy, Clin Immunol, New Haven, CT USA.	zhou_zhu@brown.edu		Mao, Jingwei/0000-0003-1896-1988	NHLBI NIH HHS [P01 HL107151] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Ambrozova G, 2016, BBA-GEN SUBJECTS, V1860, P2428, DOI 10.1016/j.bbagen.2016.07.010; Artlett CM, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1331-z; Bacha NC, 2018, STEM CELL REV REP, V14, P223, DOI 10.1007/s12015-017-9778-5; Bagnato G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0125-2016; Blaya D, 2018, HEPATOLOGY, V68, P691, DOI 10.1002/hep.29833; Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Cho JG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00294; Christmann RB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1054-6; Csak T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129251; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Elich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00931; Eramo MJ, 2016, BIOCHEM SOC T, V44, P240, DOI 10.1042/BST20150214; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fernandes S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01100; Ferreira FU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030458; Goodwin J, 2018, AM J RESP CELL MOL, V58, P216, DOI 10.1165/rcmb.2016-0186OC; Hartopo AB, 2018, PHYSIOL RES, V67, pS185, DOI 10.33549/physiolres.933812; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Johansson K, 2017, J ALLERGY CLIN IMMUN, V139, P1007, DOI 10.1016/j.jaci.2016.06.035; Kim J, 2018, BMB REP, V51, P65, DOI 10.5483/BMBRep.2018.51.2.011; Kurowska-Stolarska M, 2017, J ALLERGY CLIN IMMUN, V139, P1946, DOI 10.1016/j.jaci.2016.09.021; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lehtonen ST, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0328-5; Li HM, 2016, ACTA PHARM SIN B, V6, P531, DOI 10.1016/j.apsb.2016.06.010; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Lv Z, 2018, CRIT CARE MED, V46, pE49, DOI 10.1097/CCM.0000000000002799; Maxwell MJ, 2011, J IMMUNOL, V186, P7164, DOI 10.4049/jimmunol.1004185; Maxwelll MJ, 2014, GENES IMMUN, V15, P233, DOI 10.1038/gene.2014.9; Meadows Kafi N, 2009, J Angiogenes Res, V1, P2, DOI 10.1186/2040-2384-1-2; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Stolzenburg LR, 2018, BIOL CHEM, V399, P219, DOI 10.1515/hsz-2017-0249; Tsantikos E, 2018, J CLIN INVEST, V128, P2406, DOI 10.1172/JCI98224; Van Roosbroeck K, 2017, CLIN CANCER RES, V23, P2891, DOI 10.1158/1078-0432.CCR-16-1025; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Wang W, 2016, AM J PHYSIOL-LUNG C, V311, pL494, DOI 10.1152/ajplung.00001.2016; Waters DW, 2018, AM J PHYSIOL-LUNG C, V315, pL162, DOI 10.1152/ajplung.00037.2018; Yazdani S, 2017, ADV DRUG DELIVER REV, V121, P101, DOI 10.1016/j.addr.2017.07.010; Yin Q, 2018, J CELL PHYSIOL, V233, P2451, DOI 10.1002/jcp.26122; Yu XX, 2018, ONCOL LETT, V16, P5299, DOI 10.3892/ol.2018.9281	46	17	17	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2011	2023		10.1096/fj.201902063R	http://dx.doi.org/10.1096/fj.201902063R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907997	Bronze, Green Accepted			2022-12-26	WOS:000514663600008
J	Thomson, P; Howie, K; Leslie, SJ; Angus, NJ; Andreis, F; Thomson, R; Mohan, ARM; Mondoa, C; Chung, ML				Thomson, Patricia; Howie, Kate; Leslie, Stephen J.; Angus, Neil J.; Andreis, Federico; Thomson, Robert; Mohan, Andrea R. M.; Mondoa, Catherine; Chung, Misook L.			Evaluating emotional distress and health-related quality of life in patients with heart failure and their family caregivers: Testing dyadic dynamics using the Actor-Partner Interdependence Model	PLOS ONE			English	Article							BRIEF SYMPTOM INVENTORY; EVENT-FREE SURVIVAL; DEPRESSIVE SYMPTOMS; SELF-CARE; PSYCHOMETRIC PROPERTIES; FACTORIAL STRUCTURE; PERCEIVED CONTROL; SOCIAL SUPPORT; OUTCOMES; QUESTIONNAIRE	Purpose 1) To compare levels of emotional symptoms and health-related quality of life between patients with heart failure and their family caregivers; and 2) to examine whether patients' and caregivers' emotional symptoms were associated with their own, as well as their partner's health-related quality of life. Method In this cross-sectional study, 41 patients-caregiver dyads (78% male patients, aged 68.6 years; and 83% female caregivers, aged 65.8 years) completed all nine dimensions of the Brief Symptom Inventory and the Minnesota Living with Heart failure Questionnaire. Dyadic data were analysed for 6 sub-scales of the Brief Symptom Inventory, using the Actor-Partner Interdependence Model. Results There were no statistically significant differences in emotional symptoms and health-related quality of life between patients with heart failure and their caregivers. Patients' and caregivers' emotional symptoms were associated with their own health-related quality of life. Caregivers' anxiety, phobic anxiety, obsession-compulsion, depression and hostility negatively influenced their partner's (i.e. the patient's) health-related quality of life. There were no partner effects of patients' emotional symptoms on the health-related quality of life of caregivers. Conclusions The results of this study suggest that patients may be particularly vulnerable to the emotional distress, i.e. thoughts, impulses and actions of their caregivers. It may be possible to improve patients' health-related quality of life by targeting specific detrimental emotional symptoms of caregivers.	[Thomson, Patricia; Andreis, Federico; Mohan, Andrea R. M.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Howie, Kate] Univ Stirling, Fac Nat Sci, Stirling, Scotland; [Leslie, Stephen J.] NHS Highland, Raigmore Hosp, Cardiac Unit, Inverness, Scotland; [Angus, Neil J.] Univ Highlands & Isl, Ctr Hlth Sci, Sch Hlth Social Care & Life Sci, Inverness, Scotland; [Thomson, Robert] Univ Glasgow, Coll Med Dent & Nursing, Glasgow, Lanark, Scotland; [Mondoa, Catherine] NHS Forth Valley, Cardiol Unit, Forth Valley Royal Hosp, Larbert, Scotland; [Chung, Misook L.] Univ Kentucky, Coll Nursing, Lexington, KY USA	University of Stirling; University of Stirling; UHI Millennium Institute; University of Glasgow; University of Kentucky	Thomson, P (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	pthomson1@virginmedia.com	Chung, Misook/AAG-2499-2021	Mohan, Andrea/0000-0003-2467-7174; thomson, robert/0000-0001-6211-962X; Angus, Neil/0000-0002-5130-6777; Thomson, Patricia/0000-0003-1039-1714	Chest Heart and Stroke Scotland (Minor Grant Award) [PT SL 13/NS/0013]	Chest Heart and Stroke Scotland (Minor Grant Award)	PT SL 13/NS/0013 Chest Heart and Stroke Scotland (Minor Grant Award) The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript	Adams J, 2012, PSYCHOSOMATICS, V53, P339, DOI 10.1016/j.psym.2011.12.002; Agren S, 2012, J CARD FAIL, V18, P359, DOI 10.1016/j.cardfail.2012.01.014; Agren S, 2011, J CARDIOVASC NURS, V26, P65, DOI 10.1097/JCN.0b013e3181ec0281; Agren S, 2010, EUR J CARDIOVASC NUR, V9, P254, DOI 10.1016/j.ejcnurse.2010.03.001; [Anonymous], 1998, NAT STAT; Auld JP, 2018, EUR J CARDIOVASC NUR, V17, P543, DOI 10.1177/1474515118759074; Ayotte BJ, 2013, PSYCHOL AGING, V28, P555, DOI 10.1037/a0032454; Banerjee T, 2014, J CARDIOVASC NURS, V29, P227, DOI 10.1097/JCN.0b013e31828b2b23; Bidwell JT, 2018, HEART LUNG, V47, P32, DOI 10.1016/j.hrtlng.2017.11.001; Bidwell JT, 2017, J CARDIOVASC NURS, V32, P372, DOI 10.1097/JCN.0000000000000350; Buck HG, 2015, EUR J CARDIOVASC NUR, V14, P79, DOI 10.1177/1474515113518434; Carstairs V., 1991, DEPRIVATION HLTH SCO; Chung ML, 2016, J CARDIOVASC NURS, V31, pE8, DOI 10.1097/JCN.0000000000000232; Chung ML, 2016, EUR J CARDIOVASC NUR, V15, P30, DOI 10.1177/1474515114535329; Chung ML, 2011, HEART LUNG, V40, P492, DOI [10.1016/j.hrtlng.2010.08.001, 10.1016/j.hrtlng.2010.11.005]; Chung ML, 2010, J CARDIOVASC NURS, V25, P411, DOI 10.1097/JCN.0b013e3181d2a58d; Chung ML, 2009, J PSYCHOSOM RES, V67, P29, DOI 10.1016/j.jpsychores.2009.01.009; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; CROOG SH, 1990, ARCH INTERN MED, V150, P1733, DOI 10.1001/archinte.150.8.1733; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; Daoud FS, 2010, EUR J PSYCHOL ASSESS, V26, P116, DOI 10.1027/1015-5759/a000016; De Jong Marla, 2005, Prog Cardiovasc Nurs, V20, P155, DOI 10.1111/j.0889-7204.2005.04649.x; De Jong MJ, 2011, HEART LUNG, V40, P393, DOI 10.1016/j.hrtlng.2011.02.002; Dekker RL, 2014, EUR J CARDIOVASC NUR, V13, P168, DOI 10.1177/1474515113519520; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Derogratis LR, 1993, BRIEF SYMPTOM INVENT; Easton K, 2016, J CARDIOVASC NURS, V31, P367, DOI 10.1097/JCN.0000000000000265; Evangelista LS, 2002, J CARD FAIL, V8, P300, DOI 10.1054/jcaf.2002.128005; FRANCIS VM, 1990, BRIT J CLIN PSYCHOL, V29, P115, DOI 10.1111/j.2044-8260.1990.tb00857.x; Garin O, 2013, QUAL LIFE RES, V22, P2675, DOI 10.1007/s11136-013-0383-z; Goodman H, 2013, INT J NURS STUD, V50, P945, DOI 10.1016/j.ijnurstu.2012.11.007; Gump BB, 1997, J PERS SOC PSYCHOL, V72, P305, DOI 10.1037/0022-3514.72.2.305; Heo S, 2005, NURS RES, V54, P265; Heo S, 2014, INT J NURS STUD, V51, P1482, DOI 10.1016/j.ijnurstu.2014.03.005; Hooker SA, 2018, EUR J CARDIOVASC NUR, V17, P102, DOI 10.1177/1474515117730184; Hooker Stephanie A, 2015, J Cardiovasc Nurs, V30, pS52, DOI 10.1097/JCN.0000000000000270; Hooley Peter J D, 2005, Congest Heart Fail, V11, P303, DOI 10.1111/j.1527-5299.2005.03620.x; Jeon YH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-77; Kellett S, 2004, CLIN PSYCHOL PSYCHOT, V11, P275, DOI 10.1002/cpp.410; Kenny D. A., 2006, DYADIC DATA ANAL; Kessing D, 2016, PSYCHOSOM MED, V78, P412, DOI 10.1097/PSY.0000000000000270; Khalil AA, 2011, ARCH PSYCHIAT NURS, V25, P419, DOI 10.1016/j.apnu.2010.12.005; KUSHNER MG, 1989, J PSYCHOSOM RES, V33, P207, DOI 10.1016/0022-3999(89)90048-2; Lee CS, 2017, EUR J CARDIOVASC NUR, V16, P595, DOI 10.1177/1474515117700760; Lee CS, 2009, EUR J CARDIOVASC NUR, V8, P259, DOI 10.1016/j.ejcnurse.2009.04.002; Lee KS, 2014, QUAL LIFE RES, V23, P1869, DOI 10.1007/s11136-014-0636-5; Lewin RJ, 2009, HEART, V95, P63, DOI 10.1136/hrt.2007.129890; Liljeroos M, 2018, EUR J CARDIOVASC NUR, V17, P527, DOI 10.1177/1474515118755721; Liljeroos M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018236; Liljeroos M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138058; Loutsiou-Ladd A, 2008, INT J TEST, V8, P90, DOI 10.1080/15305050701808680; Lum HD, 2014, HEART LUNG, V43, P306, DOI 10.1016/j.hrtlng.2014.05.002; Luttik ML, 2007, EUR J HEART FAIL, V9, P695, DOI 10.1016/j.ejheart.2007.01.006; Lyons Karen S, 2015, J Cardiovasc Nurs, V30, pS64, DOI 10.1097/JCN.0000000000000234; Martensson J, 2003, J HEART LUNG TRANSPL, V22, P460, DOI 10.1016/S1053-2498(02)00818-5; Mohammadkhani P, 2010, INT J CLIN HLTH PSYC, V10, P541; Molloy GJ, 2005, EUR J HEART FAIL, V7, P592, DOI 10.1016/j.ejheart.2004.07.008; Moser DK, 2010, HEART LUNG, V39, P378, DOI 10.1016/j.hrtlng.2009.10.017; Navidian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130973; Neumann R, 2000, J PERS SOC PSYCHOL, V79, P211, DOI 10.1037//0022-3514.79.2.211; Pereda N, 2007, PSICOTHEMA, V19, P634; Pietri G, 2004, MLHF MINNESOTA LIVIN; Pihl E, 2005, EUR J HEART FAIL, V7, P583, DOI 10.1016/j.ejheart.2004.07.016; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Pressler SJ, 2013, J CARDIOVASC NURS, V28, P417, DOI 10.1097/JCN.0b013e3182563877; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Retrum JH, 2013, J CARDIOVASC NURS, V28, P129, DOI 10.1097/JCN.0b013e3182435f27; Riegel B, 2002, NURS RES, V51, P209, DOI 10.1097/00006199-200207000-00001; Rohrbaugh MJ, 2009, HEART LUNG, V38, P298, DOI 10.1016/j.hrtlng.2008.10.008; Roser LP., 2016, THESIS; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Ryan C, 2007, PSYCHOL PSYCHOTHER-T, V80, P183, DOI 10.1348/147608306X111165; Schwannauer M, 2007, CLIN PSYCHOL PSYCHOT, V14, P221, DOI 10.1002/cpp.539; Schwarz KA, 2003, HEART LUNG, V32, P88, DOI 10.1067/mhl.2003.15; Scott LD, 2000, ADV NURS SCI, V23, P82, DOI 10.1097/00012272-200012000-00008; Sears SF, 2007, PACE, V30, P858, DOI 10.1111/j.1540-8159.2007.00773.x; Stamp KD, 2014, J CARDIOVASC NURS, V29, P517, DOI 10.1097/JCN.0000000000000097; Stas L, 2018, PERS RELATIONSHIP, V25, P103, DOI 10.1111/pere.12230; Thomson P, 2019, J CARDIOVASC NURS, V34, P250, DOI 10.1097/JCN.0000000000000553; Thomson P, 2012, PSYCHOL HEALTH MED, V17, P35, DOI 10.1080/13548506.2011.579988; Vellone E, 2014, J FAM NURS, V20, P120, DOI 10.1177/1074840713510205; Vilchinsky N, 2011, HEALTH PSYCHOL, V30, P411, DOI 10.1037/a0023453; Vongmany J, 2016, EUR J CARDIOVASC NUR, V15, P478, DOI 10.1177/1474515116635923; Wickham RE, 2012, PERS SOC PSYCHOL REV, V16, P375, DOI 10.1177/1088868312447897; Wieland J, 2012, J INTELL DISABIL RES, V56, P843, DOI 10.1111/j.1365-2788.2011.01440.x	87	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227129	10.1371/journal.pone.0227129	http://dx.doi.org/10.1371/journal.pone.0227129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5DK	31914152	gold, Green Published, Green Accepted			2022-12-26	WOS:000534337700030
J	Muthu, V; Abbai, R; Nallathambi, J; Rahman, H; Ramasamy, S; Kambale, R; Thulasinathan, T; Ayyenar, B; Muthurajan, R				Muthu, Valarmathi; Abbai, Ragavendran; Nallathambi, Jagadeeshselvam; Rahman, Hifzur; Ramasamy, Sasikala; Kambale, Rohit; Thulasinathan, Thiyagarajan; Ayyenar, Bharathi; Muthurajan, Raveendran			Pyramiding QTLs controlling tolerance against drought, salinity, and submergence in rice through marker assisted breeding	PLOS ONE			English	Article							YIELD; SALT; RESISTANCE; VARIETIES; QUALITY; STRESS; GROWTH; LOCUS; GRAIN	Increases in rice productivity are significantly hampered because of the increase in the occurrence of abiotic stresses, including drought, salinity, and submergence. Developing a rice variety with inherent tolerance against these major abiotic stresses will help achieve a sustained increase in rice production under unfavorable conditions. The present study was conducted to develop abiotic stress-tolerant rice genotypes in the genetic background of the popular rice variety Improved White Ponni (IWP) by introgressing major effect quantitative trait loci (QTLs) conferring tolerance against drought (qDTY(1.1), qDTY(2.1)), salinity (Saltol), and submergence (Sub1) through a marker assisted backcross breeding approach. Genotyping of early generation backcrossed inbred lines (BILs) resulted in the identification of three progenies, 3-11-9-2, 3-11-11-1, and 3-11-11-2, possessing all four target QTLs and maximum recovery of the recurrent parent genome (88.46%). BILs exhibited consistent agronomic and grain quality characters compared to those of IWP and enhanced performance against dehydration, salinity, and submergence stress compared with the recurrent parent IWP. BILs exhibited enhanced tolerance against salinity during germination and increased shoot length, root length, and vigor index compared to those of IWP. All three BILs exhibited reduced symptoms of injury because of salinity (NaCl) and dehydration (PEG) than did IWP. At 12 days of submergence stress, BILs exhibited enhanced survival and greater recovery, whereas IWP failed completely. BILs were found to exhibit on par grain and cooking quality characteristics with their parents. Results of this study clearly demonstrated the effects of the target QTLs in reducing damage caused by drought, salinity, and submergence and lead to the development of a triple stress tolerant version of IWP.	[Muthu, Valarmathi; Abbai, Ragavendran; Nallathambi, Jagadeeshselvam; Rahman, Hifzur; Ramasamy, Sasikala; Kambale, Rohit; Thulasinathan, Thiyagarajan; Ayyenar, Bharathi; Muthurajan, Raveendran] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore, Tamil Nadu, India	Tamil Nadu Agricultural University	Muthurajan, R (corresponding author), Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore, Tamil Nadu, India.	raveendrantnau@gmail.com	Abbai, Ragavendran/AAE-1936-2019	Abbai, Ragavendran/0000-0002-5712-910X; Muthurajan, Raveendran/0000-0002-8803-7662	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Corresponding author RM received funding support from Department of Biotechnology, Government of India, New Delhi (Grant #BT/PR13454/COE/34/43/2015).; Funding support of Department of Biotechnology, Government of India, New Delhi is acknowledged.	Shamsudin NA, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0334-0; ABDULBAK.AA, 1973, CROP SCI, V13, P630, DOI 10.2135/cropsci1973.0011183X001300060013x; Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; Ashikari M, 2015, EXPLORING POWER PLAN; Ausubel F, 2003, CURRENT PROTOCOLS MO, V3, P1994; Azeez MA, 1966, DEP AGR W PAKISTAN T, P50; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Bonilla P, 2002, PHILIPPINE AGR SCI P; Cabuslay GS, 2002, PLANT SCI, V163, P815, DOI 10.1016/S0168-9452(02)00217-0; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Chaudhary R, 1996, INT NETWORK GENETIC; Dilley M, 2005, DISAST RISK MANAGE, P1; Dixit S, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0737-2; Dixit S, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1976-3; Dixit S, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0249-1; Dixit S, 2014, VULNERABLE CHILD YOU, V9, P10, DOI 10.1080/17450128.2013.804971; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; HAMPSON CR, 1990, CAN J BOT, V68, P524, DOI 10.1139/b90-072; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Huang B, 1997, CROP SCI, V37, P1863, DOI 10.2135/cropsci1997.0011183X003700060033x; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; IRRI, 2002, STAND EV SYST RIC; Juliano B.O., 1993, GRAIN QUALITY EVALUA; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; KONGSEREE N, 1972, J AGR FOOD CHEM, V20, P714, DOI 10.1021/jf60181a020; Kumar R, 2007, FIELD CROP RES, V103, P42, DOI 10.1016/j.fcr.2007.04.013; Li Z.K., 2007, ADV MOL BREEDING DRO, P531, DOI DOI 10.1007/978-1-4020-5578-2_21; Linh LH, 2012, INT J PLANT GENOMICS, V2012; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Mishra SB, 1996, FIELD CROP RES, V46, P177, DOI 10.1016/0378-4290(95)00088-7; Munns R, 2010, METHODS MOL BIOL, V639, P371, DOI 10.1007/978-1-60761-702-0_23; Muthukumar M. SR, 2017, GREEN FARMING, V8; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; PEARSON GA, 1966, SOIL SCI, V102, P151, DOI 10.1097/00010694-196609000-00003; Platen J.D., 2013, TRANSLATIONAL GENOMI, P31; Priyadarshini S, 2013, MARKER ASSISTED INTR; Rahman H, 2018, CZECH J GENET PLANT, V54, P101, DOI 10.17221/149/2017-CJGPB; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Septiningsih EM, 2015, EUPHYTICA, V202, P259, DOI 10.1007/s10681-014-1287-x; Septiningsih EM, 2009, ANN BOT-LONDON, V103, P151, DOI 10.1093/aob/mcn206; Servin B, 2002, J HERED, V93, P214, DOI 10.1093/jhered/93.3.214; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; SIDHU JS, 1975, J AGR FOOD CHEM, V23, P1183, DOI 10.1021/jf60202a035; Singh VK, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/8319879; Subramanian M, 1986, INT RICE RES NEWSLET; Swamy BPM, 2013, BIOTECHNOL ADV, V31, P1308, DOI 10.1016/j.biotechadv.2013.05.004; Hoang TML, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6040054; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Thomson MJ, 2007, P BIOASIA 2007 6 AS, P6; Thornton P.K, 2012, IMPACTS CLIMATE CHAN; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Toledo A. M. U., 2015, Plant Breeding and Biotechnology, V3, P77, DOI 10.9787/PBB.2015.3.2.077; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Unnevehr L. J., 1985, Rice grain quality and marketing: papers presented at the International Rice Research Conference, 1-5 June 1985., P15; Valarmathi Muthu, 2019, Plant Physiology Reports, V24, P262, DOI 10.1007/s40502-019-0440-x; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Vikram P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151532; Vikram P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14799; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Visscher PM, 1996, GENETICS, V144, P1923; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Xu KN, 1996, MOL BREEDING, V2, P219, DOI 10.1007/BF00564199; Yamori W, 2013, J PLANT BIOCH PHYSL	64	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227421	10.1371/journal.pone.0227421	http://dx.doi.org/10.1371/journal.pone.0227421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910435	Green Published, Green Submitted, gold			2022-12-26	WOS:000534333800047
J	Alene, KA; Viney, K; Gray, DJ; McBryde, ES; Xu, ZH; Clements, ACA				Alene, Kefyalew Addis; Viney, Kerri; Gray, Darren J.; McBryde, Emma S.; Xu, Zuhui; Clements, Archie C. A.			Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis	PLOS ONE			English	Article							DEATH	Background Treatment outcomes among patients treated for multidrug-resistant tuberculosis (MDR-TB) are often sub-optimal. Therefore, the early prediction of poor treatment outcomes may be useful in patient care, especially for clinicians when they have the ability to make treatment decisions or offer counselling or additional support to patients. The aim of this study was to develop a simple clinical risk score to predict poor treatment outcomes in patients with MDR-TB, using routinely collected data from two large countries in geographically distinct regions. Methods We used MDR-TB data collected from Hunan Chest Hospital, China and Gondar University Hospital, Ethiopia. The data were divided into derivation (n = 343; 60%) and validation groups (n = 227; 40%). A poor treatment outcome was defined as treatment failure, lost to follow up or death. A risk score for poor treatment outcomes was derived using a Cox proportional hazard model in the derivation group. The model was then validated in the validation group. Results The overall rate of poor treatment outcome was 39.5% (n = 225); 37.9% (n = 86) in the derivation group and 40.5% (n = 139) in the validation group. Three variables were identified as predictors of poor treatment outcomes, and each was assigned a number of points proportional to its regression coefficient. These predictors and their points were: 1) history of taking second-line TB treatment (2 points), 2) resistance to any fluoroquinolones (3 points), and 3) smear did not convert from positive to negative at two months (4 points). We summed these points to calculate the risk score for each patient; three risk groups were defined: low risk (0 to 2 points), medium risk (3 to 5 points), and high risk (6 to 9 points). In the derivation group, poor treatment outcomes were reported for these three groups as 14%, 27%, and 71%, respectively. The area under the receiver operating characteristic curve for the point system in the derivation group was 0.69 (95% CI 0.60 to 0.77) and was similar to that in the validation group (0.67; 95% CI 0.56 to 0.78; p = 0.82). Conclusion History of second-line TB treatment, resistance to any fluoroquinolones, and smear non-conversion at two months can be used to estimate the risk of poor treatment outcome in patients with MDR-TB with a moderate degree of accuracy (AUROC = 0.69).	[Alene, Kefyalew Addis; Viney, Kerri; Gray, Darren J.] Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Canberra, ACT, Australia; [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alene, Kefyalew Addis; Clements, Archie C. A.] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Viney, Kerri] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [McBryde, Emma S.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia; [Xu, Zuhui] TB Control Inst Hunan Prov, Dept TB Control, Changsha, Hunan, Peoples R China	Australian National University; University of Gondar; Curtin University; Karolinska Institutet; James Cook University	Alene, KA (corresponding author), Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Canberra, ACT, Australia.; Alene, KA (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.; Alene, KA (corresponding author), Curtin Univ, Fac Hlth Sci, Perth, WA, Australia.	kefyalew.alene@telethonkids.org.au	Alene, Dr Kefyalew Addis/V-8240-2018; Clements, Archie/ABD-1615-2020; Xu, Zuhui/E-6888-2015	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; Xu, Zuhui/0000-0003-0757-2768	National Health and Medical Research Council (NHMRC) through Sidney Sax Early Career Fellowship; NHMRC Senior Research Fellowship	National Health and Medical Research Council (NHMRC) through Sidney Sax Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Kerri Viney is funded by the National Health and Medical Research Council (NHMRC) through Sidney Sax Early Career Fellowship, and Archie Clements was funded by a NHMRC Senior Research Fellowship. The funder had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript.	Acha J, 2007, INT J RES POLICY PRA, V2, P404, DOI DOI 10.1080/17441690701191610; Alene KA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4099-8; Alene KA, 2019, TRANSBOUND EMERG DIS, V66, P1611, DOI 10.1111/tbed.13188; Alene KA, 2018, J INFECTION, V77, P357, DOI 10.1016/j.jinf.2018.07.007; Alene KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197880; Alene KA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2662-8; Alene KA, 2017, TROP MED INT HEALTH, V22, P351, DOI 10.1111/tmi.12826; Atif Muhammad, 2017, BMC Infect Dis, V17, P655, DOI 10.1186/s12879-017-2746-5; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Biruck Kebede BA, 2013, HLTH FDROEMO; Chia YC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007324; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Falzon D, 2012, EUROPEAN RESP J; Jabeen K, 2015, INT J INFECT DIS, V32, P118, DOI 10.1016/j.ijid.2015.01.006; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Khanal S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167559; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lee IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154772; Lv LS, 2018, INFECT DRUG RESIST, V11, P147, DOI 10.2147/IDR.S153499; Milanov V, 2015, INT J MYCOBACT, V4, P131, DOI 10.1016/j.ijmyco.2015.03.005; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Noel G. J., 2009, CLIN MED THER, V1, DOI DOI 10.4137/CMT.S28; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sharma PC, 2009, ACTA POL PHARM, V66, P587; StataCorp, 2017, STATA STAT SOFTWARE; Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; van Hoorn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154095; Wang XM, 2017, EPIDEMIOL INFECT, V145, P1805, DOI 10.1017/S0950268817000656; WB, 2011, COUNTR INC GROUPS WO; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, GLOB TUB REP 2017; WHO, 2015, END TB STRAT GEN; Wicki J, 2000, THROMB HAEMOSTASIS, V84, P548, DOI 10.1055/s-0037-1614065; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2013, US BED TREATM MULT R; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2015, US HIGH BURD COUNTR; World Health Organization, 2013, DEFINITIONS REPORTIN	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2020	15	1							e0227100	10.1371/journal.pone.0227100	http://dx.doi.org/10.1371/journal.pone.0227100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4XM	31899769	Green Published, gold, Green Accepted			2022-12-26	WOS:000534322000013
J	Bats, ML; Bougaran, P; Peghaire, C; Gueniot, F; Abelanet, A; Chan, H; Seguy, C; Jeanningros, S; Jaspard-Vinassa, B; Couffinhal, T; Duplaa, C; Dufourcq, P				Bats, Marie-Lise; Bougaran, Pauline; Peghaire, Claire; Gueniot, Florian; Abelanet, Alice; Chan, Helene; Seguy, Camille; Jeanningros, Sylvie; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale			Therapies targeting Frizzled-7/beta-catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model	FASEB JOURNAL			English	Article						Frizzled 7; Neovascularization; OIR; Retinopathy; therapeutic target; Wnt/Frizzled signaling	WNT PATHWAY; RETINAL ANGIOGENESIS; DIABETIC-RETINOPATHY; FRIZZLED 4; EXPRESSION; ANTIBODY; PREMATURITY; JAGGED1; GROWTH; CELLS	Retinopathies remain major causes of visual impairment in diabetic patients and premature infants. Introduction of anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) has transformed therapy for these proliferative retinopathies. However, limitations associated with anti-VEGF medications require to unravel new pathways of vessel growth to identify potential drug targets. Here, we investigated the role of Wnt/Frizzled-7 (Fzd7) pathway in a mouse model of oxygen-induced retinopathy (OIR). Using transgenic mice, which enabled endothelium-specific and time-specific Fzd7 deletion, we demonstrated that Fzd7 controls both vaso-obliteration and neovascular phases (NV). Deletion of Fzd7 at P12, after the ischemic phase of OIR, prevented formation of aberrant neovessels into the vitreous by suppressing proliferation of endothelial cells (EC) in tufts. Next we validated in vitro two Frd7 blocking strategies: a monoclonal antibody (mAbFzd7) against Fzd7 and a soluble Fzd7 receptor (CRD). In vivo a single intravitreal microinjection of mAbFzd7 or CRD significantly attenuated retinal neovascularization (NV) in mice with OIR. Molecular analysis revealed that Fzd7 may act through the activation of Wnt/beta-catenin and Jagged1 expression to control EC proliferation in extra-retinal neovessels. We identified Fzd7/beta-catenin signaling as new regulator of pathological retinal NV. Fzd7 appears to be a potent pharmacological target to prevent or treat aberrant angiogenesis of ischemic retinopathies.	[Bats, Marie-Lise; Bougaran, Pauline; Peghaire, Claire; Gueniot, Florian; Abelanet, Alice; Chan, Helene; Seguy, Camille; Jeanningros, Sylvie; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale] Inserm, U1034, Biol Cardiovasc Dis, 1 Ave Magellan, F-33600 Pessac, France; [Bats, Marie-Lise; Bougaran, Pauline; Gueniot, Florian; Abelanet, Alice; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale] Univ Bordeaux, U1034, Biol Cardiovasc Dis, Bordeaux, France; [Bats, Marie-Lise] CHU Bordeaux, Serv Biochim Clin, Bordeaux, France; [Peghaire, Claire] Imperial Coll London, NHLI Vasc Sci, London, England; [Couffinhal, Thierry] CHU Bordeaux, Serv Malad Cardiaques & Vasc, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Imperial College London; CHU Bordeaux	Dufourcq, P (corresponding author), Inserm, U1034, Biol Cardiovasc Dis, 1 Ave Magellan, F-33600 Pessac, France.	pascale.dufourcq@u-bordeaux.fr	Peghaire, Claire/AAD-8112-2022; Duplàa, cecile/GLU-6264-2022; Dufourcq, Pascale/ABH-6412-2020; Couffinhal, Thierry/M-6857-2014	Peghaire, Claire/0000-0003-3304-3018; Duplàa, cecile/0000-0001-8003-3969; Dufourcq, Pascale/0000-0002-9244-1879; Bougaran, Pauline/0000-0002-4064-2388; Bats, Marie-Lise/0000-0002-8359-4662; Abelanet, Alice/0000-0001-5526-9515; Couffinhal, Thierry/0000-0002-9217-2533; Jaspard-Vinassa, Beatrice/0000-0003-1623-7742	Fondation pour la Recherche Medicale (FRM) [FRM Vision DVS20131228623, FRM DEQ20170336719]; Agence Nationale de la Recherche (ANR) [ANR-16-CE17-0001-01]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: FRM Vision DVS20131228623 and FRM DEQ20170336719; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-16-CE17-0001-01	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Bucher F, 2017, CIRCULATION, V136, P180, DOI 10.1161/CIRCULATIONAHA.116.025604; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen Q, 2017, VISION RES, V139, P47, DOI 10.1016/j.visres.2017.02.007; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Descamps B, 2012, CIRC RES, V110, P47, DOI 10.1161/CIRCRESAHA.111.250936; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Fischer MM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700090; Franco CA, 2016, ELIFE, V5, DOI 10.7554/eLife.07727; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kilani B, 2019, J THROMB HAEMOST, V17, P827, DOI 10.1111/jth.14417; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Lee K, 2012, DIABETES, V61, P2948, DOI 10.2337/db11-0300; Lobo CL, 2004, J CATARACT REFR SURG, V30, P752, DOI 10.1016/S0886-3350(03)00582-0; Messersmith W, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw371.69; Nickho H, 2017, BIOENGINEERED, V8, P501, DOI 10.1080/21655979.2016.1255383; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Peghaire C, 2016, ARTERIOSCL THROM VAS, V36, P2369, DOI 10.1161/ATVBAHA.116.307926; Phesse T, 2016, CANCERS, V8, DOI 10.3390/cancers8050050; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Riley RS, 2017, SMALL, V13, DOI 10.1002/smll.201700544; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Sagara N, 1998, BIOCHEM BIOPH RES CO, V252, P117, DOI 10.1006/bbrc.1998.9607; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schulenburg WE, 2004, BRIT J OPHTHALMOL, V88, P1500, DOI 10.1136/bjo.2004.044669; Sewduth RN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag3209; Sewduth RN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5832; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Takahashi Y, 2015, FEBS LETT, V589, P1143, DOI 10.1016/j.febslet.2015.03.010; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tojais NF, 2014, CARDIOVASC RES, V103, P291, DOI 10.1093/cvr/cvu133; Tripathi S, 2017, SCI REP-UK, V7, P1, DOI [10.1038/srep43056, 10.26700/shuri.2017.04.7.1.1]; Vincan E, 2007, ONCOGENE, V26, P2340, DOI 10.1038/sj.onc.1210026; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yoon CH, 2016, CIRCULATION, V134, P233, DOI 10.1161/CIRCULATIONAHA.116.014411; Yoon CH, 2014, J MOL CELL CARDIOL, V69, P52, DOI 10.1016/j.yjmcc.2013.12.006; Zeng CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051543; Zhou T, 2012, DIABETOLOGIA, V55, P255, DOI 10.1007/s00125-011-2314-2	59	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1288	1303		10.1096/fj.201901886R	http://dx.doi.org/10.1096/fj.201901886R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914666				2022-12-26	WOS:000507308900086
J	Cruces-Sande, M; Arcones, AC; Vila-Bedmar, R; Val-Blasco, A; Sharabi, K; Diaz-Rodriguez, D; Puigserver, P; Mayor, F; Murga, C				Cruces-Sande, Marta; Arcones, Alba C.; Vila-Bedmar, Rocio; Val-Blasco, Almudena; Sharabi, Kfir; Diaz-Rodriguez, Daniel; Puigserver, Pere; Mayor, Federico, Jr.; Murga, Cristina			Autophagy mediates hepatic GRK2 degradation to facilitate glucagon-induced metabolic adaptation to fasting	FASEB JOURNAL			English	Article						autophagy; calorie restriction; fasting; glucagon signaling; gluconeogenesis; GPCR; GRK2; intermittent fasting	RECEPTOR KINASE 2; EXOGENOUS GLUCAGON; LIVER AUTOPHAGY; RAT HEPATOCYTES; DAIRY-COWS; IN-VIVO; GLUCOSE; GLUCONEOGENESIS; INSULIN; GLUCOSE-6-PHOSPHATASE	The liver plays a key role during fasting to maintain energy homeostasis and euglycemia via metabolic processes mainly orchestrated by the insulin/glucagon ratio. We report here that fasting or calorie restriction protocols in C57BL6 mice promote a marked decrease in the hepatic protein levels of G protein-coupled receptor kinase 2 (GRK2), an important negative modulator of both G protein-coupled receptors (GPCRs) and insulin signaling. Such downregulation of GRK2 levels is liver-specific and can be rapidly reversed by refeeding. We find that autophagy, and not the proteasome, represents the main mechanism implicated in fasting-induced GRK2 degradation in the liver in vivo. Reducing GRK2 levels in murine primary hepatocytes facilitates glucagon-induced glucose production and enhances the expression of the key gluconeogenic enzyme Pck1. Conversely, preventing full downregulation of hepatic GRK2 during fasting using adenovirus-driven overexpression of this kinase in the liver leads to glycogen accumulation, decreased glycemia, and hampered glucagon-induced gluconeogenesis, thus preventing a proper and complete adaptation to nutrient deprivation. Overall, our data indicate that physiological fasting-induced downregulation of GRK2 in the liver is key for allowing complete glucagon-mediated responses and efficient metabolic adaptation to fasting in vivo.	[Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Diaz-Rodriguez, Daniel; Mayor, Federico, Jr.; Murga, Cristina] Ctr Biol Mol Severo Ochoa UAM CSIC, Dept Biol Mol, Madrid, Spain; [Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Mayor, Federico, Jr.; Murga, Cristina] Inst Invest Sanitaria La Princesa, Madrid, Spain; [Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Mayor, Federico, Jr.; Murga, Cristina] ISCIII, CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Vila-Bedmar, Rocio] URJC, Area Bioquim & Biol Mol, Dept Ciencias Basicas Salud, Madrid, Spain; [Sharabi, Kfir; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sharabi, Kfir; Puigserver, Pere] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Universidad Rey Juan Carlos; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mayor, F; Murga, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fmayor@cbm.csic.es; cristina.murga@uam.es	Arcones, Alba Concepción/ABH-8685-2020	Arcones, Alba Concepción/0000-0001-8182-4973; VAL BLASCO, ALMUDENA/0000-0001-7029-2895; Sharabi, Kfir/0000-0002-7810-6521	NIH [R01 DK089883]; MINECO [SAF2017-84125-R]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO(Spanish Government)	NIH, Grant/Award Number: R01 DK089883; MINECO, Grant/Award Number: SAF2017-84125-R	BAND GC, 1980, FEBS LETT, V119, P190, DOI 10.1016/0014-5793(80)81028-3; Bobe G, 2007, ANIM REPROD SCI, V102, P194, DOI 10.1016/j.anireprosci.2006.11.003; Bobe G, 2003, J DAIRY SCI, V86, P2895, DOI 10.3168/jds.S0022-0302(03)73886-7; Charbonneau A, 2007, J PHYSIOL-LONDON, V579, P255, DOI 10.1113/jphysiol.2006.121954; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Cipolletta E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061492; CIUDAD C, 1984, EUR J BIOCHEM, V142, P511, DOI 10.1111/j.1432-1033.1984.tb08315.x; Cruces-Sande M, 2018, BBA-MOL BASIS DIS, V1864, P3655, DOI 10.1016/j.bbadis.2018.09.027; DETER RL, 1967, J CELL BIOL, V35, pC11, DOI 10.1083/jcb.35.2.C11; Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876; Esteban-Martinez L, 2015, METHODS, V75, P79, DOI 10.1016/j.ymeth.2015.01.008; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fang F, 2019, P NATL ACAD SCI USA, V116, P7449, DOI 10.1073/pnas.1901867116; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Krilov L, 2011, EXP CELL RES, V317, P2981, DOI 10.1016/j.yexcr.2011.10.001; Lombardi MS, 2002, MOL PHARMACOL, V62, P379, DOI 10.1124/mol.62.2.379; Lucas E, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0474-6; Lucas E, 2014, BBA-MOL BASIS DIS, V1842, P2448, DOI 10.1016/j.bbadis.2014.09.004; Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042; Mayor Jr F, 2018, CELL SIGNAL, V41, P7; Miller RA, 2016, DIABETOLOGIA, V59, P1376, DOI 10.1007/s00125-016-3955-y; MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Moulis M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020014; Murga C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00112; Nafikov RA, 2006, J DAIRY SCI, V89, P1533, DOI 10.3168/jds.S0022-0302(06)72221-4; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nogues L, 2016, EBIOMEDICINE, V13, P132, DOI 10.1016/j.ebiom.2016.09.030; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Quinones M, 2019, EXPERT OPIN DRUG DIS, V14, P421, DOI 10.1080/17460441.2019.1583642; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001; Taguchi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08998-5; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Valdecantos MP, 2017, HEPATOLOGY, V65, P950, DOI 10.1002/hep.28962; Vila-Bedmar R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4374; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1; Westergaard N, 1999, ARCH BIOCHEM BIOPHYS, V366, P55, DOI 10.1006/abbi.1999.1181; Yi HQ, 2012, DIS MODEL MECH, V5, P804, DOI 10.1242/dmm.009712; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang L, 2015, J PHARMACOKINET PHAR, V42, P541, DOI 10.1007/s10928-015-9445-x; Zhu L, 2017, J CLIN INVEST, V127, P2941, DOI 10.1172/JCI92913	51	3	4	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					399	409		10.1096/fj.201901444R	http://dx.doi.org/10.1096/fj.201901444R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914606	Green Accepted, Green Published			2022-12-26	WOS:000507308900028
J	Huo, W; Li, HY; Zhang, Y; Li, H				Huo, Wei; Li, Hongyan; Zhang, Yun; Li, Hai			Epigenetic silencing of microRNA-874-3p implicates in erectile dysfunction in diabetic rats by activating the Nupr1/Chop-mediated pathway	FASEB JOURNAL			English	Article						Chop; diabetic erectile dysfunction; microRNA-874-3p; Nupr1	TRANSCRIPTION FACTORS; GLUCOSE-INTOLERANCE; DOWN-REGULATION; APOPTOSIS; MELLITUS; CELLS; NUPR1; PATHOGENESIS; METHYLATION; AUTOPHAGY	Diabetes is a global medical problem that causes many deaths every year. Complications caused by diabetes are serious and affect patients' quality of life. Diabetes mellitus erectile dysfunction (DMED) affects more than half of male diabetes patients. In this study, we determined the role of microRNA-874-3p (miR-874-3p) and nuclear protein-1 (Nupr1) in streptozocin-induced DMED rats. Control rats received equal amount of vehicle. These rats were also injected with lentiviral vector or agomir to silence or overexpress miR-874-3p or Nupr1. Apomorphine (100 mu g/kg, s.c.) was used to induce erection and time of erection was recorded. Intracavernosal and mean arterial pressure ratio (ICP/MAP) were also recorded. O2- level and concentration of thiobarbituric acid reactive substances (TBARs) were detected using lucigenin-derived chemiluminescence method and Colorimetry. Rat cavernosum tissues were collected for subsequent experiments. Cavernosum smooth muscle cells (CSMCs) were also used for in vitro experiments. Nupr1 was found highly expressed (by RT-qPCR and Western blot analysis) in cavernosum tissues from DMED rats. Nupr1 silencing improved the ICP/MAP ratio and erection time. Nupr1 silencing also reduced CSMC apoptosis (by TUNEL assay) as well as decreased O2- level and TBAR concentration. Nupr1 was targeted and inhibited by miR-874-3p (by luciferase activity and RNA immunoprecipitation assays), which was downregulated in DMED. miR-874-3p downregulation was due to increased methylation at the promoter region (methylation-specific PCR). miR-874-3p overexpression improved erection time and reduced apoptosis. In summary, miR-874-3p was downregulated which led to increased apoptosis and erectile dysfunction in DMED rats, through inhibition of Nupr1-mediated pathway. This study may also provide a new therapeutic direction for the treatment of DMED.	[Huo, Wei; Li, Hongyan; Zhang, Yun; Li, Hai] Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China	Jilin University	Li, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	lihai@jlu.edu.cn						Aambo A, 2017, TIDSSKR NOR LAEGEFOR, V137; Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Barbosa-Sampaio HC, 2015, BBA-MOL BASIS DIS, V1852, P962, DOI 10.1016/j.bbadis.2015.01.013; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Cai D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.67; Di Martino MT, 2015, ONCOTARGET, V6, P19132, DOI 10.18632/oncotarget.4302; Ding Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4080364; Gallo CBM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106409; Gandhi J, 2017, CURR DIABETES REV, V13, P573, DOI 10.2174/1573399813666161122124017; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Han Y, 2014, AM J CHINESE MED, V42, P1169, DOI 10.1142/S0192415X14500736; Hatzimouratidis K, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0545-6; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Hollern DP, 2014, MOL CELL BIOL, V34, P3229, DOI 10.1128/MCB.00737-14; Hu YG, 2017, ONCOTARGET, V8, P77219, DOI 10.18632/oncotarget.20431; Hu YY, 2017, ONCOTARGET, V8, P94554, DOI 10.18632/oncotarget.21791; Huang SY, 2015, AUTOPHAGY, V11, P2172, DOI 10.1080/15548627.2015.1106663; Jiang YZ, 2015, ARTERIOSCL THROM VAS, V35, P1317, DOI 10.1161/ATVBAHA.115.303427; Kamenov ZA, 2015, EXP CLIN ENDOCR DIAB, V123, P141, DOI 10.1055/s-0034-1394383; Kara M, 2014, MOL BIOL REP, V41, P8093, DOI 10.1007/s11033-014-3707-3; Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403; La Sala L, 2018, ACTA DIABETOL, V55, P989, DOI 10.1007/s00592-018-1149-4; LaPierre MP, 2017, MOL METAB, V6, P1010, DOI 10.1016/j.molmet.2017.06.020; Li DS, 2017, BIOMED PHARMACOTHER, V92, P888, DOI 10.1016/j.biopha.2017.05.071; Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048; Li YY, 2012, BIO-MED MATER ENG, V22, P97, DOI 10.3233/BME-2012-0694; Ma JP, 2017, CLINICS, V72, P111, DOI 10.6061/clinics/2017(02)08; Maric-Bilkan C, 2017, CLIN SCI, V131, P833, DOI 10.1042/CS20160998; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Miao CG, 2018, CAN J PHYSIOL PHARM, V96, P103, DOI 10.1139/cjpp-2017-0452; Narzt MS, 2019, REDOX BIOL, V20, P467, DOI 10.1016/j.redox.2018.11.006; Pan F, 2016, MOL GENET GENOMICS, V291, P2215, DOI 10.1007/s00438-016-1250-8; Passaglia P, 2015, VASC PHARMACOL, V74, P49, DOI 10.1016/j.vph.2015.04.002; Patel DP, 2017, SEX MED REV, V5, P288, DOI 10.1016/j.sxmr.2017.04.003; Petersen KH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207867; Sebastiani G, 2017, J ENDOCRINOL INVEST, V40, P591, DOI 10.1007/s40618-017-0611-4; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Strycharz J, 2018, CURR MED CHEM, V25, P1002, DOI 10.2174/0929867324666171107103114; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Tao ZQ, 2015, CELL BIOCHEM BIOPHYS, V73, P181, DOI 10.1007/s12013-015-0598-4; Wang SM, 2017, EPIGENETICS-US, V12, P187, DOI 10.1080/15592294.2016.1273308; Wen Y, 2019, J CELL MOL MED, V23, P3257, DOI 10.1111/jcmm.14212; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yan YY, 2017, BIOMARK MED, V11, P761, DOI 10.2217/bmm-2017-0144; Zhang JJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/595742; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V48, P348, DOI 10.1159/000491741; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V45, P419, DOI 10.1159/000486919; Zhao J, 2018, EXP NEUROL, V302, P22, DOI 10.1016/j.expneurol.2017.12.015; Zhu SB, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12416	52	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1695	1709		10.1096/fj.201902086R	http://dx.doi.org/10.1096/fj.201902086R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914690	Bronze			2022-12-26	WOS:000507308900112
J	Pierre, WC; Legault, LM; Londono, I; McGraw, S; Lodygensky, GA				Pierre, Wyston C.; Legault, Lisa-Marie; Londono, Irene; McGraw, Serge; Lodygensky, Gregory A.			Alteration of the brain methylation landscape following postnatal inflammatory injury in rat pups	FASEB JOURNAL			English	Article						DNA methylation; epigenetics; lipopolysaccharide; periventricular leukomalacia	WHITE-MATTER INJURY; DNA METHYLATION; NEONATAL EXPOSURE; DEVELOPMENTAL ORIGINS; EPIGENETIC REGULATION; HIPPOCAMPAL INJURY; MEMORY IMPAIRMENT; PRETERM BIRTH; LIPOPOLYSACCHARIDE; ALPHA	Preterm infants are vulnerable to inflammation-induced white matter injury (WMI), which is associated with neurocognitive impairment and increased risk of neuropsychiatric diseases in adulthood. Epigenetic mechanisms, particularly DNA methylation, play a role in normal development and modulate the response to pathological challenges. Our aims were to determine how WMI triggered DNA methylation alterations in brains of neonatal rats and if such changes persisted over time. We used a robust model of WMI by injecting lipopolysaccharide (LPS) or sterile saline in the corpus callosum of 3-day-old (P3) rat pups. Brains were collected 24 hours (P4) and 21 days post-injection (P24). We extracted genomic DNA from the brain to establish genome-wide quantitative DNA methylation profiles using reduced representation bisulfite sequencing. Neonatal LPS exposure induced a persistent increased methylation of genes related to nervous system development and a reduced methylation of genes associated with inflammatory pathways. These findings suggest that early-life neuroinflammatory exposure impacts the cerebral methylation landscape with determining widespread epigenetic modifications especially in genes related to neurodevelopment.	[Pierre, Wyston C.; Londono, Irene; Lodygensky, Gregory A.] Univ Montreal, CHU St Justine, Res Ctr, Dept Pediat, Montreal, PQ, Canada; [Legault, Lisa-Marie; McGraw, Serge] Univ Montreal, CHU St Justine, Res Ctr, Dept Biochem & Mol Med, Montreal, PQ, Canada; [McGraw, Serge] Univ Montreal, CHU St Justine, Res Ctr, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Lodygensky, Gregory A.] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Lodygensky, GA (corresponding author), St Justine Hosp & Res Ctr, NICU, Dept Pediat, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	ga.lodygensky@umontreal.ca	McGraw, Serge/AAN-4478-2020	McGraw, Serge/0000-0002-3504-8253; Pierre, Wyston Chadwick/0000-0002-5529-6983	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [136908]; Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 136908; Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health; Health Research	Akakpo L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3793; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Allswede DM, 2016, SCHIZOPHR RES, V172, P41, DOI 10.1016/j.schres.2016.02.022; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Braun PR, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0376-y; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Ciccarone F, 2018, MECH AGEING DEV, V174, P3, DOI 10.1016/j.mad.2017.12.002; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cruickshank MN, 2013, GENOME MED, V5, DOI 10.1186/gm500; Debnath M, 2015, NEUROSCI BIOBEHAV R, V49, P90, DOI 10.1016/j.neubiorev.2014.12.003; Degos V, 2013, ANN NEUROL, V73, P667, DOI 10.1002/ana.23868; Doherty TS, 2016, BEHAV BRAIN RES, V298, P55, DOI 10.1016/j.bbr.2015.05.028; Duke CG, 2017, LEARN MEMORY, V24, P278, DOI 10.1101/lm.045112.117; Everson TM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42654-4; Fan LW, 2008, EUR J NEUROSCI, V27, P1475, DOI 10.1111/j.1460-9568.2008.06121.x; Fan LW, 2011, BRAIN BEHAV IMMUN, V25, P286, DOI 10.1016/j.bbi.2010.09.020; Fan LW, 2009, EXP NEUROL, V220, P143, DOI 10.1016/j.expneurol.2009.08.003; Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008; Frost PS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1529-x; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grova N, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/2085496; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guevara E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00358; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Halder R, 2016, NAT NEUROSCI, V19, P102, DOI 10.1038/nn.4194; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Heinonen K, 2015, PEDIATRICS, V135, pE818, DOI 10.1542/peds.2014-3556; Hodgson K, 2017, J NEUROSCI, V37, P4735, DOI 10.1523/JNEUROSCI.0177-17.2017; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Ianov L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00249; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Karlsson L, 2019, J ENDOCR SOC, V3, P250, DOI 10.1210/js.2018-00377; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kim-Ha J, 2016, BMB REP, V49, P671, DOI 10.5483/BMBRep.2016.49.12.184; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lardenoije R, 2015, PROG NEUROBIOL, V131, P21, DOI 10.1016/j.pneurobio.2015.05.002; Leenen FAD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0256-8; Legault LM, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3171; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; Lister R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00252; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lodygensky GA, 2010, BRAIN BEHAV IMMUN, V24, P759, DOI 10.1016/j.bbi.2009.11.005; Lodygensky GA, 2005, PEDIATRICS, V116, P1, DOI 10.1542/peds.2004-1275; Lodygensky GA, 2014, PEDIATR RES, V75, P415, DOI 10.1038/pr.2013.242; Lussier AA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00610; Magnus N, 2014, P NATL ACAD SCI USA, V111, P3544, DOI 10.1073/pnas.1314118111; McCoy CR, 2016, EUR J NEUROSCI, V44, P2829, DOI 10.1111/ejn.13404; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Monson BB, 2016, JAMA PEDIATR, V170, P772, DOI 10.1001/jamapediatrics.2016.0781; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pierre WC, 2017, BRAIN BEHAV IMMUN, V59, P333, DOI 10.1016/j.bbi.2016.08.018; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Rahimi S, 2019, HUM REPROD, V34, P851, DOI 10.1093/humrep/dez036; Ramachandra R., 2011, ATLAS NEONATAL RAT B; Rauscher GH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1777-9; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shinozaki G, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00311; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Smith ZD, 2017, NATURE, V549, P543, DOI 10.1038/nature23891; Sparrow S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.210; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Tan QH, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0518-8; Tartaglione AM, 2016, CURR TOP BEHAV NEURO, V29, P231, DOI 10.1007/7854_2015_416; Thompson DK, 2014, HUM BRAIN MAPP, V35, P4129, DOI 10.1002/hbm.22464; Thornton C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/506320; Tien LT, 2013, TOXICOLOGY, V308, P96, DOI 10.1016/j.tox.2013.03.014; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; van Vliet EOG, 2013, JAMA PEDIATR, V167, P662, DOI 10.1001/jamapediatrics.2013.1199; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Weng YL, 2016, EPIGENOMICS-UK, V8, P1429, DOI 10.2217/epi-2016-0058; Whidden L, 2016, HUM MOL GENET, V25, P4649, DOI 10.1093/hmg/ddw293; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Wischhof L, 2015, PROG NEURO-PSYCHOPH, V57, P17, DOI 10.1016/j.pnpbp.2014.10.004; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xu XG, 2015, ONCOTARGET, V6, P13925, DOI 10.18632/oncotarget.4215; Yin P, 2013, EPILEPSY BEHAV, V27, P9, DOI 10.1016/j.yebeh.2012.12.015; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	94	10	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					432	445		10.1096/fj.201901461R	http://dx.doi.org/10.1096/fj.201901461R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914673	Green Published, hybrid			2022-12-26	WOS:000507308900030
J	Wang, K; Xu, FH; Campbell, SP; Hart, KD; Durham, T; Maylie, J; Xu, J				Wang, Kang; Xu, Fuhua; Campbell, Shawn P.; Hart, Kyle D.; Durham, Tyler; Maylie, James; Xu, Jing			Rapid actions of anti-Mullerian hormone in regulating synaptic transmission and long-term synaptic plasticity in the hippocampus	FASEB JOURNAL			English	Article						anti-Mullerian hormone receptor 2; cognitive development; cognitive function; electrophysiological recording; postsynaptic modulation	INHIBITING SUBSTANCE; POTENTIATION; EXCITABILITY; CONTRIBUTES; EXPRESSION; RECEPTORS; MECHANISM; DELIVERY; BRAIN; CA2+	Anti-Mullerian hormone (Amh) is a peptide factor that is known to regulate sexual differentiation and gonadal function in mammals. Although Amh is also suggested to be associated with cognitive development and function in the postnatal brain, little is known about its expression or direct effects on neuronal activities in the hippocampus. Therefore, we assessed Amh and its receptor expression in the hippocampus of male and female mice using PCR, Western blot, and immunofluorescence staining. While Amh-specific receptor expression was comparable between males and females, mRNA and protein levels of Amh were higher in females than those of males. Electrophysiological recordings on acute hippocampal slices showed that exogenous Amh protein addition increased synaptic transmission and long-term synaptic plasticity at the Cornu Ammonis (CA) 3-CA1 synapses. Amh exposure also increased the excitatory postsynaptic potential at CA1 synapses. Our findings support direct and rapid actions of Amh as a paracrine and/or autocrine factor in regulating hippocampal neuronal activities. Data provide functional evidence of Amh-mediated postsynaptic modulation of synaptic transmission and Amh-regulated long-term synaptic plasticity in the hippocampus. These results suggest a potential role of Amh in learning and memory, and a possible cause of the sex differences in cognitive development and function.	[Wang, Kang; Xu, Fuhua; Campbell, Shawn P.; Hart, Kyle D.; Maylie, James; Xu, Jing] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Durham, Tyler; Xu, Jing] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Xu, J (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mayliej@ohsu.edu; xujin@ohsu.edu	Wang, Kang/AAE-1168-2019; Jing, Xu/AAF-2502-2020	Wang, Kang/0000-0002-4563-7385; Xu, Jing/0000-0003-1116-6631	HHS | National Institutes of Health (NIH) [P51OD011092, R01HD082208]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: P51OD011092 and R01HD082208	Bedussi B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00861-x; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Cabrera-Socorro A, 2006, EUR J NEUROSCI, V23, P2109, DOI 10.1111/j.1460-9568.2006.04750.x; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cimino I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10055; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Harden CL, 2016, EPILEPSY RES, V127, P66, DOI 10.1016/j.eplepsyres.2016.08.003; Hayata T, 2018, GENES CELLS, V23, P345, DOI 10.1111/gtc.12575; Josso N, 1998, MOL CELL ENDOCRINOL, V145, P3, DOI 10.1016/S0303-7207(98)00186-5; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Lebeurrier N, 2008, J CELL SCI, V121, P3357, DOI 10.1242/jcs.031872; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; Lim NKH, 2018, JOVE-J VIS EXP, DOI 10.3791/56774; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lopez-Ramos JC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.005; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Morgan K, 2017, ENDOCRINE, V57, P528, DOI 10.1007/s12020-017-1333-2; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Nelson SM, 2018, FERTIL STERIL, V110, pE106, DOI 10.1016/j.fertnstert.2018.07.321; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Pankhurst MW, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.72; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Renner MC, 2017, ELIFE, V6, DOI 10.7554/eLife.25462; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Wang PY, 2009, P NATL ACAD SCI USA, V106, P7203, DOI 10.1073/pnas.0902253106; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu J, 2005, MOL HUM REPROD, V11, P151, DOI 10.1093/molehr/gah157; Xu J, 2016, J ASSIST REPROD GEN, V33, P1665, DOI 10.1007/s10815-016-0804-3; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	38	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					706	719		10.1096/fj.201902217R	http://dx.doi.org/10.1096/fj.201902217R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914642	Green Accepted			2022-12-26	WOS:000507308900049
J	de Almeida, TR; Alix, M; Le Cam, A; Klopp, C; Montfort, J; Toomey, L; Ledor, Y; Bobe, J; Chardard, D; Schaerlinger, B; Fontaine, P				de Almeida, Taina Rocha; Alix, Maud; Le Cam, Aurelie; Klopp, Christophe; Montfort, Jerome; Toomey, Lola; Ledor, Yannick; Bobe, Julien; Chardard, Dominique; Schaerlinger, Berenice; Fontaine, Pascal			Domestication may affect the maternal mRNA profile in unfertilized eggs, potentially impacting the embryonic development of Eurasian perch (Perca fluviatilis)	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; REPRODUCTIVE-CYCLE; PREIMPLANTATION EMBRYOS; MICROSATELLITE LOCI; ATLANTIC SALMON; CIRCADIAN GENES; EXPRESSION; WILD; L.; PERFORMANCE	Domestication is an evolutionary process during which we expect populations to progressively adapt to an environment controlled by humans. It is accompanied by genetic and presumably epigenetic changes potentially leading to modifications in the transcriptomic profile in various tissues. Reproduction is a key function often affected by this process in numerous species, regardless of the mechanism. The maternal mRNA in fish eggs is crucial for the proper embryogenesis. Our working hypothesis is that modifications of maternal mRNAs may reflect potential genetic and/or epigenetic modifications occurring during domestication and could have consequences during embryogenesis. Consequently, we investigated the trancriptomic profile of unfertilized eggs from two populations of Eurasian perch. These two populations differed by their domestication histories (F1 vs. F7+-at least seven generations of reproduction in captivity) and were genetically differentiated (F-ST = 0.1055, p<0.05). A broad follow up of the oogenesis progression failed to show significant differences during oogenesis between populations. However, the F1 population spawned earlier with embryos presenting an overall higher survivorship than those from the F7+ population. The transcriptomic profile of unfertilized eggs showed 358 differentially expressed genes between populations. In conclusion, our data suggests that the domestication process may influence the regulation of the maternal transcripts in fish eggs, which could in turn explain differences of developmental success.	[de Almeida, Taina Rocha; Alix, Maud; Toomey, Lola; Ledor, Yannick; Chardard, Dominique; Schaerlinger, Berenice; Fontaine, Pascal] Univ Lorraine, INRA, UR AFPA, Nancy, France; [Le Cam, Aurelie; Montfort, Jerome; Bobe, Julien] INRA, LPGP, UR Fish Physiol & Genom 1037, Rennes, France; [Klopp, Christophe] INRA, Sigenae, MIAT, Toulouse, France	INRAE; Universite de Lorraine; INRAE; INRAE	Schaerlinger, B (corresponding author), Univ Lorraine, INRA, UR AFPA, Nancy, France.	berenice.schaerlinger@univ-lorraine.fr	Alix, Maud/W-2377-2019; Klopp, Christophe/J-3164-2019; Schaerlinger, Berenice/AAU-8024-2021	Alix, Maud/0000-0002-2365-9188; Klopp, Christophe/0000-0001-7126-5477; Toomey, Lola/0000-0001-7060-6698; Schaerlinger, Berenice/0000-0002-7449-2752	French National Research Agency ANR [ANR-13-BSV7-0015]; INRA PHASE department; Lorraine Region; Brazilian National Council for Scientific and Technological Development (CNPq) [233389/2014-8]; French Ministry of Research	French National Research Agency ANR(French National Research Agency (ANR)); INRA PHASE department; Lorraine Region(Region Grand-Est); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the French National Research Agency ANR - http://www.agence-nationale-recherche.fr/(Maternal Legacy ANR-13-BSV7-0015 to JB) and by the INRA PHASE department (http://www.phase.inra.fr/) and Lorraine Region. TRA's fellowship was provided by the Brazilian National Council for Scientific and Technological Development - http://www.cnpq.br/(CNPq -233389/2014-8). MA and LT's fellowships were provided by the French Ministry of Research (http://www.enseignementsup-recherche.gouv.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulfatah A, 2011, AQUACULTURE, V322, P169, DOI 10.1016/j.aquaculture.2011.09.002; Alix M, 2017, J ZOOL, V302, P126, DOI 10.1111/jzo.12447; Alix M, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0033-3; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Amano T, 2010, ANIM REPROD SCI, V121, P225, DOI 10.1016/j.anireprosci.2010.05.020; Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; Anastasiadi D, 2019, MOL BIOL EVOL; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Beaumont C, 2002, PROD ANIM, V15, P343; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Ben Ammar I, 2015, FISH PHYSIOL BIOCHEM, V41, P345, DOI 10.1007/s10695-014-9987-7; Ben Khadher S, 2016, AQUACULT REP, V3, P136, DOI 10.1016/j.aqrep.2015.12.003; Ben Khadher S, 2015, J GREAT LAKES RES, V41, P846, DOI 10.1016/j.jglr.2015.04.006; Bicskei B, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0200-6; Bicskei B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-884; Borer SO, 1999, MOL ECOL, V8, P336; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Castets MD, 2012, THERIOGENOLOGY, V78, P432, DOI 10.1016/j.theriogenology.2012.02.023; Cavanaugh JE, 2019, WIRES COMPUT STAT, V11, DOI 10.1002/wics.1460; Lanes CFC, 2013, MAR BIOTECHNOL, V15, P677, DOI 10.1007/s10126-013-9527-y; Christie MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10676; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Daugaard M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3180; Dekens MPS, 2003, DEVELOPMENT, V130, P3907, DOI 10.1242/dev.00606; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Farquharson KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03500-9; Gabe M, 1968, TECHNIQUES HISTOLOGI, Vvi, P1113; Gavery MR, 2018, G3-GENES GENOM GENET, V8, P3723, DOI 10.1534/g3.118.200458; GILLET C, 1995, HYDROBIOLOGIA, V300, P409, DOI 10.1007/BF00024482; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hollstein R, 2015, J MED GENET, V52, P797, DOI 10.1136/jmedgenet-2015-103344; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Iimura A, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0132-y; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khendek A, 2017, AQUACULTURE, V473, P206, DOI 10.1016/j.aquaculture.2017.02.003; Kimelman D, 2012, WIRES DEV BIOL, V1, P253, DOI 10.1002/wdev.25; Krist'an J, 2012, TURK J FISH AQUAT SC, V12, P191, DOI 10.4194/1303-2712-v12_2_01; Laing KJ, 2011, DEV COMP IMMUNOL, V35, P1282, DOI 10.1016/j.dci.2011.03.004; Lanes CFC, 2012, AQUACULTURE, V324, P267, DOI 10.1016/j.aquaculture.2011.10.036; Le Luyer J, 2017, P NATL ACAD SCI USA, V114, P12964, DOI 10.1073/pnas.1711229114; Leclerc D, 2000, MOL ECOL, V9, P995, DOI 10.1046/j.1365-294x.2000.00939-3.x; Li L, 2007, MOL ECOL NOTES, V7, P600, DOI 10.1111/j.1471-8286.2006.01645.x; Lund I., 2008, Aquaculture Nutrition, V14, P544, DOI 10.1111/j.1365-2095.2007.00560.x; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Migaud H, 2004, AQUACULTURE, V241, P561, DOI 10.1016/j.aquaculture.2004.07.031; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Mohammadi R, 2019, XENOTRANSPLANTATION, V26; Mommens M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-829; Overton JL., 2015, BIOL CULTURE PERCID, P881, DOI DOI 10.1007/978-94-017-7227-3; Ozerov MY, 2018, G3-GENES GENOM GENET, V8, P3737, DOI 10.1534/g3.118.200768; Partula S, 1999, FISH SHELLFISH IMMUN, V9, P241, DOI 10.1006/fsim.1998.0190; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; QURESHI S, 2015, BIOL CULTURE PERCID, P103, DOI DOI 10.1007/978-94-017-7227-3_3; R Core Team, 2020, R LANG ENV STAT COMP; Razaghi B, 2018, DEV DYNAM, V247, P289, DOI [10.1002/DVDY.24600, 10.1002/dvdy.24600]; Rinchard J, 1996, J FISH BIOL, V49, P883, DOI 10.1111/j.1095-8649.1996.tb00087.x; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Schaerlinger B, 2015, BIOL CULTURE PERCID, P193, DOI [10.1007/978-94-017-7227-3_6, DOI 10.1007/978-94-017-7227-3_6]; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; Steenfeldt S, 2015, BIOL CULTURE PERCID, P817, DOI DOI 10.1007/978-94-017-7227-3_32; Stepien CA., 2015, BIOL CULTURE PERCID, P3; Sulistyo I, 1998, AQUAT LIVING RESOUR, V11, P101, DOI 10.1016/S0990-7440(98)80066-1; Takada H, 2009, DEVELOPMENT, V136, P2413, DOI 10.1242/dev.029165; Teletchea F, 2014, FISH FISH, V15, P181, DOI 10.1111/faf.12006; van der Waaij EH, 2004, J ANIM SCI, V82, P973; Vogt G, 2017, ENVIRON EPIGENETICS, V3, DOI 10.1093/eep/dvx002; Wang N, 2010, REV AQUACULT, V2, P209, DOI 10.1111/j.1753-5131.2010.01037.x; Wirth T, 1999, MOL ECOL, V8, P1960, DOI 10.1046/j.1365-294x.1999.00778-3.x; Yeates SE, 2014, EVOL APPL, V7, P493, DOI 10.1111/eva.12148; Zarski D, 2012, J APPL ICHTHYOL, V28, P967, DOI 10.1111/jai.12098; Zarski D, 2017, MAR BIOTECHNOL, V19, P102, DOI 10.1007/s10126-017-9732-1; Zarski D, 2011, REPROD BIOL, V11, P194; Zarski D, 2011, AQUACULTURE, V313, P84, DOI 10.1016/j.aquaculture.2011.01.032; Zupa R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169645	82	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226878	10.1371/journal.pone.0226878	http://dx.doi.org/10.1371/journal.pone.0226878			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891603	Green Submitted, gold, Green Published			2022-12-26	WOS:000515096600040
J	Huizinga, P; Kluytmans-van den Bergh, M; Rossen, JW; Willemsen, I; Verhulst, C; Savelkoul, PHM; Friedrich, AW; Garcia-Cobos, S; Kluytmans, J				Huizinga, Pepijn; Kluytmans-van den Bergh, Marjolein; Rossen, John W.; Willemsen, Ina; Verhulst, Carlo; Savelkoul, Paul H. M.; Friedrich, Alexander W.; Garcia-Cobos, Silvia; Kluytmans, Jan			Decreasing prevalence of contamination with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in retail chicken meat in the Netherlands	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; ODDS RATIO; BACTEREMIA; VIRULENCE; STRAINS; HUMANS; RISK; FOOD; PLASMIDS	Retail chicken meat is a potential source of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). In the past decade, vast national efforts were undertaken to decrease the antibiotic use in the veterinary sector, resulting in a 58% decrease in antibiotic sales in the sector between 2009 and 2014. This decrease in antibiotic use was followed by a decrease in ESBL-E prevalence in broilers. The current study investigates the prevalence of contamination with ESBL-E in retail chicken meat purchased in the Netherlands between December 2013 and August 2015. It looks at associations between the prevalence of contamination with ESBL-E and sample characteristics such as method of farming (free-range or conventional), supermarket chain of purchase and year of purchase. In the current study, 352 chicken meat samples were investigated for the presence of ESBL-E using selective culture methods. Six samples were excluded due to missing isolates or problems obtaining a good quality sequence leaving 346 samples for further analyses. Of these 346 samples, 188 (54.3%) were positive for ESBL-E, yielding 216 ESBL-E isolates (Escherichia colt (n = 204), Klebsiella pneumoniae (n = 11) and Escherichia fergusonii (n = 1)). All ESBL-E isolates were analysed using whole-genome sequencing. The prevalence of contamination with ESBL-E in retail chicken meat decreased from 68.3% in 2014 to 44.6% in 2015, absolute risk difference 23.7% (95% confidence interval (CI): 12.6% - 34.1%). The ESBL-E prevalence was lower in free-range chicken meat (36.4%) compared with conventional chicken meat (61.5%), absolute risk difference 25.2% (95% CI: 12.9% - 36.5%). The prevalence of contamination with ESBL-E varied between supermarket chains, the highest prevalence of contamination was found in supermarket chain 4 (76.5%) and the lowest in supermarket chain 1 (37.8%). Pairwise isolate comparisons using whole-genome multilocus sequence typing (wgMLST) showed that clustering of isolates occurs more frequently within supermarket chains than between supermarket chains. In conclusion, the prevalence of contamination with ESBL-E in retail chicken in the Netherlands decreased over time; nevertheless, it remains substantial and as such a potential source for ESBL-E in humans.	[Huizinga, Pepijn; Kluytmans-van den Bergh, Marjolein; Willemsen, Ina; Verhulst, Carlo; Kluytmans, Jan] Amphia Hosp, Dept Infect Control, Breda, Netherlands; [Huizinga, Pepijn] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Kluytmans-van den Bergh, Marjolein] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein; Kluytmans, Jan] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rossen, John W.; Friedrich, Alexander W.; Garcia-Cobos, Silvia] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, Caphri Sch Publ Hlth & Primary Care, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Savelkoul, Paul H. M.] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Garcia-Cobos, Silvia] Inst Hlth Carlos III, Natl Microbiol Ctr, Reference & Res Lab Antimicrobial Resistance & He, Madrid, Spain	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Utrecht University; Utrecht University Medical Center; University of Groningen; Maastricht University; Vrije Universiteit Amsterdam	Huizinga, P (corresponding author), Amphia Hosp, Dept Infect Control, Breda, Netherlands.; Huizinga, P (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	pepijnhuizinga@gmail.com	Friedrich, Alex/ABG-9823-2020; van den Bergh, Marjolein Kluytmans -/A-7267-2016; GARCIA-COBOS, SILVIA/A-7087-2017; Rossen, John W. A./G-7564-2011	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; GARCIA-COBOS, SILVIA/0000-0002-1417-5691; Rossen, John W. A./0000-0002-7167-8623	Amphia Hospital and the medical specialist company Amphia; Interreg IVa-funded projects "EurSafety Health-Net; European Commission, German Ministry of Economic Affairs, Energy and Industry of the State of North Rhine-Westphalia; German Ministry for Economic Affairs, Labour, Transport and Digitalisation of the State of Lower Saxony; Dutch Provinces of Overijssel, Gelderland; AWF - Wellcome Trust	Amphia Hospital and the medical specialist company Amphia; Interreg IVa-funded projects "EurSafety Health-Net; European Commission, German Ministry of Economic Affairs, Energy and Industry of the State of North Rhine-Westphalia; German Ministry for Economic Affairs, Labour, Transport and Digitalisation of the State of Lower Saxony; Dutch Provinces of Overijssel, Gelderland; AWF - Wellcome Trust	Part of the sequence data were generated and reused from the Dutch Food & Nutrition Delta Programme 2013 project PathoDetect. Received by: PS. This study was also partially funded by the Amphia Hospital and the medical specialist company Amphia (MSB-A), Breda, the Netherlands. Received by: PH. This study was also partly supported by the Interreg IVa-funded projects "EurSafety Health-Net -EURegional network for patient safety and protection against infections" and "SafeGuard", as part of a Dutch-German cross-border network supported by the European Commission, German Ministry of Economic Affairs, Energy and Industry of the State of North Rhine-Westphalia, and German Ministry for Economic Affairs, Labour, Transport and Digitalisation of the State of Lower Saxony, and the Dutch Provinces of Overijssel, Gelderland, and Limburg. Received by: JR, AWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication made use of the PubMLST website (https://pubmlst.org/) developed by Keith Jolley and sited at the University of Oxford [59]. The development of that website was funded by the Wellcome Trust.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alikhan NF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007261; Beghain J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000192; Bergevoet RHM, 2019, EC ANTIBIOTIC USAGE; Borjesson S, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-3; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cassini A., 2018, LANCET INFECT DIS, V5, P1, DOI DOI 10.1016/S1473-3099(18)30605-4; Ceccarelli D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00076; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Davis GS, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1322-5; Denis B, 2015, INT J INFECT DIS, V39, P1, DOI 10.1016/j.ijid.2015.07.010; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; Ellen H, 2012, LIVESTOCK RES LELYST; European Centre for Disease Prevention and Control (ECDC), 2015, ANT RES SURV EUR 201; European Committee on Antimicrobial Susceptibility Testing, 2017, GUID DET RES MECH SP; Hayashi W, 2018, INT J FOOD MICROBIOL, V284, P98, DOI 10.1016/j.ijfoodmicro.2018.08.003; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jouini A, 2013, J FOOD PROTECT, V76, P323, DOI 10.4315/0362-028X.JFP-12-251; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, V53, P2709, DOI 10.1128/JCM.01251-15; Kluytmans-van den Bergh MFQ, 2016, J CLIN MICROBIOL, V54, P2919, DOI 10.1128/JCM.01648-16; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liu CM, 2018, MBIO, V9, DOI 10.1128/mBio.00470-18; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Ludden C, 2020, CLIN INFECT DIS, V70, P219, DOI 10.1093/cid/ciz174; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Mevius DJ, 2014, MONITORING ANTIMICRO; Miranda JM, 2008, FOOD CONTROL, V19, P412, DOI 10.1016/j.foodcont.2007.05.002; Muloi D, 2018, FOODBORNE PATHOG DIS, V15, P467, DOI 10.1089/fpd.2017.2411; Netherlands Society for Medical Microbiology, 2012, NVMM GUID LAB DET HI; Nielsen, 2017, MARK FIN; Overdevest ITMA, 2011, J CLIN MICROBIOL, V49, P519, DOI 10.1128/JCM.01953-10; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pelt van W, 2019, EUROSURVEILLANCE; Rottier WC, 2018, CLIN MICROBIOL INFEC, V24, P1315, DOI 10.1016/j.cmi.2018.03.023; Rottier WC, 2015, CLIN INFECT DIS, V60, P1622, DOI 10.1093/cid/civ121; Rottier WC, 2012, J ANTIMICROB CHEMOTH, V67, P1311, DOI 10.1093/jac/dks065; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Stobberingh EE, 1999, INFECTION, V27, P348, DOI 10.1007/s150100050041; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Terluin I, 2017, VLEESCONSUMPTIE HOOF; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MICS; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Tumbarello M, 2010, ANTIMICROB AGENTS CH, V54, P4085, DOI 10.1128/AAC.00143-10; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Veldman K., 2018, MONITORING ANTIMICRO; Veldman K., 2017, MONITORING ANTIMICRO; Veldman K, 2015, MONITORING ANTIMICRO; Veldman K, 2014, INT J FOOD MICROBIOL, V177, P72, DOI 10.1016/j.ijfoodmicro.2014.02.014; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	58	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226828	10.1371/journal.pone.0226828	http://dx.doi.org/10.1371/journal.pone.0226828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891609	gold, Green Published			2022-12-26	WOS:000515096600033
J	Roro, M; Deressa, W; Lindtjorn, B				Roro, Meselech; Deressa, Wakgari; Lindtjorn, Bernt			Intrauterine growth patterns in rural Ethiopia compared with WHO and INTERGROWTH-21st growth standards: A community-based longitudinal study	PLOS ONE			English	Article							FETAL-GROWTH; IN-UTERO; WEIGHT; RESTRICTION; CHARTS; HEALTH; HEAD; AGE	Introduction Children's well-being is highly influenced by their fetal growth. Adequate intrauterine growth (IUG) is a basic feature of a healthy pregnancy. The aim of our study was to assess IUG patterns in a rural and drought-affected population in the Rift Valley area of the Adami Tullu district in Oromia, Ethiopia. Methods We conducted a longitudinal, community-based study of IUG patterns utilizing serial ultrasound measurements. Data were collected for 17 months, from July 2016 to November 2017. We included 675 singleton foetuses <= 24 weeks old, based on ultrasound-derived estimates of gestational age, and followed them until delivery. We obtained head circumference, biparietal diameter, abdominal circumference, femur length, and estimated fetal weight at 26, 30, and 36 weeks. Fetal weight was estimated using the Hadlock algorithm, and the 5th, 10th, 25th, 50th, 75th, 90th, and 95tH centiles were developed from this model. We compared the biometric measurements and fetal weight data from our study to the World Health Organization (WHO) and INTERGROWTH-21st fetal growth reference standards. Results Distribution of the biometric measurements and estimated fetal weights in our study were similar to those for the WHO and INTERGROWTH-21st references. Most measurements were between-2 and +2 of the reference z-scores. Based on the smoothed percentiles, the 5th, 50th, and percentiles of our study had similar distribution patterns to the WHO chart, and the 50th percentile had a similar pattern to the INTERGROWTH-21st chart. Conclusions Our study determined fetal growth patterns in a drought-affected rural community of Ethiopia using common ultrasound biometric measurements. We found similar IUG patterns to those indicated in the WHO and INTERGROWTH-21st fetal growth reference standards.	[Roro, Meselech; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Roro, Meselech] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Deressa, Wakgari] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia	University of Bergen; Addis Ababa University; Addis Ababa University	Roro, M (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Roro, M (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia.	meselua@yahoo.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	University of Bergen in Norway; Research Council of Norway [220554]	University of Bergen in Norway; Research Council of Norway(Research Council of Norway)	This study was funded by University of Bergen in Norway and the Research Council of Norway (project number: 220554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) received no specific funding for this work.	[Anonymous], 2012, GUID MAN MOD AC MALN; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Deressa W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1154-2; Gari T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170898; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; HADLOCK FP, 1984, RADIOLOGY, V152, P497, DOI 10.1148/radiology.152.2.6739822; IFRC, 2016, ETH DROUGHT EM PLAN, P5; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kiserud T, 2018, AM J OBSTET GYNECOL, V218, pS619, DOI 10.1016/j.ajog.2017.12.010; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; Lausman A, 2013, J OBSTET GYNAECOL CA, V35, P741, DOI 10.1016/S1701-2163(15)30865-3; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Nyberg David A, 2003, DIAGNOSTIC IMAGING F; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Rehana AS, 2015, AFR HEALTH SCI, V15, P532, DOI 10.4314/ahs.v15i2.28; Schmiegelow C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044773; SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; The American Academy of Cardiology, 2017, HIGH BLOOD PRESS HYP; Trish C, 2004, OBSTET ULTRASOUND WH; University of Oxford, 2017, INT FET GROWTH STAND; Ververs Mija-Tesse, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.54a8b618c1bc031ea140e3f2934599c8; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wado YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096304; WHO, REC INT IMPR PRET BI; Wong Lufee, 2018, Australas J Ultrasound Med, V21, P161, DOI 10.1002/ajum.12091; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2004, INT STAT CLASS DIS R; World Health Organization (WHO), 2010, MED EL CRIT CONTR US; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226881	10.1371/journal.pone.0226881	http://dx.doi.org/10.1371/journal.pone.0226881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891599	gold, Green Published			2022-12-26	WOS:000515096600041
J	Bonsaksen, T; Thorrisen, MM; Skogen, JC; Aas, RW				Bonsaksen, Tore; Thorrisen, Mikkel Magnus; Skogen, Jens Christoffer; Aas, Randi Wago			Who reported having a high-strain job, low-strain job, active job and passive job? The WIRUS Screening study	PLOS ONE			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; CONTROL-SUPPORT MODEL; SICKNESS ABSENCE; SHIFT WORK; MENTAL-DISORDERS; RISK-FACTORS; HEALTH; POPULATION; DEMAND; PREDICTORS	Objective The Job Demands and Control model classifies job types as active, passive, low-strain or high-strain, based on a combination of job demands and control. While studies have shown high-strain jobs to have adverse consequences for health and work participation, prognostic factors for the four job types have been less explored. The aim of this study was to assess the associations between sociodemographic factors and job descriptors and being in high-strain, low-strain, active and passive jobs. Methods The WIRUS Screening study targeted Norwegian employees in private and public enterprises. In this study, associations with job types among 4,487 employees were investigated with binary logistic regression analyses, adjusting for sociodemographic and job-related variables. Results In fully adjusted models, high-strain job was associated with female gender; lower education; shift work; and doing work outside the workplace. Low-strain job was associated with opposite scores on the same variables, and with lower job position. Active job was associated with lower age; female gender; higher levels of education; higher job position level; shift work; and not doing work outside the workplace. Passive job was associated with opposite scores on the same variables. Conclusions The study corroborates the role gender and education have for experiencing the job, and expands on existing knowledge on the role of job position and irregular working hours and spaces. By identifying factors associated with job types, the prevention of health problems and work disability may become be more targeted.	[Bonsaksen, Tore; Thorrisen, Mikkel Magnus; Aas, Randi Wago] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Occupat Therapy Prosthet & Orthot, Oslo, Norway; [Bonsaksen, Tore] VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway; [Thorrisen, Mikkel Magnus; Skogen, Jens Christoffer; Aas, Randi Wago] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Skogen, Jens Christoffer] Norwegian Inst Publ Hlth, Dept Hlth Promot, Bergen, Norway; [Skogen, Jens Christoffer] Stavanger Univ Hosp, Alcohol & Drug Res, Stavanger, Norway; [Aas, Randi Wago] Presenter Making Sense Sci, Stavanger, Norway	Oslo Metropolitan University (OsloMet); VID Specialised University; Universitetet i Stavanger; Norwegian Institute of Public Health (NIPH); Stavanger University Hospital	Bonsaksen, T; Aas, RW (corresponding author), OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Occupat Therapy Prosthet & Orthot, Oslo, Norway.; Bonsaksen, T (corresponding author), VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway.; Aas, RW (corresponding author), Univ Stavanger, Fac Hlth Sci, Stavanger, Norway.; Aas, RW (corresponding author), Presenter Making Sense Sci, Stavanger, Norway.	tore.bonsaksen@oslomet.no; randi.aas@uis.no	Aas, Randi/GLN-3123-2022; Bonsaksen, Tore/U-5148-2018	Bonsaksen, Tore/0000-0001-6315-1111; Skogen, Jens Christoffer/0000-0003-0722-5440; Aas, Randi W./0000-0003-4391-6142	Norwegian Directorate of Health; Research Council of Norway	Norwegian Directorate of Health; Research Council of Norway(Research Council of Norway)	The Norwegian Directorate of Health and the Research Council of Norway funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas RW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186503; Biork IT, 2007, INT J NURS STUD, V44, P747, DOI 10.1016/j.ijnurstu.2006.01.002; Bonsaksen T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5990-8; Costa G, 2010, SAF HEALTH WORK, V1, P112, DOI 10.5491/SHAW.2010.1.2.112; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; de Vries H, 2018, J OCCUP REHABIL, V28, P393, DOI 10.1007/s10926-017-9730-1; Duijts SFA, 2007, J CLIN EPIDEMIOL, V60, P1105, DOI 10.1016/j.jclinepi.2007.04.008; Eurostat NACE Rev, 2008, STAT CLASS EC ACT EU; Field A, 2013, DISCOVERING STAT USI; Fryers T, 2003, SOC PSYCH PSYCH EPID, V38, P229, DOI 10.1007/s00127-003-0627-2; Habibi Ehsanollah, 2015, J Educ Health Promot, V4, P16, DOI 10.4103/2277-9531.154034; Hausser JA, 2010, WORK STRESS, V24, P1, DOI 10.1080/02678371003683747; Harrington JM, 2001, OCCUP ENVIRON MED, V58, P68, DOI 10.1136/oem.58.1.68; Harvey S. B., 2014, DEV MENTALLY HLTH WO; Haveraaen LA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3942-8; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kondo K, 2006, INT ARCH OCC ENV HEA, V79, P213, DOI 10.1007/s00420-005-0027-x; Kristensen TS, 2002, SCAND J PUBLIC HEALT, V30, P41, DOI 10.1177/14034948020300032401; Mather L, 2015, J OCCUP ENVIRON MED, V57, P858, DOI 10.1097/JOM.0000000000000504; Mortensen J, 2017, SCAND J WORK ENV HEA, V43, P5, DOI 10.5271/sjweh.3587; Nena E, 2018, INDIAN J OCCUP ENVIR, V22, P29, DOI 10.4103/ijoem.IJOEM_4_18; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nordaune K, 2017, SCAND J PUBLIC HEALT, V45, P749, DOI 10.1177/1403494817704109; Norwegian Ministry of Children and Families, 2015, 720152016 NORW MIN C; Roman PM, 2002, ALCOHOL RES HEALTH, V26, P49; Sanne B, 2005, OCCUP MED-OXFORD, V55, P463, DOI 10.1093/occmed/kqi071; Schulte PA, 2015, AM J PUBLIC HEALTH, V105, pE31, DOI 10.2105/AJPH.2015.302616; Skogen JC, 2019, DRUG ALCOHOL DEPEN, V202, P87, DOI 10.1016/j.drugalcdep.2019.06.002; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Statistics Norway, 2019, WORK FORC SURV SEAS; Statistics Norway, 2019, EMPL REG BAS 1626 ST; Statistics Norway, 2019, EMPL REG BAS; Statistics Norway, 2019, FACTS GEND EQ; Sterud T, 2013, SCAND J WORK ENV HEA, V39, P468, DOI 10.5271/sjweh.3359; Thorrisen MM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029184; Thorrisen MM, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0217-2; Thorrisen MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5660-x; Trybou J, 2014, J NURS SCHOLARSHIP, V46, P292, DOI 10.1111/jnu.12075; Williams-Whitt K, 2015, INT J OCCUP ENV MED, V6, P61, DOI 10.15171/ijoem.2015.553; Zeike S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021366	44	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227336	10.1371/journal.pone.0227336	http://dx.doi.org/10.1371/journal.pone.0227336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KN8JV	31887201	Green Submitted, Green Published, gold			2022-12-26	WOS:000515092200093
J	Wang, WB; He, JY; Chen, SW; Peng, P; Zhong, W; Wang, XT; Zhang, TT; Li, YP				Wang, Weibin; He, Junyu; Chen, Shengwei; Peng, Peng; Zhong, Wei; Wang, Xintian; Zhang, Tingting; Li, Yuping			Construction of a high-density genetic map and fine mapping of a candidate gene locus for a novel branched-spike mutant in barley	PLOS ONE			English	Article							F-BOX-PROTEIN; YIELD COMPONENTS; AGRONOMIC TRAITS; QTLS; POPULATION	A Yunnan branched-spike (Ynbs) barley mutant is useful for study of the genetic mechanisms underlying variation in barley spike architecture. In the current study, a mutant (Ynbs-1), a recombinant inbred line (RIL-1), and a cultivar (BDM-8) were used as parents to develop populations. Ynbs-1 exhibits typical branched spike, whereas the others exhibit six-row spike. Genetic analysis on their F1, F2 and F3 populations showed that one recessive gene is responsible for the branched spike trait. SLAF marker generated from specific locus amplified fragment sequencing (SLAF-seq) was used to genotype the populations. A high-density genetic map of barley was constructed using 14,348 SLAF markers, which covered all 7 chromosomes at 1,347.44 cM in length with an average marker density of 0.09 cM between adjacent markers. Linkage analysis of the branched-spike trait using the genetic map indicated that branched spike trait in the Ynbs-1 is controlled by single locus on chromosome 2H at the interval between 65.00 and 65.47 cM that is flanked by Marker310119 and Marker2679451. Several candidate genes that may be responsible for barley multiple-spikelet degeneration, single-floret spikelet increase and seed set rate decrease were identified in the region. The high-density genetic map and the gene locus revealed in this study provide valuable information for elucidating the genetic mechanism of spike branching in barley.	[Wang, Weibin; He, Junyu; Chen, Shengwei; Peng, Peng; Zhong, Wei; Wang, Xintian; Zhang, Tingting; Li, Yuping] Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University	Chen, SW (corresponding author), Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Yunnan, Peoples R China.	ynkmcsw@126.com	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; Wang, Weibin/AAS-7265-2020	Wang, Weibin/0000-0002-5189-0483; He, Junyu/0000-0001-6969-8580; he, Junyu/0000-0001-5585-5549	National Natural Science Foundation of China [31660434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31660434). Website: http://www.nsfc.gov.cn/.	Boisson-Dernier A, 2015, P NATL ACAD SCI USA, V112, P12211, DOI 10.1073/pnas.1512375112; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Feng ZY, 2004, HIGH TECHNOLOGY LETT, V10, P5, DOI [10.3772/j.issn.1006-6748.2004.02.002, DOI 10.3772/J.ISSN.1006-6748.2004.02.002]; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Huang BG, 2011, AGR SCI CHINA, V10, P1501, DOI 10.1016/S1671-2927(11)60144-2; Huang Bi-Guang, 2004, Yichuan, V26, P903; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Ji HuiQiang, 1995, Journal of Fujian Agricultural University, V24, P9; Jia QJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3247-4; Kang JF, 2017, PLANT BIOTECHNOL J, V15, P1175, DOI 10.1111/pbi.12707; Larsson H. E. B., 1981, Barley Genetics Newsletter, V11, P25; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Li JZ, 2006, GENOME, V49, P454, DOI 10.1139/G05-128; Li JL, 1963, J HARBIN NORMAL COLL, V132; Li M, 2011, PLANT BIOTECHNOL J, V9, P1002, DOI 10.1111/j.1467-7652.2011.00610.x; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Liu W, 2013, J EXP BOT, V64, P4389, DOI 10.1093/jxb/ert256; Ma X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186942; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; [彭澎 Peng Peng], 2018, [麦类作物学报, Journal of Triticeae Crops], V38, P134; Poursarebani N, 2015, GENETICS, V201, P155, DOI 10.1534/genetics.115.176628; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Shang Y, 2014, GENES GENOM, V36, P275, DOI 10.1007/s13258-013-0165-6; [沈真辉 Shen Zhenhui], 2017, [麦类作物学报, Journal of Triticeae Crops], V37, P66; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; von Korff M, 2008, THEOR APPL GENET, V117, P653, DOI 10.1007/s00122-008-0787-2; Wang JiaXi, 2017, Journal of Yunnan Agricultural University, V32, P387; Wang JB, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0409-y; Wang Yangkun, 2014, Yichuan, V36, P41, DOI 10.3724/SP.J.1005.2014.0041; Wendler N, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.06.0049; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Zhang CX, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2190-7; Zhang J, 1995, CHINESE J BARLEY SCI, V44, P44; Zhao CP, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4406-y; Zhou GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133161	37	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0227617	10.1371/journal.pone.0227617	http://dx.doi.org/10.1371/journal.pone.0227617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914168	gold, Green Published			2022-12-26	WOS:000534337700051
J	Martinez, P; Contreras, D; Moreno, M				Martinez, Pablo; Contreras, Daniela; Moreno, Monica			Safe mobility, socioeconomic inequalities, and aging: A 12-year multilevel interrupted time-series analysis of road traffic death rates in a Latin American country	PLOS ONE			English	Article							MEDICAL CONDITIONS; INJURY MORTALITY; BETWEEN-PERSON; WITHIN-PERSON; GLOBAL BURDEN; OLDER; FATALITIES; DRIVERS; CRASHES; HEALTHY	As the resources for road safety in developing countries are scarce and unevenly distributed, vulnerable road users-such as the elderly- may be particularly at risk of road traffic deaths. To date, the impact of road safety measures over the rate of road traffic deaths in older adults (60 years or older), considering the within-country socioeconomic inequalities, has not been explored in developing nations. This study takes the Chilean case as an example -with its 2005 traffic law reform as one of the road safety measures investigated-, in which open data available from official national sources for all its 13 regions over the 2002-2013 period were used for a multilevel interrupted time-series analysis. A statistically significant secular reduction of the rates of road traffic deaths in the elderly population was found (incidence rate ratio [IRR] 0.95, 95% confidence interval [CI] 0.91 to 0.99), but no evidence for a significant intercept or slope change after the traffic law reform was observed. Regions with the highest number of traffic offenses prosecuted in local police courts had lower rates of road traffic deaths in older adults (IRR 0.95, 95% CI 0.90 to 1.00), and those regions in the third (IRR 1.61, 95% CI 1.16 to 2.25) and the fifth (IRR 1.66, 95% CI 1.08 to 2.54) quintiles of socioeconomic deprivation had higher rates of road traffic deaths in the elderly. Such findings strongly support the conceptualization of the road safety of seniors in developing countries as a social equity issue, with implications for the design of traffic regulations and road environments.	[Martinez, Pablo; Contreras, Daniela; Moreno, Monica] Univ Santiago Chile, CITIAPS, Santiago, Chile; [Martinez, Pablo] Univ Santiago Chile, Fac Humanidades, Escuela Psicol, Santiago, Chile; [Martinez, Pablo] Hosp Clin Univ Chile, Dept Psiquiatria & Salud Mental, Santiago, Chile; [Martinez, Pablo] Inst Milenio Invest Depres & Personalidad MIDAP, Santiago, Chile; [Martinez, Pablo] Nucleo Milenio Mejorar Salud Mental Adolescentes, Santiago, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de Chile	Martinez, P (corresponding author), Univ Santiago Chile, CITIAPS, Santiago, Chile.; Martinez, P (corresponding author), Univ Santiago Chile, Fac Humanidades, Escuela Psicol, Santiago, Chile.; Martinez, P (corresponding author), Hosp Clin Univ Chile, Dept Psiquiatria & Salud Mental, Santiago, Chile.; Martinez, P (corresponding author), Inst Milenio Invest Depres & Personalidad MIDAP, Santiago, Chile.; Martinez, P (corresponding author), Nucleo Milenio Mejorar Salud Mental Adolescentes, Santiago, Chile.	pablo.martinezd@usach.cl		Martinez, Pablo/0000-0003-4482-7993	Vice-Rector of Research, Development and Innovation at the University of Santiago of Chile [PMI USA 1204]	Vice-Rector of Research, Development and Innovation at the University of Santiago of Chile	PM, DC, and MM were or are employed by the Vice-Rector of Research, Development and Innovation at the University of Santiago of Chile, under grant PMI USA 1204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Ang BH, 2017, ARCH GERONTOL GERIAT, V72, P32, DOI 10.1016/j.archger.2017.05.004; Azetsop J, 2010, PUBLIC HEALTH ETH-UK, V3, P115, DOI 10.1093/phe/phq013; Barry A., 2015, GLOBAL AGEWATCH INDE; Bonnet E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208195; Boot WR, 2014, GERONTOLOGY, V60, P90, DOI 10.1159/000354212; Borrell C, 2005, INJURY PREV, V11, P138, DOI 10.1136/ip.2004.006346; Borrell C, 2002, INJURY PREV, V8, P297, DOI 10.1136/ip.8.4.297; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; Chatterjee S., 2012, REGRESSION ANAL EXAM; Chong SL, 2018, AM J PREV MED, V55, P98, DOI 10.1016/j.amepre.2018.04.005; Cicchino JB, 2015, ACCIDENT ANAL PREV, V83, P67, DOI 10.1016/j.aap.2015.06.012; Cottrill CD, 2010, ACCIDENT ANAL PREV, V42, P1718, DOI 10.1016/j.aap.2010.04.012; Curran PJ, 2011, ANNU REV PSYCHOL, V62, P583, DOI 10.1146/annurev.psych.093008.100356; Doroudgar S, 2017, TRAFFIC INJ PREV, V18, P41, DOI 10.1080/15389588.2016.1194980; Fernandez MB, 2017, CHILE SUS MAYORES 10; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hosking J, 2013, AUST NZ J PUBL HEAL, V37, P162, DOI 10.1111/1753-6405.12034; Hosseinpoor AR, 2016, B WORLD HEALTH ORGAN, V94, P856, DOI 10.2471/BLT.15.165266; Instituto Nacional de Estadisticas de Chile (INE), ESTADISTICAS LICENCI; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Lord D, 2010, TRANSPORT RES A-POL, V44, P291, DOI 10.1016/j.tra.2010.02.001; Lyons RA, 2003, INJ PREV, V9, P33, DOI 10.1136/ip.9.1.33; McGwin G, 2000, AM J EPIDEMIOL, V152, P424, DOI 10.1093/aje/152.5.424; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Morency P, 2012, AM J PUBLIC HEALTH, V102, P1112, DOI 10.2105/AJPH.2011.300528; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Nazif-Munoz JI, 2017, INJURY PREV, V23, P291, DOI 10.1136/injuryprev-2016-042218; Nazif-Munoz JI, 2015, INJURY PREV, V21, P159, DOI 10.1136/injuryprev-2014-041358; Nazif-Munoz JI, 2014, TRAFFIC INJ PREV, V15, pS56, DOI 10.1080/15389588.2014.939270; Nevriana A, 2017, CNS DRUGS, V31, P711, DOI 10.1007/s40263-017-0445-9; Novoa AM, 2011, J EPIDEMIOL COMMUN H, V65, P218, DOI 10.1136/jech.2009.094029; Peden M., 2004, WORLD REPORT ROAD TR; Risser R, 2010, EUR J AGEING, V7, P69, DOI 10.1007/s10433-010-0146-4; Rosenbloom T, 2016, ACCIDENT ANAL PREV, V93, P23, DOI 10.1016/j.aap.2016.04.004; Sallis JF, 2016, LANCET, V388, P2936, DOI 10.1016/S0140-6736(16)30068-X; Salmi LR, 2014, INJURY PREV, V20, P210, DOI 10.1136/injuryprev-2013-040972; Sengoelge M, 2013, INJURY PREV, V19, P311, DOI 10.1136/injuryprev-2012-040624; Sivak M, 2011, TRAFFIC INJ PREV, V12, P438, DOI 10.1080/15389588.2011.588980; StataCorp, 2015, STAT STAT SOFTW REL; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Tournier I, 2016, ACCIDENT ANAL PREV, V91, P24, DOI 10.1016/j.aap.2016.02.031; Vanlaar W, 2016, J SAFETY RES, V56, P33, DOI 10.1016/j.jsr.2015.11.009; Wang LJ, 2015, PSYCHOL METHODS, V20, P63, DOI 10.1037/met0000030; Zito GA, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0175-0	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0224545	10.1371/journal.pone.0224545	http://dx.doi.org/10.1371/journal.pone.0224545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5BZ	31910212	Green Published, gold			2022-12-26	WOS:000534333800007
J	Sayyed, RZ; Wani, SJ; Alarfaj, AA; Syed, A; El-Enshasy, HA				Sayyed, R. Z.; Wani, S. J.; Alarfaj, Abdullah A.; Syed, Asad; El-Enshasy, Hesham Ali			Production, purification and evaluation of biodegradation potential of PHB depolymerase of Stenotrophomonas sp. RZS7	PLOS ONE			English	Article							EXTRACELLULAR POLY(3-HYDROXYBUTYRATE) DEPOLYMERASE; POLY(BETA-HYDROXYBUTYRATE); ISOLATE; STRAIN; ASSAY; SOIL	There are numerous reports on poly-beta-hydroxybutyrate (PHB) depolymerases produced by various microorganisms isolated from various habitats, however, reports on PHB depolymerase production by an isolate from plastic rich sites scares. Although PHB has attracted commercial significance, the inefficient production and recovery methods, inefficient purification of PHB depolymerase and lack of ample knowledge on PHB degradation by PHB depolymerase have hampered its large scale commercialization. Therefore, to ensure the biodegradability of biopolymers, it becomes imperative to study the purification of the biodegrading enzyme system. We report the production, purification, and characterization of extracellular PHB depolymerase from Stenotrophomonas sp. RZS7 isolated from a dumping yard rich in plastic waste. The isolate produced extracellular PHB depolymerase in the mineral salt medium (MSM) at 30 degrees C during 4 days of incubation under shaking. The enzyme was purified by three methods namely ammonium salt precipitation, column chromatography, and solvent purification. Among these purification methods, the enzyme was best purified by column chromatography on the Octyl-Sepharose CL-4B column giving optimum yield (0.7993 Umg(-1) mL(-1)). The molecular weight of purified PHB depolymerase was 40 kDa. Studies on the assessment of biodegradation of PHB in liquid culture medium and under natural soil conditions confirmed PHB biodegradation potential of Stenotrophomonas sp. RZS7. The results obtained in Fourier-Transform Infrared (FTIR) analysis, High-Performance Liquid Chromatography (HPLC) study and Gas Chromatography Mass-Spectrometry (GC-MS) analysis confirmed the biodegradation of PHB in liquid medium by Stenotrophomonas sp. RZS7. Changes in surface morphology of PHB film in soil burial as observed in Field Emission Scanning Electron Microscopy (FESEM) analysis confirmed the biodegradation of PHB under natural soil environment. The isolate was capable of degrading PHB and it resulted in 87.74% biodegradation. A higher rate of degradation under the natural soil condition is the result of the activity of soil microbes that complemented the biodegradation of PHB by Stenotrophomonas sp. RZS7.	[Sayyed, R. Z.; Wani, S. J.] PSGVP Mandals Arts Sci & Commerce Coll, Dept Microbiol, Shahada, Maharashtra, India; [Alarfaj, Abdullah A.; Syed, Asad] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [El-Enshasy, Hesham Ali] Univ Teknol Malaysia UTM, Inst Bioprod Dev IBD, Johor Baharu, Johor, Malaysia; [El-Enshasy, Hesham Ali] City Sci Res & Technol Applicat, Alexandria, Egypt	King Saud University; Universiti Teknologi Malaysia; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	Sayyed, RZ (corresponding author), PSGVP Mandals Arts Sci & Commerce Coll, Dept Microbiol, Shahada, Maharashtra, India.	sayyedrz@gmail.com	Sayyed, R Z/Q-4313-2016; El Enshasy, Hesham Ali/D-3733-2014; Syed, Asad/A-7828-2012; Alarfaj, Abdullah/AAA-2018-2019	Sayyed, R Z/0000-0002-1553-1213; El Enshasy, Hesham Ali/0000-0002-9712-2033; Syed, Asad/0000-0002-2824-7721; 	King Saud University, Riyadh, Saudi Arabia [RSP-2019/98]; MOE; UTM-RMC, HICOE, Malaysia [R.J130000.7846.4J262]	King Saud University, Riyadh, Saudi Arabia(King Saud University); MOE(Ministry of Higher Education & Scientific Research (MHESR)); UTM-RMC, HICOE, Malaysia	The authors extend their appreciation to The Researchers Supporting Project Number (RSP-2019/98) King Saud University, Riyadh, Saudi Arabia and MOE and UTM-RMC, HICOE, Malaysia, for funding this research through the Research Grant No. R.J130000.7846.4J262.	Calabia BP, 2006, BIOTECHNOL LETT, V28, P383, DOI 10.1007/s10529-005-6063-5; Dalev PG, 2000, J APPL POLYM SCI, V78, P1341, DOI 10.1002/1097-4628(20001114)78:7<1341::AID-APP40>3.0.CO;2-2; Gangurde NS, 2017, INDIAN J EXP BIOL, V55, P311; Gangurde NS, 2013, ENVIRON SCI POLLUT R, V20, P488, DOI 10.1007/s11356-012-1021-y; Gautam N., 2013, J ENV CHEM ECOTOXICO, V5, P147, DOI [10.5897/JECE09.022, DOI 10.5897/JECE09.022]; Gebauer B, 2006, APPL ENVIRON MICROB, V72, P6094, DOI 10.1128/AEM.01184-06; Han JS, 2002, J MICROBIOL, V40, P20; He WN, 1998, FEMS MICROBIOL LETT, V169, P45, DOI 10.1016/S0378-1097(98)00462-5; Hsu KJ, 2012, BOT STUD, V53, P307; INGEBRITSEN TS, 1979, J SUPRAMOL STR CELL, P18; Iyer S, 2000, J POLYM ENVIRON, V8, P197, DOI 10.1023/A:1015249811314; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Kansiz M, 2000, APPL ENVIRON MICROB, V66, P3415, DOI 10.1128/AEM.66.8.3415-3420.2000; Kim DY, 2002, J MICROBIOL, V40, P129; Kim HJ, 2003, ANTON LEEUW INT J G, V83, P183, DOI 10.1023/A:1023395527073; Kobayashi T, 1999, J ENVIRON POLYM DEGR, V7, P9, DOI 10.1023/A:1021885901119; Kumar MS, 2004, BIORESOURCE TECHNOL, V95, P327, DOI 10.1016/j.biortech.2004.02.019; LAW JH, 1961, J BACTERIOL, V82, P33, DOI 10.1128/JB.82.1.33-36.1961; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064; McLafferty FW, 1993, INTERPRETATION MASS, P211; Papaneophytou CP, 2009, APPL MICROBIOL BIOT, V83, P659, DOI 10.1007/s00253-008-1842-2; Sadocco P, 1997, J ENVIRON POLYM DEGR, V5, P57; Sayyed RZ, 2009, INDIAN J MICROBIOL, V49, P230, DOI 10.1007/s12088-009-0036-7; Shah AA, 2007, ANN MICROBIOL, V57, P583, DOI 10.1007/BF03175359; Shahi, 2012, CURR DISCOV, V1, P27; Shivakumar S, 2011, APPL BIOCHEM BIOTECH, V164, P1225, DOI 10.1007/s12010-011-9208-0; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Thakor N, 2005, BIORESOURCE TECHNOL, V96, P1843, DOI 10.1016/j.biortech.2005.01.030; Varda M, 2014, J ENV RES, V8, P934; Wang LA, 2008, J APPL POLYM SCI, V107, P166, DOI 10.1002/app.27004; Wani SJ, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0477-8; Wani SJ, 2016, INDIAN J BIOTECHNOL, V15, P127; Wani SJ., 2015, INT J SCI ENG, V6, P818; Zhou HL, 2009, POLYM-PLAST TECHNOL, V48, P58, DOI 10.1080/03602550802539627	35	7	7	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0220095	10.1371/journal.pone.0220095	http://dx.doi.org/10.1371/journal.pone.0220095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910206	Green Published, gold			2022-12-26	WOS:000534333800002
J	Fleer, S; Moringen, A; Klatzky, RL; Ritter, H				Fleer, Sascha; Moringen, Alexandra; Klatzky, Roberta L.; Ritter, Helge			Learning efficient haptic shape exploration with a rigid tactile sensor array	PLOS ONE			English	Article								Haptic exploration is a key skill for both robots and humans to discriminate and handle unknown objects or to recognize familiar objects. Its active nature is evident in humans who from early on reliably acquire sophisticated sensory-motor capabilities for active exploratory touch and directed manual exploration that associates surfaces and object properties with their spatial locations. This is in stark contrast to robotics. In this field, the relative lack of good real-world interaction models-along with very restricted sensors and a scarcity of suitable training data to leverage machine learning methods-has so far rendered haptic exploration a largely underdeveloped skill. In robot vision however, deep learning approaches and an abundance of available training data have triggered huge advances. In the present work, we connect recent advances in recurrent models of visual attention with previous insights about the organisation of human haptic search behavior, exploratory procedures and haptic glances for a novel architecture that learns a generative model of haptic exploration in a simulated three-dimensional environment. This environment contains a set of rigid static objects representing a selection of one-dimensional local shape features embedded in a 3D space: an edge, a flat and a convex surface. The proposed algorithm simultaneously optimizes main perception-action loop components: feature extraction, integration of features over time, and the control strategy, while continuously acquiring data online. Inspired by the Recurrent Attention Model, we formalize the target task of haptic object identification in a reinforcement learning framework and reward the learner in the case of success only. We perform a multi-module neural network training, including a feature extractor and a recurrent neural network module aiding pose control for storing and combining sequential sensory data. The resulting haptic meta-controller for the rigid 16 x 16 tactile sensor array moving in a physics-driven simulation environment, called the Haptic Attention Model, performs a sequence of haptic glances, and outputs corresponding force measurements. The resulting method has been successfully tested with four different objects. It achieved results close to 100% while performing object contour exploration that has been optimized for its own sensor morphology.	[Fleer, Sascha; Moringen, Alexandra; Ritter, Helge] Bielefeld Univ, Neuroinformat Grp, Bielefeld, Germany; [Klatzky, Roberta L.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of Bielefeld; Carnegie Mellon University	Moringen, A (corresponding author), Bielefeld Univ, Neuroinformat Grp, Bielefeld, Germany.	abarch@techfak.uni-bielefeld.de		Fleer, Sascha/0000-0003-1606-2436	424 Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld 425 University - German Research Foundation (DFG); Cluster of Excellence Cognitive Interaction Technology `CITEC' (EXC 277) at Bielefeld University - German Research Foundation (DFG)	424 Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld 425 University - German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Cognitive Interaction Technology `CITEC' (EXC 277) at Bielefeld University - German Research Foundation (DFG)(German Research Foundation (DFG))	This research/work was supported by the 424 Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld 425 University (SF, AM), which is funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research/work was supported by the Cluster of Excellence Cognitive Interaction Technology `CITEC' (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG). We also wish to acknowledge the technical support provided by Guillaume Walck.	Ba J., 2014, ARXIV; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Chu V, 2015, ROBOT AUTON SYST, V63, P279, DOI 10.1016/j.robot.2014.09.021; Chu V, 2013, IEEE INT CONF ROBOT, P3048, DOI 10.1109/ICRA.2013.6631000; Dugas C, 2001, ADV NEUR IN, V13, P472; Fei-Fei Li, 2019, MAKING SENSE VISION; Fishel Jeremy A, 2012, Front Neurorobot, V6, P4, DOI 10.3389/fnbot.2012.00004; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A., 2014, ARXIV14105401; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; He K, ABS15120 CORR; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton, 2010, ADV NEURAL INFORM PR, P1243, DOI DOI 10.18178/IJMLC.2017.7.1.610; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kalagher H, 2011, J EXP CHILD PSYCHOL, V110, P592, DOI 10.1016/j.jecp.2011.06.007; Klatzky RL, 2005, INFANT BEHAV DEV, V28, P240, DOI 10.1016/j.infbeh.2005.05.002; KLATZKY RL, 1995, PERCEPT PSYCHOPHYS, V57, P1111, DOI 10.3758/BF03208368; Klatzky RL, 1987, J EXPT PSYCHOL; Krieger K., 2016, LECT NOTES COMPUTER; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Levine S, 2018, INT J ROBOT RES, V37, P421, DOI 10.1177/0278364917710318; Martins R, ABS14096 CORR; Mathe S, 2013, ADV NEURAL INFORM PR, P1923; Mnih V, ABS14066247 CORR; Moringen A, 2017, IEEE WORLD HAPTICS; Moringen A, 2016, IEEE HAPTICS SYM, P192, DOI 10.1109/HAPTICS.2016.7463176; NESTEROV IE, 1983, DOKL AKAD NAUK SSSR+, V269, P543; Nesterov Y., 2013, INTRO LECT CONVEX OP, V87; Okamura A, 2001, FEATURE DETECTION HA, V20; Pape Leo, 2012, Front Neurorobot, V6, P6, DOI 10.3389/fnbot.2012.00006; Rajeswaran A, ABS170910087 CORR; Schurmann C., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P339, DOI 10.1109/WHC.2011.5945509; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tian S, 2019, MANIPULATION FEEL TO; van Hoof H, 2015, IEEE-RAS INT C HUMAN, P121, DOI 10.1109/HUMANOIDS.2015.7363524; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Williams RJ, 1988, NUCCS883 NE U	40	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226880	10.1371/journal.pone.0226880	http://dx.doi.org/10.1371/journal.pone.0226880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP4DA	31896135	Green Published, Green Submitted, gold			2022-12-26	WOS:000534267300011
J	Kaplan, N; Dong, Y; Wang, SJ; Yang, WD; Park, JK; Wang, JY; Fiolek, E; White, BP; Chandel, NS; Peng, H; Lavker, RM				Kaplan, Nihal; Dong, Ying; Wang, Sijia; Yang, Wending; Park, Jong Kook; Wang, Junyi; Fiolek, Elaina; Perez White, Bethany; Chandel, Navdeep S.; Peng, Han; Lavker, Robert M.			FIH-1 engages novel binding partners to positively influence epithelial proliferation via p63	FASEB JOURNAL			English	Article						ASPP2; epidermis; GADD45 alpha; limbal and corneal epithelia	STEM-CELL; ASPARAGINYL HYDROXYLATION; UNINVOLVED SKIN; DIFFERENTIATION; EXPRESSION; HYPOXIA; APOPTOSIS; PROTEIN; KERATINOCYTES; KINASE	Whereas much is known about the genes regulated by Delta Np63 alpha in keratinocytes, how Delta Np63 alpha is regulated is less clear. During studies with the hydroxylase, factor inhibiting hypoxia-inducible factor 1 (FIH-1), we observed increases in epidermal Delta Np63 alpha expression along with proliferative capacity in a conditional FIH-1 transgenic mouse. Conversely, loss of FIH-1 in vivo and in vitro attenuated Delta Np63 alpha expression. To elucidate the FIH-1/p63 relationship, BioID proteomics assays identified FIH-1 binding partners that had the potential to regulate p63 expression. FIH-1 interacts with two previously unknown partners, Plectin1 and signal transducer and activator of transcription 1 (STAT1) leading to the regulation of Delta Np63 alpha expression. Two known interactors of FIH-1, apoptosis-stimulating of P53 protein 2 (ASPP2) and histone deacetylase 1 (HDAC1), were also identified. Knockdown of ASPP2 upregulated Delta Np63 alpha and reversed the decrease in Delta Np63 alpha by FIH-1 depletion. Additionally, FIH-1 regulates growth arrest and DNA damage-45 alpha (GADD45 alpha), a negative regulator of Delta Np63 alpha by interacting with HDAC1. GADD45 alpha knockdown rescued reduction in Delta Np63 alpha by FIH-1 depletion. Collectively, our data reveal that FIH-1 positively regulates Delta Np63 alpha in keratinocytes via variety of signaling partners: (a) Plectin1/STAT1, (b) ASPP2, and (c) HDAC1/GADD45 alpha signaling pathways.	[Kaplan, Nihal; Dong, Ying; Wang, Sijia; Yang, Wending; Park, Jong Kook; Wang, Junyi; Fiolek, Elaina; Perez White, Bethany; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 E Chicago Ave Ward 9-124, Chicago, IL 60611 USA; [Dong, Ying; Wang, Junyi] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ophthalmol, Beijing, Peoples R China; [Wang, Sijia] Southern Med Univ, Nanfang Hosp, Dept Dermatol, Guangzhou, Peoples R China; [Park, Jong Kook] Hallym Univ, Dept Biomed Sci, Coll Nat Sci 8403, Chunchon, South Korea; [Chandel, Navdeep S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	Northwestern University; Chinese People's Liberation Army General Hospital; Southern Medical University - China; Hallym University; Northwestern University	Peng, H; Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 E Chicago Ave Ward 9-124, Chicago, IL 60611 USA.	han.peng@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022; White, Bethany E. Perez/AAF-7256-2020	Perez White, Bethany/0000-0002-5594-0599; Park, Jong Kook/0000-0002-3946-5687	HHS \ NIH \ National Eye Institute (NEI) [EY06769, EY017539, EY019463]; NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31300814]; Deramatology Foundation Career Development Award; Eversight Research Grant; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01AR072773]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; Comprehensive Cancer Center; National Institutes of Health [EY019463, 31300814]; National Natural Science Foundation of China; Dermatology Foundation; Core	HHS \ NIH \ National Eye Institute (NEI); NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Deramatology Foundation Career Development Award; Eversight Research Grant; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dermatology Foundation; Core(Luxembourg National Research Fund)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY06769, EY017539 and EY019463; NSFC vertical bar National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31300814; Deramatology Foundation Career Development Award; Eversight Research Grant; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: K01AR072773; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR057216; Core; Comprehensive Cancer Center; National Institutes of Health, Grant/Award Number: EY019463 and 31300814; National Natural Science Foundation of China; Dermatology Foundation	Arcidiacono P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03470-y; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Beretta C, 2005, CELL CYCLE, V4, P1625, DOI 10.4161/cc.4.11.2135; Bin BH, 2017, P NATL ACAD SCI USA, V114, P12243, DOI 10.1073/pnas.1710726114; Cable CJ, 2019, METHOD MOL BIOL, P1; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; DEBOER OJ, 1994, ARCH DERMATOL RES, V286, P304, DOI 10.1007/BF00402220; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; FORSTER S, 1983, BRIT J DERMATOL, V108, P103, DOI 10.1111/j.1365-2133.1983.tb04585.x; FRAKI JE, 1982, SCIENCE, V215, P685, DOI 10.1126/science.7036342; Hamanaka RB, 2017, J INVEST DERMATOL, V137, P1267, DOI 10.1016/j.jid.2016.12.020; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Hildesheim J, 2004, ONCOGENE, V23, P1829, DOI 10.1038/sj.onc.1207301; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kouwenhoven EN, 2015, BBA-GENE REGUL MECH, V1849, P590, DOI 10.1016/j.bbagrm.2015.03.003; KRUEGER GG, 1981, J CLIN INVEST, V68, P1548, DOI 10.1172/JCI110409; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Matheny KE, 2003, LARYNGOSCOPE, V113, P936, DOI 10.1097/00005537-200306000-00004; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mehrazarin S, 2015, J BIOL CHEM, V290, P19999, DOI 10.1074/jbc.M115.659144; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2014, AM J PATHOL, V184, P3262, DOI 10.1016/j.ajpath.2014.08.014; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; de Sousa FLP, 2017, REPROD BIOL, V17, P218, DOI 10.1016/j.repbio.2017.05.005; Riemondy K, 2014, WIRES RNA, V5, P849, DOI 10.1002/wrna.1250; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shen CS, 2005, J DERMATOL, V32, P236, DOI 10.1111/j.1346-8138.2005.tb00755.x; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Turnquist C, 2014, P NATL ACAD SCI USA, V111, P9834, DOI 10.1073/pnas.1407898111; Wang H, 2010, CELL SIGNAL, V22, P1717, DOI 10.1016/j.cellsig.2010.06.012; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; White BEP, 2017, J CELL SCI, V130, P111, DOI 10.1242/jcs.188169; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	60	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					525	539		10.1096/fj.201901512R	http://dx.doi.org/10.1096/fj.201901512R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914679	Green Accepted			2022-12-26	WOS:000507308900036
J	Kong, QR; Yang, X; Zhang, H; Liu, SC; Zhao, JC; Zhang, JM; Weng, XG; Jin, JX; Liu, ZH				Kong, Qingran; Yang, Xu; Zhang, Heng; Liu, Shichao; Zhao, Jianchao; Zhang, Jiaming; Weng, Xiaogang; Jin, Junxue; Liu, Zhonghua			Lineage specification and pluripotency revealed by transcriptome analysis from oocyte to blastocyst in pig	FASEB JOURNAL			English	Article						mammals; pig; preimplantation embryonic development; single-cell RNA-seq; transcriptome	STEM-CELLS; NAIVE; EXPRESSION; ESTABLISHMENT	The inner cell mass (ICM) in blastocyst is the origin of all somatic and germ cells in mammals and pluripotent stem cells (PSCs) in vitro. As the conserved principles between pig and human, here we performed comprehensive single-cell RNA-seq for porcine early embryos from oocyte to early blastocyst (EB). We show the specification of the ICM and trophectoderm in morula and the molecular signature of the precursors. We demonstrate the existence of naive pluripotency signature in morula and ICM of EB, and the specific pluripotent genes and the activity of signalling pathways highlight the characteristics of the naive pluripotency. We observe the absence of dosage compensation with respect to X-chromosome (XC) in morula, and incomplete dosage compensation in the EB. However, the dynamics of dosage compensation may be independent of the expression of XIST induced XC inactivation. Our study describes molecular landmarks of embryogenesis in pig that will provide a better strategy for derivation of porcine PSCs and improve research in regenerative medicine.	[Kong, Qingran; Yang, Xu; Zhang, Heng; Liu, Shichao; Zhao, Jianchao; Zhang, Jiaming; Weng, Xiaogang; Jin, Junxue; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China; [Zhang, Heng] Westlake Univ, Inst Biol, Hangzhou, Peoples R China	Northeast Agricultural University - China; Westlake University	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China.	Liuzhonghua@neau.edu.cn	Liu, Shichao/J-2954-2019	Liu, Shichao/0000-0002-4156-3876	Northeast Agricultural University (NEAU)	Northeast Agricultural University (NEAU)	Northeast Agricultural University (NEAU)	Ashida Y, 2017, GENES CELLS, V22, P189, DOI 10.1111/gtc.12467; Bou G, 2017, DEVELOPMENT, V144, P1296, DOI 10.1242/dev.141085; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Chiu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19227; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gong HX, 2016, STEM CELL REP, V7, P1050, DOI 10.1016/j.stemcr.2016.10.006; Heemskerk I, 2016, DEV DYNAM, V245, P976, DOI [10.1002/DVDY.24432, 10.1002/dvdy.24432]; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Hryhorowicz M, 2017, MOL BIOTECHNOL, V59, P435, DOI 10.1007/s12033-017-0024-9; Hwang JY, 2015, MECH DEVELOP, V138, P246, DOI 10.1016/j.mod.2015.10.005; Hwang KC, 2005, MOL REPROD DEV, V70, P314, DOI 10.1002/mrd.20204; Kubaczka C, 2017, CELL RES, V27, P961, DOI 10.1038/cr.2017.61; Kugler J, 2017, EXPERT OPIN DRUG MET, V13, P833, DOI 10.1080/17425255.2017.1351548; Li YQ, 2017, DNA CELL BIOL, V36, P725, DOI 10.1089/dna.2017.3780; Lingel A, 2017, J MED CHEM, V60, P415, DOI 10.1021/acs.jmedchem.6b01473; Liu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; de Mello JCM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11044-z; Mzoughi S, 2017, NAT GENET, V49, P1354, DOI 10.1038/ng.3922; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.03.023, 10.1016/j.cell.2016.08.009]; Posfai E, 2017, ELIFE, V6, DOI 10.7554/eLife.22906; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Ramos-Ibeas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08387-8; Suman Pankaj, 2013, JAKSTAT, V2, pe25155, DOI 10.4161/jkst.25155; Takahashi S, 2018, CELL MOL LIFE SCI, V75, P1191, DOI 10.1007/s00018-017-2703-x; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; Wang JQ, 2018, CELL, V175, P1887, DOI 10.1016/j.cell.2018.11.039; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wei QQ, 2017, BIOL REPROD, V97, P5, DOI 10.1093/biolre/iox071; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhou LQ, 2017, DEVELOPMENT, V144, P519, DOI 10.1242/dev.141390	41	29	30	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					691	705		10.1096/fj.201901818RR	http://dx.doi.org/10.1096/fj.201901818RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914626	Bronze			2022-12-26	WOS:000507308900048
J	Lee, BR; Rengaraj, D; Choi, HJ; Han, JY				Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong			A novel F-box domain containing cyclin F like gene is required for maintaining the genome stability and survival of chicken primordial germ cells	FASEB JOURNAL			English	Article						gene expression; gene identification; gene regulation	MEDIATED DEGRADATION; GENOTOXIC STRESS; MESSENGER-RNA; IN-VITRO; EXPRESSION; DNA; APOPTOSIS; HOMOLOG; INTEGRITY; OVEREXPRESSION	The stability and survival of germ cells are controlled by the germline-specific genes, however, such genes are less known in the avian species. Using a microarray-based the National Center for Biotechnology Information Gene Expression Omnibus dataset, we found an unigene (Gga.9721) that upregulated in the chicken primordial germ cells (PGCs). The unigene showed 97% identities with an uncharacterized chicken cyclin F like gene. The predicted chicken cyclin F like gene was further characterized through expression and regulation in the chicken PGCs. The sequence analysis revealed that the gene shows identities with cyclin F gene and contains an F-box domain. The expression of chicken cyclin F like was detected specifically in the gonads, PGCs, and germline cells. The knockdown of cyclin F like gene resulted in DNA damage and apoptosis in the PGCs. The genes related to stemness and germness were downregulated, whereas, genes related to apoptosis and DNA damage response were increased in the PGCs after the knockdown of chicken cyclin F like. We further observed that the Nanog homeobox controlled the transcriptional activity of chicken cyclin F like gene in PGCs. Collectively, the chicken cyclin F like gene, which is not reported in any other species, is required for maintaining the genome stability of germ cells.	[Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Bo Ram] Rural Dev Adm, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921; Lee, Bo Ram/0000-0002-0537-6205	National Research Foundation of Korea (NRF) [NRF-2015R1A3A2033826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1D1A1B03029512; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A3A2033826	Aramaki S, 2007, CELL TISSUE RES, V330, P45, DOI 10.1007/s00441-007-0435-1; Awwad SW, 2015, BIOL OPEN, V4, P498, DOI 10.1242/bio.201410991; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Bailly Aymeric, 2013, Adv Exp Med Biol, V757, P249, DOI 10.1007/978-1-4614-4015-4_9; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi HJ, 2018, FASEB J, V32, P2563, DOI 10.1096/fj.201700924RR; Choi HJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127365; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Dankert JF, 2016, MOL CELL, V64, P507, DOI 10.1016/j.molcel.2016.09.010; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; De Felici M, 2015, INT J DEV BIOL, V59, P41, DOI 10.1387/ijdb.150064md; Deshmukh RS, 2018, CANCER RES, V78, P6386, DOI 10.1158/0008-5472.CAN-18-1772; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Ge C, 2009, BIOL REPROD, V80, P528, DOI 10.1095/biolreprod.108.072728; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gong J, 2018, ONCOL LETT, V15, P8891, DOI 10.3892/ol.2018.8500; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Han JY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-220; Han JY, 2018, INT J DEV BIOL, V62, P341, DOI 10.1387/ijdb.170255jh; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0246-0; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; Han JY, 2017, METHODS MOL BIOL, V1650, P229, DOI 10.1007/978-1-4939-7216-6_15; Han JY, 2017, METHODS MOL BIOL, V1630, P153, DOI 10.1007/978-1-4939-7128-2_13; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helle F, 2012, CANCER GENE THER, V19, P299, DOI 10.1038/cgt.2012.1; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jin SD, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0133-5; Jung HG, 2018, STEM CELLS DEV, V27, P1215, DOI 10.1089/scd.2018.0059; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim H, 2006, GENOMICS, V88, P252, DOI 10.1016/j.ygeno.2006.03.015; Kim JN, 2010, BIOL REPROD, V82, P257, DOI 10.1095/biolreprod.109.079723; Kim JN, 2004, MOL REPROD DEV, V68, P81, DOI 10.1002/mrd.20051; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kost GC, 2012, MUTAT RES-FUND MOL M, V735, P51, DOI 10.1016/j.mrfmmm.2012.05.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lee BR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-60; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Li WG, 2012, GERONTOLOGY, V58, P129, DOI 10.1159/000334368; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maheshwari A, 2009, FEBS J, V276, P870, DOI 10.1111/j.1742-4658.2008.06831.x; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Naito Mitsuru, 2007, Journal of Poultry Science, V44, P416, DOI 10.2141/jpsa.44.416; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Rengaraj D, 2012, POULTRY SCI, V91, P3167, DOI 10.3382/ps.2012-02279; Rengaraj D, 2010, THERIOGENOLOGY, V74, P765, DOI 10.1016/j.theriogenology.2010.04.001; Rengaraj D, 2008, ASIAN J ANDROL, V10, P503, DOI 10.1111/j.1745-7262.2008.00360.x; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Rengaraj D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019524; Rengaraj D, 2011, DEV DYNAM, V240, P850, DOI 10.1002/dvdy.22575; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Shen J, 2017, ONCOTARGET, V8, P110650; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Skandalis A, 2016, MUTAT RES-FUND MOL M, V784, P34, DOI 10.1016/j.mrfmmm.2016.01.002; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Strome S, 2015, NAT REV MOL CELL BIO, V16, P406, DOI 10.1038/nrm4009; Tagami T, 2017, ADV EXP MED BIOL, V1001, P1, DOI 10.1007/978-981-10-3975-1_1; Tang WWC, 2016, NAT REV GENET, V17, P585, DOI 10.1038/nrg.2016.88; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Yamamoto Y, 2007, BIOL REPROD, V77, P115, DOI 10.1095/biolreprod.107.061200; Yang SY, 2018, POULTRY SCI, V97, P650, DOI 10.3382/ps/pex316; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Yu ML, 2011, AMINO ACIDS, V40, P933, DOI 10.1007/s00726-010-0717-x; Zheng YH, 2009, REPRODUCTION, V138, P483, DOI 10.1530/REP-09-0163	81	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1001	1017		10.1096/fj.201901294R	http://dx.doi.org/10.1096/fj.201901294R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914591				2022-12-26	WOS:000507308900068
J	D'Elia, J; Brandt, J; Burnett, LJ; Haig, SM; Hollenbeck, J; Kirkland, S; Marcot, BG; Punzalan, A; West, CJ; Williams-Claussen, T; Wolstenholme, R; Young, R				D'Elia, Jesse; Brandt, Joseph; Burnett, L. Joseph; Haig, Susan M.; Hollenbeck, Jeff; Kirkland, Steve; Marcot, Bruce G.; Punzalan, Arianna; West, Christopher J.; Williams-Claussen, Tiana; Wolstenholme, Rachel; Young, Rich			Applying circuit theory and landscape linkage maps to reintroduction planning for California Condors	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HABITAT SUITABILITY MODELS; GYMNOGYPS-CALIFORNIANUS; CONSERVATION TOOL; GYPAETUS-BARBATUS; ECOLOGICAL THEORY; FLIGHT BEHAVIOR; SITE SELECTION; HOME-RANGE; VULTURES	Conservation practitioners are increasingly looking to species translocations as a tool to recover imperiled taxa. Quantitative predictions of where animals are likely to move when released into new areas would allow managers to better address the social, institutional, and ecological dimensions of conservation translocations. Using >5 million California condor (Gymnogyps californianus) occurrence locations from 75 individuals, we developed and tested circuit-based models to predict condor movement away from release sites. We found that circuit-based models of electrical current were well calibrated to the distribution of condor movement data in southern and central California (continuous Boyce Index = 0.86 and 0.98, respectively). Model calibration was improved in southern California when additional nodes were added to the circuit to account for nesting and feeding areas, where condor movement densities were higher (continuous Boyce Index = 0.95). Circuit-based projections of electrical current around a proposed release site in northern California comported with the condor's historical distribution and revealed that, initially, condor movements would likely be most concentrated in northwestern California and southwest Oregon. Landscape linkage maps, which incorporate information on landscape resistance, complement circuit-based models and aid in the identification of specific avenues for population connectivity or areas where movement between populations may be constrained. We found landscape linkages in the Coast Range and the Sierra Nevada provided the most connectivity to a proposed reintroduction site in northern California. Our methods are applicable to conservation translocations for other species and are flexible, allowing researchers to develop multiple competing hypotheses when there are uncertainties about landscape or social attractants, or uncertainties in the landscape conductance surface.	[D'Elia, Jesse; Young, Rich] US Fish & Wildlife Serv, Pacific Reg Off, Portland, OR 97232 USA; [Brandt, Joseph; Kirkland, Steve] US Fish & Wildlife Serv, Calif Condor Recovery Off, Ventura, CA USA; [Burnett, L. Joseph] Ventana Wildlife Soc, Monterey, CA USA; [Haig, Susan M.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Hollenbeck, Jeff] Northwest Habitat Inst, Corvallis, OR USA; [Marcot, Bruce G.] US Forest Serv, Pacific Northwest Res Stn, Portland, OR USA; [Punzalan, Arianna] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [West, Christopher J.; Williams-Claussen, Tiana] Wildlife Program, Klamath, CA USA; [Williams-Claussen, Tiana] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Wolstenholme, Rachel] Natl Pk Serv, Pinnacles Natl Pk, Paicines, CA USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; Colorado State University; California State University System; California State Polytechnic University, Humboldt; United States Department of the Interior	D'Elia, J (corresponding author), US Fish & Wildlife Serv, Pacific Reg Off, Portland, OR 97232 USA.	jesse_delia@fws.gov		D'Elia, Jesse/0000-0002-1843-8495				Alarcon PAE, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0133-5; Alpert P, 2000, B AM METEOROL SOC, V81, P1599; Alvarez Mario, 2011, P356; [Anonymous], 1984, FED REGISTER, V49, P33885; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bakker VJ, 2017, ECOHEALTH, V14, pS92, DOI 10.1007/s10393-015-1096-2; Bar-David S, 2005, ECOL APPL, V15, P1833, DOI 10.1890/04-0798; Bar-David S, 2008, J NAT CONSERV, V16, P164, DOI 10.1016/j.jnc.2008.09.004; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; Blazquez-Cabrera S, 2016, LANDSCAPE ECOL, V31, P2355, DOI 10.1007/s10980-016-0407-5; Bogliani G, 2011, J RAPTOR RES, V45, P56, DOI 10.3356/JRR-09-69.1; Brichieri-Colombi TA, 2016, CONSERV BIOL, V30, P1159, DOI 10.1111/cobi.12743; Carroll C, 2006, BIOSCIENCE, V56, P25, DOI 10.1641/0006-3568(2006)056[0025:DRGASF]2.0.CO;2; Cianfrani C, 2013, ANIM CONSERV, V16, P584, DOI 10.1111/acv.12033; Cianfrani C, 2010, J APPL ECOL, V47, P421, DOI 10.1111/j.1365-2664.2010.01781.x; D'Elia J, 2016, CONDOR, V118, P703, DOI 10.1650/CONDOR-16-35.1; D'Elia J, 2015, BIOL CONSERV, V184, P90, DOI 10.1016/j.biocon.2015.01.002; DElia J., 2013, CALIFORNIA CONDORS P; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; DONAZAR JA, 1993, J APPL ECOL, V30, P504, DOI 10.2307/2404190; Dunham JB, 2016, REINTRODUCTION OF FISH AND WILDLIFE POPULATIONS, P79; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; Dzialak MR, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00315.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; Gavashelishvili A, 2012, BIRD STUDY, V59, P449, DOI 10.1080/00063657.2012.728194; Gilroy JJ, 2016, J ANIM ECOL, V85, P1182, DOI 10.1111/1365-2656.12545; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Grigg NP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17794-0; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Jarchow CJ, 2016, J HERPETOL, V50, P63, DOI 10.1670/14-172; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Koford C.B., 1953, 4 NAT AUD SOC; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Lambertucci SA, 2018, BIOL CONSERV, V170, P145; Leshem Y, 1998, IBIS, V140, P41, DOI 10.1111/j.1474-919X.1998.tb04539.x; Letty J, 2007, ECOSCIENCE, V14, P420, DOI 10.2980/1195-6860(2007)14[420:PEBIIA]2.0.CO;2; Lisney TJ, 2013, ANAT REC, V296, P1954, DOI 10.1002/ar.22815; Lookingbill TR, 2010, ECOL APPL, V20, P427, DOI 10.1890/09-0073.1; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; McRae B. H., LINKAGE MAPPER CONNE; McRae B.H., 2011, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mee A., 2007, CALIFORNIA CONDORS 2; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Merow C, 2014, ECOGRAPHY, V37, P1267, DOI 10.1111/ecog.00845; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Mihoub JB, 2009, OIKOS, V118, P663, DOI 10.1111/j.1600-0706.2008.17142.x; Miller ML, 2017, ECOL MODEL, V351, P77, DOI 10.1016/j.ecolmodel.2017.02.013; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Moon JB, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1974; Morandini V, 2017, ANIM BEHAV, V130, P153, DOI 10.1016/j.anbehav.2017.06.017; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Naveda-Rodriguez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151827; Nourani E, 2017, ORNITHOL SCI, V16, P5, DOI 10.2326/osj.16.5; Ovaskainen O, 2008, ECOLOGY, V89, P542, DOI 10.1890/07-0443.1; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P527; PENNYCUICK CJ, 1984, IBIS, V126, P253, DOI 10.1111/j.1474-919X.1984.tb08005.x; Phillips S.J, 2010, LESSONS CONSERV, V3, P108; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Poessel SA, 2018, IBIS, V160, P36, DOI 10.1111/ibi.12531; Poirazidis K, 2004, BIOL CONSERV, V118, P235, DOI 10.1016/j.biocon.2003.08.016; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Richardson KM, 2015, ADVANCES IN REINTRODUCTION BIOLOGY OF AUSTRALIAN AND NEW ZEALAND FAUNA, P59; Rivers JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088430; Robertson PA, 1998, J APPL ECOL, V35, P928; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; RYAN BC, 1977, J APPL METEOROL, V16, P571, DOI [10.1175/1520-0450(1977)016<0571:AMMFDA>2.0.CO;2, 10.1175/1520-0450(1977)016&lt;0571:AMMFDA&gt;2.0.CO;2]; Ryan BC, 1983, PSW73 PAC SW FOR RAN; Rytteri S, 2017, BIOL CONSERV, V215, P189, DOI 10.1016/j.biocon.2017.09.018; Sainsbury AW, 2012, CONSERV BIOL, V26, P442, DOI 10.1111/j.1523-1739.2012.01839.x; Santos CD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05319-8; Schumaker NH, 2018, LANDSCAPE ECOL, V33, P197, DOI 10.1007/s10980-017-0605-9; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shamoun-Baranes J, 2017, J COMP PHYSIOL A, V203, P509, DOI 10.1007/s00359-017-1181-9; SNYDER NFR, 1986, CONDOR, V88, P228, DOI 10.2307/1368920; Snyder NFR., 2000, CALIFORNIA CONDOR SA; Southwest Condor Working Group, 2017, CAL COND REC PROGR S; Spiegel O, 2013, AM NAT, V181, pE102, DOI 10.1086/670009; Stoynov Emilian, 2015, Vulture News, V69, P33; Torres RT, 2017, ORYX, V51, P709, DOI 10.1017/S003060531600065X; Trainor AM, 2013, LANDSCAPE ECOL, V28, P755, DOI 10.1007/s10980-013-9861-5; U.S. Fish and Wildlife Service, 2017, HOPP MOUNT NAT WILDL; Ventana Wildlife Society, 2016, VENT WILDL SOC CAL C; Ventana Wildlife Society, 2017, VENT WILDL SOC CAL C; Walters JR, 2010, AUK, V127, P969, DOI 10.1525/auk.2010.127.4.969; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Zamboni T, 2017, PERSPECT ECOL CONSER, V15, P248, DOI 10.1016/j.pecon.2017.10.001; Ziolkowska E, 2016, BIOL CONSERV, V195, P106, DOI 10.1016/j.biocon.2015.12.032	99	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226491	10.1371/journal.pone.0226491	http://dx.doi.org/10.1371/journal.pone.0226491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891594	Green Published, gold			2022-12-26	WOS:000515096600015
J	Pedraz, L; Blanco-Cabra, N; Torrents, E				Pedraz, Lucas; Blanco-Cabra, Nuria; Torrents, Eduard			Gradual adaptation of facultative anaerobic pathogens to microaerobic and anaerobic conditions	FASEB JOURNAL			English	Article						biofilm; Escherichia; oxygen; Pseudomonas; ribonucleotide	PSEUDOMONAS-AERUGINOSA PAO1; REGULATED GENE-EXPRESSION; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; PHYSIOLOGICAL HETEROGENEITY; TRANSCRIPTIONAL REGULATOR; OXYGEN CONCENTRATION; CLASS-II; FNR; NITRATE	Many notable human pathogens are facultative anaerobes. These pathogens exhibit redundant metabolic pathways and a whole array of regulatory systems to adapt to changing oxygen levels. However, our knowledge of facultative anaerobic pathogens is mostly based on fully aerobic or anaerobic cultures, which does not reflect real infection conditions, while the microaerobic range remains understudied. Here, we examine the behavior of pathogenic and nonpathogenic strains of two facultative anaerobes, Escherichia coli and Pseudomonas aeruginosa, during the aerobic-anaerobic transition. To do so, we introduce a new technique named AnaeroTrans, in which we allow self-consumption of oxygen by steady-state cultures and monitor the system by measuring the gas-phase oxygen concentration. We explore the different behavior of the studied species toward oxygen and examine how this behavior is associated with the targeted infection sites. As a model, we characterize the adaptation profile of the ribonucleotide reductase network, a complex oxygen-dependent enzymatic system responsible for the generation of the deoxyribonucleotides. We also explore the actions of the most important anaerobic regulators and how these regulators influence bacterial fitness. Our results allow us to classify the different elements that compose the aerobic-anaerobic transition into reproducible stages, thus showing the different adaptation mechanisms of the studied species.	[Pedraz, Lucas; Blanco-Cabra, Nuria; Torrents, Eduard] BIST, Inst Bioengn Catalonia IBEC, Bacterial Infect Antimicrobial Therapies Grp, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Pedraz, L; Torrents, E (corresponding author), BIST, Inst Bioengn Catalonia IBEC, Bacterial Infect Antimicrobial Therapies Grp, Barcelona, Spain.	lpedraz@ibecbarcelona.eu; etorrents@ibecbarcelona.eu	Blanco-Cabra, Nuria/AAT-9770-2021; Pedraz, Lucas/T-1731-2019; Torrents, Eduard/C-7184-2008	Blanco-Cabra, Nuria/0000-0002-4784-1072; Pedraz, Lucas/0000-0003-3666-3343; Torrents, Eduard/0000-0002-3010-1609	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER) [BIO2015-63557-R, RTI2018-098573-B-100]; Generalitat de Catalunya/CERCA Program [2017 SGR1079]; La Caixa Foundation; Catalan Cystic Fibrosis foundation; FI-DGR program [2015-FI-B-00817]; Spanish Cystic Fibrosis foundation	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER); Generalitat de Catalunya/CERCA Program; La Caixa Foundation(La Caixa Foundation); Catalan Cystic Fibrosis foundation; FI-DGR program; Spanish Cystic Fibrosis foundation	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER), Grant/Award Number: BIO2015-63557-R and RTI2018-098573-B-100; Generalitat de Catalunya/CERCA Program, Grant/Award Number: 2017 SGR1079; La Caixa Foundation, and Catalan and Spanish Cystic Fibrosis foundations; FI-DGR program, Grant/Award Number: 2015-FI-B-00817	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Becker S, 1997, ARCH MICROBIOL, V168, P290, DOI 10.1007/s002030050501; Bettenbrock K, 2014, ADV MICROB PHYSIOL, V64, P65, DOI 10.1016/B978-0-12-800143-1.00002-6; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003; Chen F, 2006, BIOTECHNOL BIOENG, V93, P1069, DOI 10.1002/bit.20812; Crespo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14051-2; Crespo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00688; Crespo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123571; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Cendra MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046350; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; GUEST JR, 1992, J GEN MICROBIOL, V138, P2253, DOI 10.1099/00221287-138-11-2253; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hong CS, 2004, J BIOSCI BIOENG, V97, P184, DOI 10.1263/jbb.97.184; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Poole AM, 2002, J MOL EVOL, V55, P180, DOI 10.1007/s00239-002-2315-3; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Rolfe MD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120091; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; SAWERS RG, 1991, MOL MICROBIOL, V5, P1469, DOI 10.1111/j.1365-2958.1991.tb00793.x; Schiessl KT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08733-w; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Tata M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147811; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; TUGGLE CK, 1986, EMBO J, V5, P1077, DOI 10.1002/j.1460-2075.1986.tb04325.x; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	64	9	9	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2912	2928		10.1096/fj.201902861R	http://dx.doi.org/10.1096/fj.201902861R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908067	Bronze			2022-12-26	WOS:000504676700001
J	Hilliard, KA; Blaho, VA; Jackson, CD; Brown, CR				Hilliard, Kinsey A.; Blaho, Victoria A.; Jackson, Christa D.; Brown, Charles R.			Leukotriene B4 receptor BLT1 signaling is critical for neutrophil apoptosis and resolution of experimental Lyme arthritis	FASEB JOURNAL			English	Article						BLT1; efferocytosis; Lyme arthritis; resolution	COLLAGEN-INDUCED ARTHRITIS; BORRELIA-BURGDORFERI; B-4 RECEPTORS; ALVEOLAR MACROPHAGES; LIPID MEDIATORS; SYNOVIAL-FLUID; HOST-DEFENSE; IN-VITRO; PHAGOCYTOSIS; INFLAMMATION	Eicosanoids are powerful mediators of inflammation and are known to drive both the progression and regression of arthritis. We previously reported the infection of C3H 5-lipoxygenase (LO)-deficient mice with Borrelia burgdorferi results in prolonged nonresolving Lyme arthritis. Here we define the role of the 5-LO metabolite leukotriene (LT)B-4 and its high-affinity receptor, BLT1, in this response. C3H and C3H BLT1(-/-) mice were infected with B. burgdorferi and arthritis progression was monitored by ankle swelling over time. Similar to 5-LO-/- mice, BLT1(-/-) mice developed nonresolving Lyme arthritis characterized by increased neutrophils in the joint at later time points than WT mice, but with fewer apoptotic (caspase-3(+)) neutrophils. In vitro, BLT1(-/-) neutrophils were defective in their ability to undergo apoptosis due to the lack of LTB4-mediated down-regulation of cAMP, subsequent failure to induce Death-Inducing Signaling Complex (DISC) components, and decreased FasL and CD36 expression. Inhibition of adenylyl cyclase with SQ 22,536 restored BLT1(-/-) BMN apoptosis, FasL and CD36 expression, and clearance by macrophages. We conclude that LTB4/BLT1 signaling has an unexpected critical role in mediating neutrophil apoptosis via the down-regulation of cAMP. Loss of BLT1 signaling led to defective clearance of neutrophils from the inflamed joint and failed arthritis resolution.	[Hilliard, Kinsey A.; Jackson, Christa D.; Brown, Charles R.] Univ Missouri, Coll Vet Med, Dept Pathobiol, Columbia, MO USA; [Blaho, Victoria A.] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, San Diego, CA USA	University of Missouri System; University of Missouri Columbia; Sanford Burnham Prebys Medical Discovery Institute	Brown, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, 315 Connaway Hall, Columbia, MO 65211 USA.	BrownChar@missouri.edu		Brown, Charles/0000-0002-1914-9601; Jackson, Christa/0000-0002-4152-2222	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR052748]; UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR052748; UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; BARTHOLD SW, 1995, J INFECT DIS, V172, P778, DOI 10.1093/infdis/172.3.778; Barthold SW, 1996, LAB INVEST, V74, P57; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; Blaho VA, 2008, ARTHRITIS RHEUM-US, V58, P1485, DOI 10.1002/art.23371; Blaho VA, 2011, J IMMUNOL, V186, P3076, DOI 10.4049/jimmunol.1003473; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Brandt SL, 2017, SEMIN IMMUNOL, V33, P37, DOI 10.1016/j.smim.2017.08.006; Brown CR, 2006, J INTERF CYTOK RES, V26, P390, DOI 10.1089/jir.2006.26.390; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Carroll JA, 2003, MICROBIOL-SGM, V149, P1819, DOI 10.1099/mic.0.26165-0; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dasgupta Y, 2016, BLOOD, V127, P2131, DOI 10.1182/blood-2015-11-681171; DeLeon-Pennell KY, 2016, CIRC-CARDIOVASC GENE, V9, P14, DOI 10.1161/CIRCGENETICS.115.001249; Diaz-Gonzalez F, 2007, ANN RHEUM DIS, V66, P628, DOI 10.1136/ard.2006.062554; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Gheorghe KR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2717; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Hashimoto A, 2003, J RHEUMATOL, V30, P1712; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Kuwabara K, 2000, EUR J PHARMACOL, V402, P275, DOI 10.1016/S0014-2999(00)00518-5; Lasky CE, 2015, INFECT IMMUN, V83, P2627, DOI 10.1128/IAI.00369-15; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Lokuta Mary A., 2007, V412, P211, DOI 10.1007/978-1-59745-467-4_14; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; MAYATEPEK E, 1993, MEDIAT INFLAMM, V2, P225, DOI 10.1155/S0962935193000304; Miyabe Y, 2017, SEMIN IMMUNOL, V33, P52, DOI 10.1016/j.smim.2017.09.009; Nagatake T, 2019, MUCOSAL IMMUNOL, V12, P1082, DOI 10.1038/s41385-019-0175-z; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Sasaki F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185133; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SCHAIBLE UE, 1989, J EXP MED, V170, P1427, DOI 10.1084/jem.170.4.1427; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Silva MT, 2010, J LEUKOCYTE BIOL, V88, P885, DOI 10.1189/jlb.0410205; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; WEINBLATT ME, 1992, J RHEUMATOL, V19, P1537; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Xu SH, 2010, RHEUMATOL INT, V30, P1183, DOI 10.1007/s00296-009-1125-y; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Zhang M, 2011, INVEST OPHTH VIS SCI, V52, P1800, DOI 10.1167/iovs.10-6904; Zhang Y, 2017, J LIPID RES, V58, P494, DOI 10.1194/jlr.M068882	55	4	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2840	2852		10.1096/fj.201902014R	http://dx.doi.org/10.1096/fj.201902014R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908031	Bronze			2022-12-26	WOS:000504270500001
J	Fichorova, RN; Morrison, CS; Chen, PL; Yamamoto, HS; Govender, Y; Junaid, D; Ryan, S; Kwok, C; Chipato, T; Salata, RA; Doncel, GF				Fichorova, Raina N.; Morrison, Charles S.; Chen, Pai-Lien; Yamamoto, Hidemi S.; Govender, Yashini; Junaid, Damilola; Ryan, Stanthia; Kwok, Cynthia; Chipato, Tsungai; Salata, Robert A.; Doncel, Gustavo F.			Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; HIV ACQUISITION; HORMONAL CONTRACEPTION; GENITAL INFLAMMATION; MEDROXYPROGESTERONE; NORETHISTERONE; PROGESTINS; INCREASES; CYTOKINES; DISEASES	Sexually transmitted infections (STIs) and vaginal dysbiosis (disturbed resident microbiota presenting with abnormal Nugent score or candidiasis) have been associated with mucosal inflammation and risk of HIV-1 infection, cancer and poor reproductive outcomes. To date, the temporal relationships between aberrant cervical innate immunity and the clinical onset of microbial disturbance have not been studied in a large population of reproductive age women. We examined data from a longitudinal cohort of 934 Ugandan and Zimbabwean women contributing 3,274 HIV-negative visits who had complete laboratory, clinical and demographic data. Among those, 207 women later acquired HIV, and 584 women were intermittently diagnosed with C. trachomatis (CT), N. gonorrhoeae (NG), genital herpes (HSV-2), T. vaginalis (TV), candidiasis, and abnormal intermediate (4-6) or high (7-10) Nugent score, i.e. bacterial vaginosis (BV). Immune biomarker concentrations in cervical swabs were analyzed by generalized linear and mixed effect models adjusting for site, age, hormonal contraceptive use (HC), pregnancy, breastfeeding, genital practices, unprotected sex and overlapping infections. High likelihood ratios (1.5-4.9) denoted the values of cervical immune biomarkers to predict onset of abnormal Nugent score and candidiasis at the next visits. When controlling for covariates, higher levels of beta-defensin-2 were antecedent to BV, CT and HSV-2, lower anti-inflammatory ratio IL-1RA:IL-1 beta-to intermediate Nugent scores and candida, lower levels of the serine protease inhibitor SLPI-to candida, lower levels of the adhesion molecule ICAM-1 -to TV, and lower levels of the oxidative stress mitigator and endothelial activation marker VEGF-to NG. Changes in innate immunity following onset of dysbiosis and infections were dependent on HC use when controlling for all other covariates. In conclusion, imminent female genital tract dysbiosis or infection can be predicted by distinct patterns of innate immunity. Future research should characterize biotic and abiotic determinants of this pre-existing innate immunity state.	[Fichorova, Raina N.; Yamamoto, Hidemi S.; Govender, Yashini; Junaid, Damilola; Ryan, Stanthia] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol, Boston, MA 02115 USA; [Morrison, Charles S.] FHI, Behav Epidemiol & Clin Sci, Durham, NC USA; [Chen, Pai-Lien; Kwok, Cynthia] FHI, Biostat, Durham, NC USA; [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe; [Salata, Robert A.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Doncel, Gustavo F.] CONRAD, Arlington, VA USA; [Doncel, Gustavo F.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Zimbabwe; Case Western Reserve University; Eastern Virginia Medical School	Fichorova, RN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol, Boston, MA 02115 USA.	rfichorova@bwh.harvard.edu		Fichorova, Raina/0000-0002-9980-5735	National Institutes of Health/National Institute of Child Health and Human Development [R01 HD077888, R01 HD0990919]	National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health/National Institute of Child Health and Human Development R01 HD077888 (CSM and RNF) and R01 HD0990919 (RNF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Achilles SL, 2018, CONTRACEPTION, V97, P346, DOI 10.1016/j.contraception.2017.09.013; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Alcaide ML, 2017, AIDS RES HUM RETROV, V33, P309, DOI [10.1089/aid.2016.0187, 10.1089/AID.2016.0187]; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; [Anonymous], 2015, TRENDS CONTR US WORL; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Barker L, 2001, AM STAT, V55, P279, DOI 10.1198/000313001753272213; Birse KD, 2017, J INFECT DIS, V215, P590, DOI 10.1093/infdis/jiw590; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Buckley N, 2016, AM J REPROD IMMUNOL, V75, P146, DOI 10.1111/aji.12461; Buve A, 2014, AIDS, V28, P2333, DOI 10.1097/QAD.0000000000000432; Consortium EfCOaHOET, 2019, LANCET; Doumas S, 2005, INFECT IMMUN, V73, P1271, DOI 10.1128/IAI.73.3.1271-1274.2005; Fichorova RN, 2015, MBIO, V6, DOI 10.1128/mBio.00221-15; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; FICHOROVA RN, 2004, J ACQUIR IMMUNE D S3, V37, pS18; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Govender Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096497; Haimovici F, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12832; Hapgood JP, 2014, AM J REPROD IMMUNOL, V71, P505, DOI 10.1111/aji.12214; Hofmeyr GJ, GATES OPEN RES, V1, P1, DOI [10.12688/gatesopenres.12756.1, DOI 10.12688/GATESOPENRES.12756.1]; Huijbregts RPH, 2014, CONTRACEPTION, V90, P123, DOI 10.1016/j.contraception.2014.02.006; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kim HS, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e49; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Louw-du Toit R, 2014, J BIOL CHEM, V289, P31136, DOI 10.1074/jbc.M114.587311; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Mauck C, 2016, AIDS RES HUM RETROV, V32, P443, DOI [10.1089/aid.2015.0088, 10.1089/AID.2015.0088]; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McKinnon LR, 2018, NAT MED, V24, P491, DOI 10.1038/nm.4506; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b; Morrison CS, 2018, AIDS RES HUM RETROV, V34, P889, DOI [10.1089/aid.2018.0022, 10.1089/AID.2018.0022]; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Murphy K, 2014, AM J REPROD IMMUNOL, V72, P228, DOI 10.1111/aji.12209; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Schwebke JR, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00252-18; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0224359	10.1371/journal.pone.0224359	http://dx.doi.org/10.1371/journal.pone.0224359			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914129	Green Published, gold			2022-12-26	WOS:000534337700007
J	Kunzmann, A; Diemel, VC				Kunzmann, Andreas; Diemel, Valeska C.			The effect of spatial position and age within an egg-clutch on embryonic development and key metabolic enzymes in two clownfish species, Amphiprion ocellaris and Amphiprion frenatus	PLOS ONE			English	Article							JUVENILE SEA-CUCUMBER; YOLK-SAC LARVAE; OXYGEN-CONSUMPTION; THERMAL-STRESS; GROWTH; TEMPERATURE; PROTEIN; SIZE	Since the size of newly hatched larval fish is directly related to egg size, small differences in initial egg size can be critical to survival and further development of offspring. Underlying processes causing size variation in fish offspring are still not entirely understood. In this study we investigated whether the spatial position of an individual egg within a clutch affects size variation in two benthic spawning coral reef fishes, the clownfishes Amphiprion ocellaris and A. frenatus. To evaluate the effects of within-clutch position on embryonic development, egg growth metrics and protein content were analysed on day 2, 5 and 8 after deposition (adp). Additionally the activities of the key metabolic enzymes citrate synthase (CS) and lactate dehydrogenase (LDH) were investigated to evaluate the physiological status of the embryos. Central eggs of A. frenatus were significantly longer and heavier than peripheral eggs only on day 2 and 5 adp (2.07 mg, 2.59 mm vs. 1.84 mg, 2.49 mm). No significant differences were observed in A. ocellaris between eggs originating from a central or peripheral (5 mm from edge) position (1.33 mg, 2.26 mm vs. 1.15 mg, 2,18 mm). Diameter of the eyes did not differ between the two fish species nor between different positions, for any age group. The protein content of eggs (7.5% of wet weight) was independent of age, position and species. Enzymatic activity increased from 2 adp until peak activity was observed for both enzymes on day 8 adp, independent from position. The range of CS- and LDH-activity was 0.3-13.0 and 0.2-71.7 U g(-1) wet weight, respectively. Significant differences in enzymatic activity were observed between age groups in both species, which in connection with significantly larger eggs of A. frenatus at day 2 and 5 adp could hint at a better O-2 supply of central eggs. Potential implications for captive breeding are given.	[Kunzmann, Andreas; Diemel, Valeska C.] Leibniz Ctr Trop Marine Res, Fahrenheitsstr, Bremen, Germany; [Diemel, Valeska C.] Univ Bremen, Bibliothekstr, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen	Kunzmann, A (corresponding author), Leibniz Ctr Trop Marine Res, Fahrenheitsstr, Bremen, Germany.	andreas.kunzmann@leibniz.zmt.de	Kunzmann, Andreas/O-1345-2013	Kunzmann, Andreas/0000-0002-9500-4332	WG Ecophysiology of ZMT	WG Ecophysiology of ZMT	WG Ecophysiology of ZMT has contributed funds.	[Anonymous], PROTEINS FISH MUSCLE; [Anonymous], INDIAN J GEOMARINE S; [Anonymous], SUCCESSFUL CAPTIVE B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLINS LA, 1993, MAR BIOL, V117, P195, DOI 10.1007/BF00345663; Cooper RU, 2002, J EXP MAR BIOL ECOL, V279, P1, DOI 10.1016/S0022-0981(02)00329-5; de Almeida-Val Vera Maria F., 2006, Fish Physiology, V21, P443; Dhaneesh K. V., 2012, Emirates Journal of Food and Agriculture, V24, P92; Fuiman LA, 1998, COPEIA, P602, DOI 10.2307/1447790; Green BS, 2006, J EXP MAR BIOL ECOL, V329, P144, DOI 10.1016/j.jembe.2005.08.012; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Hickey AJR, 2003, J COMP PHYSIOL B, V173, P113, DOI 10.1007/s00360-002-0313-9; HOCHACHKA PW, 1970, COMP BIOCHEM PHYSIOL, V33, P529, DOI 10.1016/0010-406X(70)90369-5; Kamyab E, 2017, J COMP PHYSIOL B, V187, P51, DOI 10.1007/s00360-016-1015-z; Kuhnhold H, 2017, AQUACULTURE, V467, P109, DOI 10.1016/j.aquaculture.2016.03.018; Lannig G, 2003, MAR BIOL, V142, P589, DOI 10.1007/s00227-002-0967-6; Lushchak VI, 2001, BRAZ J MED BIOL RES, V34, P1055, DOI 10.1590/S0100-879X2001000800013; Madhu Rema, 2012, Journal of the Marine Biological Association of India, V54, P77, DOI 10.6024/jmbai.2012.54.1.01698-10; Rhyne AL, 2017, PEERJ, V5, DOI 10.7717/peerj.2949; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; Smith RW, 2006, COMP BIOCHEM PHYS A, V143, P315, DOI 10.1016/j.cbpa.2005.12.005; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; Wabnitz C, 2003, OCEAN AQUARIUM; Yasir I, 2007, J MAR BIOL ASSOC UK, V87, P1025, DOI 10.1017/S0025315407054227	24	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226600	10.1371/journal.pone.0226600	http://dx.doi.org/10.1371/journal.pone.0226600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914136	Green Published, gold			2022-12-26	WOS:000534337700015
J	Steiner, B; Ferrucci, LM; Mirabello, L; Lan, Q; Hu, W; Liao, LM; Savage, SA; De Vivo, I; Hayes, RB; Rajaraman, P; Huang, WY; Freedman, ND; Loftfield, E				Steiner, Bella; Ferrucci, Leah M.; Mirabello, Lisa; Lan, Qing; Hu, Wei; Liao, Linda M.; Savage, Sharon A.; De Vivo, Immaculata; Hayes, Richard B.; Rajaraman, Preetha; Huang, Wen-Yi; Freedman, Neal D.; Loftfield, Erikka			Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial	PLOS ONE			English	Article							CIGARETTE-SMOKING; HEPATOCELLULAR-CARCINOMA; RISK; CONSUMPTION; DIETARY; REPRODUCIBILITY; QUESTIONNAIRE; METAANALYSIS; VALIDITY; DNA	Mounting evidence indicates that coffee, a commonly consumed beverage worldwide, is inversely associated with various chronic diseases and overall mortality. Few studies have evaluated the effect of coffee drinking on telomere length, a biomarker of chromosomal integrity, and results have been inconsistent. Understanding this association may provide mechanistic insight into associations of coffee with health. The aim of our study was to test the hypothesis that heavier coffee intake is associated with greater likelihood of having above-median telomere length. We evaluated the cross-sectional association between coffee intake and relative telomere length using data from 1,638 controls from four previously conducted case-control studies nested in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Coffee intake was assessed using a food frequency questionnaire, and relative telomere length was measured from buffy-coat, blood, or buccal cells. We used unconditional logistic regression models to generate multivariable-adjusted, study-specific odds ratios for the association between coffee intake and relative telomere length. We then conducted a random-effects meta-analysis to determine summary odds ratios. We found that neither summary continuous (OR = 1.01, 95% CI = 0.99-1.03) nor categorical (OR < 3 cups/day vs. none = 1.37, 95% CI = 0.71-2.65; OR >= 3 cups/day vs. none = 1.47, 95% CI = 0.81-2.66) odds ratio estimates of coffee drinking and relative telomere length were statistically significant. However, in the largest of the four contributing studies, moderate (< 3 cups/ day) and heavy coffee drinkers (>= 3 cups/day) were 2.10 times (95% CI = 1.25, 3.54) and 1.93 times as likely (95% CI = 1.17, 3.18) as nondrinkers to have above-median telomere length, respectively. In conclusion, we found no evidence that coffee drinking is associated with telomere length. Thus, it is unlikely that telomere length plays a role in potential coffeedisease associations.	[Steiner, Bella; Ferrucci, Leah M.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA; [Mirabello, Lisa; Lan, Qing; Hu, Wei; Liao, Linda M.; Savage, Sharon A.; Rajaraman, Preetha; Huang, Wen-Yi; Freedman, Neal D.; Loftfield, Erikka] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [De Vivo, Immaculata] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Hayes, Richard B.] NYU Langone Hlth, New York, NY USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; NYU Langone Medical Center	Loftfield, E (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	erikka.loftfield@nih.gov	Loftfield, Erikka/Z-2121-2018; Freedman, Neal David/B-9741-2015; Liao, Linda/B-3960-2011	Loftfield, Erikka/0000-0002-3573-8748; Freedman, Neal David/0000-0003-0074-1098; De Vivo, Immaculata/0000-0002-7185-7402; Liao, Linda/0000-0002-1923-5294; Hayes, Richard/0000-0002-0918-661X	Intramural Research Program of the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services	Intramural Research Program of the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the Intramural Research Program of the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services. There was no additional external funding received for this study.	Agricultural Research Service US Department of Agriculture, 1997, DES OP CONT SURV FOO; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Cardin R, 2013, DIGEST LIVER DIS, V45, P499, DOI 10.1016/j.dld.2012.10.021; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Guertin KA, 2016, INT J EPIDEMIOL, V45, P929, DOI 10.1093/ije/dyv104; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hu Y, 2018, GASTROENTEROLOGY, V154, P916, DOI 10.1053/j.gastro.2017.11.010; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Kasielski M, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0189-2; Liu JJ, 2016, J NUTR, V146, P1373, DOI 10.3945/jn.116.230490; Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015; Loftfield E, 2016, J NUTR, V146, P1762, DOI 10.3945/jn.116.233940; Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T; Loftfield E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju421; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Madrid AS, 2016, CLIN CHEM, V62, P1140, DOI 10.1373/clinchem.2016.258566; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Peacock SD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205697; Petrick JL, 2015, CANCER EPIDEM BIOMAR, V24, P1398, DOI 10.1158/1055-9965.EPI-15-0137; Pinsky PF, 2016, CANCER EPIDEMIOL, V45, P26, DOI 10.1016/j.canep.2016.09.003; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; Tucker LA, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0162-x; United States Department of Agriculture, 2018, COFF WORLD MARK TRAD; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walcott F, 2013, CANCER EPIDEMIOL, V37, P935, DOI 10.1016/j.canep.2013.10.002; Wan SG, 2017, CARCINOGENESIS, V38, P439, DOI 10.1093/carcin/bgx021; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993; Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13410	38	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2020	15	1							e0226972	10.1371/journal.pone.0226972	http://dx.doi.org/10.1371/journal.pone.0226972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5DK	31914160	Green Published, gold			2022-12-26	WOS:000534337700022
J	Chen, CJ; Yang, CJ; Yang, SF; Huang, MS; Liu, YP				Chen, Chao-Ju; Yang, Chih-Jen; Yang, Sheau-Fang; Huang, Ming-Shyang; Liu, Yu-Peng			The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing beta-catenin activity	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; LUNG ADENOCARCINOMA; TUMOR-CELLS; MECHANISM; RESPONSES; INTERACT; SELECTS	Cancer cells with mesenchymal attributes potentially display chemoresistance. Cancer stem cells (CSCs), which are intrinsically resistant to most chemotherapy agents, exhibit considerable phenotypic heterogeneity in their epithelial versus mesenchymal states. However, the drug response of CSCs in the epithelial and mesenchymal states has not been completely investigated. In this study, we found that epithelial-type (E-cadherin(high)/CD133(high)) CSCs displayed a higher sphere formation ability and chemoresistance than mesenchymal-type (E-cadherin(low)CD133(high)) CSCs. Gene expression profiling of the CSC and non-CSC subpopulations with distinct epithelial-to-mesenchymal transition (EMT) states showed that MyoD family inhibitor domain-containing (MDFIC) was selectively upregulated in epithelial-type CSCs. Knockdown of MDFIC sensitized epithelial-type CSCs to chemotherapy agents. Ectopic expression of MDFIC increased the chemoresistance of mesenchymal-type CSCs. In a tissue microarray, high MDFIC expression was associated with poor prognosis of non-small cell lung cancer (NSCLC) patients. A mechanistic study showed that the MDFIC p32 isoform, which is located in the cytoplasm, interacted with the destruction complex, Axin/GSK-3/beta-catenin. This interaction stabilized beta-catenin by inhibiting beta-catenin phosphorylation at S33/37 and increased the nuclear translocation and transcriptional activity of beta-catenin. Knockdown of beta-catenin decreased MDFIC-enhanced chemoresistance. These results suggested that the upregulation of MDFIC enhanced the chemoresistance of epithelial-type CSCs by elevating beta-catenin activity. Thus, targeting MDFIC-regulated beta-catenin signaling of epithelial-type CSCs may be a potential strategy to overcome chemoresistance in NSCLC.	[Chen, Chao-Ju] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chao-Ju] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Internal Med, Kaohsiung, Taiwan; [Yang, Chih-Jen] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Pathol, Kaohsiung, Taiwan; [Huang, Ming-Shyang] E DA Canc Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ming-Shyang] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Liu, YP (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.; Liu, YP (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	ypliu@kmu.edu.tw		Liu, Yu-Peng/0000-0002-2716-0050	Ministry of Science and Technology of Taiwan [MOST 107-2320-B-037-025-]; Kaohsiung Medical University Hospital [KMUH106-6M63]; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project, Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project, Ministry of Education (MOE) in Taiwan	This study was financially supported by the Ministry of Science and Technology of Taiwan (MOST 107-2320-B-037-025-) and Kaohsiung Medical University Hospital (KMUH106-6M63). This work was also financially supported by the Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. We thank Dr Michael Hsiao for providing the tissue microarray chips. We thank the assistance of the Department of Pathology and the Biobank in Kaohsiung Medical University Hospital, Kaohsiung, Taiwan for the clinical sample collection. We thank the Center for Research Resources and Development in Kaohsiung Medical University for the instrumental support for the confocal microscope and TissueFAX system. The authors thank the Immunobiology core facility of Clinical Medicine Research Center in National Cheng Kung University Hospital for assisting with the fluorescence-activated cell sorting.	Beck TN, 2016, CELL REP, V16, P657, DOI 10.1016/j.celrep.2016.06.043; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang YW, 2015, CANCER RES, V75, P3398, DOI 10.1158/0008-5472.CAN-14-3265; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Huang XJ, 2018, J BIOL CHEM, V293, P6693, DOI 10.1074/jbc.RA118.001689; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Li GM, 2018, INT J BIOL SCI, V14, P280, DOI 10.7150/ijbs.23756; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu YP, 2013, CANCER RES, V73, P406, DOI 10.1158/0008-5472.CAN-12-1733; Luo M, 2018, CELL METAB, V28, P69, DOI 10.1016/j.cmet.2018.06.006; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mittal V, 2016, ADV EXP MED BIOL, V890, P37, DOI 10.1007/978-3-319-24932-2_3; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Oakley RH, 2017, J BIOL CHEM, V292, P5825, DOI 10.1074/jbc.M116.758888; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Pore M, 2016, CLIN LUNG CANCER, V17, P535, DOI 10.1016/j.cllc.2016.05.015; Reck M, 2017, NEW ENGL J MED, V377, P849, DOI 10.1056/NEJMra1703413; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Sen Heng W, 2019, BIOCHEM PHARMACOL, V160, P121, DOI 10.1016/j.bcp.2018.12.010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Song C, 2009, BIOL CHEM, V390, P215, DOI 10.1515/BC.2009.028; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thebault S, 2001, CURR PROTEIN PEPT SC, V2, P155, DOI 10.2174/1389203013381143; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Thu Kelsie L, 2014, Oncoscience, V1, P326; Tiran V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09929-0; Tsoukalas N, 2017, ANTICANCER RES, V37, P1773, DOI 10.21873/anticanres.11510; Vijay GV, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1125-0; Wang D, 2018, CANCER BIOMARK, V22, P385, DOI 10.3233/CBM-170835; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Wu DM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1591-4; Xu YR, 2017, SEMIN CELL DEV BIOL, V63, P23, DOI 10.1016/j.semcdb.2016.07.028; Yadav AK, 2019, STEM CELL REV REP, V15, P331, DOI 10.1007/s12015-019-09887-2; Yakisich JS, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694310; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang M, 2019, CURR MOL MED, V19, P349, DOI 10.2174/1566524019666190405121139	44	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2377	2390		10.1038/s41388-019-1152-4	http://dx.doi.org/10.1038/s41388-019-1152-4		JAN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31911618				2022-12-26	WOS:000508154600002
J	Mao, YM; Chen, L; Li, JH; Shangguan, AJ; Kujawa, S; Zhao, H				Mao, Yimin; Chen, Le; Li, Jianghua; Shangguan, Anna Junjie; Kujawa, Stacy; Zhao, Hong			A network analysis revealed the essential and common downstream proteins related to inguinal hernia	PLOS ONE			English	Article							DETECTING ESSENTIAL PROTEINS; GENE PROMOTER; PPI NETWORK; GROWTH; REPAIR; CENTRALITY; ACTIVATION; RESISTANCE; RECEPTOR; TOPOLOGY	Although more than 1 in 4 men develop symptomatic inguinal hernia during their lifetime, the molecular mechanism behind inguinal hernia remains unknown. Here, we explored the protein-protein interaction network built on known inguinal hernia-causative genes to identify essential and common downstream proteins for inguinal hernia formation. We discovered that PIK3R1, PTPN11, TGFBR1, CDC42, SOS1, and KRAS were the most essential inguinal hernia-causative proteins and UBC, GRB2, CTNNB1, HSP90AA1, CBL, PLCG1, and CRK were listed as the most commonly-involved downstream proteins. In addition, the transmembrane receptor protein tyrosine kinase signaling pathway was the most frequently found inguinal hernia-related pathway. Our in silico approach was able to uncover a novel molecular mechanism underlying inguinal hernia formation by identifying inguinal hernia-related essential proteins and potential common downstream proteins of inguinal hernia-causative proteins.	[Mao, Yimin; Chen, Le; Li, Jianghua] Jiangxi Univ Sci & Technol, Sch Informat & Technol, Nanchang, Jiangxi, Peoples R China; [Mao, Yimin] Jiangxi Univ Sci & Technol, Appl Sci Inst, Nanchang, Jiangxi, Peoples R China; [Shangguan, Anna Junjie] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kujawa, Stacy; Zhao, Hong] Northwestern Univ, Dept Obstet & Gynecol, Div Reprod Sci Med, Feinberg Sch Med, Chicago, IL 60611 USA	Jiangxi University of Science & Technology; Jiangxi University of Science & Technology; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhao, H (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Div Reprod Sci Med, Feinberg Sch Med, Chicago, IL 60611 USA.	h-zhao@northwestern.edu	li, jianghua/GXG-4735-2022	Zhao, Hong/0000-0003-4616-3123				Abdeen NS, 2011, APPL RADIOL, V40, P6; Antoniou GA, 2013, VASCULAR, V21, P1, DOI 10.1258/vasc.2011.oa0322; Arozarena I, 2000, J BIOL CHEM, V275, P26441, DOI 10.1074/jbc.M002992200; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Burcharth J, 2013, HERNIA, V17, P183, DOI 10.1007/s10029-013-1060-4; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Cheung LWT, 2014, CANCER CELL, V26, P479, DOI 10.1016/j.ccell.2014.08.017; Chua HN, 2008, PROC INT C TOOLS ART, P66, DOI 10.1109/ICTAI.2008.107; Chung L, 2011, BRIT J SURG, V98, P596, DOI 10.1002/bjs.7355; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Findlay GM, 2013, CELL, V152, P1008, DOI 10.1016/j.cell.2013.01.056; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gianetta E, 1997, BRIT J SURG, V84, P983, DOI 10.1002/bjs.1800840721; Gilbert A I, 1988, J Fla Med Assoc, V75, P742; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gunnarsson U, 1999, EUR J SURG, V165, P326; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han QL, 2014, GENE, V546, P1, DOI 10.1016/j.gene.2014.05.058; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Hossain Sajjad, 2012, Genes Cancer, V3, P402, DOI 10.1177/1947601912460051; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jorgenson E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10130; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Lee YR, 2005, BIOCHEM BIOPH RES CO, V336, P1221, DOI 10.1016/j.bbrc.2005.08.256; Liem MSL, 1997, SURGERY, V122, P114, DOI 10.1016/S0039-6060(97)90273-7; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Malangoni MR, 2008, SABISTON TXB SURG; Mao YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172246; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matthews R Douglas, 2008, Curr Probl Surg, V45, P261, DOI 10.1067/j.cpsurg.2008.01.002; Matthews RD, 2007, AM J SURG, V194, P611, DOI 10.1016/j.amjsurg.2007.07.018; Peng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130743; Primatesta P, 1996, INT J EPIDEMIOL, V25, P835, DOI 10.1093/ije/25.4.835; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Raman Karthik, 2014, Syst Synth Biol, V8, P73, DOI 10.1007/s11693-013-9123-5; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Ringpfeil F, 2005, CLIN DERMATOL, V23, P41, DOI 10.1016/j.clindermatol.2004.09.006; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sezer S, 2014, HERNIA, V18, P507, DOI 10.1007/s10029-013-1147-y; Tew KL, 2007, GENOME INFORM SER, V19, P166; Nguyen TP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/686505; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621; Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Xiao X, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0880-6; Yang B, 2015, INT J SURG, V19, P134, DOI 10.1016/j.ijsu.2015.05.029; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Youssef T, 2015, INT J SURG, V20, P28, DOI 10.1016/j.ijsu.2015.05.055; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001; Zhang W, 2018, IEEE ACM T COMPUT BI, V15, P109, DOI 10.1109/TCBB.2016.2615931; Zhang X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195410; Zhang Y, 2014, HERNIA, V18, P513, DOI 10.1007/s10029-013-1199-z; Zhang Y, 2014, GENE, V535, P290, DOI 10.1016/j.gene.2013.11.012; Zhao H, 2005, CANCER RES, V65, P6864, DOI 10.1158/0008-5472.CAN-05-0181; Zhao H, 2018, P NATL ACAD SCI USA, V115, pE10427, DOI 10.1073/pnas.1807765115; Zhong JC, 2015, TSINGHUA SCI TECHNOL, V20, P491, DOI 10.1109/TST.2015.7297748; Zoller B, 2013, J AM COLL SURGEONS, V217, P289, DOI 10.1016/j.jamcollsurg.2013.04.020	73	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0226885	10.1371/journal.pone.0226885	http://dx.doi.org/10.1371/journal.pone.0226885			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910207	Green Published, gold			2022-12-26	WOS:000534333800019
J	Torreblanca-Martinez, V; Nevado-Garrosa, F; Otero-Saborido, FM; Gonzalez-Jurado, JA				Torreblanca-Martinez, Victor; Nevado-Garrosa, Fabio; Otero-Saborido, Fernando M.; Gonzalez-Jurado, Jose A.			Effects of fatigue induced by repeated-sprint on kicking accuracy and velocity in female soccer players	PLOS ONE			English	Article							INSTEP KICKING; PERFORMANCE; EXERCISE; KINEMATICS; BIOMECHANICS; PARAMETERS; ABILITY	The aim of this study was to investigate the effects of fatigue induced by repeated sprint in the kicking accuracy and velocity in female soccer players. Eighteen Under-23 female soccer players from a Spanish professional club were subjected to a fatigue protocol based on a repeated-sprint ability (RSA) test. Measurements of the kicking velocity (maximal ball velocity) and accuracy (Loughborough Soccer Shooting Test) were taken before and after fatigue induction. Correlations between the change in the maximal ball velocity/accuracy and the heart rate (HR), the fatigue index (FI), the sprint decrement (S-dec) and the rating of perceived exertion (RPE) were made. There was a significant difference between maximal ball velocity under fatigue conditions with respect to non-fatigue conditions (p = 0.001; ES = 0.89). However, despite a lower kicking accuracy punctuation with fatigue, this was not statistically significant (p = 0.433; ES = 0.22). Significant correlations were found between the maximal kicking velocity and the FI (r = 0.632, p < 0.01) and the S-dec (r = -0.554, p < 0.05) and between the kicking accuracy and the RPE (r = -0.506, p < 0.05). In conclusion, there was a significant reduction in the maximal kicking velocity, but not in the kicking accuracy, under fatigued conditions. The RSA-related FI and S-dec were the best predictors of the maximal kicking velocity and the RPE for the kicking accuracy.	[Torreblanca-Martinez, Victor; Otero-Saborido, Fernando M.; Gonzalez-Jurado, Jose A.] Pablo de Olavide Univ, Fac Sport Sci, Seville, Spain; [Nevado-Garrosa, Fabio] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain	Universidad Pablo de Olavide; Autonomous University of Madrid	Torreblanca-Martinez, V (corresponding author), Pablo de Olavide Univ, Fac Sport Sci, Seville, Spain.	victm81@hotmail.com	; Gonzalez-Jurado, Jose Antonio/C-2843-2015	Torreblanca-Martinez, Victor/0000-0001-6073-3984; Gonzalez-Jurado, Jose Antonio/0000-0003-2222-6089				Alcock AM, 2012, J SPORT SCI, V30, P387, DOI 10.1080/02640414.2011.643238; Ali A, 2007, J SPORT SCI, V25, P1461, DOI 10.1080/02640410601150470; Apriantono T, 2006, J SPORT SCI, V24, P951, DOI 10.1080/02640410500386050; Bangsbo J, 2007, INT J SPORT PHYSIOL, V2, P111, DOI 10.1123/ijspp.2.2.111; Barfield William Roy, 2002, J Sports Sci Med, V1, P72; Bjelica D, 2013, MONTENEGRIN J SPORT, V2, P5; Borg G, 1998, BORGS PERCEIVED EXER; CAMPO SS, 2009, J STRENGTH COND RES, V23, P1714, DOI DOI 10.1519/JSC.0B013E3181B3F537; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Witt JK, 2012, SPORT BIOMECH, V11, P382, DOI 10.1080/14763141.2012.661757; Ferraz R, 2011, J PHY ED SPORT, V11, P68; Ferraz R, 2012, J HUM KINET, V35, P97, DOI 10.2478/v10078-012-0083-8; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Juarez D, 2011, EUR J SPORT SCI, V11, P191, DOI 10.1080/17461391.2010.500335; Katis A., 2014, ASIAN J SPORTS MED, V5, DOI [10.5812/asjsm.24013, DOI 10.5812/asjsm.24013]; Katis A, 2015, SPORT BIOMECH, V14, P287, DOI 10.1080/14763141.2015.1056221; Kellis E, 2006, SCAND J MED SCI SPOR, V16, P334, DOI 10.1111/j.1600-0838.2005.00496.x; Lees A, 2010, J SPORT SCI, V28, P805, DOI 10.1080/02640414.2010.481305; Maly T, 2014, J HUM KINET, V40, P149, DOI 10.2478/hukin-2014-0017; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Morcillo JA, 2015, J STRENGTH COND RES, V29, P1673, DOI 10.1519/JSC.0000000000000782; Owen JA, 2013, J SPORT SCI, V31, P1, DOI 10.1080/02640414.2012.720701; Radman I, 2016, EUR J APPL PHYSIOL, V116, P373, DOI 10.1007/s00421-015-3293-7; Rodriguez-Lorenzo L, 2015, STRENGTH COND J, V37, P26, DOI 10.1519/SSC.0000000000000172; Russell M, 2011, INT J SPORT PHYSIOL, V6, P221, DOI 10.1123/ijspp.6.2.221; Smith MR, 2016, MED SCI SPORT EXER, V48, P267, DOI 10.1249/MSS.0000000000000762; Stone KJ, 2009, INT J SPORT PHYSIOL, V4, P163, DOI 10.1123/ijspp.4.2.163; Tanner RK, 2000, PHYSL TEST ELITE ATH; Torreblanca-Martinez V, 2016, J APPL BIOMECH, P1, DOI [10.1123/jab.2014-0243, DOI 10.1123/JAB.2014-0243]; van den Tillaar R, 2016, J MOTOR BEHAV, P1, DOI [10.1080/00222895.2016.1124687, DOI 10.1080/00222895.2016.1124687]; Zemkova E, 2009, KINESIOLOGY, V41, P195	32	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2020	15	1							e0227214	10.1371/journal.pone.0227214	http://dx.doi.org/10.1371/journal.pone.0227214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5BZ	31910235	Green Published, gold			2022-12-26	WOS:000534333800031
J	Dehaene, H; Praz, V; Lhote, P; Lopes, M; Herr, W				Dehaene, Harmonie; Praz, Viviane; Lhote, Philippe; Lopes, Maykel; Herr, Winship			THAP11(F80L) cobalamin disorder-associated mutation reveals normal and pathogenic THAP11 functions in gene expression and cell proliferation	PLOS ONE			English	Article							DNA-BINDING DOMAIN; COILED COILS; TRANSCRIPTIONAL REGULATOR; INTERACTIVE TREE; PROTEIN; RONIN; VP16; FAMILY; CYCLE; HCF	Twelve human THAP proteins share the THAP domain, an evolutionary conserved zinc-finger DNA-binding domain. Studies of different THAP proteins have indicated roles in gene transcription, cell proliferation and development. We have analyzed this protein family, focusing on THAP7 and THAP11. We show that human THAP proteins possess differing homo- and heterodimer formation properties and interaction abilities with the transcriptional co-regulator HCF-1. HEK-293 cells lacking THAP7 were viable but proliferated more slowly. In contrast, HEK-293 cells were very sensitive to THAP11 alteration. Nevertheless, HEK293 cells bearing a THAP11 mutation identified in a patient suffering from cobalamin disorder (THAP11(F80L)) were viable although proliferated more slowly. Cobalamin disorder is an inborn vitamin deficiency characterized by neurodevelopmental abnormalities, most often owing to biallelic mutations in the MMACHC gene, whose gene product MMACHC is a key enzyme in the cobalamin (vitamin B12) metabolic pathway. We show that THAP11(F80L) selectively affected promoter binding by THAP11, having more deleterious effects on a subset of THAP11 targets, and resulting in altered patterns of gene expression. In particular, THAP11(F80L) exhibited a strong effect on association with the MMACHC promoter and led to a decrease in MMACHC gene transcription, suggesting that the THAP11(F80L) mutation is directly responsible for the observed cobalamin disorder.	[Dehaene, Harmonie; Praz, Viviane; Lhote, Philippe; Lopes, Maykel; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Praz, Viviane] Univ Lausanne, Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Praz, Viviane] CHU Vaudois, Rue Bugnon, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	Swiss National Science Foundation [31003A170150]; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	This work was supported by the Swiss National Science Foundation grant [31003A170150] (URL: http://www.snf.ch/en/Pages/default.aspx) and the University of Lausanne to WH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate F, 2017, P NATL ACAD SCI USA, V114, P764, DOI 10.1073/pnas.1608839114; Adams, 2018, DISORDERS INTRACELLU; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakrishnan MP, 2011, BIOCHEM BIOPH RES CO, V404, P195, DOI 10.1016/j.bbrc.2010.11.092; Balakrishnan MP, 2009, AM J PHYSIOL-HEART C, V297, pH643, DOI 10.1152/ajpheart.00234.2009; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Campagne S, 2012, NUCLEIC ACIDS RES, V40, P9927, DOI 10.1093/nar/gks703; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Cukier CD, 2016, J STRUCT BIOL, V194, P337, DOI 10.1016/j.jsb.2016.03.010; Dehaene H, 2019, THESIS; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durruthy-Durruthy J, 2016, DEV CELL, V38, P100, DOI 10.1016/j.devcel.2016.06.014; Frederick NM, 2019, HUM MOL GENET, V28, P1343, DOI 10.1093/hmg/ddy433; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Fujita J, 2017, CELL REP, V21, P1562, DOI 10.1016/j.celrep.2017.10.036; Gavarini S, 2010, ANN NEUROL, V68, P549, DOI 10.1002/ana.22138; Gervais V, 2013, J BIOMOL NMR, V56, P3, DOI 10.1007/s10858-012-9699-1; Gladitz J, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0544-y; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091557; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; LeDoux MS, 2012, PARKINSONISM RELAT D, V18, P414, DOI 10.1016/j.parkreldis.2012.02.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li YH, 2017, EMBO MOL MED, V9, P933, DOI 10.15252/emmm.201607180; Lian WX, 2012, FEBS LETT, V586, P1431, DOI 10.1016/j.febslet.2012.04.016; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Miele A, 2007, J CELL BIOCHEM, V102, P136, DOI 10.1002/jcb.21284; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Ngondo-Mbongo RP, 2013, NUCLEIC ACIDS RES, V41, P4000, DOI 10.1093/nar/gkt088; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Poche RA, 2016, CELL REP, V14, P1684, DOI 10.1016/j.celrep.2016.01.039; Quintana AM, 2017, HUM MOL GENET, V26, P2838, DOI 10.1093/hmg/ddx157; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renaud M, 2014, GENOME RES, V24, P37, DOI 10.1101/gr.161570.113; Richter A, 2017, J MOL NEUROSCI, V62, P11, DOI 10.1007/s12031-017-0904-2; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Sanghavi HM, 2019, CLASSIFICATION HUMAN, P2; Santos EDS, 2008, INT J ONCOL, V33, P25; Seifert BA, 2017, STEM CELL RES, V23, P98, DOI 10.1016/j.scr.2017.06.014; Sengel C, 2011, J NEUROCHEM, V118, P1087, DOI 10.1111/j.1471-4159.2011.07386.x; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Xiromerisiou G, 2012, MOVEMENT DISORD, V27, P1290, DOI 10.1002/mds.25146; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160	67	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0224646	10.1371/journal.pone.0224646	http://dx.doi.org/10.1371/journal.pone.0224646			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905202	Green Published, Green Submitted, gold			2022-12-26	WOS:000534327700003
J	Pedersini, CA; Guardia-Olmos, J; Montala-Flaquer, M; Cardobi, N; Sanchez-Lopez, J; Parisi, G; Savazzi, S; Marzi, CA				Pedersini, Caterina A.; Guardia-Olmos, Joan; Montala-Flaquer, Marc; Cardobi, Nicolo; Sanchez-Lopez, Javier; Parisi, Giorgia; Savazzi, Silvia; Marzi, Carlo A.			Functional interactions in patients with hemianopia: A graph theory-based connectivity study of resting fMRI signal	PLOS ONE			English	Article							SCALE BRAIN NETWORKS; AGE-RELATED-CHANGES; MINI-MENTAL-STATE; DEFAULT-MODE; THEORETICAL ANALYSIS; STROKE PATIENTS; STRIATE CORTEX; SEGREGATION; RECOVERY; MRI	The assessment of task-independent functional connectivity (FC) after a lesion causing hemianopia remains an uncovered topic and represents a crucial point to better understand the neural basis of blindsight (i.e. unconscious visually triggered behavior) and visual awareness. In this light, we evaluated functional connectivity (FC) in 10 hemianopic patients and 10 healthy controls in a resting state paradigm. The main aim of this study is twofold: first of all we focused on the description and assessment of density and intensity of functional connectivity and network topology with and without a lesion affecting the visual pathway, and then we extracted and statistically compared network metrics, focusing on functional segregation, integration and specialization. Moreover, a study of 3-cycle triangles with prominent connectivity was conducted to analyze functional segregation calculated as the area of each triangle created connecting three neighboring nodes. To achieve these purposes we applied a graph theory-based approach, starting from Pearson correlation coefficients extracted from pairs of regions of interest. In these analyses we focused on the FC extracted by the whole brain as well as by four resting state networks: The Visual (VN), Salience (SN), Attention (AN) and Default Mode Network (DMN), to assess brain functional reorganization following the injury. The results showed a general decrease in density and intensity of functional connections, that leads to a less compact structure characterized by decrease in functional integration, segregation and in the number of interconnected hubs in both the Visual Network and the whole brain, despite an increase in long-range inter-modules connections (occipito-frontal connections). Indeed, the VN was the most affected network, characterized by a decrease in intra- and inter-network connections and by a less compact topology, with less interconnected nodes. Surprisingly, we observed a higher functional integration in the DMN and in the AN regardless of the lesion extent, that may indicate a functional reorganization of the brain following the injury, trying to compensate for the general reduced connectivity. Finally we observed an increase in functional specialization (lower between-network connectivity) and in inter-networks functional segregation, which is reflected in a less compact network topology, highly organized in functional clusters. These descriptive findings provide new insight on the spontaneous brain activity in hemianopic patients by showing an alteration in the intrinsic architecture of a large-scale brain system that goes beyond the impairment of a single RSN.	[Pedersini, Caterina A.; Cardobi, Nicolo; Sanchez-Lopez, Javier; Parisi, Giorgia; Savazzi, Silvia; Marzi, Carlo A.] Univ Verona, Physiol & Psychol Sect, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Guardia-Olmos, Joan] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Sch Psychol, Inst Complex Syst,Inst Neurosci, Barcelona, Spain; [Montala-Flaquer, Marc] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Sch Psychol, Inst Complex Syst, Barcelona, Spain; [Savazzi, Silvia] Univ Verona, Dept Neurosci Biomed & Movement Sci, Percept & Awareness PandA Lab, Verona, Italy; [Savazzi, Silvia; Marzi, Carlo A.] Natl Inst Neurosci, Verona, Italy	University of Verona; University of Barcelona; University of Barcelona; University of Verona	Pedersini, CA (corresponding author), Univ Verona, Physiol & Psychol Sect, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	caterinaannalaura.pedersini@univr.it	Sanchez-Lopez, Javier/AAD-2006-2019	Sanchez-Lopez, Javier/0000-0002-4291-0315; Pedersini, Caterina Annalaura/0000-0001-8557-2937; Parisi, Giorgia/0000-0002-8295-5374; Savazzi, Silvia/0000-0002-5333-9046	European Research Council (ERD) [339939]	European Research Council (ERD)	This study was supported by European Research Council (ERD) [Grant number 339939 "Perceptual Awareness" P.I. CAM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajina S, 2015, ELIFE, V4, DOI 10.7554/eLife.08935; Ajina S, 2015, J NEUROSCI, V35, P8201, DOI 10.1523/JNEUROSCI.3075-14.2015; Anderson JS, 2013, NEUROIMAGE-CLIN, V2, P703, DOI 10.1016/j.nicl.2013.05.006; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Antonenko D, 2014, GERONTOLOGY, V60, P3, DOI 10.1159/000354376; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baseler HA, 1999, J NEUROSCI, V19, P2619; Bassett DS, 2018, BIOL PSYCHIAT-COGN N, V3, P742, DOI 10.1016/j.bpsc.2018.03.015; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bohr Iwo Jerzy, 2012, Front Psychiatry, V3, P116, DOI 10.3389/fpsyt.2012.00116; Bollini A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00290; Boucard CC, 2016, BRAIN STRUCT FUNCT, V221, P2367, DOI 10.1007/s00429-015-1010-2; Braun U., 2015, ELS, P1, DOI DOI 10.1002/9780470015902.A0025783; Bridge H, 2010, NEUROPSYCHOLOGIA, V48, P4148, DOI 10.1016/j.neuropsychologia.2010.10.022; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen LL, 2019, QUANT IMAG MED SURG, V9, P603, DOI 10.21037/qims.2019.04.13; Cocchi L, 2012, HUM BRAIN MAPP, V33, P1089, DOI 10.1002/hbm.21270; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, CONSISTENT RESTINGST; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Diez I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10532; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Farras-Permanyer L, 2019, NEURAL REGEN RES, V14, P1544, DOI 10.4103/1673-5374.255976; Farras-Permanyer L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01095; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2017, INTRO RESTING STATE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fox PT, 2012, NEUROIMAGE, V61, P407, DOI 10.1016/j.neuroimage.2011.12.051; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; GAUTHIER G, 1989, REV CINEMA-IMAGE SON, P49; Goodwin D, 2014, CLIN OPHTHALMOL, V8, P1919, DOI 10.2147/OPTH.S59452; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo XL, 2014, IEEE T NEUR SYS REH, V22, P1210, DOI 10.1109/TNSRE.2014.2325601; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Higgins IA, 2018, DIFFERENTIAL DEGREE, V40, P1, DOI [10.1002/hbm.24718, DOI 10.1002/HBM.24718]; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huang CC, 2015, CNS NEUROSCI THER, V21, P817, DOI 10.1111/cns.12396; Huxin KR, 2008, VISION RES, V48, P2154, DOI 10.1016/j.visres.2008.05.022; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; Kim YH, 2019, J STROKE, V21, P207, DOI 10.5853/jos.2018.02999; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mattfeld AT, 2014, BRAIN, V137, P2423, DOI 10.1093/brain/awu137; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nelles G, 2002, STROKE, V33, P1286, DOI 10.1161/01.STR.0000013685.76973.67; Ng KK, 2016, NEUROIMAGE, V133, P321, DOI 10.1016/j.neuroimage.2016.03.029; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sbardella E, 2015, MULT SCLER J, V21, P1681, DOI 10.1177/1352458514568826; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Smitha KA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917697342; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tahedl M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00828; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urbanski M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00074; Vallar G., 1994, Archivio di Psicologia Neurologia e Psichiatria, V55, P827; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang L, 2012, IEEE ENG MED BIO, P49, DOI 10.1109/EMBC.2012.6345868; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEI J, 2018, INT J DISTRIB SENS N, V12, P1; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Wu GF, 2015, INVEST OPHTH VIS SCI, V56, P2541, DOI 10.1167/iovs.14-16315; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zalesky A, 2016, NEUROIMAGE, V142, P397, DOI 10.1016/j.neuroimage.2016.06.035; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; Zhou Yuan, 2018, Cereb Cortex, V28, P726, DOI 10.1093/cercor/bhx307	110	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2020	15	1							e0226816	10.1371/journal.pone.0226816	http://dx.doi.org/10.1371/journal.pone.0226816			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4ZR	31905211	Green Published, Green Submitted, gold			2022-12-26	WOS:000534327700010
J	Zhao, HJ; Klausen, C; Zhu, H; Chang, HM; Li, Y; Leung, PCK				Zhao, Hong-Jin; Klausen, Christian; Zhu, Hua; Chang, Hsun-Ming; Li, Yan; Leung, Peter C. K.			Bone morphogenetic protein 2 promotes human trophoblast cell invasion and endothelial-like tube formation through ID1-mediated upregulation of IGF binding protein-3	FASEB JOURNAL			English	Article						BMP2; ID1; IGFBP3; trophoblast invasion; tube formation	GROWTH-FACTOR; EMBRYO IMPLANTATION; SIGNALING PATHWAYS; OVER-EXPRESSION; ID-1 EXPRESSION; GENE-EXPRESSION; ACTIVIN-A; ANGIOGENESIS; DIFFERENTIATION; IGFBP-3	Extravillous cytotrophoblasts (EVTs) invade into the uterine wall and remodel spiral arteries for proper placentation. Studies from us and others have demonstrated that the transforming growth factor-beta superfamily member bone morphogenetic protein 2 (BMP2) plays important roles in endometrial decidualization and trophoblast cell invasion. However, BMP2 has also been shown to regulate endothelial cell migration and capillary-like tube formation, as has its downstream signaling molecule inhibitor of DNA binding 1 (ID1). Interestingly, insulin-like growth factor binding protein 3 (IGFBP3) also promotes cell migration and angiogenesis in endothelial precursor cell. Moreover, Id1 has a regulatory effect on Igfbp3 expression in rat prostate epithelial cells. However, whether ID1 and IGFBP3 are integrated in BMP2 signaling and involved in the regulation of trophoblast invasive and endovascular differentiation remains unknown. The objective of our study was to examine the effects of BMP2 on ID1 and IGFBP3 expression and their roles in BMP2-regulated human trophoblast invasion and endothelial-like tube formation. Primary and immortalized (HTR8/SVneo) cultures of human trophoblast cells were employed as study models. BMP2 treatment increased ID1 and IGFBP3 mRNA and protein levels in HTR8/SVneo and primary human EVT cells. Intriguingly, ID1 was essential for BMP2-induced IGFBP3 upregulation in both study models, and BMP2-induced trophoblast invasion was attenuated by knockdown of either ID1 or IGFBP3. In addition, BMP2 significantly increased endothelial-like tube formation and knockdown of ID1 and IGFBP3 reduced basal and BMP2-induced tube formation in HTR8/SVneo cells. Similarly, BMP2 increased placenta growth factor (PlGF) production in HTR8/SVneo cells and these effects were attenuated by knockdown of ID1 or IGFBP3. Our results reveal that BMP2 promotes trophoblast cell invasion and endothelial-like tube formation by ID1-mediated IGFBP3 upregulation.	[Zhao, Hong-Jin] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Zhao, Hong-Jin; Klausen, Christian; Zhu, Hua; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Li, Yan] Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Yan] Shandong Univ, Ctr Reprod Med, Jinan, Shandong, Peoples R China; [Li, Yan] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Shandong, Peoples R China; [Li, Yan] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of British Columbia; Shandong University; Shandong University	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.; Li, Y (corresponding author), Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	yanli.sdu@gmail.com; peter.leung@ubc.ca	Chang, Hsun-Ming/M-8584-2018; Li, Yan/AAK-5719-2020	Li, Yan/0000-0003-1813-8115; Zhao, Hong-Jin/0000-0001-5296-2293; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research [FDN-143317]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a Foundation grant (FDN-143317) from the Canadian Institutes of Health Research to PCKL	Ahn S, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12722; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Barucker C, 2015, J ALZHEIMERS DIS, V44, P613, DOI 10.3233/JAD-141902; Biadasiewicz K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115279; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Forootan SS, 2007, HUM PATHOL, V38, P1321, DOI 10.1016/j.humpath.2007.02.011; Gangopahyay A, 2011, J BIOL CHEM, V286, P33134, DOI 10.1074/jbc.M111.274100; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Han JY, 2006, MOL CELLS, V22, P168; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jc.81.7.2680; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Highet AR, 2015, EUR J CELL BIOL, V94, P589, DOI 10.1016/j.ejcb.2015.10.004; Hu Y, 2010, PLACENTA, V31, P213, DOI 10.1016/j.placenta.2009.12.011; IruelaArispe ML, 1997, J CLIN INVEST, V99, P2057, DOI 10.1172/JCI119374; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Lim KH, 1997, AM J PATHOL, V151, P1809; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Luo RC, 2014, HYPERTENSION, V64, P839, DOI 10.1161/HYPERTENSIONAHA.114.03530; Mark EB, 2006, ARCH DERMATOL RES, V297, P459, DOI 10.1007/s00403-006-0649-1; Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mayo JC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12373; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Pijnenborg R, 2011, BEST PRACT RES CL OB, V25, P273, DOI 10.1016/j.bpobgyn.2010.10.009; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Ryan DH, 2018, PREGNANCY HYPERTENS, V14, P260, DOI 10.1016/j.preghy.2018.03.003; Schmidt M, 2010, CELL MOL BIOL LETT, V15, P272, DOI 10.2478/s11658-010-0007-3; Sharma S, 2016, AM J REPROD IMMUNOL, V75, P341, DOI 10.1111/aji.12466; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x; Suman P, 2013, FERTIL STERIL, V99, P533, DOI 10.1016/j.fertnstert.2012.10.004; Terracciano D, 2012, PROSTATE, V72, P100, DOI 10.1002/pros.21411; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Xu WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14399; Xue WC, 2005, HISTOPATHOLOGY, V47, P303, DOI 10.1111/j.1365-2559.2005.02190.x; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhang QL, 2015, INT J MOL SCI, V16, P17734, DOI 10.3390/ijms160817734; Zhao HJ, 2018, ENDOCRINOLOGY, V159, P2815, DOI 10.1210/en.2018-00301; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; Zuo WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37499	69	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3151	3164		10.1096/fj.201902168RR	http://dx.doi.org/10.1096/fj.201902168RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908038	Bronze			2022-12-26	WOS:000505525800001
J	Engelhardt, J; Frisell, O; Gustavsson, H; Hansson, T; Sjoberg, R; Collier, TK; Balk, L				Engelhardt, Josefin; Frisell, Oscar; Gustavsson, Hanna; Hansson, Tomas; Sjoberg, Rajlie; Collier, Tracy K.; Balk, Lennart			Severe thiamine deficiency in eastern Baltic cod (Gadus morhua)	PLOS ONE			English	Article							EARLY MORTALITY SYNDROME; TROUT SALMO-TRUTTA; OTOLITH WEIGHT; PHYTANIC ACID; PSEUDOTERRANOVA-DECIPIENS; REPRODUCTIVE SUCCESS; NATURAL MORTALITY; STOCK ASSESSMENT; REFSUM-DISEASE; AGE	The eastern Baltic cod (Gadus morhua) population has been decreasing in the Baltic Sea for at least 30 years. Condition indices of the Baltic cod have decreased, and previous studies have suggested that this might be due to overfishing, predation, lower dissolved oxygen or changes in salinity. However, numerous studies from the Baltic Sea have demonstrated an ongoing thiamine deficiency in several animal classes, both invertebrates and vertebrates. The thiamine status of the eastern Baltic cod was investigated to determine if thiamine deficiency might be a factor in ongoing population declines. Thiamine concentrations were determined by chemical analyses of thiamine, thiamine monophosphate and thiamine diphosphate (combined SumT) in the liver using high performance liquid chromatography. Biochemical analyses measured the activity of the thiamine diphosphate-dependent enzyme transketolase to determine the proportion of apoenzymes in both liver and brain tissue. These biochemical analyses showed that 77% of the cod were thiamine deficient in the liver, of which 13% had a severe thiamine deficiency (i.e. 25% transketolase enzymes lacked thiamine diphosphate). The brain tissue of 77% of the cod showed thiamine deficiency, of which 64% showed severe thiamine deficiency. The thiamine deficiency biomarkers were investigated to find correlations to different biological parameters, such as length, weight, otolith weight, age (annuli counting) and different organ weights. The results suggested that thiamine deficiency increased with age. The SumT concentration ranged between 2.4-24 nmol/g in the liver, where the specimens with heavier otoliths had lower values of SumT (P = 0.0031). Of the cod sampled, only 2% of the specimens had a Fulton's condition factor indicating a healthy specimen, and 49% had a condition factor below 0.8, indicating poor health status. These results, showing a severe thiamine deficiency in eastern Baltic cod from the only known area where spawning presently occurs for this species, are of grave concern.	[Engelhardt, Josefin; Frisell, Oscar; Gustavsson, Hanna; Hansson, Tomas; Balk, Lennart] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Sjoberg, Rajlie] Swedish Univ Agr Sci, Inst Marine Res, Lysekil, Sweden; [Collier, Tracy K.] Western Washington Univ, Huxley Coll Environm, Bellingham, WA 98225 USA	Stockholm University; Swedish University of Agricultural Sciences; Western Washington University	Engelhardt, J; Balk, L (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	josefin.engelhardt@aces.su.se; lennart.balk@aces.su.se		Engelhardt, Josefin/0000-0002-5277-6404	Gote Borgstroms Stiftelse for Fiske-och Vattenvard [1232137, 836200-5327]	Gote Borgstroms Stiftelse for Fiske-och Vattenvard	This work was supported by: JE and LB, Grant number: 1232137, Gote Borgstroms Stiftelse for Fiske-och Vattenvard (organization number: 836200-5327), https://www.stiftelsemedel.se/gteborgstrms-stiftelse-fr-fiske-och-vattenvrd/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman G, 1996, MAR ENVIRON RES, V42, P139, DOI 10.1016/0141-1136(96)00078-5; Akerman G, 1998, AM FISH S S, V21, P41; Amcoff P, 1999, AMBIO, V28, P48; Andersen KH, 2007, ECOL MODEL, V204, P246, DOI 10.1016/j.ecolmodel.2007.01.002; [Anonymous], 1999, FANGST YRKESF; [Anonymous], 2019, ICES ADV COMM 2019, V27, P24, DOI [10.17895/ices.advice.4747, DOI 10.17895/ICES.ADVICE.4747]; [Anonymous], 2014, 2014SSGRSP0849 ICES; [Anonymous], 2015, ICES BENCH WORKSH BL; [Anonymous], 2018, ICES COD GADUS MORHU, V27, P24, DOI [10.17895/ices.pub.4378, DOI 10.17895/ICES.PUB.4378]; Araya M, 2001, FISH RES, V51, P17, DOI 10.1016/S0165-7836(00)00233-2; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; BAGGE O, 1994, ICES MAR SC, V198, P254; Bagge Ole, 1994, Dana, V10, P1; BALAGHI M, 1966, J NUTR, V89, P127, DOI 10.1093/jn/89.2.127; Balk L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38821; Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Batifoulier F, 2005, J CHROMATOGR B, V816, P67, DOI 10.1016/j.jchromb.2004.11.004; Bavington D, 2010, NAT-HIST-SOC, P1; Bellyei S, 2005, PLACENTA, V26, P34, DOI 10.1016/j.placenta.2004.03.008; Berg JM, 2012, BIOCHEMISTRY; Bishop C.A., 1994, Northwest Atlantic Fisheries Organization Scientific Council Studies, V21, P105; Blair PV, 1999, J NUTR, V129, P641, DOI 10.1093/jn/129.3.641; Busanello ENB, 2013, CEREBELLUM, V12, P362, DOI 10.1007/s12311-012-0426-y; Brown SB, 2005, J AQUAT ANIM HEALTH, V17, P59, DOI 10.1577/H04-059.1; Brown SB, 1998, AM FISH S S, V21, P73; Brown SB, 1998, AM FISH S S, V21, P18; Buchmann K, 2012, J FISH DIS, V35, P861, DOI 10.1111/j.1365-2761.2012.01409.x; BUTTERWORTH RF, 1986, NEUROCHEM RES, V11, P567, DOI 10.1007/BF00965326; CAMPBELL CH, 1984, LANCET, V2, P446; Cardinale M, 2000, FISH RES, V45, P239, DOI 10.1016/S0165-7836(99)00122-8; Carvalho PSM, 2009, J AQUAT ANIM HEALTH, V21, P315, DOI 10.1577/H08-025.1; Combs GF., 2008, VITAMINS; Dutil JD, 2000, CAN J FISH AQUAT SCI, V57, P826, DOI 10.1139/cjfas-57-4-826; Eero M, 2015, ICES J MAR SCI, V72, P2180, DOI 10.1093/icesjms/fsv109; Eero M, 2012, CONSERV LETT, V5, P486, DOI 10.1111/j.1755-263X.2012.00266.x; Fisheries and Oceans Canada (DFO), 2011037 DFO CAN SCI; Fitzsimons JD, 1995, J GREAT LAKES RES, V21, P286, DOI 10.1016/S0380-1330(95)71102-9; Fitzsimons JD, 2001, AQUAT TOXICOL, V52, P229, DOI 10.1016/S0166-445X(00)00147-8; Fitzsimons JD, 2013, T AM FISH SOC, V142, P1358, DOI 10.1080/00028487.2013.811100; Fitzsimons JD, 2009, J AQUAT ANIM HEALTH, V21, P302, DOI 10.1577/H08-019.1; FLETCHER WJ, 1991, CAN J FISH AQUAT SCI, V48, P35, DOI 10.1139/f91-005; Foulon V, 1999, P NATL ACAD SCI USA, V96, P10039, DOI 10.1073/pnas.96.18.10039; Fynn-Aikins K, 1998, T AM FISH SOC, V127, P747, DOI 10.1577/1548-8659(1998)127&lt;0747:EODAOT&gt;2.0.CO;2; Goyer A, 2010, PHYTOCHEMISTRY, V71, P1615, DOI 10.1016/j.phytochem.2010.06.022; Hamada S, 2013, J NEUROPATH EXP NEUR, V72, P1193, DOI 10.1097/NEN.0000000000000017; Hansson T, 2012, OPEN BIOMARKERS J, V5, P16; Hansson T, 2017, ICES TECHNIQUES MARI, V60; HARATA N, 1993, METAB BRAIN DIS, V8, P45, DOI 10.1007/BF01000529; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Hinrichsen HH, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150338; Honeyfield Dale C., 2016, North Pacific Anadromous Fish Commission Bulletin, P21, DOI 10.23849/npafcb6/21.31; JEYASINGHAM MD, 1986, J NEUROCHEM, V47, P278; Kankaanpaa H, 2002, AQUAT TOXICOL, V61, P155, DOI 10.1016/S0166-445X(02)00054-1; Koster FW, 2017, ICES J MAR SCI, V74, P3, DOI 10.1093/icesjms/fsw172; Koster Friedrich W., 1994, Dana, V10, P179; Kraus G, 2000, J FISH BIOL, V56, P1327, DOI 10.1111/j.1095-8649.2000.tb02146.x; LAI JCK, 1986, J NEUROCHEM, V47, P1376, DOI 10.1111/j.1471-4159.1986.tb00768.x; Lambert Y, 1997, CAN J FISH AQUAT SCI, V54, P2388, DOI 10.1139/cjfas-54-10-2388; Lee BJ, 2009, J AQUAT ANIM HEALTH, V21, P290, DOI 10.1577/H07-053.1; Lehninger AL, 2005, PRINCIPLES BIOCH; Lepak JM, 2012, CAN J FISH AQUAT SCI, V69, P1569, DOI 10.1139/F2012-081; Lou DC, 2005, FISH RES, V71, P279, DOI 10.1016/j.fishres.2004.09.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahe K, 2012, 2012 WORKSH CAN FRAN; Manzetti S, 2014, BIOCHEMISTRY-US, V53, P821, DOI 10.1021/bi401618y; Mehrdana F, 2014, VET PARASITOL, V205, P581, DOI 10.1016/j.vetpar.2014.08.027; Morner T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13884-1; Nadolna K, 2014, J HELMINTHOL, V88, P237, DOI 10.1017/S0022149X13000096; Navarro D, 2008, METAB BRAIN DIS, V23, P445, DOI 10.1007/s11011-008-9105-6; Nilsson U, 1997, J BIOL CHEM, V272, P1864, DOI 10.1074/jbc.272.3.1864; NISSLING A, 1994, J FISH BIOL, V45, P435, DOI 10.1111/j.1095-8649.1994.tb01326.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; PATON DC, 1983, AUST J ZOOL, V31, P147, DOI 10.1071/ZO9830147; Pilling GM, 2003, FISH RES, V60, P493, DOI 10.1016/S0165-7836(02)00087-5; Plambech M, 2013, J FISH BIOL, V83, P396, DOI 10.1111/jfb.12171; PRASAD R, 1980, INT J PARASITOL, V10, P93, DOI 10.1016/0020-7519(80)90017-X; Reeves SA, 2003, ICES J MAR SCI, V60, P314, DOI 10.1016/S1054-3139(03)00011-0; Rideout RM, 2006, ICES J MAR SCI, V63, P1101, DOI 10.1016/j.icesjms.2006.04.014; RINDI G, 1963, J NUTR, V81, P147, DOI 10.1093/jn/81.2.147; Rojbek MC, 2012, MAR ECOL PROG SER, V471, P215, DOI 10.3354/meps10012; Schonfeld P, 1999, FEBS LETT, V457, P179, DOI 10.1016/S0014-5793(99)01009-1; Sepulveda MS, 2004, J WILDLIFE DIS, V40, P782, DOI 10.7589/0090-3558-40.4.782; Shangari N, 2003, BIOCHEM SOC T, V31, P1390, DOI 10.1042/BST0311390; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Sniekers M, 2006, CELL MOL LIFE SCI, V63, P1553, DOI 10.1007/s00018-005-5603-4; Sutherland WJ, 2018, TRENDS ECOL EVOL, V33, P47, DOI 10.1016/j.tree.2017.11.006; Svedang H, 2017, ECOL EVOL, V7, P6089, DOI 10.1002/ece3.3173; Svedang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5152; Swain DP, 2011, EVOL APPL, V4, P18, DOI 10.1111/j.1752-4571.2010.00128.x; TATE JR, 1987, ANAL BIOCHEM, V160, P78, DOI 10.1016/0003-2697(87)90616-6; Teschner EC, 2010, J APPL ICHTHYOL, V26, P836, DOI 10.1111/j.1439-0426.2010.01485.x; TOMIYASU K, 1991, ACTA NEUROPATHOL, V81, P396, DOI 10.1007/BF00293460; Torniainen J, 2014, ICES J MAR SCI, V71, P336, DOI 10.1093/icesjms/fst153; TREBUKHINA RV, 1981, J NUTR, V111, P505, DOI 10.1093/jn/111.3.505; Vainikka A, 2009, ICES J MAR SCI, V66, P248, DOI 10.1093/icesjms/fsn199; Vallin L, 1999, AMBIO, V28, P92; Wanders RJA, 2001, J NEUROPATH EXP NEUR, V60, P1021, DOI 10.1093/jnen/60.11.1021; Wieland K, 1996J15 ICES CM; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; Xu ZP, 2002, MOL CELL BIOL, V22, P6142, DOI 10.1128/MCB.22.17.6142-6147.2002; Zuo S, 2018, J HELMINTHOL, V92, P81, DOI 10.1017/S0022149X17000025	101	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0227201	10.1371/journal.pone.0227201	http://dx.doi.org/10.1371/journal.pone.0227201			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895939	gold, Green Published			2022-12-26	WOS:000534267300014
J	Ereso, BM; Yimer, SA; Gradmann, C; Sagbakken, M				Ereso, Berhane Megerssa; Yimer, Solomon Abebe; Gradmann, Christoph; Sagbakken, Mette			Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study	PLOS ONE			English	Article							HEALTH	Background Ethiopia is one of the countries with a high burden of tuberculosis (TB). Jimma Zone has the lowest TB case notification rate compared to the national and World Health Organization's (WHO) targets. The aim of the present study was to identify barriers, and explore the origin of these barriers in relation to TB case finding. Methods A qualitative study was conducted by using different data collection methods and sources. Sixty in-depth interviews with TB treatment providers, program managers and TB patients were included. In addition, 42 governmental health facilities were observed for availability of resources. Data obtained from the in-depth interviews were transcribed, coded, categorized and thematized. Atlas.ti version 7.1 software was used for the data coding and categorizing. Results Inadequate resources for TB case finding, such as a shortage of health-care providers, inadequate basic infrastructure, and inadequate diagnostic equipment and supplies, as well as limited access to TB diagnostic services such as an absence of nearby health facilities providing TB diagnostic services and health system delays in the diagnostic process, were identified as barriers for TB case finding. We identified the absence of trained laboratory professionals in 11, the absence of clean water supply in 13 and the electricity in seven health facilities. Furthermore, we found that difficult topography, the absence of proper roads, an inadequate collaboration with other sectors (such as education), a turnover of laboratory professionals, and a low community mobilization, as the origin of some of these barriers. Conclusion Inadequate resources for TB case finding, and a limited access to diagnostic services, were major challenges affecting TB case finding. The optimal application of the directly observed treatment short course (Stop TB) strategy is crucial to increase the current low TB case notification rate. Practical strategies need to be designed to attract and retain health professionals in the health system.	[Ereso, Berhane Megerssa; Gradmann, Christoph] Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway; [Yimer, Solomon Abebe] Univ Oslo, Inst Clin Med, Dept Microbiol, Oslo, Norway; [Yimer, Solomon Abebe] CEPI, Oslo, Norway; [Sagbakken, Mette] Oslo Metropolitan Univ, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway; [Ereso, Berhane Megerssa] Jimma Univ, Inst Hlth, Fac Publ Hlth, Dept Hlth Policy & Management, Jimma, Ethiopia	University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); Jimma University	Ereso, BM (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway.; Ereso, BM (corresponding author), Jimma Univ, Inst Hlth, Fac Publ Hlth, Dept Hlth Policy & Management, Jimma, Ethiopia.	berhanemegerssa2004@gmail.com		Ereso, Berhane Megerssa/0000-0001-9260-0123	Strategic and Collaborative Capacity Development in Ethiopia and Africa (SACCADE) Project, Norwegian Program for Capacity Development in Higher Education and Research for Development (NORHAD), University of Oslo	Strategic and Collaborative Capacity Development in Ethiopia and Africa (SACCADE) Project, Norwegian Program for Capacity Development in Higher Education and Research for Development (NORHAD), University of Oslo	This study was not funded by a grant. It is a PhD project and was supported by the Strategic and Collaborative Capacity Development in Ethiopia and Africa (SACCADE) Project, Norwegian Program for Capacity Development in Higher Education and Research for Development (NORHAD), University of Oslo.	Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Bogale S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2240-0; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Central Stastistical Agency (CSA) Ethiopia, 2007, NAT POP CENS REP ETH; Chen C, 2017, INT J TUBERC LUNG D, V21, P1134, DOI 10.5588/ijtld.17.0123; Chimbatata NBW, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0279-1; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Craig GM, 2017, INT J INFECT DIS, V56, P90, DOI 10.1016/j.ijid.2016.10.011; Dabaro Desalegn, 2017, J Clin Tuberc Other Mycobact Dis, V9, P1, DOI 10.1016/j.jctube.2017.08.003; Dangisso MH, 2015, GLOBAL HLTH ACTION, V8, P1; Datiko Danial BL, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005443, DOI 10.1371/JOURNAL.PONE.0005443]; Datiko DG, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000390; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Datiko DG, 2006, B WHO, V84; de Vries SG, 2017, LANCET INFECT DIS, V17, pE128, DOI 10.1016/S1473-3099(16)30531-X; Elfil M, 2017, EMERG TEHRAN, V5, P52; Ethiopian Health and Nutrition Institute, 2011, 1 ETH NAT POP BAS TU; Federal Democratic republic of Ethiopia Ministry of Health, 2013, POCK GUID CLIN MAN T; Federal Ministry of Health Ethiopia, 2015, HLTH HLTH REL IND; Federal Ministry of Health Ethiopia, 2012, GUID CLIN PROGR MAN; Federal MoH Ethiopia, 2016, GUID CLIN PROGR MAN; Fenenga CJ, 2014, INT J HEALTH PLAN M, V29, P26, DOI 10.1002/hpm.2159; Fluegge K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5648-6; Francis E, 2018, ALEXANDRIA J MED, V54, P529, DOI [10.1016/j.ajme.2018.09, DOI 10.1016/J.AJME.2018.09]; Gebeyehu E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701429; Gebreegziabher SB, 2016, TUBERCLOSIS RES TREA, V2016; Gele AA, 2010, BMC RES NOTES, V3, DOI [10.1186/1756-0500-3-3, DOI 10.1186/1756-0500-3-3]; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Gillies D, 2015, CRISIS, V36, P316, DOI 10.1027/0227-5910/a000328; Harel Z, 2016, CLIN J AM SOC NEPHRO, V11, P901, DOI 10.2215/CJN.11481015; Huong NT, 2007, BMC PUBLIC HEALTH, V7, P1, DOI [10.1186/1471-2458-7-1, DOI 10.1186/1471-2458-7-1]; Jimma Zone health department, 2016, ANN PERF REP 2016; Kaji A, 2015, BMC HEALTH SERV RES, V15, P1, DOI [10.1186/s12913-014-0652-8, DOI 10.1186/S12913-014-0652-8]; Kerrigan D, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0206-8; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kuznetsov VN, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.23515; Li J, 2017, INT J E-NAVIG MARIT, V6, P1, DOI 10.1016/j.enavi.2017.05.001; Lonnroth K, 2009, STOP TB PATNERSHIP A; Matteelli A, 2017, PRESSE MED, V46, pE13, DOI 10.1016/j.lpm.2017.01.015; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Oshi DC, 2017, INT J MYCOBACT, V6, P246, DOI 10.4103/ijmy.ijmy_91_17; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pearson A, 2005, INT J NURSING PRACTI, V11; Rashid M, 2019, MED EDUC ONLINE, V24, DOI 10.1080/10872981.2019.1624133; Rasool G, 2019, INT J IMMUNOPATH PH, V33, DOI 10.1177/2058738419827174; Said K, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0276-4; Seid A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5823-9; Shenoi SV, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx092; Stalter AM, 2017, NURS FORUM, V52, P323, DOI 10.1111/nuf.12196; Taylor S. J., 2015, INTRO QUALITATIVE RE, V4th; The Global Fund, 2018, BEST PRACT TB CAS FI; Tuberculosis Research Advisory Committee (TRAC/FMOH), 2013, ROADM TUB OP RES ETH; Tulloch O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1523-x; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; WHO, 2014, GLOB TUB REP 2014; Woldesemayat EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116324; Woldie M., 2015, Journal of Public Health and Epidemiology, V7, P223; Workie NW, 2013, HLTH EXTENSION PROGR; World Health Organisation, 2007, STRENGTH HLTH SYST I; World Health Organization, 2017, GLOB TUB REP 2017, DOI [10.1001/jama.2014.11450, DOI 10.1001/JAMA.2014.11450]; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Yimer S, 2009, BMC PUBLIC HEALTH, V9, P1, DOI [10.1186/1471-2458-9-1, DOI 10.1186/1471-2458-9-1]; Yirgu R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2407-8	64	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2020	15	1							e0226307	10.1371/journal.pone.0226307	http://dx.doi.org/10.1371/journal.pone.0226307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP4DA	31895932	gold, Green Published, Green Submitted			2022-12-26	WOS:000534267300005
J	Hong, CJ; Yeon, J; Yeo, BK; Woo, H; An, HK; Heo, W; Kim, K; Yu, SW				Hong, Caroline Jeeyeon; Yeon, Jihye; Yeo, Bo Kyoung; Woo, Hanwoong; An, Hyun-Kyu; Heo, Woojung; Kim, Kyuhyung; Yu, Seong-Woon			Fas-apoptotic inhibitory molecule 2 localizes to the lysosome and facilitates autophagosome-lysosome fusion through the LC3 interaction region motif-dependent interaction with LC3	FASEB JOURNAL			English	Article						autolysosome; autophagosome maturation; FAIM2; LIR; MAP1LC3B; xbx-6	PROTEIN; ACIDIFICATION; DEGRADATION; ATPASE; MODULATION; MATURATION; SYNTHASE; GENES; FAIM2; TMBIM	Fas-apoptotic inhibitory molecule 2 (FAIM2) is a member of the transmembrane BAX inhibitor motif-containing (TMBIM) family. TMBIM family is comprised of six anti-apoptotic proteins that suppress cell death by regulating endoplasmic reticulum Ca2+ homeostasis. Recent studies have implicated two TMBIM proteins, GRINA and BAX Inhibitor-1, in mediating cytoprotection via autophagy. However, whether FAIM2 plays a role in autophagy has been unknown. Here we show that FAIM2 localizes to the lysosomes at basal state and facilitates autophagy through interaction with microtubule-associated protein 1 light chain 3 proteins in human neuroblastoma SH-SY5Y cells. FAIM2 overexpression increased autophagy flux, while autophagy flux was impaired in shRNA-mediated knockdown (shFAIM2) cells, and the impairment was more evident in the presence of rapamycin. In shFAIM2 cells, autophagosome maturation through fusion with lysosomes was impaired, leading to accumulation of autophagosomes. A functional LC3-interacting region motif within FAIM2 was essential for the interaction with LC3 and rescue of autophagy flux in shFAIM2 cells while LC3-binding property of FAIM2 was dispensable for the anti-apoptotic function in response to Fas receptor-mediated apoptosis. Suppression of autophagosome maturation was also observed in a null mutant of Caenorhabditis elegans lacking xbx-6, the ortholog of FAIM2. Our study suggests that FAIM2 is a novel regulator of autophagy mediating autophagosome maturation through the interaction with LC3.	[Hong, Caroline Jeeyeon; Yeon, Jihye; Yeo, Bo Kyoung; Woo, Hanwoong; An, Hyun-Kyu; Heo, Woojung; Kim, Kyuhyung; Yu, Seong-Woon] Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Yu, SW (corresponding author), Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea.	yusw@dgist.ac.kr			National Research Foundation of Korea (NRF) [2018M3C7A1056275]; DGIST Convergence Science Center Program [19-BD-0402]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); DGIST Convergence Science Center Program	National Research Foundation of Korea (NRF), Grant/Award Number: 2018M3C7A1056275; DGIST Convergence Science Center Program, Grant/Award Number: 19-BD-0402	Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Besirli CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046664; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BRENNER S, 1974, GENETICS, V77, P71; Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gauthier T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128701; Gomez NM, 2018, FASEB J, V32, P782, DOI 10.1096/fj.201700220RR; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Park H, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00046; Pawar M, 2017, CELL DEATH DIFFER, V24, P1799, DOI 10.1038/cdd.2017.109; Planells-Ferrer L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.356; Popelka H, 2015, AUTOPHAGY, V11, P2153, DOI 10.1080/15548627.2015.1111503; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Reimers K, 2006, INT J MOL MED, V18, P729; Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Schweitzer B, 2002, MOL BRAIN RES, V107, P47, DOI 10.1016/S0169-328X(02)00445-X; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Tauber SC, 2014, J NEUROPATH EXP NEUR, V73, P2, DOI 10.1097/NEN.0000000000000020; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Urresti J, 2016, J BIOL CHEM, V291, P1221, DOI 10.1074/jbc.M115.677682; Wang L, 2007, APOPTOSIS, V12, P1489, DOI 10.1007/s10495-007-0073-9; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yadav RK, 2015, AUTOPHAGY, V11, P1760, DOI 10.1080/15548627.2015.1082021; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zhang H, 2015, AUTOPHAGY, V11, P9, DOI 10.1080/15548627.2014.1003478; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	47	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					161	179		10.1096/fj.201901626R	http://dx.doi.org/10.1096/fj.201901626R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914609				2022-12-26	WOS:000507308900013
J	Kautzmann, MAI; Gordon, WC; Jun, B; Do, KV; Matherne, BJ; Fang, ZD; Bazan, NG				Kautzmann, Marie-Audrey I.; Gordon, William C.; Jun, Bokkyoo; Do, Khanh V.; Matherne, Blake J.; Fang, Zhide; Bazan, Nicolas G.			Membrane-type frizzled-related protein regulates lipidome and transcription for photoreceptor function	FASEB JOURNAL			English	Article						Adipor1; inflammatory signaling; matrix-assisted laser desorption; ionization imaging mass spectrometry (MALDI IMS); retinal degenerations; RPE cell; VLC-PUFAs	POLYENOIC FATTY-ACIDS; LONG-CHAIN PUFAS; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; MOUSE MODEL; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; GENE-THERAPY; MUTATION; MFRP	Molecular decision-makers of photoreceptor (PRC) membrane organization and gene regulation are critical to understanding sight and retinal degenerations that lead to blindness. Using Mfrp(rd6) mice, which develop PRC degeneration, we uncovered that membrane-type frizzled-related protein (MFRP) participates in docosahexaenoic acid (DHA, 22:6) enrichment in a manner similar to adiponectin receptor 1 (AdipoR1). Untargeted imaging mass spectrometry demonstrates cell-specific reduction of phospholipids containing 22:6 and very long-chain polyunsaturated fatty acids (VLC-PUFAs) in Adipor1(-/-) and Mfrp(rd6 )retinas. Gene expression of pro-inflammatory signaling pathways is increased and gene-encoding proteins for PRC function decrease in both mutants. Thus, we propose that both proteins are necessary for retinal lipidome membrane organization, visual function, and to the understanding of the early pathology of retinal degenerative diseases.	[Kautzmann, Marie-Audrey I.; Gordon, William C.; Jun, Bokkyoo; Do, Khanh V.; Matherne, Blake J.; Bazan, Nicolas G.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, New Orleans, LA USA; [Fang, Zhide] Louisiana State Univ Hlth New Orleans, Sch Publ Hlth, Biostat, New Orleans, LA USA; [Matherne, Blake J.] Louisiana State Univ Hlth New Orleans, Sch Med, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444; DO, KHANH/0000-0001-7834-3781	National Institutes of Health; National Eye Institute; National Institute of General Medical Sciences; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	National Institutes of Health; National Eye Institute; National Institute of General Medical Sciences; Research to Prevent Blindness	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Ayala-Ramirez R, 2006, MOL VIS, V12, P1483; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bazan NG, 2018, MOL ASPECTS MED, V64, P18, DOI 10.1016/j.mam.2018.09.003; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; Collery RF, 2016, INVEST OPHTH VIS SCI, V57, P6805, DOI 10.1167/iovs.16-19593; DETURCO EBR, 1991, J NEUROSCI, V11, P3667; Dinculescu A, 2014, ADV EXP MED BIOL, V801, P711, DOI 10.1007/978-1-4614-3209-8_89; Ferguson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067265; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fogerty J, 2014, ADV EXP MED BIOL, V801, P355, DOI 10.1007/978-1-4614-3209-8_45; Fogerty J, 2011, INVEST OPHTH VIS SCI, V52, P7256, DOI 10.1167/iovs.11-8112; Genetics Home Reference, 2019, NATL LIB MED; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Sanchez-Martin MJ, 2013, CHEMBIOCHEM, V14, P639, DOI 10.1002/cbic.201200687; Jun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05433-7; Kaarniranta K, 2012, NEUROSCI LETT, V513, P233, DOI 10.1016/j.neulet.2012.02.050; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kameya S, 2002, HUM MOL GENET, V11, P1879, DOI 10.1093/hmg/11.16.1879; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Krill AE, 1977, HEREDITARY RETINAL C, VII, P739; Lagali PS, 2003, INVEST OPHTH VIS SCI, V44, P2841, DOI 10.1167/iovs.02-0991; Li Y, 2014, MOL THER, V22, P1688, DOI 10.1038/mt.2014.100; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Metherel AH, 2019, J NUTR, V149, P586, DOI 10.1093/jn/nxy282; Mitchell DC, 2003, LIPIDS, V38, P437, DOI 10.1007/s11745-003-1081-1; Oresti GM, 2010, J LIPID RES, V51, P2600, DOI 10.1194/jlr.M006395; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Sluch VM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32579-9; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; Suh M, 2005, CURR EYE RES, V30, P959, DOI 10.1080/02713680500246957; Tu XY, 2014, J STRUCT BIOL, V186, P86, DOI 10.1016/j.jsb.2014.02.001; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Velez G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16275-8; Wassall SR, 2018, BBA-BIOMEMBRANES, V1860, P1985, DOI 10.1016/j.bbamem.2018.04.016; Won J, 2008, VISUAL NEUROSCI, V25, P563, DOI 10.1017/S0952523808080723; Xu M, 2016, ACTA PHARMACOL SIN, V37, P246, DOI 10.1038/aps.2015.125; Yu M, 2012, J LIPID RES, V53, P494, DOI 10.1194/jlr.M021386; Zhang JL, 2016, HUM GENET, V135, P1375, DOI 10.1007/s00439-016-1730-2	55	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					912	929		10.1096/fj.201902359R	http://dx.doi.org/10.1096/fj.201902359R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914617	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000507308900062
J	Patil, MJ; Salas, M; Bialuhin, S; Boyd, JT; Jeske, NA; Akopian, AN				Patil, Mayur J.; Salas, Margaux; Bialuhin, Siarhei; Boyd, Jacob T.; Jeske, Nathaniel A.; Akopian, Armen N.			Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association	FASEB JOURNAL			English	Article						pain; sensitization; sensory neurons; TRPA1; TRPV1	ROOT GANGLION NEURONS; ION-CHANNEL TRPA1; VANILLOID 1; SIGNALING PATHWAY; PAIN SENSATION; RECEPTOR; RAT; ACTIVATION; RESPONSES; PHOSPHORYLATION	Unique features of sensory neuron subtypes are manifest by their distinct physiological and pathophysiological functions. Using patch-clamp electrophysiology, Ca2+ imaging, calcitonin gene-related peptide release assay from tissues, protein biochemistry approaches, and behavioral physiology on pain models, this study demonstrates the diversity of sensory neuron pathophysiology is due in part to subtype-dependent sensitization of TRPV1 and TRPA1. Differential sensitization is influenced by distinct expression of inflammatory mediators, such as prostaglandin E-2 (PGE(2)), bradykinin (BK), and nerve growth factor (NGF) as well as multiple kinases, including protein kinase A (PKA) and C (PKC). However, the co-expression and interaction of TRPA1 with TRPV1 proved to be the most critical for differential sensitization of sensory neurons. We identified N- and C-terminal domains on TRPV1 responsible for TRPA1-TRPV1 (A1-V1) complex formation. Ablation of A1-V1 complex with dominant-negative peptides against these domains substantially reduced the sensitization of TRPA1, as well as BK- and CFA-induced hypersensitivity. These data indicate that often occurring TRP channel complexes regulate diversity in neuronal sensitization and may provide a therapeutic target for many neuroinflammatory pain conditions.	[Patil, Mayur J.; Salas, Margaux; Bialuhin, Siarhei; Boyd, Jacob T.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Patil, Mayur J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Salas, Margaux] US Army Inst Surg Res, Air Force 59th Med Wing, San Antonio, TX USA; [Boyd, Jacob T.; Jeske, Nathaniel A.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; United States Department of Defense; United States Army; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Akopian@UTHSCSA.edu	Belugin, Sergei/L-5005-2013	Belugin, Sergei/0000-0001-9006-7732	NIH/NINDS [NS102161]; NIH/NIGMS [GM112747]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NINDS, Grant/Award Number: NS102161; NIH/NIGMS, Grant/Award Number: GM112747	ABBADIE C, 1994, J NEUROSCI, V14, P5865; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Arcourt A, 2017, NEURON, V93, P179, DOI 10.1016/j.neuron.2016.11.027; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Brackley AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01999-4; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fang D, 2015, PAIN, V156, P1124, DOI 10.1097/j.pain.0000000000000158; Feketa Viktor V, 2015, Temperature (Austin), V2, P244, DOI 10.1080/23328940.2015.1024383; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han ZT, 2017, AM J TRANSL RES, V9, P2567; Jankowski MP, 2010, TRANSLATIONAL PAIN R; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LaMotte RH, 2007, J NEUROPHYSIOL, V97, P1, DOI 10.1152/jn.01021.2006; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Megat S, 2019, J NEUROSCI, V39, P393, DOI 10.1523/JNEUROSCI.2661-18.2018; Mizuta K., 2016, ETIOLOGY MORPHOGENES; Nielsen TA, 2018, PAIN, V159, P1989, DOI 10.1097/j.pain.0000000000001298; Patil MJ, 2013, NEUROSCIENCE, V253, P132, DOI 10.1016/j.neuroscience.2013.08.035; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Patil MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198601; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Ray P, 2018, PAIN, V159, P1325, DOI 10.1097/j.pain.0000000000001217; Reynders A, 2015, CELL REP, V10, P1007, DOI 10.1016/j.celrep.2015.01.022; Rouwette T, 2016, MOL CELL PROTEOMICS, V15, P2152, DOI 10.1074/mcp.M116.058966; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sadofsky LR, 2014, CELLS-BASEL, V3, P616, DOI 10.3390/cells3020616; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Smith JAM, 2000, EUR J NEUROSCI, V12, P3250, DOI 10.1046/j.1460-9568.2000.00218.x; Song YB, 2018, SOMATOSENS MOT RES, V35, P11, DOI 10.1080/08990220.2018.1439000; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Spahn V, 2014, MOL PHARMACOL, V85, P335, DOI 10.1124/mol.113.088997; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sun SH, 2017, NEURON, V93, P840, DOI 10.1016/j.neuron.2017.01.012; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Vermeulen W, 2013, EUR J PHARMACOL, V698, P404, DOI 10.1016/j.ejphar.2012.10.014; Wang CM, 2019, FASEB J, V33, P1360, DOI 10.1096/fj.201800615RR; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Weyer AD, 2015, J NEUROSCI, V35, P9456, DOI 10.1523/JNEUROSCI.0549-15.2015; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang J, 2016, NEURON, V92, P461, DOI 10.1016/j.neuron.2016.09.014; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	68	25	26	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					287	302		10.1096/fj.201902026R	http://dx.doi.org/10.1096/fj.201902026R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914619	Green Accepted			2022-12-26	WOS:000507308900021
J	Peters-Hall, JR; Min, J; Tedone, E; Sho, S; Siteni, S; Mender, I; Shay, JW				Peters-Hall, Jennifer R.; Min, Jaewon; Tedone, Enzo; Sho, Sei; Siteni, Silvia; Mender, Ilgen; Shay, Jerry W.			Proliferation of adult human bronchial epithelial cells without a telomere maintenance mechanism for over 200 population doublings	FASEB JOURNAL			English	Article						conditional reprogramming; low oxygen; ROCK inhibitor; senescence; telomerase	LIFE-SPAN; STEM-CELLS; PULMONARY-FIBROSIS; CYSTIC-FIBROSIS; CULTURE; OXYGEN; DIFFERENTIATION; IMMORTALIZATION; SENESCENCE; MUTATIONS	To date, there is no direct evidence of telomerase activity in adult lung epithelial cells, but typical culture conditions only support cell proliferation for 30-40 population doublings (PD), a point at which telomeres remain relatively long. Here we report that in in vitro low stress culture conditions consisting of a fibroblast feeder layer, rho-associated coiled coil protein kinase inhibitor (ROCKi), and low oxygen (2%), normal human bronchial epithelial basal progenitor cells (HBECs) divide for over 200 PD without engaging a telomere maintenance mechanism (almost four times the "Hayflick limit"). HBECs exhibit critically short telomeres at 200 PD and the population of cells start to undergo replicative senescence. Subcloning these late passage cells to clonal density, to mimic lung injury in vivo, selects for rare subsets of HBECs that activate low levels of telomerase activity to maintain short telomeres. CRISPR/Cas9 knockout of human telomerase reverse transcriptase or treatment with the telomerase-mediated telomere targeting agent 6-thio-2 ' deoxyguanosine abrogates colony growth in these late passage cultures (>200 PD) but not in early passage cultures (<200 PD). To our knowledge, this is the first study to report such long-term growth of HBECs without a telomere maintenance mechanism. This report also provides direct evidence of telomerase activation in HBECs near senescence when telomeres are critically short. This novel cell culture system provides an experimental model to understand how telomerase is regulated in normal adult tissues.	[Peters-Hall, Jennifer R.; Min, Jaewon; Tedone, Enzo; Sho, Sei; Siteni, Silvia; Mender, Ilgen; Shay, Jerry W.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu			National Cancer Institute T32 training grant [CA124334]; Cystic Fibrosis Foundation (CFF) [PETERS15F0]; CFF grant [SHAY17GO]; Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant [CA142543]; NCI SPORE [P50CA70907]; NIH [C06 RR30414]	National Cancer Institute T32 training grant; Cystic Fibrosis Foundation (CFF); CFF grant; Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was initially supported by a National Cancer Institute T32 training grant (CA124334) and later by a Cystic Fibrosis Foundation (CFF) Postdoctoral Fellowship to JRP (PETERS15F0); and a CFF grant (SHAY17GO) to JWS. We also acknowledge the Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant [CA142543] and NCI SPORE P50CA70907. This work was performed in laboratories constructed with support from NIH grant C06 RR30414. JWS holds the distinguished Southland Financial Corporation Distinguished Chair in Geriatrics Research.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Fulcher ML, 2009, AM J PHYSIOL-LUNG C, V296, pL82, DOI 10.1152/ajplung.90314.2008; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hazawa M, 2018, EMBO REP, V19, P73, DOI 10.15252/embr.201744523; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hiyama E, 1996, INT J ONCOL, V9, P453; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Huang E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05174-7; Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016; Lai TP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01291-z; Lai TP, 2016, BIOTECHNIQUES, V60, P306, DOI 10.2144/000114427; Lebkowski JS, 2001, CANCER J, V7, pS83; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Mender I, 2015, CANCER DISCOV, V5, P82, DOI 10.1158/2159-8290.CD-14-0609; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peters-Hall JR, 2018, AM J PHYSIOL-LUNG C, V315, pL313, DOI 10.1152/ajplung.00355.2017; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramirez RD, 1997, J INVEST DERMATOL, V108, P113, DOI 10.1111/1523-1747.ep12285654; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Rubin H, 1998, NAT BIOTECHNOL, V16, P396, DOI 10.1038/nbt0598-396; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wright WE, 1996, DEV GENET, V18, P173; Yasumoto S, 1996, ONCOGENE, V13, P433; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	55	9	9	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					386	398		10.1096/fj.201902376R	http://dx.doi.org/10.1096/fj.201902376R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914653	Green Accepted			2022-12-26	WOS:000507308900027
J	Watson, EL; Baker, LA; Wilkinson, TJ; Gould, DW; Graham-Brown, MPM; Major, RW; Ashford, RU; Philp, A; Smith, AC				Watson, Emma L.; Baker, Luke A.; Wilkinson, Thomas J.; Gould, Douglas W.; Graham-Brown, Matthew P. M.; Major, Rupert W.; Ashford, Robert U.; Philp, Andrew; Smith, Alice C.			Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease	FASEB JOURNAL			English	Article						chronic kidney disease; exercise; mitochondria; skeletal muscle	ALL-CAUSE MORTALITY; PHYSICAL FUNCTION; PROTEIN-METABOLISM; DYSFUNCTION; CKD; ACTIVATION; RESISTANCE; PGC-1-ALPHA; BIOGENESIS; CAPACITY	Patients with chronic kidney disease (CKD) exhibit reduced exercise capacity, poor physical function and symptoms of fatigue. The mechanisms that contribute to this are not clearly defined but may involve reductions in mitochondrial function, mass and biogenesis. Here we report on the effect of non-dialysis dependent CKD (NDD-CKD) on mitochondrial mass and basal expression of transcription factors involved in mitochondrial biogenesis compared to a healthy control cohort (HC). In addition, we sought to investigate the effect of a 12-week exercise-training programme on these aspects of mitochondrial dysfunction in a NDD-CKD cohort.For the comparison between NDD-CKD and HC populations, skeletal muscle biopsies were collected from the vastus lateralis (VL) of n=16 non-dialysis dependent CKD patient's stage 3b-5 (NDD-CKD) and n=16 healthy controls matched for age, gender and physical activity (HC). To investigate the effect of exercise training, VL biopsies were collected from n=17 NDD-CKD patients before and after a 12-week exercise intervention that was comprised of aerobic exercise (AE) or a combination of aerobic exercise and resistance training (CE). Mitochondrial mass was analysed by citrate synthase activity and mitochondrial protein content by Porin expression, whilst the expression of transcription factors involved in mitochondrial biogenesis were quantified by real-time qPCR. NDD-CKD patients exhibited a significant reduction in mitochondrial mass when compared to HC, coupled to a reduction in PGC-1 alpha, NRF-1, Nrf2, TFam, mfn2 and SOD1/2 gene expression. 12-weeks of exercise training resulted in a significant increase in PGC-1 alpha expression in both groups, with no further changes seen across indicators of mitochondrial biogenesis. No significant changes in mitochondrial mass were observed in response to either exercise programme. NDD-CKD patients exhibit reduced skeletal muscle mitochondrial mass and gene expression of transcription factors involved in mitochondrial biogenesis compared to HC. These reductions were not restored following 12-weeks of exercise training implying exercise resistance in this cohort. The reasons for this lack of improvement are currently unknown and require further investigation, as reversing the dysregulation of these processes in NDD-CKD may provide a therapeutic opportunity to improve muscle fatigue and dysfunction in this population.	[Watson, Emma L.; Gould, Douglas W.; Graham-Brown, Matthew P. M.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Baker, Luke A.; Wilkinson, Thomas J.; Major, Rupert W.; Smith, Alice C.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Gould, Douglas W.] Intens Care Natl Audit & Res Ctr, London, England; [Graham-Brown, Matthew P. M.; Major, Rupert W.; Smith, Alice C.] Univ Hosp Leicester NHS Trust, John Walls Renal Unit, Leicester, Leics, England; [Graham-Brown, Matthew P. M.] Loughborough Univ, Natl Ctr Sport & Exercise Med, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Ashford, Robert U.] Univ Hosp Leicester, Leicester Orthopaed, Leicester, Leics, England; [Ashford, Robert U.] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England; [Philp, Andrew] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Philp, Andrew] UNSW Sydney, UNSW Med, Sydney, NSW, Australia	University of Leicester; University of Leicester; Intensive Care National Audit & Research Centre; University Hospitals of Leicester NHS Trust; University of Leicester; Loughborough University; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; Garvan Institute of Medical Research; University of New South Wales Sydney	Watson, EL (corresponding author), Univ Leicester, Leicester Kidney Lifestyle Team, Dept Cardiovasc Sci, Med Sci Bldg, Leicester LE1 9HN, Leics, England.	emma.watson@le.ac.uk	Ashford, Robert U./AAT-2468-2021; Graham-Brown, Matthew/ABB-5400-2020	Ashford, Robert U./0000-0002-8246-2334; Baker, Luke/0000-0003-2111-3832; Gould, Doug/0000-0003-4148-3312; Major, Rupert/0000-0003-4920-623X; Philp, Andrew/0000-0003-3860-4136; Graham-Brown, Matthew/0000-0002-6197-180X	Kidney Research UK [PDF2/2015, TF2/2015]	Kidney Research UK(Kidney Research UK (KRUK))	Kidney Research UK, Grant/Award Number: PDF2/2015 and TF2/2015	Adams GR, 2005, MED SCI SPORT EXER, V37, P557, DOI 10.1249/01.MSS.0000159006.87769.67; Baar K., 2014, MOL EXERCISE PHYSIOL, P79; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Baria F, 2014, NEPHROL DIAL TRANSPL, V29, P857, DOI 10.1093/ndt/gft529; Boushel R, 2014, EXERC SPORT SCI REV, V42, P169, DOI 10.1249/JES.0000000000000025; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Craig DM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00296; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Enoki Y, 2017, J CACHEXIA SARCOPENI, V8, P735, DOI 10.1002/jcsm.12202; Gamboa JL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12780; Golbidi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/941868; Gonzalez-Freire M, 2018, J CACHEXIA SARCOPENI, V9, P435, DOI 10.1002/jcsm.12313; Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725; Gould DW, 2019, J CACHEXIA SARCOPENI, V10, P748, DOI 10.1002/jcsm.12429; Groennebaek T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00713; Hayot M, 2005, EUR RESPIR J, V25, P431, DOI 10.1183/09031936.05.00053404; Hedges CP, 2019, J APPL PHYSIOL, V126, P454, DOI 10.1152/japplphysiol.00777.2018; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Hiraki K, 2013, CLIN EXP NEPHROL, V17, P225, DOI 10.1007/s10157-012-0681-8; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Johansen KL, 1999, ADV RENAL REPLACE TH, V6, P141, DOI 10.1016/S1073-4449(99)70032-4; Joseph AM, 2016, J PHYSIOL-LONDON, V594, P5105, DOI 10.1113/JP270659; Kemp GJ, 2004, NEPHROL DIAL TRANSPL, V19, P1520, DOI 10.1093/ndt/gfh189; Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lawler JM, 2016, J PHYSIOL-LONDON, V594, P5161, DOI 10.1113/JP270656; Leehey DJ, 2016, AM J NEPHROL, V44, P54, DOI 10.1159/000447703; Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1007/BF02254982; MacKinnon HJ, 2018, THER ADV CHRONIC DIS, V9, P209, DOI 10.1177/2040622318785575; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; Morishita S, 2017, HEMODIAL INT, V21, P483, DOI 10.1111/hdi.12564; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; O'Sullivan TF, 2018, CLIN KIDNEY J, V11, P810, DOI 10.1093/ckj/sfy052; Perez-Schindler J, 2015, CLIN SCI, V129, P589, DOI 10.1042/CS20150246; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; PRICE SR, 1994, AM J PHYSIOL-CELL PH, V267, pC955, DOI 10.1152/ajpcell.1994.267.4.C955; Puthucheary ZA, 2018, THORAX, V73, P926, DOI 10.1136/thoraxjnl-2017-211073; Rao M, 2018, CURR OPIN NEPHROL HY, V27, P113, DOI 10.1097/MNH.0000000000000393; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Robinson KA, 2020, NEPHROL DIAL TRANSPL, V35, P1469, DOI 10.1093/ndt/gfz193; Roshanravan B, 2017, AM J KIDNEY DIS, V69, P837, DOI 10.1053/j.ajkd.2017.01.051; Roshanravan B, 2016, AM J KIDNEY DIS, V68, P658, DOI 10.1053/j.ajkd.2016.05.011; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Smiles WJ, 2015, J PHYSIOL-LONDON, V593, P2115, DOI 10.1113/JP270177; Stocks B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00941; Su Z, 2017, AM J PHYSIOL-RENAL, V312, pF1128, DOI 10.1152/ajprenal.00600.2016; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Tamaki M, 2014, KIDNEY INT, V85, P1330, DOI 10.1038/ki.2013.473; Thomas SS, 2013, KIDNEY INT, V84, P308, DOI 10.1038/ki.2013.97; Tsai YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183642; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang DT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/684965; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Watson EL, 2018, AM J PHYSIOL-RENAL, V314, pF1188, DOI 10.1152/ajprenal.00012.2018; Watson EL, 2015, AM J KIDNEY DIS, V66, P249, DOI 10.1053/j.ajkd.2014.10.019; Wilkinson TJ, 2019, NEPHROL DIAL TRANSPL, V34, P1344, DOI 10.1093/ndt/gfy139; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Yazdi PG, 2013, INT J CLIN EXP MED, V6, P532; Zaza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077847; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	70	30	30	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1755	1767		10.1096/fj.201901936RR	http://dx.doi.org/10.1096/fj.201901936RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914685	Bronze			2022-12-26	WOS:000507308900116
J	Zhu, JJ; Liu, X; Cai, XL; Ouyang, G; Fan, SJ; Wang, J; Xiao, WH				Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Fan, Sijia; Wang, Jing; Xiao, Wuhan			Zebrafish prmt7 negatively regulates antiviral responses by suppressing the retinoic acid-inducible gene-I-like receptor signaling	FASEB JOURNAL			English	Article						GCRV; irf3; Prmt7; SVCV; zebrafish	PROTEIN ARGININE METHYLTRANSFERASE; GRASS CARP REOVIRUS; SPRING VIREMIA; 7 PRMT7; RECOGNITION; METHYLATION; RNA; METASTASIS; INDUCTION; CELLS	Arginine methylation is a post-translational modification in histone and nonhistone proteins that can affect numerous cellular activities. Protein arginine methyltransferase 7 (Prmt7), a type III arginine methyltransferase, catalyzes the formation of stable monomethylarginines of histones. The role of PRMT7 in virus-induced innate immunity signaling, however, remains largely unknown. We demonstrate that zebrafish prmt7 could be inhibited by spring viremia of carp virus (SVCV) and grass carp reovirus (GCRV) infection. The overexpression of prmt7 suppresses cellular antiviral responses that are partially dependent on the arginine methyltransferase activity of prmt7. Consistently, prmt7-null zebrafish were more resistant to SVCV or GCRV infection, exhibiting enhanced expression of key antiviral genes and fewer necrotic cells in the liver and kidney upon viral infection. Furthermore, we established a zebrafish model to investigate grass carp hemorrhagic disease. Our findings suggest that by suppressing the RIG-I-like receptors signaling, zebrafish prmt7 negatively regulates antiviral responses, indicating the vital role of prmt7 and its arginine methyltransferase activity in innate immunity.	[Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Fan, Sijia; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Zhu, Junji; Cai, Xiaolian; Fan, Sijia; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Minist Agr, Key Lab Aquaculture Dis Control, Wuhan, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Zhu, Junji/AGG-9650-2022; Xiao, Wuhan/GLU-7352-2022; Zhu, Junji/GPF-8726-2022	Zhu, Junji/0000-0003-2968-180X	National Natural Science Foundation of China (NSFC) [31830101, 31721005, 31631102, 31671315]; National Key R & D Program of China [2018YFD0900602]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R & D Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31830101, 31721005, 31631102 and 31671315; National Key R & D Program of China, Grant/Award Number: 2018YFD0900602	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Blanc RS, 2016, CELL REP, V14, P1528, DOI 10.1016/j.celrep.2016.01.022; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Cheng DZ, 2018, ONCOTARGETS THER, V11, P4869, DOI 10.2147/OTT.S166412; Feng H, 2015, J IMMUNOL, V194, P1225, DOI 10.4049/jimmunol.1402415; Feng Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609271; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Greenblatt SM, 2016, EXP HEMATOL, V44, P435, DOI 10.1016/j.exphem.2016.03.009; Ji JF, 2018, J IMMUNOL, V200, P573, DOI 10.4049/jimmunol.1701149; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Liang HR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-178; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu X, 2016, J IMMUNOL, V197, P4736, DOI 10.4049/jimmunol.1601187; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Rao YL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/670437; ROY P, 1978, J VIROL, V25, P912, DOI 10.1128/JVI.25.3.912-916.1978; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wesche J, 2017, CELL MOL LIFE SCI, V74, P3305, DOI 10.1007/s00018-017-2515-z; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Ying ZZ, 2015, J IMMUNOL, V195, P1538, DOI 10.4049/jimmunol.1500224; Yu GQ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01432; Zhang HQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030364; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	19	20	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					988	1000		10.1096/fj.201902219R	http://dx.doi.org/10.1096/fj.201902219R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914680				2022-12-26	WOS:000507308900067
J	Milic, V; Colic, J; Cirkovic, A; Stanojlovic, S; Damjanov, N				Milic, Vera; Colic, Jelena; Cirkovic, Andja; Stanojlovic, Svetlana; Damjanov, Nemanja			Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography	PLOS ONE			English	Article							ACTIVITY INDEX; CLASSIFICATION CRITERIA; CONTROLLED-TRIAL; RITUXIMAB	Objectives To assess the association between salivary ultrasonography (sUS) findings and disease activity and damage in patients with primary Sjogren's syndrome (pSS). We investigated the potential prognostic role of sUS as a tool in the assessment of disease activity. Methods In 303 pSS patients, disease activity was assessed by the European League Against Rheumatism (EULAR) Sjogren's Syndrome Disease Activity Index (ESSDAI), the EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI), the Sjogren's Syndrome Disease Activity Index (SSDAI) and the Sjogren's Syndrome Disease Damage Index (SSDDI). The sUS parenchymal inhomogeneity (de Vita scoring system) was assessed in 303 pSS patients and 111 heathy controls. A receiver operating characteristic (ROC) curve was used to determine the cut-off value of the pathological sUS score. Logistic regression analysis was performed to assess risk factors for moderate and high disease activity. Results A pathological sUS score >= 2 was recorded in 271 (89.7%) patients and 8 (8.6%) healthy controls. Patients with moderate and high ESSDAI and SSDAI scores had significantly higher US activity in comparison to that of pSS patients with low disease activity (p = 0.006; p = 0.01, respectively). Additionally, pSS patients with moderate and high SSDDI scores had higher US activity (p = 0.031). Pathological sUS correlated with the glandular domain within the ESSDAI and SSDDI (p<0.001). The patients with a severe US score (5-6) had a 3.5 times greater chance of having moderate or high disease activity. The specificity of the severe de Vita sUS score for ESSDAI and SSDAI was 85.1% and 85.2%, respectively. In contrast, the sensitivity of a severe de Vita sUS score for ESSDAI was low, at 29.2%, while the sensitivity for the SSDAI was higher, 42.3%. In the analysis of disease activity, a de Vita score >= 5 could be used as a risk factor for moderate and high ESSDAI (p = 0.042) and SSDAI (p = 0.006). Conclusions Pathological salivary gland ultrasonography is associated with high disease activity and damage in pSS. Consequently, sUS abnormalities might be surrogate items for glandular domains in the assessment of disease activity and damage. Thus, ultrasonography of the salivary gland combined with clinical and serological markers might be part of the next prognostic and therapeutic algorithm in the near future.	[Milic, Vera; Colic, Jelena; Damjanov, Nemanja] Inst Rheumatol, Belgrade, Serbia; [Milic, Vera; Cirkovic, Andja; Stanojlovic, Svetlana; Damjanov, Nemanja] Univ Belgrade, Fac Med, Belgrade, Serbia; [Cirkovic, Andja] Fac Med, Dept Med Stat & Informat, Belgrade, Serbia; [Stanojlovic, Svetlana] Clin Ctr Serbia, Clin Eye Dis, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Milic, V (corresponding author), Inst Rheumatol, Belgrade, Serbia.; Milic, V (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.	veramilic@1409@gmail.com		Stanojlovic, Svetlana/0000-0002-0914-6992; Milic, Vera/0000-0003-1160-9674				Baldini C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0657-7; Borchers AT, 2003, CLIN REV ALLERG IMMU, V25, P89, DOI 10.1385/CRIAI:25:1:89; Bowman SJ, 2017, ARTHRITIS RHEUMATOL, V69, P1440, DOI 10.1002/art.40093; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; Brito-Zeron P, 2016, ANN RHEUM DIS, V75, P348, DOI 10.1136/annrheumdis-2014-206418; Coiffier G, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2019-216122; DEVITA S, 1992, CLIN EXP RHEUMATOL, V10, P351; Fidelix T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182287; Fisher BA, 2018, ANN RHEUM DIS, V77, P412, DOI 10.1136/annrheumdis-2017-212268; Inanc N, 2019, CLIN EXP RHEUMATOL, V37, pS140; Jonsson R, 2005, ARTHRITIS ALLIED CON, P1681; Jousse-Joulin S, 2016, RHEUMATOLOGY, V55, P789, DOI 10.1093/rheumatology/kev385; Jousse-Joulin S, 2015, ARTHRITIS RHEUMATOL, V67, P1623, DOI 10.1002/art.39088; Kimura-Hayama E, 2018, INT J RHEUM DIS, V21, P1293, DOI 10.1111/1756-185X.13292; Lee Kyung-Ann, 2018, Clin Exp Rheumatol, V36 Suppl 112, P165; Liang Y, 2014, ANN RHEUM DIS, V73, P1151, DOI 10.1136/annrheumdis-2013-203305; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Mariette X, 2015, ANN RHEUM DIS, V74, P526, DOI 10.1136/annrheumdis-2013-203991; Martel A, 2019, JOINT BONE SPINE, V86, P211, DOI 10.1016/j.jbspin.2018.06.014; Milic VD, 2010, SCAN J RHEUMATOL, V39, P1891; Milic V, 2012, RHEUMATOLOGY, V51, P1081, DOI 10.1093/rheumatology/ker431; Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P1354, DOI 10.1093/rheumatology/keh714; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; Ramos-Casals M, 2014, RHEUMATOLOGY, V53, P321, DOI 10.1093/rheumatology/ket349; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Takagi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195113; Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; van Nimwegen JF, 2020, ARTHRIT CARE RES, V72, P583, DOI 10.1002/acr.24017; Zabotti Alen, 2019, Clin Exp Rheumatol, V37 Suppl 118, P146	33	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2019	14	12							e0226498	10.1371/journal.pone.0226498	http://dx.doi.org/10.1371/journal.pone.0226498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8LM	31891590	Green Published, gold			2022-12-26	WOS:000515096600016
J	Li, NX; Islam, T; Kang, SC				Li, Ningxiao; Islam, Tariqul; Kang, Seogchan			Secreted metabolite-mediated interactions between rhizosphere bacteria and Trichoderma biocontrol agents	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; BIOLOGICAL-CONTROL AGENTS; PLANT-GROWTH; SYSTEMIC RESISTANCE; WOOD DECAY; HARZIANUM; INDUCTION; CUCUMBER; ANTIBIOTICS; ANTAGONISTS	Trichoderma has been used as an alternative to synthetic pesticides to control a variety of phytopathogenic fungi, oomycetes, and nematodes. Although its mechanism of pathogen suppression has been extensively studied, how Trichoderma interacts with non-target microbes is not well understood. Here, we investigated how two Trichoderma biological control agents (BCAs) interact with rhizosphere bacteria isolated from a tomato plant via secreted proteins, metabolites, and volatile compounds (VCs). Culture filtrates (CFs) of T. virens and T. harzianum, containing secreted proteins and metabolites, strongly inhibited (>75% reduction in growth) 39 and 19, respectively, out of 47 bacterial strains tested. Their CFs inhibited the remaining strains at lower degrees. Both metabolites and proteins are involved in inhibiting bacteria, but they seem to antagonize each other in inhibiting some strains. Trichoderma and bacteria suppressed the growth of each other using VCs. The secretion of antibacterial and antifungal molecules by T. virens and T. harzianum was significantly affected by VCs from some bacteria, suggesting that both Trichoderma BCAs and rhizosphere bacteria use VCs to influence each other in multiple ways. In light of these results, we discuss how metabolite-mediated interactions can potentially affect the effectiveness of biocontrol.	[Li, Ningxiao; Islam, Tariqul; Kang, Seogchan] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kang, SC (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	sxk55@psu.edu		Li, Ningxiao/0000-0002-7847-3567; Kang, Seogchan/0000-0003-2291-5634	USDA Specialty Crop Multi-State Program [AM170200XXXXG006]; USDA National Institute of Food Agriculture [PEN04655, 1016291]; Chinese Academy of Sciences President's International Fellowship Initiative [2019VCA0022]; Brian Pool program of the National Research Foundation of Korea [2019H1D3A2A01054562]	USDA Specialty Crop Multi-State Program; USDA National Institute of Food Agriculture; Chinese Academy of Sciences President's International Fellowship Initiative; Brian Pool program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the USDA Specialty Crop Multi-State Program (AM170200XXXXG006), the USDA National Institute of Food & Agriculture and Federal Appropriations (Project PEN04655; Accession #1016291), the Chinese Academy of Sciences President's International Fellowship Initiative (Grant #2019VCA0022), and the Brian Pool program of the National Research Foundation of Korea (Great #2019H1D3A2A01054562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Audrain B, 2015, FEMS MICROBIOL REV, V39, P222, DOI 10.1093/femsre/fuu013; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bitas V, 2013, MOL PLANT MICROBE IN, V26, P835, DOI 10.1094/MPMI-10-12-0249-CR; Calistru C, 1997, MYCOPATHOLOGIA, V137, P115, DOI 10.1023/A:1006802423729; Chaverri P, 2013, EVOLUTION, V67, P2823, DOI 10.1111/evo.12169; Ejechi BO, 1997, INT BIODETER BIODEGR, V39, P295, DOI 10.1016/S0964-8305(97)00023-1; Etebarian HR, 2000, EUR J PLANT PATHOL, V106, P329, DOI 10.1023/A:1008736727259; GHISALBERTI EL, 1991, SOIL BIOL BIOCHEM, V23, P1011, DOI 10.1016/0038-0717(91)90036-J; Guzman-Guzman P, 2019, PHYTOPATHOLOGY, V109, P6, DOI 10.1094/PHYTO-07-18-0218-RVW; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kai M, 2007, ARCH MICROBIOL, V187, P351, DOI 10.1007/s00203-006-0199-0; Koike N, 2001, EUR J PLANT PATHOL, V107, P523, DOI 10.1023/A:1011203826805; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee Samantha, 2016, Fungal Biol Biotechnol, V3, P7, DOI 10.1186/s40694-016-0025-7; Li N, 2018, FRONT PLANT SCI, V9, P1, DOI [10.3389/fmicb.2018.00001, DOI 10.3389/fpls.2018.00001]; Li NX, 2016, FUNGAL BIOL REV, V30, P134, DOI 10.1016/j.fbr.2016.06.004; Liu SY, 2009, J AGR FOOD CHEM, V57, P7288, DOI 10.1021/jf901405c; Liu Weiwei, 2008, Current Research in Bacteriology, V1, P28, DOI 10.3923/crb.2008.28.34; Martinez-Medina A, 2017, PLANT CELL ENVIRON, V40, P2691, DOI 10.1111/pce.13016; Mazzola M, 2017, PHYTOPATHOLOGY, V107, P256, DOI 10.1094/PHYTO-09-16-0330-RVW; Meena Mukesh, 2017, Archives of Phytopathology and Plant Protection, V50, P629, DOI 10.1080/03235408.2017.1357360; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mendoza-Mendoza A, 2018, FUNGAL BIOL REV, V32, P62, DOI 10.1016/j.fbr.2017.12.001; Monte Enrique, 2001, International Microbiology, V4, P1; Mukherjee PK, 2013, ANNU REV PHYTOPATHOL, V51, P105, DOI 10.1146/annurev-phyto-082712-102353; NRC, 2010, SUSTAINABLE AGR SYST, DOI [10.17226/12832, DOI 10.17226/12832]; Piechulla B, 2017, PLANT CELL ENVIRON, V40, P2042, DOI 10.1111/pce.13011; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Reid A, 2012, MICROBES CAN HELP FE, DOI [10.1093/biosci/biu163, DOI 10.1093/BIOSCI/BIU163]; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Rybakova D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01294; Saito M, 2000, ARBUSCULAR MYCORRHIZ, P85106, DOI [10.1007/978-94-017-0776-3_5, DOI 10.1007/978-94-017-0776-3_5]; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; SCHIRMBOCK M, 1994, APPL ENVIRON MICROB, V60, P4364; Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42; Seaman A, 2003, NEW YORK STATE INTEG; SIMON A, 1988, CAN J MICROBIOL, V34, P871, DOI 10.1139/m88-150; Singh A., 2018, INT J CURRENT MICROB, V7, P2382, DOI DOI 10.20546/IJCMAS.2018.702.291; Spraker JE, 2018, MBIO, V9, DOI 10.1128/mBio.00820-18; Spraker JE, 2014, J CHEM ECOL, V40, P502, DOI 10.1007/s10886-014-0432-2; Velivellil SLS, 2014, TRENDS BIOTECHNOL, V32, P493, DOI 10.1016/j.tibtech.2014.07.002; Wheatley R, 1997, INT BIODETER BIODEGR, V39, P199, DOI 10.1016/S0964-8305(97)00015-2; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yuan J, 2017, ENVIRON SCI POLLUT R, V24, P22485, DOI 10.1007/s11356-017-9839-y; Zeilinger S, 2016, FUNGAL BIOL REV, V30, P74, DOI 10.1016/j.fbr.2016.05.001; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	55	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2019	14	12							e0227228	10.1371/journal.pone.0227228	http://dx.doi.org/10.1371/journal.pone.0227228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8JV	31887213	gold, Green Published			2022-12-26	WOS:000515092200086
J	Kelm, M; Lehoux, S; Azcutia, V; Cummings, RD; Nusrat, A; Parkos, CA; Brazil, JC				Kelm, Matthias; Lehoux, Sylvain; Azcutia, Veronica; Cummings, Richard D.; Nusrat, Asma; Parkos, Charles A.; Brazil, Jennifer C.			Regulation of neutrophil function by selective targeting of glycan epitopes expressed on the integrin CD11b/CD18	FASEB JOURNAL			English	Article						colitis; glycans; inflammation; neutrophil	MANNOSE TYPE OLIGOSACCHARIDE; INTESTINAL EPITHELIUM; TYROSINE KINASE; PEANUT LECTIN; SIALYL-LEWIS; ADHESION; BINDING; MAC-1; APOPTOSIS; PHAGOCYTOSIS	Polymorphonuclear neutrophils (PMNs) play a critical role in the innate immune response to invading pathogens. However, dysregulated mucosal trafficking of PMNs and associated epithelial tissue damage is a pathological hallmark of numerous inflammatory conditions including inflammatory bowel disease. The glycoprotein CD11b/CD18 plays a well-described role in regulating PMN transepithelial migration and PMN inflammatory functions. Previous studies have demonstrated that targeting of the N-linked glycan Lewis X on CD11b blocks PMN transepithelial migration (TEpM). Given evidence of glycosylation-dependent regulation of CD11b/CD18 function, we performed MALDI TOF Mass Spectrometry (MS) analyses on CD11b/CD18 purified from human PMNs. Unusual glycan epitopes identified on CD11b/CD18 included high Mannose oligosaccharides recognized by the Galanthus Nivalis lectin and biantennary galactosylated N-glycans recognized by the Phaseolus Vulgaris erythroagglutinin lectin. Importantly, we show that selective targeting of glycans on CD11b with such lectins results in altered intracellular signaling events that inhibit TEpM and differentially affect key PMN inflammatory functions including phagocytosis, superoxide release and apoptosis. Taken together, these data demonstrate that discrete glycan motifs expressed on CD11b/CD18 such as biantennary galactose could represent novel targets for selective manipulation of CD11b function and reduction of PMN-associated tissue damage in chronic inflammatory diseases.	[Kelm, Matthias; Azcutia, Veronica; Nusrat, Asma; Parkos, Charles A.; Brazil, Jennifer C.] Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl,BSRB Rm 4620, Ann Arbor, MI 48109 USA; [Lehoux, Sylvain; Cummings, Richard D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brazil, JC (corresponding author), Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl,BSRB Rm 4620, Ann Arbor, MI 48109 USA.	brazilj@med.umich.edu	; Azcutia, Veronica/A-7704-2017	Brazil, Jennifer/0000-0002-5013-5291; Azcutia, Veronica/0000-0003-2160-5175	NIH [DK072564, DK079392, DK061379, DK59888, DK55679]; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation) [544596]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation (Crohn's & Colitis Foundation)	NIH, Grant/Award Number: DK072564, DK079392, DK061379, DK59888 and DK55679; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation), Grant/Award Number: SRA #544596	ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1985, FED PROC, V44, P2664; Balsam LB, 1998, J IMMUNOL, V160, P5058; BATEMAN J, 1993, CELL BIOCHEM FUNCT, V11, P87, DOI 10.1002/cbf.290110203; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Brazil JC, 2017, J LEUKOCYTE BIOL, V102, P753, DOI 10.1189/jlb.1MA0117-013R; Brazil JC, 2016, AM J PATHOL, V186, P297, DOI 10.1016/j.ajpath.2015.10.015; Brazil JC, 2013, J IMMUNOL, V191, P4804, DOI 10.4049/jimmunol.1301307; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Bressenot A, 2015, GUT, V64, P1412, DOI 10.1136/gutjnl-2014-307477; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; CLARK MA, 1995, CELL TISSUE RES, V282, P455, DOI 10.1007/BF00318877; Conejeros I, 2011, VET IMMUNOL IMMUNOP, V139, P308, DOI 10.1016/j.vetimm.2010.10.021; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dong GY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01088; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Girao DKFB, 2015, J MOL RECOGNIT, V28, P285, DOI 10.1002/jmr.2441; Flemming S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99722; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Futosi K, 2016, IMMUNOL REV, V273, P121, DOI 10.1111/imr.12455; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; HAJTO T, 1989, CANCER RES, V49, P4803; Hsu MJ, 2003, BRIT J PHARMACOL, V139, P289, DOI 10.1038/sj.bjp.0705243; Jondle CN, 2016, J IMMUNOL, V196, P3088, DOI 10.4049/jimmunol.1501790; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karlsson A, 1999, INFECT IMMUN, V67, P3461, DOI 10.1128/IAI.67.7.3461-3468.1999; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; KUEHN C, 1980, INFECT IMMUN, V29, P600; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin J, 2017, INT IMMUNOPHARMACOL, V52, P101, DOI 10.1016/j.intimp.2017.08.006; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Liu Y, 2004, J IMMUNOL, V172, P2578, DOI 10.4049/jimmunol.172.4.2578; LOCK R, 1988, ANAL BIOCHEM, V173, P450, DOI 10.1016/0003-2697(88)90213-8; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McEver RP, 1997, J CLIN INVEST, V100, pS97; MILLER LJ, 1987, J IMMUNOL, V139, P842; MILLER LJ, 1987, J IMMUNOL, V138, P2381; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Morishima S, 2003, J ENDOCRINOL, V176, P285, DOI 10.1677/joe.0.1760285; Nagae M, 2014, GLYCOBIOLOGY, V24, P368, DOI 10.1093/glycob/cwu004; Oki T, 1999, J ANTIBIOT, V52, P449, DOI 10.7164/antibiotics.52.449; PARKOS CA, 1995, AM J PHYSIOL-CELL PH, V268, pC472, DOI 10.1152/ajpcell.1995.268.2.C472; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; RYDER SD, 1994, GASTROENTEROLOGY, V106, P117, DOI 10.1016/S0016-5085(94)94775-9; SASTRE L, 1986, J IMMUNOL, V137, P1060; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schymeinsky J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001132; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sheth K, 2001, SURGERY, V130, P242, DOI 10.1067/msy.2001.115902; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; SPRINGER TA, 1985, NATURE, V314, P540, DOI 10.1038/314540a0; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Thornton BP, 1996, J IMMUNOL, V156, P1235; Tsikitis VL, 2004, SURGERY, V136, P384, DOI 10.1016/j.surg.2004.05.014; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang Q, 1998, LANCET, V352, P1831, DOI 10.1016/S0140-6736(05)79894-9; Wang X, 2017, P NATL ACAD SCI USA, V114, P4483, DOI 10.1073/pnas.1616752114; Watanabe K, 1997, J CLIN PERIODONTOL, V24, P814, DOI 10.1111/j.1600-051X.1997.tb01195.x; Werner Lael, 2013, J Crohns Colitis, V7, pe522, DOI 10.1016/j.crohns.2013.03.009; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270; Zerfaoui M, 2000, EUR J BIOCHEM, V267, P53, DOI 10.1046/j.1432-1327.2000.00958.x; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	83	14	16	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2326	2343		10.1096/fj.201902542R	http://dx.doi.org/10.1096/fj.201902542R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907993	Green Accepted			2022-12-26	WOS:000504094800001
J	Wu, ZY; Liu, H; Xu, LS; Chen, HF; Feng, Y				Wu, Zhiyun; Liu, Hao; Xu, Lishi; Chen, Hai-Feng; Feng, Yan			Algorithm-based coevolution network identification reveals key functional residues of the alpha/beta hydrolase subfamilies	FASEB JOURNAL			English	Article						algorithm optimization; enzyme; mutant library; protein engineering; statistical coupling analysis	ANTARCTICA LIPASE-B; CANDIDA-ANTARCTICA; MOLECULAR-DYNAMICS; INACTIVATION; RESOLUTION; EVOLUTION; SEQUENCE; MOTIONS; DESIGN; SITE	Covariant residues identified by computational algorithms have provided new insights into enzyme evolutionary routes. However, the reliability and accuracy of routine statistical coupling analysis (SCA) are unable to satisfy the needs of protein engineering because SCA depends only on sequence information. Here, we set up a new SCA algorithm, SCA.SIM, by integrating structure information and MD simulation data. The more reliable covariant residues with high-quality scores are obtained from sequence alignment weighted by residual movement for eight related subfamilies, belonging to alpha/beta hydrolase family, with Candida antarctica lipase B (CALB). The 38 predicted covariant residues are tested for function by high-throughput quantitative evaluation in combination with activity and thermostability assays of a mutant library and deep sequencing. Based on the landscapes of both activity and thermostability, most mutants play key roles in catalysis, and some mutants gain 2.4- to 6-fold increase in half-life at 50 degrees C and 9- to 12-fold improvement in catalytic efficiency. The activity of double mutants for A225F/T103A is higher than those of A225F and T103A which means that SCA.SIM method might be useful for identifying the allosteric coupling. The SCA.SIM algorithm can be used for protein coevolution and enzyme engineering research.	[Wu, Zhiyun; Liu, Hao; Xu, Lishi; Chen, Hai-Feng; Feng, Yan] Shanghai Jiao Tong Univ, Natl Expt Teaching Ctr Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, State Key Lab Microbial Metab,Sch Life Sci & Biot, Shanghai 200240, Peoples R China; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Chen, HF; Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Natl Expt Teaching Ctr Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, State Key Lab Microbial Metab,Sch Life Sci & Biot, Shanghai 200240, Peoples R China.	haifengchen@sjtu.edu.cn; haifengchen@sjtu.edu.cn	Liu, Hao/AAJ-4404-2021; Chen, Haifeng/AAT-7444-2020	Liu, Hao/0000-0003-0994-6284; 	National Natural Science Foundation of China (NSFC) [31770771, 31620103901]; Research and Development [31770771, 31620103901, 2017YFE0103300, YG2017MS08]; Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research and Development; Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31770771 and 31620103901; Research and Development, Grant/Award Number: 2017YFE0103300, 31770771, 31620103901 and YG2017MS08; Shanghai Jiao Tong University	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; Anishchenko I, 2017, P NATL ACAD SCI USA, V114, P9122, DOI 10.1073/pnas.1702664114; Bai F, 2016, P NATL ACAD SCI USA, V113, pE8051, DOI 10.1073/pnas.1615932113; Case D., 2015, AMBER, V14; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Engstrom K, 2011, ORG BIOMOL CHEM, V9, P81, DOI 10.1039/c0ob00748j; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fuentes G, 2004, PROTEIN SCI, V13, P3092, DOI 10.1110/ps.04724504; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hamberg A, 2012, CHEM COMMUN, V48, P10013, DOI 10.1039/c2cc34684b; Hong SY, 2013, APPL BIOCHEM BIOTECH, V170, P925, DOI 10.1007/s12010-013-0237-8; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Irani M, 2013, BIOCHEMISTRY-US, V52, P1280, DOI 10.1021/bi301298m; Jacob E, 2015, ELIFE, V4, DOI 10.7554/eLife.08932; Juhl PB, 2010, J BIOTECHNOL, V150, P474, DOI 10.1016/j.jbiotec.2010.09.951; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Linder M, 2011, J MOL MODEL, V17, P833, DOI 10.1007/s00894-010-0775-8; Liu DN, 2010, CHEMBIOCHEM, V11, P789, DOI 10.1002/cbic.200900776; Liu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24117; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Park CG, 2011, BIOTECHNOL PROGR, V27, P47, DOI 10.1002/btpr.532; Park HJ, 2013, J BIOTECHNOL, V163, P346, DOI 10.1016/j.jbiotec.2012.11.006; Peng XQ, 2013, APPL BIOCHEM BIOTECH, V169, P351, DOI 10.1007/s12010-012-9954-7; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rotticci D, 2001, CHEMBIOCHEM, V2, P766, DOI 10.1002/1439-7633(20011001)2:10<766::AID-CBIC766>3.0.CO;2-K; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salinas VH, 2018, ELIFE, V7, DOI 10.7554/eLife.34300; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stone J., 2012, DYNAMICAL NETWORK AN; Sun ZT, 2019, CHEM REV, V119, P1626, DOI 10.1021/acs.chemrev.8b00290; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Tanino T, 2007, APPL MICROBIOL BIOT, V75, P1319, DOI 10.1007/s00253-007-0959-z; Tosco P, 2011, J MOL MODEL, V17, P201, DOI 10.1007/s00894-010-0684-x; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Vallin M, 2010, CHEMBIOCHEM, V11, P411, DOI 10.1002/cbic.200900635; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wu Q, 2013, J AM CHEM SOC, V135, P1872, DOI 10.1021/ja310455t; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074	57	3	4	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1983	1995		10.1096/fj.201900948RR	http://dx.doi.org/10.1096/fj.201900948RR		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907985	Bronze			2022-12-26	WOS:000504091600001
